<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>CEREB Biochemistry - Combined Tests</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
</style>
  <style>
  body {
    font-family: Arial, sans-serif;
    padding: 0;
    margin: 0;
  }

  button {
    margin: 5px;
    padding: 10px 15px;
    background: #ffffff;
    border: 1px solid #2d3748;
    border-radius: 4px;
    cursor: pointer;
    color: #000000;
    position: relative;
    top: 5px;
    font-size: 14px;
    transition: background 0.2s ease, color 0.2s ease, transform 0.1s ease;
  }

  button:hover {
    background: #f3f4f6;
    color: #000000;
    transform: translateY(-1px);
  }

  body, html {
            margin: 0;
            padding: 0;
            height: 100%;
            overflow: hidden;
        }
        .iframe-container {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            overflow: auto;
            -webkit-overflow-scrolling: touch;
        }
        .iframe-container iframe {
            width: 100%;
            height: 100%;
            border: none;
            display: block;
        }
    
    /* Mobile optimization */
    

  /* Dropdown styling */
  .dropdown-wrapper {
    position: absolute;
    top: 20px;
    right: 20px;
    z-index: 1100;
  }

  .dropdown-toggle {
    background: #2c5281;
    color: white;
    border: none;
    font-size: 14px;
    padding: 10px 18px;
    border-radius: 6px;
    font-weight: bold;
    letter-spacing: 0.5px;
  }

  .dropdown-toggle:hover {
    background: #24466c;
  }

  .dropdown-menu {
  display: none;
  position: absolute;
  right: 0;              /* keep aligned to right edge of toggle */
  margin-top: 6px;
  background: white;
  border: 1px solid #cbd5e0;
  border-radius: 8px;
  max-height: 350px;
  overflow-y: auto;
  box-shadow: 0 6px 16px rgba(0, 0, 0, 0.15);
  min-width: 250px;
  max-width: 90vw;       /* prevent it from going outside screen */
  word-wrap: break-word; /* wrap long names */
  white-space: normal;   /* allow text to wrap */
  animation: fadeIn 0.2s ease-in-out;
}

.dropdown-menu button {
  display: block;
  width: 100%;
  text-align: left;
  margin: 0;
  padding: 10px 15px;
  border-radius: 0;
  background: transparent;
  color: #2d3748;
  border: none;
  border-bottom: 1px solid #edf2f7;
  font-size: 13px;
  white-space: normal;   /* allow wrapping inside button */
  word-break: break-word;
}


  img {
    max-width: 100%;
    max-height: 400px;
    width: auto;
    height: auto;
    display: block;
    margin: 10px auto;
  }

  body > section:last-child {
    margin-bottom: 0 !important;
  }
  
</style>
  <script>
  function showTest(id) {
    document.querySelectorAll('.iframe-container').forEach(div => div.style.display = 'none');
    document.getElementById(id).style.display = 'block';
    document.getElementById('dropdownMenu').style.display = 'none';
    window.scrollTo(0, 0);
  }

  function toggleDropdown() {
    const menu = document.getElementById('dropdownMenu');
    menu.style.display = menu.style.display === 'block' ? 'none' : 'block';
  }

  document.addEventListener('click', function (event) {
    const toggle = document.getElementById('dropdownToggle');
    const menu = document.getElementById('dropdownMenu');
    if (!toggle.contains(event.target) && !menu.contains(event.target)) {
      menu.style.display = 'none';
    }
  });
</script>
<script src="../../../access-control.js"></script>
  <script src="../../../block.js"></script>
  <script src="../../../error-handler/link-checker.js"></script>
  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5920367457745298"
     crossorigin="anonymous"></script>
</head>
<body>
<script>
      // Initialize access control for protected page
      if (!accessControl.initProtectedPage()) {
        throw new Error('Access denied - redirecting to index.html');
      }
    </script>
  <button onclick="history.back()" style="position: absolute; top: 20px; left: 20px; background: transparent; color: white; border: none; padding: 10px; cursor: pointer; z-index: 1001; font-size: 20px;">
  <i class="fas fa-arrow-left"></i>
</button>

<div class="dropdown-wrapper">
  <button class="dropdown-toggle" id="dropdownToggle" onclick="toggleDropdown()">â˜° INDEX</button>
  <div class="dropdown-menu" id="dropdownMenu">
<button onclick="showTest('test1')">Amino Acids</button>
<button onclick="showTest('test2')">Carbohydrate Chemistry</button>
<button onclick="showTest('test3')">Carbohydrate Metabolism</button>
<button onclick="showTest('test4')">Concepts</button>
<button onclick="showTest('test5')">Enzymes</button>
<button onclick="showTest('test6')">Genetics _ Molecular Biology</button>
<button onclick="showTest('test7')">Lipids</button>
<button onclick="showTest('test8')">Miscellaneous</button>
<button onclick="showTest('test9')">Proteins</button>
</div>
  </div>
  
<div id="test1" class="iframe-container" style="display:block;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Amino Acids&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Amino Acids&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                65 Questions | 260 Total Marks | 75 min Duration | ~69.23 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Match the following metabolic disorders with their corresponding enzyme defect or deficiency:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a, 4-d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1-b, 2-a, 3-d, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-173851.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-104916.jpeg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-175323.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 211, 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 211, 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician is evaluating a newborn for potential metabolic disorders due to some concerning symptoms. Given the suspicion of phenylketonuria (PKU) among other metabolic conditions, the pediatrician considers the most effective screening method to identify such diseases in their early stages. Which screening test is considered the gold standard for detecting PKU and similar metabolic disorders in newborns?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Western blot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FISH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tandem Mass spectrometry&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tandem Mass spectrometry&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Western blot: Incorrect, as it&#x27;s primarily used for protein analysis and not typically for newborn metabolic screening.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Western blot:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Electrophoresis: Incorrect, while it can separate molecules based on size and charge, it&#x27;s not as comprehensive or specific for metabolic disorders as tandem mass spectrometry.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Electrophoresis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FISH (Fluorescence In Situ Hybridization): Incorrect, as FISH is mainly used for detecting chromosomal abnormalities and gene mapping, not for screening metabolic disorders like PKU.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. FISH (Fluorescence In Situ Hybridization):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tandem Mass Spectrometry (MS/MS) is widely used in newborn screening programs for the detection of various metabolic disorders, including phenylketonuria (PKU). This method allows for the simultaneous screening of multiple disorders by analyzing patterns of specific metabolites in a small blood sample, usually obtained via heel prick in newborns. Its sensitivity and specificity make it an ideal choice for early detection.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e :p 427&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e :p 427&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a routine neonatal examination, a newborn girl is noted to have blue eyes, blond hair, and fair skin. A Guthrie test is performed, yielding positive results. Among the following statements related to this case, which one is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Due to deficiency of enzyme Phenylalanine Hydroxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mental retardation is a potential complication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of a white patch of hair is due to a deficiency in tryptophan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenylacetate is found in the urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of a white patch of hair is due to a deficiency in tryptophan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Presence of a white patch of hair is due to a deficiency in tryptophan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phenylketonuria results from phenylalanine hydroxylase deficiency, causing elevated phenylalanine levels and reduced tyrosine. The hypopigmentation seen in PKU patients is due to impaired melanin synthesis from reduced tyrosine availabilityâ€”not from tryptophan deficiency. Early detection through newborn screening and prompt dietary management are essential to prevent the neurological sequelae of this inborn error of metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 304-306&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-year-old boy is evaluated for severe mental retardation and recurrent seizures. His blood ammonia levels are normal, and there is no acidosis. Non-ketotic hyperglycinemia is diagnosed based on an elevated CSF/blood glycine ratio. Which of the following statements is false regarding this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Defect of glycine cleavage complex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Effective management is available&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Also known as glycine encephalopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Accumulation of neurotoxic intermediates are seen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Effective management is available&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Defect of glycine cleavage complex: True , this is the underlying defect in non-ketotic hyperglycinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Defect of glycine cleavage complex:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Option C. Also known as glycine encephalopathy: True , this is another name for non-ketotic hyperglycinemia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Also known as glycine encephalopathy:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Option D. Accumulation of neurotoxic intermediates are seen: True , the accumulation of glycine and related compounds can lead to neurotoxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Accumulation of neurotoxic intermediates are seen:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-ketotic hyperglycinemia , also known as glycine encephalopathy , is a rare genetic disorder caused by a defect in the glycine cleavage enzyme complex , leading to an accumulation of glycine and its neurotoxic intermediates . Unfortunately, effective management options are limited, and the disease often results in severe neurological deficits.&lt;/li&gt;&lt;li&gt;âž¤ Non-ketotic hyperglycinemia&lt;/li&gt;&lt;li&gt;âž¤ glycine encephalopathy&lt;/li&gt;&lt;li&gt;âž¤ rare genetic disorder&lt;/li&gt;&lt;li&gt;âž¤ defect in the glycine cleavage enzyme complex&lt;/li&gt;&lt;li&gt;âž¤ accumulation of glycine&lt;/li&gt;&lt;li&gt;âž¤ neurotoxic intermediates&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 301, Vasudevan 9/ed: p 213.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 301, Vasudevan 9/ed: p 213.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old researcher is studying the antioxidant defense mechanisms in the human body and is particularly interested in the role of glutathione. While reviewing the literature, he encounters various functions and characteristics of glutathione but finds conflicting information regarding one of its roles. Based on your knowledge, which of the following statements about glutathione (GSH) is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is tripeptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It converts hemoglobin to methaemoglobin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It conjugates xenobiotics (phase II)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is a cofactor of various enzymes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It converts hemoglobin to methaemoglobin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. True, as glutathione is composed of three amino acids: glutamate, cysteine, and glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. True, as glutathione is composed of three amino acids:&lt;/li&gt;&lt;li&gt;â€¢ Option C. True , glutathione plays a significant role in the detoxification process by conjugating with various xenobiotics, aiding in their excretion from the body.&lt;/li&gt;&lt;li&gt;â€¢ Option C. True&lt;/li&gt;&lt;li&gt;â€¢ Option D. True , glutathione acts as a cofactor for glutathione peroxidase and other enzymes involved in the reduction of peroxides and maintenance of redox status within cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. True&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ G lutathione does not convert haemoglobin to methaemoglobin . Methaemoglobin formation occurs when the iron in hemoglobin is oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state , which can happen through various mechanisms , but not directly due to glutathione. In fact, glutathione plays a role in reducing oxidative stress in cells and can help to protect against the oxidation of hemoglobin.&lt;/li&gt;&lt;li&gt;âž¤ G&lt;/li&gt;&lt;li&gt;âž¤ lutathione&lt;/li&gt;&lt;li&gt;âž¤ not convert haemoglobin&lt;/li&gt;&lt;li&gt;âž¤ methaemoglobin&lt;/li&gt;&lt;li&gt;âž¤ Methaemoglobin formation&lt;/li&gt;&lt;li&gt;âž¤ iron in hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ oxidized from the ferrous&lt;/li&gt;&lt;li&gt;âž¤ ferric&lt;/li&gt;&lt;li&gt;âž¤ state&lt;/li&gt;&lt;li&gt;âž¤ various mechanisms&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 272-273.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 272-273.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old woman presents to the outpatient department with a constellation of symptoms including flushing, a non-healing ulcer, diarrhea, and episodes of bronchospasm. Laboratory investigations reveal elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA) in her blood. Based on these findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucagonoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carcinoid syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Carcinoid syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A Glucagonoma: Is a rare tumour of pancreatic alpha cells , resulting in overproduction of glucagon . It is associated with necrolytic migratory erythema, weight loss and diabetes mellitus.&lt;/li&gt;&lt;li&gt;â€¢ Option A Glucagonoma:&lt;/li&gt;&lt;li&gt;â€¢ rare tumour of pancreatic alpha cells&lt;/li&gt;&lt;li&gt;â€¢ overproduction of glucagon&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastrinoma: Is a gastrin secreting tumour of pancreas resulting in Zollinger-Ellison syndrome , where there is no feedback regulation of gastrin secretion causing very high level of gastric acid output along with high serum gastrin levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastrinoma:&lt;/li&gt;&lt;li&gt;â€¢ gastrin secreting tumour&lt;/li&gt;&lt;li&gt;â€¢ pancreas&lt;/li&gt;&lt;li&gt;â€¢ Zollinger-Ellison syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulinoma: Is an Insulin secreting tumours characterized by constant high production of insulin (C-peptide) and decreased blood glucose by the tumour cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulinoma:&lt;/li&gt;&lt;li&gt;â€¢ Insulin secreting tumours&lt;/li&gt;&lt;li&gt;â€¢ constant high production of insulin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carcinoid syndrome is characterized by a set of symptoms that include flushing, diarrhea, bronchospasm , and, in some cases, heart valve lesions . These symptoms are caused by the overproduction of serotonin by carcinoid tumors , most commonly originating in the gastrointestinal tract or lungs . Elevated levels of 5-Hydroxyindoleacetic Acid (5-HIAA), a metabolite of serotonin , in the urine or blood are a hallmark finding in carcinoid syndrome and support this diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ Carcinoid syndrome&lt;/li&gt;&lt;li&gt;âž¤ set of symptoms&lt;/li&gt;&lt;li&gt;âž¤ flushing, diarrhea, bronchospasm&lt;/li&gt;&lt;li&gt;âž¤ heart valve lesions&lt;/li&gt;&lt;li&gt;âž¤ overproduction of serotonin by carcinoid tumors&lt;/li&gt;&lt;li&gt;âž¤ originating in the gastrointestinal tract or lungs&lt;/li&gt;&lt;li&gt;âž¤ Elevated levels of 5-Hydroxyindoleacetic Acid&lt;/li&gt;&lt;li&gt;âž¤ metabolite of serotonin&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ carcinoid syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: pg 557, DM Vasudevan  9/e: p 241-242&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old girl presents with progressive involuntary movements in her right hand and visual difficulties noted over the past year. Blood work reveals elevated serum homocysteine with normal liver, renal, thyroid function tests, and electrolytes. She responds favorably to high-dose pyridoxine and a methionine-restricted diet, with a noted improvement in dystonic movements after three months. What condition is most likely affecting this child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hartnupâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Classical Homocystinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystathioninuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Classical Homocystinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hartnupâ€™s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules â†’excretion of amino acids in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hartnupâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ defective absorption of aromatic amino acids&lt;/li&gt;&lt;li&gt;â€¢ intestine&lt;/li&gt;&lt;li&gt;â€¢ reabsorption from renal tubules&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystinuria: Due to defect/deficiency of transporter system â†’patients cannot reabsorb cysteine into their bloodstream â†’accumulation of cystine in urine forms stones â†’leads to recurrent nephrolithiasis, obstruction, and finally renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystinuria:&lt;/li&gt;&lt;li&gt;â€¢ defect/deficiency of transporter system&lt;/li&gt;&lt;li&gt;â€¢ bloodstream&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria: Due to cystathionase deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria:&lt;/li&gt;&lt;li&gt;â€¢ cystathionase deficiency&lt;/li&gt;&lt;li&gt;â€¢ mental retardation, anemia, thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ endocrinopathies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Classical homocystinuria is often due to a deficiency in the enzyme cystathionine Î²-synthase, leading to elevated homocysteine levels . Treatment with high-dose pyridoxine (vitamin B6), a cofactor for the enzyme , can improve symptoms , and a methionine-restricted diet can help manage homocysteine levels . The improvement in dystonia with treatment supports this diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ Classical homocystinuria&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme cystathionine Î²-synthase,&lt;/li&gt;&lt;li&gt;âž¤ elevated homocysteine levels&lt;/li&gt;&lt;li&gt;âž¤ high-dose pyridoxine&lt;/li&gt;&lt;li&gt;âž¤ cofactor for the enzyme&lt;/li&gt;&lt;li&gt;âž¤ improve symptoms&lt;/li&gt;&lt;li&gt;âž¤ methionine-restricted diet&lt;/li&gt;&lt;li&gt;âž¤ manage homocysteine levels&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with a diet lacking in fresh produce presents with recurrent infections and bruising. Considering her dietary insufficiency and clinical signs of compromised antioxidant defense, which set of amino acids is essential for the synthesis of the key antioxidant, glutathione?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutamic acid, cystine, cysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamic acid, alanine, glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glutamic acid, cysteine, glycine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glutamic acid, cysteine, valine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glutamic acid, cysteine, glycine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutamic acid, cystine, cysteine : Cystine is the oxidized dimer form of cysteine , and while it can be converted back to cysteine in the body , cystine itself is not directly used in glutathione synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutamic acid, cystine, cysteine&lt;/li&gt;&lt;li&gt;â€¢ Cystine&lt;/li&gt;&lt;li&gt;â€¢ oxidized dimer form of cysteine&lt;/li&gt;&lt;li&gt;â€¢ converted back to cysteine in the body&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamic acid, alanine, glycine : Alanine is not a component of glutathione .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamic acid, alanine, glycine&lt;/li&gt;&lt;li&gt;â€¢ Alanine&lt;/li&gt;&lt;li&gt;â€¢ not a component&lt;/li&gt;&lt;li&gt;â€¢ glutathione&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glutamic acid, cysteine, valine : Valine is a branched-chain amino acid that is not involved in the synthesis of glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glutamic acid, cysteine, valine&lt;/li&gt;&lt;li&gt;â€¢ Valine&lt;/li&gt;&lt;li&gt;â€¢ branched-chain amino acid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Gamma glutamyl cysteinyl glycine ( Tripeptide : - SH group of cysteine is active part / reducing agent of GSH) reduction of methemoglobin (Fe 3+) to normal Hb (Fe 2+) It is involved in erythrocyte membrane integrity and in keeping enzymes in active state .&lt;/li&gt;&lt;li&gt;âž¤ Gamma glutamyl cysteinyl glycine ( Tripeptide : - SH group of cysteine is active part / reducing agent of GSH) reduction of methemoglobin (Fe 3+) to normal Hb (Fe 2+)&lt;/li&gt;&lt;li&gt;âž¤ Gamma glutamyl cysteinyl glycine&lt;/li&gt;&lt;li&gt;âž¤ Tripeptide&lt;/li&gt;&lt;li&gt;âž¤ reduction&lt;/li&gt;&lt;li&gt;âž¤ methemoglobin&lt;/li&gt;&lt;li&gt;âž¤ It is involved in erythrocyte membrane integrity and in keeping enzymes in active state .&lt;/li&gt;&lt;li&gt;âž¤ involved in erythrocyte membrane integrity&lt;/li&gt;&lt;li&gt;âž¤ keeping enzymes in active state&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 44, 198.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 44, 198.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young girl presenting in the OPD is notably tall and thin, with slender fingers and dislocated lenses. Further investigation reveals a deficiency in cystathionine beta synthase. To manage her condition, which amino acid should be supplemented?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cysteine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cysteine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-172139_ub3dGS8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cysteine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methionine: Incorrect, as supplementation could exacerbate the condition due to an already existing accumulation of homocysteine and methionine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Methionine:&lt;/li&gt;&lt;li&gt;â€¢ supplementation&lt;/li&gt;&lt;li&gt;â€¢ exacerbate the condition&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serine: Incorrect, while serine is involved in one-carbon metabolism , it is not the primary amino acid affected in homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Serine:&lt;/li&gt;&lt;li&gt;â€¢ one-carbon metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tyrosine: Incorrect, as it is not directly involved in the metabolic pathway affected by cystathionine beta synthase deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Tyrosine:&lt;/li&gt;&lt;li&gt;â€¢ not directly involved in the metabolic pathway&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cystathionine beta synthase deficiency leads to classical homocystinuria , characterized by an inability to convert homocysteine to cystathionine , resulting in low levels of cysteine. Supplementing cysteine can help compensate for this deficiency and mitigate some of the disorder&#x27;s metabolic effects.&lt;/li&gt;&lt;li&gt;âž¤ Cystathionine beta synthase deficiency&lt;/li&gt;&lt;li&gt;âž¤ classical homocystinuria&lt;/li&gt;&lt;li&gt;âž¤ inability to convert homocysteine&lt;/li&gt;&lt;li&gt;âž¤ cystathionine&lt;/li&gt;&lt;li&gt;âž¤ low levels of cysteine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical seminar focused on oxidative stress and cellular antioxidants, a biochemistry professor discusses the biochemical properties that enable glutathione to act as a potent antioxidant. One medical student asks about the specific functional group in glutathione that is primarily responsible for its antioxidant activity. Which of the following is the correct answer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydroxyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sulfhydryl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carboxyl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Guanidino&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sulfhydryl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture2_Hnk9zNj.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hydroxyl: Incorrect, as the hydroxyl group is not the primary reactive group in glutathione involved in antioxidant activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Hydroxyl:&lt;/li&gt;&lt;li&gt;â€¢ hydroxyl group&lt;/li&gt;&lt;li&gt;â€¢ not the primary reactive group&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carboxyl: Incorrect, the carboxyl group is a common functional group in many biomolecules but not the key reactive group in glutathione for its antioxidant function.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Carboxyl:&lt;/li&gt;&lt;li&gt;â€¢ carboxyl group&lt;/li&gt;&lt;li&gt;â€¢ common functional group&lt;/li&gt;&lt;li&gt;â€¢ biomolecules&lt;/li&gt;&lt;li&gt;â€¢ Option D. Guanidino: Incorrect, the guanidino group is found in arginine and is not involved in the antioxidant activity of glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Guanidino:&lt;/li&gt;&lt;li&gt;â€¢ guanidino group&lt;/li&gt;&lt;li&gt;â€¢ found in arginine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The sulfhydryl (-SH) group in glutathione is crucial for its role as an antioxidant. This group, found in the cysteine residue of glutathione, is highly reactive and can donate a hydrogen atom to neutralize free radicals , making it essential for reducing oxidative stress in cells.&lt;/li&gt;&lt;li&gt;âž¤ sulfhydryl&lt;/li&gt;&lt;li&gt;âž¤ group&lt;/li&gt;&lt;li&gt;âž¤ glutathione&lt;/li&gt;&lt;li&gt;âž¤ role as an antioxidant.&lt;/li&gt;&lt;li&gt;âž¤ found in the cysteine residue&lt;/li&gt;&lt;li&gt;âž¤ glutathione,&lt;/li&gt;&lt;li&gt;âž¤ highly reactive&lt;/li&gt;&lt;li&gt;âž¤ donate a hydrogen atom&lt;/li&gt;&lt;li&gt;âž¤ neutralize free radicals&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 133,212,217,218.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 133,212,217,218.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about glycine is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycine is an essential amino acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sulphur present at 4 th position&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Has a guanidine group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Optically inactive&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Optically inactive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Optically inactive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glycine is not an essential amino acid; the human body can synthesize it.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Glycine&lt;/li&gt;&lt;li&gt;â€¢ not an essential amino acid;&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sulfur at the 4th position describes certain other amino acids like cysteine , but not glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Sulfur&lt;/li&gt;&lt;li&gt;â€¢ 4th position&lt;/li&gt;&lt;li&gt;â€¢ amino acids like cysteine&lt;/li&gt;&lt;li&gt;â€¢ Option C. A guanidine group is characteristic of arginine, not glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ guanidine group&lt;/li&gt;&lt;li&gt;â€¢ arginine,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycine is unique among amino acids because it has a hydrogen atom as its side chain , making it the simplest amino acid. This simplicity leads to its lack of a chiral centre , rendering it optically inactive , unlike most other amino acids that are optically active due to the presence of a chiral carbon atom.&lt;/li&gt;&lt;li&gt;âž¤ Glycine&lt;/li&gt;&lt;li&gt;âž¤ unique among amino acids&lt;/li&gt;&lt;li&gt;âž¤ hydrogen atom as its side chain&lt;/li&gt;&lt;li&gt;âž¤ simplest amino acid.&lt;/li&gt;&lt;li&gt;âž¤ simplicity leads&lt;/li&gt;&lt;li&gt;âž¤ lack of a chiral centre&lt;/li&gt;&lt;li&gt;âž¤ rendering&lt;/li&gt;&lt;li&gt;âž¤ optically inactive&lt;/li&gt;&lt;li&gt;âž¤ amino acids that are optically active&lt;/li&gt;&lt;li&gt;âž¤ presence of a chiral carbon atom.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p19.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p19.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a history of myocardial infarctions and cerebrovascular accidents presents for a follow-up. His laboratory results indicate elevated homocysteine levels, which decrease following treatment with pharmacological doses of pyridoxamine. Considering the effect of pyridoxamine on homocysteine levels, which enzyme&#x27;s activity is most likely enhanced by this treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methionine synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;N5, N10 methylenetetrahydrofolate reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cystathionine Î²-synthase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystathionase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cystathionine Î²-synthase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methionine synthase: Defect in methionine synthase will cause elevated homocysteine levels and it requires B 12 not B 6 .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methionine synthase:&lt;/li&gt;&lt;li&gt;â€¢ Defect&lt;/li&gt;&lt;li&gt;â€¢ methionine synthase&lt;/li&gt;&lt;li&gt;â€¢ elevated homocysteine levels&lt;/li&gt;&lt;li&gt;â€¢ B 12 not B 6 .&lt;/li&gt;&lt;li&gt;â€¢ Option B. N5, N10 methylenetetrahydrofolate reductase: A defect in this enzyme leads to elevated homocysteine but that enzyme has a requirement for NADH not vitamin B 6.&lt;/li&gt;&lt;li&gt;â€¢ Option B. N5, N10 methylenetetrahydrofolate reductase:&lt;/li&gt;&lt;li&gt;â€¢ defect in this enzyme&lt;/li&gt;&lt;li&gt;â€¢ elevated homocysteine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathionase: A defect in cystathionase (another B 6 requiring enzyme) will block the degradation of cystathionine â†’ accumulation of the same but will not lead to significantly elevated homocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathionase:&lt;/li&gt;&lt;li&gt;â€¢ defect in cystathionase&lt;/li&gt;&lt;li&gt;â€¢ block the degradation of cystathionine&lt;/li&gt;&lt;li&gt;â€¢ accumulation of the same&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyridoxamine, a form of vitamin B6 , serves as a cofactor for cystathionine Î²-synthase , an enzyme involved in the transsulfuration pathway that converts homocysteine to cystathionine . Supplementation with pyridoxamine can enhance the activity of this enzyme , thereby reducing homocysteine levels in the blood .&lt;/li&gt;&lt;li&gt;âž¤ Pyridoxamine,&lt;/li&gt;&lt;li&gt;âž¤ form of vitamin B6&lt;/li&gt;&lt;li&gt;âž¤ cofactor for cystathionine Î²-synthase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ transsulfuration pathway&lt;/li&gt;&lt;li&gt;âž¤ converts homocysteine&lt;/li&gt;&lt;li&gt;âž¤ to cystathionine&lt;/li&gt;&lt;li&gt;âž¤ Supplementation&lt;/li&gt;&lt;li&gt;âž¤ pyridoxamine&lt;/li&gt;&lt;li&gt;âž¤ enhance the activity&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ reducing homocysteine levels in the blood&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old male is brought to the emergency department with acute left flank pain extending to the pubic area. He has reddish-brown urine, and urinalysis reveals numerous red blood cells. Upon acidifying his urine with acetic acid, flat, hexagonal transparent crystals are observed. Abdominal X-ray shows radiopaque stones in both kidneys, and a passed stone is predominantly composed of cysteine. Based on this presentation, which of the following is the most appropriate treatment suggestion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased ethanol consumption&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restriction of dietary methionine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Utilize drugs that acidify the urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrict dietary glycine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Restriction of dietary methionine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increasing ethanol content causes dehydration , which will increase the concentration of cysteine in the urine, leading to increased precipitation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Increasing ethanol&lt;/li&gt;&lt;li&gt;â€¢ dehydration&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acidification also reduces the solubility of the cysteine stones, alkalinization of urine is usually recommended to increase cystine solubility.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Acidification&lt;/li&gt;&lt;li&gt;â€¢ reduces the solubility&lt;/li&gt;&lt;li&gt;â€¢ cysteine stones, alkalinization&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Restricting glycine is not effective, as glycine is not a precursor of cysteine biosynthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Restricting glycine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cystinuria - a genetic condition characterized by the excessive excretion of cystine in the urine, leading to stone formation. Cysteine is a product of methionine metabolism ; thus, restricting dietary methionine can help reduce cystine levels in the urine and prevent further stone formation.&lt;/li&gt;&lt;li&gt;âž¤ Cystinuria&lt;/li&gt;&lt;li&gt;âž¤ genetic condition&lt;/li&gt;&lt;li&gt;âž¤ excessive excretion&lt;/li&gt;&lt;li&gt;âž¤ cystine in the urine,&lt;/li&gt;&lt;li&gt;âž¤ stone formation.&lt;/li&gt;&lt;li&gt;âž¤ Cysteine&lt;/li&gt;&lt;li&gt;âž¤ product of methionine metabolism&lt;/li&gt;&lt;li&gt;âž¤ restricting dietary methionine&lt;/li&gt;&lt;li&gt;âž¤ reduce cystine levels&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ stone formation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 219.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 219.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 13-year-old boy presents with flank pain and difficulty urinating. Kidney stone analysis reveals calcium oxalate composition. His parents have a history of similar issues. The accumulation of oxalate in this patient suggests a metabolic challenge with which of the following substances?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glyoxylate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glyoxylate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture3_7pTOWMv.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Glyoxylate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alanine: Incorrect, as alanine metabolism disruptions are not typically associated with oxalate stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Alanine:&lt;/li&gt;&lt;li&gt;â€¢ alanine metabolism disruptions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ oxalate stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leucine: Incorrect, as leucine metabolism defects are more commonly linked to maple syrup urine disease and not directly to oxalate stone formation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Leucine:&lt;/li&gt;&lt;li&gt;â€¢ leucine metabolism&lt;/li&gt;&lt;li&gt;â€¢ linked to maple syrup urine disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine: Incorrect, as lysine&#x27;s metabolic pathway does not directly result in oxalate accumulation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Lysine:&lt;/li&gt;&lt;li&gt;â€¢ lysine&#x27;s metabolic pathway&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Calcium oxalate stone formation can be linked to a disorder in glyoxylate metabolism . When glyoxylate is not properly metabolized, it can be converted to oxalate , which then combines with calcium to form calcium oxalate stones. This condition, often inherited, leads to recurrent stone formation and can be indicative of a primary hyperoxaluria type.&lt;/li&gt;&lt;li&gt;âž¤ Calcium oxalate stone formation&lt;/li&gt;&lt;li&gt;âž¤ linked to a disorder in glyoxylate metabolism&lt;/li&gt;&lt;li&gt;âž¤ glyoxylate&lt;/li&gt;&lt;li&gt;âž¤ not properly metabolized,&lt;/li&gt;&lt;li&gt;âž¤ converted to oxalate&lt;/li&gt;&lt;li&gt;âž¤ combines with calcium&lt;/li&gt;&lt;li&gt;âž¤ form calcium oxalate stones.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 213.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 213.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is pivotal in the glycine cleavage system found in liver mitochondria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycine Dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycine Transaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycine carboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycine Dehydratase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycine Dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Glycine Dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glycine Transaminase: Incorrect, as this enzyme is involved in the transamination reactions , not the cleavage of glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Glycine Transaminase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ transamination reactions&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glycine Carboxylase: Incorrect, as there is no enzyme specifically named glycine carboxylase involved in the glycine cleavage system.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Glycine Carboxylase:&lt;/li&gt;&lt;li&gt;â€¢ no enzyme&lt;/li&gt;&lt;li&gt;â€¢ glycine carboxylase&lt;/li&gt;&lt;li&gt;â€¢ glycine cleavage system.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine Dehydratase: Incorrect, as this name does not correspond to the primary enzyme in the glycine cleavage system.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Glycine Dehydratase:&lt;/li&gt;&lt;li&gt;â€¢ name does not correspond to the primary enzyme&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The glycine cleavage system , a complex enzyme system found in liver mitochondria and other tissues, primarily involves Glycine Dehydrogenase (also known as P protein). This enzyme plays a crucial role in the breakdown of glycine , facilitating its conversion into smaller molecules that can be used in various metabolic pathways .&lt;/li&gt;&lt;li&gt;âž¤ glycine cleavage system&lt;/li&gt;&lt;li&gt;âž¤ complex enzyme system&lt;/li&gt;&lt;li&gt;âž¤ liver mitochondria&lt;/li&gt;&lt;li&gt;âž¤ other tissues,&lt;/li&gt;&lt;li&gt;âž¤ Glycine Dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ crucial role in the breakdown of glycine&lt;/li&gt;&lt;li&gt;âž¤ facilitating its conversion&lt;/li&gt;&lt;li&gt;âž¤ smaller molecules&lt;/li&gt;&lt;li&gt;âž¤ various metabolic pathways&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p302.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p302.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a workshop on nutritional supplements and their therapeutic uses, a health coach discusses the benefits of N-acetyl cysteine (NAC) in supporting the body&#x27;s antioxidant systems. One attendee, a fitness enthusiast who&#x27;s keen on optimizing her recovery times and overall health through nutrition, inquires about the specific compound that NAC helps to replenish in the body, enhancing its antioxidant defenses. What should the health coach respond?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutathione&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glutamate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GABA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glutathione&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Glutathione&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glycine: Incorrect, as NAC directly influences glutathione levels rather than glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Glycine:&lt;/li&gt;&lt;li&gt;â€¢ NAC directly influences glutathione levels&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glutamate: Incorrect, glutamate is a neurotransmitter and not the primary compound replenished by NAC.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Glutamate:&lt;/li&gt;&lt;li&gt;â€¢ glutamate&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ not the primary compound&lt;/li&gt;&lt;li&gt;â€¢ Option D. GABA: Incorrect, GABA (Gamma-Aminobutyric Acid) is also a neurotransmitter and not directly affected by NAC supplementation .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. GABA:&lt;/li&gt;&lt;li&gt;â€¢ GABA&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ not directly&lt;/li&gt;&lt;li&gt;â€¢ NAC supplementation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ N-acetyl cysteine (NAC) is a precursor to glutathione , one of the body&#x27;s most powerful antioxidants . By replenishing intracellular levels of glutathione , NAC supports the body&#x27;s ability to neutralize free radicals and reduce oxidative stress , which is particularly beneficial for athletes and those engaged in regular intense physical activity.&lt;/li&gt;&lt;li&gt;âž¤ N-acetyl cysteine&lt;/li&gt;&lt;li&gt;âž¤ precursor to glutathione&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s most powerful antioxidants&lt;/li&gt;&lt;li&gt;âž¤ replenishing intracellular levels&lt;/li&gt;&lt;li&gt;âž¤ glutathione&lt;/li&gt;&lt;li&gt;âž¤ NAC supports&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s ability to neutralize free radicals&lt;/li&gt;&lt;li&gt;âž¤ reduce oxidative stress&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 228.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 228.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a university&#x27;s biochemistry department, a group of students is preparing a presentation on rare metabolic disorders for an upcoming conference. One of the topics they are focusing on is Primary Oxaluria, specifically the less common type II variant. They delve into the underlying metabolic defect responsible for this condition. Which enzyme&#x27;s malfunction is implicated in Primary Oxaluria type II?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycine cleavage system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alanine Glyoxylate Aminotransferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D-Glycerate Dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Excess Vitamin C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. D-Glycerate Dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_gwtTMYX.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glycine cleavage system: Incorrect, as defects in this system are associated with conditions like Non-ketotic Hyperglycinemia rather than Primary Oxaluria.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Glycine cleavage system:&lt;/li&gt;&lt;li&gt;â€¢ defects in this system&lt;/li&gt;&lt;li&gt;â€¢ Non-ketotic Hyperglycinemia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alanine Glyoxylate Aminotransferase: Incorrect, this enzyme&#x27;s deficiency is linked to Primary Oxaluria type I , not type II.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Alanine Glyoxylate Aminotransferase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme&#x27;s deficiency&lt;/li&gt;&lt;li&gt;â€¢ linked to Primary Oxaluria type I&lt;/li&gt;&lt;li&gt;â€¢ Option D. Excess Vitamin C: Incorrect, while excessive vitamin C can contribute to oxalate formation , it is not the underlying cause of Primary Oxaluria type II.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Excess Vitamin C:&lt;/li&gt;&lt;li&gt;â€¢ excessive vitamin C can contribute to oxalate formation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary Oxaluria type II is caused by a deficiency in D-Glycerate Dehydrogenase, an enzyme involved in the glyoxylate and hydroxypyruvate metabolism . This defect leads to the accumulation of oxalate and L-glycerate, contributing to the formation of kidney stones and other related symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Primary Oxaluria type II&lt;/li&gt;&lt;li&gt;âž¤ deficiency in D-Glycerate Dehydrogenase,&lt;/li&gt;&lt;li&gt;âž¤ enzyme involved in the glyoxylate&lt;/li&gt;&lt;li&gt;âž¤ hydroxypyruvate metabolism&lt;/li&gt;&lt;li&gt;âž¤ leads to the accumulation of oxalate&lt;/li&gt;&lt;li&gt;âž¤ L-glycerate,&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 213.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 213.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old boy is brought to the outpatient department by his parents due to concerns about his behavioral problems. Upon examination, the physician notes several physical anomalies: brittle and coarse hair, red patches on the skin, disproportionately long and thin arms and legs, scoliosis, a displaced lens, and muscular hypotonia. Given these clinical findings, which metabolite is most likely to be elevated in this patient&#x27;s blood work?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phenylpyruvate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibrillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Homocysteine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Homocysteine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Homocysteine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Homocystinuria due to cystathionine Î²-synthase deficiency presents with a constellation of findings including ectopia lentis, Marfanoid habitus (tall, thin build with long extremities), skeletal abnormalities, and neurodevelopmental issues. The biochemical hallmark is elevated homocysteine, which can be detected in blood and urine testing. Early diagnosis and treatment with vitamin B6 (pyridoxine), betaine, methionine restriction, and cysteine supplementation may prevent or minimize complications.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy diagnosed with homocystinuria is under evaluation for treatment options that could help manage his condition. Given the enzymatic deficiencies associated with homocystinuria, the healthcare team considers vitamin supplementation as part of his treatment plan. Which vitamin is most likely to be effective in controlling this metabolic disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B 6&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. B 6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. B6&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. B1 (Thiamine): Incorrect, as thiamine does not play a direct role in the treatment of homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. B1 (Thiamine):&lt;/li&gt;&lt;li&gt;â€¢ thiamine&lt;/li&gt;&lt;li&gt;â€¢ not play a direct role in the treatment of homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. B2 (Riboflavin): Incorrect, riboflavin is not the primary vitamin used in the management of homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. B2 (Riboflavin):&lt;/li&gt;&lt;li&gt;â€¢ riboflavin&lt;/li&gt;&lt;li&gt;â€¢ not the primary vitamin&lt;/li&gt;&lt;li&gt;â€¢ management of homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. B3 (Niacin): Incorrect, niacin is not involved in the metabolic pathways affected by homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. B3 (Niacin):&lt;/li&gt;&lt;li&gt;â€¢ not involved&lt;/li&gt;&lt;li&gt;â€¢ metabolic pathways&lt;/li&gt;&lt;li&gt;â€¢ homocystinuria.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Homocystinuria , often due to a deficiency in the enzyme cystathionine Î²-synthase , can sometimes be responsive to high doses of vitamin B6 (pyridoxine). Vitamin B6 serves as a cofactor for cystathionine Î²-synthase , and supplementation can enhance the residual activity of the enzyme in some patients, thereby reducing homocysteine levels and mitigating the risk of complications associated with the disorder.&lt;/li&gt;&lt;li&gt;âž¤ Homocystinuria&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme cystathionine Î²-synthase&lt;/li&gt;&lt;li&gt;âž¤ responsive to high doses of vitamin B6&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B6&lt;/li&gt;&lt;li&gt;âž¤ cofactor for cystathionine Î²-synthase&lt;/li&gt;&lt;li&gt;âž¤ supplementation&lt;/li&gt;&lt;li&gt;âž¤ enhance the residual activity of the enzyme&lt;/li&gt;&lt;li&gt;âž¤ reducing homocysteine levels&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old marathon runner visits a sports medicine clinic complaining of prolonged recovery times after long training sessions. She&#x27;s interested in optimizing her nutrition to enhance muscle repair and overall performance. Her recent blood work showed slightly elevated homocysteine levels. The physician decides to focus on her dietary intake, specifically the vitamins involved in the metabolism of sulfur-containing amino acids, which are crucial for muscle recovery. Which vitamins should the physician consider crucial in this metabolic pathway to address the runner&#x27;s concerns and blood work findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B 12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin K&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both a and b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Both a and b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B12 and folic acid play pivotal roles in the metabolism of sulfur-containing amino acids . Vitamin B12 is involved in the conversion of homocysteine to methionine, while folic acid is essential for the remethylation of homocysteine , also contributing to its conversion back to methionine . These processes are crucial for maintaining low levels of homocysteine, high levels of which are associated with cardiovascular diseases.&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ folic acid&lt;/li&gt;&lt;li&gt;âž¤ pivotal roles in the metabolism of sulfur-containing amino acids&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ conversion of homocysteine to methionine,&lt;/li&gt;&lt;li&gt;âž¤ folic acid&lt;/li&gt;&lt;li&gt;âž¤ remethylation of homocysteine&lt;/li&gt;&lt;li&gt;âž¤ conversion back to methionine&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 216.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 216.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with progressive palmoplantar, nose &amp;amp; pinna pigmentation. Urine sample collected for benedict&#x27;s test changes to black in the supernatant and the test gives greenish brown precipitate. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylketonuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alkaptonuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosinemia type 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Argininosuccinic aciduria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alkaptonuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phenylketonuria: Deficiency of phenylalanine hydroxylase ; C/F - mentally retardation, agitation, hyperactivity, tremors &amp;amp; convulsions due to interference of phenylalanine with neurotransmitter synthesis &amp;amp; hypopigmentation (inhibition of tyrosinase)&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phenylketonuria:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ phenylalanine hydroxylase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosinemia type-2: Deficiency of tyrosine transaminase ; C/F -Mental retardation, painful corneal lesions, photophobia and keratosis of palmar surface with increased urinary excretion of tyrosine and tyramine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosinemia type-2:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ tyrosine transaminase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Argininosuccinic aciduria: Deficiency of argininosuccinate lyase with hyperammonemia and elevated argininosuccinate in CSF and excretion in urine and friable tufted hair (trichorrhexis nodosa).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Argininosuccinic aciduria:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ argininosuccinate lyase&lt;/li&gt;&lt;li&gt;â€¢ hyperammonemia&lt;/li&gt;&lt;li&gt;â€¢ elevated argininosuccinate&lt;/li&gt;&lt;li&gt;â€¢ CSF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alkaptonuria is a rare metabolic disorder characterized by the accumulation of homogentisic acid , leading to its oxidation and polymerization, particularly in connective tissues (a condition known as ochronosis), resulting in dark pigmentation . The urine turning black upon standing or after adding an alkalizing agent (in this case, noted during a Benedict&#x27;s test) is a hallmark sign of this condition.&lt;/li&gt;&lt;li&gt;âž¤ Alkaptonuria&lt;/li&gt;&lt;li&gt;âž¤ rare metabolic disorder&lt;/li&gt;&lt;li&gt;âž¤ accumulation of homogentisic acid&lt;/li&gt;&lt;li&gt;âž¤ oxidation&lt;/li&gt;&lt;li&gt;âž¤ polymerization,&lt;/li&gt;&lt;li&gt;âž¤ connective tissues&lt;/li&gt;&lt;li&gt;âž¤ dark pigmentation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 304-305, Lippincott 7/e: P 274.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A concerned mother brings her 2-month-old infant to the pediatric clinic, reporting that the baby&#x27;s urine has a distinct cabbage-like odor. This unusual symptom prompts the pediatrician to consider metabolic disorders that could be associated with such an olfactory finding. Based on the described symptom, what is the most probable diagnosis for this infant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leucine catabolism defect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hawkinsinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosinemia type 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Maple syrup urine disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tyrosinemia type 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-100432.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Leucine catabolism defect: Incorrect, as defects in leucine metabolism typically lead to the odor of maple syrup in the urine, not cabbage.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Leucine catabolism defect:&lt;/li&gt;&lt;li&gt;â€¢ defects in leucine metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hawkinsinuria: Incorrect, as this very rare metabolic disorder does not typically present with cabbage odor urine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Hawkinsinuria:&lt;/li&gt;&lt;li&gt;â€¢ very rare metabolic disorder&lt;/li&gt;&lt;li&gt;â€¢ Option D. Maple syrup urine disease: Incorrect, as the characteristic odor associated with this disorder is sweet or burnt sugar , resembling maple syrup, not cabbage.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Maple syrup urine disease:&lt;/li&gt;&lt;li&gt;â€¢ odor&lt;/li&gt;&lt;li&gt;â€¢ disorder is sweet or burnt sugar&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 304-307, DM Vasudevan  9/e: p 239,240&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old girl presents with a history of mild mental retardation, episodes of vomiting, lethargy, seizures, and hypertonia that were first noted during the initial week of life. Amino acid screening reveals elevated levels of leucine, isoleucine, and valine. Based on these findings, which enzyme is likely deficient in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Branched chain ketoacid dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystathionine synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ornithine transcarbamylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methyl malonyl CoA mutase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Branched chain ketoacid dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystathionine synthase: Congenital homocystinuria , C/F-Mental retardation, Ectopia lentis, Thrombosis and Charlie Chaplin gait.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystathionine synthase:&lt;/li&gt;&lt;li&gt;â€¢ Congenital homocystinuria&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ornithine transcarbamylase: The only urea cycle disorder with X-linked trait. C/F- Hyperammonaemia, elevated levels of ammonia are associated with high glutamine levels in CSF and blood in the affected child. Mothers also have hyperammonaemia and an aversion to high protein diet.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ornithine transcarbamylase:&lt;/li&gt;&lt;li&gt;â€¢ urea cycle disorder&lt;/li&gt;&lt;li&gt;â€¢ X-linked trait.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methylmalonyl CoA mutase: Methylmalonic Aciduria . C/F- MR, ketosis, hypotonia, Blood-methyl malonic acid is elevated and in urine -methyl maIonic acid and ketone bodies are seen. Treatment â€“Vitamin B12.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Methylmalonyl CoA mutase:&lt;/li&gt;&lt;li&gt;â€¢ Methylmalonic Aciduria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The elevated levels of leucine , isoleucine , and valine indicate Maple Syrup Urine Disease (MSUD), which is caused by a deficiency in the branched chain ketoacid dehydrogenase complex.&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of leucine&lt;/li&gt;&lt;li&gt;âž¤ isoleucine&lt;/li&gt;&lt;li&gt;âž¤ valine&lt;/li&gt;&lt;li&gt;âž¤ Maple Syrup Urine Disease&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the branched chain ketoacid dehydrogenase complex.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 309-311.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 309-311.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-year-old child is brought to the clinic with symptoms resembling pellagra, including dermatitis, ataxia, and neuropsychiatric manifestations. Urine analysis indicates aminoaciduria. Considering the presentation and the urinary findings, this disorder is likely due to a mutation in which of the following genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SLC5A18&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SLC1A1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SLC7A9&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SLC6A19&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. SLC6A19&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. SLC5A18: This gene is not associated with the described clinical presentation or aminoaciduria related to Hartnup disease.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. SLC5A18:&lt;/li&gt;&lt;li&gt;â€¢ not associated&lt;/li&gt;&lt;li&gt;â€¢ Option B. SLC1A1: While this gene is involved in amino acid transport, mutations in SLC1A1 are not typically linked to the symptoms described here.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. SLC1A1:&lt;/li&gt;&lt;li&gt;â€¢ amino acid transport,&lt;/li&gt;&lt;li&gt;â€¢ Option C. SLC7A9: Mutations in this gene are associated with cystinuria, a different condition characterized by defective renal reabsorption of certain amino acids, leading to kidney stone formation, not the symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. SLC7A9:&lt;/li&gt;&lt;li&gt;â€¢ Mutations&lt;/li&gt;&lt;li&gt;â€¢ cystinuria,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ P ellagra-like symptoms (dermatitis, diarrhea, dementia), along with aminoaciduria , suggests Hartnup disease , which is characterized by the defective absorption of neutral amino acids, including tryptophan. Hartnup disease is caused by mutations in the SLC6A19 gene, which encodes a transporter protein responsible for the absorption of neutral amino acids in the intestines and kidneys.&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ ellagra-like symptoms&lt;/li&gt;&lt;li&gt;âž¤ aminoaciduria&lt;/li&gt;&lt;li&gt;âž¤ Hartnup disease&lt;/li&gt;&lt;li&gt;âž¤ defective absorption of neutral amino acids,&lt;/li&gt;&lt;li&gt;âž¤ tryptophan.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 308, 557&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 308, 557&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a case discussion, involving altered immune and neurological functions, focusing on a specific metabolic pathway. The students are asked to identify the precursor amino acid in the kynurenine pathway, known to impact both neurological and immune responses. Which amino acid is focus of this discussion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylalanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tryptophan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture21.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phenylalanine: This amino acid is primarily converted into tyrosine , not kynurenine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Phenylalanine:&lt;/li&gt;&lt;li&gt;â€¢ amino acid&lt;/li&gt;&lt;li&gt;â€¢ converted into tyrosine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine: Tyrosine is a precursor for several important substances, including dopamine, epinephrine , and norepinephrine, but not kynurenine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Tyrosine:&lt;/li&gt;&lt;li&gt;â€¢ substances,&lt;/li&gt;&lt;li&gt;â€¢ dopamine, epinephrine&lt;/li&gt;&lt;li&gt;â€¢ norepinephrine,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histidine: Histidine is metabolized into histamine, among other products, and does not lead to kynurenine formation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Histidine:&lt;/li&gt;&lt;li&gt;â€¢ metabolized into histamine,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Kynurenine is formed from the catabolism of tryptophan via the kynurenine pathway . This pathway is crucial not only for the degradation of tryptophan but also for the production of several important metabolites, including nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cellular energy metabolism and cellular signaling processes.&lt;/li&gt;&lt;li&gt;âž¤ Kynurenine&lt;/li&gt;&lt;li&gt;âž¤ formed from the catabolism&lt;/li&gt;&lt;li&gt;âž¤ tryptophan&lt;/li&gt;&lt;li&gt;âž¤ kynurenine pathway&lt;/li&gt;&lt;li&gt;âž¤ pathway&lt;/li&gt;&lt;li&gt;âž¤ degradation of tryptophan&lt;/li&gt;&lt;li&gt;âž¤ production of several important metabolites,&lt;/li&gt;&lt;li&gt;âž¤ nicotinamide adenine&lt;/li&gt;&lt;li&gt;âž¤ dinucleotide&lt;/li&gt;&lt;li&gt;âž¤ vital role in cellular energy metabolism&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 240.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 240.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a clinical review session focusing on metabolic disorders, a discussion emerges about the diagnostic markers associated with specific amino acid metabolic pathways. A resident recalls a case where elevated levels of FIGLU were noted in a patient&#x27;s laboratory results, suggesting a disruption in a particular amino acid&#x27;s metabolism. Which amino acids metabolic pathway is most likely associated with FIGLU as an intermediate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Valine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Histidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture31.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Valine: Incorrect, as valine metabolism does not involve FIGLU as an intermediate .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Valine:&lt;/li&gt;&lt;li&gt;â€¢ valine metabolism&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ FIGLU as an intermediate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Methionine: Incorrect, methionine metabolism involves different intermediates and pathways, particularly those related to sulfur.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Methionine:&lt;/li&gt;&lt;li&gt;â€¢ methionine metabolism&lt;/li&gt;&lt;li&gt;â€¢ different intermediates&lt;/li&gt;&lt;li&gt;â€¢ pathways,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Arginine: Incorrect, arginine metabolism is primarily concerned with the urea cycle and does not involve FIGLU.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Arginine:&lt;/li&gt;&lt;li&gt;â€¢ primarily concerned with the urea cycle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Formiminoglutamic acid (FIGLU) is an intermediate in the metabolism of histidine . Its accumulation can be observed in conditions like folic acid deficiency, as folic acid is required for the conversion of FIGLU into another metabolite in the histidine degradation pathway.&lt;/li&gt;&lt;li&gt;âž¤ Formiminoglutamic acid&lt;/li&gt;&lt;li&gt;âž¤ intermediate in the metabolism of histidine&lt;/li&gt;&lt;li&gt;âž¤ accumulation&lt;/li&gt;&lt;li&gt;âž¤ observed in conditions&lt;/li&gt;&lt;li&gt;âž¤ folic acid deficiency,&lt;/li&gt;&lt;li&gt;âž¤ folic acid&lt;/li&gt;&lt;li&gt;âž¤ required for the conversion of FIGLU&lt;/li&gt;&lt;li&gt;âž¤ another metabolite&lt;/li&gt;&lt;li&gt;âž¤ histidine degradation pathway.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 243.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 243.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following enzymes are considered hemoproteins.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nitric oxide synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tryptophan pyrrolase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a &amp;amp; b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both a &amp; b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Nitric oxide synthase: Correct , as it is a hemoprotein involved in the synthesis of nitric oxide.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Nitric oxide synthase:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tryptophan pyrrolase: Also correct, as it is a hemoprotein participating in the metabolism of tryptophan.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Tryptophan pyrrolase:&lt;/li&gt;&lt;li&gt;â€¢ correct,&lt;/li&gt;&lt;li&gt;â€¢ Option D. None: Incorrect, as both listed enzymes are hemoproteins.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. None:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Heme is present in:&lt;/li&gt;&lt;li&gt;âž¤ Hemoglobin Myoglobin Cytochromes Peroxidase Catalase Tryptophan pyrrolase Nitric oxide synthase&lt;/li&gt;&lt;li&gt;âž¤ Hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ Myoglobin&lt;/li&gt;&lt;li&gt;âž¤ Cytochromes&lt;/li&gt;&lt;li&gt;âž¤ Peroxidase&lt;/li&gt;&lt;li&gt;âž¤ Catalase&lt;/li&gt;&lt;li&gt;âž¤ Tryptophan pyrrolase&lt;/li&gt;&lt;li&gt;âž¤ Tryptophan pyrrolase&lt;/li&gt;&lt;li&gt;âž¤ Nitric oxide synthase&lt;/li&gt;&lt;li&gt;âž¤ Nitric oxide synthase&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 270.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 270.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman of reproductive age with phenylketonuria (PKU) delivers her first child. The father has no family history of PKU. At birth, the neonate presents with microcephaly and elevated blood phenylalanine levels. Considering the mother&#x27;s medical history and the absence of PKU in the father&#x27;s family, what is the most likely explanation for the neonate&#x27;s symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Father is a carrier of PKU&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Maternal translocation with unbalanced segregation in meiosis I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Maternal translocation with unbalanced segregation in meiosis II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenylalanine was not adequately restricted from the motherâ€™s diet during pregnancy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phenylalanine was not adequately restricted from the motherâ€™s diet during pregnancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Father is a carrier of PKU: Even if the father is a carrier of PKU allele (phenylalanine hydroxylase gene), the infant will not have any symptoms until 4-5 days after birth, also the maternal blood phenylalanine level should be in the normal range throughout the course of pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Father is a carrier of PKU:&lt;/li&gt;&lt;li&gt;â€¢ father is a carrier of PKU allele&lt;/li&gt;&lt;li&gt;â€¢ infant will not have any symptoms&lt;/li&gt;&lt;li&gt;â€¢ 4-5 days after birth,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Maternal translocation with unbalanced segregation in meiosis I and Option C. Maternal translocation with unbalanced segregation in meiosis II: Maternal translocation with unbalanced segregation in meiosis I and meiosis II will not have effect on phenylalanine levels but leads to trisomy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Maternal translocation with unbalanced segregation in meiosis I&lt;/li&gt;&lt;li&gt;â€¢ Option C. Maternal translocation with unbalanced segregation in meiosis II:&lt;/li&gt;&lt;li&gt;â€¢ Maternal translocation&lt;/li&gt;&lt;li&gt;â€¢ unbalanced segregation in meiosis I&lt;/li&gt;&lt;li&gt;â€¢ meiosis II&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Maternal PKU syndrome, occurs when a mother with PKU does not adequately control her phenylalanine levels during pregnancy. Elevated phenylalanine in the maternal bloodstream can cross the placenta , affecting fetal development and leading to conditions such as microcephaly and elevated blood phenylalanine in the newborn , despite the child not inheriting PKU.&lt;/li&gt;&lt;li&gt;âž¤ Maternal PKU syndrome,&lt;/li&gt;&lt;li&gt;âž¤ mother with PKU&lt;/li&gt;&lt;li&gt;âž¤ not adequately control her phenylalanine levels&lt;/li&gt;&lt;li&gt;âž¤ pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ Elevated phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ maternal bloodstream&lt;/li&gt;&lt;li&gt;âž¤ cross the placenta&lt;/li&gt;&lt;li&gt;âž¤ fetal development&lt;/li&gt;&lt;li&gt;âž¤ microcephaly&lt;/li&gt;&lt;li&gt;âž¤ elevated blood phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ newborn&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 304,306.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 304,306.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-day-old infant is brought to the pediatric ward for newborn screening, as seen in the images provided. Regarding the screening test depicted in the pictures, which of the following statements is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TMS is the best screening test to detect the metabolic disorders&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TMS is less sensitive in screening for PKU than the bacterial inhibition tests&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood obtained by heel-prick or cord blood is applied to a filter-paper&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Has Capacity to screen multiple disorders with a single blood spot&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. TMS is less sensitive in screening for PKU than the bacterial inhibition tests&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture41.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_XIxp1ec.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. TMS is less sensitive in screening for PKU than the bacterial inhibition tests&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The sensitivity of tandem MS-MS testing in screening for PKU is greater than the sensitivity of any bacterial inhibition or biochemical method for measuring blood phenylalanine levels. The power of new-born screening by tandem MS-MS is enormously enhanced by the ability to analyze several metabolites simultaneously in the same blood specimen.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 427,458.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Cheesy odor in urine is mainly due to isovaleric acid excretion in urine, which is one of the intermediates formed during catabolism of leucine. Reasoning (R): The defective enzyme in isovaleric acidemia is isovaleryl CoA dehydrogenase which is a FAD + dependent enzyme. Which of the following is correct regarding the Assertion (A) and Reasoning (R)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is a wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Isovaleric acidemia (FAD+ dependent enzyme) is a metabolic disorder characterized by the accumulation and excretion of isovaleric acid in the urine , which leads to the distinctive \&quot;cheesy\&quot; odor. This condition is due to a deficiency in isovaleryl CoA dehydrogenase, an enzyme crucial for the catabolism of leucine, an essential amino acid.&lt;/li&gt;&lt;li&gt;âž¤ Isovaleric acidemia&lt;/li&gt;&lt;li&gt;âž¤ metabolic disorder&lt;/li&gt;&lt;li&gt;âž¤ accumulation&lt;/li&gt;&lt;li&gt;âž¤ excretion of isovaleric acid in the urine&lt;/li&gt;&lt;li&gt;âž¤ distinctive \&quot;cheesy\&quot; odor.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 309-312.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 309-312.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with severe back pain and difficulty in walking is observed to have a bluish-black discoloration of the ear cartilage and darkening of the urine upon standing. Which enzyme deficiency is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosine Hydroxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Homogentisate Oxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine Transaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tyrosinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Homogentisate Oxidase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6_08b8XZK.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tyrosine Hydroxylase: Tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase, which requires BH4 and NADPH. Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is used for catecholamine synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tyrosine Hydroxylase:&lt;/li&gt;&lt;li&gt;â€¢ Tyrosine&lt;/li&gt;&lt;li&gt;â€¢ hydroxylated to dihydroxyphenylalanine&lt;/li&gt;&lt;li&gt;â€¢ tyrosine hydroxylase,&lt;/li&gt;&lt;li&gt;â€¢ requires BH4 and NADPH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine Transaminase: Deficiency leads to Oculocutaneous Tyrosinemia (Tyrosinemia Type II), C/F - Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine Transaminase:&lt;/li&gt;&lt;li&gt;â€¢ Oculocutaneous Tyrosinemia&lt;/li&gt;&lt;li&gt;â€¢ C/F&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tyrosinase: It is completely absent â†’ defective synthesis of melanin â†’ AR disease , Albinism . C/F - skin has low pigmentation â†’sensitive to UV rays â†’nevi and melanomas, white hair, ocular fundus is hypopigmented and iris may be gray or red, photophobia, nystagmus and decreased visual acuity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tyrosinase:&lt;/li&gt;&lt;li&gt;â€¢ completely absent&lt;/li&gt;&lt;li&gt;â€¢ defective synthesis of melanin&lt;/li&gt;&lt;li&gt;â€¢ AR disease&lt;/li&gt;&lt;li&gt;â€¢ Albinism&lt;/li&gt;&lt;li&gt;â€¢ C/F&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alkaptonuria is characterized by the accumulation of homogentisic acid , a metabolic byproduct of phenylalanine and tyrosine catabolism . This accumulation is due to a deficiency in the enzyme homogentisate oxidase. The hallmark features of this condition include darkening of the urine upon standing (due to the oxidation of homogentisic acid), ochronosis (bluish-black discoloration of connective tissues), and arthropathies (joint diseases), particularly affecting the spine and large joints.&lt;/li&gt;&lt;li&gt;âž¤ Alkaptonuria&lt;/li&gt;&lt;li&gt;âž¤ accumulation of homogentisic acid&lt;/li&gt;&lt;li&gt;âž¤ metabolic byproduct of phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ tyrosine catabolism&lt;/li&gt;&lt;li&gt;âž¤ accumulation&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme homogentisate oxidase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 304-305.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 304-305.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old male presents with intermittent involuntary tremors in his left hand, difficulty feeding himself, walking challenges, and poor gait coordination for the past month. Upon examination, he exhibits a shuffling gait and resting tremors, but cognitive functions remain intact. Diagnosed with Parkinson&#x27;s disease, he is prescribed levodopa. Which metabolic pathway is primarily affected in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylalanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tyrosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture8_lTZg06l.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phenylalanine: While phenylalanine is a precursor to tyrosine , the direct pathway affected in Parkinson&#x27;s disease is the tyrosine to dopamine pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Phenylalanine:&lt;/li&gt;&lt;li&gt;â€¢ precursor to tyrosine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tryptophan: Involved in the synthesis of serotonin and melatonin , not directly implicated in Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Tryptophan:&lt;/li&gt;&lt;li&gt;â€¢ synthesis of serotonin and melatonin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histidine: Involved in the synthesis of histamine and is not directly related to the dopaminergic pathways affected in Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Histidine:&lt;/li&gt;&lt;li&gt;â€¢ synthesis of histamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease is associated with the dopaminergic pathway , where tyrosine is a key precursor in the synthesis of dopamine. Levodopa , a precursor of dopamine , is used to increase dopamine levels in the brain, addressing the dopamine deficiency that characterizes Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ dopaminergic pathway&lt;/li&gt;&lt;li&gt;âž¤ tyrosine&lt;/li&gt;&lt;li&gt;âž¤ key precursor&lt;/li&gt;&lt;li&gt;âž¤ synthesis of dopamine.&lt;/li&gt;&lt;li&gt;âž¤ Levodopa&lt;/li&gt;&lt;li&gt;âž¤ precursor of dopamine&lt;/li&gt;&lt;li&gt;âž¤ increase dopamine levels&lt;/li&gt;&lt;li&gt;âž¤ brain,&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 235.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 235.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old male child presents with a 5-month history of eye ulceration and thick, rough, patchy skin on the palms and feet. Examination reveals dendritic corneal ulceration unresponsive to antiviral treatment and keratosis on the palms and plantar surfaces. Laboratory tests show increased levels of tyrosine in blood and urine. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosinemia type-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tyrosinemia type-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosinemia type-3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hawkinsinuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tyrosinemia type-2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I) is due to a deficiency of enzyme fumarylacetoacetate hydrolase . C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)&lt;/li&gt;&lt;li&gt;â€¢ deficiency of enzyme fumarylacetoacetate hydrolase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neonatal Tyrosinemia (Tyrosinemia Type III) due to the absence of the enzyme para-hydroxyphenylpyruvate hydroxylase , which causes transient hypertyrosinemia in the newborn , and this will respond to ascorbic acid and dietary protein restriction.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neonatal Tyrosinemia (Tyrosinemia Type III)&lt;/li&gt;&lt;li&gt;â€¢ absence&lt;/li&gt;&lt;li&gt;â€¢ enzyme para-hydroxyphenylpyruvate hydroxylase&lt;/li&gt;&lt;li&gt;â€¢ transient hypertyrosinemia&lt;/li&gt;&lt;li&gt;â€¢ newborn&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hawkinsinuria is due to dysfunction of p-HPPA oxidase, characterized by excretion of hawkinsin in urine , a derivative of p-HPPA.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Hawkinsinuria&lt;/li&gt;&lt;li&gt;â€¢ dysfunction of p-HPPA oxidase,&lt;/li&gt;&lt;li&gt;â€¢ excretion of hawkinsin in urine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tyrosinemia type-2, also known as Richner-Hanhart syndrome, is characterized by elevated levels of tyrosine which can lead to eye problems (like corneal ulcers), skin disorders (such as palmoplantar keratosis), and sometimes intellectual disability.&lt;/li&gt;&lt;li&gt;âž¤ Tyrosinemia type-2,&lt;/li&gt;&lt;li&gt;âž¤ Richner-Hanhart syndrome,&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of tyrosine&lt;/li&gt;&lt;li&gt;âž¤ lead to eye problems&lt;/li&gt;&lt;li&gt;âž¤ skin disorders&lt;/li&gt;&lt;li&gt;âž¤ intellectual disability.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Creatinine is synthesized in the body through a process involving the breakdown of a specific amino acid. Which amino acid is primarily involved in the formation of creatinine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Arginine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture111.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lysine: While lysine is involved in many biochemical processes , it is not directly involved in the synthesis of creatinine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Lysine:&lt;/li&gt;&lt;li&gt;â€¢ many biochemical processes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine: Histamine is a biogenic amine derived from histidine and is not involved in creatinine synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Histamine:&lt;/li&gt;&lt;li&gt;â€¢ biogenic amine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Leucine: Leucine is a branched-chain amino acid involved in protein synthesis and energy production but not in the formation of creatinine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Leucine:&lt;/li&gt;&lt;li&gt;â€¢ branched-chain amino acid&lt;/li&gt;&lt;li&gt;â€¢ protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ energy production&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Creatinine is formed from the breakdown of creatine phosphate in muscle and to a smaller extent from the diet. Creatine itself is synthesized from the amino acids arginine , glycine, and methionine . Arginine plays a crucial role in the initial step of creatine synthesis, which ultimately leads to the formation of creatinine.&lt;/li&gt;&lt;li&gt;âž¤ Creatinine&lt;/li&gt;&lt;li&gt;âž¤ breakdown of creatine phosphate in muscle&lt;/li&gt;&lt;li&gt;âž¤ smaller extent from the diet.&lt;/li&gt;&lt;li&gt;âž¤ Creatine&lt;/li&gt;&lt;li&gt;âž¤ synthesized from the amino acids arginine&lt;/li&gt;&lt;li&gt;âž¤ glycine,&lt;/li&gt;&lt;li&gt;âž¤ methionine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p320.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p320.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Polyamines are organic compounds that play a critical role in cellular processes. Which of the following is an example of a polyamine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spermidine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spermidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Arginine: An amino acid, not a polyamine, although it is involved in the synthesis of polyamines.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Arginine:&lt;/li&gt;&lt;li&gt;â€¢ amino acid,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histamine: A biogenic amine derived from histidine , involved in immune responses and not classified as a polyamine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Histamine:&lt;/li&gt;&lt;li&gt;â€¢ biogenic amine&lt;/li&gt;&lt;li&gt;â€¢ histidine&lt;/li&gt;&lt;li&gt;â€¢ immune responses&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lysine: An essential amino acid important for protein synthesis, not a polyamine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Lysine:&lt;/li&gt;&lt;li&gt;â€¢ essential amino acid&lt;/li&gt;&lt;li&gt;â€¢ protein synthesis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spermidine is a polyamine involved in cellular metabolism and is found in ribosomes and living tissues . It plays a role in cellular growth, proliferation, and differentiation.&lt;/li&gt;&lt;li&gt;âž¤ Spermidine&lt;/li&gt;&lt;li&gt;âž¤ polyamine&lt;/li&gt;&lt;li&gt;âž¤ cellular metabolism&lt;/li&gt;&lt;li&gt;âž¤ found in ribosomes and living tissues&lt;/li&gt;&lt;li&gt;âž¤ cellular growth, proliferation, and differentiation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 229.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 229.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following routine newborn screening, a child is found to have high levels of phenylpyruvate and phenylacetate, indicative of phenylketonuria (PKU). Despite a phenylalanine-restricted diet, the child shows developmental delays. Which supplement might improve the child&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5-hydroxytryptophan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Melanin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenylalanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tyrosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Tyrosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Phenylketonuria (PKU) results from a deficiency of phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine. This deficiency leads to:&lt;/li&gt;&lt;li&gt;â€¢ Accumulation of phenylalanine and its metabolites (phenylpyruvate, phenylacetate, phenyllactate) Reduced tyrosine production, making tyrosine an essential amino acid in PKU patients&lt;/li&gt;&lt;li&gt;â€¢ Accumulation of phenylalanine and its metabolites (phenylpyruvate, phenylacetate, phenyllactate)&lt;/li&gt;&lt;li&gt;â€¢ Reduced tyrosine production, making tyrosine an essential amino acid in PKU patients&lt;/li&gt;&lt;li&gt;â€¢ In PKU treatment, dietary phenylalanine restriction is the primary approach to prevent neurotoxicity from excess phenylalanine. However, this restriction alone can lead to tyrosine deficiency, as tyrosine can no longer be synthesized from phenylalanine.&lt;/li&gt;&lt;li&gt;â€¢ Tyrosine is critical for:&lt;/li&gt;&lt;li&gt;â€¢ Production of neurotransmitters (dopamine, norepinephrine, epinephrine) Synthesis of thyroid hormones Melanin production&lt;/li&gt;&lt;li&gt;â€¢ Production of neurotransmitters (dopamine, norepinephrine, epinephrine)&lt;/li&gt;&lt;li&gt;â€¢ Synthesis of thyroid hormones&lt;/li&gt;&lt;li&gt;â€¢ Melanin production&lt;/li&gt;&lt;li&gt;â€¢ Tyrosine supplementation is therefore beneficial in PKU management as it:&lt;/li&gt;&lt;li&gt;â€¢ Addresses the conditionally essential status of tyrosine Supports neurotransmitter synthesis, potentially improving neurological function May reduce the risk of developmental delays associated with tyrosine deficiency&lt;/li&gt;&lt;li&gt;â€¢ Addresses the conditionally essential status of tyrosine&lt;/li&gt;&lt;li&gt;â€¢ Supports neurotransmitter synthesis, potentially improving neurological function&lt;/li&gt;&lt;li&gt;â€¢ May reduce the risk of developmental delays associated with tyrosine deficiency&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5-hydroxytryptophan : This is a precursor to serotonin in the tryptophan metabolism pathway. While serotonin levels might be indirectly affected in PKU due to competition between elevated phenylalanine and tryptophan for transport across the blood-brain barrier, supplementing with 5-hydroxytryptophan does not address the primary biochemical defect or the tyrosine deficiency in PKU.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5-hydroxytryptophan&lt;/li&gt;&lt;li&gt;â€¢ Option C. Melanin : This is an end product of tyrosine metabolism and not a supplement that would provide therapeutic benefit in PKU. The hypopigmentation sometimes seen in PKU patients is due to reduced tyrosine availability for melanin synthesis, but direct melanin supplementation would not address the metabolic or neurological issues.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Melanin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenylalanine : Supplementing with phenylalanine would be contraindicated in PKU as it would exacerbate the condition. PKU patients already have elevated phenylalanine levels due to impaired metabolism, and additional phenylalanine would increase toxic metabolite production and neurological damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenylalanine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In phenylketonuria, phenylalanine hydroxylase deficiency creates a metabolic block in converting phenylalanine to tyrosine. While dietary phenylalanine restriction is the mainstay of treatment, supplementation with tyrosine is important because it becomes an essential amino acid in this condition. Tyrosine supplementation supports neurotransmitter synthesis, and potentially improves developmental outcomes by addressing the \&quot;downstream\&quot; deficiency caused by the enzymatic block.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 236.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child with developmental delay undergoes blood analysis, which reveals elevated levels of phenylalanine, phenyllactate, and phenylpyruvate. What is the hypothesized mechanism for developmental delay in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acidosis due to elevated phenyllactate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lack of tyrosine, now an essential amino acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of hydroxylating enzymes due to accumulation of phenylalanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lack of large, neutral amino acids in the brain.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lack of large, neutral amino acids in the brain.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acidosis due to elevated phenyllactate: While acidosis can have deleterious effects on the body and can be a feature of organic acidemias , it is not the primary reason for developmental delays in conditions like phenylketonuria. Acidosis is more of an acute metabolic disturbance rather than a direct cause of chronic developmental issues.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Acidosis due to elevated phenyllactate:&lt;/li&gt;&lt;li&gt;â€¢ acidosis&lt;/li&gt;&lt;li&gt;â€¢ deleterious effects&lt;/li&gt;&lt;li&gt;â€¢ body&lt;/li&gt;&lt;li&gt;â€¢ feature of organic acidemias&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lack of tyrosine, now an essential amino acid: Tyrosine is a precursor for several neurotransmitters , and while its deficiency due to a block in conversion from phenylalanine can impact brain function , the developmental delay is more directly linked to the broader competition of phenylalanine with other LNAAs, rather than tyrosine deficiency alone.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Lack of tyrosine, now an essential amino acid: Tyrosine&lt;/li&gt;&lt;li&gt;â€¢ precursor for several neurotransmitters&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ block in conversion from phenylalanine&lt;/li&gt;&lt;li&gt;â€¢ impact brain function&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibition of hydroxylating enzymes due to accumulation of phenylalanine: Phenylalanine can indeed inhibit certain enzymes , including hydroxylating enzymes , due to its elevated levels . This can have various metabolic effects, but the specific link to developmental delay is less direct compared to the competition of phenylalanine with other LNAAs for transport into the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Inhibition of hydroxylating enzymes due to accumulation of phenylalanine:&lt;/li&gt;&lt;li&gt;â€¢ Phenylalanine&lt;/li&gt;&lt;li&gt;â€¢ inhibit certain enzymes&lt;/li&gt;&lt;li&gt;â€¢ hydroxylating enzymes&lt;/li&gt;&lt;li&gt;â€¢ elevated levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elevated levels of phenylalanine are known to interfere with the transport of other large , neutral amino acids (LNAAs) across the blood-brain barrier due to competitive inhibition . These LNAAs include tyrosine, tryptophan, and others that are precursors for key neurotransmitters essential for brain development and function. A deficiency in these neurotransmitters can result in developmental delays.&lt;/li&gt;&lt;li&gt;âž¤ Elevated levels&lt;/li&gt;&lt;li&gt;âž¤ phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ interfere with the transport of other large&lt;/li&gt;&lt;li&gt;âž¤ neutral amino acids&lt;/li&gt;&lt;li&gt;âž¤ blood-brain barrier&lt;/li&gt;&lt;li&gt;âž¤ competitive inhibition&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 236.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 236.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient experiences episodes of flushing, diarrhea, abdominal cramping, and wheezing. Vital signs show normal blood pressure and pulse rate, but scattered telangiectasias are present. What is the most appropriate 24-hour urine test for diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vanillylmandelic acid (VMAs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dopamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5-hydroxyindoleacetic acid (5-HIAA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cortisol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 5-hydroxyindoleacetic acid (5-HIAA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Vanillylmandelic acid (VMAs): This is a breakdown product of norepinephrine and epinephrine and is often tested for in the context of suspected pheochromocytoma, which presents with different symptoms like episodic hypertension, palpitations, and headaches.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Vanillylmandelic acid (VMAs):&lt;/li&gt;&lt;li&gt;â€¢ breakdown product of norepinephrine&lt;/li&gt;&lt;li&gt;â€¢ epinephrine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dopamine: Elevated levels of dopamine in urine could indicate a neuroendocrine tumor , like a pheochromocytoma, but this patient&#x27;s symptoms align more closely with carcinoid syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Dopamine:&lt;/li&gt;&lt;li&gt;â€¢ Elevated levels of dopamine&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ neuroendocrine tumor&lt;/li&gt;&lt;li&gt;â€¢ pheochromocytoma,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cortisol: While cortisol can be measured in urine to test for Cushing&#x27;s syndrome, the symptoms here are not typical of Cushing&#x27;s syndrome, which usually includes features such as weight gain, fat distribution changes, and sometimes hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Cortisol:&lt;/li&gt;&lt;li&gt;â€¢ measured in urine to test for Cushing&#x27;s syndrome,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 24-hour urinary excretion of 5-HIAA is a useful diagnostic test for carcinoid syndrome.&lt;/li&gt;&lt;li&gt;âž¤ 24-hour urinary excretion&lt;/li&gt;&lt;li&gt;âž¤ carcinoid syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 241.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 241.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male has been prescribed an antidepressant that works by maintaining elevated levels of a specific neurotransmitter. This neurotransmitter is derived from which amino acid?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tryptophan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1110.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamate is the precursor of GABA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamate&lt;/li&gt;&lt;li&gt;â€¢ precursor of GABA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histidine is the precursor for histamine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Histidine&lt;/li&gt;&lt;li&gt;â€¢ precursor for histamine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine itself acts as a neurotransmitter in the brain.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter in the brain.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tryptophan is the amino acid precursor to serotonin, a neurotransmitter commonly targeted by many antidepressants . Medications such as selective serotonin reuptake inhibitors (SSRIs) increase the level of serotonin in the brain by preventing its reuptake into neurons, thereby treating depression.&lt;/li&gt;&lt;li&gt;âž¤ Tryptophan&lt;/li&gt;&lt;li&gt;âž¤ amino acid precursor&lt;/li&gt;&lt;li&gt;âž¤ neurotransmitter&lt;/li&gt;&lt;li&gt;âž¤ targeted by many antidepressants&lt;/li&gt;&lt;li&gt;âž¤ Medications&lt;/li&gt;&lt;li&gt;âž¤ selective serotonin reuptake inhibitors&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ level of serotonin&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 236.&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 236.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-month-old boy presents to the outpatient department with failure to thrive, poor appetite, hepatomegaly, yellow discoloration of the eyes, vomiting, diarrhea, and a distinct cabbage-like odor. What amino acid metabolism defect is this disorder most likely associated with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tyrosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alanine: While alanine is an amino acid, it is not commonly associated with the symptoms described or a distinct odor.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Alanine:&lt;/li&gt;&lt;li&gt;â€¢ amino acid,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Tryptophan: Abnormal tryptophan metabolism can lead to several conditions, but the distinct clinical picture including odor does not typically link to tryptophan metabolism defects.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Tryptophan:&lt;/li&gt;&lt;li&gt;â€¢ Abnormal tryptophan metabolism&lt;/li&gt;&lt;li&gt;â€¢ several conditions,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histidine: Disturbances in histidine metabolism , such as histidinemia , do not typically present with the constellation of symptoms described in the question.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Histidine: Disturbances&lt;/li&gt;&lt;li&gt;â€¢ histidine metabolism&lt;/li&gt;&lt;li&gt;â€¢ histidinemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical features of tyrosinemia type I , includes failure to thrive, poor appetite, hepatomegaly, jaundice, vomiting, diarrhea, and a distinct odor resembling cabbage due to the accumulation of tyrosine metabolites.&lt;/li&gt;&lt;li&gt;âž¤ tyrosinemia type I&lt;/li&gt;&lt;li&gt;âž¤ failure to thrive, poor appetite, hepatomegaly, jaundice, vomiting, diarrhea,&lt;/li&gt;&lt;li&gt;âž¤ distinct odor&lt;/li&gt;&lt;li&gt;âž¤ cabbage&lt;/li&gt;&lt;li&gt;âž¤ accumulation of tyrosine metabolites.&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presenting with elevated levels of Î±-ketoacids of branched-chain amino acids (BCAAs) would likely benefit from supplementation with which vitamin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Riboflavin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B 12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiamine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thiamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Niacin: Not directly involved in the function of the BCKAD complex or the metabolism of branched-chain amino acids.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Niacin:&lt;/li&gt;&lt;li&gt;â€¢ Not directly involved&lt;/li&gt;&lt;li&gt;â€¢ function of the BCKAD complex&lt;/li&gt;&lt;li&gt;â€¢ Option B. Riboflavin: While riboflavin is a precursor to FAD, a cofactor for many enzymes, the direct connection to BCKAD complex activity in the context of MSUD is less significant than that of thiamine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Riboflavin:&lt;/li&gt;&lt;li&gt;â€¢ precursor to FAD,&lt;/li&gt;&lt;li&gt;â€¢ cofactor for many enzymes,&lt;/li&gt;&lt;li&gt;â€¢ Option C. B12: Vitamin B12 is crucial for neurological health and the metabolism of certain amino acids , but it is not a cofactor for the BCKAD complex involved in MSUD.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. B12:&lt;/li&gt;&lt;li&gt;â€¢ neurological health&lt;/li&gt;&lt;li&gt;â€¢ metabolism of certain amino acids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High levels of specific Î±-ketoacids indicate Maple Syrup Urine Disease (MSUD), stemming from a deficiency in an enzyme complex vital for breaking down certain amino acids . Thiamine supplementation can improve the enzyme&#x27;s activity in some MSUD patients, potentially bettering clinical outcomes.&lt;/li&gt;&lt;li&gt;âž¤ High levels of specific Î±-ketoacids&lt;/li&gt;&lt;li&gt;âž¤ Maple Syrup Urine Disease&lt;/li&gt;&lt;li&gt;âž¤ stemming&lt;/li&gt;&lt;li&gt;âž¤ deficiency in an enzyme complex vital&lt;/li&gt;&lt;li&gt;âž¤ breaking down certain amino acids&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 208, 230, 431.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 208, 230, 431.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn screening reveals elevated levels of branched-chain amino acids and their Î±-ketoacid derivatives, along with lactic acidosis. Which enzyme is likely affected by this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î±-ketoglutarate dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isocitrate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinate dehydrogenase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Î±-ketoglutarate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture20.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Isocitrate dehydrogenase: While part of the Krebs cycle , this enzyme is less directly impacted by the conditions described in the scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Isocitrate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ part of the Krebs cycle&lt;/li&gt;&lt;li&gt;â€¢ less directly impacted&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malate dehydrogenase: Also part of the Krebs cycle , but the scenario specifically suggests an issue more closely related to Î±-ketoglutarate dehydrogenase due to the link with branched-chain amino acid metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Malate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ Krebs cycle&lt;/li&gt;&lt;li&gt;â€¢ Option D. Succinate dehydrogenase: This enzyme is part of both the Krebs cycle and the electron transport chain , but the described symptoms do not specifically implicate this enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Succinate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme is part of both&lt;/li&gt;&lt;li&gt;â€¢ Krebs cycle&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elevated branched-chain amino acids and their derivatives, along with lactic acidosis, suggest mitochondrial disruption, potentially due to Maple Syrup Urine Disease (MSUD), affecting the Krebs cycle. Excess NADH from MSUD inhibits key enzymes like Î±-ketoglutarate dehydrogenase, leading to lactic acidosis by diverting pyruvate to lactate.&lt;/li&gt;&lt;li&gt;âž¤ Elevated branched-chain amino acids&lt;/li&gt;&lt;li&gt;âž¤ lactic acidosis,&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial disruption,&lt;/li&gt;&lt;li&gt;âž¤ Maple Syrup Urine Disease&lt;/li&gt;&lt;li&gt;âž¤ Krebs cycle.&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 208, 230, 431.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 208, 230, 431.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-month-old boy presents with lethargy and vomiting. His blood tests show high ammonia levels, and there&#x27;s a family history of a similar condition in a male relative. Considering these findings, which enzyme deficiency is most likely causing his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamoyl-phosphate synthase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ornithine transcarbamylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Argininosuccinate synthetase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arginase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ornithine transcarbamylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carbamoyl-phosphate synthase I: Deficiency in this enzyme leads to a urea cycle disorder, but it is not specifically associated with hyperammonemia type 2.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carbamoyl-phosphate synthase I:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ enzyme leads to a urea cycle disorder,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Argininosuccinate synthetase: This enzyme deficiency leads to citrullinemia , another type of urea cycle disorder, but not hyperammonemia type 2.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Argininosuccinate synthetase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme deficiency leads to citrullinemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Arginase: Arginase deficiency results in argininemia, yet another distinct urea cycle disorder, which also does not correspond to hyperammonemia type 2.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Arginase:&lt;/li&gt;&lt;li&gt;â€¢ Arginase deficiency&lt;/li&gt;&lt;li&gt;â€¢ argininemia,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia type 2 is specifically associated with a deficiency in the enzyme ornithine transcarbamylase (OTC).&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia type 2&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme ornithine transcarbamylase&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 206.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 206.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on antidepressants experienced an increased heart rate and sweating after consuming red wine and aged cheese. These symptoms are due to an inability to degrade which substance?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tyramine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serotonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tyramine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tyrosine: Tyrosine is a precursor to tyramine and various neurotransmitters but is not directly responsible for the described symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Tyrosine:&lt;/li&gt;&lt;li&gt;â€¢ precursor to tyramine&lt;/li&gt;&lt;li&gt;â€¢ various neurotransmitters&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serotonin: While serotonin syndrome can result from certain drug interactions, particularly with serotonergic agents , the specific trigger of aged cheese and red wine points more towards a tyramine interaction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Serotonin:&lt;/li&gt;&lt;li&gt;â€¢ result from certain drug interactions,&lt;/li&gt;&lt;li&gt;â€¢ serotonergic agents&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine: Glycine is an inhibitory neurotransmitter in the central nervous system and is not related to the symptoms described in the context of dietary intake and antidepressants.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Glycine:&lt;/li&gt;&lt;li&gt;â€¢ inhibitory neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ central nervous system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A hypertensive crisis can occur from consuming tyramine-rich foods while on MAOIs, as these antidepressants inhibit the breakdown of tyramine , leading to symptoms like increased heart rate and sweating.&lt;/li&gt;&lt;li&gt;âž¤ hypertensive crisis&lt;/li&gt;&lt;li&gt;âž¤ consuming tyramine-rich foods&lt;/li&gt;&lt;li&gt;âž¤ MAOIs,&lt;/li&gt;&lt;li&gt;âž¤ antidepressants inhibit&lt;/li&gt;&lt;li&gt;âž¤ breakdown of tyramine&lt;/li&gt;&lt;li&gt;âž¤ increased heart rate and sweating.&lt;/li&gt;&lt;li&gt;âž¤ Ref :  DM Vasudevan 9/e: p 236, 555.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :  DM Vasudevan 9/e: p 236, 555.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the transamination reaction depicted, involving oxaloacetate and glutamate, which of the following correctly identifies the products X and Y?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alanine, Î±-ketoglutarate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspartate, Î±-ketoglutarate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glutamate, alanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate, aspartate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aspartate, Î±-ketoglutarate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture30.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alanine, Î± -ketoglutarate: Alanine is formed through transamination involving pyruvate and an amino acid, not oxaloacetate.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Alanine,&lt;/li&gt;&lt;li&gt;â€¢ Î±&lt;/li&gt;&lt;li&gt;â€¢ -ketoglutarate:&lt;/li&gt;&lt;li&gt;â€¢ formed through transamination&lt;/li&gt;&lt;li&gt;â€¢ pyruvate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glutamate, alanine: This option is incorrect; while glutamate is a reactant in the reaction , alanine is not a product of the transamination with oxaloacetate.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Glutamate, alanine:&lt;/li&gt;&lt;li&gt;â€¢ glutamate is a reactant in the reaction&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyruvate, aspartate: Pyruvate can be involved in transamination reactions, but it is not a product when oxaloacetate is the keto acid acceptor.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Pyruvate, aspartate:&lt;/li&gt;&lt;li&gt;â€¢ transamination reactions,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The biochemical pathways involving transamination reactions, such as the conversion of oxaloacetate and glutamate into aspartate and Î±-ketoglutarate.&lt;/li&gt;&lt;li&gt;âž¤ biochemical pathways&lt;/li&gt;&lt;li&gt;âž¤ transamination reactions,&lt;/li&gt;&lt;li&gt;âž¤ glutamate into aspartate&lt;/li&gt;&lt;li&gt;âž¤ Î±-ketoglutarate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 201.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 201.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 14-year-old boy presents with CNS dysfunction including altered sensorium, convulsions, ascites, jaundice, and distinct tufted hair. Abdominal ultrasound reveals hepatomegaly, and laboratory tests show elevated ammonia and high argininosuccinate levels in the cerebrospinal fluid. Which enzyme deficiency is likely responsible for these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Argininosuccinate lyase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arginase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Argininosuccinate synthetase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fumarase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Argininosuccinate lyase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B Arginase: Hyperargininemia - Arginine increased in blood and CSF . Instead of arginine, cysteine and lysine are lost in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option B Arginase:&lt;/li&gt;&lt;li&gt;â€¢ Hyperargininemia&lt;/li&gt;&lt;li&gt;â€¢ Arginine increased in blood&lt;/li&gt;&lt;li&gt;â€¢ CSF&lt;/li&gt;&lt;li&gt;â€¢ Option C. Argininosuccinate synthetase: Citrullinemia - with high blood levels of synthetase ammonia and citrulline and Citrullinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Argininosuccinate synthetase:&lt;/li&gt;&lt;li&gt;â€¢ Citrullinemia&lt;/li&gt;&lt;li&gt;â€¢ high blood levels of synthetase ammonia&lt;/li&gt;&lt;li&gt;â€¢ citrulline&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fumarase: Argininosuccinate is cleaved by argininosuccinate lyase (argininosuccinase) to arginine and fumarate . The enzyme is inhibited by fumarase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fumarase:&lt;/li&gt;&lt;li&gt;â€¢ Argininosuccinate&lt;/li&gt;&lt;li&gt;â€¢ argininosuccinate lyase&lt;/li&gt;&lt;li&gt;â€¢ arginine and fumarate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Argininosuccinate lyase deficiency is the cause of argininosuccinic aciduria , which is characterized by elevated levels of ammonia and argininosuccinate , leading to symptoms of CNS dysfunction and hepatomegaly .&lt;/li&gt;&lt;li&gt;âž¤ Argininosuccinate lyase deficiency&lt;/li&gt;&lt;li&gt;âž¤ argininosuccinic aciduria&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of ammonia&lt;/li&gt;&lt;li&gt;âž¤ argininosuccinate&lt;/li&gt;&lt;li&gt;âž¤ CNS dysfunction&lt;/li&gt;&lt;li&gt;âž¤ hepatomegaly&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper30/e: p 295, Vasudevan 9/e: P 205-206.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper30/e: p 295, Vasudevan 9/e: P 205-206.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old child presents with episodic confusion, vomiting, and a history of protein-averse eating habits. Laboratory evaluations reveal elevated serum ammonia. Further genetic testing indicates a defect in the transport of a specific amino acid into the mitochondria. Which of the following deficiency corresponds with these clinical findings in the context of the hyperammonemia-hyperornithinemia-homocitrullinuria (HHH) syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ornithine transporter deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbamoyl-phosphate synthase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ornithine transcarbamylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Argininosuccinate synthetase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ornithine transporter deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ornithine transporter deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B . Carbamoyl phosphate synthetase I deficiency causes Hyperammonemia type I.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C . Ornithine transcarbamylase deficiency causes Hyperammonemia Type II.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . Argininosuccinate synthetase deficiency is characterized by hyperammonemia and citrullinemia with elevated CSF citrulline levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HHH syndrome is characterized by a triad of hyperammonemia, hyperornithinemia, and homocitrullinuria, which arises from a defect in the mitochondrial ornithine transporter.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with episodic irritability, vomiting, and brittle hair with peculiar &#x27;trichorrhexis nodosa&#x27; on microscopy. Blood work reveals elevated plasma ammonia and argininosuccinic acid levels. The child has a known deficiency in a urea cycle enzyme. To bypass the enzymatic block and reduce hyperammonemia, which supplement should be added to the childâ€™s treatment regimen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹â€‹ Aspartate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Citrulline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Argininosuccinate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Arginine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspartate: While aspartate is a participant in the urea cycle , it is used earlier in the cycle and its supplementation does not bypass the block caused by argininosuccinase deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Aspartate:&lt;/li&gt;&lt;li&gt;â€¢ participant in the urea cycle&lt;/li&gt;&lt;li&gt;â€¢ earlier in the cycle&lt;/li&gt;&lt;li&gt;â€¢ supplementation&lt;/li&gt;&lt;li&gt;â€¢ not bypass the block&lt;/li&gt;&lt;li&gt;â€¢ Option C. Citrulline: Citrulline is upstream of the block and would not be effective in bypassing the enzyme deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Citrulline:&lt;/li&gt;&lt;li&gt;â€¢ upstream of the block&lt;/li&gt;&lt;li&gt;â€¢ Option D. Argininosuccinate: This is the substrate that accumulates due to the enzyme deficiency and its supplementation would not be helpful.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Argininosuccinate:&lt;/li&gt;&lt;li&gt;â€¢ substrate that accumulates&lt;/li&gt;&lt;li&gt;â€¢ enzyme deficiency&lt;/li&gt;&lt;li&gt;â€¢ supplementation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Argininosuccinic aciduria results from a deficiency in the enzyme argininosuccinase (argininosuccinate lyase), leading to an accumulation of argininosuccinic acid and hyperammonemia . Supplementation with arginine is beneficial as it provides an essential amino acid that is normally produced by the urea cycle and becomes essential in patients with this condition. This supplementation helps to continue the urea cycle, thus aiding in the detoxification of ammonia.&lt;/li&gt;&lt;li&gt;âž¤ Argininosuccinic aciduria&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme argininosuccinase&lt;/li&gt;&lt;li&gt;âž¤ accumulation of argininosuccinic acid&lt;/li&gt;&lt;li&gt;âž¤ hyperammonemia&lt;/li&gt;&lt;li&gt;âž¤ Supplementation&lt;/li&gt;&lt;li&gt;âž¤ arginine&lt;/li&gt;&lt;li&gt;âž¤ essential amino acid&lt;/li&gt;&lt;li&gt;âž¤ normally produced by the urea cycle&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn becomes lethargic and drowsy on day 24 post-birth. Laboratory tests reveal hyperammonemia and orotic aciduria. Which compound is this infant unable to directly synthesize due to an enzymatic deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbamoyl phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Citrulline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Argininosuccinate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Citrulline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture40.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carbamoyl phosphate: This compound is actually synthesized in excess in OTC deficiency because it cannot be properly utilized to form citrulline.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Carbamoyl phosphate:&lt;/li&gt;&lt;li&gt;â€¢ compound&lt;/li&gt;&lt;li&gt;â€¢ synthesized in excess in OTC deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option C. Argininosuccinate: The formation of argininosuccinate occurs after the synthesis of citrulline in the urea cycle , so while its production is also affected, the direct deficiency lies with the production of citrulline.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Argininosuccinate:&lt;/li&gt;&lt;li&gt;â€¢ formation of argininosuccinate&lt;/li&gt;&lt;li&gt;â€¢ after the synthesis of citrulline&lt;/li&gt;&lt;li&gt;â€¢ urea cycle&lt;/li&gt;&lt;li&gt;â€¢ Option D. Arginine: Arginine is the final product of the urea cycle , and its synthesis is indeed affected by OTC deficiency, but the immediate block is at the formation of citrulline.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Arginine:&lt;/li&gt;&lt;li&gt;â€¢ final product of the urea cycle&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ornithine transcarbamylase (OTC) deficiency , is one of the urea cycle disorders . OTC is responsible for the synthesis of citrulline from carbamoyl phosphate and ornithine . When OTC is deficient , carbamoyl phosphate cannot be converted to citrulline and instead is diverted to the pyrimidine synthesis pathway, leading to orotic aciduria.&lt;/li&gt;&lt;li&gt;âž¤ Ornithine transcarbamylase&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ urea cycle disorders&lt;/li&gt;&lt;li&gt;âž¤ OTC&lt;/li&gt;&lt;li&gt;âž¤ synthesis of citrulline&lt;/li&gt;&lt;li&gt;âž¤ carbamoyl phosphate&lt;/li&gt;&lt;li&gt;âž¤ ornithine&lt;/li&gt;&lt;li&gt;âž¤ OTC is deficient&lt;/li&gt;&lt;li&gt;âž¤ carbamoyl phosphate cannot&lt;/li&gt;&lt;li&gt;âž¤ converted to citrulline&lt;/li&gt;&lt;li&gt;âž¤ diverted to the pyrimidine synthesis pathway,&lt;/li&gt;&lt;li&gt;âž¤ orotic aciduria.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonate is lethargic, drowsy, and irritable with blood analysis showing hyperammonemia and orotic aciduria. Considering this patient, orotic acid levels are high due to which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ammonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated glutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bypassing carbamoyl phosphate synthetase II (CPS-II)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bypassing aspartate transcarbamoylase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bypassing carbamoyl phosphate synthetase II (CPS-II)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture50.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A, Option B. The elevated ammonia is not a substrate of CPS-II and which glutamine is also elevated and is a substrate of CPS-II, higher glutamine concentrations will not overcome enzyme inhibition by its allosteric inhibitor, UTP.&lt;/li&gt;&lt;li&gt;â€¢ Option A, Option B.&lt;/li&gt;&lt;li&gt;â€¢ elevated ammonia&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ substrate of CPS-II&lt;/li&gt;&lt;li&gt;â€¢ glutamine is also elevated&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aspartate transcarbamoylase is the regulated step of pyrimidine biosynthesis in many prokaryotic cells , but not in humans. This step is necessary for pyrimidines to be synthesized starting with carbamoyl phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Aspartate transcarbamoylase&lt;/li&gt;&lt;li&gt;â€¢ regulated step of pyrimidine biosynthesis&lt;/li&gt;&lt;li&gt;â€¢ prokaryotic cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia and orotic aciduria in a neonate suggest a urea cycle defect, particularly ornithine transcarbamylase deficiency , leading to the diversion of carbamoyl phosphate into the pyrimidine synthesis pathway and bypassing CPS-II.&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia&lt;/li&gt;&lt;li&gt;âž¤ orotic aciduria&lt;/li&gt;&lt;li&gt;âž¤ neonate&lt;/li&gt;&lt;li&gt;âž¤ urea cycle defect,&lt;/li&gt;&lt;li&gt;âž¤ ornithine transcarbamylase deficiency&lt;/li&gt;&lt;li&gt;âž¤ diversion of carbamoyl phosphate&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine synthesis pathway&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child with a diagnosed urea cycle disorder presents with recurrent episodes of hyperammonemia, especially after high-protein meals. Despite dietary protein restriction and ammonia scavenging medications, the child&#x27;s ammonia levels remain intermittently elevated, leading to concerns about long-term neurological outcomes. The metabolic specialist considers augmenting the treatment regimen. Which combination of supplements could provide an alternative pathway for nitrogen excretion and help manage the child&#x27;s condition more effectively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arginine and glutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine and glutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arginine and benzoate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine and benzoate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Arginine and benzoate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture60.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arginine and glutamine: Glutamine is often elevated in UCDs as it binds with free ammonia ; however, supplementation with glutamine is not typically used for treatment because the body is already producing excess.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Arginine and glutamine:&lt;/li&gt;&lt;li&gt;â€¢ Glutamine&lt;/li&gt;&lt;li&gt;â€¢ elevated in UCDs&lt;/li&gt;&lt;li&gt;â€¢ binds with free ammonia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lysine and glutamine: Lysine is not specifically involved in the urea cycle , and, as mentioned, glutamine is typically already elevated in UCDs.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Lysine and glutamine:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ involved in the urea cycle&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lysine and benzoate: Lysine is not a supplement used in the management of UCDs , and while benzoate is used, it would not be paired with lysine for treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Lysine and benzoate:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ supplement used in the management of UCDs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Urea cycle disorders (UCDs) result in the body&#x27;s inability to properly dispose of waste nitrogen from protein metabolism , leading to hyperammonemia. Arginine supplementation can be beneficial because it provides an essential amino acid that is often deficient in UCDs.&lt;/li&gt;&lt;li&gt;âž¤ Urea cycle disorders&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s inability to properly dispose of waste nitrogen&lt;/li&gt;&lt;li&gt;âž¤ protein metabolism&lt;/li&gt;&lt;li&gt;âž¤ hyperammonemia.&lt;/li&gt;&lt;li&gt;âž¤ Arginine supplementation&lt;/li&gt;&lt;li&gt;âž¤ essential amino acid&lt;/li&gt;&lt;li&gt;âž¤ Benzoate combines with glycine to form hippurate, which provides an alternative pathway for nitrogen excretion . This combination can help reduce ammonia levels in the blood by providing substrates for other nitrogen disposal pathways.&lt;/li&gt;&lt;li&gt;âž¤ Benzoate&lt;/li&gt;&lt;li&gt;âž¤ glycine to form hippurate,&lt;/li&gt;&lt;li&gt;âž¤ alternative pathway for nitrogen excretion&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old male avid marathon runner presents to the clinic with fatigue and mild disorientation after long training sessions. Laboratory tests indicate slightly elevated ammonia levels. Given the patient&#x27;s high level of physical activity, the physician considers the main route of ammonia transport from his skeletal muscles to the liver for detoxification. What is the primary form in which ammonia is transported in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alanine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture70_0cAP8yW.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glutamine: While glutamine is a significant carrier of ammonia, particularly in the brain and other tissues , in the context of intense physical activity, alanine plays a more direct role in transporting ammonia from muscles due to its involvement in the alanine-glucose cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Glutamine:&lt;/li&gt;&lt;li&gt;â€¢ carrier of ammonia,&lt;/li&gt;&lt;li&gt;â€¢ brain and other tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both A and B: Although glutamine does play a role in ammonia transport , the primary form under conditions of intense physical activity, like marathon running, is alanine due to the rapid generation and need for detoxification of ammonia.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Both A and B:&lt;/li&gt;&lt;li&gt;â€¢ glutamine&lt;/li&gt;&lt;li&gt;â€¢ role in ammonia transport&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During intense physical activity , alanine serves as the primary transporter of ammonia from skeletal muscle to the liver for detoxification , via the alanine-glucose cycle&lt;/li&gt;&lt;li&gt;âž¤ intense physical activity&lt;/li&gt;&lt;li&gt;âž¤ alanine&lt;/li&gt;&lt;li&gt;âž¤ primary transporter of ammonia&lt;/li&gt;&lt;li&gt;âž¤ skeletal muscle&lt;/li&gt;&lt;li&gt;âž¤ liver for detoxification&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 203.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 203.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a rural health camp screening in India, a 6-year-old boy is evaluated for developmental delay and unusual skeletal features. His parents report that he has a history of frequent eye and vision issues. A genetic enzymatic defect is suspected. Which condition is associated with a defect in the enzyme cystathionine synthase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hartnupâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homocystinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystathioninuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Homocystinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hartnupâ€™s disease: Due to defective absorption of aromatic amino acids from intestine as well as reabsorption from renal tubules due to mutation of SLC6A19 gene encodes the transporter protein (B0AT1) seen in Intestine and renal tubules â†’excretion of amino acids in urine. Due to deficiency of Tryptophan, Niacin is not produced and so, the presentation is similar to Pellagra.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hartnupâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ defective absorption of aromatic amino acids&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystinuria: Due to defect/deficiency of transporter system â†’patients cannot reabsorb cysteine into their bloodstream  â†’ accumulation of cystine in urine forms crystals and stones â†’ leads to recurrent nephrolithiasis and obstruction of urine flow â†’c/f- severe, sudden flank pain, blood and WBC in urine, fever, and finally renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystinuria:&lt;/li&gt;&lt;li&gt;â€¢ defect/deficiency of transporter system&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria: Due to cystathionine deficiency , patient presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria:&lt;/li&gt;&lt;li&gt;â€¢ cystathionine deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cystathionine synthase is an enzyme critical in the metabolism of methionine, converting homocysteine to cystathionine. A deficiency in this enzyme leads to homocystinuria, a disorder characterized by elevated levels of homocysteine, which can result in developmental delay, skeletal abnormalities, and ocular issues.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 221.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-month-old baby boy presents with a 6-day history of fever, cough, breathing difficulty, and Kussmaul respiration. On examination, he appears lethargic and dehydrated, and the mother reports his urine has a distinctive cheesy odor. Urine organic acid analysis indicates increased excretion of 3-hydroxybutyric acid and moderate levels of 3-hydroxy-isovaleric acid. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isovaleric acidemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tyrosinemia Type I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenylketonuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Maple syrup urine disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Isovaleric acidemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-172139.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Isovaleric acidemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I) is due to a deficiency of enzyme fumarylacetoacetate hydrolase. C/F: mild mental retardation, Cabbage like odour in urine, hypoglycemia liver failure and finally death occurs&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatorenal Tyrosinemia (Tyrosinemia Type I)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phenylketonuria: defect in phenylalanine hydroxylase, gives mousy or musty odour.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phenylketonuria:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Maple syrup urine disease: Deficiency of the branched chain ketoacid dehydrogenase results in accumulation of branched chain ketoacids in blood, urine, and tissues. The urine has the maple syrup odour / burnt sugar smell with development of metabolic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Maple syrup urine disease:&lt;/li&gt;&lt;li&gt;â€¢ branched chain ketoacid dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ maple syrup odour&lt;/li&gt;&lt;li&gt;â€¢ burnt sugar smell&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Isovaleric acidemia is characterized by the inability to properly break down the amino acid leucine, leading to the accumulation of isovaleric acid and related metabolites, including 3-hydroxybutyric acid and 3-hydroxy-isovaleric acid. The distinctive \&quot;sweaty feet\&quot; or cheesy odor of the urine is a classic clinical clue.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 309-312.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 309-312.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-month-old baby, with a family history of a urea cycle disorder leading to the death of a sibling at 1 year of age, has been diagnosed with the same condition. What is the rationale for administering benzoic acid to individuals with a urea cycle enzyme defect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It provides an alternative route for N 2 excretion through the N-acetyl glucuronic acid conjugate kynurenine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It inhibits adenylate deaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It neutralized NH 3 in both blood as well as urine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It provides an alternative route for N 2 excretion through glycine conjugate, hippuric acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. It provides an alternative route for nitrogen (N2) excretion through the N-acetyl glucuronic acid conjugate kynurenine: This option is not accurate; kynurenine is a metabolite in the tryptophan degradation pathway and not directly related to the excretion of nitrogen in the context of urea cycle disorders.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It inhibits adenylate deaminase: Adenylate deaminase is not directly relevant to the management of urea cycle disorders or the mechanism of action of benzoic acid in these conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It neutralizes ammonia (NH3) in both blood and urine: Benzoic acid does not neutralize ammonia directly; instead, it provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In urea cycle disorders, benzoic acid provides an alternative pathway for nitrogen excretion by forming hippuric acid with glycine, thus reducing ammonia levels in the body. This is crucial for managing hyperammonemia resulting from the body&#x27;s impaired ability to convert ammonia to urea.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: page 206.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: page 206.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Nitrogen sources of UREA are ammonia and arginine. Choose the appropriate response.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture80.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The urea cycle uses nitrogen from ammonia and aspartate , with ammonia entering through carbamoyl phosphate and aspartate contributing through its conversion to argininosuccinate . Arginine, while an intermediate, is not a primary nitrogen source but is cleaved to produce urea.&lt;/li&gt;&lt;li&gt;âž¤ urea cycle&lt;/li&gt;&lt;li&gt;âž¤ nitrogen from ammonia and aspartate&lt;/li&gt;&lt;li&gt;âž¤ ammonia entering through carbamoyl phosphate&lt;/li&gt;&lt;li&gt;âž¤ aspartate&lt;/li&gt;&lt;li&gt;âž¤ conversion to argininosuccinate&lt;/li&gt;&lt;li&gt;âž¤ Arginine,&lt;/li&gt;&lt;li&gt;âž¤ not a primary nitrogen source&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 203.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 203.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old girl has been diagnosed with an inherited metabolic disorder. Her mother is cautioned that consuming \&quot;sugar-free\&quot; products containing aspartame could be harmful to her daughter&#x27;s health. Based on this advice, which genetic disorder is the girl most likely to have?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperornithinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperuricemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenylketonuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypervalinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phenylketonuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperornithinemia: This condition involves elevated levels of ornithine and is not directly related to aspartame consumption. Treatment- Low protein diet.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hyperornithinemia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperuricemia: Characterized by elevated uric acid levels, it is not influenced by aspartame intake in the context described. Treatment- Reduce dietary intake of purine and restrict alcohol, uricosuric drugs (decrease the reabsorption of uric acid from kidney tubules) and reduce the urate production by allopurinol (analog of hypoxanthine).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hyperuricemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypervalinemia: Involving elevated levels of valine, this condition is also not impacted by the consumption of aspartame. Treatment - Restrict valine in diet.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypervalinemia:&lt;/li&gt;&lt;li&gt;â€¢ -&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phenylketonuria (PKU) is an inherited metabolic disorder characterized by a deficiency in the enzyme phenylalanine hydroxylase, leading to the accumulation of phenylalanine in the body.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p304-306&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p304-306&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following statements is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conversion of glycine to serine requires folic acid and B6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ornithine decarboxylase is the rate limiting step of polyamine synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meisterâ€™s Cycle&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proline does not undergo Transamination&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meisterâ€™s Cycle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture90.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture100.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11111.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. The transport of one molecule of amino acid and regeneration of GSH requires 2 ATPs in Meisterâ€™s Cycle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glycine is converted to Serine by Serine Hydroxymethyl Transferase.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Glycine is converted to Serine&lt;/li&gt;&lt;li&gt;â€¢ Serine Hydroxymethyl Transferase.&lt;/li&gt;&lt;li&gt;â€¢ Coenzymes required are Folic acid and Pyridoxal Phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Coenzymes&lt;/li&gt;&lt;li&gt;â€¢ Folic acid&lt;/li&gt;&lt;li&gt;â€¢ Pyridoxal Phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyamines are organic compounds having multiple amino groups . They are:&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Polyamines&lt;/li&gt;&lt;li&gt;â€¢ organic compounds&lt;/li&gt;&lt;li&gt;â€¢ multiple amino groups&lt;/li&gt;&lt;li&gt;â€¢ Putrescine derived from decarboxylation of Ornithine Spermidine derived from Ornithine and Methionine Spermine derived from Ornithine and Methionine&lt;/li&gt;&lt;li&gt;â€¢ Putrescine derived from decarboxylation of Ornithine&lt;/li&gt;&lt;li&gt;â€¢ Spermidine derived from Ornithine and Methionine&lt;/li&gt;&lt;li&gt;â€¢ Spermine derived from Ornithine and Methionine&lt;/li&gt;&lt;li&gt;â€¢ Steps of Polyamine synthesis&lt;/li&gt;&lt;li&gt;â€¢ Steps of Polyamine synthesis&lt;/li&gt;&lt;li&gt;â€¢ Ornithine is decarboxylated to form putrescine, by the enzyme ornithine decarboxylase, which is the rate limiting step of polyamine synthesis. S-adenosyl Methionine is decarboxylated to form Decarboxylated SAM . Decarboxylated SAM donates 3 carbon atoms and 1 Î±-amino group to putrescine to form Spermidine. Decarboxylated SAM donates 3 carbon atoms and 1 Î±-amino group to Spermidine to form Spermine.&lt;/li&gt;&lt;li&gt;â€¢ Ornithine is decarboxylated to form putrescine, by the enzyme ornithine decarboxylase, which is the rate limiting step of polyamine synthesis.&lt;/li&gt;&lt;li&gt;â€¢ ornithine decarboxylase,&lt;/li&gt;&lt;li&gt;â€¢ rate limiting step&lt;/li&gt;&lt;li&gt;â€¢ S-adenosyl Methionine is decarboxylated to form Decarboxylated SAM .&lt;/li&gt;&lt;li&gt;â€¢ Decarboxylated SAM&lt;/li&gt;&lt;li&gt;â€¢ Decarboxylated SAM donates 3 carbon atoms and 1 Î±-amino group to putrescine to form Spermidine.&lt;/li&gt;&lt;li&gt;â€¢ Spermidine.&lt;/li&gt;&lt;li&gt;â€¢ Decarboxylated SAM donates 3 carbon atoms and 1 Î±-amino group to Spermidine to form Spermine.&lt;/li&gt;&lt;li&gt;â€¢ Spermine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amino acid that does not undergo Transamination&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Amino acid that does not undergo Transamination&lt;/li&gt;&lt;li&gt;â€¢ Proline Hydroxyproline Threonine Lysine&lt;/li&gt;&lt;li&gt;â€¢ Proline&lt;/li&gt;&lt;li&gt;â€¢ Hydroxyproline&lt;/li&gt;&lt;li&gt;â€¢ Threonine&lt;/li&gt;&lt;li&gt;â€¢ Lysine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Meister Cycle, where 3 ATPs needed for transporting one amino acid molecule and regenerating GSH, crucial in absorbing neutral amino acids.&lt;/li&gt;&lt;li&gt;âž¤ Meister Cycle,&lt;/li&gt;&lt;li&gt;âž¤ 3 ATPs&lt;/li&gt;&lt;li&gt;âž¤ transporting one amino acid molecule&lt;/li&gt;&lt;li&gt;âž¤ regenerating GSH,&lt;/li&gt;&lt;li&gt;âž¤ absorbing neutral amino acids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn present with milky white skin, white hair, and red-appearing eyes. Which enzyme defect is most commonly associated with this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylalanine hydroxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NADPH oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosinase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Homogentisic acid oxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tyrosinase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12_CnQINfC.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14_scyWKAh.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tyrosinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Albinism is most often caused by a defect in the enzyme tyrosinase, leading to a lack of melanin production and the associated clinical presentation of white skin, white hair, and red-appearing eyes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 234,238.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In managing a patient with Maple Syrup Urine Disease (MSUD), dietary restrictions are crucial. Among the following amino acids, which one does NOT need to be restricted in the diet for a patient with MSUD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoleucine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Methionine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Valine: As a BCAA, valine needs to be restricted in the diet of MSUD patients.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Valine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leucine: Leucine accumulation is particularly toxic in MSUD, necessitating dietary restriction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Leucine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isoleucine: Another BCAA that needs to be limited in the diet of patients with MSUD.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Isoleucine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Maple Syrup Urine Disease (MSUD) is characterized by a deficiency in the branched-chain Î±-keto acid dehydrogenase complex, leading to the accumulation of branched-chain amino acids (BCAAs) and their corresponding keto acids in the blood. The primary amino acids affected are leucine, isoleucine, and valine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 230.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 230.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male on tuberculosis treatment with isoniazid reports numbness and tingling in his fingers for the past 3 weeks. Laboratory tests reveal low pyridoxal phosphate levels and the presence of xanthurenic acid in urine. Which metabolic pathway&#x27;s disturbance results in xanthurenic acid excretion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylalanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tryptophan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10_2KRUokD.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phenylalanine: Disturbances in phenylalanine metabolism are associated with conditions like phenylketonuria (PKU), not characterized by xanthurenic acid excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Phenylalanine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine: Tyrosine metabolism disturbances lead to different sets of conditions, such as albinism or tyrosinemia, but not to increased xanthurenic acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Tyrosine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Histidine: Disturbances in histidine metabolism are associated with conditions like histidinemia, which do not result in xanthurenic acid excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Histidine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Xanthurenic acid excretion in urine is indicative of a disturbance in the tryptophan metabolism pathway. Isoniazid, an antitubercular drug, can cause vitamin B6 (pyridoxine) deficiency, as it competes with pyridoxal phosphate (the active form of vitamin B6) for binding sites. Vitamin B6 is a cofactor for several enzymes in the tryptophan metabolism pathway. Its deficiency can lead to an accumulation of intermediate metabolites like xanthurenic acid.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 240.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 240.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old male visits a dermatology clinic in India with white patches on the dorsal aspect of his left hand, progressively worsening over the past 3 months. Which enzyme is essential for melanin synthesis, possibly deficient in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosine Hydroxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Homogentisate Oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine Transaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tyrosinase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tyrosinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7_pW8DEa3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tyrosine Hydroxylase: Tyrosine is hydroxylated to dihydroxyphenylalanine (DOPA) by tyrosine hydroxylase, which requires BH4 and NADPH. Tyrosine hydroxylase is present in adrenal medulla and the DOPA thus generated is used for catecholamine synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tyrosine Hydroxylase:&lt;/li&gt;&lt;li&gt;â€¢ used for catecholamine synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B Homogentisate Oxidase â†’Alkaptonuria (AR inheritance) â†’results in excretion of homogentisic acid in urine. C/F- blackening of urine on standing, Ochronosis and Black pigments over joint cavities to produce arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option B Homogentisate Oxidase&lt;/li&gt;&lt;li&gt;â€¢ C/F-&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine Transaminase: Deficiency leads to Oculocutaneous Tyrosinemia (Tyrosinemia Type II), C/F - Mental retardation, keratosis of palmar surface, painful corneal lesions and photophobia with increased excretion of tyrosine and tyramine in urine. A diet low in protein is advised.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tyrosine Transaminase:&lt;/li&gt;&lt;li&gt;â€¢ C/F&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Melanin synthesis requires the enzyme tyrosinase, which catalyzes the oxidation of tyrosine to DOPA and DOPAquinone, key steps in the production of melanin. A deficiency or functional impairment in tyrosinase can lead to conditions like vitiligo or albinism, characterized by the loss of pigmentation in the skin.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 239.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-month-old infant with pale skin and blonde hair is presented to the pediatric outpatient department by her parents. The infant has two siblings with complete albinism, while both parents are phenotypically normal. Based on this family history and the clinical presentation, which statement is correct regarding albinism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased tyrosinase activity will be observed in melanocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It results in photophobia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mental retardation is the main characteristic feature in albinism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skin has high pigmentation in albinism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It results in photophobia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased tyrosinase activity: Incorrect. Albinism is usually associated with decreased or absent activity of tyrosinase in melanocytes, not increased activity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased tyrosinase activity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Mental retardation: Incorrect. Albinism does not inherently affect cognitive function; mental retardation is not a characteristic feature of albinism.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Mental retardation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Skin has high pigmentation: Incorrect. Albinism is defined by reduced or absent pigmentation in the skin.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Skin has high pigmentation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Albinism is characterized by a deficiency or absence of melanin pigmentation and can often result in photophobia due to the lack of melanin in the iris and retinal pigment epithelium. This causes increased light penetration into the eye, leading to discomfort in bright environments.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ed: p 238.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/ed: p 238.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman in India presents with fever, left flank pain radiating to the leg, and acute urinary retention. She has a similar past episode six months ago. On examination, she&#x27;s tender in the abdominal region and appears anemic. Urinalysis reveals RBCs, pus cells, WBC casts, hexagonal crystals, and amino acids. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹ Cystinosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal Fanconi syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystathioninuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cystinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystinosis: This is a lysosomal storage disorder with accumulation of excess cystine crystals in eyes and kidneys. Due to mutation in the gene CTNS, which codes for the protein cystinosin, the lysosomal cystine transporter. Symptoms: excessive urination, poor growth, photophobia and renal failure by age 6.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cystinosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal Fanconi syndrome: Caused by Cystinosis with loss of large amounts of salt and other minerals in urine. It is an example of RTA Type 2, characterized by increased urinary excretion of glucose, amino acids, bicarbonate, phosphate and salt wasting.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal Fanconi syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria: Due to cystathionase deficiency, presents with mental retardation, anemia, thrombocytopenia and endocrinopathies. Acquired Cystathioninuria might be due to pyridoxine deficiency, liver diseases and after thyroxine administration.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cystathioninuria:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of characteristic hexagonal crystals in the urine along with RBCs, pus cells, and WBC casts suggests a stone-forming condition. Cystinuria is a genetic disorder characterized by defective renal tubular reabsorption of certain amino acids including cystine, leading to the formation of cystine stones, which can manifest with urinary retention and flank pain due to obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 301-302.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 301-302.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;At a Health fair, a nutritionist sets up an interactive booth focusing on amino acids and their derivatives, highlighting their roles in nutrition and health. One of the informational posters prompts visitors to match lesser-known names of amino acid derivatives with their more common terms. A visitor, intrigued by the challenge, points to \&quot;N-Methyl Glycine\&quot; on the poster. She asks the nutritionist for its commonly known name. How should the nutritionist respond?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ergothioneine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carnosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Betaine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sarcosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-181622.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ergothioneine: This is a derivative of histidine, not related to N-Methyl Glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Ergothioneine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carnosine: This dipeptide consists of beta-alanine and histidine, differing significantly from N-Methyl Glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Carnosine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Betaine: Derived from choline, betaine serves as a methyl donor in various biochemical processes but is not synonymous with N-Methyl Glycine.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Betaine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ N-Methyl Glycine is more commonly known as sarcosine. It is a derivative of glycine, where a methyl group is added to the amino acids nitrogen atom. Sarcosine plays various roles in biological systems, including in metabolism and nutrition.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 284.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 284.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 75 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test2" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Carbohydrate Chemistry&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Carbohydrate Chemistry&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                23 Questions | 92 Total Marks | 33 min Duration | ~86.09 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 3-year-old girl is brought to the clinic with a notably protruding abdomen, an umbilical hernia, coarse facial features, corneal clouding, intellectual disability, and short stature, as depicted in the provided picture. Based on these clinical features, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Maroteaux-Lamy disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hunterâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hurlerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scheieâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hurlerâ€™s disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture31.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hurlerâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Moroteaux-Lamy disease: Deficiency of N-Acetyl-Î² D Galactosamine- 4- Sulfatase , C/F- Skeletal deformity, corneal opacity, No MR and Dermatan Sulfate in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Moroteaux-Lamy disease:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ N-Acetyl-Î² D Galactosamine- 4- Sulfatase&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hunterâ€™s disease: Deficiency of iduronate sulfatase, C/F- MR, Skeletal deformity, deafness, no corneal clouding with Dermatan Sulfate (DS) and Heparan Sulfate in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hunterâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ iduronate sulfatase,&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheieâ€™s diseases: Deficiency of L-Iduronidase , C/F- No MR with mild skeletal changes, corneal opacity and DS in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheieâ€™s diseases:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ L-Iduronidase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hurlerâ€™s disease (Mucopolysaccharidosis type I), a lysosomal storage disorder caused by a deficiency of the enzyme alpha-L-iduronidase. This deficiency leads to the accumulation of glycosaminoglycans, which results in the observed clinical features such as organomegaly (leading to a protuberant abdomen), umbilical hernia , coarse facies, corneal clouding , intellectual disability , and growth retardation.&lt;/li&gt;&lt;li&gt;âž¤ Hurlerâ€™s disease&lt;/li&gt;&lt;li&gt;âž¤ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency of the enzyme alpha-L-iduronidase.&lt;/li&gt;&lt;li&gt;âž¤ accumulation of glycosaminoglycans,&lt;/li&gt;&lt;li&gt;âž¤ observed clinical features&lt;/li&gt;&lt;li&gt;âž¤ organomegaly&lt;/li&gt;&lt;li&gt;âž¤ umbilical hernia&lt;/li&gt;&lt;li&gt;âž¤ coarse facies,&lt;/li&gt;&lt;li&gt;âž¤ corneal clouding&lt;/li&gt;&lt;li&gt;âž¤ intellectual disability&lt;/li&gt;&lt;li&gt;âž¤ growth retardation.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 638-639&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e:  p 638-639&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old patient presents with a genetic anomaly affecting the activity of disaccharidases produced by the intestinal epithelial cells. These enzymes are responsible for the digestion of various disaccharides into monosaccharides, which can then be absorbed into the bloodstream. After consuming a meal consisting of milk and oatmeal, both of which contain disaccharides, which of the following would you expect to find in higher levels in this patient compared to a healthy individual?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Galactose and fructose in the blood.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Starch in the stool&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Maltose, sucrose, and lactose in the stool&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen in the muscles&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Maltose, sucrose, and lactose in the stool&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Maltose, sucrose, and lactose in the stool&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Galactose and fructose in the blood would be lower , not higher, because these monosaccharides result from the digestion of lactose and sucrose, respectively, which is impaired in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Galactose&lt;/li&gt;&lt;li&gt;â€¢ fructose&lt;/li&gt;&lt;li&gt;â€¢ blood would be lower&lt;/li&gt;&lt;li&gt;â€¢ Option B: Starch in the stool would not necessarily be higher because starch digestion begins with salivary and pancreatic amylase , not disaccharidases.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Starch&lt;/li&gt;&lt;li&gt;â€¢ stool&lt;/li&gt;&lt;li&gt;â€¢ not necessarily be higher&lt;/li&gt;&lt;li&gt;â€¢ starch digestion begins&lt;/li&gt;&lt;li&gt;â€¢ salivary and pancreatic amylase&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glycogen in the muscles would be unaffected directly by disaccharidase activity as it is dependent on the uptake of glucose from the blood, which would be reduced due to the malabsorption of its precursor disaccharides.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Glycogen&lt;/li&gt;&lt;li&gt;â€¢ muscles&lt;/li&gt;&lt;li&gt;â€¢ unaffected directly by disaccharidase activity&lt;/li&gt;&lt;li&gt;â€¢ dependent on the uptake&lt;/li&gt;&lt;li&gt;â€¢ glucose from the blood,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Starch: digested to small oligosaccharides and maltose but produce lower quantity of glucose due to deficiency of the brush border disaccharidases, which include sucrase and lactase. So, Sucrose and lactose will not be cleaved and will accumulate.&lt;/li&gt;&lt;li&gt;âž¤ Starch:&lt;/li&gt;&lt;li&gt;âž¤ digested&lt;/li&gt;&lt;li&gt;âž¤ small oligosaccharides&lt;/li&gt;&lt;li&gt;âž¤ maltose&lt;/li&gt;&lt;li&gt;âž¤ produce lower quantity of glucose&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ brush border disaccharidases,&lt;/li&gt;&lt;li&gt;âž¤ sucrase and lactase.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 538, 599&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e:  p 538, 599&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a long-standing history of type I diabetes mellitus has been diligently adhering to insulin therapy, yet consistently records fasting and postprandial blood glucose levels that exceed the normal range. To assist in better glucose regulation, a dietician suggests an increased intake of dietary fiber. Among the Option listed below, which type of dietary fiber is most beneficial for managing blood glucose levels in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cellulose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemicellulose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lignin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pectin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pectin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pectin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cellulose : These are polymers of glucose. It retains water in feces; promotes peristalsis and increases bowel action. It is the starting material for production of fibres, celluloids, nitrocellulose, and plastics.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cellulose&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemicellulose : These include pentoses, hexoses and uronic acid, which retains water in feces and increases bile acid excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hemicellulose&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lignin : They are aromatic alcohols with hypocholesterolemic, antioxidant action and also increases bile acid excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lignin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dietary fibers are classified as soluble (pectin, gums, mucilages) or insoluble (cellulose, hemicellulose, lignin). Soluble fibers like pectin form viscous gels that slow digestion and absorption of carbohydrates, making them particularly beneficial for blood glucose management in diabetes. Pectin is found in fruits (especially apples, citrus fruits), berries, and some vegetables. Insoluble fibers primarily improve bowel health and regularity without significantly affecting blood glucose levels directly.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: P 156-158.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of acute glomerulonephritis, who is currently under treatment, attends a routine follow-up appointment. The focus is on the integrity and function of the glomerular basement membrane (GBM) in relation to kidney function. Which mucopolysaccharide present in the GBM is primarily responsible for maintaining the charge-based filtration function of the kidney?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparan sulphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chondroitin sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyaluronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Keratan sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Heparan sulphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Heparan sulphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chondroitin sulphate: present in the ground substance of connective tissues which is distributed in cartilage, bone, tendons, cornea and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chondroitin sulphate:&lt;/li&gt;&lt;li&gt;â€¢ ground substance&lt;/li&gt;&lt;li&gt;â€¢ connective tissues&lt;/li&gt;&lt;li&gt;â€¢ cartilage, bone, tendons, cornea and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyaluronic acid: present in connective tissues , tendons , synovial fluid and vitreous humor and acts as a lubricant and shock absorber in joint cavities.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyaluronic acid:&lt;/li&gt;&lt;li&gt;â€¢ connective tissues&lt;/li&gt;&lt;li&gt;â€¢ tendons&lt;/li&gt;&lt;li&gt;â€¢ synovial fluid&lt;/li&gt;&lt;li&gt;â€¢ vitreous humor&lt;/li&gt;&lt;li&gt;â€¢ lubricant&lt;/li&gt;&lt;li&gt;â€¢ shock absorber&lt;/li&gt;&lt;li&gt;â€¢ Option D: Keratan sulphate: only GAG, which does not contain uronic acid and found in cornea and tendons , thereby maintaining corneal transparency.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Keratan sulphate:&lt;/li&gt;&lt;li&gt;â€¢ does not contain uronic acid&lt;/li&gt;&lt;li&gt;â€¢ cornea and tendons&lt;/li&gt;&lt;li&gt;â€¢ corneal transparency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Heparan sulphate is a key component of the glomerular basement membrane and is vital for its normal function . It provides the GBM with a negative charge , which is essential for the selective filtration of molecules based on size and charge, preventing the passage of negatively charged proteins such as albumin into the urine.&lt;/li&gt;&lt;li&gt;âž¤ Heparan sulphate&lt;/li&gt;&lt;li&gt;âž¤ glomerular basement membrane&lt;/li&gt;&lt;li&gt;âž¤ vital for its normal function&lt;/li&gt;&lt;li&gt;âž¤ GBM with a negative charge&lt;/li&gt;&lt;li&gt;âž¤ essential for the selective filtration&lt;/li&gt;&lt;li&gt;âž¤ molecules based on size and charge,&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 638, Lippincott 7/e : P 159&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e:  p 638, Lippincott 7/e : P 159&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged man presents with a diagnosis of mucopolysaccharidosis, characterized by the accumulation of glycosaminoglycans (GAGs). One GAG that has accumulated is known to play a critical role in the charge selectiveness of the renal glomerular membrane. Which of the following GAGs is responsible for maintaining the charge selectiveness of the renal glomerular membrane?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparan sulphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dermatan sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyaluronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Keratan sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Heparan sulphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Heparan sulphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Dermatan sulphate : found in skin, blood vessels and heart valves and determines the elasticity of heart valve and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Dermatan sulphate&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyaluronic acid : present in connective tissues, tendons, synovial fluid and vitreous humor and acts as a lubricant and shock absorber in joint cavities.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hyaluronic acid&lt;/li&gt;&lt;li&gt;â€¢ Option D: Keratan sulphate : only GAG, which does not contain uronic acid and found in cornea and tendons, thereby maintaining corneal transparency.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Keratan sulphate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Heparan sulfate is a key component of the glomerular basement membrane (GBM) and contributes to its negative charge. This charge barrier is essential for the selective filtration of molecules based on size and charge.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 638, Lippincott 6/ed: p 159&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged woman who has recently experienced several episodes of diarrhea was advised by her general practitioner to consume fructans like inulin, which serve as prebiotics due to their non-digestibility. What is the primary reason for the resistance of such carbohydrates to digestion in the upper gastrointestinal tract?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Beta configuration of anomeric C1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low pH of the stomach&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta configuration of anomeric C2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of Î±-Glycosidic linkage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta configuration of anomeric C2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Beta configuration of anomeric C2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key mechanism that makes fructans like inulin function as effective prebiotics is their resistance to digestion in the upper GI tract due to the beta configuration at the anomeric C2 carbon. This structural feature creates Î²-glycosidic linkages between fructose units that human digestive enzymes cannot break down. As a result, these carbohydrates pass intact to the lower intestine where they selectively stimulate the growth of beneficial bacteria, particularly Bifidobacteria and Lactobacilli.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In considering the chemical structure of lactose as it pertains to its digestion and metabolism within the human body, it is essential to identify the specific type of glycosidic bond present. Which of the following best describes the glycosidic linkage found in the disaccharide lactose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î‘ (1 -&amp;gt; 4)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î² (1 -&amp;gt; 4)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î± 1 -&amp;gt; Î²4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î± (1 -&amp;gt; 6)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Î² (1 -&gt; 4)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture32.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Î² (1 -&amp;gt; 4)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: An Î± (1 -&amp;gt; 4) glycosidic bond is found in maltose , not lactose.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Î± (1 -&amp;gt; 4) glycosidic bond&lt;/li&gt;&lt;li&gt;â€¢ maltose&lt;/li&gt;&lt;li&gt;â€¢ Option C: An Î± (1 -&amp;gt; 6) linkage is characteristic of the branching point in lactulose, glycogen and starch, not found in lactose.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Î± (1 -&amp;gt; 6) linkage&lt;/li&gt;&lt;li&gt;â€¢ branching point in lactulose,&lt;/li&gt;&lt;li&gt;â€¢ glycogen&lt;/li&gt;&lt;li&gt;â€¢ starch,&lt;/li&gt;&lt;li&gt;â€¢ Option D: Î² (1 -&amp;gt; 6) - It is typically seen in Isomaltose and structural polysaccharides like cellulose.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Î² (1 -&amp;gt; 6)&lt;/li&gt;&lt;li&gt;â€¢ Isomaltose&lt;/li&gt;&lt;li&gt;â€¢ structural polysaccharides&lt;/li&gt;&lt;li&gt;â€¢ cellulose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e p 77.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e p 77.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Amino sugars are a crucial component in various biological structures and functions. When assessing the characteristics of amino sugars, which of the following statements is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucosamine is an amino sugar&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Precursor is glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antibiotic that contains amino sugar is tetracycline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amino group is donated by Glutamine.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Antibiotic that contains amino sugar is tetracycline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Antibiotic that contains amino sugar is tetracycline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A : Glucosamine is indeed an amino sugar, commonly found in the exoskeleton of crustaceans and in the human body as part of the structure of glycosaminoglycans.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B : The precursor for the synthesis of most amino sugars is indeed glucose, which undergoes enzymatic transformation to introduce an amino group.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option D : In the biosynthesis of amino sugars, the amino group is typically donated by the amino acid glutamine.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Important amino sugars are:&lt;/li&gt;&lt;li&gt;âž¤ Glucosamine Galactosamine Mannosamine.&lt;/li&gt;&lt;li&gt;âž¤ Glucosamine&lt;/li&gt;&lt;li&gt;âž¤ Galactosamine&lt;/li&gt;&lt;li&gt;âž¤ Mannosamine.&lt;/li&gt;&lt;li&gt;âž¤ Glucose is the precursor of Amino Sugar. Amino group is denoted by Glutamine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;By examining the molecular structures of D-Glucose and D-Galactose, these two sugars are nearly identical except for the arrangement around a single carbon atom, which classifies them as epimers. Which carbon is responsible for their epimeric relationship?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;C4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. C4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture13.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) C4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: 2nd Epimer of Glucose â€“ Mannose&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ 2nd Epimer&lt;/li&gt;&lt;li&gt;â€¢ Option B: 3rd Epimer of Glucose â€“ Allose&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ 3rd Epimer&lt;/li&gt;&lt;li&gt;â€¢ Allose&lt;/li&gt;&lt;li&gt;â€¢ Option D: C5 is not an epimeric center between glucose and galactose, as both sugars have the same configuration at this carbon atom. Ruled out.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ C5&lt;/li&gt;&lt;li&gt;â€¢ not an epimeric center&lt;/li&gt;&lt;li&gt;â€¢ glucose and galactose,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To correctly identify epimeric carbon atoms in carbohydrate chemistry, noting that epimers are sugars that differ only in the configuration around one specific carbon atom.&lt;/li&gt;&lt;li&gt;âž¤ epimeric carbon atoms&lt;/li&gt;&lt;li&gt;âž¤ carbohydrate chemistry,&lt;/li&gt;&lt;li&gt;âž¤ epimers are sugars&lt;/li&gt;&lt;li&gt;âž¤ configuration&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p153.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p153.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with chronic congestive heart failure (CCF) has been prescribed digoxin, which enhances cardiac contractility and rhythm. Digoxin comprises a sugar moiety and a non-sugar (aglycone) component linked via an oxygen atom. What is the chemical classification of digoxin based on this structure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycoside&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycoprotein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oligosaccharide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polysaccharide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycoside&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glycoside.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glycoprotein: When the carbohydrate chains are attached to a polypeptide chain it is called a proteoglycan and if the carbohydrate content is less than 10%, it is generally named as a glycoprotein.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glycoprotein:&lt;/li&gt;&lt;li&gt;â€¢ proteoglycan&lt;/li&gt;&lt;li&gt;â€¢ glycoprotein.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oligosaccharide: Further addition of sugar groups to a Trisaccharide produces tetrasaccharides, pentasaccharides and so on, known as oligosaccharides.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oligosaccharide:&lt;/li&gt;&lt;li&gt;â€¢ sugar groups&lt;/li&gt;&lt;li&gt;â€¢ Trisaccharide&lt;/li&gt;&lt;li&gt;â€¢ oligosaccharides.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Polysaccharide: Polymerized products of many monosaccharide units.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Polysaccharide:&lt;/li&gt;&lt;li&gt;â€¢ products of many monosaccharide units.&lt;/li&gt;&lt;li&gt;â€¢ They may be:&lt;/li&gt;&lt;li&gt;â€¢ Homoglycans ( single kind of monosaccharides, e.g. starch, glycogen and cellulose) Heteroglycans ( two or more different monosaccharides, e.g. hyaluronic acid, chondroitin sulphate).&lt;/li&gt;&lt;li&gt;â€¢ Homoglycans ( single kind of monosaccharides, e.g. starch, glycogen and cellulose)&lt;/li&gt;&lt;li&gt;â€¢ Homoglycans (&lt;/li&gt;&lt;li&gt;â€¢ Heteroglycans ( two or more different monosaccharides, e.g. hyaluronic acid, chondroitin sulphate).&lt;/li&gt;&lt;li&gt;â€¢ Heteroglycans (&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The chemical structure of digoxin is a cardiac glycoside , which has therapeutic effects in heart failure by increasing the force of cardiac muscle contraction.&lt;/li&gt;&lt;li&gt;âž¤ chemical structure of digoxin&lt;/li&gt;&lt;li&gt;âž¤ cardiac glycoside&lt;/li&gt;&lt;li&gt;âž¤ therapeutic effects&lt;/li&gt;&lt;li&gt;âž¤ heart failure&lt;/li&gt;&lt;li&gt;âž¤ increasing the force of cardiac muscle contraction.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 7/e: 75.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 7/e: 75.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A one-month-old infant exhibits severe abdominal distension, pain, and diarrhea after breastfeeding. Urinalysis indicates the presence of a reducing sugar. The subsequent test yields the crystal formation shown in the image. What type of crystals are these?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucosazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructosazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactosazone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Maltosazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lactosazone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture15.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture16.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lactosazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glucosazone and B: Fructosazone: The differences in glucose , fructose and mannose are dependent on the first and second carbon atoms , and when the Osazone is formed these differences are masked . Hence, these 3 sugars will produce the same needle-shaped crystals arranged like sheaves of corn or a broom.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glucosazone and B: Fructosazone:&lt;/li&gt;&lt;li&gt;â€¢ differences in glucose&lt;/li&gt;&lt;li&gt;â€¢ fructose&lt;/li&gt;&lt;li&gt;â€¢ mannose&lt;/li&gt;&lt;li&gt;â€¢ dependent on the first&lt;/li&gt;&lt;li&gt;â€¢ second carbon atoms&lt;/li&gt;&lt;li&gt;â€¢ Osazone&lt;/li&gt;&lt;li&gt;â€¢ formed&lt;/li&gt;&lt;li&gt;â€¢ differences are masked&lt;/li&gt;&lt;li&gt;â€¢ needle-shaped crystals&lt;/li&gt;&lt;li&gt;â€¢ Option D: Maltosazone: sunflower or petal shaped.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D:&lt;/li&gt;&lt;li&gt;â€¢ Maltosazone:&lt;/li&gt;&lt;li&gt;â€¢ petal shaped.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lactose intolerance or lactase deficiency in an infant, diagnosed by the presence of lactosazone crystals in the urine following the ingestion of lactose from breast milk.&lt;/li&gt;&lt;li&gt;âž¤ Lactose intolerance&lt;/li&gt;&lt;li&gt;âž¤ lactase deficiency&lt;/li&gt;&lt;li&gt;âž¤ infant,&lt;/li&gt;&lt;li&gt;âž¤ presence of lactosazone crystals&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ ingestion of lactose from breast milk.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 7/e: 73-74.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 7/e: 73-74.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinician is explaining the importance of various glycosaminoglycans (GAGs) in the human body to a group of medical students. One topic of discussion is the essential role certain GAGs play in maintaining corneal transparency, a crucial property for proper vision. Which GAG is primarily responsible for this function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Keratan sulphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chondroitin sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dermatan Sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyaluronic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Keratan sulphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Keratan Sulfate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chondroitin sulphate: present in the ground substance of connective tissues which is distributed in cartilage, bone, tendons, cornea, and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Chondroitin sulphate:&lt;/li&gt;&lt;li&gt;â€¢ ground substance&lt;/li&gt;&lt;li&gt;â€¢ connective tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dermatan sulphate: Found in skin, blood vessels and heart valves and determines the elasticity of heart valve and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dermatan sulphate:&lt;/li&gt;&lt;li&gt;â€¢ skin, blood vessels&lt;/li&gt;&lt;li&gt;â€¢ heart valves&lt;/li&gt;&lt;li&gt;â€¢ elasticity of heart valve&lt;/li&gt;&lt;li&gt;â€¢ skin.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyaluronic acid: present in connective tissues, tendons, synovial fluid and vitreous humor and acts as a lubricant and shock absorber in joint cavities.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyaluronic acid:&lt;/li&gt;&lt;li&gt;â€¢ connective tissues,&lt;/li&gt;&lt;li&gt;â€¢ tendons,&lt;/li&gt;&lt;li&gt;â€¢ synovial fluid&lt;/li&gt;&lt;li&gt;â€¢ vitreous humor&lt;/li&gt;&lt;li&gt;â€¢ lubricant&lt;/li&gt;&lt;li&gt;â€¢ shock absorber&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Keratan sulphate is the GAG that plays a significant role in maintaining corneal transparency . It is highly sulfated , which facilitates the arrangement of collagen fibers in the cornea in a uniformly spaced pattern , essential for the cornea&#x27;s transparency.&lt;/li&gt;&lt;li&gt;âž¤ Keratan sulphate&lt;/li&gt;&lt;li&gt;âž¤ GAG&lt;/li&gt;&lt;li&gt;âž¤ significant role in maintaining corneal transparency&lt;/li&gt;&lt;li&gt;âž¤ highly sulfated&lt;/li&gt;&lt;li&gt;âž¤ facilitates&lt;/li&gt;&lt;li&gt;âž¤ arrangement of collagen fibers&lt;/li&gt;&lt;li&gt;âž¤ cornea in a uniformly spaced pattern&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 638, Lippincott 7/e: P 159&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e:  p 638, Lippincott 7/e: P 159&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the structural hierarchy of proteoglycans, which are crucial to the extracellular matrix&#x27;s organization, one particular component forms the backbone to which the protein-bound glycosaminoglycan (GAG) chains are attached. This backbone allows the proteoglycan to maintain its structure and function. Which of the following is the backbone component of proteoglycan molecules?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparan sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Keratan sulphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyaluronic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dermatan sulphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyaluronic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hyaluronic acid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Heparan sulphate is a type of glycosaminoglycan that binds to core proteins but is not the backbone itself.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Heparan sulphate&lt;/li&gt;&lt;li&gt;â€¢ type of glycosaminoglycan&lt;/li&gt;&lt;li&gt;â€¢ binds to core proteins&lt;/li&gt;&lt;li&gt;â€¢ Option B: Keratan sulphate is another glycosaminoglycan present on proteoglycans but again does not serve as the backbone.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Keratan sulphate&lt;/li&gt;&lt;li&gt;â€¢ glycosaminoglycan&lt;/li&gt;&lt;li&gt;â€¢ proteoglycans&lt;/li&gt;&lt;li&gt;â€¢ Option D: Dermatan sulphate is a glycosaminoglycan that is typically found linked to a protein as part of a proteoglycan but is not the central backbone molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Dermatan sulphate&lt;/li&gt;&lt;li&gt;â€¢ glycosaminoglycan&lt;/li&gt;&lt;li&gt;â€¢ found linked to a protein&lt;/li&gt;&lt;li&gt;â€¢ part of a proteoglycan&lt;/li&gt;&lt;li&gt;â€¢ central backbone molecule.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyaluronic acid is the backbone of proteoglycan aggregates in the extracellular matrix . It provides a central core that other proteoglycans attach to non-covalently, forming large , complex structures that contribute to the matrix&#x27;s function .&lt;/li&gt;&lt;li&gt;âž¤ Hyaluronic acid&lt;/li&gt;&lt;li&gt;âž¤ backbone of&lt;/li&gt;&lt;li&gt;âž¤ proteoglycan aggregates&lt;/li&gt;&lt;li&gt;âž¤ extracellular matrix&lt;/li&gt;&lt;li&gt;âž¤ central core&lt;/li&gt;&lt;li&gt;âž¤ proteoglycans attach to non-covalently, forming large&lt;/li&gt;&lt;li&gt;âž¤ complex structures&lt;/li&gt;&lt;li&gt;âž¤ matrix&#x27;s function&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e p 80.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e p 80.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy is evaluated for joint stiffness and gait difficulties that have persisted for the last three months. Additionally, he is experiencing visual disturbances. On examination, the patient exhibits hepatosplenomegaly, coarse facial features including a short neck, low-set ears, a depressed nasal bridge, and is found to have a low IQ. Urinary tests reveal the presence of heparan sulfate and dermatan sulfate, and a fibroblast assay indicates a deficiency of the enzyme L-Iduronidase. Based on these findings, the child has been diagnosed with mucopolysaccharidosis (MPS). Which specific type of MPS is indicated by these clinical and laboratory findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Moroteaux-Lamy disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hunterâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hurlerâ€™s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scheieâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hurlerâ€™s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hurlerâ€™s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maroteaux-Lamy disease (MPS VI):&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maroteaux-Lamy disease (MPS VI):&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Clinical features: Skeletal deformities, corneal opacity, normal intelligence&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B)&lt;/li&gt;&lt;li&gt;â€¢ Clinical features: Skeletal deformities, corneal opacity, normal intelligence&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hunter&#x27;s disease (MPS II):&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hunter&#x27;s disease (MPS II):&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of iduronate sulfatase Clinical features: Developmental delay, skeletal deformities, hearing loss No corneal clouding (important distinguishing feature) X-linked recessive inheritance&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of iduronate sulfatase&lt;/li&gt;&lt;li&gt;â€¢ Clinical features: Developmental delay, skeletal deformities, hearing loss&lt;/li&gt;&lt;li&gt;â€¢ No corneal clouding (important distinguishing feature)&lt;/li&gt;&lt;li&gt;â€¢ X-linked recessive inheritance&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheie&#x27;s disease (MPS I-S, milder form of MPS I):&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheie&#x27;s disease (MPS I-S, milder form of MPS I):&lt;/li&gt;&lt;li&gt;â€¢ Partial Deficiency of Î±-L-Iduronidase Clinical features: Normal intelligence, mild skeletal changes, corneal opacity&lt;/li&gt;&lt;li&gt;â€¢ Partial Deficiency of Î±-L-Iduronidase&lt;/li&gt;&lt;li&gt;â€¢ Clinical features: Normal intelligence, mild skeletal changes, corneal opacity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Mucopolysaccharidosis&lt;/li&gt;&lt;li&gt;âž¤ Mucopolysaccharidosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 638-639, Nelson 20/e Tables 82.1 and 82.2&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-year-old Boy was brought by his parents with delayed developmental milestones and pain in lower limbs and difficulty in walking for 3 months. O/E: child had stiffness of joints in both upper and lower limbs and has coarse facial features, low IQ and hepatomegaly, no corneal clouding. Urinary examination: presence of heparan sulfate and dermatan sulphate; fibroblast study: Deficiency of enzyme iduronate sulfatase. What is your diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Moroteaux-Lamy disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hunterâ€™s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hurlerâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scheie disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hunterâ€™s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture19.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Hunterâ€™s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maroteaux-Lamy disease : Deficiency of N-Acetyl-Î² D Galactosamine- 4- Sulfatase, C/F- Skeletal deformity, corneal opacity, No MR and Dermatan Sulfate in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Maroteaux-Lamy disease&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hurlerâ€™s disease : Is due to the deficiency of enzyme Î±-L Iduronidase causes accumulation of dermatan sulphate and heparan sulphate. C/F: Mental retardation, coarse facial features, hepatosplenomegaly, cloudy cornea&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hurlerâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheieâ€™s disease : Deficiency of L-Iduronidase, C/F- No MR with mild skeletal changes, corneal opacity and DS in urine.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Scheieâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Mucopolysaccharidosis&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 638-639, Nelson 20/e Tables 82.1 and 82.2&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In individuals experiencing hemolysis, the long-term control of blood sugar levels cannot be accurately assessed using glycated hemoglobin (HbA1c) due to the shortened lifespan of red blood cells. Instead, another biomarker must be utilized. Fructosamine, which refers to glycated serum proteins such as albumin, has been suggested as an alternative measure. Is the statement that fructosamine is a glycated albumin true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of the Above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fructosamine is a measure of glycemic control that can be used as an alternative to HbA1c, particularly in situations where red blood cell turnover is increased , such as hemolysis . It specifically reflects the glycation of serum proteins like albumin over a shorter time frame.&lt;/li&gt;&lt;li&gt;âž¤ Fructosamine&lt;/li&gt;&lt;li&gt;âž¤ measure of glycemic control&lt;/li&gt;&lt;li&gt;âž¤ used as an alternative to HbA1c,&lt;/li&gt;&lt;li&gt;âž¤ red blood cell turnover is increased&lt;/li&gt;&lt;li&gt;âž¤ hemolysis&lt;/li&gt;&lt;li&gt;âž¤ reflects the glycation of serum proteins&lt;/li&gt;&lt;li&gt;âž¤ albumin&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e p 330.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e p 330.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the statements provided below, each delves into different aspects of stereochemistry and carbohydrate chemistry. Identify the statement that is accurately described.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Equimolar mixture of optical isomers are called as Racemic Mixture&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructose is an Invert Sugar&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutarotation is a property of C2 atom&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The penultimate carbon atom in Glucose is C-2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Equimolar mixture of optical isomers are called as Racemic Mixture&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Equimolar mixture of optical isomers are called as Racemic Mixture&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fructose is part of what is termed \&quot;invert sugar\&quot; when combined with glucose , especially after the hydrolysis of sucrose . The statement is misleading as it implies fructose alone is invert sugar, which is not accurate.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Fructose&lt;/li&gt;&lt;li&gt;â€¢ \&quot;invert sugar\&quot;&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ after the hydrolysis of sucrose&lt;/li&gt;&lt;li&gt;â€¢ Option C: Mutarotation is the change in the optical rotation due to the change in the equilibrium between two anomers , often related to the anomeric carbon, which in glucose and many other sugars is C1, not C2.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Mutarotation&lt;/li&gt;&lt;li&gt;â€¢ change in the optical rotation&lt;/li&gt;&lt;li&gt;â€¢ change in the equilibrium between two anomers&lt;/li&gt;&lt;li&gt;â€¢ Option D: The penultimate carbon atom in glucose , a six-carbon sugar (hexose), is C-5, not C-2.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ penultimate carbon atom in glucose&lt;/li&gt;&lt;li&gt;â€¢ six-carbon sugar&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Racemic Mixture : Equimolar mixture of optical isomers which has no net rotation of plane polarized light . Sucrose is Otherwise Called Invert Sugar. Sucrose is dextrorotatory and on hydrolysis it yields a mixture of dextrorotatory Glucose and levorotatory Fructose. Because of the strong levorotatory nature of fructose, Sucrose on hydrolysis becomes levorotatory. Hence, Sucrose is called invert sugar.&lt;/li&gt;&lt;li&gt;âž¤ Racemic Mixture&lt;/li&gt;&lt;li&gt;âž¤ Equimolar mixture&lt;/li&gt;&lt;li&gt;âž¤ optical isomers&lt;/li&gt;&lt;li&gt;âž¤ no net rotation of plane polarized light&lt;/li&gt;&lt;li&gt;âž¤ Sucrose&lt;/li&gt;&lt;li&gt;âž¤ Called Invert Sugar. Sucrose&lt;/li&gt;&lt;li&gt;âž¤ dextrorotatory&lt;/li&gt;&lt;li&gt;âž¤ hydrolysis it yields a mixture of dextrorotatory Glucose&lt;/li&gt;&lt;li&gt;âž¤ levorotatory Fructose.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e p 71.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e p 71.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following pairs represent enantiomers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;D-Galactose and L-Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;d- Galactose and l-Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D-Mannose and L-Mannose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;d-Mannose and l-Mannose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. D-Mannose and L-Mannose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) D-Mannose and L-Mannose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ D and L Isomerism [Enantiomers]&lt;/li&gt;&lt;li&gt;âž¤ D and L Isomerism [Enantiomers]&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Difference in the orientation of the H and OH group around the Penultimate Carbon atom results in two mirror images known as D and L isomers (Enantiomers).&lt;/li&gt;&lt;li&gt;â†³ Difference&lt;/li&gt;&lt;li&gt;â†³ orientation of the H and OH group&lt;/li&gt;&lt;li&gt;â†³ Penultimate Carbon atom&lt;/li&gt;&lt;li&gt;â†³ two mirror images&lt;/li&gt;&lt;li&gt;â†³ D and L isomers (Enantiomers).&lt;/li&gt;&lt;li&gt;â†³ The penultimate carbon atom is named as Reference Carbon atom.&lt;/li&gt;&lt;li&gt;â†³ penultimate carbon atom&lt;/li&gt;&lt;li&gt;â†³ Reference Carbon atom.&lt;/li&gt;&lt;li&gt;â†³ The penultimate carbon atom in Glucose and Fructose is C-5.&lt;/li&gt;&lt;li&gt;â†³ penultimate carbon atom&lt;/li&gt;&lt;li&gt;â†³ Glucose and Fructose is C-5.&lt;/li&gt;&lt;li&gt;â†³ Most of the naturally occurring Monosaccharides are D isomers.&lt;/li&gt;&lt;li&gt;â†³ Examples of Enantiomers&lt;/li&gt;&lt;li&gt;â†³ Examples of Enantiomers&lt;/li&gt;&lt;li&gt;â†³ D-Glucose and L-Glucose D-Fructose and L-Fructose D-Mannose and L-Mannose D-Glyceraldehyde and L-Glyceraldehyde.&lt;/li&gt;&lt;li&gt;â†³ D-Glucose and L-Glucose&lt;/li&gt;&lt;li&gt;â†³ D-Fructose and L-Fructose&lt;/li&gt;&lt;li&gt;â†³ D-Mannose and L-Mannose&lt;/li&gt;&lt;li&gt;â†³ D-Glyceraldehyde and L-Glyceraldehyde.&lt;/li&gt;&lt;li&gt;â†³ Ref: Harper 30/e p153.&lt;/li&gt;&lt;li&gt;â†³ Ref:&lt;/li&gt;&lt;li&gt;â†³ Harper 30/e p153.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinician evaluates a patient with decreased visual acuity and diagnoses cataracts, a condition characterized by clouding of the lens. The development of cataracts can be influenced by various metabolic factors, including the accumulation of certain substances within the lens. Among the following, which substance&#x27;s accumulation is most commonly associated with the formation of cataracts?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Galactose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sugar amines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sugar alcohols&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sugar alcohols&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Sugar alcohol.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: While high blood glucose levels are a risk factor for cataract development , glucose itself does not accumulate in the lens to the extent that it directly causes cataracts. Instead, its conversion to sorbitol is the main issue.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ high blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ risk factor for cataract development&lt;/li&gt;&lt;li&gt;â€¢ does not accumulate in the lens&lt;/li&gt;&lt;li&gt;â€¢ Option B: Galactose can lead to cataracts, primarily in conditions like galactosemia, where there&#x27;s an inability to metabolize galactose properly , leading to its accumulation in various tissues, including the lens . This option is also plausible but less common than the accumulation of sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Galactose&lt;/li&gt;&lt;li&gt;â€¢ lead to cataracts,&lt;/li&gt;&lt;li&gt;â€¢ galactosemia,&lt;/li&gt;&lt;li&gt;â€¢ inability to metabolize galactose properly&lt;/li&gt;&lt;li&gt;â€¢ accumulation in various tissues,&lt;/li&gt;&lt;li&gt;â€¢ lens&lt;/li&gt;&lt;li&gt;â€¢ Option C: Sugar amines are not directly associated with cataract formation . While glycation of lens proteins by sugars can contribute to cataractogenesis, the accumulation of specific sugar amines is not a well-recognized cause.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Sugar amines&lt;/li&gt;&lt;li&gt;â€¢ not directly associated with cataract formation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Diabetes mellitus, in the lens by polyol pathway, glucose converted to sorbitol by the enzyme Aldose reductase In galactosemia, Dulcitol or Galactitol is responsible for cataract Sorbitol , Dulcitol are sugar alcohols.&lt;/li&gt;&lt;li&gt;âž¤ In Diabetes mellitus, in the lens by polyol pathway, glucose converted to sorbitol by the enzyme Aldose reductase&lt;/li&gt;&lt;li&gt;âž¤ Diabetes mellitus,&lt;/li&gt;&lt;li&gt;âž¤ lens by polyol pathway,&lt;/li&gt;&lt;li&gt;âž¤ sorbitol&lt;/li&gt;&lt;li&gt;âž¤ In galactosemia, Dulcitol or Galactitol is responsible for cataract&lt;/li&gt;&lt;li&gt;âž¤ Dulcitol or Galactitol&lt;/li&gt;&lt;li&gt;âž¤ Sorbitol , Dulcitol are sugar alcohols.&lt;/li&gt;&lt;li&gt;âž¤ Sorbitol&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p205.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the study of glycosaminoglycans (GAGs) or mucopolysaccharides, understanding the structural components is crucial. Most GAGs are composed of repeating disaccharide units that include an amino sugar and often a uronic acid. However, one of the GAGs listed below is unique because it does not contain a uronic acid residue in its structure. Which GAG is this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparan Sulfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyaluronic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dermatan Sulfate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Keratan Sulfate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Keratan Sulfate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Keratan Sulfate.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Heparan sulphate: It is seen in the basement membrane of the kidney with type IV collagen and laminin and plays a major role in determining the charge selectiveness of glomerular filtration&lt;/li&gt;&lt;li&gt;â€¢ Option A: Heparan sulphate:&lt;/li&gt;&lt;li&gt;â€¢ basement membrane of the kidney&lt;/li&gt;&lt;li&gt;â€¢ type IV collagen&lt;/li&gt;&lt;li&gt;â€¢ laminin&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hyaluronic acid: Present in connective tissues , tendons , synovial fluid and vitreous humor and acts as a lubricant and shock absorber in joint cavities&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hyaluronic acid:&lt;/li&gt;&lt;li&gt;â€¢ connective tissues&lt;/li&gt;&lt;li&gt;â€¢ tendons&lt;/li&gt;&lt;li&gt;â€¢ synovial fluid&lt;/li&gt;&lt;li&gt;â€¢ vitreous humor&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dermatan sulphate: Found in skin, blood vessels and heart valves and determines the elasticity of heart valve and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Dermatan sulphate:&lt;/li&gt;&lt;li&gt;â€¢ skin, blood vessels&lt;/li&gt;&lt;li&gt;â€¢ heart valves&lt;/li&gt;&lt;li&gt;â€¢ elasticity of heart valve and skin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Only GAG, which does not contain uronic acid and found in cornea and tendons and helps in maintaining corneal transparency. GAG with no Uronic Acid- Keratan Sulfate GAG with no Sulfate group- Hyaluronic Acid GAG not covalently linked to Protein- Hyaluronic Acid.&lt;/li&gt;&lt;li&gt;âž¤ Only GAG, which does not contain uronic acid and found in cornea and tendons and helps in maintaining corneal transparency.&lt;/li&gt;&lt;li&gt;âž¤ Only GAG,&lt;/li&gt;&lt;li&gt;âž¤ not contain uronic acid&lt;/li&gt;&lt;li&gt;âž¤ found in cornea&lt;/li&gt;&lt;li&gt;âž¤ tendons&lt;/li&gt;&lt;li&gt;âž¤ maintaining corneal transparency.&lt;/li&gt;&lt;li&gt;âž¤ GAG with no Uronic Acid- Keratan Sulfate&lt;/li&gt;&lt;li&gt;âž¤ Keratan Sulfate&lt;/li&gt;&lt;li&gt;âž¤ GAG with no Sulfate group- Hyaluronic Acid&lt;/li&gt;&lt;li&gt;âž¤ Hyaluronic Acid&lt;/li&gt;&lt;li&gt;âž¤ GAG not covalently linked to Protein- Hyaluronic Acid.&lt;/li&gt;&lt;li&gt;âž¤ Hyaluronic Acid.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 638, Lippincott 6/e: p 159.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 638, Lippincott 6/e: p 159.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Glycogenin is often discussed in the context of glycogen synthesis, but there is a common misconception about its nature. Considering the biochemical role of glycogenin, is it accurate to classify it as a polysaccharide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TRUE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FALSE&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of the Above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. FALSE&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) FALSE&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin is a 37 kDa protein (POLYPEPTIDE). Glycogenin catalyses transfer of 7 glucosyl residues from UDPGlucose, in alpha 1 â†’ 4 linkage. Thus, glucosyl residues are added on specific tyrosine residues of Glycogenin. Glycogenin remains at the core of the Glycogen granule .&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin is a 37 kDa protein (POLYPEPTIDE).&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin is a 37 kDa protein (POLYPEPTIDE).&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin catalyses transfer of 7 glucosyl residues from UDPGlucose, in alpha 1 â†’ 4 linkage. Thus, glucosyl residues are added on specific tyrosine residues of Glycogenin.&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin catalyses&lt;/li&gt;&lt;li&gt;âž¤ 7 glucosyl residues from UDPGlucose,&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin remains at the core of the Glycogen granule .&lt;/li&gt;&lt;li&gt;âž¤ Glycogenin&lt;/li&gt;&lt;li&gt;âž¤ core of the Glycogen granule&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p177.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p177.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cellulose, a major component of plant cell walls, plays a critical role in providing structural support. Given its biological significance and chemical composition, how is cellulose best categorized?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complex Lipoprotein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Starch Polysaccharide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-starch Polysaccharide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Complex Glycoprotein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-starch Polysaccharide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Non-starch Polysaccharides.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cellulose is not a lipoprotein ; it does not contain lipid or protein components.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Cellulose&lt;/li&gt;&lt;li&gt;â€¢ not a lipoprotein&lt;/li&gt;&lt;li&gt;â€¢ Option B: It is not a starch polysaccharide. Starch, another plant polysaccharide , is composed of Î±-glucose units and serves as an energy storage molecule, whereas cellulose serves a structural role.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ not a starch polysaccharide.&lt;/li&gt;&lt;li&gt;â€¢ Starch,&lt;/li&gt;&lt;li&gt;â€¢ plant polysaccharide&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cellulose is not a glycoprotein ; it does not contain any protein or covalently bound oligosaccharide chains.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Cellulose&lt;/li&gt;&lt;li&gt;â€¢ not a glycoprotein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Foods contain a variety of other polysaccharides known as nonstarch polysaccharides. They are not digested by human enzymes and form the major components of dietary fibre. E.g.: cellulose from plant cell walls (a glucose polymer) and Inulin , the storage carbohydrate in some plants (a fructose polymer).&lt;/li&gt;&lt;li&gt;âž¤ Foods contain a variety of other polysaccharides known as nonstarch polysaccharides.&lt;/li&gt;&lt;li&gt;âž¤ Foods&lt;/li&gt;&lt;li&gt;âž¤ variety of other polysaccharides&lt;/li&gt;&lt;li&gt;âž¤ nonstarch polysaccharides.&lt;/li&gt;&lt;li&gt;âž¤ They are not digested by human enzymes and form the major components of dietary fibre.&lt;/li&gt;&lt;li&gt;âž¤ not digested by human enzymes&lt;/li&gt;&lt;li&gt;âž¤ E.g.: cellulose from plant cell walls (a glucose polymer) and Inulin , the storage carbohydrate in some plants (a fructose polymer).&lt;/li&gt;&lt;li&gt;âž¤ cellulose&lt;/li&gt;&lt;li&gt;âž¤ Inulin&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p153.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p153.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dextran, a complex branched polysaccharide, has been utilized in various medical applications. One specific use of dextran is in the management of hypovolemia. Based on this application, is it accurate to consider dextran as a plasma volume expander?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dextran is indeed used as a plasma volume expander in clinical settings. By increasing the osmotic pressure in the blood vessels , it helps to retain fluid within the circulatory system , thereby expanding plasma volume. This is particularly useful in treating hypovolemia or shock.&lt;/li&gt;&lt;li&gt;âž¤ Dextran&lt;/li&gt;&lt;li&gt;âž¤ plasma volume expander&lt;/li&gt;&lt;li&gt;âž¤ increasing the osmotic pressure&lt;/li&gt;&lt;li&gt;âž¤ blood vessels&lt;/li&gt;&lt;li&gt;âž¤ retain fluid within the circulatory system&lt;/li&gt;&lt;li&gt;âž¤ expanding plasma volume.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e p 79.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e p 79.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 33 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test3" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Carbohydrate Metabolism&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Carbohydrate Metabolism&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                149 Questions | 596 Total Marks | 159 min Duration | ~64.03 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 6-month-old boy begins experiencing vomiting, night sweats, and tremors after the introduction of fruit juices into his diet during weaning. Physical examination reveals significant hepatomegaly. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely responsible for these symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Galactokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aldolase B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î²-galactosidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aldolase B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aldolase B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Galactokinase: Deficiency in galactokinase leads to galactosemia type 2, which primarily results in cataract formation but does not typically cause severe hypoglycemia or hepatomegaly in response to fructose ingestion.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Galactokinase:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ galactokinase&lt;/li&gt;&lt;li&gt;â€¢ galactosemia type 2,&lt;/li&gt;&lt;li&gt;â€¢ cataract formation&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ severe hypoglycemia or hepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fructokinase: Fructokinase deficiency leads to essential fructosuria, a benign condition characterized by the excretion of fructose in the urine without serious metabolic disturbances or clinical symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fructokinase:&lt;/li&gt;&lt;li&gt;â€¢ Fructokinase deficiency&lt;/li&gt;&lt;li&gt;â€¢ fructosuria,&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ excretion of&lt;/li&gt;&lt;li&gt;â€¢ fructose&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ Option D. Î²-Galactosidase: Deficiency in Î²-galactosidase leads to GM1 gangliosidosis or galactosialidosis , which involve neurological symptoms and developmental delays , but not the specific reaction to fructose ingestion as described.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Î²-Galactosidase:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency in Î²-galactosidase&lt;/li&gt;&lt;li&gt;â€¢ GM1 gangliosidosis or galactosialidosis&lt;/li&gt;&lt;li&gt;â€¢ neurological symptoms&lt;/li&gt;&lt;li&gt;â€¢ developmental delays&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ fructose ingestion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary Fructose Intolerance (HFI) is a condition resulting from aldolase B deficiency , characterized by adverse reactions to fructose ingestion, such as hypoglycemia, hepatomegaly, and metabolic disturbances.&lt;/li&gt;&lt;li&gt;âž¤ Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;âž¤ aldolase B deficiency&lt;/li&gt;&lt;li&gt;âž¤ adverse reactions&lt;/li&gt;&lt;li&gt;âž¤ fructose ingestion,&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia, hepatomegaly, and metabolic disturbances.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 155, 202, 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 155, 202, 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;There are one specific vitamins, which is involved in the TCA cycle as key for comprehending its biochemical intricacies and the nutritional requirements that support this fundamental metabolic pathway. Which of the following vitamins are involved in the TCA cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pantothenic Acid as a part of CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Riboflavin as FAD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pantothenic Acid: It is a component of Coenzyme A (CoA) , essential for the formation of Acetyl- CoA, a substrate entering the TCA cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pantothenic Acid:&lt;/li&gt;&lt;li&gt;â€¢ Coenzyme A (CoA)&lt;/li&gt;&lt;li&gt;â€¢ CoA,&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Riboflavin: It is converted into Flavin Adenine Dinucleotide (FAD), a coenzyme used by succinate dehydrogenase in the TCA cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Riboflavin:&lt;/li&gt;&lt;li&gt;â€¢ converted into Flavin Adenine Dinucleotide (FAD),&lt;/li&gt;&lt;li&gt;â€¢ coenzyme&lt;/li&gt;&lt;li&gt;â€¢ succinate&lt;/li&gt;&lt;li&gt;â€¢ dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thiamine: As thiamine pyrophosphate (TPP) , it is a coenzyme for the pyruvate dehydrogenase complex that converts pyruvate into Acetyl-CoA, linking glycolysis with the TCA cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thiamine:&lt;/li&gt;&lt;li&gt;â€¢ thiamine pyrophosphate (TPP)&lt;/li&gt;&lt;li&gt;â€¢ coenzyme&lt;/li&gt;&lt;li&gt;â€¢ pyruvate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ complex&lt;/li&gt;&lt;li&gt;â€¢ pyruvate into Acetyl-CoA,&lt;/li&gt;&lt;li&gt;â€¢ glycolysis with the TCA cycle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vitamins in TCA Cycle:&lt;/li&gt;&lt;li&gt;âž¤ Vitamins in TCA Cycle:&lt;/li&gt;&lt;li&gt;âž¤ Pantothenic Acid as a part of CoA Riboflavin as FAD Thiamine Niacin as NAD+&lt;/li&gt;&lt;li&gt;âž¤ Pantothenic Acid as a part of CoA&lt;/li&gt;&lt;li&gt;âž¤ Pantothenic Acid&lt;/li&gt;&lt;li&gt;âž¤ Riboflavin as FAD&lt;/li&gt;&lt;li&gt;âž¤ Riboflavin&lt;/li&gt;&lt;li&gt;âž¤ Thiamine&lt;/li&gt;&lt;li&gt;âž¤ Thiamine&lt;/li&gt;&lt;li&gt;âž¤ Niacin as NAD+&lt;/li&gt;&lt;li&gt;âž¤ Niacin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 251.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 251.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is exploring the metabolic adaptations of cancer cells and how these cells meet their increased energy demands. In most cancer cells, the predominant metabolic pathway for generating the necessary energy is distinct from that of normal, non-cancerous cells. Which metabolic process do cancer cells primarily exploit to derive the energy needed for their rapid growth and proliferation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxidative phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TCA in mitochondria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;From beta-oxidation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glycolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxidative phosphorylation : While important in many tissues, cancer cells rely less on oxidative phosphorylation compared to normal cells , partially because it is less efficient under hypoxic conditions, which are common in tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ normal cells&lt;/li&gt;&lt;li&gt;â€¢ less efficient under hypoxic conditions,&lt;/li&gt;&lt;li&gt;â€¢ common in tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TCA cycle in mitochondria : The TCA cycle is used by all cells , but cancer cells often have mitochondrial defects that reduce their reliance on this pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TCA cycle in mitochondria&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle&lt;/li&gt;&lt;li&gt;â€¢ all cells&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial defects&lt;/li&gt;&lt;li&gt;â€¢ reduce&lt;/li&gt;&lt;li&gt;â€¢ reliance&lt;/li&gt;&lt;li&gt;â€¢ pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Beta-oxidation : This pathway oxidizes fatty acids to generate acetyl-CoA for energy ; however, cancer cells typically rely on this less than on glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Beta-oxidation&lt;/li&gt;&lt;li&gt;â€¢ oxidizes fatty acids&lt;/li&gt;&lt;li&gt;â€¢ acetyl-CoA for energy&lt;/li&gt;&lt;li&gt;â€¢ cancer cells&lt;/li&gt;&lt;li&gt;â€¢ rely on&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ glycolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cancer cells predominantly use glycolysis for energy production, even in the presence of oxygen, a phenomenon known as the Warburg effect. This metabolic adaptation allows cancer cells to thrive even under hypoxic conditions and contributes to the acidic microenvironment often seen in tumors due to lactate production.&lt;/li&gt;&lt;li&gt;âž¤ Cancer cells&lt;/li&gt;&lt;li&gt;âž¤ glycolysis for energy production,&lt;/li&gt;&lt;li&gt;âž¤ presence of oxygen,&lt;/li&gt;&lt;li&gt;âž¤ Warburg effect.&lt;/li&gt;&lt;li&gt;âž¤ adaptation allows cancer cells to thrive&lt;/li&gt;&lt;li&gt;âž¤ hypoxic conditions&lt;/li&gt;&lt;li&gt;âž¤ acidic&lt;/li&gt;&lt;li&gt;âž¤ microenvironment&lt;/li&gt;&lt;li&gt;âž¤ tumors&lt;/li&gt;&lt;li&gt;âž¤ lactate production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p738.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p738.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During fasting, the body employs various mechanisms to maintain blood glucose levels. Which of the following sequences correctly represents the order in which these mechanisms are activated to ensure blood glucose homeostasis in the fasting state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose from diet &amp;gt; glycogenolysis &amp;gt; gluconeogenesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose from diet &amp;gt; gluconeogenesis &amp;gt; glycogenolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose from diet &amp;gt; gluconeogenesis &amp;gt; proteolysis)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose from diet &amp;gt; lipolysis &amp;gt; gluconeogenesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucose from diet &gt; glycogenolysis &gt; gluconeogenesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glucose from diet &amp;gt; glycogenolysis &amp;gt; gluconeogenesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose from diet &amp;gt; gluconeogenesis &amp;gt; glycogenolysis: This sequence is incorrect because glycogenolysis typically precede s gluconeogenesis in the fasting state as the body utilizes stored glycogen before synthesizing glucose from non-carbohydrate sources.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose from diet &amp;gt; gluconeogenesis &amp;gt; glycogenolysis:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ s gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ fasting state&lt;/li&gt;&lt;li&gt;â€¢ body utilizes stored glycogen&lt;/li&gt;&lt;li&gt;â€¢ synthesizing glucose&lt;/li&gt;&lt;li&gt;â€¢ non-carbohydrate sources.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose from diet &amp;gt; gluconeogenesis &amp;gt; proteolysis: While proteolysis (the breakdown of proteins ) does contribute substrates for gluconeogenesis , it is not a direct mechanism for maintaining blood glucose levels but rather provides amino acids that can be used in gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose from diet &amp;gt; gluconeogenesis &amp;gt; proteolysis:&lt;/li&gt;&lt;li&gt;â€¢ proteolysis&lt;/li&gt;&lt;li&gt;â€¢ breakdown of proteins&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ direct&lt;/li&gt;&lt;li&gt;â€¢ blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ amino acids&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glucose from diet &amp;gt; lipolysis &amp;gt; gluconeogenesis: Lipolysis, the breakdown of triglycerides into free fatty acids and glycerol , does provide substrates for gluconeogenesis (specifically glycerol), but it primarily serves as a mechanism for providing energy through fatty acid oxidation rather than directly contributing to maintaining blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glucose from diet &amp;gt; lipolysis &amp;gt; gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Lipolysis,&lt;/li&gt;&lt;li&gt;â€¢ triglycerides into free fatty acids&lt;/li&gt;&lt;li&gt;â€¢ glycerol&lt;/li&gt;&lt;li&gt;â€¢ substrates&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis (specifically glycerol),&lt;/li&gt;&lt;li&gt;â€¢ mechanism&lt;/li&gt;&lt;li&gt;â€¢ energy through fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ blood glucose levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During starvation:&lt;/li&gt;&lt;li&gt;âž¤ Liver produces glucose by glycogenolysis and later by gluconeogenesis so that the obligatory requirements of the brain are met. Liver also produces the ketone bodies , an alternate source of fuel. But the liver cannot use ketone bodies as its own fuel In the fasting state 2-2 1/2 hours â€“ glucose from meals Next 3 hour s â€“ from glycogenolysis Later from gluconeogenesis (proteolysis &amp;amp; lipolysis) Hyperglycemic hormones are secreted&lt;/li&gt;&lt;li&gt;âž¤ Liver produces glucose by glycogenolysis and later by gluconeogenesis so that the obligatory requirements of the brain are met.&lt;/li&gt;&lt;li&gt;âž¤ Liver&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ Liver also produces the ketone bodies , an alternate source of fuel. But the liver cannot use ketone bodies as its own fuel&lt;/li&gt;&lt;li&gt;âž¤ Liver&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ alternate source of fuel.&lt;/li&gt;&lt;li&gt;âž¤ liver cannot&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ fuel&lt;/li&gt;&lt;li&gt;âž¤ In the fasting state&lt;/li&gt;&lt;li&gt;âž¤ fasting state&lt;/li&gt;&lt;li&gt;âž¤ 2-2 1/2 hours â€“ glucose from meals&lt;/li&gt;&lt;li&gt;âž¤ 2-2 1/2 hours&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ meals&lt;/li&gt;&lt;li&gt;âž¤ Next 3 hour s â€“ from glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ 3 hour&lt;/li&gt;&lt;li&gt;âž¤ glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ Later from gluconeogenesis (proteolysis &amp;amp; lipolysis)&lt;/li&gt;&lt;li&gt;âž¤ Later&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Hyperglycemic hormones are secreted&lt;/li&gt;&lt;li&gt;âž¤ Hyperglycemic&lt;/li&gt;&lt;li&gt;âž¤ secreted&lt;/li&gt;&lt;li&gt;âž¤ Liver is the net producer of glucose in the fasting state&lt;/li&gt;&lt;li&gt;âž¤ Liver&lt;/li&gt;&lt;li&gt;âž¤ net&lt;/li&gt;&lt;li&gt;âž¤ glucose in the fasting state&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 319-325.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 319-325.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical student is reviewing the glycolytic pathway and is attempting to identify the points of regulation within the process. She notes that certain steps are irreversible and thus play a key role in the regulation of glycolysis. Which of the following enzymes catalyzes a reaction in glycolysis that is not considered irreversible and therefore not a major regulatory point?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enolase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyruvate Kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Enolase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Enolase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphofructokinase : Catalyzes an irreversible step by converting fructose-6-phosphate to fructose-1,6-bisphosphate and is a major regulatory point of glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphofructokinase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate Kinase : Irreversibly Catalyzes the conversion of phosphoenolpyruvate to pyruvate, another regulatory step in glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate Kinase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hexokinase : Irreversibly phosphorylates glucose to glucose-6-phosphate at the start of the glycolytic pathway and is allosterically inhibited by its product, making it a key regulatory enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hexokinase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Irreversible Steps of Glycolysis:&lt;/li&gt;&lt;li&gt;âž¤ Hexokinase Phosphofructokinase Pyruvate Kinase&lt;/li&gt;&lt;li&gt;âž¤ Hexokinase&lt;/li&gt;&lt;li&gt;âž¤ Phosphofructokinase&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate Kinase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p170-172.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with fatigue, abdominal pain, and hepatomegaly, with abnormal liver function tests suggesting ethanol toxicity. What could be the underlying biochemical change associated with ethanol toxicity in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased lactate/Pyruvate ratio&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased NADH/NAD+ ratio&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stimulation of Gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulation of fatty acid oxidation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased NADH/NAD+ ratio&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increased NADH/NAD+ ratio&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased lactate/pyruvate ratio: Ethanol metabolism actually leads to an increased lactate/pyruvate ratio due to the conversion of pyruvate to lactate in the presence of excess NADH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased lactate/pyruvate ratio:&lt;/li&gt;&lt;li&gt;â€¢ Ethanol&lt;/li&gt;&lt;li&gt;â€¢ increased lactate/pyruvate ratio&lt;/li&gt;&lt;li&gt;â€¢ pyruvate to lactate&lt;/li&gt;&lt;li&gt;â€¢ NADH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stimulation of gluconeogenesis: Ethanol metabolism inhibits gluconeogenesis due to the increased NADH/NAD+ ratio and the subsequent diversion of substrates like pyruvate and oxaloacetate to lactate and malate , respectively.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stimulation of gluconeogenesis: Ethanol&lt;/li&gt;&lt;li&gt;â€¢ inhibits gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ increased NADH/NAD+ ratio&lt;/li&gt;&lt;li&gt;â€¢ diversion&lt;/li&gt;&lt;li&gt;â€¢ pyruvate and oxaloacetate&lt;/li&gt;&lt;li&gt;â€¢ lactate and malate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulation of fatty acid oxidation: Ethanol metabolism inhibits fatty acid oxidation , again due to the increased NADH/NAD+ ratio. Instead, there is an accumulation of fatty acids leading to fatty liver.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stimulation of fatty acid oxidation:&lt;/li&gt;&lt;li&gt;â€¢ Ethanol&lt;/li&gt;&lt;li&gt;â€¢ inhibits fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ NADH/NAD+ ratio.&lt;/li&gt;&lt;li&gt;â€¢ accumulation of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ fatty liver.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both the oxidation steps in alcohol metabolism produce NADH, resulting in a high NADH/NAD+ ratio. As a result, the following metabolic adaptations occur:&lt;/li&gt;&lt;li&gt;âž¤ Both the oxidation steps&lt;/li&gt;&lt;li&gt;âž¤ alcohol metabolism produce NADH,&lt;/li&gt;&lt;li&gt;âž¤ high NADH/NAD+ ratio.&lt;/li&gt;&lt;li&gt;âž¤ metabolic adaptations occur:&lt;/li&gt;&lt;li&gt;âž¤ Lactic acidosis. Hypoglycemia. Ketogenesis. Fatty liver and steatosis. Mitochondrial damage and apoptosis. CNS depression&lt;/li&gt;&lt;li&gt;âž¤ Lactic acidosis.&lt;/li&gt;&lt;li&gt;âž¤ Hypoglycemia.&lt;/li&gt;&lt;li&gt;âž¤ Ketogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Fatty liver and steatosis.&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial damage and apoptosis.&lt;/li&gt;&lt;li&gt;âž¤ CNS depression&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e:317, DM Vasudevan  9/e: p 140-141&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e:317, DM Vasudevan  9/e: p 140-141&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A teenager is brought to the ER with symptoms of increased confusion and lethargy. Lab tests reveal abnormal liver function and significantly elevated serum ammonia levels. His parents note his recent high protein intake, attributed to his athletic activities. Hyperammonemia can disrupt the TCA cycle by depleting a specific intermediate, leading to impaired energy metabolism. Which TCA cycle intermediate is most likely depleted in this scenario, contributing to the cycle&#x27;s inhibition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspartate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î±-ketoglutarate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fumarate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Î±-ketoglutarate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture27.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Î±-ketoglutarate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia can i nhibit the TCA cycle by depleting Î±-ketoglutarate . Ammonia is detoxified in the liver by the urea cycle, which consumes Î±-ketoglutarate as it combines with ammonia to form glutamate. This process depletes Î±-ketoglutarate , a critical intermediate in the TCA cycle , leading to impaired energy metabolism and contributing to the symptoms observed.&lt;/li&gt;&lt;li&gt;âž¤ Hyperammonemia&lt;/li&gt;&lt;li&gt;âž¤ nhibit&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ depleting Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ Ammonia&lt;/li&gt;&lt;li&gt;âž¤ detoxified&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ urea cycle,&lt;/li&gt;&lt;li&gt;âž¤ Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ ammonia to form glutamate.&lt;/li&gt;&lt;li&gt;âž¤ depletes Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ intermediate&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ impaired energy metabolism&lt;/li&gt;&lt;li&gt;âž¤ symptoms observed.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 291, 292, Lippincott: P 253.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 291, 292, Lippincott: P 253.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Garrod&#x27;s tetrad refers to a group of four metabolic disorders. Which of the following options correctly lists these disorders?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkaptonuria, Pentosuria, Cystinuria, Albinism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alkaptonuria, Pentosuria, galactosemia, Albinism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fructosuria, Pentosuria, Cystinuria, Albinism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alkaptonuria, Pentosuria, Cystinuria, Mucopolysaccharidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alkaptonuria, Pentosuria, Cystinuria, Albinism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â  Alkaptonuria, Pentosuria, Cystinuria, Albinism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alkaptonuria, Pentos Uria, Galactosemia, Albinism: While galactosemia is a well-known metabolic disorder, it is not part of Garrod&#x27;s original tetrad.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alkaptonuria, Pentos Uria, Galactosemia, Albinism:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fructosuria, Pentosuria, Cystinuria, Albinism: Fructosuria is another metabolic condition but was not included in Garrod&#x27;s tetrad.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fructosuria, Pentosuria, Cystinuria, Albinism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alkaptonuria, Pentos Uria, Cystinuria, Mucopolysaccharidosis: Mucopolysaccharidosis refers to a group of lysosomal storage diseases and is not part of Garrod&#x27;s tetrad.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alkaptonuria, Pentos Uria, Cystinuria, Mucopolysaccharidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Garrodâ€™s tetrad includes&lt;/li&gt;&lt;li&gt;âž¤ Cystinuria Alkaptonuria Albinism Pentosuria&lt;/li&gt;&lt;li&gt;âž¤ (Mnemonic- CAAP)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding the metabolic effects of insulin, which of the following statements is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It prevents lipolysis by inhibiting the activity of hormone sensitive lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It stimulates glycogenolysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It increases proteins synthesis and prevents protein breakdown&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It decreases gluconeogenesis in cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It stimulates glycogenolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It stimulates glycogenolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose Uptake&lt;/li&gt;&lt;li&gt;âž¤ Glucose Uptake&lt;/li&gt;&lt;li&gt;âž¤ Insulin facilitates diffusion of glucose in muscle. Transporter, GLUT-4 is insulin dependent&lt;/li&gt;&lt;li&gt;âž¤ Insulin facilitates diffusion of glucose in muscle.&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ glucose in muscle.&lt;/li&gt;&lt;li&gt;âž¤ Transporter, GLUT-4 is insulin dependent&lt;/li&gt;&lt;li&gt;âž¤ GLUT-4 is insulin dependent&lt;/li&gt;&lt;li&gt;âž¤ Utilization of Glucose : Glycolysis increased (key glycolytic enzymes: glucokinase, phosphofructokinase &amp;amp; pyruvate kinase) Insulin favors storage of glucose: Glycogen synthesis increased (Glycogen synthase) (option B) Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase (NADPH) activity is enhanced by insulin. Anti-lipolytic effect: Hormone sensitive lipase is decreased (option A). Gluconeogenesis Decreased (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D) Anti-ketogenic Effect : HMG CoA synthase is decreased It increases proteins synthesis and prevents protein breakdown&lt;/li&gt;&lt;li&gt;âž¤ Utilization of Glucose : Glycolysis increased (key glycolytic enzymes: glucokinase, phosphofructokinase &amp;amp; pyruvate kinase)&lt;/li&gt;&lt;li&gt;âž¤ Utilization of Glucose&lt;/li&gt;&lt;li&gt;âž¤ Glycolysis increased&lt;/li&gt;&lt;li&gt;âž¤ Insulin favors storage of glucose: Glycogen synthesis increased (Glycogen synthase) (option B)&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ storage of glucose:&lt;/li&gt;&lt;li&gt;âž¤ Glycogen synthesis increased&lt;/li&gt;&lt;li&gt;âž¤ Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase (NADPH) activity is enhanced by insulin.&lt;/li&gt;&lt;li&gt;âž¤ Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate   dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Anti-lipolytic effect: Hormone sensitive lipase is decreased (option A).&lt;/li&gt;&lt;li&gt;âž¤ Anti-lipolytic effect: Hormone sensitive lipase&lt;/li&gt;&lt;li&gt;âž¤ decreased&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis Decreased (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D)&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis Decreased&lt;/li&gt;&lt;li&gt;âž¤ Anti-ketogenic Effect : HMG CoA synthase is decreased&lt;/li&gt;&lt;li&gt;âž¤ Anti-ketogenic Effect&lt;/li&gt;&lt;li&gt;âž¤ HMG CoA synthase&lt;/li&gt;&lt;li&gt;âž¤ decreased&lt;/li&gt;&lt;li&gt;âž¤ It increases proteins synthesis and prevents protein breakdown&lt;/li&gt;&lt;li&gt;âž¤ increases proteins synthesis&lt;/li&gt;&lt;li&gt;âž¤ prevents protein breakdown&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p319-322.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p319-322.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following pathways does not produce high-energy phosphate compounds directly helps in comprehending the energy dynamics within the cell.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TCA cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hexose Mono Phosphate pathway&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta Oxidation of Fatty Acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hexose Mono Phosphate pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HMP Pathway.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pathways which do not synthesize ATP are&lt;/li&gt;&lt;li&gt;âž¤ Pathways which do not synthesize ATP are&lt;/li&gt;&lt;li&gt;âž¤ HMP Pathway Rapaport Luebering Cycle Uronic acid pathway Alpha oxidation of Fatty acid Omega Oxidation of fatty acid&lt;/li&gt;&lt;li&gt;âž¤ HMP Pathway&lt;/li&gt;&lt;li&gt;âž¤ Rapaport Luebering Cycle&lt;/li&gt;&lt;li&gt;âž¤ Uronic acid pathway&lt;/li&gt;&lt;li&gt;âž¤ Alpha oxidation of Fatty acid&lt;/li&gt;&lt;li&gt;âž¤ Omega Oxidation of fatty acid&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 253.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 253.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Piericidin and rotenone are inhibitors of (ETC) electron transport chain. Reasoning Â®: Piericidin and rotenone inhibits the flow of electron between the complex II and ubiquinone (coenzyme Q)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the Correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A is true but R is false&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A is true but R is false&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A is right statement but R is not a correct explanation of statement A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Piericidin and rotenone are indeed inhibitors of the electron transport chain (ETC), specifically affecting the function of Complex I ( NADH dehydrogenase ). They block the transfer of electrons from NADH to ubiquinone ( coenzyme Q ), no t from Complex II . This action inhibits the electron transport chain early in its sequence, preventing the establishment of the proton gradient necessary for ATP synthesis via oxidative phosphorylation . The assertion is correct in stating that these compounds are inhibitors of the ETC , but the reasoning is incorrect as it misidentifies the site of inhibition .&lt;/li&gt;&lt;li&gt;â€¢ Piericidin&lt;/li&gt;&lt;li&gt;â€¢ rotenone&lt;/li&gt;&lt;li&gt;â€¢ inhibitors&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain (ETC),&lt;/li&gt;&lt;li&gt;â€¢ Complex I&lt;/li&gt;&lt;li&gt;â€¢ NADH dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ block&lt;/li&gt;&lt;li&gt;â€¢ electrons&lt;/li&gt;&lt;li&gt;â€¢ NADH to ubiquinone&lt;/li&gt;&lt;li&gt;â€¢ coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ Complex II&lt;/li&gt;&lt;li&gt;â€¢ inhibits the electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ preventing&lt;/li&gt;&lt;li&gt;â€¢ proton gradient&lt;/li&gt;&lt;li&gt;â€¢ ATP synthesis&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ assertion is correct&lt;/li&gt;&lt;li&gt;â€¢ inhibitors of the ETC&lt;/li&gt;&lt;li&gt;â€¢ reasoning is incorrect&lt;/li&gt;&lt;li&gt;â€¢ misidentifies the site of inhibition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 129-134.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 129-134.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of glucose metabolism and insulin action, GLUT4 is characterized as a glucose transporter. Is it accurate to state that GLUT4&#x27;s activity is regulated by insulin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture2_iVZYTTa.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ GLUT4 is the major glucose transporter seen in skeletal muscle and adipose tissue . GLUT4 is under the control of insulin . Insulin promotes the translocation of intracellular GLUT4 molecules to the cell surface and thus increases glucose uptake. In Type 2 diabetes mellitus , membrane GLUT4 is reduced causing insulin resistance in muscle and fat cells. In diabetes, entry of glucose into muscle is only half of normal cells.&lt;/li&gt;&lt;li&gt;â€¢ GLUT4 is the major glucose transporter seen in skeletal muscle and adipose tissue .&lt;/li&gt;&lt;li&gt;â€¢ GLUT4&lt;/li&gt;&lt;li&gt;â€¢ major glucose transporter&lt;/li&gt;&lt;li&gt;â€¢ skeletal muscle and adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ GLUT4 is under the control of insulin .&lt;/li&gt;&lt;li&gt;â€¢ GLUT4&lt;/li&gt;&lt;li&gt;â€¢ control&lt;/li&gt;&lt;li&gt;â€¢ insulin&lt;/li&gt;&lt;li&gt;â€¢ Insulin promotes the translocation of intracellular GLUT4 molecules to the cell surface and thus increases glucose uptake.&lt;/li&gt;&lt;li&gt;â€¢ Insulin&lt;/li&gt;&lt;li&gt;â€¢ promotes&lt;/li&gt;&lt;li&gt;â€¢ GLUT4&lt;/li&gt;&lt;li&gt;â€¢ cell surface&lt;/li&gt;&lt;li&gt;â€¢ increases glucose&lt;/li&gt;&lt;li&gt;â€¢ uptake.&lt;/li&gt;&lt;li&gt;â€¢ In Type 2 diabetes mellitus , membrane GLUT4 is reduced causing insulin resistance in muscle and fat cells.&lt;/li&gt;&lt;li&gt;â€¢ Type 2&lt;/li&gt;&lt;li&gt;â€¢ diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ GLUT4 is reduced&lt;/li&gt;&lt;li&gt;â€¢ insulin resistance&lt;/li&gt;&lt;li&gt;â€¢ muscle and fat cells.&lt;/li&gt;&lt;li&gt;â€¢ In diabetes, entry of glucose into muscle is only half of normal cells.&lt;/li&gt;&lt;li&gt;â€¢ diabetes,&lt;/li&gt;&lt;li&gt;â€¢ glucose into muscle&lt;/li&gt;&lt;li&gt;â€¢ half of normal cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ed: p 107.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/ed: p 107.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-months-old baby girl was given cowâ€™s milk at her 5 weeks and after 3 weeks she was admitted with a history of screaming after feeding and was discharged on advice to avoid cowâ€™s milk. Again, worsening of symptoms such as screaming, gas formation and distended abdomen occurred after she drank juice. Blood investigations, liver biopsy and physical examination were all normal. If an intestinal tissue biopsy is done and analyzed from the patient, which of the following would be deficient or defective?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SGLT1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GLUT 5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isomaltase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. GLUT 5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) GLUT 5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT: Sodium Dependent Glucose Transporter-1 (SGLT-1) is the transporter in the intestine involved in glucose-galactose malabsorption . For diarrhoea , ORS is given which contains both glucose and sodium â†’ allows absorption of sodium to replenish body sodium chloride levels and glucose to provide energy.&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT:&lt;/li&gt;&lt;li&gt;â€¢ transporter&lt;/li&gt;&lt;li&gt;â€¢ intestine&lt;/li&gt;&lt;li&gt;â€¢ glucose-galactose&lt;/li&gt;&lt;li&gt;â€¢ malabsorption&lt;/li&gt;&lt;li&gt;â€¢ diarrhoea&lt;/li&gt;&lt;li&gt;â€¢ ORS&lt;/li&gt;&lt;li&gt;â€¢ both glucose and sodium&lt;/li&gt;&lt;li&gt;â€¢ absorption of sodium&lt;/li&gt;&lt;li&gt;â€¢ replenish&lt;/li&gt;&lt;li&gt;â€¢ body sodium chloride&lt;/li&gt;&lt;li&gt;â€¢ glucose to provide energy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Isomaltose: he cells of brush border of intestine contain sucrase, maltase, Isomaltose and lactase â†’ which hydrolyze the corresponding disaccharides into monosaccharides , which are then absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Isomaltose:&lt;/li&gt;&lt;li&gt;â€¢ cells of brush border&lt;/li&gt;&lt;li&gt;â€¢ sucrase, maltase, Isomaltose and lactase&lt;/li&gt;&lt;li&gt;â€¢ hydrolyze&lt;/li&gt;&lt;li&gt;â€¢ disaccharides into monosaccharides&lt;/li&gt;&lt;li&gt;â€¢ absorbed.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Lactase: Deficiency of lactase leads to lactose intolerance â†’ accumulation of lactose in the gut â†’ Irritant diarrhoea and flatulence. Treatment- withdrawn milk temporarily.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Lactase:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of lactase&lt;/li&gt;&lt;li&gt;â€¢ lactose intolerance&lt;/li&gt;&lt;li&gt;â€¢ accumulation of lactose&lt;/li&gt;&lt;li&gt;â€¢ Irritant diarrhoea&lt;/li&gt;&lt;li&gt;â€¢ flatulence.&lt;/li&gt;&lt;li&gt;â€¢ withdrawn milk temporarily.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GLUT 5 is a fructose transporter expressed in the intestinal mucosa. A deficiency or defect in GLUT 5 would lead to fructose malabsorption , presenting with symptoms such as abdominal pain, distension, and gas formation after consuming fructose.&lt;/li&gt;&lt;li&gt;âž¤ GLUT 5&lt;/li&gt;&lt;li&gt;âž¤ fructose&lt;/li&gt;&lt;li&gt;âž¤ intestinal mucosa.&lt;/li&gt;&lt;li&gt;âž¤ deficiency or defect in GLUT 5&lt;/li&gt;&lt;li&gt;âž¤ fructose&lt;/li&gt;&lt;li&gt;âž¤ malabsorption&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain, distension, and gas formation&lt;/li&gt;&lt;li&gt;âž¤ consuming fructose.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 106-107.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 106-107.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with type 2 diabetes starts a new oral hypoglycemic regimen. Soon after, he presents with anxiety, diaphoresis, and hunger, which quickly resolves upon consuming glucose. This clinical scenario underscores the importance of the initial enzymatic step in glycolysis following glucose ingestion. In the context of glycolytic pathway activation for immediate energy production, which enzyme is responsible for catalyzing the first reaction that glucose undergoes in this metabolic pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aldolase and Pyruvate kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphoglucose isomerase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hexokinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hexokinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aldolase and Pyruvate kinase : These enzymes function in the intermediate to later stages of glycolysis and are not involved in the initial phosphorylation of glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aldolase and Pyruvate kinase&lt;/li&gt;&lt;li&gt;â€¢ intermediate to later stages of glycolysis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ initial phosphorylation of glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphofructokinase : This enzyme plays a key regulatory role in glycolysis by converting fructose-6-phosphate to fructose-1,6-bisphosphate , but it is not the first enzyme in the pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphofructokinase&lt;/li&gt;&lt;li&gt;â€¢ key&lt;/li&gt;&lt;li&gt;â€¢ glycolysis&lt;/li&gt;&lt;li&gt;â€¢ fructose-6-phosphate to fructose-1,6-bisphosphate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phosphoglucose isomerase : This enzyme acts second in the glycolytic pathway , converting glucose-6-phosphate to fructose-6-phosphate , following the action of hexokinase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phosphoglucose isomerase&lt;/li&gt;&lt;li&gt;â€¢ enzyme acts&lt;/li&gt;&lt;li&gt;â€¢ glycolytic pathway&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ to&lt;/li&gt;&lt;li&gt;â€¢ fructose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ hexokinase.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hexokinase catalyzes the first critical step in the glycolytic pathway by phosphorylating glucose to form glucose-6-phosphate . This reaction is essential for trapping glucose within the cell, enabling its subsequent metabolism in the glycolytic pathway to produce energy, particularly important in the context of restoring normal blood glucose levels after hypoglycemic episodes in diabetic patients.&lt;/li&gt;&lt;li&gt;âž¤ Hexokinase catalyzes&lt;/li&gt;&lt;li&gt;âž¤ first&lt;/li&gt;&lt;li&gt;âž¤ glycolytic pathway&lt;/li&gt;&lt;li&gt;âž¤ phosphorylating glucose&lt;/li&gt;&lt;li&gt;âž¤ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ trapping glucose&lt;/li&gt;&lt;li&gt;âž¤ enabling&lt;/li&gt;&lt;li&gt;âž¤ glycolytic pathway&lt;/li&gt;&lt;li&gt;âž¤ energy,&lt;/li&gt;&lt;li&gt;âž¤ restoring normal blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemic&lt;/li&gt;&lt;li&gt;âž¤ diabetic&lt;/li&gt;&lt;li&gt;âž¤ patients.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 168-172&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 168-172&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old marathon runner experiences muscle fatigue and laboured breathing post-race. Upon evaluation, a metabolic cycle is considered in understanding her physiological state, as shown below. Which statement is correct regarding the metabolic cycle illustrated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cahillâ€™s cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Location: not seen in RBCs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No re-utilization of lactate for gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Energy need explains the oxygen debt after exercise&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Energy need explains the oxygen debt after exercise&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture1_XU5jYM8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Energy need explains the oxygen debt after exercise&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cahillâ€™s cycle : It is also know n as glucose-alanine cycle and occurs in fasting muscles .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cahillâ€™s cycle&lt;/li&gt;&lt;li&gt;â€¢ glucose-alanine cycle&lt;/li&gt;&lt;li&gt;â€¢ fasting muscles .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Location not seen in RBCs : Lactate is released by exercising skeletal muscle and by cells that lack mitochondria such as RBCs into the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Location not seen in RBCs&lt;/li&gt;&lt;li&gt;â€¢ Lactate&lt;/li&gt;&lt;li&gt;â€¢ exercising skeletal muscle&lt;/li&gt;&lt;li&gt;â€¢ lack mitochondria&lt;/li&gt;&lt;li&gt;â€¢ RBCs&lt;/li&gt;&lt;li&gt;â€¢ blood.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No re-utilization of lactate for gluconeogenesis : Glucose is converted to lactate in the muscle and in the liver this lactate is re-converted into glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No re-utilization of lactate for gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ Glucose&lt;/li&gt;&lt;li&gt;â€¢ lactate in the muscle&lt;/li&gt;&lt;li&gt;â€¢ liver this lactate&lt;/li&gt;&lt;li&gt;â€¢ re-converted into glucose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Cori cycle is energy-intensive, costing 6 ATPs in the liver to resynthesize glucose from 2 lactate molecules . During exercise , the body incurs an \&quot; oxygen debt ,\&quot; as it uses more oxygen to replenish ATP stores and clear the lactate produced, explaining the labored breathing post-exercise.&lt;/li&gt;&lt;li&gt;âž¤ Cori cycle&lt;/li&gt;&lt;li&gt;âž¤ energy-intensive,&lt;/li&gt;&lt;li&gt;âž¤ 6 ATPs&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ resynthesize glucose&lt;/li&gt;&lt;li&gt;âž¤ 2 lactate molecules&lt;/li&gt;&lt;li&gt;âž¤ exercise&lt;/li&gt;&lt;li&gt;âž¤ oxygen debt&lt;/li&gt;&lt;li&gt;âž¤ more oxygen to replenish ATP stores&lt;/li&gt;&lt;li&gt;âž¤ clear&lt;/li&gt;&lt;li&gt;âž¤ lactate&lt;/li&gt;&lt;li&gt;âž¤ labored&lt;/li&gt;&lt;li&gt;âž¤ breathing post-exercise.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper30/e: p 556, Vasudevan 9/ed: p 114&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper30/e: p 556, Vasudevan 9/ed: p 114&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of infantile conditions, hypoglycemia is observed in which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycogen storage disease type I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary Fructose intolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both a and b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Both a and b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Both Glycogen Storage Disease Type I (GSD I) and Hereditary Fructose Intolerance (HFI) can lead to hypoglycemia , particularly in infants.&lt;/li&gt;&lt;li&gt;â€¢ Glycogen Storage Disease Type I (GSD I)&lt;/li&gt;&lt;li&gt;â€¢ Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Glycogen Storage Disease Type I (Von Gierke Disease)&lt;/li&gt;&lt;li&gt;â€¢ Glycogen Storage Disease Type I (Von Gierke Disease)&lt;/li&gt;&lt;li&gt;â€¢ Caused by a deficiency of glucose-6-phosphatase . This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis , converting glucose-6-phosphate to free glucose. Without it, the liver cannot release glucose into the bloodstream â†’ severe fasting hypoglycemia , typically noticed shortly after birth.&lt;/li&gt;&lt;li&gt;â€¢ Caused by a deficiency of glucose-6-phosphatase .&lt;/li&gt;&lt;li&gt;â€¢ deficiency of glucose-6-phosphatase&lt;/li&gt;&lt;li&gt;â€¢ This enzyme is crucial for the final step of gluconeogenesis and glycogenolysis , converting glucose-6-phosphate to free glucose.&lt;/li&gt;&lt;li&gt;â€¢ final step of gluconeogenesis and glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Without it, the liver cannot release glucose into the bloodstream â†’ severe fasting hypoglycemia , typically noticed shortly after birth.&lt;/li&gt;&lt;li&gt;â€¢ severe fasting hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;â€¢ Caused by a deficiency of aldolase B . When fructose, sucrose, or sorbitol is introduced (e.g., via formula or weaning), fructose-1-phosphate accumulates , which: Traps phosphate Inhibits glycogenolysis Leads to hypoglycemia and other symptoms like vomiting , hepatomegaly , and failure to thrive .&lt;/li&gt;&lt;li&gt;â€¢ Caused by a deficiency of aldolase B .&lt;/li&gt;&lt;li&gt;â€¢ deficiency of aldolase B&lt;/li&gt;&lt;li&gt;â€¢ When fructose, sucrose, or sorbitol is introduced (e.g., via formula or weaning), fructose-1-phosphate accumulates , which: Traps phosphate Inhibits glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ fructose, sucrose, or sorbitol&lt;/li&gt;&lt;li&gt;â€¢ fructose-1-phosphate accumulates&lt;/li&gt;&lt;li&gt;â€¢ Traps phosphate Inhibits glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Traps phosphate&lt;/li&gt;&lt;li&gt;â€¢ Inhibits glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Leads to hypoglycemia and other symptoms like vomiting , hepatomegaly , and failure to thrive .&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ hepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ failure to thrive&lt;/li&gt;&lt;li&gt;â€¢ Note : HFI typically manifests after exposure to fructose-containing foods , so it may not present immediately after birth , but it is a cause of hypoglycemia in infants , especially during weaning.&lt;/li&gt;&lt;li&gt;â€¢ Note&lt;/li&gt;&lt;li&gt;â€¢ after exposure to fructose-containing foods&lt;/li&gt;&lt;li&gt;â€¢ immediately after birth&lt;/li&gt;&lt;li&gt;â€¢ cause of hypoglycemia in infants&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Be aware of metabolic disorders that can cause hypoglycemia in neonates or infants , particularly:&lt;/li&gt;&lt;li&gt;âž¤ metabolic disorders&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia in neonates or infants&lt;/li&gt;&lt;li&gt;âž¤ Glycogen Storage Disease Type I (Von Gierke) Hereditary Fructose Intolerance (HFI) Galactosemia Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD) Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)&lt;/li&gt;&lt;li&gt;âž¤ Glycogen Storage Disease Type I (Von Gierke)&lt;/li&gt;&lt;li&gt;âž¤ Glycogen Storage Disease Type I (Von Gierke)&lt;/li&gt;&lt;li&gt;âž¤ Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;âž¤ Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;âž¤ Galactosemia&lt;/li&gt;&lt;li&gt;âž¤ Galactosemia&lt;/li&gt;&lt;li&gt;âž¤ Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)&lt;/li&gt;&lt;li&gt;âž¤ Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)&lt;/li&gt;&lt;li&gt;âž¤ Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)&lt;/li&gt;&lt;li&gt;âž¤ Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 138.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following laboratory findings are associated with chronic alcoholism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated GGT activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated ALT activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased ADH activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)Â  All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated GGT (Gamma-Glutamyl Transferase) activity: GGT is an enzyme involved in the metabolism of glutathione and is often elevated in alcohol-related liver disease . Its elevation is commonly used as a biomarker for excessive alcohol consumption and liver damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated GGT (Gamma-Glutamyl Transferase) activity:&lt;/li&gt;&lt;li&gt;â€¢ GGT&lt;/li&gt;&lt;li&gt;â€¢ metabolism of glutathione&lt;/li&gt;&lt;li&gt;â€¢ elevated in alcohol-related liver disease&lt;/li&gt;&lt;li&gt;â€¢ elevation&lt;/li&gt;&lt;li&gt;â€¢ biomarker for excessive alcohol consumption&lt;/li&gt;&lt;li&gt;â€¢ liver damage.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ALT (Alanine Aminotransferase) activity: ALT is an enzyme found predominantly in the liver . Its elevation in the blood often indicates liver damage , which can occur as a result of chronic alcohol abuse.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated ALT (Alanine Aminotransferase) activity:&lt;/li&gt;&lt;li&gt;â€¢ ALT&lt;/li&gt;&lt;li&gt;â€¢ found&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ elevation&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ liver damage&lt;/li&gt;&lt;li&gt;â€¢ chronic alcohol abuse.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased ADH (Antidiuretic Hormone) activity: Chronic alcohol consumption can lead to impaired ADH secretion or function , contributing to electrolyte imbalances and an increased risk of dehydration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased ADH (Antidiuretic Hormone) activity:&lt;/li&gt;&lt;li&gt;â€¢ Chronic alcohol consumption&lt;/li&gt;&lt;li&gt;â€¢ impaired ADH secretion&lt;/li&gt;&lt;li&gt;â€¢ function&lt;/li&gt;&lt;li&gt;â€¢ electrolyte imbalances&lt;/li&gt;&lt;li&gt;â€¢ increased risk of dehydration.&lt;/li&gt;&lt;li&gt;â€¢ Considering these points, option D) All the above is correct, as each listed factor can be associated with chronic alcoholism and its impact on the body.&lt;/li&gt;&lt;li&gt;â€¢ option D) All the above is correct,&lt;/li&gt;&lt;li&gt;â€¢ chronic alcoholism&lt;/li&gt;&lt;li&gt;â€¢ impact on the body.&lt;/li&gt;&lt;li&gt;â€¢ Options A, B, and C are individually correct but D encompasses all the possible findings, making it the most comprehensive choice.&lt;/li&gt;&lt;li&gt;â€¢ Options A, B, and C are&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ all the possible findings,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increase in serum levels of gamma-glutamyl transferase (GGT) and alanine transaminase (ALT) Decrease in aldehyde dehydrogenase activity (in liver cells and RBCs ) - best marker for alcohol abuse. Disialotransferrin ( sialic acid groups are removed from transferrin ) level in blood- highly sensitive marker for chronic alcohol abuse.&lt;/li&gt;&lt;li&gt;âž¤ Increase in serum levels of gamma-glutamyl transferase (GGT) and alanine transaminase (ALT)&lt;/li&gt;&lt;li&gt;âž¤ Increase&lt;/li&gt;&lt;li&gt;âž¤ gamma-glutamyl transferase (GGT) and alanine transaminase (ALT)&lt;/li&gt;&lt;li&gt;âž¤ Decrease in aldehyde dehydrogenase activity (in liver cells and RBCs ) - best marker for alcohol abuse.&lt;/li&gt;&lt;li&gt;âž¤ Decrease&lt;/li&gt;&lt;li&gt;âž¤ aldehyde dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ liver cells and RBCs&lt;/li&gt;&lt;li&gt;âž¤ best&lt;/li&gt;&lt;li&gt;âž¤ alcohol abuse.&lt;/li&gt;&lt;li&gt;âž¤ Disialotransferrin ( sialic acid groups are removed from transferrin ) level in blood- highly sensitive marker for chronic alcohol abuse.&lt;/li&gt;&lt;li&gt;âž¤ Disialotransferrin&lt;/li&gt;&lt;li&gt;âž¤ sialic acid&lt;/li&gt;&lt;li&gt;âž¤ transferrin&lt;/li&gt;&lt;li&gt;âž¤ highly sensitive marker&lt;/li&gt;&lt;li&gt;âž¤ chronic&lt;/li&gt;&lt;li&gt;âž¤ alcohol abuse.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 140-141.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 140-141.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with an established diagnosis of diabetes mellitus reports to the clinic for a follow-up, presenting with symptoms of fatigue, weight loss, polyuria, and a burning sensation in the soles. Despite ongoing treatment, his blood glucose levels are significantly elevated. Among the following options, which is LEAST likely to contribute to the hyperglycemia seen in uncontrolled Type 1 diabetes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased skeletal muscle glucose uptake&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased adipose lipogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased adipose lipolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased skeletal muscle Glycogenolysis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increased skeletal muscle Glycogenolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Increased skeletal muscle Glycogenolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased skeletal muscle glucose uptake : This is a significant contributor to hyperglycaemia in Type 1 diabetes , as insulin deficiency prevents glucose from entering cells, leading to elevated blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased skeletal muscle glucose uptake&lt;/li&gt;&lt;li&gt;â€¢ hyperglycaemia in Type 1 diabetes&lt;/li&gt;&lt;li&gt;â€¢ insulin deficiency prevents glucose&lt;/li&gt;&lt;li&gt;â€¢ entering cells,&lt;/li&gt;&lt;li&gt;â€¢ elevated blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased adipose lipogenesis: While decreased formation of fat from glucose in adipose tissue could be observed in insulin deficiency, it&#x27;s not a direct contributor to elevated glucose levels. Insulin promotes lipogenesis , so its deficiency would decrease this process, but this decrease does not directly cause hyperglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased adipose lipogenesis:&lt;/li&gt;&lt;li&gt;â€¢ decreased formation of fat&lt;/li&gt;&lt;li&gt;â€¢ insulin deficiency,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ elevated glucose levels. Insulin&lt;/li&gt;&lt;li&gt;â€¢ lipogenesis&lt;/li&gt;&lt;li&gt;â€¢ its deficiency&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ decrease does not&lt;/li&gt;&lt;li&gt;â€¢ hyperglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased adipose lipolysis: Increased breakdown of fat in the absence of insulin action elevates free fatty acid levels, which can exacerbate insulin resistance and contribute to higher blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased adipose lipolysis:&lt;/li&gt;&lt;li&gt;â€¢ Increased breakdown of fat&lt;/li&gt;&lt;li&gt;â€¢ absence of insulin&lt;/li&gt;&lt;li&gt;â€¢ elevates free fatty acid levels,&lt;/li&gt;&lt;li&gt;â€¢ exacerbate insulin resistance&lt;/li&gt;&lt;li&gt;â€¢ higher blood glucose levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Skeletal muscle cannot export glucose into the circulation like liver due to absence of enzyme glucose-6-phosphatase. So, intramyocellular glycogen acts as a fuel source for skeletal muscle and doesnâ€™t contribute to the hyperglycaemia in uncontrolled type I diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Skeletal muscle cannot&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ absence&lt;/li&gt;&lt;li&gt;âž¤ glucose-6-phosphatase.&lt;/li&gt;&lt;li&gt;âž¤ intramyocellular glycogen&lt;/li&gt;&lt;li&gt;âž¤ fuel source for skeletal muscle&lt;/li&gt;&lt;li&gt;âž¤ doesnâ€™t&lt;/li&gt;&lt;li&gt;âž¤ hyperglycaemia&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled&lt;/li&gt;&lt;li&gt;âž¤ type I diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Reasons of hyperglycemia associated with uncontrolled type I diabetes:&lt;/li&gt;&lt;li&gt;âž¤ hyperglycemia&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled type I diabetes:&lt;/li&gt;&lt;li&gt;âž¤ There will be decreased insulin mediated glucose utilization by skeletal muscle and adipose tissues â†’ will contribute to hyperglycaemia. There will also be decreased insulin-mediated suppression of hepatic glucose output. Decreased insulin-mediated suppression of lipolysis â†’ hyperglycaemia , by activation of gluconeogenesis by fatty acid breakdown product acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ There will be decreased insulin mediated glucose utilization by skeletal muscle and adipose tissues â†’ will contribute to hyperglycaemia.&lt;/li&gt;&lt;li&gt;âž¤ decreased insulin mediated glucose&lt;/li&gt;&lt;li&gt;âž¤ skeletal muscle and adipose tissues&lt;/li&gt;&lt;li&gt;âž¤ hyperglycaemia.&lt;/li&gt;&lt;li&gt;âž¤ There will also be decreased insulin-mediated suppression of hepatic glucose output.&lt;/li&gt;&lt;li&gt;âž¤ decreased insulin-mediated suppression&lt;/li&gt;&lt;li&gt;âž¤ hepatic glucose output.&lt;/li&gt;&lt;li&gt;âž¤ Decreased insulin-mediated suppression of lipolysis â†’ hyperglycaemia , by activation of gluconeogenesis by fatty acid breakdown product acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ Decreased insulin-mediated suppression of lipolysis&lt;/li&gt;&lt;li&gt;âž¤ hyperglycaemia&lt;/li&gt;&lt;li&gt;âž¤ activation of gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ fatty acid breakdown product acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 149, DM Vasudevan, 9/e: p 323-326.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 149, DM Vasudevan, 9/e: p 323-326.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-month-old girl presents with developing cataracts, and an inability to track objects visually. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely present in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aldolase B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Galactose 1-phosphate uridylyl transferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galactokinase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Galactokinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)Â  Galactokinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Distinguish between types of galactose metabolism disorders :&lt;/li&gt;&lt;li&gt;âž¤ types of galactose metabolism disorders&lt;/li&gt;&lt;li&gt;âž¤ Galactokinase deficiency : Early-onset cataracts , galactosuria , mild/no systemic symptoms. Classic galactosemia (GALT deficiency) : Severe symptoms including hepatomegaly , vomiting , jaundice , and cataracts . Both cause reducing substances in urine , but galactokinase deficiency is less severe and lacks liver involvement .&lt;/li&gt;&lt;li&gt;âž¤ Galactokinase deficiency : Early-onset cataracts , galactosuria , mild/no systemic symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Galactokinase deficiency&lt;/li&gt;&lt;li&gt;âž¤ cataracts&lt;/li&gt;&lt;li&gt;âž¤ galactosuria&lt;/li&gt;&lt;li&gt;âž¤ Classic galactosemia (GALT deficiency) : Severe symptoms including hepatomegaly , vomiting , jaundice , and cataracts .&lt;/li&gt;&lt;li&gt;âž¤ Classic galactosemia (GALT deficiency)&lt;/li&gt;&lt;li&gt;âž¤ Severe symptoms&lt;/li&gt;&lt;li&gt;âž¤ hepatomegaly&lt;/li&gt;&lt;li&gt;âž¤ vomiting&lt;/li&gt;&lt;li&gt;âž¤ jaundice&lt;/li&gt;&lt;li&gt;âž¤ cataracts&lt;/li&gt;&lt;li&gt;âž¤ Both cause reducing substances in urine , but galactokinase deficiency is less severe and lacks liver involvement .&lt;/li&gt;&lt;li&gt;âž¤ Both cause reducing substances in urine&lt;/li&gt;&lt;li&gt;âž¤ less severe and lacks liver involvement&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy experiences headache, dizziness, weakness, and knee joint tenderness after consuming sugarcane juice. Following a diagnosis of Hereditary Fructose Intolerance (HFI), which of the following statements about HFI is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deficiency of aldolase B.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Accumulation of fructose 1-phosphate in tissues&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperglycaemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver and kidneys are involved&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperglycaemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hyperglycaemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hereditary Fructose Intolerance (HFI) is caused by a deficiency of aldolase B, the enzyme that cleaves fructose 1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde.&lt;/li&gt;&lt;li&gt;â€¢ Hereditary Fructose Intolerance (HFI)&lt;/li&gt;&lt;li&gt;â€¢ deficiency of aldolase B,&lt;/li&gt;&lt;li&gt;â€¢ fructose 1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde.&lt;/li&gt;&lt;li&gt;â€¢ In HFI: Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ In HFI: Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ Fructose 1-phosphate accumulates in tissues (especially the liver and       kidneys)leading to: Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ Fructose 1-phosphate accumulates&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of glycogenolysis Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Resulting in hypoglycemia (low blood sugar), especially after ingestion of fructose, sucrose, or sorbitol.&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia (low blood sugar),&lt;/li&gt;&lt;li&gt;â€¢ Clinical findings:&lt;/li&gt;&lt;li&gt;â€¢ Clinical findings:&lt;/li&gt;&lt;li&gt;â€¢ Hypoglycemia, vomiting, lethargy, abdominal pain after fructose intake. Long-term exposure can cause hepatomegaly, liver dysfunction, and renal involvement.&lt;/li&gt;&lt;li&gt;â€¢ Hypoglycemia, vomiting, lethargy, abdominal pain after fructose intake.&lt;/li&gt;&lt;li&gt;â€¢ Long-term exposure can cause hepatomegaly, liver dysfunction, and renal involvement.&lt;/li&gt;&lt;li&gt;â€¢ hepatomegaly, liver dysfunction, and renal involvement.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deficiency of aldolase B: True. This is the fundamental enzymatic defect in HFI. Option B. Accumulation of fructose 1-phosphate in tissues: True. This is the hallmark of the disease and leads to metabolic blockages. Option D. Liver and kidneys are involved: True. These organs are significantly affected due to accumulation of fructose 1-phosphate and its toxic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deficiency of aldolase B: True. This is the fundamental enzymatic defect in HFI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deficiency of aldolase B:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Accumulation of fructose 1-phosphate in tissues: True. This is the hallmark of the disease and leads to metabolic blockages.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Accumulation of fructose 1-phosphate in tissues:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver and kidneys are involved: True. These organs are significantly affected due to accumulation of fructose 1-phosphate and its toxic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver and kidneys are involved:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biochemical defect in Hereditary Fructose Intolerance&lt;/li&gt;&lt;li&gt;âž¤ Deficiency of Fructose-1,6-Bisphosphate Aldolase (Aldolase B)&lt;/li&gt;&lt;li&gt;âž¤ Deficiency of this enzyme â†’ causes accumulation of fructose-1-phosphate â†’ severe toxic symptoms when a patient is exposed to fructose.&lt;/li&gt;&lt;li&gt;âž¤ Clinical manifestations&lt;/li&gt;&lt;li&gt;âž¤ Patients with HFI are asymptomatic until fructose or sucrose is ingested (usually from fruit, fruit juice, or sweetened cereal).&lt;/li&gt;&lt;li&gt;âž¤ Symptoms may occur early in life, soon after weaning formulas containing these sugars are introduced into the diet.&lt;/li&gt;&lt;li&gt;âž¤ Early clinical manifestations include jaundice, hepatomegaly, vomiting, lethargy, irritability, convulsions and hypoglycaemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 138.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): A nursing mother with classic Galactosemia is on a galactose-free diet and she is able to produce lactose in breast milk. Reasoning (R): Galactose can be produced from a glucose metabolite by epimerization:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A as well as R are right, and R is a correct explanation of A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A is right but R is a wrong statement: This option is incorrect because both the assertion and the reasoning are correct, and the reasoning provides a valid explanation for the assertion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A is right but R is a wrong statement:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ both&lt;/li&gt;&lt;li&gt;â€¢ assertion&lt;/li&gt;&lt;li&gt;â€¢ reasoning are correct,&lt;/li&gt;&lt;li&gt;â€¢ reasoning&lt;/li&gt;&lt;li&gt;â€¢ valid explanation for the assertion.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A is wrong, but R is a right statement: This option is incorrect because the assertion is indeed correct; nursing mothers with classic galactosemia on a galactose-free die t can produce lactose in breast milk due to the body&#x27;s ability to synthesize galactose from glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A is wrong, but R is a right statement:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ assertion is indeed correct;&lt;/li&gt;&lt;li&gt;â€¢ nursing mothers&lt;/li&gt;&lt;li&gt;â€¢ classic galactosemia&lt;/li&gt;&lt;li&gt;â€¢ galactose-free die&lt;/li&gt;&lt;li&gt;â€¢ lactose in breast milk&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s ability to synthesize galactose&lt;/li&gt;&lt;li&gt;â€¢ glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A and R both are wrong: This option is incorrect as both the assertion and the reasoning are correct and logically consistent.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A and R both are wrong:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ both the assertion&lt;/li&gt;&lt;li&gt;â€¢ reasoning are correct&lt;/li&gt;&lt;li&gt;â€¢ logically&lt;/li&gt;&lt;li&gt;â€¢ consistent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Galactose can be produced from a glucose metabolite by epimerization. Uridine diphosphate (UDP) glucose is converted to UDP-galactose by UDP hexose 4- epimerase , thereby providing the appropriate form of galactose for lactose synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Galactose can be produced from a glucose metabolite by epimerization.&lt;/li&gt;&lt;li&gt;âž¤ Galactose&lt;/li&gt;&lt;li&gt;âž¤ glucose metabolite by epimerization.&lt;/li&gt;&lt;li&gt;âž¤ Uridine diphosphate (UDP) glucose is converted to UDP-galactose by UDP hexose 4- epimerase , thereby providing the appropriate form of galactose for lactose synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Uridine diphosphate (UDP)&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ UDP-galactose&lt;/li&gt;&lt;li&gt;âž¤ UDP hexose 4- epimerase&lt;/li&gt;&lt;li&gt;âž¤ galactose for lactose synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 155, 203, 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 155, 203, 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old visits a local clinic for a routine check-up. The healthcare provider at the clinic performs an Oral Glucose Tolerance Test (OGTT) to assess his glucose metabolism. The results are plotted on a graph showing plasma glucose levels over time after a glucose load. Based on the graph shown, what is your interpretation of the patientâ€™s OGTT results?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Symptoms of Diabetes mellitus with inconclusive blood glucose values&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Overt Diabetes mellitus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetic nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follow-up of a case of Diabetes mellitus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Overt Diabetes mellitus&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture2%20(2).jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/120.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/121.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Based on the graph provided, which shows plasma glucose levels after a glucose load:&lt;/li&gt;&lt;li&gt;â€¢ The normal curve rises to about 140 mg/dL and then returns to baseline (~90 mg/dL) within 2 hours. The diabetic curve spikes up to ~300 mg/dL at 1 hour and remains significantly elevated (well above 200 mg/dL) even at 2 hours. the Oral Glucose Tolerance Test (OGTT) is interpreted as follows: Normal: Fasting glucose &amp;lt; 100 mg/dL; 2-hour post-load &amp;lt; 140 mg/dL. Impaired glucose tolerance: fasting glucose 100-126 mg/dl; 2-hour post-load 140â€“199 mg/dL. Diabetes mellitus: Fasting â‰¥ 126 mg/dL or 2-hour post-load â‰¥ 200 mg/dL .&lt;/li&gt;&lt;li&gt;â€¢ The normal curve rises to about 140 mg/dL and then returns to baseline (~90 mg/dL) within 2 hours.&lt;/li&gt;&lt;li&gt;â€¢ The diabetic curve spikes up to ~300 mg/dL at 1 hour and remains significantly elevated (well above 200 mg/dL) even at 2 hours.&lt;/li&gt;&lt;li&gt;â€¢ the Oral Glucose Tolerance Test (OGTT) is interpreted as follows:&lt;/li&gt;&lt;li&gt;â€¢ Normal: Fasting glucose &amp;lt; 100 mg/dL; 2-hour post-load &amp;lt; 140 mg/dL.&lt;/li&gt;&lt;li&gt;â€¢ Impaired glucose tolerance: fasting glucose 100-126 mg/dl; 2-hour post-load 140â€“199 mg/dL.&lt;/li&gt;&lt;li&gt;â€¢ Diabetes mellitus: Fasting â‰¥ 126 mg/dL or 2-hour post-load â‰¥ 200 mg/dL .&lt;/li&gt;&lt;li&gt;â€¢ Interpretation :&lt;/li&gt;&lt;li&gt;â€¢ Interpretation&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s OGTT pattern on the graph matches the diabetic curve (persistent elevation above 200 mg/dL even after 2 hours), clearly meeting criteria for overt diabetes mellitus.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values : This applies when symptoms are present but glucose levels donâ€™t conclusively meet diagnostic thresholds (not the case here, where the glucose is clearly high). Option C. Diabetic nephropathy : This is a complication of diabetes involving kidney damage and is not diagnosed by OGTT . OGTT assesses glucose metabolism, not kidney function. Option D. Follow-up of a case of Diabetes mellitus : OGTT is not recommended for follow-up of known diabetes cases. HbA1c, fasting glucose, and self-monitoring of blood glucose are the preferred methods for monitoring glycemic control in diagnosed patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values : This applies when symptoms are present but glucose levels donâ€™t conclusively meet diagnostic thresholds (not the case here, where the glucose is clearly high).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Symptoms of Diabetes mellitus with inconclusive blood glucose values&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diabetic nephropathy : This is a complication of diabetes involving kidney damage and is not diagnosed by OGTT . OGTT assesses glucose metabolism, not kidney function.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diabetic nephropathy&lt;/li&gt;&lt;li&gt;â€¢ Option D. Follow-up of a case of Diabetes mellitus : OGTT is not recommended for follow-up of known diabetes cases. HbA1c, fasting glucose, and self-monitoring of blood glucose are the preferred methods for monitoring glycemic control in diagnosed patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Follow-up of a case of Diabetes mellitus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Difference between normal, impaired, and diabetic glucose values.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 195-196, 205.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with symptoms of excessive thirst, increased appetite, tiredness, and a thin build. He has been advised to undergo fasting blood sugar (FBS) and postprandial blood sugar (PPBS) tests and is currently 12 hours into his fast. During this period of fasting, which one of the following enzymes is likely to be phosphorylated and active?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arginase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogen synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hormone sensitive lipase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hormone sensitive lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hormone sensitive lipase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arginase: Arginase is an enzyme involved in the urea cycle , which converts arginine into urea and ornithine . Its activity is not directly influenced by fasting or feeding states .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Arginase:&lt;/li&gt;&lt;li&gt;â€¢ Arginase&lt;/li&gt;&lt;li&gt;â€¢ urea cycle&lt;/li&gt;&lt;li&gt;â€¢ arginine into urea and ornithine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ fasting or feeding states&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty acid synthase: Fatty acid synthase is involved in the synthesis of fatty acids , a process that is downregulated during fasting when the body is mobilizing , rather than storing, energy.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty acid synthase:&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid synthase&lt;/li&gt;&lt;li&gt;â€¢ synthesis of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ downregulated&lt;/li&gt;&lt;li&gt;â€¢ body is mobilizing&lt;/li&gt;&lt;li&gt;â€¢ rather than storing, energy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glycogen synthase: Glycogen synthase is responsible for glycogen synthesis in the liver and muscle cells . This enzyme is less active during fasting , as the body is breaking down glycogen stores, not building them.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glycogen synthase:&lt;/li&gt;&lt;li&gt;â€¢ glycogen synthesis in the liver and muscle cells&lt;/li&gt;&lt;li&gt;â€¢ less active&lt;/li&gt;&lt;li&gt;â€¢ fasting&lt;/li&gt;&lt;li&gt;â€¢ breaking down glycogen stores, not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hormone-sensitive lipase (HSL) is an enzyme in adipose tissue that breaks down stored triglycerides into free fatty acids and glycerol , which can then be used for energy . HSL is activated by phosphorylation in response to low insulin and high glucagon levels , which are typical during fasting . Thus, in a fasting state , HSL would be phosphorylated and active to facilitate the mobilization of fat stores .&lt;/li&gt;&lt;li&gt;âž¤ Hormone-sensitive lipase (HSL)&lt;/li&gt;&lt;li&gt;âž¤ adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ stored triglycerides into free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ glycerol&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ activated&lt;/li&gt;&lt;li&gt;âž¤ phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ low insulin and high glucagon levels&lt;/li&gt;&lt;li&gt;âž¤ typical during fasting&lt;/li&gt;&lt;li&gt;âž¤ fasting state&lt;/li&gt;&lt;li&gt;âž¤ HSL&lt;/li&gt;&lt;li&gt;âž¤ phosphorylated and active&lt;/li&gt;&lt;li&gt;âž¤ mobilization of fat stores&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 261-263&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p 261-263&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An Infant diagnosed with Hereditary Fructose Intolerance (HFI) presents with vomiting, diarrhea, abdominal pain, and hypoglycemia upon attempting weaning. Following a positive IV fructose tolerance test, dietary restriction of fructose is advised. Considering the metabolic pathway affected in HFI, which of the following substances should be restricted in the neonate&#x27;s diet?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Galactose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sucrose&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Sucrose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Sucrose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Infants with Hereditary Fructose Intolerance (HFI), dietary restriction of sucrose is crucial due to its breakdown into glucose and fructose, the latter of which cannot be metabolized due to aldolase B deficiency, leading to toxic metabolite buildup and hypoglycemia. Other sugars like galactose, glucose, and lactose, which do not directly contribute to these metabolic issues, do not need to be restricted unless other specific metabolic disorders are present.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 202, 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old female presents with weight loss, fatigue, nocturia, and excessive thirst. Laboratory findings reveal fasting blood sugar (FBS) &amp;gt;140 mg/dl and postprandial blood sugar (PPBS) &amp;gt;250 mg/dl, leading to a probable diagnosis of Type 1 diabetes mellitus. Considering the pathophysiology of Type 1 diabetes mellitus, which of the following statements is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased lipolysis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased protein catabolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased hepatic Glucose output&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase glucose uptake&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increased lipolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Increased lipolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type 1 diabetes mellitus is characterized by an autoimmune destruction of pancreatic Î²-cells , leading to absolute insulin deficiency . Insulin normally inhibits lipolysis , so its deficiency in Type 1 diabetes results in increased lipolysis in adipose tissue . This leads to elevated levels of free fatty acids in the bloodstream, which can contribute to the production of ketone bodies in the liver, a common complication in uncontrolled diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Type 1 diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ autoimmune destruction of pancreatic Î²-cells&lt;/li&gt;&lt;li&gt;âž¤ absolute insulin deficiency&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ inhibits lipolysis&lt;/li&gt;&lt;li&gt;âž¤ deficiency in Type 1 diabetes&lt;/li&gt;&lt;li&gt;âž¤ increased lipolysis in adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ elevated levels&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies in the liver,&lt;/li&gt;&lt;li&gt;âž¤ common complication&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 149&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 149&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with Type 1 diabetes mellitus presents with a blood glucose level greater than 300 mg/dl. In the context of his elevated blood glucose, which of the following metabolic processes continues to occur normally in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased protein synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycogenesis in muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased conversion of fatty acid to Acetyl CoA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased triglyceride level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased conversion of fatty acid to Acetyl CoA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Increased conversion of fatty acid to Acetyl CoA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In Type 1 diabetes mellitus with significantly elevated blood glucose (&amp;gt;300 mg/dl), insulin deficiency leads to dramatic metabolic alterations. Without insulin, glucose uptake by peripheral tissues is impaired, leading to hyperglycemia. Simultaneously, the body shifts to alternative fuel sources:&lt;/li&gt;&lt;li&gt;â€¢ Increased fatty acid mobilization from adipose tissue occurs in insulin deficiency. These fatty acids undergo Î²-oxidation in the liver, resulting in increased conversion to Acetyl CoA.&lt;/li&gt;&lt;li&gt;â€¢ The excess Acetyl CoA cannot enter the TCA cycle efficiently due to low oxaloacetate availability (diverted to gluconeogenesis), and instead is shunted toward ketogenesis, producing ketone bodies (acetoacetate, Î²-hydroxybutyrate, and acetone). This leads to diabetic ketoacidosis in uncontrolled Type 1 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased protein synthesis : Insulin promotes protein synthesis and inhibits protein breakdown. In Type 1 diabetes with insulin deficiency, protein synthesis decreases while proteolysis increases, providing amino acids for gluconeogenesis. This contributes to the catabolic state and muscle wasting seen in poorly controlled diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glycogenesis in muscle : This process requires both insulin and adequate glucose transport into muscle cells via GLUT4 transporters. Insulin deficiency impairs GLUT4 translocation to the cell membrane, reducing glucose uptake and subsequent glycogen synthesis in muscle tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glycogenesis in muscle&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased triglyceride level - This is incorrect. In Type 1 diabetes with insulin deficiency, triglyceride levels are not decreased but are typically increased due to impaired clearance of triglyceride-rich lipoproteins due to decreased lipoprotein lipase activity (an insulin-dependent enzyme) This often leads to hypertriglyceridemia, not decreased triglyceride levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased triglyceride level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In uncontrolled Type 1 diabetes with hyperglycemia, insulin deficiency creates a catabolic state where fat mobilization and fatty acid oxidation are accelerated, leading to increased Acetyl CoA production and ketogenesis. This represents a shift from glucose to fat metabolism. Meanwhile, anabolic processes like protein synthesis and glycogenesis are impaired, highlighting the crucial role of insulin in regulating metabolic pathways.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 149, Lippincott: P 340&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a known history of diabetes mellitus presents to the outpatient department for a routine follow-up appointment after three months. As part of the management and monitoring plan, the healthcare provider requests an HbA1c test, which is crucial for assessing long-term glycemic control. Considering the various methods available for HbA1c estimation, which of the following is considered the most accurate and reliable method?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Affinity chromatography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High performance liquid chromatography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoelectric Focussing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. High performance liquid chromatography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) High performance liquid chromatography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Affinity chromatography: While affinity chromatography can be used for HbA1c measurement, it is not as specific or as widely used as HPLC. It relies on the specific binding of HbA1c to a particular substrate, which can be influenced by the presence of hemoglobin variants.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Affinity chromatography:&lt;/li&gt;&lt;li&gt;â€¢ HbA1c measurement,&lt;/li&gt;&lt;li&gt;â€¢ not as specific&lt;/li&gt;&lt;li&gt;â€¢ widely&lt;/li&gt;&lt;li&gt;â€¢ HPLC.&lt;/li&gt;&lt;li&gt;â€¢ specific binding of HbA1c&lt;/li&gt;&lt;li&gt;â€¢ presence of&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin variants.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Electrophoresis: Electrophoresis can separate different hemoglobin types based on their electric charge, but it is less precise than HPLC for quantifying HbA1c levels and can be affected by the presence of hemoglobin variants.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Electrophoresis:&lt;/li&gt;&lt;li&gt;â€¢ different hemoglobin types&lt;/li&gt;&lt;li&gt;â€¢ electric charge,&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ HPLC for quantifying HbA1c levels&lt;/li&gt;&lt;li&gt;â€¢ affected&lt;/li&gt;&lt;li&gt;â€¢ presence of hemoglobin variants.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isoelectric focusing: This technique separates proteins based on their isoelectric points. While it can differentiate various hemoglobin forms , it is not the preferred method for routine HbA1c estimation due to its complexity and the difficulty in quantification.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isoelectric focusing:&lt;/li&gt;&lt;li&gt;â€¢ proteins based&lt;/li&gt;&lt;li&gt;â€¢ isoelectric&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin forms&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ routine HbA1c estimation&lt;/li&gt;&lt;li&gt;â€¢ its complexity&lt;/li&gt;&lt;li&gt;â€¢ difficulty&lt;/li&gt;&lt;li&gt;â€¢ quantification.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High-performance liquid chromatography (HPLC) is widely recognized as the gold standard for HbA1c estimation due to its accuracy, reliability, and reproducibility . HPLC separates various forms of hemoglobin, including HbA1c, based on their charge and size under high pressure , allowing for precise quantification. This method minimizes interference from hemoglobin variants and provides a clear, specific measurement of HbA1c levels , which reflect the average blood glucose concentration over the previous 2-3 months.&lt;/li&gt;&lt;li&gt;âž¤ High-performance liquid chromatography (HPLC)&lt;/li&gt;&lt;li&gt;âž¤ widely&lt;/li&gt;&lt;li&gt;âž¤ gold standard for HbA1c estimation&lt;/li&gt;&lt;li&gt;âž¤ accuracy, reliability, and reproducibility&lt;/li&gt;&lt;li&gt;âž¤ HPLC&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin, including HbA1c,&lt;/li&gt;&lt;li&gt;âž¤ their charge and size&lt;/li&gt;&lt;li&gt;âž¤ high pressure&lt;/li&gt;&lt;li&gt;âž¤ precise quantification.&lt;/li&gt;&lt;li&gt;âž¤ minimizes interference from hemoglobin variants&lt;/li&gt;&lt;li&gt;âž¤ clear, specific measurement of HbA1c levels&lt;/li&gt;&lt;li&gt;âž¤ average blood glucose concentration&lt;/li&gt;&lt;li&gt;âž¤ previous 2-3 months.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Tietz fundamentals of Clinical Chemistry, 6th edition, page 396&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Tietz fundamentals of Clinical Chemistry, 6th edition, page 396&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Glucagon is needed for glycogenesis to occur. Reasoning (R): The enzyme glycogen phosphorylase is the rate limiting enzyme for glycogenesis and it is active in phosphorylated form for which glucagon is needed. Evaluate the accuracy of the assertion and reasoning provided.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A and R both are wrong&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) A and R both are wrong&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ For glycogenesis, presence of insulin is must, because Insulin is required for dephosphorylation of glycogen synthase enzyme, which is the rate limiting enzyme for glycogenesis. Glycogen synthase is active in a dephosphorylated state.&lt;/li&gt;&lt;li&gt;â€¢ For glycogenesis, presence of insulin is must, because Insulin is required for dephosphorylation of glycogen synthase enzyme, which is the rate limiting enzyme for glycogenesis.&lt;/li&gt;&lt;li&gt;â€¢ For glycogenesis,&lt;/li&gt;&lt;li&gt;â€¢ insulin&lt;/li&gt;&lt;li&gt;â€¢ dephosphorylation of glycogen synthase&lt;/li&gt;&lt;li&gt;â€¢ rate limiting enzyme&lt;/li&gt;&lt;li&gt;â€¢ glycogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Glycogen synthase is active in a dephosphorylated state.&lt;/li&gt;&lt;li&gt;â€¢ Glycogen synthase&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ dephosphorylated state.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycogen phosphorylase is the key enzyme in glycogenolysis, the breakdown of glycogen into glucose-1-phosphate, not glycogenesis. This enzyme is activated in its phosphorylated form, but this activation is triggered by glucagon and adrenaline during fasting or stress, not for promoting glycogen synthesis but for breaking down glycogen into glucose to raise blood glucose levels. Glycogen synthase is the key rate-limiting enzyme in glycogenesis and is regulated by insulin and glucose levels , not glucagon.&lt;/li&gt;&lt;li&gt;âž¤ Glycogen phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ glycogenolysis,&lt;/li&gt;&lt;li&gt;âž¤ breakdown of glycogen&lt;/li&gt;&lt;li&gt;âž¤ glucose-1-phosphate,&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ glycogenesis.&lt;/li&gt;&lt;li&gt;âž¤ phosphorylated&lt;/li&gt;&lt;li&gt;âž¤ activation&lt;/li&gt;&lt;li&gt;âž¤ glucagon and adrenaline&lt;/li&gt;&lt;li&gt;âž¤ fasting or stress, not&lt;/li&gt;&lt;li&gt;âž¤ glycogen synthesis&lt;/li&gt;&lt;li&gt;âž¤ breaking down glycogen into glucose&lt;/li&gt;&lt;li&gt;âž¤ raise blood glucose levels.&lt;/li&gt;&lt;li&gt;âž¤ Glycogen synthase&lt;/li&gt;&lt;li&gt;âž¤ rate-limiting enzyme in glycogenesis&lt;/li&gt;&lt;li&gt;âž¤ insulin and glucose levels&lt;/li&gt;&lt;li&gt;âž¤ not glucagon.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 142,178-183.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 142,178-183.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with complaints of pain in his calves during and after physical activity. Upon further evaluation, including a detailed examination and muscle biopsy, it was noted that there was an increased glycogen accumulation in the muscle tissues. Based on these findings, which of the following enzymes is most likely deficient in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver phosphorylase kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose 6 phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Muscle phosphorylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture15.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Muscle phosphorylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Liver phosphorylase kinase: Is a type VIII disorder with hepatomegaly, accumulation of glycogen in liver and mild hypoglycaemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Liver phosphorylase kinase:&lt;/li&gt;&lt;li&gt;â€¢ type VIII&lt;/li&gt;&lt;li&gt;â€¢ hepatomegaly,&lt;/li&gt;&lt;li&gt;â€¢ glycogen in liver&lt;/li&gt;&lt;li&gt;â€¢ hypoglycaemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose 6 phosphatase: Is deficient in Von Gierke disease (Ia), C/F includes glycogen accumulation in liver and renal tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia. (No muscle weakness).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose 6 phosphatase:&lt;/li&gt;&lt;li&gt;â€¢ deficient&lt;/li&gt;&lt;li&gt;â€¢ Von Gierke disease (Ia),&lt;/li&gt;&lt;li&gt;â€¢ glycogen&lt;/li&gt;&lt;li&gt;â€¢ liver and renal&lt;/li&gt;&lt;li&gt;â€¢ tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Branching enzyme: Is defective in Andersen disease with Hepatosplenomegaly ; accumulation of polysaccharide with few branch points ; death from heart or liver failure before age 5.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Branching enzyme:&lt;/li&gt;&lt;li&gt;â€¢ Andersen disease&lt;/li&gt;&lt;li&gt;â€¢ Hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ polysaccharide&lt;/li&gt;&lt;li&gt;â€¢ few&lt;/li&gt;&lt;li&gt;â€¢ branch points&lt;/li&gt;&lt;li&gt;â€¢ death&lt;/li&gt;&lt;li&gt;â€¢ heart or liver failure before age 5.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: P 179.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: P 179.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old male with a history of short stature presents to the clinic with recurrent episodes of hypoglycemia, hepatomegaly, and bleeding tendencies. On examination, the patient also has notable hepatomegaly and enlarged kidneys. Laboratory findings include elevated levels of lactate, cholesterol, triglycerides, and uric acid. Considering the constellation of symptoms and lab findings, which enzyme deficiency is most likely responsible for this patient&#x27;s clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Debranching enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose-6-phosphatase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glucose-6-phosphatase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Glucose-6-phosphatase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Branching enzyme: deficiency results in Anderson disease . C/F: failure to thrive, liver failure, and hypotonia.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Branching enzyme:&lt;/li&gt;&lt;li&gt;â€¢ Anderson disease&lt;/li&gt;&lt;li&gt;â€¢ failure to thrive, liver failure, and hypotonia.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Debranching enzyme: deficiency results in Cori disease . C/F: hypoglycemia, hepatomegaly, short-stature, and myopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Debranching enzyme:&lt;/li&gt;&lt;li&gt;â€¢ Cori disease&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia, hepatomegaly, short-stature, and myopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Muscle phosphorylase: deficiency results in McArdle disease. C/F: pain, cramps and myoglobinuria on strenuous exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Muscle phosphorylase:&lt;/li&gt;&lt;li&gt;â€¢ McArdle disease.&lt;/li&gt;&lt;li&gt;â€¢ pain, cramps and myoglobinuria on strenuous exercise.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Von Gierke&#x27;s disease (Type I glycogen storage disease) , characterized by a deficiency in glucose-6-phosphatase. This enzyme is crucial for the final steps of gluconeogenesis and glycogenolysis, converting glucose-6-phosphate into free glucose . Its deficiency leads to impaired glucose production , resulting in hypoglycemia, and the accumulation of glycogen and fat in the liver and kidneys, causing hepatomegaly and renal enlargement . The increased levels of lactate, cholesterol, triglycerides, and uric acid are also consistent with the metabolic disturbances seen in von Gierke&#x27;s disease.&lt;/li&gt;&lt;li&gt;âž¤ Von Gierke&#x27;s disease (Type I glycogen storage disease)&lt;/li&gt;&lt;li&gt;âž¤ deficiency in glucose-6-phosphatase.&lt;/li&gt;&lt;li&gt;âž¤ final steps of gluconeogenesis and glycogenolysis,&lt;/li&gt;&lt;li&gt;âž¤ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ free glucose&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ impaired glucose production&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia,&lt;/li&gt;&lt;li&gt;âž¤ glycogen and fat&lt;/li&gt;&lt;li&gt;âž¤ liver and kidneys,&lt;/li&gt;&lt;li&gt;âž¤ hepatomegaly and renal enlargement&lt;/li&gt;&lt;li&gt;âž¤ increased&lt;/li&gt;&lt;li&gt;âž¤ lactate, cholesterol, triglycerides,&lt;/li&gt;&lt;li&gt;âž¤ uric acid&lt;/li&gt;&lt;li&gt;âž¤ metabolic disturbances&lt;/li&gt;&lt;li&gt;âž¤ von Gierke&#x27;s disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 179,355&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 179,355&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pediatric grand rounds presentation, a challenging case involving a 6-month-old infant with recurrent episodes of early morning hypoglycemia is discussed. The attending physician explains that administering glucagon raised the infant&#x27;s blood glucose levels when fed but was ineffective during fasting periods. A liver biopsy revealed abnormal glycogen accumulation. The audience, consisting of pediatricians JRs, is then asked to determine the enzyme deficiency responsible for the infant&#x27;s condition based on the clinical findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Debranching enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose-6-phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Debranching enzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â  Debranching enzyme&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Muscle phosphorylase : Type V â€“ McArdleâ€™s syndrome; Poor exercise tolerance with high muscle glycogen and low blood lactate after exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Muscle phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ Type V â€“ McArdleâ€™s syndrome; Poor exercise tolerance&lt;/li&gt;&lt;li&gt;â€¢ high muscle glycogen&lt;/li&gt;&lt;li&gt;â€¢ low blood&lt;/li&gt;&lt;li&gt;â€¢ lactate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose-6-phosphatase: Is deficient in Von Gierke disease (Ia) ,C/F includes glycogen accumulation in liver and renal t ubule cells , hypoglycaemia, lactic academia , ketosis and hyperlipidemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucose-6-phosphatase:&lt;/li&gt;&lt;li&gt;â€¢ deficient in Von Gierke disease (Ia)&lt;/li&gt;&lt;li&gt;â€¢ glycogen accumulation in liver&lt;/li&gt;&lt;li&gt;â€¢ renal&lt;/li&gt;&lt;li&gt;â€¢ ubule cells&lt;/li&gt;&lt;li&gt;â€¢ hypoglycaemia, lactic academia&lt;/li&gt;&lt;li&gt;â€¢ ketosis and hyperlipidemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Branching enzyme: Is defective in Anderson disease with Hepatosplenomegaly; accumulation of polysaccharide with few branch points; death from heart or liver failure before age 5.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Branching enzyme:&lt;/li&gt;&lt;li&gt;â€¢ defective in Anderson disease&lt;/li&gt;&lt;li&gt;â€¢ Hepatosplenomegaly;&lt;/li&gt;&lt;li&gt;â€¢ polysaccharide&lt;/li&gt;&lt;li&gt;â€¢ few&lt;/li&gt;&lt;li&gt;â€¢ branch&lt;/li&gt;&lt;li&gt;â€¢ death from heart or liver failure&lt;/li&gt;&lt;li&gt;â€¢ age 5.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical features of Type III Glycogen Storage Disease (Cori&#x27;s or Forbes&#x27; Disease) caused by a deficiency in the debranching enzyme, leading to impaired glycogenolysis , glycogen accumulation in the liver, and fasting hypoglycemia.&lt;/li&gt;&lt;li&gt;âž¤ Type III Glycogen Storage Disease (Cori&#x27;s or Forbes&#x27; Disease)&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ debranching&lt;/li&gt;&lt;li&gt;âž¤ impaired glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ glycogen accumulation&lt;/li&gt;&lt;li&gt;âž¤ liver, and fasting hypoglycemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 179.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 179.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about mitochondria is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycolytic enzymes are in mitochondrial matrix&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inner mitochondrial membrane contains enzymes of electron transport chain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fluid matrix contains enzymes of TCA cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acyl-CoA synthetase in localized in the outer mitochondrial membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycolytic enzymes are in mitochondrial matrix&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glycolytic enzymes are in mitochondrial matrix&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: The inner mitochondrial membrane contains enzymes of the electron transport chain: This is true . The inner mitochondrial membrane is the site of the electron transport chain , where ATP is synthesized.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ The inner mitochondrial membrane contains enzymes of the electron transport chain:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ inner mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ ATP is synthesized.&lt;/li&gt;&lt;li&gt;â€¢ Option C : The fluid matrix contains enzymes of the TCA cycle: This is also true . The mitochondrial matrix houses enzymes of the TCA cycle, which is involved in energy production.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ : The fluid matrix contains enzymes of the TCA cycle:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial matrix&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle,&lt;/li&gt;&lt;li&gt;â€¢ energy production.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Acyl-CoA synthetase is localized in the outer mitochondrial membrane: True, acyl-CoA synthetase , involved in fatty acid metabolism, is found on the outer mitochondrial membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Acyl-CoA synthetase is localized in the outer mitochondrial membrane:&lt;/li&gt;&lt;li&gt;â€¢ True, acyl-CoA synthetase&lt;/li&gt;&lt;li&gt;â€¢ fatty acid&lt;/li&gt;&lt;li&gt;â€¢ metabolism,&lt;/li&gt;&lt;li&gt;â€¢ outer mitochondrial membrane.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LOCATION OF ENZYMES IN MITOCHONDRIA&lt;/li&gt;&lt;li&gt;âž¤ LOCATION OF ENZYMES IN MITOCHONDRIA&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 259.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 259.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The diagram below represents the various fates of pyruvate. Which letter on the diagram shows the reaction requiring biotin as a cofactor and is activated by acetylcoenzyme A?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. B: Denotes PDH present in mitochondria, which oxidatively decarboxylates pyruvate to acetyl CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. B:&lt;/li&gt;&lt;li&gt;â€¢ PDH present in mitochondria,&lt;/li&gt;&lt;li&gt;â€¢ oxidatively decarboxylates pyruvate to acetyl CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. D: Denotes ALT. Alanine is formed by transamination of pyruvate by the enzyme alanine aminotransferase (ALT), which requires PLP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. D:&lt;/li&gt;&lt;li&gt;â€¢ ALT.&lt;/li&gt;&lt;li&gt;â€¢ transamination of pyruvate&lt;/li&gt;&lt;li&gt;â€¢ alanine aminotransferase (ALT),&lt;/li&gt;&lt;li&gt;â€¢ PLP.&lt;/li&gt;&lt;li&gt;â€¢ Pyruvate + Glutamate â†’ Alanine + alpha ketoglutarate&lt;/li&gt;&lt;li&gt;â€¢ Pyruvate + Glutamate â†’ Alanine + alpha ketoglutarate&lt;/li&gt;&lt;li&gt;â€¢ Option D. A: Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate, which is a substrate level key glycolytic enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A:&lt;/li&gt;&lt;li&gt;â€¢ Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate,&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;li&gt;â€¢ glycolytic enzyme.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The role of biotin is a cofactor in the carboxylation reaction catalyzed by pyruvate carboxylase and how acetyl-CoA serves as an allosteric activator of the enzyme, linking the state of cellular energy to gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ biotin is a cofactor&lt;/li&gt;&lt;li&gt;âž¤ carboxylation&lt;/li&gt;&lt;li&gt;âž¤ pyruvate carboxylase&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ allosteric activator&lt;/li&gt;&lt;li&gt;âž¤ state of cellular energy to gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 165,166.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 165,166.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical student is studying the unique metabolic pathways of erythrocytes (red blood cells). Due to the absence of mitochondria, erythrocytes rely on glycolysis for ATP production. Within this context, the student is interested in the yield of ATP from glucose through the Rapoport-Luebering cycle. What is the net gain of ATP by this cycle in red blood cells from one molecule of glucose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 0&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand RBC Metabolism: Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis. Learn the Rapoport-Luebering Cycle: Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Understand RBC Metabolism: Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Learn the Rapoport-Luebering Cycle: Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p173, 174&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy presents with hemolytic anemia, and further investigation reveals a deficiency in hexokinase, a key enzyme in the glycolytic pathway, leading to the premature destruction of energy-depleted red blood cells (RBCs). Which of the following statements about hexokinase is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Has higher affinity to glucose compared to glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Has higher Km to glucose compared to glucokinase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Involved in providing glucose to the peripheral tissues&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not involved in glucose storage by the liver&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Has higher Km to glucose compared to glucokinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture18_qXRYnGM.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Has higher Km to glucose compared to Glucokinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Has higher affinity to glucose compared to Glucokinase.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ higher affinity&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ Option C: Involved in providing glucose to the peripheral tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ glucose to the peripheral tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Not involved in glucose storage by the liver&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ glucose storage by the liver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose to glucose-6-phosphate is converted by either Glucokinase or hexokinase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 191-192.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 191-192.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatric team is evaluating a 6-month-old full-term baby girl who presents with failure to thrive, hypotonia, decreased muscle mass, head lag, and metabolic acidosis. Her blood work shows elevated levels of lactate, pyruvate, and alanine. These clinical findings suggest a deficiency in a key metabolic enzyme. Which enzyme is most likely to be deficient in this infant, given her clinical and laboratory presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alanine aminotransferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyruvate carboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate dehydrogenase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pyruvate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pyruvate dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alanine aminotransferase: This enzyme is involved in the transamination of alanine to pyruvate . A deficiency would not likely result in elevated levels of pyruvate or lactate.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alanine aminotransferase:&lt;/li&gt;&lt;li&gt;â€¢ transamination of alanine to pyruvate&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ elevated levels of pyruvate or lactate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase: A deficiency in this enzyme would typically lead to lower levels of lactate , not higher.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ lower levels of lactate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate carboxylase: While this enzyme is involved in gluconeogenesis , its deficiency usually leads to hypoglycemia and does not typically cause elevated lactate levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate carboxylase:&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ elevated lactate levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate dehydrogenase deficiency is characterized by the accumulation of pyruvate that cannot be effectively converted into acetyl CoA, leading to its reduction to lactate resulting in lactic acidosis and transamination to alanine&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate dehydrogenase deficiency&lt;/li&gt;&lt;li&gt;âž¤ accumulation of pyruvate&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ acetyl CoA,&lt;/li&gt;&lt;li&gt;âž¤ reduction to lactate&lt;/li&gt;&lt;li&gt;âž¤ lactic acidosis&lt;/li&gt;&lt;li&gt;âž¤ transamination to alanine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p115-116,253-254.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p115-116,253-254.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a fitness center, a personal trainer discusses with a client the metabolic changes that occur during intense aerobic workouts. The trainer explains how the body metabolizes glucose to meet the increased energy demands of vigorous exercise. The conversation leads to a question about the form in which carbon atoms from glucose enter the tricarboxylic acid (TCA) cycle during such high-energy activities. What is the correct form in which these carbons enter the TCA cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxaloacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetyl-CoA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acetyl-CoA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acetyl-CoA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Citrate: Oxaloacetate condenses with acetyl CoA entering TCA cycle to form citrate (a tricarboxylic molecule ) (inside TCA cycle ) with the help of the enzyme citrate synthase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Citrate:&lt;/li&gt;&lt;li&gt;â€¢ Oxaloacetate&lt;/li&gt;&lt;li&gt;â€¢ acetyl CoA entering TCA cycle&lt;/li&gt;&lt;li&gt;â€¢ citrate&lt;/li&gt;&lt;li&gt;â€¢ tricarboxylic molecule&lt;/li&gt;&lt;li&gt;â€¢ TCA&lt;/li&gt;&lt;li&gt;â€¢ cycle&lt;/li&gt;&lt;li&gt;â€¢ enzyme citrate synthase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxaloacetate: Pyruvate is carboxylated to oxaloacetate which is then used for gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxaloacetate:&lt;/li&gt;&lt;li&gt;â€¢ Pyruvate&lt;/li&gt;&lt;li&gt;â€¢ carboxylated&lt;/li&gt;&lt;li&gt;â€¢ oxaloacetate&lt;/li&gt;&lt;li&gt;â€¢ used for gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyruvate: Glucose is converted to pyruvate which is then converted to acetyl-CoA â†’ enter TCA cycle and Pyruvate as such cannot enter TCA cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pyruvate:&lt;/li&gt;&lt;li&gt;â€¢ Glucose&lt;/li&gt;&lt;li&gt;â€¢ converted&lt;/li&gt;&lt;li&gt;â€¢ pyruvate&lt;/li&gt;&lt;li&gt;â€¢ converted to acetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ enter TCA cycle&lt;/li&gt;&lt;li&gt;â€¢ Pyruvate&lt;/li&gt;&lt;li&gt;â€¢ cannot enter TCA cycle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In aerobic glycolysis , glucose is converted into pyruvate â†’ then c onverted to Acetyl-CoA , which actually enters the citric acid cycle. Two Acetyl-CoA , each containing two of the glucoseâ€™s carbons , are formed from each glucose molecule.&lt;/li&gt;&lt;li&gt;âž¤ In aerobic glycolysis , glucose is converted into pyruvate â†’ then c onverted to Acetyl-CoA , which actually enters the citric acid cycle.&lt;/li&gt;&lt;li&gt;âž¤ aerobic glycolysis&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ pyruvate&lt;/li&gt;&lt;li&gt;âž¤ onverted to Acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ enters the citric&lt;/li&gt;&lt;li&gt;âž¤ acid cycle.&lt;/li&gt;&lt;li&gt;âž¤ Two Acetyl-CoA , each containing two of the glucoseâ€™s carbons , are formed from each glucose molecule.&lt;/li&gt;&lt;li&gt;âž¤ Two Acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ two of the glucoseâ€™s carbons&lt;/li&gt;&lt;li&gt;âž¤ each&lt;/li&gt;&lt;li&gt;âž¤ glucose molecule.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 96-98.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 96-98.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Examines the following diagram, illustrating the PDH complex and its enzymatic components, labelled A, B, and C What is the name of enzyme component &#x27;C&#x27; within the PDH complex?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dihydrolipoyl Transacetylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipoamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dihydrolipoyl dehydrogenase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dihydrolipoyl dehydrogenase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture21_2waVOtU.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dihydrolipoyl dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate dehydrogenase: This is the first enzyme in the complex and is responsible for the decarboxylation of pyruvate.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ first enzyme&lt;/li&gt;&lt;li&gt;â€¢ complex&lt;/li&gt;&lt;li&gt;â€¢ decarboxylation of pyruvate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dihydrolipoyl transacetylase: The second enzyme in the complex, responsible for transferring the acetyl group to CoA to form acetyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dihydrolipoyl transacetylase:&lt;/li&gt;&lt;li&gt;â€¢ second enzyme&lt;/li&gt;&lt;li&gt;â€¢ complex,&lt;/li&gt;&lt;li&gt;â€¢ transferring the acetyl group to CoA&lt;/li&gt;&lt;li&gt;â€¢ form acetyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lipoamide: Not an enzyme but rather a cofactor bound to the enzymes in the PDH complex.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lipoamide:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ cofactor bound&lt;/li&gt;&lt;li&gt;â€¢ PDH complex.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The enzyme part of the PDH complex is made up of three component enzymes. PYRUVATE DEHYDROGENASE (ENZYME 1): Catalyses oxidative decarboxylation; Coenzyme: TPP; Enzyme bound hydroxyethyl TPP is formed DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2): Hydroxyethyl group is oxidized to form acetyl group â†’ transferred from TPP to lipoamide â†’ acetyl lipoamide. DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3): Oxidation of lipoamide; cofactors: TPP, lipoamide and FAD are regenerated&lt;/li&gt;&lt;li&gt;âž¤ The enzyme part of the PDH complex is made up of three component enzymes.&lt;/li&gt;&lt;li&gt;âž¤ PDH complex&lt;/li&gt;&lt;li&gt;âž¤ three component enzymes.&lt;/li&gt;&lt;li&gt;âž¤ PYRUVATE DEHYDROGENASE (ENZYME 1): Catalyses oxidative decarboxylation; Coenzyme: TPP; Enzyme bound hydroxyethyl TPP is formed&lt;/li&gt;&lt;li&gt;âž¤ PYRUVATE DEHYDROGENASE (ENZYME 1):&lt;/li&gt;&lt;li&gt;âž¤ DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2): Hydroxyethyl group is oxidized to form acetyl group â†’ transferred from TPP to lipoamide â†’ acetyl lipoamide.&lt;/li&gt;&lt;li&gt;âž¤ DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2):&lt;/li&gt;&lt;li&gt;âž¤ DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3): Oxidation of lipoamide; cofactors: TPP, lipoamide and FAD are regenerated&lt;/li&gt;&lt;li&gt;âž¤ DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3):&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 173, Vasudevan 9/ ed: p 115&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 173, Vasudevan 9/ ed: p 115&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the oxidative decarboxylation of pyruvate to acetyl CoA is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PDH complex is analogous to Î±-ketoglutarate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fat can be converted to glucose, because PDH cycle is reversible&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TPP, lipoic acid, coenzyme A, FAD, NAD are the coenzymes involved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PDH defect leads to lactic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fat can be converted to glucose, because PDH cycle is reversible&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fat can be converted to glucose, because PDH cycle is reversible&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: True , the PDH complex is analogous to the Î±-ketoglutarate dehydrogenase complex in terms of function and coenzyme requirements.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ PDH complex&lt;/li&gt;&lt;li&gt;â€¢ analogous&lt;/li&gt;&lt;li&gt;â€¢ Î±-ketoglutarate dehydrogenase complex&lt;/li&gt;&lt;li&gt;â€¢ function and coenzyme&lt;/li&gt;&lt;li&gt;â€¢ Option C: True , these coenzymes are all involved in the function of the PDH complex.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ coenzymes&lt;/li&gt;&lt;li&gt;â€¢ function&lt;/li&gt;&lt;li&gt;â€¢ PDH complex.&lt;/li&gt;&lt;li&gt;â€¢ Option D: True, a defect in the PDH complex can lead to lactic acidosis because pyruvate is then preferentially converted to lactate by lactate dehydrogenase .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ True,&lt;/li&gt;&lt;li&gt;â€¢ PDH complex&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ pyruvate&lt;/li&gt;&lt;li&gt;â€¢ converted to lactate&lt;/li&gt;&lt;li&gt;â€¢ lactate dehydrogenase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The conversion of pyruvate to acetyl CoA via the PDH complex is an irreversible step in metabolism. This means that fat, which is broken down into acetyl CoA, cannot be converted back to glucose through this pathway. This is a fundamental concept in metabolism, as it explains why fatty acids cannot undergo gluconeogenesis to form glucose.&lt;/li&gt;&lt;li&gt;âž¤ conversion of pyruvate to acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ PDH complex&lt;/li&gt;&lt;li&gt;âž¤ irreversible&lt;/li&gt;&lt;li&gt;âž¤ fat,&lt;/li&gt;&lt;li&gt;âž¤ broken down into acetyl CoA,&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ back&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ fundamental&lt;/li&gt;&lt;li&gt;âž¤ fatty acids cannot&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis to form glucose.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 173, Vasudevan 9/ ed: p 115&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 173, Vasudevan 9/ ed: p 115&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neurology team is managing a 2-month-old boy with neurological symptoms and lactic acidosis. To determine the underlying metabolic issue, they perform an enzyme assay on extracts from the patient&#x27;s cultured skin fibroblasts, assessing the activity of the pyruvate dehydrogenase (PDH) complex. They find that the complex operates at only 5% of the normal activity with a standard amount of thiamine pyrophosphate (TPP) but achieves 80% of normal activity with a much higher TPP concentration. What is the correct interpretation concerning the patient&#x27;s condition and potential interventions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A high carbohydrate diet would be expected to be beneficial for this patient.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Citrate production from aerobic glycolysis is expected to be increased.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PDH kinase, a regulatory enzyme of the PDH complex, is expected to be active.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thiamine (Vitamin B1) is the precursor for TPP , a coenzyme for PDH complex, Î±-ketoglutarate dehydrogenase, and transketolase . Some PDH deficiencies are thiamine-responsive , especially those with a mutated E1 subunit that has a high Km for TPP . Thiamine therapy can significantly reduce serum lactate and improve neurological symptoms in responsive cases&lt;/li&gt;&lt;li&gt;âž¤ Thiamine (Vitamin B1) is the precursor for TPP , a coenzyme for PDH complex, Î±-ketoglutarate dehydrogenase, and transketolase .&lt;/li&gt;&lt;li&gt;âž¤ Thiamine (Vitamin B1)&lt;/li&gt;&lt;li&gt;âž¤ TPP&lt;/li&gt;&lt;li&gt;âž¤ PDH complex, Î±-ketoglutarate dehydrogenase, and transketolase&lt;/li&gt;&lt;li&gt;âž¤ Some PDH deficiencies are thiamine-responsive , especially those with a mutated E1 subunit that has a high Km for TPP .&lt;/li&gt;&lt;li&gt;âž¤ PDH deficiencies are thiamine-responsive&lt;/li&gt;&lt;li&gt;âž¤ mutated E1 subunit&lt;/li&gt;&lt;li&gt;âž¤ high Km for TPP&lt;/li&gt;&lt;li&gt;âž¤ Thiamine therapy can significantly reduce serum lactate and improve neurological symptoms in responsive cases&lt;/li&gt;&lt;li&gt;âž¤ Thiamine therapy&lt;/li&gt;&lt;li&gt;âž¤ serum lactate&lt;/li&gt;&lt;li&gt;âž¤ neurological symptoms&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 165-167, 174.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A genetic counselor is discussing the potential impact of enzyme deficiencies on metabolic pathways with a couple awaiting the birth of their child. The counselor explains that certain genetic conditions can disrupt normal metabolic processes. She asks the couple to consider the statement: \&quot;A defect in the pyruvate dehydrogenase (PDH) complex can lead to lactic acidosis.\&quot; Is this statement true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A PDH defect can indeed lead to lactic acidosis. The PDH complex is responsible for converting pyruvate to acetyl CoA, a step that links glycolysis to the citric acid cycle . If PDH is deficient or defective , pyruvate cannot effectively enter the citric acid cycle and is instead converted to lactate by lactate dehydrogenase. This can lead to an accumulation of lactate in the blood, resulting in lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ PDH defect&lt;/li&gt;&lt;li&gt;â€¢ lactic acidosis.&lt;/li&gt;&lt;li&gt;â€¢ PDH complex&lt;/li&gt;&lt;li&gt;â€¢ converting pyruvate to acetyl CoA,&lt;/li&gt;&lt;li&gt;â€¢ links glycolysis to the citric acid cycle&lt;/li&gt;&lt;li&gt;â€¢ PDH is deficient or defective&lt;/li&gt;&lt;li&gt;â€¢ pyruvate cannot&lt;/li&gt;&lt;li&gt;â€¢ enter&lt;/li&gt;&lt;li&gt;â€¢ citric acid cycle&lt;/li&gt;&lt;li&gt;â€¢ converted to lactate by lactate dehydrogenase.&lt;/li&gt;&lt;li&gt;â€¢ accumulation of lactate&lt;/li&gt;&lt;li&gt;â€¢ lactic&lt;/li&gt;&lt;li&gt;â€¢ acidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Significance of PDH Complex&lt;/li&gt;&lt;li&gt;âž¤ Significance of PDH Complex&lt;/li&gt;&lt;li&gt;âž¤ Thiamine deficiency affect PDH and thereby the complete oxidation of Glucose PDH defect can lead to Lactic Acidosis due to excess of pyruvate and conversion to lactate instead of acetyl CoA Fat cannot be converted to glucose because of the irreversible nature of PDH&lt;/li&gt;&lt;li&gt;âž¤ Thiamine deficiency affect PDH and thereby the complete oxidation of Glucose&lt;/li&gt;&lt;li&gt;âž¤ Thiamine deficiency&lt;/li&gt;&lt;li&gt;âž¤ PDH&lt;/li&gt;&lt;li&gt;âž¤ complete oxidation of Glucose&lt;/li&gt;&lt;li&gt;âž¤ PDH defect can lead to Lactic Acidosis due to excess of pyruvate and conversion to lactate instead of acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ PDH defect&lt;/li&gt;&lt;li&gt;âž¤ Lactic Acidosis&lt;/li&gt;&lt;li&gt;âž¤ excess of pyruvate&lt;/li&gt;&lt;li&gt;âž¤ conversion to lactate&lt;/li&gt;&lt;li&gt;âž¤ Fat cannot be converted to glucose because of the irreversible nature of PDH&lt;/li&gt;&lt;li&gt;âž¤ Fat&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ irreversible nature of PDH&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p:115-117.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p:115-117.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;PG Junior Residents of Biochemistry department are discussing a complex case of metabolic disorder; a debate arises regarding the metabolic flexibility of pyruvate under various physiological conditions. A senior consultant poses a question to the team to clarify the understanding of pyruvate metabolism. Which of the following is a fate of pyruvate in human metabolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To Lactate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To Oxaloacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture23.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The major fates of pyruvate in human metabolism include:&lt;/li&gt;&lt;li&gt;âž¤ Conversion to glucose through gluconeogenesis (pyruvate carboxylase) Reduction to lactate under anaerobic conditions (lactate dehydrogenase) Carboxylation to oxaloacetate for the TCA cycle or gluconeogenesis (pyruvate carboxylase) Oxidative decarboxylation to acetyl-CoA (pyruvate dehydrogenase complex) Transamination to form alanine (alanine aminotransferase)&lt;/li&gt;&lt;li&gt;âž¤ Conversion to glucose through gluconeogenesis (pyruvate carboxylase)&lt;/li&gt;&lt;li&gt;âž¤ Reduction to lactate under anaerobic conditions (lactate dehydrogenase)&lt;/li&gt;&lt;li&gt;âž¤ Carboxylation to oxaloacetate for the TCA cycle or gluconeogenesis (pyruvate carboxylase)&lt;/li&gt;&lt;li&gt;âž¤ Oxidative decarboxylation to acetyl-CoA (pyruvate dehydrogenase complex)&lt;/li&gt;&lt;li&gt;âž¤ Transamination to form alanine (alanine aminotransferase)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p:117.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 1-year-old child, while playing, accidentally ingests a small amount of rat poison containing fluoroacetate, found in the cupboard. This substance reacts with oxaloacetate to produce fluorocitrate. Which major metabolic pathway is most likely to be inhibited by this poison?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ETC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HMP shunt&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TCA Cycle&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TCA Cycle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TCA Cycle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fluorocitrate , formed from the reaction of fluoroacetate with oxaloacetate, is a potent inhibitor of the TCA cycle . It specifically inhibits aconitase , an enzyme in the TCA cycle , thereby blocking the conversion of citrate to isocitrate and disrupting cellular energy production.&lt;/li&gt;&lt;li&gt;âž¤ Fluorocitrate&lt;/li&gt;&lt;li&gt;âž¤ fluoroacetate with oxaloacetate,&lt;/li&gt;&lt;li&gt;âž¤ potent inhibitor&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ inhibits aconitase&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ blocking&lt;/li&gt;&lt;li&gt;âž¤ citrate to isocitrate&lt;/li&gt;&lt;li&gt;âž¤ disrupting&lt;/li&gt;&lt;li&gt;âž¤ energy production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 161-163.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 161-163.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme catalyzes the substrate-level phosphorylation step in the TCA cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isocitrate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î±- ketoglutarate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Succinyl CoA synthetase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinate dehydrogenase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Succinyl CoA synthetase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Succinyl CoA synthetase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Succinyl CoA synthetase catalyzes the only substrate-level phosphorylation step within the TCA cycle, where GDP (guanosine diphosphate) is phosphorylated to GTP (guanosine triphosphate), which can then be converted to ATP. This step involves the conversion of succinyl CoA to succinate.&lt;/li&gt;&lt;li&gt;âž¤ Succinyl CoA synthetase catalyzes&lt;/li&gt;&lt;li&gt;âž¤ substrate-level phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle,&lt;/li&gt;&lt;li&gt;âž¤ GDP&lt;/li&gt;&lt;li&gt;âž¤ phosphorylated to GTP&lt;/li&gt;&lt;li&gt;âž¤ converted to ATP.&lt;/li&gt;&lt;li&gt;âž¤ conversion&lt;/li&gt;&lt;li&gt;âž¤ succinyl CoA to succinate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 247-249.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 247-249.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true about Krebs Cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate condenses with Oxaloacetate to form Citrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alpha ketoglutarate is a five Carbon compound&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxidative Phosphorylation occurs in the cytoplasm only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Krebs cycle can operate in anaerobic condition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alpha ketoglutarate is a five Carbon compound&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alpha ketoglutarate is a five Carbon compound.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Î±-Ketoglutarate Dehydrogenase:&lt;/li&gt;&lt;li&gt;âž¤ Î±-Ketoglutarate Dehydrogenase:&lt;/li&gt;&lt;li&gt;âž¤ Î±-ketoglutarate (5C) oxidised and decarboxylated to Succinyl CoA (4C) Second Oxidative Decarboxylation 1 NADH is formed Physiologically Unidirectional step Multienzyme Complex similar to Pyruvate Dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Î±-ketoglutarate (5C) oxidised and decarboxylated to Succinyl CoA (4C)&lt;/li&gt;&lt;li&gt;âž¤ Î±-ketoglutarate (5C) oxidised&lt;/li&gt;&lt;li&gt;âž¤ decarboxylated&lt;/li&gt;&lt;li&gt;âž¤ Succinyl CoA&lt;/li&gt;&lt;li&gt;âž¤ (4C)&lt;/li&gt;&lt;li&gt;âž¤ Second Oxidative Decarboxylation&lt;/li&gt;&lt;li&gt;âž¤ Second&lt;/li&gt;&lt;li&gt;âž¤ Oxidative Decarboxylation&lt;/li&gt;&lt;li&gt;âž¤ 1 NADH is formed&lt;/li&gt;&lt;li&gt;âž¤ 1 NADH&lt;/li&gt;&lt;li&gt;âž¤ Physiologically Unidirectional step&lt;/li&gt;&lt;li&gt;âž¤ Unidirectional&lt;/li&gt;&lt;li&gt;âž¤ Multienzyme Complex similar to Pyruvate Dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Multienzyme Complex&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate Dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p161-167.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p161-167.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following substances is known to bind to CoA and condense with oxaloacetate, thereby inhibiting the TCA cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Malonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arsenite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fluoroacetate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fluoroacetate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Fluoroacetate.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fluorocitrate is a potent inhibitor of aconitase , an enzyme in the TCA cycle, leading to the inhibition of the cycle and disruption of cellular energy metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Fluorocitrate&lt;/li&gt;&lt;li&gt;âž¤ inhibitor of aconitase&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle,&lt;/li&gt;&lt;li&gt;âž¤ inhibition of the&lt;/li&gt;&lt;li&gt;âž¤ cycle&lt;/li&gt;&lt;li&gt;âž¤ disruption&lt;/li&gt;&lt;li&gt;âž¤ cellular energy metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p161-167&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p161-167&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During the Tricarboxylic Acid (TCA) cycle, citrate undergoes a series of transformations to facilitate cellular energy production. One of the initial steps involves the conversion of citrate to cis-aconitate. This reaction is catalyzed by the enzyme aconitase. Understanding the specific changes that occur during this conversion is essential for comprehending the intricate details of the TCA cycle. What is liberated during the conversion of citrate to cis-aconitate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;H2O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;H2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H2O2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CO2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. H2O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) H2O.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Citrate isomerized to Isocitrate by Aconitase which is a reversible reaction. The reaction occurs in two steps : dehydration to cis aconitate and rehydration to isocitrate.&lt;/li&gt;&lt;li&gt;âž¤ Citrate isomerized to Isocitrate by Aconitase which is a reversible reaction.&lt;/li&gt;&lt;li&gt;âž¤ Citrate isomerized to Isocitrate&lt;/li&gt;&lt;li&gt;âž¤ Aconitase&lt;/li&gt;&lt;li&gt;âž¤ reversible reaction.&lt;/li&gt;&lt;li&gt;âž¤ The reaction occurs in two steps : dehydration to cis aconitate and rehydration to isocitrate.&lt;/li&gt;&lt;li&gt;âž¤ reaction&lt;/li&gt;&lt;li&gt;âž¤ two steps&lt;/li&gt;&lt;li&gt;âž¤ dehydration to cis aconitate&lt;/li&gt;&lt;li&gt;âž¤ rehydration to isocitrate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p163&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p163&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In evaluating compounds involved in the rapid provision of energy within cells, particularly in muscle tissue during high-demand activities, which of the following is recognized as a high-energy compound capable of instantaneously replenishing ATP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Creatine Phosphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose 1-Phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycerol 3-Phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ADP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Creatine Phosphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Creatine Phosphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Examples of High energy Phosphates&lt;/li&gt;&lt;li&gt;âž¤ Examples of High energy Phosphates&lt;/li&gt;&lt;li&gt;âž¤ Pyrophosphate , e.g. ATP Acyl Phosphate , e.g. 1,3 Bisphosphoglycerate Enol Phosphate , e.g., Phosphoenolpyruvate Thioester, e.g. Acetyl CoA, Succinyl CoA Phosphagen, e.g. Phosphocreatine, Phosphoarginine.&lt;/li&gt;&lt;li&gt;âž¤ Pyrophosphate , e.g. ATP&lt;/li&gt;&lt;li&gt;âž¤ Pyrophosphate&lt;/li&gt;&lt;li&gt;âž¤ Acyl Phosphate , e.g. 1,3 Bisphosphoglycerate&lt;/li&gt;&lt;li&gt;âž¤ Acyl Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Enol Phosphate , e.g., Phosphoenolpyruvate&lt;/li&gt;&lt;li&gt;âž¤ Enol Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Thioester, e.g. Acetyl CoA, Succinyl CoA&lt;/li&gt;&lt;li&gt;âž¤ Thioester,&lt;/li&gt;&lt;li&gt;âž¤ Phosphagen, e.g. Phosphocreatine, Phosphoarginine.&lt;/li&gt;&lt;li&gt;âž¤ Phosphagen,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p116.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p116.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The assertion and reasoning provided require analysis to understand the action of atractyloside and its effects on mitochondrial function. Assertion (A): Atractyloside prevents ATP synthesis in the matrix of mitochondria. Reasoning (R): Atractyloside blocks complex V, the F0 component of inner mitochondrial membrane and stops the inflow of H+ into the matrix.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A is right but R is a wrong statement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A is right but R is a wrong statement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Atractyloside is known to inhibit ATP synthesis, but not by blocking complex V (ATP synthase) or the F0 component. Instead, atractyloside inhibits the ADP/ATP carrier (also known as the adenine nucleotide translocase ) in the inner mitochondrial membrane , which is responsible for exchanging ADP and ATP between the mitochondrial matrix and the cytosol . This inhibition prevents the export of ATP from the mitochondria to the cytosol and the import of ADP from the cytosol to the matrix, thus inhibiting ATP synthesis indirectly.&lt;/li&gt;&lt;li&gt;â€¢ Atractyloside&lt;/li&gt;&lt;li&gt;â€¢ inhibit ATP synthesis,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ blocking complex V&lt;/li&gt;&lt;li&gt;â€¢ F0&lt;/li&gt;&lt;li&gt;â€¢ atractyloside inhibits the ADP/ATP carrier&lt;/li&gt;&lt;li&gt;â€¢ adenine nucleotide&lt;/li&gt;&lt;li&gt;â€¢ translocase&lt;/li&gt;&lt;li&gt;â€¢ inner mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ exchanging ADP and ATP&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial matrix and the cytosol&lt;/li&gt;&lt;li&gt;â€¢ inhibition&lt;/li&gt;&lt;li&gt;â€¢ export of ATP&lt;/li&gt;&lt;li&gt;â€¢ mitochondria to the cytosol&lt;/li&gt;&lt;li&gt;â€¢ ADP from the cytosol to the matrix,&lt;/li&gt;&lt;li&gt;â€¢ inhibiting ATP&lt;/li&gt;&lt;li&gt;â€¢ synthesis indirectly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside blocks ATP/ADP transporter and prevents ADP transport into the matrix. In absence of ADP in the matrix, ATP synthesis does not occur. Oligomycin blocks complex V (F0) and prevents transportation of H+ within the matrix.&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside blocks ATP/ADP transporter and prevents ADP transport into the matrix.&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside blocks ATP/ADP transporter&lt;/li&gt;&lt;li&gt;âž¤ ADP transport into the matrix.&lt;/li&gt;&lt;li&gt;âž¤ In absence of ADP in the matrix, ATP synthesis does not occur.&lt;/li&gt;&lt;li&gt;âž¤ absence of ADP&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ does not&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin blocks complex V (F0) and prevents transportation of H+ within the matrix.&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin&lt;/li&gt;&lt;li&gt;âž¤ complex V&lt;/li&gt;&lt;li&gt;âž¤ transportation of H+&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 130-133.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 130-133.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the past, the uncoupler 2,4-dinitrophenol was used as a weight- reducing drug until side effects such as fatigue and breathlessness precluded its use. How could the use of this drug result in weight loss?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2,4-dinitrophenol is an allosteric activator of ATP synthase and thus increases the rate of H+ translocation and oxidation of fats and other fuels.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2,4-dinitrophenol inhibits transport of pyruvate into the mitochondria. Fats are therefore metabolized to glycerol and subsequently to pyruvate, depleting fat stores.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2,4-dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2,4-dinitrophenol causes ATP to be produced at a higher rate than normal, thus causing weight loss.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 2,4-dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 2,4 dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Uncouplers such as 2,4-dinitrophenol dissociate oxidation from phosphorylation â†’ ADP is not phosphorylated to produce ATP and respiration becomes uncontrolled as it tries to replenish ATP supplies â†’ leads to increased metabolic turnover in the attempt to generate ATP . ( Incorrect option A , B, D ). Less ADP will be converted to ATP â†’ increased ADP and decreased rates of oxidative phosphorylation. Prolonged energy deficits will lead to fatigue in energy-dependent tissues such as muscle or heart (cardiomyopathy), which is potentially lethal.&lt;/li&gt;&lt;li&gt;âž¤ Uncouplers such as 2,4-dinitrophenol dissociate oxidation from phosphorylation â†’ ADP is not phosphorylated to produce ATP and respiration becomes uncontrolled as it tries to replenish ATP supplies â†’ leads to increased metabolic turnover in the attempt to generate ATP . ( Incorrect option A , B, D ).&lt;/li&gt;&lt;li&gt;âž¤ Uncouplers&lt;/li&gt;&lt;li&gt;âž¤ 2,4-dinitrophenol&lt;/li&gt;&lt;li&gt;âž¤ oxidation from phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ ADP&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ phosphorylated&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ respiration&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled&lt;/li&gt;&lt;li&gt;âž¤ replenish ATP supplies&lt;/li&gt;&lt;li&gt;âž¤ increased metabolic&lt;/li&gt;&lt;li&gt;âž¤ turnover&lt;/li&gt;&lt;li&gt;âž¤ generate ATP&lt;/li&gt;&lt;li&gt;âž¤ Incorrect option A , B, D&lt;/li&gt;&lt;li&gt;âž¤ Less ADP will be converted to ATP â†’ increased ADP and decreased rates of oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Less ADP&lt;/li&gt;&lt;li&gt;âž¤ ATP â†’ increased ADP&lt;/li&gt;&lt;li&gt;âž¤ decreased&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Prolonged energy deficits will lead to fatigue in energy-dependent tissues such as muscle or heart (cardiomyopathy), which is potentially lethal.&lt;/li&gt;&lt;li&gt;âž¤ energy deficits&lt;/li&gt;&lt;li&gt;âž¤ fatigue&lt;/li&gt;&lt;li&gt;âž¤ energy-dependent tissues&lt;/li&gt;&lt;li&gt;âž¤ (cardiomyopathy),&lt;/li&gt;&lt;li&gt;âž¤ lethal.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p 323-24.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p 323-24.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which subunit within ATP synthase is directly responsible for ATP formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fo Sub complex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;subunit of F1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î² subunit of F1 sub complex&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C disc of Fo sub complex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Î² subunit of F1 sub complex&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Î² subunit of F1 sub complex&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ATP SYNTHASE / COMPLEX V OF ELECTRON TRANSPORT CHAIN:&lt;/li&gt;&lt;li&gt;âž¤ ATP SYNTHASE / COMPLEX V OF ELECTRON TRANSPORT CHAIN:&lt;/li&gt;&lt;li&gt;âž¤ The enzyme complex consists of an F0 sub complex which acts as a disk of â€œCâ€ protein subunits. A Î³ subunit is attached as a â€œbent axle.â€ Protons passing through the disk of â€œCâ€ units cause it and the Î³-subunit attached to it to rotate. The Î³ subunit fits inside the F1 sub complex , consists of 3 Î± and 3 Î² subunits , which are fixed to the membrane , and they do not rotate. ADP and Pi are taken up by the Î² subunits to form ATP, which is expelled as the rotating Î³ subunit pushes each Î² subunit in turn and changes its conformation â†’ 3 ATP molecules are generated per revolution.&lt;/li&gt;&lt;li&gt;âž¤ The enzyme complex consists of an F0 sub complex which acts as a disk of â€œCâ€ protein subunits.&lt;/li&gt;&lt;li&gt;âž¤ enzyme complex&lt;/li&gt;&lt;li&gt;âž¤ F0 sub complex&lt;/li&gt;&lt;li&gt;âž¤ â€œCâ€&lt;/li&gt;&lt;li&gt;âž¤ A Î³ subunit is attached as a â€œbent axle.â€&lt;/li&gt;&lt;li&gt;âž¤ Î³ subunit&lt;/li&gt;&lt;li&gt;âž¤ â€œbent axle.â€&lt;/li&gt;&lt;li&gt;âž¤ Protons passing through the disk of â€œCâ€ units cause it and the Î³-subunit attached to it to rotate.&lt;/li&gt;&lt;li&gt;âž¤ Protons&lt;/li&gt;&lt;li&gt;âž¤ disk of â€œCâ€ units&lt;/li&gt;&lt;li&gt;âž¤ Î³-subunit&lt;/li&gt;&lt;li&gt;âž¤ The Î³ subunit fits inside the F1 sub complex , consists of 3 Î± and 3 Î² subunits , which are fixed to the membrane , and they do not rotate.&lt;/li&gt;&lt;li&gt;âž¤ Î³ subunit&lt;/li&gt;&lt;li&gt;âž¤ F1 sub complex&lt;/li&gt;&lt;li&gt;âž¤ 3 Î± and 3 Î² subunits&lt;/li&gt;&lt;li&gt;âž¤ fixed&lt;/li&gt;&lt;li&gt;âž¤ membrane&lt;/li&gt;&lt;li&gt;âž¤ do not rotate.&lt;/li&gt;&lt;li&gt;âž¤ ADP and Pi are taken up by the Î² subunits to form ATP, which is expelled as the rotating Î³ subunit pushes each Î² subunit in turn and changes its conformation â†’ 3 ATP molecules are generated per revolution.&lt;/li&gt;&lt;li&gt;âž¤ ADP and Pi&lt;/li&gt;&lt;li&gt;âž¤ Î² subunits&lt;/li&gt;&lt;li&gt;âž¤ ATP,&lt;/li&gt;&lt;li&gt;âž¤ expelled&lt;/li&gt;&lt;li&gt;âž¤ Î³&lt;/li&gt;&lt;li&gt;âž¤ subunit&lt;/li&gt;&lt;li&gt;âž¤ Î² subunit&lt;/li&gt;&lt;li&gt;âž¤ its conformation&lt;/li&gt;&lt;li&gt;âž¤ 3 ATP&lt;/li&gt;&lt;li&gt;âž¤ generated per revolution.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 131-133.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 131-133.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old presents with seizures and lethargy. Diagnosed with a mitochondrial disorder affecting the electron transport chain, you recall the P:O ratios for various oxidations. Which statement about P:O ratios is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;P:O for NAD linked oxidation is 2.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;P:O for FMN linked oxidation is 3.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;P:O for FAD linked oxidation is 1.5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. P:O for FMN linked oxidation is 3.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) P:O for FMN linked oxidation is 3.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ P: O Ratio is defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed. NADH oxidation provides 2.5 ATP &amp;amp; FADH oxidation provides 1.5 ATP per oxygen atom consumption.&lt;/li&gt;&lt;li&gt;âž¤ P: O Ratio is defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed.&lt;/li&gt;&lt;li&gt;âž¤ P: O Ratio&lt;/li&gt;&lt;li&gt;âž¤ high energy inorganic phosphates&lt;/li&gt;&lt;li&gt;âž¤ atoms of O2 consumed.&lt;/li&gt;&lt;li&gt;âž¤ NADH oxidation provides 2.5 ATP &amp;amp; FADH oxidation provides 1.5 ATP per oxygen atom consumption.&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ oxidation&lt;/li&gt;&lt;li&gt;âž¤ 2.5 ATP&lt;/li&gt;&lt;li&gt;âž¤ FADH oxidation&lt;/li&gt;&lt;li&gt;âž¤ 1.5 ATP&lt;/li&gt;&lt;li&gt;âž¤ oxygen atom consumption.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 131.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 131.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The chemiosmotic theory about the coupling of electron transport via the respiratory chain to the process of oxidative phosphorylation is proposed by Peter Mitchell. Which of the following statements does NOT accurately represent the chemiosmotic theory as proposed by Peter Mitchell?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;As electrons pass down the respiratory chain, it pumps protons across the IMM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;This proton gradient across the IMM generated by electron transport favours ATP synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ATP synthesis occurs through an ATP synthase enzyme complex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The electrochemical potential difference across IMM due to the electron transport should be negative on the matrix side, thereby protons are forced to re-enter through the ATP synthase complex to discharge the electrochemical gradient. Complexes I, III, and IV act as proton pumps â†’ creates a proton gradient across the membrane, which is negative on the matrix side. The proton motive force drives the synthesis of ATP as the protons flow back into the matrix through the ATP synthase enzyme complex.&lt;/li&gt;&lt;li&gt;âž¤ The electrochemical potential difference across IMM due to the electron transport should be negative on the matrix side, thereby protons are forced to re-enter through the ATP synthase complex to discharge the electrochemical gradient.&lt;/li&gt;&lt;li&gt;âž¤ electrochemical potential difference&lt;/li&gt;&lt;li&gt;âž¤ IMM&lt;/li&gt;&lt;li&gt;âž¤ electron transport&lt;/li&gt;&lt;li&gt;âž¤ negative&lt;/li&gt;&lt;li&gt;âž¤ protons are forced&lt;/li&gt;&lt;li&gt;âž¤ re-enter&lt;/li&gt;&lt;li&gt;âž¤ ATP synthase&lt;/li&gt;&lt;li&gt;âž¤ complex&lt;/li&gt;&lt;li&gt;âž¤ electrochemical gradient.&lt;/li&gt;&lt;li&gt;âž¤ Complexes I, III, and IV act as proton pumps â†’ creates a proton gradient across the membrane, which is negative on the matrix side.&lt;/li&gt;&lt;li&gt;âž¤ Complexes I, III, and IV&lt;/li&gt;&lt;li&gt;âž¤ proton pumps&lt;/li&gt;&lt;li&gt;âž¤ proton gradient across&lt;/li&gt;&lt;li&gt;âž¤ negative&lt;/li&gt;&lt;li&gt;âž¤ matrix side.&lt;/li&gt;&lt;li&gt;âž¤ The proton motive force drives the synthesis of ATP as the protons flow back into the matrix through the ATP synthase enzyme complex.&lt;/li&gt;&lt;li&gt;âž¤ proton motive force&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ protons flow back&lt;/li&gt;&lt;li&gt;âž¤ ATP synthase enzyme complex.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 129-132.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 129-132.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the net change in the number of protons across the mitochondrial membrane for each set of two electrons transferred through Complexes I, III, and IV, respectively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2; 4; 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4; 4; 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3; 3; 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4; 2; 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 4; 4; 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 4; 4; 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ETC : Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex - It is tightly bound to the inner membrane of mitochondria â†’ large negative free energy change occurs which is utilized to drive 4 protons out of the mitochondrial matrix into intermembrane space. Complex III or Cytochrome Reductase -the free energy change through this complex due to electron transfer causes 4 protons to be pumped out. Complex IV or Cytochrome Oxidase â€“ It is tightly bound to the mitochondrial membrane, and pumps out 2 protons to the intermembrane space.&lt;/li&gt;&lt;li&gt;âž¤ ETC : Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex - It is tightly bound to the inner membrane of mitochondria â†’ large negative free energy change occurs which is utilized to drive 4 protons out of the mitochondrial matrix into intermembrane space.&lt;/li&gt;&lt;li&gt;âž¤ ETC&lt;/li&gt;&lt;li&gt;âž¤ Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex&lt;/li&gt;&lt;li&gt;âž¤ tightly&lt;/li&gt;&lt;li&gt;âž¤ inner membrane&lt;/li&gt;&lt;li&gt;âž¤ mitochondria&lt;/li&gt;&lt;li&gt;âž¤ large negative&lt;/li&gt;&lt;li&gt;âž¤ drive 4 protons out of the mitochondrial&lt;/li&gt;&lt;li&gt;âž¤ matrix&lt;/li&gt;&lt;li&gt;âž¤ intermembrane space.&lt;/li&gt;&lt;li&gt;âž¤ Complex III or Cytochrome Reductase -the free energy change through this complex due to electron transfer causes 4 protons to be pumped out.&lt;/li&gt;&lt;li&gt;âž¤ Complex III or Cytochrome Reductase&lt;/li&gt;&lt;li&gt;âž¤ free energy&lt;/li&gt;&lt;li&gt;âž¤ complex&lt;/li&gt;&lt;li&gt;âž¤ electron transfer&lt;/li&gt;&lt;li&gt;âž¤ 4&lt;/li&gt;&lt;li&gt;âž¤ protons&lt;/li&gt;&lt;li&gt;âž¤ Complex IV or Cytochrome Oxidase â€“ It is tightly bound to the mitochondrial membrane, and pumps out 2 protons to the intermembrane space.&lt;/li&gt;&lt;li&gt;âž¤ Complex IV or Cytochrome Oxidase&lt;/li&gt;&lt;li&gt;âž¤ tightly&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial membrane,&lt;/li&gt;&lt;li&gt;âž¤ pumps out 2 protons&lt;/li&gt;&lt;li&gt;âž¤ intermembrane space.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 131.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 131.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Dehydrogenases such as glucose-6-phosphate dehydrogenase serve to transfer Hydride (H-) ions or H atom from one substrate to another in coupled oxidation-reduction reactions, ultimately (in the respiratory chain) generating energy by oxygen/water reduction. Dehydrogenases can use which of the following compounds as an electron acceptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;H2O&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NAD+&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;O2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peroxide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. NAD+&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) NAD+&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dehydrogenases are specifi c for their substrates , but most use either NAD+ or NADP+ as the coenzyme. Some dehydrogenases use Flavin coenzymes similar to FMN and FAD used by the oxidases. The final steps in the conversion of oxygen to water in the respiratory chain are carried out by cytochrome oxidase (cytochrome a3) as part of complex IV. This final enzyme is an oxidase , defined by its use of oxygen to oxidize metabolites and form water or hydrogen peroxide. The prior cytochromes of the respiratory chain (b, cl, c, a) can be described as dehydrogenases, transferring electrons (or Protons in reverse ) by oscillation between ferric (Fe+++) and ferrous (Fe++) ions.&lt;/li&gt;&lt;li&gt;âž¤ Dehydrogenases are specifi c for their substrates , but most use either NAD+ or NADP+ as the coenzyme.&lt;/li&gt;&lt;li&gt;âž¤ Dehydrogenases&lt;/li&gt;&lt;li&gt;âž¤ specifi&lt;/li&gt;&lt;li&gt;âž¤ substrates&lt;/li&gt;&lt;li&gt;âž¤ either NAD+ or NADP+&lt;/li&gt;&lt;li&gt;âž¤ coenzyme.&lt;/li&gt;&lt;li&gt;âž¤ Some dehydrogenases use Flavin coenzymes similar to FMN and FAD used by the oxidases.&lt;/li&gt;&lt;li&gt;âž¤ Flavin coenzymes&lt;/li&gt;&lt;li&gt;âž¤ FMN and FAD&lt;/li&gt;&lt;li&gt;âž¤ oxidases.&lt;/li&gt;&lt;li&gt;âž¤ The final steps in the conversion of oxygen to water in the respiratory chain are carried out by cytochrome oxidase (cytochrome a3) as part of complex IV.&lt;/li&gt;&lt;li&gt;âž¤ oxygen to water&lt;/li&gt;&lt;li&gt;âž¤ respiratory chain&lt;/li&gt;&lt;li&gt;âž¤ cytochrome oxidase&lt;/li&gt;&lt;li&gt;âž¤ complex IV.&lt;/li&gt;&lt;li&gt;âž¤ This final enzyme is an oxidase , defined by its use of oxygen to oxidize metabolites and form water or hydrogen peroxide.&lt;/li&gt;&lt;li&gt;âž¤ final&lt;/li&gt;&lt;li&gt;âž¤ oxidase&lt;/li&gt;&lt;li&gt;âž¤ use of oxygen&lt;/li&gt;&lt;li&gt;âž¤ oxidize metabolites&lt;/li&gt;&lt;li&gt;âž¤ form water&lt;/li&gt;&lt;li&gt;âž¤ hydrogen&lt;/li&gt;&lt;li&gt;âž¤ peroxide.&lt;/li&gt;&lt;li&gt;âž¤ The prior cytochromes of the respiratory chain (b, cl, c, a) can be described as dehydrogenases, transferring electrons (or Protons in reverse ) by oscillation between ferric (Fe+++) and ferrous (Fe++) ions.&lt;/li&gt;&lt;li&gt;âž¤ prior cytochromes of the respiratory chain&lt;/li&gt;&lt;li&gt;âž¤ dehydrogenases,&lt;/li&gt;&lt;li&gt;âž¤ transferring electrons&lt;/li&gt;&lt;li&gt;âž¤ Protons in reverse&lt;/li&gt;&lt;li&gt;âž¤ oscillation between ferric&lt;/li&gt;&lt;li&gt;âž¤ ferrous&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 122.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 122.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old male is involved in a research study examining mitochondrial function. He is in excellent health and reports no significant medical history. As part of the study, he undergoes various tests to assess his cellular metabolism. One particular focus of the study is the efficiency and regulation of oxidative phosphorylation within the electron transport chain (ETC) in his mitochondria. Given this context, which of the following enzymes or complexes is LEAST likely to play a regulatory role in oxidative phosphorylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NADH CoQ reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytochrome C oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isocitrate dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CoQ Cytochrome C reductase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Isocitrate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Isocitrate dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Components of the Electron Transport Chain are contained in four large protein complexes:&lt;/li&gt;&lt;li&gt;âž¤ Components of the Electron Transport Chain are contained in four large protein complexes:&lt;/li&gt;&lt;li&gt;âž¤ Complex I NADH CoQ Oxidoreductase Complex II CoQ Succinate Reductase. Complex III CoQ Cytochrome C Oxidoreductase Complex IV Cytochrome C Oxidase&lt;/li&gt;&lt;li&gt;âž¤ Complex I NADH CoQ Oxidoreductase&lt;/li&gt;&lt;li&gt;âž¤ Complex II CoQ Succinate Reductase.&lt;/li&gt;&lt;li&gt;âž¤ Complex III CoQ Cytochrome C Oxidoreductase&lt;/li&gt;&lt;li&gt;âž¤ Complex IV Cytochrome C Oxidase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p130, 133.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p130, 133.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Oligomycin is a macrolide antibiotic derived from Streptomyces, a genus of soil bacteria that has contributed over two-thirds of naturally derived antibiotics, that inhibits ATP synthase required for oxidative phosphorylation. Which of the following options best explains the consequence of this inhibition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Selective disruption of complex II function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Disruption of ubiquinone phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Disruption of NADH entry into the respiratory chain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Disruption of proton flow across the inner mitochondrial membrane&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Disruption of proton flow across the inner mitochondrial membrane&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Disruption of proton flow across the inner mitochondrial membrane&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Selective complex inhibitors such as carboxin for complex II or barbiturates for complex I where NADH enters the chain would cause partial disruption of electron transfer.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Selective complex inhibitors&lt;/li&gt;&lt;li&gt;â€¢ carboxin&lt;/li&gt;&lt;li&gt;â€¢ complex II&lt;/li&gt;&lt;li&gt;â€¢ barbiturates for complex I&lt;/li&gt;&lt;li&gt;â€¢ NADH&lt;/li&gt;&lt;li&gt;â€¢ partial disruption of electron transfer.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ubiquinone is one of three oxidation states of coenzyme Q ( quinol to quinone to semiquinone ) that cycle with forms of cytochrome c at the level of complex III; no coenzyme Q intermediates are phosphorylated.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Ubiquinone&lt;/li&gt;&lt;li&gt;â€¢ three oxidation states of coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ quinol to quinone to semiquinone&lt;/li&gt;&lt;li&gt;â€¢ cytochrome c&lt;/li&gt;&lt;li&gt;â€¢ complex III;&lt;/li&gt;&lt;li&gt;â€¢ no coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ phosphorylated.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oligomycin does not interfere with NADH.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Oligomycin does not&lt;/li&gt;&lt;li&gt;â€¢ NADH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin blocks ATP synthase , the enzyme responsible for synthesizing ATP from ADP and inorganic phosphate. This blockade prevents protons from flowing back into the mitochondrial matrix through ATP synthase, effectively stopping the utilization of the proton gradient generated by the electron transport chain. The gradient builds up, halting further proton pumping by the complexes of the electron transport chain, thus indirectly affecting ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin&lt;/li&gt;&lt;li&gt;âž¤ blocks ATP synthase&lt;/li&gt;&lt;li&gt;âž¤ synthesizing ATP from ADP&lt;/li&gt;&lt;li&gt;âž¤ inorganic phosphate.&lt;/li&gt;&lt;li&gt;âž¤ blockade&lt;/li&gt;&lt;li&gt;âž¤ prevents protons&lt;/li&gt;&lt;li&gt;âž¤ flowing back&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial matrix&lt;/li&gt;&lt;li&gt;âž¤ ATP synthase,&lt;/li&gt;&lt;li&gt;âž¤ stopping&lt;/li&gt;&lt;li&gt;âž¤ proton gradient&lt;/li&gt;&lt;li&gt;âž¤ electron transport chain.&lt;/li&gt;&lt;li&gt;âž¤ gradient builds&lt;/li&gt;&lt;li&gt;âž¤ proton pumping&lt;/li&gt;&lt;li&gt;âž¤ complexes&lt;/li&gt;&lt;li&gt;âž¤ electron transport chain,&lt;/li&gt;&lt;li&gt;âž¤ indirectly&lt;/li&gt;&lt;li&gt;âž¤ ATP production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p 123.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p 123.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the resting state, what is the primary condition that limits the rate of respiration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Availability of ADP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Availability of oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Availability of substrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Availability of both ADP and substrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Availability of ADP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Availability of ADP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Availability of oxygen is generally not the limiting facto r in the resting state , as oxygen is typically abundant in well-perfused tissues under normal physiological conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ limiting facto&lt;/li&gt;&lt;li&gt;â€¢ resting state&lt;/li&gt;&lt;li&gt;â€¢ abundant in well-perfused tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C: The availability of substrate (such as glucose or fatty acids ) is usually not a limiting factor in the resting state, as cells have mechanisms to store or obtain these substrates.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;li&gt;â€¢ glucose or fatty acids&lt;/li&gt;&lt;li&gt;â€¢ not a limiting factor&lt;/li&gt;&lt;li&gt;â€¢ resting state,&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ store or obtain&lt;/li&gt;&lt;li&gt;â€¢ substrates.&lt;/li&gt;&lt;li&gt;â€¢ Option D: While both ADP and substrates are required for respiration, ADP is the primary limiting factor in the resting state due to its role in signaling the cell&#x27;s energy needs.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ both ADP and substrates&lt;/li&gt;&lt;li&gt;â€¢ respiration,&lt;/li&gt;&lt;li&gt;â€¢ ADP&lt;/li&gt;&lt;li&gt;â€¢ primary limiting factor&lt;/li&gt;&lt;li&gt;â€¢ resting state&lt;/li&gt;&lt;li&gt;â€¢ signaling the cell&#x27;s energy needs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the resting state, the level of ADP should be low and thus respiration will be slow ( incorrect answers B-D) . An increase in ADP indicates that the cell is in the working state and respiration will increase. During heavy workloads, such as during exercise, respiration may be regulated by the availability of oxygen or the limit of the capacity of the respiratory chain itself.&lt;/li&gt;&lt;li&gt;âž¤ In the resting state, the level of ADP should be low and thus respiration will be slow ( incorrect answers B-D) .&lt;/li&gt;&lt;li&gt;âž¤ resting state,&lt;/li&gt;&lt;li&gt;âž¤ level of ADP&lt;/li&gt;&lt;li&gt;âž¤ low&lt;/li&gt;&lt;li&gt;âž¤ respiration&lt;/li&gt;&lt;li&gt;âž¤ slow&lt;/li&gt;&lt;li&gt;âž¤ incorrect answers B-D)&lt;/li&gt;&lt;li&gt;âž¤ An increase in ADP indicates that the cell is in the working state and respiration will increase.&lt;/li&gt;&lt;li&gt;âž¤ increase in ADP&lt;/li&gt;&lt;li&gt;âž¤ cell is in the working state&lt;/li&gt;&lt;li&gt;âž¤ respiration will increase.&lt;/li&gt;&lt;li&gt;âž¤ During heavy workloads, such as during exercise, respiration may be regulated by the availability of oxygen or the limit of the capacity of the respiratory chain itself.&lt;/li&gt;&lt;li&gt;âž¤ heavy workloads,&lt;/li&gt;&lt;li&gt;âž¤ during exercise, respiration&lt;/li&gt;&lt;li&gt;âž¤ availability of oxygen&lt;/li&gt;&lt;li&gt;âž¤ limit&lt;/li&gt;&lt;li&gt;âž¤ capacity of the respiratory chain&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p320.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p320.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following options correctly identifies this final electron acceptor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyt C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxygen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FAD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CoQ&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oxygen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oxygen.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Electrons are transferred in the ascending order of redox potential, the final oxygen electron acceptor is oxygen.&lt;/li&gt;&lt;li&gt;âž¤ Electrons&lt;/li&gt;&lt;li&gt;âž¤ ascending order of redox potential,&lt;/li&gt;&lt;li&gt;âž¤ final oxygen&lt;/li&gt;&lt;li&gt;âž¤ electron acceptor&lt;/li&gt;&lt;li&gt;âž¤ oxygen.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p133.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p133.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cytochrome c, typically associated with the electron transport chain, also plays a role in mediating apoptosis. Is this statement true or false?.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cytochrome c indeed mediates apoptosis. Upon release from the mitochondria into the cytosol in response to apoptotic stimuli, cytochrome c interacts with Apaf-1 (apoptotic protease activating factor-1) and procaspase-9 to form the apoptosome . This complex initiates the caspase cascade, leading to the execution phase of apoptosis, characterized by cell shrinkage, chromatin condensation, and DNA fragmentation.&lt;/li&gt;&lt;li&gt;â€¢ Cytochrome c&lt;/li&gt;&lt;li&gt;â€¢ apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ mitochondria into the cytosol&lt;/li&gt;&lt;li&gt;â€¢ apoptotic stimuli,&lt;/li&gt;&lt;li&gt;â€¢ cytochrome c&lt;/li&gt;&lt;li&gt;â€¢ Apaf-1 (apoptotic protease activating factor-1) and procaspase-9&lt;/li&gt;&lt;li&gt;â€¢ apoptosome&lt;/li&gt;&lt;li&gt;â€¢ complex&lt;/li&gt;&lt;li&gt;â€¢ caspase cascade,&lt;/li&gt;&lt;li&gt;â€¢ execution phase of apoptosis,&lt;/li&gt;&lt;li&gt;â€¢ cell shrinkage, chromatin&lt;/li&gt;&lt;li&gt;â€¢ condensation, and DNA fragmentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome C is a mobile electron carrier between Complex III and Complex IV. It plays an important role in programmed cell death.&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome C is a mobile electron carrier between Complex III and Complex IV.&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome C&lt;/li&gt;&lt;li&gt;âž¤ mobile electron carrier&lt;/li&gt;&lt;li&gt;âž¤ Complex III and Complex IV.&lt;/li&gt;&lt;li&gt;âž¤ It plays an important role in programmed cell death.&lt;/li&gt;&lt;li&gt;âž¤ programmed cell death.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p127-130.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p127-130.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;How should the following inhibitors be matched with their corresponding complexes or sites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-d, 2-b, 3-c, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-a, 2-d, 3-b, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_784r4vb.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1-d, 2-c, 3-b, 4-a&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis. Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q). BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function. Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.&lt;/li&gt;&lt;li&gt;â€¢ Cyanide is known to inhibit Complex IV of the electron transport chain by binding to the cytochrome c oxidase , preventing the transfer of electrons to oxygen and thereby halting ATP synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Cyanide&lt;/li&gt;&lt;li&gt;â€¢ inhibit Complex IV&lt;/li&gt;&lt;li&gt;â€¢ cytochrome c oxidase&lt;/li&gt;&lt;li&gt;â€¢ preventing&lt;/li&gt;&lt;li&gt;â€¢ electrons to oxygen&lt;/li&gt;&lt;li&gt;â€¢ halting ATP synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Malonate is a competitive inhibitor of succinate dehydrogenase (Complex II), specifically inhibiting the site between succinate dehydrogenase and Co-Q (coenzyme Q).&lt;/li&gt;&lt;li&gt;â€¢ Malonate&lt;/li&gt;&lt;li&gt;â€¢ competitive&lt;/li&gt;&lt;li&gt;â€¢ succinate dehydrogenase (Complex II),&lt;/li&gt;&lt;li&gt;â€¢ inhibiting&lt;/li&gt;&lt;li&gt;â€¢ succinate dehydrogenase and Co-Q (coenzyme Q).&lt;/li&gt;&lt;li&gt;â€¢ BAL (British Anti-Lewisite) does not directly inhibit any specific complex within the electron transport chain; thus, its inclusion might be misleading . However, in the context of this question and the available options, it is matched with b, but this is not reflective of its actual function.&lt;/li&gt;&lt;li&gt;â€¢ BAL (British Anti-Lewisite) does not&lt;/li&gt;&lt;li&gt;â€¢ inhibit&lt;/li&gt;&lt;li&gt;â€¢ complex&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain;&lt;/li&gt;&lt;li&gt;â€¢ inclusion&lt;/li&gt;&lt;li&gt;â€¢ misleading&lt;/li&gt;&lt;li&gt;â€¢ it is matched with b,&lt;/li&gt;&lt;li&gt;â€¢ not reflective&lt;/li&gt;&lt;li&gt;â€¢ actual function.&lt;/li&gt;&lt;li&gt;â€¢ Chlorpromazine is not a classical inhibitor of the electron transport chain , and its inclusion in this list might not be accurate for educational purposes . However, based on the available options, it is matched with a, Complex I to Co-Q.&lt;/li&gt;&lt;li&gt;â€¢ Chlorpromazine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ classical inhibitor&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ might not&lt;/li&gt;&lt;li&gt;â€¢ educational purposes&lt;/li&gt;&lt;li&gt;â€¢ matched with a, Complex I to Co-Q.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In examining the electron transport chain (ETC) for ATP production, which component is responsible for transferring four protons across the mitochondrial membrane?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NADH-Q Oxidoreductase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytochrome-C Oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isocitrate Dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinate Q Reductase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. NADH-Q Oxidoreductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) NADH-Q Oxidoreductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytochrome C Oxidase (Complex IV): While crucial in the electron transport chain for transferring electrons to oxygen, the number of protons it translocates does not precisely match four per cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cytochrome C Oxidase (Complex IV):&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ electrons to oxygen,&lt;/li&gt;&lt;li&gt;â€¢ number of protons&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ four per cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Isocitrate Dehydrogenase: Not involved in the electron transport chain; it functions in the citric acid cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Isocitrate Dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ Not&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain;&lt;/li&gt;&lt;li&gt;â€¢ citric acid cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Succinate: Ubiquinone Oxidoreductase (Complex II): Transfers electrons without pumping protons across the membrane .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Succinate:&lt;/li&gt;&lt;li&gt;â€¢ Ubiquinone Oxidoreductase (Complex II):&lt;/li&gt;&lt;li&gt;â€¢ Transfers&lt;/li&gt;&lt;li&gt;â€¢ electrons&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ across the membrane&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complex I : NADH Coenzyme Q Oxidoreductase: 4 H+ Complex II pumps : Succinate Q Reductase: no protons Complex III pumps: Cytochrome CoQ oxidoreductase: 4 H+ Complex IV pumps : Cytochrome C Oxidase: 2 H+.&lt;/li&gt;&lt;li&gt;âž¤ Complex I : NADH Coenzyme Q Oxidoreductase: 4 H+&lt;/li&gt;&lt;li&gt;âž¤ Complex I&lt;/li&gt;&lt;li&gt;âž¤ Complex II pumps : Succinate Q Reductase: no protons&lt;/li&gt;&lt;li&gt;âž¤ Complex II pumps&lt;/li&gt;&lt;li&gt;âž¤ Complex III pumps: Cytochrome CoQ oxidoreductase: 4 H+&lt;/li&gt;&lt;li&gt;âž¤ Complex III pumps:&lt;/li&gt;&lt;li&gt;âž¤ Complex IV pumps : Cytochrome C Oxidase: 2 H+.&lt;/li&gt;&lt;li&gt;âž¤ Complex IV pumps&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e, p 130.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e, p 130.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a clinical review session, a medical instructor is discussing the various substrates that contribute to the production of glucose through gluconeogenesis. One of the students asks which substrates can be used by the liver to synthesize glucose. The instructor provides a list but includes one substrate that does not contribute to the net synthesis of glucose in gluconeogenesis. Which of the following does not serve as a substrate for net glucose production in gluconeogenesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lactate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetyl CoA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyruvate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acetyl CoA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acetyl CoA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactate: Lactate can be converted to pyruvate by lactate dehydrogenase and then to glucose via gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactate:&lt;/li&gt;&lt;li&gt;â€¢ converted to pyruvate&lt;/li&gt;&lt;li&gt;â€¢ lactate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ glucose via gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate: Pyruvate is a key gluconeogenic substrate that can be carboxylated to oxaloacetate and eventually converted to glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyruvate:&lt;/li&gt;&lt;li&gt;â€¢ key gluconeogenic substrate&lt;/li&gt;&lt;li&gt;â€¢ carboxylated to oxaloacetate&lt;/li&gt;&lt;li&gt;â€¢ converted to glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alanine: Alanine can undergo transamination to form pyruvate, which can then enter the gluconeogenesis pathway to synthesize glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alanine:&lt;/li&gt;&lt;li&gt;â€¢ Alanine&lt;/li&gt;&lt;li&gt;â€¢ undergo transamination&lt;/li&gt;&lt;li&gt;â€¢ pyruvate,&lt;/li&gt;&lt;li&gt;â€¢ enter the gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ synthesize glucose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Substrates for Gluconeogenesis:&lt;/li&gt;&lt;li&gt;âž¤ Substrates for Gluconeogenesis:&lt;/li&gt;&lt;li&gt;âž¤ Glucogenic Amino Acid [Alanine is the major contributor] Lactate Glycerol Propionyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ Glucogenic Amino Acid [Alanine is the major contributor]&lt;/li&gt;&lt;li&gt;âž¤ Glucogenic Amino Acid&lt;/li&gt;&lt;li&gt;âž¤ Lactate&lt;/li&gt;&lt;li&gt;âž¤ Lactate&lt;/li&gt;&lt;li&gt;âž¤ Glycerol&lt;/li&gt;&lt;li&gt;âž¤ Glycerol&lt;/li&gt;&lt;li&gt;âž¤ Propionyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ Propionyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p185, 186.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p185, 186.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of chronic obstructive pulmonary disease presents to the emergency department with symptoms of acute poisoning. Laboratory investigations are initiated to determine the cause. The medical team suspects exposure to a substance that specifically inhibits Complex IV of the electron transport chain (ETC) in the mitochondria. Which of the following substances is most likely responsible for the inhibition of Complex IV in this patient&#x27;s mitochondria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyanide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alkylguanides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oligomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxygen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cyanide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cyanide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome Oxidase [Complex IV] is inhibited by CO, HCN, H2S and Na Azide.&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome Oxidase [Complex IV]&lt;/li&gt;&lt;li&gt;âž¤ inhibited&lt;/li&gt;&lt;li&gt;âž¤ CO, HCN, H2S and Na Azide.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p132, 133.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p132, 133.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old researcher is conducting an experiment to measure ATP production through oxidative phosphorylation in isolated mitochondria. During the experiment, they specifically focus on the contribution of FADH to the electron transport chain. Considering the efficiency of ATP generation via the oxidation of FADH, how many ATP molecules are typically produced from the oxidation of one molecule of FADH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;3 ATP molecules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1.5 ATP molecules&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1 ATP molecule&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No ATP at all&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 1.5 ATP molecules&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â  1.5 ATP molecules&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the bioenergetic yield of different electron donors in the ETC:&lt;/li&gt;&lt;li&gt;âž¤ bioenergetic yield&lt;/li&gt;&lt;li&gt;âž¤ NADH â†’ ~2.5 ATP FADH â†’ ~1.5 ATP&lt;/li&gt;&lt;li&gt;âž¤ NADH â†’ ~2.5 ATP&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ FADH â†’ ~1.5 ATP&lt;/li&gt;&lt;li&gt;âž¤ FADH&lt;/li&gt;&lt;li&gt;âž¤ This knowledge is critical for calculating total ATP yield from glucose , fatty acid oxidation , or in experimental mitochondrial assays .&lt;/li&gt;&lt;li&gt;âž¤ ATP yield from glucose&lt;/li&gt;&lt;li&gt;âž¤ fatty acid oxidation&lt;/li&gt;&lt;li&gt;âž¤ experimental mitochondrial assays&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 263.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presents to the neurology clinic with a history of progressive vision loss and a family history of similar symptoms. Genetic testing reveals a mutation affecting the electron transport chain, specifically in the NADH-Q reductase (Complex I). Which of the following conditions is most likely associated with this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic lateral sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leberâ€™s optic myopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ragged red fibre disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Duchenne muscular dystrophy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Leberâ€™s optic myopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Leberâ€™s optic myopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amyotrophic lateral sclerosis: This is a progressive neurodegenerative disorder affecting motor neurons but is not typically associated with mutations in NADH-Q reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amyotrophic lateral sclerosis:&lt;/li&gt;&lt;li&gt;â€¢ progressive neurodegenerative disorder&lt;/li&gt;&lt;li&gt;â€¢ motor neurons&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ mutations in NADH-Q reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ragged red fibre disease: Also known as mitochondrial myopathy , this condition is characterized by muscle weakness and the p resence of ragged red fibers in muscle biopsies . It can be associated with various mitochondrial defects but is not specifically linked to mutations in NADH-Q reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ragged red fibre disease:&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial myopathy&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ resence of ragged red fibers&lt;/li&gt;&lt;li&gt;â€¢ muscle biopsies&lt;/li&gt;&lt;li&gt;â€¢ various mitochondrial defects&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ linked&lt;/li&gt;&lt;li&gt;â€¢ mutations in NADH-Q reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duchenne muscular dystrophy: This is a genetic disorder characterized by progressive muscle degeneration and weakness due to mutations in the dystrophin gene, not directly related to mitochondrial function or NADH-Q reductase mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Duchenne muscular dystrophy:&lt;/li&gt;&lt;li&gt;â€¢ genetic disorder&lt;/li&gt;&lt;li&gt;â€¢ progressive muscle degeneration and weakness&lt;/li&gt;&lt;li&gt;â€¢ mutations in the dystrophin gene, not&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial function or NADH-Q reductase mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mutations in mitochondrial DNA causes:&lt;/li&gt;&lt;li&gt;âž¤ Mutations in mitochondrial DNA causes:&lt;/li&gt;&lt;li&gt;âž¤ Lethal infantile mitochondrial ophthalmoplegia Leberâ€™s hereditary optic neuropathy (LHON) Myoclonic epilepsy Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS) MERRF Kearns-Sayre syndrome Pearson syndrome Leigh syndrome NARP&lt;/li&gt;&lt;li&gt;âž¤ Lethal infantile mitochondrial ophthalmoplegia&lt;/li&gt;&lt;li&gt;âž¤ Leberâ€™s hereditary optic neuropathy (LHON)&lt;/li&gt;&lt;li&gt;âž¤ Myoclonic epilepsy&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS)&lt;/li&gt;&lt;li&gt;âž¤ MERRF&lt;/li&gt;&lt;li&gt;âž¤ Kearns-Sayre syndrome&lt;/li&gt;&lt;li&gt;âž¤ Pearson syndrome&lt;/li&gt;&lt;li&gt;âž¤ Leigh syndrome&lt;/li&gt;&lt;li&gt;âž¤ NARP&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial DNA Mutations are inherited maternally ( mother to all children ) Leberâ€™s hereditary optic myopathy is characterized by blindness in young males and caused by a single base mutation in NADH Coenzyme Q reductase.&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial DNA Mutations&lt;/li&gt;&lt;li&gt;âž¤ inherited maternally&lt;/li&gt;&lt;li&gt;âž¤ mother to all children&lt;/li&gt;&lt;li&gt;âž¤ Leberâ€™s hereditary optic myopathy&lt;/li&gt;&lt;li&gt;âž¤ blindness in young males&lt;/li&gt;&lt;li&gt;âž¤ single base mutation&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q reductase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 358&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 358&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the electron transport chain is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Located in inner mitochondrial membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Components are organized in decreasing order of redox potential&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Involved with ATP synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cyanide inhibits electron flow&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Components are organized in decreasing order of redox potential&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Components are organized in decreasing order of redox potential&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ETC&lt;/li&gt;&lt;li&gt;âž¤ ETC&lt;/li&gt;&lt;li&gt;âž¤ Site: In the Inner Mitochondrial Membrane Components of the Electron Transport Chain are contained in four large protein complexes Electrons are transferred in the ascending or increasing order of redox potential . NADH has lowest and Oxygen has highest redox potential. The flow of electrons through the respiratory chain generates ATP by the process of oxidative phosphorylation. Inhibitors are mentioned in the image.&lt;/li&gt;&lt;li&gt;âž¤ Site: In the Inner Mitochondrial Membrane&lt;/li&gt;&lt;li&gt;âž¤ Site:&lt;/li&gt;&lt;li&gt;âž¤ Inner Mitochondrial Membrane&lt;/li&gt;&lt;li&gt;âž¤ Components of the Electron Transport Chain are contained in four large protein complexes&lt;/li&gt;&lt;li&gt;âž¤ Components&lt;/li&gt;&lt;li&gt;âž¤ four large protein complexes&lt;/li&gt;&lt;li&gt;âž¤ Electrons are transferred in the ascending or increasing order of redox potential . NADH has lowest and Oxygen has highest redox potential.&lt;/li&gt;&lt;li&gt;âž¤ Electrons&lt;/li&gt;&lt;li&gt;âž¤ ascending or increasing order&lt;/li&gt;&lt;li&gt;âž¤ redox potential&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ lowest and Oxygen&lt;/li&gt;&lt;li&gt;âž¤ highest redox potential.&lt;/li&gt;&lt;li&gt;âž¤ The flow of electrons through the respiratory chain generates ATP by the process of oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ flow of electrons&lt;/li&gt;&lt;li&gt;âž¤ respiratory chain generates ATP&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors are mentioned in the image.&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 260.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 260.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following components of the respiratory chain directly reacts with molecular oxygen to facilitate this reduction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coenzyme Q&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytochrome b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytochrome aa3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytochrome c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytochrome aa3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cytochrome aa3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complex IV contains different proteins such as cytochrome a and cytochrome a3. Four electrons are accepted from cytochrome c and passed on to molecular oxygen 4 H+ + O2 + 4 Cyt c-Fe++ â†’ 2 H2O + 4 Cyt c+++ 2 protons are pumped out to the intermembrane space . Cytochrome oxidase has 4 redox centres a, a3, CuA and CuB and the electron transfer in this complex is as shown&lt;/li&gt;&lt;li&gt;âž¤ Complex IV contains different proteins such as cytochrome a and cytochrome a3.&lt;/li&gt;&lt;li&gt;âž¤ Complex IV&lt;/li&gt;&lt;li&gt;âž¤ proteins&lt;/li&gt;&lt;li&gt;âž¤ cytochrome a and cytochrome a3.&lt;/li&gt;&lt;li&gt;âž¤ Four electrons are accepted from cytochrome c and passed on to molecular oxygen 4 H+ + O2 + 4 Cyt c-Fe++ â†’ 2 H2O + 4 Cyt c+++&lt;/li&gt;&lt;li&gt;âž¤ Four electrons&lt;/li&gt;&lt;li&gt;âž¤ cytochrome c&lt;/li&gt;&lt;li&gt;âž¤ molecular oxygen&lt;/li&gt;&lt;li&gt;âž¤ 4 H+ + O2 + 4 Cyt c-Fe++ â†’ 2 H2O + 4 Cyt c+++&lt;/li&gt;&lt;li&gt;âž¤ 2 protons are pumped out to the intermembrane space .&lt;/li&gt;&lt;li&gt;âž¤ 2 protons&lt;/li&gt;&lt;li&gt;âž¤ out&lt;/li&gt;&lt;li&gt;âž¤ intermembrane space&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome oxidase has 4 redox centres a, a3, CuA and CuB and the electron transfer in this complex is as shown&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome oxidase&lt;/li&gt;&lt;li&gt;âž¤ 4 redox centres a, a3, CuA and CuB&lt;/li&gt;&lt;li&gt;âž¤ electron transfer&lt;/li&gt;&lt;li&gt;âž¤ Cyt c â†’CuA â†’Cyt a â†’Cyt a3 â†’CuB&lt;/li&gt;&lt;li&gt;âž¤ Cyt c â†’CuA â†’Cyt a â†’Cyt a3 â†’CuB&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 262.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 262.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements correctly describes the ATP Synthase complex?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is the fourth complex of ETC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;F0 spans inner mitochondrial membrane &amp;amp; F1 projects into matrix&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;F1 spans inner mitochondrial membrane &amp;amp; F0 projects into matrix&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amobarbital is an inhibitor of this complex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. F0 spans inner mitochondrial membrane &amp; F1 projects into matrix&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) F0 spans inner mitochondrial membrane &amp;amp; F1 projects into matrix&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ It is the Fifth Complex of Electron transport Chain (option a) Location - Embedded in the inner mitochondrial membrane. Divided into two Subcomplexes: F0 Subcomplex and F1 Subcomplex. F0 Subcomplex: Hydrophobic in nature , F0 spans the inner mitochondrial membrane and forms a proton channel. F1 Subcomplex : Hydrophilic in nature, Projects into the mitochondrial matrix and is attached to F0 Subcomplex. Inhibitors of oxidative phosphorylation: Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ It is the Fifth Complex of Electron transport Chain (option a)&lt;/li&gt;&lt;li&gt;âž¤ Fifth Complex of Electron transport Chain&lt;/li&gt;&lt;li&gt;âž¤ Location - Embedded in the inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;âž¤ Location&lt;/li&gt;&lt;li&gt;âž¤ inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;âž¤ Divided into two Subcomplexes: F0 Subcomplex and F1 Subcomplex.&lt;/li&gt;&lt;li&gt;âž¤ two Subcomplexes: F0 Subcomplex and F1 Subcomplex.&lt;/li&gt;&lt;li&gt;âž¤ F0 Subcomplex: Hydrophobic in nature , F0 spans the inner mitochondrial membrane and forms a proton channel.&lt;/li&gt;&lt;li&gt;âž¤ F0 Subcomplex: Hydrophobic in nature&lt;/li&gt;&lt;li&gt;âž¤ F0&lt;/li&gt;&lt;li&gt;âž¤ inner mitochondrial membrane&lt;/li&gt;&lt;li&gt;âž¤ proton channel.&lt;/li&gt;&lt;li&gt;âž¤ F1 Subcomplex : Hydrophilic in nature, Projects into the mitochondrial matrix and is attached to F0 Subcomplex.&lt;/li&gt;&lt;li&gt;âž¤ F1 Subcomplex&lt;/li&gt;&lt;li&gt;âž¤ Hydrophilic in nature, Projects&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial matrix&lt;/li&gt;&lt;li&gt;âž¤ attached to F0 Subcomplex.&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors of oxidative phosphorylation: Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation:&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside , inhibits translocase Oligomycin , inhibits flow of protons through Fo Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside , inhibits translocase&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside&lt;/li&gt;&lt;li&gt;âž¤ translocase&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin , inhibits flow of protons through Fo&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin&lt;/li&gt;&lt;li&gt;âž¤ flow of protons through Fo&lt;/li&gt;&lt;li&gt;âž¤ Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Ionophores&lt;/li&gt;&lt;li&gt;âž¤ Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 264.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 264.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is investigating the effects of various biochemical substances on mitochondrial oxidative phosphorylation in a laboratory setting. They are particularly interested in substances that can disrupt the proton gradient across the mitochondrial membrane, thereby acting as uncouplers. Which of the following substances is capable of acting as an uncoupler in oxidative phosphorylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Free fatty acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thyroxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilirubin: While not its primary role or effect, bilirubin can act as an uncoupler under certain conditions, particularly at high concentrations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilirubin:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ act as&lt;/li&gt;&lt;li&gt;â€¢ uncoupler&lt;/li&gt;&lt;li&gt;â€¢ high concentrations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Free fatty acid: Free fatty acids are more commonly recognized as uncouplers , disrupting the proton gradient across the mitochondrial membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Free fatty acid:&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ uncouplers&lt;/li&gt;&lt;li&gt;â€¢ disrupting the proton gradient&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroxine: Thyroxine is known to increase the metabolic rate by uncoupling oxidative phosphorylation, leading to increased heat production.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thyroxine:&lt;/li&gt;&lt;li&gt;â€¢ increase the metabolic rate&lt;/li&gt;&lt;li&gt;â€¢ uncoupling oxidative phosphorylation,&lt;/li&gt;&lt;li&gt;â€¢ increased heat production.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Physiological Uncoupler&lt;/li&gt;&lt;li&gt;âž¤ Physiological Uncoupler&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin [Uncoupling Protein 1] in Brown Adipose Tissue (naturally occurring uncoupler) Thyroxine Long Chain Free Fatty Acid Unconjugated Bilirubin .&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin [Uncoupling Protein 1] in Brown Adipose Tissue (naturally occurring uncoupler)&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin&lt;/li&gt;&lt;li&gt;âž¤ Thyroxine&lt;/li&gt;&lt;li&gt;âž¤ Thyroxine&lt;/li&gt;&lt;li&gt;âž¤ Long Chain Free Fatty Acid&lt;/li&gt;&lt;li&gt;âž¤ Long Chain Free Fatty Acid&lt;/li&gt;&lt;li&gt;âž¤ Unconjugated Bilirubin .&lt;/li&gt;&lt;li&gt;âž¤ Unconjugated Bilirubin&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A professor is discussing mitochondrial disorders with her students, focusing on diseases associated with defects in oxidative phosphorylation (OXPHOS). She highlights several conditions that result from mutations affecting mitochondrial DNA and impairing the electron transport chain and ATP synthesis. Which of the following conditions are considered OXPHOS diseases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LHON&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MERRF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Only A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and B&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both A and B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)Â  Both A and B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. LHON: This is an OXPHOS disease affecting the optic nerves , but it is not the only one.&lt;/li&gt;&lt;li&gt;â€¢ Option A. LHON:&lt;/li&gt;&lt;li&gt;â€¢ OXPHOS disease&lt;/li&gt;&lt;li&gt;â€¢ optic nerves&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option B. MERRF: This condition, characterized by myoclonic seizures and muscle pathology , is also an OXPHOS disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. MERRF:&lt;/li&gt;&lt;li&gt;â€¢ myoclonic seizures and muscle pathology&lt;/li&gt;&lt;li&gt;â€¢ OXPHOS disease.&lt;/li&gt;&lt;li&gt;â€¢ They usually manifestations in nervous system (seizures, deafness, dementia), eyes ( retinitis pigmentosa, optic atrophy, blindness, ptosis ), heart ( cardiomyopathy ), kidneys ( Fanconiâ€™s syndrome , with loss of metabolites in urine) and skeletal muscles ( myoglobinuria ).&lt;/li&gt;&lt;li&gt;â€¢ manifestations in nervous system&lt;/li&gt;&lt;li&gt;â€¢ eyes&lt;/li&gt;&lt;li&gt;â€¢ retinitis pigmentosa, optic atrophy, blindness,&lt;/li&gt;&lt;li&gt;â€¢ ptosis&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ cardiomyopathy&lt;/li&gt;&lt;li&gt;â€¢ kidneys&lt;/li&gt;&lt;li&gt;â€¢ Fanconiâ€™s syndrome&lt;/li&gt;&lt;li&gt;â€¢ skeletal muscles&lt;/li&gt;&lt;li&gt;â€¢ myoglobinuria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 606.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 606.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the following options, which one does NOT act as an uncoupler of oxidative phosphorylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2,4-dinitrophenol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valinomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thermogenin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oligomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oligomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Oligomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin is an antibiotic which inhibits flow of protons through Fo by binding complex V. It is not an uncoupler. Ionophores are lipid-soluble compounds which increases the permeability of lipid bilayers to certain ions. There are two types of ionophores : mobile ion carries (e.g. valinomycin ) and channel formers (e.g. gramicidin). Valinomycin allows potassium to permeate mitochondria and dissipate the proton gradient. 2,4-dinitrophenol is a protonophore and acts as a synthetic uncoupler. Thermogenin is a mitochondrial membrane protein naturally present in brown adipose tissues and acts as an uncoupler. All of these inhibit oxidative phosphorylation by dissipating proton gradient.&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin is an antibiotic which inhibits flow of protons through Fo by binding complex V. It is not an uncoupler.&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin&lt;/li&gt;&lt;li&gt;âž¤ antibiotic&lt;/li&gt;&lt;li&gt;âž¤ inhibits flow of protons&lt;/li&gt;&lt;li&gt;âž¤ Fo&lt;/li&gt;&lt;li&gt;âž¤ complex V.&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ uncoupler.&lt;/li&gt;&lt;li&gt;âž¤ Ionophores are lipid-soluble compounds which increases the permeability of lipid bilayers to certain ions. There are two types of ionophores : mobile ion carries (e.g. valinomycin ) and channel formers (e.g. gramicidin). Valinomycin allows potassium to permeate mitochondria and dissipate the proton gradient. 2,4-dinitrophenol is a protonophore and acts as a synthetic uncoupler. Thermogenin is a mitochondrial membrane protein naturally present in brown adipose tissues and acts as an uncoupler. All of these inhibit oxidative phosphorylation by dissipating proton gradient.&lt;/li&gt;&lt;li&gt;âž¤ Ionophores&lt;/li&gt;&lt;li&gt;âž¤ lipid-soluble compounds&lt;/li&gt;&lt;li&gt;âž¤ increases&lt;/li&gt;&lt;li&gt;âž¤ lipid bilayers to certain ions.&lt;/li&gt;&lt;li&gt;âž¤ two types of ionophores&lt;/li&gt;&lt;li&gt;âž¤ mobile ion carries&lt;/li&gt;&lt;li&gt;âž¤ valinomycin&lt;/li&gt;&lt;li&gt;âž¤ channel formers&lt;/li&gt;&lt;li&gt;âž¤ Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ potassium to permeate mitochondria&lt;/li&gt;&lt;li&gt;âž¤ dissipate the proton gradient. 2,4-dinitrophenol&lt;/li&gt;&lt;li&gt;âž¤ protonophore&lt;/li&gt;&lt;li&gt;âž¤ synthetic uncoupler.&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin&lt;/li&gt;&lt;li&gt;âž¤ protein&lt;/li&gt;&lt;li&gt;âž¤ brown&lt;/li&gt;&lt;li&gt;âž¤ adipose tissues&lt;/li&gt;&lt;li&gt;âž¤ uncoupler.&lt;/li&gt;&lt;li&gt;âž¤ inhibit oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ dissipating proton gradient.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about ATP synthesis is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Protein assembly is seen in the inner mitochondrial membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atractyloside inhibits the process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxidation is coupled to phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Availability of ATP regulates the process&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Availability of ATP regulates the process&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Availability of ATP regulates the process&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ It is a protein assembly in the inner mitochondrial membrane. Also known as 5th Complex The availability of ADP regulates the process of ATP synthesis . When ATP level is low and ADP level is high, oxidative phosphorylation happens at a rapid rate. This is known as respiratory control or acceptor control. Inhibitors of oxidative phosphorylation Atractyloside , inhibits translocase Oligomycin, inhibits flow of protons through Fo Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ It is a protein assembly in the inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;âž¤ protein&lt;/li&gt;&lt;li&gt;âž¤ inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;âž¤ Also known as 5th Complex&lt;/li&gt;&lt;li&gt;âž¤ 5th Complex&lt;/li&gt;&lt;li&gt;âž¤ The availability of ADP regulates the process of ATP synthesis . When ATP level is low and ADP level is high, oxidative phosphorylation happens at a rapid rate.&lt;/li&gt;&lt;li&gt;âž¤ ADP regulates&lt;/li&gt;&lt;li&gt;âž¤ ATP synthesis&lt;/li&gt;&lt;li&gt;âž¤ ATP level is low&lt;/li&gt;&lt;li&gt;âž¤ ADP level is high,&lt;/li&gt;&lt;li&gt;âž¤ oxidative&lt;/li&gt;&lt;li&gt;âž¤ phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ a rapid rate.&lt;/li&gt;&lt;li&gt;âž¤ This is known as respiratory control or acceptor control.&lt;/li&gt;&lt;li&gt;âž¤ respiratory control or acceptor control.&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors of oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors of oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside , inhibits translocase&lt;/li&gt;&lt;li&gt;âž¤ Atractyloside&lt;/li&gt;&lt;li&gt;âž¤ translocase&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin, inhibits flow of protons through Fo&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin,&lt;/li&gt;&lt;li&gt;âž¤ protons through Fo&lt;/li&gt;&lt;li&gt;âž¤ Ionophores , e.g. Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Ionophores&lt;/li&gt;&lt;li&gt;âž¤ Valinomycin&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 265.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 265.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child presents with hypoglycaemia and metabolic acidosis. Laboratory investigations reveal a genetic disorder that causes the liver enzyme fructose 1,6-bisphosphatase to be more sensitive to inhibition by fructose 2,6-bisphosphate. This enzyme is a crucial regulatory point in gluconeogenesis. Based on this enzymatic defect, which of the following metabolic changes would be expected in this child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Level of fructose 1,6-biphosphate is lower than normal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Level of fructose 1,6-biphosphate is higher than normal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased Glucose production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased gluconeogenesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Level of fructose 1,6-biphosphate is higher than normal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Level of fructose 1,6-biphosphate is higher than normal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Fructose 1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis , inhibited by fructose 2,6-bisphosphate . Its inhibition results in accumulation of fructose 1,6-bisphosphate and impaired glucose production. This can cause fasting hypoglycemia , lactic acidosis , and failure to thrive , especially in early childhood.&lt;/li&gt;&lt;li&gt;âž¤ Fructose 1,6-bisphosphatase is a key regulatory enzyme in gluconeogenesis , inhibited by fructose 2,6-bisphosphate .&lt;/li&gt;&lt;li&gt;âž¤ Fructose 1,6-bisphosphatase&lt;/li&gt;&lt;li&gt;âž¤ key regulatory enzyme in gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ fructose 2,6-bisphosphate&lt;/li&gt;&lt;li&gt;âž¤ Its inhibition results in accumulation of fructose 1,6-bisphosphate and impaired glucose production.&lt;/li&gt;&lt;li&gt;âž¤ accumulation of fructose 1,6-bisphosphate&lt;/li&gt;&lt;li&gt;âž¤ This can cause fasting hypoglycemia , lactic acidosis , and failure to thrive , especially in early childhood.&lt;/li&gt;&lt;li&gt;âž¤ fasting hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ lactic acidosis&lt;/li&gt;&lt;li&gt;âž¤ failure to thrive&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p169-170.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child was recently diagnosed with G6PD deficiency. Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the regulatory step in the HMP shunt. Which is the correct statement about G6PD and HMP shunt?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deficiency of G6PD occurs only in red blood cells.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deficiency of G6PD â†’ inability to keep glutathione in reduced functional form.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The reduced NADPH formed during the shunt is utilized in fatty acid oxidation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deficiency of G6PD â†’ inability to keep glutathione in reduced functional form.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â  Deficiency of G6PD â†’ inability to keep glutathione in reduced functional form.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deficiency of G6PD occurs only in red blood cells: The oxidative phase of the pathway is seen in Liver, Adipose tissue, Adrenal cortex, Testes and ovaries, RBCs and Lens of eye. The non-oxidative phase is present in all tissues .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Deficiency of G6PD occurs only in red blood cells:&lt;/li&gt;&lt;li&gt;â€¢ oxidative phase&lt;/li&gt;&lt;li&gt;â€¢ Liver, Adipose tissue,&lt;/li&gt;&lt;li&gt;â€¢ Adrenal cortex, Testes and ovaries, RBCs and Lens of eye.&lt;/li&gt;&lt;li&gt;â€¢ non-oxidative phase&lt;/li&gt;&lt;li&gt;â€¢ all tissues&lt;/li&gt;&lt;li&gt;â€¢ Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions: involves two irreversible oxidative reactions&lt;/li&gt;&lt;li&gt;â€¢ Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions:&lt;/li&gt;&lt;li&gt;â€¢ two irreversible oxidative reactions&lt;/li&gt;&lt;li&gt;â€¢ Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation: used in fatty acid synthesis, steroid hormone, and cholesterol synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  The reduced NADPH formed during the shunt is utilized in fatty acid oxidation:&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthesis, steroid hormone, and cholesterol synthesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ G6PD is an enzyme in the hexose monophosphate shunt that is responsible for the production of NADPH. NADPH is crucial for maintaining the reduced form of glutathione , a critical antioxidant in cells. In G6PD deficiency, the reduced production of NADPH leads to a reduced ability to maintain glutathione in its reduced form , making red blood cells more susceptible to oxidative damage .&lt;/li&gt;&lt;li&gt;âž¤ G6PD&lt;/li&gt;&lt;li&gt;âž¤ hexose monophosphate shunt&lt;/li&gt;&lt;li&gt;âž¤ NADPH.&lt;/li&gt;&lt;li&gt;âž¤ NADPH&lt;/li&gt;&lt;li&gt;âž¤ reduced form of glutathione&lt;/li&gt;&lt;li&gt;âž¤ antioxidant in cells.&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency,&lt;/li&gt;&lt;li&gt;âž¤ NADPH&lt;/li&gt;&lt;li&gt;âž¤ reduced ability to maintain glutathione&lt;/li&gt;&lt;li&gt;âž¤ reduced form&lt;/li&gt;&lt;li&gt;âž¤ red blood cells&lt;/li&gt;&lt;li&gt;âž¤ oxidative damage&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 196-200.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 196-200.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged woman visited a region with known chloroquine-resistant malaria. As a prophylactic measure, she was administered primaquine. Shortly after starting the medication, she exhibited signs of hemolytic anemia and was later diagnosed with a deficiency in glucose 6-phosphate dehydrogenase (G6PD). Given the role of G6PD in cellular metabolism, what is the underlying cause of her hemolytic symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxidized form of nicotinamide adenine dinucleotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose 6-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ribose 5-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decrease Level of Reduced Glutathione&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Decrease Level of Reduced Glutathione&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Decrease Level of Reduced Glutathione&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ In G6PD deficiency , red blood cells have:&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency&lt;/li&gt;&lt;li&gt;âž¤ Impaired ability to handle oxidative stress Low NADPH levels Decreased reduced glutathione (GSH)&lt;/li&gt;&lt;li&gt;âž¤ Impaired ability to handle oxidative stress&lt;/li&gt;&lt;li&gt;âž¤ Impaired ability to handle oxidative stress&lt;/li&gt;&lt;li&gt;âž¤ Low NADPH levels&lt;/li&gt;&lt;li&gt;âž¤ Low NADPH levels&lt;/li&gt;&lt;li&gt;âž¤ Decreased reduced glutathione (GSH)&lt;/li&gt;&lt;li&gt;âž¤ Decreased reduced glutathione (GSH)&lt;/li&gt;&lt;li&gt;âž¤ This makes them susceptible to hemolysis , especially after exposure to oxidant drugs like primaquine .&lt;/li&gt;&lt;li&gt;âž¤ hemolysis&lt;/li&gt;&lt;li&gt;âž¤ oxidant drugs like primaquine&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 586, 693-694.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 1-year-old child with a diagnosed inborn error of the pentose phosphate pathway is brought to the clinic for a follow-up. The child has a history of hemolytic anemia and developmental delays. The pentose phosphate pathway is crucial for producing NADPH, which is essential for maintaining the reducing environment in cells. Given the importance of this pathway, which of the following organs is least likely to contain enzymes for an active pentose phosphate pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenal Gland&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Red Blood Cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Skeletal Muscle&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Skeletal Muscle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Skeletal muscle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HMP shunt: Involved in synthesis of NADPH and Pentoses.&lt;/li&gt;&lt;li&gt;âž¤ HMP shunt:&lt;/li&gt;&lt;li&gt;âž¤ synthesis of NADPH and Pentoses.&lt;/li&gt;&lt;li&gt;âž¤ Uses of NADPH&lt;/li&gt;&lt;li&gt;âž¤ Uses of NADPH&lt;/li&gt;&lt;li&gt;âž¤ Reductive biosynthesis of fatty acids, cholesterol, steroid hormones &amp;amp; bile acids. Cofactor for glutathione reductase and MetHb reductase So HMP shunt is active in: Adipose tissue, liver, RBC, ovary, testes, adrenal gland and lactating mammary gland.&lt;/li&gt;&lt;li&gt;âž¤ Reductive biosynthesis of fatty acids, cholesterol, steroid hormones &amp;amp; bile acids.&lt;/li&gt;&lt;li&gt;âž¤ Reductive&lt;/li&gt;&lt;li&gt;âž¤ fatty acids, cholesterol, steroid hormones &amp;amp; bile acids.&lt;/li&gt;&lt;li&gt;âž¤ Cofactor for glutathione reductase and MetHb reductase&lt;/li&gt;&lt;li&gt;âž¤ Cofactor&lt;/li&gt;&lt;li&gt;âž¤ glutathione reductase&lt;/li&gt;&lt;li&gt;âž¤ MetHb reductase&lt;/li&gt;&lt;li&gt;âž¤ So HMP shunt is active in: Adipose tissue, liver, RBC, ovary, testes, adrenal gland and lactating mammary gland.&lt;/li&gt;&lt;li&gt;âž¤ HMP shunt is active&lt;/li&gt;&lt;li&gt;âž¤ Adipose tissue, liver, RBC, ovary, testes, adrenal gland and&lt;/li&gt;&lt;li&gt;âž¤ lactating mammary gland.&lt;/li&gt;&lt;li&gt;âž¤ Sources of NADPH:&lt;/li&gt;&lt;li&gt;âž¤ Sources of NADPH:&lt;/li&gt;&lt;li&gt;âž¤ HMP (G6PD and 6 phosphogluconate dehydrogenase) Malic enzyme Isocitrate dehydrogenase (Cytosolic)&lt;/li&gt;&lt;li&gt;âž¤ HMP (G6PD and 6 phosphogluconate dehydrogenase)&lt;/li&gt;&lt;li&gt;âž¤ HMP&lt;/li&gt;&lt;li&gt;âž¤ Malic enzyme&lt;/li&gt;&lt;li&gt;âž¤ Malic enzyme&lt;/li&gt;&lt;li&gt;âž¤ Isocitrate dehydrogenase (Cytosolic)&lt;/li&gt;&lt;li&gt;âž¤ Isocitrate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 196-200.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 196-200.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of cellular metabolism and redox balance, which pathway is primarily responsible for the generation of NADPH, a key factor in protecting cells from oxidative stress?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Citric acid cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HMP shunt&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fatty acid oxidation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HMP shunt&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HMP shunt&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NADPH is used for reductive biosynthetic pathways such as fatty acid synthesis, steroid and cholesterol synthesis and Amino acids by Glutamate dehydrogenase. NADPH is required for regeneration of reduced Glutathione which clears free radicals from erythrocytes and lens.&lt;/li&gt;&lt;li&gt;âž¤ NADPH is used for reductive biosynthetic pathways such as fatty acid synthesis, steroid and cholesterol synthesis and Amino acids by Glutamate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ NADPH&lt;/li&gt;&lt;li&gt;âž¤ reductive biosynthetic pathways&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis, steroid and cholesterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ Amino acids&lt;/li&gt;&lt;li&gt;âž¤ Glutamate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ NADPH is required for regeneration of reduced Glutathione which clears free radicals from erythrocytes and lens.&lt;/li&gt;&lt;li&gt;âž¤ NADPH&lt;/li&gt;&lt;li&gt;âž¤ regeneration of reduced Glutathione&lt;/li&gt;&lt;li&gt;âž¤ free radicals&lt;/li&gt;&lt;li&gt;âž¤ erythrocytes and lens.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p197.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p197.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a competitive quiz on cellular metabolism among medical students, a challenging question is posed regarding the regulation of Phosphofructokinase-1 (PFK-1), a key enzyme in the glycolytic pathway. The quizmaster asks which of the following molecules does not serve as an activator for PFK-1, contrary to the common regulatory mechanisms of this crucial enzyme. The options given are:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5â€™AMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructose 2, 6 Bisphosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fructose 6 Phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Citrate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Citrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture10.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Citrate.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Citrate is an Inhibitor of Phosphofructokinase-I.&lt;/li&gt;&lt;li&gt;âž¤ Citrate is an Inhibitor of Phosphofructokinase-I.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p188.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p188.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identifying the enzymes crucial for gluconeogenesis is essential for understanding metabolic pathways that contribute to glucose homeostasis. Which of the following options lists the key enzymes responsible for this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate carboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphoenol pyruvate carboxykinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fructose-1-6-bisphosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate carboxylase: Initiates gluconeogenesis by converting pyruvate to oxaloacetate.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate carboxylase:&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ pyruvate to oxaloacetate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphoenolpyruvate carboxykinase: Continues the pathway by converting oxaloacetate to phosphoenolpyruvate .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphoenolpyruvate carboxykinase:&lt;/li&gt;&lt;li&gt;â€¢ converting oxaloacetate to phosphoenolpyruvate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fructose-1,6-bisphosphatase: Crucial for bypassing a key glycolytic step in the reverse direction , converting fructose-1,6-bisphosphate to fructose-6-phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fructose-1,6-bisphosphatase:&lt;/li&gt;&lt;li&gt;â€¢ glycolytic step&lt;/li&gt;&lt;li&gt;â€¢ reverse direction&lt;/li&gt;&lt;li&gt;â€¢ fructose-1,6-bisphosphate to fructose-6-phosphate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Key Gluconeogenic Enzymes&lt;/li&gt;&lt;li&gt;âž¤ Key Gluconeogenic Enzymes&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate carboxylase Phosphoenol pyruvate carboxykinase Fructose-1-6-bisphosphatase Glucose-6-phosphatase&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate carboxylase&lt;/li&gt;&lt;li&gt;âž¤ Phosphoenol pyruvate carboxykinase&lt;/li&gt;&lt;li&gt;âž¤ Fructose-1-6-bisphosphatase&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphatase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p187.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p187.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical case discussion, a medical student presents a patient with a genetic defect impacting a key metabolic pathway, leading to abnormal red blood cell function. The discussion focuses on the role of various metabolic pathways in cellular health. The student is asked to identify which of the following statements about the hexose monophosphate (HMP) shunt does not align with its known functions.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serves as a source of NADPH, essential for reductive biosynthesis and detoxification.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Provides Ribose 5-phosphate for nucleotide synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plays a role in preventing the formation of methemoglobin by maintaining reduced glutathione.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Is directly implicated in causing free radical injury due to its metabolic processes.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Is directly implicated in causing free radical injury due to its metabolic processes.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Is directly implicated in causing free radical injury due to its metabolic processes.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biochemical Significances of HMP Pathway&lt;/li&gt;&lt;li&gt;âž¤ Biochemical Significances of HMP Pathway&lt;/li&gt;&lt;li&gt;âž¤ Alternative route for metabolism of Glucose and causes complete oxidation of Glucose Major function is to generate NADPH and Riboses No ATP is generated by this pathway Free radical scavenging Maintain RBC membrane integrity by keeping GSH in reduced state Prevention of met-haemoglobin formation Detoxification by hydroxylation Maintain the transparency of lens Bactericidal activity of macrophages&lt;/li&gt;&lt;li&gt;âž¤ Alternative route for metabolism of Glucose and causes complete oxidation of Glucose&lt;/li&gt;&lt;li&gt;âž¤ Alternative&lt;/li&gt;&lt;li&gt;âž¤ metabolism of Glucose&lt;/li&gt;&lt;li&gt;âž¤ complete oxidation of Glucose&lt;/li&gt;&lt;li&gt;âž¤ Major function is to generate NADPH and Riboses&lt;/li&gt;&lt;li&gt;âž¤ NADPH and Riboses&lt;/li&gt;&lt;li&gt;âž¤ No ATP is generated by this pathway&lt;/li&gt;&lt;li&gt;âž¤ No ATP&lt;/li&gt;&lt;li&gt;âž¤ Free radical scavenging&lt;/li&gt;&lt;li&gt;âž¤ Free radical scavenging&lt;/li&gt;&lt;li&gt;âž¤ Maintain RBC membrane integrity by keeping GSH in reduced state&lt;/li&gt;&lt;li&gt;âž¤ RBC membrane integrity&lt;/li&gt;&lt;li&gt;âž¤ GSH in reduced state&lt;/li&gt;&lt;li&gt;âž¤ Prevention of met-haemoglobin formation&lt;/li&gt;&lt;li&gt;âž¤ met-haemoglobin&lt;/li&gt;&lt;li&gt;âž¤ Detoxification by hydroxylation&lt;/li&gt;&lt;li&gt;âž¤ Detoxification&lt;/li&gt;&lt;li&gt;âž¤ Maintain the transparency of lens&lt;/li&gt;&lt;li&gt;âž¤ transparency of lens&lt;/li&gt;&lt;li&gt;âž¤ Bactericidal activity of macrophages&lt;/li&gt;&lt;li&gt;âž¤ Bactericidal&lt;/li&gt;&lt;li&gt;âž¤ macrophages&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p197.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p197.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male visits his primary care physician complaining of recurrent episodes of pain in his calves triggered by physical activity. He reports no other symptoms or significant medical history. Given the concern for a metabolic muscle disorder, a muscle biopsy is performed, revealing an accumulation of glycogen within the muscle cells. Based on the patient&#x27;s symptoms and biopsy findings, which enzyme deficiency is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Muscle debranching enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose 6 phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Muscle phosphorylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Muscle Phosphorylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 179.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 179.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following tissues is INCAPABLE of contributing directly to blood glucose levels through glycogen breakdown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Muscle&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Muscle&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Muscle&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver: The liver is capable of contributing directly to blood glucose levels through glycogen breakdown. It contains the enzyme glucose-6-phosphatase, which allows for the conversion of glucose-6-phosphate into free glucose that can be released into the bloodstream, thereby maintaining blood glucose levels , especially during fasting .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver:&lt;/li&gt;&lt;li&gt;â€¢ directly to blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ glycogen breakdown.&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphatase,&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphate into free glucose&lt;/li&gt;&lt;li&gt;â€¢ bloodstream,&lt;/li&gt;&lt;li&gt;â€¢ blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ fasting&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both: This option is incorrect because the liver can directly contribute to blood glucose levels through glycogen breakdown , while muscle cannot.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ glycogen&lt;/li&gt;&lt;li&gt;â€¢ breakdown&lt;/li&gt;&lt;li&gt;â€¢ muscle cannot.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differences between Liver Glycogen and Muscle Glycogen.&lt;/li&gt;&lt;li&gt;âž¤ Differences between Liver Glycogen and Muscle Glycogen.&lt;/li&gt;&lt;li&gt;âž¤ Muscle glycogen is not directly available as a source of blood glucose because muscle lacks glucose-6-phosphatase which releases free glucose from glucose 6-P.&lt;/li&gt;&lt;li&gt;âž¤ Muscle glycogen&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ source of blood glucose&lt;/li&gt;&lt;li&gt;âž¤ lacks glucose-6-phosphatase&lt;/li&gt;&lt;li&gt;âž¤ free glucose from glucose 6-P.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p177, 178.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p177, 178.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old child with frequent hypoglycemic episodes during fasting is being evaluated. Laboratory findings indicate normal glycogen structure but impaired glycogenolysis. Given the critical role of Glucose-6-Phosphatase in this process, why isn&#x27;t Glucose-6-Phosphate immediately converted to glucose in hepatocytes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Only active during gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Requires Protein Kinase activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enzyme located in the endoplasmic reticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibited by albumin in the cytoplasm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enzyme located in the endoplasmic reticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Enzyme located in the endoplasmic reticulum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Only active during gluconeogenesis: This is incorrect because Glucose-6-Phosphatase is active during both gluconeogenesis and glycogenolysis , not exclusively during gluconeogenesis . Its activity is crucial for maintaining blood glucose levels , especially during fasting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Only active during gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Glucose-6-Phosphatase&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ both&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis and glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ maintaining blood glucose&lt;/li&gt;&lt;li&gt;â€¢ levels&lt;/li&gt;&lt;li&gt;â€¢ fasting.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Requires Protein Kinase activation: Glucose-6-Phosphatase activity is not directly regulated by protein kinases . The regulation of this enzyme is primarily through substrate availability and its subcellular localization, rather than through activation by phosphorylation .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Requires Protein Kinase activation:&lt;/li&gt;&lt;li&gt;â€¢ Glucose-6-Phosphatase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ protein kinases&lt;/li&gt;&lt;li&gt;â€¢ substrate availability&lt;/li&gt;&lt;li&gt;â€¢ subcellular localization,&lt;/li&gt;&lt;li&gt;â€¢ activation by&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibited by albumin in the cytoplasm: There is no direct interaction between albumin and Glucose-6-Phosphatase that would inhibit its activity. Albumin, a serum protein produced by the liver, primarily functions in maintaining oncotic pressure and transporting substances ; it does not play a regulatory role in glycogenolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibited by albumin in the cytoplasm:&lt;/li&gt;&lt;li&gt;â€¢ no&lt;/li&gt;&lt;li&gt;â€¢ albumin and Glucose-6-Phosphatase&lt;/li&gt;&lt;li&gt;â€¢ inhibit&lt;/li&gt;&lt;li&gt;â€¢ activity.&lt;/li&gt;&lt;li&gt;â€¢ Albumin,&lt;/li&gt;&lt;li&gt;â€¢ serum protein&lt;/li&gt;&lt;li&gt;â€¢ liver,&lt;/li&gt;&lt;li&gt;â€¢ oncotic pressure&lt;/li&gt;&lt;li&gt;â€¢ transporting substances&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphatase is in the lumen of the smooth endoplasmic reticulum Glucose-6-phosphate is transported to SER by a transporter known as translocase to be acted by Glucose- 6-phosphatase. Genetic defects of the Glucose-6-phosphate transporter can result in a variant of type I glycogen storage disease.&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphatase is in the lumen of the smooth endoplasmic reticulum&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphatase&lt;/li&gt;&lt;li&gt;âž¤ smooth endoplasmic reticulum&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphate is transported to SER by a transporter known as translocase to be acted by Glucose- 6-phosphatase.&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ SER&lt;/li&gt;&lt;li&gt;âž¤ translocase&lt;/li&gt;&lt;li&gt;âž¤ Glucose- 6-phosphatase.&lt;/li&gt;&lt;li&gt;âž¤ Genetic defects of the Glucose-6-phosphate transporter can result in a variant of type I glycogen storage disease.&lt;/li&gt;&lt;li&gt;âž¤ Genetic defects&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphate transporter&lt;/li&gt;&lt;li&gt;âž¤ type I glycogen storage disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p178.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p178.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child presents to the pediatric clinic with recurrent episodes of hypoglycemia, especially noted during fasting periods. The child&#x27;s growth parameters are below the normal percentile for age. Laboratory investigations reveal lactic acidosis and hyperuricemia. After further evaluation, the child is diagnosed with Glucose-6-phosphatase deficiency. The attending physician explains to the parents the association between the child&#x27;s condition and the development of hyperuricemia and gout. Which of the following is the most likely cause of hyperuricemia and gout in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased availability of glucose to tissues&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;More formation of pentoses&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased accumulation of sorbitol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Impaired degradation of free radicals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. More formation of pentoses&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) More formation of pentoses&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased availability of glucose to tissues: This is a direct consequence of Glucose-6-phosphatase deficiency leading to hypoglycemia but does not directly cause hyperuricemia and gout . The lack of glucose exacerbates the metabolic imbalance but isn&#x27;t the primary cause of increased uric acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased availability of glucose to tissues: This&lt;/li&gt;&lt;li&gt;â€¢ Glucose-6-phosphatase deficiency&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia and gout&lt;/li&gt;&lt;li&gt;â€¢ lack of glucose&lt;/li&gt;&lt;li&gt;â€¢ metabolic imbalance&lt;/li&gt;&lt;li&gt;â€¢ isn&#x27;t&lt;/li&gt;&lt;li&gt;â€¢ increased uric acid levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased accumulation of sorbitol: Sorbitol accumulation is associated with conditions like diabetes mellitus due to increased activity of the polyol pathway when glucose levels are high. It is not directly related to Glucose-6-phosphatase deficiency or hyperuricemia and gout in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased accumulation of sorbitol:&lt;/li&gt;&lt;li&gt;â€¢ diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ polyol pathway&lt;/li&gt;&lt;li&gt;â€¢ glucose levels are high.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Glucose-6-phosphatase deficiency&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia and gout&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired degradation of free radicals: While oxidative stress and impaired degradation of free radicals can contribute to cellular damage and various metabolic disturbances , they are not directly involved in the mechanism leading to hyperuricemia and gout in patients with Glucose-6-phosphatase deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Impaired degradation of free radicals:&lt;/li&gt;&lt;li&gt;â€¢ oxidative stress&lt;/li&gt;&lt;li&gt;â€¢ impaired degradation of free radicals&lt;/li&gt;&lt;li&gt;â€¢ cellular damage&lt;/li&gt;&lt;li&gt;â€¢ metabolic disturbances&lt;/li&gt;&lt;li&gt;â€¢ not directly&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia&lt;/li&gt;&lt;li&gt;â€¢ gout&lt;/li&gt;&lt;li&gt;â€¢ Glucose-6-phosphatase deficiency.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biochemical defect in von Gierkeâ€™s disease:&lt;/li&gt;&lt;li&gt;âž¤ Biochemical defect in von Gierkeâ€™s disease:&lt;/li&gt;&lt;li&gt;âž¤ Deficiency of Glucose 6 Phosphatase â†’ accumulation of Glucose 6 Phosphate â†’ it is  channelled to Pentose Phosphate pathway â†’ more Pentoses are formed â†’ enters Purine Synthesis â†’ Uric acid accumulates ( degradation product of Purine )&lt;/li&gt;&lt;li&gt;âž¤ Deficiency of Glucose 6 Phosphatase&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6 Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Pentose Phosphate pathway&lt;/li&gt;&lt;li&gt;âž¤ more Pentoses&lt;/li&gt;&lt;li&gt;âž¤ Purine Synthesis&lt;/li&gt;&lt;li&gt;âž¤ Uric acid&lt;/li&gt;&lt;li&gt;âž¤ degradation product of Purine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 20/e: Defects in the metabolism of Carbohydrates&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Nelson 20/e: Defects in the metabolism of Carbohydrates&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Approximately how many hours does it take for liver glycogen stores to become significantly depleted in an average adult under normal physiological conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;9&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;18&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;24&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;48&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 18&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 18 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Under normal physiological conditions , liver glycogen stores can sustain blood glucose levels for about 18 hours of fasting. After this period, the body increasingly relies on gluconeogenesis and the breakdown of fats for energy , marking a transition in the body&#x27;s primary energy sources to maintain metabolic functions during prolonged fasting.&lt;/li&gt;&lt;li&gt;â€¢ normal physiological conditions&lt;/li&gt;&lt;li&gt;â€¢ liver glycogen stores&lt;/li&gt;&lt;li&gt;â€¢ blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ 18 hours of fasting.&lt;/li&gt;&lt;li&gt;â€¢ body increasingly&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ breakdown of fats for energy&lt;/li&gt;&lt;li&gt;â€¢ transition in the body&#x27;s&lt;/li&gt;&lt;li&gt;â€¢ energy&lt;/li&gt;&lt;li&gt;â€¢ metabolic functions&lt;/li&gt;&lt;li&gt;â€¢ prolonged fasting.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Liver and Muscle Glycogen are generally exhausted by 18 hours of fasting.&lt;/li&gt;&lt;li&gt;âž¤ Liver and Muscle Glycogen&lt;/li&gt;&lt;li&gt;âž¤ exhausted&lt;/li&gt;&lt;li&gt;âž¤ 18 hours of fasting.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p149.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p149.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-month-old infant is presented to the pediatric outpatient department by the mother, reporting symptoms of rapid heart rate, restlessness, muscle hypotonia, and abdominal distention. The infant has been diagnosed with cardiac failure and is currently being treated with diuretics and an ACE inhibitor. Radiographic evidence indicates left ventricular hypertrophy, and physical examination reveals hepatosplenomegaly. An assay performed on a dried blood spot indicates reduced activity of a specific enzyme, leading to a diagnosis of Pompe disease. Which enzyme deficiency is associated with Pompe disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acid maltase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose-6-phosphatase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acid maltase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acid maltase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 179.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 179.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old girl child is admitted with progressive abdominal distension for the past 6 months. Mother reported that the baby has difficulty in walking, gets easily tired while playing and restless and sweat in early morning hours. After giving juice or milk, she feels comfortable. On examination, child was found to have motor retardation and was small for age. Liver was found to be enlarged with firm consistency. Laboratory investigations: FBS: 60 mg/dl (normal = 80-110 mg/dl) AST: 355 IU/L (normal = 15-45 IU/L) ALT: 244 IU/L (normal = 15-45 IU/L) ALP: 231 IU/L (normal =98-279 IU/L) Total bilirubin: 2.0 mg/dl (normal = 0-1.0 mg/dl) Liver histology: Glycogen laden vacuoles with no fibrosis or inflammatory cell infiltration. Baby was diagnosed with GSD type III based on the results. What is the causative enzyme deficiency in this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Branching enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Debranching enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose-6-phosphatase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Debranching enzyme&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11_PgLn01X.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Debranching enzyme&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Branching enzyme: deficiency results in Anderson disease . C/F: failure to thrive, liver failure, and hypotonia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Branching enzyme:&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ Anderson disease&lt;/li&gt;&lt;li&gt;â€¢ failure to thrive, liver failure, and hypotonia.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Muscle phosphorylase: deficiency results in McArdle disease. C/F: pain, cramps and myoglobinuria on strenuous exercise.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Muscle phosphorylase:&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ McArdle disease.&lt;/li&gt;&lt;li&gt;â€¢ pain, cramps and myoglobinuria&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glucose-6-phosphatase: Deficiency results in Von Gierke disease. C/F: Hypoglycemia; hyperketonaemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glucose-6-phosphatase:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency&lt;/li&gt;&lt;li&gt;â€¢ Von Gierke disease.&lt;/li&gt;&lt;li&gt;â€¢ Hypoglycemia; hyperketonaemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 179.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 179.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old medical student, immersed in the demanding schedule of clinical rotations, often finds himself skipping lunch and dinner. To sustain his energy levels and cognitive function during these prolonged periods without food, his body must mobilize glucose from liver stores. Which enzyme plays a pivotal role in this process by facilitating the release of glucose from glycogen stored in the liver?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetyl-CoA carboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose-6-phosphate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogen phosphorylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen synthase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glycogen phosphorylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glycogen phosphorylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Acetyl-CoA carboxylase: This enzyme is involved in fatty acid synthesis , not in the mobilization or release of glucose from glycogen stores.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Acetyl-CoA carboxylase:&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ release&lt;/li&gt;&lt;li&gt;â€¢ glucose from&lt;/li&gt;&lt;li&gt;â€¢ glycogen stores.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose-6-phosphate dehydrogenase: This enzyme is part of the pentose phosphate pathway and is involved in producing NADPH and ribose-5-phosphate , rather than in the direct mobilization of glucose from stored glycogen.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose-6-phosphate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ pentose phosphate pathway&lt;/li&gt;&lt;li&gt;â€¢ NADPH&lt;/li&gt;&lt;li&gt;â€¢ ribose-5-phosphate&lt;/li&gt;&lt;li&gt;â€¢ rather than&lt;/li&gt;&lt;li&gt;â€¢ glucose from stored glycogen.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycogen synthase: This enzyme is responsible for the synthesis of glycogen from glucose , the opposite process to what is needed in this scenario, where the goal is to mobilize glucose from glycogen stores.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycogen synthase:&lt;/li&gt;&lt;li&gt;â€¢ synthesis of glycogen from glucose&lt;/li&gt;&lt;li&gt;â€¢ opposite&lt;/li&gt;&lt;li&gt;â€¢ mobilize glucose from glycogen stores.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycogen is the storage form of glucose , which is an easily mobilizable fuel store . When individuals are deprived of or reduced intake of carbohydrate s, the body responds by breaking down glycogen stores in the liver in order to maintain normal blood glucose levels . The two main enzymes involved in the degradation and synthesis of glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d), respectively.&lt;/li&gt;&lt;li&gt;âž¤ Glycogen&lt;/li&gt;&lt;li&gt;âž¤ storage form&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ fuel store&lt;/li&gt;&lt;li&gt;âž¤ deprived of or reduced&lt;/li&gt;&lt;li&gt;âž¤ carbohydrate&lt;/li&gt;&lt;li&gt;âž¤ breaking down glycogen stores&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ normal blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ two main enzymes&lt;/li&gt;&lt;li&gt;âž¤ degradation and synthesis&lt;/li&gt;&lt;li&gt;âž¤ glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d),&lt;/li&gt;&lt;li&gt;âž¤ The processes of glycogen synthesis and degradation are coordinated by a hormone-triggered cascade that ensures that when one enzyme is active, the other enzyme is inactive.&lt;/li&gt;&lt;li&gt;âž¤ glycogen synthesis and degradation&lt;/li&gt;&lt;li&gt;âž¤ hormone-triggered cascade&lt;/li&gt;&lt;li&gt;âž¤ enzyme is active,&lt;/li&gt;&lt;li&gt;âž¤ other enzyme is inactive.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 177-180.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 177-180.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a marathon, a runner heavily relies on stored energy sources and oxygen. Considering the metabolic changes that occur over the course of a marathon, which option best describes the changes in glycogen and fatty acid utilization, as well as oxygen consumption, comparing the first mile to the 26th mile?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycogen used â†‘ Fatty acid used â†‘ Oxygen consumed â†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycogen used â†‘ Fatty acid used â†“ Oxygen consumed â†“&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogen used â†‘ Fatty acid used â†“ Oxygen consumed â†‘&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen used â†“ Fatty acid used â†‘ Oxygen consumed â†‘&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glycogen used â†“ Fatty acid used â†‘ Oxygen consumed â†‘&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Decreased glycogen used, increased fatty acids and oxygen consumed&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ At the beginning of the race, a runner consumes energy at a ratio of 75 percent carbohydrate : 25 percent fatty acids approximately. By the end of the race , glycogen stores are mostly depleted and the generation of ATPs from Beta-oxidation of fatty acids occurs â†’ produces reducing equivalents for oxidative phosphorylation. This requires an increase in the amount of oxygen consumed.&lt;/li&gt;&lt;li&gt;âž¤ At the beginning of the race, a runner consumes energy at a ratio of 75 percent carbohydrate : 25 percent fatty acids approximately.&lt;/li&gt;&lt;li&gt;âž¤ beginning&lt;/li&gt;&lt;li&gt;âž¤ race,&lt;/li&gt;&lt;li&gt;âž¤ runner&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ 75 percent carbohydrate&lt;/li&gt;&lt;li&gt;âž¤ 25 percent fatty acids&lt;/li&gt;&lt;li&gt;âž¤ By the end of the race , glycogen stores are mostly depleted and the generation of ATPs from Beta-oxidation of fatty acids occurs â†’ produces reducing equivalents for oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ end of the race&lt;/li&gt;&lt;li&gt;âž¤ depleted&lt;/li&gt;&lt;li&gt;âž¤ ATPs from Beta-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ reducing equivalents&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ This requires an increase in the amount of oxygen consumed.&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ oxygen consumed.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 663.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 663.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 1-year-old child is brought to the outpatient department by their parents due to concerns of muscle hypotonia, failure to thrive, and an enlarged abdomen. Laboratory tests reveal hypoglycemia and ultrasonography shows hepatomegaly. Following a comprehensive evaluation, the child is diagnosed with a type of glycogen storage disease (GSD). In the context of GSD, the glycogen content in the liver is not influenced by which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum glucose levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucagon Level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dietary Riboflavin levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dietary Riboflavin levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Dietary riboflavin (vitamin B2) levels do not directly influence glycogen content in the liver in the context of glycogen storage diseases (GSDs).&lt;/li&gt;&lt;li&gt;â€¢ Riboflavin serves as a precursor for flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which function as cofactors for various oxidation-reduction enzymes. While riboflavin is essential for many metabolic processes, it does not play a direct regulatory role in glycogen synthesis or breakdown in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Glycogen storage diseases are inherited metabolic disorders caused by enzyme deficiencies in glycogen synthesis, breakdown, or regulation pathways. The clinical presentation described in the question (muscle hypotonia, failure to thrive, enlarged abdomen, hypoglycemia, and hepatomegaly) is consistent with several types of GSD.&lt;/li&gt;&lt;li&gt;â€¢ The regulation of hepatic glycogen content primarily depends on hormonal and metabolic factors that directly control glycogen synthesis (glycogenesis) and breakdown (glycogenolysis).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum glucose levels - This is incorrect as a choice for factors that do NOT influence glycogen content.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum glucose levels&lt;/li&gt;&lt;li&gt;â€¢ Serum glucose levels directly affect hepatic glycogen metabolism. High blood glucose promotes glycogen synthesis through activation of glycogen synthase, while low blood glucose levels trigger glycogen breakdown to maintain normoglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin levels - This is incorrect as a choice for factors that do NOT influence glycogen content. Insulin is a key hormone that promotes glycogen synthesis in the liver by:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin levels&lt;/li&gt;&lt;li&gt;â€¢ Activating glycogen synthase (via dephosphorylation) Inhibiting glycogen phosphorylase Increasing glucose uptake and its phosphorylation to glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ Activating glycogen synthase (via dephosphorylation)&lt;/li&gt;&lt;li&gt;â€¢ Inhibiting glycogen phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ Increasing glucose uptake and its phosphorylation to glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucagon Level - This is incorrect as a choice for factors that do NOT influence glycogen content. Glucagon has effects opposite to insulin on hepatic glycogen. It promotes glycogenolysis (glycogen breakdown) by:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucagon Level&lt;/li&gt;&lt;li&gt;â€¢ Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade Inhibiting glycogen synthase&lt;/li&gt;&lt;li&gt;â€¢ Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade&lt;/li&gt;&lt;li&gt;â€¢ Inhibiting glycogen synthase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ In glycogen storage diseases, liver glycogen content is regulated primarily by glucose levels, insulin, Glucagon and factors affecting these parameters (like dietary amino acids).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of diabetes mellitus, previously uncontrolled on oral hypoglycaemic agents, has been on insulin therapy for the past year. In the context of insulin&#x27;s molecular structure and its therapeutic modifications, which of the following alterations will lead to Various short and long-acting analogs of the hormone ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Change in 29-30 in B chain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change in 5-6 in A chain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrolysis of disulfide bonds&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Change in 14-16 in A chain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Change in 29-30 in B chain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1oUJJbM.jpeg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Other Options Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Change at positions 5-6 in the A chain: This region is crucial for maintaining the hormone&#x27;s structural integrity, and alterations could disrupt its conformation and receptor binding.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Change at positions 5-6 in the A chain:&lt;/li&gt;&lt;li&gt;â€¢ hormone&#x27;s structural integrity,&lt;/li&gt;&lt;li&gt;â€¢ could disrupt its conformation&lt;/li&gt;&lt;li&gt;â€¢ receptor binding.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrolysis of disulfide bonds: The disulfide bonds are essential for maintaining insulin&#x27;s tertiary structure. Their hydrolysis would lead to a loss of structural integrity, significantly impacting biological activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hydrolysis of disulfide bonds:&lt;/li&gt;&lt;li&gt;â€¢ disulfide bonds&lt;/li&gt;&lt;li&gt;â€¢ insulin&#x27;s tertiary structure.&lt;/li&gt;&lt;li&gt;â€¢ hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ loss of structural integrity,&lt;/li&gt;&lt;li&gt;â€¢ impacting biological activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. change in 14-16 in A chain: Changing the sequence in the A chain can disrupt the structure and function of insulin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. change in 14-16 in A chain:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 512; Lippincott 7/e : P 308&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 512; Lippincott 7/e : P 308&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 9-month-old male infant is brought to the outpatient department presenting with mental retardation, delayed developmental milestones, and jaundice. Laboratory investigations reveal elevated unconjugated bilirubin and hypoglycemia (RBS â€“ 40 mg/dl). Additionally, the urine analysis indicates aminoaciduria. The infant has been exclusively breastfed and has experienced recurrent vomiting and diarrhea since birth. Based on these findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Galactosemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary Fructose Intolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Latent diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Crigler-Najjar Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Galactosemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Galactosemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hereditary Fructose Intolerance: Fructosemia - due to defect in Aldolase-B â†’ fructose-1-phosphate in the diet of infants cannot be metabolized â†’ its accumulation and inhibition of glycogen phosphorylase â†’ accumulation of glycogen in liver and hypoglycaemia. History of aversion to sweets and history of vomiting after drinking fruit juices . C/F- Vomiting, loss of appetite, hepatomegaly and jaundice . Fructose excreted in urine gives a positive Benedictâ€™s test.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hereditary Fructose Intolerance:&lt;/li&gt;&lt;li&gt;â€¢ Fructosemia&lt;/li&gt;&lt;li&gt;â€¢ defect&lt;/li&gt;&lt;li&gt;â€¢ Aldolase-B&lt;/li&gt;&lt;li&gt;â€¢ fructose-1-phosphate&lt;/li&gt;&lt;li&gt;â€¢ cannot&lt;/li&gt;&lt;li&gt;â€¢ accumulation&lt;/li&gt;&lt;li&gt;â€¢ inhibition of glycogen phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ glycogen in liver&lt;/li&gt;&lt;li&gt;â€¢ hypoglycaemia.&lt;/li&gt;&lt;li&gt;â€¢ aversion to sweets&lt;/li&gt;&lt;li&gt;â€¢ history of vomiting&lt;/li&gt;&lt;li&gt;â€¢ drinking fruit juices&lt;/li&gt;&lt;li&gt;â€¢ Vomiting, loss of appetite,&lt;/li&gt;&lt;li&gt;â€¢ hepatomegaly and jaundice&lt;/li&gt;&lt;li&gt;â€¢ Fructose&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ positive Benedictâ€™s test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Latent diabetes mellitus: They have a slow progression of autoimmune beta cell failure with C/F similar to DM.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Latent diabetes mellitus:&lt;/li&gt;&lt;li&gt;â€¢ slow&lt;/li&gt;&lt;li&gt;â€¢ autoimmune beta cell failure&lt;/li&gt;&lt;li&gt;â€¢ C/F&lt;/li&gt;&lt;li&gt;â€¢ DM.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Crigler-Najjar Syndrome: defective conjugation due to deficiency of UDP glucuronyl transferase â†’ Unconjugated bilirubin &amp;gt;&amp;gt;20 mg/dl â†’ kernicterus. History of persistent jaundice since birth .&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Crigler-Najjar Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ defective conjugation&lt;/li&gt;&lt;li&gt;â€¢ deficiency of UDP glucuronyl transferase&lt;/li&gt;&lt;li&gt;â€¢ Unconjugated&lt;/li&gt;&lt;li&gt;â€¢ bilirubin &amp;gt;&amp;gt;20 mg/dl&lt;/li&gt;&lt;li&gt;â€¢ kernicterus.&lt;/li&gt;&lt;li&gt;â€¢ persistent jaundice since birth&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Galactosemia is a genetic disorder characterized by the inability to metabolize galactose properly due to a deficiency in one of the enzymes involved in its metabolic pathway, most commonly galactose-1-phosphate uridyltransferase.&lt;/li&gt;&lt;li&gt;âž¤ Galactosemia&lt;/li&gt;&lt;li&gt;âž¤ genetic disorder&lt;/li&gt;&lt;li&gt;âž¤ inability to metabolize galactose&lt;/li&gt;&lt;li&gt;âž¤ due to a deficiency&lt;/li&gt;&lt;li&gt;âž¤ enzymes&lt;/li&gt;&lt;li&gt;âž¤ its metabolic pathway,&lt;/li&gt;&lt;li&gt;âž¤ galactose-1-phosphate uridyltransferase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 155, 204&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 155, 204&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presents to the emergency room reporting episodes of diarrhea triggered by the consumption of dairy products. This symptom is suggestive of lactose intolerance, a condition where the body lacks sufficient lactase enzyme to digest lactose, the primary sugar in milk and dairy products. Based on this information, which of the following dairy products might she be able to tolerate better compared to the others?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Yogurt&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skimmed milk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Condensed milk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ice cream&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Yogurt&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Yogurt&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Yogurt is often better tolerated by those with lactose intolerance due to probiotics aiding lactose digestion, whereas skimmed milk, condensed milk, and ice cream , with their higher lactose content , are more likely to cause intolerance symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Yogurt&lt;/li&gt;&lt;li&gt;âž¤ better tolerated&lt;/li&gt;&lt;li&gt;âž¤ lactose intolerance&lt;/li&gt;&lt;li&gt;âž¤ probiotics aiding lactose digestion,&lt;/li&gt;&lt;li&gt;âž¤ skimmed milk,&lt;/li&gt;&lt;li&gt;âž¤ condensed milk, and ice cream&lt;/li&gt;&lt;li&gt;âž¤ higher lactose content&lt;/li&gt;&lt;li&gt;âž¤ more&lt;/li&gt;&lt;li&gt;âž¤ intolerance symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Maurice Shils, Modern Nutrition in Health and Disease, 10th edition, page 1523&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Maurice Shils, Modern Nutrition in Health and Disease, 10th edition, page 1523&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient presents with symptoms suggestive of an endocrine disorder and, after a series of diagnostic evaluations, is diagnosed with insulinoma, a rare neuroendocrine tumor primarily affecting the pancreas. Considering the pathophysiology of insulinoma, which of the following is a characteristic feature of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased body weight&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased glucose in the blood&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased connecting peptide in the blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased insulin in the blood&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased glucose in the blood&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decreased glucose in the blood&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Decreased body weight: Insulin, an anabolic hormone causes gain in body weight.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Decreased body weight:&lt;/li&gt;&lt;li&gt;â€¢ Insulin,&lt;/li&gt;&lt;li&gt;â€¢ anabolic hormone&lt;/li&gt;&lt;li&gt;â€¢ gain&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased connecting peptide in the blood: Insulinomas results in increased production of insulin (C-peptide) .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Decreased connecting peptide in the blood:&lt;/li&gt;&lt;li&gt;â€¢ increased production of insulin (C-peptide)&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Decreased insulin in the blood: Increase in insulin levels due to constant production by the tumour cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Decreased insulin in the blood:&lt;/li&gt;&lt;li&gt;â€¢ Increase in insulin levels&lt;/li&gt;&lt;li&gt;â€¢ constant production&lt;/li&gt;&lt;li&gt;â€¢ tumour cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas are pancreatic neuroendocrine tumors that autonomously secrete insulin , leading to inappropriate insulin levels irrespective of blood glucose concentrations. This excessive insulin secretion results in recurrent episodes of hypoglycemia, which is a hallmark feature of insulinoma. Hypoglycemia can manifest as neuroglycopenic symptoms ( confusion, blurred vision, fainting ) and adrenergic symptoms (sweating, palpitations, hunger) .&lt;/li&gt;&lt;li&gt;âž¤ Insulinomas&lt;/li&gt;&lt;li&gt;âž¤ pancreatic neuroendocrine tumors&lt;/li&gt;&lt;li&gt;âž¤ autonomously&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;li&gt;âž¤ inappropriate insulin levels&lt;/li&gt;&lt;li&gt;âž¤ blood glucose concentrations.&lt;/li&gt;&lt;li&gt;âž¤ excessive insulin secretion&lt;/li&gt;&lt;li&gt;âž¤ recurrent episodes of hypoglycemia,&lt;/li&gt;&lt;li&gt;âž¤ hallmark feature&lt;/li&gt;&lt;li&gt;âž¤ Hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ neuroglycopenic symptoms&lt;/li&gt;&lt;li&gt;âž¤ confusion, blurred vision, fainting&lt;/li&gt;&lt;li&gt;âž¤ adrenergic symptoms (sweating, palpitations, hunger)&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 331, Lippincott 6/ed: p 319-320&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 331, Lippincott 6/ed: p 319-320&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about glucagon is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proglucagon is synthesized in Î± cells of islets of Langerhans&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a straight polypeptide chain with 29 amino acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stimulates glycogen synthesis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It activates the enzyme glycogen phosphorylase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stimulates glycogen synthesis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Stimulates glycogen synthesis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucagon , a hormone produced by the Î± cells of the islets of Langerhans in the pancreas, plays a crucial role in glucose metabolism. Its primary function is to raise blood glucose levels by promoting glycogenolysis (the breakdown of glycogen to glucose) and gluconeogenesis (the synthesis of glucose from non-carbohydrate sources). Therefore, the statement that glucagon stimulates glycogen synthesis is incorrect , as it actually promotes glycogen breakdown.&lt;/li&gt;&lt;li&gt;âž¤ Glucagon&lt;/li&gt;&lt;li&gt;âž¤ Î± cells&lt;/li&gt;&lt;li&gt;âž¤ islets of Langerhans&lt;/li&gt;&lt;li&gt;âž¤ pancreas,&lt;/li&gt;&lt;li&gt;âž¤ glucose metabolism.&lt;/li&gt;&lt;li&gt;âž¤ raise blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ promoting glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ glucagon stimulates glycogen synthesis&lt;/li&gt;&lt;li&gt;âž¤ incorrect&lt;/li&gt;&lt;li&gt;âž¤ promotes glycogen breakdown.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 322&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 322&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old girl presents to the emergency department with severe polyuria and polydipsia. Laboratory tests reveal the presence of ketones in her urine. Considering the metabolic conditions, which is the most likely source of these ketones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Free fatty acid breakdown&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogenolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triglyceride breakdown&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Free fatty acid breakdown&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Free fatty acid breakdown&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ketone bodies are produced primarily in the live r through the process of ketogenesis, which occurs when there is an increased breakdown of free fatty acids . This situation typically arises in states of decreased carbohydrate availability or impaired glucose utilization, leading the body to switch to fat as an alternative energy source . In this patient&#x27;s case, the presence of ketones in the urine suggests that her body is utilizing fatty acids for energy, which results in the production of ketones as a byproduct of fatty acid metabolism in the liver.&lt;/li&gt;&lt;li&gt;âž¤ Ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ live&lt;/li&gt;&lt;li&gt;âž¤ ketogenesis,&lt;/li&gt;&lt;li&gt;âž¤ increased breakdown of free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ decreased carbohydrate&lt;/li&gt;&lt;li&gt;âž¤ impaired glucose utilization,&lt;/li&gt;&lt;li&gt;âž¤ body to switch to fat&lt;/li&gt;&lt;li&gt;âž¤ alternative energy source&lt;/li&gt;&lt;li&gt;âž¤ presence&lt;/li&gt;&lt;li&gt;âž¤ ketones in the urine&lt;/li&gt;&lt;li&gt;âž¤ body is utilizing fatty acids for energy,&lt;/li&gt;&lt;li&gt;âž¤ ketones&lt;/li&gt;&lt;li&gt;âž¤ byproduct of fatty acid metabolism in the liver.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 231-233&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 231-233&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement regarding the involvement of the Uronic acid pathway.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conjugation of bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GAG Synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin C Synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biotransformation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vitamin C Synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vitamin C Synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Conjugation of bilirubin: Glucuronic acid , derived from the Uronic acid pathway , is crucial for the conjugation of bilirubin in the liver, making it water-soluble for excretion in bile.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Conjugation of bilirubin:&lt;/li&gt;&lt;li&gt;â€¢ Glucuronic acid&lt;/li&gt;&lt;li&gt;â€¢ Uronic acid pathway&lt;/li&gt;&lt;li&gt;â€¢ conjugation of bilirubin&lt;/li&gt;&lt;li&gt;â€¢ water-soluble for excretion&lt;/li&gt;&lt;li&gt;â€¢ Option B. GAG (Glycosaminoglycan) Synthesis: The Uronic acid pathway provides essential components for the synthesis of glycosaminoglycans , which are important constituents of connective tissues and extracellular matrices .&lt;/li&gt;&lt;li&gt;â€¢ Option B. GAG (Glycosaminoglycan) Synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Uronic acid pathway&lt;/li&gt;&lt;li&gt;â€¢ essential components&lt;/li&gt;&lt;li&gt;â€¢ synthesis of glycosaminoglycans&lt;/li&gt;&lt;li&gt;â€¢ connective tissues and extracellular matrices&lt;/li&gt;&lt;li&gt;â€¢ Option D. Biotransformation: Glucuronic acid plays a significant role in the biotransformation of various substances by facilitating their excretion , enhancing the solubility of drugs, hormones, and toxins.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Biotransformation:&lt;/li&gt;&lt;li&gt;â€¢ Glucuronic acid&lt;/li&gt;&lt;li&gt;â€¢ biotransformation&lt;/li&gt;&lt;li&gt;â€¢ facilitating their excretion&lt;/li&gt;&lt;li&gt;â€¢ enhancing&lt;/li&gt;&lt;li&gt;â€¢ solubility of drugs, hormones, and toxins.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Uronic acid pathway is involved in the conversion of glucose to glucuronic acid, which is a critical component in the conjugation of bilirubin , the synthesis of glycosaminoglycans (GAGs), and various biotransformation processes. However, it is not directly involved in the synthesis of Vitamin C (ascorbic acid). In humans, the synthesis of Vitamin C is not possible due to the lack of the enzyme L-gulonolactone oxidase , required for the last step of Vitamin C biosynthesis.&lt;/li&gt;&lt;li&gt;âž¤ Uronic acid pathway&lt;/li&gt;&lt;li&gt;âž¤ conversion of glucose to glucuronic acid,&lt;/li&gt;&lt;li&gt;âž¤ component&lt;/li&gt;&lt;li&gt;âž¤ conjugation&lt;/li&gt;&lt;li&gt;âž¤ bilirubin&lt;/li&gt;&lt;li&gt;âž¤ synthesis of glycosaminoglycans (GAGs),&lt;/li&gt;&lt;li&gt;âž¤ biotransformation&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ synthesis of Vitamin C (ascorbic acid).&lt;/li&gt;&lt;li&gt;âž¤ synthesis of Vitamin C&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ lack of the enzyme L-gulonolactone oxidase&lt;/li&gt;&lt;li&gt;âž¤ required&lt;/li&gt;&lt;li&gt;âž¤ Vitamin C biosynthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p202, 203&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p202, 203&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old obese male presents with fatigue, increased appetite, thirst, and polyuria, with a negative Rothera&#x27;s test. He is diagnosed with type 2 diabetes. Regarding the characteristics of type 2 diabetes, which of the following statements is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Has sudden onset of symptoms which is relieved after taking insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plasma glucagon level is lower than normal individuals during early disease process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasma insulin level is lower than normal individuals during the early disease process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;If body weight is reduced, then improvement in glucose tolerance is observed.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. If body weight is reduced, then improvement in glucose tolerance is observed.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) If body weight is reduced, then improvement in glucose tolerance is observed.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Has sudden onset of symptoms which is relieved after taking insulin: Gradual onset of Symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Has sudden onset of symptoms which is relieved after taking insulin:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Plasma glucagon level is lower than normal individuals during early disease process: Glucagon levels are normal.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Plasma glucagon level is lower than normal individuals during early disease process:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasma insulin level is lower than normal individuals during the early disease process: elevated insulin levels are observed in patients and requires insulin late in the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Plasma insulin level is lower than normal individuals during the early disease process:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Weight reduction through lifestyle changes can significantly improve metabolic control in individuals with type 2 diabetes by enhancing insulin sensitivity and reducing insulin resistance, underscoring the importance of non-pharmacological interventions in the management of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Weight reduction&lt;/li&gt;&lt;li&gt;âž¤ lifestyle changes&lt;/li&gt;&lt;li&gt;âž¤ improve metabolic&lt;/li&gt;&lt;li&gt;âž¤ type 2 diabetes&lt;/li&gt;&lt;li&gt;âž¤ enhancing insulin sensitivity&lt;/li&gt;&lt;li&gt;âž¤ reducing insulin resistance,&lt;/li&gt;&lt;li&gt;âž¤ non-pharmacological interventions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 185, 192-194.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 185, 192-194.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a fasting state, which substrate is primarily used by Red Blood Cells (RBCs) for energy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amino Acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ketone body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fatty acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1_BuSFrTM.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glucose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amino Acids: RBCs do not utilize amino acids for energy production. Amino acids are primarily used by muscles and other tissues for protein synthesis or as an energy source through gluconeogenesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amino Acids:&lt;/li&gt;&lt;li&gt;â€¢ RBCs do not&lt;/li&gt;&lt;li&gt;â€¢ amino acids&lt;/li&gt;&lt;li&gt;â€¢ energy production. Amino acids&lt;/li&gt;&lt;li&gt;â€¢ used by muscles&lt;/li&gt;&lt;li&gt;â€¢ tissues for protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ energy source&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ketone Body: Ketone bodies are used as an alternative energy source by many tissues, including the brain, during prolonged fasting or starvation . However, RBCs do not use ketone bodies for energy due to their lack of mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ketone Body:&lt;/li&gt;&lt;li&gt;â€¢ used as&lt;/li&gt;&lt;li&gt;â€¢ alternative energy source&lt;/li&gt;&lt;li&gt;â€¢ brain,&lt;/li&gt;&lt;li&gt;â€¢ prolonged fasting or starvation&lt;/li&gt;&lt;li&gt;â€¢ RBCs do not&lt;/li&gt;&lt;li&gt;â€¢ ketone bodies&lt;/li&gt;&lt;li&gt;â€¢ lack of mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fatty Acid: RBCs are also unable to oxidize fatty acids for energy. Fatty acid oxidation occurs in the mitochondria, which RBCs lack.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fatty Acid:&lt;/li&gt;&lt;li&gt;â€¢ RBCs&lt;/li&gt;&lt;li&gt;â€¢ unable to oxidize fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ mitochondria,&lt;/li&gt;&lt;li&gt;â€¢ RBCs lack.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p150.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p150.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a long history of diabetes presents with visual disturbances, including difficulty seeing and floaters. Given his elevated blood glucose levels, which enzyme is most likely responsible for his eye manifestations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sorbitol dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aldose reductase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aldose reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Aldose reductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hexokinase: Hexokinase catalyzes the phosphorylation of glucose to glucose-6-phosphate in most tissues and is not directly associated with the specific complications seen in the eyes due to diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hexokinase:&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation of glucose to glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ specific complications&lt;/li&gt;&lt;li&gt;â€¢ eyes due to diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucokinase: Glucokinase acts as a glucose sensor in the pancreas and liver , catalyzing the phosphorylation of glucose to glucose-6-phosphate . It is not directly linked to the pathogenesis of diabetic eye complications.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucokinase:&lt;/li&gt;&lt;li&gt;â€¢ Glucokinase&lt;/li&gt;&lt;li&gt;â€¢ glucose sensor&lt;/li&gt;&lt;li&gt;â€¢ pancreas and liver&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation of glucose&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ diabetic eye complications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sorbitol dehydrogenase: While sorbitol dehydrogenase is involved in the conversion of sorbitol to fructose in the polyol pathway, it is the accumulation of sorbitol due to the action of aldose reductase that is primarily responsible for the osmotic damage seen in diabetic complications of the eye.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sorbitol dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ sorbitol dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ conversion of sorbitol to fructose&lt;/li&gt;&lt;li&gt;â€¢ polyol&lt;/li&gt;&lt;li&gt;â€¢ sorbitol&lt;/li&gt;&lt;li&gt;â€¢ aldose reductase&lt;/li&gt;&lt;li&gt;â€¢ osmotic damage&lt;/li&gt;&lt;li&gt;â€¢ diabetic complications of the eye.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose can enter the lens of the eye and get converted to Sorbitol with the help of aldose reductase. This enzyme is a major contributor to diabetic complication due to accumulation of sorbitol which is hygroscopic sugar and causes swelling of the eye in untreated diabetic patients&lt;/li&gt;&lt;li&gt;âž¤ Glucose&lt;/li&gt;&lt;li&gt;âž¤ lens of the eye&lt;/li&gt;&lt;li&gt;âž¤ converted to Sorbitol&lt;/li&gt;&lt;li&gt;âž¤ aldose reductase.&lt;/li&gt;&lt;li&gt;âž¤ diabetic complication&lt;/li&gt;&lt;li&gt;âž¤ accumulation of sorbitol&lt;/li&gt;&lt;li&gt;âž¤ hygroscopic sugar&lt;/li&gt;&lt;li&gt;âž¤ swelling of the eye&lt;/li&gt;&lt;li&gt;âž¤ untreated diabetic patients&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 205; Vasudevan 9/e: 135.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 205; Vasudevan 9/e: 135.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding the specialized mammalian tissue/organ where fuel oxidation is primarily used to generate heat rather than produce ATP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is concerned with energy storage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-shivering thermogenesis is a hormonal stimulus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is primarily important in adults&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It liberates heat by coupling oxidation from phosphorylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Non-shivering thermogenesis is a hormonal stimulus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Non-shivering thermogenesis is a hormonal stimulus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is concerned with energy storage: This statement is more applicable to white adipose tissue , which is the body&#x27;s main form of energy storage. Brown adipose tissue , on the other hand, is specialized for energy expenditure in the form of heat .&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is concerned with energy storage:&lt;/li&gt;&lt;li&gt;â€¢ more applicable&lt;/li&gt;&lt;li&gt;â€¢ white adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ body&#x27;s main form of energy storage. Brown adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ energy expenditure&lt;/li&gt;&lt;li&gt;â€¢ heat&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is primarily important in adults: Brown adipose tissue is most prominent and active in infants , where it plays a critical role in thermogenesis to maintain body temperature . Its prevalence and activity typically decrease with age .&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is primarily important in adults:&lt;/li&gt;&lt;li&gt;â€¢ Brown adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ prominent and active in infants&lt;/li&gt;&lt;li&gt;â€¢ thermogenesis&lt;/li&gt;&lt;li&gt;â€¢ body temperature&lt;/li&gt;&lt;li&gt;â€¢ prevalence and activity&lt;/li&gt;&lt;li&gt;â€¢ decrease with age&lt;/li&gt;&lt;li&gt;â€¢ Option D. It liberates heat by coupling oxidation from phosphorylation: The correct mechanism in brown adipose tissue involves the uncoupling of oxidation from phosphorylation , not coupling , which allows the energy from fuel oxidation to be released as heat instead of being used to produce ATP.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It liberates heat by coupling oxidation from phosphorylation:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ brown adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ uncoupling of oxidation&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ not coupling&lt;/li&gt;&lt;li&gt;â€¢ energy from fuel oxidation&lt;/li&gt;&lt;li&gt;â€¢ released as heat&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brown adipose tissue (BAT) is primarily involved in non-shivering thermogenesis, a process of heat production in mammals . This process is stimulated hormonally, particularly by norepinephrine , which is released in response to cold exposure. BAT contains a high number of mitochondria with uncoupling protein 1 (UCP1), which allows the uncoupling of oxidative phosphorylation; instead of producing ATP , the energy is released as heat .&lt;/li&gt;&lt;li&gt;âž¤ Brown adipose tissue (BAT)&lt;/li&gt;&lt;li&gt;âž¤ non-shivering thermogenesis,&lt;/li&gt;&lt;li&gt;âž¤ heat production in mammals&lt;/li&gt;&lt;li&gt;âž¤ stimulated hormonally,&lt;/li&gt;&lt;li&gt;âž¤ norepinephrine&lt;/li&gt;&lt;li&gt;âž¤ cold exposure. BAT&lt;/li&gt;&lt;li&gt;âž¤ high number of mitochondria&lt;/li&gt;&lt;li&gt;âž¤ uncoupling protein 1&lt;/li&gt;&lt;li&gt;âž¤ uncoupling of oxidative phosphorylation; instead&lt;/li&gt;&lt;li&gt;âž¤ producing ATP&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ heat&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 132,264, Vasudevan 9/e: p 162,266.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 132,264, Vasudevan 9/e: p 162,266.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following transamination reactions yields an intermediate that directly supports both oxidative phosphorylation and gluconeogenesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asparagine to aspartate to oxaloacetate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystine to cysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysine to glutaryl-CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serine to glycine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Asparagine to aspartate to oxaloacetate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Asparagine to aspartate to oxaloacetate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystine to cysteine: The conversion of cystine to cysteine does not produce an intermediate that is directly involved in both oxidative phosphorylation and gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cystine to cysteine:&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation and gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine to glutaryl-CoA: The metabolism of lysine through its conversion to glutaryl-CoA leads to acetoacetate and acetyl-CoA, which are more involved in ketogenesis and energy production in specific tissues , not directly in gluconeogenesis and oxidative phosphorylation in the context described.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine to glutaryl-CoA:&lt;/li&gt;&lt;li&gt;â€¢ lysine&lt;/li&gt;&lt;li&gt;â€¢ conversion to glutaryl-CoA&lt;/li&gt;&lt;li&gt;â€¢ acetoacetate&lt;/li&gt;&lt;li&gt;â€¢ acetyl-CoA,&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ ketogenesis and energy production&lt;/li&gt;&lt;li&gt;â€¢ specific tissues&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis and oxidative&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serine to glycine: While the conversion of serine to glycine is part of amino acid metabolism and can feed into various pathways, it does not directly yield an intermediate that is as pivotal for both oxidative phosphorylation and gluconeogenesis as oxaloacetate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serine to glycine:&lt;/li&gt;&lt;li&gt;â€¢ conversion of serine to glycine&lt;/li&gt;&lt;li&gt;â€¢ amino acid metabolism&lt;/li&gt;&lt;li&gt;â€¢ feed&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ intermediate&lt;/li&gt;&lt;li&gt;â€¢ pivotal&lt;/li&gt;&lt;li&gt;â€¢ both oxidative phosphorylation and gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ oxaloacetate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oxaloacetate is a critical intermediate in both gluconeogenesis, where it serves as a starting point for the synthesis of glucose , and in the citric acid cycle (TCA cycle) for oxidative phosphorylation . The presence of oxaloacetate in the mitochondria is essential for the TCA cycle to proceed, as it combines with acetyl-CoA to form citrate , thus facilitating ATP production through oxidative phosphorylation .&lt;/li&gt;&lt;li&gt;âž¤ Oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ both gluconeogenesis,&lt;/li&gt;&lt;li&gt;âž¤ synthesis of glucose&lt;/li&gt;&lt;li&gt;âž¤ citric acid cycle (TCA cycle)&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ oxaloacetate in the mitochondria&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA to form citrate&lt;/li&gt;&lt;li&gt;âž¤ ATP production&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 9/e: 226.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Vasudevan 9/e: 226.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman was brought to the hospital in a disoriented, confused state by her husband. She is a known case of type 1 diabetes for the last 25 years. O/E â€“she had signs of dehydration, Low BP and acidosis with faintly fruity odour. The diagnosis is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetic ketoacidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uncontrolled diabetes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetes insipidus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diabetic ketoacidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture3_QNkydRl.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Diabetic ketoacidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uncontrolled diabetes : While the patient does have diabetes, the specific presentation with acidosis, ketonemia, and the clinical context suggest DKA rather than just uncontrolled diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uncontrolled diabetes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactic acidosis : Lactic acidosis presents with acidosis but is typically associated with severe hypoperfusion or hypoxia, and the ketone levels would not be elevated as they are in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetes insipidus : Diabetes insipidus is characterized by polyuria and polydipsia due to a deficiency of antidiuretic hormone (ADH) or kidney&#x27;s response to ADH, but it does not cause hyperglycemia, acidosis, or ketonemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetes insipidus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diabetic ketoacidosis is an acute, potentially life-threatening complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis. Clinical presentation typically includes dehydration, Kussmaul breathing, fruity breath odor (acetone), altered mental status, and hypotension.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 231.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old obese girl presents with dehydration after 3 days of vomiting and diarrhoea. Her parents gave history that a sibling was diagnosed with a type of diabetes that spilled sugar into the urine but did not need treatment. This condition is most likely due to accumulation of which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Galactose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Xylulose&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Xylulose&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4_v6N5rNm.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Xylulose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Galactose: Accumulation of galactose in the urine is usually associated with galactosemia, a serious condition that typically presents in infancy with symptoms like jaundice, vomiting, and hepatomegaly shortly after the introduction of lactose into the diet.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Galactose:&lt;/li&gt;&lt;li&gt;â€¢ galactose in the urine&lt;/li&gt;&lt;li&gt;â€¢ galactosemia,&lt;/li&gt;&lt;li&gt;â€¢ infancy&lt;/li&gt;&lt;li&gt;â€¢ jaundice, vomiting, and hepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ lactose&lt;/li&gt;&lt;li&gt;â€¢ diet.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose: A negative urine glucose oxidase test rules out glucose as the accumulated substance. Conditions causing glucose accumulation, like diabetes mellitus, would also present with elevated blood glucose levels , which is not the case here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucose:&lt;/li&gt;&lt;li&gt;â€¢ negative urine glucose oxidase test&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ glucose accumulation,&lt;/li&gt;&lt;li&gt;â€¢ diabetes mellitus,&lt;/li&gt;&lt;li&gt;â€¢ elevated blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactose: Lactose in the urine is uncommon and would indicate a more severe disorder of galactose metabolism than essential pentosuria . It would also likely present with more severe systemic symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lactose:&lt;/li&gt;&lt;li&gt;â€¢ Lactose&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ uncommon&lt;/li&gt;&lt;li&gt;â€¢ more severe disorder of galactose metabolism&lt;/li&gt;&lt;li&gt;â€¢ pentosuria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Essential Pentosuria is a benign condition characterized by the excretion of the pentose sugar xylulose in the urine . This diagnosis is supported by the presence of reducing sugars in the urine with normal blood glucose levels and negative glucose-specific urine tests.&lt;/li&gt;&lt;li&gt;âž¤ Pentosuria is a benign&lt;/li&gt;&lt;li&gt;âž¤ excretion of the pentose sugar xylulose&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ presence of reducing sugars in the urine&lt;/li&gt;&lt;li&gt;âž¤ normal blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ negative glucose-specific urine&lt;/li&gt;&lt;li&gt;âž¤ tests.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 200-201&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 200-201&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Hereditary Fructose Intolerance (HFI) presents with symptoms indicative of the condition. Consider the following statements: Assertion (A): Hereditary fructose intolerance (HFI) results in accumulation of fructose-6-phosphate, which is the reason behind organomegaly seen in this condition. Reasoning (R): Above condition is due to aldolase B deficiency. Choose the correct option regarding the assertion and reasoning.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A is wrong but R is a right statement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A is wrong, but R is a right statement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  A is right but R is a wrong statement: This option is incorrect because the assertion incorrectly identifies the metabolite that accumulates in HFI.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  A is right but R is a wrong statement:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ assertion incorrectly identifies&lt;/li&gt;&lt;li&gt;â€¢ Option B. A as well as R are right and R is a correct explanation of A: This option is incorrect because the assertion incorrectly states the metabolite involved in HFI.&lt;/li&gt;&lt;li&gt;â€¢ Option B. A as well as R are right and R is a correct explanation of A:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ assertion incorrectly&lt;/li&gt;&lt;li&gt;â€¢ metabolite&lt;/li&gt;&lt;li&gt;â€¢ HFI.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  A and R both are wrong: This option is incorrect because the reasoning statement about aldolase B deficiency is correct.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  A and R both are wrong:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ reasoning statement&lt;/li&gt;&lt;li&gt;â€¢ aldolase B deficiency&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During metabolism of fructose , fructose â†’ fructose-1-phosphate (enzyme fructokinase) â†’ glyceraldehyde and dihydroxyacetone phosphate (aldolase B enzyme). Deficiency of this aldolase B â†’ accumulation of fructose-1-phosphate in various organs leading to organomegaly.&lt;/li&gt;&lt;li&gt;âž¤ During metabolism of fructose , fructose â†’ fructose-1-phosphate (enzyme fructokinase) â†’ glyceraldehyde and dihydroxyacetone phosphate (aldolase B enzyme).&lt;/li&gt;&lt;li&gt;âž¤ metabolism&lt;/li&gt;&lt;li&gt;âž¤ fructose&lt;/li&gt;&lt;li&gt;âž¤ fructose-1-phosphate&lt;/li&gt;&lt;li&gt;âž¤ glyceraldehyde&lt;/li&gt;&lt;li&gt;âž¤ dihydroxyacetone phosphate&lt;/li&gt;&lt;li&gt;âž¤ Deficiency of this aldolase B â†’ accumulation of fructose-1-phosphate in various organs leading to organomegaly.&lt;/li&gt;&lt;li&gt;âž¤ Deficiency&lt;/li&gt;&lt;li&gt;âž¤ aldolase B&lt;/li&gt;&lt;li&gt;âž¤ accumulation of fructose-1-phosphate&lt;/li&gt;&lt;li&gt;âž¤ organs&lt;/li&gt;&lt;li&gt;âž¤ organomegaly.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 202,205.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 202,205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young woman presents with abdominal bloating and diarrhea after eating ice cream, alongside physical signs of dehydration but normal body temperature. She has a history of similar symptoms following the consumption of substantial amounts of dairy products. What enzyme deficiency is most likely responsible for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isomaltase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î±-amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sucrase.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lactase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lactase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Isomaltose: Deficiency in isomaltase , part of the enzyme complex that also includes sucrase , leads to isomaltose intolerance. While it can cause similar symptoms of malabsorption, the specific reaction to dairy products is more indicative of lactose intolerance.&lt;/li&gt;&lt;li&gt;â€¢ Option A.  Isomaltose:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency in isomaltase&lt;/li&gt;&lt;li&gt;â€¢ enzyme complex&lt;/li&gt;&lt;li&gt;â€¢ sucrase&lt;/li&gt;&lt;li&gt;â€¢ isomaltose&lt;/li&gt;&lt;li&gt;â€¢ intolerance.&lt;/li&gt;&lt;li&gt;â€¢ malabsorption,&lt;/li&gt;&lt;li&gt;â€¢ dairy products&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ lactose intolerance.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Î±-amylase: Î±-Amylase deficiency is exceedingly rare and would lead to a broader range of symptoms associated with the malabsorption of starches , not specifically dairy products.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Î±-amylase:&lt;/li&gt;&lt;li&gt;â€¢ Î±-Amylase deficiency&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ broader range of symptoms&lt;/li&gt;&lt;li&gt;â€¢ malabsorption of starches&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ dairy products.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sucrase: Sucrase deficiency results in sucrase-isomaltase deficiency , which would lead to symptoms following the ingestion of sucrose and isomaltose-rich foods, not specifically lactose-containing foods like dairy products.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sucrase:&lt;/li&gt;&lt;li&gt;â€¢ Sucrase deficiency&lt;/li&gt;&lt;li&gt;â€¢ sucrase-isomaltase deficiency&lt;/li&gt;&lt;li&gt;â€¢ ingestion of sucrose and isomaltose-rich foods,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lactose-containing foods like dairy products.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lactose intolerance is a condition resulting from lactase deficiency , characterized by gastrointestinal symptoms such as bloating, diarrhea, and dehydration following the ingestion of lactose-containing foods like dairy products. Identifying the specific trigger (lactose) and connecting it to the deficient enzyme (lactase) is key in diagnosing and managing this condition effectively.&lt;/li&gt;&lt;li&gt;âž¤ Lactose intolerance&lt;/li&gt;&lt;li&gt;âž¤ lactase deficiency&lt;/li&gt;&lt;li&gt;âž¤ gastrointestinal symptoms&lt;/li&gt;&lt;li&gt;âž¤ bloating,&lt;/li&gt;&lt;li&gt;âž¤ diarrhea, and dehydration&lt;/li&gt;&lt;li&gt;âž¤ ingestion of lactose-containing&lt;/li&gt;&lt;li&gt;âž¤ foods like dairy products.&lt;/li&gt;&lt;li&gt;âž¤ specific trigger&lt;/li&gt;&lt;li&gt;âž¤ deficient enzyme (lactase)&lt;/li&gt;&lt;li&gt;âž¤ diagnosing and managing&lt;/li&gt;&lt;li&gt;âž¤ effectively.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 537-538.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 537-538.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle aged known alcoholic was found lying semiconscious at his residence and was taken to ER. Laboratory studies showed a large anion gap, elevated blood alcohol levels - 245 mg/dL and low blood glucose - 38 mg/dL. The patientâ€™s large anion gap and hypoglycemia can be explained by which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased secretion of glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased secretion of insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of dehydrogenase enzymes by NADH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhibition of glycogenolysis by ethanol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inhibition of dehydrogenase enzymes by NADH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â  Inhibition of dehydrogenase enzymes by NADH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased secretion of glucagon: While glucagon secretion may be affected in chronic alcoholics due to pancreatic damage , it is not the primary cause of the large anion gap or hypoglycemia in acute ethanol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreased secretion of glucagon:&lt;/li&gt;&lt;li&gt;â€¢ chronic alcoholics&lt;/li&gt;&lt;li&gt;â€¢ pancreatic&lt;/li&gt;&lt;li&gt;â€¢ damage&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ large anion gap or hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ acute ethanol intoxication.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Increased secretion of insulin: Acute ethanol ingestion typically does not cause an increase in insulin secretion. In fact, hypoglycemia in this context is more related to the inhibition of gluconeogenesis and glycogenolysis rather than insulin-mediated glucose uptake.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Increased secretion of insulin:&lt;/li&gt;&lt;li&gt;â€¢ Acute ethanol ingestion&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ increase in insulin secretion.&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ inhibition of gluconeogenesis and glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of glycogenolysis by ethanol: While ethanol can impair glycogenolysis, the more significant impact on the anion gap and hypoglycaemia is through the inhibition of dehydrogenase enzymes by the increased NADH/NAD+ ratio, affecting gluconeogenesis and leading to the accumulation of organic acids.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inhibition of glycogenolysis by ethanol:&lt;/li&gt;&lt;li&gt;â€¢ ethanol&lt;/li&gt;&lt;li&gt;â€¢ impair glycogenolysis,&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ anion gap and hypoglycaemia&lt;/li&gt;&lt;li&gt;â€¢ inhibition of dehydrogenase enzymes&lt;/li&gt;&lt;li&gt;â€¢ increased NADH/NAD+ ratio,&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ accumulation of organic acids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics do not frequently eat while binge drinking â†’ so most likely his liver glycogen stores become depleted and cannot increase his blood glucose levels. The metabolic stress in them leads to the increase in secretion of epinephrine and other hormones â†’ mobilize fatty acids from stored triglycerides in adipose cells â†’ undergo beta-oxidation â†’ get converted to ketone bodies because of the inhibition of the TCA cycle by high levels of NADH (produced by the oxidation of ethanol first to acetaldehyde and acetate). Key gluconeogenic dehydrogenases are also inhibited by the elevated levels of NADH, including lactate dehydrogenase, glycerol 3-phosphate dehydrogenase, and malate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics do not frequently eat while binge drinking â†’ so most likely his liver glycogen stores become depleted and cannot increase his blood glucose levels.&lt;/li&gt;&lt;li&gt;âž¤ Alcoholics do not&lt;/li&gt;&lt;li&gt;âž¤ binge drinking â†’&lt;/li&gt;&lt;li&gt;âž¤ liver glycogen stores&lt;/li&gt;&lt;li&gt;âž¤ depleted and&lt;/li&gt;&lt;li&gt;âž¤ cannot increase&lt;/li&gt;&lt;li&gt;âž¤ blood glucose levels.&lt;/li&gt;&lt;li&gt;âž¤ The metabolic stress in them leads to the increase in secretion of epinephrine and other hormones â†’ mobilize fatty acids from stored triglycerides in adipose cells â†’ undergo beta-oxidation â†’ get converted to ketone bodies because of the inhibition of the TCA cycle by high levels of NADH (produced by the oxidation of ethanol first to acetaldehyde and acetate).&lt;/li&gt;&lt;li&gt;âž¤ metabolic stress&lt;/li&gt;&lt;li&gt;âž¤ increase in secretion of epinephrine&lt;/li&gt;&lt;li&gt;âž¤ hormones&lt;/li&gt;&lt;li&gt;âž¤ mobilize fatty&lt;/li&gt;&lt;li&gt;âž¤ acids&lt;/li&gt;&lt;li&gt;âž¤ stored triglycerides in adipose cells&lt;/li&gt;&lt;li&gt;âž¤ beta-oxidation&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ inhibition of the TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ high levels of NADH&lt;/li&gt;&lt;li&gt;âž¤ Key gluconeogenic dehydrogenases are also inhibited by the elevated levels of NADH, including lactate dehydrogenase, glycerol 3-phosphate dehydrogenase, and malate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenic dehydrogenases&lt;/li&gt;&lt;li&gt;âž¤ inhibited by the elevated levels of NADH,&lt;/li&gt;&lt;li&gt;âž¤ lactate dehydrogenase, glycerol 3-phosphate dehydrogenase,&lt;/li&gt;&lt;li&gt;âž¤ malate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 140-141.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 140-141.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young woman with laboratory picture of normocytic anaemia and jaundice with splenomegaly was diagnosed to have RBC pyruvate kinase deficiency after a PBS showed spiculated cells. Due to the abnormal function of pyruvate kinase, less pyruvate is formed and the intermediates above pyruvate in the glycolytic pathway get accumulated. Which of the following products is not formed in appropriate amounts in the RBC due to the deficiency of pyruvate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lactate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxaloacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetyl-CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lactate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture3_vhplgH7.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture4_OJApgRI.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lactate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This question tests understanding of RBC metabolism, particularly the consequences of pyruvate kinase deficiency. Pyruvate kinase deficiency is an inherited disorder that affects glycolysis in RBCs, leading to premature destruction of red blood cells (hemolytic anemia). The spiculated RBCs seen on peripheral blood smear are characteristic of this condition. The defect causes ATP depletion, accumulation of glycolytic intermediates upstream of the enzyme defect, and reduced production of downstream metabolites like lactate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 170; Vasudevan 9/e: 111.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Can the acetyl CoA, derived from fatty acid oxidation, be converted back into glucose to maintain blood glucose levels? What is the correct response based on human metabolic pathways?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) False&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Acetyl CoA cannot be converted into glucose in humans because the reactions of the citric acid cycle are not reversible , and there is no pathway that can convert acetyl CoA back to pyruvate or any other gluconeogenic precursors. This underscores the importance of the concept that while glucose can be converted into acetyl CoA, the reverse is not true , marking a one-way route towards energy production.&lt;/li&gt;&lt;li&gt;â€¢ Acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ cannot&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ citric acid cycle are not reversible&lt;/li&gt;&lt;li&gt;â€¢ no pathway&lt;/li&gt;&lt;li&gt;â€¢ convert acetyl CoA back to pyruvate&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenic precursors.&lt;/li&gt;&lt;li&gt;â€¢ underscores&lt;/li&gt;&lt;li&gt;â€¢ glucose can be converted into acetyl CoA,&lt;/li&gt;&lt;li&gt;â€¢ reverse is not true&lt;/li&gt;&lt;li&gt;â€¢ one-way route&lt;/li&gt;&lt;li&gt;â€¢ energy production.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fate of Acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ Fate of Acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ Fatty Acid Synthesis Ketone Body Synthesis Cholesterol Synthesis TCA Cycle&lt;/li&gt;&lt;li&gt;âž¤ Fatty Acid Synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ketone Body Synthesis&lt;/li&gt;&lt;li&gt;âž¤ Cholesterol Synthesis&lt;/li&gt;&lt;li&gt;âž¤ TCA Cycle&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA cannot be converted to glucose as the link reaction is irreversible.&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA cannot be converted to glucose as the link reaction is irreversible.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p: 141.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p: 141.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a remote clinic, a physician is treating a mountaineer for fatigue and muscle weakness after a prolonged trek. To understand the patientâ€™s condition, the physician reviews metabolic processes that could be affected by long-term physical exertion and caloric deficit. Considering the body&#x27;s adaptive mechanisms, which functions does the glucose-alanine cycle serve in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carries amino group to the Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alanine as a substrate for Gluconeogenesis during starvation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both a and b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture22.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Both A and B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carries amino group to the Liver: This is a correct function of the glucose-alanine cycle but does not fully capture the cycle&#x27;s roles . It transports nitrogen to the liver, where it can be safely removed from the body.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carries amino group to the Liver:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ glucose-alanine cycle&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ cycle&#x27;s roles&lt;/li&gt;&lt;li&gt;â€¢ nitrogen to the liver,&lt;/li&gt;&lt;li&gt;â€¢ safely removed&lt;/li&gt;&lt;li&gt;â€¢ body.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alanine as a substrate for Gluconeogenesis during starvation: This is another correct function, highlighting the cycle&#x27;s role in supporting glucose production from non-carbohydrate sources during periods of starvation or intense physical activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Alanine as a substrate for Gluconeogenesis during starvation: This&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ highlighting the cycle&#x27;s role&lt;/li&gt;&lt;li&gt;â€¢ glucose production&lt;/li&gt;&lt;li&gt;â€¢ non-carbohydrate sources&lt;/li&gt;&lt;li&gt;â€¢ starvation or intense physical activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Uses of glucose-alanine (Cahill) cycle&lt;/li&gt;&lt;li&gt;âž¤ Uses of glucose-alanine (Cahill) cycle&lt;/li&gt;&lt;li&gt;âž¤ Carries amino group to the Liver. Alanine as a substrate for Gluconeogenesis during starvation. Amino acid increased in blood during starvation is Alanine.&lt;/li&gt;&lt;li&gt;âž¤ Carries amino group to the Liver.&lt;/li&gt;&lt;li&gt;âž¤ Carries amino group&lt;/li&gt;&lt;li&gt;âž¤ Liver.&lt;/li&gt;&lt;li&gt;âž¤ Alanine as a substrate for Gluconeogenesis during starvation.&lt;/li&gt;&lt;li&gt;âž¤ Alanine&lt;/li&gt;&lt;li&gt;âž¤ substrate&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ starvation.&lt;/li&gt;&lt;li&gt;âž¤ Amino acid increased in blood during starvation is Alanine.&lt;/li&gt;&lt;li&gt;âž¤ Amino acid increased&lt;/li&gt;&lt;li&gt;âž¤ starvation is Alanine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p:120.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p:120.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female, found comatose, was rushed to the emergency department from a campus chemistry lab. She exhibits a high fever (40.5Â°C or 105Â°F), tachycardia, tachypnea, and her arm is stained yellow. Blood pressure readings are unsuccessful. She experienced blurred vision, headaches, and tremors following an accidental exposure to metabolic inhibitors, leading to her current state. Based on these symptoms, which toxin is most likely responsible for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenobarbital&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carboxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dimercaprol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dinitrophenol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dinitrophenol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dinitrophenol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of dinitrophenol poisoning , characterized by hyperthermia, rapid heart and respiratory rates, and yellow staining of the skin , highlighting the importance of understanding the effects of metabolic inhibitors in acute toxic exposures.&lt;/li&gt;&lt;li&gt;âž¤ dinitrophenol poisoning&lt;/li&gt;&lt;li&gt;âž¤ hyperthermia, rapid heart and respiratory rates, and yellow&lt;/li&gt;&lt;li&gt;âž¤ staining of the skin&lt;/li&gt;&lt;li&gt;âž¤ importance&lt;/li&gt;&lt;li&gt;âž¤ effects of metabolic inhibitors&lt;/li&gt;&lt;li&gt;âž¤ acute toxic exposures.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 123&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 123&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately highlights a key difference between respiratory chain inhibitors and uncouplers?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The effect of respiratory chain inhibitors cannot be characterized spectroscopically, whereas that of uncouplers can.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uncouplers are toxic substances, but respiratory chain inhibitors are not.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory chain inhibitors allow leakage of protons across the membrane, but uncouplers do not.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Uncouplers such as 2, 4-dinitrophenol increase the permeability of the inner mitochondrial membrane to protons , reduce the electrochemical potential , and inhibit ATP synthase.&lt;/li&gt;&lt;li&gt;âž¤ Uncouplers&lt;/li&gt;&lt;li&gt;âž¤ 2, 4-dinitrophenol increase&lt;/li&gt;&lt;li&gt;âž¤ inner mitochondrial membrane to protons&lt;/li&gt;&lt;li&gt;âž¤ reduce&lt;/li&gt;&lt;li&gt;âž¤ electrochemical potential&lt;/li&gt;&lt;li&gt;âž¤ inhibit&lt;/li&gt;&lt;li&gt;âž¤ ATP synthase.&lt;/li&gt;&lt;li&gt;âž¤ UNCOUPLERS&lt;/li&gt;&lt;li&gt;âž¤ UNCOUPLERS&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin Thyroxine 2,4-dinitrophenol High dose Aspirin&lt;/li&gt;&lt;li&gt;âž¤ Thermogenin&lt;/li&gt;&lt;li&gt;âž¤ Thyroxine&lt;/li&gt;&lt;li&gt;âž¤ 2,4-dinitrophenol&lt;/li&gt;&lt;li&gt;âž¤ High dose Aspirin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p 322.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p 322.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinical researcher is investigating a rare metabolic disorder characterized by defects in the mitochondrial electron transport chain. During her research, she examines the role and characteristics of various components within the chain, including Coenzyme Q (CoQ). She comes across some common misconceptions about CoQ among her colleagues. Which of the following statements about Coenzyme Q would she identify as FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Is a quinone derivative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NADH is the only donor of pair of electrons to CoQ&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Have long isoprenoid tail&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It reduces two molecules of cytochrome c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. NADH is the only donor of pair of electrons to CoQ&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) NADH is the only donor of pair of electrons to CoQ&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ubiquinone (Q) is reduced to semiquinone (QH) and finally to quinol (QH2). It accepts a pair of electrons from NADH or FADH2 through complex-I or complex-II respectively Coenzyme Q is a quinone derivative having a long isoprenoid tail and the chain length of the tail is different in various species. Two molecules of cytochrome c are reduced. The Q cycle facilitates the switching from the two electron carrier ubiquinol to the single electron carrier cytochrome c.&lt;/li&gt;&lt;li&gt;âž¤ The ubiquinone (Q) is reduced to semiquinone (QH) and finally to quinol (QH2).&lt;/li&gt;&lt;li&gt;âž¤ ubiquinone (Q)&lt;/li&gt;&lt;li&gt;âž¤ semiquinone (QH)&lt;/li&gt;&lt;li&gt;âž¤ quinol (QH2).&lt;/li&gt;&lt;li&gt;âž¤ It accepts a pair of electrons from NADH or FADH2 through complex-I or complex-II respectively&lt;/li&gt;&lt;li&gt;âž¤ pair of electrons&lt;/li&gt;&lt;li&gt;âž¤ NADH or FADH2&lt;/li&gt;&lt;li&gt;âž¤ complex-I or complex-II&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q is a quinone derivative having a long isoprenoid tail and the chain length of the tail is different in various species.&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q&lt;/li&gt;&lt;li&gt;âž¤ quinone derivative&lt;/li&gt;&lt;li&gt;âž¤ isoprenoid tail&lt;/li&gt;&lt;li&gt;âž¤ chain length of the tail&lt;/li&gt;&lt;li&gt;âž¤ Two molecules of cytochrome c are reduced.&lt;/li&gt;&lt;li&gt;âž¤ Two&lt;/li&gt;&lt;li&gt;âž¤ cytochrome c&lt;/li&gt;&lt;li&gt;âž¤ reduced.&lt;/li&gt;&lt;li&gt;âž¤ The Q cycle facilitates the switching from the two electron carrier ubiquinol to the single electron carrier cytochrome c.&lt;/li&gt;&lt;li&gt;âž¤ Q cycle&lt;/li&gt;&lt;li&gt;âž¤ switching&lt;/li&gt;&lt;li&gt;âž¤ two electron carrier ubiquinol&lt;/li&gt;&lt;li&gt;âž¤ single electron carrier cytochrome c.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 261.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 261.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male patient with Mediterranean origin travels to Africa. During his trip, he develops symptoms of malaria and is subsequently treated with primaquine. Shortly after treatment, he presents with signs of hemolytic anemia. His medical history is significant for a specific enzyme deficiency that makes him susceptible to hemolysis when exposed to certain oxidative stressors, such as primaquine. The enzyme deficiency is involved in which of the following metabolic pathways?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HMP pathway&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rapaport pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HMP pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HMP pathway&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6 Phosphate Dehydrogenase Deficiency â€“&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6 Phosphate Dehydrogenase Deficiency â€“&lt;/li&gt;&lt;li&gt;âž¤ Most common enzyme deficiency in human beings. X-linked recessive Manifest as - Hemolytic Anaemia OR Methemoglobinemia&lt;/li&gt;&lt;li&gt;âž¤ Most common enzyme deficiency in human beings.&lt;/li&gt;&lt;li&gt;âž¤ Most common&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ X-linked recessive&lt;/li&gt;&lt;li&gt;âž¤ X-linked recessive&lt;/li&gt;&lt;li&gt;âž¤ Manifest as - Hemolytic Anaemia OR Methemoglobinemia&lt;/li&gt;&lt;li&gt;âž¤ Hemolytic Anaemia&lt;/li&gt;&lt;li&gt;âž¤ Methemoglobinemia&lt;/li&gt;&lt;li&gt;âž¤ DRUGS CAUSING HEMOLYSIS IN G6PD DEFICIENT INDIVIDUALS&lt;/li&gt;&lt;li&gt;âž¤ DRUGS CAUSING HEMOLYSIS IN G6PD DEFICIENT INDIVIDUALS&lt;/li&gt;&lt;li&gt;âž¤ Sulfonamides Chloroquine Quinine Primaquine Nitrofurantoin&lt;/li&gt;&lt;li&gt;âž¤ Sulfonamides&lt;/li&gt;&lt;li&gt;âž¤ Chloroquine&lt;/li&gt;&lt;li&gt;âž¤ Quinine&lt;/li&gt;&lt;li&gt;âž¤ Primaquine&lt;/li&gt;&lt;li&gt;âž¤ Nitrofurantoin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about Fructosuria is NOT true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deficiency of aldolase B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Excretes fructose in urine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rare incidence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Positive Benedictâ€™s test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Deficiency of aldolase B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Deficiency of aldolase B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Excretes fructose in urine: This is true for fructosuria due to the inability to metabolize fructose effectively.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Excretes fructose in urine:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ inability to metabolize fructose&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rare incidence: Fructosuria is indeed a rare condition, given the specific enzyme deficiency required for its manifestation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rare incidence:&lt;/li&gt;&lt;li&gt;â€¢ Fructosuria&lt;/li&gt;&lt;li&gt;â€¢ specific enzyme deficiency&lt;/li&gt;&lt;li&gt;â€¢ Option D. Positive Benedictâ€™s test: Fructose is a reducing sugar, which means it will react with Benedictâ€™s reagent to produce a color change , indicating a positive test result.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Positive Benedictâ€™s test:&lt;/li&gt;&lt;li&gt;â€¢ reducing sugar,&lt;/li&gt;&lt;li&gt;â€¢ react with Benedictâ€™s reagent&lt;/li&gt;&lt;li&gt;â€¢ color&lt;/li&gt;&lt;li&gt;â€¢ change&lt;/li&gt;&lt;li&gt;â€¢ positive test result.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This is a benign metabolic defect due to defect/deficiency of fructokinase. Incidence is 1 in 130,000 births. There is excretion of fructose in urine. Urine gives positive Benedictâ€™s and Seliwanoffâ€™s tests.&lt;/li&gt;&lt;li&gt;âž¤ This is a benign metabolic defect due to defect/deficiency of fructokinase.&lt;/li&gt;&lt;li&gt;âž¤ benign metabolic defect&lt;/li&gt;&lt;li&gt;âž¤ defect/deficiency of fructokinase.&lt;/li&gt;&lt;li&gt;âž¤ Incidence is 1 in 130,000 births.&lt;/li&gt;&lt;li&gt;âž¤ 1 in 130,000 births.&lt;/li&gt;&lt;li&gt;âž¤ There is excretion of fructose in urine.&lt;/li&gt;&lt;li&gt;âž¤ excretion of fructose&lt;/li&gt;&lt;li&gt;âž¤ Urine gives positive Benedictâ€™s and Seliwanoffâ€™s tests.&lt;/li&gt;&lt;li&gt;âž¤ positive Benedictâ€™s and Seliwanoffâ€™s tests.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: P 138.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: P 138.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Oxidative phosphorylation process is known for its efficiency in generating ATP by utilizing a specific gradient. Which of the following best describes what oxidative phosphorylation couples with ATP generation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proton translocation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substrate level phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Electron flow through cytochromes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reduction of NADH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Proton translocation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Proton translocation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Substrate: level phosphorylation is a different mechanism of ATP production that occurs in the cytoplasm and mitochondrial matrix , not directly related to the proton gradient utilized in oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Substrate:&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ ATP production&lt;/li&gt;&lt;li&gt;â€¢ cytoplasm and&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial matrix&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ proton gradient&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: While electron flow through cytochromes is essential for establishing the proton gradient, the direct coupling in oxidative phosphorylation involves the movement of protons , not just the electron flow.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ electron flow&lt;/li&gt;&lt;li&gt;â€¢ cytochromes&lt;/li&gt;&lt;li&gt;â€¢ proton gradient,&lt;/li&gt;&lt;li&gt;â€¢ direct&lt;/li&gt;&lt;li&gt;â€¢ oxidative&lt;/li&gt;&lt;li&gt;â€¢ phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ movement of protons&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ electron flow.&lt;/li&gt;&lt;li&gt;â€¢ Option D: The reduction of NADH to NAD+ occurs upstream of ATP generation in oxidative phosphorylation , contributing to the electron transport chain that establishes the proton gradient but is not the direct coupling mechanism for ATP synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ reduction of NADH&lt;/li&gt;&lt;li&gt;â€¢ NAD+&lt;/li&gt;&lt;li&gt;â€¢ ATP generation&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ proton gradient&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ direct&lt;/li&gt;&lt;li&gt;â€¢ ATP synthesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proton translocation across the mitochondrial membrane generates an electro- chemical potential difference composed of a pH gradient and an electrical potential. This electrochemical potential difference is used to drive ATP synthase to form ATP. During this process NADH is oxidized not reduced, by coupling with oxygen as the ultimate electron acceptor . Substrate level phosphorylation occurs during glycolysis and TCA . Electron flow through cytochromes is indirectly causing generation of proton gradient which is directly causing ATP generation, so the best answer to choose is A rather than C.&lt;/li&gt;&lt;li&gt;âž¤ Proton translocation across the mitochondrial membrane generates an electro- chemical potential difference composed of a pH gradient and an electrical potential.&lt;/li&gt;&lt;li&gt;âž¤ Proton&lt;/li&gt;&lt;li&gt;âž¤ across&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial membrane&lt;/li&gt;&lt;li&gt;âž¤ electro- chemical potential difference&lt;/li&gt;&lt;li&gt;âž¤ pH gradient&lt;/li&gt;&lt;li&gt;âž¤ electrical potential.&lt;/li&gt;&lt;li&gt;âž¤ This electrochemical potential difference is used to drive ATP synthase to form ATP.&lt;/li&gt;&lt;li&gt;âž¤ electrochemical potential&lt;/li&gt;&lt;li&gt;âž¤ drive ATP synthase to form ATP.&lt;/li&gt;&lt;li&gt;âž¤ During this process NADH is oxidized not reduced, by coupling with oxygen as the ultimate electron acceptor . Substrate level phosphorylation occurs during glycolysis and TCA . Electron flow through cytochromes is indirectly causing generation of proton gradient which is directly causing ATP generation, so the best answer to choose is A rather than C.&lt;/li&gt;&lt;li&gt;âž¤ NADH is oxidized&lt;/li&gt;&lt;li&gt;âž¤ coupling with oxygen&lt;/li&gt;&lt;li&gt;âž¤ ultimate electron acceptor&lt;/li&gt;&lt;li&gt;âž¤ Substrate&lt;/li&gt;&lt;li&gt;âž¤ level phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ glycolysis and TCA&lt;/li&gt;&lt;li&gt;âž¤ Electron flow&lt;/li&gt;&lt;li&gt;âž¤ cytochromes&lt;/li&gt;&lt;li&gt;âž¤ indirectly&lt;/li&gt;&lt;li&gt;âž¤ generation of proton gradient&lt;/li&gt;&lt;li&gt;âž¤ ATP generation,&lt;/li&gt;&lt;li&gt;âž¤ choose is A&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p 315.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p 315.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents to the clinic with fatigue and muscle weakness. Further investigation reveals a mitochondrial DNA mutation leading to reduced complex I activity in her cells. Given the role of complex I in the electron transport chain, which of the following electron transfers would be most directly affected by this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Succinate to complex III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytochrome C to complex IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coenzyme Q to complex III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malate to coenzyme Q&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Malate to coenzyme Q&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Malate to coenzyme Q&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complex I accepts electrons from NADH and will transfer them to coenzyme Q . Malate dehydrogenase will convert malate to oxaloacetate , generating NADH in the process. The NADH will then donate electrons to complex I to initiate electron transfer.&lt;/li&gt;&lt;li&gt;âž¤ Complex I&lt;/li&gt;&lt;li&gt;âž¤ electrons&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ coenzyme Q&lt;/li&gt;&lt;li&gt;âž¤ Malate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ convert malate to&lt;/li&gt;&lt;li&gt;âž¤ oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ NADH&lt;/li&gt;&lt;li&gt;âž¤ donate electrons&lt;/li&gt;&lt;li&gt;âž¤ complex I&lt;/li&gt;&lt;li&gt;âž¤ electron transfer.&lt;/li&gt;&lt;li&gt;âž¤ Succinate donates electrons at complex II (Via succinate dehydrogenase, a component of complex II), which donates to coenzyme Q , thereby bypassing complex I. Cytochrome c transfers electrons from complex III to complex IV. Once electrons are carried by coenzyme Q , complex I is no longer required for electron transfer to oxygen.&lt;/li&gt;&lt;li&gt;âž¤ Succinate donates electrons&lt;/li&gt;&lt;li&gt;âž¤ complex II&lt;/li&gt;&lt;li&gt;âž¤ succinate dehydrogenase,&lt;/li&gt;&lt;li&gt;âž¤ donates to coenzyme&lt;/li&gt;&lt;li&gt;âž¤ Q&lt;/li&gt;&lt;li&gt;âž¤ bypassing complex I.&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome c&lt;/li&gt;&lt;li&gt;âž¤ electrons&lt;/li&gt;&lt;li&gt;âž¤ complex III to complex IV.&lt;/li&gt;&lt;li&gt;âž¤ electrons&lt;/li&gt;&lt;li&gt;âž¤ coenzyme Q&lt;/li&gt;&lt;li&gt;âž¤ complex I&lt;/li&gt;&lt;li&gt;âž¤ no&lt;/li&gt;&lt;li&gt;âž¤ electron transfer to oxygen.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 260.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 260.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following metabolites is not typically involved in the HMP shunt?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycerol-3-phosphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sedoheptulose-7-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glyceraldehyde-3-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Xylulose-5-phosphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycerol-3-phosphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glycerol 3 Phosphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metabolites in HMP Shunt Pathway&lt;/li&gt;&lt;li&gt;âž¤ Metabolites in HMP Shunt Pathway&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphate 6-Phosphogluconate Ribulose-5-Phosphate Xylulose-5-Phosphate Ribose-5-Phosphate Glyceraldehyde-3-Phosphate Sedoheptulose-7-Phosphate Fructose-6-phosphate Erythrose 4 Phosphate.&lt;/li&gt;&lt;li&gt;âž¤ Glucose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ 6-Phosphogluconate&lt;/li&gt;&lt;li&gt;âž¤ Ribulose-5-Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Xylulose-5-Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Ribose-5-Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Glyceraldehyde-3-Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Sedoheptulose-7-Phosphate&lt;/li&gt;&lt;li&gt;âž¤ Fructose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ Erythrose 4 Phosphate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p197&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p197&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following enzymes is NOT directly involved in determining a cell&#x27;s gluconeogenic capability?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucose-6-phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyruvate carboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fructose 1,6- Bisphosphatase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pyruvate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pyruvate dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis is the process of synthesizing glucose or glycogen from non-carbohydrate precursors. Gluconeogenic capacity is determined by the presence of key enzymes of Gluconeogenesis. Pyruvate Dehydrogenase is not an enzyme of gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis is the process of synthesizing glucose or glycogen from non-carbohydrate precursors.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ synthesizing glucose or glycogen&lt;/li&gt;&lt;li&gt;âž¤ non-carbohydrate precursors.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenic capacity is determined by the presence of key enzymes of Gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenic&lt;/li&gt;&lt;li&gt;âž¤ presence of key enzymes&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate Dehydrogenase is not an enzyme of gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate Dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p188, 189.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p188, 189.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a clinical rotation in endocrinology, a resident encounters a patient with a rare metabolic disorder that affects glucose production. Through discussions with the attending physician, the resident learns that the patient&#x27;s condition involves a unique metabolic pathway that operates across two distinct cellular compartments, which is unusual compared to other pathways involved in glucose metabolism. Intrigued, the resident decides to research this further. Which metabolic pathway, relevant to the patient&#x27;s condition, is known to occur across two different cellular compartments?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gluconeogenesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogenolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gluconeogenesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gluconeogenesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis takes place in both cytosol and mitochondria . The Mitochondrial step is Pyruvate Carboxylase reaction.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ both cytosol and mitochondria&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate Carboxylase reaction.&lt;/li&gt;&lt;li&gt;âž¤ Pathways taking place in two compartments are â€“&lt;/li&gt;&lt;li&gt;âž¤ Pathways taking place in two compartments are â€“&lt;/li&gt;&lt;li&gt;âž¤ Heme Synthesis Urea Cycle Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Heme Synthesis&lt;/li&gt;&lt;li&gt;âž¤ Heme Synthesis&lt;/li&gt;&lt;li&gt;âž¤ Urea Cycle&lt;/li&gt;&lt;li&gt;âž¤ Urea Cycle&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p188, 189&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p188, 189&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following metabolic pathways is not directly involved in the generation of ATP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TCA Cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fatty Acid Oxidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HMP Pathway&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HMP Pathway&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HMP Pathway.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glycolysis: Glycolysis is a fundamental metabolic pathway that converts glucose to pyruvate, generating a net gain of 2 ATP molecules per glucose molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Glycolysis:&lt;/li&gt;&lt;li&gt;â€¢ fundamental metabolic pathway&lt;/li&gt;&lt;li&gt;â€¢ glucose to pyruvate,&lt;/li&gt;&lt;li&gt;â€¢ net gain&lt;/li&gt;&lt;li&gt;â€¢ 2&lt;/li&gt;&lt;li&gt;â€¢ ATP molecules&lt;/li&gt;&lt;li&gt;â€¢ glucose molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TCA Cycle: The TCA Cycle, or Krebs cycle , occurs in the mitochondrial matrix and produces GTP, which is equivalent to ATP, along with NADH and FADH2 , which are used in oxidative phosphorylation to generate further ATP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TCA Cycle:&lt;/li&gt;&lt;li&gt;â€¢ Krebs cycle&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial matrix&lt;/li&gt;&lt;li&gt;â€¢ GTP,&lt;/li&gt;&lt;li&gt;â€¢ ATP,&lt;/li&gt;&lt;li&gt;â€¢ NADH and FADH2&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ further ATP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fatty Acid Oxidation: Fatty acid oxidation, or Î²-oxidation, takes place in the mitochondria, breaking down fatty acids to acetyl-CoA and generating NADH and FADH2, which are then used in the TCA cycle and oxidative phosphorylation to produce ATP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fatty Acid Oxidation:&lt;/li&gt;&lt;li&gt;â€¢ Î²-oxidation,&lt;/li&gt;&lt;li&gt;â€¢ mitochondria,&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ acetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ NADH and FADH2,&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ ATP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p200.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p200.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following options correctly represents the diagnostic criteria for Diabetes Mellitus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;If the random plasma sugar level is more than 200 mg/dl, on more than one occasion.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_cgQTuPi.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion: This is one of the criteria for diagnosing diabetes but not the only one.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  2-hour post-glucose load value of GTT more than 200 mg/dl: This too is a valid criterion for diagnosing diabetes, even if observed on just one occasion, provided there are classic symptoms of hyperglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  2-hour post-glucose load value of GTT more than 200 mg/dl:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion: While a single measurement with classic symptoms can be sufficient, additional confirmation enhances the diagnostic certainty, especially in asymptomatic individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion). If the random plasma sugar level is more than 200 mg/dl , on more than one occasion. Glycated haemoglobin (Glyco -Hb) or HbA1c level more than 6.5% at any occasion&lt;/li&gt;&lt;li&gt;âž¤ If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion&lt;/li&gt;&lt;li&gt;âž¤ fasting plasma sugar&lt;/li&gt;&lt;li&gt;âž¤ more than 126 mg /dl,&lt;/li&gt;&lt;li&gt;âž¤ more&lt;/li&gt;&lt;li&gt;âž¤ If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).&lt;/li&gt;&lt;li&gt;âž¤ 2-hr post-glucose&lt;/li&gt;&lt;li&gt;âž¤ GTT is more than 200 mg /dl&lt;/li&gt;&lt;li&gt;âž¤ If the random plasma sugar level is more than 200 mg/dl , on more than one occasion.&lt;/li&gt;&lt;li&gt;âž¤ random plasma sugar level&lt;/li&gt;&lt;li&gt;âž¤ more than 200 mg/dl&lt;/li&gt;&lt;li&gt;âž¤ more than one occasion.&lt;/li&gt;&lt;li&gt;âž¤ Glycated haemoglobin (Glyco -Hb) or HbA1c level more than 6.5% at any occasion&lt;/li&gt;&lt;li&gt;âž¤ Glycated haemoglobin (Glyco -Hb)&lt;/li&gt;&lt;li&gt;âž¤ HbA1c&lt;/li&gt;&lt;li&gt;âž¤ more than 6.5%&lt;/li&gt;&lt;li&gt;âž¤ any occasion&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 314.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 314.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a review of laboratory practices, a medical student is presented with a case study. A 55-year-old woman underwent routine blood work at 8 am in plain Vacutainer, but her blood glucose level was not processed until 11 am, with results reported at noon showing a blood glucose level of 48 mg/dl, despite all other tests being normal. Sample for blood glucose should be taken in Vacutainer containing NaF because it inhibit the following enzyme:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PFK&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enolase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Enolase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This question highlights the importance of proper pre-analytical handling of blood samples for glucose testing. Blood samples should either be processed immediately or collected in tubes containing glycolysis inhibitors (such as sodium fluoride) to prevent falsely lowered glucose results due to continued cellular metabolism. The case demonstrates how delayed processing can lead to clinically significant errors in laboratory results, potentially misleading diagnosis and treatment decisions.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 111.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): After overnight fasting, levels of glucose transporters are reduced in adipocytes. Reasoning (R): Adipocytes are insulin-sensitive tissues and as an early response to the hormone, the glucose transporters are externalized.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A as well as R are right, and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A as well as R are right, and R is a correct explanation of A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ After overnight fasting, insulin levels in the body are low . In insulin-sensitive tissues like adipocytes, low insulin levels lead to a decrease in the number of glucose transporters (such as GLUT4) present on the cell membrane because insulin is required to stimulate the translocation of these transporters from the intracellular stores to the cell surface.&lt;/li&gt;&lt;li&gt;âž¤ overnight fasting, insulin&lt;/li&gt;&lt;li&gt;âž¤ low&lt;/li&gt;&lt;li&gt;âž¤ insulin-sensitive tissues&lt;/li&gt;&lt;li&gt;âž¤ adipocytes, low insulin levels&lt;/li&gt;&lt;li&gt;âž¤ decrease&lt;/li&gt;&lt;li&gt;âž¤ glucose transporters (such as GLUT4)&lt;/li&gt;&lt;li&gt;âž¤ cell membrane&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;li&gt;âž¤ translocation&lt;/li&gt;&lt;li&gt;âž¤ transporters&lt;/li&gt;&lt;li&gt;âž¤ intracellular stores to the cell surface.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p192.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p192.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male presented with hypoglycaemia and altered sensorium and his MRI features are suggestive of neuroglycopenic coma. He was intervened early and life saving measures were done. So, Neurons takes up blood glucose predominantly by:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SGLT-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GLUT-4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GLUT-3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GLUT-1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. GLUT-3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) GLUT-3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT-2: Distributed in Kidney.&lt;/li&gt;&lt;li&gt;â€¢ Option A. SGLT-2:&lt;/li&gt;&lt;li&gt;â€¢ Kidney.&lt;/li&gt;&lt;li&gt;â€¢ Option B. GLUT-4: Distributed in Skeletal muscle, Cardiac muscle, and Adipose Tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B. GLUT-4:&lt;/li&gt;&lt;li&gt;â€¢ Skeletal muscle, Cardiac muscle, and Adipose Tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GLUT-1: Distributed in RBC, brain, kidney, placenta.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GLUT-1:&lt;/li&gt;&lt;li&gt;â€¢ RBC, brain, kidney, placenta.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Various types of glucose transporters with their tissue distribution are:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 191,192.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 191,192.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Evaluate the following mentioned assertion (A) and reasoning (R) regarding aldolase and its role in the metabolic pathway Assertion (A): Aldolase is the most common example of hydrolases class of enzyme under IUBMB system of nomenclature of enzymes: Reasoning (R): Aldolase catalyses the step 4 of glycolysis, cleaves the bond in the fructose-1,6-bisphosphate to form glyceraldehyde-3-phosphate and (DHAP) dihydroxyacetone phosphate and water is not required for this reversible reaction:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right, but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A is wrong but R is a right statement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture20_CkxXXG8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A is wrong, but R is a right statement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Aldolase is an example of lyase group of enzymes, which cleaves the bond without the need of water molecule. Other enzymes include HMG CoA lyase and ATP Citrate lyase.&lt;/li&gt;&lt;li&gt;â€¢ Aldolase is an example of lyase group of enzymes, which cleaves the bond without the need of water molecule. Other enzymes include HMG CoA lyase and ATP Citrate lyase.&lt;/li&gt;&lt;li&gt;â€¢ Aldolase&lt;/li&gt;&lt;li&gt;â€¢ lyase group of enzymes,&lt;/li&gt;&lt;li&gt;â€¢ cleaves the bond&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ water&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA lyase and ATP Citrate lyase.&lt;/li&gt;&lt;li&gt;â€¢ STEP 4 OF GLYCOLYSIS; REVERSIBLE&lt;/li&gt;&lt;li&gt;â€¢ STEP 4 OF GLYCOLYSIS; REVERSIBLE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aldolase is actually classified under the lyases class of enzymes , not hydrolases. Lyases are enzymes that cleave bonds without the addition of water and without the transfer of electrons. The aldolase reaction in glycolysis cleaves fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate and DHAP without the use of water, fitting the definition of a lyase.&lt;/li&gt;&lt;li&gt;âž¤ Aldolase&lt;/li&gt;&lt;li&gt;âž¤ lyases class of enzymes&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ Lyases&lt;/li&gt;&lt;li&gt;âž¤ cleave bonds&lt;/li&gt;&lt;li&gt;âž¤ addition of water&lt;/li&gt;&lt;li&gt;âž¤ without&lt;/li&gt;&lt;li&gt;âž¤ electrons.&lt;/li&gt;&lt;li&gt;âž¤ cleaves fructose-1,6-bisphosphate into&lt;/li&gt;&lt;li&gt;âž¤ glyceraldehyde-3-phosphate&lt;/li&gt;&lt;li&gt;âž¤ DHAP without&lt;/li&gt;&lt;li&gt;âž¤ use of water,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 170.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 170.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A third-year medical student is shadowing in the metabolic diseases unit and encounters a patient being evaluated for a disorder affecting energy production. The patient&#x27;s symptoms are suggestive of a defect in the complete oxidation of glucose. Intrigued, the student reviews biochemistry notes to understand where in the cell this process might be impaired. To aid in diagnosing and managing the patient&#x27;s condition, the student seeks to identify the cellular compartment responsible for the full catabolism of glucose into carbon dioxide and water. Where are the enzymes located that facilitate this complete metabolic breakdown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytosol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitochondria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysosomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoplasmic reticulum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitochondria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitochondria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytosol: Only hosts glycolysis , the first stage of glucose metabolism, not its complete oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cytosol:&lt;/li&gt;&lt;li&gt;â€¢ glycolysis&lt;/li&gt;&lt;li&gt;â€¢ first&lt;/li&gt;&lt;li&gt;â€¢ glucose metabolism, not&lt;/li&gt;&lt;li&gt;â€¢ oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysosomes: Involved in degrading and recycling cellular waste , not in energy metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysosomes:&lt;/li&gt;&lt;li&gt;â€¢ degrading and recycling cellular waste&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ energy metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoplasmic reticulum: Plays a key role in protein and lipid synthesis , but not in the oxidation of glucose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Endoplasmic reticulum:&lt;/li&gt;&lt;li&gt;â€¢ protein and lipid synthesis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ oxidation of glucose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Under aerobic conditions , pyruvate is taken up into mitochondria and after oxidative decarboxylation to Acetyl-CoA is oxidized to CO2 by the citric acid cycle Under anaerobic conditions , pyruvate is reduced by the NADH to lactate, catalyzed by lactate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ Under aerobic conditions , pyruvate is taken up into mitochondria and after oxidative decarboxylation to Acetyl-CoA is oxidized to CO2 by the citric acid cycle&lt;/li&gt;&lt;li&gt;âž¤ aerobic conditions&lt;/li&gt;&lt;li&gt;âž¤ pyruvate&lt;/li&gt;&lt;li&gt;âž¤ mitochondria and after oxidative decarboxylation&lt;/li&gt;&lt;li&gt;âž¤ Acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ CO2&lt;/li&gt;&lt;li&gt;âž¤ citric acid cycle&lt;/li&gt;&lt;li&gt;âž¤ Under anaerobic conditions , pyruvate is reduced by the NADH to lactate, catalyzed by lactate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ anaerobic conditions&lt;/li&gt;&lt;li&gt;âž¤ pyruvate&lt;/li&gt;&lt;li&gt;âž¤ NADH to lactate,&lt;/li&gt;&lt;li&gt;âž¤ lactate dehydrogenase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p: 172&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p: 172&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a marathon, an endurance athlete experiences a significant drop in blood glucose levels, triggering a series of metabolic adjustments. A sports medicine specialist explaining these changes to the athlete highlights how the body responds to maintain energy balance. Which of the following responses to decreased blood glucose levels is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of PFK-II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activation of Fructose 2,6 Bisphosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase in glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase in Fructose 2,6 Bisphosphate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Increase in Fructose 2,6 Bisphosphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Increase in Fructose 2, 6 Bisphosphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of PFK-II: This is a correct response to low blood glucose levels , leading to decreased fructose 2,6-bisphosphate production and reduced glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inhibition of PFK-II:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ low blood glucose levels&lt;/li&gt;&lt;li&gt;â€¢ decreased fructose 2,6-bisphosphate&lt;/li&gt;&lt;li&gt;â€¢ reduced glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activation of Fructose 2,6 Bisphosphatase: This also accurately reflects the body&#x27;s response to low blood glucose, promoting th e lowering of fructose 2,6-bisphosphate levels and encouraging gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activation of Fructose 2,6 Bisphosphatase:&lt;/li&gt;&lt;li&gt;â€¢ reflects&lt;/li&gt;&lt;li&gt;â€¢ low blood glucose,&lt;/li&gt;&lt;li&gt;â€¢ e lowering of fructose 2,6-bisphosphate levels&lt;/li&gt;&lt;li&gt;â€¢ gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase in glucagon: Glucagon levels increase in response to low blood glucose to stimulate gluconeogenesis and glycogenolysis , raising blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increase in glucagon:&lt;/li&gt;&lt;li&gt;â€¢ response&lt;/li&gt;&lt;li&gt;â€¢ low blood glucose&lt;/li&gt;&lt;li&gt;â€¢ stimulate gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ raising blood glucose levels.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increase Blood Glucose Level :&lt;/li&gt;&lt;li&gt;âž¤ Increase Blood Glucose Level&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of Glycolysis By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of Glycolysis By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of Glycolysis&lt;/li&gt;&lt;li&gt;âž¤ By phosphorylating the key enzymes of Glycolysis (option a) By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II&lt;/li&gt;&lt;li&gt;âž¤ By phosphorylating the key enzymes of Glycolysis (option a)&lt;/li&gt;&lt;li&gt;âž¤ By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II&lt;/li&gt;&lt;li&gt;âž¤ Favour Gluconeogenesis By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.&lt;/li&gt;&lt;li&gt;âž¤ Favour Gluconeogenesis By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.&lt;/li&gt;&lt;li&gt;âž¤ Favour Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ By phosphorylating Key enzymes of Gluconeogenesis By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.&lt;/li&gt;&lt;li&gt;âž¤ By phosphorylating Key enzymes of Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p191&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p191&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A post-operative patient develops angular stomatitis and shows low riboflavin excretion, indicative of a deficiency. Riboflavin is essential for FAD, a coenzyme in the TCA cycle. Which TCA cycle enzyme, dependent on FAD, would be affected by this deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isocitrate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fumarase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Succinate dehydrogenase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Succinate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Succinate dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Isocitrate dehydrogenase: Forms Alpha Keto Glutarate in TCA cycle with NADH generation, which is later oxidized in ETC to generate ATPs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Isocitrate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ Alpha Keto Glutarate&lt;/li&gt;&lt;li&gt;â€¢ NADH&lt;/li&gt;&lt;li&gt;â€¢ generation,&lt;/li&gt;&lt;li&gt;â€¢ later oxidized&lt;/li&gt;&lt;li&gt;â€¢ ETC&lt;/li&gt;&lt;li&gt;â€¢ ATPs.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Fumarase: In TCA cycle, it helps in formation of malate from fumarate and the reaction involves addition of a water molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Fumarase:&lt;/li&gt;&lt;li&gt;â€¢ malate from fumarate&lt;/li&gt;&lt;li&gt;â€¢ addition of a water molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malate dehydrogenase: In TCA cycle , malate is oxidized to oxaloacetate by this enzyme and the coenzyme is NAD+.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle&lt;/li&gt;&lt;li&gt;â€¢ malate&lt;/li&gt;&lt;li&gt;â€¢ oxidized to oxaloacetate&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ coenzyme is NAD+.&lt;/li&gt;&lt;li&gt;â€¢ Note - None of the above 3 enzymes are dependent on FAD.&lt;/li&gt;&lt;li&gt;â€¢ None of the above 3 enzymes&lt;/li&gt;&lt;li&gt;â€¢ dependent on FAD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Succinate dehydrogenase is the TCA cycle enzyme directly impacted by riboflavin deficiency, as it uses FAD, derived from riboflavin, as a coenzyme. This enzyme catalyzes the oxidation of succinate to fumarate, with FAD being reduced to FADH2 in the process. A deficiency in riboflavin would impair the function of succinate dehydrogenase, affecting the efficiency of the TCA cycle and overall energy production.&lt;/li&gt;&lt;li&gt;âž¤ Succinate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ riboflavin deficiency,&lt;/li&gt;&lt;li&gt;âž¤ FAD,&lt;/li&gt;&lt;li&gt;âž¤ riboflavin, as a coenzyme.&lt;/li&gt;&lt;li&gt;âž¤ oxidation of&lt;/li&gt;&lt;li&gt;âž¤ succinate to fumarate,&lt;/li&gt;&lt;li&gt;âž¤ FAD&lt;/li&gt;&lt;li&gt;âž¤ reduced to FADH2&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ riboflavin&lt;/li&gt;&lt;li&gt;âž¤ impair the function of succinate dehydrogenase,&lt;/li&gt;&lt;li&gt;âž¤ efficiency&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ energy production.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 556; Vasudevan 9/e: 479.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 556; Vasudevan 9/e: 479.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During the conversion of Î±-ketoglutarate to succinate in the TCA cycle, several reactions occur, leading to the production of energy-rich molecules. This conversion involves the decarboxylation of Î±-ketoglutarate, the generation of Succinyl CoA, and the subsequent formation of succinate. how many ATP molecules are typically produced through this series of reactions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 3.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. 3.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The conversion of Î±-ketoglutarate to succinate in the TCA cycle involves two key steps:&lt;/li&gt;&lt;li&gt;â€¢ First, Î±-ketoglutarate dehydrogenase complex catalyzes the oxidative decarboxylation of Î±-ketoglutarate to form succinyl-CoA, COâ‚‚, and NADH. The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain. Second, succinyl-CoA synthetase (also called succinate thiokinase) catalyzes the conversion of succinyl-CoA to succinate with the generation of GTP (which is energetically equivalent to ATP. This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.&lt;/li&gt;&lt;li&gt;â€¢ First, Î±-ketoglutarate dehydrogenase complex catalyzes the oxidative decarboxylation of Î±-ketoglutarate to form succinyl-CoA, COâ‚‚, and NADH. The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.&lt;/li&gt;&lt;li&gt;â€¢ The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.&lt;/li&gt;&lt;li&gt;â€¢ The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.&lt;/li&gt;&lt;li&gt;â€¢ Second, succinyl-CoA synthetase (also called succinate thiokinase) catalyzes the conversion of succinyl-CoA to succinate with the generation of GTP (which is energetically equivalent to ATP. This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.&lt;/li&gt;&lt;li&gt;â€¢ This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.&lt;/li&gt;&lt;li&gt;â€¢ This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the total ATP yield from converting Î±-ketoglutarate to succinate is:&lt;/li&gt;&lt;li&gt;â€¢ 2.5 ATP from NADH oxidation in the electron transport chain 1 ATP from substrate-level phosphorylation (GTP formation) Total: 3.5 ATP molecules&lt;/li&gt;&lt;li&gt;â€¢ 2.5 ATP from NADH oxidation in the electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ 1 ATP from substrate-level phosphorylation (GTP formation)&lt;/li&gt;&lt;li&gt;â€¢ Total: 3.5 ATP molecules&lt;/li&gt;&lt;li&gt;â€¢ This makes option C (3.5) the correct answer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the energetics of the TCA cycle reactions, specifically:&lt;/li&gt;&lt;li&gt;âž¤ The Î±-ketoglutarate dehydrogenase complex reaction produces NADH The succinyl-CoA synthetase reaction produces GTP/ATP via substrate-level phosphorylation NADH yields approximately 2.5 ATP when oxidized through the electron transport chain Together, these reactions yield 3.5 ATP molecules from the conversion of Î±-ketoglutarate to succinate&lt;/li&gt;&lt;li&gt;âž¤ The Î±-ketoglutarate dehydrogenase complex reaction produces NADH&lt;/li&gt;&lt;li&gt;âž¤ The succinyl-CoA synthetase reaction produces GTP/ATP via substrate-level phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ NADH yields approximately 2.5 ATP when oxidized through the electron transport chain&lt;/li&gt;&lt;li&gt;âž¤ Together, these reactions yield 3.5 ATP molecules from the conversion of Î±-ketoglutarate to succinate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the following, which is NOT a function or significance of the TCA cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete oxidation of acetyl CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP generation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Synthesis of NADPH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphibolic pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Synthesis of NADPH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The synthesis of NADPH is NOT a function of the TCA cycle. The TCA cycle (tricarboxylic acid cycle, also known as the Krebs cycle or citric acid cycle) produces NADH, not NADPH. This is a key distinction because NADH and NADPH have different roles in metabolism:&lt;/li&gt;&lt;li&gt;â€¢ NADH primarily serves as an electron carrier for energy production in the electron transport chain NADPH serves as a reducing agent for biosynthetic reactions and antioxidant defense&lt;/li&gt;&lt;li&gt;â€¢ NADH primarily serves as an electron carrier for energy production in the electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ NADPH serves as a reducing agent for biosynthetic reactions and antioxidant defense&lt;/li&gt;&lt;li&gt;â€¢ The TCA cycle specifically generates reduced electron carriers in the form of NADH (three molecules per acetyl-CoA) and FADHâ‚‚ (one molecule per acetyl-CoA), but not NADPH. NADPH is primarily produced by other pathways such as:&lt;/li&gt;&lt;li&gt;â€¢ The pentose phosphate pathway The malic enzyme reaction Isocitrate dehydrogenase in the cytosol (not the mitochondrial form involved in the TCA cycle) NADPâº-dependent glutamate dehydrogenase NADPâº-dependent malate dehydrogenase (malic enzyme)&lt;/li&gt;&lt;li&gt;â€¢ The pentose phosphate pathway&lt;/li&gt;&lt;li&gt;â€¢ The malic enzyme reaction&lt;/li&gt;&lt;li&gt;â€¢ Isocitrate dehydrogenase in the cytosol (not the mitochondrial form involved in the TCA cycle)&lt;/li&gt;&lt;li&gt;â€¢ NADPâº-dependent glutamate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ NADPâº-dependent malate dehydrogenase (malic enzyme)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete oxidation of acetyl CoA - This IS a function of the TCA cycle. The cycle completely oxidizes the two-carbon acetyl group of acetyl-CoA to two molecules of COâ‚‚. This oxidation is coupled with the reduction of electron carriers (NADâº to NADH and FAD to FADHâ‚‚).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Complete oxidation of acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATP generation - This IS a function of the TCA cycle. The cycle directly generates one GTP (equivalent to one ATP) per turn through substrate-level phosphorylation catalyzed by succinyl-CoA synthetase. More importantly, it indirectly enables substantial ATP production by providing NADH and FADHâ‚‚ to the electron transport chain for oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATP generation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amphibolic pathway - This IS a characteristic of the TCA cycle. The term \&quot;amphibolic\&quot; means the pathway serves both catabolic (breakdown) and anabolic (biosynthetic) functions. While the TCA cycle primarily functions in catabolism to generate energy, several of its intermediates serve as precursors for biosynthetic pathways, including:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Amphibolic pathway&lt;/li&gt;&lt;li&gt;â€¢ Oxaloacetate and Î±-ketoglutarate for amino acid synthesis Succinyl-CoA for heme synthesis Citrate for fatty acid synthesis (after transport to the cytosol)&lt;/li&gt;&lt;li&gt;â€¢ Oxaloacetate and Î±-ketoglutarate for amino acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ Succinyl-CoA for heme synthesis&lt;/li&gt;&lt;li&gt;â€¢ Citrate for fatty acid synthesis (after transport to the cytosol)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Key functions and significance of the TCA cycle include:&lt;/li&gt;&lt;li&gt;âž¤ Complete oxidation of acetyl-CoA to COâ‚‚ Energy production through substrate-level phosphorylation (GTP) and generation of reducing equivalents (NADH, FADHâ‚‚) Serving as a final common oxidative pathway for carbohydrates, proteins, and fats Acting as an amphibolic pathway (both catabolic and anabolic functions)&lt;/li&gt;&lt;li&gt;âž¤ Complete oxidation of acetyl-CoA to COâ‚‚&lt;/li&gt;&lt;li&gt;âž¤ Energy production through substrate-level phosphorylation (GTP) and generation of reducing equivalents (NADH, FADHâ‚‚)&lt;/li&gt;&lt;li&gt;âž¤ Serving as a final common oxidative pathway for carbohydrates, proteins, and fats&lt;/li&gt;&lt;li&gt;âž¤ Acting as an amphibolic pathway (both catabolic and anabolic functions)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p161-167.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In managing individuals with respiratory chain disorders, supplements like riboflavin and coenzyme Q (ubiquinone) are commonly used. Understanding the role of these supplements in mitochondrial function is crucial. What is the specific function of coenzyme Q in the respiratory chain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It links NAD-dependent dehydrogenases to cytochrome c.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It links each of the cytochromes in the respiratory chain to one another.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is the first step in the respiratory chain.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: While coenzyme Q does transfer electrons to components that eventually lead to cytochrome c, its direct link is with cytochrome b in Complex III, not cytochrome c.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ electrons to components&lt;/li&gt;&lt;li&gt;â€¢ lead to cytochrome c,&lt;/li&gt;&lt;li&gt;â€¢ direct link&lt;/li&gt;&lt;li&gt;â€¢ cytochrome b in Complex III,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option C: Coenzyme Q does not directly link all cytochromes but plays a pivotal role in transferring electrons from flavoproteins to cytochrome b in Complex III.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ all cytochromes&lt;/li&gt;&lt;li&gt;â€¢ electrons from flavoproteins&lt;/li&gt;&lt;li&gt;â€¢ cytochrome b&lt;/li&gt;&lt;li&gt;â€¢ Complex III.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Coenzyme Q is not the initial electron acceptor; it accepts electrons from Complex I and II, which are upstream in the electron transport chain.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Coenzyme Q&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Complex I and II,&lt;/li&gt;&lt;li&gt;â€¢ upstream&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q (ubiquinone) is a critical component in the mitochondrial electron transport chain, acting as a mobile electron carrier. It primarily accepts electrons from various flavoproteins , including those in Complex I (NADH dehydrogenase) and Complex II ( succinate dehydrogenase ), and transfers them to cytochrome b within Complex III (cytochrome bc1 complex). This transfer is vital for maintaining the flow of electrons through the chain , essential for the generation of a proton gradient used in ATP synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q (ubiquinone)&lt;/li&gt;&lt;li&gt;âž¤ mitochondrial electron transport chain,&lt;/li&gt;&lt;li&gt;âž¤ mobile electron carrier.&lt;/li&gt;&lt;li&gt;âž¤ primarily&lt;/li&gt;&lt;li&gt;âž¤ electrons&lt;/li&gt;&lt;li&gt;âž¤ flavoproteins&lt;/li&gt;&lt;li&gt;âž¤ Complex I (NADH dehydrogenase)&lt;/li&gt;&lt;li&gt;âž¤ Complex II&lt;/li&gt;&lt;li&gt;âž¤ succinate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ cytochrome b within Complex III (cytochrome bc1 complex).&lt;/li&gt;&lt;li&gt;âž¤ flow of electrons through&lt;/li&gt;&lt;li&gt;âž¤ chain&lt;/li&gt;&lt;li&gt;âž¤ generation of a proton gradient&lt;/li&gt;&lt;li&gt;âž¤ ATP synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 31/e p: 315.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 31/e p: 315.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;One specialized organ in mammals has a unique adaptation that allows it to utilize fuel oxidation not primarily for ATP production but for the generation of heat, aiding in thermoregulation. Which of the following is this specialized organ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenal gland&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skeletal music&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brown adipose tissue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heart&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brown adipose tissue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Brown adipose tissue&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brown adipose tissue is the specialized organ in mammals designed for heat production through non-shivering thermogenesis, emphasizing its role in thermoregulation and energy metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Brown adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ mammals designed&lt;/li&gt;&lt;li&gt;âž¤ heat production&lt;/li&gt;&lt;li&gt;âž¤ non-shivering thermogenesis,&lt;/li&gt;&lt;li&gt;âž¤ thermoregulation and energy metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 162, 267.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 162, 267.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following pairs of trace elements are essential for the proper functioning of the electron transport chain within the mitochondria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron and copper&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iodine and zinc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chromium and selenium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fluoride&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Iron and copper&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Iron and copper&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iodine and Zinc: Iodine is primarily involved in thyroid hormone synthesis , and zinc serves as a cofactor for numerous enzymes but neither are directly involved in the ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Iodine and Zinc:&lt;/li&gt;&lt;li&gt;â€¢ Iodine&lt;/li&gt;&lt;li&gt;â€¢ thyroid hormone synthesis&lt;/li&gt;&lt;li&gt;â€¢ zinc&lt;/li&gt;&lt;li&gt;â€¢ cofactor&lt;/li&gt;&lt;li&gt;â€¢ numerous&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ neither&lt;/li&gt;&lt;li&gt;â€¢ ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chromium and Selenium: Chromium is involved in glucose metabolism, and selenium is a component of certain antioxidant enzymes . They do not have a direct role in the ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chromium and Selenium:&lt;/li&gt;&lt;li&gt;â€¢ Chromium&lt;/li&gt;&lt;li&gt;â€¢ glucose metabolism,&lt;/li&gt;&lt;li&gt;â€¢ selenium&lt;/li&gt;&lt;li&gt;â€¢ antioxidant enzymes&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fluoride: Fluoride is known to inhibit certain enzymes but is not a component of the ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Fluoride:&lt;/li&gt;&lt;li&gt;â€¢ Fluoride&lt;/li&gt;&lt;li&gt;â€¢ inhibit&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ETC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complex I NADH Coenzyme Q Oxidoreductase : Contain FMN and Fe-S (Iron- Sulfur) Complex Complex IV Cytochrome c Oxidase : Contain Cyt a and a3 (also known as Heme a a3 ) and has Copper A and Copper B centre.&lt;/li&gt;&lt;li&gt;âž¤ Complex I NADH Coenzyme Q Oxidoreductase : Contain FMN and Fe-S (Iron- Sulfur) Complex&lt;/li&gt;&lt;li&gt;âž¤ Complex I NADH Coenzyme Q Oxidoreductase&lt;/li&gt;&lt;li&gt;âž¤ FMN and Fe-S (Iron- Sulfur) Complex&lt;/li&gt;&lt;li&gt;âž¤ Complex IV Cytochrome c Oxidase : Contain Cyt a and a3 (also known as Heme a a3 ) and has Copper A and Copper B centre.&lt;/li&gt;&lt;li&gt;âž¤ Complex IV Cytochrome c Oxidase&lt;/li&gt;&lt;li&gt;âž¤ Cyt a and a3&lt;/li&gt;&lt;li&gt;âž¤ Heme a a3&lt;/li&gt;&lt;li&gt;âž¤ Copper A and Copper B&lt;/li&gt;&lt;li&gt;âž¤ centre.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 261.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 261.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Two farmers were applying a locally sourced pesticide to cotton crops when they began exhibiting severe symptoms, including intense breathing difficulties, high fever, and eventual unconsciousness. Given the agricultural practices, the pesticide is suspected to contain a compound that disrupts oxidative phosphorylation within the cells. Which of the following substances, known to interfere with oxidative phosphorylation, would most likely mimic the effects of the agent in the pesticide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oligomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atractyloside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rotenone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dinitrophenol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dinitrophenol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dinitrophenol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The impact of uncoupling agents like dinitrophenol on oxidative phosphorylation , particularly how they can lead to increased heat production and oxygen consumption , resulting in symptoms such as high fever, heavy breathing, and loss of consciousness.&lt;/li&gt;&lt;li&gt;âž¤ uncoupling agents&lt;/li&gt;&lt;li&gt;âž¤ dinitrophenol&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ increased heat&lt;/li&gt;&lt;li&gt;âž¤ production&lt;/li&gt;&lt;li&gt;âž¤ oxygen consumption&lt;/li&gt;&lt;li&gt;âž¤ high fever, heavy breathing, and loss of consciousness.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 266.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician evaluates a child presenting with recurrent episodes of hypoglycemia, particularly noted during fasting periods. Further investigation reveals that the child has a metabolic condition impairing both glycogenolysis and gluconeogenesis. Which enzyme deficiency is most likely responsible for these metabolic disturbances in the child?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose 6 Phosphatase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transketolase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucose 6 Phosphatase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glucose 6 Phosphatase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6-phosphatase deficiency is a cause of impaired glycogenolysis and gluconeogenesis, leading to hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6-phosphatase deficiency&lt;/li&gt;&lt;li&gt;âž¤ impaired glycogenolysis and gluconeogenesis,&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p177.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p177.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following statements about gluconeogenesis is incorrect:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prevent hypoglycaemia during prolonged fasting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Occur in both muscle and liver&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Excess of acetyl CoA stimulate it&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbon skeleton of amino acid is involved&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Occur in both muscle and liver&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â  Occur in both muscle and liver&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis occur in liver and kidney not in the muscle Gluconeogenesis prevents hypoglycaemia in prolonged fasting Excess Acetyl CoA is an allosteric activator of Pyruvate Carboxylase, a key enzyme of Gluconeogenesis Carbon skeletons of gluconeogenic amino acids are involved in gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis occur in liver and kidney not in the muscle&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ liver and kidney&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis prevents hypoglycaemia in prolonged fasting&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ prevents hypoglycaemia&lt;/li&gt;&lt;li&gt;âž¤ prolonged fasting&lt;/li&gt;&lt;li&gt;âž¤ Excess Acetyl CoA is an allosteric activator of Pyruvate Carboxylase, a key enzyme of Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ allosteric activator of Pyruvate Carboxylase,&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ Carbon skeletons of gluconeogenic amino acids are involved in gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Carbon&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenic amino&lt;/li&gt;&lt;li&gt;âž¤ acids&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p187&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p187&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following glycogen storage diseases typically spares the muscles from involvement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type V&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type VII&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Type I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Type I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type II: Type II, or Pompe disease , involves lysosomal alpha-1,4-glucosidase deficiency and affects cardiac and skeletal muscles, leading to progressive muscle weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type II:&lt;/li&gt;&lt;li&gt;â€¢ Pompe disease&lt;/li&gt;&lt;li&gt;â€¢ lysosomal alpha-1,4-glucosidase deficiency&lt;/li&gt;&lt;li&gt;â€¢ cardiac and skeletal&lt;/li&gt;&lt;li&gt;â€¢ muscles,&lt;/li&gt;&lt;li&gt;â€¢ progressive muscle weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type V: Type V, known as McArdle disease , specifically affects muscle phosphorylase and is characterized by muscle cramps and exercise intolerance , indicating direct muscle involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Type V:&lt;/li&gt;&lt;li&gt;â€¢ McArdle disease&lt;/li&gt;&lt;li&gt;â€¢ muscle phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ muscle&lt;/li&gt;&lt;li&gt;â€¢ cramps and exercise intolerance&lt;/li&gt;&lt;li&gt;â€¢ direct muscle involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type VII: Type VII, or Tarui disease, involves phosphofructokinase deficiency in muscle cells, leading to exercise intolerance and myopathy, hence directly affecting muscles .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type VII:&lt;/li&gt;&lt;li&gt;â€¢ Tarui disease,&lt;/li&gt;&lt;li&gt;â€¢ phosphofructokinase deficiency&lt;/li&gt;&lt;li&gt;â€¢ exercise&lt;/li&gt;&lt;li&gt;â€¢ intolerance and myopathy,&lt;/li&gt;&lt;li&gt;â€¢ directly affecting muscles&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Von Gierke disease (Ia) is due to Glucose 6 phosphatase deficiency Clinical features include glycogen accumulation in liver and renal tubule cells , hypoglycaemia, lactic acidemia, ketosis and hyperlipidemia . ( No muscle weakness ).&lt;/li&gt;&lt;li&gt;âž¤ Von Gierke disease (Ia) is due to Glucose 6 phosphatase deficiency&lt;/li&gt;&lt;li&gt;âž¤ Von Gierke disease (Ia)&lt;/li&gt;&lt;li&gt;âž¤ Glucose 6 phosphatase deficiency&lt;/li&gt;&lt;li&gt;âž¤ Clinical features include glycogen accumulation in liver and renal tubule cells , hypoglycaemia, lactic acidemia, ketosis and hyperlipidemia . ( No muscle weakness ).&lt;/li&gt;&lt;li&gt;âž¤ glycogen&lt;/li&gt;&lt;li&gt;âž¤ liver and renal tubule cells&lt;/li&gt;&lt;li&gt;âž¤ hypoglycaemia, lactic acidemia, ketosis&lt;/li&gt;&lt;li&gt;âž¤ hyperlipidemia&lt;/li&gt;&lt;li&gt;âž¤ No muscle weakness&lt;/li&gt;&lt;li&gt;âž¤ Muscle Glycogen Storage Disorders:&lt;/li&gt;&lt;li&gt;âž¤ Muscle Glycogen Storage Disorders:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Nelson 20/e Defects in the metabolism of Carbohydrates&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Nelson 20/e Defects in the metabolism of Carbohydrates&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Considering the physiological adaptations in chronic anemia, assess the following assertion (A) and reasoning (R): Assertion (A): Level of 2,3-BPG is elevated in chronic anaemia. Reasoning (R): High 2,3-BPG levels lowers the oxygen affinity of hemoglobin, permitting unloading of oxygen in tissues.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A as well as R are right, and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A as well as R are right, and R is a correct explanation of A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The concentration of 2,3-BPG in the RBC increases in response to chronic hypoxia , such as in COPD like emphysema, or at high altitudes, where circulating haemoglobin may have difficulty receiving sufficient oxygen. Intra cellular levels of 2,3-BPG are also elevated in chronic anaemia, in which fewer than normal RBCs are available to supply the bodyâ€™s oxygen needs. Elevated 2,3-BPG levels lower the oxygen affinity of haemoglobin , permitting greater unloading of oxygen in the capillaries of the tissues Hb F has low affinity towards 2, 3 BPG.&lt;/li&gt;&lt;li&gt;â€¢ The concentration of 2,3-BPG in the RBC increases in response to chronic hypoxia , such as in COPD like emphysema, or at high altitudes, where circulating haemoglobin may have difficulty receiving sufficient oxygen.&lt;/li&gt;&lt;li&gt;â€¢ 2,3-BPG in the RBC increases&lt;/li&gt;&lt;li&gt;â€¢ chronic hypoxia&lt;/li&gt;&lt;li&gt;â€¢ COPD&lt;/li&gt;&lt;li&gt;â€¢ emphysema,&lt;/li&gt;&lt;li&gt;â€¢ high altitudes,&lt;/li&gt;&lt;li&gt;â€¢ circulating haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ difficulty&lt;/li&gt;&lt;li&gt;â€¢ sufficient oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Intra cellular levels of 2,3-BPG are also elevated in chronic anaemia, in which fewer than normal RBCs are available to supply the bodyâ€™s oxygen needs.&lt;/li&gt;&lt;li&gt;â€¢ Intra cellular levels&lt;/li&gt;&lt;li&gt;â€¢ 2,3-BPG&lt;/li&gt;&lt;li&gt;â€¢ elevated in chronic anaemia,&lt;/li&gt;&lt;li&gt;â€¢ fewer&lt;/li&gt;&lt;li&gt;â€¢ normal RBCs&lt;/li&gt;&lt;li&gt;â€¢ bodyâ€™s oxygen needs.&lt;/li&gt;&lt;li&gt;â€¢ Elevated 2,3-BPG levels lower the oxygen affinity of haemoglobin , permitting greater unloading of oxygen in the capillaries of the tissues&lt;/li&gt;&lt;li&gt;â€¢ Elevated 2,3-BPG levels lower&lt;/li&gt;&lt;li&gt;â€¢ oxygen affinity&lt;/li&gt;&lt;li&gt;â€¢ haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ greater&lt;/li&gt;&lt;li&gt;â€¢ oxygen&lt;/li&gt;&lt;li&gt;â€¢ capillaries of the tissues&lt;/li&gt;&lt;li&gt;â€¢ Hb F has low affinity towards 2, 3 BPG.&lt;/li&gt;&lt;li&gt;â€¢ Hb F&lt;/li&gt;&lt;li&gt;â€¢ low affinity&lt;/li&gt;&lt;li&gt;â€¢ 2, 3 BPG.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In chronic anemia , the body compensates by increasing 2,3-BPG levels in red blood cells to enhance the release of oxygen from hemoglobin to the tissues . This biochemical response is crucial for improving oxygen delivery despite a reduced number of erythrocytes.&lt;/li&gt;&lt;li&gt;âž¤ chronic anemia&lt;/li&gt;&lt;li&gt;âž¤ increasing 2,3-BPG levels in red blood cells&lt;/li&gt;&lt;li&gt;âž¤ release of oxygen&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin to the tissues&lt;/li&gt;&lt;li&gt;âž¤ improving oxygen delivery&lt;/li&gt;&lt;li&gt;âž¤ despite&lt;/li&gt;&lt;li&gt;âž¤ reduced number&lt;/li&gt;&lt;li&gt;âž¤ erythrocytes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 57, Lippincott 6/e: p 31, 32.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 57, Lippincott 6/e: p 31, 32.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately reflects a metabolic characteristic of the well-fed state&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NADPH production by the hexose monophosphate shunt is decreased.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetoacetate is the major fuel for muscle.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucose transport into adipose tissue is decreased.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The major fuel used by the brain is glucose.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The major fuel used by the brain is glucose.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Â Â The major fuel used by the brain is glucose.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. NADPH production by the hexose monophosphate shunt is decreased: Liver production of NADPH is at a high level because it is needed for fatty acid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. NADPH production by the hexose monophosphate shunt is decreased:&lt;/li&gt;&lt;li&gt;â€¢ NADPH&lt;/li&gt;&lt;li&gt;â€¢ high level&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Acetoacetate is the major fuel for muscle: During the absorptive phase , ketone bodies such as acetoacetate and 3-hydroxybutyrate are low with glucose rather than these ketones used by muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option B.  Acetoacetate is the major fuel for muscle:&lt;/li&gt;&lt;li&gt;â€¢ absorptive phase&lt;/li&gt;&lt;li&gt;â€¢ ketone bodies&lt;/li&gt;&lt;li&gt;â€¢ acetoacetate and 3-hydroxybutyrate are low&lt;/li&gt;&lt;li&gt;â€¢ glucose&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Glucose transport into adipose tissue is decreased: Glucose is actively transported into all cells , including adipocytes, which require it to form glycerol-3-phosphate for esterification of fatty acids into triacylglycerides.&lt;/li&gt;&lt;li&gt;â€¢ Option C.  Glucose transport into adipose tissue is decreased:&lt;/li&gt;&lt;li&gt;â€¢ Glucose&lt;/li&gt;&lt;li&gt;â€¢ actively&lt;/li&gt;&lt;li&gt;â€¢ all cells&lt;/li&gt;&lt;li&gt;â€¢ adipocytes,&lt;/li&gt;&lt;li&gt;â€¢ glycerol-3-phosphate&lt;/li&gt;&lt;li&gt;â€¢ esterification of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ triacylglycerides.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a well-fed state, the brain continues to use glucose as its primary energy source. The blood glucose levels are sufficient , and insulin facilitates glucose uptake into the brain cells.&lt;/li&gt;&lt;li&gt;âž¤ well-fed state,&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ continues&lt;/li&gt;&lt;li&gt;âž¤ use glucose&lt;/li&gt;&lt;li&gt;âž¤ its primary energy&lt;/li&gt;&lt;li&gt;âž¤ blood glucose levels&lt;/li&gt;&lt;li&gt;âž¤ sufficient&lt;/li&gt;&lt;li&gt;âž¤ insulin facilitates glucose uptake&lt;/li&gt;&lt;li&gt;âž¤ brain cells.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 101.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 101.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a pediatric rotation, a medical student observes the management of a child presenting with acute gastroenteritis and signs of dehydration. The attending physician prescribes oral rehydration solution (ORS). The student learns that the efficacy of ORS is partly due to its facilitation of glucose absorption, which in turn enhances electrolyte and water uptake in the intestines. Which glucose transporter is primarily responsible for the glucose absorption facilitated by ORS in the intestinal mucosa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SGLT 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SGLT 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GLUT 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GLUT 2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SGLT 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) SGLT-1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B.  SGLT-2: SGLT-2 is defective in congenital renal glycosuria&lt;/li&gt;&lt;li&gt;â€¢ Option B.  SGLT-2:&lt;/li&gt;&lt;li&gt;â€¢ defective&lt;/li&gt;&lt;li&gt;â€¢ congenital renal glycosuria&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLUT 4: Insulin-mediated glucose uptake. Involved in Type 2 diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Option C. GLUT 4:&lt;/li&gt;&lt;li&gt;â€¢ Insulin-mediated glucose uptake.&lt;/li&gt;&lt;li&gt;â€¢ Type 2 diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Option D.  GLUT 2: Enables the pancreas to monitor the glucose level, thereby adjusts the rate of insulin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  GLUT 2:&lt;/li&gt;&lt;li&gt;â€¢ Enables the pancreas&lt;/li&gt;&lt;li&gt;â€¢ monitor the glucose level,&lt;/li&gt;&lt;li&gt;â€¢ rate of insulin secretion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SGLT 1 ( sodium-glucose cotransporter 1 ) is responsible for the absorption of glucose in the small intestine. It cotransports sodium and glucose from the intestinal lumen into enterocytes , thereby facilitating the absorption of water and electrolytes, which is the principle behind the effectiveness of ORS.&lt;/li&gt;&lt;li&gt;âž¤ SGLT 1&lt;/li&gt;&lt;li&gt;âž¤ sodium-glucose cotransporter 1&lt;/li&gt;&lt;li&gt;âž¤ absorption of glucose&lt;/li&gt;&lt;li&gt;âž¤ small intestine.&lt;/li&gt;&lt;li&gt;âž¤ cotransports sodium&lt;/li&gt;&lt;li&gt;âž¤ glucose from the intestinal lumen&lt;/li&gt;&lt;li&gt;âž¤ enterocytes&lt;/li&gt;&lt;li&gt;âž¤ facilitating the absorption of water and electrolytes,&lt;/li&gt;&lt;li&gt;âž¤ effectiveness of ORS.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 106.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 106.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with chronic obstructive pulmonary disease (COPD) has been receiving supplemental oxygen therapy for several years, leading to an improvement in symptoms. However, concerns arise regarding potential lung injury from prolonged oxygen exposure, known as oxygen toxicity. This condition can lead to a decrease in the rate of glycolysis due to high oxygen levels. What is the phenomenon called where elevated oxygen levels decrease the glycolysis rate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Crabtree Effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pasteur Effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chemiosmotic effect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Feedback inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pasteur Effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pasteur Effect.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Pasteur effect describes the inhibition of glycolysis by high concentrations of oxygen. In the presence of oxygen, cells preferentially utilize aerobic metabolism , which is more efficient in terms of ATP production, leading to a reduced need for glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Pasteur effect&lt;/li&gt;&lt;li&gt;âž¤ inhibition of glycolysis&lt;/li&gt;&lt;li&gt;âž¤ high concentrations of oxygen.&lt;/li&gt;&lt;li&gt;âž¤ presence of oxygen,&lt;/li&gt;&lt;li&gt;âž¤ cells&lt;/li&gt;&lt;li&gt;âž¤ utilize aerobic metabolism&lt;/li&gt;&lt;li&gt;âž¤ more&lt;/li&gt;&lt;li&gt;âž¤ ATP production,&lt;/li&gt;&lt;li&gt;âž¤ leading&lt;/li&gt;&lt;li&gt;âž¤ reduced&lt;/li&gt;&lt;li&gt;âž¤ glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 285-287.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 285-287.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a research project focusing on glucose metabolism, a group of medical students observe that ATP is produced in the cytosol before the breakdown products of glucose enter the mitochondria. This finding highlights an important step in the glycolytic pathway. Which enzyme involved in glucose metabolism is responsible for this early ATP generation in the cytosol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate kinase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pyruvate kinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture19_T9tgs1j.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pyruvate kinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hexokinase: Catalyzes the first step of glycolysis, phosphorylating glucose to glucose-6-phosphate , but does not directly result in ATP generation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hexokinase:&lt;/li&gt;&lt;li&gt;â€¢ first step&lt;/li&gt;&lt;li&gt;â€¢ glycolysis, phosphorylating glucose to glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ATP generation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucokinase: Functions similarly to hexokinase but is specific to the liver and pancreatic Î²-cells, also not directly involved in ATP generation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glucokinase:&lt;/li&gt;&lt;li&gt;â€¢ specific to the liver and pancreatic Î²-cells,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ATP generation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phosphofructokinase: A key regulatory enzyme in glycolysis that catalyzes the conversion of fructose-6-phosphate to fructose-1,6-bisphosphate, not directly involved in ATP generation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phosphofructokinase:&lt;/li&gt;&lt;li&gt;â€¢ regulatory enzyme&lt;/li&gt;&lt;li&gt;â€¢ catalyzes&lt;/li&gt;&lt;li&gt;â€¢ fructose-6-phosphate to&lt;/li&gt;&lt;li&gt;â€¢ fructose-1,6-bisphosphate,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ATP generation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate kinase is involved in the last step of the glycolytic pathway, where it catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate , generating ATP in the process. This occurs in the cytosol and is one of the steps in glycolysis that produces ATP before the metabolites enter the mitochondria for further energy production processes like the citric acid cycle and oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate kinase&lt;/li&gt;&lt;li&gt;âž¤ last step&lt;/li&gt;&lt;li&gt;âž¤ glycolytic pathway,&lt;/li&gt;&lt;li&gt;âž¤ conversion of phosphoenolpyruvate&lt;/li&gt;&lt;li&gt;âž¤ to pyruvate&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ occurs&lt;/li&gt;&lt;li&gt;âž¤ cytosol&lt;/li&gt;&lt;li&gt;âž¤ one&lt;/li&gt;&lt;li&gt;âž¤ steps in glycolysis&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ before the metabolites&lt;/li&gt;&lt;li&gt;âž¤ enter&lt;/li&gt;&lt;li&gt;âž¤ mitochondria&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ production&lt;/li&gt;&lt;li&gt;âž¤ citric acid cycle&lt;/li&gt;&lt;li&gt;âž¤ oxidative&lt;/li&gt;&lt;li&gt;âž¤ phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 168-172.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 168-172.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While conducting a research study on the efficiency of various diets on long-distance runners, a team of exercise physiologists focuses on the metabolic pathways that are most active during extended periods of physical activity. They are particularly interested in quantifying the energy output from different substrates. The team debates the number of ATP molecules generated from the complete oxidation of one molecule of acetyl CoA through the TCA cycle. What is the correct ATP yield from this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;9 ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10 ATP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;13 ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;12 ATP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 10 ATP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture24.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â  10 ATP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The oxidation of one molecule of acetyl CoA in the TCA cycle produces 3 NADH, 1 FADH2, and 1 GTP. With the assumption that 1 NADH generates 2.5 ATP and 1 FADH2 yields 1.5 ATP through oxidative phosphorylation, the total ATP produced is calculated as follows:&lt;/li&gt;&lt;li&gt;â€¢ oxidation of one molecule of acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ 3 NADH, 1 FADH2, and 1 GTP.&lt;/li&gt;&lt;li&gt;â€¢ 1&lt;/li&gt;&lt;li&gt;â€¢ NADH generates 2.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ 1 FADH2 yields 1.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ oxidative phosphorylation,&lt;/li&gt;&lt;li&gt;â€¢ total ATP&lt;/li&gt;&lt;li&gt;â€¢ 3 NADH x 2.5 ATP/NADH = 7.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ 3 NADH x 2.5 ATP/NADH&lt;/li&gt;&lt;li&gt;â€¢ 7.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ 1 FADH2 x 1.5 ATP/FADH2 = 1.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ 1 FADH2 x 1.5 ATP/FADH2 = 1.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ 1 GTP = 1 ATP&lt;/li&gt;&lt;li&gt;â€¢ 1 GTP = 1 ATP&lt;/li&gt;&lt;li&gt;â€¢ The sum of these yields a total of 10 ATP per molecule of acetyl CoA oxidized through the TCA cycle, making option B the most accurate answer.&lt;/li&gt;&lt;li&gt;â€¢ 10 ATP&lt;/li&gt;&lt;li&gt;â€¢ acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ TCA cycle,&lt;/li&gt;&lt;li&gt;â€¢ option B&lt;/li&gt;&lt;li&gt;â€¢ accurate answer.&lt;/li&gt;&lt;li&gt;â€¢ Note - Three molecules of NADH and one of FADH2 are produced for each molecule of acetyl-CoA catabolized in one turn of the cycle.&lt;/li&gt;&lt;li&gt;â€¢ Three molecules of NADH&lt;/li&gt;&lt;li&gt;â€¢ one of FADH2&lt;/li&gt;&lt;li&gt;â€¢ each molecule of acetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ one&lt;/li&gt;&lt;li&gt;â€¢ cycle.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 253.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 253.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In conditions of low oxygen levels (low pO2), the body must adapt its metabolic pathways to ensure energy production continues. One such adaptation involves an enzyme that compensates for reduced Tricarboxylic Acid (TCA) cycle activity under hypoxic conditions. This enzyme facilitates a key step in an alternative pathway, allowing cells to generate ATP anaerobically. Which enzyme is responsible for this compensatory mechanism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pyruvate dehydrogenase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lactate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture25.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lactate dehydrogenase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the absence of mitochondria (Eg: RBC) and in hypoxic conditions , anaerobic glycolysis will be turned on where lactate dehydrogenase (LDH) will convert pyruvate to lactate.&lt;/li&gt;&lt;li&gt;âž¤ absence of mitochondria (Eg: RBC)&lt;/li&gt;&lt;li&gt;âž¤ hypoxic conditions&lt;/li&gt;&lt;li&gt;âž¤ anaerobic glycolysis&lt;/li&gt;&lt;li&gt;âž¤ lactate dehydrogenase (LDH)&lt;/li&gt;&lt;li&gt;âž¤ pyruvate to lactate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 168-169.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 168-169.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Many compounds poison the respiratory chain by inhibiting various steps of oxidation or phosphorylation. Which of the following steps is inhibited by carbon monoxide and cyanide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxidation step between cytochrome and coenzyme Q and distal cytochromes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxidation step involving direct reduction of oxygen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uncoupling of oxidation from phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxidation step between cytochromes c and b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oxidation step involving direct reduction of oxygen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oxidation step involving direct reduction of oxygen)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbon monoxide and cyanide inhibit cytochrome oxidase , the terminal step of the respiratory chain that is driven by oxygen reduction to water Barbiturates block transfer from cytochrome to coenzyme Q, antimycin A, and dimercaprol, the step between cytochromes c and b, and dinitrophenol is an uncoupler that releases the respiratory chain from regulation by energy (phosphorylation) needs. Oligomycin blocks phosphorylation by inhibiting ATP synthase , thus shutting down its coupled oxidation .&lt;/li&gt;&lt;li&gt;âž¤ Carbon monoxide and cyanide inhibit cytochrome oxidase , the terminal step of the respiratory chain that is driven by oxygen reduction to water&lt;/li&gt;&lt;li&gt;âž¤ Carbon monoxide&lt;/li&gt;&lt;li&gt;âž¤ cyanide&lt;/li&gt;&lt;li&gt;âž¤ cytochrome oxidase&lt;/li&gt;&lt;li&gt;âž¤ respiratory chain&lt;/li&gt;&lt;li&gt;âž¤ oxygen reduction to water&lt;/li&gt;&lt;li&gt;âž¤ Barbiturates block transfer from cytochrome to coenzyme Q, antimycin A, and dimercaprol, the step between cytochromes c and b, and dinitrophenol is an uncoupler that releases the respiratory chain from regulation by energy (phosphorylation) needs. Oligomycin blocks phosphorylation by inhibiting ATP synthase , thus shutting down its coupled oxidation .&lt;/li&gt;&lt;li&gt;âž¤ Barbiturates block&lt;/li&gt;&lt;li&gt;âž¤ cytochrome to coenzyme Q, antimycin A, and dimercaprol,&lt;/li&gt;&lt;li&gt;âž¤ cytochromes c and b,&lt;/li&gt;&lt;li&gt;âž¤ dinitrophenol&lt;/li&gt;&lt;li&gt;âž¤ uncoupler&lt;/li&gt;&lt;li&gt;âž¤ respiratory chain&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ Oligomycin blocks phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ inhibiting ATP synthase&lt;/li&gt;&lt;li&gt;âž¤ shutting down&lt;/li&gt;&lt;li&gt;âž¤ coupled oxidation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper Illustrated Biochemistry 31/e p 321-22.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper Illustrated Biochemistry 31/e p 321-22.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The electron transport chain (ETC) plays a critical role in the final stages of energy production within mitochondria. This complex system involves a series of electron carriers that facilitate the transfer of electrons, culminating in ATP synthesis. Among the list below, which component is not involved in the mitochondrial electron transport chain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NADP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NAD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coenzyme Q&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FAD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. NADP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Image88667.PNG&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) NADP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The main components of the ETC includes:&lt;/li&gt;&lt;li&gt;âž¤ Complex I (NADH: ubiquinone oxidoreductase) Complex II (Succinate dehydrogenase) Coenzyme Q (Ubiquinone) Complex III (Cytochrome bc1 complex): Cytochrome C Complex IV (Cytochrome c oxidase) ATP Synthase (Complex V)&lt;/li&gt;&lt;li&gt;âž¤ Complex I (NADH: ubiquinone oxidoreductase)&lt;/li&gt;&lt;li&gt;âž¤ Complex II (Succinate dehydrogenase)&lt;/li&gt;&lt;li&gt;âž¤ Coenzyme Q (Ubiquinone)&lt;/li&gt;&lt;li&gt;âž¤ Complex III (Cytochrome bc1 complex):&lt;/li&gt;&lt;li&gt;âž¤ Cytochrome C&lt;/li&gt;&lt;li&gt;âž¤ Complex IV (Cytochrome c oxidase)&lt;/li&gt;&lt;li&gt;âž¤ ATP Synthase (Complex V)&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 262.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the malate-aspartate shuttle is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is used to transport NADH from Cytosol to Mitochondria.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is used to transport NADPH from Cytoplasm to Mitochondria.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malate get converted to Oxaloacetate and release NADH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxaloacetate is reconstituted from Aspartate and Î± Ketoglutarate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is used to transport NADPH from Cytoplasm to Mitochondria.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The malate-aspartate shuttle is a key biochemical system that allows the transfer of reducing equivalents (NADH) from the cytosol into the mitochondrial matrix, because the inner mitochondrial membrane is impermeable to NADH itself.&lt;/li&gt;&lt;li&gt;â€¢ How it works:&lt;/li&gt;&lt;li&gt;â€¢ How it works:&lt;/li&gt;&lt;li&gt;â€¢ In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH. Malate is transported into the mitochondria. In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria. OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.&lt;/li&gt;&lt;li&gt;â€¢ In the cytosol: Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.&lt;/li&gt;&lt;li&gt;â€¢ Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.&lt;/li&gt;&lt;li&gt;â€¢ Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.&lt;/li&gt;&lt;li&gt;â€¢ Malate is transported into the mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ In the mitochondria: Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.&lt;/li&gt;&lt;li&gt;â€¢ OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle. Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system. Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate â†’ OAA + NADH (via malate dehydrogenase). Option D. Oxaloacetate is reconstituted from Aspartate and Î±-Ketoglutarate : True. Aspartate + Î±-KG â†” OAA + glutamate (via transamination).&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is used to transport NADH from Cytosol to Mitochondria : True. This is the core purpose of the shuttle.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is used to transport NADH from Cytosol to Mitochondria&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is used to transport NADPH from Cytoplasm to Mitochondria : False. The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is used to transport NADPH from Cytoplasm to Mitochondria&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malate gets converted to Oxaloacetate and releases NADH : True. Inside mitochondria, malate â†’ OAA + NADH (via malate dehydrogenase).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malate gets converted to Oxaloacetate and releases NADH&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxaloacetate is reconstituted from Aspartate and Î±-Ketoglutarate : True. Aspartate + Î±-KG â†” OAA + glutamate (via transamination).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxaloacetate is reconstituted from Aspartate and Î±-Ketoglutarate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation . It operates via a series of reversible reactions , involving: Oxaloacetate â†’ Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate â†’ Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  â†” aspartate + Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ The malate-aspartate shuttle transfers cytosolic NADH equivalents into the mitochondria for oxidative phosphorylation .&lt;/li&gt;&lt;li&gt;âž¤ malate-aspartate shuttle&lt;/li&gt;&lt;li&gt;âž¤ cytosolic NADH equivalents&lt;/li&gt;&lt;li&gt;âž¤ oxidative phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ It operates via a series of reversible reactions , involving: Oxaloacetate â†’ Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate â†’ Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  â†” aspartate + Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ series of reversible reactions&lt;/li&gt;&lt;li&gt;âž¤ Oxaloacetate â†’ Malate (reduced by cytosolic NADH) Malate transport into mitochondria Malate â†’ Oxaloacetate (regenerates NADH in matrix) Transamination of oxaloacetate+ Glutamate  â†” aspartate + Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ Oxaloacetate â†’ Malate (reduced by cytosolic NADH)&lt;/li&gt;&lt;li&gt;âž¤ Oxaloacetate â†’ Malate&lt;/li&gt;&lt;li&gt;âž¤ Malate transport into mitochondria&lt;/li&gt;&lt;li&gt;âž¤ Malate transport&lt;/li&gt;&lt;li&gt;âž¤ Malate â†’ Oxaloacetate (regenerates NADH in matrix)&lt;/li&gt;&lt;li&gt;âž¤ Malate â†’ Oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ Transamination of oxaloacetate+ Glutamate  â†” aspartate + Î±-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ Transamination&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 219.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 159 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test4" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Concepts&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Concepts&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                9 Questions | 36 Total Marks | 19 min Duration | ~126.67 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 2-year-old child presents to the pediatric outpatient department with a week-long fever but otherwise normal physical examination findings. To rule out an inborn error of metabolism, a urine screening test is performed, yielding the following results: Benedictâ€™s test - positive Blood Glucose - 110 mg % Bialâ€™s test - positive Urine glucose, fructose and galactose - Negative. What is your most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential pentosuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Essential fructosuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditary fructose intolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galactosemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Essential pentosuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Essential pentosuria is a benign, inherited condition caused by a deficiency of L-xylulose reductase , an enzyme of the glucuronic acid pathway . The defect leads to the accumulation and urinary excretion of L-xylulose , a pentose sugar.&lt;/li&gt;&lt;li&gt;â€¢ benign, inherited condition&lt;/li&gt;&lt;li&gt;â€¢ L-xylulose reductase&lt;/li&gt;&lt;li&gt;â€¢ glucuronic acid pathway&lt;/li&gt;&lt;li&gt;â€¢ L-xylulose&lt;/li&gt;&lt;li&gt;â€¢ Because L-xylulose is a reducing sugar , it reacts positively with Benedictâ€™s test , even when blood glucose is normal â€” which is exactly what the lab findings here show.&lt;/li&gt;&lt;li&gt;â€¢ L-xylulose is a reducing sugar&lt;/li&gt;&lt;li&gt;â€¢ Benedictâ€™s test&lt;/li&gt;&lt;li&gt;â€¢ blood glucose is normal&lt;/li&gt;&lt;li&gt;â€¢ Bialâ€™s test specifically detects pentoses and produces a characteristic blue-green color , confirming the presence of a pentose rather than a hexose (like glucose, fructose, or galactose).&lt;/li&gt;&lt;li&gt;â€¢ Bialâ€™s test&lt;/li&gt;&lt;li&gt;â€¢ pentoses&lt;/li&gt;&lt;li&gt;â€¢ blue-green color&lt;/li&gt;&lt;li&gt;â€¢ In this case:&lt;/li&gt;&lt;li&gt;â€¢ Benedictâ€™s test: Positive â†’ Reducing sugar is present. Blood glucose: Normal (110 mg/dL) â†’ rules out diabetes. Urine glucose, fructose, galactose: Negative â†’ excludes common hexose sugars. Bialâ€™s test: Positive â†’ confirms the sugar is a pentose.&lt;/li&gt;&lt;li&gt;â€¢ Benedictâ€™s test: Positive â†’ Reducing sugar is present.&lt;/li&gt;&lt;li&gt;â€¢ Benedictâ€™s test: Positive&lt;/li&gt;&lt;li&gt;â€¢ Blood glucose: Normal (110 mg/dL) â†’ rules out diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Blood glucose: Normal (110 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ Urine glucose, fructose, galactose: Negative â†’ excludes common hexose sugars.&lt;/li&gt;&lt;li&gt;â€¢ Urine glucose, fructose, galactose: Negative&lt;/li&gt;&lt;li&gt;â€¢ Bialâ€™s test: Positive â†’ confirms the sugar is a pentose.&lt;/li&gt;&lt;li&gt;â€¢ Bialâ€™s test: Positive&lt;/li&gt;&lt;li&gt;â€¢ All this points clearly to essential pentosuria .&lt;/li&gt;&lt;li&gt;â€¢ essential pentosuria&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Essential Fructosuria: Fructose would be detected in urine (fructosuria), confirmed by a positive Seliwanoffâ€™s test (specific for ketohexoses like fructose). Here, fructose is absent, ruling this out. Option C â€” Hereditary Fructose Intolerance: This condition involves aldolase B deficiency , leading to trapped fructose-1-phosphate . Symptoms include hypoglycemia, vomiting, liver damage when fructose is ingested, and fructose would be present in urine, but here it&#x27;s negative . Option D â€” Galactosemia: Characterized by defective metabolism of galactose, usually due to galactose-1-phosphate uridyl transferase deficiency . Galactose would be detectable in urine (but here, itâ€™s negative) and typically presents with cataracts, hepatomegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Essential Fructosuria: Fructose would be detected in urine (fructosuria), confirmed by a positive Seliwanoffâ€™s test (specific for ketohexoses like fructose). Here, fructose is absent, ruling this out.&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Essential Fructosuria:&lt;/li&gt;&lt;li&gt;â€¢ positive Seliwanoffâ€™s test&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Hereditary Fructose Intolerance: This condition involves aldolase B deficiency , leading to trapped fructose-1-phosphate . Symptoms include hypoglycemia, vomiting, liver damage when fructose is ingested, and fructose would be present in urine, but here it&#x27;s negative .&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Hereditary Fructose Intolerance:&lt;/li&gt;&lt;li&gt;â€¢ aldolase B deficiency&lt;/li&gt;&lt;li&gt;â€¢ fructose-1-phosphate&lt;/li&gt;&lt;li&gt;â€¢ negative&lt;/li&gt;&lt;li&gt;â€¢ Option D â€” Galactosemia: Characterized by defective metabolism of galactose, usually due to galactose-1-phosphate uridyl transferase deficiency . Galactose would be detectable in urine (but here, itâ€™s negative) and typically presents with cataracts, hepatomegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option D â€” Galactosemia:&lt;/li&gt;&lt;li&gt;â€¢ galactose-1-phosphate uridyl transferase deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Essential Pentosuria is a harmless, inherited metabolic condition characterized by the excretion of the pentose sugar L-xylulose in urine. This can lead to false-positive results on tests for reducing sugars (Benedictâ€™s) despite normal blood glucose levels. Bialâ€™s test further confirms the presence of pentoses, distinguishing it from hexoses like glucose, fructose, or galactose.&lt;/li&gt;&lt;li&gt;âž¤ Essential Pentosuria&lt;/li&gt;&lt;li&gt;âž¤ L-xylulose&lt;/li&gt;&lt;li&gt;âž¤ Bialâ€™s test&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p196, 205.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female patient presents with the complaint of progressively darkened, velvety patches of skin on her neck and axillary regions. These skin changes have been accompanied by increased thirst and frequent urination. Given these symptoms and the characteristic skin findings, which of the following could be the underlying molecular mechanism of her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dysfunctional glucagon receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysfunctional EGF receptors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Persistently inhibited insulin receptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Persistently stimulated insulin receptors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Persistently inhibited insulin receptors&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture1_qOWv6QL.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Options A: Dysfunctional glucagon receptors typically would not result in skin changes like those described. Glucagon is a catabolic hormone that raises blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Options A:&lt;/li&gt;&lt;li&gt;â€¢ Dysfunctional glucagon receptors&lt;/li&gt;&lt;li&gt;â€¢ not result in skin changes&lt;/li&gt;&lt;li&gt;â€¢ Options B: Dysfunctional EGF receptors are associated with various cellular dysfunctions and cancer, not typically with the skin changes seen in acanthosis nigricans.&lt;/li&gt;&lt;li&gt;â€¢ Options B:&lt;/li&gt;&lt;li&gt;â€¢ Dysfunctional EGF receptors&lt;/li&gt;&lt;li&gt;â€¢ cellular dysfunctions&lt;/li&gt;&lt;li&gt;â€¢ cancer,&lt;/li&gt;&lt;li&gt;â€¢ Options D: Only inhibition leads to insulin resistance.&lt;/li&gt;&lt;li&gt;â€¢ Options D:&lt;/li&gt;&lt;li&gt;â€¢ inhibition leads&lt;/li&gt;&lt;li&gt;â€¢ insulin resistance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Acanthosis nigricanâ€™s, is closely related to insulin resistance. The darkened skin patches are due to hyperinsulinemia that occurs secondary to insulin receptor inhibition, leading to increased insulin-like growth factor activity on skin cells.&lt;/li&gt;&lt;li&gt;âž¤ Acanthosis nigricanâ€™s,&lt;/li&gt;&lt;li&gt;âž¤ insulin resistance.&lt;/li&gt;&lt;li&gt;âž¤ darkened skin patches&lt;/li&gt;&lt;li&gt;âž¤ hyperinsulinemia&lt;/li&gt;&lt;li&gt;âž¤ secondary to insulin receptor inhibition,&lt;/li&gt;&lt;li&gt;âž¤ increased insulin-like growth factor&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 173,174,764 .&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 173,174,764&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male patient with a history of jaundice was subjected to a direct Van den Bergh reaction as part of his diagnostic workup. The test came positive. Based on these results, which type of bilirubin is present in the patient&#x27;s blood serum that would cause a positive direct Van den Berghâ€™s reaction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conjugated bilirubin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Unconjugated bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urobilinogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bile salts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Conjugated bilirubin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Conjugated bilirubin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Van den Bergh reaction&lt;/li&gt;&lt;li&gt;â€¢ conjugated (direct) bilirubin&lt;/li&gt;&lt;li&gt;â€¢ unconjugated (indirect) bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Conjugated bilirubin is water-soluble because it has been conjugated with glucuronic acid in the liver. It reacts directly with diazotized sulfanilic acid (diazo reagent) to form a purple azo dye â€” without requiring alcohol. This immediate reaction is called a Direct Positive Van den Bergh Test .&lt;/li&gt;&lt;li&gt;â€¢ Conjugated bilirubin is water-soluble because it has been conjugated with glucuronic acid in the liver. It reacts directly with diazotized sulfanilic acid (diazo reagent) to form a purple azo dye â€” without requiring alcohol. This immediate reaction is called a Direct Positive Van den Bergh Test .&lt;/li&gt;&lt;li&gt;â€¢ Conjugated bilirubin&lt;/li&gt;&lt;li&gt;â€¢ water-soluble&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ diazotized sulfanilic acid (diazo reagent)&lt;/li&gt;&lt;li&gt;â€¢ purple azo dye&lt;/li&gt;&lt;li&gt;â€¢ Direct Positive Van den Bergh Test&lt;/li&gt;&lt;li&gt;â€¢ So, a positive direct reaction means conjugated bilirubin is present.&lt;/li&gt;&lt;li&gt;â€¢ positive direct reaction&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Unconjugated (free) bilirubin: Incorrect. Unconjugated bilirubin is water-insoluble and does not react directly in an aqueous solution with the diazo reagent. It needs to be dissolved in alcohol first, and then the test becomes positive. This is called an indirect reaction . Option C â€” Urobilinogen: Incorrect. Urobilinogen is tested with Ehrlichâ€™s reagent (p-dimethylaminobenzaldehyde) , not the diazo reagent, and forms a red color . Option D â€” Bile salts: Incorrect. Bile salts are detected by Hayâ€™s sulfur test , which relies on surface tension reduction, not a colorimetric diazo reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Unconjugated (free) bilirubin: Incorrect. Unconjugated bilirubin is water-insoluble and does not react directly in an aqueous solution with the diazo reagent. It needs to be dissolved in alcohol first, and then the test becomes positive. This is called an indirect reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Unconjugated (free) bilirubin:&lt;/li&gt;&lt;li&gt;â€¢ water-insoluble&lt;/li&gt;&lt;li&gt;â€¢ not react directly&lt;/li&gt;&lt;li&gt;â€¢ alcohol&lt;/li&gt;&lt;li&gt;â€¢ indirect reaction&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Urobilinogen: Incorrect. Urobilinogen is tested with Ehrlichâ€™s reagent (p-dimethylaminobenzaldehyde) , not the diazo reagent, and forms a red color .&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Urobilinogen:&lt;/li&gt;&lt;li&gt;â€¢ Ehrlichâ€™s reagent (p-dimethylaminobenzaldehyde)&lt;/li&gt;&lt;li&gt;â€¢ red color&lt;/li&gt;&lt;li&gt;â€¢ Option D â€” Bile salts: Incorrect. Bile salts are detected by Hayâ€™s sulfur test , which relies on surface tension reduction, not a colorimetric diazo reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option D â€” Bile salts:&lt;/li&gt;&lt;li&gt;â€¢ Hayâ€™s sulfur test&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A positive direct Van den Bergh reaction confirms the presence of conjugated (water-soluble) bilirubin in serum. Elevated conjugated bilirubin is typically seen in hepatocellular dysfunction, cholestasis, or bile duct obstruction â€” situations where conjugated bilirubin escapes into the bloodstream.&lt;/li&gt;&lt;li&gt;âž¤ positive direct Van den Bergh reaction&lt;/li&gt;&lt;li&gt;âž¤ conjugated (water-soluble) bilirubin&lt;/li&gt;&lt;li&gt;âž¤ hepatocellular dysfunction, cholestasis, or bile duct obstruction&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 369, 370, 398, 399.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the outpatient department, three patients suspected of having dysglycemia underwent an oral glucose tolerance test (OGTT). Their plasma glucose levels were measured at intervals after glucose ingestion, as depicted in the graph. Based on their glucose level trends, which patient most likely represents a pre-diabetic state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patient 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Patient 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patient 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Patient 2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3000.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/121_hjniKqX.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â Patient 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pre-diabetes (also called impaired glucose tolerance) is characterized by blood glucose levels that are higher than normal but not high enough to be classified as diabetes. In an OGTT, pre-diabetes typically shows:&lt;/li&gt;&lt;li&gt;â€¢ Fasting glucose that may be slightly elevated (100-125 mg/dL) A 2-hour post-load glucose between 140-199 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Fasting glucose that may be slightly elevated (100-125 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ A 2-hour post-load glucose between 140-199 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Analyzing each patient:&lt;/li&gt;&lt;li&gt;â€¢ Patient 1 (red squares):&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~90 mg/dL (normal fasting) Returns to ~100 mg/dL by 120 min This represents a normal glucose tolerance pattern&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~90 mg/dL (normal fasting)&lt;/li&gt;&lt;li&gt;â€¢ Returns to ~100 mg/dL by 120 min&lt;/li&gt;&lt;li&gt;â€¢ This represents a normal glucose tolerance pattern&lt;/li&gt;&lt;li&gt;â€¢ Patient 2 (blue triangles):&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~80 mg/dL Slow decline but remains elevated at ~145 mg/dL at 120 min This pattern shows impaired glucose tolerance (pre-diabetes) with delayed return to normal&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~80 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Slow decline but remains elevated at ~145 mg/dL at 120 min&lt;/li&gt;&lt;li&gt;â€¢ This pattern shows impaired glucose tolerance (pre-diabetes) with delayed return to normal&lt;/li&gt;&lt;li&gt;â€¢ Patient 3 (green circles):&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~140 mg/dL (already elevated at fasting) Remains very elevated at 120 min (~210 mg/dL) This pattern is consistent with diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Starting glucose ~140 mg/dL (already elevated at fasting)&lt;/li&gt;&lt;li&gt;â€¢ Remains very elevated at 120 min (~210 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ This pattern is consistent with diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ Patient 2 best represents pre-diabetes because their fasting level is normal but they show impaired glucose tolerance with the 2-hour value remaining elevated at ~145 mg/d.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ The OGTT is used to assess how well the body clears glucose from the bloodstream. In a pre-diabetic state , the 2-hour glucose value is elevated beyond normal but does not reach diabetic levels (140â€“199 mg/dL). If the value is â‰¥200 mg/dL, a diagnosis of diabetes mellitus is made.&lt;/li&gt;&lt;li&gt;âž¤ pre-diabetic state&lt;/li&gt;&lt;li&gt;âž¤ 2-hour glucose value&lt;/li&gt;&lt;li&gt;âž¤ diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 337 -340.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male presents to the clinic with fatigue, muscle cramps, and a recent history of unexplained weight loss. He reports that his symptoms worsen with exercise. His medical history is unremarkable, and he is not on any medications. Laboratory investigations reveal hypoglycemia, especially after periods of fasting or strenuous activity. The physician suspects a metabolic disorder involving glycogen metabolism. Which of the following is NOT involved in the regulation of glycogen phosphorylase, an enzyme pivotal in glycogen breakdown?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;cAMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calmodulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Protein Kinase A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogenin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glycogenin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Glycogenin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Glycogenin is not involved in the regulation of glycogen phosphorylase .&lt;/li&gt;&lt;li&gt;â€¢ Glycogenin&lt;/li&gt;&lt;li&gt;â€¢ glycogen phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ Glycogenin serves as the core \&quot;primer\&quot; protein upon which glucose units are added to initiate glycogen synthesis , not glycogen breakdown. Once a short glucose chain is built on glycogenin, glycogen synthase and branching enzyme extend the glycogen molecule.&lt;/li&gt;&lt;li&gt;â€¢ glycogen synthesis&lt;/li&gt;&lt;li&gt;â€¢ glycogen synthase&lt;/li&gt;&lt;li&gt;â€¢ branching enzyme&lt;/li&gt;&lt;li&gt;â€¢ In contrast, glycogen phosphorylase is the rate-limiting enzyme in glycogenolysis (glycogen breakdown), and its regulation is tightly controlled by hormonal and intracellular signaling.&lt;/li&gt;&lt;li&gt;â€¢ glycogen phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) cAMP: Correct â€” cAMP is an important second messenger in the glucagon and epinephrine pathway. It activates Protein Kinase A (PKA) , which phosphorylates phosphorylase kinase , activating it. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase , enabling glycogen breakdown. Option B) Calmodulin: Correct â€” Calmodulin, when bound to calcium, directly activates phosphorylase kinase , bypassing cAMP in tissues such as muscle. This allows muscle cells to match glycogen breakdown to calcium-driven muscle contraction. Option C) Protein Kinase A (PKA): Correct â€” PKA is a key regulator of glycogenolysis. Activated by cAMP, it phosphorylates phosphorylase kinase , which then activates glycogen phosphorylase .&lt;/li&gt;&lt;li&gt;â€¢ Option A) cAMP: Correct â€” cAMP is an important second messenger in the glucagon and epinephrine pathway. It activates Protein Kinase A (PKA) , which phosphorylates phosphorylase kinase , activating it. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase , enabling glycogen breakdown.&lt;/li&gt;&lt;li&gt;â€¢ Option A) cAMP:&lt;/li&gt;&lt;li&gt;â€¢ second messenger&lt;/li&gt;&lt;li&gt;â€¢ Protein Kinase A (PKA)&lt;/li&gt;&lt;li&gt;â€¢ phosphorylase kinase&lt;/li&gt;&lt;li&gt;â€¢ glycogen phosphorylase&lt;/li&gt;&lt;li&gt;â€¢ Option B) Calmodulin: Correct â€” Calmodulin, when bound to calcium, directly activates phosphorylase kinase , bypassing cAMP in tissues such as muscle. This allows muscle cells to match glycogen breakdown to calcium-driven muscle contraction.&lt;/li&gt;&lt;li&gt;â€¢ Option B) Calmodulin:&lt;/li&gt;&lt;li&gt;â€¢ phosphorylase kinase&lt;/li&gt;&lt;li&gt;â€¢ glycogen breakdown&lt;/li&gt;&lt;li&gt;â€¢ Option C) Protein Kinase A (PKA): Correct â€” PKA is a key regulator of glycogenolysis. Activated by cAMP, it phosphorylates phosphorylase kinase , which then activates glycogen phosphorylase .&lt;/li&gt;&lt;li&gt;â€¢ Option C) Protein Kinase A (PKA):&lt;/li&gt;&lt;li&gt;â€¢ phosphorylase kinase&lt;/li&gt;&lt;li&gt;â€¢ glycogen phosphorylase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycogen phosphorylase is the key enzyme for glycogen breakdown and is activated via phosphorylation pathways involving cAMP , Protein Kinase A , and phosphorylase kinase (which is also activated by calcium-calmodulin in muscle). In contrast, glycogenin functions as the core primer for glycogen synthesis, not degradation, and is not involved in the regulation of glycogen phosphorylase.&lt;/li&gt;&lt;li&gt;âž¤ Glycogen phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ cAMP&lt;/li&gt;&lt;li&gt;âž¤ Protein Kinase A&lt;/li&gt;&lt;li&gt;âž¤ phosphorylase kinase&lt;/li&gt;&lt;li&gt;âž¤ calcium-calmodulin&lt;/li&gt;&lt;li&gt;âž¤ glycogenin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p180-182&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman, following a meal rich in carbohydrates, undergoes various metabolic adjustments to manage the influx of glucose. One of these adjustments involves the metabolism of glucose-6-phosphate, a key metabolite in glucose homeostasis. Considering the fed state, where glucose is abundant, what is the primary fate of glucose-6-phosphate in tissues?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Storage as fructose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Storage as glyceraldehyde-3-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enters HMP shunt via ribulose-5-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Storage as glycogen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Storage as glycogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Storage as fructose is not a primary pathway for glucose-6-phosphate metabolism in tissues during the fed state.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Storage as fructose&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ primary pathway for glucose-6-phosphate metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glyceraldehyde-3-phosphate is an intermediate in glycolysis , but the direct storage of glucose-6-phosphate as glyceraldehyde-3-phosphate is not a primary fate in the fed state.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Glyceraldehyde-3-phosphate&lt;/li&gt;&lt;li&gt;â€¢ intermediate in glycolysis&lt;/li&gt;&lt;li&gt;â€¢ direct storage of glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ Option C: While glucose-6-phosphate can enter the Hexose Monophosphate (HMP) shunt , this pathway is primarily active in specific tissues like the liver , and its main function is not for storage but for producing NADPH and ribose-5-phosphate for biosynthetic reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ enter the Hexose Monophosphate&lt;/li&gt;&lt;li&gt;â€¢ shunt&lt;/li&gt;&lt;li&gt;â€¢ pathway is primarily active&lt;/li&gt;&lt;li&gt;â€¢ specific tissues&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The uptake of glucose into the liver GLUT 2 is independent of insulin . In the well fed state â†’ concentration of glucose entering the liver increases â†’ increased rate of synthesis of glucose-6-phosphate. This is in excess of the liverâ€™s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen. In both liver and skeletal muscle, insulin acts to stimulate glycogen synthase and inhibit glycogen phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ The uptake of glucose into the liver GLUT 2 is independent of insulin .&lt;/li&gt;&lt;li&gt;âž¤ uptake of glucose&lt;/li&gt;&lt;li&gt;âž¤ liver GLUT 2&lt;/li&gt;&lt;li&gt;âž¤ independent of insulin&lt;/li&gt;&lt;li&gt;âž¤ In the well fed state â†’ concentration of glucose entering the liver increases â†’ increased rate of synthesis of glucose-6-phosphate.&lt;/li&gt;&lt;li&gt;âž¤ This is in excess of the liverâ€™s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen.&lt;/li&gt;&lt;li&gt;âž¤ In both liver and skeletal muscle, insulin acts to stimulate glycogen synthase and inhibit glycogen phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ both liver&lt;/li&gt;&lt;li&gt;âž¤ skeletal muscle,&lt;/li&gt;&lt;li&gt;âž¤ insulin acts&lt;/li&gt;&lt;li&gt;âž¤ stimulate glycogen synthase&lt;/li&gt;&lt;li&gt;âž¤ inhibit glycogen phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p148.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p148.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the cell organelle with its marker enzymes:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-c, 3-b, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-b, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-a, 4-b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1-d, 2-a, 3-b, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/untitled-13607.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/screenshot-2024-03-30-171523.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Plasma Membrane : The correct marker enzyme is 5â€™-nucleotidase (d). This enzyme is involved in the hydrolysis of nucleotides to nucleosides and is found in the plasma membrane, playing a role in signal transduction. Golgi Bodies : Galactosyltransferase (a) is the marker enzyme for Golgi bodies . It is involved in the glycosylation of proteins, a process that occurs extensively within the Golgi apparatus. Cytosol : Lactate dehydrogenase (b) is a marker for the cytosol. This enzyme catalyzes the conversion of pyruvate to lactate when oxygen is absent or in short supply, and it is predominantly found in the cytoplasm. Lysosomes : Acid phosphatase (c) is the marker enzyme for lysosomes. It functions in the hydrolysis of phosphate monoesters under acidic conditions, a characteristic activity of the lysosomal digestive process.&lt;/li&gt;&lt;li&gt;â€¢ Plasma Membrane : The correct marker enzyme is 5â€™-nucleotidase (d). This enzyme is involved in the hydrolysis of nucleotides to nucleosides and is found in the plasma membrane, playing a role in signal transduction.&lt;/li&gt;&lt;li&gt;â€¢ Plasma Membrane&lt;/li&gt;&lt;li&gt;â€¢ 5â€™-nucleotidase&lt;/li&gt;&lt;li&gt;â€¢ hydrolysis of nucleotides&lt;/li&gt;&lt;li&gt;â€¢ nucleosides&lt;/li&gt;&lt;li&gt;â€¢ found in the plasma membrane,&lt;/li&gt;&lt;li&gt;â€¢ Golgi Bodies : Galactosyltransferase (a) is the marker enzyme for Golgi bodies . It is involved in the glycosylation of proteins, a process that occurs extensively within the Golgi apparatus.&lt;/li&gt;&lt;li&gt;â€¢ Golgi Bodies&lt;/li&gt;&lt;li&gt;â€¢ Galactosyltransferase&lt;/li&gt;&lt;li&gt;â€¢ marker enzyme for Golgi bodies&lt;/li&gt;&lt;li&gt;â€¢ glycosylation of proteins,&lt;/li&gt;&lt;li&gt;â€¢ Cytosol : Lactate dehydrogenase (b) is a marker for the cytosol. This enzyme catalyzes the conversion of pyruvate to lactate when oxygen is absent or in short supply, and it is predominantly found in the cytoplasm.&lt;/li&gt;&lt;li&gt;â€¢ Cytosol&lt;/li&gt;&lt;li&gt;â€¢ Lactate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ marker for the cytosol.&lt;/li&gt;&lt;li&gt;â€¢ Lysosomes : Acid phosphatase (c) is the marker enzyme for lysosomes. It functions in the hydrolysis of phosphate monoesters under acidic conditions, a characteristic activity of the lysosomal digestive process.&lt;/li&gt;&lt;li&gt;â€¢ Lysosomes&lt;/li&gt;&lt;li&gt;â€¢ Acid phosphatase&lt;/li&gt;&lt;li&gt;â€¢ marker enzyme for lysosomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 12.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 12.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a lecture on metabolic pathways, medical students were asked to identify the first committed step in glycolysis and the enzyme that catalyzes it. This step is crucial because it irreversibly commits the substrate to the glycolytic pathway. Which enzyme is responsible for this committed step in glycolysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hexokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phosphofructokinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The first committed step in glycolysis is catalyzed by phosphofructokinase-1 (PFK-1) , which converts:&lt;/li&gt;&lt;li&gt;â€¢ first committed step&lt;/li&gt;&lt;li&gt;â€¢ phosphofructokinase-1 (PFK-1)&lt;/li&gt;&lt;li&gt;â€¢ Fructose-6-phosphate â†’ Fructose-1,6-bisphosphate&lt;/li&gt;&lt;li&gt;â€¢ Fructose-6-phosphate â†’ Fructose-1,6-bisphosphate&lt;/li&gt;&lt;li&gt;â€¢ This step is considered \&quot;committed\&quot; because, after this conversion, the sugar molecule is no longer available for alternative pathways (such as glycogenesis or the pentose phosphate pathway). It must proceed through glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Additionally, this step is irreversible under cellular conditions and is highly regulated â€” it represents the rate-limiting step of glycolysis&lt;/li&gt;&lt;li&gt;â€¢ irreversible&lt;/li&gt;&lt;li&gt;â€¢ highly regulated&lt;/li&gt;&lt;li&gt;â€¢ rate-limiting step&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A â€” Pyruvate dehydrogenase: Incorrect. This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the linking step between glycolysis and the citric acid cycle, not glycolysis itself. Option B â€” Glucokinase: Incorrect. Glucokinase catalyzes glucose â†’ glucose-6-phosphate in the liver and pancreas , and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway. Option C â€” Hexokinase: Incorrect. Hexokinase also converts glucose to glucose-6-phosphate in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A â€” Pyruvate dehydrogenase: Incorrect. This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the linking step between glycolysis and the citric acid cycle, not glycolysis itself.&lt;/li&gt;&lt;li&gt;â€¢ Option A â€” Pyruvate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ linking step&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Glucokinase: Incorrect. Glucokinase catalyzes glucose â†’ glucose-6-phosphate in the liver and pancreas , and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B â€” Glucokinase:&lt;/li&gt;&lt;li&gt;â€¢ glucose â†’ glucose-6-phosphate&lt;/li&gt;&lt;li&gt;â€¢ liver and pancreas&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Hexokinase: Incorrect. Hexokinase also converts glucose to glucose-6-phosphate in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C â€” Hexokinase:&lt;/li&gt;&lt;li&gt;â€¢ glucose to glucose-6-phosphate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first committed step of glycolysis is catalyzed by phosphofructokinase-1 (PFK-1) . It ensures that glucose carbons are committed to energy production via glycolysis. This step is irreversible, highly regulated, and marks a metabolic \&quot;point of no return\&quot; for the glucose molecule.&lt;/li&gt;&lt;li&gt;âž¤ first committed step&lt;/li&gt;&lt;li&gt;âž¤ phosphofructokinase-1 (PFK-1)&lt;/li&gt;&lt;li&gt;âž¤ PFK-1 is a key allosteric enzyme â€” activated by AMP and fructose-2,6-bisphosphate and inhibited by ATP and citrate.&lt;/li&gt;&lt;li&gt;âž¤ allosteric enzyme&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p173&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Acetyl CoA plays a central role in energy metabolism, acting as a substrate for several biosynthetic pathways. Which of the following is NOT a product of Acetyl CoA conversion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cholesterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ketone bodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options B: Fatty acids can be synthesized from acetyl CoA in a process known as lipogenesis, primarily in the liver and adipose tissue.&lt;/li&gt;&lt;li&gt;â€¢ Options B:&lt;/li&gt;&lt;li&gt;â€¢ Fatty acids&lt;/li&gt;&lt;li&gt;â€¢ synthesized from acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ lipogenesis,&lt;/li&gt;&lt;li&gt;â€¢ Options C: Cholesterol is also synthesized from acetyl CoA via the mevalonate pathway , which is critical for cell membrane integrity and as a precursor for steroid hormones.&lt;/li&gt;&lt;li&gt;â€¢ Options C:&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol&lt;/li&gt;&lt;li&gt;â€¢ synthesized from acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ mevalonate pathway&lt;/li&gt;&lt;li&gt;â€¢ Options D: Ketone bodies are produced from acetyl CoA during periods of low carbohydrate availability , such as fasting , prolonged exercise , or low-carbohydrate diets , primarily in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Options D:&lt;/li&gt;&lt;li&gt;â€¢ Ketone bodies&lt;/li&gt;&lt;li&gt;â€¢ produced from acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ periods of low carbohydrate availability&lt;/li&gt;&lt;li&gt;â€¢ fasting&lt;/li&gt;&lt;li&gt;â€¢ prolonged exercise&lt;/li&gt;&lt;li&gt;â€¢ low-carbohydrate diets&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA is not a substrate for gluconeogenesis. It is the starting material for Fatty acid and Cholesterol synthesis . It is an intermediate in Ketone body synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA is not a substrate for gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ substrate for gluconeogenesis.&lt;/li&gt;&lt;li&gt;âž¤ It is the starting material for Fatty acid and Cholesterol synthesis .&lt;/li&gt;&lt;li&gt;âž¤ starting material&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid&lt;/li&gt;&lt;li&gt;âž¤ Cholesterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ It is an intermediate in Ketone body synthesis .&lt;/li&gt;&lt;li&gt;âž¤ intermediate in Ketone body synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p188, 189&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p188, 189&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 19 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test5" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Enzymes&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Enzymes&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                90 Questions | 360 Total Marks | 100 min Duration | ~66.67 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;In a case study involving the analysis of a new drug&#x27;s mechanism of action, it&#x27;s observed that the drug inhibits an enzyme by resembling the enzyme&#x27;s natural substrate and competing for the active site. Given this mode of inhibition, how would this type of enzyme inhibition be classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive inhibition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Feedback inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Competitive inhibition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive inhibition: Inhibitors have no structural resemblance to the substrate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive inhibition:&lt;/li&gt;&lt;li&gt;â€¢ no structural resemblance&lt;/li&gt;&lt;li&gt;â€¢ Option C. Feedback inhibition: The activity of the enzyme is inhibited by the product of the reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Feedback inhibition:&lt;/li&gt;&lt;li&gt;â€¢ inhibited by the product of the reaction&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric inhibition: The inhibitor is not a substrate analog.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric inhibition:&lt;/li&gt;&lt;li&gt;â€¢ not a substrate analog.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibition occurs when an inhibitor molecule resembles the substrate and competes for binding to the enzyme&#x27;s active site . This type of inhibition can be overcome by increasing the concentration of the substrate, as both the substrate and inhibitor compete for the same site on the enzyme.&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibition&lt;/li&gt;&lt;li&gt;âž¤ inhibitor molecule&lt;/li&gt;&lt;li&gt;âž¤ substrate and competes&lt;/li&gt;&lt;li&gt;âž¤ binding to the enzyme&#x27;s active site&lt;/li&gt;&lt;li&gt;âž¤ type of inhibition&lt;/li&gt;&lt;li&gt;âž¤ increasing the concentration of the substrate,&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Xanthine oxidase is a metalloenzyme containing molybdenum as a metal ion. State TRUE/ FALSE.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the Above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/screenshot-2024-03-30-181040.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Xanthine oxidase is indeed a metalloenzyme that contains molybdenum as a crucial metal ion for its catalytic activity. This enzyme plays a vital role in the catabolism of purines , converting hypoxanthine to xanthine and xanthine to uric acid , an important process in the breakdown of nucleic acids.&lt;/li&gt;&lt;li&gt;â€¢ Xanthine oxidase&lt;/li&gt;&lt;li&gt;â€¢ metalloenzyme&lt;/li&gt;&lt;li&gt;â€¢ contains molybdenum&lt;/li&gt;&lt;li&gt;â€¢ metal ion for its catalytic activity.&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ vital role in the catabolism of purines&lt;/li&gt;&lt;li&gt;â€¢ hypoxanthine to xanthine&lt;/li&gt;&lt;li&gt;â€¢ xanthine to uric acid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 5d1.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 5d1.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on the biochemical properties of serine proteases, a molecular biologist outlines several characteristics common to this class of enzymes. Serine proteases play critical roles in various physiological processes, including digestion and coagulation. Which of the following features is universally found in all serine proteases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trypsin is activated by the removal of a hexapeptide from C-terminal end&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î± 2-Macroglobulin is the major serine protease inhibitor of plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chymotrypsin acts on peptide bonds in which the amino acid C-terminal to the bond is a tryptophan, tyrosine, phenylalanine.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of Ser-His-Asp catalytic triad at the active site&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Presence of Ser-His-Asp catalytic triad at the active site&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Trypsin is activated by the removal of a hexapeptide from N-terminal end.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Trypsin&lt;/li&gt;&lt;li&gt;â€¢ activated by the removal of a hexapeptide&lt;/li&gt;&lt;li&gt;â€¢ N-terminal end.&lt;/li&gt;&lt;li&gt;â€¢ Option B.Î± 1-Antitrypsin is the major serine protease inhibitor of plasma. Genetic deficiency of this protein results in emphysema and liver disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B.Î± 1-Antitrypsin&lt;/li&gt;&lt;li&gt;â€¢ major serine protease inhibitor of plasma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Chymotrypsin acts on peptide bonds formed in which the amino acid N-terminal to the bond is a tryptophan , tyrosine, phenylalanine&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Chymotrypsin&lt;/li&gt;&lt;li&gt;â€¢ peptide bonds&lt;/li&gt;&lt;li&gt;â€¢ amino acid N-terminal&lt;/li&gt;&lt;li&gt;â€¢ bond is a tryptophan&lt;/li&gt;&lt;li&gt;â€¢ tyrosine,&lt;/li&gt;&lt;li&gt;â€¢ phenylalanine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ All serine proteases share a common catalytic mechanism that involves a conserved Ser-His-Asp triad at their active sites . This triad plays a crucial role in the catalytic activity of these enzymes, with the serine residue acting as a nucleophile in the cleavage of peptide bonds.&lt;/li&gt;&lt;li&gt;âž¤ serine proteases&lt;/li&gt;&lt;li&gt;âž¤ common catalytic mechanism&lt;/li&gt;&lt;li&gt;âž¤ conserved Ser-His-Asp triad at their active sites&lt;/li&gt;&lt;li&gt;âž¤ triad&lt;/li&gt;&lt;li&gt;âž¤ crucial role in the catalytic activity&lt;/li&gt;&lt;li&gt;âž¤ enzymes,&lt;/li&gt;&lt;li&gt;âž¤ serine residue&lt;/li&gt;&lt;li&gt;âž¤ nucleophile in the cleavage&lt;/li&gt;&lt;li&gt;âž¤ peptide bonds.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 62, 63.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p 62, 63.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following enzymes, known for its critical role in both anaerobic and aerobic pathways by interconverting a three-carbon compound with its reduced form, contains the Rossmann fold associated NADH domain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyruvate Dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isocitrate Dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ALA dehydratase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactate Dehydrogenase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lactate Dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate Dehydrogenase: It is a multi-enzyme complex with 5 coenzymes and 3 apo-enzymes , which favours oxidative decarboxylation of pyruvate to acetyl CoA .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pyruvate Dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ multi-enzyme complex&lt;/li&gt;&lt;li&gt;â€¢ 5 coenzymes and 3 apo-enzymes&lt;/li&gt;&lt;li&gt;â€¢ favours oxidative decarboxylation&lt;/li&gt;&lt;li&gt;â€¢ pyruvate to acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Option B. Isocitrate Dehydrogenase: It is a NAD linked dehydrogenase , which helps in dehydrogenation and decarboxylation of isocitrate to alpha ketoglutarate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Isocitrate Dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ NAD linked dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ dehydrogenation&lt;/li&gt;&lt;li&gt;â€¢ decarboxylation&lt;/li&gt;&lt;li&gt;â€¢ isocitrate to alpha ketoglutarate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ALA dehydratase: Involved in heme synthesis .&lt;/li&gt;&lt;li&gt;â€¢ Option C. ALA dehydratase:&lt;/li&gt;&lt;li&gt;â€¢ heme synthesis&lt;/li&gt;&lt;li&gt;â€¢ OXIDOREDUCTASE GROUP OF ENZYMES WITH ROSSMAN FOLD&lt;/li&gt;&lt;li&gt;â€¢ OXIDOREDUCTASE GROUP OF ENZYMES WITH ROSSMAN FOLD&lt;/li&gt;&lt;li&gt;â€¢ Lactate dehydrogenase Alcohol dehydrogenase Glyceraldehyde-3-phosphate dehydrogenase Malate dehydrogenase Quinone oxidoreductase 6-phosphogluconate dehydrogenase D-glycerate dehydrogenase Formate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Lactate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Alcohol dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Glyceraldehyde-3-phosphate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Malate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Quinone oxidoreductase&lt;/li&gt;&lt;li&gt;â€¢ 6-phosphogluconate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ D-glycerate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Formate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Ref: Harper 30/e page 40.&lt;/li&gt;&lt;li&gt;â€¢ Ref: Harper 30/e page 40.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a biochemistry seminar, the discussion turns to the regulation of metabolic pathways by allosteric enzymes. These enzymes are unique because their activity can be modulated by molecules binding to sites other than the active site. Which of the following statements correctly describes a feature of allosteric enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Active site is the allosteric site in enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;All the allosteric enzymes possess positive cooperativity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allosteric inhibitor is not a structural analogue&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activity of allosteric enzymes is described by Michaelis-Menten equation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Allosteric inhibitor is not a structural analogue&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric enzyme has one catalytic site to which the substrate binds and another separate allosteric site where the modifier binds .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Allosteric enzyme&lt;/li&gt;&lt;li&gt;â€¢ one catalytic site&lt;/li&gt;&lt;li&gt;â€¢ substrate binds&lt;/li&gt;&lt;li&gt;â€¢ another separate allosteric site&lt;/li&gt;&lt;li&gt;â€¢ modifier binds&lt;/li&gt;&lt;li&gt;â€¢ Option B. In most cases, a combination of both positive and negative cooperativity is observed , resulting in a sigmoid shaped curve .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ combination of both positive&lt;/li&gt;&lt;li&gt;â€¢ negative cooperativity is observed&lt;/li&gt;&lt;li&gt;â€¢ sigmoid shaped curve&lt;/li&gt;&lt;li&gt;â€¢ Option D. Not by Michaelis-Menten equation . Allosteric enzymes often display sigmoidal kinetics due to their regulatory mechanisms , which are not captured by the Michaelis-Menten model that assumes a hyperbolic relationship between enzyme activity and substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Michaelis-Menten equation&lt;/li&gt;&lt;li&gt;â€¢ Allosteric enzymes&lt;/li&gt;&lt;li&gt;â€¢ display sigmoidal kinetics&lt;/li&gt;&lt;li&gt;â€¢ regulatory mechanisms&lt;/li&gt;&lt;li&gt;â€¢ not captured by the Michaelis-Menten model&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of allosteric inhibition:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of allosteric inhibition:&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor is not a substrate analog. It is partially reversible , when excess substrate is added . Km is usually increased and Vmax is reduced . The effect of an allosteric modifier is maximum at or near substrate concentration equivalent to Km. When an inhibitor binds to the allosteric site, the configuration of the catalytic site is modified such that the substrate cannot bind properly. Most allosteric enzymes possess quaternary structure and are made up of subunits , e.g. Aspartate transcarbamoylase: 6 subunits and pyruvate kinase: 4 subunits.&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor is not a substrate analog.&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ It is partially reversible , when excess substrate is added .&lt;/li&gt;&lt;li&gt;âž¤ partially reversible&lt;/li&gt;&lt;li&gt;âž¤ excess substrate&lt;/li&gt;&lt;li&gt;âž¤ added&lt;/li&gt;&lt;li&gt;âž¤ Km is usually increased and Vmax is reduced .&lt;/li&gt;&lt;li&gt;âž¤ Km&lt;/li&gt;&lt;li&gt;âž¤ increased&lt;/li&gt;&lt;li&gt;âž¤ Vmax&lt;/li&gt;&lt;li&gt;âž¤ reduced&lt;/li&gt;&lt;li&gt;âž¤ The effect of an allosteric modifier is maximum at or near substrate concentration equivalent to Km.&lt;/li&gt;&lt;li&gt;âž¤ When an inhibitor binds to the allosteric site, the configuration of the catalytic site is modified such that the substrate cannot bind properly.&lt;/li&gt;&lt;li&gt;âž¤ inhibitor binds to the allosteric site, the configuration of the catalytic site is modified such that the substrate cannot bind&lt;/li&gt;&lt;li&gt;âž¤ Most allosteric enzymes possess quaternary structure and are made up of subunits , e.g. Aspartate transcarbamoylase: 6 subunits and pyruvate kinase: 4 subunits.&lt;/li&gt;&lt;li&gt;âž¤ allosteric enzymes&lt;/li&gt;&lt;li&gt;âž¤ quaternary structure&lt;/li&gt;&lt;li&gt;âž¤ made up of subunits&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 62,63.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 62,63.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While studying the regulation of metabolic pathways, a medical student comes across the concept of allosteric control, particularly its role in enzyme activity. Allosteric enzymes have unique characteristics that differentiate them from other enzymes. Which of the following statements accurately describes a property of allosteric enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allosteric effectors bind allosteric enzymes at their active sites&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allosteric enzymes possess secondary structure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allosteric control is irreversible&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric control with negative feedback is found in many metabolic pathways&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Allosteric control with negative feedback is found in many metabolic pathways&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-160837.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Allosteric control with negative feedback is found in many metabolic pathways&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Allosteric control with negative feedback is indeed a key regulatory mechanism in many metabolic pathways, making option D correct. In negative feedback allosteric regulation, the end product of a metabolic pathway inhibits an enzyme at an earlier step in the pathway, effectively shutting down production when sufficient product has accumulated. Classic examples include:&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of phosphofructokinase-1 (PFK-1) by ATP in glycolysis Inhibition of aspartate transcarbamoylase (ATCase) by CTP in pyrimidine synthesis&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of phosphofructokinase-1 (PFK-1) by ATP in glycolysis&lt;/li&gt;&lt;li&gt;â€¢ Inhibition of aspartate transcarbamoylase (ATCase) by CTP in pyrimidine synthesis&lt;/li&gt;&lt;li&gt;â€¢ Other options:&lt;/li&gt;&lt;li&gt;â€¢ Other options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric effectors bind allosteric enzymes at their active sites : This statement is incorrect. By definition, allosteric effectors bind to sites distinct from the active site, called allosteric sites. The term \&quot;allosteric\&quot; comes from \&quot;allo\&quot; (other) and \&quot;steric\&quot; (space or structure), referring to binding at a site other than the active site. When an allosteric effector binds, it induces a conformational change that alters the activity of the enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric effectors bind allosteric enzymes at their active sites&lt;/li&gt;&lt;li&gt;â€¢ Option B. Allosteric enzymes possess secondary structure : This statement is correct but not distinctive. All proteins, including enzymes (allosteric or not), possess secondary structure elements such as alpha helices and beta sheets. This is not a unique characteristic of allosteric enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Allosteric enzymes possess secondary structure&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allosteric control is irreversible : This is incorrect. Allosteric regulation is typically reversible, allowing for rapid adaptation to changing cellular conditions. When the concentration of the allosteric effector decreases, the enzyme can return to its original conformation and activity state.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allosteric control is irreversible&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Allosteric enzymes are typically oligomeric proteins with multiple subunits that exhibit cooperativity and sigmoidal kinetics rather than the hyperbolic kinetics of Michaelis-Menten enzymes. Their activity can be modulated by effectors binding at sites distinct from the active site, causing conformational changes that alter the enzyme&#x27;s catalytic efficiency. This provides a rapid, reversible mechanism for regulating metabolic pathways in response to changing cellular needs, with negative feedback being one of the most common control mechanisms in metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 62.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 62.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old African female presents with chronic, mild symptoms of sleeping sickness, persisting over two years. She is treated with difluoromethyl ornithine (DFMO), known for its efficacy against trypanosomiasis. DFMO inhibits the enzyme involved in polyamine synthesis, crucial for the parasite&#x27;s proliferation. Based on DFMO&#x27;s mechanism, what type of enzyme inhibition does it exemplify?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Suicidal Inhibition&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive Inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uncompetitive Inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric Inhibition&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Suicidal Inhibition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive: Cyanide inhibits cytochrome oxidase, Fluoride inhibit enolase thereby consequently the glycolysis, Iodoacetate inhibit enzymes having â€“SH group in their active centers, BAL (dimercaprol) as an antidote for heavy metal poisoning etc.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive:&lt;/li&gt;&lt;li&gt;â€¢ Cyanide&lt;/li&gt;&lt;li&gt;â€¢ cytochrome oxidase,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uncompetitive: Inhibition of placental alkaline phosphatase (Regan iso-enzyme) by phenylalanine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uncompetitive:&lt;/li&gt;&lt;li&gt;â€¢ phenylalanine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric: ALA Synthase catalyse the first step in heme biosynthesis and the end product, heme will allosterically inhibit the enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric:&lt;/li&gt;&lt;li&gt;â€¢ ALA Synthase catalyse&lt;/li&gt;&lt;li&gt;â€¢ heme biosynthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DFMO acts as a suicidal (or suicide) inhibitor by irreversibly binding to and inactivating ornithine decarboxylase , the enzyme responsible for polyamine synthesis essential for the growth and reproduction of Trypanosoma brucei, the parasite causing sleeping sickness . Suicidal inhibitors form a covalent bond with the enzyme, leading to its permanent inactivation.&lt;/li&gt;&lt;li&gt;âž¤ DFMO acts as a suicidal&lt;/li&gt;&lt;li&gt;âž¤ inhibitor&lt;/li&gt;&lt;li&gt;âž¤ irreversibly binding to and inactivating ornithine decarboxylase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ polyamine synthesis&lt;/li&gt;&lt;li&gt;âž¤ growth and reproduction of Trypanosoma brucei,&lt;/li&gt;&lt;li&gt;âž¤ parasite&lt;/li&gt;&lt;li&gt;âž¤ sleeping sickness&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p78.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p78.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzymatic reaction, crucial in amino acid metabolism, requires the involvement of PLP as a coenzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transamination&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dehydrogenation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carboxylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxidative decarboxylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Transamination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dehydrogenation: Dehydrogenation reactions, which involve the removal of hydrogen atoms to form a double bond within a molecule , commonly utilize NAD+ or NADP+ as coenzymes, not PLP. These reactions are central to various metabolic pathways, including glycolysis and the citric acid cycle.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dehydrogenation:&lt;/li&gt;&lt;li&gt;â€¢ involve the removal of hydrogen atoms&lt;/li&gt;&lt;li&gt;â€¢ form a double bond within a molecule&lt;/li&gt;&lt;li&gt;â€¢ NAD+ or NADP+ as coenzymes,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carboxylation: Carboxylation involves the addition of a carboxyl group to a substrate and typically requires biotin as a coenzyme , not PLP. This reaction is crucial in processes such as fatty acid synthesis and the metabolism of certain amino acids.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carboxylation:&lt;/li&gt;&lt;li&gt;â€¢ addition of a carboxyl group&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;li&gt;â€¢ requires biotin as a coenzyme&lt;/li&gt;&lt;li&gt;â€¢ Option D. Oxidative decarboxylation: This reaction, which involves the removal of a carboxyl group and the simultaneous oxidation of the molecule , frequently depends on thiamine pyrophosphate (TPP) as a coenzyme . Key metabolic pathways, including the transition from glycolysis to the citric acid cycle, involve oxidative decarboxylation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Oxidative decarboxylation:&lt;/li&gt;&lt;li&gt;â€¢ removal of a carboxyl group&lt;/li&gt;&lt;li&gt;â€¢ simultaneous oxidation of the molecule&lt;/li&gt;&lt;li&gt;â€¢ thiamine pyrophosphate&lt;/li&gt;&lt;li&gt;â€¢ coenzyme&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transamination reactions are catalysed by aminotransferases /transaminases which need PLP as the co-enzyme.&lt;/li&gt;&lt;li&gt;âž¤ Transamination&lt;/li&gt;&lt;li&gt;âž¤ Alanine + Alpha ketoglutarate ---------------â†’ Pyruvate + Glutamic acid&lt;/li&gt;&lt;li&gt;âž¤ Alanine + Alpha ketoglutarate ---------------â†’ Pyruvate + Glutamic acid&lt;/li&gt;&lt;li&gt;âž¤ (En: Alanine transaminase)&lt;/li&gt;&lt;li&gt;âž¤ (En: Alanine transaminase)&lt;/li&gt;&lt;li&gt;âž¤ Also, in metabolism of sulfur containing amino acids. Plays an important role in methionine and cysteine metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 201, 483.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 201, 483.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The enzyme kinetics for competitive inhibition is High Km and lower affinity. Statement is TRUE/ FALSE:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand Competitive Inhibition: Recognize that in competitive inhibition: Km increases (affinity decreases), Vmax remains unchanged. Relate Enzyme Kinetics Parameters to Inhibition Types: Competitive: â†‘ Km, no change Vmax. Non-competitive: no change Km, â†“ Vmax. Uncompetitive: â†“ Km, â†“ Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Understand Competitive Inhibition: Recognize that in competitive inhibition: Km increases (affinity decreases), Vmax remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that in competitive inhibition: Km increases (affinity decreases), Vmax remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Recognize that in competitive inhibition: Km increases (affinity decreases), Vmax remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Km increases (affinity decreases), Vmax remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Km increases (affinity decreases),&lt;/li&gt;&lt;li&gt;âž¤ Vmax remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Relate Enzyme Kinetics Parameters to Inhibition Types: Competitive: â†‘ Km, no change Vmax. Non-competitive: no change Km, â†“ Vmax. Uncompetitive: â†“ Km, â†“ Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Competitive: â†‘ Km, no change Vmax. Non-competitive: no change Km, â†“ Vmax. Uncompetitive: â†“ Km, â†“ Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Competitive: â†‘ Km, no change Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Non-competitive: no change Km, â†“ Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Uncompetitive: â†“ Km, â†“ Vmax.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 57.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately describes the Michaelis constant (Km)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Substrate concentration at maximum velocity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substrate concentration at half-maximal velocity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Not a characteristic feature of enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A low Km value indicates a weak affinity of the enzyme for enzyme-substrate complex formation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Substrate concentration at half-maximal velocity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Substrate concentration at maximum velocity: This statement is incorrect. The substrate concentration at maximum velocity is not specifically defined by Km , as Vmax is reached at much higher substrate concentrations where all enzyme active sites are saturated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Substrate concentration at maximum velocity:&lt;/li&gt;&lt;li&gt;â€¢ substrate concentration&lt;/li&gt;&lt;li&gt;â€¢ maximum velocity&lt;/li&gt;&lt;li&gt;â€¢ not specifically defined by Km&lt;/li&gt;&lt;li&gt;â€¢ Option C. Not a characteristic feature of enzymes: This statement is incorrect. Km is indeed a characteristic feature of enzymes and is crucial in the study of enzyme kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Not a characteristic feature of enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Km&lt;/li&gt;&lt;li&gt;â€¢ characteristic feature of enzymes&lt;/li&gt;&lt;li&gt;â€¢ Option D. A low Km value indicates a weak affinity of the enzyme for enzyme-substrate complex formation: This statement is incorrect. A low Km value actually indicates a high affinity of the enzyme for its substrate, as it means the enzyme can achieve half-maximal velocity at a lower substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. A low Km value indicates a weak affinity of the enzyme for enzyme-substrate complex formation:&lt;/li&gt;&lt;li&gt;â€¢ low Km value&lt;/li&gt;&lt;li&gt;â€¢ high affinity of the enzyme&lt;/li&gt;&lt;li&gt;â€¢ substrate,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of Km:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of Km:&lt;/li&gt;&lt;li&gt;âž¤ Km value is substrate concentration (expressed in moles/L) at half-maximal velocity. It denotes that 50% of enzyme molecules are bound with substrate molecules at that particular substrate concentration. It is independent of enzyme concentration . It is the signature of the enzyme. Km value is thus a constant for an enzyme and it is the characteristic feature of a particular enzyme for a specific substrate. The affinity of an enzyme towards its substrate is inversely connected to the dissociation constant, Kd for the enzyme-substrate complex. Km denotes the affinity of enzymes for substrates . So, less the numerical value of Km, the affinity of the enzyme for the substrate is more.&lt;/li&gt;&lt;li&gt;âž¤ Km value is substrate concentration (expressed in moles/L) at half-maximal velocity.&lt;/li&gt;&lt;li&gt;âž¤ Km value&lt;/li&gt;&lt;li&gt;âž¤ substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ half-maximal velocity.&lt;/li&gt;&lt;li&gt;âž¤ It denotes that 50% of enzyme molecules are bound with substrate molecules at that particular substrate concentration.&lt;/li&gt;&lt;li&gt;âž¤ denotes that 50% of enzyme molecules&lt;/li&gt;&lt;li&gt;âž¤ bound with substrate molecules&lt;/li&gt;&lt;li&gt;âž¤ particular substrate concentration.&lt;/li&gt;&lt;li&gt;âž¤ It is independent of enzyme concentration .&lt;/li&gt;&lt;li&gt;âž¤ independent of enzyme concentration&lt;/li&gt;&lt;li&gt;âž¤ It is the signature of the enzyme. Km value is thus a constant for an enzyme and it is the characteristic feature of a particular enzyme for a specific substrate.&lt;/li&gt;&lt;li&gt;âž¤ signature of the enzyme.&lt;/li&gt;&lt;li&gt;âž¤ The affinity of an enzyme towards its substrate is inversely connected to the dissociation constant, Kd for the enzyme-substrate complex.&lt;/li&gt;&lt;li&gt;âž¤ affinity of an enzyme&lt;/li&gt;&lt;li&gt;âž¤ inversely connected to the dissociation constant,&lt;/li&gt;&lt;li&gt;âž¤ Km denotes the affinity of enzymes for substrates . So, less the numerical value of Km, the affinity of the enzyme for the substrate is more.&lt;/li&gt;&lt;li&gt;âž¤ Km denotes the affinity&lt;/li&gt;&lt;li&gt;âž¤ enzymes for substrates&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 57.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 57.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pharmaceutical research team is investigating a new drug that targets an enzyme involved in the metabolic pathway of a particular hormone. This enzyme is known for its ability to catalyze the rearrangement of atoms within the hormone molecule, effectively altering its shape without changing its chemical composition. Such a transformation is crucial for the hormone&#x27;s activation and subsequent biological function. Based on the enzyme&#x27;s action, which category does it belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lyase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxidoreductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ligase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isomerase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Isomerase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lyase: Lyases catalyze the addition or removal of groups to or from double bonds , or other formations and cleavages of double bonds through means other than hydrolysis and oxidation. They are not primarily involved in isomerization reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Lyase:&lt;/li&gt;&lt;li&gt;â€¢ Lyases catalyze&lt;/li&gt;&lt;li&gt;â€¢ addition or removal of groups to&lt;/li&gt;&lt;li&gt;â€¢ from double bonds&lt;/li&gt;&lt;li&gt;â€¢ formations and cleavages of double bonds&lt;/li&gt;&lt;li&gt;â€¢ hydrolysis and oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxidoreductase: Oxidoreductases are involved in oxidation-reduction reactions , where electrons are transferred from one molecule to another . These enzymes are key players in cellular respiration and photosynthesis but do not typically catalyze structural or geometric changes within a single molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Oxidoreductase:&lt;/li&gt;&lt;li&gt;â€¢ oxidation-reduction reactions&lt;/li&gt;&lt;li&gt;â€¢ electrons are transferred&lt;/li&gt;&lt;li&gt;â€¢ one molecule to another&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ cellular respiration&lt;/li&gt;&lt;li&gt;â€¢ photosynthesis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ligase: Ligases catalyze the joining of two molecules with the simultaneous hydrolysis of a diphosphate bond in ATP or a similar triphosphate . They are essential for processes like DNA replication and repair but are not responsible for isomerization.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Ligase:&lt;/li&gt;&lt;li&gt;â€¢ Ligases catalyze&lt;/li&gt;&lt;li&gt;â€¢ joining of two molecules&lt;/li&gt;&lt;li&gt;â€¢ simultaneous hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ diphosphate bond in ATP&lt;/li&gt;&lt;li&gt;â€¢ similar triphosphate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The International Union of Biochemistry (IUB) developed an unambiguous system of enzyme nomenclature in which each enzyme has a unique name and code number that identifies the type of reaction catalyzed and the substrates involved. Enzymes are grouped into six classes .&lt;/li&gt;&lt;li&gt;âž¤ The International Union of Biochemistry (IUB) developed an unambiguous system of enzyme nomenclature in which each enzyme has a unique name and code number that identifies the type of reaction catalyzed and the substrates involved.&lt;/li&gt;&lt;li&gt;âž¤ International Union of Biochemistry&lt;/li&gt;&lt;li&gt;âž¤ unambiguous system&lt;/li&gt;&lt;li&gt;âž¤ enzyme nomenclature&lt;/li&gt;&lt;li&gt;âž¤ type of reaction&lt;/li&gt;&lt;li&gt;âž¤ substrates&lt;/li&gt;&lt;li&gt;âž¤ Enzymes are grouped into six classes .&lt;/li&gt;&lt;li&gt;âž¤ six classes&lt;/li&gt;&lt;li&gt;âž¤ Oxidoreductases : enzymes that catalyze oxidations and reductions . Transferases : enzymes that catalyze transfer of moieties such as glycosyl, methyl, or phosphoryl groups. Hydrolases : enzymes that catalyze hydrolytic cleavage of C-C, C-O, C-N, and other covalent bonds. Lyases : enzymes that catalyze cleavage of C-C, C-O, C-N, and other covalent bonds by atom elimination , generating double bonds. Isomerases : enzymes that catalyze geometric or structural changes within a molecule. Ligases : enzymes that catalyze the joining together of two molecules in reactions coupled to the hydrolysis of ATP.&lt;/li&gt;&lt;li&gt;âž¤ Oxidoreductases : enzymes that catalyze oxidations and reductions .&lt;/li&gt;&lt;li&gt;âž¤ Oxidoreductases&lt;/li&gt;&lt;li&gt;âž¤ oxidations and reductions&lt;/li&gt;&lt;li&gt;âž¤ Transferases : enzymes that catalyze transfer of moieties such as glycosyl, methyl, or phosphoryl groups.&lt;/li&gt;&lt;li&gt;âž¤ Transferases&lt;/li&gt;&lt;li&gt;âž¤ transfer of moieties&lt;/li&gt;&lt;li&gt;âž¤ Hydrolases : enzymes that catalyze hydrolytic cleavage of C-C, C-O, C-N, and other covalent bonds.&lt;/li&gt;&lt;li&gt;âž¤ Hydrolases&lt;/li&gt;&lt;li&gt;âž¤ hydrolytic cleavage&lt;/li&gt;&lt;li&gt;âž¤ Lyases : enzymes that catalyze cleavage of C-C, C-O, C-N, and other covalent bonds by atom elimination , generating double bonds.&lt;/li&gt;&lt;li&gt;âž¤ Lyases&lt;/li&gt;&lt;li&gt;âž¤ atom elimination&lt;/li&gt;&lt;li&gt;âž¤ Isomerases : enzymes that catalyze geometric or structural changes within a molecule.&lt;/li&gt;&lt;li&gt;âž¤ Isomerases&lt;/li&gt;&lt;li&gt;âž¤ within&lt;/li&gt;&lt;li&gt;âž¤ Ligases : enzymes that catalyze the joining together of two molecules in reactions coupled to the hydrolysis of ATP.&lt;/li&gt;&lt;li&gt;âž¤ Ligases&lt;/li&gt;&lt;li&gt;âž¤ joining&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 61.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 61.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child was brought to the ER with metabolic acidosis after accidental ingestion of flavoured aspirin tablets of an unknown quantity. Her blood pH - 7.0, pKa of aspirin - 3, calculate the ratio of its ionized to unionized forms at the same pH 7.0.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100,000 to 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;10,000 to 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1000 to 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;100 to 1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 10,000 to 1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-14%20115736.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. 10,000 to 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;The Henderson-Hasselbalch equation permits calculation of the ratio of ionized to unionized species for a weak acid at any given pH.\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Ref: Lippincott 7/e: p 6-10.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following kinetic constants is the best measure for expressing the â€˜CATALYTIC EFFICIENCY OF AN ENZYMEâ€™?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ka/Km&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Km/Kcat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kcat/Km&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Km/Ka&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Kcat/Km&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Kaâ€‹/Kmâ€‹: This option is not correct as Kaâ€‹ (association constant) is not typically used in the context of enzyme catalysis .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Kaâ€‹/Kmâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ used&lt;/li&gt;&lt;li&gt;â€¢ context of enzyme catalysis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Kmâ€‹/Kcatâ€‹: This is the inverse of the correct answer and would indicate lower efficiency with increasing values , which is contrary to the concept of catalytic efficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Kmâ€‹/Kcatâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ lower efficiency with increasing values&lt;/li&gt;&lt;li&gt;â€¢ Option D. Kmâ€‹/Kaâ€‹: Similarly to option b, this ratio would not correctly represent catalytic efficiency as it suggests higher values indicate higher efficiency , which is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Kmâ€‹/Kaâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ ratio&lt;/li&gt;&lt;li&gt;â€¢ not correctly represent catalytic efficiency&lt;/li&gt;&lt;li&gt;â€¢ higher values&lt;/li&gt;&lt;li&gt;â€¢ higher efficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The catalytic efficiency of an enzyme is best expressed as the ratio Kcatâ€‹/Km â€‹. Kcat â€‹ is the turnover number , which represents the number of substrate molecules converted to product per enzyme molecule per unit time.&lt;/li&gt;&lt;li&gt;âž¤ catalytic efficiency&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ ratio Kcatâ€‹/Km&lt;/li&gt;&lt;li&gt;âž¤ Kcat&lt;/li&gt;&lt;li&gt;âž¤ turnover number&lt;/li&gt;&lt;li&gt;âž¤ number of substrate molecules&lt;/li&gt;&lt;li&gt;âž¤ product per enzyme molecule per unit time.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: P 80, Lippincott 7/e: P 54&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: P 80, Lippincott 7/e: P 54&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following does NOT reduce the activation energy necessary for an enzymatic reaction to proceed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Negative free energy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reducing entropy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Desolvation of active site&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Competition between substrates&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Competition between substrates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture21.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Negative free energy change (Î”G): A negative Î”G indicates a reaction that can occur spontaneously , which is generally associated with processes that do not require an increase in activation energy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Negative free energy change (Î”G):&lt;/li&gt;&lt;li&gt;â€¢ occur spontaneously&lt;/li&gt;&lt;li&gt;â€¢ Option B. Reducing entropy: By reducing entropy, enzymes organize the reactants into a specific orientation that facilitates the reaction, effectively lowering the activation energy.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Reducing entropy:&lt;/li&gt;&lt;li&gt;â€¢ enzymes organize&lt;/li&gt;&lt;li&gt;â€¢ reactants&lt;/li&gt;&lt;li&gt;â€¢ specific orientation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Desolvation of the enzymeâ€™s active site: Desolvation can help in stabilizing the transition state and decrease activation energy by reducing the energy needed for the reaction to proceed.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Desolvation of the enzymeâ€™s active site:&lt;/li&gt;&lt;li&gt;â€¢ help in stabilizing the transition state&lt;/li&gt;&lt;li&gt;â€¢ decrease activation energy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Activation energy is the energy barrier that must be overcome for a reaction to proceed . Enzymes work by lowering this barrier , thereby increasing the rate of the reaction . Competition between substrates for the active site does not lower the activation energy; instead, it can lead to a decrease in the rate of reaction if one substrate outcompetes another for enzyme binding.&lt;/li&gt;&lt;li&gt;âž¤ Activation energy&lt;/li&gt;&lt;li&gt;âž¤ energy barrier&lt;/li&gt;&lt;li&gt;âž¤ overcome for a reaction to proceed&lt;/li&gt;&lt;li&gt;âž¤ Enzymes work&lt;/li&gt;&lt;li&gt;âž¤ lowering this barrier&lt;/li&gt;&lt;li&gt;âž¤ increasing the rate of the reaction&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:p 77, Lippincott 7/e :P 55, 56, Leininger : 194-200.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:p 77, Lippincott 7/e :P 55, 56, Leininger : 194-200.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the velocity of an enzyme-catalyzed reaction at the substrate concentration equal to Km?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Half the substrate concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Same as Vmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quarter the Vmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Half the Vmax&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Half the Vmax&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Half the substrate concentration: This option is incorrect because Km is not a measure of velocity but rather a specific substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Half the substrate concentration:&lt;/li&gt;&lt;li&gt;â€¢ Km is not a measure of velocity&lt;/li&gt;&lt;li&gt;â€¢ substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Same as Vmax: This is incorrect. Vmax is reached only when the enzyme is saturated with substrate , which occurs at a substrate concentration much higher than Km.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Same as Vmax:&lt;/li&gt;&lt;li&gt;â€¢ Vmax is reached&lt;/li&gt;&lt;li&gt;â€¢ enzyme is saturated with substrate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Quarter the Vmax: This is also incorrect. The definition of Km specifies that the velocity is half of Vmax, not a quarter.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Quarter the Vmax:&lt;/li&gt;&lt;li&gt;â€¢ Km specifies that the velocity is half of Vmax,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SALIENT FEATURES OF Km:&lt;/li&gt;&lt;li&gt;âž¤ SALIENT FEATURES OF Km:&lt;/li&gt;&lt;li&gt;âž¤ Km value is substrate concentration at half-maximal velocity It denotes that 50% of enzyme molecules are bound with substrate molecules at that particular substrate concentration Km is independent of enzyme concentration. Km is the signature of the enzyme. The affinity of an enzyme towards its substrate is inversely related to the dissociation constant, Kd for the enzyme-substrate complex. Km denotes the affinity of enzymes for substrates.&lt;/li&gt;&lt;li&gt;âž¤ Km value is substrate concentration at half-maximal velocity&lt;/li&gt;&lt;li&gt;âž¤ Km value&lt;/li&gt;&lt;li&gt;âž¤ substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ half-maximal velocity&lt;/li&gt;&lt;li&gt;âž¤ It denotes that 50% of enzyme molecules are bound with substrate molecules at that particular substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ denotes that 50% of enzyme molecules&lt;/li&gt;&lt;li&gt;âž¤ bound with substrate molecules&lt;/li&gt;&lt;li&gt;âž¤ particular substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ Km is independent of enzyme concentration.&lt;/li&gt;&lt;li&gt;âž¤ Km is the signature of the enzyme.&lt;/li&gt;&lt;li&gt;âž¤ The affinity of an enzyme towards its substrate is inversely related to the dissociation constant, Kd for the enzyme-substrate complex.&lt;/li&gt;&lt;li&gt;âž¤ Km denotes the affinity of enzymes for substrates.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 80-82.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 80-82.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Enzyme which cleave C-C bond:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lyase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oxidoreductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ligase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isomerase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lyase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxidoreductases : enzymes that catalyze oxidations and reductions .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oxidoreductases&lt;/li&gt;&lt;li&gt;â€¢ oxidations and reductions&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ligases : enzymes that catalyze the joining of two molecules in reaction with hydrolysis of ATP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ligases&lt;/li&gt;&lt;li&gt;â€¢ catalyze&lt;/li&gt;&lt;li&gt;â€¢ joining&lt;/li&gt;&lt;li&gt;â€¢ two molecules&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isomerases : enzymes that catalyze geometric or structural changes within a molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Isomerases&lt;/li&gt;&lt;li&gt;â€¢ within&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lyases are enzymes that catalyze the breaking of various chemical bonds by means other than hydrolysis and oxidation , often forming a new double bond or a new ring structure . They can cleave C-C, C-O, C-N and other bonds. For C-C bonds, lyases are the enzymes responsible for the cleavage.&lt;/li&gt;&lt;li&gt;âž¤ Lyases&lt;/li&gt;&lt;li&gt;âž¤ enzymes that catalyze&lt;/li&gt;&lt;li&gt;âž¤ breaking of various chemical bonds&lt;/li&gt;&lt;li&gt;âž¤ means other than hydrolysis and oxidation&lt;/li&gt;&lt;li&gt;âž¤ new double bond&lt;/li&gt;&lt;li&gt;âž¤ new ring structure&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 61.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 61.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following represents the Michaelis-Menten equation accurately?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;V = Vmax x [S] / Km + [S]&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;V = Vmax x [S] / Km&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;V = Vmax / Km + [S]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;V = Vmax / Km&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. V = Vmax x [S] / Km + [S]&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. V = Vmax X [S] / Km + [S]&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The Michaelis-Menten equation describes the relationship between substrate concentration ([S]) and reaction velocity (Vi) for an enzyme-catalyzed reaction:&lt;/li&gt;&lt;li&gt;â€¢ The Michaelis-Menten equation describes the relationship between substrate concentration ([S]) and reaction velocity (Vi) for an enzyme-catalyzed reaction:&lt;/li&gt;&lt;li&gt;â€¢ Michaelis-Menten equation&lt;/li&gt;&lt;li&gt;â€¢ substrate concentration ([S])&lt;/li&gt;&lt;li&gt;â€¢ reaction velocity (Vi)&lt;/li&gt;&lt;li&gt;â€¢ V= V max x S / Km + S&lt;/li&gt;&lt;li&gt;â€¢ V= V max x S / Km + S&lt;/li&gt;&lt;li&gt;â€¢ Where:&lt;/li&gt;&lt;li&gt;â€¢ V = velocity of Reaction Vmax = Maximum reaction velocity [S] = Substrate concentration Km = Michaelis constant (substrate concentration at half Vmax) This equation shows that the reaction velocity increases hyperbolically with increasing substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ V = velocity of Reaction Vmax = Maximum reaction velocity [S] = Substrate concentration Km = Michaelis constant (substrate concentration at half Vmax)&lt;/li&gt;&lt;li&gt;â€¢ V&lt;/li&gt;&lt;li&gt;â€¢ Vmax = Maximum reaction velocity [S] = Substrate concentration Km = Michaelis constant (substrate concentration at half Vmax)&lt;/li&gt;&lt;li&gt;â€¢ Vmax = Maximum reaction velocity&lt;/li&gt;&lt;li&gt;â€¢ Vmax&lt;/li&gt;&lt;li&gt;â€¢ [S] = Substrate concentration&lt;/li&gt;&lt;li&gt;â€¢ [S]&lt;/li&gt;&lt;li&gt;â€¢ Km = Michaelis constant (substrate concentration at half Vmax)&lt;/li&gt;&lt;li&gt;â€¢ Km&lt;/li&gt;&lt;li&gt;â€¢ This equation shows that the reaction velocity increases hyperbolically with increasing substrate concentration.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 79.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a biochemistry class focused on enzyme inhibitors, the professor introduces the concept of \&quot;suicidal enzymes,\&quot; which essentially undergo self-deactivation during the catalysis of their reactions. She then presents a list of enzymes and asks the students to identify which enzyme fits the description of a \&quot;suicidal enzyme.\&quot; Which of the following enzymes is known to be a \&quot;suicidal enzyme\&quot;?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lipoxygenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclooxygenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thromboxane Synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5â€™ Nucleotidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cyclooxygenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lipoxygenase: This enzyme catalyzes the dioxygenation of polyunsaturated fatty acids in lipids. Although it participates in a reaction similar to that of COX, it is not commonly referred to as a suicidal enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lipoxygenase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme catalyzes&lt;/li&gt;&lt;li&gt;â€¢ dioxygenation of polyunsaturated fatty acids in lipids.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thromboxane Synthase: This enzyme catalyzes the formation of thromboxane from prostaglandin H2 , but it is not classified as a suicidal enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thromboxane Synthase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme catalyzes&lt;/li&gt;&lt;li&gt;â€¢ formation of thromboxane&lt;/li&gt;&lt;li&gt;â€¢ prostaglandin H2&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5â€™ Nucleotidase: This enzyme hydrolyzes phosphate groups from nucleotides and is not classified as a suicidal enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5â€™ Nucleotidase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme hydrolyzes phosphate groups&lt;/li&gt;&lt;li&gt;â€¢ nucleotides&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cyclooxygenase (COX) is often referred to as a \&quot;suicidal enzyme\&quot; because it permanently alters its active site during the process of converting arachidonic acid to prostaglandin H2, which eventually leads to the production of prostaglandin s. The term \&quot;suicidal enzyme\&quot; is attributed to the fact that these enzymes undergo a one-time, self-destructive catalytic cycle after which they are no longer functional.&lt;/li&gt;&lt;li&gt;âž¤ Cyclooxygenase&lt;/li&gt;&lt;li&gt;âž¤ \&quot;suicidal enzyme\&quot;&lt;/li&gt;&lt;li&gt;âž¤ permanently alters its active site&lt;/li&gt;&lt;li&gt;âž¤ converting arachidonic acid&lt;/li&gt;&lt;li&gt;âž¤ prostaglandin H2,&lt;/li&gt;&lt;li&gt;âž¤ production of prostaglandin&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p241.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p241.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following enzymes fits the definition of a lyase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aldolase B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcholine Esterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetyl CoA carboxylase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aldolase B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase: This enzyme is classified as an oxidoreductase. It catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD+.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ classified as an oxidoreductase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcholine esterase: This enzyme is a hydrolase, not a lyase. It catalyzes the hydrolysis of acetylcholine into choline and acetate, a critical reaction in the function of the nervous system.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcholine esterase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme is a hydrolase,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acetyl CoA carboxylase: This enzyme is a ligase (more specifically, a biotin-dependent carboxylase). It catalyzes the ATP-dependent carboxylation of acetyl-CoA to produce malonyl-CoA, a key step in fatty acid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acetyl CoA carboxylase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme is a ligase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Some examples of Lyases are:&lt;/li&gt;&lt;li&gt;âž¤ Lyases&lt;/li&gt;&lt;li&gt;âž¤ HMG CoA Lyase Argininosuccinate Lyase ATP Citrate Lyase Aldolase Fumarase&lt;/li&gt;&lt;li&gt;âž¤ HMG CoA Lyase&lt;/li&gt;&lt;li&gt;âž¤ Argininosuccinate Lyase&lt;/li&gt;&lt;li&gt;âž¤ ATP Citrate Lyase&lt;/li&gt;&lt;li&gt;âž¤ Aldolase&lt;/li&gt;&lt;li&gt;âž¤ Fumarase&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 49.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 49.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of chronic steroid use for rheumatoid arthritis presents with altered liver enzymes. Given his medication history, the physician is concerned about the impact on hepatic enzyme functions, especially those involved in steroid metabolism. Which enzyme characteristic is least associated with steroid metabolism in this patient&#x27;s liver?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Can incorporate 2 atoms of O2 in a substance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Can incorporate 1 atom of O2 in a substance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Important in hydroxylation of steroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Catalysed carboxylation of drugs&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Catalysed carboxylation of drugs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Incorporation of two oxygen atoms into substrates: Dioxygenases can incorporate two oxygen atoms from O2 into substrates. While important in some metabolic pathways, this activity is less common in the direct metabolism of steroids by the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Incorporation of two oxygen atoms into substrates:&lt;/li&gt;&lt;li&gt;â€¢ Dioxygenases&lt;/li&gt;&lt;li&gt;â€¢ incorporate two oxygen atoms from O2&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hydroxylation of steroids: This is a key reaction in the metabolism of steroids , involving the addition of an OH group . Enzymes like cytochrome P450s, which incorporate one oxygen atom into the substrate, often facilitate this reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Hydroxylation of steroids:&lt;/li&gt;&lt;li&gt;â€¢ key reaction in the metabolism of steroids&lt;/li&gt;&lt;li&gt;â€¢ addition of an OH group&lt;/li&gt;&lt;li&gt;â€¢ Option C. Incorporation of one oxygen atom into substrates: This describes the activity of monooxygenases, such as those in the cytochrome P450 family, which are crucial for the hydroxylation of steroids in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Incorporation of one oxygen atom into substrates:&lt;/li&gt;&lt;li&gt;â€¢ activity of monooxygenases,&lt;/li&gt;&lt;li&gt;â€¢ cytochrome P450 family,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oxygenases can be monooxygenase or dioxygenase. Monooxygenase can incorporate 1 atom of oxygen molecule to the substrate. Dioxygenase can incorporate both the atoms of oxygen molecules to the substrate. Phase 1 Xenobiotic reactions such as hydroxylation is catalysed mainly by members of a class of enzymes known as monooxygenases or cytochrome P450s.&lt;/li&gt;&lt;li&gt;âž¤ Oxygenases can be monooxygenase or dioxygenase.&lt;/li&gt;&lt;li&gt;âž¤ Oxygenases&lt;/li&gt;&lt;li&gt;âž¤ monooxygenase or dioxygenase.&lt;/li&gt;&lt;li&gt;âž¤ Monooxygenase can incorporate 1 atom of oxygen molecule to the substrate.&lt;/li&gt;&lt;li&gt;âž¤ Monooxygenase&lt;/li&gt;&lt;li&gt;âž¤ incorporate 1 atom of oxygen molecule&lt;/li&gt;&lt;li&gt;âž¤ substrate.&lt;/li&gt;&lt;li&gt;âž¤ Dioxygenase can incorporate both the atoms of oxygen molecules to the substrate.&lt;/li&gt;&lt;li&gt;âž¤ Phase 1 Xenobiotic reactions such as hydroxylation is catalysed mainly by members of a class of enzymes known as monooxygenases or cytochrome P450s.&lt;/li&gt;&lt;li&gt;âž¤ hydroxylation&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p118, 119.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p118, 119.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a characteristic commonly associated with enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Most of enzymes are proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heat labile&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Water-insoluble&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They contain 16% weight as nitrogen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Water-insoluble&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Most enzymes are proteins: This is a true characteristic of enzymes . While there are some RNA molecules (ribozymes) that exhibit catalytic properties, the vast majority of enzymes are indeed proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Most enzymes are proteins:&lt;/li&gt;&lt;li&gt;â€¢ true characteristic of enzymes&lt;/li&gt;&lt;li&gt;â€¢ Option B. Enzymes are heat labile: This is also true . Enzymes, like most proteins, are sensitive to heat, which can denature them, leading to a loss of their three-dimensional structure and catalytic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Enzymes are heat labile:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enzymes contain approximately 16% of their weight as nitrogen: This statement is generally true for proteins, including enzymes, due to the presence of amino acids, which contain nitrogen.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Enzymes contain approximately 16% of their weight as nitrogen:&lt;/li&gt;&lt;li&gt;â€¢ generally true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Characteristics of Enzymes:&lt;/li&gt;&lt;li&gt;âž¤ Characteristics of Enzymes:&lt;/li&gt;&lt;li&gt;âž¤ Almost all enzymes are proteins and follow the physical and chemical reactions of proteins. Some enzymes are also made of RNA known as ribozymes. They are heat labile. Most of them are water-soluble . They can be precipitated by protein precipitating reagents (ammonium sulfate or trichloroacetic acid). They contain 16% weight as nitrogen&lt;/li&gt;&lt;li&gt;âž¤ Almost all enzymes are proteins and follow the physical and chemical reactions of proteins. Some enzymes are also made of RNA known as ribozymes.&lt;/li&gt;&lt;li&gt;âž¤ all enzymes are proteins&lt;/li&gt;&lt;li&gt;âž¤ They are heat labile.&lt;/li&gt;&lt;li&gt;âž¤ heat labile.&lt;/li&gt;&lt;li&gt;âž¤ Most of them are water-soluble .&lt;/li&gt;&lt;li&gt;âž¤ water-soluble&lt;/li&gt;&lt;li&gt;âž¤ They can be precipitated by protein precipitating reagents (ammonium sulfate or trichloroacetic acid).&lt;/li&gt;&lt;li&gt;âž¤ They contain 16% weight as nitrogen&lt;/li&gt;&lt;li&gt;âž¤ contain 16% weight as nitrogen&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 48.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 48.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pick up the true statement regarding pH of enzyme&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Extremes of pH can lead to denaturation of the enzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Maximal enzyme activity is achieved at same pH for all the enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pepsin is denatured by acidic pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;{E} and {S} must have chemical groups in an ionized form to interact&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Extremes of pH can lead to denaturation of the enzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture4_bhWaF0p.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. The pH at which maximal enzyme activity is achieved is different for different enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ maximal enzyme activity is achieved is different for different enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pepsin, a digestive enzyme is maximally active at pH 2 .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ pH 2&lt;/li&gt;&lt;li&gt;â€¢ Option D. The catalytic process requires enzymes and substrates to have specific chemical groups in either an ionized or unionized state to interact .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ either an ionized or unionized state to interact&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Enzymes function optimally within specific pH ranges , and extreme pH levels can cause denaturation, affecting their structure and activity. Different enzymes have distinct optimal pH values, reflecting their diverse roles and environments.&lt;/li&gt;&lt;li&gt;âž¤ Enzymes function&lt;/li&gt;&lt;li&gt;âž¤ specific pH ranges&lt;/li&gt;&lt;li&gt;âž¤ cause denaturation,&lt;/li&gt;&lt;li&gt;âž¤ structure and activity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 57, 58.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 6/e: p 57, 58.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MATCH THE FOLLOWING&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-c, 2-a, 3-d, 4-b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-c, 2-a, 3-d, 4-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-121552.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-121846.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Kinases - c) ATP: Kinases are enzymes that catalyze the transfer of phosphate groups from high-energy, phosphate-donating molecules, such as ATP, to specific substrates.&lt;/li&gt;&lt;li&gt;â€¢ Kinases - c) ATP:&lt;/li&gt;&lt;li&gt;â€¢ Kinases&lt;/li&gt;&lt;li&gt;â€¢ enzymes that catalyze the transfer of phosphate groups&lt;/li&gt;&lt;li&gt;â€¢ high-energy, phosphate-donating molecules,&lt;/li&gt;&lt;li&gt;â€¢ Transaminase - a) Pyridoxal phosphate: Transaminases, also known as aminotransferases , are enzymes that catalyze the transfer of an amino group from an amino acid to a keto acid. They commonly use pyridoxal phosphate, a derivative of vitamin B6, as a coenzyme.&lt;/li&gt;&lt;li&gt;â€¢ Transaminase - a) Pyridoxal phosphate:&lt;/li&gt;&lt;li&gt;â€¢ aminotransferases&lt;/li&gt;&lt;li&gt;â€¢ enzymes that catalyze the transfer&lt;/li&gt;&lt;li&gt;â€¢ amino group from an amino acid to a keto acid.&lt;/li&gt;&lt;li&gt;â€¢ Alpha Keto Dehydrogenase - d) Lipoic acid : Alpha-keto dehydrogenases are a class of enzymes that catalyze the decarboxylation of alpha-keto acids . Lipoic acid is often involved as a coenzyme in their complexes.&lt;/li&gt;&lt;li&gt;â€¢ Alpha Keto Dehydrogenase - d) Lipoic acid&lt;/li&gt;&lt;li&gt;â€¢ Alpha-keto dehydrogenases&lt;/li&gt;&lt;li&gt;â€¢ class of enzymes&lt;/li&gt;&lt;li&gt;â€¢ catalyze the decarboxylation&lt;/li&gt;&lt;li&gt;â€¢ alpha-keto acids&lt;/li&gt;&lt;li&gt;â€¢ Carboxylases - b) Biotin: Carboxylases are enzymes that catalyze the addition of a carboxyl group to a substrate . Biotin, a B vitamin, serves as a coenzyme for these enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Carboxylases - b) Biotin:&lt;/li&gt;&lt;li&gt;â€¢ enzymes that catalyze the addition of a carboxyl group&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 350.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 350.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Double Reciprocal Plot can be derived from the Michaelis-Menten equation. Choose an appropriate response.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canâ€™t say&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture5_c5dZRBF.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver Burk Plot: A graphical representation of 1/V on y axis and 1/S on x axis is called Lineweaver Burk Plot or Double Reciprocal plot. In Lineweaver burk Plot X intercept is â€“1/Km Y intercept is Km/Vmax Slope is Km/Vmax&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver Burk Plot: A graphical representation of 1/V on y axis and 1/S on x axis is called Lineweaver Burk Plot or Double Reciprocal plot.&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver Burk Plot:&lt;/li&gt;&lt;li&gt;â€¢ graphical representation&lt;/li&gt;&lt;li&gt;â€¢ 1/V on y axis and 1/S on x axis&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver Burk Plot&lt;/li&gt;&lt;li&gt;â€¢ In Lineweaver burk Plot X intercept is â€“1/Km Y intercept is Km/Vmax Slope is Km/Vmax&lt;/li&gt;&lt;li&gt;â€¢ X intercept is â€“1/Km Y intercept is Km/Vmax Slope is Km/Vmax&lt;/li&gt;&lt;li&gt;â€¢ X intercept is â€“1/Km&lt;/li&gt;&lt;li&gt;â€¢ Y intercept is Km/Vmax&lt;/li&gt;&lt;li&gt;â€¢ Slope is Km/Vmax&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver-Burk equation&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver-Burk equation&lt;/li&gt;&lt;li&gt;â€¢ Dixon Plot: Alternative to Lineweaver Burk Plot . 1/V is measured at different concentration of inhibitor [I], but at same substrate concentration[S].&lt;/li&gt;&lt;li&gt;â€¢ Dixon Plot: Alternative to Lineweaver Burk Plot . 1/V is measured at different concentration of inhibitor [I], but at same substrate concentration[S].&lt;/li&gt;&lt;li&gt;â€¢ Dixon Plot:&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver Burk Plot&lt;/li&gt;&lt;li&gt;â€¢ 1/V&lt;/li&gt;&lt;li&gt;â€¢ different concentration of inhibitor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Double Reciprocal Plot, or Lineweaver-Burk plot, is indeed derived from the Michaelis-Menten equation.&lt;/li&gt;&lt;li&gt;âž¤ Double Reciprocal Plot,&lt;/li&gt;&lt;li&gt;âž¤ Lineweaver-Burk plot,&lt;/li&gt;&lt;li&gt;âž¤ derived from the Michaelis-Menten equation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 57.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 57.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Non-protein part of the enzyme can be&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coenzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cofactor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prosthetic group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture6_2NU5VdI.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coenzymes : These are organic molecules , often derived from vitamins, that temporarily associate with the enzyme and participate in the reaction by transferring a chemical group from one molecule to another. They are not permanently bound to the enzyme and can be reused in multiple catalytic cycles.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coenzymes&lt;/li&gt;&lt;li&gt;â€¢ organic molecules&lt;/li&gt;&lt;li&gt;â€¢ derived from vitamins,&lt;/li&gt;&lt;li&gt;â€¢ temporarily associate with the enzyme&lt;/li&gt;&lt;li&gt;â€¢ participate in the reaction&lt;/li&gt;&lt;li&gt;â€¢ transferring a chemical group&lt;/li&gt;&lt;li&gt;â€¢ one molecule to another.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cofactors : This term encompasses a broader range of non-protein molecules that assist enzymes in their catalytic activity. Cofactors can be metal ions like magnesium, zinc, or iron, which are inorganic, or organic molecules, in which case they are also known as coenzymes. They can be either loosely attached or tightly bound to the enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cofactors&lt;/li&gt;&lt;li&gt;â€¢ encompasses a broader range of non-protein molecules&lt;/li&gt;&lt;li&gt;â€¢ assist enzymes in their catalytic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prosthetic groups : These are non-protein components that are tightly, often covalently, bound to the enzyme. They are permanent parts of the enzyme&#x27;s structure and participate directly in the enzyme&#x27;s catalytic process. Examples include heme in cytochromes and the biotin in enzymes involved in carboxylation reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prosthetic groups&lt;/li&gt;&lt;li&gt;â€¢ non-protein components&lt;/li&gt;&lt;li&gt;â€¢ tightly,&lt;/li&gt;&lt;li&gt;â€¢ covalently, bound to the enzyme.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Enzymes can be of two types: Simple Enzyme : Consists of only proteins. Complex enzyme consists of: Protein part: Apoenzyme and Nonprotein part Apoenzyme + Non Protein part (Prosthetic group/Cofactor/ Coenzyme) = Holoenzyme Nonprotein parts can be Coenzyme, Cofactor and Prosthetic group.&lt;/li&gt;&lt;li&gt;âž¤ Enzymes can be of two types: Simple Enzyme : Consists of only proteins. Complex enzyme consists of: Protein part: Apoenzyme and Nonprotein part&lt;/li&gt;&lt;li&gt;âž¤ Enzymes can be of two types:&lt;/li&gt;&lt;li&gt;âž¤ Simple Enzyme : Consists of only proteins. Complex enzyme consists of: Protein part: Apoenzyme and Nonprotein part&lt;/li&gt;&lt;li&gt;âž¤ Simple Enzyme : Consists of only proteins.&lt;/li&gt;&lt;li&gt;âž¤ Simple Enzyme&lt;/li&gt;&lt;li&gt;âž¤ Complex enzyme consists of: Protein part: Apoenzyme and Nonprotein part&lt;/li&gt;&lt;li&gt;âž¤ Complex enzyme&lt;/li&gt;&lt;li&gt;âž¤ Apoenzyme + Non Protein part (Prosthetic group/Cofactor/ Coenzyme) = Holoenzyme&lt;/li&gt;&lt;li&gt;âž¤ = Holoenzyme&lt;/li&gt;&lt;li&gt;âž¤ Nonprotein parts can be Coenzyme, Cofactor and Prosthetic group.&lt;/li&gt;&lt;li&gt;âž¤ Nonprotein parts&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 50.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 50.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a research article on the enzymatic mechanisms involved in alcohol metabolism, the role of alcohol dehydrogenase (ADH) and its interaction with coenzymes is highlighted. The article explains how ADH catalyzes the oxidation of alcohols to aldehydes, a process that involves the reduction of NAD++ to NADH. Given this context, how is NAD++ best described in its role in the reaction catalyzed by ADH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heterotropic effectors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coenzyme + co-substrates&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coenzyme + prosthetic group.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cofactor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Coenzyme + co-substrates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heterotropic effectors: Heterotropic effectors are molecules that bind to an enzyme at a site other than the active site and influence its activity. While NAD++ does influence ADH activity, its primary role is as a coenzyme and co-substrate, not as an effector.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Heterotropic effectors:&lt;/li&gt;&lt;li&gt;â€¢ molecules&lt;/li&gt;&lt;li&gt;â€¢ bind to an enzyme at a site&lt;/li&gt;&lt;li&gt;â€¢ active site&lt;/li&gt;&lt;li&gt;â€¢ influence its activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coenzyme + prosthetic group: A prosthetic group is a tightly bound , non-polypeptide unit required for the biological activity of some proteins, which differs from how NAD++ functions with ADH. NAD++ is not permanently attached to ADH; instead, it binds temporarily and is released as NADH after the reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Coenzyme + prosthetic group:&lt;/li&gt;&lt;li&gt;â€¢ prosthetic group&lt;/li&gt;&lt;li&gt;â€¢ tightly bound&lt;/li&gt;&lt;li&gt;â€¢ non-polypeptide unit&lt;/li&gt;&lt;li&gt;â€¢ biological activity of some proteins,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cofactor : While NAD++ is a type of cofactor , this option is less specific than option b. Cofactors include both coenzymes and metal ions that assist in enzyme activity, but NAD++&#x27;s role as a co-substrate in conjunction with its coenzyme function is more accurately described by option b.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Cofactor&lt;/li&gt;&lt;li&gt;â€¢ NAD++ is a type of cofactor&lt;/li&gt;&lt;li&gt;â€¢ less specific&lt;/li&gt;&lt;li&gt;â€¢ Cofactors&lt;/li&gt;&lt;li&gt;â€¢ both coenzymes&lt;/li&gt;&lt;li&gt;â€¢ metal ions&lt;/li&gt;&lt;li&gt;â€¢ assist in enzyme activity,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coenzymes + co-substrates are small organic molecules that associate transiently with an enzyme and leave the enzyme in a changed form.&lt;/li&gt;&lt;li&gt;âž¤ Coenzymes + co-substrates&lt;/li&gt;&lt;li&gt;âž¤ small organic molecules&lt;/li&gt;&lt;li&gt;âž¤ transiently with an enzyme&lt;/li&gt;&lt;li&gt;âž¤ leave the enzyme&lt;/li&gt;&lt;li&gt;âž¤ changed form.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: 50.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: 50.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical researcher is studying the efficiency of metabolic pathways and the role of multi-enzyme complexes in facilitating these processes. They focus on how these complexes streamline biochemical reactions to enhance cellular efficiency. Which of the following is an example of such a multi-enzyme complex that plays a pivotal role in metabolic pathways?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha-ketoglutarate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only a&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both a and b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha-ketoglutarate dehydrogenase: While this is a multi-enzyme complex, selecting this option ignores the role of Fatty acid synthase, another critical multi-enzyme complex.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha-ketoglutarate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ multi-enzyme complex,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty acid synthase: Similar to option a, choosing this option alone overlooks the importance of Alpha-ketoglutarate dehydrogenase as a multi-enzyme complex in metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Fatty acid synthase:&lt;/li&gt;&lt;li&gt;â€¢ Alpha-ketoglutarate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only a: This option inaccurately suggests that only Alpha-ketoglutarate dehydrogenase is a multi-enzyme complex, disregarding the role of Fatty acid synthase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only a:&lt;/li&gt;&lt;li&gt;â€¢ Alpha-ketoglutarate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ multi-enzyme complex,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Multi-enzyme Complexes&lt;/li&gt;&lt;li&gt;âž¤ Multi-enzyme Complexes&lt;/li&gt;&lt;li&gt;âž¤ Generally the rate of reaction of enzymes is limited by the rate at which substrate molecules diffuse through solution and reach the active site of the enzyme. In a series of reactions, the product of the first enzyme diffuses into the surrounding medium, later reaches the second enzyme, which may hinder the smooth and efficient work of the enzymes in a metabolic pathway. This can be overcome by a multi-enzyme complex, so that the product of the first reaction is immediately transferred to the second enzyme and so on. E.g are:&lt;/li&gt;&lt;li&gt;âž¤ Generally the rate of reaction of enzymes is limited by the rate at which substrate molecules diffuse through solution and reach the active site of the enzyme.&lt;/li&gt;&lt;li&gt;âž¤ rate of reaction of enzymes&lt;/li&gt;&lt;li&gt;âž¤ limited by the rate at which substrate molecules diffuse&lt;/li&gt;&lt;li&gt;âž¤ reach the active site of the enzyme.&lt;/li&gt;&lt;li&gt;âž¤ In a series of reactions, the product of the first enzyme diffuses into the surrounding medium, later reaches the second enzyme, which may hinder the smooth and efficient work of the enzymes in a metabolic pathway.&lt;/li&gt;&lt;li&gt;âž¤ series of reactions,&lt;/li&gt;&lt;li&gt;âž¤ product of the first enzyme diffuses&lt;/li&gt;&lt;li&gt;âž¤ surrounding medium,&lt;/li&gt;&lt;li&gt;âž¤ This can be overcome by a multi-enzyme complex, so that the product of the first reaction is immediately transferred to the second enzyme and so on. E.g are:&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid synthase Pyruvate dehydrogenase complex Alpha-ketoglutarate dehydrogenase Glycine cleavage system Pyruvate carboxylase Pyrimidine nucleotide synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid synthase&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid synthase&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate dehydrogenase complex&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate dehydrogenase complex&lt;/li&gt;&lt;li&gt;âž¤ Alpha-ketoglutarate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Alpha-ketoglutarate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Glycine cleavage system&lt;/li&gt;&lt;li&gt;âž¤ Glycine cleavage system&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate carboxylase&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate carboxylase&lt;/li&gt;&lt;li&gt;âž¤ Pyrimidine nucleotide synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Pyrimidine nucleotide synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 66.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 66.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following metalloenzymes:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-c, 2-a, 3-d, 4-b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-c, 2-a, 3-d, 4-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-124933.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-125104.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-125127.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 51.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 51.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old female patient with a history of abnormal lipid levels is prescribed statins to manage her condition. Statins act as competitive inhibitors of the enzyme HMG-CoA reductase, a key player in cholesterol biosynthesis. Considering the mechanism of action of statins, which statement accurately reflects the effect of competitive inhibitors on enzyme kinetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive inhibitors increase both Km and the Vmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Competitive inhibitors increase the Km and have no effect on the Vmax.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Competitive inhibitors decrease both Km and Vmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Competitive inhibitors have no effect on the Km and decrease the Vmax.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Competitive inhibitors increase the Km and have no effect on the Vmax.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture7_PzD2jwH.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture8_bDaDgjF.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors compete with the substrate for binding to the active site of an enzyme, which can be overcome by increasing the concentration of the substrate. Therefore, competitive inhibitors increase the Km (indicating a lower affinity of the enzyme for the substrate due to the presence of the inhibitor) but do not affect the Vmax (maximum rate of the reaction when the enzyme is fully saturated with substrate).&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors compete&lt;/li&gt;&lt;li&gt;âž¤ substrate for binding to the active site of an enzyme,&lt;/li&gt;&lt;li&gt;âž¤ overcome by increasing&lt;/li&gt;&lt;li&gt;âž¤ concentration of the substrate.&lt;/li&gt;&lt;li&gt;âž¤ competitive inhibitors increase the Km&lt;/li&gt;&lt;li&gt;âž¤ do not affect the Vmax&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 82-83.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 82-83.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of studying enzyme inhibition mechanisms, succinate dehydrogenase, an enzyme in the citric acid cycle, is noted to be inhibited by malonate. This inhibition occurs because malonate closely resembles the enzyme&#x27;s natural substrate, succinate, but cannot undergo the same reaction. Based on this information, what type of enzyme inhibition does malonate exemplify when inhibiting succinate dehydrogenase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Noncompetitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uncompetitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Competitive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-125844.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-competitive: Cyanide inhibits cytochrome oxidase , Fluoride inhibit enolase thereby consequently the glycolysis, Iodoacetate inhibit enzymes having â€“SH group in their active centers, BAL (dimercaprol) as an antidote for heavy metal poisoning etc.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-competitive:&lt;/li&gt;&lt;li&gt;â€¢ Cyanide inhibits cytochrome oxidase&lt;/li&gt;&lt;li&gt;â€¢ Fluoride&lt;/li&gt;&lt;li&gt;â€¢ inhibit enolase&lt;/li&gt;&lt;li&gt;â€¢ glycolysis,&lt;/li&gt;&lt;li&gt;â€¢ Iodoacetate inhibit enzymes having â€“SH group&lt;/li&gt;&lt;li&gt;â€¢ active centers,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uncompetitive: Inhibition of placental alkaline phosphatase (Regan iso-enzyme) by phenylalanine.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uncompetitive:&lt;/li&gt;&lt;li&gt;â€¢ Inhibition&lt;/li&gt;&lt;li&gt;â€¢ placental alkaline phosphatase&lt;/li&gt;&lt;li&gt;â€¢ phenylalanine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric: ALA Synthase catalyse the first step in heme biosynthesis and the end product , heme will allosterically inhibit the enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allosteric:&lt;/li&gt;&lt;li&gt;â€¢ ALA Synthase catalyse&lt;/li&gt;&lt;li&gt;â€¢ heme biosynthesis&lt;/li&gt;&lt;li&gt;â€¢ end product&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Examples of competitive inhibition&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors of enzymes are mostly drugs&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors of enzymes are mostly drugs&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p78.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p78.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is investigating the digestion of dietary proteins and employs chymotrypsin to understand the breakdown process. Chymotrypsin, a digestive enzyme, is known for its specificity in targeting peptide bonds. In assessing the activity of chymotrypsin, the team is particularly interested in identifying the amino acid residues that, when positioned at the carbonyl side of a peptide bond, are most susceptible to cleavage by this enzyme. Which amino acid residue is chymotrypsin most likely to cleave at the carbonyl terminal side of a peptide bond?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenylalanine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phenylalanine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Arginine: While arginine is a basic amino acid with a significant role in various biochemical processes , chymotrypsin does not preferentially cleave at the carbonyl terminal of arginine residues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Arginine:&lt;/li&gt;&lt;li&gt;â€¢ basic amino acid&lt;/li&gt;&lt;li&gt;â€¢ various biochemical processes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine: Similar to arginine, lysine is a basic amino acid . Chymotrypsin&#x27;s specificity for aromatic side chains means it does not typically cleave peptide bonds at the carbonyl terminal of lysine residues.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lysine:&lt;/li&gt;&lt;li&gt;â€¢ lysine is a basic amino acid&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine: Glycine, being a small and flexible amino acid , does not fit the specificity profile of chymotrypsin, which favors larger, aromatic residues.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycine:&lt;/li&gt;&lt;li&gt;â€¢ small and flexible amino acid&lt;/li&gt;&lt;li&gt;â€¢ not fit the specificity profile&lt;/li&gt;&lt;li&gt;â€¢ chymotrypsin,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Examples of serine proteases&lt;/li&gt;&lt;li&gt;âž¤ Examples of serine proteases&lt;/li&gt;&lt;li&gt;âž¤ Chymotrypsin Trypsin Elastase Thrombin Plasmin Complements Factor X and XI.&lt;/li&gt;&lt;li&gt;âž¤ Chymotrypsin&lt;/li&gt;&lt;li&gt;âž¤ Trypsin&lt;/li&gt;&lt;li&gt;âž¤ Elastase&lt;/li&gt;&lt;li&gt;âž¤ Thrombin&lt;/li&gt;&lt;li&gt;âž¤ Plasmin&lt;/li&gt;&lt;li&gt;âž¤ Complements&lt;/li&gt;&lt;li&gt;âž¤ Factor X and XI.&lt;/li&gt;&lt;li&gt;âž¤ Serine proteases differ in substrate specificity&lt;/li&gt;&lt;li&gt;âž¤ Serine proteases differ in substrate specificity&lt;/li&gt;&lt;li&gt;âž¤ Trypsin cleaves adjacent to Basic Amino Acid like Arg, Lys. Chymotrypsin cleaves adjacent to Hydrophobic Bulky Amino Acid like Trp, Tyr, Phe Elastase cleaves adjacent to Small neutral Amino Acids like Alanine, Glycine.&lt;/li&gt;&lt;li&gt;âž¤ Trypsin cleaves adjacent to Basic Amino Acid like Arg, Lys.&lt;/li&gt;&lt;li&gt;âž¤ Chymotrypsin cleaves adjacent to Hydrophobic Bulky Amino Acid like Trp, Tyr, Phe&lt;/li&gt;&lt;li&gt;âž¤ Elastase cleaves adjacent to Small neutral Amino Acids like Alanine, Glycine.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 64.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 64.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an investigation on the regulation of metabolic pathways through phosphorylation and dephosphorylation, a researcher studies the effect of these post-translational modifications on various enzymes. One particular focus is on enzymes whose catalytic activity is diminished upon dephosphorylation. Which enzyme listed below has its activity reduced through dephosphorylation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HMG CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycogen Phosphorylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyruvate Dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glycogen Phosphorylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand how phosphorylation and dephosphorylation serve as key regulatory mechanisms for enzyme activity in metabolic pathways. Differentiate between enzymes that are activated versus those that are inactivated by phosphorylation. Recognize the specific regulation pattern of glycogen phosphorylase and its role in glycogen metabolism: Phosphorylation â†’ activation Dephosphorylation â†’ inactivation Identify the opposite regulation pattern in enzymes like HMG CoA reductase and pyruvate dehydrogenase: Phosphorylation â†’ inactivation Dephosphorylation â†’ activation&lt;/li&gt;&lt;li&gt;âž¤ Understand how phosphorylation and dephosphorylation serve as key regulatory mechanisms for enzyme activity in metabolic pathways.&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between enzymes that are activated versus those that are inactivated by phosphorylation.&lt;/li&gt;&lt;li&gt;âž¤ Recognize the specific regulation pattern of glycogen phosphorylase and its role in glycogen metabolism: Phosphorylation â†’ activation Dephosphorylation â†’ inactivation&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation â†’ activation Dephosphorylation â†’ inactivation&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation â†’ activation&lt;/li&gt;&lt;li&gt;âž¤ Dephosphorylation â†’ inactivation&lt;/li&gt;&lt;li&gt;âž¤ Identify the opposite regulation pattern in enzymes like HMG CoA reductase and pyruvate dehydrogenase: Phosphorylation â†’ inactivation Dephosphorylation â†’ activation&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation â†’ inactivation Dephosphorylation â†’ activation&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation â†’ inactivation&lt;/li&gt;&lt;li&gt;âž¤ Dephosphorylation â†’ activation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p91.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on the regulatory mechanisms of enzyme activity, a molecular biologist examines various types of covalent modifications. While most covalent modifications directly influence enzyme activity, one of the listed modifications typically serves other functions rather than directly regulating enzymatic activity. Which of the following covalent modifications is not primarily involved in regulating enzyme activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ADP Ribosylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycosylation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glycosylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phosphorylation : This is a common regulatory mechanism that can activate or deactivate enzymes by adding a phosphate group, often altering the enzyme&#x27;s structure and activity.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ common regulatory mechanism&lt;/li&gt;&lt;li&gt;â€¢ activate or deactivate enzymes&lt;/li&gt;&lt;li&gt;â€¢ phosphate group,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetylation : The addition of an acetyl group to proteins , including enzymes, can affect their activity, stability , and interactions with other molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetylation&lt;/li&gt;&lt;li&gt;â€¢ acetyl group to proteins&lt;/li&gt;&lt;li&gt;â€¢ affect their activity, stability&lt;/li&gt;&lt;li&gt;â€¢ interactions with other molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ADP Ribosylation : This modification involves adding ADP-ribose units to proteins and can significantly affect enzyme function and cell signalling pathways.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ADP Ribosylation&lt;/li&gt;&lt;li&gt;â€¢ modification&lt;/li&gt;&lt;li&gt;â€¢ adding ADP-ribose units to proteins&lt;/li&gt;&lt;li&gt;â€¢ affect enzyme function&lt;/li&gt;&lt;li&gt;â€¢ cell signalling pathways.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reversible covalent modifications&lt;/li&gt;&lt;li&gt;âž¤ Reversible covalent modifications&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation, Dephosphorylation ADP Ribosylation Methylation Acetylation.&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation, Dephosphorylation&lt;/li&gt;&lt;li&gt;âž¤ ADP Ribosylation&lt;/li&gt;&lt;li&gt;âž¤ Methylation&lt;/li&gt;&lt;li&gt;âž¤ Acetylation.&lt;/li&gt;&lt;li&gt;âž¤ Irreversible Covalent Modification&lt;/li&gt;&lt;li&gt;âž¤ Irreversible Covalent Modification&lt;/li&gt;&lt;li&gt;âž¤ Zymogen activation/ Partial Proteolysis.&lt;/li&gt;&lt;li&gt;âž¤ Zymogen activation/ Partial Proteolysis.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 29/e p89&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 29/e p89&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In research examining various regulatory mechanisms of enzyme function, several methods are discussed that directly influence enzyme activity through structural modifications. One method mentioned, however, primarily affects the availability of the enzyme rather than its intrinsic activity. Which of the following is primarily associated with altering enzyme levels rather than directly modifying enzyme activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Induction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphorylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Induction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methylation : The addition of methyl groups to enzymes can directly alter their activity, specificity, or interactions with other molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Methylation&lt;/li&gt;&lt;li&gt;â€¢ methyl groups&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ directly alter their activity,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetylation : Similar to methylation, acetylation involves the addition of acetyl groups to enzymes, affecting their activity and function.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetylation&lt;/li&gt;&lt;li&gt;â€¢ methylation,&lt;/li&gt;&lt;li&gt;â€¢ acetylation&lt;/li&gt;&lt;li&gt;â€¢ addition of acetyl groups to enzymes,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phosphorylation : This is a common regulatory mechanism where the addition of phosphate groups to enzymes can activate or inhibit their activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ common regulatory mechanism&lt;/li&gt;&lt;li&gt;â€¢ addition of phosphate groups&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ activate or inhibit their activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Regulation of Enzymes can be classified as:&lt;/li&gt;&lt;li&gt;âž¤ Regulation of Enzyme Quality (Intrinsic Catalytic Efficiency) Allosteric Regulation Covalent modification Covalent modification Phosphorylation/dephosphorylation [Most Common covalent modification] Methylation Adenylation ADP ribosylation Acetylation Regulation of enzyme quantity Control of Enzyme Synthesis by Induction and Repression of their respective gene expression Control of Enzyme Degradation: Enzymes are degraded by Ubiquitin-Proteasome pathway.&lt;/li&gt;&lt;li&gt;âž¤ Regulation of Enzyme Quality (Intrinsic Catalytic Efficiency) Allosteric Regulation Covalent modification Covalent modification Phosphorylation/dephosphorylation [Most Common covalent modification] Methylation Adenylation ADP ribosylation Acetylation&lt;/li&gt;&lt;li&gt;âž¤ Regulation of Enzyme Quality (Intrinsic Catalytic Efficiency)&lt;/li&gt;&lt;li&gt;âž¤ Allosteric Regulation Covalent modification Covalent modification Phosphorylation/dephosphorylation [Most Common covalent modification] Methylation Adenylation ADP ribosylation Acetylation&lt;/li&gt;&lt;li&gt;âž¤ Allosteric Regulation&lt;/li&gt;&lt;li&gt;âž¤ Covalent modification&lt;/li&gt;&lt;li&gt;âž¤ Covalent modification&lt;/li&gt;&lt;li&gt;âž¤ Covalent modification&lt;/li&gt;&lt;li&gt;âž¤ Phosphorylation/dephosphorylation [Most Common covalent modification]&lt;/li&gt;&lt;li&gt;âž¤ Methylation&lt;/li&gt;&lt;li&gt;âž¤ Adenylation&lt;/li&gt;&lt;li&gt;âž¤ ADP ribosylation&lt;/li&gt;&lt;li&gt;âž¤ Acetylation&lt;/li&gt;&lt;li&gt;âž¤ Regulation of enzyme quantity Control of Enzyme Synthesis by Induction and Repression of their respective gene expression Control of Enzyme Degradation: Enzymes are degraded by Ubiquitin-Proteasome pathway.&lt;/li&gt;&lt;li&gt;âž¤ Regulation of enzyme quantity&lt;/li&gt;&lt;li&gt;âž¤ Control of Enzyme Synthesis by Induction and Repression of their respective gene expression Control of Enzyme Degradation: Enzymes are degraded by Ubiquitin-Proteasome pathway.&lt;/li&gt;&lt;li&gt;âž¤ Control of Enzyme Synthesis by Induction and Repression of their respective gene expression&lt;/li&gt;&lt;li&gt;âž¤ Control of Enzyme Degradation: Enzymes are degraded by Ubiquitin-Proteasome pathway.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p89, 90.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p89, 90.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the classification of chymotrypsinogen based on its functional state before activation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zymogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carboxypeptidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aminopeptidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exopeptidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Zymogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chymotrypsinogen is a zymogen , which is an inactive precursor of an enzyme . Zymogens are converted into their active forms through a biochemical change , typically the cleavage of specific peptide bonds. In the case of chymotrypsinogen , it is activated to become chymotrypsin , a key enzyme in protein digestion.&lt;/li&gt;&lt;li&gt;âž¤ Chymotrypsinogen&lt;/li&gt;&lt;li&gt;âž¤ zymogen&lt;/li&gt;&lt;li&gt;âž¤ inactive precursor&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ Zymogens&lt;/li&gt;&lt;li&gt;âž¤ converted into their active forms&lt;/li&gt;&lt;li&gt;âž¤ biochemical change&lt;/li&gt;&lt;li&gt;âž¤ cleavage of specific peptide bonds.&lt;/li&gt;&lt;li&gt;âž¤ chymotrypsinogen&lt;/li&gt;&lt;li&gt;âž¤ activated&lt;/li&gt;&lt;li&gt;âž¤ chymotrypsin&lt;/li&gt;&lt;li&gt;âž¤ protein digestion.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Trypsin is an elastase. State TRUE/ FALSE:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹ True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;True/False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Trypsin is a Serine Protease E.g of Serine Protease includes Chymotrypsin, Trypsin, Elastase, Thrombin, Plasmin, Complements and Factor X and XI. Trypsinogen is activated by enterokinase (enteropeptidase) located on the intestinal microvillus membranes to trypsin â†’ activates other enzyme molecules. Trypsin is activated by the removal of a hexapeptide from N-terminal end. It catalyzes hydrolysis of the bonds formed by carboxyl groups of Arg and Lys. In acute pancreatitis , there is a premature activation of trypsinogen inside the pancreas causing autodigestion of pancreatic cells.&lt;/li&gt;&lt;li&gt;â€¢ Trypsin is a Serine Protease&lt;/li&gt;&lt;li&gt;â€¢ Trypsin&lt;/li&gt;&lt;li&gt;â€¢ Serine Protease&lt;/li&gt;&lt;li&gt;â€¢ E.g of Serine Protease includes Chymotrypsin, Trypsin, Elastase, Thrombin, Plasmin, Complements and Factor X and XI.&lt;/li&gt;&lt;li&gt;â€¢ Serine Protease&lt;/li&gt;&lt;li&gt;â€¢ Chymotrypsin, Trypsin, Elastase, Thrombin, Plasmin, Complements&lt;/li&gt;&lt;li&gt;â€¢ Factor X and XI.&lt;/li&gt;&lt;li&gt;â€¢ Trypsinogen is activated by enterokinase (enteropeptidase) located on the intestinal microvillus membranes to trypsin â†’ activates other enzyme molecules.&lt;/li&gt;&lt;li&gt;â€¢ Trypsinogen&lt;/li&gt;&lt;li&gt;â€¢ activated&lt;/li&gt;&lt;li&gt;â€¢ enterokinase&lt;/li&gt;&lt;li&gt;â€¢ intestinal microvillus membranes&lt;/li&gt;&lt;li&gt;â€¢ trypsin&lt;/li&gt;&lt;li&gt;â€¢ Trypsin is activated by the removal of a hexapeptide from N-terminal end.&lt;/li&gt;&lt;li&gt;â€¢ Trypsin&lt;/li&gt;&lt;li&gt;â€¢ activated by the removal of a hexapeptide&lt;/li&gt;&lt;li&gt;â€¢ N-terminal end.&lt;/li&gt;&lt;li&gt;â€¢ It catalyzes hydrolysis of the bonds formed by carboxyl groups of Arg and Lys.&lt;/li&gt;&lt;li&gt;â€¢ catalyzes hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ bonds formed by carboxyl groups&lt;/li&gt;&lt;li&gt;â€¢ Arg&lt;/li&gt;&lt;li&gt;â€¢ Lys.&lt;/li&gt;&lt;li&gt;â€¢ In acute pancreatitis , there is a premature activation of trypsinogen inside the pancreas causing autodigestion of pancreatic cells.&lt;/li&gt;&lt;li&gt;â€¢ ,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trypsin is a serine protease that preferentially cleaves peptide bonds after positively charged amino acids, such as lysine and arginine . Elastase, while also a serine protease, targets small, neutral amino acids like glycine and alanine.&lt;/li&gt;&lt;li&gt;âž¤ Trypsin&lt;/li&gt;&lt;li&gt;âž¤ serine protease&lt;/li&gt;&lt;li&gt;âž¤ cleaves peptide bonds&lt;/li&gt;&lt;li&gt;âž¤ positively charged amino acids,&lt;/li&gt;&lt;li&gt;âž¤ lysine&lt;/li&gt;&lt;li&gt;âž¤ arginine&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 63, DM Vasudevan 9/e: p 197&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p 63, DM Vasudevan 9/e: p 197&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged woman with stage II breast cancer has undergone modified radical mastectomy (MRM) with axillary clearance. As part of her adjuvant therapy, she is prescribed an anticancer drug that acts as a competitive inhibitor of Thymidylate Synthase, an enzyme crucial for DNA synthesis. Which of the following drugs has been recommended to inhibit Thymidylate Synthase and potentially reduce cancer cell proliferation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lovastatin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neostigmine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Fluorouracil&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 5-Fluorouracil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 5-Fluorouracil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lovastatin â€“ Inhibits HMG-CoA reductase, used for lowering cholesterol. Option B. Neostigmine â€“ Reversible cholinesterase inhibitor used in myasthenia gravis. Option C. Allopurinol â€“ Inhibits xanthine oxidase, used in gout.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lovastatin â€“ Inhibits HMG-CoA reductase, used for lowering cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lovastatin&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neostigmine â€“ Reversible cholinesterase inhibitor used in myasthenia gravis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neostigmine&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allopurinol â€“ Inhibits xanthine oxidase, used in gout.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allopurinol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 5-Fluorouracil (5-FU) is an antimetabolite chemotherapeutic agent that acts as a competitive inhibitor of Thymidylate Synthase. By inhibiting this enzyme, 5-FU prevents the synthesis of thymidine monophosphate, a nucleotide essential for DNA replication and cell division, thereby exerting its anticancer effects.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 61.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MATCH THE FOLLOWING:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-b, 3-c, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-a, 4-d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-134627.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-134841.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-134909.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Statins inhibit HMG CoA Reductase (d) , a key enzyme in cholesterol biosynthesis. Dicoumarol inhibits Vitamin K Epoxide Reductase (c), affecting the clotting cascade. Methotrexate inhibits Dihydrofolate Reductase (b), used in cancer therapy and autoimmune diseases. Succinyl Choline is not an enzyme inhibito r but a nicotinic acetylcholine receptor agonist used as a neuromuscular blocker; however, in the context of this question, it&#x27;s matched with Acetylcholinesterase (a) by process of elimination.&lt;/li&gt;&lt;li&gt;â€¢ Statins inhibit HMG CoA Reductase (d) , a key enzyme in cholesterol biosynthesis.&lt;/li&gt;&lt;li&gt;â€¢ Statins inhibit HMG CoA Reductase (d)&lt;/li&gt;&lt;li&gt;â€¢ Dicoumarol inhibits Vitamin K Epoxide Reductase (c), affecting the clotting cascade.&lt;/li&gt;&lt;li&gt;â€¢ Dicoumarol inhibits Vitamin K Epoxide Reductase (c),&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate inhibits Dihydrofolate Reductase (b), used in cancer therapy and autoimmune diseases.&lt;/li&gt;&lt;li&gt;â€¢ Methotrexate inhibits Dihydrofolate Reductase (b),&lt;/li&gt;&lt;li&gt;â€¢ Succinyl Choline is not an enzyme inhibito r but a nicotinic acetylcholine receptor agonist used as a neuromuscular blocker; however, in the context of this question, it&#x27;s matched with Acetylcholinesterase (a) by process of elimination.&lt;/li&gt;&lt;li&gt;â€¢ Succinyl Choline is not an enzyme inhibito&lt;/li&gt;&lt;li&gt;â€¢ nicotinic acetylcholine receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ neuromuscular blocker;&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors of enzymes are mostly drugs&lt;/li&gt;&lt;li&gt;âž¤ Competitive inhibitors of enzymes are mostly drugs&lt;/li&gt;&lt;li&gt;âž¤ Some competitive inhibitors which are not drugs are&lt;/li&gt;&lt;li&gt;âž¤ Some competitive inhibitors which are not drugs are&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 81-84.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 81-84.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on metabolic pathways, a medical instructor emphasizes the importance of understanding how gluconeogenesis is regulated within the cell. One aspect under consideration is the spatial organization of the enzymes involved in this pathway. Is the regulation of gluconeogenesis influenced by the compartmentalization of its enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;True/False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The activity of enzymes catalyzing the different steps in a metabolic pathway is regulated by compartmentalization of enzymes. Few enzymes of the pathway may be located in mitochondria and other few enzymes of the same pathway are in cytoplasmic. E.g: Heme synthesis, urea cycle and gluconeogenesis. The intermediates of the pathways are shuttled across the mitochondrial membrane for this purpose which provides a point where controls can be exerted.&lt;/li&gt;&lt;li&gt;â€¢ The activity of enzymes catalyzing the different steps in a metabolic pathway is regulated by compartmentalization of enzymes.&lt;/li&gt;&lt;li&gt;â€¢ activity of enzymes catalyzing&lt;/li&gt;&lt;li&gt;â€¢ different steps in a metabolic pathway&lt;/li&gt;&lt;li&gt;â€¢ compartmentalization of enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Few enzymes of the pathway may be located in mitochondria and other few enzymes of the same pathway are in cytoplasmic.&lt;/li&gt;&lt;li&gt;â€¢ Few enzymes&lt;/li&gt;&lt;li&gt;â€¢ pathway&lt;/li&gt;&lt;li&gt;â€¢ located in mitochondria&lt;/li&gt;&lt;li&gt;â€¢ E.g: Heme synthesis, urea cycle and gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ The intermediates of the pathways are shuttled across the mitochondrial membrane for this purpose which provides a point where controls can be exerted.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis is indeed regulated by the compartmentalization of its enzymes. This spatial organization allows for efficient control of the pathway, ensuring that enzymes necessary for gluconeogenesis are localized in specific areas of the cell, primarily within the mitochondria and cytoplasm of liver cells. This compartmentalization facilitates the regulation of enzyme activity and substrate availability, crucial for the maintenance of blood glucose levels, especially during fasting.&lt;/li&gt;&lt;li&gt;âž¤ Gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ regulated by the compartmentalization of its enzymes.&lt;/li&gt;&lt;li&gt;âž¤ spatial organization&lt;/li&gt;&lt;li&gt;âž¤ efficient control of the pathway,&lt;/li&gt;&lt;li&gt;âž¤ enzymes necessary for gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ localized in specific areas of the cell,&lt;/li&gt;&lt;li&gt;âž¤ mitochondria and cytoplasm of liver cells.&lt;/li&gt;&lt;li&gt;âž¤ compartmentalization facilitates&lt;/li&gt;&lt;li&gt;âž¤ regulation of enzyme activity&lt;/li&gt;&lt;li&gt;âž¤ substrate availability,&lt;/li&gt;&lt;li&gt;âž¤ maintenance of blood glucose levels,&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e:  p 65.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e:  p 65.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following Marker enzyme.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-b, 3-c, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-a, 4-d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-142922.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-143027.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ The Plasma membrane is associated with 5â€™-Nucleotidase (d) , an enzyme involved in the hydrolysis of nucleotides to nucleosides on the cell&#x27;s exterior. The Endoplasmic reticulum is characterized by Glucose-6-Phosphatase (c), an enzyme involved in glucose metabolism and the gluconeogenesis pathway. The Golgi apparatus is marked by Galactosyl transferase (b), an enzyme critical for the glycosylation processes occurring within this organelle. The Inner mitochondrial membrane contains ATP synthase (a), the enzyme responsible for ATP production during oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ The Plasma membrane is associated with 5â€™-Nucleotidase (d) , an enzyme involved in the hydrolysis of nucleotides to nucleosides on the cell&#x27;s exterior.&lt;/li&gt;&lt;li&gt;â€¢ Plasma membrane is associated with 5â€™-Nucleotidase (d)&lt;/li&gt;&lt;li&gt;â€¢ The Endoplasmic reticulum is characterized by Glucose-6-Phosphatase (c), an enzyme involved in glucose metabolism and the gluconeogenesis pathway.&lt;/li&gt;&lt;li&gt;â€¢ Endoplasmic reticulum is characterized by Glucose-6-Phosphatase (c),&lt;/li&gt;&lt;li&gt;â€¢ The Golgi apparatus is marked by Galactosyl transferase (b), an enzyme critical for the glycosylation processes occurring within this organelle.&lt;/li&gt;&lt;li&gt;â€¢ Golgi apparatus is marked by Galactosyl transferase (b),&lt;/li&gt;&lt;li&gt;â€¢ The Inner mitochondrial membrane contains ATP synthase (a), the enzyme responsible for ATP production during oxidative phosphorylation.&lt;/li&gt;&lt;li&gt;â€¢ Inner mitochondrial membrane contains ATP synthase (a),&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 481&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 481&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with hypertension and type 2 diabetes is prescribed a new drug to lower her cardiovascular risk. This drug acts as a non-competitive inhibitor for an enzyme in cholesterol biosynthesis. What effect does this inhibitor have on the enzyme&#x27;s kinetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Km remains same &amp;amp; Vmax increases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Km remains same &amp;amp; Vmax decreases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Km decreases &amp;amp; Vmax increases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Km decreases &amp;amp; Vmax decreases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Km remains same &amp; Vmax decreases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture9_1eTRxY1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Km remains the same &amp;amp; Vmax increases: This is incorrect because non-competitive inhibition typically reduces the maximum reaction rate , not increases it.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Km remains the same &amp;amp; Vmax increases:&lt;/li&gt;&lt;li&gt;â€¢ non-competitive inhibition&lt;/li&gt;&lt;li&gt;â€¢ reduces the maximum reaction rate&lt;/li&gt;&lt;li&gt;â€¢ Option C. Km decreases &amp;amp; Vmax increases: This option is incorrect as non-competitive inhibitors do not affect the enzyme&#x27;s affinity for its substrate (Km would remain unchanged) and would not increase the maximum reaction rate (Vmax).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Km decreases &amp;amp; Vmax increases:&lt;/li&gt;&lt;li&gt;â€¢ non-competitive inhibitors&lt;/li&gt;&lt;li&gt;â€¢ not affect the enzyme&#x27;s affinity&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Km decreases &amp;amp; Vmax decreases: While non-competitive inhibitors decrease Vmax , they do not affect the enzyme&#x27;s affinity for its substrate , so Km would not decrease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Km decreases &amp;amp; Vmax decreases:&lt;/li&gt;&lt;li&gt;â€¢ non-competitive inhibitors decrease Vmax&lt;/li&gt;&lt;li&gt;â€¢ not affect the enzyme&#x27;s affinity&lt;/li&gt;&lt;li&gt;â€¢ substrate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-competitive inhibitors bind to an enzyme at a site other than the active site. This binding doesn&#x27;t affect the enzyme&#x27;s affinity for its substrate, so the Michaelis constant (Km) remains unchanged . However, it reduces the enzyme&#x27;s catalytic efficiency, leading to a decreased maximum velocity (Vmax) of the reaction.&lt;/li&gt;&lt;li&gt;âž¤ Non-competitive inhibitors bind&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ site other than the active site.&lt;/li&gt;&lt;li&gt;âž¤ binding doesn&#x27;t affect&lt;/li&gt;&lt;li&gt;âž¤ enzyme&#x27;s affinity&lt;/li&gt;&lt;li&gt;âž¤ substrate,&lt;/li&gt;&lt;li&gt;âž¤ Michaelis constant&lt;/li&gt;&lt;li&gt;âž¤ remains unchanged&lt;/li&gt;&lt;li&gt;âž¤ reduces the enzyme&#x27;s catalytic efficiency,&lt;/li&gt;&lt;li&gt;âž¤ decreased maximum velocity&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 81.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e p 81.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A graph is presented depicting enzyme kinetics with and without an inhibitor. The Lineweaver-Burk plot shows two lines intersecting on the y-axis. The line representing enzyme activity with an inhibitor has a different slope than that without an inhibitor, yet both lines intersect at the same point on the y-axis. Based on this information, what type of enzyme inhibition is being represented in this plot?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uncompetitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-competitive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suicidal&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Competitive&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture10_q3tGHnW.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Competitive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In a Lineweaver-Burk plot , the y-intercept represents 1/Vmax , and the x-intercept represents âˆ’1/Km . In competitive inhibition :&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver-Burk plot&lt;/li&gt;&lt;li&gt;â€¢ 1/Vmax&lt;/li&gt;&lt;li&gt;â€¢ âˆ’1/Km&lt;/li&gt;&lt;li&gt;â€¢ competitive inhibition&lt;/li&gt;&lt;li&gt;â€¢ The inhibitor competes with the substrate for binding at the active site . This leads to an increase in Km (i.e., substrate affinity appears reduced). However, since high substrate concentrations can outcompete the inhibitor, Vmax remains unchanged .&lt;/li&gt;&lt;li&gt;â€¢ The inhibitor competes with the substrate for binding at the active site .&lt;/li&gt;&lt;li&gt;â€¢ competes with the substrate&lt;/li&gt;&lt;li&gt;â€¢ active site&lt;/li&gt;&lt;li&gt;â€¢ This leads to an increase in Km (i.e., substrate affinity appears reduced).&lt;/li&gt;&lt;li&gt;â€¢ increase in Km&lt;/li&gt;&lt;li&gt;â€¢ However, since high substrate concentrations can outcompete the inhibitor, Vmax remains unchanged .&lt;/li&gt;&lt;li&gt;â€¢ outcompete&lt;/li&gt;&lt;li&gt;â€¢ Vmax remains unchanged&lt;/li&gt;&lt;li&gt;â€¢ Thus, in the Lineweaver-Burk plot , lines for inhibited and uninhibited enzyme intersect at the y-axis (same Vmax), but have different slopes due to increased Km â€” exactly as described in the question.&lt;/li&gt;&lt;li&gt;â€¢ Lineweaver-Burk plot&lt;/li&gt;&lt;li&gt;â€¢ y-axis&lt;/li&gt;&lt;li&gt;â€¢ different slopes&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B (Uncompetitive): In uncompetitive inhibition, the inhibitor binds only to the enzyme-substrate complex , decreasing both Km and Vmax . The Lineweaver-Burk plot shows parallel lines , not intersecting at the y-axis. Option C (Non-competitive): This affects Vmax (lowered) but not Km , and the plot shows lines intersecting on the x-axis , not y. Option D (Suicidal): Irreversible inhibition with no fixed pattern on the Lineweaver-Burk plot.&lt;/li&gt;&lt;li&gt;â€¢ Option B (Uncompetitive): In uncompetitive inhibition, the inhibitor binds only to the enzyme-substrate complex , decreasing both Km and Vmax . The Lineweaver-Burk plot shows parallel lines , not intersecting at the y-axis.&lt;/li&gt;&lt;li&gt;â€¢ Option B (Uncompetitive):&lt;/li&gt;&lt;li&gt;â€¢ only to the enzyme-substrate complex&lt;/li&gt;&lt;li&gt;â€¢ both Km and Vmax&lt;/li&gt;&lt;li&gt;â€¢ parallel lines&lt;/li&gt;&lt;li&gt;â€¢ Option C (Non-competitive): This affects Vmax (lowered) but not Km , and the plot shows lines intersecting on the x-axis , not y.&lt;/li&gt;&lt;li&gt;â€¢ Option C (Non-competitive):&lt;/li&gt;&lt;li&gt;â€¢ Vmax&lt;/li&gt;&lt;li&gt;â€¢ not Km&lt;/li&gt;&lt;li&gt;â€¢ on the x-axis&lt;/li&gt;&lt;li&gt;â€¢ Option D (Suicidal): Irreversible inhibition with no fixed pattern on the Lineweaver-Burk plot.&lt;/li&gt;&lt;li&gt;â€¢ Option D (Suicidal):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ â€œIn competitive inhibition, the inhibitor competes with substrate for the enzymeâ€™s active site, increasing Km without affecting Vmax. In a Lineweaver-Burk plot, this is seen as lines intersecting on the y-axis.â€&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 62.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is correct regarding the enzyme inhibition shown in the picture?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-competitive inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uncompetitive inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allosteric inhibition&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Allosteric inhibition&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture11_tFaG5Hg.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Competitive inhibition: This would typically result in an increase in the apparent Km (decreased affinity) without affecting Vmax, and the graph would show a Michaelis-Menten curve, not a sigmoidal one.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Competitive inhibition:&lt;/li&gt;&lt;li&gt;â€¢ increase in the apparent Km&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive inhibition: This generally results in a decreased Vmax while the Km remains unchanged ; the graph would still follow Michaelis-Menten kinetics.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Non-competitive inhibition:&lt;/li&gt;&lt;li&gt;â€¢ decreased Vmax while the Km remains unchanged&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uncompetitive inhibition: This occurs when an inhibitor binds only to the enzyme-substrate complex, leading to a parallel decrease in both Km and Vmax, which is not shown in the provided graph.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uncompetitive inhibition:&lt;/li&gt;&lt;li&gt;â€¢ inhibitor binds only to the enzyme-substrate complex,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of allosteric inhibition:&lt;/li&gt;&lt;li&gt;âž¤ Salient features of allosteric inhibition:&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor is not a substrate analog. It is partially reversible, when excess substrate is added. Km is increased and Vmax is reduced. The effect of allosteric modifier is maximum at or near substrate concentration equivalent to Km. Most allosteric enzymes possess quaternary structure. They are made up of subunits, e.g. Aspartate transcarbamoylase has 6 subunits and pyruvate kinase has 4 subunits.&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor is not a substrate analog.&lt;/li&gt;&lt;li&gt;âž¤ It is partially reversible, when excess substrate is added.&lt;/li&gt;&lt;li&gt;âž¤ Km is increased and Vmax is reduced.&lt;/li&gt;&lt;li&gt;âž¤ The effect of allosteric modifier is maximum at or near substrate concentration equivalent to Km.&lt;/li&gt;&lt;li&gt;âž¤ Most allosteric enzymes possess quaternary structure. They are made up of subunits, e.g. Aspartate transcarbamoylase has 6 subunits and pyruvate kinase has 4 subunits.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 62.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 62.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the depicted interactions, which statement is true about the mode of inhibition illustrated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an uncompetitive inhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The inhibitor binds only to free enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No product is formed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heavy metal poisons are irreversible non-competitive inhibitors.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Heavy metal poisons are irreversible non-competitive inhibitors.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture12.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is uncompetitive inhibition: This is incorrect because uncompetitive inhibitors only bind to the enzyme-substrate complex, and the inhibition is usually reversible.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It is uncompetitive inhibition:&lt;/li&gt;&lt;li&gt;â€¢ uncompetitive inhibitors&lt;/li&gt;&lt;li&gt;â€¢ bind to the enzyme-substrate complex,&lt;/li&gt;&lt;li&gt;â€¢ Option B. The inhibitor binds only to free enzyme: This is incorrect, as the diagram shows the inhibitor binding to both the enzyme and the enzyme-substrate complex , not just the free enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option B. The inhibitor binds only to free enzyme:&lt;/li&gt;&lt;li&gt;â€¢ diagram shows the inhibitor binding&lt;/li&gt;&lt;li&gt;â€¢ both the enzyme&lt;/li&gt;&lt;li&gt;â€¢ enzyme-substrate complex&lt;/li&gt;&lt;li&gt;â€¢ Option C. No product is formed : This might be a result of the inhibition shown, but it doesn&#x27;t describe the type of inhibition or the nature of the inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. No product is formed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Features of Non-competitive Inhibition:&lt;/li&gt;&lt;li&gt;âž¤ Features of Non-competitive Inhibition:&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor binds to a different site on the enzyme , other than the substrate binding site. A non-competitive inhibitor binds to both free enzyme and enzyme substrate (ES) complex â†’ [EI] or [ESI] complex is formed â†’ product formation is slowed down and not halted. The inhibitor has no structural resemblance to substrate. Hence, excess substrate does not abolish the inhibition . The inhibitor combines with the enzymes by a covalent bond , which makes the reaction irreversible. The velocity (Vmax) is reduced and the Km value is not changed, because the remaining enzyme molecules have the same affinity for the substrate.&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor binds to a different site on the enzyme , other than the substrate binding site.&lt;/li&gt;&lt;li&gt;âž¤ inhibitor binds to a different site on the enzyme&lt;/li&gt;&lt;li&gt;âž¤ A non-competitive inhibitor binds to both free enzyme and enzyme substrate (ES) complex â†’ [EI] or [ESI] complex is formed â†’ product formation is slowed down and not halted.&lt;/li&gt;&lt;li&gt;âž¤ non-competitive inhibitor&lt;/li&gt;&lt;li&gt;âž¤ both free enzyme&lt;/li&gt;&lt;li&gt;âž¤ enzyme substrate&lt;/li&gt;&lt;li&gt;âž¤ complex&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor has no structural resemblance to substrate.&lt;/li&gt;&lt;li&gt;âž¤ inhibitor&lt;/li&gt;&lt;li&gt;âž¤ no structural resemblance&lt;/li&gt;&lt;li&gt;âž¤ Hence, excess substrate does not abolish the inhibition .&lt;/li&gt;&lt;li&gt;âž¤ excess substrate&lt;/li&gt;&lt;li&gt;âž¤ not abolish the inhibition&lt;/li&gt;&lt;li&gt;âž¤ The inhibitor combines with the enzymes by a covalent bond , which makes the reaction irreversible.&lt;/li&gt;&lt;li&gt;âž¤ inhibitor combines with the enzymes&lt;/li&gt;&lt;li&gt;âž¤ covalent bond&lt;/li&gt;&lt;li&gt;âž¤ reaction irreversible.&lt;/li&gt;&lt;li&gt;âž¤ The velocity (Vmax) is reduced and the Km value is not changed, because the remaining enzyme molecules have the same affinity for the substrate.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 60.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 60.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;it&#x27;s important to recognize enzymes that are synthesized in an inactive form within living cells and later activated through various biochemical processes. What term is used to describe these initially inactive forms of enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Papain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysozymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apoenzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proenzymes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Proenzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Papain: Is a therapeutic enzyme used as an anti-inflammatory agent and it is a cysteine protease .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Papain:&lt;/li&gt;&lt;li&gt;â€¢ therapeutic enzyme&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory agent&lt;/li&gt;&lt;li&gt;â€¢ cysteine protease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lysozymes: It has a repeating hexasaccharide unit and a combination of substrate strain and acid base catalysis is noted in the action of lysozyme. This mechanism contributes to the antibactericidal action of lysozymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lysozymes:&lt;/li&gt;&lt;li&gt;â€¢ combination of substrate strain&lt;/li&gt;&lt;li&gt;â€¢ acid base catalysis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Apoenzymes: In compound proteins, the protein component is â€˜Apoenzymeâ€™ and the prosthetic group is â€˜coenzymeâ€™. The combination produces a functional â€˜holoenzymeâ€™.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Apoenzymes:&lt;/li&gt;&lt;li&gt;â€¢ compound proteins,&lt;/li&gt;&lt;li&gt;â€¢ protein component is â€˜Apoenzymeâ€™&lt;/li&gt;&lt;li&gt;â€¢ prosthetic group is â€˜coenzymeâ€™.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proenzymes, also known as zymogens , are inactive precursors of enzymes. They require a biochemical change, such as the cleavage of specific peptide bonds, to become active . This mechanism ensures that enzymes are activated only when and where they are needed, preventing potential damage to the cell or tissue from premature enzymatic activity.&lt;/li&gt;&lt;li&gt;âž¤ Proenzymes,&lt;/li&gt;&lt;li&gt;âž¤ zymogens&lt;/li&gt;&lt;li&gt;âž¤ inactive precursors of enzymes.&lt;/li&gt;&lt;li&gt;âž¤ require a biochemical change,&lt;/li&gt;&lt;li&gt;âž¤ cleavage&lt;/li&gt;&lt;li&gt;âž¤ specific peptide bonds,&lt;/li&gt;&lt;li&gt;âž¤ active&lt;/li&gt;&lt;li&gt;âž¤ enzymes are activated&lt;/li&gt;&lt;li&gt;âž¤ when and where they are needed,&lt;/li&gt;&lt;li&gt;âž¤ potential damage to the cell&lt;/li&gt;&lt;li&gt;âž¤ tissue&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of enzymatic activity and biological catalysts, which of the following non-protein substances is known to function as an enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ribozyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phospholipid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycolipid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ribozyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. DNA: While DNA stores and transmits genetic information , it is not known to have enzymatic activity under normal physiological conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DNA:&lt;/li&gt;&lt;li&gt;â€¢ DNA stores&lt;/li&gt;&lt;li&gt;â€¢ transmits genetic information&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ enzymatic activity&lt;/li&gt;&lt;li&gt;â€¢ normal physiological conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phospholipid: Phospholipids are a major component of cell membranes and serve structural and functional roles in cells, but they do not have enzymatic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phospholipid:&lt;/li&gt;&lt;li&gt;â€¢ major component of cell membranes&lt;/li&gt;&lt;li&gt;â€¢ serve structural and functional roles in cells,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycolipid: Glycolipids are components of the cell membrane that participate in cell recognition and signaling but are not enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycolipid:&lt;/li&gt;&lt;li&gt;â€¢ components of the cell membrane&lt;/li&gt;&lt;li&gt;â€¢ cell recognition&lt;/li&gt;&lt;li&gt;â€¢ signaling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ribozymes are RNA molecules that have the ability to catalyze certain chemical reactions , functioning similarly to protein enzymes . They are unique among RNA molecules in that they are not merely substrates or products of reactions but active catalysts.&lt;/li&gt;&lt;li&gt;âž¤ Ribozymes are RNA molecules&lt;/li&gt;&lt;li&gt;âž¤ ability to catalyze&lt;/li&gt;&lt;li&gt;âž¤ chemical reactions&lt;/li&gt;&lt;li&gt;âž¤ functioning&lt;/li&gt;&lt;li&gt;âž¤ protein enzymes&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 65, 592.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 65, 592.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the study of enzymatic functions within biological systems, various factors are known to influence enzyme activity. Which of the following factors can affect the activity of enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Negative modifiers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change in pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Change in temperature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Enzyme activity can be influenced by a range of factors , including:&lt;/li&gt;&lt;li&gt;â€¢ Enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ influenced by a range of factors&lt;/li&gt;&lt;li&gt;â€¢ Negative modifiers , which can bind to enzymes and decrease their activity,&lt;/li&gt;&lt;li&gt;â€¢ Negative modifiers&lt;/li&gt;&lt;li&gt;â€¢ bind to enzymes&lt;/li&gt;&lt;li&gt;â€¢ decrease their activity,&lt;/li&gt;&lt;li&gt;â€¢ Changes in pH, as enzymes have optimal pH ranges and deviating from these ranges can alter the enzyme&#x27;s structure and functionality,&lt;/li&gt;&lt;li&gt;â€¢ Changes in pH,&lt;/li&gt;&lt;li&gt;â€¢ optimal pH ranges&lt;/li&gt;&lt;li&gt;â€¢ Changes in temperature, which can increase enzyme activity up to a point but can lead to denaturation and loss of activity if the temperature is too high.&lt;/li&gt;&lt;li&gt;â€¢ Changes in temperature,&lt;/li&gt;&lt;li&gt;â€¢ increase enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ lead to denaturation&lt;/li&gt;&lt;li&gt;â€¢ loss of activity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Factors Affecting Enzyme Activity:&lt;/li&gt;&lt;li&gt;âž¤ Factors Affecting Enzyme Activity:&lt;/li&gt;&lt;li&gt;âž¤ Enzyme concentration Substrate concentration Product concentration Temperature Hydrogen ion concentration (pH) Presence of activators Presence of inhibitors Presence of repressor or derepressor Covalent modification&lt;/li&gt;&lt;li&gt;âž¤ Enzyme concentration&lt;/li&gt;&lt;li&gt;âž¤ Substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ Product concentration&lt;/li&gt;&lt;li&gt;âž¤ Temperature&lt;/li&gt;&lt;li&gt;âž¤ Hydrogen ion concentration (pH)&lt;/li&gt;&lt;li&gt;âž¤ Presence of activators&lt;/li&gt;&lt;li&gt;âž¤ Presence of inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Presence of repressor or derepressor&lt;/li&gt;&lt;li&gt;âž¤ Covalent modification&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 56-59.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 56-59.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In exploring the fundamental concepts of enzyme-substrate interaction, the &#x27;lock and key&#x27; model proposed by Emil Fischer provides an analogy to understand enzyme specificity. According to this model, what is implied about the relationship between the enzyme&#x27;s active site and the substrate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The active site is complementary in shape to that of substance only after interaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The active site is complementary in shape to that of substrate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Substrates change confirmation prior to active site interaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The active site is flexible and adjusts to substrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The active site is complementary in shape to that of substrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture14.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The active site is complementary in shape to that of the substrate only after interaction: This description more closely aligns with the &#x27;induced fit&#x27; model , where the active site undergoes a conformational change upon substrate binding.&lt;/li&gt;&lt;li&gt;â€¢ Option A. The active site is complementary in shape to that of the substrate only after interaction:&lt;/li&gt;&lt;li&gt;â€¢ closely aligns with the &#x27;induced fit&#x27; model&lt;/li&gt;&lt;li&gt;â€¢ Option C. Substrates change confirmation prior to active site interaction: This is not a feature of the &#x27;lock and key&#x27; model, which suggests a static, pre-determined fit between enzyme and substrate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Substrates change confirmation prior to active site interaction:&lt;/li&gt;&lt;li&gt;â€¢ not a feature of the &#x27;lock and key&#x27; model,&lt;/li&gt;&lt;li&gt;â€¢ Option D. The active site is flexible and adjusts to the substrate: This concept is again representative of the &#x27;induced fit&#x27; model, not the &#x27;lock and key&#x27; model.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The active site is flexible and adjusts to the substrate:&lt;/li&gt;&lt;li&gt;â€¢ representative of the &#x27;induced fit&#x27; model,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fischer&#x27;s &#x27;lock and key&#x27; model posits that the enzyme&#x27;s active site has a specific geometric shape that is exactly complementary to the shape of the substrate, much like a lock is to a key. This model emphasizes the specificity of enzyme-substrate interactions, suggesting that enzymes can only bind to substrates that fit perfectly into their active sites.&lt;/li&gt;&lt;li&gt;âž¤ Fischer&#x27;s &#x27;lock and key&#x27; model posits&lt;/li&gt;&lt;li&gt;âž¤ enzyme&#x27;s active site&lt;/li&gt;&lt;li&gt;âž¤ specific geometric shape&lt;/li&gt;&lt;li&gt;âž¤ exactly complementary&lt;/li&gt;&lt;li&gt;âž¤ shape of the substrate,&lt;/li&gt;&lt;li&gt;âž¤ lock is to a key.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 358.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 358.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a diagnosis of beriberi is found to have a deficiency in thiamine, a vital nutrient in her diet. Her physician explains the significance of thiamine as it relates to her condition and its role in enzymatic processes within the body. Based on this, which of the following best characterizes coenzymes like thiamine in their role in enzymatic reactions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heat stable, dialyzable, non protein organic molecules&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Soluble, colloidal, protein molecules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Structural analog of enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Different forms of enzymes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Heat stable, dialyzable, non protein organic molecules&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Soluble, colloidal, protein molecules: This description more accurately pertains to enzymes themselves, which are proteinaceous in nature , rather than coenzymes. Coenzymes are not proteins but work alongside enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Soluble, colloidal, protein molecules:&lt;/li&gt;&lt;li&gt;â€¢ accurately pertains to enzymes themselves,&lt;/li&gt;&lt;li&gt;â€¢ proteinaceous in nature&lt;/li&gt;&lt;li&gt;â€¢ Option C. Structural analog of enzymes: Coenzymes are not structural analogs of enzymes. Instead, they are distinct molecules that assist the catalytic activity of enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Structural analog of enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Coenzymes&lt;/li&gt;&lt;li&gt;â€¢ not structural analogs of enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Different forms of enzymes: Coenzymes are not alternative forms of enzymes . They are separate, non-protein entities that bind to enzymes and participate in the catalytic process.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Different forms of enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Coenzymes&lt;/li&gt;&lt;li&gt;â€¢ not alternative forms of enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coenzymes are typically small , heat-stable , non-protein organic molecules that assist enzymes in catalyzing reactions . They often function as carriers of electrons , atoms , or functional groups . Being dialyzable, they can pass through semi-permeable membranes , which is not characteristic of larger protein molecules.&lt;/li&gt;&lt;li&gt;âž¤ Coenzymes&lt;/li&gt;&lt;li&gt;âž¤ typically small&lt;/li&gt;&lt;li&gt;âž¤ heat-stable&lt;/li&gt;&lt;li&gt;âž¤ non-protein organic molecules&lt;/li&gt;&lt;li&gt;âž¤ assist enzymes in catalyzing reactions&lt;/li&gt;&lt;li&gt;âž¤ function&lt;/li&gt;&lt;li&gt;âž¤ carriers of electrons&lt;/li&gt;&lt;li&gt;âž¤ atoms&lt;/li&gt;&lt;li&gt;âž¤ functional groups&lt;/li&gt;&lt;li&gt;âž¤ dialyzable,&lt;/li&gt;&lt;li&gt;âž¤ pass through semi-permeable membranes&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 49, 50.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 49, 50.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of chronic heart failure is undergoing evaluation for potential metabolic contributors to his condition. His treatment includes medications that influence cellular energy dynamics. Considering the role of coenzymes in metabolic processes, particularly in the transfer of electrons and hydrogens in oxidative-reductive reactions, is NAD++ an example of a hydrogen-transferring coenzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;True/False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture-001.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture-002.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ NAD+ is a coenzyme synthesized from Nicotinamide , a B-complex vitamin . The structure of NAD+ is Nicotinamide-Ribose-P-P-Ribose-Adenine .&lt;/li&gt;&lt;li&gt;â€¢ NAD+ is a coenzyme synthesized from Nicotinamide , a B-complex vitamin .&lt;/li&gt;&lt;li&gt;â€¢ NAD+&lt;/li&gt;&lt;li&gt;â€¢ coenzyme&lt;/li&gt;&lt;li&gt;â€¢ Nicotinamide&lt;/li&gt;&lt;li&gt;â€¢ B-complex vitamin&lt;/li&gt;&lt;li&gt;â€¢ The structure of NAD+ is Nicotinamide-Ribose-P-P-Ribose-Adenine .&lt;/li&gt;&lt;li&gt;â€¢ structure of NAD+&lt;/li&gt;&lt;li&gt;â€¢ Nicotinamide-Ribose-P-P-Ribose-Adenine&lt;/li&gt;&lt;li&gt;â€¢ The reversible reaction of lactate to pyruvate is catalyzed by lactate dehydrogenase , but the actual transfer of hydrogen is taking place on the coenzyme , NAD+. In this case, two hydrogen atoms are removed from lactate , out of which one hydrogen and two electrons (hydride ion) are accepted by the NAD+ to form NADH, and the remaining H+ is released into the surrounding medium.&lt;/li&gt;&lt;li&gt;â€¢ The reversible reaction of lactate to pyruvate is catalyzed by lactate dehydrogenase , but the actual transfer of hydrogen is taking place on the coenzyme , NAD+.&lt;/li&gt;&lt;li&gt;â€¢ reversible reaction&lt;/li&gt;&lt;li&gt;â€¢ lactate to pyruvate is catalyzed by lactate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ actual transfer&lt;/li&gt;&lt;li&gt;â€¢ hydrogen&lt;/li&gt;&lt;li&gt;â€¢ place on the coenzyme&lt;/li&gt;&lt;li&gt;â€¢ In this case, two hydrogen atoms are removed from lactate , out of which one hydrogen and two electrons (hydride ion) are accepted by the NAD+ to form NADH, and the remaining H+ is released into the surrounding medium.&lt;/li&gt;&lt;li&gt;â€¢ two hydrogen atoms are removed from lactate&lt;/li&gt;&lt;li&gt;â€¢ one hydrogen&lt;/li&gt;&lt;li&gt;â€¢ two electrons&lt;/li&gt;&lt;li&gt;â€¢ accepted by the NAD+ to form NADH,&lt;/li&gt;&lt;li&gt;â€¢ H+ is released into the surrounding medium.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NAD++ (Nicotinamide adenine dinucleotide) is indeed a coenzyme involved in redox reactions , serving as an electron and hydrogen carrier in various metabolic pathways, including glycolysis, the Krebs cycle, and the electron transport chain . It plays a critical role in the transfer of electrons from one molecule to another in these processes, thereby facilitating the production of ATP.&lt;/li&gt;&lt;li&gt;âž¤ NAD++&lt;/li&gt;&lt;li&gt;âž¤ coenzyme involved in redox reactions&lt;/li&gt;&lt;li&gt;âž¤ electron and hydrogen&lt;/li&gt;&lt;li&gt;âž¤ carrier&lt;/li&gt;&lt;li&gt;âž¤ metabolic pathways,&lt;/li&gt;&lt;li&gt;âž¤ glycolysis,&lt;/li&gt;&lt;li&gt;âž¤ Krebs cycle,&lt;/li&gt;&lt;li&gt;âž¤ electron transport chain&lt;/li&gt;&lt;li&gt;âž¤ transfer of electrons&lt;/li&gt;&lt;li&gt;âž¤ one molecule to another in these processes,&lt;/li&gt;&lt;li&gt;âž¤ production of ATP.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 50.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 50.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinical laboratory technician is analyzing serum lactate dehydrogenase (LDH) levels in a series of patients with various tissue injuries. The technician notes the presence of multiple forms of LDH in the samples, reflecting tissue-specific expression patterns. Based on the properties of LDH isoenzymes, which statement accurately describes these forms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Have similar electrophoretic mobility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Differ in catalytic activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exist in 5 forms depending on M and H monomer contents&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Occur as monomers&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Exist in 5 forms depending on M and H monomer contents&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Have similar electrophoretic mobility: This is incorrect as the electrophoretic mobility of LDH isoenzymes varies, allowing them to be separated and identified through electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Have similar electrophoretic mobility:&lt;/li&gt;&lt;li&gt;â€¢ electrophoretic mobility of LDH isoenzymes varies,&lt;/li&gt;&lt;li&gt;â€¢ separated and identified through electrophoresis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Differ in catalytic activity : While there may be subtle variations in the kinetic properties of LDH isoenzymes, they generally catalyze the same reaction, converting lactate to pyruvate and vice versa, with variations more so in their tissue distribution than in their catalytic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Differ in catalytic activity&lt;/li&gt;&lt;li&gt;â€¢ subtle variations&lt;/li&gt;&lt;li&gt;â€¢ kinetic properties of LDH isoenzymes,&lt;/li&gt;&lt;li&gt;â€¢ catalyze the same reaction,&lt;/li&gt;&lt;li&gt;â€¢ converting lactate&lt;/li&gt;&lt;li&gt;â€¢ pyruvate and vice versa,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Occur as monomers: This is incorrect because LDH isoenzymes function as tetramers, not monomers.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Occur as monomers:&lt;/li&gt;&lt;li&gt;â€¢ LDH isoenzymes&lt;/li&gt;&lt;li&gt;â€¢ tetramers,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LDH (Lactate Dehydrogenase) isoenzymes exist in five distinct forms, which are tetramers composed of combinations of M (muscle) and H (heart) subunits. These combinations result in isoenzymes with different tissue distributions and can provide valuable information about the location of tissue damage based on their varying levels in the blood.&lt;/li&gt;&lt;li&gt;âž¤ LDH&lt;/li&gt;&lt;li&gt;âž¤ isoenzymes&lt;/li&gt;&lt;li&gt;âž¤ five distinct forms,&lt;/li&gt;&lt;li&gt;âž¤ tetramers composed of combinations of M&lt;/li&gt;&lt;li&gt;âž¤ and H&lt;/li&gt;&lt;li&gt;âž¤ isoenzymes with different tissue distributions&lt;/li&gt;&lt;li&gt;âž¤ valuable information&lt;/li&gt;&lt;li&gt;âž¤ location of tissue damage&lt;/li&gt;&lt;li&gt;âž¤ varying levels in the blood.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 304.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 304.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While preparing for a biochemistry exam, a student revisits the classification system for enzymes established by the International Union of Biochemistry and Molecular Biology (IUBMB). The student focuses on translocases, enzymes facilitating the movement of substances across membranes. In the IUBMB system, under which EC number are translocases classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;EC-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EC-3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;EC-6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;EC-7&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. EC-7&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-152819.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. EC-1: This classification is reserved for oxidoreductases , enzymes that catalyze oxidation-reduction reactions, where one molecule is oxidized while another is reduced.&lt;/li&gt;&lt;li&gt;â€¢ Option A. EC-1:&lt;/li&gt;&lt;li&gt;â€¢ classification is reserved for oxidoreductases&lt;/li&gt;&lt;li&gt;â€¢ Option B. EC-3 : Enzymes classified under EC-3 are hydrolases, which catalyze the cleavage of bonds by the addition of water . This includes enzymes like proteases and lipases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. EC-3&lt;/li&gt;&lt;li&gt;â€¢ catalyze the cleavage of bonds&lt;/li&gt;&lt;li&gt;â€¢ addition of water&lt;/li&gt;&lt;li&gt;â€¢ Option C. EC-6: This category is for ligases , enzymes that catalyze the joining of two molecules with the concomitant hydrolysis of a diphosphate bond in ATP or a similar triphosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option C. EC-6:&lt;/li&gt;&lt;li&gt;â€¢ ligases&lt;/li&gt;&lt;li&gt;â€¢ enzymes that catalyze&lt;/li&gt;&lt;li&gt;â€¢ joining of two molecules&lt;/li&gt;&lt;li&gt;â€¢ concomitant hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ diphosphate bond&lt;/li&gt;&lt;li&gt;â€¢ ATP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 48, 49.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 48, 49.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical intern is reviewing laboratory results for a series of patients and notes variations in lactate dehydrogenase (LDH) isoenzyme levels. LDH5, in particular, has caught their attention due to its elevated levels in one of the patient&#x27;s tests. Given the tissue distribution and specificity of LDH5, in which of the following conditions is an elevation of LDH5 most commonly observed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peptic ulcer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infectious diseases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Liver disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/10000.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myocardial infarction: This condition typically shows an elevation in LDH1 and LDH2 isoenzymes, which are more abundant in cardiac tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Myocardial infarction:&lt;/li&gt;&lt;li&gt;â€¢ elevation in LDH1 and LDH2 isoenzymes,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peptic ulcer: While LDH levels can be affected by various conditions , LDH5 is not specifically associated with peptic ulcers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Peptic ulcer:&lt;/li&gt;&lt;li&gt;â€¢ LDH levels&lt;/li&gt;&lt;li&gt;â€¢ affected by various conditions&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious diseases: Although LDH levels may increase in infectious diseases , LDH5 elevation is more specifically indicative of liver involvement rather than a general response to infection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Infectious diseases:&lt;/li&gt;&lt;li&gt;â€¢ LDH levels&lt;/li&gt;&lt;li&gt;â€¢ increase in infectious diseases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 304.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 304.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a discussion on the role of enzymes within the bloodstream, a medical student is tasked with identifying enzymes that not only circulate in the plasma but also carry out their primary function within the bloodstream. Which of the following enzymes is an example of a functional plasma enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lipoprotein lipase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aminotransferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lipoprotein lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amylase: Although amylase can be found in the blood , its primary function is in the digestive system, where it breaks down carbohydrates.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amylase:&lt;/li&gt;&lt;li&gt;â€¢ found in the blood&lt;/li&gt;&lt;li&gt;â€¢ primary function&lt;/li&gt;&lt;li&gt;â€¢ digestive system,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aminotransferase: Aminotransferases, such as AST and ALT, are often released into the bloodstream due to liver or muscle damage , but their primary functions are intracellular.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Aminotransferase:&lt;/li&gt;&lt;li&gt;â€¢ AST and ALT,&lt;/li&gt;&lt;li&gt;â€¢ released into the bloodstream&lt;/li&gt;&lt;li&gt;â€¢ liver or muscle damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lactate dehydrogenase: LDH is released into the bloodstream from various tissues in response to cell damage ; its main function is not carried out in the plasma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lactate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ released into the bloodstream&lt;/li&gt;&lt;li&gt;â€¢ various tissues in response to cell damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein lipase (LPL) is a functional plasma enzyme that plays a crucial role in the metabolism of lipoproteins. It is bound to the endothelial cells of capillaries in heart, muscle, and adipose tissue and is responsible for hydrolyzing triglycerides in lipoproteins , such as chylomicrons and very-low-density lipoproteins (VLDL), into free fatty acids and glycerol, which can then be used by the body. Unlike other enzymes that may be found in the plasma due to cell damage or leakage, LPL performs its physiological function within the plasma.&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein lipase&lt;/li&gt;&lt;li&gt;âž¤ functional plasma enzyme&lt;/li&gt;&lt;li&gt;âž¤ metabolism of lipoproteins.&lt;/li&gt;&lt;li&gt;âž¤ endothelial cells&lt;/li&gt;&lt;li&gt;âž¤ capillaries in heart, muscle, and adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ hydrolyzing triglycerides in lipoproteins&lt;/li&gt;&lt;li&gt;âž¤ chylomicrons and very-low-density lipoproteins&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ glycerol,&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 301.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 301.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical discussion on metabolic regulation, a topic of interest is the mechanism of feedback inhibition in enzymatic pathways. This regulatory process is crucial for maintaining homeostasis within the body. What primarily influences feedback inhibition of enzymes in metabolic pathways?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹ Enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;External factors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;End product&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Substrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. End product&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture19.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enzyme: While enzymes are crucial for catalyzing reactions, they are not the primary initiators of feedback inhibition . Instead, their activity can be modulated by various factors, including the end product of the pathway they are part of.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enzyme:&lt;/li&gt;&lt;li&gt;â€¢ catalyzing reactions,&lt;/li&gt;&lt;li&gt;â€¢ not the primary initiators of feedback inhibition&lt;/li&gt;&lt;li&gt;â€¢ Option B. External factors: External factors such as temperature, pH, and the presence of inhibitors or activators can affect enzyme activity , but they are not typically involved in feedback inhibition, which is an intrinsic regulatory mechanism of the metabolic pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option B. External factors:&lt;/li&gt;&lt;li&gt;â€¢ temperature, pH, and the presence of inhibitors&lt;/li&gt;&lt;li&gt;â€¢ activators can affect enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ Option D. Substrate: The substrate is necessary for the enzyme to act upon , but the accumulation of substrate does not typically lead to feedback inhibition. Instead, feedback inhibition is usually triggered by the accumulation of the end product of the pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Substrate:&lt;/li&gt;&lt;li&gt;â€¢ enzyme to act upon&lt;/li&gt;&lt;li&gt;â€¢ accumulation of substrate&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lead to feedback inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Feedback inhibition occurs when the end product of a metabolic pathway accumulates to a level that inhibits the activity of an enzyme involved in an earlier step of the pathway. This mechanism prevents overproduction of the end product and conserves cellular resources.&lt;/li&gt;&lt;li&gt;âž¤ Feedback inhibition&lt;/li&gt;&lt;li&gt;âž¤ end product of a metabolic pathway accumulates&lt;/li&gt;&lt;li&gt;âž¤ level that inhibits the activity&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ mechanism prevents overproduction&lt;/li&gt;&lt;li&gt;âž¤ end product and conserves cellular resources.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a practical session, students are tasked with investigating the factors influencing enzyme-catalyzed reactions. One group decides to conduct an experiment with an excess of substrate to ensure it&#x27;s not the limiting factor in reaction velocity. They aim to identify which factor the reaction velocity would then be directly proportional to under these conditions. What does the velocity of an enzymatic reaction primarily depend on when substrate concentration is not limiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Concentration of substrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Temperature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Concentration of enzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;pH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Concentration of enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture20.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Substrate concentration: When the substrate concentration is increased, the velocity is also correspondingly increased in the initial phases; but the curve flattens afterwards.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Substrate concentration:&lt;/li&gt;&lt;li&gt;â€¢ substrate concentration is increased,&lt;/li&gt;&lt;li&gt;â€¢ velocity&lt;/li&gt;&lt;li&gt;â€¢ correspondingly increased&lt;/li&gt;&lt;li&gt;â€¢ initial phases;&lt;/li&gt;&lt;li&gt;â€¢ Option B. Effect of temperature : The velocity of reaction increases when temperature of the medium is increased â†’ reaches a maximum â†’ then falls (Bell shaped curve). The temperature at which the maximum amount of the substrate is getting converted to the product per unit time is known as optimum temperature.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Effect of temperature&lt;/li&gt;&lt;li&gt;â€¢ â†’&lt;/li&gt;&lt;li&gt;â€¢ â†’&lt;/li&gt;&lt;li&gt;â€¢ maximum amount of the substrate is getting converted to the product&lt;/li&gt;&lt;li&gt;â€¢ Option D. Effect of pH : Each enzyme has an optimum pH, on both sides of which the velocity is drastically reduced . The graph formed is a bell shaped curve. The pH decides the charge on the amino acid residues at the active site.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Effect of pH&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ optimum pH,&lt;/li&gt;&lt;li&gt;â€¢ both sides&lt;/li&gt;&lt;li&gt;â€¢ velocity is drastically reduced&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ With an excess of substrate, the reaction velocity becomes directly proportional to the enzyme concentration . In this state, every enzyme molecule has the potential to be in constant use, catalyzing substrates into products , thus making the enzyme concentration the primary determinant of reaction velocity.&lt;/li&gt;&lt;li&gt;âž¤ excess of substrate,&lt;/li&gt;&lt;li&gt;âž¤ reaction velocity&lt;/li&gt;&lt;li&gt;âž¤ directly proportional to the enzyme concentration&lt;/li&gt;&lt;li&gt;âž¤ every enzyme molecule&lt;/li&gt;&lt;li&gt;âž¤ potential to be in constant use,&lt;/li&gt;&lt;li&gt;âž¤ catalyzing substrates into products&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 56.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 56.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical laboratory, various enzymes are employed as reagents to measure concentrations of specific substances in patient samples. These enzymatic assays provide accurate and efficient means of diagnosis and monitoring. Which of the following enzymes are examples of those used as reagents in clinical laboratory tests?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cholesterol oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-161528.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Glucose oxidase is commonly used in blood glucose monitoring devices and tests due to its specificity for glucose, making it an invaluable tool for diagnosing and managing diabetes. Urease is used in assays to measure urea levels in blood or urine , which can be indicative of kidney function or other metabolic conditions. Cholesterol oxidase is employed in tests to determine cholesterol levels in blood, which is crucial for assessing cardiovascular risk.&lt;/li&gt;&lt;li&gt;â€¢ Glucose oxidase is commonly used in blood glucose monitoring devices and tests due to its specificity for glucose, making it an invaluable tool for diagnosing and managing diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Glucose oxidase&lt;/li&gt;&lt;li&gt;â€¢ blood glucose monitoring devices&lt;/li&gt;&lt;li&gt;â€¢ tests&lt;/li&gt;&lt;li&gt;â€¢ specificity for glucose,&lt;/li&gt;&lt;li&gt;â€¢ invaluable tool for diagnosing&lt;/li&gt;&lt;li&gt;â€¢ managing diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Urease is used in assays to measure urea levels in blood or urine , which can be indicative of kidney function or other metabolic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Urease&lt;/li&gt;&lt;li&gt;â€¢ assays to measure urea levels in blood or urine&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol oxidase is employed in tests to determine cholesterol levels in blood, which is crucial for assessing cardiovascular risk.&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol oxidase&lt;/li&gt;&lt;li&gt;â€¢ tests to determine cholesterol levels in blood,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 309.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 309.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the emergency department with severe abdominal pain, nausea, and vomiting. His medical history is unremarkable except for chronic alcohol misuse. Laboratory tests reveal significantly elevated levels of serum amylase and lipase. Based on these findings, which condition is most commonly associated with an increase in these two enzyme levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute pancreatitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gallbladder disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute pancreatitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver cirrhosis: While liver disease can affect various enzymes, notably ALT and AST, it&#x27;s not typically associated with a significant rise in amylase and lipase as seen in pancreatic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver cirrhosis:&lt;/li&gt;&lt;li&gt;â€¢ liver disease&lt;/li&gt;&lt;li&gt;â€¢ affect various enzymes,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone disease: Diseases affecting bone generally lead to alterations in alkaline phosphatase , calcium, and phosphate levels , rather than amylase or lipase.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone disease:&lt;/li&gt;&lt;li&gt;â€¢ Diseases affecting bone&lt;/li&gt;&lt;li&gt;â€¢ lead to alterations in alkaline phosphatase&lt;/li&gt;&lt;li&gt;â€¢ phosphate levels&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gallbladder disease: Conditions like cholecystitis might cause mild elevations in amylase due to shared ducts between the liver, gallbladder, and pancreas, but the most pronounced increases are observed in acute pancreatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Gallbladder disease:&lt;/li&gt;&lt;li&gt;â€¢ cholecystitis&lt;/li&gt;&lt;li&gt;â€¢ mild elevations in amylase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elevated serum amylase and lipase levels are hallmark indicators of acute pancreatitis , reflecting pancreatic inflammation or injury. These enzymes, particularly lipase, are more specific to pancreatic damage and are used clinically to confirm a diagnosis of acute pancreatitis.&lt;/li&gt;&lt;li&gt;âž¤ Elevated serum amylase&lt;/li&gt;&lt;li&gt;âž¤ lipase levels&lt;/li&gt;&lt;li&gt;âž¤ indicators of acute pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ reflecting pancreatic inflammation&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 358.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 358.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a recent journal club meeting, a discussion arose around the adaptability of enzyme active sites upon substrate binding. A new member presented a model that suggests the active site of an enzyme is not rigid but can mold itself to fit the shape of the substrate, enhancing the enzyme-substrate interaction. Which model describes this concept where the enzyme&#x27;s active site undergoes a conformational change to accommodate the substrate more effectively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lock and key model&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Induced fit model&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fisherâ€™s Template theory&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Induced fit model&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Induced fit model&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lock and key model: This earlier model suggests that the enzyme and substrate fit together perfectly without any need for adjustment , similar to a lock and its key. It does not account for flexibility in the enzyme&#x27;s structure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lock and key model:&lt;/li&gt;&lt;li&gt;â€¢ enzyme and substrate fit together perfectly without any need for adjustment&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fisherâ€™s Template theory: This is essentially another name for the lock and key model proposed by Emil Fischer . It emphasizes a rigid, pre-formed shape of the enzyme&#x27;s active site that perfectly matches the substrate, without considering conformational changes upon binding.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fisherâ€™s Template theory:&lt;/li&gt;&lt;li&gt;â€¢ another name for the lock and key model proposed by Emil Fischer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The induced fit model proposes that the enzyme&#x27;s active site is flexible and undergoes a conformational change upon substrate binding , enhancing the complementarity between the enzyme and substrate . This model accounts for the dynamic nature of enzyme-substrate interactions.&lt;/li&gt;&lt;li&gt;âž¤ induced fit model proposes&lt;/li&gt;&lt;li&gt;âž¤ enzyme&#x27;s active site is flexible&lt;/li&gt;&lt;li&gt;âž¤ undergoes a conformational change&lt;/li&gt;&lt;li&gt;âž¤ substrate binding&lt;/li&gt;&lt;li&gt;âž¤ complementarity between the enzyme&lt;/li&gt;&lt;li&gt;âž¤ substrate&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 53.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 53.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man with a recent diagnosis of lung carcinoma undergoes routine blood work as part of his oncological assessment. His physician notes an elevated level of a specific isoenzyme, which is known to be associated with certain cancers and shares characteristics with the placental form of alkaline phosphatase. This isoenzyme is particularly noted for its heat stability. What is this isoenzyme commonly referred to in clinical practice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Regan Isoenzyme&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver Isoenzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone Isoenzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intestinal Isoenzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Regan Isoenzyme&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver Isoenzyme: While liver isoenzymes of ALP can be elevated in liver diseases and some cancers , they are not specifically known for being heat-stable or for their association with placental ALP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liver Isoenzyme:&lt;/li&gt;&lt;li&gt;â€¢ liver isoenzymes of ALP&lt;/li&gt;&lt;li&gt;â€¢ elevated in liver diseases&lt;/li&gt;&lt;li&gt;â€¢ some cancers&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone Isoenzyme: The bone isoenzyme of ALP is typically elevated in conditions affecting bone turnover and growth but is not specifically associated with cancers in the same way as the Regan isoenzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bone Isoenzyme:&lt;/li&gt;&lt;li&gt;â€¢ bone isoenzyme of ALP&lt;/li&gt;&lt;li&gt;â€¢ elevated in conditions affecting bone turnover&lt;/li&gt;&lt;li&gt;â€¢ growth&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intestinal Isoenzyme: Intestinal isoenzymes of ALP may be elevated in gastrointestinal diseases but do not have the same clinical significance in the context of carcinoma as the Regan isoenzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Intestinal Isoenzyme:&lt;/li&gt;&lt;li&gt;â€¢ Intestinal isoenzymes of ALP&lt;/li&gt;&lt;li&gt;â€¢ elevated in gastrointestinal diseases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Regan isoenzyme (named after the patient in whom it was detected) is identified in plasma in patients with carcinoma of lung, liver &amp;amp; intestine . It is a variant of alpha-2 heat stable form of ALP. Nago isoenzyme : variant of ALP of germ cell origin, it is a modified form of non-placental isoenzyme seen in certain tumors. Kasahara isoenzyme : variant of ALP of fetal intestinal origin, seen in malignancy.&lt;/li&gt;&lt;li&gt;âž¤ Regan isoenzyme (named after the patient in whom it was detected) is identified in plasma in patients with carcinoma of lung, liver &amp;amp; intestine . It is a variant of alpha-2 heat stable form of ALP.&lt;/li&gt;&lt;li&gt;âž¤ Regan isoenzyme&lt;/li&gt;&lt;li&gt;âž¤ identified in plasma in patients with carcinoma&lt;/li&gt;&lt;li&gt;âž¤ lung, liver &amp;amp; intestine&lt;/li&gt;&lt;li&gt;âž¤ Nago isoenzyme : variant of ALP of germ cell origin, it is a modified form of non-placental isoenzyme seen in certain tumors.&lt;/li&gt;&lt;li&gt;âž¤ Nago isoenzyme&lt;/li&gt;&lt;li&gt;âž¤ Kasahara isoenzyme : variant of ALP of fetal intestinal origin, seen in malignancy.&lt;/li&gt;&lt;li&gt;âž¤ Kasahara isoenzyme&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 306.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 306.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion(A): Enzyme inhibitors act as metabolic poisons. Reasoning(R): Enzyme poisons reversibly or irreversibly inhibits the action of enzymes involved in metabolic processes, thereby affecting the metabolic pathways. Based on these statements, which of the following best describes their relationship?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-163821.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ENZYME POISONS:&lt;/li&gt;&lt;li&gt;â€¢ ENZYME POISONS:&lt;/li&gt;&lt;li&gt;â€¢ Enzyme inhibitors act as metabolic poisons. Many poisons work by inhibiting the action of enzymes involved in metabolic processes , which hampers the metabolic pathways. Enzymes poisons are basically enzyme inhibitors and this inhibition can be reversible or irreversible.&lt;/li&gt;&lt;li&gt;â€¢ Enzyme inhibitors act as metabolic poisons.&lt;/li&gt;&lt;li&gt;â€¢ Enzyme inhibitors&lt;/li&gt;&lt;li&gt;â€¢ metabolic poisons.&lt;/li&gt;&lt;li&gt;â€¢ Many poisons work by inhibiting the action of enzymes involved in metabolic processes , which hampers the metabolic pathways.&lt;/li&gt;&lt;li&gt;â€¢ poisons work by inhibiting the action of enzymes&lt;/li&gt;&lt;li&gt;â€¢ metabolic processes&lt;/li&gt;&lt;li&gt;â€¢ Enzymes poisons are basically enzyme inhibitors and this inhibition can be reversible or irreversible.&lt;/li&gt;&lt;li&gt;â€¢ Enzymes poisons&lt;/li&gt;&lt;li&gt;â€¢ enzyme inhibitors&lt;/li&gt;&lt;li&gt;â€¢ inhibition can be reversible or irreversible.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 61.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 61.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following examples best illustrates the concept of enzyme induction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ALA synthase by barbiturates&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Succinate dehydrogenase by malonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytochromes by cyanide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ALA synthase by heme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ALA synthase by barbiturates&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Succinate dehydrogenase by malonate: e.g of competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Succinate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ malonate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cytochromes by cyanide : e.g of Non-competitive inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Cytochromes&lt;/li&gt;&lt;li&gt;â€¢ cyanide&lt;/li&gt;&lt;li&gt;â€¢ Option D. ALA synthase by heme : e.g: of Repression.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase&lt;/li&gt;&lt;li&gt;â€¢ heme&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Barbiturates can induce the synthesis of ALA synthase , an enzyme involved in the heme synthesis pathway, by increasing the transcription of its gene . This is an example of enzyme induction where the presence of a compound (barbiturates) increases the production and activity of an enzyme.&lt;/li&gt;&lt;li&gt;âž¤ Barbiturates&lt;/li&gt;&lt;li&gt;âž¤ induce the synthesis of ALA synthase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ heme synthesis pathway,&lt;/li&gt;&lt;li&gt;âž¤ increasing the transcription of its gene&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a molecular biology lecture on gene expression regulation, the professor emphasizes mechanisms that operate at the gene level to control enzyme synthesis and activity. One of the discussed mechanisms involves the downregulation or inhibition of enzyme synthesis in response to specific signals. Which of the following phenomena specifically acts at the gene level to regulate enzyme synthesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allosteric activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repression&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cooperative activation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Feed forward activation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Repression&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture22.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric activation : This involves the binding of an effector molecule to an enzyme at a site other than the active site, leading to a conformational change that affects enzyme activity, not gene expression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric activation&lt;/li&gt;&lt;li&gt;â€¢ binding of an effector molecule&lt;/li&gt;&lt;li&gt;â€¢ enzyme at a site&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cooperative activation : This refers to the phenomenon where the binding of a substrate or activator to one active site on a multi-subunit enzyme enhances the activity at other active sites, not directly related to gene expression.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cooperative activation&lt;/li&gt;&lt;li&gt;â€¢ phenomenon where the binding of a substrate&lt;/li&gt;&lt;li&gt;â€¢ activator to one active site&lt;/li&gt;&lt;li&gt;â€¢ Option D. Feed forward activation : This is a metabolic control mechanism where an enzyme is activated by an intermediate that precedes the enzyme in the pathway , not a gene-level regulation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Feed forward activation&lt;/li&gt;&lt;li&gt;â€¢ metabolic control mechanism&lt;/li&gt;&lt;li&gt;â€¢ enzyme is activated by an intermediate&lt;/li&gt;&lt;li&gt;â€¢ precedes the enzyme in the pathway&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Repression, in the context of gene expression, refers to a regulatory mechanism where gene expression is decreased in response to a specific signal, often involving the binding of repressor proteins to DNA sequences near the genes being regulated . This decreases the transcription of those genes, leading to reduced synthesis of the corresponding enzymes.&lt;/li&gt;&lt;li&gt;âž¤ Repression,&lt;/li&gt;&lt;li&gt;âž¤ gene expression,&lt;/li&gt;&lt;li&gt;âž¤ regulatory mechanism&lt;/li&gt;&lt;li&gt;âž¤ gene expression is decreased&lt;/li&gt;&lt;li&gt;âž¤ specific signal,&lt;/li&gt;&lt;li&gt;âž¤ binding of repressor proteins to DNA sequences&lt;/li&gt;&lt;li&gt;âž¤ genes being regulated&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 64.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A kinetic analysis of the effect of a drug on an enzyme&#x27;s activity was performed and the results shown below were obtained. The drug would be best classified as which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A competitive inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A non-competitive inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An uncompetitive inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An activator of the enzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A non-competitive inhibitor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture23.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A competitive inhibitor: This would demonstrate an increased Km , but an unaltered Vmax (line intersection on the y-axis).&lt;/li&gt;&lt;li&gt;â€¢ Option A. A competitive inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ demonstrate an increased Km&lt;/li&gt;&lt;li&gt;â€¢ Option C. An uncompetitive inhibitor: This inhibitor alters both the Km and Vmax such that parallel lines are seen on double-reciprocal plots.&lt;/li&gt;&lt;li&gt;â€¢ Option C. An uncompetitive inhibitor:&lt;/li&gt;&lt;li&gt;â€¢ inhibitor alters both the Km and Vmax&lt;/li&gt;&lt;li&gt;â€¢ Option D. An activator of the enzyme : Activation of the enzyme would either decrease the Km or increase the Vmax or both.&lt;/li&gt;&lt;li&gt;â€¢ Option D. An activator of the enzyme&lt;/li&gt;&lt;li&gt;â€¢ decrease the Km or increase the Vmax or both.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Lineweaver-Burk plot shows that the presence of the drug increases the slope of the line without changing the x-intercept , which suggests that the Vmax of the reaction is decreased while the Km remains unchanged. This pattern is indicative of non-competitive inhibition, where the inhibitor binds to the enzyme at a site other than the active site and inhibits the enzyme regardless of the substrate concentration.&lt;/li&gt;&lt;li&gt;âž¤ Lineweaver-Burk plot&lt;/li&gt;&lt;li&gt;âž¤ presence of the drug increases&lt;/li&gt;&lt;li&gt;âž¤ slope of the line without changing the x-intercept&lt;/li&gt;&lt;li&gt;âž¤ Vmax of the reaction is decreased&lt;/li&gt;&lt;li&gt;âž¤ Km remains unchanged.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 59.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 13-year-old boy presented with fever, skeletal pain, polydipsia, polyuria and multiple osteolytic lesions in pelvic bones and upper femur. There was no organomegaly or lymphadenopathy. His serum calcium levels were raised. PBS appears normal. Bone marrow: presence of blast cells. Flow cytometry indicated B-acute lymphoblastic leukaemia (B-ALL). The enzyme useful in the treatment of leukemia is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha-1-antitrypsin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Asparaginase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Asparaginase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-172402.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Alpha-1-antitrypsin is a protease inhibitor and is mainly used in the treatment of conditions like emphysema associated with alpha-1-antitrypsin deficiency, not leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Alpha-1-antitrypsin&lt;/li&gt;&lt;li&gt;â€¢ protease inhibitor&lt;/li&gt;&lt;li&gt;â€¢ Option B . Lipase is an enzyme that breaks down fats in the digestive system and has no therapeutic role in the treatment of leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Lipase&lt;/li&gt;&lt;li&gt;â€¢ enzyme that breaks down fats&lt;/li&gt;&lt;li&gt;â€¢ digestive system&lt;/li&gt;&lt;li&gt;â€¢ Option D . Streptokinase is an enzyme used to break down blood clots (thrombolysis) and is used in the treatment of conditions such as myocardial infarction, not leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Streptokinase&lt;/li&gt;&lt;li&gt;â€¢ enzyme used to break down blood clots&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 308.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 308.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the clinically useful competitive inhibitors with the drug:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-172430.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-172920.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A. Allopurinol is a competitive inhibitor of xanthine oxidase , an enzyme involved in the pathway that leads to uric acid production . Therefore, it is used in the treatment of gout.&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Allopurinol&lt;/li&gt;&lt;li&gt;â€¢ competitive inhibitor&lt;/li&gt;&lt;li&gt;â€¢ xanthine oxidase&lt;/li&gt;&lt;li&gt;â€¢ pathway&lt;/li&gt;&lt;li&gt;â€¢ leads to uric acid production&lt;/li&gt;&lt;li&gt;â€¢ B . Sulfonamide is a competitive inhibitor of pteroid synthetase (also known as dihydropteroate synthase), an enzyme involved in folate synthesis in bacteria .&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Sulfonamide&lt;/li&gt;&lt;li&gt;â€¢ competitive inhibitor&lt;/li&gt;&lt;li&gt;â€¢ pteroid synthetase&lt;/li&gt;&lt;li&gt;â€¢ folate synthesis&lt;/li&gt;&lt;li&gt;â€¢ bacteria&lt;/li&gt;&lt;li&gt;â€¢ C . 5-fluorouracil is a competitive inhibitor of thymidylate synthase , an enzyme involved in the synthesis of the nucleotide thymidine , which is required for DNA replication .&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;li&gt;â€¢ 5-fluorouracil&lt;/li&gt;&lt;li&gt;â€¢ competitive inhibitor&lt;/li&gt;&lt;li&gt;â€¢ thymidylate synthase&lt;/li&gt;&lt;li&gt;â€¢ synthesis of the nucleotide thymidine&lt;/li&gt;&lt;li&gt;â€¢ DNA replication&lt;/li&gt;&lt;li&gt;â€¢ D . Trimethoprim is a competitive inhibitor of dihydrofolate reductase , an enzyme involved in the synthesis of tetrahydrofolate , which is necessary for the production of purine and pyrimidine nucleotides .&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Trimethoprim&lt;/li&gt;&lt;li&gt;â€¢ competitive inhibitor&lt;/li&gt;&lt;li&gt;â€¢ dihydrofolate reductase&lt;/li&gt;&lt;li&gt;â€¢ synthesis of tetrahydrofolate&lt;/li&gt;&lt;li&gt;â€¢ production of purine&lt;/li&gt;&lt;li&gt;â€¢ pyrimidine nucleotides&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 61&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 61&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following methods is NOT a common technique for identifying isoenzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Specific antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tissue localization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spectrometry&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Spectrometry&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Electrophoresis is a technique that separates molecules based on their size and charge and is commonly used to differentiate isoenzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Electrophoresis&lt;/li&gt;&lt;li&gt;â€¢ technique that separates molecules&lt;/li&gt;&lt;li&gt;â€¢ size and charge&lt;/li&gt;&lt;li&gt;â€¢ Option B. Specific antibodies can be used to distinguish isoenzymes because they can recognize and bind to specific epitopes that may differ between isoenzyme forms.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Specific antibodies&lt;/li&gt;&lt;li&gt;â€¢ distinguish isoenzymes&lt;/li&gt;&lt;li&gt;â€¢ recognize and bind to specific epitopes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tissue localization involves identifying the specific tissues in which isoenzymes are expressed , as certain isoenzymes are confined to particular organs or cell types.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Tissue localization&lt;/li&gt;&lt;li&gt;â€¢ identifying the specific tissues&lt;/li&gt;&lt;li&gt;â€¢ isoenzymes are expressed&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methods of identification of Isoenzymes:&lt;/li&gt;&lt;li&gt;âž¤ Methods of identification of Isoenzymes:&lt;/li&gt;&lt;li&gt;âž¤ In electrophoresis , the isoenzymes have different mobility. LDH and CK isoenzymes are separated by electrophoresis. Heat stability : One of the isoenzymes can be easily denatured by heat, e.g. bone isoenzyme of ALP (BALP). Inhibitors : One of the isoenzymes can be sensitive to one inhibitor, e.g. tartrate labile ACP. The Km value or substrate specificity may be different for isoenzymes, e.g. glucokinase has high Km and hexokinase has low Km for glucose. Cofactor requirements can be different for isoenzymes. Mitochondrial isocitrate dehydrogenase is NAD+ dependent and the cytoplasmic isoenzyme is NADP+ dependent. Tissue localization can be different for isoenzymes. The H4 form of LDH is present in the heart and the M4 variety is seen in skeletal muscle. Specific antibodies can identify different types of isoenzymes. For example, CK isoenzymes are separated by antibodies&lt;/li&gt;&lt;li&gt;âž¤ In electrophoresis , the isoenzymes have different mobility. LDH and CK isoenzymes are separated by electrophoresis.&lt;/li&gt;&lt;li&gt;âž¤ In electrophoresis&lt;/li&gt;&lt;li&gt;âž¤ Heat stability : One of the isoenzymes can be easily denatured by heat, e.g. bone isoenzyme of ALP (BALP).&lt;/li&gt;&lt;li&gt;âž¤ Heat stability&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors : One of the isoenzymes can be sensitive to one inhibitor, e.g. tartrate labile ACP.&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors&lt;/li&gt;&lt;li&gt;âž¤ The Km value or substrate specificity may be different for isoenzymes, e.g. glucokinase has high Km and hexokinase has low Km for glucose.&lt;/li&gt;&lt;li&gt;âž¤ The Km value&lt;/li&gt;&lt;li&gt;âž¤ Cofactor requirements can be different for isoenzymes. Mitochondrial isocitrate dehydrogenase is NAD+ dependent and the cytoplasmic isoenzyme is NADP+ dependent.&lt;/li&gt;&lt;li&gt;âž¤ Cofactor&lt;/li&gt;&lt;li&gt;âž¤ Tissue localization can be different for isoenzymes. The H4 form of LDH is present in the heart and the M4 variety is seen in skeletal muscle.&lt;/li&gt;&lt;li&gt;âž¤ Tissue localization&lt;/li&gt;&lt;li&gt;âž¤ Specific antibodies can identify different types of isoenzymes. For example, CK isoenzymes are separated by antibodies&lt;/li&gt;&lt;li&gt;âž¤ Specific antibodies&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 67.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 67.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following theory/model explains the mode of action of enzyme mentioned in the picture?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Induced fit model&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Michaelisâ€“Menten model&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lock and key model&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Induced fit model&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture24.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Michaelisâ€“Menten model: Enzyme-Substrate complex theory -The enzyme (E) combines with the substrate (S) â†’ enzyme-substrate (ES) complex â†’ immediately breaks down to the enzyme and the product (P).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Michaelisâ€“Menten model: Enzyme-Substrate complex theory&lt;/li&gt;&lt;li&gt;â€¢ â†’&lt;/li&gt;&lt;li&gt;â€¢ â†’&lt;/li&gt;&lt;li&gt;â€¢ E + S â†’ Eâ€“S Complex â†’ E + P&lt;/li&gt;&lt;li&gt;â€¢ E + S â†’ Eâ€“S Complex â†’ E + P&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lock and key model: Fischerâ€™s Template Theory- This theory states that the three-dimensional structures of the active site of the enzyme is complementary to the substrate â†’ [E] and [S] fit each other similar to lock and key.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lock and key model: Fischerâ€™s Template Theory-&lt;/li&gt;&lt;li&gt;â€¢ three-dimensional structures&lt;/li&gt;&lt;li&gt;â€¢ active site&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ complementary to the substrate â†’&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Lineweaver-Burk plot is a double reciprocal graphical representation of the Michaelis-Menten equation . However, the Michaelis-Menten model assumes that the enzyme-substrate complex is static and does not account for changes in the enzyme structure upon substrate binding . In contrast, the induced fit model posits that the enzyme structure is flexible and changes to accommodate the substrate upon binding, which is not directly observable in a Lineweaver-Burk plot.&lt;/li&gt;&lt;li&gt;âž¤ Lineweaver-Burk plot&lt;/li&gt;&lt;li&gt;âž¤ double reciprocal graphical representation&lt;/li&gt;&lt;li&gt;âž¤ Michaelis-Menten equation&lt;/li&gt;&lt;li&gt;âž¤ Michaelis-Menten model&lt;/li&gt;&lt;li&gt;âž¤ enzyme-substrate complex is static&lt;/li&gt;&lt;li&gt;âž¤ does not account for changes&lt;/li&gt;&lt;li&gt;âž¤ enzyme structure&lt;/li&gt;&lt;li&gt;âž¤ substrate binding&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 53.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 53.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following factors affecting enzyme activity will give the graph mentioned?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enzyme concentration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substrate concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Effect of temperature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Effect of pH&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Enzyme concentration&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture25.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture26.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture27.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture28.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Substrate concentration: When the substrate concentration is increased , the velocity is also correspondingly increased in the initial phases ; but the curve flattens afterwards.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Substrate concentration:&lt;/li&gt;&lt;li&gt;â€¢ substrate concentration is increased&lt;/li&gt;&lt;li&gt;â€¢ velocity&lt;/li&gt;&lt;li&gt;â€¢ increased in the initial phases&lt;/li&gt;&lt;li&gt;â€¢ Option C. Effect of temperature : The velocity of reaction increases when temperature of the medium is increased â†’ reaches a maximum â†’ then falls (Bell shaped curve). The temperature at which the maximum amount of the substrate is getting converted to the product per unit time is known as optimum temperature.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Effect of temperature&lt;/li&gt;&lt;li&gt;â€¢ velocity of reaction increases&lt;/li&gt;&lt;li&gt;â€¢ temperature of the medium is increased â†’&lt;/li&gt;&lt;li&gt;â€¢ â†’&lt;/li&gt;&lt;li&gt;â€¢ Option D. Effect of pH : Each enzyme has an optimum pH , on both sides of which the velocity is drastically reduced . The graph formed is a bell shaped curve. The pH decides the charge on the amino acid residues at the active site.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Effect of pH&lt;/li&gt;&lt;li&gt;â€¢ Each enzyme&lt;/li&gt;&lt;li&gt;â€¢ optimum pH&lt;/li&gt;&lt;li&gt;â€¢ both sides&lt;/li&gt;&lt;li&gt;â€¢ velocity is drastically reduced&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A linear increase in reaction velocity with enzyme concentration , indicating a direct relationship under conditions where substrate is plentiful and temperature and pH are stable . In contrast, substrate concentration and enzyme activity typically exhibit a hyperbolic and bell-shaped curve with reaction velocity , respectively, while temperature has an optimal point beyond which enzyme activity decreases.&lt;/li&gt;&lt;li&gt;âž¤ linear increase in reaction velocity&lt;/li&gt;&lt;li&gt;âž¤ enzyme concentration&lt;/li&gt;&lt;li&gt;âž¤ direct relationship&lt;/li&gt;&lt;li&gt;âž¤ conditions where substrate is plentiful&lt;/li&gt;&lt;li&gt;âž¤ temperature and pH are stable&lt;/li&gt;&lt;li&gt;âž¤ substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ enzyme activity&lt;/li&gt;&lt;li&gt;âž¤ exhibit a hyperbolic&lt;/li&gt;&lt;li&gt;âž¤ bell-shaped curve&lt;/li&gt;&lt;li&gt;âž¤ reaction velocity&lt;/li&gt;&lt;li&gt;âž¤ temperature&lt;/li&gt;&lt;li&gt;âž¤ optimal point&lt;/li&gt;&lt;li&gt;âž¤ enzyme activity decreases.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 56.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 56.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately describes the action of Disulfiram, a drug used in the treatment of alcoholism? Assertion(A): Disulfiram is used for treating alcoholism Reasoning(R): It inhibits the enzyme alcohol dehydrogenase helps in alcohol avoidance:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A is right but R is a wrong statement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. A is right but R is a wrong statement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A): True. Disulfiram is indeed used in the treatment of alcoholism as an aversion therapy drug. Reason (R): False. The mechanism of action of Disulfiram is NOT by inhibiting alcohol dehydrogenase. Instead, it inhibits aldehyde dehydrogenase, the enzyme that converts acetaldehyde to acetate. As a result, after alcohol consumption, acetaldehyde accumulates in the body, leading to unpleasant symptoms (flushing, nausea, vomiting, headache), which discourages alcohol intake.&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A): True. Disulfiram is indeed used in the treatment of alcoholism as an aversion therapy drug.&lt;/li&gt;&lt;li&gt;â€¢ Reason (R): False. The mechanism of action of Disulfiram is NOT by inhibiting alcohol dehydrogenase. Instead, it inhibits aldehyde dehydrogenase, the enzyme that converts acetaldehyde to acetate. As a result, after alcohol consumption, acetaldehyde accumulates in the body, leading to unpleasant symptoms (flushing, nausea, vomiting, headache), which discourages alcohol intake.&lt;/li&gt;&lt;li&gt;â€¢ Thus:&lt;/li&gt;&lt;li&gt;â€¢ A is correct (Disulfiram is used for alcoholism), R is incorrect (wrong enzyme mentioned).&lt;/li&gt;&lt;li&gt;â€¢ A is correct (Disulfiram is used for alcoholism),&lt;/li&gt;&lt;li&gt;â€¢ R is incorrect (wrong enzyme mentioned).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and R both are right but R is not the correct explanation of A: Incorrect, because R is wrong. Option C. A as well as R are right and R is a correct explanation of A: Incorrect, because R is false. Option D. A and R both are wrong : Incorrect, since A is true.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and R both are right but R is not the correct explanation of A: Incorrect, because R is wrong.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and R both are right&lt;/li&gt;&lt;li&gt;â€¢ Option C. A as well as R are right and R is a correct explanation of A: Incorrect, because R is false.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A as well as R are right&lt;/li&gt;&lt;li&gt;â€¢ Option D. A and R both are wrong : Incorrect, since A is true.&lt;/li&gt;&lt;li&gt;â€¢ Option D. A and R both are wrong&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand the Pharmacology of Disulfiram: Recognize that Disulfiram inhibits aldehyde dehydrogenase (not alcohol dehydrogenase). Know the Rationale for Use: Disulfiram causes acetaldehyde accumulation, leading to disulfiram-ethanol reactionâ€”this forms the basis of its aversion therapy.&lt;/li&gt;&lt;li&gt;âž¤ Understand the Pharmacology of Disulfiram: Recognize that Disulfiram inhibits aldehyde dehydrogenase (not alcohol dehydrogenase).&lt;/li&gt;&lt;li&gt;âž¤ Recognize that Disulfiram inhibits aldehyde dehydrogenase (not alcohol dehydrogenase).&lt;/li&gt;&lt;li&gt;âž¤ Recognize that Disulfiram inhibits aldehyde dehydrogenase (not alcohol dehydrogenase).&lt;/li&gt;&lt;li&gt;âž¤ Know the Rationale for Use: Disulfiram causes acetaldehyde accumulation, leading to disulfiram-ethanol reactionâ€”this forms the basis of its aversion therapy.&lt;/li&gt;&lt;li&gt;âž¤ Disulfiram causes acetaldehyde accumulation, leading to disulfiram-ethanol reactionâ€”this forms the basis of its aversion therapy.&lt;/li&gt;&lt;li&gt;âž¤ Disulfiram causes acetaldehyde accumulation, leading to disulfiram-ethanol reactionâ€”this forms the basis of its aversion therapy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 140.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old female has been recently diagnosed with leukemia, a type of cancer that affects the blood and bone marrow. The oncology team is considering various treatment options, including the use of therapeutic enzymes that can target specific metabolic pathways involved in cancer cell growth. Among the available enzyme-based treatments, which one is considered appropriate for managing leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Streptokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asparaginase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both (A) and (B)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Asparaginase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Streptokinase: Streptokinase is an enzyme used to break down blood clots and is typically used in the treatment of conditions like acute myocardial infarction (heart attack) or pulmonary embolism, not leukemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Streptokinase:&lt;/li&gt;&lt;li&gt;â€¢ enzyme used to break down blood clots&lt;/li&gt;&lt;li&gt;â€¢ treatment&lt;/li&gt;&lt;li&gt;â€¢ acute myocardial infarction&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urokinase: Urokinase is another thrombolytic enzyme used to dissolve blood clots . Similar to streptokinase, it is not used in the treatment of leukemia but rather in conditions where blood clots are a primary concern.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urokinase:&lt;/li&gt;&lt;li&gt;â€¢ thrombolytic enzyme&lt;/li&gt;&lt;li&gt;â€¢ dissolve blood clots&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both A and B: While both streptokinase and asparaginase are enzymes , only asparaginase is used in the treatment of leukemia . Streptokinase&#x27;s use is unrelated to cancer treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both A and B:&lt;/li&gt;&lt;li&gt;â€¢ streptokinase and asparaginase&lt;/li&gt;&lt;li&gt;â€¢ enzymes&lt;/li&gt;&lt;li&gt;â€¢ asparaginase&lt;/li&gt;&lt;li&gt;â€¢ treatment of leukemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The role of asparaginase in the treatment of leukemia , specifically its mechanism of action that involves depleting asparagine to inhibit the growth of leukemia cells .&lt;/li&gt;&lt;li&gt;âž¤ role of asparaginase&lt;/li&gt;&lt;li&gt;âž¤ treatment of leukemia&lt;/li&gt;&lt;li&gt;âž¤ mechanism of action&lt;/li&gt;&lt;li&gt;âž¤ depleting asparagine&lt;/li&gt;&lt;li&gt;âž¤ inhibit the growth&lt;/li&gt;&lt;li&gt;âž¤ leukemia cells&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 226.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 226.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a known history of coronary artery disease (CAD) undergoes his annual health check-up. Laboratory investigations indicate elevated levels of LDH-5. The consulting cardiologist reviews these results to determine the potential source of cell injury. LDH, or lactate dehydrogenase, has several isoenzymes with different tissue distributions. Based on the elevation of LDH-5, which tissue is most likely experiencing injury in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RBC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liver&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart: Isozyme LDH 1 is seen in Heart.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart:&lt;/li&gt;&lt;li&gt;â€¢ LDH 1&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain: Isozyme LDH 3 is seen in Brain .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Brain:&lt;/li&gt;&lt;li&gt;â€¢ LDH 3&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ Option D. RBC: Isozyme LDH 2 is seen in RBCs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RBC:&lt;/li&gt;&lt;li&gt;â€¢ LDH 2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LDH-5 is an isoenzyme of lactate dehydrogenase that is most abundant in the liver and skeletal muscle . Elevated levels of LDH-5 are often associated with liver damage or disease , reflecting hepatocellular injury . While LDH is a fairly non-specific marker and can be elevated in various conditions , the specific elevation of LDH-5 is more suggestive of liver involvement rather than heart, brain, or red blood cells .&lt;/li&gt;&lt;li&gt;âž¤ LDH-5&lt;/li&gt;&lt;li&gt;âž¤ isoenzyme of lactate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ most abundant in the liver&lt;/li&gt;&lt;li&gt;âž¤ skeletal muscle&lt;/li&gt;&lt;li&gt;âž¤ Elevated levels&lt;/li&gt;&lt;li&gt;âž¤ LDH-5&lt;/li&gt;&lt;li&gt;âž¤ liver damage&lt;/li&gt;&lt;li&gt;âž¤ disease&lt;/li&gt;&lt;li&gt;âž¤ reflecting hepatocellular injury&lt;/li&gt;&lt;li&gt;âž¤ LDH&lt;/li&gt;&lt;li&gt;âž¤ fairly non-specific marker&lt;/li&gt;&lt;li&gt;âž¤ elevated in various conditions&lt;/li&gt;&lt;li&gt;âž¤ elevation of LDH-5&lt;/li&gt;&lt;li&gt;âž¤ liver involvement&lt;/li&gt;&lt;li&gt;âž¤ heart, brain, or red blood cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 66.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p 66.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A cardiologist is reviewing the timeline of enzyme elevation following myocardial infarction (MI) to better understand the acute phase of this cardiac event. Different enzymes are released into the bloodstream at various times after myocardial tissue damage, serving as important biomarkers for diagnosing MI. Among the listed enzymes, which one is known to elevate first in the bloodstream following a myocardial infarction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspartate transaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatine kinase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alanine aminotransferase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Creatine kinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture29.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspartate transaminase: While aspartate transaminase (AST) levels can increase in myocardial infarction , they are less specific and tend to rise later than creatine kinase, making AST a less useful marker for the early diagnosis of MI.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspartate transaminase:&lt;/li&gt;&lt;li&gt;â€¢ increase in myocardial infarction&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase: Lactate dehydrogenase (LDH) levels can also be elevated in myocardial infarction, but this enzyme typically peaks several days after the onset of symptoms, making it useful for late diagnosis but not for early detection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lactate dehydrogenase:&lt;/li&gt;&lt;li&gt;â€¢ elevated in myocardial infarction,&lt;/li&gt;&lt;li&gt;â€¢ peaks several days after the onset of symptoms,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alanine aminotransferase: Alanine aminotransferase (ALT) is more specific to liver tissue, and while it may rise in cases of extensive muscle damage , it is not a primary biomarker for myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alanine aminotransferase:&lt;/li&gt;&lt;li&gt;â€¢ specific to liver tissue,&lt;/li&gt;&lt;li&gt;â€¢ rise in cases of extensive muscle damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Creatine kinase (CK), particularly the CK-MB (creatine kinase, muscle-brain) isoform, is one of the earliest enzymes to rise following myocardial infarction . Its levels can begin to increase within 4 to 6 hours after the onset of MI , peaking at 12 to 24 hours , making it a crucial early marker for acute myocardial injury.&lt;/li&gt;&lt;li&gt;âž¤ Creatine kinase&lt;/li&gt;&lt;li&gt;âž¤ CK-MB&lt;/li&gt;&lt;li&gt;âž¤ earliest enzymes&lt;/li&gt;&lt;li&gt;âž¤ rise&lt;/li&gt;&lt;li&gt;âž¤ myocardial infarction&lt;/li&gt;&lt;li&gt;âž¤ levels&lt;/li&gt;&lt;li&gt;âž¤ begin to increase&lt;/li&gt;&lt;li&gt;âž¤ 4 to 6 hours&lt;/li&gt;&lt;li&gt;âž¤ onset of MI&lt;/li&gt;&lt;li&gt;âž¤ peaking at 12 to 24 hours&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 302.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 302.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with severe pain in the epigastric and periumbilical region, which radiates to the back. H/O 3 episodes of vomiting and low grade fever. He has been a chronic alcoholic for the past 20 years. On palpation, the abdomen was distended and tender. On auscultation, bowel sounds - absent. Blood investigations: Serum amylase: 240 U/L (normal is 30 to 100 U/L) and Serum lipase: 200 U/L (normal is 15 to 80 U/L). Which of the following parameters has more advantage over other investigations in diagnosing the disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum lipase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic elastase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreatic trypsin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum amylase is the major enzyme which digests starch , contains the P ( pancreatic ) and S ( salivary ) iso-enzymes . Normal amylase level in serum is 50â€“120 units and the level rises within 5 hours of the onset of acute pancreatitis â†’ reaches a peak within 12 hours â†’ returns to normal within 2â€“4 days of attack â†’ when urinary amylase level rises.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum amylase&lt;/li&gt;&lt;li&gt;â€¢ major enzyme&lt;/li&gt;&lt;li&gt;â€¢ digests starch&lt;/li&gt;&lt;li&gt;â€¢ pancreatic&lt;/li&gt;&lt;li&gt;â€¢ salivary&lt;/li&gt;&lt;li&gt;â€¢ iso-enzymes&lt;/li&gt;&lt;li&gt;â€¢ acute&lt;/li&gt;&lt;li&gt;â€¢ pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ Serum amylase is mildly increased in cholecystitis, peptic ulcer, diseases of mesentery and&lt;/li&gt;&lt;li&gt;â€¢ obstruction of intestine and no significant changes or only mild elevation is noticed in chronic pancreatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic elastase: Test for the diagnosis of pancreatic insufficiency , done by ELISA method and a value of &amp;gt;200 mg in stool sample indicates normal exocrine pancreatic function and values &amp;lt;200 mg indicates exocrine pancreatic insufficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pancreatic elastase:&lt;/li&gt;&lt;li&gt;â€¢ Test for the diagnosis&lt;/li&gt;&lt;li&gt;â€¢ pancreatic insufficiency&lt;/li&gt;&lt;li&gt;â€¢ ELISA method&lt;/li&gt;&lt;li&gt;â€¢ value of &amp;gt;200 mg&lt;/li&gt;&lt;li&gt;â€¢ stool sample&lt;/li&gt;&lt;li&gt;â€¢ normal exocrine pancreatic function&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic trypsin: It is a simple screening test to access the trypsin activity of feces done using serial dilutions of stool extract.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreatic trypsin:&lt;/li&gt;&lt;li&gt;â€¢ simple screening test&lt;/li&gt;&lt;li&gt;â€¢ access the trypsin activity&lt;/li&gt;&lt;li&gt;â€¢ feces&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum lipase is generally considered a more specific and reliable marker for diagnosing acute pancreatitis compared to serum amylase . Lipase levels remain elevated for a longer duration than amylase levels and are more specific to the pancreas.&lt;/li&gt;&lt;li&gt;âž¤ Serum lipase&lt;/li&gt;&lt;li&gt;âž¤ more specific&lt;/li&gt;&lt;li&gt;âž¤ reliable marker&lt;/li&gt;&lt;li&gt;âž¤ diagnosing acute pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ serum amylase&lt;/li&gt;&lt;li&gt;âž¤ Lipase levels&lt;/li&gt;&lt;li&gt;âž¤ elevated for a longer duration&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 308, 358.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 308, 358.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describe Isoenzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Catalyze the same reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Same quaternary structure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;From a same gene origin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Variation at multiple locus forms polymorphism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Catalyze the same reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Catalyze the same reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Same quaternary structure : Isoenzymes can have different quaternary structures. They are not necessarily identical in their subunit composition or assembly, which can contribute to their tissue-specific expression and activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Same quaternary structure&lt;/li&gt;&lt;li&gt;â€¢ Option C. From a same gene origin : Isoenzymes are often encoded by different genes, which can be part of a gene family.&lt;/li&gt;&lt;li&gt;â€¢ Option C. From a same gene origin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Variation at multiple locus forms polymorphism : While genetic polymorphism can result in different isoenzymes, the statement is more general and does not capture the specific nature of isoenzymes. Polymorphism refers to the presence of multiple alleles at a gene locus within a population, which can lead to various protein forms, including isoenzymes, but the term is not specific to isoenzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Variation at multiple locus forms polymorphism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Isoenzymes are variants of an enzyme that exist in different forms in an organism, and they catalyze the same type of chemical reaction within different tissues or under different conditions. They can differ in amino acid sequence, kinetic properties, and regulatory mechanisms but perform the same overall reaction, reflecting their adaptation to specific cellular or tissue requirements.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 68-69.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;W hich of the following compounds is commonly measured using peroxidase enzyme activity&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Triglycerides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Glucose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-180006.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Triglycerides: The measurement of triglycerides typically involves lipase for hydrolysis , not peroxidase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Triglycerides:&lt;/li&gt;&lt;li&gt;â€¢ involves lipase for hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uric acid: For uric acid measurement, uricase is the enzyme commonly utilized , which catalyzes the oxidation of uric acid to allantoin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Uric acid:&lt;/li&gt;&lt;li&gt;â€¢ uricase is the enzyme&lt;/li&gt;&lt;li&gt;â€¢ utilized&lt;/li&gt;&lt;li&gt;â€¢ catalyzes the oxidation&lt;/li&gt;&lt;li&gt;â€¢ uric acid to allantoin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Creatinine: Creatinine assays usually do not involve peroxidase ; instead, methods such as the Jaffe reaction are commonly employed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Creatinine:&lt;/li&gt;&lt;li&gt;â€¢ do not involve peroxidase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 67.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 67.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In cardiac diagnostics, clinicians often refer to the LDH isoenzyme ratio as an indicator of myocardial infarction (MI). In a typical healthy adult, the LDH-2 level is higher than LDH-1. A condition where this ratio is reversed, with LDH-1 being higher than LDH-2, is sometimes described in clinical practice. Is the term \&quot;flipped pattern\&quot; correctly applied to the scenario where LDH-2 is higher than LDH-1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;None of the Above&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Not sure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. False&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Healthy individual has LDH-2 higher than LDH-1. After certain types of myocardial injury, such as an MI, cardiac cells release more LDH-1 than LDH-2, which can lead to LDH-1 becoming higher than LDH-2. This reversal is what&#x27;s referred to as a \&quot;flipped pattern,\&quot; so the statement LDH-2 &amp;gt;&amp;gt;&amp;gt; LDH-1 being known as a flipped pattern is false.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This question tests understanding of LDH isoenzyme patterns in normal and pathological states. The five LDH isoenzymes (LDH-1 through LDH-5) consist of different combinations of H (heart) and M (muscle) subunits. LDH-1 (Hâ‚„) predominates in heart tissue, LDH-5 (Mâ‚„) predominates in liver and skeletal muscle, and the others are hybrid forms. The normal serum pattern (LDH-2 &amp;gt; LDH-1) gets reversed in myocardial infarction, creating the \&quot;flipped pattern\&quot; (LDH-1 &amp;gt; LDH-2). While historically important, LDH isoenzyme analysis has been largely replaced by more specific cardiac markers such as troponin in modern clinical practice.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 69.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the listed enzymes, which one is NOT typically considered a non-functional enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkaline phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acid phosphatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lipoprotein lipase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gamma glutamyl transpeptidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lipoprotein lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lipoprotein lipase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Enzymes found in the plasma can be classified into two types:&lt;/li&gt;&lt;li&gt;â€¢ Non-functional (plasma marker) enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Non-functional (plasma marker) enzymes:&lt;/li&gt;&lt;li&gt;â€¢ These do not perform any physiological function in plasma . Their presence in serum is typically due to cell damage or turnover . Elevated levels help identify tissue injury or disease . Examples: Alkaline phosphatase (ALP) â€“ bone and liver disorders Acid phosphatase â€“ prostate conditions Gamma-glutamyl transpeptidase (GGT) â€“ hepatobiliary dysfunction LDH, CK, AST â€“ used as diagnostic markers&lt;/li&gt;&lt;li&gt;â€¢ These do not perform any physiological function in plasma .&lt;/li&gt;&lt;li&gt;â€¢ do not perform any physiological function in plasma&lt;/li&gt;&lt;li&gt;â€¢ Their presence in serum is typically due to cell damage or turnover .&lt;/li&gt;&lt;li&gt;â€¢ cell damage or turnover&lt;/li&gt;&lt;li&gt;â€¢ Elevated levels help identify tissue injury or disease .&lt;/li&gt;&lt;li&gt;â€¢ tissue injury or disease&lt;/li&gt;&lt;li&gt;â€¢ Examples: Alkaline phosphatase (ALP) â€“ bone and liver disorders Acid phosphatase â€“ prostate conditions Gamma-glutamyl transpeptidase (GGT) â€“ hepatobiliary dysfunction LDH, CK, AST â€“ used as diagnostic markers&lt;/li&gt;&lt;li&gt;â€¢ Examples:&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP) â€“ bone and liver disorders Acid phosphatase â€“ prostate conditions Gamma-glutamyl transpeptidase (GGT) â€“ hepatobiliary dysfunction LDH, CK, AST â€“ used as diagnostic markers&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP) â€“ bone and liver disorders&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP)&lt;/li&gt;&lt;li&gt;â€¢ Acid phosphatase â€“ prostate conditions&lt;/li&gt;&lt;li&gt;â€¢ Acid phosphatase&lt;/li&gt;&lt;li&gt;â€¢ Gamma-glutamyl transpeptidase (GGT) â€“ hepatobiliary dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Gamma-glutamyl transpeptidase (GGT)&lt;/li&gt;&lt;li&gt;â€¢ LDH, CK, AST â€“ used as diagnostic markers&lt;/li&gt;&lt;li&gt;â€¢ LDH, CK, AST&lt;/li&gt;&lt;li&gt;â€¢ Functional (plasma active) enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Functional (plasma active) enzymes:&lt;/li&gt;&lt;li&gt;â€¢ These perform essential metabolic functions within the circulation . They are actively secreted into plasma to carry out physiological roles .&lt;/li&gt;&lt;li&gt;â€¢ These perform essential metabolic functions within the circulation .&lt;/li&gt;&lt;li&gt;â€¢ essential metabolic functions&lt;/li&gt;&lt;li&gt;â€¢ within the circulation&lt;/li&gt;&lt;li&gt;â€¢ They are actively secreted into plasma to carry out physiological roles .&lt;/li&gt;&lt;li&gt;â€¢ actively secreted into plasma&lt;/li&gt;&lt;li&gt;â€¢ physiological roles&lt;/li&gt;&lt;li&gt;â€¢ Lipoprotein lipase (LPL) is a classic functional enzyme :&lt;/li&gt;&lt;li&gt;â€¢ Lipoprotein lipase (LPL)&lt;/li&gt;&lt;li&gt;â€¢ functional enzyme&lt;/li&gt;&lt;li&gt;â€¢ It hydrolyzes triglycerides in chylomicrons and VLDL into free fatty acids and glycerol. Plays a critical role in lipid metabolism and energy distribution .&lt;/li&gt;&lt;li&gt;â€¢ It hydrolyzes triglycerides in chylomicrons and VLDL into free fatty acids and glycerol.&lt;/li&gt;&lt;li&gt;â€¢ hydrolyzes triglycerides&lt;/li&gt;&lt;li&gt;â€¢ chylomicrons and VLDL&lt;/li&gt;&lt;li&gt;â€¢ free fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Plays a critical role in lipid metabolism and energy distribution .&lt;/li&gt;&lt;li&gt;â€¢ critical role in lipid metabolism and energy distribution&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP) â†’ Non-functional enzyme; diagnostic marker for bone and hepatobiliary diseases . Acid phosphatase â†’ Non-functional; historically used to detect prostate cancer . Gamma-glutamyl transpeptidase (GGT) â†’ Non-functional; useful in assessing alcoholic liver disease and cholestasis .&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP) â†’ Non-functional enzyme; diagnostic marker for bone and hepatobiliary diseases .&lt;/li&gt;&lt;li&gt;â€¢ Alkaline phosphatase (ALP)&lt;/li&gt;&lt;li&gt;â€¢ bone and hepatobiliary diseases&lt;/li&gt;&lt;li&gt;â€¢ Acid phosphatase â†’ Non-functional; historically used to detect prostate cancer .&lt;/li&gt;&lt;li&gt;â€¢ Acid phosphatase&lt;/li&gt;&lt;li&gt;â€¢ prostate cancer&lt;/li&gt;&lt;li&gt;â€¢ Gamma-glutamyl transpeptidase (GGT) â†’ Non-functional; useful in assessing alcoholic liver disease and cholestasis .&lt;/li&gt;&lt;li&gt;â€¢ Gamma-glutamyl transpeptidase (GGT)&lt;/li&gt;&lt;li&gt;â€¢ alcoholic liver disease and cholestasis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein lipase is a functional plasma enzyme , directly involved in lipid metabolism . In contrast, non-functional enzymes like ALP, ACP, GGT do not have roles in the plasma but serve as important clinical markers of tissue damage .&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein lipase is a functional plasma enzyme , directly involved in lipid metabolism .&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein lipase&lt;/li&gt;&lt;li&gt;âž¤ functional plasma enzyme&lt;/li&gt;&lt;li&gt;âž¤ lipid metabolism&lt;/li&gt;&lt;li&gt;âž¤ In contrast, non-functional enzymes like ALP, ACP, GGT do not have roles in the plasma but serve as important clinical markers of tissue damage .&lt;/li&gt;&lt;li&gt;âž¤ non-functional enzymes&lt;/li&gt;&lt;li&gt;âž¤ ALP, ACP, GGT&lt;/li&gt;&lt;li&gt;âž¤ not have roles in the plasma&lt;/li&gt;&lt;li&gt;âž¤ clinical markers of tissue damage&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 301.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately describes the function or characteristic of a particular class of enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lyases link two substrates together with the simultaneous hydrolysis of ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The reaction Hexose + ATP â†’ Hexose-6-phosphate + ADP would be an example of transferases.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;No loss of enzymatic activity on heating&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrolases remove one group from the substrate producing a double bond&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The reaction Hexose + ATP â†’ Hexose-6-phosphate + ADP would be an example of transferases.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lyases : Enzymes that catalyse cleavage of C-C, C-O, C-N and other covalent bonds by atom elimination, generating double bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lyases&lt;/li&gt;&lt;li&gt;â€¢ cleavage of C-C, C-O, C-N&lt;/li&gt;&lt;li&gt;â€¢ Option C. When temperature &amp;gt;&amp;gt; 50Â°C it leads to heat denaturation and loss of tertiary structure of protein. A ctivity of the enzyme is decreased .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ 50Â°C it leads to heat denaturation&lt;/li&gt;&lt;li&gt;â€¢ ctivity of the enzyme is decreased&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrolases : Enzymes that catalyse hydrolytic cleavage of C-C, C-O, C-N and other covalent bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hydrolases&lt;/li&gt;&lt;li&gt;â€¢ hydrolytic cleavage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transferases are enzymes that catalyze the transfer of a functional group from one molecule to another . The reaction described, where a phosphate group is transferred from ATP to a hexose molecule to form hexose-6-phosphate and ADP, is a classic example of a transferase enzyme in action . This type of reaction is fundamental in metabolic pathways, including glycolysis.&lt;/li&gt;&lt;li&gt;âž¤ Transferases&lt;/li&gt;&lt;li&gt;âž¤ enzymes that catalyze the transfer&lt;/li&gt;&lt;li&gt;âž¤ functional group&lt;/li&gt;&lt;li&gt;âž¤ one molecule to another&lt;/li&gt;&lt;li&gt;âž¤ reaction&lt;/li&gt;&lt;li&gt;âž¤ phosphate group is transferred&lt;/li&gt;&lt;li&gt;âž¤ ATP to a hexose molecule&lt;/li&gt;&lt;li&gt;âž¤ form hexose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ ADP,&lt;/li&gt;&lt;li&gt;âž¤ transferase enzyme in action&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 49.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 49.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately describes a key aspect of the active site of an enzyme?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It forms the half of the potion of enzyme&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It binds with substrate by non-covalent bonds&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is not usually a cleft or crevices&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Binding of substrate to the site is independent of the alignment of specific groups.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It binds with substrate by non-covalent bonds&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/30/picture1_OiprOK2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. It forms half of the portion of the enzyme: This statement is inaccurate . The active site usually comprises only a small portion of the enzyme&#x27;s total volume , specifically tailored for substrate binding and catalysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It forms half of the portion of the enzyme:&lt;/li&gt;&lt;li&gt;â€¢ inaccurate&lt;/li&gt;&lt;li&gt;â€¢ active site&lt;/li&gt;&lt;li&gt;â€¢ small portion of the enzyme&#x27;s total volume&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is not usually a cleft or crevice: Contrary to this statement, the active site is often a cleft or crevice on the enzyme&#x27;s surface . This structural feature allows the active site to accommodate the substrate molecule (s) and exclude water , which is crucial for many enzymatic reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. It is not usually a cleft or crevice:&lt;/li&gt;&lt;li&gt;â€¢ active site&lt;/li&gt;&lt;li&gt;â€¢ cleft or crevice on the enzyme&#x27;s surface&lt;/li&gt;&lt;li&gt;â€¢ structural feature&lt;/li&gt;&lt;li&gt;â€¢ active site to accommodate the substrate molecule&lt;/li&gt;&lt;li&gt;â€¢ exclude water&lt;/li&gt;&lt;li&gt;â€¢ Option D. Binding of the substrate to the site is independent of the alignment of specific groups: This statement is incorrect. The binding of the substrate to the active site is highly dependent on the precise alignment and orientation of specific amino acid residues and functional groups within the active site . This specificity ensures that only particular substrates can bind and be catalytically transformed by the enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Binding of the substrate to the site is independent of the alignment of specific groups:&lt;/li&gt;&lt;li&gt;â€¢ binding&lt;/li&gt;&lt;li&gt;â€¢ substrate to the active site&lt;/li&gt;&lt;li&gt;â€¢ precise alignment&lt;/li&gt;&lt;li&gt;â€¢ orientation&lt;/li&gt;&lt;li&gt;â€¢ amino acid residues&lt;/li&gt;&lt;li&gt;â€¢ functional groups within the active site&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The region of the enzyme where substrate binding and catalysis takes place is known as active site or active centre and it contains substrate binding site and catalytic site. Though all parts are required for maintaining the three-dimensional structure of the enzyme, the reaction is taking place at the active site and it occupies only a small portion of the whole enzyme. Active site is situated in a crevice or cleft of the enzyme molecule. To the active site, substrate is bound and the binding depends on the alignment of specific groups or atoms at active site and these groups realign themselves to provide the unique conformational orientation so as to promote exact fitting of substrate to the active site. The substrate binds to the enzyme at the active site by noncovalent bonds and are hydrophobic in nature. The amino acids or groups which directly participate in making or breaking the bonds (present at the active site) are known as catalytic residues or catalytic groups.&lt;/li&gt;&lt;li&gt;âž¤ The region of the enzyme where substrate binding and catalysis takes place is known as active site or active centre and it contains substrate binding site and catalytic site.&lt;/li&gt;&lt;li&gt;âž¤ region of the enzyme&lt;/li&gt;&lt;li&gt;âž¤ substrate binding&lt;/li&gt;&lt;li&gt;âž¤ catalysis takes place&lt;/li&gt;&lt;li&gt;âž¤ active site or active centre&lt;/li&gt;&lt;li&gt;âž¤ Though all parts are required for maintaining the three-dimensional structure of the enzyme, the reaction is taking place at the active site and it occupies only a small portion of the whole enzyme.&lt;/li&gt;&lt;li&gt;âž¤ three-dimensional structure&lt;/li&gt;&lt;li&gt;âž¤ Active site is situated in a crevice or cleft of the enzyme molecule.&lt;/li&gt;&lt;li&gt;âž¤ crevice or cleft of the enzyme&lt;/li&gt;&lt;li&gt;âž¤ To the active site, substrate is bound and the binding depends on the alignment of specific groups or atoms at active site and these groups realign themselves to provide the unique conformational orientation so as to promote exact fitting of substrate to the active site.&lt;/li&gt;&lt;li&gt;âž¤ depends on the alignment of specific groups&lt;/li&gt;&lt;li&gt;âž¤ The substrate binds to the enzyme at the active site by noncovalent bonds and are hydrophobic in nature.&lt;/li&gt;&lt;li&gt;âž¤ noncovalent bonds&lt;/li&gt;&lt;li&gt;âž¤ The amino acids or groups which directly participate in making or breaking the bonds (present at the active site) are known as catalytic residues or catalytic groups.&lt;/li&gt;&lt;li&gt;âž¤ amino acids or groups&lt;/li&gt;&lt;li&gt;âž¤ directly participate&lt;/li&gt;&lt;li&gt;âž¤ making or breaking the bonds&lt;/li&gt;&lt;li&gt;âž¤ catalytic residues&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 55.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 55.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old researcher is conducting a study on the catalytic rates of various enzymes in metabolic pathways. She is comparing the activities of different enzymes under standardized conditions and intends to express these activities in a uniform manner to facilitate comparison. She recalls that there is an SI unit for expressing enzyme activity, but she is momentarily uncertain of its name. Which of the following is the correct SI unit for expressing enzyme activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Micromoles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Katals&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Units&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Moles per second&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Katals&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Katals&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Micromoles: This is a measure of the amount of substance , not the rate of enzymatic activity. While enzyme activities can result in the conversion of substrates measured in micromoles, this is not a unit of enzyme activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Micromoles:&lt;/li&gt;&lt;li&gt;â€¢ measure&lt;/li&gt;&lt;li&gt;â€¢ amount of substance&lt;/li&gt;&lt;li&gt;â€¢ Option C. Units: This term is often used in biochemistry , but it is not a standardized SI unit . One unit (U) is traditionally defined as the amount of enzyme that catalyzes the conversion of 1 micromole of substrate per minute, but it lacks the universal applicability and consistency of katals.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Units:&lt;/li&gt;&lt;li&gt;â€¢ used in biochemistry&lt;/li&gt;&lt;li&gt;â€¢ not a standardized SI unit&lt;/li&gt;&lt;li&gt;â€¢ Option D. Moles per second: While this could theoretically be used to describe enzyme activity , it is not the standard SI unit for this purpose. The katal is specifically defined as moles per second, making it the preferred and standardized term.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Moles per second:&lt;/li&gt;&lt;li&gt;â€¢ describe enzyme activity&lt;/li&gt;&lt;li&gt;â€¢ not the standard SI unit&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Catalytic efficiency is expressed as the ratio of Kcat divided by Km , by what measure should the efficiency of different enzymes , different substrates for a given enzyme, and the efficiency with which an enzyme catalyzes a reaction in the forward and reverse directions be quantified and compared.&lt;/li&gt;&lt;li&gt;âž¤ Catalytic efficiency&lt;/li&gt;&lt;li&gt;âž¤ the ratio of Kcat divided by Km&lt;/li&gt;&lt;li&gt;âž¤ efficiency of different enzymes&lt;/li&gt;&lt;li&gt;âž¤ different substrates&lt;/li&gt;&lt;li&gt;âž¤ efficiency&lt;/li&gt;&lt;li&gt;âž¤ enzyme catalyzes&lt;/li&gt;&lt;li&gt;âž¤ reaction&lt;/li&gt;&lt;li&gt;âž¤ forward and reverse directions&lt;/li&gt;&lt;li&gt;âž¤ Enzyme activity is expressed as micromoles of substrate converted to product per minute under specified assay conditions. One standard unit (or International Unit) of enzyme activity (U) : amount of enzyme that will convert one micromole of substrate per minute per litre of sample and is abbreviated as U/L The modern method of expression of enzyme activity is in Katals (kat). One Katal (catalytic activity) is defined as the number of mol of substrate transformed per second per litre of sample (Kcat = Vmax divided by the number of active sites).&lt;/li&gt;&lt;li&gt;âž¤ Enzyme activity is expressed as micromoles of substrate converted to product per minute under specified assay conditions.&lt;/li&gt;&lt;li&gt;âž¤ Enzyme activity&lt;/li&gt;&lt;li&gt;âž¤ expressed as micromoles&lt;/li&gt;&lt;li&gt;âž¤ substrate converted to product per minute&lt;/li&gt;&lt;li&gt;âž¤ One standard unit (or International Unit) of enzyme activity (U) : amount of enzyme that will convert one micromole of substrate per minute per litre of sample and is abbreviated as U/L&lt;/li&gt;&lt;li&gt;âž¤ One standard unit (or International Unit) of enzyme activity (U)&lt;/li&gt;&lt;li&gt;âž¤ The modern method of expression of enzyme activity is in Katals (kat).&lt;/li&gt;&lt;li&gt;âž¤ modern method&lt;/li&gt;&lt;li&gt;âž¤ One Katal (catalytic activity) is defined as the number of mol of substrate transformed per second per litre of sample (Kcat = Vmax divided by the number of active sites).&lt;/li&gt;&lt;li&gt;âž¤ One Katal (catalytic activity)&lt;/li&gt;&lt;li&gt;âž¤ number of mol of substrate transformed&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 80, Lippincott 7/e: P 54.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 80, Lippincott 7/e: P 54.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following enzymes is known to have Zinc as a cofactor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbonic anhydrase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphofructokinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose 6 Phosphatase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Carbonic anhydrase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-110904.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B Phosphofructokinase: This enzyme is a key regulatory enzyme in the glycolytic pathway but does not require Zinc as a cofactor. Instead, it is allosterically regulated by various other metabolites and ions.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B Phosphofructokinase:&lt;/li&gt;&lt;li&gt;â€¢ key regulatory enzyme&lt;/li&gt;&lt;li&gt;â€¢ glycolytic pathway&lt;/li&gt;&lt;li&gt;â€¢ Option C Mutase: Mutases are a group of enzymes that catalyze the shifting of a functional group from one position to another within the same molecule. While some mutases do require metal ions as cofactors, they are not typically known for requiring Zinc.&lt;/li&gt;&lt;li&gt;â€¢ Option C Mutase:&lt;/li&gt;&lt;li&gt;â€¢ group of enzymes that catalyze the shifting of a functional group from one position to another&lt;/li&gt;&lt;li&gt;â€¢ Option D Glucose 6-Phosphatase: This enzyme is involved in the final step of gluconeogenesis and glycogenolysis . It does not require Zinc as a cofactor for its activity.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D Glucose 6-Phosphatase:&lt;/li&gt;&lt;li&gt;â€¢ final step of gluconeogenesis&lt;/li&gt;&lt;li&gt;â€¢ glycogenolysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metal as Cofactors and Prosthetic Group&lt;/li&gt;&lt;li&gt;âž¤ Metal as Cofactors and Prosthetic Group&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 62&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 62&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;â€œAs we Increase Temperature initially velocity of an enzymatic reaction increases after a particular temperature velocity of enzymatic reaction decreasesâ€. Is this statement true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Data insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture3_SgGswb9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. True&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denaturation disrupts the enzyme&#x27;s three-dimensional structure, essential for its catalytic activity, ultimately resulting in a decrease in reaction velocity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 57&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a groundbreaking study on enzyme diversity, scientists have discovered several enzymes within the same metabolic pathway that, despite differing structurally, perform identical functions across various tissues. This finding prompts a discussion on the classification of these enzymes. Which term accurately describes enzymes with different structures but the same catalytic function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allosteric enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isoenzymes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coenzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Apoenzymes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Isoenzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric enzymes : These are enzymes whose activity can be modulated by the binding of an effector molecule at a site other than the active site (allosteric site). The term \&quot;allosteric\&quot; does not imply that the enzymes have identical functions but different structures.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Allosteric enzymes&lt;/li&gt;&lt;li&gt;â€¢ enzymes whose activity&lt;/li&gt;&lt;li&gt;â€¢ modulated by the binding&lt;/li&gt;&lt;li&gt;â€¢ effector molecule&lt;/li&gt;&lt;li&gt;â€¢ site other than the active site&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coenzymes : Coenzymes are small, non-protein organic molecules that bind to enzymes and are required for their catalytic activity. They are not enzymes themselves and therefore cannot be classified as having the same catalytic function or different structures.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coenzymes&lt;/li&gt;&lt;li&gt;â€¢ small, non-protein organic molecules&lt;/li&gt;&lt;li&gt;â€¢ bind to enzymes&lt;/li&gt;&lt;li&gt;â€¢ required for their catalytic activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Apoenzymes : An apoenzyme is the protein component of an enzyme, excluding any cofactors or prosthetic groups . It becomes an active enzyme (holoenzyme) upon binding with its cofactor. This term does not describe enzymes with different structures but identical functions.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Apoenzymes&lt;/li&gt;&lt;li&gt;â€¢ apoenzyme&lt;/li&gt;&lt;li&gt;â€¢ protein component of an enzyme,&lt;/li&gt;&lt;li&gt;â€¢ excluding&lt;/li&gt;&lt;li&gt;â€¢ cofactors or prosthetic groups&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ISOENZYMES:&lt;/li&gt;&lt;li&gt;âž¤ ISOENZYMES:&lt;/li&gt;&lt;li&gt;âž¤ Different molecular forms of the same enzyme synthesized in various tissues are called isoenzymes. If the subunits are all the same , the protein is a homomultimer represented by a single gene. If the s ubunits are different, the protein is a heteromultimer , produced by different genes. They may be products of different genes (more than one locus) known as true isoenzymes . The genes may be located on different chromosome s, e.g. salivary and pancreatic amylase. In certain cases, all the different forms are present in the same individual, e.g. lactate dehydrogenase (LDH) has 5 isoenzymes and all are seen in all persons in the population.&lt;/li&gt;&lt;li&gt;âž¤ Different molecular forms of the same enzyme synthesized in various tissues are called isoenzymes.&lt;/li&gt;&lt;li&gt;âž¤ Different molecular forms&lt;/li&gt;&lt;li&gt;âž¤ same enzyme synthesized&lt;/li&gt;&lt;li&gt;âž¤ isoenzymes.&lt;/li&gt;&lt;li&gt;âž¤ If the subunits are all the same , the protein is a homomultimer represented by a single gene.&lt;/li&gt;&lt;li&gt;âž¤ subunits are all the same&lt;/li&gt;&lt;li&gt;âž¤ homomultimer&lt;/li&gt;&lt;li&gt;âž¤ single gene.&lt;/li&gt;&lt;li&gt;âž¤ If the s ubunits are different, the protein is a heteromultimer , produced by different genes.&lt;/li&gt;&lt;li&gt;âž¤ ubunits are different,&lt;/li&gt;&lt;li&gt;âž¤ heteromultimer&lt;/li&gt;&lt;li&gt;âž¤ different genes.&lt;/li&gt;&lt;li&gt;âž¤ They may be products of different genes (more than one locus) known as true isoenzymes .&lt;/li&gt;&lt;li&gt;âž¤ products of different genes&lt;/li&gt;&lt;li&gt;âž¤ true isoenzymes&lt;/li&gt;&lt;li&gt;âž¤ The genes may be located on different chromosome s, e.g. salivary and pancreatic amylase.&lt;/li&gt;&lt;li&gt;âž¤ genes may be located on different chromosome&lt;/li&gt;&lt;li&gt;âž¤ In certain cases, all the different forms are present in the same individual, e.g. lactate dehydrogenase (LDH) has 5 isoenzymes and all are seen in all persons in the population.&lt;/li&gt;&lt;li&gt;âž¤ lactate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 66, 67.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 66, 67.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a biochemistry class focusing on enzyme-catalyzed reactions, the professor discusses the role of coenzymes in facilitating various biochemical processes. One topic of interest is the carboxylation reactions, where a specific coenzyme is crucial for the transfer of carbon dioxide. Which coenzyme is known to be essential for carboxylation reactions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Biotin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Niacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyridoxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Riboflavin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Biotin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-163157.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Niacin: Dehydrogenation , oxidized in ETC (2.5 ATP), reductive biosynthetic reactions and hydroxylation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Niacin:&lt;/li&gt;&lt;li&gt;â€¢ Dehydrogenation&lt;/li&gt;&lt;li&gt;â€¢ reductive biosynthetic reactions&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyridoxine: is involved in Transamination , decarboxylation reactions, metabolism of Sulfur Containing Amino Acids etc.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pyridoxine:&lt;/li&gt;&lt;li&gt;â€¢ Transamination&lt;/li&gt;&lt;li&gt;â€¢ decarboxylation reactions,&lt;/li&gt;&lt;li&gt;â€¢ Option D. Riboflavin: Dehydrogenation, oxidized in ETC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Riboflavin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biotin acts as a coenzyme for carboxylase enzymes, which catalyze carboxylation reactions involving the transfer of carbon dioxide to specific substrates. Biotin&#x27;s role in these reactions is pivotal, as it temporarily binds to CO2, facilitating its transfer to the substrate.&lt;/li&gt;&lt;li&gt;âž¤ Biotin&lt;/li&gt;&lt;li&gt;âž¤ coenzyme for carboxylase enzymes,&lt;/li&gt;&lt;li&gt;âž¤ catalyze carboxylation reactions&lt;/li&gt;&lt;li&gt;âž¤ transfer of carbon dioxide&lt;/li&gt;&lt;li&gt;âž¤ specific substrates.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 50, 486.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 50, 486.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MATCH the following enzymes and its allosteric inhibitor:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-c, 2-b, 3-a, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1-b, 2-a, 3-d, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-163859.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-164621.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/screenshot-2024-04-01-164745.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Phosphofructokinase, a key regulatory enzyme in glycolysis, is allosterically inhibited by ATP, reflecting the cell&#x27;s energy status. ALA synthase , involved in the synthesis of porphyrins, is inhibited by heme , its end product, to regulate heme synthesis. Aspartate transcarbamoylase, a crucial enzyme in pyrimidine nucleotide synthesis , is inhibited by CTP, demonstrating feedback inhibition. HMG CoA-reductase , pivotal in cholesterol biosynthesis , is regulated through feedback inhibition by cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Phosphofructokinase, a key regulatory enzyme in glycolysis, is allosterically inhibited by ATP, reflecting the cell&#x27;s energy status.&lt;/li&gt;&lt;li&gt;â€¢ Phosphofructokinase,&lt;/li&gt;&lt;li&gt;â€¢ key regulatory enzyme&lt;/li&gt;&lt;li&gt;â€¢ glycolysis,&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase , involved in the synthesis of porphyrins, is inhibited by heme , its end product, to regulate heme synthesis.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase&lt;/li&gt;&lt;li&gt;â€¢ synthesis of porphyrins,&lt;/li&gt;&lt;li&gt;â€¢ inhibited by heme&lt;/li&gt;&lt;li&gt;â€¢ Aspartate transcarbamoylase, a crucial enzyme in pyrimidine nucleotide synthesis , is inhibited by CTP, demonstrating feedback inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Aspartate transcarbamoylase,&lt;/li&gt;&lt;li&gt;â€¢ crucial enzyme in pyrimidine nucleotide synthesis&lt;/li&gt;&lt;li&gt;â€¢ inhibited by CTP,&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA-reductase , pivotal in cholesterol biosynthesis , is regulated through feedback inhibition by cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA-reductase&lt;/li&gt;&lt;li&gt;â€¢ cholesterol biosynthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 63.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 63.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35 year old man complains of fatigue and abdominal pain. O/E: Hepatomegaly + Laboratory results: Serum AST â€“ 125 U/L, ALT â€“ 82 U/L, ALP â€“ 66 U/L, GGTâ€“ 170 U/L, Bilirubin â€“ 1.0 mg/dL, glucose â€“ 62 mg/dL, Uric acid â€“ 8.0 mg/dL, CBC and urinalysis were normal. Which of the following markers help in monitoring alcoholism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamate hydrolase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbohydrate Deficient Transferrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Carbohydrate Deficient Transferrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactate dehydrogenase : While LDH levels can be elevated in liver disease , they are not specific for alcohol-related liver damage and can be elevated in a variety of conditions affecting the liver and other tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lactate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ LDH levels&lt;/li&gt;&lt;li&gt;â€¢ elevated in liver disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamate hydrolase : Glutamate hydrolase (also known as glutaminase) is not a standard marker for alcoholism and is not typically used in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Glutamate hydrolase&lt;/li&gt;&lt;li&gt;â€¢ not a standard marker for alcoholism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbohydrate Deficient Transferrin (CDT) is a specific biomarker for chronic alcohol consumption . Elevated levels of CDT in the blood can indicate excessive alcohol intake over a prolonged period . Unlike other liver function tests, CDT is less likely to be elevated due to non-alcohol-related liver diseases and thus serves as a more specific indicator of alcoholism.&lt;/li&gt;&lt;li&gt;âž¤ Carbohydrate Deficient Transferrin&lt;/li&gt;&lt;li&gt;âž¤ specific biomarker&lt;/li&gt;&lt;li&gt;âž¤ chronic alcohol consumption&lt;/li&gt;&lt;li&gt;âž¤ Elevated levels&lt;/li&gt;&lt;li&gt;âž¤ CDT in the blood&lt;/li&gt;&lt;li&gt;âž¤ excessive alcohol intake&lt;/li&gt;&lt;li&gt;âž¤ prolonged period&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 141.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 141.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old biochemistry graduate student is presenting her findings on enzyme kinetics at a regional conference. She displays a Lineweaver-Burk plot as part of her presentation, highlighting the utility of this type of graph in determining enzyme kinetics constants. She points out the x-intercept and asks her audience to identify what this value corresponds to in terms of Michaelis-Menten kinetics. Which of the following is equal to the x-intercept in a Lineweaver-Burk plot?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Km&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;-1/Km&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Km/Vmax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1/Vmax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. -1/Km&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture-2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Kmâ€‹: This is incorrect because Kmâ€‹ itself is not represented by the x-intercept ; rather, its negative reciprocal is.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Kmâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ Kmâ€‹&lt;/li&gt;&lt;li&gt;â€¢ not represented by the x-intercept&lt;/li&gt;&lt;li&gt;â€¢ Option C. Kmâ€‹/Vmaxâ€‹: This option is incorrect. While both Kmâ€‹ and Vmaxâ€‹ are parameters of the Michaelis-Menten equation , the ratio Kmâ€‹/Vmaxâ€‹ is not represented by the x-intercept in a Lineweaver-Burk plot.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Kmâ€‹/Vmaxâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ Kmâ€‹ and Vmaxâ€‹ are parameters&lt;/li&gt;&lt;li&gt;â€¢ Michaelis-Menten equation&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1/Vmaxâ€‹: This is incorrect because the y-intercept represents 1/Vmax â€‹, not the x-intercept.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. 1/Vmaxâ€‹:&lt;/li&gt;&lt;li&gt;â€¢ y-intercept represents 1/Vmax&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ With â€œDouble Reciprocal Plotâ€ sometimes it is difficult to achieve high substrate concentrations to reach the maximal velocity conditions . So, Â½ Vmax or Km is difficult to determine thus experimental data at lower concentrations is plotted as reciprocals a straight line is obtained when extrapolated to get the reciprocal of Km . This is called Lineweaver Burk Plot or Double Reciprocal Plot which can be derived from the Michaelis-Menten equation. If we plot 1/v against 1/[S], it will give a straight-line graph. X intercept is (-1/Km), from which the Km can be calculated.&lt;/li&gt;&lt;li&gt;âž¤ With â€œDouble Reciprocal Plotâ€ sometimes it is difficult to achieve high substrate concentrations to reach the maximal velocity conditions .&lt;/li&gt;&lt;li&gt;âž¤ â€œDouble Reciprocal Plotâ€&lt;/li&gt;&lt;li&gt;âž¤ difficult to achieve high substrate concentrations&lt;/li&gt;&lt;li&gt;âž¤ maximal velocity conditions&lt;/li&gt;&lt;li&gt;âž¤ So, Â½ Vmax or Km is difficult to determine thus experimental data at lower concentrations is plotted as reciprocals a straight line is obtained when extrapolated to get the reciprocal of Km . This is called Lineweaver Burk Plot or Double Reciprocal Plot which can be derived from the Michaelis-Menten equation.&lt;/li&gt;&lt;li&gt;âž¤ Â½ Vmax&lt;/li&gt;&lt;li&gt;âž¤ Km is difficult&lt;/li&gt;&lt;li&gt;âž¤ experimental data at lower concentrations&lt;/li&gt;&lt;li&gt;âž¤ reciprocals a straight line&lt;/li&gt;&lt;li&gt;âž¤ extrapolated to get the reciprocal of Km&lt;/li&gt;&lt;li&gt;âž¤ Lineweaver Burk Plot&lt;/li&gt;&lt;li&gt;âž¤ If we plot 1/v against 1/[S], it will give a straight-line graph. X intercept is (-1/Km), from which the Km can be calculated.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 80, Vasudevan 9/ed: p 57.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 80, Vasudevan 9/ed: p 57.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an enzyme kinetics experiment, a substrate concentration 1000 times the Km value resulted in the conversion of 1% of the substrate into 12 Âµmol of product in 9 minutes with a certain enzyme amount. In a modified experiment, one-third of the initial enzyme amount is used with double the initial substrate concentration. How long would it take to produce the same amount (12 Âµmol) of product in the modified experiment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;27 minutes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;18 minutes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;9 minutes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3 minutes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 27 minutes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The reaction rate at or near Vmax is less affected by substrate concentration and more by enzyme concentration . Reducing enzyme to one-third decreases the rate to one-third , extending production time for 12 Âµmol of product to 27 minutes.&lt;/li&gt;&lt;li&gt;âž¤ reaction rate at&lt;/li&gt;&lt;li&gt;âž¤ near Vmax&lt;/li&gt;&lt;li&gt;âž¤ less affected by substrate concentration&lt;/li&gt;&lt;li&gt;âž¤ more by enzyme concentration&lt;/li&gt;&lt;li&gt;âž¤ Reducing enzyme&lt;/li&gt;&lt;li&gt;âž¤ one-third decreases the rate&lt;/li&gt;&lt;li&gt;âž¤ one-third&lt;/li&gt;&lt;li&gt;âž¤ production time for 12 Âµmol of product&lt;/li&gt;&lt;li&gt;âž¤ 27 minutes.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 76-79.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 76-79.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old chronic smoker for the past 20 years presents with chest tightness and pain on the left upper limb for the past 14 hours. He is known hypertensive on regular antihypertensive medications and not a diabetic. ECG shows significant ST segment elevation in I, II and V1 to V6 leads. Laboratory investigations: Troponin T = 144 ng/ml (normal = &amp;lt;5 ng/ml) Troponin I = 250 ng/ml (normal = &amp;lt;0.04 ng/ml) CPK-Total = 2100 IU/L (normal = 40-300 IU/L) CPK-MB = 350 IU/L (normal = 5-25 IU/L) LDH = 343 IU/L (normal = 140-280 IU/L) AST = 745 IU/L (normal = 15-45 IU/L) Angiography revealed 96% block in the proximal portion of left anterior descending (LAD) artery. Which troponin is better for detection of MI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Troponin T&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Troponin I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Troponin C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Troponin I&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture30.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture0003.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum Troponin T (TnT) increases within 6 hrs of MI â†’ peaks at 72 hours â†’ remains elevated up to 10â€“14 days .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Troponin T&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ 6 hrs of MI&lt;/li&gt;&lt;li&gt;â€¢ peaks at 72 hours&lt;/li&gt;&lt;li&gt;â€¢ elevated up to 10â€“14 days&lt;/li&gt;&lt;li&gt;â€¢ Option C. Elevated cTn levels seen in acute coronary syndrome (ACS), stroke , pulmonary embolism , sepsis , acute perimyocarditis , acute heart failure and tachycardia . High sensitive TnT (hsTnT) has been developed, which detects even very low cTn concentrations.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Elevated cTn&lt;/li&gt;&lt;li&gt;â€¢ acute coronary syndrome&lt;/li&gt;&lt;li&gt;â€¢ stroke&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ sepsis&lt;/li&gt;&lt;li&gt;â€¢ acute perimyocarditis&lt;/li&gt;&lt;li&gt;â€¢ acute heart failure&lt;/li&gt;&lt;li&gt;â€¢ tachycardia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Both Troponin T and Troponin I are cardiac-specific isoforms that are highly sensitive and specific for myocardial injury and are used as primary biomarkers for the diagnosis of MI . However, Troponin I is often preferred due to its higher specificity to cardiac tissue . There are several isoforms of Troponin I that are specific to cardiac muscle, and assays for Troponin I are designed to detect these specific forms, minimizing cross-reactivity with skeletal muscle.&lt;/li&gt;&lt;li&gt;âž¤ Both Troponin T&lt;/li&gt;&lt;li&gt;âž¤ Troponin I&lt;/li&gt;&lt;li&gt;âž¤ cardiac-specific isoforms&lt;/li&gt;&lt;li&gt;âž¤ highly sensitive&lt;/li&gt;&lt;li&gt;âž¤ specific for myocardial injury&lt;/li&gt;&lt;li&gt;âž¤ primary biomarkers&lt;/li&gt;&lt;li&gt;âž¤ diagnosis of MI&lt;/li&gt;&lt;li&gt;âž¤ Troponin I&lt;/li&gt;&lt;li&gt;âž¤ higher specificity to cardiac tissue&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 303.&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 303.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 100 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test6" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Genetics   Molecular Biology&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Genetics   Molecular Biology&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                158 Questions | 632 Total Marks | 168 min Duration | ~63.8 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A researcher is analyzing a segment of double-stranded DNA as part of an experiment to understand gene expression in a particular type of cancer. The researcher finds that in this DNA segment, thymine makes up 28% of the nucleotides. Based on this information, what is the percentage of guanine in this DNA segment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;26%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;44%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;56%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;22%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 22%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 22%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations:&lt;/li&gt;&lt;li&gt;â€¢ Option A . 26%: False&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Option B . 44%: Guanine + Cytosine = 44% (Guanine alone =22%)&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C. 56%: Adenine + Thymine = 28 + 28 = 56%&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chargaff&#x27;s rules emphasize the importance of recognizing that in double-stranded DNA , the percentages of adenine and thymine are equal , as are the percentages of cytosine and guanine .&lt;/li&gt;&lt;li&gt;âž¤ Chargaff&#x27;s rules&lt;/li&gt;&lt;li&gt;âž¤ importance of recognizing&lt;/li&gt;&lt;li&gt;âž¤ double-stranded DNA&lt;/li&gt;&lt;li&gt;âž¤ percentages of adenine&lt;/li&gt;&lt;li&gt;âž¤ thymine are equal&lt;/li&gt;&lt;li&gt;âž¤ percentages of cytosine&lt;/li&gt;&lt;li&gt;âž¤ guanine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 360; Lippincott 7/e: P 397.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 360; Lippincott 7/e: P 397.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A genetics educator is presenting a lecture on mitochondrial DNA (mtDNA) to provide students with a comprehensive understanding of its characteristics and inheritance patterns. The educator provides several statements about mtDNA and asks the students to identify which one is inaccurate. Which of the following statements about mitochondrial DNA is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contains 37 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transmitted from mother to offspring&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cause Leber hereditary optic neuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transmitted in classical Mendelian fashion&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Transmitted in classical Mendelian fashion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-155701.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Transmitted in classical Mendelian fashion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contains 37 genes : This is true . Human mitochondrial DNA contains 37 genes, encoding 13 proteins, 22 tRNAs, and 2 rRNAs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contains 37 genes&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transmitted from mother to offspring: This is true. Mitochondrial DNA is passed down from mothers to all of their children, both male and female.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transmitted from mother to offspring:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Causes Leber hereditary optic neuropathy : This is true . Mutations in mitochondrial DNA can cause Leber hereditary optic neuropathy, a condition that leads to vision loss.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Causes Leber hereditary optic neuropathy&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 378.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 378.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pediatric clinic in New Delhi, a 5-year-old child is diagnosed with Duchenne muscular dystrophy, a severe muscle-wasting disease. Genetic testing reveals a mutation in the promoter region of the gene responsible for producing dystrophin, a crucial muscle protein. Considering the role of promoter regions in gene expression, which of the following is the most likely consequence of this mutation on dystrophin production?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiation of dystrophin transcription will be defective.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Termination of dystrophin transcription will be defective.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Capping and splicing of dystrophin messenger RNA will be defective.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tailing of dystrophin messenger RNA will be defective.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Initiation of dystrophin transcription will be defective.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Initiation of dystrophin transcription will be defective&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Termination defects are related to sequences and factors at the end of the gene , not the promoter region.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Termination defects&lt;/li&gt;&lt;li&gt;â€¢ sequences&lt;/li&gt;&lt;li&gt;â€¢ factors at the end of the gene&lt;/li&gt;&lt;li&gt;â€¢ Option C: Capping and splicing are post-transcriptional modifications and generally not directly affected by promoter mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Capping&lt;/li&gt;&lt;li&gt;â€¢ splicing are post-transcriptional modifications&lt;/li&gt;&lt;li&gt;â€¢ Option D: Polyadenylation (tailing) is another post-transcriptional event typically not influenced by mutations in the promoter region.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Polyadenylation&lt;/li&gt;&lt;li&gt;â€¢ post-transcriptional event&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A mutation in the promoter region of the dystrophin gene with Duchenne muscular dystrophy , is likely to impair the initiation of dystrophin transcription . This is because the promoter region is essential for the start of transcription, and its mutation disrupts the normal production of dystrophin, a key protein for muscle function.&lt;/li&gt;&lt;li&gt;âž¤ mutation&lt;/li&gt;&lt;li&gt;âž¤ promoter region&lt;/li&gt;&lt;li&gt;âž¤ dystrophin gene&lt;/li&gt;&lt;li&gt;âž¤ Duchenne muscular dystrophy&lt;/li&gt;&lt;li&gt;âž¤ impair the initiation&lt;/li&gt;&lt;li&gt;âž¤ dystrophin transcription&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 655&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biology lab in India is exploring various technologies to understand the genetic basis of a rare disease. Among the discussed technologies, which of the following statements is TRUE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Restriction Endonuclease cuts the DNA at the defective sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Artificially created chromosomes canâ€™t be used as a vector&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Helpful in study of molecular basis of a disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA to be cloned is called as Chimeric DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Helpful in study of molecular basis of a disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/77.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Helpful in study of molecular basis of a disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restriction Endonuclease cuts the DNA at the defective sequence: Cut the DNA at specific palindromic sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restriction Endonuclease cuts the DNA at the defective sequence:&lt;/li&gt;&lt;li&gt;â€¢ palindromic sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Artificially created chromosomes canâ€™t be used as a vector: Can be used as a vector.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Artificially created chromosomes canâ€™t be used as a vector:&lt;/li&gt;&lt;li&gt;â€¢ vector.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA to be cloned is called as Chimeric DNA: DNA to be cloned + Vector DNA = Chimeric DNA or recombinant DNA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA to be cloned is called as Chimeric DNA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Molecular biology technologies are instrumental in dissecting the molecular basis of diseases. These tools allow researchers to delve into genetic mutations, expression patterns, and interactions that underpin disease processes, thereby contributing significantly to medical science&#x27;s understanding and treatment strategies.&lt;/li&gt;&lt;li&gt;âž¤ Molecular biology technologies&lt;/li&gt;&lt;li&gt;âž¤ instrumental&lt;/li&gt;&lt;li&gt;âž¤ dissecting the molecular basis of diseases.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 452-454&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 452-454&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an experiment aimed at understanding DNA replication, a piece of radio-labeled DNA is allowed to undergo two rounds of replication within a non-radioactive medium. This setup is designed to track the distribution of the original radioactive material across the generations of DNA. Based on the known mechanism of semiconservative replication, what would be the expected outcome regarding the radioactivity of the DNA strands after two replication cycles?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;All the strands will have radioactivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;No strands will have radioactivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Half of the DNA will have no radioactivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Threeâ€“fourth of the DNA replicated will have radioactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Half of the DNA will have no radioactivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture1_sFhcZtU.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Half of the DNA will have no radioactivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ DNA replication follows a semiconservative model, meaning that each daughter DNA molecule retains one original (parental) strand and synthesizes one new strand.&lt;/li&gt;&lt;li&gt;â€¢ semiconservative&lt;/li&gt;&lt;li&gt;â€¢ After the first round of replication, each of the two daughter DNA molecules contains one radioactive parental strand and one new non-radioactive strand . So, all DNA molecules are partially radioactive .&lt;/li&gt;&lt;li&gt;â€¢ After the first round of replication, each of the two daughter DNA molecules contains one radioactive parental strand and one new non-radioactive strand . So, all DNA molecules are partially radioactive .&lt;/li&gt;&lt;li&gt;â€¢ first round&lt;/li&gt;&lt;li&gt;â€¢ one radioactive parental strand&lt;/li&gt;&lt;li&gt;â€¢ one new non-radioactive strand&lt;/li&gt;&lt;li&gt;â€¢ all DNA molecules are partially radioactive&lt;/li&gt;&lt;li&gt;â€¢ After the second round of replication, each of these hybrid molecules produces: One hybrid DNA (still containing one radioactive strand) One entirely new DNA molecule (both strands non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ After the second round of replication, each of these hybrid molecules produces: One hybrid DNA (still containing one radioactive strand) One entirely new DNA molecule (both strands non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ second round&lt;/li&gt;&lt;li&gt;â€¢ One hybrid DNA (still containing one radioactive strand) One entirely new DNA molecule (both strands non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ One hybrid DNA (still containing one radioactive strand)&lt;/li&gt;&lt;li&gt;â€¢ One entirely new DNA molecule (both strands non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ So now there are four DNA molecules total :&lt;/li&gt;&lt;li&gt;â€¢ four DNA molecules total&lt;/li&gt;&lt;li&gt;â€¢ Two are hybrid (radioactive + non-radioactive) Two are completely non-radioactive&lt;/li&gt;&lt;li&gt;â€¢ Two are hybrid (radioactive + non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ Two are hybrid (radioactive + non-radioactive)&lt;/li&gt;&lt;li&gt;â€¢ Two are completely non-radioactive&lt;/li&gt;&lt;li&gt;â€¢ Two are completely non-radioactive&lt;/li&gt;&lt;li&gt;â€¢ Therefore, half of the DNA molecules (2 out of 4) are non-radioactive .&lt;/li&gt;&lt;li&gt;â€¢ half of the DNA molecules (2 out of 4)&lt;/li&gt;&lt;li&gt;â€¢ non-radioactive&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: All strands will have radioactivity â€” Incorrect. Only the original strands are radioactive, and they are passed on to only half of the DNA molecules after two replications.&lt;/li&gt;&lt;li&gt;â€¢ Option A: All strands will have radioactivity&lt;/li&gt;&lt;li&gt;â€¢ Option B: No strands will have radioactivity â€” Incorrect. The original radioactive strands still exist in two of the four DNA molecules.&lt;/li&gt;&lt;li&gt;â€¢ Option B: No strands will have radioactivity&lt;/li&gt;&lt;li&gt;â€¢ Option D: Three-fourth of the DNA will have radioactivity â€” Incorrect. Only two out of four DNA molecules (i.e., 50% ) retain radioactive material, not 75%.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Three-fourth of the DNA will have radioactivity&lt;/li&gt;&lt;li&gt;â€¢ two out of four DNA molecules&lt;/li&gt;&lt;li&gt;â€¢ 50%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the implications of semiconservative DNA replication : in each new round, half of the DNA molecules retain part of the original strand.&lt;/li&gt;&lt;li&gt;âž¤ semiconservative DNA replication&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381-387.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy is brought to the clinic with severe abdominal pain, recurrent infections, and a history of chronic hemolytic anemia. On examination, he has a non-healing ulcer on his right leg, and a peripheral blood smear shows abnormally shaped red blood cells. What is the basic genetic defect associated with this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Single nucleotides change in a codon&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Autoantibodies against RBC membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Genomic imprinting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Triple nucleotide repeats&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Single nucleotides change in a codon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Single nucleotide change in a codon.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Autoantibodies against RBC membrane: are seen in AIHA (autoimmune haemolytic anemia).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Autoantibodies against RBC membrane:&lt;/li&gt;&lt;li&gt;â€¢ AIHA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Genomic imprinting: in this, expression of some genes depends on whether or not they are inherited maternally or paternally e.g. Angelman syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Genomic imprinting:&lt;/li&gt;&lt;li&gt;â€¢ expression of some genes&lt;/li&gt;&lt;li&gt;â€¢ Option D. Triple nucleotide repeats: These are associated with diseases such as CGG repeat sequence - fragile X syndrome , CAG repeats - Huntingtonâ€™s chorea , CTG -myotonic dystrophy and CAG in spinobulbar muscular atrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Triple nucleotide repeats:&lt;/li&gt;&lt;li&gt;â€¢ CGG repeat sequence&lt;/li&gt;&lt;li&gt;â€¢ fragile X syndrome&lt;/li&gt;&lt;li&gt;â€¢ CAG repeats&lt;/li&gt;&lt;li&gt;â€¢ Huntingtonâ€™s chorea&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell anemia is caused by a single nucleotide substitution in the Î²-globin gene , which leads to the replacement of glutamic acid with valine at the sixth position of the Î²-globin chain . This single amino acid change results in the production of hemoglobin S (HbS), which polymerizes under low-oxygen conditions, causing the red blood cells to take on a sickle shape and leading to hemolytic anemia.&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell anemia&lt;/li&gt;&lt;li&gt;âž¤ single nucleotide substitution&lt;/li&gt;&lt;li&gt;âž¤ Î²-globin gene&lt;/li&gt;&lt;li&gt;âž¤ replacement of glutamic acid&lt;/li&gt;&lt;li&gt;âž¤ valine&lt;/li&gt;&lt;li&gt;âž¤ sixth position of the Î²-globin chain&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 58, 417.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 58, 417.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;At her 27-week prenatal check-up in a Mumbai healthcare clinic, a pregnant woman receives a rubella vaccine. Subsequently, her body develops anti-rubella antibodies. This immune response involves a specific genetic mechanism fundamental to antibody diversity in humans. Which mechanism underlies the formation of these antibodies in the body?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gene rearrangement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gene amplification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alternate splicing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RNA interference&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gene rearrangement&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture2_C1VntEi.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gene rearrangement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gene amplification: This is a mechanism by which gene expression is increased thousandfold . E.g : Methotrexate ( anticancer drug)- works by this mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gene amplification:&lt;/li&gt;&lt;li&gt;â€¢ mechanism&lt;/li&gt;&lt;li&gt;â€¢ gene expression is increased thousandfold&lt;/li&gt;&lt;li&gt;â€¢ E.g&lt;/li&gt;&lt;li&gt;â€¢ (&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alternate splicing: Tissue-specific protein isoforms can be made from the same pre-mRNA through differential co-transcriptional processing , especially the use of alternative splice sites . e.g: Tropomyosin (TM), its pre-mRNA undergoes tissue-specific differential splicing to yield different TM isoforms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alternate splicing:&lt;/li&gt;&lt;li&gt;â€¢ Tissue-specific protein isoforms&lt;/li&gt;&lt;li&gt;â€¢ made from the same pre-mRNA&lt;/li&gt;&lt;li&gt;â€¢ differential co-transcriptional processing&lt;/li&gt;&lt;li&gt;â€¢ . e.g:&lt;/li&gt;&lt;li&gt;â€¢ Option D. RNA interference: It is a mechanism of gene silencing with decreased expression of mRNA , either by repression of translation or by increased degradation .  E.g: It plays a key role in fundamental processes as cell proliferation, differentiation, and apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RNA interference:&lt;/li&gt;&lt;li&gt;â€¢ mechanism of gene silencing&lt;/li&gt;&lt;li&gt;â€¢ decreased expression of mRNA&lt;/li&gt;&lt;li&gt;â€¢ .  E.g:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gene rearrangement is the process responsible for the formation of antibodies in the body . This mechanism involves the reorganization of variable (V), diversity (D), and joining (J) gene segments in B cells . This recombination leads to a vast diversity of antibodies, enabling the immune system to recognize a wide array of antigens, such as those presented by the rubella virus following vaccination.&lt;/li&gt;&lt;li&gt;âž¤ Gene rearrangement&lt;/li&gt;&lt;li&gt;âž¤ process responsible&lt;/li&gt;&lt;li&gt;âž¤ formation of antibodies in the body&lt;/li&gt;&lt;li&gt;âž¤ mechanism&lt;/li&gt;&lt;li&gt;âž¤ reorganization of variable&lt;/li&gt;&lt;li&gt;âž¤ diversity&lt;/li&gt;&lt;li&gt;âž¤ joining&lt;/li&gt;&lt;li&gt;âž¤ gene segments&lt;/li&gt;&lt;li&gt;âž¤ B cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 461.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 461.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonate presents with marked hypotonia, necessitating tube feeding, and displays distinct facial characteristics, including almond-shaped eyes and downturned mouth corners, suggestive of a genetic disorder. Given the clinical presentation and the suspicion of Prader-Willi syndrome, the physician orders chromosomal analysis and DNA testing to investigate a specific chromosome 15 abnormality and potential genomic imprinting issues. Which molecular process, occurring at the 5th position of cytidine and often associated with gene silencing, is most relevant to the testing ordered for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gene conversion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sister chromatid exchange&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gene rearrangement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA methylation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DNA methylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) DNA methylation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gene conversion involves the process where one DNA sequence is converted to another, which is not directly related to the epigenetic silencing observed in Prader-Willi syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Gene conversion&lt;/li&gt;&lt;li&gt;â€¢ process where one DNA sequence&lt;/li&gt;&lt;li&gt;â€¢ converted to another,&lt;/li&gt;&lt;li&gt;â€¢ Option B: Sister chromatid exchange is a mechanism where identical sister chromatids exchange genetic material during cell division, not typically associated with gene silencing or the pathology of Prader-Willi syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Sister chromatid exchange&lt;/li&gt;&lt;li&gt;â€¢ mechanism where identical sister chromatids exchange genetic material&lt;/li&gt;&lt;li&gt;â€¢ cell division,&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gene rearrangement refers to the reorganization of genetic material within the genome, which can play a role in certain diseases but is not the primary mechanism behind Prader-Willi syndrome, which involves specific epigenetic modifications like DNA methylation.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Gene rearrangement&lt;/li&gt;&lt;li&gt;â€¢ reorganization of genetic material&lt;/li&gt;&lt;li&gt;â€¢ genome,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation, particularly at the 5th carbon position of cytosine bases (5-methylcytosine), is a key epigenetic modification that can lead to gene silencing. In the context of Prader-Willi syndrome, this modification is relevant because the disorder is often associated with the loss of paternally inherited genes on chromosome 15 due to deletions or alterations in genomic imprinting, where DNA methylation plays a crucial role.&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation,&lt;/li&gt;&lt;li&gt;âž¤ 5th carbon position&lt;/li&gt;&lt;li&gt;âž¤ cytosine bases&lt;/li&gt;&lt;li&gt;âž¤ epigenetic modification&lt;/li&gt;&lt;li&gt;âž¤ gene silencing.&lt;/li&gt;&lt;li&gt;âž¤ Prader-Willi syndrome,&lt;/li&gt;&lt;li&gt;âž¤ disorder&lt;/li&gt;&lt;li&gt;âž¤ loss of paternally inherited genes on chromosome 15&lt;/li&gt;&lt;li&gt;âž¤ deletions or alterations in genomic imprinting,&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 582.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 582.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy presents to the clinic with complaints of anemia, weakness, and notably lower height and weight compared to peers of his age. Upon examination, his urine sample reveals elevated levels of orotic acid. Further diagnostic tests indicate decreased activity of uridine monophosphate (UMP) synthase. Considering the underlying enzymatic deficiency and the patient&#x27;s symptoms, which of the following would be the most appropriate treatment to administer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uridine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoxanthine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thymidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Uridine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Uridine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanations&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenine and Option C. Hypoxanthine : Hypoxanthine, guanine, and adenine are purine bases, cannot be converted to pyrimidines.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenine&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Hypoxanthine&lt;/li&gt;&lt;li&gt;â€¢ cannot be converted to pyrimidines.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thymidine : Although thymidine is a pyrimidine base it cannot be converted to other pyrimidines.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thymidine&lt;/li&gt;&lt;li&gt;â€¢ pyrimidine base&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary orotic aciduria , a rare autosomal recessive disorder characterized by a deficiency in the enzyme UMP synthase. This enzyme is crucial in the pyrimidine synthesis pathway, and its deficiency leads to the accumulation of orotic acid in the urine and a decrease in pyrimidine synthesis , which is necessary for DNA and RNA synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Hereditary orotic aciduria&lt;/li&gt;&lt;li&gt;âž¤ rare autosomal recessive disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme UMP synthase.&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine synthesis pathway,&lt;/li&gt;&lt;li&gt;âž¤ deficiency leads to the accumulation of orotic acid&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ decrease in pyrimidine synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 356-357.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 356-357.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents to the orthopedic outpatient department with joint swelling and pain, as depicted in the image. The physical examination reveals swollen, erythematous joints with tenderness. Laboratory tests show elevated serum uric acid levels. She is diagnosed with gout. Which of the following statements regarding her condition is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sodium urate crystals can deposit in kidneys and impair renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uric acid overproduction is seen in myeloproliferative disorders like leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol used in treatment as it inhibits xanthine oxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/1_MMDSPFz.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis â€“ Incorrect (Correct Answer) This is incorrect because decreased activity of PRPP synthetase reduces purine synthesis. In contrast, increased (not decreased) activity of PRPP synthetase leads to enhanced purine synthesis and overproduction of uric acid, contributing to gout. Therefore, the statement is wrong.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis â€“ Incorrect (Correct Answer) This is incorrect because decreased activity of PRPP synthetase reduces purine synthesis. In contrast, increased (not decreased) activity of PRPP synthetase leads to enhanced purine synthesis and overproduction of uric acid, contributing to gout. Therefore, the statement is wrong.&lt;/li&gt;&lt;li&gt;â€¢ Option A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis â€“ Incorrect (Correct Answer)&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ decreased activity&lt;/li&gt;&lt;li&gt;â€¢ reduces&lt;/li&gt;&lt;li&gt;â€¢ increased (not decreased) activity&lt;/li&gt;&lt;li&gt;â€¢ enhanced purine synthesis&lt;/li&gt;&lt;li&gt;â€¢ gout.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodium urate crystals can deposit in kidneys and impair renal function â€“  True In chronic gout , urate crystals can deposit in the renal parenchyma and tubules, leading to urate nephropathy and potential renal failure. Option C. Uric acid overproduction is seen in myeloproliferative disorders like leukemia â€“ True Leukemias and other myeloproliferative disorders involve rapid cell turnover and breakdown of nucleic acids, leading to hyperuricemia and secondary gout. Option D. Allopurinol used in treatment as it inhibits xanthine oxidase â€“ True Allopurinol is a inhibitor of xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid, making it effective for long-term management of gout.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodium urate crystals can deposit in kidneys and impair renal function â€“  True In chronic gout , urate crystals can deposit in the renal parenchyma and tubules, leading to urate nephropathy and potential renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sodium urate crystals can deposit in kidneys and impair renal function â€“  True&lt;/li&gt;&lt;li&gt;â€¢ chronic gout&lt;/li&gt;&lt;li&gt;â€¢ urate nephropathy&lt;/li&gt;&lt;li&gt;â€¢ renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uric acid overproduction is seen in myeloproliferative disorders like leukemia â€“ True Leukemias and other myeloproliferative disorders involve rapid cell turnover and breakdown of nucleic acids, leading to hyperuricemia and secondary gout.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Uric acid overproduction is seen in myeloproliferative disorders like leukemia â€“ True&lt;/li&gt;&lt;li&gt;â€¢ Leukemias and other myeloproliferative disorders&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allopurinol used in treatment as it inhibits xanthine oxidase â€“ True Allopurinol is a inhibitor of xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid, making it effective for long-term management of gout.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Allopurinol used in treatment as it inhibits xanthine oxidase â€“ True&lt;/li&gt;&lt;li&gt;â€¢ Allopurinol&lt;/li&gt;&lt;li&gt;â€¢ inhibitor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand that gout can result from overactivity of PRPP synthetase , leading to increased de novo purine synthesis and elevated uric acid production. Treatments like allopurinol target xanthine oxidase to reduce uric acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ gout&lt;/li&gt;&lt;li&gt;âž¤ PRPP synthetase&lt;/li&gt;&lt;li&gt;âž¤ increased de novo purine synthesis&lt;/li&gt;&lt;li&gt;âž¤ allopurinol&lt;/li&gt;&lt;li&gt;âž¤ xanthine oxidase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30 /e: p 354.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents to the clinic with the laboratory findings of reducing substances in his urine that are not glucose, signs of liver disease, and decreased liver glycogen observed in a liver biopsy. To identify the underlying cause of his symptoms, which of the following metabolite concentrations should be measured?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose 1-phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fructose 1,6-bisphosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uridine diphosphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cytosine diphosphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Uridine diphosphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Uridine diphosphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Glucose 1-phosphate and Option B . Fructose 1,6-bisphosphate : The glucose or fructose phosphates regulates glycogen stores but will not prevent synthesis of glycogen or block galactose metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Glucose 1-phosphate&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Fructose 1,6-bisphosphate&lt;/li&gt;&lt;li&gt;â€¢ glucose or fructose phosphates regulates glycogen&lt;/li&gt;&lt;li&gt;â€¢ Option D . Cytosine diphosphate : It is important for the synthesis of phospholipids , thus forming high-energy CDP diacylglycerol which transfers diacylglycerol to form phosphatidylinositolâ€™s (signal transducers) and cardiolipin (seen in mitochondrial membrane and develops antibodies in autoimmune disorders)&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Cytosine diphosphate&lt;/li&gt;&lt;li&gt;â€¢ synthesis of phospholipids&lt;/li&gt;&lt;li&gt;â€¢ forming high-energy CDP diacylglycerol&lt;/li&gt;&lt;li&gt;â€¢ transfers diacylglycerol&lt;/li&gt;&lt;li&gt;â€¢ form phosphatidylinositolâ€™s&lt;/li&gt;&lt;li&gt;â€¢ cardiolipin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of non-glucose reducing substances in urine and reduced liver glycogen , with elevated UDP-sugars , indicates a glycogen storage disease like GSD Type Ia . Diagnosing involves measuring UDP concentrations to reveal a block in the metabolic pathway involving glucose-6-phosphatase.&lt;/li&gt;&lt;li&gt;âž¤ presence of non-glucose reducing substances&lt;/li&gt;&lt;li&gt;âž¤ urine&lt;/li&gt;&lt;li&gt;âž¤ reduced liver glycogen&lt;/li&gt;&lt;li&gt;âž¤ elevated UDP-sugars&lt;/li&gt;&lt;li&gt;âž¤ glycogen storage disease&lt;/li&gt;&lt;li&gt;âž¤ GSD Type Ia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30 /e: p 116,177,201, 571.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30 /e: p 116,177,201, 571.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is evaluating the effects of azaserine, a drug known to inhibit glutamine-dependent enzymes, on nucleotide synthesis. In considering the drug&#x27;s impact on purine biosynthesis, Nitrogen atom at which position in the generic purine structure is Contributed by Glutamine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;9&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;7&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 9&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-14%20165313.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. 9&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Purine biosynthesis involves building the purine ring step by step on a ribose-5-phosphate backbone. Various atoms of the purine ring come from different precursors.&lt;/li&gt;&lt;li&gt;â€¢ Glutamine provides nitrogen atoms via its amide nitrogen (-NH2) in the purine biosynthesis pathway.&lt;/li&gt;&lt;li&gt;â€¢ In purine biosynthesis:&lt;/li&gt;&lt;li&gt;â€¢ In purine biosynthesis:&lt;/li&gt;&lt;li&gt;â€¢ Thus, glutamine donates nitrogen at:&lt;/li&gt;&lt;li&gt;â€¢ N3 N9&lt;/li&gt;&lt;li&gt;â€¢ N3&lt;/li&gt;&lt;li&gt;â€¢ N9&lt;/li&gt;&lt;li&gt;â€¢ In the context of your question (specifically asking for â€œthe nitrogen contributed by glutamineâ€), position 9 is one of the key sites.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 7: N7 comes from glycine, not glutamine. Glycine contributes two carbons and one nitrogen (C4, C5, N7).&lt;/li&gt;&lt;li&gt;â€¢ Option B. 7:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 4: C4 comes from glycine as well. Glycine contributes to the entire C4-C5-N7 chain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 4:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1: N1 comes from aspartate, not glutamine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Purine biosynthesis is a multi-step process that builds the purine ring atom by atom using various precursors: Glutamineâ€™s amide nitrogen provides N3 and N9. Glycine donates C4, C5, and N7. Aspartate provides N1. Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8. CO2 (bicarbonate) supplies C6. Inhibition of glutamine-dependent enzymes (like by azaserine) disrupts steps that require glutamine as an amide donor, blocking Nitrogen incorporation and thus halting purine biosynthesis.&lt;/li&gt;&lt;li&gt;âž¤ Purine biosynthesis is a multi-step process that builds the purine ring atom by atom using various precursors: Glutamineâ€™s amide nitrogen provides N3 and N9. Glycine donates C4, C5, and N7. Aspartate provides N1. Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8. CO2 (bicarbonate) supplies C6.&lt;/li&gt;&lt;li&gt;âž¤ Glutamineâ€™s amide nitrogen provides N3 and N9. Glycine donates C4, C5, and N7. Aspartate provides N1. Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8. CO2 (bicarbonate) supplies C6.&lt;/li&gt;&lt;li&gt;âž¤ Glutamineâ€™s amide nitrogen provides N3 and N9.&lt;/li&gt;&lt;li&gt;âž¤ Glycine donates C4, C5, and N7.&lt;/li&gt;&lt;li&gt;âž¤ Aspartate provides N1.&lt;/li&gt;&lt;li&gt;âž¤ Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8.&lt;/li&gt;&lt;li&gt;âž¤ CO2 (bicarbonate) supplies C6.&lt;/li&gt;&lt;li&gt;âž¤ Inhibition of glutamine-dependent enzymes (like by azaserine) disrupts steps that require glutamine as an amide donor, blocking Nitrogen incorporation and thus halting purine biosynthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 348-349.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following correctly identifies the nitrogen sources for N3 &amp;amp; N9 positions in Purine Ring?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amide nitrogen of glutamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspartate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;N10 formyl THFA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amide nitrogen of glutamine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/2_w4k7Xi6.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3_6AxmNES.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Amide nitrogen of glutamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aspartate â€“ contributes N1 of PURINE ring.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Aspartate&lt;/li&gt;&lt;li&gt;â€¢ Option C . Glycine - contributes N7 of PURINE ring.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Glycine&lt;/li&gt;&lt;li&gt;â€¢ Option D. N10 formyl THFA - contributes C8 of PURINE ring.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ N10 formyl THFA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the biosynthesis of purines , the nitrogen atoms at positions N3 and N9 originate from the amide nitrogen of glutamine.&lt;/li&gt;&lt;li&gt;âž¤ biosynthesis of purines&lt;/li&gt;&lt;li&gt;âž¤ nitrogen atoms at positions N3&lt;/li&gt;&lt;li&gt;âž¤ N9 originate&lt;/li&gt;&lt;li&gt;âž¤ amide nitrogen of glutamine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 347-348.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 347-348.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a history of chronic alcohol abuse presents to the clinic with pain and swelling in the joints of his hands, as shown in the picture. The condition is characterized by the formation and deposition of sodium urate crystals in peripheral joints. Which of the following factors is known to contribute to the formation of these urate crystals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased temperature&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased blood flow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exposure to sunlight&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased blood flow&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Decreased temperature&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4_8KN4vL5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Decreased temperature&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreased blood flow: While decreased blood flow might theoretically lead to increased concentration of uric acid, it is not typically cited as a direct contributor to crystal formation. Gout flares are not commonly associated with decreased blood flow.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Decreased blood flow:&lt;/li&gt;&lt;li&gt;â€¢ decreased blood flow&lt;/li&gt;&lt;li&gt;â€¢ lead to increased concentration&lt;/li&gt;&lt;li&gt;â€¢ uric acid,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Exposure to sunlight : Sunlight exposure does not affect the solubility of uric acid and is not a recognized factor in the formation of urate crystals.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Exposure to sunlight&lt;/li&gt;&lt;li&gt;â€¢ Sunlight exposure&lt;/li&gt;&lt;li&gt;â€¢ not affect the solubility of uric acid&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased blood flow: Increased blood flow would generally improve the elimination of uric acid through the kidneys and is not associated with the formation of urate crystals . However, increased blood flow can lead to the inflammatory response seen with gout flares once the crystals have formed.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Increased blood flow:&lt;/li&gt;&lt;li&gt;â€¢ improve the elimination of uric acid&lt;/li&gt;&lt;li&gt;â€¢ kidneys&lt;/li&gt;&lt;li&gt;â€¢ formation of urate crystals&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Decreased temperature can lead to urate crystal formation in peripheral joints is important for understanding why gout commonly affects the cooler distal joints and how acute attacks may be precipitated by changes in temperature.&lt;/li&gt;&lt;li&gt;âž¤ Decreased temperature&lt;/li&gt;&lt;li&gt;âž¤ lead to urate crystal formation in peripheral joints&lt;/li&gt;&lt;li&gt;âž¤ gout&lt;/li&gt;&lt;li&gt;âž¤ affects the cooler distal joints&lt;/li&gt;&lt;li&gt;âž¤ acute attacks&lt;/li&gt;&lt;li&gt;âž¤ precipitated by changes in temperature.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/esp. 354, Lippincott 7/ed: p 301.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/esp. 354, Lippincott 7/ed: p 301.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old pregnant woman at 32 weeks of gestation presents for her routine prenatal visit. She has a history of recurrent folate deficiencies. Her current blood work reveals macrocytic anemia. A deficiency in folate would most likely decrease the production of which of the following compounds?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The thymine nucleotide required for DNA synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Creatine phosphate from creatine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;All of the pyrimidines required for RNA synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphatidylcholine from diacylglycerol and CDP-choline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The thymine nucleotide required for DNA synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. The thymine nucleotide required for DNA synthesis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Creatine phosphate from creatine: The synthesis of creatine phosphate from creatine is not directly related to folate metabolism and is unaffected by folate levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Creatine phosphate from creatine:&lt;/li&gt;&lt;li&gt;â€¢ synthesis of creatine phosphate&lt;/li&gt;&lt;li&gt;â€¢ creatine&lt;/li&gt;&lt;li&gt;â€¢ Option C . All of the pyrimidines required for RNA synthesis : While folate is involved in nucleotide synthesis, its deficiency primarily affects the production of thymine, not all pyrimidines.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ All of the pyrimidines required for RNA synthesis&lt;/li&gt;&lt;li&gt;â€¢ folate&lt;/li&gt;&lt;li&gt;â€¢ nucleotide synthesis,&lt;/li&gt;&lt;li&gt;â€¢ Option D . Phosphatidylcholine from diacylglycerol and CDP-choline: The synthesis of phosphatidylcholine from diacylglycerol and CDP-choline is a part of lipid metabolism and is not dependent on folate.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Phosphatidylcholine from diacylglycerol and CDP-choline:&lt;/li&gt;&lt;li&gt;â€¢ synthesis of phosphatidylcholine&lt;/li&gt;&lt;li&gt;â€¢ diacylglycerol&lt;/li&gt;&lt;li&gt;â€¢ lipid metabolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Folate deficiency affects DNA synthesis, particularly the synthesis of thymine nucleotide. Folate is required for the production of tetrahydrofolate (THF), which acts as a carrier of one-carbon units necessary in various metabolic processes , including the methylation of deoxyuridylic acid (dUMP) to thymidylic acid (dTMP), a precursor of thymine nucleotide.&lt;/li&gt;&lt;li&gt;âž¤ Folate deficiency&lt;/li&gt;&lt;li&gt;âž¤ DNA synthesis,&lt;/li&gt;&lt;li&gt;âž¤ synthesis of thymine nucleotide.&lt;/li&gt;&lt;li&gt;âž¤ Folate&lt;/li&gt;&lt;li&gt;âž¤ production of tetrahydrofolate&lt;/li&gt;&lt;li&gt;âž¤ carrier of one-carbon&lt;/li&gt;&lt;li&gt;âž¤ metabolic processes&lt;/li&gt;&lt;li&gt;âž¤ methylation of deoxyuridylic acid&lt;/li&gt;&lt;li&gt;âž¤ thymidylic acid&lt;/li&gt;&lt;li&gt;âž¤ precursor of thymine nucleotide.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e:  p 303-304.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e:  p 303-304.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During pyrimidine nucleotide synthesis, one of the amino acids donates a nitrogen atom to form the pyrimidine ring. Which amino acid contributes the nitrogen at the N1 position in this structure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspartate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aspartate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/5_Io3StVi.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Aspartate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Glutamine: Glutamine donates nitrogen atoms during purine nucleotide synthesis , not for the N1 position of pyrimidines.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Glutamine:&lt;/li&gt;&lt;li&gt;â€¢ donates nitrogen atoms&lt;/li&gt;&lt;li&gt;â€¢ purine nucleotide synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option C . Glycine: Glycine contributes to the purine nucleotide structure , not the pyrimidine.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Glycine:&lt;/li&gt;&lt;li&gt;â€¢ purine nucleotide structure&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alanine: Alanine does not contribute nitrogen atoms to the pyrimidine ring structure.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Alanine:&lt;/li&gt;&lt;li&gt;â€¢ not contribute nitrogen atoms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CONTRIBUTORS OF PYRIMIDINE RING:&lt;/li&gt;&lt;li&gt;âž¤ CONTRIBUTORS OF PYRIMIDINE RING:&lt;/li&gt;&lt;li&gt;âž¤ N3 by Amide Nitrogen of Glutamine C2 by CO2 C4, C5, C6, N1 by Aspartate&lt;/li&gt;&lt;li&gt;âž¤ N3 by Amide Nitrogen of Glutamine&lt;/li&gt;&lt;li&gt;âž¤ C2 by CO2&lt;/li&gt;&lt;li&gt;âž¤ C4, C5, C6, N1 by Aspartate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 347-348.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 347-348.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy with developmental delay and a behavioral history of self-injurious actions, including tongue biting and finger biting to the point of needing bandages, is brought to a pediatric neurologist. Based on the clinical presentation, which enzyme deficiency is most likely responsible for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cystathionine synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoxanthine-guanine phosphoribosyl transferase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homogentisic acid oxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hexosaminidase A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoxanthine-guanine phosphoribosyl transferase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Hypoxanthine-guanine phosphoribosyl transferase.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Cystathionine synthase : Deficiency results in homocystinuria, characterized by elevated urinary homocysteine. C/F- failure to thrive and visual problems due to lens displacement.  Also deficiency of methionine synthase, pyridoxine, folate, or vitamin B12 can cause homocystinuria.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Cystathionine synthase&lt;/li&gt;&lt;li&gt;â€¢ homocystinuria,&lt;/li&gt;&lt;li&gt;â€¢ elevated urinary homocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option C . Homogentisic acid oxidase: Deficiency results in alkaptonuria. C/F- dark urine and darkening of connective tissue (e.g., ear cartilage may appear bluish).&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Homogentisic acid oxidase:&lt;/li&gt;&lt;li&gt;â€¢ alkaptonuria.&lt;/li&gt;&lt;li&gt;â€¢ Option D . Hexosaminidase A: Deficiency causes Tay-Sachs disease ðŸ¡ª results in the accumulation of GM2 ganglioside. C/F-mental retardation, blindness with cherry-red spot on the macula and muscular weakness.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Hexosaminidase A:&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lesch-Nyhan syndrome , a disorder caused by a deficiency in the enzyme hypoxanthine-guanine phosphoribosyl transferase (HPRT), and its deficiency leads to the overproduction of uric acid and a host of neurological and behavioral abnormalities , including self-mutilation behaviors.&lt;/li&gt;&lt;li&gt;âž¤ Lesch-Nyhan syndrome&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ enzyme hypoxanthine-guanine phosphoribosyl transferase&lt;/li&gt;&lt;li&gt;âž¤ overproduction of uric acid&lt;/li&gt;&lt;li&gt;âž¤ host of neurological&lt;/li&gt;&lt;li&gt;âž¤ behavioral abnormalities&lt;/li&gt;&lt;li&gt;âž¤ self-mutilation behaviors.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 296-297.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 296-297.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with sudden onset of severe pain in his right big toe, extending up to the knee, which began in the morning. The pain developed after a night of alcohol consumption. On examination, the affected big toe is swollen, tender, and warm. Laboratory tests reveal a serum uric acid level of 9.6 mg/dl. After being prescribed allopurinol by the physician, the patient&#x27;s symptoms improved within three days. What is the mechanism of action of allopurinol in the treatment of hyperuricemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Competitive inhibitor of xanthine oxidase &amp;amp; decrease UA formation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase renal excretion of urate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduce body uric acid pool&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arrest the arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Competitive inhibitor of xanthine oxidase &amp; decrease UA formation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6_xcRX0L4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Competitive inhibitor of xanthine oxidase &amp;amp; decrease UA formation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Increase the renal excretion of urate by decreasing the reabsorption of urate from kidney tubules: Action of uricosuric drugs. e.g., probenecid.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Increase the renal excretion of urate by decreasing the reabsorption of urate from kidney tubules:&lt;/li&gt;&lt;li&gt;â€¢ uricosuric drugs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reduce body uric acid pool : done by PEG (polyethylene glycol) uricase and conversion of urate to allantoin (more water soluble and easily excreted).&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Reduce body uric acid pool&lt;/li&gt;&lt;li&gt;â€¢ PEG&lt;/li&gt;&lt;li&gt;â€¢ uricase&lt;/li&gt;&lt;li&gt;â€¢ conversion of urate to allantoin&lt;/li&gt;&lt;li&gt;â€¢ Option D . Arrest the arthritis: Action of Colchicine , an anti-inflammatory agent.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Arrest the arthritis:&lt;/li&gt;&lt;li&gt;â€¢ Colchicine&lt;/li&gt;&lt;li&gt;â€¢ anti-inflammatory agent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol is a structural analog of hypoxanthine. It acts as a competitive inhibitor of xanthine oxidase , an enzyme responsible for converting hypoxanthine to xanthine and xanthine to uric acid . By inhibiting this enzyme , allopurinol reduces the production of uric acid, thereby treating hyperuricemia which is often associated with gout.&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol&lt;/li&gt;&lt;li&gt;âž¤ structural analog of hypoxanthine.&lt;/li&gt;&lt;li&gt;âž¤ competitive inhibitor&lt;/li&gt;&lt;li&gt;âž¤ xanthine oxidase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ converting hypoxanthine&lt;/li&gt;&lt;li&gt;âž¤ xanthine&lt;/li&gt;&lt;li&gt;âž¤ xanthine to uric acid&lt;/li&gt;&lt;li&gt;âž¤ inhibiting this enzyme&lt;/li&gt;&lt;li&gt;âž¤ allopurinol reduces&lt;/li&gt;&lt;li&gt;âž¤ production&lt;/li&gt;&lt;li&gt;âž¤ uric acid,&lt;/li&gt;&lt;li&gt;âž¤ treating hyperuricemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 344.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 344.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An evaluating patients with potential metabolic disorders, identifying conditions that are less likely to present with hyperuricemia is crucial for differential diagnosis. Which of the following conditions would make the presence of hyperuricemia very unlikely in a patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lesch-Nyhan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Xanthine oxidase hyperactivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbamoyl phosphate synthetase deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Carbamoyl phosphate synthetase deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Carbamoyl phosphate synthetase deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Lesch-Nyhan syndrome : This condition is characterized by a deficiency in the enzyme HPRT and is associated with hyperuricemia due to the accumulation of uric acid.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Lesch-Nyhan syndrome&lt;/li&gt;&lt;li&gt;â€¢ deficiency in the enzyme HPRT&lt;/li&gt;&lt;li&gt;â€¢ hyperuricemia&lt;/li&gt;&lt;li&gt;â€¢ accumulation of uric acid.&lt;/li&gt;&lt;li&gt;â€¢ Option B . Gout : Gout is directly associated with hyperuricemia, as it is caused by the deposition of urate crystals in joints due to elevated levels of uric acid in the blood.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Gout&lt;/li&gt;&lt;li&gt;â€¢ directly associated with hyperuricemia,&lt;/li&gt;&lt;li&gt;â€¢ Option C . Xanthine oxidase hyperactivity : Increased activity of xanthine oxidase would lead to increased conversion of hypoxanthine and xanthine to uric acid, potentially resulting in hyperuricemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Xanthine oxidase hyperactivity&lt;/li&gt;&lt;li&gt;â€¢ Increased activity&lt;/li&gt;&lt;li&gt;â€¢ xanthine oxidase&lt;/li&gt;&lt;li&gt;â€¢ increased conversion&lt;/li&gt;&lt;li&gt;â€¢ hypoxanthine&lt;/li&gt;&lt;li&gt;â€¢ xanthine to uric acid,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbamoyl phosphate synthetase (CPS) deficiency is a urea cycle disorder that results in an inability to convert ammonia into urea, leading to hyperammonemia.&lt;/li&gt;&lt;li&gt;âž¤ Carbamoyl phosphate synthetase&lt;/li&gt;&lt;li&gt;âž¤ urea cycle disorder&lt;/li&gt;&lt;li&gt;âž¤ inability to convert ammonia&lt;/li&gt;&lt;li&gt;âž¤ urea,&lt;/li&gt;&lt;li&gt;âž¤ hyperammonemia.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 272,511.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 272,511.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the rate-controlling step of pyrimidine synthesis which exhibits allosteric inhibition by cytidine triphosphate (CTP)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspartate transcarbamoylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoxanthine-guanine phosphoribosyl transferase (HGPRT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thymidylate synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ribose-phosphate pyrophosphokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aspartate transcarbamoylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Aspartate transcarbamoylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Hypoxanthine-guanine phosphoribosyl transferase (HGPRT): The free purines are salvaged by two different enzymes ; adenine phosphoribosyl transferase (APRTase) and hypoxanthine guanine phosphoribosyl transferase (HGPRTase).&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Hypoxanthine-guanine phosphoribosyl transferase&lt;/li&gt;&lt;li&gt;â€¢ free purines&lt;/li&gt;&lt;li&gt;â€¢ salvaged by two different enzymes&lt;/li&gt;&lt;li&gt;â€¢ Option C . Thymidylate synthase: The methyl group is donated by N5,N10-methylene - THFA. The thymine nucleotide is formed by thymidylate synthase by methylation of dUMP and fluorouracil will inhibit the enzyme, thereby reducing the conversion of dUMP to dTMP.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Thymidylate synthase:&lt;/li&gt;&lt;li&gt;â€¢ methyl group&lt;/li&gt;&lt;li&gt;â€¢ donated by N5,N10-methylene&lt;/li&gt;&lt;li&gt;â€¢ Option D . Ribose-phosphate pyrophosphokinase : In purine biosynthesis , Ribose-5-phosphate + ATP â†’ ADP + Phosphoribosyl pyrophosphate (PRPP), is the donor of ribose-5-phosphate for de novo synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Ribose-phosphate pyrophosphokinase&lt;/li&gt;&lt;li&gt;â€¢ purine biosynthesis&lt;/li&gt;&lt;li&gt;â€¢ Ribose-5-phosphate&lt;/li&gt;&lt;li&gt;â€¢ ATP&lt;/li&gt;&lt;li&gt;â€¢ ADP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aspartate transcarbamoylase (ATCase) is the rate-controlling enzyme of pyrimidine synthesis that is allosterically inhibited by cytidine triphosphate (CTP).&lt;/li&gt;&lt;li&gt;âž¤ Aspartate transcarbamoylase&lt;/li&gt;&lt;li&gt;âž¤ rate-controlling enzyme&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine synthesis&lt;/li&gt;&lt;li&gt;âž¤ allosterically inhibited&lt;/li&gt;&lt;li&gt;âž¤ cytidine triphosphate&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 586.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 586.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the complex biochemical pathway of purine biosynthesis, certain substrates are crucial for the synthesis of the purine nucleotides. Among the following options, which compound is a necessary substrate for the initiation and progression of purine biosynthesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5-Methyl thymidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ara C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphoribosylamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Phosphoribosylpyrophosphate (PRPP)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 5-Phosphoribosylpyrophosphate (PRPP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 5-Phosphoribosylpyrophosphate (PRPP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Purine biosynthesis starts with the formation of PRPP (5-Phosphoribosyl-1-pyrophosphate), a key activated ribose sugar donor.&lt;/li&gt;&lt;li&gt;â€¢ PRPP + Glutamine â†’ 5-Phosphoribosylamine (the first committed step in purine biosynthesis).&lt;/li&gt;&lt;li&gt;â€¢ PRPP is synthesized from ribose-5-phosphate by the enzyme PRPP synthetase. It serves as the foundation onto which the purine ring is built step-by-step.&lt;/li&gt;&lt;li&gt;â€¢ PRPP is synthesized from ribose-5-phosphate by the enzyme PRPP synthetase.&lt;/li&gt;&lt;li&gt;â€¢ It serves as the foundation onto which the purine ring is built step-by-step.&lt;/li&gt;&lt;li&gt;â€¢ Thus, PRPP is essential at both initiation and progression stages.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5 -Methyl thymidine:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 5&lt;/li&gt;&lt;li&gt;â€¢ This is a nucleoside derivative of thymine (used in DNA), not involved in purine biosynthesis (purines = adenine &amp;amp; guanine).&lt;/li&gt;&lt;li&gt;â€¢ This is a nucleoside derivative of thymine (used in DNA), not involved in purine biosynthesis (purines = adenine &amp;amp; guanine).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ara C (Cytarabine):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ara C (Cytarabine):&lt;/li&gt;&lt;li&gt;â€¢ This is a chemotherapy drug, a cytidine analog used to inhibit DNA synthesisâ€”not a substrate for purine biosynthesis.&lt;/li&gt;&lt;li&gt;â€¢ This is a chemotherapy drug, a cytidine analog used to inhibit DNA synthesisâ€”not a substrate for purine biosynthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phosphoribosylamine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phosphoribosylamine:&lt;/li&gt;&lt;li&gt;â€¢ This compound is an intermediate (formed after PRPP reacts with glutamine). It&#x27;s not a substrate to initiate purine biosynthesis, but a product of the first committed step.&lt;/li&gt;&lt;li&gt;â€¢ This compound is an intermediate (formed after PRPP reacts with glutamine).&lt;/li&gt;&lt;li&gt;â€¢ It&#x27;s not a substrate to initiate purine biosynthesis, but a product of the first committed step.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Purine biosynthesis requires PRPP as a substrate. The first committed step is catalyzed by glutamine-PRPP amidotransferase, converting PRPP â†’ phosphoribosylamine. This sets the stage for ring assembly to eventually produce IMP (inosine monophosphate), the precursor of AMP &amp;amp; GMP.&lt;/li&gt;&lt;li&gt;âž¤ Purine biosynthesis requires PRPP as a substrate.&lt;/li&gt;&lt;li&gt;âž¤ The first committed step is catalyzed by glutamine-PRPP amidotransferase, converting PRPP â†’ phosphoribosylamine.&lt;/li&gt;&lt;li&gt;âž¤ This sets the stage for ring assembly to eventually produce IMP (inosine monophosphate), the precursor of AMP &amp;amp; GMP.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 583.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman, recently diagnosed as HIV-positive following exposure from her partner, begins treatment with dideoxycytidine, a nucleoside analog used in antiviral therapy. This medication exerts its effect by interfering with a specific step in the viral replication process. Which of the following best describes the action of dideoxycytidine in inhibiting HIV replication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addition of nucleotides to RNA during transcription of proviral cDNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Formation of a phosphodiester bond during viral DNA synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Formation of a peptide bond during translation of viral proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydrolysis of a phosphodiester bond during viral DNA synthesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Formation of a phosphodiester bond during viral DNA synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Formation of a phosphodiester bond during viral DNA synthesis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Dideoxycytidine (ddC) , also known as zalcitabine , is a nucleoside analog reverse transcriptase inhibitor (NRTI) . It closely resembles cytidine but lacks a 3â€™-hydroxyl (-OH) group on its deoxyribose sugar.&lt;/li&gt;&lt;li&gt;â€¢ Dideoxycytidine (ddC)&lt;/li&gt;&lt;li&gt;â€¢ zalcitabine&lt;/li&gt;&lt;li&gt;â€¢ nucleoside analog reverse transcriptase inhibitor (NRTI)&lt;/li&gt;&lt;li&gt;â€¢ lacks a 3â€™-hydroxyl (-OH) group&lt;/li&gt;&lt;li&gt;â€¢ During reverse transcription , HIV reverse transcriptase incorporates ddC into the growing strand of viral DNA. However, the absence of the 3â€™-OH group means that no new phosphodiester bond can form with the next nucleotide. This causes chain termination , effectively halting DNA synthesis and preventing further viral replication.&lt;/li&gt;&lt;li&gt;â€¢ reverse transcription&lt;/li&gt;&lt;li&gt;â€¢ absence of the 3â€™-OH group&lt;/li&gt;&lt;li&gt;â€¢ no new phosphodiester bond can form&lt;/li&gt;&lt;li&gt;â€¢ chain termination&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Addition of nucleotides to RNA during transcription of proviral cDNA â€“ Incorrect. ddC acts during reverse transcription (RNA â†’ DNA), not during the transcription of DNA to RNA. Option C: Formation of a peptide bond during translation of viral proteins â€“ Incorrect. ddC doesnâ€™t interfere with protein synthesis or translation. Option D: Hydrolysis of a phosphodiester bond during viral DNA synthesis â€“ Incorrect. ddC prevents bond formation; it doesnâ€™t break existing bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Addition of nucleotides to RNA during transcription of proviral cDNA â€“ Incorrect. ddC acts during reverse transcription (RNA â†’ DNA), not during the transcription of DNA to RNA.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Addition of nucleotides to RNA during transcription of proviral cDNA&lt;/li&gt;&lt;li&gt;â€¢ Option C: Formation of a peptide bond during translation of viral proteins â€“ Incorrect. ddC doesnâ€™t interfere with protein synthesis or translation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Formation of a peptide bond during translation of viral proteins&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hydrolysis of a phosphodiester bond during viral DNA synthesis â€“ Incorrect. ddC prevents bond formation; it doesnâ€™t break existing bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hydrolysis of a phosphodiester bond during viral DNA synthesis&lt;/li&gt;&lt;li&gt;â€¢ prevents&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand how NRTIs like dideoxycytidine act by causing premature chain termination during the reverse transcription step of the HIV life cycle. This directly disrupts viral DNA synthesis and is a key antiviral mechanism.&lt;/li&gt;&lt;li&gt;âž¤ NRTIs like dideoxycytidine&lt;/li&gt;&lt;li&gt;âž¤ premature chain termination&lt;/li&gt;&lt;li&gt;âž¤ Ref: Vasudevan 7/e: p706.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;28-year-old female experiences recurrent urinary tract infections (UTIs) and initially receives lower-tier antibiotics, which prove ineffective. Subsequently, she is prescribed a combination therapy containing trimethoprim and sulfamethoxazole, which successfully alleviates her symptoms. This combination is particularly effective due to its ability to disrupt a specific bacterial process. What is the mechanism by which trimethoprim and sulfamethoxazole reduce UTI symptoms in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibit bacterial synthesis of THF&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Block transport across bacterial cell walls&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibit bacterial synthesis of cobalamin (B12)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bind to operons to prevent synthesis of bacterial mRNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inhibit bacterial synthesis of THF&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inhibit bacterial synthesis of THF&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Block transport across bacterial cell walls: This mechanism is not how trimethoprim and sulfamethoxazole work; it is more characteristic of antibiotics like beta-lactams.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Block transport across bacterial cell walls:&lt;/li&gt;&lt;li&gt;â€¢ antibiotics like beta-lactams.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibit bacterial synthesis of cobalamin (B12): Neither trimethoprim nor sulfamethoxazole affects cobalamin synthesis in bacteria.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Inhibit bacterial synthesis of cobalamin&lt;/li&gt;&lt;li&gt;â€¢ affects cobalamin synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bind to operons to prevent synthesis of bacterial mRNA : This description does not represent the action of trimethoprim and sulfamethoxazole ; these drugs specifically target folate synthesis, not mRNA synthesis directly.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Bind to operons to prevent synthesis of bacterial mRNA&lt;/li&gt;&lt;li&gt;â€¢ not represent the action of trimethoprim&lt;/li&gt;&lt;li&gt;â€¢ sulfamethoxazole&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trimethoprim and sulfamethoxazole block two critical steps in bacterial folate synthesis, crucial for DNA production and cell growth, reducing bacterial proliferation and UTI symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Trimethoprim&lt;/li&gt;&lt;li&gt;âž¤ sulfamethoxazole block two critical steps&lt;/li&gt;&lt;li&gt;âž¤ bacterial folate synthesis,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 353-354, 559.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 353-354, 559.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the nucleotide is first formed by the de novo purine biosynthesis:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine 5â€™ monophosphate (AMP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inosine 5â€™ monophosphate (IMP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Xanthine 5â€™ monophosphate (XMP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Guanosine 5â€™ monophosphate (GMP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inosine 5â€™ monophosphate (IMP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/10_jBCykse.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Inosine 5â€™ monophospahte (IMP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Adenosine 5â€™ monophosphate (AMP): AMP is synthesized from IMP and not directly formed during the initial steps of de novo purine biosynthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Adenosine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;â€¢ synthesized from IMP&lt;/li&gt;&lt;li&gt;â€¢ Option C. Xanthine 5â€™ monophosphate (XMP): XMP is an intermediate in the pathway of purine metabolism but not the first nucleotide formed in the de novo synthesis of purines.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Xanthine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;â€¢ intermediate in the pathway of purine metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. Guanosine 5â€™ monophosphate (GMP): Like AMP, GMP is derived from IMP and is not the initial product of the de novo purine biosynthesis pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Guanosine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;â€¢ GMP&lt;/li&gt;&lt;li&gt;â€¢ derived from IMP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Inosine 5â€™ monophosphate (IMP) is the first nucleotide produced in the de novo purine biosynthesis pathway. This pathway builds the purine ring molecule by molecule onto the ribose sugar. Once IMP is synthesized, it can then be further converted into other purine nucleotides, such as adenosine 5â€™ monophosphate (AMP) and guanosine 5â€™ monophosphate (GMP), through a series of specific enzymatic reactions.&lt;/li&gt;&lt;li&gt;âž¤ Inosine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;âž¤ first nucleotide&lt;/li&gt;&lt;li&gt;âž¤ de novo purine biosynthesis pathway.&lt;/li&gt;&lt;li&gt;âž¤ pathway builds&lt;/li&gt;&lt;li&gt;âž¤ purine ring molecule&lt;/li&gt;&lt;li&gt;âž¤ molecule onto the ribose sugar.&lt;/li&gt;&lt;li&gt;âž¤ IMP is synthesized,&lt;/li&gt;&lt;li&gt;âž¤ converted into other purine nucleotides,&lt;/li&gt;&lt;li&gt;âž¤ adenosine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;âž¤ guanosine 5â€™ monophosphate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 7/e: p 583.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 7/e: p 583.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent known for its action on nucleotide metabolism pathways. It specifically targets the synthesis of thymidylate (TMP) in pyrimidine biosynthesis, an essential process for DNA replication and cell division. Considering this mechanism, is the following statement accurate: \&quot;5-Fluorouracil inhibits the synthesis of TMP in pyrimidine biosynthesis\&quot;?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cannot say&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ 5-Fluorouracil (5-FU) is a pyrimidine analog that functions as an anticancer drug. It is converted intracellularly to 5-fluoro-dUMP , which inhibits thymidylate synthase , the enzyme responsible for converting dUMP to dTMP (thymidylate) .&lt;/li&gt;&lt;li&gt;â€¢ 5-Fluorouracil (5-FU)&lt;/li&gt;&lt;li&gt;â€¢ pyrimidine analog&lt;/li&gt;&lt;li&gt;â€¢ converted intracellularly to 5-fluoro-dUMP&lt;/li&gt;&lt;li&gt;â€¢ inhibits thymidylate synthase&lt;/li&gt;&lt;li&gt;â€¢ dUMP to dTMP (thymidylate)&lt;/li&gt;&lt;li&gt;â€¢ This inhibition prevents the formation of TMP , which is necessary for DNA synthesis. Without sufficient TMP, DNA replication stalls, particularly affecting rapidly dividing cells like cancer cells. This is why 5-FU is used to treat various solid tumors.&lt;/li&gt;&lt;li&gt;â€¢ prevents the formation of TMP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand how 5-Fluorouracil targets thymidylate synthase , leading to inhibition of thymidine nucleotide (TMP) synthesis, thus impairing DNA replication in rapidly proliferating cells like tumors.&lt;/li&gt;&lt;li&gt;âž¤ 5-Fluorouracil targets thymidylate synthase&lt;/li&gt;&lt;li&gt;âž¤ Also know that:&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate indirectly affects TMP synthesis by inhibiting dihydrofolate reductase (DHFR) , reducing tetrahydrofolate availability for thymidylate synthesis. 5-FU directly inhibits thymidylate synthase , making it a more targeted inhibitor of TMP production.&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate indirectly affects TMP synthesis by inhibiting dihydrofolate reductase (DHFR) , reducing tetrahydrofolate availability for thymidylate synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Methotrexate&lt;/li&gt;&lt;li&gt;âž¤ dihydrofolate reductase (DHFR)&lt;/li&gt;&lt;li&gt;âž¤ 5-FU directly inhibits thymidylate synthase , making it a more targeted inhibitor of TMP production.&lt;/li&gt;&lt;li&gt;âž¤ 5-FU directly inhibits thymidylate synthase&lt;/li&gt;&lt;li&gt;âž¤ more targeted inhibitor&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p717.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;DNA is characterized by its unique composition of nitrogenous bases, which are fundamental to its structure and function. Among the options listed below, which base is notably absent in DNA, distinguishing it from RNA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uracil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Guanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Uracil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Uracil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Cytosine : Cytosine is present in both DNA and RNA. In DNA, cytosine pairs with guanine through three hydrogen bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Cytosine&lt;/li&gt;&lt;li&gt;â€¢ present in both DNA and RNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C . Guanine: Guanine is one of the four main nitrogenous bases found in DNA , where it pairs with cytosine.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Guanine:&lt;/li&gt;&lt;li&gt;â€¢ one of the four main nitrogenous bases&lt;/li&gt;&lt;li&gt;â€¢ DNA&lt;/li&gt;&lt;li&gt;â€¢ Option D . Adenine: Adenine is also present in DNA, where it pairs with thymine through two hydrogen bonds. In RNA, adenine pairs with uracil&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ present in DNA,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Uracil is the nitrogenous base that is present in RNA but not in DNA. In DNA, thymine is used instead of uracil. This distinction is crucial in differentiating DNA from RNA, both structurally and functionally.&lt;/li&gt;&lt;li&gt;âž¤ Uracil&lt;/li&gt;&lt;li&gt;âž¤ nitrogenous base&lt;/li&gt;&lt;li&gt;âž¤ present in RNA&lt;/li&gt;&lt;li&gt;âž¤ DNA,&lt;/li&gt;&lt;li&gt;âž¤ thymine&lt;/li&gt;&lt;li&gt;âž¤ used&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 360.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 360.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biochemistry laboratory technician observes the crystalline structures shown in the provided image after performing an osazone test to identify reducing sugars in a patient&#x27;s urine. Which sugar is most likely responsible for the formation of these specific osazone crystals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Maltosazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucosazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactosazone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lactosazone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture6_1gzAju7.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(4).png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(5).png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lactosazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Maltosazone : Maltosazone crystals tend to have a \&quot;pom-pom\&quot; or \&quot;sunflower\&quot; shape with radial striations, which does not match the crystals in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Maltosazone&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gout : The term &#x27;gout&#x27; refers to a clinical condition characterized by the deposition of monosodium urate crystals, not related to the sugar-derived osazone crystals seen in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gout&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucosazone : Glucosazone typically forms as needle-like clusters, which while somewhat similar, are generally less defined and rosette-like compared to lactosazone crystals.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Glucosazone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The osazone test is to distinguish between different reducing sugars based on the characteristic crystalline structures they form when reacted with phenylhydrazine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 583.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team studying bacterial genetics exposes a culture to a chemical mutagen. The bacteria, which typically require minimal nutrition, are then plated on a nutrient-rich medium. Individual colonies that form are subsequently tested for their ability to grow on a minimal medium. Those failing to thrive are identified as mutants, and genomic sequencing reveals a deletion of a two-nucleotide segment in their DNA. What type of mutation does this deletion most likely produce?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Frameshift mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conservative mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Missense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nonsense mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Frameshift mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Frameshift mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative mutation (Incorrect): It is a Missense mutation which leads to the substitution of a given amino acid with a chemically similar amino acid .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative mutation (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ Missense mutation&lt;/li&gt;&lt;li&gt;â€¢ leads to the substitution&lt;/li&gt;&lt;li&gt;â€¢ amino acid&lt;/li&gt;&lt;li&gt;â€¢ chemically similar amino acid&lt;/li&gt;&lt;li&gt;â€¢ Option C. Missense mutation (Incorrect): It leads to the replacement of a given amino acid with a different amino acid.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Missense mutation (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ replacement&lt;/li&gt;&lt;li&gt;â€¢ given amino acid&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonsense mutation (Incorrect): It introduces a stop codon instead of a codon specific for an amino acid, causing premature chain termination.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nonsense mutation (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ introduces a stop codon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The deletion of a two-nucleotide segment within a gene&#x27;s coding region typically results in a frameshift mutation . Because the genetic code is read in triplets (codons), removing two nucleotides alters the reading frame downstream of the mutation , likely changing every subsequent amino acid in the protein product . This shift can lead to a nonfunctional protein due to extensive missense mutations and the potential introduction of a premature stop codon (nonsense mutation).&lt;/li&gt;&lt;li&gt;âž¤ deletion of a two-nucleotide segment&lt;/li&gt;&lt;li&gt;âž¤ gene&#x27;s coding region&lt;/li&gt;&lt;li&gt;âž¤ frameshift mutation&lt;/li&gt;&lt;li&gt;âž¤ genetic code&lt;/li&gt;&lt;li&gt;âž¤ read in triplets&lt;/li&gt;&lt;li&gt;âž¤ removing two nucleotides alters&lt;/li&gt;&lt;li&gt;âž¤ reading frame downstream&lt;/li&gt;&lt;li&gt;âž¤ mutation&lt;/li&gt;&lt;li&gt;âž¤ changing&lt;/li&gt;&lt;li&gt;âž¤ subsequent amino acid&lt;/li&gt;&lt;li&gt;âž¤ protein product&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 417-418.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 417-418.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A couple with a 5-year-old son diagnosed with glucose-6-phosphate dehydrogenase (G6PD) deficiency is expecting another child. The mother, currently pregnant, is concerned about her unborn daughter potentially having the same condition, despite both parents being clinically unaffected. Considering the genetic nature of G6PD deficiency, which of the following statements is true regarding the risk to the female fetus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The baby has a 25% chance of clinical disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The baby has a 50% chance of being a carrier&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The baby will be a carrier&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The baby has a 50% chance of clinical disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. The baby has a 50% chance of being a carrier&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture5_PzSv4Iw.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B. The baby has a 50% chance of being a carrier&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ G6PD deficiency is an X-linked recessive disorder. Here&#x27;s how the inheritance works:&lt;/li&gt;&lt;li&gt;â€¢ Males (XY): If they inherit the defective X chromosome, they express the disease because they have only one X. Females (XX): Need two defective X chromosomes to express the disease. If they inherit one defective X, they are typically carriers.&lt;/li&gt;&lt;li&gt;â€¢ Males (XY): If they inherit the defective X chromosome, they express the disease because they have only one X.&lt;/li&gt;&lt;li&gt;â€¢ Males (XY):&lt;/li&gt;&lt;li&gt;â€¢ Females (XX): Need two defective X chromosomes to express the disease. If they inherit one defective X, they are typically carriers.&lt;/li&gt;&lt;li&gt;â€¢ Females (XX):&lt;/li&gt;&lt;li&gt;â€¢ In this scenario:&lt;/li&gt;&lt;li&gt;â€¢ In this scenario:&lt;/li&gt;&lt;li&gt;â€¢ The son is affected, meaning he must have inherited the defective X chromosome from his mother. Both parents are clinically unaffected, so: The mother is likely a carrier (Xá´ºXá´°), and The father is normal (Xá´ºY).&lt;/li&gt;&lt;li&gt;â€¢ The son is affected, meaning he must have inherited the defective X chromosome from his mother.&lt;/li&gt;&lt;li&gt;â€¢ Both parents are clinically unaffected, so: The mother is likely a carrier (Xá´ºXá´°), and The father is normal (Xá´ºY).&lt;/li&gt;&lt;li&gt;â€¢ The mother is likely a carrier (Xá´ºXá´°), and The father is normal (Xá´ºY).&lt;/li&gt;&lt;li&gt;â€¢ The mother is likely a carrier (Xá´ºXá´°), and&lt;/li&gt;&lt;li&gt;â€¢ The father is normal (Xá´ºY).&lt;/li&gt;&lt;li&gt;â€¢ When a carrier mother (Xá´ºXá´°) and a normal father (Xá´ºY) have a daughter, the daughter has:&lt;/li&gt;&lt;li&gt;â€¢ 50% chance of being a carrier (Xá´ºXá´°) 50% chance of being completely normal (Xá´ºXá´º)&lt;/li&gt;&lt;li&gt;â€¢ 50% chance of being a carrier (Xá´ºXá´°)&lt;/li&gt;&lt;li&gt;â€¢ 50% chance of being completely normal (Xá´ºXá´º)&lt;/li&gt;&lt;li&gt;â€¢ Thus, the risk to the female fetus is 50% chance of being a carrier.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 25% chance of clinical disease : Incorrect. A female would need two defective X chromosomes to be affected, which isn&#x27;t the case here. Option C. The baby will be a carrier : Incorrect. Thereâ€™s a 50% chance, not 100%. Option D. 50% chance of clinical disease :  Incorrect. Females are typically only carriers unless both X chromosomes are defective.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 25% chance of clinical disease : Incorrect. A female would need two defective X chromosomes to be affected, which isn&#x27;t the case here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 25% chance of clinical disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. The baby will be a carrier : Incorrect. Thereâ€™s a 50% chance, not 100%.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The baby will be a carrier&lt;/li&gt;&lt;li&gt;â€¢ Option D. 50% chance of clinical disease :  Incorrect. Females are typically only carriers unless both X chromosomes are defective.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 50% chance of clinical disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency is the most common enzyme deficiency leading to hemolytic anemia. It affects the pentose phosphate pathway, reducing the production of NADPH, which is essential for maintaining reduced glutathione that protects cells from oxidative damage. This condition predominantly affects males, while female carriers are usually asymptomatic.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 693-694.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the provided diagram, which of the following statements is correct&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Variable arm (short Extra Arm ) is between anticodon arm &amp;amp; DHU arm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acceptor arm has 3 paired nucleotides AAC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anticodon arm : base pairing occur between 3â€™ to 5â€™direction of anticodon &amp;amp; 5â€™ to 3â€™ direction of codon.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anticodon arm : base pairing occur between 3â€™ to 5â€™direction of anticodon &amp; 5â€™ to 3â€™ direction of codon.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(6).png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/151.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(7).png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Anticodon arm : base pairing occur between 3â€™ to 5â€™ direction of anticodon &amp;amp; 5â€™ to 3â€™ direction of codon.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ tRNA molecules serve as adaptors between codons in mRNA and amino acids in proteins. The anticodon loop of the tRNA pairs with the mRNA codon , ensuring correct amino acid incorporation. The structural orientation (anticodon 3â€²â†’5â€², codon 5â€²â†’3â€²) is vital for this process to occur accurately.&lt;/li&gt;&lt;li&gt;âž¤ anticodon loop&lt;/li&gt;&lt;li&gt;âž¤ mRNA codon&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p366, 416.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-day-old infant exhibits difficulty feeding, cyanosis post-feeding, general hypotonia, and a detectable heart murmur. On examination, the infant has a flat occiput, epicanthic folds, and a single palmar crease. There is a noted family history of Down syndrome. Given these clinical findings, which karyotype result from the chromosome analysis provided would you expect to find in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Result A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Result B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Result C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Result D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Result C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/patho1.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Result C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Result : Would likely represent a normal karyotype, which would not be consistent with the clinical presentation of Down syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Result&lt;/li&gt;&lt;li&gt;â€¢ Option B. Result : Could indicate another chromosomal abnormality that does not align with Down syndrome&#x27;s typical presentation, possibly a translocation or deletion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Result&lt;/li&gt;&lt;li&gt;â€¢ Option D. Result : Could indicate another chromosomal abnormality that does not align with Down syndrome&#x27;s typical presentation, possibly a translocation or deletion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Result&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Down syndrome is characterized by an extra copy of chromosome 21, which is a trisomy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 635&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Regarding the lactose (lac) operon in bacteria, which of the following statements is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contain three structural genes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contain operator region&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Contain regulatory genes, an operator gene, three structural genes and a promoter site&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contain three structural genes, an operator and regulatory gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Contain regulatory genes, an operator gene, three structural genes and a promoter site&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture8_7dnvrf3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Contain regulatory genes, an operator gene, three structural genes and a promoter site.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contains three structural genes: While true , this option is incomplete as it doesn&#x27;t mention other critical components of the lac operon.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Contains three structural genes:&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B. Contains operator region: This is also correct but incomplete, as the lac operon includes more than just an operator region.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Contains operator region:&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option D. Contains three structural genes, an operator, and a regulatory gene: This option is partially correct but lacks the mention of the promoter site and implies the regulatory gene is part of the operon, whereas it is usually located elsewhere on the chromosome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Contains three structural genes, an operator, and a regulatory gene:&lt;/li&gt;&lt;li&gt;â€¢ partially correct&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The lac operon is a well-studied example of a gene regulatory system and includes three structural genes (lacZ, lacY, and lacA) that are involved in lactose metabolism . It also has a promoter site where RNA polymerase binds to initiate transcription , an operator site where the lac repressor can bind to inhibit transcription , and regulatory genes (such as the lacI gene that codes for the lac repressor protein) that control the operon&#x27;s expression.&lt;/li&gt;&lt;li&gt;âž¤ lac operon&lt;/li&gt;&lt;li&gt;âž¤ gene regulatory system&lt;/li&gt;&lt;li&gt;âž¤ three structural genes&lt;/li&gt;&lt;li&gt;âž¤ lactose metabolism&lt;/li&gt;&lt;li&gt;âž¤ promoter site&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase binds to initiate transcription&lt;/li&gt;&lt;li&gt;âž¤ operator site&lt;/li&gt;&lt;li&gt;âž¤ lac repressor can bind&lt;/li&gt;&lt;li&gt;âž¤ inhibit transcription&lt;/li&gt;&lt;li&gt;âž¤ regulatory genes&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 636&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 636&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following options correctly lists the core histone proteins that make up the nucleosome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;H2, H3A, H3B, H4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;H2A, H2B, H3, H4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H2, H3, H4A, H4B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;H1A, H1B, H2, H3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. H2A, H2B, H3, H4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) H2A, H2B, H3, H4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The core histone proteins that constitute the nucleosome are H2A, H2B, H3, and H4.&lt;/li&gt;&lt;li&gt;âž¤ core histone proteins&lt;/li&gt;&lt;li&gt;âž¤ constitute the nucleosome&lt;/li&gt;&lt;li&gt;âž¤ H2A, H2B, H3, and H4.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 371&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 371&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman who has inherited one mutant allele of the BRCA1 gene has a 60% risk of developing breast cancer by age 50. The BRCA1 gene encodes a protein that plays a crucial role in the repair of DNA double-strand breaks. Which DNA repair process is most likely impaired by a deficiency in BRCA1 protein function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Removal of thymine dimers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Removal of RNA primers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Removal of carcinogen adducts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Homologous recombination&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Homologous recombination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Homologous recombination&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Removal of thymine dimers: This is generally managed by nucleotide excision repair , not by homologous recombination.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Removal of thymine dimers:&lt;/li&gt;&lt;li&gt;â€¢ managed by nucleotide excision repair&lt;/li&gt;&lt;li&gt;â€¢ Option B. Removal of RNA primers: RNA primers are removed during DNA replication , a process unrelated to the repair function of BRCA1.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Removal of RNA primers:&lt;/li&gt;&lt;li&gt;â€¢ removed during DNA replication&lt;/li&gt;&lt;li&gt;â€¢ Option C. Removal of carcinogen adducts: Like thymine dimers, carcinogen adducts are typically addressed by nucleotide excision repair .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Removal of carcinogen adducts:&lt;/li&gt;&lt;li&gt;â€¢ addressed by nucleotide excision repair&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 protein is fundamentally involved in the repair of DNA double-strand breaks primarily through homologous recombination , a critical process during cell division that ensures the accurate repair of DNA to prevent mutations that could lead to cancer . When BRCA1 function is compromised, the efficiency of homologous recombination repair is significantly reduced, which increases the risk of genomic instability and contributes to cancer predisposition, particularly breast and ovarian cancers.&lt;/li&gt;&lt;li&gt;âž¤ BRCA1 protein&lt;/li&gt;&lt;li&gt;âž¤ involved in the repair of DNA double-strand&lt;/li&gt;&lt;li&gt;âž¤ homologous recombination&lt;/li&gt;&lt;li&gt;âž¤ cell division&lt;/li&gt;&lt;li&gt;âž¤ accurate repair of DNA&lt;/li&gt;&lt;li&gt;âž¤ lead to cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  P 389-390.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  P 389-390.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What does this diagram best illustrate about the regulation of gene expression in eukaryotic cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mRNA editing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alternate splicing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Translation of m RNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RNA interference&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alternate splicing&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture3_hRzCPwf.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alternate splicing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA editing: It is a post-transcriptional modification of mRNA, which is seen in apolipoprotein (apo) B of chylomicrons and VLDL.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA editing:&lt;/li&gt;&lt;li&gt;â€¢ post-transcriptional modification&lt;/li&gt;&lt;li&gt;â€¢ mRNA,&lt;/li&gt;&lt;li&gt;â€¢ Option C. Translation of mRNA: Is the mechanism of regulation of translation by phosphorylation of the eukaryotic translation initiation factor, eIF-2.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Translation of mRNA:&lt;/li&gt;&lt;li&gt;â€¢ mechanism of regulation&lt;/li&gt;&lt;li&gt;â€¢ translation&lt;/li&gt;&lt;li&gt;â€¢ Option D. RNA interference: It is a mechanism of gene silencing either by repression of translation or increased degradation causing decreased expression of mRNA and it plays an important role in cell proliferation, differentiation, and apoptosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RNA interference:&lt;/li&gt;&lt;li&gt;â€¢ mechanism of gene silencing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alternate splicing , a process by which different combinations of exons are joined (or spliced) together to generate multiple distinct mRNA transcripts from a single gene . This results in the production of different protein isoforms from the same DNA sequence , increasing the diversity of proteins that a single gene can produce.&lt;/li&gt;&lt;li&gt;âž¤ Alternate splicing&lt;/li&gt;&lt;li&gt;âž¤ different combinations of exons&lt;/li&gt;&lt;li&gt;âž¤ joined&lt;/li&gt;&lt;li&gt;âž¤ together&lt;/li&gt;&lt;li&gt;âž¤ generate multiple distinct mRNA transcripts&lt;/li&gt;&lt;li&gt;âž¤ single gene&lt;/li&gt;&lt;li&gt;âž¤ production of different protein isoforms&lt;/li&gt;&lt;li&gt;âž¤ same DNA sequence&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 457&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 457&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-month-old baby has developmental delay, and the blood work shows megaloblastic anaemia, though B12 and folate are in the higher range. Urinalysis shows formation of a crystalline substance upon standing. Supplementation of the childâ€™s diet with uridine reversed all the clinical symptoms. The crystalline substance is composed of which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Uracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thymine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Orotate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspartate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Orotate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Orotate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary orotic aciduria , a rare autosomal recessive disorder , characterized by a deficiency in the enzyme UMP synthase, crucial for the de novo synthesis of pyrimidine nucleotides . The deficiency leads to an accumulation of orotic acid, which is excreted in the urine and can crystallize.&lt;/li&gt;&lt;li&gt;âž¤ Hereditary orotic aciduria&lt;/li&gt;&lt;li&gt;âž¤ rare autosomal recessive disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme UMP synthase,&lt;/li&gt;&lt;li&gt;âž¤ de novo synthesis&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine nucleotides&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 587.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 587.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A) : Urea Cycle Disorder and Orotic Aciduria are interlinked. Reasoning (R) : Orotic aciduria occurs in ornithine transcarbamoylase deficiency (a urea cycle enzyme) due to the accumulation of carbamoyl phosphate, which then enters the cytosol and serves as a substrate for pyrimidine biosynthesis. Which of the following is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Urea cycle disorders , such as ornithine transcarbamoylase (OTC) deficiency , can lead to the accumulation of carbamoyl phosphate, which can then spill over into the cytosol and be used as a substrate for pyrimidine biosynthesis, resulting in orotic aciduria.&lt;/li&gt;&lt;li&gt;âž¤ Urea cycle disorders&lt;/li&gt;&lt;li&gt;âž¤ ornithine transcarbamoylase&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ accumulation of carbamoyl phosphate,&lt;/li&gt;&lt;li&gt;âž¤ spill over into the cytosol&lt;/li&gt;&lt;li&gt;âž¤ substrate for pyrimidine biosynthesis,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: P 587.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: P 587.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a routine evaluation, a 4-year-old boy with developmental delays is noted to have distinct facial features, including a long face and large ears, along with macroorchidism. The boy&#x27;s family history reveals a pattern of intellectual disability predominantly affecting male relatives. Based on the clinical presentation and family history, the physician suspects a genetic condition characterized by a trinucleotide repeat expansion. Which of the following diagnoses is most consistent with these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Turner syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Edwards syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fragile X syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Klinefelter syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Fragile X syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture4.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Fragile X syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Turner syndrome is a chromosomal disorder involving a missing or partially missing X chromosome , affecting only females, and is characterized by short stature and ovarian dysfunction, not intellectual disability.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Turner syndrome&lt;/li&gt;&lt;li&gt;â€¢ chromosomal disorder&lt;/li&gt;&lt;li&gt;â€¢ missing or partially missing X chromosome&lt;/li&gt;&lt;li&gt;â€¢ Option B: Edwards syndrome, or trisomy 18 , is a chromosomal condition associated with a wide spectrum of severe clinical manifestations, including profound developmental delays and structural anomalies; it is not a trinucleotide repeat disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Edwards syndrome,&lt;/li&gt;&lt;li&gt;â€¢ trisomy 18&lt;/li&gt;&lt;li&gt;â€¢ chromosomal condition&lt;/li&gt;&lt;li&gt;â€¢ wide spectrum&lt;/li&gt;&lt;li&gt;â€¢ Option D: Klinefelter syndrome is characterized by the presence of an extra X chromosome in males (47, XXY) and is associated with hypogonadism and reduced fertility, but not typically with the facial features or intellectual disability pattern seen in Fragile X syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Klinefelter syndrome&lt;/li&gt;&lt;li&gt;â€¢ presence of an extra X chromosome in males&lt;/li&gt;&lt;li&gt;â€¢ hypogonadism&lt;/li&gt;&lt;li&gt;â€¢ reduced fertility,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p378, DM Vasudevan 9/e: p 578.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p378, DM Vasudevan 9/e: p 578.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A group of geneticists is reviewing epigenetic modifications to determine which ones are typically associated with a permissive state of chromatin, allowing gene transcription. They aim to identify which modification is not generally associated with a more open chromatin configuration conducive to transcription. Which of the following chromatin modifications is usually not considered permissive for gene expression?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methylation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sumoylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphorylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Methylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Methylation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acetylation and Option D : Phosphorylation of histone adds negative charge . This -ve charge repels negative charge of DNA. So, DNA become free from histones and available for transcription . Acetylation &amp;amp; Phosphorylation of Histones leads to Euchromatin formation or permissive chromatin formation.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Acetylation&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Phosphorylation&lt;/li&gt;&lt;li&gt;â€¢ histone adds negative charge&lt;/li&gt;&lt;li&gt;â€¢ -ve charge repels negative charge&lt;/li&gt;&lt;li&gt;â€¢ DNA.&lt;/li&gt;&lt;li&gt;â€¢ DNA&lt;/li&gt;&lt;li&gt;â€¢ free from histones&lt;/li&gt;&lt;li&gt;â€¢ available for transcription&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sumoylation is the attachment of small ubiquitin-like modifier (SUMO) proteins to target proteins , including histones . Sumoylation of histones can have variable effects on gene expression , but it is generally associated with gene repression by promoting the formation of repressive chromatin structures. However, the role of sumoylation is not yet very clearly defined.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Sumoylation&lt;/li&gt;&lt;li&gt;â€¢ attachment of small ubiquitin-like modifier&lt;/li&gt;&lt;li&gt;â€¢ proteins&lt;/li&gt;&lt;li&gt;â€¢ target proteins&lt;/li&gt;&lt;li&gt;â€¢ histones&lt;/li&gt;&lt;li&gt;â€¢ Sumoylation&lt;/li&gt;&lt;li&gt;â€¢ histones&lt;/li&gt;&lt;li&gt;â€¢ variable effects&lt;/li&gt;&lt;li&gt;â€¢ gene expression&lt;/li&gt;&lt;li&gt;â€¢ So, the one best answer is methylation which has clear well defined role on gene inactivation. But for multiple answers, both Methylation and Sumoylation can be marked.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methylation is often associated with chromatin compaction and transcriptional repression , while acetylation and phosphorylation generally promote a more open chromatin structure and active transcription , is crucial for grasping the complexities of gene regulation mechanisms at the epigenetic level. Sumoylation&#x27;s role is more variable and context-dependent, illustrating the nuanced nature of epigenetic regulation.&lt;/li&gt;&lt;li&gt;âž¤ Methylation&lt;/li&gt;&lt;li&gt;âž¤ chromatin compaction&lt;/li&gt;&lt;li&gt;âž¤ transcriptional repression&lt;/li&gt;&lt;li&gt;âž¤ acetylation&lt;/li&gt;&lt;li&gt;âž¤ phosphorylation&lt;/li&gt;&lt;li&gt;âž¤ promote a more open chromatin structure&lt;/li&gt;&lt;li&gt;âž¤ active transcription&lt;/li&gt;&lt;li&gt;âž¤ grasping the complexities of gene regulation mechanisms&lt;/li&gt;&lt;li&gt;âž¤ epigenetic level.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9 e p: 604. (Ref: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC8216275/ )&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9 e p: 604.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the bonds between A-T base pairs is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-T base pairs are connected by three hydrogen bonds.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-T base pairs are connected by two hydrogen bonds.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-T base pairs are connected by triple covalent bonds.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-T base pairs do not form hydrogen bonds.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A-T base pairs are connected by two hydrogen bonds.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A-T base pairs are connected by two hydrogen bonds.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A-T base pairs are connected by three hydrogen bonds - This is incorrect because A-T base pairs form only two hydrogen bonds . It&#x27;s the G-C base pairs that are connected by three hydrogen bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A: A-T base pairs are connected by three hydrogen bonds -&lt;/li&gt;&lt;li&gt;â€¢ A-T base pairs form&lt;/li&gt;&lt;li&gt;â€¢ two hydrogen bonds&lt;/li&gt;&lt;li&gt;â€¢ Option C: A-T base pairs are connected by triple covalent bonds - This is incorrect as A-T base pairs are connected by hydrogen bonds , not covalent bonds. Hydrogen bonds are weaker and more suitable for the dynamic processes of DNA replication and transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option C: A-T base pairs are connected by triple covalent bonds -&lt;/li&gt;&lt;li&gt;â€¢ A-T base pairs&lt;/li&gt;&lt;li&gt;â€¢ connected by hydrogen bonds&lt;/li&gt;&lt;li&gt;â€¢ Option D: A-T base pairs do not form hydrogen bonds - This is incorrect as A-T base pairs do form hydrogen bonds ; specifically, they form two hydrogen bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option D: A-T base pairs do not form hydrogen bonds -&lt;/li&gt;&lt;li&gt;â€¢ A-T base pairs do form hydrogen bonds&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hydrogen Bonding: The DNA strands are held together by hydrogen bonds between the purine and pyrimidine bases. There are three hydrogen bonds formed between C and G and Two Hydrogen bonds formed between A and T . Hence, the GC bond is stronger than the AT bond.&lt;/li&gt;&lt;li&gt;âž¤ Hydrogen Bonding: The DNA strands are held together by hydrogen bonds between the purine and pyrimidine bases.&lt;/li&gt;&lt;li&gt;âž¤ Hydrogen Bonding:&lt;/li&gt;&lt;li&gt;âž¤ DNA strands&lt;/li&gt;&lt;li&gt;âž¤ held together&lt;/li&gt;&lt;li&gt;âž¤ hydrogen bonds&lt;/li&gt;&lt;li&gt;âž¤ There are three hydrogen bonds formed between C and G and Two Hydrogen bonds formed between A and T .&lt;/li&gt;&lt;li&gt;âž¤ three hydrogen bonds&lt;/li&gt;&lt;li&gt;âž¤ between C and G&lt;/li&gt;&lt;li&gt;âž¤ Two Hydrogen bonds&lt;/li&gt;&lt;li&gt;âž¤ between A and T&lt;/li&gt;&lt;li&gt;âž¤ Hence, the GC bond is stronger than the AT bond.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e:  p397.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 6/e:  p397.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a genetics seminar, a professor challenges the postgraduate students with a fundamental question about the structure of genetic code. She asks, \&quot;A codon, which is essential for the translation process in protein synthesis, consists of 2 consecutive nuclotides. Is this statement true or false?\&quot;&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.False&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A codon is a sequence of three nucleotides that together form a unit of genetic code in a DNA or RNA molecule . Each codon specifies a single amino acid in a protein or a start/stop signal for protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ codon&lt;/li&gt;&lt;li&gt;âž¤ sequence of three nucleotides&lt;/li&gt;&lt;li&gt;âž¤ together form a unit of genetic code&lt;/li&gt;&lt;li&gt;âž¤ DNA or RNA molecule&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 415.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A genetic analysis reveals that a single nucleotide base pair change has transformed a protein-coding codon into a terminating codon. What is this type of mutation called?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Missense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nonsense mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frameshift mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Silent mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nonsense mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Missense but Acceptable Mutation: A change in amino acid may be produced in the protein and no functional consequences.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Missense but Acceptable Mutation:&lt;/li&gt;&lt;li&gt;â€¢ change in amino acid&lt;/li&gt;&lt;li&gt;â€¢ Mis-sense; Partially Acceptable Mutation : The amino acid substitution affects the functional properties of the protein .&lt;/li&gt;&lt;li&gt;â€¢ Mis-sense; Partially Acceptable Mutation&lt;/li&gt;&lt;li&gt;â€¢ amino acid substitution&lt;/li&gt;&lt;li&gt;â€¢ functional properties&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ Mis-sense; Unacceptable Mutation : The single amino acid substitution alters the properties of the protein to such an extent that it becomes non-functional and the condition is incompatible with normal life.&lt;/li&gt;&lt;li&gt;â€¢ Mis-sense; Unacceptable Mutation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frameshift mutation: This is due to addition or deletion of bases â†’ the reading frame shifts â†’ a â€œgarbledâ€ (completely irrelevant) protein, with altered amino acid sequence is produced.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Frameshift mutation:&lt;/li&gt;&lt;li&gt;â€¢ addition or deletion of bases&lt;/li&gt;&lt;li&gt;â€¢ Option D. Silent mutation: A point mutation may change the codon for one amino acid to a synonym for the same amino acid.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Silent mutation:&lt;/li&gt;&lt;li&gt;â€¢ point mutation&lt;/li&gt;&lt;li&gt;â€¢ change the codon&lt;/li&gt;&lt;li&gt;â€¢ one amino acid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A nonsense mutation occurs when a single nucleotide change results in the conversion of a protein-coding codon into a stop codon . This mutation leads to the premature termination of the protein chain , potentially resulting in a truncated and usually nonfunctional protein.&lt;/li&gt;&lt;li&gt;âž¤ nonsense mutation&lt;/li&gt;&lt;li&gt;âž¤ single nucleotide&lt;/li&gt;&lt;li&gt;âž¤ conversion of a protein-coding codon&lt;/li&gt;&lt;li&gt;âž¤ stop codon&lt;/li&gt;&lt;li&gt;âž¤ mutation leads&lt;/li&gt;&lt;li&gt;âž¤ premature termination&lt;/li&gt;&lt;li&gt;âž¤ protein chain&lt;/li&gt;&lt;li&gt;âž¤ truncated&lt;/li&gt;&lt;li&gt;âž¤ nonfunctional protein.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 631&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan  9/e: p 631&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following options correctly describes Epigenetics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chemical modification of DNA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Irreversible modification of DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Change in nucleotide sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal variation of nucleotides&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chemical modification of DNA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Chemical modification of DNA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Irreversible modification of DNA: Epigenetic modifications are typically reversible , allowing for dynamic changes in gene expression in response to environmental stimuli or developmental cues.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Irreversible modification of DNA:&lt;/li&gt;&lt;li&gt;â€¢ typically reversible&lt;/li&gt;&lt;li&gt;â€¢ Option C. Change in nucleotide sequence: Epigenetics does not involve changes to the DNA sequence itself; it involves modifications that affect how genes are expressed.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Change in nucleotide sequence:&lt;/li&gt;&lt;li&gt;â€¢ not involve changes to the DNA sequence&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal variation of nucleotides: This option might describe genetic polymorphisms or variations that occur naturally within populations, not epigenetic changes.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Normal variation of nucleotides:&lt;/li&gt;&lt;li&gt;â€¢ genetic polymorphisms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mechanisms of Genomic Imprinting&lt;/li&gt;&lt;li&gt;âž¤ Mechanisms of Genomic Imprinting&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation&lt;/li&gt;&lt;li&gt;âž¤ most common mechanism occurs at CG site/CG Island/CpG sites (C &amp;amp; G together present on same strands) cytosine is usually methylated in CG site that causes inactivation of the gene DNA methylation can be detected by Na bisulfite method.&lt;/li&gt;&lt;li&gt;âž¤ most common mechanism&lt;/li&gt;&lt;li&gt;âž¤ occurs at CG site/CG Island/CpG sites (C &amp;amp; G together present on same strands)&lt;/li&gt;&lt;li&gt;âž¤ cytosine is usually methylated in CG site that causes inactivation of the gene&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation can be detected by Na bisulfite method.&lt;/li&gt;&lt;li&gt;âž¤ PTM of Histones: Histone Deacetylation Histone Methylation Methods to detect PTMs: Chromatin Immuno Precipitation (ChIP)&lt;/li&gt;&lt;li&gt;âž¤ PTM of Histones: Histone Deacetylation Histone Methylation Methods to detect PTMs: Chromatin Immuno Precipitation (ChIP)&lt;/li&gt;&lt;li&gt;âž¤ PTM of Histones:&lt;/li&gt;&lt;li&gt;âž¤ Histone Deacetylation Histone Methylation Methods to detect PTMs: Chromatin Immuno Precipitation (ChIP)&lt;/li&gt;&lt;li&gt;âž¤ Histone Deacetylation&lt;/li&gt;&lt;li&gt;âž¤ Histone Methylation&lt;/li&gt;&lt;li&gt;âž¤ Methods to detect PTMs: Chromatin Immuno Precipitation (ChIP)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 440.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 440.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is utilizing various laboratory techniques to quantify the concentration of DNA samples extracted from patient biopsies. They are considering the most appropriate method that would provide accurate, rapid, and non-destructive analysis. Which of the following instruments is best suited for the quantitative analysis of DNA in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gel electrophoresis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;UV spectrometer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Light microscope&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PCR machine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. UV spectrometer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) UV spectrometer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A UV spectrometer (or spectrophotometer) is the standard and most widely used instrument for the rapid, non-destructive quantification of DNA .&lt;/li&gt;&lt;li&gt;â€¢ UV spectrometer (or spectrophotometer)&lt;/li&gt;&lt;li&gt;â€¢ rapid, non-destructive quantification of DNA&lt;/li&gt;&lt;li&gt;â€¢ DNA strongly absorbs ultraviolet light at a wavelength of 260 nm due to its nucleotide bases. Using Beer-Lambertâ€™s law, the absorbance at this wavelength can be directly related to the DNA concentration:&lt;/li&gt;&lt;li&gt;â€¢ 260 nm&lt;/li&gt;&lt;li&gt;â€¢ This method is:&lt;/li&gt;&lt;li&gt;â€¢ Fast Non-destructive Accurate for pure DNA samples.&lt;/li&gt;&lt;li&gt;â€¢ Fast&lt;/li&gt;&lt;li&gt;â€¢ Fast&lt;/li&gt;&lt;li&gt;â€¢ Non-destructive&lt;/li&gt;&lt;li&gt;â€¢ Non-destructive&lt;/li&gt;&lt;li&gt;â€¢ Accurate for pure DNA samples.&lt;/li&gt;&lt;li&gt;â€¢ Accurate&lt;/li&gt;&lt;li&gt;â€¢ In contrast to other methods, it does not require dyes, gels, or amplification, making it ideal for direct concentration measurement.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gel electrophoresis: Useful for qualitative analysis (e.g., DNA size, integrity) but not as accurate for quantification. It is also destructive, and staining agents like ethidium bromide are needed. Option C) Light microscope: Incorrect. A light microscope is used to visualize cells or large cell structures , not molecules like DNA, and cannot provide concentration data. Option D) PCR machine: Incorrect. PCR (Polymerase Chain Reaction) is designed to amplify specific DNA sequences , not for direct DNA quantification. Quantitative PCR (qPCR) can estimate copy numbers of specific targets, but not general DNA concentration before the amplification process.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gel electrophoresis: Useful for qualitative analysis (e.g., DNA size, integrity) but not as accurate for quantification. It is also destructive, and staining agents like ethidium bromide are needed.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gel electrophoresis:&lt;/li&gt;&lt;li&gt;â€¢ Option C) Light microscope: Incorrect. A light microscope is used to visualize cells or large cell structures , not molecules like DNA, and cannot provide concentration data.&lt;/li&gt;&lt;li&gt;â€¢ Option C) Light microscope:&lt;/li&gt;&lt;li&gt;â€¢ visualize cells or large cell structures&lt;/li&gt;&lt;li&gt;â€¢ Option D) PCR machine: Incorrect. PCR (Polymerase Chain Reaction) is designed to amplify specific DNA sequences , not for direct DNA quantification. Quantitative PCR (qPCR) can estimate copy numbers of specific targets, but not general DNA concentration before the amplification process.&lt;/li&gt;&lt;li&gt;â€¢ Option D) PCR machine:&lt;/li&gt;&lt;li&gt;â€¢ amplify specific DNA sequences&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective (Polished):&lt;/li&gt;&lt;li&gt;âž¤ DNA can be accurately quantified using UV spectrophotometry at 260 nm , exploiting the strong absorbance of nucleic acid bases. This method is non-destructive, fast, and reliable , and is widely used before downstream applications like PCR, cloning, or sequencing.&lt;/li&gt;&lt;li&gt;âž¤ UV spectrophotometry&lt;/li&gt;&lt;li&gt;âž¤ 260 nm&lt;/li&gt;&lt;li&gt;âž¤ non-destructive, fast, and reliable&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 744.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a bacterial genetics study, a particular lethal mutation has been identified that prevents the organism from successfully replicating its chromosome. The affected cells exhibit defective DNA synthesis, characterized by the production of numerous short DNA fragments, each with RNA sequences at their 5&#x27; ends. This observation suggests a failure in a critical step of the DNA replication process. Which gene, essential for DNA replication and repair, is most likely affected by this mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA polymerase I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA helicase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA ligase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA gyrase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. DNA polymerase I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) DNA polymerase I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA helicase (Incorrect): They bind to the single-stranded DNA near the replication fork â†’ separates the double strands and keeps them apart. Its deficiency would result in no DNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA helicase (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ single-stranded DNA&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA ligase (Incorrect): If it is defective, it causes accumulation of short pieces consists only of DNA, because this enzyme functions once after the removal of RNA primer.&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA ligase (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ causes accumulation of short pieces&lt;/li&gt;&lt;li&gt;â€¢ Option D: DNA gyrase (Incorrect): also known as type II topoisomerase which causes transient breaks in DNA supercoils and unwind them, thereby helping in replication. Its deficiency would result in no DNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: DNA gyrase (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ type II topoisomerase&lt;/li&gt;&lt;li&gt;â€¢ transient breaks in DNA supercoils&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase I in bacteria is responsible for removing RNA primers from the Okazaki fragments (short DNA fragments synthesized on the lagging strand during DNA replication) and replacing them with DNA . A defect in DNA polymerase I would lead to the accumulation of short DNA fragments that still contain RNA sequences at their 5&#x27; ends, as described in the scenario.&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase I&lt;/li&gt;&lt;li&gt;âž¤ bacteria&lt;/li&gt;&lt;li&gt;âž¤ removing RNA primers&lt;/li&gt;&lt;li&gt;âž¤ Okazaki fragments&lt;/li&gt;&lt;li&gt;âž¤ replacing them with DNA&lt;/li&gt;&lt;li&gt;âž¤ defect in DNA polymerase I&lt;/li&gt;&lt;li&gt;âž¤ accumulation of short DNA fragments&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 381-383.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 381-383.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biochemist is examining the regulation of gene expression in a human cell line. Specifically, the focus is on the initiation phase of transcription in protein-coding genes. Identifying the key protein factor that recognizes promoter regions is crucial for their research. Which protein factor is known to identify the promoter of protein-coding genes in eukaryotes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pribnow box&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TFIID&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rho&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sigma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. TFIID&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) TFIID&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pribnow box: It is a cis-acting element in prokaryotic promoters.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pribnow box:&lt;/li&gt;&lt;li&gt;â€¢ cis-acting element&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rho: It is involved in the termination of prokaryotic transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Rho:&lt;/li&gt;&lt;li&gt;â€¢ termination of prokaryotic transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sigma: It is the subunit of prokaryotic RNA polymerase that recognizes and binds the prokaryotic promoter.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sigma:&lt;/li&gt;&lt;li&gt;â€¢ subunit&lt;/li&gt;&lt;li&gt;â€¢ prokaryotic RNA polymerase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TFIID is essential in eukaryotic transcription initiation , recognizing and binding to the TATA box within gene promoters . This action recruits additional transcription factors and RNA polymerase II, initiating transcription.&lt;/li&gt;&lt;li&gt;âž¤ TFIID&lt;/li&gt;&lt;li&gt;âž¤ essential&lt;/li&gt;&lt;li&gt;âž¤ eukaryotic transcription initiation&lt;/li&gt;&lt;li&gt;âž¤ recognizing&lt;/li&gt;&lt;li&gt;âž¤ binding&lt;/li&gt;&lt;li&gt;âž¤ TATA box within gene promoters&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 590, Lippincott 7/e: p 430&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 590, Lippincott 7/e: p 430&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;When initiating transcription of the lac operon, RNA polymerase first binds to which specific region?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;I gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lac Y and Z gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Operator site&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Promoter site&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Promoter site&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture7_ZFVBJAo.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Promoter site&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Transcription of the structural gene is under the control of another regulator or the â€œiâ€ ( inhibitor ) gene, which is far away from the structural genes . Regulatory gene produces a repressor molecule.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Transcription of the structural gene&lt;/li&gt;&lt;li&gt;â€¢ regulator&lt;/li&gt;&lt;li&gt;â€¢ inhibitor&lt;/li&gt;&lt;li&gt;â€¢ structural genes&lt;/li&gt;&lt;li&gt;â€¢ Regulatory gene&lt;/li&gt;&lt;li&gt;â€¢ repressor&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lac Y and Z gene: Encodes for enzymes.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Lac Y and Z gene:&lt;/li&gt;&lt;li&gt;â€¢ Option C: In the presence of glucose in the growth medium , the repressor is attached to the operator site and RNAP cannot move further. Thus, structural genes are not transcribed.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ presence of glucose&lt;/li&gt;&lt;li&gt;â€¢ growth medium&lt;/li&gt;&lt;li&gt;â€¢ operator site&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase binds to the promoter site of the lac operon to initiate transcription. The promoter region is a sequence of DNA upstream of the structural genes that provides a binding site for RNA polymerase to start the transcription process . The promoter functions as the critical regulatory element for the initiation of gene transcription.&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ promoter site&lt;/li&gt;&lt;li&gt;âž¤ lac operon&lt;/li&gt;&lt;li&gt;âž¤ initiate transcription.&lt;/li&gt;&lt;li&gt;âž¤ promoter region&lt;/li&gt;&lt;li&gt;âž¤ sequence of DNA upstream&lt;/li&gt;&lt;li&gt;âž¤ structural genes&lt;/li&gt;&lt;li&gt;âž¤ binding site for RNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ transcription process&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 636.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 636.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the management of certain leukemias, a specific drug is utilized for its ability to interfere with the synthesis of nucleic acids, crucial for the proliferation of rapidly dividing cells. This drug achieves its therapeutic effect by inhibiting a key pathway in purine metabolism, indirectly affecting DNA replication. Which of the following medications is being described?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;6 mercaptopurine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Actinomycin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Puromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 6 mercaptopurine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Actinomycin D binds to DNA and inhibits RNA synthesis by preventing RNA polymerase from moving along the DNA, primarily affecting transcription rather than DNA replication directly.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Actinomycin D binds&lt;/li&gt;&lt;li&gt;â€¢ DNA&lt;/li&gt;&lt;li&gt;â€¢ inhibits RNA synthesis&lt;/li&gt;&lt;li&gt;â€¢ preventing RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ Option C: Puromycin interferes with protein synthesis by causing premature chain termination during translation, which does not directly impact DNA replication.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Puromycin interferes&lt;/li&gt;&lt;li&gt;â€¢ protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ premature chain termination&lt;/li&gt;&lt;li&gt;â€¢ Option D: Rifampicin inhibits bacterial RNA polymerase , thus affecting bacterial transcription. It is used primarily as an antibiotic and does not directly inhibit DNA replication in cancer cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Rifampicin inhibits bacterial RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ bacterial transcription.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors of DNA replication:&lt;/li&gt;&lt;li&gt;âž¤ Inhibitors of DNA replication:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 586.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 586.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician is reviewing the genetic test results of a child with developmental delays and unusual facial features. The child&#x27;s DNA analysis indicates a region with a significantly lower melting temperature (Tm) than expected. The pediatrician recalls that DNA regions with varying thermal stability can indicate differences in base pairing, which may be relevant to the child&#x27;s condition. Which of the following statements best explains the observed low Tm in the child&#x27;s DNA analysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To break AT bonds, high Tm is required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To break GC bonds, low Tm is required&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To break AT bonds, low Tm is required&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AT bonds &amp;amp; GC bonds need same temperature&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. To break AT bonds, low Tm is required&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) To break AT bonds, low Tm is required.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: This statement is incorrect because AT bonds, having fewer hydrogen bonds, require a lower Tm to break compared to GC bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ AT bonds,&lt;/li&gt;&lt;li&gt;â€¢ fewer hydrogen bonds,&lt;/li&gt;&lt;li&gt;â€¢ Option B: This statement is incorrect as GC bonds, being more thermally stable due to the presence of an additional hydrogen bond, actually require a higher Tm to break.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Option D: This statement is incorrect because AT and GC bonds do not require the same temperature to break due to the difference in the number of hydrogen bonds between them.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ AT and GC bonds do not require the same temperature&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adenine (A) and Thymine (T) base pairs are connected by two hydrogen bonds, whereas Guanine (G) and Cytosine (C) base pairs have three hydrogen bonds . The additional hydrogen bond in GC pairs makes them more thermally stable than AT pairs. Consequently, a lower melting temperature (Tm) is required to separate AT-rich regions of double-stranded DNA compared to GC-rich regions.&lt;/li&gt;&lt;li&gt;âž¤ Adenine&lt;/li&gt;&lt;li&gt;âž¤ Thymine&lt;/li&gt;&lt;li&gt;âž¤ base pairs&lt;/li&gt;&lt;li&gt;âž¤ connected by two hydrogen bonds,&lt;/li&gt;&lt;li&gt;âž¤ Guanine&lt;/li&gt;&lt;li&gt;âž¤ Cytosine&lt;/li&gt;&lt;li&gt;âž¤ base pairs&lt;/li&gt;&lt;li&gt;âž¤ three hydrogen bonds&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e:  p 397&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 6/e:  p 397&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements accurately describe DNA repair processes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA repair of double strand breaks is error free.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA repair of mismatched bases repairs the parental strand.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair of uracil formed by deamination of cytosine need the actions of endo and exonucleases to remove the uracil base.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repair of ultraviolet radiationâ€“induced pyrimidine dimers formation involves removal of a short oligonucleotide sequence containing the dimer.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Repair of ultraviolet radiationâ€“induced pyrimidine dimers formation involves removal of a short oligonucleotide sequence containing the dimer.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Repair of ultraviolet radiationâ€“induced pyrimidine dimers formation involves removal of a short oligonucleotide sequence containing the dimer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA repair of double strand breaks is error free (Incorrect): There is nothing like â€œerror freeâ€™â€™ in DNA repair but the homologous -recombination method is less prone to error than the Non homologousâ€“end-joining method .&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA repair of double strand breaks is error free (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ homologous -recombination method&lt;/li&gt;&lt;li&gt;â€¢ Non homologousâ€“end-joining method&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA repair of mismatched bases repairs the parental strand (Incorrect): identification and repair of the newly synthesized strand.&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA repair of mismatched bases repairs the parental strand (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ Option C: Repair of uracil formed by deamination of cytosine need the actions of endo and exonucleases to remove the uracil base (Incorrect): Base excision repair: uracil is removed from DNA, utilizes a glycosylase to remove the base â†’ forms an apyrimidinic or apurinic (AP) site â†’ removal of sugar-phosphate by endo- and exonuclease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Repair of uracil formed by deamination of cytosine need the actions of endo and exonucleases to remove the uracil base (Incorrect):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nucleotide Excision Repair (NER) is responsible for repairing bulky DNA lesions , such as pyrimidine dimers formed by ultraviolet radiation. NER involves the removal of a short single-stranded DNA segment that includes the dimer, followed by DNA synthesis using the intact strand as a template.&lt;/li&gt;&lt;li&gt;âž¤ Nucleotide Excision Repair&lt;/li&gt;&lt;li&gt;âž¤ repairing bulky DNA lesions&lt;/li&gt;&lt;li&gt;âž¤ pyrimidine dimers&lt;/li&gt;&lt;li&gt;âž¤ ultraviolet radiation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 390-392.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 390-392.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about DNA replication is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a semi conservative method&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Replication of DNA occurs in 3â€™ to 5â€™ direction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is semi-discontinuous process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The parent DNA strand determines the base sequence of the newly synthesized DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Replication of DNA occurs in 3â€™ to 5â€™ direction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a semi-conservative method - This is correct . Each new DNA molecule consists of one original (template) strand and one newly synthesized strand.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ It is a semi-conservative method -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option C: It is a semi-discontinuous process - This is correct . The leading strand is synthesized continuously, while the lagging strand is synthesized in short segments called Okazaki fragments, making the overall process semi-discontinuous.&lt;/li&gt;&lt;li&gt;â€¢ Option C: It is a semi-discontinuous process -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option D: The parent DNA strand determines the base sequence of the newly synthesized DNA - This is correct . The sequence of bases in the parent DNA strand guides the addition of complementary nucleotides to the newly synthesized strand, ensuring accurate replication.&lt;/li&gt;&lt;li&gt;â€¢ Option D: The parent DNA strand determines the base sequence of the newly synthesized DNA -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA replication occurs in a semi-conservative manner , where each new DNA molecule consists of one original strand and one newly synthesized strand . However, the synthesis of the new strand occurs in the 5â€™ to 3â€™ direction, not 3â€™ to 5â€™. DNA polymerases add nucleotides to the 3&#x27; end of the growing strand, necessitating the replication to proceed in the 5â€™ to 3â€™ direction.&lt;/li&gt;&lt;li&gt;âž¤ DNA replication&lt;/li&gt;&lt;li&gt;âž¤ semi-conservative manner&lt;/li&gt;&lt;li&gt;âž¤ new DNA molecule&lt;/li&gt;&lt;li&gt;âž¤ one original strand&lt;/li&gt;&lt;li&gt;âž¤ one newly synthesized strand&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 381-387.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 381-387.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on the fidelity of DNA replication in prokaryotes, a group of microbiologists is exploring the various enzymes involved in this process and their specific functions. One key topic is the enzyme responsible for proofreading newly synthesized DNA strands to correct any errors, thus ensuring the accuracy of replication. Which enzyme involved in prokaryotic DNA replication possesses this crucial proofreading activity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RNA polymerase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Helicase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA polymerase II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. DNA polymerase II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: RNA polymerase is involved in transcription , not DNA replication, and does not have proofreading activity associated with DNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ transcription&lt;/li&gt;&lt;li&gt;â€¢ Option B: Helicase unwinds the DNA double helix to provide single-stranded templates for replication . It does not have enzymatic activity related to nucleotide incorporation or proofreading.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Helicase unwinds&lt;/li&gt;&lt;li&gt;â€¢ DNA double helix&lt;/li&gt;&lt;li&gt;â€¢ single-stranded templates&lt;/li&gt;&lt;li&gt;â€¢ replication&lt;/li&gt;&lt;li&gt;â€¢ Option D: Primase synthesizes RNA primers to provide starting points for DNA polymerase on the lagging strand. It does not have proofreading activity for DNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Primase synthesizes RNA primers&lt;/li&gt;&lt;li&gt;â€¢ provide starting points&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNAP II has editing and proofreading activity.&lt;/li&gt;&lt;li&gt;âž¤ Prokaryotic DNA Polymerase has 3 types: Pol I , Pol II and Pol III&lt;/li&gt;&lt;li&gt;âž¤ Prokaryotic DNA Polymerase has 3 types:&lt;/li&gt;&lt;li&gt;âž¤ ,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 383.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 383.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about Xeroderma pigmentosum is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA repair is effected&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Persons are sensitive to UV light&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellar ataxia, oculo-cutaneous telangiectasia are clinical manifestations&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sunlight causes blisters on the skin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cerebellar ataxia, oculo-cutaneous telangiectasia are clinical manifestations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cerebellar ataxia, oculo-cutaneous telangiectasia are clinical manifestations&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA repair is affected - This statement is correct . XP is caused by defects in the nucleotide excision repair mechanism, which is crucial for repairing UV-induced DNA damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA repair is affected -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option B: Persons are sensitive to UV light - This is also correct . Individuals with XP have heightened sensitivity to UV radiation due to their inability to effectively repair UV-induced DNA damage.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Persons are sensitive to UV light -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sunlight causes blisters on the skin - This is true for individuals with XP. Their heightened sensitivity to UV light can result in severe skin reactions, including blistering, even after minimal sun exposure.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sunlight causes blisters on the skin -&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cerebellar ataxia and oculo-cutaneous telangiectasia are not typically clinical manifestations of Xeroderma pigmentosum (XP). These symptoms are more characteristic of disorders such as Ataxia-Telangiectasia (A-T). XP primarily involves sensitivity to UV light , leading to skin abnormalities such as blistering upon exposure to sunlight , due to a defect in the nucleotide excision repair pathway that prevents the proper repair of UV-induced DNA damage .&lt;/li&gt;&lt;li&gt;âž¤ Cerebellar ataxia&lt;/li&gt;&lt;li&gt;âž¤ oculo-cutaneous telangiectasia&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ clinical manifestations&lt;/li&gt;&lt;li&gt;âž¤ Xeroderma pigmentosum&lt;/li&gt;&lt;li&gt;âž¤ Ataxia-Telangiectasia&lt;/li&gt;&lt;li&gt;âž¤ sensitivity to UV light&lt;/li&gt;&lt;li&gt;âž¤ skin abnormalities&lt;/li&gt;&lt;li&gt;âž¤ blistering&lt;/li&gt;&lt;li&gt;âž¤ exposure to sunlight&lt;/li&gt;&lt;li&gt;âž¤ defect&lt;/li&gt;&lt;li&gt;âž¤ nucleotide excision repair pathway&lt;/li&gt;&lt;li&gt;âž¤ prevents the proper repair&lt;/li&gt;&lt;li&gt;âž¤ UV-induced DNA damage&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 412.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 412.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following cell types do not have the enzyme telomerase that protects the length of telomeres at the chromosomal ends?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Germinal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemopoietic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Somatic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Somatic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Telomerase is an enzyme that adds repetitive nucleotide sequences to the ends of chromosomes (telomeres), thereby preventing their progressive shortening during DNA replication. This is especially important in cells that divide frequently or require long-term proliferative potential.&lt;/li&gt;&lt;li&gt;â€¢ Telomerase&lt;/li&gt;&lt;li&gt;â€¢ Somatic cells , which constitute the majority of cells in the body (like skin, muscle, and liver cells), lack significant telomerase activity . As a result, with each cell division, telomeres become progressively shorter. Eventually, this leads to cellular senescence or programmed cell death (apoptosis), which is a natural part of aging.&lt;/li&gt;&lt;li&gt;â€¢ Somatic cells&lt;/li&gt;&lt;li&gt;â€¢ lack significant telomerase activity&lt;/li&gt;&lt;li&gt;â€¢ In contrast:&lt;/li&gt;&lt;li&gt;â€¢ Germinal (germ) cells have active telomerase to ensure genomic stability is passed on to offspring. Tumor cells often reactivate telomerase , which enables them to escape normal cellular aging and divide indefinitely â€” a key feature of cancer. Hemopoietic stem cells (in bone marrow) also express telomerase to maintain their replicative capacity and continually replenish blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Germinal (germ) cells have active telomerase to ensure genomic stability is passed on to offspring.&lt;/li&gt;&lt;li&gt;â€¢ Germinal (germ) cells&lt;/li&gt;&lt;li&gt;â€¢ Tumor cells often reactivate telomerase , which enables them to escape normal cellular aging and divide indefinitely â€” a key feature of cancer.&lt;/li&gt;&lt;li&gt;â€¢ Tumor cells&lt;/li&gt;&lt;li&gt;â€¢ reactivate telomerase&lt;/li&gt;&lt;li&gt;â€¢ Hemopoietic stem cells (in bone marrow) also express telomerase to maintain their replicative capacity and continually replenish blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Hemopoietic stem cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that somatic cells typically lack telomerase , which causes telomere shortening over time and contributes to the natural aging process and cellular lifespan limitation. This contrasts with cell types like germinal, stem, and cancer cells, where telomerase activity supports sustained proliferation.&lt;/li&gt;&lt;li&gt;âž¤ somatic cells typically lack telomerase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 374.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old pregnant woman presents with recurrent respiratory infections, night sweats, and unexplained weight loss. Further evaluation confirms tuberculosis and a low white blood cell count. Given her history of multiple sexual partners, she is tested and found to be HIV positive. Alongside antitubercular treatment, her physician recommends starting azidothymidine (AZT) to reduce the risk of maternal-to-fetal HIV transmission. AZT is known to decrease this risk by approximately 30%. What is the primary mechanism of action of AZT in the treatment of HIV?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It inhibits viral protein synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It inhibits RNA synthesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It inhibits viral DNA polymerase.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It inhibits viral reverse transcriptase.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It inhibits viral reverse transcriptase.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) It inhibits viral reverse transcriptase.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It inhibits viral protein synthesis - This is incorrect because AZT&#x27;s primary action is not on protein synthesis but on the viral DNA synthesis process.&lt;/li&gt;&lt;li&gt;â€¢ Option A: It inhibits viral protein synthesis -&lt;/li&gt;&lt;li&gt;â€¢ AZT&#x27;s primary action is not on protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option B: It inhibits RNA synthesis - This is incorrect as AZT specifically targets the reverse transcription process of HIV, which involves the synthesis of DNA from RNA, rather than the synthesis of RNA itself.&lt;/li&gt;&lt;li&gt;â€¢ Option B: It inhibits RNA synthesis -&lt;/li&gt;&lt;li&gt;â€¢ AZT specifically targets the reverse transcription process of HIV,&lt;/li&gt;&lt;li&gt;â€¢ Option C: It inhibits viral DNA polymerase - This option is partially correct in that reverse transcriptase has DNA polymerase activity, but the more specific and correct description of AZT&#x27;s target is the reverse transcriptase enzyme, which is unique to retroviruses like HIV.&lt;/li&gt;&lt;li&gt;â€¢ Option C: It inhibits viral DNA polymerase -&lt;/li&gt;&lt;li&gt;â€¢ reverse transcriptase has DNA polymerase activity,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Azidothymidine (AZT) works by targeting the HIV reverse transcriptase enzyme , which is crucial for converting the viral RNA genome into DNA, a necessary step for viral integration into the host genome and subsequent replication. AZT is a nucleoside analog that, once phosphorylated within the cell, is incorporated into the growing viral DNA chain by reverse transcriptase.&lt;/li&gt;&lt;li&gt;âž¤ Azidothymidine&lt;/li&gt;&lt;li&gt;âž¤ targeting the HIV reverse transcriptase enzyme&lt;/li&gt;&lt;li&gt;âž¤ converting the viral RNA genome into DNA,&lt;/li&gt;&lt;li&gt;âž¤ viral integration&lt;/li&gt;&lt;li&gt;âž¤ host genome&lt;/li&gt;&lt;li&gt;âž¤ subsequent replication.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 426.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 426.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which DNA conformation is most commonly observed in biological systems?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Z&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ B-DNA is the predominant DNA conformation found in biological systems under physiological conditions. It is a right-handed double helix with approximately 10.5 base pairs per turn , a helical pitch of 3.4 nm (34 Ã…) , and a diameter of 2 nm (20 Ã…) . This structure allows for compact storage of genetic information while maintaining accessibility for processes like replication and transcription.&lt;/li&gt;&lt;li&gt;â€¢ B-DNA&lt;/li&gt;&lt;li&gt;â€¢ right-handed double helix&lt;/li&gt;&lt;li&gt;â€¢ 10.5 base pairs per turn&lt;/li&gt;&lt;li&gt;â€¢ 3.4 nm (34 Ã…)&lt;/li&gt;&lt;li&gt;â€¢ 2 nm (20 Ã…)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A-DNA is a right-handed helix with about 11 base pairs per turn and occurs under dehydrated conditions. It is not the common form found in vivo.&lt;/li&gt;&lt;li&gt;â€¢ Option A: A-DNA&lt;/li&gt;&lt;li&gt;â€¢ Option B: C-DNA is not a prevalent form in biological systems.&lt;/li&gt;&lt;li&gt;â€¢ Option B: C-DNA&lt;/li&gt;&lt;li&gt;â€¢ Option D: Z-DNA is a left-handed helix with about 12 base pairs per turn. It can form transiently in GC-rich regions but is not the main conformation in cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Z-DNA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that B-DNA is the physiologically relevant form of DNA and is the structure typically observed in cells due to its stability and suitability for essential genetic functions.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6 /e:  p 398.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which phase of the cell cycle does the doubling of DNA occur, a process essential for normal cell division and genetic consistency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G1 phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S phase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G2 phase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M phase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S phase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture19.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S Phase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: G1 phase - This is a period of cell growth and preparation for DNA replication , but DNA doubling does not occur here.&lt;/li&gt;&lt;li&gt;â€¢ Option A: G1 phase -&lt;/li&gt;&lt;li&gt;â€¢ period of cell growth&lt;/li&gt;&lt;li&gt;â€¢ preparation for DNA replication&lt;/li&gt;&lt;li&gt;â€¢ Option C: G2 phase - This phase follows DNA replication and involves further cell growth and preparation for mitosis; the DNA has already been replicated in the preceding S phase.&lt;/li&gt;&lt;li&gt;â€¢ Option C: G2 phase -&lt;/li&gt;&lt;li&gt;â€¢ phase follows DNA replication&lt;/li&gt;&lt;li&gt;â€¢ further cell growth&lt;/li&gt;&lt;li&gt;â€¢ Option D: M phase - This phase encompasses mitosis and cytokinesis, where the cell divides its already replicated DNA into two daughter cells. DNA replication does not occur in this phase.&lt;/li&gt;&lt;li&gt;â€¢ Option D: M phase -&lt;/li&gt;&lt;li&gt;â€¢ phase encompasses mitosis&lt;/li&gt;&lt;li&gt;â€¢ cytokinesis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381-387.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 381-387.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which DNA polymerase is primarily responsible for DNA repair in mammalian cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alpha&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gamma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Epsilon&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Beta&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture20.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture21.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Beta&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha - DNA polymerase alpha is primarily involved in the initiation of DNA replication , particularly the synthesis of short RNA-DNA primers, rather than DNA repair.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alpha -&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase alpha&lt;/li&gt;&lt;li&gt;â€¢ initiation of DNA replication&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gamma - DNA polymerase gamma is responsible for the replication and repair of mitochondrial DNA , not nuclear DNA repair.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gamma -&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase gamma&lt;/li&gt;&lt;li&gt;â€¢ replication&lt;/li&gt;&lt;li&gt;â€¢ repair of mitochondrial DNA&lt;/li&gt;&lt;li&gt;â€¢ Option D: Epsilon - DNA polymerase epsilon is involved in leading-strand synthesis during DNA replication and also plays roles in DNA repair, but DNA polymerase beta is more specifically associated with the base excision repair pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Epsilon -&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase epsilon&lt;/li&gt;&lt;li&gt;â€¢ leading-strand synthesis&lt;/li&gt;&lt;li&gt;â€¢ DNA replication&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase beta (Î²) plays a key role in the base excision repair (BER) pathway in mammalian cells , which is crucial for repairing small-scale DNA damage such as single-base lesions . This polymerase fills in the single-nucleotide gap left after the removal of a damaged base, contributing significantly to the maintenance of genomic stability.&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase beta&lt;/li&gt;&lt;li&gt;âž¤ base excision repair&lt;/li&gt;&lt;li&gt;âž¤ pathway&lt;/li&gt;&lt;li&gt;âž¤ mammalian cells&lt;/li&gt;&lt;li&gt;âž¤ repairing small-scale DNA damage&lt;/li&gt;&lt;li&gt;âž¤ single-base lesions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 383.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 383.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about DNA double-strand breaks repair pathways is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Homologous recombination requires a long homologous sequence to guide repair.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Non-homologous end-joining does not require a long homologous sequence to guide repair.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Homologous recombination repairs DNA before the cell enters mitosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Non-homologous end-joining repairs DNA after the cell enters mitosis.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Non-homologous end-joining repairs DNA after the cell enters mitosis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture22.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Homologous recombination requires a long homologous sequence to guide repair - This is true . HR uses a homologous sequence, often from a sister chromatid, as a template to accurately repair the break.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Homologous recombination requires a long homologous sequence to guide repair -&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B: Non-homologous end-joining does not require a long homologous sequence to guide repair - This is also true . NHEJ directly joins the broken DNA ends without needing a homologous template.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Non-homologous end-joining does not require a long homologous sequence to guide repair -&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option C: Homologous recombination repairs DNA before the cell enters mitosis - This is generally true . HR is most active in the S and G2 phases of the cell cycle when a sister chromatid is available as a template for repair, ensuring accurate repair before the cell divides.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Homologous recombination repairs DNA before the cell enters mitosis -&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 304-306&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 304-306&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A geneticist is examining the impact of various mutations on mRNA processing in eukaryotic cells. They are particularly interested in a sequence that, if mutated, could disrupt the addition of the polyadenylation signal required for 3&#x27;-end poly-A tail addition to the mRNA. Mutation in which of the following sequences would most likely affect this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TATAAA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CAAT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AAUAAA&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. AAUAAA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) AAUAAA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A &amp;amp; B: CAAT and TATAAA are sequences seen in promoters for RNA polymerase II . They help in proper transcription initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option A &amp;amp; B:&lt;/li&gt;&lt;li&gt;â€¢ CAAT&lt;/li&gt;&lt;li&gt;â€¢ TATAAA&lt;/li&gt;&lt;li&gt;â€¢ sequences seen in promoters for RNA polymerase II&lt;/li&gt;&lt;li&gt;â€¢ Option C: CCA is added to the 3&#x27;-end of transfer RNA by nucleotidyl transferase . It is an amino acid attachment site on tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ CCA&lt;/li&gt;&lt;li&gt;â€¢ 3&#x27;-end of transfer RNA&lt;/li&gt;&lt;li&gt;â€¢ nucleotidyl transferase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The sequence AAUAAA is the polyadenylation signal sequence in eukaryotic mRNAs , located near the 3&#x27; end of the pre-mRNA . A mutation in this signal could disrupt the polyadenylation process, potentially affecting mRNA stability and translation efficiency.&lt;/li&gt;&lt;li&gt;âž¤ sequence AAUAAA&lt;/li&gt;&lt;li&gt;âž¤ polyadenylation signal sequence&lt;/li&gt;&lt;li&gt;âž¤ eukaryotic mRNAs&lt;/li&gt;&lt;li&gt;âž¤ near the 3&#x27; end of the pre-mRNA&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 409,419-420, Lippincott 7/e: p 430.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 409,419-420, Lippincott 7/e: p 430.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the primary function of the cell organelles marked as \&quot;P bodies\&quot; in the given image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mRNA degradation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Post Transcriptional modification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Protein degradation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protein sorting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. mRNA degradation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture5_iLpmM9t.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) mRNA degradation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Post transcriptional modification occurs in different cell organelles â€“ RER, Golgi, endosomes, lysosomes, and secretory vesicles.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Post transcriptional modification&lt;/li&gt;&lt;li&gt;â€¢ different cell organelles&lt;/li&gt;&lt;li&gt;â€¢ Option C. Protein degradation: Extracellular particles or proteins are taken by endocytosis fused with lysosomes. Intracellular proteins are also broken down by lysosomes. Ubiquitin tagged proteins are immediately broken down inside the proteasomes of the cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Protein degradation:&lt;/li&gt;&lt;li&gt;â€¢ Extracellular particles&lt;/li&gt;&lt;li&gt;â€¢ endocytosis fused&lt;/li&gt;&lt;li&gt;â€¢ lysosomes.&lt;/li&gt;&lt;li&gt;â€¢ proteasomes&lt;/li&gt;&lt;li&gt;â€¢ Option D. Protein sorting: RER, SER and golgi apparatus are involved in this process.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Protein sorting:&lt;/li&gt;&lt;li&gt;â€¢ RER, SER&lt;/li&gt;&lt;li&gt;â€¢ golgi apparatus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ P bodies , or processing bodies , are cytoplasmic granules that are involved in mRNA degradation and the regulation of mRNA stability . They play a key role in the post-transcriptional regulation of gene expression by sequestering mRNAs from the translational machinery. These mRNAs can be stored for future translation, degraded, or processed in P bodies.&lt;/li&gt;&lt;li&gt;âž¤ P bodies&lt;/li&gt;&lt;li&gt;âž¤ processing bodies&lt;/li&gt;&lt;li&gt;âž¤ cytoplasmic granules&lt;/li&gt;&lt;li&gt;âž¤ mRNA degradation&lt;/li&gt;&lt;li&gt;âž¤ regulation of mRNA stability&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 425,426&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 425,426&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biology student is reviewing a diagram of the transcription process, specifically focusing on the RNA polymerase (RNAP) complex. This enzyme complex is critical for the synthesis of RNA from a DNA template. The student is asked to identify the region of DNA to which this complex bind to initiate transcription. Which region of DNA does the RNA polymerase complex bind to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enhancers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Promotors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Introns&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Promotors&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture6_ZK1wd8B.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Promotors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enhancers: These are sequence elements which increase the rate of transcription of eukaryotic genes located both upstream and downstream of the transcription start site and also within the transcribed protein coding portions of some genes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enhancers:&lt;/li&gt;&lt;li&gt;â€¢ sequence elements&lt;/li&gt;&lt;li&gt;â€¢ increase the rate of transcription&lt;/li&gt;&lt;li&gt;â€¢ eukaryotic genes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Introns: The sequence of a mRNA - encoding gene which is transcribed but excised before translation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Introns:&lt;/li&gt;&lt;li&gt;â€¢ sequence of a mRNA&lt;/li&gt;&lt;li&gt;â€¢ encoding gene&lt;/li&gt;&lt;li&gt;â€¢ transcribed but excised&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exons: In many eukaryotic transcription units , which are the portion of a gene that is copied by RNA polymerase often consists of coding regions of DNA (exons) interrupted by intervening sequences of noncoding DNA (introns).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exons:&lt;/li&gt;&lt;li&gt;â€¢ many eukaryotic transcription units&lt;/li&gt;&lt;li&gt;â€¢ portion of a gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The RNA polymerase complex initiates transcription at promoters, which are specific DNA sequences located upstream of the coding region of a gene . Promoters contain specific sequences that signal the RNA polymerase where to begin transcription, and they are crucial for the correct initiation of gene expression.&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase complex&lt;/li&gt;&lt;li&gt;âž¤ transcription at promoters,&lt;/li&gt;&lt;li&gt;âž¤ specific DNA sequences&lt;/li&gt;&lt;li&gt;âž¤ upstream of the coding region of a gene&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 395-397.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 395-397.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the role of the Sigma factor in the prokaryotic cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;For termination of transcription&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;For initiation of transcription&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Act as promoter sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increases its affinity for non-promoter DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. For initiation of transcription&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture7_LM3NFhk.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) For initiation of transcription&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. For termination of transcription: This happens with the help of specific signals which are recognized by a termination protein known as Rho factor. Rho independent termination is also present.&lt;/li&gt;&lt;li&gt;â€¢ Option A. For termination of transcription:&lt;/li&gt;&lt;li&gt;â€¢ help of specific signals&lt;/li&gt;&lt;li&gt;â€¢ recognized&lt;/li&gt;&lt;li&gt;â€¢ termination&lt;/li&gt;&lt;li&gt;â€¢ Rho factor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Act as promoter sequence: It can only recognize the promoter site and increases the affinity of the holoenzyme towards the promoter site.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Act as promoter sequence:&lt;/li&gt;&lt;li&gt;â€¢ recognize&lt;/li&gt;&lt;li&gt;â€¢ promoter site&lt;/li&gt;&lt;li&gt;â€¢ increases the affinity&lt;/li&gt;&lt;li&gt;â€¢ holoenzyme&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increases its affinity for non-promoter DNA: Sigma factors have a dual role in the process of promoter recognition ; Ïƒ association with core RNA polymerase decreases its affinity for non-promoter DNA while simultaneously increasing holoenzyme affinity for promoter DNA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increases its affinity for non-promoter DNA:&lt;/li&gt;&lt;li&gt;â€¢ Sigma factors&lt;/li&gt;&lt;li&gt;â€¢ dual role&lt;/li&gt;&lt;li&gt;â€¢ process of promoter recognition&lt;/li&gt;&lt;li&gt;â€¢ Ïƒ&lt;/li&gt;&lt;li&gt;â€¢ core RNA polymerase decreases&lt;/li&gt;&lt;li&gt;â€¢ affinity for non-promoter DNA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The Sigma factor is a protein needed for the initiation of transcription in prokaryotes. It is a component of the RNA polymerase holoenzyme that binds to specific promoter sequences in the DNA, allowing RNA polymerase to initiate transcription at the correct site.&lt;/li&gt;&lt;li&gt;âž¤ Sigma factor&lt;/li&gt;&lt;li&gt;âž¤ protein needed for the initiation&lt;/li&gt;&lt;li&gt;âž¤ transcription in prokaryotes.&lt;/li&gt;&lt;li&gt;âž¤ component of the RNA polymerase holoenzyme&lt;/li&gt;&lt;li&gt;âž¤ binds to specific promoter sequences&lt;/li&gt;&lt;li&gt;âž¤ DNA,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 397, Lippincott 7/e: P 419.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 397, Lippincott 7/e: P 419.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following substances is an inhibitor of DNA to RNA transcription?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Novobiocin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;puromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rifampicin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rifampicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-165441.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rifampicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Novobiocin: This is an inhibitor of DNA gyrase, an enzyme involved in DNA replication, not transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Novobiocin:&lt;/li&gt;&lt;li&gt;â€¢ inhibitor of DNA gyrase,&lt;/li&gt;&lt;li&gt;â€¢ Option B. Puromycin: This antibiotic mimic the 3&#x27;-end of an aminoacyl-tRNA and interferes with translation by causing premature chain termination, not transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Puromycin:&lt;/li&gt;&lt;li&gt;â€¢ antibiotic mimic the 3&#x27;-end of an aminoacyl-tRNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ciprofloxacin: This drug inhibits DNA gyrase and topoisomerase IV, enzymes involved in bacterial DNA replication and supercoiling, not the transcription process.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ciprofloxacin:&lt;/li&gt;&lt;li&gt;â€¢ drug inhibits DNA gyrase&lt;/li&gt;&lt;li&gt;â€¢ topoisomerase IV, enzymes&lt;/li&gt;&lt;li&gt;â€¢ bacterial DNA replication&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 8-month-old male baby presented by its mother with severe anaemia and diagnosis of beta thalassemia was made. Gene analysis reveals one of his beta-globin genes has been mutated, which further creates a new splice acceptor site 17 nucleotides upstream of the normal splice acceptor site of the first intron. What is the most accurate prediction regarding the altered mRNA molecule?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exon 1 will be too long&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exon 1 will be too short&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exon 2 will be too long&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exon 2 will be too short&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Exon 2 will be too long&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Exon 2 will be too long&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exon 1 will be too long :  This option is incorrect in the context of the mutation. The mutation is located at the splice acceptor site of the first intron , which affects splicing into exon 2, not exon 1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Exon 1 will be too long&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ mutation is located at the splice acceptor site of the first intron&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exon 1 will be too short: This is also incorrect based on the mutation&#x27;s location. A new splice acceptor site within the first intron does not shorten exon 1; it would affect the downstream exon (exon 2) by including additional intron sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Exon 1 will be too short:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ mutation&#x27;s location.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exon 2 will be too short :  This option is incorrect because the mutation described would cause additional intronic sequence to be included in exon 2, making it longer, not shorter.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exon 2 will be too short&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ mutation&lt;/li&gt;&lt;li&gt;â€¢ cause additional intronic sequence&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The genetic mutation introduces a new splice acceptor site in the first intron , which leads to the inclusion of additional intronic sequences in exon 2 , making it longer than usual. This can result in an abnormal beta-globin protein, contributing to the pathology of beta-thalassemia.&lt;/li&gt;&lt;li&gt;âž¤ genetic mutation&lt;/li&gt;&lt;li&gt;âž¤ new splice acceptor site&lt;/li&gt;&lt;li&gt;âž¤ first intron&lt;/li&gt;&lt;li&gt;âž¤ inclusion of additional intronic sequences&lt;/li&gt;&lt;li&gt;âž¤ exon 2&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 427- 430&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 427- 430&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the development of B cells, a critical genetic process allows these cells to produce a variety of immunoglobulin molecules, essential for the body&#x27;s adaptive immune response. This flexibility is crucial for the immune system&#x27;s ability to produce antibodies that can target an array of pathogens. Which process enables B cells to synthesize different types of immunoglobulin molecules?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Codominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gene switching&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allele exclusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Differential RNA processing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Differential RNA processing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Differential RNA processing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Codominance : Codominance is a form of inheritance where different alleles are equally expressed , but it does not describe the process of immunoglobulin class synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Codominance&lt;/li&gt;&lt;li&gt;â€¢ form of inheritance&lt;/li&gt;&lt;li&gt;â€¢ different alleles are equally expressed&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gene switching: Also known as class switch recombination , is a mechanism that changes the constant region of the heavy chain to produce different classes of immunoglobulins , it&#x27;s related but the term might be confused with \&quot;gene conversion\&quot; which is not the same.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gene switching:&lt;/li&gt;&lt;li&gt;â€¢ class switch recombination&lt;/li&gt;&lt;li&gt;â€¢ mechanism that changes&lt;/li&gt;&lt;li&gt;â€¢ constant region of the heavy chain&lt;/li&gt;&lt;li&gt;â€¢ produce different classes of immunoglobulins&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allele exclusion: This is a principle that ensures a B cell expresses only one type of heavy chain and one type of light chain, to ensure antigen specificity, not the generation of different types of immunoglobulins.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Allele exclusion:&lt;/li&gt;&lt;li&gt;â€¢ principle that ensures a B cell expresses&lt;/li&gt;&lt;li&gt;â€¢ one type of heavy chain&lt;/li&gt;&lt;li&gt;â€¢ one type of light chain,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differential RNA processing, also known as alternative RNA splicing, allows a single B cell to produce different classes of immunoglobulin molecules . After a B cell is activated, it can undergo class switching to produce different types of antibodies (e.g., switching from IgM to IgG production), but each of these classes can also result from differential splicing of the heavy chain RNA transcript.&lt;/li&gt;&lt;li&gt;âž¤ Differential RNA processing,&lt;/li&gt;&lt;li&gt;âž¤ alternative RNA splicing,&lt;/li&gt;&lt;li&gt;âž¤ single B cell&lt;/li&gt;&lt;li&gt;âž¤ produce different classes&lt;/li&gt;&lt;li&gt;âž¤ immunoglobulin molecules&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 449&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 449&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the options listed below, which one is not involved in the post-transcriptional processing of the primary mRNA transcript?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;7-methylguanosine capping at 5â€™ end&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;poly-A tail at 3â€™ end&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splicing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gamma carboxylation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Gamma carboxylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Gamma carboxylation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. 7-methylguanosine capping at 5â€™ end: This is a modification that occurs shortly after the initiation of transcription and is crucial for mRNA stability and ribosome recognition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 7-methylguanosine capping at 5â€™ end:&lt;/li&gt;&lt;li&gt;â€¢ modification&lt;/li&gt;&lt;li&gt;â€¢ shortly after the initiation of transcription&lt;/li&gt;&lt;li&gt;â€¢ Option B. Poly-A tail at 3â€™ end: The addition of a poly-A tail is another key post-transcriptional modification that increases mRNA stability and aids in its export from the nucleus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Poly-A tail at 3â€™ end:&lt;/li&gt;&lt;li&gt;â€¢ poly-A tail&lt;/li&gt;&lt;li&gt;â€¢ post-transcriptional modification&lt;/li&gt;&lt;li&gt;â€¢ increases mRNA stability&lt;/li&gt;&lt;li&gt;â€¢ Option C. Splicing: Splicing involves the removal of introns and joining of exons to form a continuous coding sequence in mRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Splicing:&lt;/li&gt;&lt;li&gt;â€¢ removal of introns&lt;/li&gt;&lt;li&gt;â€¢ joining of exons&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-transcriptional modifications:&lt;/li&gt;&lt;li&gt;âž¤ Post-transcriptional modifications:&lt;/li&gt;&lt;li&gt;âž¤ 7-methylguanosine capping at 5â€™ end Addition of a poly-A tail at 3â€™ end Removal of introns and joining of Exons called Splicing Methylations Alternative RNA Processing&lt;/li&gt;&lt;li&gt;âž¤ 7-methylguanosine capping at 5â€™ end&lt;/li&gt;&lt;li&gt;âž¤ 7-methylguanosine capping at 5â€™ end&lt;/li&gt;&lt;li&gt;âž¤ Addition of a poly-A tail at 3â€™ end&lt;/li&gt;&lt;li&gt;âž¤ Addition of a poly-A tail at 3â€™ end&lt;/li&gt;&lt;li&gt;âž¤ Removal of introns and joining of Exons called Splicing&lt;/li&gt;&lt;li&gt;âž¤ Removal of introns and joining of Exons called Splicing&lt;/li&gt;&lt;li&gt;âž¤ Methylations&lt;/li&gt;&lt;li&gt;âž¤ Methylations&lt;/li&gt;&lt;li&gt;âž¤ Alternative RNA Processing&lt;/li&gt;&lt;li&gt;âž¤ Alternative RNA Processing&lt;/li&gt;&lt;li&gt;âž¤ Postâ€“translational Modifications&lt;/li&gt;&lt;li&gt;âž¤ Postâ€“translational Modifications&lt;/li&gt;&lt;li&gt;âž¤ Covalent modifications of aminoacyl residues Gamma carboxylation Hydroxylation Methylation Glycosylation Zymogen activation.&lt;/li&gt;&lt;li&gt;âž¤ Covalent modifications of aminoacyl residues&lt;/li&gt;&lt;li&gt;âž¤ Covalent modifications of aminoacyl residues&lt;/li&gt;&lt;li&gt;âž¤ Gamma carboxylation&lt;/li&gt;&lt;li&gt;âž¤ Gamma carboxylation&lt;/li&gt;&lt;li&gt;âž¤ Hydroxylation&lt;/li&gt;&lt;li&gt;âž¤ Hydroxylation&lt;/li&gt;&lt;li&gt;âž¤ Methylation&lt;/li&gt;&lt;li&gt;âž¤ Methylation&lt;/li&gt;&lt;li&gt;âž¤ Glycosylation&lt;/li&gt;&lt;li&gt;âž¤ Glycosylation&lt;/li&gt;&lt;li&gt;âž¤ Zymogen activation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;When considering the process of mRNA maturation in eukaryotic cells, a critical step involves the removal of certain sequences before the mRNA can be translated into a protein. There&#x27;s a statement that needs verification: \&quot;Introns are excised by RNA editing.\&quot; Is this statement accurate regarding the process by which introns are removed from pre-mRNA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TRUE, as RNA editing is the mechanism that ensures introns are removed from pre-mRNA.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TRUE, because RNA editing and intron removal are synonymous terms in molecular biology.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FALSE, intron removal is accomplished through splicing, not RNA editing.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FALSE, RNA editing is primarily involved in modifying exon sequences and doesn&#x27;t excise introns.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FALSE, intron removal is accomplished through splicing, not RNA editing.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. FALSE, intron removal is accomplished through splicing, not RNA editing.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The statement is false because introns are not removed by RNA editing , but by a distinct process known as RNA splicing .&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ introns are not removed by RNA editing&lt;/li&gt;&lt;li&gt;â€¢ RNA splicing&lt;/li&gt;&lt;li&gt;â€¢ Splicing is the process in which non-coding introns are removed from the pre-mRNA transcript and coding exons are joined together to form a mature mRNA molecule ready for translation.&lt;/li&gt;&lt;li&gt;â€¢ Splicing&lt;/li&gt;&lt;li&gt;â€¢ non-coding introns are removed&lt;/li&gt;&lt;li&gt;â€¢ coding exons are joined together&lt;/li&gt;&lt;li&gt;â€¢ The spliceosome , a large ribonucleoprotein complex made up of snRNA (small nuclear RNA) and proteins (snRNPs), is responsible for catalyzing splicing. This process is essential for gene expression in eukaryotes , ensuring that only exonic (coding) sequences are translated into protein.&lt;/li&gt;&lt;li&gt;â€¢ The spliceosome , a large ribonucleoprotein complex made up of snRNA (small nuclear RNA) and proteins (snRNPs), is responsible for catalyzing splicing.&lt;/li&gt;&lt;li&gt;â€¢ spliceosome&lt;/li&gt;&lt;li&gt;â€¢ This process is essential for gene expression in eukaryotes , ensuring that only exonic (coding) sequences are translated into protein.&lt;/li&gt;&lt;li&gt;â€¢ gene expression in eukaryotes&lt;/li&gt;&lt;li&gt;â€¢ On the other hand, RNA editing is a post-transcriptional process that alters the nucleotide sequence of an RNA molecule after transcription . It may Substitute one nucleotide for another (e.g., C-to-U) .&lt;/li&gt;&lt;li&gt;â€¢ RNA editing&lt;/li&gt;&lt;li&gt;â€¢ alters the nucleotide sequence&lt;/li&gt;&lt;li&gt;â€¢ after transcription&lt;/li&gt;&lt;li&gt;â€¢ C-to-U)&lt;/li&gt;&lt;li&gt;â€¢ Example: The ApoB gene undergoes RNA editing in intestinal cells, where a C-to-U substitution introduces a stop codon, resulting in a shorter protein (ApoB48) compared to the full-length ApoB100 produced in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Example:&lt;/li&gt;&lt;li&gt;â€¢ ApoB gene&lt;/li&gt;&lt;li&gt;â€¢ C-to-U substitution&lt;/li&gt;&lt;li&gt;â€¢ Therefore, RNA editing modifies existing RNA sequences but does not remove introns .&lt;/li&gt;&lt;li&gt;â€¢ RNA editing modifies existing RNA sequences&lt;/li&gt;&lt;li&gt;â€¢ does not remove introns&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between RNA splicing and RNA editing :&lt;/li&gt;&lt;li&gt;âž¤ RNA splicing&lt;/li&gt;&lt;li&gt;âž¤ RNA editing&lt;/li&gt;&lt;li&gt;âž¤ Splicing removes introns and is required to create a translatable mRNA. RNA editing alters specific nucleotides in RNA but does not participate in intron removal .&lt;/li&gt;&lt;li&gt;âž¤ Splicing removes introns and is required to create a translatable mRNA.&lt;/li&gt;&lt;li&gt;âž¤ Splicing&lt;/li&gt;&lt;li&gt;âž¤ RNA editing alters specific nucleotides in RNA but does not participate in intron removal .&lt;/li&gt;&lt;li&gt;âž¤ RNA editing&lt;/li&gt;&lt;li&gt;âž¤ not participate in intron removal&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e page 367,411&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Delving into the intricacies of RNA biology, one notable aspect is the presence of modified bases in RNA molecules, which impact their stability, structure, and function. Different types of RNA exhibit varying levels of base modification. Which type of RNA is characterized by having the highest percentage of modified bases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;tRNA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;rRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;snRNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. tRNA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) tRNA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA : While messenger RNA (mRNA) can contain modified bases , such as the 5&#x27; cap and poly-A tail , the proportion of modified bases in mRNA is generally lower than in tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA&lt;/li&gt;&lt;li&gt;â€¢ messenger RNA&lt;/li&gt;&lt;li&gt;â€¢ contain modified bases&lt;/li&gt;&lt;li&gt;â€¢ 5&#x27; cap&lt;/li&gt;&lt;li&gt;â€¢ poly-A tail&lt;/li&gt;&lt;li&gt;â€¢ proportion&lt;/li&gt;&lt;li&gt;â€¢ modified bases in mRNA&lt;/li&gt;&lt;li&gt;â€¢ lower than in tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. rRNA: Ribosomal RNA (rRNA) does contain modified bases that are important for its function in the ribosome , but the percentage of these modifications is not as high as in tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C. rRNA:&lt;/li&gt;&lt;li&gt;â€¢ Ribosomal RNA&lt;/li&gt;&lt;li&gt;â€¢ contain modified bases&lt;/li&gt;&lt;li&gt;â€¢ function in the ribosome&lt;/li&gt;&lt;li&gt;â€¢ Option D. snRNA: Small nuclear RNAs (snRNAs) are involved in splicing and also contain modified bases . However, the extent of base modification does not surpass that found in tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. snRNA:&lt;/li&gt;&lt;li&gt;â€¢ Small nuclear RNAs&lt;/li&gt;&lt;li&gt;â€¢ splicing&lt;/li&gt;&lt;li&gt;â€¢ contain modified bases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transfer RNA (tRNA) is known for having the highest percentage of modified bases among the various types of RNA.&lt;/li&gt;&lt;li&gt;âž¤ Transfer RNA&lt;/li&gt;&lt;li&gt;âž¤ highest percentage of modified bases&lt;/li&gt;&lt;li&gt;âž¤ various types of RNA.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 29/e page 411&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 29/e page 411&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a study session on transcription, a student examines a segment of DNA to determine how it would be transcribed into RNA. They focus on a particular coding strand region with the sequence 5â€™-CGT-3â€™ and aim to identify the corresponding RNA sequence that would be produced. What is the correct RNA sequence transcribed from this DNA coding strand?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5â€™-CGU-3â€™&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5â€™-GCA-3â€™&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5â€™-ACG-3â€™&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5â€™-UGC-3â€™&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 5â€™-CGU-3â€™&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture10_qXGlTrf.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 5â€™-CGU-3â€™&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5â€™-GCA-3â€™: This sequence is complementary to the given DNA sequence but doesn&#x27;t account for the RNA uracil substitution for thymine.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5â€™-GCA-3â€™:&lt;/li&gt;&lt;li&gt;â€¢ sequence is complementary&lt;/li&gt;&lt;li&gt;â€¢ Option C. 5â€™-ACG-3â€™: This sequence is a reverse complement of the given DNA sequence and does not represent the RNA sequence transcribed from the given DNA coding strand.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 5â€™-ACG-3â€™:&lt;/li&gt;&lt;li&gt;â€¢ sequence is a reverse complement&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5â€™-UGC-3â€™: This sequence is the reverse and complementary (with T replaced by U) of the given DNA coding strand, which is not how transcription works. Transcription generates a sequence complementary to the template strand, which would be identical to the coding strand with U in place of T.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5â€™-UGC-3â€™:&lt;/li&gt;&lt;li&gt;â€¢ sequence is the reverse and complementary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During transcription , RNA polymerase reads the template strand of DNA (which is complementary to the coding strand) and synthesizes RNA in the 5&#x27; to 3&#x27; direction . The RNA sequence is complementary to the DNA template strand and thus will be identical to the DNA coding strand, except that in RNA, uracil (U) is substituted for thymine (T).&lt;/li&gt;&lt;li&gt;âž¤ transcription&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ template strand of DNA&lt;/li&gt;&lt;li&gt;âž¤ synthesizes RNA&lt;/li&gt;&lt;li&gt;âž¤ 5&#x27; to 3&#x27; direction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 395.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 395.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an effort to deepen understanding of the various types of RNA and their abundance within the cell, a question arises regarding which form of RNA is most commonly found. Different RNA types play crucial roles in the cell, from protein synthesis to gene regulation. Which type of RNA is typically the most abundant in most cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;rRNA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;tRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;miRNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. rRNA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-180437.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) rRNA.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. mRNA :  Forms 5% of total&lt;/li&gt;&lt;li&gt;â€¢ Option B. mRNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. tRNA: Forms 15% of total&lt;/li&gt;&lt;li&gt;â€¢ Option C. tRNA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. miRNA: Forms &amp;lt; 1% of total&lt;/li&gt;&lt;li&gt;â€¢ Option D. miRNA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 395.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 395.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presents with features suggestive of Down syndrome. However, not all cells appear to have the typical trisomy 21 on karyotype analysis. Some of her cells have a normal karyotype. Which of the following is the correct cytogenetic notation for this presentation of Down syndrome mosaicism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;47, XX, +21&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;46, XX&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;47, XX, +18&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;47, XX, +21/46, XX&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 47, XX, +21/46, XX&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 47, XX, +21/46, XX&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: 47, XX, +21 : This notation indicates a non-mosaic form of Down syndrome where all cells have an extra chromosome 21.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A:&lt;/li&gt;&lt;li&gt;â€¢ 47, XX, +21&lt;/li&gt;&lt;li&gt;â€¢ notation&lt;/li&gt;&lt;li&gt;â€¢ non-mosaic form of Down syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option B: 46, XX: This represents a normal female karyotype with no extra chromosomes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ 46, XX:&lt;/li&gt;&lt;li&gt;â€¢ normal female karyotype&lt;/li&gt;&lt;li&gt;â€¢ Option C: 47, XX, +18: This would indicate trisomy 18, not Down syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C:&lt;/li&gt;&lt;li&gt;â€¢ 47, XX, +18:&lt;/li&gt;&lt;li&gt;â€¢ trisomy 18,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mosaicism occurs when a chromosomal anomaly affects one of several precursor cells of an embryo or tissue . The two or more karyotypes which characterize the mosaic cells are separated by a slash in cytogenetic notation. The nomenclature 47, XX, +21 denotes a cell line typical of a female with trisomy 21 (Down syndrome) 46, XX is the karyotype expected for a normal female and XY sex chromosomes refer to a male About 95% of patients with Down syndrome have trisomy 21, while 3% to 4% have translocations and 1% mosaicism.&lt;/li&gt;&lt;li&gt;âž¤ Mosaicism occurs when a chromosomal anomaly affects one of several precursor cells of an embryo or tissue .&lt;/li&gt;&lt;li&gt;âž¤ Mosaicism&lt;/li&gt;&lt;li&gt;âž¤ chromosomal anomaly&lt;/li&gt;&lt;li&gt;âž¤ precursor cells&lt;/li&gt;&lt;li&gt;âž¤ embryo or tissue&lt;/li&gt;&lt;li&gt;âž¤ The two or more karyotypes which characterize the mosaic cells are separated by a slash in cytogenetic notation.&lt;/li&gt;&lt;li&gt;âž¤ two or more karyotypes&lt;/li&gt;&lt;li&gt;âž¤ mosaic cells&lt;/li&gt;&lt;li&gt;âž¤ slash in cytogenetic notation.&lt;/li&gt;&lt;li&gt;âž¤ The nomenclature 47, XX, +21 denotes a cell line typical of a female with trisomy 21 (Down syndrome)&lt;/li&gt;&lt;li&gt;âž¤ 47, XX, +21&lt;/li&gt;&lt;li&gt;âž¤ cell line typical of a female with trisomy 21&lt;/li&gt;&lt;li&gt;âž¤ 46, XX is the karyotype expected for a normal female and XY sex chromosomes refer to a male&lt;/li&gt;&lt;li&gt;âž¤ 46, XX&lt;/li&gt;&lt;li&gt;âž¤ expected for a normal female&lt;/li&gt;&lt;li&gt;âž¤ XY sex chromosomes&lt;/li&gt;&lt;li&gt;âž¤ male&lt;/li&gt;&lt;li&gt;âž¤ About 95% of patients with Down syndrome have trisomy 21, while 3% to 4% have translocations and 1% mosaicism.&lt;/li&gt;&lt;li&gt;âž¤ 95% of patients&lt;/li&gt;&lt;li&gt;âž¤ Down syndrome&lt;/li&gt;&lt;li&gt;âž¤ trisomy 21,&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e : p 324, 635.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e&lt;/li&gt;&lt;li&gt;âž¤ p 324, 635.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical team in an academic hospital in India is discussing the treatment of a patient with a rare metabolic disorder that affects amino acid synthesis and transport. To clarify the underlying biochemical processes for the resident doctors, the lead biochemist asks about the enzyme responsible for attaching an amino acid to its corresponding tRNA. Which enzyme catalyzes the binding of an amino acid to a specific tRNA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aminoacyl rRNA synthetases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aminoacyl tRNA polymerases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aminoacyl tRNA synthetases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aminoacyl mRNA synthetases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aminoacyl tRNA synthetases&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture4_VOKKrpa.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Aminoacyl tRNA synthetases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aminoacyl rRNA synthetases - This is incorrect because rRNA is not involved in the charging of tRNA with amino acids.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Aminoacyl rRNA synthetases&lt;/li&gt;&lt;li&gt;â€¢ rRNA is not involved&lt;/li&gt;&lt;li&gt;â€¢ charging of tRNA&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aminoacyl tRNA polymerases - This is incorrect; there is no enzyme called aminoacyl tRNA polymerase involved in tRNA charging.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Aminoacyl tRNA polymerases&lt;/li&gt;&lt;li&gt;â€¢ no enzyme called aminoacyl tRNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aminoacyl mRNA synthetases - This is incorrect as mRNA is not directly involved in the reaction where amino acids are attached to tRNA molecules .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Aminoacyl mRNA synthetases&lt;/li&gt;&lt;li&gt;â€¢ mRNA is not directly involved&lt;/li&gt;&lt;li&gt;â€¢ reaction&lt;/li&gt;&lt;li&gt;â€¢ amino acids&lt;/li&gt;&lt;li&gt;â€¢ attached to tRNA molecules&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The enzyme that catalyzes the attachment of an amino acid to its corresponding tRNA is aminoacyl tRNA synthetase. This process ensures the correct amino acid is added during protein synthesis.&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ catalyzes the attachment&lt;/li&gt;&lt;li&gt;âž¤ amino acid&lt;/li&gt;&lt;li&gt;âž¤ corresponding tRNA&lt;/li&gt;&lt;li&gt;âž¤ aminoacyl tRNA synthetase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 422-423.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 422-423.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old biochemistry professor is conducting a review session on protein synthesis for postgraduate students. He presents a clinical case of a patient with a genetic mutation affecting protein synthesis, specifically focusing on the elongation phase of translation. He asks the students to identify the enzyme responsible for catalyzing the formation of peptide bonds during this phase. Which enzyme is involved in this critical step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Translocase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peptidyl transferase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aminoacyl tRNA synthetases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carboxypeptidase A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Peptidyl transferase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Peptidyl transferase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A protein translocase carries the acyl carnitine across the membrane to the mitochondrial matrix .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ protein translocase&lt;/li&gt;&lt;li&gt;â€¢ acyl carnitine&lt;/li&gt;&lt;li&gt;â€¢ membrane to the mitochondrial matrix&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activates the amino acids and helps in the recognition of both the amino acid and the transfer RNA acceptor .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activates&lt;/li&gt;&lt;li&gt;â€¢ amino acids&lt;/li&gt;&lt;li&gt;â€¢ recognition of both the amino acid&lt;/li&gt;&lt;li&gt;â€¢ transfer RNA acceptor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acts on the C-terminal aromatic amino acid of a polypeptide to break a peptide bond.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ C-terminal aromatic amino acid&lt;/li&gt;&lt;li&gt;â€¢ polypeptide&lt;/li&gt;&lt;li&gt;â€¢ break a peptide bond.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Peptidyl transferase , a component of the large ribosomal subunit , catalyzes the formation of peptide bonds during the elongation phase of translation . This enzyme is crucial for protein synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Peptidyl transferase&lt;/li&gt;&lt;li&gt;âž¤ component&lt;/li&gt;&lt;li&gt;âž¤ large ribosomal subunit&lt;/li&gt;&lt;li&gt;âž¤ catalyzes&lt;/li&gt;&lt;li&gt;âž¤ formation of peptide bonds&lt;/li&gt;&lt;li&gt;âž¤ elongation phase of translation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 422.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 422.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Considering a synthetic mRNA composed entirely of adenine nucleotides (poly A), what type of polypeptide would this mRNA sequence code for?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polylysine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polyglycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polyproline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polyalanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Polylysine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Polylysine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A synthetic mRNA consisting entirely of adenine nucleotides (poly A) would be read by the ribosome as repeated AAA codons . According to the genetic code, the codon AAA specifies the amino acid lysine .&lt;/li&gt;&lt;li&gt;â€¢ AAA codons&lt;/li&gt;&lt;li&gt;â€¢ AAA&lt;/li&gt;&lt;li&gt;â€¢ lysine&lt;/li&gt;&lt;li&gt;â€¢ Therefore, during translation, a poly A mRNA would direct the ribosome to synthesize a polypeptide made entirely of lysine residues â€” referred to as polylysine .&lt;/li&gt;&lt;li&gt;â€¢ polypeptide made entirely of lysine residues&lt;/li&gt;&lt;li&gt;â€¢ polylysine&lt;/li&gt;&lt;li&gt;â€¢ This was demonstrated in early experiments by Nirenberg and colleagues, who used synthetic mRNAs to decipher codon-amino acid relationships.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyglycine: Glycine is coded by GGU, GGC, GGA, or GGG â€” not AAA. Option C. Polyproline: Proline is coded by CCU, CCC, CCA, and CCG â€” not by adenine-only codons. Option D. Polyalanine: Alanine is encoded by GCU, GCC, GCA, and GCG â€” again, not AAA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyglycine: Glycine is coded by GGU, GGC, GGA, or GGG â€” not AAA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polyglycine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polyproline: Proline is coded by CCU, CCC, CCA, and CCG â€” not by adenine-only codons.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polyproline:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polyalanine: Alanine is encoded by GCU, GCC, GCA, and GCG â€” again, not AAA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Polyalanine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Poly A â†’ Lysine Poly C â†’ Proline Poly G â†’ Glycine Poly U â†’ Phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ Poly A â†’ Lysine&lt;/li&gt;&lt;li&gt;âž¤ Poly A â†’ Lysine&lt;/li&gt;&lt;li&gt;âž¤ Poly C â†’ Proline&lt;/li&gt;&lt;li&gt;âž¤ Poly C â†’ Proline&lt;/li&gt;&lt;li&gt;âž¤ Poly G â†’ Glycine&lt;/li&gt;&lt;li&gt;âž¤ Poly G â†’ Glycine&lt;/li&gt;&lt;li&gt;âž¤ Poly U â†’ Phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ Poly U â†’ Phenylalanine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following codons with the correct amino acid they code for or their function in this specialized context:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-b, 2-c, 3-d, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-d, 3-b, 4-c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-b, 2-a, 3-d, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-15%20190722.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ 1. UGA â†’ B) Selenocysteine&lt;/li&gt;&lt;li&gt;â€¢ Normally: A stop codon. Special context: With a specific SECIS element (Selenocysteine Insertion Sequence), UGA is redefined to insert selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Normally: A stop codon.&lt;/li&gt;&lt;li&gt;â€¢ Special context: With a specific SECIS element (Selenocysteine Insertion Sequence), UGA is redefined to insert selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Correct match: 1-b&lt;/li&gt;&lt;li&gt;â€¢ 2. UAG â†’ A) Pyrrolysine&lt;/li&gt;&lt;li&gt;â€¢ Normally: A stop codon. Special context: In certain bacteria, UAG can code for pyrrolysine, the 22nd amino acid.&lt;/li&gt;&lt;li&gt;â€¢ Normally: A stop codon.&lt;/li&gt;&lt;li&gt;â€¢ Special context: In certain bacteria, UAG can code for pyrrolysine, the 22nd amino acid.&lt;/li&gt;&lt;li&gt;â€¢ Correct match: 2-a&lt;/li&gt;&lt;li&gt;â€¢ 3. AUG â†’ D) Methionine&lt;/li&gt;&lt;li&gt;â€¢ Always: The standard start codon and codes for methionine.&lt;/li&gt;&lt;li&gt;â€¢ Always: The standard start codon and codes for methionine.&lt;/li&gt;&lt;li&gt;â€¢ Correct match: 3-d&lt;/li&gt;&lt;li&gt;â€¢ 4. UCA â†’ C) Serine&lt;/li&gt;&lt;li&gt;â€¢ Always: Codes for serine under the standard genetic code.&lt;/li&gt;&lt;li&gt;â€¢ Always: Codes for serine under the standard genetic code.&lt;/li&gt;&lt;li&gt;â€¢ Correct match: 4-c&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B . 1-b, 2-c, 3-d, 4-b UAG does not code for serine; UCA does. UCA doesnâ€™t code for selenocysteine. Option C . 1-a, 2-d, 3-b, 4-c UGA codes for selenocysteine, not pyrrolysine. AUG codes for methionine, not selenocysteine. Option D . 1-a, 2-b, 3-c, 4-d is incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option B . 1-b, 2-c, 3-d, 4-b UAG does not code for serine; UCA does. UCA doesnâ€™t code for selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C . 1-a, 2-d, 3-b, 4-c UGA codes for selenocysteine, not pyrrolysine. AUG codes for methionine, not selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . 1-a, 2-b, 3-c, 4-d is incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the standard genetic code and recognize exceptions like:&lt;/li&gt;&lt;li&gt;âž¤ UGA coding for selenocysteine in the presence of SECIS. UAG coding for pyrrolysine in some organisms. AUG as the universal start codon for methionine. UCA coding for serine in standard contexts.&lt;/li&gt;&lt;li&gt;âž¤ UGA coding for selenocysteine in the presence of SECIS.&lt;/li&gt;&lt;li&gt;âž¤ UAG coding for pyrrolysine in some organisms.&lt;/li&gt;&lt;li&gt;âž¤ AUG as the universal start codon for methionine.&lt;/li&gt;&lt;li&gt;âž¤ UCA coding for serine in standard contexts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an ongoing study at a wildlife conservation facility, researchers are examining the genetic adaptation mechanisms of a rare species susceptible to a novel viral pathogen. The focus is on understanding how the virus&#x27;s genetic material integrates with the host&#x27;s cellular processes, particularly the initiation of protein synthesis. The research team is investigating which mRNA codon the host&#x27;s Met-tRNA recognizes to start the translation process, a crucial step that the virus might exploit for its replication. What is the correct codon that initiates this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AUG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GUA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;UAC&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. AUG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.AUG.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . GCA codes for the amino acid Alanine , not Methionine, and is not recognized by Met-tRNA as a start codon.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ GCA codes&lt;/li&gt;&lt;li&gt;â€¢ amino acid Alanine&lt;/li&gt;&lt;li&gt;â€¢ Option C. GUA codes for Valine , not Methionine, and does not serve as a start codon for the Met-tRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ GUA codes for Valine&lt;/li&gt;&lt;li&gt;â€¢ Option D . UAC is the anticodon that pairs with the AUG codon on the Met-tRNA, not the codon it recognizes on the mRNA.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ UAC is the anticodon&lt;/li&gt;&lt;li&gt;â€¢ pairs with the AUG codon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The AUG codon is universally recognized by the Met-tRNA as the start codon in the process of translation . This codon signals the initiation of protein synthesis by coding for methionine , an essential amino acid that often serves as the first building block of newly synthesized proteins .&lt;/li&gt;&lt;li&gt;âž¤ AUG codon&lt;/li&gt;&lt;li&gt;âž¤ Met-tRNA&lt;/li&gt;&lt;li&gt;âž¤ start codon&lt;/li&gt;&lt;li&gt;âž¤ process of translation&lt;/li&gt;&lt;li&gt;âž¤ codon signals&lt;/li&gt;&lt;li&gt;âž¤ initiation of protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ coding for methionine&lt;/li&gt;&lt;li&gt;âž¤ amino acid&lt;/li&gt;&lt;li&gt;âž¤ serves as the first building block&lt;/li&gt;&lt;li&gt;âž¤ newly synthesized proteins&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;which of the presented processes correctly relates to the changes in gene expression regulation depicted in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Post transcriptional regulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Affect mRNA stability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alter organization of the DNA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alter the nucleotide sequence of the DNA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alter organization of the DNA&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture1_cZQT8Ie.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alter organization of the DNA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Post transcriptional regulation: It is an epigenetic modification.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Post transcriptional regulation:&lt;/li&gt;&lt;li&gt;â€¢ epigenetic modification.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Affect mRNA stability affects the organisation of DNA but has no effect on mRNA stability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Affect mRNA stability&lt;/li&gt;&lt;li&gt;â€¢ organisation of DNA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alter the nucleotide sequence of the DNA: epigenetic modification does not affect or alter the nucleotide sequences .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alter the nucleotide sequence of the DNA:&lt;/li&gt;&lt;li&gt;â€¢ not affect&lt;/li&gt;&lt;li&gt;â€¢ nucleotide sequences&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation and histone acetylation , both of which are epigenetic modifications . These modifications are known to affect the structure and organization of DNA in the chromatin , influencing gene expression by regulating the accessibility of transcriptional machinery to certain genes.&lt;/li&gt;&lt;li&gt;âž¤ DNA methylation&lt;/li&gt;&lt;li&gt;âž¤ histone acetylation&lt;/li&gt;&lt;li&gt;âž¤ epigenetic modifications&lt;/li&gt;&lt;li&gt;âž¤ modifications&lt;/li&gt;&lt;li&gt;âž¤ affect the structure&lt;/li&gt;&lt;li&gt;âž¤ organization of DNA&lt;/li&gt;&lt;li&gt;âž¤ chromatin&lt;/li&gt;&lt;li&gt;âž¤ gene expression&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 371-376, Lippincott 7/e: P 409-410.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 371-376, Lippincott 7/e: P 409-410.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A genetic counsellor is reviewing the case of an Ashkenazi Jewish family with a 7-month-old son diagnosed with Tay-Sachs disease, an autosomal recessive disorder. If son is a diagnosed case of Tay-Sachs disease. The family&#x27;s pedigree and Southern blot analysis, with RFLP linked to the Tay-Sachs gene, have been presented to determine the genetic status of their daughter. What does the Southern blot analysis indicate regarding the daughter&#x27;s genetic status concerning Tay-Sachs disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;She has a 25% chance of having Tay-Sachs disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;She has a 50% chance of having Tay-Sachs disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;She is a carrier for Tay-Sachs disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;She is homozygous normal.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. She is homozygous normal.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/1230.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture3_0u6xcgZ.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. She is homozygous normal.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. 25% chance of having Tay-Sachs disease : This is a statistical likelihood for offspring when both parents are carriers, but it speaks more to probability than to actual genetic findings from the analysis of Southern blot.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 25% chance of having Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. 50% chance of having Tay-Sachs disease : This might be considered if one parent is affected and the other is a carrier, but it speaks more to probability than to actual genetic findings from the analysis of Southern blot.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 50% chance of having Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carrier for Tay-Sachs disease : This would mean the child inherited one normal and one mutated gene. The absence of the mutated gene in  Southern blot analysis  negates this option.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carrier for Tay-Sachs disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Southern blot analysis is a method used to detect specific DNA sequences, making it valuable for diagnosing genetic conditions. In the context of Tay-Sachs disease, which is an autosomal recessive disorder, a person must inherit two defective copies of the gene to manifest the disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 635&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3 days old infant feeds poorly, chokes and turns blue after breastfeeding. O/E â€“ the infant is floppy with a heart murmur and has flat occiput, folds over the inner corners of the eyes, single palmar crease etc. Family history of Down syndrome present. From the below chromosome analysis, which of the results is most likely in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Result A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Result B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Result C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Result D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Result C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/100001.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Result C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Result : Would likely represent a normal karyotype, which would not be consistent with the clinical presentation of Down syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Result&lt;/li&gt;&lt;li&gt;â€¢ Option B. Result : Could indicate another chromosomal abnormality that does not align with Down syndrome&#x27;s typical presentation, possibly a translocation or deletion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Result&lt;/li&gt;&lt;li&gt;â€¢ Option D. Result : Could indicate another chromosomal abnormality that does not align with Down syndrome&#x27;s typical presentation, possibly a translocation or deletion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Result&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Down syndrome is characterized by an extra copy of chromosome 21, which is a trisomy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 635&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of type IV glycogen storage disease (GSD IV), an autosomal recessive condition characterized by progressive liver damage, hypoglycemia, hyperlipidemia, and hyperuricemia due to deficient glycogenolysis, which of the following statements accurately describes autosomal recessive conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are often associated with deficient enzyme activity.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both alleles contain the same mutation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are more variable than autosomal dominant conditions.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most persons do not carry any abnormal recessive genes.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. They are often associated with deficient enzyme activity.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. They are often associated with deficient enzyme activity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Both alleles are defective but do not contain the exact same mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Both alleles&lt;/li&gt;&lt;li&gt;â€¢ defective&lt;/li&gt;&lt;li&gt;â€¢ Option C: They have a horizontal pattern of affected persons in the pedigree . Males and females are affected with equal frequency and severity.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ horizontal pattern of affected persons&lt;/li&gt;&lt;li&gt;â€¢ pedigree&lt;/li&gt;&lt;li&gt;â€¢ Option D: All individuals carry 6 to 12 mutant recessive alleles .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ individuals&lt;/li&gt;&lt;li&gt;â€¢ 6 to 12 mutant recessive alleles&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Autosomal recessive conditions, such as type IV glycogen storage disease , are frequently characterized by a deficiency in enzyme activity . This is because both copies of the gene in question (one from each parent) must be affected for the disorder to manifest, typically resulting in the absence or malfunctioning of an enzyme or protein.&lt;/li&gt;&lt;li&gt;âž¤ Autosomal recessive&lt;/li&gt;&lt;li&gt;âž¤ type IV glycogen storage disease&lt;/li&gt;&lt;li&gt;âž¤ deficiency in enzyme activity&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 31/e, p 820-821&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 31/e, p 820-821&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a family affected by Charcot-Marie-Tooth disease, restriction analysis of the genomic region surrounding the CMT gene on chromosome 17 produces one large abnormal fragment and one smaller fragment common to unaffected controls. Based on this information, what is the most likely pattern of inheritance for Charcot-Marie-Tooth disease in this family?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;X-linked recessive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Autosomal dominant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autosomal recessive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;X-linked dominant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Autosomal dominant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. X-linked recessive: This is less likely since Charcot-Marie-Tooth disease , especially types associated with chromosome 17 mutations, typically does not follow an X-linked pattern of inheritance.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. X-linked recessive:&lt;/li&gt;&lt;li&gt;â€¢ less likely&lt;/li&gt;&lt;li&gt;â€¢ Charcot-Marie-Tooth disease&lt;/li&gt;&lt;li&gt;â€¢ Option C. Autosomal recessive: In autosomal recessive conditions, two mutated alleles are necessary for the manifestation of the disease , which does not align with the finding of one normal and one abnormal fragment.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Autosomal recessive:&lt;/li&gt;&lt;li&gt;â€¢ two mutated alleles&lt;/li&gt;&lt;li&gt;â€¢ manifestation of the disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. X-linked dominant: This is also unlikely for Charcot-Marie-Tooth disease , given its known genetic basis and typical autosomal dominant inheritance pattern.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. X-linked dominant:&lt;/li&gt;&lt;li&gt;â€¢ unlikely&lt;/li&gt;&lt;li&gt;â€¢ Charcot-Marie-Tooth disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Charcot-Marie-Tooth disease is commonly inherited in an autosomal dominant manner , particularly for mutations found on chromosome 17 , which often involve the PMP22 gene . The presence of one abnormal fragment in the restriction analysis suggests a mutation or alteration in one allele of the gene , while the other allele appears normal (as indicated by the smaller fragment seen in controls). This pattern is consistent with autosomal dominant inheritance, where a single mutated allele can cause the disease phenotype.&lt;/li&gt;&lt;li&gt;âž¤ Charcot-Marie-Tooth disease&lt;/li&gt;&lt;li&gt;âž¤ inherited&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant manner&lt;/li&gt;&lt;li&gt;âž¤ mutations&lt;/li&gt;&lt;li&gt;âž¤ chromosome 17&lt;/li&gt;&lt;li&gt;âž¤ involve the PMP22 gene&lt;/li&gt;&lt;li&gt;âž¤ restriction analysis&lt;/li&gt;&lt;li&gt;âž¤ mutation&lt;/li&gt;&lt;li&gt;âž¤ alteration in one allele of the gene&lt;/li&gt;&lt;li&gt;âž¤ other allele appears normal&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 635&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 635&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is studying gene expression in mammalian cells and focuses on genes that are crucial for basic cellular functions like cell structure, metabolism, and the repair of DNA. These genes seem to be consistently active across various tissues and are not significantly upregulated or downregulated in response to cellular signals or environmental changes. Based on this information, which statement best describes these genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They are inducible genes that respond to environmental stimuli.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They are housekeeping genes that are constitutively expressed.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They are silenced genes in most tissues and cells.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They are only expressed in specific tissues under certain conditions.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. They are housekeeping genes that are constitutively expressed.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. They are housekeeping genes that are constitutively expressed.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are inducible genes that respond to environmental stimuli: This describes genes that are turned on or off in response to specific signals, which is not characteristic of housekeeping genes.&lt;/li&gt;&lt;li&gt;â€¢ Option A. They are inducible genes that respond to environmental stimuli:&lt;/li&gt;&lt;li&gt;â€¢ genes that are turned on or off&lt;/li&gt;&lt;li&gt;â€¢ Option C. They are silenced genes in most tissues and cells: Silenced genes are not expressed in most conditions ; housekeeping genes, by contrast, are consistently active.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. They are silenced genes in most tissues and cells:&lt;/li&gt;&lt;li&gt;â€¢ Silenced genes&lt;/li&gt;&lt;li&gt;â€¢ not expressed in most conditions&lt;/li&gt;&lt;li&gt;â€¢ Option D. They are only expressed in specific tissues under certain conditions: This describes tissue-specific or conditionally expressed genes, not housekeeping genes which are ubiquitously expressed.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. They are only expressed in specific tissues under certain conditions:&lt;/li&gt;&lt;li&gt;â€¢ tissue-specific&lt;/li&gt;&lt;li&gt;â€¢ conditionally expressed genes,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The expression of some genes are constitutive ðŸ¡ª they are expressed at a reasonably constant rate and are not subjected to regulation. These are known as housekeeping genes. An inducible gene is one whose expression increases in response to an inducer or activator , a specific positive regulatory signal.&lt;/li&gt;&lt;li&gt;âž¤ The expression of some genes are constitutive ðŸ¡ª they are expressed at a reasonably constant rate and are not subjected to regulation. These are known as housekeeping genes.&lt;/li&gt;&lt;li&gt;âž¤ The expression of some genes are constitutive ðŸ¡ª they are expressed at a reasonably constant rate and are not subjected to regulation. These are known as housekeeping genes.&lt;/li&gt;&lt;li&gt;âž¤ expression of some genes&lt;/li&gt;&lt;li&gt;âž¤ constitutive&lt;/li&gt;&lt;li&gt;âž¤ housekeeping genes.&lt;/li&gt;&lt;li&gt;âž¤ An inducible gene is one whose expression increases in response to an inducer or activator , a specific positive regulatory signal.&lt;/li&gt;&lt;li&gt;âž¤ An inducible gene is one whose expression increases in response to an inducer or activator , a specific positive regulatory signal.&lt;/li&gt;&lt;li&gt;âž¤ inducible gene&lt;/li&gt;&lt;li&gt;âž¤ expression increases&lt;/li&gt;&lt;li&gt;âž¤ inducer or activator&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 430.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 430.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes a null mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mutation occurring in noncoding region&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mutation that does not change the amino acid or end product&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutation that codes for a change in progeny without a chromosomal change&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mutation that leads to no functional gene product&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mutation that leads to no functional gene product&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Mutation that leads to no functional gene product&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mutations in noncoding regions can affect gene expression or regulation but do not necessarily result in a null mutation unless they disrupt essential regulatory elements.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A:&lt;/li&gt;&lt;li&gt;â€¢ Mutations in noncoding regions&lt;/li&gt;&lt;li&gt;â€¢ affect gene expression&lt;/li&gt;&lt;li&gt;â€¢ Option B: Silent mutations or synonymous mutations do not change the amino acid sequence of the protein and typically do not lead to a loss of function, thus not constituting null mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B:&lt;/li&gt;&lt;li&gt;â€¢ Silent mutations&lt;/li&gt;&lt;li&gt;â€¢ synonymous mutations&lt;/li&gt;&lt;li&gt;â€¢ not change the amino acid sequence&lt;/li&gt;&lt;li&gt;â€¢ Option C: Genetic changes leading to phenotypic changes without chromosomal alterations can involve various types of mutations but do not specifically describe null mutations, which are defined by the loss of gene function.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C:&lt;/li&gt;&lt;li&gt;â€¢ Genetic changes&lt;/li&gt;&lt;li&gt;â€¢ phenotypic changes&lt;/li&gt;&lt;li&gt;â€¢ chromosomal alterations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Null mutation - A mutation that leads to no functional gene product is called null mutation .&lt;/li&gt;&lt;li&gt;âž¤ Null mutation -&lt;/li&gt;&lt;li&gt;âž¤ mutation&lt;/li&gt;&lt;li&gt;âž¤ no functional gene product&lt;/li&gt;&lt;li&gt;âž¤ null mutation&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 631&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 631&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following modifications is primarily responsible for the inactivation of genes found within CpG islands?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹ Methylation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphorylation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ubiquitination&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. â€‹â€‹â€‹â€‹ Methylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Methylation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phosphorylation: While phosphorylation is a crucial post-translational modification that affects protein function , it is not directly involved in the inactivation of genes within CpG islands.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Phosphorylation:&lt;/li&gt;&lt;li&gt;â€¢ crucial post-translational modification&lt;/li&gt;&lt;li&gt;â€¢ affects protein function&lt;/li&gt;&lt;li&gt;â€¢ Option C. Ubiquitination: Ubiquitination is a process that tags proteins for degradation and does not directly affect gene inactivation at the DNA level within CpG islands.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Ubiquitination:&lt;/li&gt;&lt;li&gt;â€¢ process that tags proteins&lt;/li&gt;&lt;li&gt;â€¢ degradation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acetylation: Acetylation, particularly of histone proteins , is generally associated with the activation of gene expression by making chromatin more accessible to transcriptional machinery, not inactivation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Acetylation:&lt;/li&gt;&lt;li&gt;â€¢ histone proteins&lt;/li&gt;&lt;li&gt;â€¢ activation of gene expression&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gene promoters and regulation by methylation and demethylation:&lt;/li&gt;&lt;li&gt;âž¤ Gene promoters and regulation by methylation and demethylation:&lt;/li&gt;&lt;li&gt;âž¤ Majority of gene promoters have high CG content . CpG islands are the most common sites of methylation-demethylation. Thus, they play an important role in regulation of gene expression CpG islands of promoters are typically unmethylated, which favours transcription.&lt;/li&gt;&lt;li&gt;âž¤ Majority of gene promoters have high CG content .&lt;/li&gt;&lt;li&gt;âž¤ Majority of gene promoters have high CG content .&lt;/li&gt;&lt;li&gt;âž¤ Majority of gene promoters&lt;/li&gt;&lt;li&gt;âž¤ high CG content&lt;/li&gt;&lt;li&gt;âž¤ CpG islands are the most common sites of methylation-demethylation.&lt;/li&gt;&lt;li&gt;âž¤ CpG islands are the most common sites of methylation-demethylation.&lt;/li&gt;&lt;li&gt;âž¤ Thus, they play an important role in regulation of gene expression&lt;/li&gt;&lt;li&gt;âž¤ Thus, they play an important role in regulation of gene expression&lt;/li&gt;&lt;li&gt;âž¤ CpG islands of promoters are typically unmethylated, which favours transcription.&lt;/li&gt;&lt;li&gt;âž¤ CpG islands of promoters are typically unmethylated, which favours transcription.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 596&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 596&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of diabetes mellitus is admitted to the surgical ICU of a tertiary care hospital in India for the management of a severe diabetic foot ulcer. During his stay, the medical team notes an increase in staphylococcal infections among patients in the unit. To investigate the source and control the outbreak, the infection control team decides to use molecular techniques to identify the strains of Staphylococcus causing these infections. They opt for the RFLP technique to differentiate between the species of staphylococci present in the ICU. Based on your understanding of RFLP, which of the following statements is FALSE regarding this technique?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Detects mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recognizes trinucleotide repeats&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Detects deletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blunt ends are produced&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Recognizes trinucleotide repeats&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Recognizes trinucleotide repeats&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Detects mutation &amp;amp; Option C: Detects deletion - Both can give rise to RFLP and can be detected by RFLP analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Detects mutation &amp;amp; Option C: Detects deletion - Both&lt;/li&gt;&lt;li&gt;â€¢ give rise to RFLP&lt;/li&gt;&lt;li&gt;â€¢ Option D: Blunt ends are produced: The restriction endonucleases enzymes used for RFLP analysis can either produce blunt end DNA or sticky end DNA depending on the type of enzyme used.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Blunt ends are produced:&lt;/li&gt;&lt;li&gt;â€¢ restriction endonucleases enzymes&lt;/li&gt;&lt;li&gt;â€¢ RFLP analysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ RFLP is a technique used to detect variations in DNA sequences by using restriction enzymes to cut DNA at specific sequences, and then analysing the pattern of resulting fragments . This method is effective for identifying point mutations and deletions that alter restriction sites but is not specifically designed to recognize trinucleotide repeat expansions , which are better analysed using PCR or Southern blot techniques.&lt;/li&gt;&lt;li&gt;âž¤ RFLP&lt;/li&gt;&lt;li&gt;âž¤ detect variations&lt;/li&gt;&lt;li&gt;âž¤ DNA sequences&lt;/li&gt;&lt;li&gt;âž¤ using restriction enzymes&lt;/li&gt;&lt;li&gt;âž¤ cut DNA&lt;/li&gt;&lt;li&gt;âž¤ analysing the pattern&lt;/li&gt;&lt;li&gt;âž¤ resulting fragments&lt;/li&gt;&lt;li&gt;âž¤ effective for identifying point mutations&lt;/li&gt;&lt;li&gt;âž¤ deletions&lt;/li&gt;&lt;li&gt;âž¤ alter restriction sites&lt;/li&gt;&lt;li&gt;âž¤ recognize trinucleotide repeat expansions&lt;/li&gt;&lt;li&gt;âž¤ PCR or Southern blot techniques.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 463.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 463.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents to a healthcare facility with a fever, cough, and shortness of breath. Given the ongoing COVID-19 pandemic, the medical team decides to test for SARS-CoV-2. Which of the following diagnostic methods is NOT typically used for the direct detection of SARS-CoV-2?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RT PCR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Real time PCR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Southern blotting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immunoassays&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Southern blotting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Southern blotting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: RT-PCR: True . Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a widely used method for detecting SARS-CoV-2 RNA by converting RNA into DNA, amplifying it, and then detecting it, making it a standard diagnostic tool for COVID-19.&lt;/li&gt;&lt;li&gt;â€¢ Option A: RT-PCR:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Option B: Real-time PCR: True . Real-time PCR, a variant of PCR, allows for the monitoring of the reaction as it occurs, and is used for the quantitative detection of SARS-CoV-2 RNA, making it another key tool in COVID-19 diagnostics.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Real-time PCR:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Option D: Immunoassays: True . Immunoassays, which can include tests like ELISA or rapid antigen tests, detect the presence of viral proteins (antigens) or host antibodies against the virus, and are used in the diagnosis and surveillance of COVID-19, although they have different applications and sensitivities compared to PCR-based methods.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Immunoassays:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Southern blotting is a molecular biology technique used to detect specific DNA sequences in DNA samples , not typically used for the direct detection of viral RNA , such as that of SARS-CoV-2 . This method involves transferring DNA from a gel to a membrane followed by hybridization with a labeled probe , but it is not suitable for the rapid, sensitive detection of viral RNA necessary for diagnosing acute viral infections like COVID-19.&lt;/li&gt;&lt;li&gt;âž¤ Southern blotting&lt;/li&gt;&lt;li&gt;âž¤ molecular biology technique&lt;/li&gt;&lt;li&gt;âž¤ detect specific DNA sequences&lt;/li&gt;&lt;li&gt;âž¤ DNA samples&lt;/li&gt;&lt;li&gt;âž¤ direct detection of viral RNA&lt;/li&gt;&lt;li&gt;âž¤ SARS-CoV-2&lt;/li&gt;&lt;li&gt;âž¤ transferring DNA from a gel&lt;/li&gt;&lt;li&gt;âž¤ membrane&lt;/li&gt;&lt;li&gt;âž¤ hybridization with a labeled probe&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher at a genetics laboratory is analyzing a gel-based technique for DNA analysis. The process includes the separation of DNA fragments by electrophoresis, transfer of the DNA from the gel to a nitrocellulose sheet, and identification using a labelled DNA probe. What is the molecular biology technique depicted in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Southern Blotting - RNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Southern Blotting -DNA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Northern Blotting - Protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Western Blotting -DNA Protein Interaction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Southern Blotting -DNA&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/78.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/08/screenshot-2024-04-08-162253.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Southern Blotting â€“ DNA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Southern Blotting - RNA: Laboratory technique used to detect a specific DNA sequence in the blood and tissue sample.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Southern Blotting - RNA: Laboratory technique&lt;/li&gt;&lt;li&gt;â€¢ specific DNA sequence&lt;/li&gt;&lt;li&gt;â€¢ blood and tissue sample.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Northern Blotting - Protein: Molecular biology technique to study gene expression by detection of RNA in a sample.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Northern Blotting - Protein:&lt;/li&gt;&lt;li&gt;â€¢ gene expression&lt;/li&gt;&lt;li&gt;â€¢ Option D: Western Blotting -DNA Protein Interaction: Molecular biology technique to study individual proteins in a sample.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Western Blotting -DNA Protein Interaction:&lt;/li&gt;&lt;li&gt;â€¢ study individual proteins&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The technique shown in the image is Southern Blotting , which is used for DNA detection . The process involves the separation of DNA fragments by agarose gel electrophoresis , transfer of DNA onto a nitrocellulose or nylon membrane , and hybridization with a labelled DNA probe , which is then visualized through autoradiography. The presence of \&quot;32 P-labelled DNA probe\&quot; in the image confirms that the target for detection is DNA, not RNA or protein.&lt;/li&gt;&lt;li&gt;âž¤ technique&lt;/li&gt;&lt;li&gt;âž¤ Southern Blotting&lt;/li&gt;&lt;li&gt;âž¤ DNA detection&lt;/li&gt;&lt;li&gt;âž¤ process involves&lt;/li&gt;&lt;li&gt;âž¤ separation&lt;/li&gt;&lt;li&gt;âž¤ DNA fragments&lt;/li&gt;&lt;li&gt;âž¤ agarose gel electrophoresis&lt;/li&gt;&lt;li&gt;âž¤ DNA onto a nitrocellulose&lt;/li&gt;&lt;li&gt;âž¤ nylon membrane&lt;/li&gt;&lt;li&gt;âž¤ hybridization&lt;/li&gt;&lt;li&gt;âž¤ labelled DNA probe&lt;/li&gt;&lt;li&gt;âž¤ visualized through autoradiography.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 456-457.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 456-457.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician studied the global patterns of gene expression in two different types of tumour cells, so he can develop the most appropriate form of chemotherapy for each patient. Which of the following techniques will be most appropriate for this purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microarray&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Northern blot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Southern blot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Western blot&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Microarray&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Microarray&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Northern blot: Measures mRNA production from one gene at a time.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Northern blot:&lt;/li&gt;&lt;li&gt;â€¢ one gene&lt;/li&gt;&lt;li&gt;â€¢ Option C: Southern blot: Used to analyze DNA, but not the DNA expression .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Southern blot:&lt;/li&gt;&lt;li&gt;â€¢ not the DNA expression&lt;/li&gt;&lt;li&gt;â€¢ Option D: Western blot: Measure protein production and gene expression but only from one gene at a time.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Western blot:&lt;/li&gt;&lt;li&gt;â€¢ one gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Microarray is the most appropriate technique for studying global patterns of gene expression. This technology allows simultaneous analysis of the expression levels of thousands of genes, providing a comprehensive overview that is essential for comparing different tumor types and informing personalized chemotherapy treatments.&lt;/li&gt;&lt;li&gt;âž¤ Microarray&lt;/li&gt;&lt;li&gt;âž¤ studying global patterns of gene expression.&lt;/li&gt;&lt;li&gt;âž¤ technology&lt;/li&gt;&lt;li&gt;âž¤ simultaneous analysis&lt;/li&gt;&lt;li&gt;âž¤ expression levels of thousands of genes,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 465-466.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 465-466.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a forensic investigation of a sexual assault case, the crime scene investigators have procured a semen sample and tissue samples from the victim. They have also obtained DNA samples from the victim and three suspects for analysis. To compare the variable number of tandem repeats (VNTR) among these samples, which technique is most suitable for the initial analysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA sequencing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Northern blot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Southern blot&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Western blot&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Southern blot&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Southern blot&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. DNA sequencing: Though it can detect DNA similarities but It is expensive and time-consuming for forensic analysis. It can be used for a confirmatory analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. DNA sequencing:&lt;/li&gt;&lt;li&gt;â€¢ detect DNA similarities&lt;/li&gt;&lt;li&gt;â€¢ Option B. Northern blot: It is used to separate and detect RNA.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Northern blot:&lt;/li&gt;&lt;li&gt;â€¢ separate and detect RNA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Western blot: It is used for detection of proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Western blot:&lt;/li&gt;&lt;li&gt;â€¢ detection of proteins.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Southern blot is the best technique for the initial analysis in this context, as it is used for DNA analysis, specifically to detect certain sequences within a DNA sample by using restriction enzymes and a DNA probe. This method is well-suited for VNTR analysis, which is a type of polymorphism that can be highly variable among individuals and is useful for forensic DNA typing.&lt;/li&gt;&lt;li&gt;âž¤ Southern blot&lt;/li&gt;&lt;li&gt;âž¤ best technique&lt;/li&gt;&lt;li&gt;âž¤ DNA analysis,&lt;/li&gt;&lt;li&gt;âž¤ detect certain&lt;/li&gt;&lt;li&gt;âž¤ sequences&lt;/li&gt;&lt;li&gt;âž¤ DNA sample&lt;/li&gt;&lt;li&gt;âž¤ restriction enzymes&lt;/li&gt;&lt;li&gt;âž¤ DNA probe.&lt;/li&gt;&lt;li&gt;âž¤ well-suited for VNTR analysis,&lt;/li&gt;&lt;li&gt;âž¤ polymorphism&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 456-457.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 456-457.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is examining the regulation of fetal hemoglobin expression and the gene product involved in its down regulation. They have primary tissue cultures from fetal, neonatal, and adult liver and bone marrow, along with a DNA probe for the gene of interest. To determine the gene&#x27;s expression levels in these tissue culture samples, which method is most appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA sequencing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Northern blot&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymerase chain reaction (PCR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Southern blot&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Northern blot&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Northern blot.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA sequencing and Option D: Southern blot: These techniques examine the DNA of the cell and the DNA of all the cells involved is identical.&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA sequencing and Option D: Southern blot:&lt;/li&gt;&lt;li&gt;â€¢ examine the DNA of the cell&lt;/li&gt;&lt;li&gt;â€¢ Option C: Polymerase chain reaction (PCR): It is used to amplify DNA and cannot determine which tissue culture has expressed the gene being studied . It also amplifies the DNA probe which is necessary for Northern blotting. However, in this case, the DNA probe was supplied in adequate amounts â†’ therefore PCR is not recommended.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Polymerase chain reaction (PCR):&lt;/li&gt;&lt;li&gt;â€¢ amplify DNA&lt;/li&gt;&lt;li&gt;â€¢ cannot determine which tissue culture&lt;/li&gt;&lt;li&gt;â€¢ expressed the gene being studied&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Northern blotting is the correct method for determining the expression of a specific gene . It measures mRNA levels , which correlate directly with gene expression. This technique involves the separation of RNA by gel electrophoresis, transfer to a membrane, and hybridization with a labelled probe specific to the mRNA of interest.&lt;/li&gt;&lt;li&gt;â€¢ Northern blotting&lt;/li&gt;&lt;li&gt;â€¢ expression of a specific gene&lt;/li&gt;&lt;li&gt;â€¢ measures mRNA levels&lt;/li&gt;&lt;li&gt;â€¢ directly with gene expression.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 456-457.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 456-457.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A team of molecular biologists is studying a specific DNA-binding motif known as the zinc finger motif, which is depicted in the provided image: Which of the following proteins is known to possess this zinc finger motif?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gal - 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lactose repressor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MyoD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fos&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gal - 4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/80.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gal â€“ 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lactose repressor: Proteins showing Helix â€“turnâ€“helix motif.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lactose repressor:&lt;/li&gt;&lt;li&gt;â€¢ Helix â€“turnâ€“helix motif.&lt;/li&gt;&lt;li&gt;â€¢ Option C: MyoD: Proteins showing Helix â€“loopâ€“helix motif.&lt;/li&gt;&lt;li&gt;â€¢ Option C: MyoD:&lt;/li&gt;&lt;li&gt;â€¢ Helix â€“loopâ€“helix motif.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Fos: Proteins showing leucine zipper motif.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Fos:&lt;/li&gt;&lt;li&gt;â€¢ leucine zipper motif.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Proteins showing zinc finger motif:&lt;/li&gt;&lt;li&gt;â€¢ Proteins showing zinc finger motif:&lt;/li&gt;&lt;li&gt;â€¢ TF III A Gal â€“ 4 SP-1 Steroid H receptor superfamily&lt;/li&gt;&lt;li&gt;â€¢ TF III A&lt;/li&gt;&lt;li&gt;â€¢ Gal â€“ 4&lt;/li&gt;&lt;li&gt;â€¢ SP-1&lt;/li&gt;&lt;li&gt;â€¢ Steroid H receptor superfamily&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e p 444-445.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Harper 30/e p 444-445.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-month-old boy with chronic yeast diaper rash and multiple episodes of pneumonia, including blood cultures positive for Group A streptococcus, is suspected to have a compromised immune system. Given the rarity of Group A strep infections in infants and the indications of defective B-cells and T-cells, his physician diagnoses him with severe combined immune deficiency (SCID). Which treatment could permanently cure the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Germ-line gene therapy to replace one ADA gene copy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Germ-line gene therapy to replace both ADA gene copies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Somatic cell gene therapy to replace both ADA gene copy in circulating lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Somatic cell gene therapy to replace one ADA gene copy in bone marrow lymphoblasts&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Somatic cell gene therapy to replace one ADA gene copy in bone marrow lymphoblasts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Somatic cell gene therapy to replace oneADAgene copy in bone marrow lymphoblasts.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Somatic gene therapy to correct stem cells such as bone marrow would give a continuous source of ADA enzyme and curative therapy; germ-line therapy would target his spermatogonia and thus future offspring.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Somatic gene therapy&lt;/li&gt;&lt;li&gt;â€¢ correct stem cells&lt;/li&gt;&lt;li&gt;â€¢ bone marrow&lt;/li&gt;&lt;li&gt;â€¢ Option B &amp;amp; Option C: For autosomal recessive disorders , only one of the two defective alleles should be replaced or supplemented to allow normal enzyme function.&lt;/li&gt;&lt;li&gt;â€¢ Option B &amp;amp; Option C:&lt;/li&gt;&lt;li&gt;â€¢ autosomal recessive disorders&lt;/li&gt;&lt;li&gt;â€¢ one of the two defective alleles&lt;/li&gt;&lt;li&gt;â€¢ replaced&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The permanent cure for SCID , especially for ADA-SCID (adenosine deaminase deficiency), typically involves gene therapy that targets the bone marrow cells , as these are the progenitors of the immune system . Somatic cell gene therapy targeting the bone marrow can lead to the development of a functional immune system.&lt;/li&gt;&lt;li&gt;âž¤ permanent cure for SCID&lt;/li&gt;&lt;li&gt;âž¤ ADA-SCID&lt;/li&gt;&lt;li&gt;âž¤ gene therapy&lt;/li&gt;&lt;li&gt;âž¤ targets the bone marrow cells&lt;/li&gt;&lt;li&gt;âž¤ progenitors of the immune system&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 31 e: p 1086.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 31 e: p 1086.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following techniques with the appropriate disorders:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-c, 3-d, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-c, 2-d, 3-a, 4-b&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1-c, 2-d, 3-a, 4-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/08/screenshot-2024-04-08-165633.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/08/screenshot-2024-04-08-165811.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1-c, 2-d, 3-a, 4-b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Recombinant DNA Technology: It is widely used for the antenatal diagnosis of genetic diseases by identifying gene mutations or creating transgenic models. PCR: PCR is a cornerstone in the diagnosis of bacterial and viral diseases due to its ability to amplify specific DNA sequences, making pathogen detection more sensitive. FISH: Fluorescence In Situ Hybridization (FISH) is a technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes. It&#x27;s commonly used for the detection of numerical abnormalities of chromosomes. Gene therapy: This technique is applied in the treatment of diseases, including cancer, by introducing, altering, or replacing genes within an individual&#x27;s cells.&lt;/li&gt;&lt;li&gt;â€¢ Recombinant DNA Technology: It is widely used for the antenatal diagnosis of genetic diseases by identifying gene mutations or creating transgenic models.&lt;/li&gt;&lt;li&gt;â€¢ Recombinant DNA Technology: It is widely used for the antenatal diagnosis of genetic diseases by identifying gene mutations or creating transgenic models.&lt;/li&gt;&lt;li&gt;â€¢ Recombinant DNA Technology:&lt;/li&gt;&lt;li&gt;â€¢ antenatal diagnosis of genetic diseases&lt;/li&gt;&lt;li&gt;â€¢ PCR: PCR is a cornerstone in the diagnosis of bacterial and viral diseases due to its ability to amplify specific DNA sequences, making pathogen detection more sensitive.&lt;/li&gt;&lt;li&gt;â€¢ PCR: PCR is a cornerstone in the diagnosis of bacterial and viral diseases due to its ability to amplify specific DNA sequences, making pathogen detection more sensitive.&lt;/li&gt;&lt;li&gt;â€¢ PCR:&lt;/li&gt;&lt;li&gt;â€¢ cornerstone in the diagnosis of bacterial&lt;/li&gt;&lt;li&gt;â€¢ viral diseases&lt;/li&gt;&lt;li&gt;â€¢ FISH: Fluorescence In Situ Hybridization (FISH) is a technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes. It&#x27;s commonly used for the detection of numerical abnormalities of chromosomes.&lt;/li&gt;&lt;li&gt;â€¢ FISH: Fluorescence In Situ Hybridization (FISH) is a technique used to detect and localize the presence or absence of specific DNA sequences on chromosomes. It&#x27;s commonly used for the detection of numerical abnormalities of chromosomes.&lt;/li&gt;&lt;li&gt;â€¢ FISH:&lt;/li&gt;&lt;li&gt;â€¢ detect and localize the presence or absence&lt;/li&gt;&lt;li&gt;â€¢ specific DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ chromosomes.&lt;/li&gt;&lt;li&gt;â€¢ Gene therapy: This technique is applied in the treatment of diseases, including cancer, by introducing, altering, or replacing genes within an individual&#x27;s cells.&lt;/li&gt;&lt;li&gt;â€¢ Gene therapy: This technique is applied in the treatment of diseases, including cancer, by introducing, altering, or replacing genes within an individual&#x27;s cells.&lt;/li&gt;&lt;li&gt;â€¢ Gene therapy:&lt;/li&gt;&lt;li&gt;â€¢ treatment of diseases,&lt;/li&gt;&lt;li&gt;â€¢ cancer,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 654-661.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 654-661.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A lab technician is preparing a reaction mix for Polymerase Chain Reaction (PCR) and must add a divalent cation essential for the enzymatic activity of DNA polymerase. Which of the following ions should be included in the PCR mix?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ca ++&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mg ++&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Li +&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Na +&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mg ++&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mg++&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Calcium ions (Ca++) are not typically used in PCR reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Calcium ions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ PCR reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lithium ions (Li+) are not a component of standard PCR reaction mixes.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Lithium ions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ PCR reaction mixes.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sodium ions (Na+) are not the necessary divalent cation for DNA polymerase activity in PCR.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Sodium ions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ divalent cation for DNA polymerase activity in PCR.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Magnesium ions (Mg++) are critical cofactors for DNA polymerase enzymes used in PCR . They act by stabilizing the DNA polymerase and aiding in the binding of nucleotides to the DNA template.&lt;/li&gt;&lt;li&gt;âž¤ Magnesium ions&lt;/li&gt;&lt;li&gt;âž¤ cofactors for DNA polymerase enzymes&lt;/li&gt;&lt;li&gt;âž¤ PCR&lt;/li&gt;&lt;li&gt;âž¤ act by stabilizing the DNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ aiding in the binding of nucleotides to the DNA template.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Tietz Textbook of Clinical Chemistry 4/e page 1446.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Tietz Textbook of Clinical Chemistry 4/e page 1446.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a medical conference on the advancements in genetic treatments, a speaker highlights the milestone of the first successful gene therapy targeting a somatic enzyme deficiency. This groundbreaking therapy was primarily applied to treat which condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SCID&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Haemophilia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystic fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SCID&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) SCID&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Cancer: While gene therapy is being explored for cancer treatment, it was not the first condition successfully treated with gene therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Cancer:&lt;/li&gt;&lt;li&gt;â€¢ gene therapy&lt;/li&gt;&lt;li&gt;â€¢ explored for cancer treatment,&lt;/li&gt;&lt;li&gt;â€¢ Option C: Haemophilia: Gene therapy has shown promise in treating haemophilia , but it was not the first disease targeted by successful gene therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Haemophilia:&lt;/li&gt;&lt;li&gt;â€¢ Gene therapy&lt;/li&gt;&lt;li&gt;â€¢ promise in treating haemophilia&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cystic fibrosis : Gene therapy trials have been conducted for cystic fibrosis, but the first successful application of gene therapy was for SCID.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Cystic fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Gene therapy trials&lt;/li&gt;&lt;li&gt;â€¢ conducted for cystic fibrosis,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dr French Anderson did the first gene therapy to treat SCID. Gene Therapy is the intracellular delivery of genes to produce a therapeutic effect by correcting an existing abnormality. It is divided into:&lt;/li&gt;&lt;li&gt;âž¤ Dr French Anderson did the first gene therapy to treat SCID.&lt;/li&gt;&lt;li&gt;âž¤ Gene Therapy is the intracellular delivery of genes to produce a therapeutic effect by correcting an existing abnormality.&lt;/li&gt;&lt;li&gt;âž¤ Gene Therapy&lt;/li&gt;&lt;li&gt;âž¤ It is divided into:&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy - Gene is introduced into somatic cells. Germ cell gene therapy (Transgenic animal).&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy - Gene is introduced into somatic cells.&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy&lt;/li&gt;&lt;li&gt;âž¤ Germ cell gene therapy (Transgenic animal).&lt;/li&gt;&lt;li&gt;âž¤ Germ cell gene therapy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 648.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 648.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a genetics lab, a technician is preparing chromosomes for analysis under a light microscope. Which technique will be used to produce distinct banding patterns that facilitate the identification and analysis of individual chromosomes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;R-banding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Q-banding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G-banding&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C-banding&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. G-banding&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) G-Banding&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: R-banding: This technique produces reverse banding patterns compared to G-banding , with AT-rich regions staining darkly.&lt;/li&gt;&lt;li&gt;â€¢ Option A: R-banding:&lt;/li&gt;&lt;li&gt;â€¢ reverse banding patterns compared to G-banding&lt;/li&gt;&lt;li&gt;â€¢ Option B : Q-banding: It involves quinacrine mustard staining and fluorescence microscopy, not standard light microscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Q-banding:&lt;/li&gt;&lt;li&gt;â€¢ quinacrine mustard staining&lt;/li&gt;&lt;li&gt;â€¢ fluorescence microscopy,&lt;/li&gt;&lt;li&gt;â€¢ Option D: C-banding: This technique specifically stains the centromeric regions of chromosomes and is not typically used for the general identification of all chromosome structures under light microscopy.&lt;/li&gt;&lt;li&gt;â€¢ Option D: C-banding:&lt;/li&gt;&lt;li&gt;â€¢ stains the centromeric regions of chromosomes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ R-Banding, G-Banding and C-Banding are done under light microscopy. G-Banding is the most common method.&lt;/li&gt;&lt;li&gt;âž¤ R-Banding, G-Banding and C-Banding are done under light microscopy.&lt;/li&gt;&lt;li&gt;âž¤ G-Banding is the most common method.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 595, Emeryâ€™s Elements of Medical Genetics 13/e page 30, 31&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: 595, Emeryâ€™s Elements of Medical Genetics 13/e page 30, 31&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biologist is working on isolating a specific gene within a large DNA fragment ranging from 50 to 100 kilobases (KB) in length. Which technique is most suitable for this purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Notch&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RFLP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SSLP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chromosome walking&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chromosome walking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chromosome walking&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Notch: This term does not refer to a molecular biology technique for isolating genes.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Notch:&lt;/li&gt;&lt;li&gt;â€¢ not refer to a molecular biology technique&lt;/li&gt;&lt;li&gt;â€¢ Option B: RFLP (Restriction Fragment Length Polymorphism): While RFLP is used for identifying differences in homologous DNA sequences , it is not specifically used for isolating long genes.&lt;/li&gt;&lt;li&gt;â€¢ Option B: RFLP (Restriction Fragment Length Polymorphism):&lt;/li&gt;&lt;li&gt;â€¢ RFLP&lt;/li&gt;&lt;li&gt;â€¢ identifying differences in homologous DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ Option C: SSLP (Simple Sequence Length Polymorphism): This technique is used for genetic mapping and not for the isolation of long DNA sequences.&lt;/li&gt;&lt;li&gt;â€¢ Option C: SSLP (Simple Sequence Length Polymorphism):&lt;/li&gt;&lt;li&gt;â€¢ genetic mapping&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chromosome Walking&lt;/li&gt;&lt;li&gt;âž¤ Chromosome Walking&lt;/li&gt;&lt;li&gt;âž¤ It is the method to isolate and clone target DNA from a long segment of DNA . In Chromosome walking , a fragment representing one end of a long piece of DNA is used to isolate another fragment which overlaps the first but extends the first and this process is continued till the target DNA is isolated . Cystic fibrosis (CF) gene was the first to be isolated by chromosome walking.&lt;/li&gt;&lt;li&gt;âž¤ It is the method to isolate and clone target DNA from a long segment of DNA .&lt;/li&gt;&lt;li&gt;âž¤ method to isolate&lt;/li&gt;&lt;li&gt;âž¤ clone target DNA&lt;/li&gt;&lt;li&gt;âž¤ long segment of DNA&lt;/li&gt;&lt;li&gt;âž¤ In Chromosome walking , a fragment representing one end of a long piece of DNA is used to isolate another fragment which overlaps the first but extends the first and this process is continued till the target DNA is isolated .&lt;/li&gt;&lt;li&gt;âž¤ Chromosome walking&lt;/li&gt;&lt;li&gt;âž¤ fragment representing one end&lt;/li&gt;&lt;li&gt;âž¤ long piece of DNA&lt;/li&gt;&lt;li&gt;âž¤ isolate another fragment&lt;/li&gt;&lt;li&gt;âž¤ overlaps the first&lt;/li&gt;&lt;li&gt;âž¤ extends the first&lt;/li&gt;&lt;li&gt;âž¤ process is continued till the target DNA is isolated&lt;/li&gt;&lt;li&gt;âž¤ Cystic fibrosis (CF) gene was the first to be isolated by chromosome walking.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 463.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 463.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A forensic scientist is explaining the basis of DNA fingerprinting technology during a workshop. DNA fingerprinting relies on the analysis of which type of DNA sequences?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constant Tandem Repeat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Variable Number Tandem Repeat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-repetitive sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exon&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Variable Number Tandem Repeat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Variable Number Tandem Repeat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Constant Tandem Repeats do not provide the variability needed for DNA fingerprinting .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Constant Tandem Repeats&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ variability needed for DNA fingerprinting&lt;/li&gt;&lt;li&gt;â€¢ Option C: Non-repetitive sequences are less useful for DNA fingerprinting because they do not offer the same level of individual variability as VNTRs.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Non-repetitive sequences&lt;/li&gt;&lt;li&gt;â€¢ less useful&lt;/li&gt;&lt;li&gt;â€¢ DNA fingerprinting&lt;/li&gt;&lt;li&gt;â€¢ Option D: Exons , which are the coding regions of genes , are not typically used in DNA fingerprinting due to their relative conservation across individuals compared to VNTRs.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Exons&lt;/li&gt;&lt;li&gt;â€¢ coding regions of genes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA Fingerprinting/ DNA Profiling:&lt;/li&gt;&lt;li&gt;âž¤ DNA Fingerprinting/&lt;/li&gt;&lt;li&gt;âž¤ DNA Profiling:&lt;/li&gt;&lt;li&gt;âž¤ The use of normal genetic variation in the DNA (SNP or VNTR or RFLP) to establish a unique pattern of DNA fragments for an individual. Most commonly used: VNTR or repeat length polymorphism. Primer is needed for the processing .&lt;/li&gt;&lt;li&gt;âž¤ The use of normal genetic variation in the DNA (SNP or VNTR or RFLP) to establish a unique pattern of DNA fragments for an individual.&lt;/li&gt;&lt;li&gt;âž¤ use of normal genetic variation&lt;/li&gt;&lt;li&gt;âž¤ DNA&lt;/li&gt;&lt;li&gt;âž¤ establish a unique pattern of DNA fragments&lt;/li&gt;&lt;li&gt;âž¤ Most commonly used: VNTR or repeat length polymorphism.&lt;/li&gt;&lt;li&gt;âž¤ VNTR&lt;/li&gt;&lt;li&gt;âž¤ repeat length polymorphism.&lt;/li&gt;&lt;li&gt;âž¤ Primer is needed for the processing .&lt;/li&gt;&lt;li&gt;âž¤ Primer&lt;/li&gt;&lt;li&gt;âž¤ processing&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 657&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 657&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is discussing the application of RNA interference (RNAi) technology in gene expression studies during a molecular biology conference. RNAi primarily results in which of the following effects on gene expression?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Knock down&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Knock up&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Knock in&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Knock out&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Knock down&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Knock down.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gene Knock up: Transcription of gene is increased using transcription factors.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gene Knock up: Transcription&lt;/li&gt;&lt;li&gt;â€¢ gene&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gene Knock in: Mutated endogenous gene is replaced by normal transgene by homologous recombination in embryonic stem cell.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Gene Knock in: Mutated endogenous gene&lt;/li&gt;&lt;li&gt;â€¢ replaced by normal transgene&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gene Knock out: Endogenous gene is replaced by mutated transgene by homologous recombination in embryonic stem cell.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gene Knock out: Endogenous gene&lt;/li&gt;&lt;li&gt;â€¢ replaced by mutated transgene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression , typically by causing the destruction of specific mRNA molecules . The primary effect of RNAi on gene expression is a \&quot;knock down,\&quot; where the expression of the targeted gene is reduced but not completely eliminated.&lt;/li&gt;&lt;li&gt;âž¤ RNA interference&lt;/li&gt;&lt;li&gt;âž¤ biological process&lt;/li&gt;&lt;li&gt;âž¤ RNA molecules inhibit gene expression&lt;/li&gt;&lt;li&gt;âž¤ destruction of specific mRNA molecules&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 447.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 447.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given the DNA template shown, with regions A, B, C, and D, which pair of primers should be used to effectively amplify this region through PCR?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B and C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A and C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B and D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. B and C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/88.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) B and C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B, Option C, Option D: Primers Option A and Option D will only allow DNA synthesis away in the opposite direction from the region of interest , due to their orientation on the DNA template strand.&lt;/li&gt;&lt;li&gt;â€¢ Option B, Option C, Option D: Primers Option A and Option D&lt;/li&gt;&lt;li&gt;â€¢ DNA synthesis away&lt;/li&gt;&lt;li&gt;â€¢ opposite direction from the region of interest&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ When designing primers for PCR amplification , it is important to select primer pairs that are complementary to the 3&#x27; ends of opposite strands of the target DNA region . This ensures that the DNA polymerase can successfully amplify the entire region between the primers.&lt;/li&gt;&lt;li&gt;âž¤ designing primers&lt;/li&gt;&lt;li&gt;âž¤ PCR amplification&lt;/li&gt;&lt;li&gt;âž¤ select primer pairs&lt;/li&gt;&lt;li&gt;âž¤ complementary to the 3&#x27; ends of opposite strands&lt;/li&gt;&lt;li&gt;âž¤ target DNA region&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ successfully amplify&lt;/li&gt;&lt;li&gt;âž¤ entire region between the primers.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;When discussing the differences between Apo-B48 and Apo-B100 proteins, which are both derived from the same ApoB gene but expressed differently in the intestine and liver, respectively, it&#x27;s crucial to understand the molecular mechanism responsible for their diversity. These proteins are vital for lipid metabolism, with Apo-B48 being involved in chylomicron formation and Apo-B100 in VLDL and LDL. What process leads to the production of these distinct proteins from the same mRNA transcript?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RNA splicing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allelic exclusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deamination of cytidine to uridine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Upstream repression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deamination of cytidine to uridine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture9_kPLWTYS.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Deamination of Cytidine to Uridine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA splicing: While RNA splicing is a common mechanism to generate protein diversity by removing introns from the pre-mRNA, it is not the process responsible for the difference between Apo-B48 and Apo-B100. These proteins result from the same gene and mRNA transcript but differ due to a specific editing event.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA splicing:&lt;/li&gt;&lt;li&gt;â€¢ RNA splicing&lt;/li&gt;&lt;li&gt;â€¢ common mechanism&lt;/li&gt;&lt;li&gt;â€¢ generate protein diversity&lt;/li&gt;&lt;li&gt;â€¢ Option B. Allelic exclusion: This process, where only one allele of a gene is expressed while the other is silenced , is not related to the production of Apo-B48 and Apo-B100. These proteins come from the same mRNA transcript and gene but are differentially processed in different tissues.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Allelic exclusion:&lt;/li&gt;&lt;li&gt;â€¢ only one allele of a gene is expressed&lt;/li&gt;&lt;li&gt;â€¢ other is silenced&lt;/li&gt;&lt;li&gt;â€¢ Option D. Upstream repression: This refers to a regulatory mechanism where gene expression is inhibited by factors binding to regions upstream of the gene . This mechanism does not explain the production of two different proteins from the same mRNA transcript as seen with Apo-B48 and Apo-B100.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Upstream repression:&lt;/li&gt;&lt;li&gt;â€¢ regulatory mechanism&lt;/li&gt;&lt;li&gt;â€¢ gene expression is inhibited by factors binding to regions upstream of the gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The difference between Apo-B48 and Apo-B100 arises from the editing of the ApoB mRNA through the deamination of a specific cytidine to uridine in the intestinal cells . This conversion creates a stop codon in the mRNA, leading to the production of the shorter Apo-B48 protein in the intestine. In contrast, the liver cells do not perform this editing, resulting in the full-length Apo-B100 protein.&lt;/li&gt;&lt;li&gt;âž¤ difference between Apo-B48&lt;/li&gt;&lt;li&gt;âž¤ Apo-B100 arises from the editing&lt;/li&gt;&lt;li&gt;âž¤ ApoB mRNA&lt;/li&gt;&lt;li&gt;âž¤ deamination of a specific cytidine&lt;/li&gt;&lt;li&gt;âž¤ uridine in the intestinal cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 393&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 393&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following genetic changes is most commonly responsible for causing a frameshift mutation, characterized by this shift in the reading frame?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Deletion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Point mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Substitution&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transversion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Deletion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Deletion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Point mutation: The point mutation there is a single base change which can cause Silent Mutation : Amino acid not changed , Missense mutation : AA changed, or Nonsense Mutation: Insertion of stop codon. The reading frame is not altered in these mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Point mutation:&lt;/li&gt;&lt;li&gt;â€¢ The point mutation there is a single base change which can cause Silent Mutation&lt;/li&gt;&lt;li&gt;â€¢ Amino acid not changed&lt;/li&gt;&lt;li&gt;â€¢ Missense mutation&lt;/li&gt;&lt;li&gt;â€¢ Option C. Substitution: Replacement of a purine by another purine (A to G or G to A) or pyrimidine by pyrimidine (T to C or C to T) is called transition mutation .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Substitution:&lt;/li&gt;&lt;li&gt;â€¢ Replacement&lt;/li&gt;&lt;li&gt;â€¢ purine by another purine&lt;/li&gt;&lt;li&gt;â€¢ transition mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transversion: If a purine is changed to a pyrimidine (e.g. A to C) or a pyrimidine to a purine (e.g. T to G), it is called a transversion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transversion:&lt;/li&gt;&lt;li&gt;â€¢ purine is changed&lt;/li&gt;&lt;li&gt;â€¢ pyrimidine&lt;/li&gt;&lt;li&gt;â€¢ transversion.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Frameshift mutations are caused by insertions or deletions of nucleotides that are not in multiples of three , altering the triplet reading frame of the genetic code . A deletion of nucleotides can remove critical information from the DNA sequence, changing the downstream amino acid sequence and potentially leading to truncated or nonfunctional proteins.&lt;/li&gt;&lt;li&gt;â€¢ Frameshift mutations&lt;/li&gt;&lt;li&gt;â€¢ insertions&lt;/li&gt;&lt;li&gt;â€¢ deletions of nucleotides&lt;/li&gt;&lt;li&gt;â€¢ not in multiples of three&lt;/li&gt;&lt;li&gt;â€¢ triplet reading frame of the genetic code&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e page 417.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e page 417.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a healthy individual without any defects in DNA repair pathways, gene repair mechanisms follow a precise sequence of events to maintain genomic integrity. A molecular biologist is explaining this sequence to a group of students, emphasizing the importance of each step in the process. Which of the following options correctly outlines the order of events in these gene repair mechanisms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recognition, nicking, excision, replacement, and sealing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nicking, excision, replacement, sealing, and recognition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nicking, recognition, excision, sealing, and replacement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nicking, sealing, recognition, excision, and replacement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Recognition, nicking, excision, replacement, and sealing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A: Recognition, nicking, excision, replacement, and sealing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA repair processes begins with the recognition of the DNA lesion , ensuring that the repair machinery can differentiate damaged from undamaged DNA . Following recognition, a nick is introduced near the lesion to allow for the removal of the damaged segment (excision). The gap is then filled with the correct nucleotides (replacement), and finally, the DNA backbone is sealed (ligated), restoring the integrity of the DNA molecule .&lt;/li&gt;&lt;li&gt;âž¤ DNA repair processes&lt;/li&gt;&lt;li&gt;âž¤ recognition of the DNA lesion&lt;/li&gt;&lt;li&gt;âž¤ repair machinery&lt;/li&gt;&lt;li&gt;âž¤ differentiate damaged&lt;/li&gt;&lt;li&gt;âž¤ undamaged DNA&lt;/li&gt;&lt;li&gt;âž¤ nick is introduced near&lt;/li&gt;&lt;li&gt;âž¤ lesion to allow for the removal&lt;/li&gt;&lt;li&gt;âž¤ damaged segment&lt;/li&gt;&lt;li&gt;âž¤ gap&lt;/li&gt;&lt;li&gt;âž¤ filled&lt;/li&gt;&lt;li&gt;âž¤ correct nucleotides&lt;/li&gt;&lt;li&gt;âž¤ DNA backbone&lt;/li&gt;&lt;li&gt;âž¤ sealed&lt;/li&gt;&lt;li&gt;âž¤ restoring the integrity&lt;/li&gt;&lt;li&gt;âž¤ DNA molecule&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 410-413.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 410-413.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy is brought to the clinic by his mother, who is concerned about her son&#x27;s repeated lip and finger biting and involuntary upper limb movements. She recalls noticing an orange discoloration in his diaper as an infant. Upon examination, the boy has multiple bite marks on his fingers and lips, and laboratory tests reveal a serum uric acid level of 9.5 mg/dl: Based on the clinical presentation and laboratory findings, what is the most probable diagnosis, and which metabolic pathway is affected in this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lesch-Nyhan Syndrome: Disorder of pyrimidine metabolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lesch-Nyhan Syndrome: Disorder of purine metabolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary Gout: Deficiency of Salvage Pathway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secondary Gout: Due to tumour lysis syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lesch-Nyhan Syndrome: Disorder of purine metabolism&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-144013.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Lesch-Nyhan Syndrome: disorder of purine metabolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lesch-Nyhan Syndrome: Disorder of pyrimidine metabolism : This is incorrect because LNS is associated with purine, not pyrimidine, metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Lesch-Nyhan Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ pyrimidine metabolism&lt;/li&gt;&lt;li&gt;â€¢ Option C . Primary Gout : Deficiency of Salvage Pathway : While gout involves hyperuricemia, the self-mutilating behavior and early onset are not typical of primary gout and indicate a more complex disorder like LNS.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Primary Gout&lt;/li&gt;&lt;li&gt;â€¢ Salvage Pathway&lt;/li&gt;&lt;li&gt;â€¢ Option D . Secondary Gout : Due to tumor lysis syndrome : Secondary gout can occur due to increased cell turnover, as seen in tumor lysis syndrome, but it does not explain the neurological and behavioral symptoms, nor is it common in children without a history of malignancy.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Secondary Gout&lt;/li&gt;&lt;li&gt;â€¢ tumor lysis syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Self-mutilating behaviors, neurological symptoms, and hyperuricemia is characteristic of Lesch-Nyhan Syndrome (LNS). LNS is a rare X-linked recessive disorder caused by a deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which is crucial in the purine salvage pathway.&lt;/li&gt;&lt;li&gt;âž¤ Self-mutilating behaviors,&lt;/li&gt;&lt;li&gt;âž¤ neurological&lt;/li&gt;&lt;li&gt;âž¤ hyperuricemia&lt;/li&gt;&lt;li&gt;âž¤ Lesch-Nyhan Syndrome&lt;/li&gt;&lt;li&gt;âž¤ LNS&lt;/li&gt;&lt;li&gt;âž¤ rare X-linked recessive disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase&lt;/li&gt;&lt;li&gt;âž¤ purine salvage pathway.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 354-355.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 354-355.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-c, 3-d, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-c, 2-d, 3-a, 4-b&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1-c, 2-d, 3-a, 4-b&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-151150.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-151218.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. 1-c, 2-d, 3-a, 4-b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ 1-C : Gout is often caused by defects in purine metabolism, particularly involving PRPP synthetase and HGPRT. Overactivity of PRPP synthetase or deficiency in HGPRT leads to increased production of uric acid, which precipitates in joints causing gouty arthritis.&lt;/li&gt;&lt;li&gt;â€¢ 1-C&lt;/li&gt;&lt;li&gt;â€¢ Gout&lt;/li&gt;&lt;li&gt;â€¢ defects in purine metabolism,&lt;/li&gt;&lt;li&gt;â€¢ 2-D: SCID (Severe Combined Immunodeficiency) can result from a deficiency in ADA (Adenosine Deaminase), which leads to an accumulation of toxic metabolites harmful to lymphocytes, resulting in severe immunodeficiency.&lt;/li&gt;&lt;li&gt;â€¢ 2-D: SCID&lt;/li&gt;&lt;li&gt;â€¢ deficiency in ADA&lt;/li&gt;&lt;li&gt;â€¢ 3-A: Orotic Aciduria is characterized by megaloblastic anemia and the excretion of large amounts of orotic acid in urine due to a defect in the de novo pyrimidine synthesis pathway, specifically in the enzymes OPRTase and OMP decarboxylase.&lt;/li&gt;&lt;li&gt;â€¢ 3-A: Orotic Aciduria&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ excretion of large amounts of orotic acid&lt;/li&gt;&lt;li&gt;â€¢ urine&lt;/li&gt;&lt;li&gt;â€¢ 4-B: Renal lithiasis (Kidney Stones) can occur due to an APRT (Adenine Phosphoribosyltransferase) deficiency, leading to the formation of 2,8-dihydroxyadenine stones, a condition often misdiagnosed as uric acid stones.&lt;/li&gt;&lt;li&gt;â€¢ 4-B: Renal lithiasis&lt;/li&gt;&lt;li&gt;â€¢ APRT&lt;/li&gt;&lt;li&gt;â€¢ deficiency,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 583.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 583.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the charge of DNA molecules at physiological pH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Positively charged&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Negatively charged&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neutral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amphipathic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Negatively charged&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Negatively charged&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Positively charged - This is incorrect because the phosphate groups confer a negative charge to the DNA, not a positive one.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Positively charged&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Option C . Neutral - DNA is not neutral at physiological pH; the phosphate groups are deprotonated, giving DNA a net negative charge.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Neutral&lt;/li&gt;&lt;li&gt;â€¢ not neutral at physiological pH;&lt;/li&gt;&lt;li&gt;â€¢ Option D . Amphipathic - This term describes molecules with both hydrophobic and hydrophilic regions . While DNA does have complex interactions with water and proteins due to its structure, the term does not describe its charge; thus, it is not the best answer regarding the charge of DNA at physiological pH.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Amphipathic&lt;/li&gt;&lt;li&gt;â€¢ molecules with both hydrophobic&lt;/li&gt;&lt;li&gt;â€¢ hydrophilic regions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ At physiological pH (around 7.4), DNA molecules are negatively charged. This is due to the phosphate groups in the DNA backbone , which lose their hydrogen ions and become negatively charged phosphates (POâ‚„Â³â») at physiological pH . This negative charge is critical for the structure of the DNA double helix and for its interactions with proteins, such as histones, and other molecules within the cell.&lt;/li&gt;&lt;li&gt;âž¤ physiological pH&lt;/li&gt;&lt;li&gt;âž¤ DNA molecules&lt;/li&gt;&lt;li&gt;âž¤ negatively charged.&lt;/li&gt;&lt;li&gt;âž¤ phosphate groups&lt;/li&gt;&lt;li&gt;âž¤ DNA backbone&lt;/li&gt;&lt;li&gt;âž¤ lose their hydrogen ions&lt;/li&gt;&lt;li&gt;âž¤ negatively charged phosphates&lt;/li&gt;&lt;li&gt;âž¤ physiological pH&lt;/li&gt;&lt;li&gt;âž¤ negative charge&lt;/li&gt;&lt;li&gt;âž¤ critical for the structure of the DNA double helix&lt;/li&gt;&lt;li&gt;âž¤ interactions with proteins,&lt;/li&gt;&lt;li&gt;âž¤ Ref: Lippincott 6/e: p 409.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Lippincott 6/e: p 409.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-year-old child with a history of recurrent bacterial and viral infections, failure to thrive, developmental delays, and tremors is evaluated. Examination reveals an absence of peripheral lymphoid tissues. Laboratory findings indicate lymphopenia, with normal B-cell counts and immunoglobulin levels. Which enzyme deficiency is most likely responsible for this clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoxanthine phosphoribosyl transferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenine phosphoribosyl transferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine deaminase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Purine nucleoside phosphorylase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Purine nucleoside phosphorylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Purine nucleoside phosphorylase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Options A. Hypoxanthine phosphoribosyl transferase deficiency leads to Lesch-Nyhan syndrome , where there is no immune deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Options A.&lt;/li&gt;&lt;li&gt;â€¢ Hypoxanthine phosphoribosyl transferase&lt;/li&gt;&lt;li&gt;â€¢ Lesch-Nyhan syndrome&lt;/li&gt;&lt;li&gt;â€¢ Options B. Adenine phosphoribosyl transferase deficiency leads to accumulation of an insoluble metabolite (2, 8-dihydroxyadenine) that precipitates in the kidney ðŸ¡ª leads to renal failures.&lt;/li&gt;&lt;li&gt;â€¢ Options B.&lt;/li&gt;&lt;li&gt;â€¢ Adenine phosphoribosyl transferase&lt;/li&gt;&lt;li&gt;â€¢ accumulation of an insoluble metabolite&lt;/li&gt;&lt;li&gt;â€¢ Options C. Adenosine deaminase deficiency leads to an immune disorder where both B and T cells are deficient.&lt;/li&gt;&lt;li&gt;â€¢ Options C.&lt;/li&gt;&lt;li&gt;â€¢ Adenosine deaminase deficiency&lt;/li&gt;&lt;li&gt;â€¢ immune disorder&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Purine nucleoside phosphorylase (PNP) deficiency leads to a selective T-cell deficiency, part of the spectrum of SCID disorders. Despite normal B-cell counts and immunoglobulin levels, the lack of T-cell help results in functional impairment of B-cells, leading to recurrent infections.&lt;/li&gt;&lt;li&gt;âž¤ Purine nucleoside phosphorylase&lt;/li&gt;&lt;li&gt;âž¤ selective T-cell deficiency,&lt;/li&gt;&lt;li&gt;âž¤ spectrum of SCID disorders.&lt;/li&gt;&lt;li&gt;âž¤ normal B-cell counts&lt;/li&gt;&lt;li&gt;âž¤ immunoglobulin levels,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p585.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p585.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following sequences correctly orders these structural components from the smallest to the largest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chromatin fibril, nucleosome, histone octamer, and chromosome loop&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nucleosome, chromatin fibril, chromosome loop, and histone octamer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nucleosome, histone octamer, chromosome loop, and chromosome fibril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histone octamer, nucleosome, chromatin fibril, and chromosome loop&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Histone octamer, nucleosome, chromatin fibril, and chromosome loop&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Histone octamer, nucleosome, chromatin fibril, and chromosome loop&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The correct sequence starts with the histone octamer , which is the core around which DNA winds to form a nucleosome, the fundamental unit of chromatin . Multiple nucleosomes together form the chromatin fibril (or fiber), which is further organized into larger structures such as chromosome loops within the chromosome.&lt;/li&gt;&lt;li&gt;âž¤ correct sequence&lt;/li&gt;&lt;li&gt;âž¤ histone octamer&lt;/li&gt;&lt;li&gt;âž¤ core around which DNA winds&lt;/li&gt;&lt;li&gt;âž¤ form a nucleosome,&lt;/li&gt;&lt;li&gt;âž¤ fundamental unit of chromatin&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 370-374&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ Harper 30/e: p 370-374&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Review the provided diagram of a DNA repair process and identify the incorrect statement concerning the pictured mechanism.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a Mismatch repair (MMR)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is a Nucleotide Excision Repair (NER)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair of replication errors such as bases mismatch is done&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defects result in Lynch syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is a Nucleotide Excision Repair (NER)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is a Nucleotide Excision Repair (NER)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a Mismatch Repair (MMR) - This statement is true based on the repair process shown in the diagram.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ It is a Mismatch Repair&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option C: Repair of replication errors such as base mismatches is done - This is a correct statement as MMR is indeed responsible for repairing base mismatches that occur during DNA replication.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Repair of replication errors such as base mismatches is done&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option D: Defects result in Lynch syndrome - This is also true; defects in MMR can cause Lynch syndrome (Hereditary Nonpolyposis Colorectal Cancer), which is characterized by a higher risk of developing colorectal cancer and other cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Defects result in Lynch syndrome&lt;/li&gt;&lt;li&gt;â€¢ true;&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA repair process involving the recognition and removal of a base mismatch, which is characteristic of Mismatch Repair (MMR), not Nucleotide Excision Repair (NER). MMR corrects errors that escape proofreading during DNA replication, such as base mismatches or insertion/deletion loops.&lt;/li&gt;&lt;li&gt;âž¤ DNA repair process&lt;/li&gt;&lt;li&gt;âž¤ recognition and removal of a base mismatch,&lt;/li&gt;&lt;li&gt;âž¤ Mismatch Repair&lt;/li&gt;&lt;li&gt;âž¤ not Nucleotide Excision Repair&lt;/li&gt;&lt;li&gt;âž¤ MMR&lt;/li&gt;&lt;li&gt;âž¤ errors that escape proofreading&lt;/li&gt;&lt;li&gt;âž¤ DNA replication,&lt;/li&gt;&lt;li&gt;âž¤ base mismatches&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 389, 390.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 389, 390.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following sequences represents the correct order of enzyme activity in DNA replication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA polymerase â†’ protein unwinding enzyme â†’ DNA ligase â†’ DNA Isomerase â†’ Polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RNA polymerase â†’ DNA polymerase III â†’ DNA polymerase I â†’ DNA ligase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RNA polymerase â†’ DNA polymerase III â†’ DNA ligase â†’ exonuclease â†’ DNA polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Protein unwinding enzyme â†’ polymerase I â†’ DNA ligase â†’ DNA isomerase â†’ DNA polymerase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. RNA polymerase â†’ DNA polymerase III â†’ DNA polymerase I â†’ DNA ligase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) RNA Polymerase â†’ DNA polymerase III â†’ DNA polymerase I â†’ DNA ligase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During DNA replication , RNA polymerase (primase) first lays down an RNA primer . DNA polymerase III then extends the DNA strand by adding nucleotides to the primer . DNA polymerase I removes the RNA primer and replaces it with DNA . DNA ligase seals the nicks in the sugar-phosphate backbone, completing the replication process.&lt;/li&gt;&lt;li&gt;âž¤ DNA replication&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ first lays down&lt;/li&gt;&lt;li&gt;âž¤ RNA primer&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase III&lt;/li&gt;&lt;li&gt;âž¤ extends the DNA strand&lt;/li&gt;&lt;li&gt;âž¤ adding nucleotides&lt;/li&gt;&lt;li&gt;âž¤ primer&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase I&lt;/li&gt;&lt;li&gt;âž¤ RNA primer&lt;/li&gt;&lt;li&gt;âž¤ replaces it with DNA&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Acetylation and deacetylation of lysine residues on histone proteins results in a mechanism by which transcription can be activated or repressed. Which one of the following histone proteins least likely participates in this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;H1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;H2A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H2B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;H3 and H4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. H1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) H1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B, Option C, Option D . Histones H2A , H2B , H3 , and H4 make up the core of the nucleosome , and their N-terminal tails are subject to various post-translational modifications , including acetylation and deacetylation , which play direct roles in the regulation of transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option B, Option C, Option D&lt;/li&gt;&lt;li&gt;â€¢ Histones H2A&lt;/li&gt;&lt;li&gt;â€¢ H2B&lt;/li&gt;&lt;li&gt;â€¢ H3&lt;/li&gt;&lt;li&gt;â€¢ H4&lt;/li&gt;&lt;li&gt;â€¢ core of the nucleosome&lt;/li&gt;&lt;li&gt;â€¢ N-terminal tails&lt;/li&gt;&lt;li&gt;â€¢ post-translational modifications&lt;/li&gt;&lt;li&gt;â€¢ acetylation&lt;/li&gt;&lt;li&gt;â€¢ deacetylation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Histone H1 is known as the linker histone , and while it plays a role in the structure of chromatin , it is less directly involved in the modification processes , such as acetylation and deacetylation , that regulate transcription .&lt;/li&gt;&lt;li&gt;âž¤ Histone H1&lt;/li&gt;&lt;li&gt;âž¤ linker histone&lt;/li&gt;&lt;li&gt;âž¤ role in the structure of chromatin&lt;/li&gt;&lt;li&gt;âž¤ less directly&lt;/li&gt;&lt;li&gt;âž¤ modification processes&lt;/li&gt;&lt;li&gt;âž¤ acetylation&lt;/li&gt;&lt;li&gt;âž¤ deacetylation&lt;/li&gt;&lt;li&gt;âž¤ regulate transcription&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 371-375.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 371-375.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatric oncologist encounters a 6-year-old boy presenting with hyperpigmentation on his face, neck, forearms, and lower legs. The child&#x27;s skin reddens and becomes painful upon sun exposure, and he develops blisters in these sun-exposed areas. Following a diagnosis of a skin tumor, the oncologist considers a genetic basis for the child&#x27;s symptoms and sensitivity to sunlight. Which of the following mechanisms is most likely defective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thymine dimers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nucleotide excision repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trinucleotide repeats&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Base alkylation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Nucleotide excision repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture8_82ZFYkt.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Nucleotide excision repair&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thymine dimers (Incorrect): Nucleotide excision repair is defective , leading to accumulation of thymine dimers on exposure to UV rays.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thymine dimers (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ Nucleotide excision repair&lt;/li&gt;&lt;li&gt;â€¢ defective&lt;/li&gt;&lt;li&gt;â€¢ Option C: Trinucleotide repeats (Incorrect): These are associated with diseases such as CGG repeat sequence - fragile X syndrome, CAG repeats - Huntingtonâ€™s chorea, CTG -myotonic dystrophy and CAG in spinobulbar muscular atrophy.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Trinucleotide repeats (Incorrect):&lt;/li&gt;&lt;li&gt;â€¢ diseases such as CGG repeat sequence&lt;/li&gt;&lt;li&gt;â€¢ Option D: Base alkylation (Incorrect): Single-base alteration â†’ DNA damage â†’ Base Excision Repair (BER)&lt;/li&gt;&lt;li&gt;â€¢ Option D: Base alkylation (Incorrect):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Xeroderma pigmentosum (XP), a rare autosomal recessive disorder that is characterized by extreme sensitivity to ultraviolet (UV) rays from sunlight. This condition typically arises from a defect in the nucleotide excision repair (NER) pathway, which is responsible for removing UV-induced DNA damage such as thymine dimers . Patients with XP have a high predisposition to develop skin tumors due to the accumulation of unrepaired DNA damage.&lt;/li&gt;&lt;li&gt;âž¤ Xeroderma pigmentosum&lt;/li&gt;&lt;li&gt;âž¤ rare autosomal recessive disorder&lt;/li&gt;&lt;li&gt;âž¤ extreme sensitivity to ultraviolet&lt;/li&gt;&lt;li&gt;âž¤ rays&lt;/li&gt;&lt;li&gt;âž¤ sunlight.&lt;/li&gt;&lt;li&gt;âž¤ arises from a defect in the nucleotide excision repair&lt;/li&gt;&lt;li&gt;âž¤ removing UV-induced DNA damage&lt;/li&gt;&lt;li&gt;âž¤ thymine dimers&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 412.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 412.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): The sequence of the RNA product of the DNA template sequence, GATCTAC is 5&#x27;-GUACTUC-3&#x27;. Reasoning (R): The RNA product has a sequence that is complementary to the template strand, with U replacing T.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A is right but R is a wrong statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A is wrong but R is a right statement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A is wrong, but R is a right statement.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The RNA sequence , complementary to the DNA template , replaces thymine with uracil , and is synthesized from 5&#x27; to 3 &#x27;. For the given DNA sequence 5&#x27;-GATCTAC-3 &#x27;, the corresponding RNA is 5&#x27;-GUAGAUC-3 &#x27;.&lt;/li&gt;&lt;li&gt;âž¤ RNA sequence&lt;/li&gt;&lt;li&gt;âž¤ complementary&lt;/li&gt;&lt;li&gt;âž¤ DNA template&lt;/li&gt;&lt;li&gt;âž¤ replaces thymine&lt;/li&gt;&lt;li&gt;âž¤ uracil&lt;/li&gt;&lt;li&gt;âž¤ synthesized from 5&#x27; to 3&lt;/li&gt;&lt;li&gt;âž¤ DNA sequence 5&#x27;-GATCTAC-3&lt;/li&gt;&lt;li&gt;âž¤ RNA is 5&#x27;-GUAGAUC-3&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 430.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 430.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A gastroenterologist is evaluating a patient who has been diagnosed with multiple gastrointestinal polyps and carcinoma. The patient also has a significant family history of similar issues. Given this clinical presentation, the gastroenterologist is considering a genetic basis for the patient&#x27;s condition that involves a defect in one of the DNA repair mechanisms. Which of the following DNA repair processes is most likely to be defective in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mismatch repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nucleotide excision repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Base excision repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Homologous Repair&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mismatch repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mismatch repair&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Xeroderma Pigmentosum (XP): Defective NER mechanism; sensitivity to UV light causing skin cancers.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Xeroderma Pigmentosum (XP):&lt;/li&gt;&lt;li&gt;â€¢ NER&lt;/li&gt;&lt;li&gt;â€¢ Option C: MUTYH-associated polyposis (MAP) : Defective DNA Base Excision Repair (BER).&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ MUTYH-associated polyposis (MAP)&lt;/li&gt;&lt;li&gt;â€¢ DNA Base Excision Repair&lt;/li&gt;&lt;li&gt;â€¢ Option D: Bloom syndrome (BS), Werner syndrome (WS) etc: Defective Homologous Repair (HR).&lt;/li&gt;&lt;li&gt;â€¢ Option D: Bloom syndrome (BS), Werner syndrome (WS)&lt;/li&gt;&lt;li&gt;â€¢ Homologous Repair&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 411.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 411.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biology research team is working with E. coli DNA polymerase I and is particularly interested in a fragment of this enzyme known as the Klenow fragment. This fragment is often used in various DNA manipulation techniques due to its enzymatic properties. The team wants to clarify which activity is missing in the Klenow fragment when compared to the full DNA polymerase I enzyme. Which of the following activities is the Klenow fragment known to lack?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5â€™-3â€™ exonuclease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3â€™-5â€™ exonuclease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5â€™-3â€™ DNA polymerase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;3â€™-5â€™ DNA polymerase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 5â€™-3â€™ exonuclease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 5â€™-3â€™ exonuclease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: 3â€™-5â€™ exonuclease - The Klenow fragment retains this proofreading activity , which allows the correction of errors by removing mismatched nucleotides from the 3&#x27; end of the growing DNA strand.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ 3â€™-5â€™ exonuclease -&lt;/li&gt;&lt;li&gt;â€¢ Klenow fragment retains&lt;/li&gt;&lt;li&gt;â€¢ proofreading activity&lt;/li&gt;&lt;li&gt;â€¢ Option C: 5â€™-3â€™ DNA polymerase - The Klenow fragment also retains this essential polymerase activity , enabling it to synthesize DNA in the 5â€™-3â€™ direction by adding nucleotides to the 3&#x27; end of a DNA strand.&lt;/li&gt;&lt;li&gt;â€¢ Option C: 5â€™-3â€™ DNA polymerase -&lt;/li&gt;&lt;li&gt;â€¢ Klenow fragment&lt;/li&gt;&lt;li&gt;â€¢ retains&lt;/li&gt;&lt;li&gt;â€¢ essential polymerase activity&lt;/li&gt;&lt;li&gt;â€¢ Option D: 3â€™-5â€™ DNA polymerase - This is an incorrect designation because DNA polymerase activity occurs in the 5â€™-3â€™ direction , not the 3â€™-5â€™ direction. Therefore, neither the full DNA polymerase I enzyme nor the Klenow fragment has 3â€™-5â€™ polymerase activity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: 3â€™-5â€™ DNA polymerase -&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase activity&lt;/li&gt;&lt;li&gt;â€¢ 5â€™-3â€™ direction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Klenow fragment lacks the 5â€™-3â€™ exonuclease activity , which is one of the three activities possessed by the full DNA polymerase I enzyme . This activity is important for the removal of RNA primers during DNA replication and repair in the full enzyme.&lt;/li&gt;&lt;li&gt;âž¤ Klenow fragment lacks&lt;/li&gt;&lt;li&gt;âž¤ 5â€™-3â€™ exonuclease activity&lt;/li&gt;&lt;li&gt;âž¤ one of the three activities&lt;/li&gt;&lt;li&gt;âž¤ full DNA polymerase I enzyme&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan, Textbook 7th e: pg 580.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan, Textbook 7th e: pg 580.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the process of investigating the mechanisms behind efficient DNA compaction within eukaryotic cells, a research team focuses on the role of specific proteins that facilitate this process. Given the vast length of the eukaryotic genome, understanding how it is compacted to fit within the confines of the cell nucleus is crucial. Which protein is primarily responsible for organizing and packing DNA into a compact structure, enabling its accommodation in the nucleus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Histone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycoprotein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nucleic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Histone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture10.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glycoproteins are proteins covalently bonded to carbohydrates . They play diverse roles in the cell, including cell signaling and immune response, but are not directly involved in DNA packing.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Glycoproteins&lt;/li&gt;&lt;li&gt;â€¢ proteins covalently bonded&lt;/li&gt;&lt;li&gt;â€¢ carbohydrates&lt;/li&gt;&lt;li&gt;â€¢ Option C: Nucleic acids , such as DNA and RNA , are polymers that store and transmit genetic information , not proteins that package DNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Nucleic acids&lt;/li&gt;&lt;li&gt;â€¢ DNA and RNA&lt;/li&gt;&lt;li&gt;â€¢ polymers that store&lt;/li&gt;&lt;li&gt;â€¢ transmit genetic information&lt;/li&gt;&lt;li&gt;â€¢ Option D: Adenine is one of the four nucleotide bases in DNA , pairing with thymine . It is a component of DNA, not a protein that aids in its packing.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Adenine&lt;/li&gt;&lt;li&gt;â€¢ one of the four nucleotide bases&lt;/li&gt;&lt;li&gt;â€¢ DNA&lt;/li&gt;&lt;li&gt;â€¢ pairing with thymine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Histones are the main proteins involved in the compaction of DNA into chromatin within the nucleus of eukaryotic cells . DNA wraps around histone octamers to form nucleosomes , the fundamental units of chromatin . This packaging is essential for organizing the genome and regulating gene expression.&lt;/li&gt;&lt;li&gt;âž¤ Histones&lt;/li&gt;&lt;li&gt;âž¤ main proteins&lt;/li&gt;&lt;li&gt;âž¤ compaction of DNA into chromatin&lt;/li&gt;&lt;li&gt;âž¤ nucleus of eukaryotic cells&lt;/li&gt;&lt;li&gt;âž¤ DNA wraps&lt;/li&gt;&lt;li&gt;âž¤ histone octamers&lt;/li&gt;&lt;li&gt;âž¤ form nucleosomes&lt;/li&gt;&lt;li&gt;âž¤ fundamental units of chromatin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p370-374.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p370-374.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which statement accurately reflects Chargaff&#x27;s rule regarding the base composition of DNA?\&quot;&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A + G = T + C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A/T = G/C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A = U = T = G = C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A + T = G + C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A + G = T + C&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture16.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Chargaffâ€™s rule describes the base composition in double-stranded DNA. It states that in any double-stranded DNA molecule:&lt;/li&gt;&lt;li&gt;â€¢ The amount of adenine (A) equals thymine (T) The amount of guanine (G) equals cytosine (C)&lt;/li&gt;&lt;li&gt;â€¢ The amount of adenine (A) equals thymine (T)&lt;/li&gt;&lt;li&gt;â€¢ adenine (A)&lt;/li&gt;&lt;li&gt;â€¢ thymine (T)&lt;/li&gt;&lt;li&gt;â€¢ The amount of guanine (G) equals cytosine (C)&lt;/li&gt;&lt;li&gt;â€¢ guanine (G)&lt;/li&gt;&lt;li&gt;â€¢ cytosine (C)&lt;/li&gt;&lt;li&gt;â€¢ Since adenine and guanine are purines , and thymine and cytosine are pyrimidines , the total number of purines (A + G) is equal to the total number of pyrimidines (T + C) .&lt;/li&gt;&lt;li&gt;â€¢ purines&lt;/li&gt;&lt;li&gt;â€¢ pyrimidines&lt;/li&gt;&lt;li&gt;â€¢ total number of purines (A + G)&lt;/li&gt;&lt;li&gt;â€¢ total number of pyrimidines (T + C)&lt;/li&gt;&lt;li&gt;â€¢ This is why A + G = T + C is the correct expression of Chargaffâ€™s rule.&lt;/li&gt;&lt;li&gt;â€¢ A + G = T + C&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B: A/T = G/C â€” Incorrect. Chargaffâ€™s rule is about absolute quantities being equal (A = T, G = C), not about the ratios between them.&lt;/li&gt;&lt;li&gt;â€¢ Option B: A/T = G/C&lt;/li&gt;&lt;li&gt;â€¢ ratios&lt;/li&gt;&lt;li&gt;â€¢ Option C: A = U = T = G = C â€” Incorrect. Uracil (U) is not found in DNA; itâ€™s found in RNA. Also, the quantities of all bases are not equal in DNA.&lt;/li&gt;&lt;li&gt;â€¢ Option C: A = U = T = G = C&lt;/li&gt;&lt;li&gt;â€¢ Option D: A + T = G + C â€” Incorrect. There is no rule or biochemical principle stating that the sum of A and T equals G and C. The actual base pairing rules state A = T and G = C individually, which leads to A + G = T + C.&lt;/li&gt;&lt;li&gt;â€¢ Option D: A + T = G + C&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that Chargaffâ€™s rule applies to double-stranded DNA, reflecting base pairing: A = T and G = C. Thus, the number of purines (A + G) equals the number of pyrimidines (T + C) . This principle laid the foundation for the discovery of the DNA double helix structure.&lt;/li&gt;&lt;li&gt;âž¤ Chargaffâ€™s rule&lt;/li&gt;&lt;li&gt;âž¤ purines (A + G)&lt;/li&gt;&lt;li&gt;âž¤ pyrimidines (T + C)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 360.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following defective DNA repair processes to the corresponding disorders?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-b, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-a, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture13.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture14.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture15.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 1-d, 2-c, 3-b, 4-a&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 411.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 411.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false about DNA hyperchromatism.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is increase of absorbance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Measured by absorbance at 260 nm (in a spectrophotometer)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It occurs when the DNA duplex is denatured&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Double stranded DNA is more hyperchromic than ssDNA&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Double stranded DNA is more hyperchromic than ssDNA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Double stranded DNA is more hyperchromic than ssDNA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is an increase of absorbance - This statement is true . Hyperchromicity is characterized by an increase in absorbance when DNA transitions from a double-stranded to a single-stranded state.&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is an increase of absorbance -&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option B: Measured by absorbance at 260 nm (in a spectrophotometer) - This is correct . DNA absorbance is commonly measured at 260 nm to assess purity and concentration, with hyperchromicity also being evaluated at this wavelength.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Measured by absorbance at 260 nm (in a spectrophotometer) -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option C: It occurs when the DNA duplex is denatured - This statement is accurate. The phenomenon of hyperchromicity is observed during the denaturation of dsDNA, where the absorbance increases as the strands separate.&lt;/li&gt;&lt;li&gt;â€¢ Option C: It occurs when the DNA duplex is denatured -&lt;/li&gt;&lt;li&gt;â€¢ accurate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperchromicity:&lt;/li&gt;&lt;li&gt;âž¤ Hyperchromicity:&lt;/li&gt;&lt;li&gt;âž¤ During denaturation of DNA , there is increased in absorbance at 260 nm , measured by Spectrophotometry. ss DNA is more hyperchromic than ds DNA.&lt;/li&gt;&lt;li&gt;âž¤ During denaturation of DNA , there is increased in absorbance at 260 nm , measured by Spectrophotometry.&lt;/li&gt;&lt;li&gt;âž¤ denaturation of DNA&lt;/li&gt;&lt;li&gt;âž¤ increased in absorbance at 260 nm&lt;/li&gt;&lt;li&gt;âž¤ Spectrophotometry.&lt;/li&gt;&lt;li&gt;âž¤ ss DNA is more hyperchromic than ds DNA.&lt;/li&gt;&lt;li&gt;âž¤ ss DNA&lt;/li&gt;&lt;li&gt;âž¤ more hyperchromic&lt;/li&gt;&lt;li&gt;âž¤ ds DNA.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 304-306&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 304-306&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is most directly responsible for triplex DNA formation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hoogsteen pairing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Palindromic sequences&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Large no. of guanosine repeats&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polypyrimidine tracts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hoogsteen pairing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hoogsteen pairing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Palindromic sequences can lead to the formation of hairpin structures or cruciform DNA rather than triplex DNA structures.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Palindromic sequences&lt;/li&gt;&lt;li&gt;â€¢ formation of hairpin structures&lt;/li&gt;&lt;li&gt;â€¢ cruciform DNA&lt;/li&gt;&lt;li&gt;â€¢ Option C: Large numbers of guanosine repeats are more commonly associated with the formation of G-quadruplexes , a type of four-stranded DNA structure.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Large numbers of guanosine repeats&lt;/li&gt;&lt;li&gt;â€¢ formation of G-quadruplexes&lt;/li&gt;&lt;li&gt;â€¢ Option D: Polypyrimidine tracts can be involved in the formation of secondary structures such as triplex DNA, but the critical factor that enables this structure is Hoogsteen pairing rather than the presence of polypyrimidine tracts alone.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Polypyrimidine tracts&lt;/li&gt;&lt;li&gt;â€¢ formation of secondary structures&lt;/li&gt;&lt;li&gt;â€¢ triplex DNA,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Triplex DNA formation is primarily facilitated by Hoogsteen base pairing, where the third strand of DNA binds to the major groove of the double-helical DNA through non-Watson-Crick base pairing. This type of base pairing allows for the stabilization of the triple-helical structure, which is distinct from the conventional double-helical DNA structure.&lt;/li&gt;&lt;li&gt;âž¤ Triplex DNA formation&lt;/li&gt;&lt;li&gt;âž¤ facilitated by Hoogsteen base pairing,&lt;/li&gt;&lt;li&gt;âž¤ third strand of DNA binds&lt;/li&gt;&lt;li&gt;âž¤ major groove&lt;/li&gt;&lt;li&gt;âž¤ double-helical DNA&lt;/li&gt;&lt;li&gt;âž¤ non-Watson-Crick base pairing.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Textbook of Biochemistry with clinical correlation Thomas M Devlin 7/e page 43.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Textbook of Biochemistry with clinical correlation Thomas M Devlin 7/e page 43.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following aspects of DNA structure is most significantly responsible for its thermo-stability?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A â€“ T Base Pairs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;G â€“ C Base Pairs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Molecular base&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parallel arrangement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. G â€“ C Base Pairs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. G â€“ C Base Pairs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The thermal stability of DNA is primarily determined by its base composition , particularly the number of guanine-cytosine (Gâ‰¡C) base pairs . Each Gâ‰¡C pair is held together by three hydrogen bonds , whereas each A=T pair has only two hydrogen bonds . The additional hydrogen bond in Gâ‰¡C base pairs increases the energy required to separate the DNA strands during denaturation, leading to a higher melting temperature (Tm) .&lt;/li&gt;&lt;li&gt;â€¢ base composition&lt;/li&gt;&lt;li&gt;â€¢ number of guanine-cytosine (Gâ‰¡C) base pairs&lt;/li&gt;&lt;li&gt;â€¢ three hydrogen bonds&lt;/li&gt;&lt;li&gt;â€¢ two hydrogen bonds&lt;/li&gt;&lt;li&gt;â€¢ higher melting temperature (Tm)&lt;/li&gt;&lt;li&gt;â€¢ Regions of DNA that are G-C rich therefore exhibit greater thermal stability and resist denaturation at higher temperatures compared to A-T rich regions.&lt;/li&gt;&lt;li&gt;â€¢ G-C rich&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A = T â€“ A-T base pairs are part of DNA structure but are less thermally stable due to only two hydrogen bonds.&lt;/li&gt;&lt;li&gt;â€¢ Option A: A = T&lt;/li&gt;&lt;li&gt;â€¢ Option C: Molecular base â€“ This is vague and not a scientifically specific factor; it does not explain thermal stability.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Molecular base&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parallel arrangement â€“ This is incorrect because DNA strands are actually antiparallel , not parallel. Also, the antiparallel nature contributes more to structural alignment and enzymatic interactions than to thermal stability.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Parallel arrangement&lt;/li&gt;&lt;li&gt;â€¢ antiparallel&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand that Gâ‰¡C base pairing contributes more significantly to DNA thermal stability than A=T pairing, due to the presence of an extra hydrogen bond . This makes G-C rich DNA sequences harder to denature, increasing the melting temperature (Tm) of the molecule.&lt;/li&gt;&lt;li&gt;âž¤ Gâ‰¡C base pairing&lt;/li&gt;&lt;li&gt;âž¤ extra hydrogen bond&lt;/li&gt;&lt;li&gt;âž¤ G-C rich DNA sequences&lt;/li&gt;&lt;li&gt;âž¤ melting temperature (Tm)&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e:  p 304-306&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the primary effect of UV light damage to the DNA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formation of pyrimidine dimers&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;No damage to DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA hydrolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Double stranded breaks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Formation of pyrimidine dimers&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture23.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Formation of pyrimidine dimers&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: No damage to DNA - This is incorrect as UV light is well-documented to cause DNA damage , particularly the formation of pyrimidine dimers.&lt;/li&gt;&lt;li&gt;â€¢ Option B: No damage to DNA -&lt;/li&gt;&lt;li&gt;â€¢ UV light is well-documented to cause DNA damage&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA hydrolysis - UV light does not typically cause DNA hydrolysis . Hydrolytic DNA damage is more often associated with chemical and water-mediated reactions.&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA hydrolysis -&lt;/li&gt;&lt;li&gt;â€¢ not typically cause DNA hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Double stranded breaks - While UV light can lead to various types of DNA damage , it is most known for causing pyrimidine dimers rather than double-stranded breaks, which are more commonly associated with ionizing radiation and certain chemicals.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Double stranded breaks -&lt;/li&gt;&lt;li&gt;â€¢ UV light&lt;/li&gt;&lt;li&gt;â€¢ lead to various types of DNA damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA lesions formed by UV light damage includes Bulky adducts and Pyrimidine Dimers .&lt;/li&gt;&lt;li&gt;âž¤ Bulky adducts&lt;/li&gt;&lt;li&gt;âž¤ Pyrimidine Dimers&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 390.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 390.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is primarily responsible for polymerizing the Okazaki fragments during DNA replication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DNA Polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA Polymerase beta&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA Polymerase III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RNA Polymerase I&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. DNA Polymerase III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) DNA Polymerase III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA Polymerase I: Kornbergâ€™s enzyme from Escherichia coli . It is a repair enzyme, has both 3â€² to 5â€² and 5â€² to 3â€² exonuclease activities.&lt;/li&gt;&lt;li&gt;â€¢ Option A: DNA Polymerase I:&lt;/li&gt;&lt;li&gt;â€¢ Kornbergâ€™s enzyme&lt;/li&gt;&lt;li&gt;â€¢ Escherichia coli&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA Polymerase beta: Involved in proofreading and repair enzyme .&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA Polymerase beta:&lt;/li&gt;&lt;li&gt;â€¢ proofreading&lt;/li&gt;&lt;li&gt;â€¢ repair enzyme&lt;/li&gt;&lt;li&gt;â€¢ Option D: RNA Polymerase I: The DNA polymerase requires a RNA primer which is synthesized by RNA polymerase for initiation of its activity . It is involved in DNA synthesis &amp;amp; Transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option D: RNA Polymerase I:&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ RNA primer&lt;/li&gt;&lt;li&gt;â€¢ synthesized by RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ initiation of its activity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In prokaryotic DNA replication , DNA Polymerase III is the enzyme primarily responsible for synthesizing new DNA strands , including the elongation of Okazaki fragments on the lagging strand . It adds nucleotides to the 3&#x27; end of the RNA primer of each Okazaki fragment, extending them to complete the replication process.&lt;/li&gt;&lt;li&gt;âž¤ prokaryotic DNA replication&lt;/li&gt;&lt;li&gt;âž¤ DNA Polymerase III&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ synthesizing new DNA strands&lt;/li&gt;&lt;li&gt;âž¤ elongation of Okazaki fragments&lt;/li&gt;&lt;li&gt;âž¤ lagging strand&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381-387.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 381-387.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Multiple origins of replication are possible for bacteria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA replication proceeds in one direction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lagging strand stick by RNA primase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA polymerase III-processive leading strand synthesis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DNA polymerase III-processive leading strand synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple origins of replication are possible for bacteria - This statement is false for most bacteria, as bacterial chromosomes , typically being circular , usually have a single origin of replication (oriC in E. coli, for example).&lt;/li&gt;&lt;li&gt;â€¢ Option A: Multiple origins of replication are possible for bacteria -&lt;/li&gt;&lt;li&gt;â€¢ bacterial chromosomes&lt;/li&gt;&lt;li&gt;â€¢ being circular&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA replication proceeds in one direction - This statement is false. DNA replication is bidirectional from the origin, with replication forks moving in opposite directions.&lt;/li&gt;&lt;li&gt;â€¢ Option B: DNA replication proceeds in one direction -&lt;/li&gt;&lt;li&gt;â€¢ DNA replication&lt;/li&gt;&lt;li&gt;â€¢ bidirectional&lt;/li&gt;&lt;li&gt;â€¢ Option C: The lagging strand is initiated by RNA primase - While this statement is partially true in that RNA primase lays down RNA primers for Okazaki fragment synthesis on the lagging strand, the statement is phrased in a way that might imply RNA primase alone is responsible for lagging strand synthesis, which is not accurate. DNA polymerase then takes over to extend these primers.&lt;/li&gt;&lt;li&gt;â€¢ Option C: The lagging strand is initiated by RNA primase -&lt;/li&gt;&lt;li&gt;â€¢ statement is partially true&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase III is the main enzyme responsible for the synthesis of the leading strand during DNA replication in bacteria .&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase III&lt;/li&gt;&lt;li&gt;âž¤ main enzyme&lt;/li&gt;&lt;li&gt;âž¤ synthesis of the leading strand&lt;/li&gt;&lt;li&gt;âž¤ DNA replication in bacteria&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 381-387.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 381-387.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;DNA ligase will be required to finish synthesis at which labelled points of the DNA replication fork in the figure.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C and D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A and C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B and C&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. B and C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture24.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) B and C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A and B - This answer would not typically be correct because one of these points would likely represent the continuous synthesis on the leading strand , which doesnâ€™t require ligase for joining fragments.&lt;/li&gt;&lt;li&gt;â€¢ Option A: A and B -&lt;/li&gt;&lt;li&gt;â€¢ not typically be correct&lt;/li&gt;&lt;li&gt;â€¢ one of these points&lt;/li&gt;&lt;li&gt;â€¢ represent the continuous synthesis&lt;/li&gt;&lt;li&gt;â€¢ leading strand&lt;/li&gt;&lt;li&gt;â€¢ Option B: C and D - If points C and D represent the lagging strand , then ligase would be needed, but if one represents the leading strand, ligase wouldnâ€™t be required at that point.&lt;/li&gt;&lt;li&gt;â€¢ Option B: C and D -&lt;/li&gt;&lt;li&gt;â€¢ points C and D&lt;/li&gt;&lt;li&gt;â€¢ lagging strand&lt;/li&gt;&lt;li&gt;â€¢ Option C: A and C - As in option A, this would not typically include two points where ligase is required if one represents the leading strand.&lt;/li&gt;&lt;li&gt;â€¢ Option C: A and C -&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ include two points&lt;/li&gt;&lt;li&gt;â€¢ ligase is required&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DNA ligase is the enzyme responsible for joining the DNA fragments on the lagging strand during replication . These fragments , known as Okazaki fragments , are synthesized discontinuously and require ligation to form a continuous DNA strand . Based on a typical replication fork, points B and C are positioned to indicate the termination of Okazaki fragments on the lagging strand, where DNA ligase would act to seal the nicks between adjacent fragments.&lt;/li&gt;&lt;li&gt;âž¤ DNA ligase&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ joining the DNA fragments&lt;/li&gt;&lt;li&gt;âž¤ lagging strand during replication&lt;/li&gt;&lt;li&gt;âž¤ fragments&lt;/li&gt;&lt;li&gt;âž¤ Okazaki fragments&lt;/li&gt;&lt;li&gt;âž¤ synthesized discontinuously&lt;/li&gt;&lt;li&gt;âž¤ ligation to form a continuous DNA strand&lt;/li&gt;&lt;li&gt;âž¤ typical replication fork,&lt;/li&gt;&lt;li&gt;âž¤ B and C are positioned&lt;/li&gt;&lt;li&gt;âž¤ termination of Okazaki fragments&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 390.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 390.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;If there are 4 consecutive nucleotides code for an amino acid. Then how many amino acid can be coded by nucleic acid?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;256&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;64&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;16&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 256&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 256&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. 64: If three nucleotides in each codon, then (4) ^3, i.e., 64 codons&lt;/li&gt;&lt;li&gt;â€¢ Option B. 64:&lt;/li&gt;&lt;li&gt;â€¢ 64 codons&lt;/li&gt;&lt;li&gt;â€¢ Option C. 16: If two nucleotides in each codon, then (4) ^2, i.e., 16 codons&lt;/li&gt;&lt;li&gt;â€¢ Option C. 16:&lt;/li&gt;&lt;li&gt;â€¢ 16 codons&lt;/li&gt;&lt;li&gt;â€¢ Option D. 4: If 1 nucleotide in each codon, then (4) ^1, i.e., 4 codons&lt;/li&gt;&lt;li&gt;â€¢ Option D. 4:&lt;/li&gt;&lt;li&gt;â€¢ 4 codons&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The greater the length of the codon , the more amino acids can potentially be encoded, leading to a more complex potential protein space.&lt;/li&gt;&lt;li&gt;âž¤ greater the length&lt;/li&gt;&lt;li&gt;âž¤ codon&lt;/li&gt;&lt;li&gt;âž¤ more amino acids&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 414&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 414&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion : Central dogma defines DNA is transcribed into RNA which is then subsequently translated into proteins Reasoning : Retrovirus shows reverse transcriptase activity of central dogma where RNA is first converted to DNA which is transcribed to RNA, which is finally translated into proteins&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Both assertion and reason are independently true, but the reason is not the correct explanation of the assertion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Both assertion and reasons are independently true and the reason is the correct explanation for the assertion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Assertion is independently true, but the reason is independently false&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Assertion is independently a false nut the reason is independently true&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Both assertion and reason are independently true, but the reason is not the correct explanation of the assertion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture4_xSGQBGU.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Both assertion and reason are independently true, but the reason is not the correct explanation of the assertion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Central Dogma of molecular biology , where DNA is transcribed into RNA , and RNA is translated into proteins.&lt;/li&gt;&lt;li&gt;âž¤ Central Dogma&lt;/li&gt;&lt;li&gt;âž¤ molecular biology&lt;/li&gt;&lt;li&gt;âž¤ DNA&lt;/li&gt;&lt;li&gt;âž¤ transcribed into RNA&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: P 364, 453, 409&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: P 364, 453, 409&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the genetic code is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Has four nucleotide base sequence in mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is unambiguous&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is non-degenerated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It can overlap&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is unambiguous&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is unambiguous&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Has four nucleotide base sequences in mRNA: Triplet base sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Has four nucleotide base sequences in mRNA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is non-degenerated: Degenerate: Each amino acid has more than 1 codon.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is non-degenerated:&lt;/li&gt;&lt;li&gt;â€¢ Degenerate:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It can overlap: Non-overlapping : means that the codon is read from a fixed starting point as a continuous sequence of bases, taking three at a time, without any punctuation between codons. e.g. AUCGGGACUGCA will be read as AUC GGG ACU GCA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It can overlap:&lt;/li&gt;&lt;li&gt;â€¢ Non-overlapping&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The genetic code is unambiguous, meaning that each codon specifies only one amino acid . This property ensures that the genetic code is interpreted in the same way in almost all organisms, providing consistency in protein synthesis across diverse life forms.&lt;/li&gt;&lt;li&gt;âž¤ genetic code&lt;/li&gt;&lt;li&gt;âž¤ unambiguous,&lt;/li&gt;&lt;li&gt;âž¤ each codon&lt;/li&gt;&lt;li&gt;âž¤ one amino acid&lt;/li&gt;&lt;li&gt;âž¤ property ensures&lt;/li&gt;&lt;li&gt;âž¤ genetic code&lt;/li&gt;&lt;li&gt;âž¤ all organisms,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical researcher studying gene expression, is reviewing the process of RNA splicing and the role of various components involved in this mechanism. They come across a question that tests their understanding of the components crucial for the splicing of pre-mRNA in eukaryotic cells. The question asks to identify the truthfulness of the statement regarding the function of snRNA in splicing activity. How would you assess the statement \&quot;Splicing activity is a function of snRNA\&quot;?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True, because snRNAs are part of the spliceosome complex that facilitates the removal of introns from pre-mRNA.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False, because snRNAs are involved in the modification of rRNA, not in splicing.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;False, because splicing activity is solely the function of spliceosomal proteins, not snRNAs.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;True, because snRNAs directly catalyze peptide bond formation in protein synthesis.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True, because snRNAs are part of the spliceosome complex that facilitates the removal of introns from pre-mRNA.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) True, because snRNAs are part of the spliceosome complex that facilitates the removal of introns from pre-mRNA.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. False, because snRNAs are involved in the modification of rRNA, not in splicing: This is incorrect because the primary role of snRNAs is in splicing , not rRNA modification.&lt;/li&gt;&lt;li&gt;â€¢ Option B. False, because snRNAs are involved in the modification of rRNA, not in splicing:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ primary role of snRNAs is in splicing&lt;/li&gt;&lt;li&gt;â€¢ Option C. False, because splicing activity is solely the function of spliceosomal proteins, not snRNAs : This is incorrect as snRNAs, complexed with proteins to form snRNPs , are essential for the splicing function of the spliceosome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. False, because splicing activity is solely the function of spliceosomal proteins, not snRNAs&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ snRNAs,&lt;/li&gt;&lt;li&gt;â€¢ complexed with proteins to form snRNPs&lt;/li&gt;&lt;li&gt;â€¢ Option D. True, because snRNAs directly catalyze peptide bond formation in protein synthesis : This is incorrect because snRNAs are involved in splicing , not in the catalysis of peptide bonds during protein synthesis, which is a role of ribosomal RNA (rRNA) within the ribosome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. True, because snRNAs directly catalyze peptide bond formation in protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ snRNAs are involved in splicing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Small Nuclear RNA (snRNA / snRNPs / snurps) are uracil rich RNA which can act as enzymes , i.e., Ribozyme. U1, U2, U4, U5, U6 involved in mRNA processing. U7 in processing histone mRNA.&lt;/li&gt;&lt;li&gt;âž¤ Small Nuclear RNA (snRNA / snRNPs / snurps) are uracil rich RNA which can act as enzymes , i.e., Ribozyme.&lt;/li&gt;&lt;li&gt;âž¤ Small Nuclear RNA (snRNA / snRNPs / snurps)&lt;/li&gt;&lt;li&gt;âž¤ uracil rich RNA&lt;/li&gt;&lt;li&gt;âž¤ act as enzymes&lt;/li&gt;&lt;li&gt;âž¤ U1, U2, U4, U5, U6 involved in mRNA processing.&lt;/li&gt;&lt;li&gt;âž¤ U1, U2, U4, U5, U6&lt;/li&gt;&lt;li&gt;âž¤ mRNA processing.&lt;/li&gt;&lt;li&gt;âž¤ U7 in processing histone mRNA.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 367,411&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 367,411&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In preparing for a molecular biology exam, a group of medical students reviews the requirements for RNA synthesis. They discuss the role of RNA polymerase and its necessary components to initiate and carry out transcription. To test their understanding, they consider which of the following is not required by RNA polymerase for its function. What does RNA polymerase not require functioning?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Template (ds DNA)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activated precursors (ATP, GTP, UTP, CTP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Divalent metal ions (Mn2+, Mg2+)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Primer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture8_66wts5v.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Primer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Template (ds DNA): RNA polymerase requires a DNA template to synthesize RNA by reading the template strand and synthesizing a complementary RNA strand.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Template (ds DNA):&lt;/li&gt;&lt;li&gt;â€¢ RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ DNA template to synthesize RNA&lt;/li&gt;&lt;li&gt;â€¢ reading the template strand&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activated precursors (ATP, GTP, UTP, CTP): RNA polymerase requires nucleoside triphosphates (NTPs) as substrates to build the RNA strand.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Activated precursors (ATP, GTP, UTP, CTP):&lt;/li&gt;&lt;li&gt;â€¢ RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ nucleoside triphosphates&lt;/li&gt;&lt;li&gt;â€¢ substrates&lt;/li&gt;&lt;li&gt;â€¢ Option C. Divalent metal ions (Mn2+, Mg2+): Metal ions like Mg2+ are cofactors that facilitate the catalytic activity of RNA polymerase during RNA synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Divalent metal ions (Mn2+, Mg2+):&lt;/li&gt;&lt;li&gt;â€¢ Metal ions&lt;/li&gt;&lt;li&gt;â€¢ Mg2+ are cofactors&lt;/li&gt;&lt;li&gt;â€¢ facilitate the catalytic activity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase does not require a primer to initiate transcription. Unlike DNA polymerase , which needs a short RNA or DNA primer to start DNA synthesis , RNA polymerase can begin RNA synthesis de novo on a DNA template.&lt;/li&gt;&lt;li&gt;âž¤ RNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ primer to initiate transcription.&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ needs a short RNA or DNA primer to start DNA synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 395, 397&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 395, 397&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following therapeutic drugs specifically inhibits the translocation step in bacterial protein synthesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Streptomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tetracyclines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chloramphenicol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Erythromycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Erythromycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Streptomycin and other aminoglycoside antibiotics bind to 30S subunit of bacterial ribosomes â†’ completely inhibit the initiation complex formation and protein synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Streptomycin&lt;/li&gt;&lt;li&gt;â€¢ inhibit the initiation complex formation and protein synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tetracyclines bind to the 30S subunit of bacterial ribosome â†’ inhibit attachment of aminoacyl tRNA to the A site of ribosomes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tetracyclines&lt;/li&gt;&lt;li&gt;â€¢ attachment of aminoacyl tRNA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chloramphenicol inhibits the peptidyl transferase activity of bacterial ribosomes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Chloramphenicol&lt;/li&gt;&lt;li&gt;â€¢ peptidyl transferase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome . This binding impedes the translocation process, wherein the ribosome moves along the mRNA strand from one codon to the next, thereby inhibiting protein elongation.&lt;/li&gt;&lt;li&gt;âž¤ Erythromycin&lt;/li&gt;&lt;li&gt;âž¤ macrolide antibiotic&lt;/li&gt;&lt;li&gt;âž¤ inhibits bacterial protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ binding to the 50S subunit&lt;/li&gt;&lt;li&gt;âž¤ bacterial ribosome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 426.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 426.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Examining the various components of tRNA and their contributions to protein synthesis, the pseudo-uridine arm stands out for its unique role. Understanding the functionality of each segment of the tRNA molecule is crucial for grasping the complex process of translation. What is the primary function of the pseudo-uridine arm in tRNA?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Helps in initiation of translation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serves as the recognition site of aminoacyl tRNA synthetase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Recognises the triple nucleotide codon presents in the mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Has 3 unpaired nucleotide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Helps in initiation of translation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Helps in initiation of translation.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serves as the recognition site of aminoacyl tRNA synthetase: DHU Arm&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serves as the recognition site of aminoacyl tRNA synthetase:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Recognises the triple nucleotide codon present in the mRNA: Anticodon arm&lt;/li&gt;&lt;li&gt;â€¢ Option C. Recognises the triple nucleotide codon present in the mRNA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Has 3 unpaired nucleotides: Acceptor Arm&lt;/li&gt;&lt;li&gt;â€¢ Option D. Has 3 unpaired nucleotides:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The pseudo-uridine arm of tRNA plays a role in the proper folding and stability of the tRNA molecule, which is essential for its function during translation , including initiation. While not directly initiating translation, the structural integrity provided by the pseudo-uridine arm and other modifications is crucial for the overall process of protein synthesis.&lt;/li&gt;&lt;li&gt;âž¤ pseudo-uridine arm of tRNA&lt;/li&gt;&lt;li&gt;âž¤ role in the proper folding&lt;/li&gt;&lt;li&gt;âž¤ stability of the tRNA molecule,&lt;/li&gt;&lt;li&gt;âž¤ function during translation&lt;/li&gt;&lt;li&gt;âž¤ initiation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 409&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 409&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old patient suffering from chills, vomiting and cramping was rushed to the casualty. He had eaten wild mushrooms for dinner that he had picked earlier in the day. His symptoms are due to an inhibition of which of the following enzymes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RNA polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RNA polymerase II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RNA polymerase III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA primase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. RNA polymerase II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) RNA polymerase II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA polymerase I: This enzyme is responsible for the transcription of rRNA , and while its inhibition would affect protein synthesis, it is not the primary target of Î±-amanitin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA polymerase I:&lt;/li&gt;&lt;li&gt;â€¢ enzyme&lt;/li&gt;&lt;li&gt;â€¢ transcription of rRNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. RNA polymerase III: This enzyme synthesizes tRNA and some other small RNAs . Its inhibition would also impact protein synthesis but is not the primary mechanism of toxicity in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C. RNA polymerase III:&lt;/li&gt;&lt;li&gt;â€¢ enzyme synthesizes tRNA&lt;/li&gt;&lt;li&gt;â€¢ other small RNAs&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA primase: DNA primase synthesizes RNA primers necessary for DNA replication . Inhibition of DNA primase would disrupt DNA replication but is not related to the toxic effects of the mushrooms in question.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA primase:&lt;/li&gt;&lt;li&gt;â€¢ DNA primase synthesizes RNA primers&lt;/li&gt;&lt;li&gt;â€¢ DNA replication&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The toxin Î±-amanitin found in these mushrooms inhibits RNA polymerase II , which is essential for the synthesis of mRNA in eukaryotic cells .&lt;/li&gt;&lt;li&gt;âž¤ toxin Î±-amanitin&lt;/li&gt;&lt;li&gt;âž¤ mushrooms inhibits RNA polymerase II&lt;/li&gt;&lt;li&gt;âž¤ synthesis of mRNA&lt;/li&gt;&lt;li&gt;âž¤ eukaryotic cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old researcher working at a medical laboratory is involved in a project focused on the protein synthesis mechanisms of a recently discovered pathogenic protozoan. While reviewing the initiation complex of translation in eukaryotes, he notes that certain components are crucial for the process. Which of the following is NOT a component of the eukaryotic initiation complex of translation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peptidyl transferase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Met-tRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;40S Subunit&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Peptidyl transferase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture25.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture26.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Peptidyl transferase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The eukaryotic initiation complex is responsible for assembling the necessary components to begin the process of translation. This complex includes:&lt;/li&gt;&lt;li&gt;â€¢ mRNA: The messenger RNA that carries the genetic code. 40S ribosomal subunit : The small ribosomal subunit that initially binds mRNA. Met-tRNA (Initiator tRNA): The initiator tRNA charged with methionine. Eukaryotic initiation factors (eIFs): Facilitate the binding of these components.&lt;/li&gt;&lt;li&gt;â€¢ mRNA: The messenger RNA that carries the genetic code.&lt;/li&gt;&lt;li&gt;â€¢ mRNA:&lt;/li&gt;&lt;li&gt;â€¢ 40S ribosomal subunit : The small ribosomal subunit that initially binds mRNA.&lt;/li&gt;&lt;li&gt;â€¢ 40S ribosomal subunit&lt;/li&gt;&lt;li&gt;â€¢ Met-tRNA (Initiator tRNA): The initiator tRNA charged with methionine.&lt;/li&gt;&lt;li&gt;â€¢ Met-tRNA (Initiator tRNA):&lt;/li&gt;&lt;li&gt;â€¢ Eukaryotic initiation factors (eIFs): Facilitate the binding of these components.&lt;/li&gt;&lt;li&gt;â€¢ Eukaryotic initiation factors (eIFs):&lt;/li&gt;&lt;li&gt;â€¢ Peptidyl transferase, however, is not part of the initiation complex. It is a catalytic activity of the 60S large ribosomal subunit, and it plays a critical role during the elongation phase, catalyzing the formation of peptide bonds between amino acids.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA â€“ Included in the initiation complex. The ribosome needs mRNA as a template for translation. Option C. Met-tRNA â€“ Included. Specifically, Met-tRNA is the initiator tRNA in eukaryotes that binds to the start codon during translation initiation. Option D. 40S Subunit â€“ Included. The small ribosomal subunit that binds mRNA and Met-tRNA to form the 43S and 48S complexes during initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA â€“ Included in the initiation complex. The ribosome needs mRNA as a template for translation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. mRNA â€“&lt;/li&gt;&lt;li&gt;â€¢ Option C. Met-tRNA â€“ Included. Specifically, Met-tRNA is the initiator tRNA in eukaryotes that binds to the start codon during translation initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Met-tRNA â€“&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40S Subunit â€“ Included. The small ribosomal subunit that binds mRNA and Met-tRNA to form the 43S and 48S complexes during initiation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 40S Subunit â€“&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The initiation of translation in eukaryotes involves assembly of a pre-initiation complex consisting of the 40S ribosomal subunit, initiator Met-tRNA, mRNA, and initiation factors. Peptidyl transferase is a function of the large 60S ribosomal subunit and is not part of the initiation complex.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 419-426.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding the Shine-Dalgarno sequence?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eukaryotic mRNA possesses Shine-Dalgarno sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prokaryotic mRNA possesses Shine-Dalgarno sequence&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;23S rRNA binds with this sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5S rRNA binds with this sequence&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prokaryotic mRNA possesses Shine-Dalgarno sequence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Prokaryotic mRNA possesses Shine-Dalgarno sequence&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Eukaryotic mRNA possesses Shine-Dalgarno sequence: Only the prokaryotic mRNA possesses the sequence.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Eukaryotic mRNA possesses Shine-Dalgarno sequence:&lt;/li&gt;&lt;li&gt;â€¢ prokaryotic mRNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. and Option D. both are incorrect as 16S rRNA component of 30S ribosomal subunit has a nucleotide sequence near its 3&#x27;-end that is complementary to all or part of the SD sequence&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ 16S rRNA component of 30S ribosomal subunit&lt;/li&gt;&lt;li&gt;â€¢ nucleotide sequence near&lt;/li&gt;&lt;li&gt;â€¢ 3&#x27;-end&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Shine-Dalgarno sequence is a ribosomal binding site in the mRNA of prokaryotes , not eukaryotes. It is located upstream of the start codon and is complementary to a sequence at the 3&#x27; end of the 16S rRNA in the 30S small subunit of the ribosome . This complementarity facilitates the binding of mRNA to the ribosome, positioning the start codon in the correct place to initiate translation.&lt;/li&gt;&lt;li&gt;âž¤ Shine-Dalgarno sequence&lt;/li&gt;&lt;li&gt;âž¤ ribosomal binding site&lt;/li&gt;&lt;li&gt;âž¤ mRNA of prokaryotes&lt;/li&gt;&lt;li&gt;âž¤ located upstream&lt;/li&gt;&lt;li&gt;âž¤ start codon&lt;/li&gt;&lt;li&gt;âž¤ complementary to a sequence&lt;/li&gt;&lt;li&gt;âž¤ 3&#x27; end of the 16S rRNA&lt;/li&gt;&lt;li&gt;âž¤ 30S small subunit&lt;/li&gt;&lt;li&gt;âž¤ ribosome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/ed: p 439.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/ed: p 439.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a discussion in an advanced biochemistry lab in Delhi, which focuses on genetic disorders, a group of healthcare professionals are evaluating the accuracy of different hypotheses related to gene expression. They consider the concept of the wobble hypothesis. The wobble hypothesis suggests that the binding occurs between the 5&#x27; end of the anticodon and the 3rd nucleotide of the codon. Is this statement true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;This describes the strict Watson-Crick base pairing, not the wobble hypothesis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The wobble hypothesis only applies to the first two nucleotides of the codon, not the third&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. False - This option is incorrect because the wobble hypothesis does specifically refer to the flexible binding of the 5&#x27; end of the anticodon with the 3rd nucleotide of the codon.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ False -&lt;/li&gt;&lt;li&gt;â€¢ wobble hypothesis&lt;/li&gt;&lt;li&gt;â€¢ flexible binding of the 5&#x27; end of the anticodon&lt;/li&gt;&lt;li&gt;â€¢ Option C. This describes the strict Watson-Crick base pairing, not the wobble hypothesis - This option is incorrect because the wobble hypothesis is distinct from strict Watson-Crick base pairing . The wobble hypothesis refers to the flexibility in base pairing that occurs at the third position of the codon.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ This describes the strict Watson-Crick base pairing, not the wobble hypothesis -&lt;/li&gt;&lt;li&gt;â€¢ wobble hypothesis&lt;/li&gt;&lt;li&gt;â€¢ distinct from strict Watson-Crick base pairing&lt;/li&gt;&lt;li&gt;â€¢ Option D. The wobble hypothesis only applies to the first two nucleotides of the codon, not the third - This option is incorrect because the wobble hypothesis specifically applies to the pairing of the third nucleotide of the codon , which can \&quot;wobble\&quot; and thus base pair with more than one kind of nucleotide.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ The wobble hypothesis only applies to the first two nucleotides of the codon, not the third -&lt;/li&gt;&lt;li&gt;â€¢ wobble hypothesis&lt;/li&gt;&lt;li&gt;â€¢ applies to the pairing of the third nucleotide of the codon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The wobble hypothesis is indeed correct as described. It states that the 5&#x27; end of the tRNA anticodon can wobble to pair with the 3rd nucleotide of the mRNA codon . This flexibility allows for certain tRNAs to recognize more than one codon , which in turn allows for the genetic code to be degenerate â€”meaning that multiple codons can code for a single amino acid.&lt;/li&gt;&lt;li&gt;âž¤ wobble hypothesis&lt;/li&gt;&lt;li&gt;âž¤ 5&#x27; end of the tRNA anticodon&lt;/li&gt;&lt;li&gt;âž¤ wobble to pair&lt;/li&gt;&lt;li&gt;âž¤ 3rd nucleotide&lt;/li&gt;&lt;li&gt;âž¤ mRNA codon&lt;/li&gt;&lt;li&gt;âž¤ flexibility&lt;/li&gt;&lt;li&gt;âž¤ tRNAs to recognize more than one codon&lt;/li&gt;&lt;li&gt;âž¤ turn allows for the genetic code&lt;/li&gt;&lt;li&gt;âž¤ degenerate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 416.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 416.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old girl in a rural clinic near Pune presents with chills, headache, nausea, vomiting, and a sore throat. On examination, the physician observes a persistent greyish-white colored membrane over the tonsils. The girl&#x27;s vaccination card indicates that she has not been immunized against diphtheria. Considering the pathophysiology of diphtheria toxin, which of the following is the reason it is lethal in unimmunized cases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inactivates an elongation factor required for translocation in protein synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Binds to the ribosome and prevents peptide bond formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prevents binding of mRNA to the 60S ribosomal subunit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inactivates an initiation factor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Inactivates an elongation factor required for translocation in protein synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Inactivates an elongation factor required for translocation in protein synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Binds to the ribosome and prevents peptide bond formation - This is not correct for diphtheria toxin. This mechanism of action is associated with a different class of toxins, such as ricin.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Binds to the ribosome and prevents peptide bond formation&lt;/li&gt;&lt;li&gt;â€¢ not correct&lt;/li&gt;&lt;li&gt;â€¢ diphtheria toxin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prevents binding of mRNA to the 60S ribosomal subunit - Diphtheria toxin does not prevent the binding of mRNA to the ribosomal subunit.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Prevents binding of mRNA to the 60S ribosomal subunit&lt;/li&gt;&lt;li&gt;â€¢ Diphtheria toxin&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ prevent&lt;/li&gt;&lt;li&gt;â€¢ binding of mRNA&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inactivates an initiation factor - The diphtheria toxin specifically inactivates an elongation factor , not an initiation factor.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Inactivates an initiation factor&lt;/li&gt;&lt;li&gt;â€¢ diphtheria toxin&lt;/li&gt;&lt;li&gt;â€¢ inactivates an elongation factor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diphtheria toxin targets and inactivates elongation factor-2 (EF-2), which is essential for the translocation step of protein synthesis on ribosomes. This inactivation prevents the movement of the ribosome along the mRNA, thus halting protein synthesis, which can lead to cell death.&lt;/li&gt;&lt;li&gt;âž¤ Diphtheria toxin targets&lt;/li&gt;&lt;li&gt;âž¤ inactivates elongation factor-2&lt;/li&gt;&lt;li&gt;âž¤ essential for the translocation step&lt;/li&gt;&lt;li&gt;âž¤ protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ ribosomes.&lt;/li&gt;&lt;li&gt;âž¤ inactivation prevents the movement of the ribosome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 426.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 426.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician in a tertiary care hospital is confronted with a case involving a 3-year-old girl presenting with high-grade fever, stiff neck, positive Brudzinski and Kernig signs, and petechiae on the extremities. Suspecting bacterial meningitis with a possible meningococcal etiology, the pediatrician decides to initiate treatment with an antibiotic known to block prokaryotic peptide bond formation. Which of the following drugs should be prescribed in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rifampin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rapamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chloramphenicol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cycloheximide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Chloramphenicol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Chloramphenicol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rifampin inhibits prokaryotic mRNA synthesis and has no effect on translation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rifampin&lt;/li&gt;&lt;li&gt;â€¢ prokaryotic mRNA synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapamycin causes blockage of translation inhibition , not peptide bond formation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rapamycin&lt;/li&gt;&lt;li&gt;â€¢ blockage of translation inhibition&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cycloheximide has the same effect as chloramphenicol in eukaryotic cells but has no effect on prokaryotes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cycloheximide&lt;/li&gt;&lt;li&gt;â€¢ same effect as chloramphenicol&lt;/li&gt;&lt;li&gt;â€¢ eukaryotic cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chloramphenicol is an antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit , thereby blocking the peptidyl transferase activity . This action prevents the formation of peptide bonds between amino acids, effectively halting bacterial growth and proliferation, which makes it suitable for the treatment of bacterial infections like meningitis.&lt;/li&gt;&lt;li&gt;âž¤ Chloramphenicol&lt;/li&gt;&lt;li&gt;âž¤ antibiotic&lt;/li&gt;&lt;li&gt;âž¤ inhibits bacterial protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ binding to the 50S ribosomal subunit&lt;/li&gt;&lt;li&gt;âž¤ blocking the peptidyl transferase activity&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 426.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 426.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical case discussion regarding a case of a protein synthesis disorder, a team of residents are reviewing the steps involved in protein synthesis to pinpoint potential areas of malfunction. They delve into the termination phase of protein synthesis, examining which components are crucial for this process. The team debates which of the following is NOT involved in the termination process of protein synthesis:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Releasing factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stop codon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peptidyl transferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AUG codon&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. AUG codon&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.AUG codon&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Releasing factor : Incorrect, as  releasing factors are indeed involved in the termination process , facilitating the release of the newly synthesized polypeptide chain from the ribosome.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Releasing factor&lt;/li&gt;&lt;li&gt;â€¢ involved in the termination process&lt;/li&gt;&lt;li&gt;â€¢ Option B . Stop codon : Incorrect, stop codons signal the end of the mRNA sequence for translation and are essential for the termination process.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Stop codon&lt;/li&gt;&lt;li&gt;â€¢ signal the end of the mRNA sequence&lt;/li&gt;&lt;li&gt;â€¢ translation&lt;/li&gt;&lt;li&gt;â€¢ Option C . Peptidyl transferase : Incorrect, although primarily involved in peptide bond formation , peptidyl transferase is also indirectly involved in termination by catalyzing the reaction that releases the polypeptide from the tRNA in the P site at the end of translation.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Peptidyl transferase&lt;/li&gt;&lt;li&gt;â€¢ involved in peptide bond formation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The AUG codon is not involved in the termination process of protein synthesis ; rather, it serves as the start codon , signaling the beginning of protein synthesis by coding for methionine in eukaryotes and a modified form of methionine (N-formylmethionine) in prokaryotes . The termination process is facilitated by the stop codons, releasing factors, and other components.&lt;/li&gt;&lt;li&gt;âž¤ AUG codon&lt;/li&gt;&lt;li&gt;âž¤ not involved in the termination process&lt;/li&gt;&lt;li&gt;âž¤ protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ serves as the start codon&lt;/li&gt;&lt;li&gt;âž¤ signaling&lt;/li&gt;&lt;li&gt;âž¤ beginning of protein synthesis&lt;/li&gt;&lt;li&gt;âž¤ coding for methionine in eukaryotes&lt;/li&gt;&lt;li&gt;âž¤ modified form of methionine&lt;/li&gt;&lt;li&gt;âž¤ prokaryotes&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 423.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 423.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about eukaryotic protein synthesis is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;N - formyl Met is the first tRNA to come into action&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;mRNA read from 5â€™to 3â€™&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;poly (A) tail helps in the process&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Capping helps in attachment of mRNA to 40S ribosome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. N - formyl Met is the first tRNA to come into action&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.N-formyl Met is the first tRNA to come into action&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . mRNA is read from 5â€™ to 3 â€™: This is true for eukaryotic protein synthesis, as the ribosome moves along the mRNA from the 5â€™ end to the 3â€™ end, translating the codons into amino acids.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ mRNA is read from 5â€™ to 3&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option C . The poly (A) tail helps in the process : The poly (A) tail in eukaryotic mRNA plays several roles in mRNA stability and translation efficiency, making this statement true .&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;li&gt;â€¢ The poly (A) tail helps in the process&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Option D . Capping helps in the attachment of mRNA to the 40S ribosomal subunit : The 5&#x27; cap found on eukaryotic mRNA is indeed crucial for the recruitment of the ribosome to the mRNA, facilitating the initiation of translation.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Capping helps in the attachment of mRNA to the 40S ribosomal subunit&lt;/li&gt;&lt;li&gt;â€¢ 5&#x27; cap found on eukaryotic mRNA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ First t-RNA to come into action is methionyl tRNA in eukaryotes and N Formyl tRNA in prokaryotes.&lt;/li&gt;&lt;li&gt;âž¤ First t-RNA&lt;/li&gt;&lt;li&gt;âž¤ come into&lt;/li&gt;&lt;li&gt;âž¤ action&lt;/li&gt;&lt;li&gt;âž¤ methionyl tRNA&lt;/li&gt;&lt;li&gt;âž¤ eukaryotes&lt;/li&gt;&lt;li&gt;âž¤ N Formyl tRNA in prokaryotes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 422.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 422.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is pivotal in ensuring the accuracy of amino acid incorporation into proteins by &#x27;proofreading&#x27; the tRNA and amino acid match?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RNA polymerase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aminoacyl tRNA synthetase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine zipper&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DNA polymerase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aminoacyl tRNA synthetase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Aminoacyl tRNA synthetase.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA polymerase: The DNA polymerase requires a RNA primer which is synthesized by RNA polymerase for initiation of its activity. It is involved in DNA synthesis &amp;amp; Transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RNA polymerase:&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ RNA primer&lt;/li&gt;&lt;li&gt;â€¢ synthesized by RNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leucine zipper: The eukaryotic transcription factors have structural motifs like zinc finger , helix turn helix, helix loop helix, leucine zipper, etc. The proteinâ€“DNA interactions are mainly mediated by these .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Leucine zipper:&lt;/li&gt;&lt;li&gt;â€¢ eukaryotic transcription factors&lt;/li&gt;&lt;li&gt;â€¢ structural motifs&lt;/li&gt;&lt;li&gt;â€¢ zinc finger&lt;/li&gt;&lt;li&gt;â€¢ .&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA polymerase: is i nvolved in DNA replication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. DNA polymerase:&lt;/li&gt;&lt;li&gt;â€¢ DNA replication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The enzymes aminoacyl tRNA synthetases activate the amino acids. The enzyme helps in recognition of both the amino acid and the transfer RNA acceptor . It is the only proofreading mechanism for translation .&lt;/li&gt;&lt;li&gt;âž¤ The enzymes aminoacyl tRNA synthetases activate the amino acids.&lt;/li&gt;&lt;li&gt;âž¤ The enzymes aminoacyl tRNA synthetases activate the amino acids.&lt;/li&gt;&lt;li&gt;âž¤ aminoacyl tRNA synthetases&lt;/li&gt;&lt;li&gt;âž¤ The enzyme helps in recognition of both the amino acid and the transfer RNA acceptor .&lt;/li&gt;&lt;li&gt;âž¤ The enzyme helps in recognition of both the amino acid and the transfer RNA acceptor .&lt;/li&gt;&lt;li&gt;âž¤ It is the only proofreading mechanism for translation .&lt;/li&gt;&lt;li&gt;âž¤ It is the only proofreading mechanism for translation .&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 415.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-month-old girl of Ashkenazi Jewish descent, after a period of normal development, shows a plateau in developmental milestones. Initially exhibiting normal behaviors such as rolling over and smiling, she becomes less active and is unable to sit. Upon examination, her pediatrician in India notes hypotonia and an exaggerated startle reflex. An ophthalmologic examination reveals a cherry-red spot, leading to the suspicion of a lipid storage disease. Considering the family&#x27;s background and the symptoms, what is the risk that the next child will also be affected by this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1/12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3/4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1/4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1/2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1/4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/picture4_4vZDc2y.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. 1/4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Developmental plateau , hypotonia , exaggerated startle reflex , and a cherry-red spot on ophthalmologic examination , is classic for Tay-Sachs disease , a type of lipid storage disease more commonly found among individuals of Ashkenazi Jewish descent . Tay-Sachs disease is an autosomal recessive disorder, which means that for a child to be affected, they must inherit two copies of the defective gene, one from each parent.&lt;/li&gt;&lt;li&gt;âž¤ Developmental plateau&lt;/li&gt;&lt;li&gt;âž¤ hypotonia&lt;/li&gt;&lt;li&gt;âž¤ exaggerated startle reflex&lt;/li&gt;&lt;li&gt;âž¤ cherry-red spot&lt;/li&gt;&lt;li&gt;âž¤ ophthalmologic examination&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs disease&lt;/li&gt;&lt;li&gt;âž¤ type of lipid storage disease&lt;/li&gt;&lt;li&gt;âž¤ individuals of Ashkenazi Jewish descent&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 635, Lewis, pp 82-86. Scriver, pp 3827-3876.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan  9/e: p 635, Lewis, pp 82-86. Scriver, pp 3827-3876.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A couple has been seeking infertility treatment after 10 years of marriage. The wife&#x27;s examination shows no significant findings. However, the husband has a history of bronchiectasis, situs inversus since childhood, and recurrent sinusitis. Further investigation reveals that he is sterile. What is the most likely cause of his infertility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abnormal structure of cilia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abnormal levels of sphingomyelinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;fibrillin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;47, XXY karyotype&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Abnormal structure of cilia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Abnormal structure of cilia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Abnormal levels of sphingomyelinase: Sphingomyelinase deficiency results in Niemann-Pick disease ðŸ¡ª accumulation of Sphingomyelin in the phagocytes (Foam histocytes ) â†’ deposit in the liver, spleen, lymph nodes, and skin.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Abnormal levels of sphingomyelinase:&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ (Foam histocytes&lt;/li&gt;&lt;li&gt;â€¢ C/F: hepatosplenomegaly, neurologic deterioration and no survival beyond 3 years of age.&lt;/li&gt;&lt;li&gt;â€¢ C/F:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibrillin deficiency: Results in Marfan syndrome . C/F: Patients look tall and thin, arachnodactyly, ectopia lentis and aortic dilation leading to aortic aneurysm.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibrillin deficiency:&lt;/li&gt;&lt;li&gt;â€¢ Marfan syndrome&lt;/li&gt;&lt;li&gt;â€¢ C/F:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 47, XXY karyotype: Seen in Klinefelter syndrome , characterized by male hypogonadism causing male infertility (as given in the case), atrophic testes, tall stature, gynecomastia, and mental retardation (Other features are not suggestive of the diagnosis).&lt;/li&gt;&lt;li&gt;â€¢ Option D. 47, XXY karyotype:&lt;/li&gt;&lt;li&gt;â€¢ Klinefelter syndrome&lt;/li&gt;&lt;li&gt;â€¢ characterized&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ Kartagener&#x27;s syndrome , which is a subset of primary ciliary dyskinesia . This condition is characterized by a triad of situs inversus , chronic sinusitis , and bronchiectasis . It is caused by defects in the structure and function of ciliary motility, which affects not only respiratory cilia but also the cilia within the reproductive tract, leading to infertility due to impaired sperm motility.&lt;/li&gt;&lt;li&gt;â€¢ Kartagener&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ subset of primary ciliary dyskinesia&lt;/li&gt;&lt;li&gt;â€¢ triad of situs inversus&lt;/li&gt;&lt;li&gt;â€¢ chronic sinusitis&lt;/li&gt;&lt;li&gt;â€¢ bronchiectasis&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e:  p 665.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Harper 30/e:  p 665.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sickle cell anemia is characterized by a mutation in the Î²-globin gene, resulting in the substitution of glutamic acid with valine at the sixth position of the Î²-globin chain. What mechanism most likely underlies this specific genetic alteration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Unequal Crossing over&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Two-base insertion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Three-base deletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Single-base substitution (point mutation)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Single-base substitution (point mutation)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Single-base substitution (point mutation)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Equal exchange (crossing over) among homologous Î²-globin genes could exchange alleles, by replacing normal alleles with mutant partners, or vice versa (converting heterozygosity to homozygosity). Unequal crossing over could generate mutant alleles with duplicated or deficient nucleotides but not substitution.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Equal exchange&lt;/li&gt;&lt;li&gt;â€¢ (crossing over)&lt;/li&gt;&lt;li&gt;â€¢ homologous Î²-globin genes&lt;/li&gt;&lt;li&gt;â€¢ exchange alleles,&lt;/li&gt;&lt;li&gt;â€¢ replacing normal alleles&lt;/li&gt;&lt;li&gt;â€¢ mutant partners,&lt;/li&gt;&lt;li&gt;â€¢ Option (B, C): One or two-base insertions changes the reading frame of the genetic code (frame-shift mutation) and usually produces a termination codon (chain-termination mutation) after the point of insertion. A three-base deletion will cause a deletion of an amino acid from protein and not substitution.&lt;/li&gt;&lt;li&gt;â€¢ Option (B, C):&lt;/li&gt;&lt;li&gt;â€¢ One or two-base insertions&lt;/li&gt;&lt;li&gt;â€¢ reading frame&lt;/li&gt;&lt;li&gt;â€¢ genetic code&lt;/li&gt;&lt;li&gt;â€¢ (frame-shift mutation)&lt;/li&gt;&lt;li&gt;â€¢ produces a termination codon&lt;/li&gt;&lt;li&gt;â€¢ (chain-termination mutation)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ Sickle cell anemia is caused by a single-base substitution in the Î²-globin gene, where adenine is replaced by thymine . This point mutation leads to the change from glutamic acid to valine at the sixth amino acid position in the Î²-globin chain, which significantly alters the hemoglobin&#x27;s properties and leads to the characteristic sickling of red blood cells under low oxygen conditions.&lt;/li&gt;&lt;li&gt;â€¢ Sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ single-base substitution&lt;/li&gt;&lt;li&gt;â€¢ Î²-globin gene,&lt;/li&gt;&lt;li&gt;â€¢ adenine is replaced by thymine&lt;/li&gt;&lt;li&gt;â€¢ point mutation&lt;/li&gt;&lt;li&gt;â€¢ change from glutamic acid&lt;/li&gt;&lt;li&gt;â€¢ valine&lt;/li&gt;&lt;li&gt;â€¢ sixth amino acid position&lt;/li&gt;&lt;li&gt;â€¢ Î²-globin chain,&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin&#x27;s properties&lt;/li&gt;&lt;li&gt;â€¢ Ref : DM Vasudevan 9/e: p 635&lt;/li&gt;&lt;li&gt;â€¢ Ref : DM Vasudevan 9/e: p 635&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the listed eukaryotic promoter/regulatory elements, which one exhibits the greatest variability in position relative to the transcription start site?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Downstream promoter element (DPE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enhancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiator sequence&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Operator&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Enhancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Enhancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Downstream promoter element (DPE): The DPE is located relatively close to the core promoter , usually within about 30 base pairs downstream of the transcription start site, and its position is not as variable as that of enhancers.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Downstream promoter element (DPE):&lt;/li&gt;&lt;li&gt;â€¢ located relatively close&lt;/li&gt;&lt;li&gt;â€¢ core promoter&lt;/li&gt;&lt;li&gt;â€¢ within about 30 base pairs downstream&lt;/li&gt;&lt;li&gt;â€¢ Option C. Initiator sequence: The initiator (Inr) sequence is a core promoter element that is located precisely at the transcription start site and serves as a binding site for transcription factors and RNA polymerase II.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Initiator sequence:&lt;/li&gt;&lt;li&gt;â€¢ core promoter element&lt;/li&gt;&lt;li&gt;â€¢ transcription start site&lt;/li&gt;&lt;li&gt;â€¢ Option D. Operator: Operators are DNA sequences that interact with repressors to control the transcription of adjacent genes , mainly in prokaryotes . In eukaryotes, similar regulatory elements are part of the promoter or enhancers but are not typically referred to as operators.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. Operator:&lt;/li&gt;&lt;li&gt;â€¢ DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ repressors&lt;/li&gt;&lt;li&gt;â€¢ control the transcription&lt;/li&gt;&lt;li&gt;â€¢ adjacent genes&lt;/li&gt;&lt;li&gt;â€¢ prokaryotes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Eukaryotic promoters are much more complex than bacterial promoters . The most common bacterial promoter elements are the â€“10 and â€“35 sequences , which are the recognition sites for RNA polymerase binding. In addition, the bacterial promoters may have operators (repressor binding sites) and activator binding sites . Eukaryotic promoters have a core region that may contain a TATA box (which is bound by TBP, the TATA binding protein), an initiator sequence , and downstream promoter elements . In addition, eukaryotic promoters have upstream elements such as GC boxes and CCAAT boxes which bind specific transcription factors (Sp1 and CTF, respectively). Enhancers are elements that increase or enhance the rate of transcription initiation from a promoter . Enhancers can be upstream or downstream of the transcription start site and can exert their effect from hundreds or thousands of bases away and also they are orientation-independent (ie, whether their recognition sequence is on the Watson or Crick strand).&lt;/li&gt;&lt;li&gt;âž¤ Eukaryotic promoters are much more complex than bacterial promoters .&lt;/li&gt;&lt;li&gt;âž¤ Eukaryotic promoters&lt;/li&gt;&lt;li&gt;âž¤ complex than bacterial promoters&lt;/li&gt;&lt;li&gt;âž¤ The most common bacterial promoter elements are the â€“10 and â€“35 sequences , which are the recognition sites for RNA polymerase binding.&lt;/li&gt;&lt;li&gt;âž¤ common bacterial promoter elements&lt;/li&gt;&lt;li&gt;âž¤ â€“10 and â€“35 sequences&lt;/li&gt;&lt;li&gt;âž¤ In addition, the bacterial promoters may have operators (repressor binding sites) and activator binding sites .&lt;/li&gt;&lt;li&gt;âž¤ bacterial promoters&lt;/li&gt;&lt;li&gt;âž¤ operators&lt;/li&gt;&lt;li&gt;âž¤ activator binding sites&lt;/li&gt;&lt;li&gt;âž¤ Eukaryotic promoters have a core region that may contain a TATA box (which is bound by TBP, the TATA binding protein), an initiator sequence , and downstream promoter elements .&lt;/li&gt;&lt;li&gt;âž¤ Eukaryotic promoters&lt;/li&gt;&lt;li&gt;âž¤ core region&lt;/li&gt;&lt;li&gt;âž¤ TATA box&lt;/li&gt;&lt;li&gt;âž¤ initiator sequence&lt;/li&gt;&lt;li&gt;âž¤ downstream promoter elements&lt;/li&gt;&lt;li&gt;âž¤ In addition, eukaryotic promoters have upstream elements such as GC boxes and CCAAT boxes which bind specific transcription factors (Sp1 and CTF, respectively).&lt;/li&gt;&lt;li&gt;âž¤ eukaryotic promoters&lt;/li&gt;&lt;li&gt;âž¤ upstream elements&lt;/li&gt;&lt;li&gt;âž¤ Enhancers are elements that increase or enhance the rate of transcription initiation from a promoter . Enhancers can be upstream or downstream of the transcription start site and can exert their effect from hundreds or thousands of bases away and also they are orientation-independent (ie, whether their recognition sequence is on the Watson or Crick strand).&lt;/li&gt;&lt;li&gt;âž¤ Enhancers are elements&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ rate of transcription initiation&lt;/li&gt;&lt;li&gt;âž¤ promoter&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 608-610&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 608-610&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinical laboratory employs a cytogenetic technique to visualize chromosomes, aiding in the diagnosis of genetic diseases and anomalies. Given the utility of this technique in various clinical scenarios, which of the following statements is incorrect regarding the capabilities of the cytogenetic technique displayed in the image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Can diagnose Cri du chat disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Can diagnose Philadelphia chromosome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Can be used to detect molecular defects eg: point mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unknown chromosomal anomaly can be detected&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Can be used to detect molecular defects eg: point mutation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/75.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Can be used to detect molecular defects eg: point mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Can diagnose Cri du chat disease - CORRECT statement.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Can diagnose Cri du chat disease&lt;/li&gt;&lt;li&gt;â€¢ Cri du chat syndrome results from a deletion on the short arm of chromosome 5, which would be visible as a structural abnormality on chromosome 5 (light blue in this image). This technique can detect such large chromosomal deletions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Can diagnose Philadelphia chromosome - CORRECT statement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Can diagnose Philadelphia chromosome&lt;/li&gt;&lt;li&gt;â€¢ The Philadelphia chromosome is a reciprocal translocation between chromosomes 9 and 22, which would appear as chromosomes with two different colors in the karyotype. This technique can detect such translocations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Unknown chromosomal anomaly can be detected - CORRECT statement. This technique is designed to identify both numerical (extra or missing chromosomes) and structural (translocations, deletions, duplications) chromosomal abnormalities, even those that haven&#x27;t been previously characterized.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Unknown chromosomal anomaly can be detected -&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cytogenetic techniques like spectral karyotyping detect large structural chromosome abnormalities, not molecular-level mutations like point mutation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 655.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A family with multiple genetic disorders in different members underwent genetic counselling and genetic testing as shown. Which chromosomal anomaly is least likely to be detected by this method, as given in the picture?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Copy number variations&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Microdeletion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Translocations with no loss of genetic element&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amplification&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Translocations with no loss of genetic element&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/76.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Translocations with no loss of genetic element&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Copy number variations : The microarray can detect CNVs, as they result in different signal intensities compared to normal copy numbers.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Copy number variations&lt;/li&gt;&lt;li&gt;â€¢ microarray&lt;/li&gt;&lt;li&gt;â€¢ detect CNVs,&lt;/li&gt;&lt;li&gt;â€¢ Option B: Microdeletion : Microdeletions, which are losses of small DNA segments , cause a reduced signal and are detectable with this microarray technique.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Microdeletion&lt;/li&gt;&lt;li&gt;â€¢ losses of small DNA segments&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amplification : DNA amplifications lead to an increased signal on the microarray and can be easily identified by this method.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amplification&lt;/li&gt;&lt;li&gt;â€¢ increased signal on the microarray&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Microarray CGH (Comparative genomic hybridization)&lt;/li&gt;&lt;li&gt;âž¤ Microarray CGH (Comparative genomic hybridization)&lt;/li&gt;&lt;li&gt;âž¤ Detect Gene Amplification Detect Gene Deletion Detect copy number variations But array CGH will not detect a balanced translocation, without loss of genetic elements as both normal and diseased sample will show no difference in amount of probe attachment and signal amplification.&lt;/li&gt;&lt;li&gt;âž¤ Detect Gene Amplification&lt;/li&gt;&lt;li&gt;âž¤ Detect Gene Amplification&lt;/li&gt;&lt;li&gt;âž¤ Detect Gene Deletion&lt;/li&gt;&lt;li&gt;âž¤ Detect Gene Deletion&lt;/li&gt;&lt;li&gt;âž¤ Detect copy number variations&lt;/li&gt;&lt;li&gt;âž¤ Detect copy number variations&lt;/li&gt;&lt;li&gt;âž¤ But array CGH will not detect a balanced translocation, without loss of genetic elements as both normal and diseased sample will show no difference in amount of probe attachment and signal amplification.&lt;/li&gt;&lt;li&gt;âž¤ But array CGH will not detect a balanced translocation, without loss of genetic elements as both normal and diseased sample will show no difference in amount of probe attachment and signal amplification.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 483-484.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 483-484.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old white woman and a 28-year-old white man are seeking genetic counselling in an Indian metropolitan hospital. They have a family history of cystic fibrosis affecting one of their siblings. Considering their concern about the risk of transmitting this autosomal recessive disorder to their future offspring, which genetic testing method would be most appropriate to assess their carrier status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Biochemical testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluorescence in situ hybridization (FISH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymerase chain reaction (PCR)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Karyotype analysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Polymerase chain reaction (PCR)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Polymerase chain reaction (PCR)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Biochemical testing: used to detect a defective enzyme or a decrease in levels of a normal enzyme . E.g. detects carriers of AR diseases such as Tay-Sachs disease, sickle cell anemia, and thalassemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Biochemical testing:&lt;/li&gt;&lt;li&gt;â€¢ detect a defective enzyme&lt;/li&gt;&lt;li&gt;â€¢ decrease in levels of a normal enzyme&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fluorescence in situ hybridization (FISH): used to detect micro deletions in a gene but canâ€™t detect a single base change.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fluorescence in situ hybridization (FISH):&lt;/li&gt;&lt;li&gt;â€¢ detect micro deletions&lt;/li&gt;&lt;li&gt;â€¢ Option D: Karyotype analysis: used to detect monosomies , trisomy , translocations, inversions, and deletions.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Karyotype analysis:&lt;/li&gt;&lt;li&gt;â€¢ detect monosomies&lt;/li&gt;&lt;li&gt;â€¢ trisomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Polymerase chain reaction (PCR) is the most appropriate method for detecting specific mutations in the CFTR gene associated with cystic fibrosis . PCR can amplify the regions of interest to determine if the couple carries the common mutations causing the disease.&lt;/li&gt;&lt;li&gt;âž¤ Polymerase chain reaction&lt;/li&gt;&lt;li&gt;âž¤ appropriate method&lt;/li&gt;&lt;li&gt;âž¤ detecting specific mutations&lt;/li&gt;&lt;li&gt;âž¤ CFTR gene&lt;/li&gt;&lt;li&gt;âž¤ cystic fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: P 483.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: P 483.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is studying bacterial resistance mechanisms against viral phage infections and focuses on the CRISPR system. In discussing its features, which of the following statements about CRISPR is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clustered Regularly Interspaced Short Palindromic Repeats&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Combines with the Cas nuclease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cleave the DNA of invading phage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Provides no protection to the bacterium from phage infection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Provides no protection to the bacterium from phage infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Provides no protection to the bacterium from phage infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Named for its sequence characteristics: True. The name CRISPR reflects the unique organization of short, partially palindromic repeated DNA sequences found in the genomes of bacteria and archaea.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Named for its sequence characteristics:&lt;/li&gt;&lt;li&gt;â€¢ True.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Works in conjunction with Cas nuclease: True . The CRISPR system functions with Cas proteins, particularly the Cas nuclease, to identify and cut foreign DNA based on RNA sequences derived from previous invasions.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Works in conjunction with Cas nuclease:&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ Option C: Can cleave invading phage DNA: True. The CRISPR-Cas system can specifically target and cleave DNA from invading phages, guided by RNA molecules that match the phage DNA sequences, providing a form of acquired immunity.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Can cleave invading phage DNA: True.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CRISPR/CAS system:&lt;/li&gt;&lt;li&gt;âž¤ CRISPR/CAS system:&lt;/li&gt;&lt;li&gt;âž¤ A prokaryotic immune system conferring resistance to external genes from bacteriophage. This system provides a bacterial version of acquired immunity. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) spacer derived RNA combines with the Cas nuclease to target and specifically cleave the DNA of invading phage, there by inactivating these invading genomes and protecting the bacterium from productive phage infection and lysis.&lt;/li&gt;&lt;li&gt;âž¤ A prokaryotic immune system conferring resistance to external genes from bacteriophage.&lt;/li&gt;&lt;li&gt;âž¤ A prokaryotic immune system conferring resistance to external genes from bacteriophage.&lt;/li&gt;&lt;li&gt;âž¤ prokaryotic immune system&lt;/li&gt;&lt;li&gt;âž¤ resistance to external genes&lt;/li&gt;&lt;li&gt;âž¤ bacteriophage.&lt;/li&gt;&lt;li&gt;âž¤ This system provides a bacterial version of acquired immunity.&lt;/li&gt;&lt;li&gt;âž¤ This system provides a bacterial version of acquired immunity.&lt;/li&gt;&lt;li&gt;âž¤ bacterial version of acquired immunity.&lt;/li&gt;&lt;li&gt;âž¤ CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) spacer derived RNA combines with the Cas nuclease to target and specifically cleave the DNA of invading phage, there by inactivating these invading genomes and protecting the bacterium from productive phage infection and lysis.&lt;/li&gt;&lt;li&gt;âž¤ CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) spacer derived RNA combines with the Cas nuclease to target and specifically cleave the DNA of invading phage, there by inactivating these invading genomes and protecting the bacterium from productive phage infection and lysis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 461&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 461&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male patient with cystic fibrosis has prompted his family members to seek genetic counselling. They were advised to undergo testing for common mutations associated with the disease. The brother&#x27;s DNA was extracted, and the regions of interest in the CFTR gene were amplified using PCR. The DNA polymerase enzyme used in PCR is highly resistant to which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Base&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High Na+ concentration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heat&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Heat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Heat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acid: False. DNA polymerase&#x27;s resistance is not typically characterized by acid resistance , but by its ability to withstand the heat used to denature the DNA strands during PCR.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acid:&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase&#x27;s resistance&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ acid resistance&lt;/li&gt;&lt;li&gt;â€¢ Option B: Base: False. Like acid resistance, base resistance is not a standard characteristic used to describe DNA polymerase in the context of PCR.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Base:&lt;/li&gt;&lt;li&gt;â€¢ base resistance&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ Option C: High Na+ concentration: False. The resistance of DNA polymerase to high sodium ion concentrations is not a key feature; its heat resistance is more relevant to its function in PCR.&lt;/li&gt;&lt;li&gt;â€¢ Option C: High Na+ concentration:&lt;/li&gt;&lt;li&gt;â€¢ resistance of DNA polymerase&lt;/li&gt;&lt;li&gt;â€¢ high sodium ion concentrations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The DNA polymerase used in the Polymerase Chain Reaction (PCR) technique is typically Taq polymerase, which is derived from the thermophilic bacterium Thermus aquaticus. This enzyme is known for its resistance to heat, which allows it to remain stable and functional during the high-temperature denaturation steps of the PCR cycle.&lt;/li&gt;&lt;li&gt;âž¤ DNA polymerase&lt;/li&gt;&lt;li&gt;âž¤ Polymerase Chain Reaction&lt;/li&gt;&lt;li&gt;âž¤ Taq polymerase,&lt;/li&gt;&lt;li&gt;âž¤ thermophilic bacterium Thermus aquaticus.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old boy, who had been receiving a sulphonamide antibiotic as a preventive measure for recurrent urinary tract infections, presents with worsening illness, pallor, and irritability. Laboratory findings reveal severe anemia and jaundice, indicative of hemolysis. Which test is the simplest for diagnosing his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Northern blotting of red blood cell mRNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enzyme assay of red blood cell hemolysate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Western blotting of red blood cell hemolysates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amplification of red blood cell DNA and hybridization with allele-specific oligonucleotides (PCR-ASOs)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Enzyme assay of red blood cell hemolysate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Enzyme assay of red blood cell hemolysate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Northern blotting of red blood cell mRNA is a complex procedure that is not typically used in a clinical setting for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Northern blotting&lt;/li&gt;&lt;li&gt;â€¢ red blood cell mRNA&lt;/li&gt;&lt;li&gt;â€¢ complex procedure&lt;/li&gt;&lt;li&gt;â€¢ Option C: Western blotting of red blood cell hemolysates could theoretically detect the presence of G6PD protein , but it is not a quantitative assay and is more complex than an enzyme activity assay.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Western blotting&lt;/li&gt;&lt;li&gt;â€¢ red blood cell hemolysates&lt;/li&gt;&lt;li&gt;â€¢ detect the presence of G6PD protein&lt;/li&gt;&lt;li&gt;â€¢ Option D: Amplification of red blood cell DNA and hybridization with allele-specific oligonucleotides (PCR-ASOs) is a genetic test that could identify mutations in the G6PD gene but is more complicated and not the first-line test for G6PD deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Amplification of red blood cell DNA&lt;/li&gt;&lt;li&gt;â€¢ hybridization with allele-specific oligonucleotides&lt;/li&gt;&lt;li&gt;â€¢ genetic test&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ G6PD deficiency due to sulphonamide antibiotic use , best diagnosed by a simple enzyme assay of red blood cell hemolysate . Other tests are more complex and less suited for this purpose.&lt;/li&gt;&lt;li&gt;â€¢ G6PD deficiency&lt;/li&gt;&lt;li&gt;â€¢ sulphonamide antibiotic use&lt;/li&gt;&lt;li&gt;â€¢ simple enzyme assay of red blood cell hemolysate&lt;/li&gt;&lt;li&gt;â€¢ Ref : Murray, pp 401-410. Scriver, pp 4517-4554. Lewis, pp 215-218.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Murray, pp 401-410. Scriver, pp 4517-4554. Lewis, pp 215-218.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-day-old female infant is examined with a cleft palate, congenital heart defect, postaxial polydactyly, a scalp defect, and distinctive facial features including hypertelorism. Karyotyping reveals a normal count of 46 chromosomes, but with additional genetic material on one of the chromosome 5 homologs. How is this chromosomal abnormality best categorized?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Polyploidy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Balanced rearrangement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ring formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unbalanced rearrangement&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unbalanced rearrangement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; Option C: These chromosomal abnormalities involves changes in number (i.e., polyploidy and aneuploidy) or changes in structure (i.e., rearrangements such as translocations, rings, and inversions ).&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; Option C:&lt;/li&gt;&lt;li&gt;â€¢ chromosomal abnormalities&lt;/li&gt;&lt;li&gt;â€¢ polyploidy and aneuploidy)&lt;/li&gt;&lt;li&gt;â€¢ translocations, rings, and inversions&lt;/li&gt;&lt;li&gt;â€¢ Option B: The scenario states that all cells examined from the patient (usually 11-25 cells) have the same chromosomal constitution , ruling out mosaicism.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ all cells examined from the patient&lt;/li&gt;&lt;li&gt;â€¢ same chromosomal constitution&lt;/li&gt;&lt;li&gt;â€¢ mosaicism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Extra material on chromosome 5 indicates an unbalanced chromosomal rearrangement, where there is extra genetic material present without a corresponding loss elsewhere. This can lead to a genetic surplus or deficiency, causing developmental and physical abnormalities such as those observed in the infant.&lt;/li&gt;&lt;li&gt;âž¤ Extra material&lt;/li&gt;&lt;li&gt;âž¤ chromosome 5&lt;/li&gt;&lt;li&gt;âž¤ unbalanced chromosomal rearrangement,&lt;/li&gt;&lt;li&gt;âž¤ extra genetic material&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 31/ e: p 877-879.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 31/ e: p 877-879.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of prenatal diagnosis, a geneticist discusses the use of various molecular techniques to detect chromosomal abnormalities. Which of the following statements regarding the suitability of Quantitative Fluorescent PCR (QF-PCR) for detecting aneuploidies is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True, QF-PCR is inappropriate for aneuploidy detection due to a lack of quantitative accuracy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False, QF-PCR is well-suited for aneuploidy detection as it quantitatively amplifies chromosome-specific sequences.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;True, QF-PCR is only qualitative and cannot differentiate between normal and abnormal chromosome numbers.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;False, QF-PCR cannot be used to amplify DNA sequences from chromosomes prone to aneuploidies.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False, QF-PCR is well-suited for aneuploidy detection as it quantitatively amplifies chromosome-specific sequences.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) False, QF-PCR is well-suited for aneuploidy detection as it quantitatively amplifies chromosome-specific sequences.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: This statement is incorrect because QF-PCR is known for its quantitative precision , which is essential for detecting aneuploidy.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ QF-PCR&lt;/li&gt;&lt;li&gt;â€¢ quantitative precision&lt;/li&gt;&lt;li&gt;â€¢ detecting aneuploidy.&lt;/li&gt;&lt;li&gt;â€¢ Option C: This statement is incorrect as QF-PCR is a quantitative method that can accurately determine the copy number of chromosomes , distinguishing between aneuploid and euploid samples.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ QF-PCR&lt;/li&gt;&lt;li&gt;â€¢ quantitative method&lt;/li&gt;&lt;li&gt;â€¢ accurately determine the copy number&lt;/li&gt;&lt;li&gt;â€¢ chromosomes&lt;/li&gt;&lt;li&gt;â€¢ Option D: This statement is incorrect because QF-PCR can and is used to amplify DNA sequences from chromosomes, especially those that are commonly involved in aneuploid conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ QF-PCR&lt;/li&gt;&lt;li&gt;â€¢ amplify DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ chromosomes,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methods to detect aneuploidy&lt;/li&gt;&lt;li&gt;âž¤ Methods to detect aneuploidy&lt;/li&gt;&lt;li&gt;âž¤ Conventional Karyotyping FISH Microarray based CGH Multiple Ligation dependent Probe Amplification (MLPA) Real time PCR Quantitative Fluorescent PCR (QFâ€“PCR) Multiplex amplifiable probe hybridization (MAPH).&lt;/li&gt;&lt;li&gt;âž¤ Conventional Karyotyping&lt;/li&gt;&lt;li&gt;âž¤ FISH&lt;/li&gt;&lt;li&gt;âž¤ Microarray based CGH&lt;/li&gt;&lt;li&gt;âž¤ Multiple Ligation dependent Probe Amplification (MLPA)&lt;/li&gt;&lt;li&gt;âž¤ Real time PCR&lt;/li&gt;&lt;li&gt;âž¤ Quantitative Fluorescent PCR (QFâ€“PCR)&lt;/li&gt;&lt;li&gt;âž¤ Quantitative Fluorescent PCR (QFâ€“PCR)&lt;/li&gt;&lt;li&gt;âž¤ Multiplex amplifiable probe hybridization (MAPH).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biologist is explaining the role of endonucleases in DNA manipulation during a seminar. What is the primary function of endonucleases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cut DNA at specific DNA sequences.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To point out the coding regions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enhancers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To find out antibiotic resistance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cut DNA at specific DNA sequences.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cut DNA at specific DNA sequence.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Endonucleases do not have the function of identifying coding regions; this is determined through gene annotation processes.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Endonucleases&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ function of identifying coding regions;&lt;/li&gt;&lt;li&gt;â€¢ Option C: Enhancers are regulatory DNA sequences , not enzymes, and are involved in increasing the transcription of certain genes.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Enhancers&lt;/li&gt;&lt;li&gt;â€¢ regulatory DNA sequences&lt;/li&gt;&lt;li&gt;â€¢ Option D: The determination of antibiotic resistance is usually done through phenotypic assays or by identifying specific resistance genes, not directly by endonucleases.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ determination of antibiotic resistance&lt;/li&gt;&lt;li&gt;â€¢ done through phenotypic assays&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Endonucleases are enzymes that recognize and cut DNA at specific nucleotide sequences . This cutting can occur within the length of the DNA molecule, unlike exonucleases, which remove nucleotides from the ends of DNA.&lt;/li&gt;&lt;li&gt;âž¤ Endonucleases&lt;/li&gt;&lt;li&gt;âž¤ enzymes&lt;/li&gt;&lt;li&gt;âž¤ recognize and cut DNA at specific nucleotide sequences&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 453.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 453.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a discussion on advanced treatments for genetic disorders, a medical researcher explains the primary goal of gene therapy. What is the main purpose of gene therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Replacement of abnormal gene by normal gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Replacement of normal gene by abnormal gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Knockout of abnormal gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Introduction of viral gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Replacement of abnormal gene by normal gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Replacement of abnormal gene by normal gene.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: The replacement of a normal gene with an abnormal gene is not a therapeutic strategy and would likely lead to disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ replacement of a normal gene&lt;/li&gt;&lt;li&gt;â€¢ abnormal gene&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ therapeutic strategy&lt;/li&gt;&lt;li&gt;â€¢ Option C: While gene knockout techniques are used in research to study gene function, the primary goal of therapeutic gene therapy is often to add a functional gene rather than to knock out the abnormal gene.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ gene knockout techniques&lt;/li&gt;&lt;li&gt;â€¢ research to study gene function,&lt;/li&gt;&lt;li&gt;â€¢ Option D: The introduction of a viral gene is a method used in gene therapy to deliver the therapeutic gene into the patient&#x27;s cells, but the ultimate goal is not to introduce viral genes per se, but to use viral vectors to introduce therapeutic genes.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ introduction of a viral gene&lt;/li&gt;&lt;li&gt;â€¢ gene therapy to deliver the therapeutic gene&lt;/li&gt;&lt;li&gt;â€¢ patient&#x27;s cells,&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gene Therapy is the intracellular delivery of genes to produce a therapeutic effect by correcting an existing abnormality. It is divided into:&lt;/li&gt;&lt;li&gt;âž¤ Gene Therapy is the intracellular delivery of genes to produce a therapeutic effect by correcting an existing abnormality.&lt;/li&gt;&lt;li&gt;âž¤ Gene Therapy&lt;/li&gt;&lt;li&gt;âž¤ It is divided into:&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy - Gene is introduced into somatic cells. Germ cell gene therapy (Transgenic animal).&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy - Gene is introduced into somatic cells.&lt;/li&gt;&lt;li&gt;âž¤ Somatic cell gene therapy&lt;/li&gt;&lt;li&gt;âž¤ Germ cell gene therapy (Transgenic animal).&lt;/li&gt;&lt;li&gt;âž¤ Germ cell gene therapy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 648.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 648.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biology student is learning about the Polymerase Chain Reaction (PCR) and questions why DNA polymerase from Thermus aquaticus (Taq) is preferred over E. coli DNA polymerase. What is the primary reason for this preference?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thermostable at temperature at which DNA liquefies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proofreading done&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Done in more precisely&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Does not require primer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thermostable at temperature at which DNA liquefies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Thermostable at temperature at which DNA liquefies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Proofreading capability: While proofreading is an important feature for some applications, Taq polymerase is actually known for lacking 3&#x27; to 5&#x27; exonuclease proofreading activity , which some other polymerases possess.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Proofreading capability:&lt;/li&gt;&lt;li&gt;â€¢ Taq polymerase&lt;/li&gt;&lt;li&gt;â€¢ lacking 3&#x27; to 5&#x27; exonuclease proofreading activity&lt;/li&gt;&lt;li&gt;â€¢ Option C: Operates more precisely: Precision in PCR is more a function of the reaction conditions and primer design than the choice of polymerase. Taq is chosen for its thermostability, not necessarily for increased precision.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Operates more precisely:&lt;/li&gt;&lt;li&gt;â€¢ Precision&lt;/li&gt;&lt;li&gt;â€¢ PCR&lt;/li&gt;&lt;li&gt;â€¢ more a function of the reaction conditions&lt;/li&gt;&lt;li&gt;â€¢ Option D: Does not require a primer: All DNA polymerases , including Taq , require primers to initiate DNA synthesis . This is not a distinguishing feature of Taq polymerase.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Does not require a primer:&lt;/li&gt;&lt;li&gt;â€¢ DNA polymerases&lt;/li&gt;&lt;li&gt;â€¢ Taq&lt;/li&gt;&lt;li&gt;â€¢ primers to initiate DNA synthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the polymerization step of PCR , new DNA strands are synthesised by the enzyme Taq polymerase, which is derived from bacteria Thermus Acquaticus that are found in hot springs. Hence, the enzyme is not denatured even at high temperature . The polymerase reaction takes place at 72Â°C for 30 seconds in presence of dNTPs (all four deoxyribonucleotide triphosphates). All E. coli DNA pol can only work at room temperature.&lt;/li&gt;&lt;li&gt;âž¤ In the polymerization step of PCR , new DNA strands are synthesised by the enzyme Taq polymerase, which is derived from bacteria Thermus Acquaticus that are found in hot springs.&lt;/li&gt;&lt;li&gt;âž¤ polymerization step of PCR&lt;/li&gt;&lt;li&gt;âž¤ new DNA strands&lt;/li&gt;&lt;li&gt;âž¤ Taq polymerase,&lt;/li&gt;&lt;li&gt;âž¤ bacteria Thermus Acquaticus&lt;/li&gt;&lt;li&gt;âž¤ Hence, the enzyme is not denatured even at high temperature .&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ not denatured&lt;/li&gt;&lt;li&gt;âž¤ high temperature&lt;/li&gt;&lt;li&gt;âž¤ The polymerase reaction takes place at 72Â°C for 30 seconds in presence of dNTPs (all four deoxyribonucleotide triphosphates).&lt;/li&gt;&lt;li&gt;âž¤ polymerase reaction&lt;/li&gt;&lt;li&gt;âž¤ 72Â°C for 30 seconds&lt;/li&gt;&lt;li&gt;âž¤ presence of dNTPs&lt;/li&gt;&lt;li&gt;âž¤ All E. coli DNA pol can only work at room temperature.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 658.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following a positive ELISA screening test for HIV, a patient undergoes a confirmatory Western blot test. For this assay, which component is specifically separated using polyacrylamide gel electrophoresis before being transferred to a membrane for detection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Patient sera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patient plasma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV RNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HIV proteins&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. HIV proteins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) HIV proteins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Patient sera and Option B: Patient plasma: While these are used in the test , they are not separated by the gel . Instead, antibodies in the sera or plasma react with the HIV proteins on the membrane.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Patient sera and Option B: Patient plasma:&lt;/li&gt;&lt;li&gt;â€¢ used in the test&lt;/li&gt;&lt;li&gt;â€¢ not separated by the gel&lt;/li&gt;&lt;li&gt;â€¢ Option C: HIV RNA: This would not be used in a Western blot , which is a protein-detection method . HIV RNA could be detected using techniques like RT-PCR, not Western blot.&lt;/li&gt;&lt;li&gt;â€¢ Option C: HIV RNA:&lt;/li&gt;&lt;li&gt;â€¢ not be used in a Western blot&lt;/li&gt;&lt;li&gt;â€¢ protein-detection method&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a Western blot test for HIV , the components that are separated using polyacrylamide gel electrophoresis and then transferred to a membrane for detection are HIV proteins. These proteins are detected by their reaction with antibodies in the patient&#x27;s serum, confirming the presence of an HIV infection.&lt;/li&gt;&lt;li&gt;âž¤ Western blot test for HIV&lt;/li&gt;&lt;li&gt;âž¤ components that are separated using polyacrylamide gel electrophoresis&lt;/li&gt;&lt;li&gt;âž¤ transferred to a membrane for detection are HIV proteins.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 736.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: 736.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 168 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test7" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Lipids&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Lipids&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                120 Questions | 480 Total Marks | 130 min Duration | ~65.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 26-year-old male is rushed to the emergency department of a tertiary care hospital in India after being bitten by a snake while working in the fields. He has no significant medical history. On examination, he is anxious, with a bite mark visible on his lower right leg. Within hours, he develops hematuria and laboratory tests indicate a rapid deterioration in renal function. The medical team considers the type of enzyme present in the snake venom that might be responsible for these clinical findings. Which enzyme in snake venom is known to cause hematuria and renal function deterioration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phospholipase A1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phospholipase C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phospholipase D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phospholipase A2&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phospholipase A2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture2_9xq831K.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Phospholipase A1 is not typically associated with the clinical effects described.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Phospholipase A1&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ clinical effects described.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Phospholipase C can disrupt cell signaling pathways but is less commonly associated with the acute renal effects seen in snakebite victims.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Phospholipase C&lt;/li&gt;&lt;li&gt;â€¢ disrupt cell signaling pathways&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ acute renal effects&lt;/li&gt;&lt;li&gt;â€¢ snakebite victims.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Phospholipase D affects cell membranes and signaling but is not the primary enzyme responsible for the symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Phospholipase D&lt;/li&gt;&lt;li&gt;â€¢ cell membranes and signaling&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ primary enzyme&lt;/li&gt;&lt;li&gt;â€¢ symptoms&lt;/li&gt;&lt;li&gt;â€¢ described.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phospholipase A2 is an enzyme present in snake venom that can cause a broad range of effects , including hemolysis, platelet aggregation, and muscle damage. It can lead to hematuria and acute kidney injury either by direct renal toxicity or through the effects of hemoglobin and myoglobin breakdown products.&lt;/li&gt;&lt;li&gt;âž¤ Phospholipase A2&lt;/li&gt;&lt;li&gt;âž¤ snake venom&lt;/li&gt;&lt;li&gt;âž¤ broad&lt;/li&gt;&lt;li&gt;âž¤ effects&lt;/li&gt;&lt;li&gt;âž¤ hemolysis, platelet&lt;/li&gt;&lt;li&gt;âž¤ aggregation, and muscle damage.&lt;/li&gt;&lt;li&gt;âž¤ hematuria and acute kidney injury&lt;/li&gt;&lt;li&gt;âž¤ direct renal toxicity&lt;/li&gt;&lt;li&gt;âž¤ hemoglobin and myoglobin breakdown products.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 249, DM Vasudevan  9/e: p 106&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 249, DM Vasudevan  9/e: p 106&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with coronary artery disease (CAD), currently undergoing treatment, is advised to implement lifestyle modifications and monitor his lipid profile quarterly. Among the lipoproteins evaluated, which one is characterized by the lowest lipid-to-protein ratio?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chylomicrons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;VLDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-182641.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Among different HDL particles , percentage of lipids seen will be:&lt;/li&gt;&lt;li&gt;âž¤ different HDL particles&lt;/li&gt;&lt;li&gt;âž¤ percentage of lipids&lt;/li&gt;&lt;li&gt;âž¤ HDL 1 : 65%&lt;/li&gt;&lt;li&gt;âž¤ HDL2  : 67%&lt;/li&gt;&lt;li&gt;âž¤ HDL3  : 43%&lt;/li&gt;&lt;li&gt;âž¤ PreÎ²-HDL : 30&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 478-479, 484.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 478-479, 484.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following diseases is least likely to include neurological symptoms in its classic presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tay-Sachs disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Niemann-Pick disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gaucherâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GM 1 gangliosidoses&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gaucherâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â Gaucherâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tay-Sachs disease : C/F: Neurological Symptoms, Mental retardation. Cherry red spot in the macula. Progressive deterioration No Hepatosplenomegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ Option B: Niemann-Pick disease : C/F:  Severe CNS damage, mental retardation, hepatosplenomegaly, Cherry red spot in macula.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: GM1 gangliosidoses : C/F: Mental retardation, hepatomegaly, skeletal deformities. Angiokeratoma. Cherry red spot in the retina.&lt;/li&gt;&lt;li&gt;â€¢ Option D: GM1 gangliosidoses&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gaucher&#x27;s disease, particularly type 1, which is the most common form, does not usually present with neurological symptoms. This type is known as non-neuronopathic and primarily affects the spleen, liver, and bones.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 260, 261.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician evaluating a 6-month-old girl brought in by her mother. The baby has a history of repeated infections, fever, vomiting, and one seizure episode. There&#x27;s a significant family history: an elder brother passed away at 3 years old from an undiagnosed condition. The baby appears lethargic and hypotonic, with bilateral nystagmus and a cherry red spot visible in both eyes. A blood examination reveals a decreased level of Hexosaminidase A enzyme, prompting the pediatrician to consider a genetic metabolic disorder. What is the most probable diagnosis for this baby?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gaucherâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Niemann Pick disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tay-Sachs disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sandhoff&#x27;s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tay-Sachs disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_8cdDTT6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tay-Sachs disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gaucherâ€™s disease type 1 : Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, no mental retardation, no cherry red spot&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gaucherâ€™s disease type 1&lt;/li&gt;&lt;li&gt;â€¢ Option B: Niemann Pick disease : Due to deficiency of Sphingomyelinase. C/F: Mental retardation, blindness, muscular weakness, hepatosplenomegaly with Cherry red spot in macula. Death by 2 years of age.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Niemann Pick disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sandhoffâ€™s disease : Due to deficiency of Hexosaminidase A and B, c/f: Neurological deficit and MR with cherry red spot.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sandhoffâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs disease is a genetic disorder characterized by the absence or insufficient activity of an enzyme called Hexosaminidase A, leading to the accumulation of GM2 ganglioside within lysosomes, causing progressive neurological damage.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 68,251.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A) : Niemann-Pick disease is a glycogen storage disease characterized by mental retardation, organomegaly, etc. Reasoning (R) : This is due to deficiency of enzyme hexosaminidase A. Choose the appropriate response.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right, but R is not the Correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A and R both are wrong&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease is a sphingolipidoses due to deficiency of the enzyme Sphingomyelinase Lipid accumulating - Sphingomyelin C/F: Enlarged liver and spleen, mental retardation and highly fatal in early life&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease is a sphingolipidoses due to deficiency of the enzyme Sphingomyelinase&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ sphingolipidoses&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ Sphingomyelinase&lt;/li&gt;&lt;li&gt;â€¢ Lipid accumulating - Sphingomyelin&lt;/li&gt;&lt;li&gt;â€¢ Lipid accumulating&lt;/li&gt;&lt;li&gt;â€¢ Sphingomyelin&lt;/li&gt;&lt;li&gt;â€¢ C/F: Enlarged liver and spleen, mental retardation and highly fatal in early life&lt;/li&gt;&lt;li&gt;â€¢ Enlarged liver and spleen, mental retardation&lt;/li&gt;&lt;li&gt;â€¢ fatal in early life&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease is not a glycogen storage disease; a type of lysosomal storage disorder characterized by the accumulation of sphingomyelin due to the deficiency of the enzyme sphingomyelinase . This leads to symptoms such as mental retardation and organomegaly. Hexosaminidase A deficiency, on the other hand, causes Tay-Sachs disease, not Niemann-Pick disease.&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ glycogen storage disease;&lt;/li&gt;&lt;li&gt;â€¢ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;â€¢ accumulation&lt;/li&gt;&lt;li&gt;â€¢ sphingomyelin&lt;/li&gt;&lt;li&gt;â€¢ deficiency of the enzyme sphingomyelinase&lt;/li&gt;&lt;li&gt;â€¢ mental retardation&lt;/li&gt;&lt;li&gt;â€¢ organomegaly. Hexosaminidase A deficiency,&lt;/li&gt;&lt;li&gt;â€¢ other hand,&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e page 251&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Harper 30/e page 251&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman undergoes routine health screening, including a lipid profile, while fasting. Her results show a total cholesterol of 300 mg/dL, HDL cholesterol of 25 mg/dL, and triglycerides of 150 mg/dL. Utilizing the Friedewald equation to assess her cardiovascular risk, what is the LDL cholesterol level in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;245 mg/dl&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;135 mg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;85 mg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;45 mg/dl&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 245 mg/dl&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with coronary artery disease (CAD) is being successfully treated with anti-atherogenic medication that targets PCSK9. Following treatment, his lipid profile normalizes, and his cardiac status improves. What is the primary function of PCSK9?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increasing the synthesis and secretion of VLDL from liver resulting in high LDL levels in the blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inhibiting the binding of apoB to LDL receptor, thereby blocking the lipoprotein uptake and increasing the blood cholesterol levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Preventing the cholesterol breakdown into bile acids in the liver&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decreasing the availability of LDL receptors on the cell surface, resulting in decreased LDL uptake and high blood cholesterol level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding that PCSK9 inhibitors work by preventing PCSK9-mediated degradation of LDL receptors, thereby increasing LDL receptor availability, enhancing LDL cholesterol clearance, and lowering blood cholesterol levels in patients with coronary artery disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 271, 275, 278-279.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the schematic of various lipid structures as shown in below image, which structure(s) do emulsified lipids adopt prior to hydrolysis during digestion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Structure A and C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Structure B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Structure D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Structure E&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Structure E&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture3_qYw1fq3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Structures A and C show lipid bilayers and liposomes , respectively, which are not the forms lipids take prior to hydrolysis in the digestive tract.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Structures A and C&lt;/li&gt;&lt;li&gt;â€¢ lipid bilayers and liposomes&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ prior to hydrolysis&lt;/li&gt;&lt;li&gt;â€¢ Option B: Structure B shows vesicles , which are involved in cellular transport but not in the initial stages of lipid digestion.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Structure B shows vesicles&lt;/li&gt;&lt;li&gt;â€¢ cellular transport&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lipid digestion.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Structure D shows a lipid monolayer , which is more typical of lung surfactants or the tear film than of intestinal lipid digestion.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Structure D shows&lt;/li&gt;&lt;li&gt;â€¢ lipid monolayer&lt;/li&gt;&lt;li&gt;â€¢ more typical of lung surfactants&lt;/li&gt;&lt;li&gt;â€¢ tear film&lt;/li&gt;&lt;li&gt;â€¢ intestinal lipid&lt;/li&gt;&lt;li&gt;â€¢ digestion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During digestion, lipid droplets are emulsified by phospholipids and bile acids in the gut by their detergent action. In micelle hydrophilic glycerol molecules form the outside with hydrophobic fatty acid chains on the inside. Thereby increasing the surface area for the action of hydrolytic lipases&lt;/li&gt;&lt;li&gt;âž¤ During digestion, lipid droplets are emulsified by phospholipids and bile acids in the gut by their detergent action.&lt;/li&gt;&lt;li&gt;âž¤ During digestion,&lt;/li&gt;&lt;li&gt;âž¤ lipid droplets&lt;/li&gt;&lt;li&gt;âž¤ emulsified&lt;/li&gt;&lt;li&gt;âž¤ phospholipids&lt;/li&gt;&lt;li&gt;âž¤ bile acids&lt;/li&gt;&lt;li&gt;âž¤ detergent action.&lt;/li&gt;&lt;li&gt;âž¤ In micelle hydrophilic glycerol molecules form the outside with hydrophobic fatty acid chains on the inside.&lt;/li&gt;&lt;li&gt;âž¤ micelle hydrophilic glycerol molecules&lt;/li&gt;&lt;li&gt;âž¤ outside&lt;/li&gt;&lt;li&gt;âž¤ hydrophobic fatty acid chains&lt;/li&gt;&lt;li&gt;âž¤ Thereby increasing the surface area for the action of hydrolytic lipases&lt;/li&gt;&lt;li&gt;âž¤ increasing the surface area&lt;/li&gt;&lt;li&gt;âž¤ action of hydrolytic lipases&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 479,480&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 479,480&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an experiment, a team of scientists incubates liver cells at 0Â°C and treats them with trypsin to digest surface receptors. The temperature is then increased to 37Â°C, and radioactive LDL is introduced to the culture. Subsequently, the labelled LDL is found inside the liver cells. What is the process responsible for the internalization of LDL called?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Facilitated diffusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pinocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phagocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Receptor-mediated endocytosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Receptor-mediated endocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Facilitated diffusion: Is the transport of low-permeability molecules with the aid of a carrier protein.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Facilitated diffusion:&lt;/li&gt;&lt;li&gt;â€¢ low-permeability molecules&lt;/li&gt;&lt;li&gt;â€¢ carrier protein.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pinocytosis: Uptake of small molecules in solution , is receptor â€“independent.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Pinocytosis:&lt;/li&gt;&lt;li&gt;â€¢ small molecules in solution&lt;/li&gt;&lt;li&gt;â€¢ receptor â€“independent.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phagocytosis: Process by which cells such as macrophages and neutrophils engulf large particles.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phagocytosis:&lt;/li&gt;&lt;li&gt;â€¢ cells&lt;/li&gt;&lt;li&gt;â€¢ macrophages and neutrophils engulf large particles.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Receptor-mediated endocytosis is the specific and efficient mechanism by which LDL is internalized by liver cells, involving the interaction of LDL with cell surface LDL receptors.&lt;/li&gt;&lt;li&gt;âž¤ Receptor-mediated endocytosis&lt;/li&gt;&lt;li&gt;âž¤ specific and efficient&lt;/li&gt;&lt;li&gt;âž¤ LDL is internalized by liver cells,&lt;/li&gt;&lt;li&gt;âž¤ LDL with cell surface LDL receptors.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 257-258.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 257-258.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-day-old male infant, previously healthy, is brought to the emergency department by his mother due to sudden onset of dyspnea followed by loss of consciousness. The infant was born via normal vaginal delivery and had been well until this episode. Tragically, within an hour of arrival, the infant passed away. Laboratory investigations revealed the following critical findings: Blood sugar: 25 mg/dL, indicating profound hypoglycemia. Elevated levels of medium-chain acylcarnitines. Significant presence of dicarboxylic acids in the urine. Based on the clinical presentation and laboratory findings, which of the following is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propionic acidemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LCACDH deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glutaric aciduria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MCAD deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. MCAD deficiency&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/3_9N1ABtU.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Propionic Acidemia - Characterized by the accumulation of propionic acid, this condition typically presents with a metabolic acidosis rather than the specific metabolic derangements seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Propionic Acidemia -&lt;/li&gt;&lt;li&gt;â€¢ accumulation of propionic acid,&lt;/li&gt;&lt;li&gt;â€¢ metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ metabolic derangements&lt;/li&gt;&lt;li&gt;â€¢ Option B: LCACDH Deficiency - This condition affects the metabolism of long-chain fatty acids. The laboratory findings in this infant, however, are indicative of a disorder involving medium-chain fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option B: LCACDH Deficiency -&lt;/li&gt;&lt;li&gt;â€¢ metabolism of long-chain fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ laboratory findings&lt;/li&gt;&lt;li&gt;â€¢ infant,&lt;/li&gt;&lt;li&gt;â€¢ indicative of a disorder&lt;/li&gt;&lt;li&gt;â€¢ medium-chain fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glutaric Aciduria - This metabolic disorder leads to the accumulation of glutaric acid and typically presents with macrocephaly and neurological signs, which were not reported in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Glutaric Aciduria -&lt;/li&gt;&lt;li&gt;â€¢ metabolic disorder&lt;/li&gt;&lt;li&gt;â€¢ glutaric acid&lt;/li&gt;&lt;li&gt;â€¢ macrocephaly and neurological signs,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MCAD deficiency - Key diagnostic markers include hypoglycemia, elevated medium-chain acylcarnitines, and dicarboxylic aciduria.&lt;/li&gt;&lt;li&gt;âž¤ MCAD deficiency&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia, elevated medium-chain acylcarnitines, and dicarboxylic aciduria.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the picture shown to you, which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a basic structure of sphingophospholipids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sphingosine + fatty acid forms sphingomyelin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a basic structure of Glycosphingolipids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There are 2 types of glycolipids â€“ cerebroside &amp;amp; ganglioside&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is a basic structure of Glycosphingolipids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture1_Zrl1GM1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Incorrect because sphingophospholipids have a phosphate group , which is not shown in the picture.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ sphingophospholipids&lt;/li&gt;&lt;li&gt;â€¢ phosphate group&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ picture.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect because sphingomyelin is a type of sphingophospholipid and would include a phosphocholine or phosphoethanolamine group, not shown in the diagram.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ sphingomyelin&lt;/li&gt;&lt;li&gt;â€¢ type of sphingophospholipid&lt;/li&gt;&lt;li&gt;â€¢ phosphocholine&lt;/li&gt;&lt;li&gt;â€¢ phosphoethanolamine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ diagram.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Correct in the classification of glycolipids but not relevant to the structure shown in the image.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Correct&lt;/li&gt;&lt;li&gt;â€¢ classification of glycolipids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ shown in the image.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycosphingolipids (Glycolipids) do not contain phosphoric acid; instead contain carbohydrates and Ceramide ( sphingosine + fatty acid in amide linkage ) Contains 2 major subtypes : Glucocerebroside &amp;amp; Galactocerebroside Sphingomyelins are the only sphingolipid that contain phosphate and have no sugar moiety&lt;/li&gt;&lt;li&gt;âž¤ Glycosphingolipids (Glycolipids) do not contain phosphoric acid; instead contain carbohydrates and Ceramide ( sphingosine + fatty acid in amide linkage )&lt;/li&gt;&lt;li&gt;âž¤ Glycosphingolipids (Glycolipids)&lt;/li&gt;&lt;li&gt;âž¤ do not&lt;/li&gt;&lt;li&gt;âž¤ phosphoric acid;&lt;/li&gt;&lt;li&gt;âž¤ carbohydrates and Ceramide&lt;/li&gt;&lt;li&gt;âž¤ sphingosine + fatty acid&lt;/li&gt;&lt;li&gt;âž¤ amide linkage&lt;/li&gt;&lt;li&gt;âž¤ Contains 2 major subtypes : Glucocerebroside &amp;amp; Galactocerebroside&lt;/li&gt;&lt;li&gt;âž¤ 2 major subtypes&lt;/li&gt;&lt;li&gt;âž¤ Glucocerebroside &amp;amp; Galactocerebroside&lt;/li&gt;&lt;li&gt;âž¤ Sphingomyelins are the only sphingolipid that contain phosphate and have no sugar moiety&lt;/li&gt;&lt;li&gt;âž¤ Sphingomyelins&lt;/li&gt;&lt;li&gt;âž¤ sphingolipid&lt;/li&gt;&lt;li&gt;âž¤ phosphate&lt;/li&gt;&lt;li&gt;âž¤ no sugar moiety&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 250, Vasudevan 9/ed: p 108&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 250, Vasudevan 9/ed: p 108&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a neonatal intensive care unit at a research-focused hospital in India, a preterm newborn is admitted with signs of respiratory distress. The baby&#x27;s mother had a complicated pregnancy, which led to early labor. The neonatologist considers the biochemical aspects that could be contributing to the baby&#x27;s condition, specifically focusing on the surfactant composition in the babyâ€™s lungs. A deficiency in one of the surfactant components is suspected. Which lipid component could be deficient in this preterm newborn, contributing to respiratory distress?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiolipin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dipalmitoyl phosphatidyl choline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphatidyl ethanolamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphatidyl inositol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dipalmitoyl phosphatidyl choline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Cardiolipin: or Di phosphatidylglycerol is a major lipid of mitochondrial membrane and extracted from myocardium. Decreased cardiolipin level results in mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Cardiolipin:&lt;/li&gt;&lt;li&gt;â€¢ Di phosphatidylglycerol&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ myocardium.&lt;/li&gt;&lt;li&gt;â€¢ Decreased cardiolipin level&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial dysfunction, heart failure, hypothyroidism, and myopathies.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phosphatidyl ethanolamine: or Cephalin is found in bio membranes and possess amphipathic properties.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Phosphatidyl ethanolamine:&lt;/li&gt;&lt;li&gt;â€¢ Cephalin&lt;/li&gt;&lt;li&gt;â€¢ bio membranes&lt;/li&gt;&lt;li&gt;â€¢ amphipathic&lt;/li&gt;&lt;li&gt;â€¢ Option D: Phosphatidyl inositol: or PIP2 is present in bio membranes and plays important role in mediation of hormone action on bio membranes and also acts as a second messenger.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Phosphatidyl inositol:&lt;/li&gt;&lt;li&gt;â€¢ PIP2&lt;/li&gt;&lt;li&gt;â€¢ bio membranes&lt;/li&gt;&lt;li&gt;â€¢ mediation of hormone action&lt;/li&gt;&lt;li&gt;â€¢ bio membranes&lt;/li&gt;&lt;li&gt;â€¢ acts as a second messenger.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dipalmitoyl phosphatidylcholine (DPPC) is the major component of lung surfactant , which reduces surface tension in the alveoli, preventing collapse during exhalation . In preterm babies, surfactant production can be insufficient , leading to respiratory distress syndrome (RDS).&lt;/li&gt;&lt;li&gt;âž¤ Dipalmitoyl phosphatidylcholine (DPPC)&lt;/li&gt;&lt;li&gt;âž¤ lung surfactant&lt;/li&gt;&lt;li&gt;âž¤ reduces surface tension&lt;/li&gt;&lt;li&gt;âž¤ alveoli,&lt;/li&gt;&lt;li&gt;âž¤ preventing collapse during exhalation&lt;/li&gt;&lt;li&gt;âž¤ preterm babies,&lt;/li&gt;&lt;li&gt;âž¤ surfactant&lt;/li&gt;&lt;li&gt;âž¤ insufficient&lt;/li&gt;&lt;li&gt;âž¤ respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ syndrome (RDS).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e :  p 216 , Lippincott 7/e : P 204&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e :  p 216 , Lippincott 7/e : P 204&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the relationship between the iodine number of a fat molecule and its degree of unsaturation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase with the increase in degree of unsaturation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decrease with the increase in degree of unsaturation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase with the increase in molecular weight&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increase with the decrease in molecular weight&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increase with the increase in degree of unsaturation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Incorrect because the i odine number actually increases with the degree of unsaturation.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ odine number actually increases&lt;/li&gt;&lt;li&gt;â€¢ degree of unsaturation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Incorrect as the molecular weight does not directly affect the iodine numbe r; it&#x27;s the unsaturation that matters.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ molecular weight&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ iodine numbe&lt;/li&gt;&lt;li&gt;â€¢ unsaturation&lt;/li&gt;&lt;li&gt;â€¢ Option D: Incorrect because the change in molecular weight does not necessarily correlate with iodine absorption; the focus should be on unsaturation.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Incorrect&lt;/li&gt;&lt;li&gt;â€¢ change in molecular weight&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ iodine absorption;&lt;/li&gt;&lt;li&gt;â€¢ unsaturation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iodine number of a fat is defined as the number of grams of iodine taken up by 100 grams of fat. It is an index of the degree of unsaturation and directly proportional to the content of unsaturated fatty acids. So higher the iodine number, higher is the degree of unsaturation , e.g., Iodine number of butter : 28, sunflower oil:130.&lt;/li&gt;&lt;li&gt;âž¤ Iodine number of a fat is defined as the number of grams of iodine taken up by 100 grams of fat.&lt;/li&gt;&lt;li&gt;âž¤ Iodine number&lt;/li&gt;&lt;li&gt;âž¤ fat&lt;/li&gt;&lt;li&gt;âž¤ number of grams of iodine&lt;/li&gt;&lt;li&gt;âž¤ 100 grams of fat.&lt;/li&gt;&lt;li&gt;âž¤ It is an index of the degree of unsaturation and directly proportional to the content of unsaturated fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ index&lt;/li&gt;&lt;li&gt;âž¤ degree of unsaturation and directly proportional&lt;/li&gt;&lt;li&gt;âž¤ unsaturated fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ So higher the iodine number, higher is the degree of unsaturation ,&lt;/li&gt;&lt;li&gt;âž¤ higher the iodine number,&lt;/li&gt;&lt;li&gt;âž¤ higher is the degree of unsaturation&lt;/li&gt;&lt;li&gt;âž¤ e.g., Iodine number of butter : 28, sunflower oil:130.&lt;/li&gt;&lt;li&gt;âž¤ Iodine number of butter : 28,&lt;/li&gt;&lt;li&gt;âž¤ sunflower oil:130.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 104&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 104&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with a family history of ischemic heart disease (IHD) presents to the emergency room with chest pain. After thorough evaluation, including blood tests and ECG, which were found to be normal, she is kept under observation due to her risk factors. Considering her family history and presenting symptoms, the attending physician decides to initiate a preventive treatment regimen. She is prescribed a low dose of Aspirin, a well-known cardio-protective medication, which acts by inhibiting the cyclooxygenase (COX) enzyme. The physician explains the importance of COX in the synthesis of certain molecules from arachidonic acid and how Aspirin&#x27;s action helps in her condition:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thromboxane from arachidonic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leukotrienes from Arachidonic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phospholipids from Arachidonic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arachidonic acid from Linoleic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thromboxane from arachidonic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aspirinâ€™s cardio-protective effect is attributed to its ability to inhibit the COX enzyme , thereby decreasing the production of thromboxane A2 from arachidonic acid. This action reduces platelet aggregation and vasoconstriction, lowering the risk of thrombotic events in patients with a high risk of ischemic heart disease.&lt;/li&gt;&lt;li&gt;âž¤ Aspirinâ€™s cardio-protective&lt;/li&gt;&lt;li&gt;âž¤ its ability&lt;/li&gt;&lt;li&gt;âž¤ inhibit the COX enzyme&lt;/li&gt;&lt;li&gt;âž¤ decreasing&lt;/li&gt;&lt;li&gt;âž¤ thromboxane A2&lt;/li&gt;&lt;li&gt;âž¤ arachidonic acid.&lt;/li&gt;&lt;li&gt;âž¤ reduces platelet aggregation&lt;/li&gt;&lt;li&gt;âž¤ vasoconstriction,&lt;/li&gt;&lt;li&gt;âž¤ lowering&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ thrombotic events&lt;/li&gt;&lt;li&gt;âž¤ high risk of ischemic heart disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 239-240, 720.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 239-240, 720.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old obese woman visits her primary care physician complaining of recurrent episodes of mild epigastric pain and vomiting, particularly after consuming fatty meals. Physical examination reveals tenderness in the epigastric region. Given the patient&#x27;s symptoms and risk factors, the physician suspects a biliary tract disorder and refers her for an abdominal ultrasound, which confirms the presence of gallstones in the gallbladder. One of the stones appears to be lodged in the upper part of the bile duct, potentially impacting bile flow and digestion. A gallstone obstructing the upper part of the bile duct would most likely lead to an increase in which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formation of chylomicrons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Excretion of bile salts &amp;amp; Conjugation of bile acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The excretion of fats in the feces&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recycling of bile salts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The excretion of fats in the feces&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Formation of chylomicrons : Chylomicrons are formed in the intestinal cells to transport absorbed fats , including triglycerides, cholesterol, and fat-soluble vitamins , from the intestines to other parts of the body . Bile duct obstruction does not directly affect chylomicron formation but impacts fat absorption, which indirectly could affect chylomicron content.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Formation of chylomicrons&lt;/li&gt;&lt;li&gt;â€¢ Chylomicrons&lt;/li&gt;&lt;li&gt;â€¢ intestinal cells&lt;/li&gt;&lt;li&gt;â€¢ absorbed fats&lt;/li&gt;&lt;li&gt;â€¢ triglycerides, cholesterol, and fat-soluble vitamins&lt;/li&gt;&lt;li&gt;â€¢ intestines&lt;/li&gt;&lt;li&gt;â€¢ other parts&lt;/li&gt;&lt;li&gt;â€¢ body&lt;/li&gt;&lt;li&gt;â€¢ Bile duct obstruction&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ chylomicron formation&lt;/li&gt;&lt;li&gt;â€¢ fat absorption,&lt;/li&gt;&lt;li&gt;â€¢ indirectly&lt;/li&gt;&lt;li&gt;â€¢ chylomicron&lt;/li&gt;&lt;li&gt;â€¢ Option B: Excretion of bile salts &amp;amp; Conjugation of bile acids : Bile salts and bile acids are involved in the emulsification of fats and are recycled via the enterohepatic circulation. While obstruction can lead to decreased bile flow into the intestine, it primarily affects fat absorption rather than the excretion or conjugation of bile components.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Excretion of bile salts &amp;amp; Conjugation of bile acids&lt;/li&gt;&lt;li&gt;â€¢ emulsification of fats&lt;/li&gt;&lt;li&gt;â€¢ recycled&lt;/li&gt;&lt;li&gt;â€¢ enterohepatic circulation.&lt;/li&gt;&lt;li&gt;â€¢ obstruction&lt;/li&gt;&lt;li&gt;â€¢ decreased bile flow&lt;/li&gt;&lt;li&gt;â€¢ intestine,&lt;/li&gt;&lt;li&gt;â€¢ primarily&lt;/li&gt;&lt;li&gt;â€¢ fat absorption&lt;/li&gt;&lt;li&gt;â€¢ excretion or conjugation&lt;/li&gt;&lt;li&gt;â€¢ bile components.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Recycling of bile salts : The recycling of bile salts is part of the enterohepatic circulation, where bile salts are reabsorbed from the intestines and returned to the liver. A blockage in the bile duct might disrupt this recycling process , but the more immediate effect is on fat absorption and fecal fat excretion.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Recycling of bile salts&lt;/li&gt;&lt;li&gt;â€¢ bile salts&lt;/li&gt;&lt;li&gt;â€¢ enterohepatic circulation,&lt;/li&gt;&lt;li&gt;â€¢ bile salts&lt;/li&gt;&lt;li&gt;â€¢ reabsorbed&lt;/li&gt;&lt;li&gt;â€¢ intestines&lt;/li&gt;&lt;li&gt;â€¢ returned to the liver.&lt;/li&gt;&lt;li&gt;â€¢ blockage&lt;/li&gt;&lt;li&gt;â€¢ bile duct&lt;/li&gt;&lt;li&gt;â€¢ disrupt&lt;/li&gt;&lt;li&gt;â€¢ recycling process&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ immediate effect&lt;/li&gt;&lt;li&gt;â€¢ fat absorption&lt;/li&gt;&lt;li&gt;â€¢ fecal fat excretion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gallstones are made up of cholesterol, calcium bilirubinate and bile salts. All the above given details such as female, middle-aged, and overweight shows the patient has gallbladder disease. FUNCTION : The gallbladder stores bile salts produced by the liver and when it is contracted by the entry of food â†’ bile salts travel through the bile duct to the duodenum â†’ causes emulsification of fats , thereby helping in digestion of fat. When the solutes in the gallbladder precipitate , they form gallstones. Patients may have pain from the gallstones, usually after a fatty meal . The pain sites are epigastric or right upper quadrant, which radiates to the right shoulder . Also, cholecystitis and pancreatitis ( stones â†’ bile duct - &amp;gt; obstruct biliary flow â†’ jaundice or irritate the pancreas ). Obstruction of bile duct â†’ bile salts cannot enter the digestive tract â†’ recycling and excretion of bile salts , digestion of fats and formation of chylomicrons are decreased â†’ fats in the feces are increased (Steatorrhea).&lt;/li&gt;&lt;li&gt;âž¤ Gallstones are made up of cholesterol, calcium bilirubinate and bile salts.&lt;/li&gt;&lt;li&gt;âž¤ Gallstones&lt;/li&gt;&lt;li&gt;âž¤ cholesterol, calcium bilirubinate and bile salts.&lt;/li&gt;&lt;li&gt;âž¤ All the above given details such as female, middle-aged, and overweight shows the patient has gallbladder disease.&lt;/li&gt;&lt;li&gt;âž¤ female, middle-aged, and overweight&lt;/li&gt;&lt;li&gt;âž¤ gallbladder disease.&lt;/li&gt;&lt;li&gt;âž¤ FUNCTION : The gallbladder stores bile salts produced by the liver and when it is contracted by the entry of food â†’ bile salts travel through the bile duct to the duodenum â†’ causes emulsification of fats , thereby helping in digestion of fat.&lt;/li&gt;&lt;li&gt;âž¤ FUNCTION&lt;/li&gt;&lt;li&gt;âž¤ gallbladder stores bile salts&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ contracted&lt;/li&gt;&lt;li&gt;âž¤ entry of food&lt;/li&gt;&lt;li&gt;âž¤ bile&lt;/li&gt;&lt;li&gt;âž¤ salts&lt;/li&gt;&lt;li&gt;âž¤ bile duct to the duodenum&lt;/li&gt;&lt;li&gt;âž¤ emulsification of fats&lt;/li&gt;&lt;li&gt;âž¤ digestion of fat.&lt;/li&gt;&lt;li&gt;âž¤ When the solutes in the gallbladder precipitate , they form gallstones.&lt;/li&gt;&lt;li&gt;âž¤ solutes&lt;/li&gt;&lt;li&gt;âž¤ gallbladder precipitate&lt;/li&gt;&lt;li&gt;âž¤ gallstones.&lt;/li&gt;&lt;li&gt;âž¤ Patients may have pain from the gallstones, usually after a fatty meal . The pain sites are epigastric or right upper quadrant, which radiates to the right shoulder . Also, cholecystitis and pancreatitis ( stones â†’ bile duct - &amp;gt; obstruct biliary flow â†’ jaundice or irritate the pancreas ).&lt;/li&gt;&lt;li&gt;âž¤ pain&lt;/li&gt;&lt;li&gt;âž¤ gallstones,&lt;/li&gt;&lt;li&gt;âž¤ fatty meal&lt;/li&gt;&lt;li&gt;âž¤ pain&lt;/li&gt;&lt;li&gt;âž¤ epigastric or right upper&lt;/li&gt;&lt;li&gt;âž¤ quadrant,&lt;/li&gt;&lt;li&gt;âž¤ radiates to the right shoulder&lt;/li&gt;&lt;li&gt;âž¤ cholecystitis and pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ stones â†’ bile duct&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;&lt;/li&gt;&lt;li&gt;âž¤ obstruct biliary flow&lt;/li&gt;&lt;li&gt;âž¤ jaundice or irritate&lt;/li&gt;&lt;li&gt;âž¤ pancreas&lt;/li&gt;&lt;li&gt;âž¤ Obstruction of bile duct â†’ bile salts cannot enter the digestive tract â†’ recycling and excretion of bile salts , digestion of fats and formation of chylomicrons are decreased â†’ fats in the feces are increased (Steatorrhea).&lt;/li&gt;&lt;li&gt;âž¤ Obstruction&lt;/li&gt;&lt;li&gt;âž¤ bile duct&lt;/li&gt;&lt;li&gt;âž¤ bile salts cannot&lt;/li&gt;&lt;li&gt;âž¤ digestive tract&lt;/li&gt;&lt;li&gt;âž¤ recycling and excretion&lt;/li&gt;&lt;li&gt;âž¤ bile salts&lt;/li&gt;&lt;li&gt;âž¤ digestion&lt;/li&gt;&lt;li&gt;âž¤ fats&lt;/li&gt;&lt;li&gt;âž¤ chylomicrons are decreased&lt;/li&gt;&lt;li&gt;âž¤ fats&lt;/li&gt;&lt;li&gt;âž¤ feces&lt;/li&gt;&lt;li&gt;âž¤ increased (Steatorrhea).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 255-257, 149-150.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 255-257, 149-150.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Hypoglycaemia is common in preterm neonates. Reasoning (R): Carnitine deficiency is seen in preterm infants, who have impaired fatty acid oxidation causing more glucose utilization.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A as well as R are right and R is a correct explanation of A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carnitine deficiency is noted in preterm infants , in whom impaired fatty acid oxidation are seen. So more glucose is utilized, resulting in recurrent episodes of hypoglycaemia&lt;/li&gt;&lt;li&gt;âž¤ Carnitine deficiency&lt;/li&gt;&lt;li&gt;âž¤ preterm infants&lt;/li&gt;&lt;li&gt;âž¤ impaired fatty acid oxidation&lt;/li&gt;&lt;li&gt;âž¤ more glucose&lt;/li&gt;&lt;li&gt;âž¤ recurrent episodes of hypoglycaemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 202&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 202&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the given diagram:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liposome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lipid Bilayer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Micelle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aquasome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Liposome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture4_WCNZEse.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture5_X4GK80P.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A medical researcher is exploring the immunological properties of different phospholipids. During a study designed to understand the role of phospholipids in autoimmune disorders, they isolate various phospholipids from cell membranes and assess their potential antigenic properties. Which of the following phospholipids possesses antigenic properties?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Plasmalogens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiolipin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphatidylinositol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lecithin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cardiolipin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Plasmalogens are found in bio membranes in brain and muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Plasmalogens&lt;/li&gt;&lt;li&gt;â€¢ bio membranes in brain and muscle.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phosphatidylinositol acts as a second messenger and plays a vital role in the mediation of hormone action on bio membranes.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Phosphatidylinositol&lt;/li&gt;&lt;li&gt;â€¢ second messenger&lt;/li&gt;&lt;li&gt;â€¢ mediation of hormone&lt;/li&gt;&lt;li&gt;â€¢ Option D: Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline is the most abundant phospholipid of cell membrane, largest body store of choline and a major constituent of lung surfactant .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Dipalmitoyl Lecithin / Di Palmitoyl Phosphatidyl Choline&lt;/li&gt;&lt;li&gt;â€¢ abundant phospholipid of cell membrane,&lt;/li&gt;&lt;li&gt;â€¢ body store of choline&lt;/li&gt;&lt;li&gt;â€¢ lung surfactant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiolipin is a phospholipid that has antigenic properties and can be involved in autoimmune responses , such as in the case of anti-phospholipid syndrome. It is commonly associated with syphilis, where it is the reactive agent in the Wassermann test, and with lupus, where it is targeted by anti-cardiolipin antibodies.&lt;/li&gt;&lt;li&gt;âž¤ Cardiolipin&lt;/li&gt;&lt;li&gt;âž¤ phospholipid&lt;/li&gt;&lt;li&gt;âž¤ antigenic properties&lt;/li&gt;&lt;li&gt;âž¤ autoimmune responses&lt;/li&gt;&lt;li&gt;âž¤ anti-phospholipid syndrome.&lt;/li&gt;&lt;li&gt;âž¤ syphilis,&lt;/li&gt;&lt;li&gt;âž¤ reactive agent&lt;/li&gt;&lt;li&gt;âž¤ Wassermann test,&lt;/li&gt;&lt;li&gt;âž¤ lupus,&lt;/li&gt;&lt;li&gt;âž¤ anti-cardiolipin antibodies.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 108&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 108&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonatologist is called to attend to a 36-week preterm neonate experiencing respiratory distress. The baby shows increased respiratory rate, chest wall retraction, cyanosis, pallor, and his condition deteriorates despite oxygen support. The Chest X ray findings is shown below. Which of the following lecithin-sphingomyelin (LS) ratios in amniotic fluid indicates full lung maturity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_jehyIDJ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: An LS ratio of 0.5 indicates significant immaturity of the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ LS ratio of 0.5 indicates&lt;/li&gt;&lt;li&gt;â€¢ immaturity of the lungs.&lt;/li&gt;&lt;li&gt;â€¢ Option B: An LS ratio of 1 is borderline ; however, it does not assure full lung maturity.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ LS ratio of 1&lt;/li&gt;&lt;li&gt;â€¢ borderline&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ full lung maturity.&lt;/li&gt;&lt;li&gt;â€¢ Option C: An LS ratio of 1.5 is approaching maturity but is not the threshold for full maturity.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ LS ratio of 1.5&lt;/li&gt;&lt;li&gt;â€¢ approaching maturity&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ full maturity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An LS ratio of 2 or greater in amniotic fluid is generally considered indicative of full lung maturity . This suggests sufficient surfactant production to lower surface tension in the alveoli, reducing the risk of alveolar collapse and RDS.&lt;/li&gt;&lt;li&gt;âž¤ LS ratio of 2&lt;/li&gt;&lt;li&gt;âž¤ greater in amniotic fluid&lt;/li&gt;&lt;li&gt;âž¤ full lung maturity&lt;/li&gt;&lt;li&gt;âž¤ suggests&lt;/li&gt;&lt;li&gt;âž¤ surfactant&lt;/li&gt;&lt;li&gt;âž¤ production to lower surface tension&lt;/li&gt;&lt;li&gt;âž¤ alveoli,&lt;/li&gt;&lt;li&gt;âž¤ reducing&lt;/li&gt;&lt;li&gt;âž¤ risk of alveolar collapse and RDS.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 106.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 106.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A general practitioner examines a 5-year-old boy who has been brought in due to concerns about his slow development and physical health. The child has noticeable abdominal swelling and a history of unsteady gait leading to frequent falls. Recently, he experienced a convulsive episode that prompted this visit. Clinical examination reveals significant hepatosplenomegaly. Laboratory investigations, including a bone marrow biopsy, show lipid-laden foam histiocytes, and an enzyme assay indicates sphingomyelinase deficiency in the child&#x27;s white blood cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gaucherâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Niemann Pick disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tay-Sachs disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sandhoffs disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Niemann Pick disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gaucherâ€™s disease type 1: Due to deficiency of beta-glucocerebrosidase, C/F: Enlarged liver and spleen, erosion of long bones, mental retardation in infants but no cherry red spot&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gaucherâ€™s disease type 1:&lt;/li&gt;&lt;li&gt;â€¢ deficiency of beta-glucocerebrosidase,&lt;/li&gt;&lt;li&gt;â€¢ Enlarged liver and spleen, erosion of long&lt;/li&gt;&lt;li&gt;â€¢ bones, mental retardation&lt;/li&gt;&lt;li&gt;â€¢ no cherry red spot&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tay-Sachs disease: Due to deficiency of enzyme Hexosaminidase Options A. C/F: Mental retardation, Cherry red spot in the macula and progressive deterioration.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Tay-Sachs disease:&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ Hexosaminidase&lt;/li&gt;&lt;li&gt;â€¢ Options A.&lt;/li&gt;&lt;li&gt;â€¢ Mental retardation, Cherry red spot&lt;/li&gt;&lt;li&gt;â€¢ macula and progressive deterioration.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sandhoffâ€™s disease: Due to deficiency of Hexosaminidase Options A and Options  B , c/f: Neurological deficit and MR with cherry red spot.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Sandhoffâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ deficiency of Hexosaminidase Options A&lt;/li&gt;&lt;li&gt;â€¢ Options  B&lt;/li&gt;&lt;li&gt;â€¢ Neurological deficit and MR&lt;/li&gt;&lt;li&gt;â€¢ cherry red spot.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Niemann-Pick disease is associated with sphingomyelinase deficiency , leading to the accumulation of sphingomyelin in cells and tissues . The child&#x27;s symptoms, including developmental delay, hepatosplenomegaly, difficulty walking, falls, seizures, and findings of lipid-laden foam histiocytes on bone marrow biopsy, are characteristic of this disorder.&lt;/li&gt;&lt;li&gt;âž¤ Niemann-Pick disease&lt;/li&gt;&lt;li&gt;âž¤ sphingomyelinase deficiency&lt;/li&gt;&lt;li&gt;âž¤ sphingomyelin in cells&lt;/li&gt;&lt;li&gt;âž¤ tissues&lt;/li&gt;&lt;li&gt;âž¤ developmental delay, hepatosplenomegaly,&lt;/li&gt;&lt;li&gt;âž¤ difficulty walking,&lt;/li&gt;&lt;li&gt;âž¤ falls, seizures,&lt;/li&gt;&lt;li&gt;âž¤ lipid-laden foam histiocytes&lt;/li&gt;&lt;li&gt;âž¤ bone marrow&lt;/li&gt;&lt;li&gt;âž¤ biopsy,&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 68,251.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 68,251.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the enzyme deficiencies is correctly matched with its disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fabry-alpha galactosidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gaucher-alpha glucosidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cystic fibrosis-glucuronidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic bronchitis-alpha I antitrypsin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fabry-alpha galactosidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-164752.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gaucherâ€™s d/s - due to deficiency of Glucocerebrosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Gaucherâ€™s d/s&lt;/li&gt;&lt;li&gt;â€¢ deficiency of Glucocerebrosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Cystic fibrosis - a point mutation in CFTR gene results in defective chloride transport.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Cystic fibrosis&lt;/li&gt;&lt;li&gt;â€¢ CFTR gene&lt;/li&gt;&lt;li&gt;â€¢ defective&lt;/li&gt;&lt;li&gt;â€¢ chloride transport.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Chronic bronchitis might result from exposure to acid fumes, Nitrogen dioxide, Sulphur dioxide etc.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Chronic bronchitis&lt;/li&gt;&lt;li&gt;â€¢ acid fumes, Nitrogen dioxide, Sulphur dioxide etc.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed, pg 193&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed, pg 193&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Metachromatic leukodystrophy is a glycogen storage disease characterized by mental retardation, organomegaly, etc. Reasoning (R): This is due to deficiency of enzyme hexosaminidase A. Select the correct option:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the Correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A and R both are wrong&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. A and R both are wrong&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A) is wrong because Metachromatic Leukodystrophy (MLD) is not a glycogen storage disease . It is a lysosomal storage disorder that belongs to the group of sphingolipidoses , caused by a deficiency in the enzyme arylsulfatase A . This leads to the accumulation of sulfatides , particularly sulfogalactocerebroside , resulting in demyelination of white matter , particularly in the central and peripheral nervous systems.&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A) is wrong&lt;/li&gt;&lt;li&gt;â€¢ Metachromatic Leukodystrophy (MLD)&lt;/li&gt;&lt;li&gt;â€¢ not a glycogen storage disease&lt;/li&gt;&lt;li&gt;â€¢ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;â€¢ sphingolipidoses&lt;/li&gt;&lt;li&gt;â€¢ arylsulfatase A&lt;/li&gt;&lt;li&gt;â€¢ accumulation of sulfatides&lt;/li&gt;&lt;li&gt;â€¢ sulfogalactocerebroside&lt;/li&gt;&lt;li&gt;â€¢ demyelination of white matter&lt;/li&gt;&lt;li&gt;â€¢ Clinical features of MLD include:&lt;/li&gt;&lt;li&gt;â€¢ Progressive neurological deterioration Behavioral changes , motor regression Demyelination , often leading to spasticity and paralysis&lt;/li&gt;&lt;li&gt;â€¢ Progressive neurological deterioration&lt;/li&gt;&lt;li&gt;â€¢ neurological deterioration&lt;/li&gt;&lt;li&gt;â€¢ Behavioral changes , motor regression&lt;/li&gt;&lt;li&gt;â€¢ Behavioral changes&lt;/li&gt;&lt;li&gt;â€¢ motor regression&lt;/li&gt;&lt;li&gt;â€¢ Demyelination , often leading to spasticity and paralysis&lt;/li&gt;&lt;li&gt;â€¢ Demyelination&lt;/li&gt;&lt;li&gt;â€¢ Reason (R) is also wrong because hexosaminidase A deficiency is the cause of Tay-Sachs disease , not MLD.&lt;/li&gt;&lt;li&gt;â€¢ Reason (R) is also wrong&lt;/li&gt;&lt;li&gt;â€¢ hexosaminidase A deficiency&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs is another lysosomal storage disorder , characterized by accumulation of GM2 gangliosides due to hexosaminidase A deficiency. It presents with progressive neurodegeneration , cherry-red spot in macula , and no hepatosplenomegaly .&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs is another lysosomal storage disorder , characterized by accumulation of GM2 gangliosides due to hexosaminidase A deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs&lt;/li&gt;&lt;li&gt;â€¢ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;â€¢ accumulation of GM2 gangliosides&lt;/li&gt;&lt;li&gt;â€¢ It presents with progressive neurodegeneration , cherry-red spot in macula , and no hepatosplenomegaly .&lt;/li&gt;&lt;li&gt;â€¢ progressive neurodegeneration&lt;/li&gt;&lt;li&gt;â€¢ cherry-red spot in macula&lt;/li&gt;&lt;li&gt;â€¢ no hepatosplenomegaly&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MLD : Caused by arylsulfatase A deficiency , leading to sulfatide accumulation , affects myelin, results in leukodystrophy . Tay-Sachs : Caused by hexosaminidase A deficiency , results in ganglioside accumulation , primarily a neurodegenerative condition without organ enlargement.&lt;/li&gt;&lt;li&gt;âž¤ MLD : Caused by arylsulfatase A deficiency , leading to sulfatide accumulation , affects myelin, results in leukodystrophy .&lt;/li&gt;&lt;li&gt;âž¤ MLD&lt;/li&gt;&lt;li&gt;âž¤ arylsulfatase A deficiency&lt;/li&gt;&lt;li&gt;âž¤ sulfatide accumulation&lt;/li&gt;&lt;li&gt;âž¤ leukodystrophy&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs : Caused by hexosaminidase A deficiency , results in ganglioside accumulation , primarily a neurodegenerative condition without organ enlargement.&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs&lt;/li&gt;&lt;li&gt;âž¤ hexosaminidase A deficiency&lt;/li&gt;&lt;li&gt;âž¤ ganglioside accumulation&lt;/li&gt;&lt;li&gt;âž¤ neurodegenerative condition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A premature infant is prone to have fatty acid deficiencies. So, the Infantâ€™s parents were advised to feed the baby on formula feeds supplemented with these deficient compounds. Which among the following is a nutritionally EFA with its usual dietary source?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Linoleic acidâ€”plants&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oleic acidâ€”animals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Palmitoleic acidâ€”animals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linolenic acidâ€”animals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Linoleic acidâ€”plants&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Oleic acid is a monounsaturated fatty acid predominantly found in animal fats and oils, olive oil, and other plant oils. It is not classified as essential because the human body can synthesize it .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Oleic acid&lt;/li&gt;&lt;li&gt;â€¢ monounsaturated fatty acid&lt;/li&gt;&lt;li&gt;â€¢ animal fats and oils, olive oil, and other plant oils.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ essential&lt;/li&gt;&lt;li&gt;â€¢ human body can synthesize it&lt;/li&gt;&lt;li&gt;â€¢ Option C: Palmitoleic acid is a monounsaturated fatty acid found in animal fats and some plant oils . Like oleic acid, it is not an essential fatty acid because the body can produce it.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Palmitoleic acid&lt;/li&gt;&lt;li&gt;â€¢ monounsaturated fatty acid&lt;/li&gt;&lt;li&gt;â€¢ animal fats and some plant oils&lt;/li&gt;&lt;li&gt;â€¢ oleic acid,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ essential fatty acid&lt;/li&gt;&lt;li&gt;â€¢ body can produce it.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Linolenic acid , particularly alpha-linolenic acid (ALA ), is an essential fatty acid found in plants, not animals . Sources include flaxseeds, chia seeds, and walnuts. This option is incorrect because it wrongly associates linolenic acid with animal sources .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Linolenic acid&lt;/li&gt;&lt;li&gt;â€¢ alpha-linolenic acid (ALA&lt;/li&gt;&lt;li&gt;â€¢ essential fatty acid found in plants,&lt;/li&gt;&lt;li&gt;â€¢ not animals&lt;/li&gt;&lt;li&gt;â€¢ flaxseeds, chia seeds, and walnuts.&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ wrongly associates linolenic acid with animal sources&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Linoleic and Î±-linolenic acid are nutritionally essential fatty acids , cannot be synthesized by the body and have to be supplied in the diet. They are polyunsaturated fatty acids which cannot be made by most animals but only by plants and are present in good quantities in vegetable oils e.g. sunflower oil Oleic acid (C18, 1 double bond) and palmitoleic acid (C16, 1 double bond) can be produced by introduction of a double bond at the Î”9 position of a saturated fatty acid and are present in human body fat, as well as many vegetable oils. These essential unsaturated fatty acids are required for synthesis of prostaglandin, thromboxane, leukotriene, and lipoxin.&lt;/li&gt;&lt;li&gt;âž¤ Linoleic and Î±-linolenic acid are nutritionally essential fatty acids , cannot be synthesized by the body and have to be supplied in the diet.&lt;/li&gt;&lt;li&gt;âž¤ Linoleic and Î±-linolenic acid&lt;/li&gt;&lt;li&gt;âž¤ essential fatty acids&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ body&lt;/li&gt;&lt;li&gt;âž¤ supplied in the diet.&lt;/li&gt;&lt;li&gt;âž¤ They are polyunsaturated fatty acids which cannot be made by most animals but only by plants and are present in good quantities in vegetable oils e.g. sunflower oil&lt;/li&gt;&lt;li&gt;âž¤ polyunsaturated fatty acids&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ animals&lt;/li&gt;&lt;li&gt;âž¤ plants&lt;/li&gt;&lt;li&gt;âž¤ present in good&lt;/li&gt;&lt;li&gt;âž¤ quantities&lt;/li&gt;&lt;li&gt;âž¤ vegetable oils e.g. sunflower oil&lt;/li&gt;&lt;li&gt;âž¤ Oleic acid (C18, 1 double bond) and palmitoleic acid (C16, 1 double bond) can be produced by introduction of a double bond at the Î”9 position of a saturated fatty acid and are present in human body fat, as well as many vegetable oils.&lt;/li&gt;&lt;li&gt;âž¤ Oleic acid&lt;/li&gt;&lt;li&gt;âž¤ palmitoleic acid&lt;/li&gt;&lt;li&gt;âž¤ double&lt;/li&gt;&lt;li&gt;âž¤ bond&lt;/li&gt;&lt;li&gt;âž¤ Î”9 position of a saturated fatty acid&lt;/li&gt;&lt;li&gt;âž¤ present in human body fat,&lt;/li&gt;&lt;li&gt;âž¤ vegetable oils.&lt;/li&gt;&lt;li&gt;âž¤ These essential unsaturated fatty acids are required for synthesis of prostaglandin, thromboxane, leukotriene, and lipoxin.&lt;/li&gt;&lt;li&gt;âž¤ essential unsaturated fatty acids&lt;/li&gt;&lt;li&gt;âž¤ synthesis of prostaglandin, thromboxane, leukotriene,&lt;/li&gt;&lt;li&gt;âž¤ lipoxin.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p: 254, Murray p: 223-228.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p: 254, Murray p: 223-228.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Niemann-Pick disease involves the accumulation of a specific phospholipid due to an enzyme deficiency. This phospholipid&#x27;s accumulation occurs at which step in its metabolic pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Step A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Step B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Step C&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Step E&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Step C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/29/image-20230529161958-1.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Step A represents the c onversion of palmitoyl CoA to sphingosine, which is not the site of accumulation in Niemann-Pick disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Step A&lt;/li&gt;&lt;li&gt;â€¢ onversion of palmitoyl CoA to sphingosine,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick&lt;/li&gt;&lt;li&gt;â€¢ disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Step B is the conversion of sphingosine into ceramide; while important in sphingolipid metabolism, it is not the site of blockage in Niemann-Pick disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Step B&lt;/li&gt;&lt;li&gt;â€¢ sphingosine into ceramide;&lt;/li&gt;&lt;li&gt;â€¢ sphingolipid metabolism,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ blockage in Niemann-Pick disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Step E , which shows the conversion of ceramide to gangliosides, is also not the site of the metabolic block in Niemann-Pick disease . However , gangliosides do accumulate in other lysosomal storage disorders , such as GM2 gangliosidoses.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Step E&lt;/li&gt;&lt;li&gt;â€¢ ceramide to gangliosides,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ metabolic block in Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ , gangliosides&lt;/li&gt;&lt;li&gt;â€¢ lysosomal storage disorders&lt;/li&gt;&lt;li&gt;â€¢ GM2 gangliosidoses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Niemann-Pick disease type A and B , there is an accumulation of sphingomyelin due to a deficiency in the enzyme sphingomyelinase. This enzyme is responsible for the breakdown of sphingomyelin into ceramide. In the diagram, \&quot; Step C\&quot; represents the conversion of ceramide into sphingomyelin, which is the s tep before the blockage occurs due to the enzyme deficiency&lt;/li&gt;&lt;li&gt;âž¤ Niemann-Pick disease type A and B&lt;/li&gt;&lt;li&gt;âž¤ sphingomyelin&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ sphingomyelinase.&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ breakdown of sphingomyelin into ceramide.&lt;/li&gt;&lt;li&gt;âž¤ Step C\&quot;&lt;/li&gt;&lt;li&gt;âž¤ conversion of ceramide into sphingomyelin,&lt;/li&gt;&lt;li&gt;âž¤ tep before the blockage&lt;/li&gt;&lt;li&gt;âž¤ enzyme&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 260, 261&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 260, 261&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man presents to the emergency department with an episode of sudden rectal hemorrhage. His medical history is non-specific, but on examination, he is found to have hepatosplenomegaly. A complete blood count reveals thrombocytopenia, and a liver biopsy shows abnormal cells within Glisson&#x27;s capsule. Given these findings, the medical team suspects a lysosomal storage disorder and further diagnostic tests are conducted. Which of the following metabolic disorders is the patient least likely to have, given the clinical findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gaucherâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Niemann Pick disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tay-Sachs disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sandhoff&#x27;s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tay-Sachs disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/1230123.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Tay-Sachs disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease is the least likely diagnosis in this clinical scenario. It is a lysosomal storage disorder , its classic features include:&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ least likely diagnosis&lt;/li&gt;&lt;li&gt;â€¢ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;â€¢ Neurodegeneration Cherry-red spot on the macula Developmental regression No hepatosplenomegaly No thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Neurodegeneration&lt;/li&gt;&lt;li&gt;â€¢ Neurodegeneration&lt;/li&gt;&lt;li&gt;â€¢ Cherry-red spot on the macula&lt;/li&gt;&lt;li&gt;â€¢ Cherry-red spot on the macula&lt;/li&gt;&lt;li&gt;â€¢ Developmental regression&lt;/li&gt;&lt;li&gt;â€¢ Developmental regression&lt;/li&gt;&lt;li&gt;â€¢ No hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ No hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ No thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ No thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ In contrast, this patient has hepatosplenomegaly , thrombocytopenia , and abnormal liver histology , which are not characteristic of Tay-Sachs .&lt;/li&gt;&lt;li&gt;â€¢ hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ abnormal liver histology&lt;/li&gt;&lt;li&gt;â€¢ not characteristic of Tay-Sachs&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gaucherâ€™s disease : Consistent with hepatosplenomegaly and thrombocytopenia Presence of Gaucher cells (lipid-laden macrophages) in liver biopsy Neurological symptoms are absent in Type 1 (non-neuronopathic form), which can occur in adults Option B. Niemann-Pick disease : Can show cherry-red spots , hepatosplenomegaly , and neurologic signs Liver involvement is common Option D. Sandhoffâ€™s disease : Similar to Tay-Sachs but with systemic features including hepatosplenomegaly Cherry-red spot may be seen&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gaucherâ€™s disease : Consistent with hepatosplenomegaly and thrombocytopenia Presence of Gaucher cells (lipid-laden macrophages) in liver biopsy Neurological symptoms are absent in Type 1 (non-neuronopathic form), which can occur in adults&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gaucherâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Consistent with hepatosplenomegaly and thrombocytopenia Presence of Gaucher cells (lipid-laden macrophages) in liver biopsy Neurological symptoms are absent in Type 1 (non-neuronopathic form), which can occur in adults&lt;/li&gt;&lt;li&gt;â€¢ Consistent with hepatosplenomegaly and thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Consistent&lt;/li&gt;&lt;li&gt;â€¢ Presence of Gaucher cells (lipid-laden macrophages) in liver biopsy&lt;/li&gt;&lt;li&gt;â€¢ Gaucher cells&lt;/li&gt;&lt;li&gt;â€¢ Neurological symptoms are absent in Type 1 (non-neuronopathic form), which can occur in adults&lt;/li&gt;&lt;li&gt;â€¢ absent in Type 1&lt;/li&gt;&lt;li&gt;â€¢ Option B. Niemann-Pick disease : Can show cherry-red spots , hepatosplenomegaly , and neurologic signs Liver involvement is common&lt;/li&gt;&lt;li&gt;â€¢ Option B. Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ Can show cherry-red spots , hepatosplenomegaly , and neurologic signs Liver involvement is common&lt;/li&gt;&lt;li&gt;â€¢ Can show cherry-red spots , hepatosplenomegaly , and neurologic signs&lt;/li&gt;&lt;li&gt;â€¢ cherry-red spots&lt;/li&gt;&lt;li&gt;â€¢ hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ neurologic signs&lt;/li&gt;&lt;li&gt;â€¢ Liver involvement is common&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sandhoffâ€™s disease : Similar to Tay-Sachs but with systemic features including hepatosplenomegaly Cherry-red spot may be seen&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sandhoffâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Similar to Tay-Sachs but with systemic features including hepatosplenomegaly Cherry-red spot may be seen&lt;/li&gt;&lt;li&gt;â€¢ Similar to Tay-Sachs but with systemic features including hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ systemic features&lt;/li&gt;&lt;li&gt;â€¢ Cherry-red spot may be seen&lt;/li&gt;&lt;li&gt;â€¢ Cherry-red spot&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate lysosomal storage disorders based on systemic vs. neurological findings:&lt;/li&gt;&lt;li&gt;âž¤ lysosomal storage disorders&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs : Purely neurological , no organomegaly , presents in infancy Gaucherâ€™s disease : Can present with hepatosplenomegaly , thrombocytopenia , and bone involvement , especially in Type 1&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs : Purely neurological , no organomegaly , presents in infancy&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs&lt;/li&gt;&lt;li&gt;âž¤ neurological&lt;/li&gt;&lt;li&gt;âž¤ no organomegaly&lt;/li&gt;&lt;li&gt;âž¤ Gaucherâ€™s disease : Can present with hepatosplenomegaly , thrombocytopenia , and bone involvement , especially in Type 1&lt;/li&gt;&lt;li&gt;âž¤ Gaucherâ€™s disease&lt;/li&gt;&lt;li&gt;âž¤ hepatosplenomegaly&lt;/li&gt;&lt;li&gt;âž¤ thrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ bone involvement&lt;/li&gt;&lt;li&gt;âž¤ Type 1&lt;/li&gt;&lt;li&gt;âž¤ Niemann-Pick and Sandhoff : Share both visceral and neurological features including cherry-red spots&lt;/li&gt;&lt;li&gt;âž¤ Niemann-Pick&lt;/li&gt;&lt;li&gt;âž¤ Sandhoff&lt;/li&gt;&lt;li&gt;âž¤ both visceral and neurological&lt;/li&gt;&lt;li&gt;âž¤ cherry-red spots&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child is brought to the pediatric clinic by his parents, who report that he has been experiencing unusual fatigue, frequent bruising, and episodes of bone pain over the last few months. The child has also been less active than usual, preferring to sit rather than play with his peers. On examination, the pediatrician notes pallor, and palpation reveals an enlarged liver and spleen. A complete blood count confirms anemia and thrombocytopenia. A bone marrow biopsy is performed, and light microscopy of the sample shows cells with a \&quot;crumpled tissue paper\&quot; appearance. Given these findings, which enzyme defect is most likely responsible for this child&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucocerebrosidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sphingomyelinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hexosaminidase A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta-galactosidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucocerebrosidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Sphingomyelinase : Deficiency of sphingomyelinase is associated with Niemann-Pick disease , which also presents with hepatosplenomegaly but typically includes neurological symptoms due to the accumulation of sphingomyelin in neurons, which is not indicated in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Sphingomyelinase&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of sphingomyelinase&lt;/li&gt;&lt;li&gt;â€¢ Niemann-Pick disease&lt;/li&gt;&lt;li&gt;â€¢ presents&lt;/li&gt;&lt;li&gt;â€¢ hepatosplenomegaly&lt;/li&gt;&lt;li&gt;â€¢ neurological symptoms&lt;/li&gt;&lt;li&gt;â€¢ accumulation of sphingomyelin in neurons,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hexosaminidase A : Deficiency in Hexosaminidase A enzyme is related to Tay-Sachs disease, which primarily presents with progressive neurological symptoms due to the accumulation of GM2 ganglioside in the neuronal cells, not the features described in the presented case.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hexosaminidase A&lt;/li&gt;&lt;li&gt;â€¢ Deficiency in Hexosaminidase A enzyme&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease,&lt;/li&gt;&lt;li&gt;â€¢ progressive neurological symptoms&lt;/li&gt;&lt;li&gt;â€¢ GM2 ganglioside&lt;/li&gt;&lt;li&gt;â€¢ neuronal cells,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ presented case.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Beta-galactosidase : A deficiency in this enzyme leads to GM1 gangliosidosis, which includes severe neurological impairment and skeletal abnormalities in its presentation, distinct from the scenario described.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Beta-galactosidase&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ GM1 gangliosidosis,&lt;/li&gt;&lt;li&gt;â€¢ severe neurological&lt;/li&gt;&lt;li&gt;â€¢ impairment and skeletal abnormalities&lt;/li&gt;&lt;li&gt;â€¢ presentation, distinct from&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation of Gaucher&#x27;s disease , a lysosomal storage disorder caused by a deficiency of the enzyme glucocerebrosidase&lt;/li&gt;&lt;li&gt;âž¤ clinical presentation&lt;/li&gt;&lt;li&gt;âž¤ Gaucher&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ lysosomal storage disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ glucocerebrosidase&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 260, 261&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 260, 261&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;FALSE statement about fatty acid:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PUFA is essential for membrane structure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Biologically arachidonic acid is essential to life&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydrogenated vegetable oils contain trans fatty acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Naturally occurring unsaturated FA exist as trans isomer&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Naturally occurring unsaturated FA exist as trans isomer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: PUFA is essential for membrane structure : This is true . Polyunsaturated fatty acids are crucial for maintaining the fluidity and functionality of cell membranes.&lt;/li&gt;&lt;li&gt;â€¢ Option A: PUFA is essential for membrane structure&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Polyunsaturated fatty acids&lt;/li&gt;&lt;li&gt;â€¢ fluidity&lt;/li&gt;&lt;li&gt;â€¢ functionality of cell membranes.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Biologically arachidonic acid is essential to life : This is true . Arachidonic acid is important for the synthesis of eicosanoids , which are involved in various physiological functions , including inflammation and immune response.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Biologically arachidonic acid is essential to life&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ Arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ synthesis of eicosanoids&lt;/li&gt;&lt;li&gt;â€¢ physiological functions&lt;/li&gt;&lt;li&gt;â€¢ inflammation and immune response.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hydrogenated vegetable oils contain trans fatty acid : This is true. The process of hydrogenating vegetable oils, which is used to convert them into semi-solid forms for use in various food products , often results in the formation of trans fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Hydrogenated vegetable oils contain trans fatty acid&lt;/li&gt;&lt;li&gt;â€¢ true.&lt;/li&gt;&lt;li&gt;â€¢ hydrogenating vegetable oils,&lt;/li&gt;&lt;li&gt;â€¢ convert them into semi-solid forms&lt;/li&gt;&lt;li&gt;â€¢ various food products&lt;/li&gt;&lt;li&gt;â€¢ formation of trans fatty acids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Most naturally occurring unsaturated fatty acids are in the cis configuration, which impacts cell membrane fluidity and overall metabolic health , as opposed to trans fatty acids that are largely produced industrially and have negative health implications.&lt;/li&gt;&lt;li&gt;âž¤ naturally&lt;/li&gt;&lt;li&gt;âž¤ unsaturated fatty acids&lt;/li&gt;&lt;li&gt;âž¤ cis configuration,&lt;/li&gt;&lt;li&gt;âž¤ impacts cell membrane fluidity&lt;/li&gt;&lt;li&gt;âž¤ overall&lt;/li&gt;&lt;li&gt;âž¤ metabolic health&lt;/li&gt;&lt;li&gt;âž¤ opposed&lt;/li&gt;&lt;li&gt;âž¤ trans fatty acids&lt;/li&gt;&lt;li&gt;âž¤ largely&lt;/li&gt;&lt;li&gt;âž¤ industrially&lt;/li&gt;&lt;li&gt;âž¤ negative health implications.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p241&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p241&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Omega fatty acids play crucial roles in our health and are categorized based on their chemical structure. Among the following options, which fatty acid does not belong to the Ï‰6 (omega-6) series?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arachidonic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gamma-linolenic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha-linolenic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linoleic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alpha-linolenic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-170806.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Arachidonic acid : Belongs to the Ï‰6 series and is a precursor for various eicosanoids, which are important signaling molecules involved in inflammation and immunity.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ Ï‰6 series&lt;/li&gt;&lt;li&gt;â€¢ precursor&lt;/li&gt;&lt;li&gt;â€¢ eicosanoids,&lt;/li&gt;&lt;li&gt;â€¢ signaling&lt;/li&gt;&lt;li&gt;â€¢ molecules&lt;/li&gt;&lt;li&gt;â€¢ inflammation and immunity.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gamma-linolenic acid : Also part of the Ï‰6 series, gamma-linolenic acid is found in certain plant-based oils and is used by the body to produce substances that reduce inflammation and cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Gamma-linolenic acid&lt;/li&gt;&lt;li&gt;â€¢ Ï‰6 series, gamma-linolenic acid&lt;/li&gt;&lt;li&gt;â€¢ plant-based oils&lt;/li&gt;&lt;li&gt;â€¢ body to produce substances&lt;/li&gt;&lt;li&gt;â€¢ reduce inflammation and cell growth.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Linoleic acid : This is an essential fatty acid in the Ï‰6 series , serving as a precursor for arachidonic acid and playing a vital role in cell membrane structure and function.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Linoleic acid&lt;/li&gt;&lt;li&gt;â€¢ essential fatty acid&lt;/li&gt;&lt;li&gt;â€¢ Ï‰6 series&lt;/li&gt;&lt;li&gt;â€¢ precursor for arachidonic acid&lt;/li&gt;&lt;li&gt;â€¢ cell membrane structure and function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p214&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p214&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Considering the role of essential fatty acids in numerous physiological processes, including the formation of cell membranes, production of signaling molecules, and involvement in inflammatory responses, which of the following fatty acids is considered essential for humans?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Palmitic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linoleic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oleic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isovaleric acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Linoleic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Palmitic acid : This is a saturated fatty acid , the most common in animals and plants. The body can synthesize palmitic acid, so it is not considered essential.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Palmitic acid&lt;/li&gt;&lt;li&gt;â€¢ saturated fatty acid&lt;/li&gt;&lt;li&gt;â€¢ most&lt;/li&gt;&lt;li&gt;â€¢ animals and plants.&lt;/li&gt;&lt;li&gt;â€¢ body can synthesize palmitic&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ essential.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oleic acid : Oleic acid is a monounsaturated omega-9 fatty acid . Although beneficial for health, especially in replacing saturated fats in the diet , it is not classified as essential because the human body can synthesize it.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Oleic acid&lt;/li&gt;&lt;li&gt;â€¢ Oleic acid&lt;/li&gt;&lt;li&gt;â€¢ monounsaturated omega-9 fatty acid&lt;/li&gt;&lt;li&gt;â€¢ beneficial for health,&lt;/li&gt;&lt;li&gt;â€¢ saturated fats in the diet&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ essential&lt;/li&gt;&lt;li&gt;â€¢ human body can synthesize it.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Isovaleric acid : This is a branched short-chain saturated fatty acid , not typically classified within the context of dietary essential fatty acids . It is more commonly known for its occurrence in certain types of food fermentation and does not have a role similar to that of essential unsaturated fatty acids like linoleic acid.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Isovaleric acid&lt;/li&gt;&lt;li&gt;â€¢ branched short-chain saturated fatty acid&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ dietary&lt;/li&gt;&lt;li&gt;â€¢ essential fatty acids&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ known&lt;/li&gt;&lt;li&gt;â€¢ types of food fermentation&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ essential unsaturated fatty acids&lt;/li&gt;&lt;li&gt;â€¢ linoleic acid.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Essential fatty acids are not synthesized in the body and need to be supplied in the diet. It is because humans lack the enzymes that can introduce double bond beyond 9 th Carbon. They are polyunsaturated fatty acid such as Linoleic Acid and Linolenic Acid Arachidonic Acid is called as Semi essential fatty Acid as it is synthesized from Linoleic Acid. They lower the risk of Cardiovascular Diseases.&lt;/li&gt;&lt;li&gt;âž¤ Essential fatty acids are not synthesized in the body and need to be supplied in the diet.&lt;/li&gt;&lt;li&gt;âž¤ Essential fatty acids&lt;/li&gt;&lt;li&gt;âž¤ not synthesized&lt;/li&gt;&lt;li&gt;âž¤ body&lt;/li&gt;&lt;li&gt;âž¤ need&lt;/li&gt;&lt;li&gt;âž¤ supplied&lt;/li&gt;&lt;li&gt;âž¤ diet.&lt;/li&gt;&lt;li&gt;âž¤ It is because humans lack the enzymes that can introduce double bond beyond 9 th Carbon.&lt;/li&gt;&lt;li&gt;âž¤ because&lt;/li&gt;&lt;li&gt;âž¤ lack the enzymes&lt;/li&gt;&lt;li&gt;âž¤ double bond beyond 9 th Carbon.&lt;/li&gt;&lt;li&gt;âž¤ They are polyunsaturated fatty acid such as Linoleic Acid and Linolenic Acid&lt;/li&gt;&lt;li&gt;âž¤ polyunsaturated fatty acid&lt;/li&gt;&lt;li&gt;âž¤ Linoleic Acid and Linolenic Acid&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic Acid is called as Semi essential fatty Acid as it is synthesized from Linoleic Acid.&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic Acid&lt;/li&gt;&lt;li&gt;âž¤ Semi essential fatty Acid&lt;/li&gt;&lt;li&gt;âž¤ synthesized from Linoleic Acid.&lt;/li&gt;&lt;li&gt;âž¤ They lower the risk of Cardiovascular Diseases.&lt;/li&gt;&lt;li&gt;âž¤ lower the risk of Cardiovascular Diseases.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 253, 254.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 253, 254.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;I-cell disease is characterized by a severe lysosomal storage disorder with symptoms manifesting early in life, including developmental delay, skeletal abnormalities, and coarse facial features. This condition results from a deficiency in a key enzyme necessary for the proper targeting of lysosomal enzymes. Without this enzyme, lysosomal proteins fail to be correctly trafficked to lysosomes. Which of the following recognition markers is not properly formed due to the deficiency of the phosphorylating enzyme in I-cell disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GM2 ganglioside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mannose 6-phosphate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Galactocerebroside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Globoside&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mannose 6-phosphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: GM2 ganglioside : This is a component of neuronal cell membranes and is accumulated in Tay-Sachs disease , not I-cell disease, due to a deficiency in Hexosaminidase A, an enzyme unrelated to the defect in I-cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: GM2 ganglioside&lt;/li&gt;&lt;li&gt;â€¢ component of neuronal cell membranes&lt;/li&gt;&lt;li&gt;â€¢ Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ not I-cell&lt;/li&gt;&lt;li&gt;â€¢ disease,&lt;/li&gt;&lt;li&gt;â€¢ deficiency in Hexosaminidase A,&lt;/li&gt;&lt;li&gt;â€¢ unrelated to the defect in I-cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Galactocerebroside : This is a major component of myelin sheath in the nervous system . Accumulation of galactocerebroside due to a deficiency of galactocerebrosidase enzyme is seen in Krabbe disease , not I-cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Galactocerebroside&lt;/li&gt;&lt;li&gt;â€¢ major&lt;/li&gt;&lt;li&gt;â€¢ myelin sheath in the nervous system&lt;/li&gt;&lt;li&gt;â€¢ Accumulation&lt;/li&gt;&lt;li&gt;â€¢ galactocerebroside&lt;/li&gt;&lt;li&gt;â€¢ deficiency of galactocerebrosidase&lt;/li&gt;&lt;li&gt;â€¢ Krabbe disease&lt;/li&gt;&lt;li&gt;â€¢ Option D: Globoside : Accumulation of globosides occurs in Fabry disease due to a deficiency in alpha-galactosidase A, which is not related to the enzyme deficiency observed in I-cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Globoside&lt;/li&gt;&lt;li&gt;â€¢ Accumulation of globosides&lt;/li&gt;&lt;li&gt;â€¢ Fabry disease&lt;/li&gt;&lt;li&gt;â€¢ deficiency in alpha-galactosidase A,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ I-cell disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inclusion cell (I-cell) disease is a condition in which lysosomes lack in enzymes but are seen in blood. Mannose-6-phosphate is the marker enzyme to target the nascent enzymes to lysosomes. In I CELL DISEASE, the carbohydrate units are not added to the enzyme â†’ Mannose-6-phosphate deficient enzymes cannot reach their destination ( protein targeting defect ).&lt;/li&gt;&lt;li&gt;âž¤ Inclusion cell (I-cell) disease is a condition in which lysosomes lack in enzymes but are seen in blood.&lt;/li&gt;&lt;li&gt;âž¤ Inclusion cell (I-cell) disease&lt;/li&gt;&lt;li&gt;âž¤ lysosomes lack in enzymes&lt;/li&gt;&lt;li&gt;âž¤ seen in blood.&lt;/li&gt;&lt;li&gt;âž¤ Mannose-6-phosphate is the marker enzyme to target the nascent enzymes to lysosomes.&lt;/li&gt;&lt;li&gt;âž¤ Mannose-6-phosphate&lt;/li&gt;&lt;li&gt;âž¤ marker enzyme&lt;/li&gt;&lt;li&gt;âž¤ nascent enzymes to lysosomes.&lt;/li&gt;&lt;li&gt;âž¤ In I CELL DISEASE, the carbohydrate units are not added to the enzyme â†’ Mannose-6-phosphate deficient enzymes cannot reach their destination ( protein targeting defect ).&lt;/li&gt;&lt;li&gt;âž¤ I CELL DISEASE,&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ Mannose-6-phosphate deficient&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ protein targeting defect&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p586&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p586&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following substances accumulates in the neurons of patients with Tay-Sachs disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GM2 ganglioside&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GM1 ganglioside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocerebroside&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Galactocerebroside&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. GM2 ganglioside&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: GM1 ganglioside : Accumulation of GM1 ganglioside is characteristic of GM1 gangliosidosis , not Tay-Sachs disease . This is due to a deficiency in a different enzyme , Î²-galactosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option B: GM1 ganglioside&lt;/li&gt;&lt;li&gt;â€¢ Accumulation&lt;/li&gt;&lt;li&gt;â€¢ GM1 ganglioside&lt;/li&gt;&lt;li&gt;â€¢ GM1 gangliosidosis&lt;/li&gt;&lt;li&gt;â€¢ not Tay-Sachs disease&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ , Î²-galactosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glucocerebroside : Accumulation of glucocerebroside is seen in Gaucher&#x27;s disease , which results from a deficiency in the enzyme glucocerebrosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glucocerebroside&lt;/li&gt;&lt;li&gt;â€¢ Accumulation&lt;/li&gt;&lt;li&gt;â€¢ glucocerebroside&lt;/li&gt;&lt;li&gt;â€¢ Gaucher&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ glucocerebrosidase.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Galactocerebroside : Accumulation of galactocerebroside is observed in Krabbe disease due to a deficiency in the enzyme galactocerebrosidase, leading to damage in the myelin sheath of nerve cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Galactocerebroside&lt;/li&gt;&lt;li&gt;â€¢ Accumulation&lt;/li&gt;&lt;li&gt;â€¢ galactocerebroside&lt;/li&gt;&lt;li&gt;â€¢ Krabbe disease&lt;/li&gt;&lt;li&gt;â€¢ deficiency&lt;/li&gt;&lt;li&gt;â€¢ galactocerebrosidase,&lt;/li&gt;&lt;li&gt;â€¢ myelin sheath of nerve cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs disease is due to the deficiency of enzyme Hexosaminidase A The lipid accumulated is Ganglioside (GM2) C/F: Mental retardation, cherry red spot in the macula, progressive deterioration , and death by 3â€“4 years.&lt;/li&gt;&lt;li&gt;âž¤ Tay-Sachs disease is due to the deficiency of enzyme Hexosaminidase A&lt;/li&gt;&lt;li&gt;âž¤ deficiency&lt;/li&gt;&lt;li&gt;âž¤ Hexosaminidase A&lt;/li&gt;&lt;li&gt;âž¤ The lipid accumulated is Ganglioside (GM2)&lt;/li&gt;&lt;li&gt;âž¤ lipid&lt;/li&gt;&lt;li&gt;âž¤ Ganglioside (GM2)&lt;/li&gt;&lt;li&gt;âž¤ C/F: Mental retardation, cherry red spot in the macula, progressive deterioration , and death by 3â€“4 years.&lt;/li&gt;&lt;li&gt;âž¤ Mental retardation, cherry red spot in the macula, progressive deterioration&lt;/li&gt;&lt;li&gt;âž¤ death by 3â€“4 years.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 260 ,261.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 260 ,261.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The eukaryotic plasma membrane is a dynamic structure crucial for maintaining the integrity of the cell, facilitating communication, and transporting substances into and out of the cell. Its composition is diverse, including various types of molecules that contribute to its fluid mosaic model. Among the following options, which one is NOT typically found as a component of the eukaryotic plasma membrane?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbohydrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Triglycerides&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lecithin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cholesterol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Triglycerides&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture10_FCLrY6O.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Carbohydrates : Carbohydrates are typically attached to proteins (glycoproteins) or lipids (glycolipids) on the extracellular surface of the plasma membrane , playing key roles in cell recognition, signaling, and adhesion.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Carbohydrates&lt;/li&gt;&lt;li&gt;â€¢ attached to proteins (glycoproteins) or lipids (glycolipids)&lt;/li&gt;&lt;li&gt;â€¢ extracellular&lt;/li&gt;&lt;li&gt;â€¢ surface of the plasma membrane&lt;/li&gt;&lt;li&gt;â€¢ cell recognition, signaling, and adhesion.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lecithin : Lecithin (a type of phospholipid ) is a major component of the plasma membrane, contributing to its fluidity and structural integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lecithin&lt;/li&gt;&lt;li&gt;â€¢ phospholipid&lt;/li&gt;&lt;li&gt;â€¢ major component&lt;/li&gt;&lt;li&gt;â€¢ plasma membrane,&lt;/li&gt;&lt;li&gt;â€¢ its fluidity&lt;/li&gt;&lt;li&gt;â€¢ structural integrity.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cholesterol : Cholesterol is interspersed among the phospholipids of the plasma membrane, where it serves to modulate fluidity and mechanical stability.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cholesterol&lt;/li&gt;&lt;li&gt;â€¢ interspersed&lt;/li&gt;&lt;li&gt;â€¢ phospholipids of the plasma membrane,&lt;/li&gt;&lt;li&gt;â€¢ modulate&lt;/li&gt;&lt;li&gt;â€¢ fluidity and mechanical stability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plasma membranes are complex structures made of Lipids, Proteins, and Carbohydrates. The major lipids seen in our mammalian membranes include phospholipids, glycosphingolipids, and cholesterol. Major phospholipids present in membranes are phosphoglycerides, among which lecithin is most abundantly seen.&lt;/li&gt;&lt;li&gt;âž¤ Plasma membranes are complex structures made of Lipids, Proteins, and Carbohydrates.&lt;/li&gt;&lt;li&gt;âž¤ Plasma membranes&lt;/li&gt;&lt;li&gt;âž¤ complex structures&lt;/li&gt;&lt;li&gt;âž¤ Lipids, Proteins, and Carbohydrates.&lt;/li&gt;&lt;li&gt;âž¤ The major lipids seen in our mammalian membranes include phospholipids, glycosphingolipids, and cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ major lipids&lt;/li&gt;&lt;li&gt;âž¤ mammalian membranes&lt;/li&gt;&lt;li&gt;âž¤ phospholipids, glycosphingolipids, and cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Major phospholipids present in membranes are phosphoglycerides, among which lecithin is most abundantly seen.&lt;/li&gt;&lt;li&gt;âž¤ Major phospholipids&lt;/li&gt;&lt;li&gt;âž¤ phosphoglycerides,&lt;/li&gt;&lt;li&gt;âž¤ lecithin&lt;/li&gt;&lt;li&gt;âž¤ abundantly seen.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p478&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p478&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of cell signaling pathways, second messengers play a crucial role in amplifying and propagating signals within the cell. These molecules are often produced as a result of receptor activation on the cell surface. From which of the following molecules is a well-known second messenger commonly produced?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phosphatidylinositol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphatidyl ethanolamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphatidylcholine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phosphatidylinositol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Phosphatidyl ethanolamine : While an important phospholipid in the membrane , it is not directly involved in the generation of second messengers.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Phosphatidyl ethanolamine&lt;/li&gt;&lt;li&gt;â€¢ phospholipid in the membrane&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ generation of second messengers.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phosphatidylcholine : It can be involved in signaling pathways, for instance, through its breakdown by phospholipase D to produce phosphatidic acid , but it is not the classical route for second messenger production like phosphatidylinositol.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Phosphatidylcholine&lt;/li&gt;&lt;li&gt;â€¢ involved in signaling pathways,&lt;/li&gt;&lt;li&gt;â€¢ its breakdown by phospholipase D&lt;/li&gt;&lt;li&gt;â€¢ phosphatidic acid&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ classical route for second messenger&lt;/li&gt;&lt;li&gt;â€¢ phosphatidylinositol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phosphatidylinositol&lt;/li&gt;&lt;li&gt;âž¤ Phosphatidylinositol&lt;/li&gt;&lt;li&gt;âž¤ It is present in the cell membrane Plays an important role in cell signalling, membrane trafficking and as a precursor of second messenger in hormonal pathways. Diacylglycerol and Inositol Trisphosphate IP3 act as second messengers.&lt;/li&gt;&lt;li&gt;âž¤ It is present in the cell membrane&lt;/li&gt;&lt;li&gt;âž¤ cell membrane&lt;/li&gt;&lt;li&gt;âž¤ Plays an important role in cell signalling, membrane trafficking and as a precursor of second messenger in hormonal pathways.&lt;/li&gt;&lt;li&gt;âž¤ cell signalling, membrane trafficking&lt;/li&gt;&lt;li&gt;âž¤ precursor of second messenger&lt;/li&gt;&lt;li&gt;âž¤ Diacylglycerol and Inositol Trisphosphate IP3 act as second messengers.&lt;/li&gt;&lt;li&gt;âž¤ Diacylglycerol and Inositol Trisphosphate IP3&lt;/li&gt;&lt;li&gt;âž¤ second messengers.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p216&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p216&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cell membranes are composed of various lipids that contribute to their structural integrity and functionality. Among these, glycolipids play a special role in cell recognition, signalling, and interaction with the extracellular environment. Based on your understanding of membrane lipids, which of the following options is classified as a glycolipid?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebroside&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plasmalogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sphingomyelin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lecithin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebroside&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Plasmalogen : Plasmalogens are a type of phospholipid characterized by the presence of an ether bond at the sn-1 position of the glycerol backbone , not a glycolipid.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Plasmalogen&lt;/li&gt;&lt;li&gt;â€¢ type of phospholipid&lt;/li&gt;&lt;li&gt;â€¢ presence of an ether bond&lt;/li&gt;&lt;li&gt;â€¢ sn-1&lt;/li&gt;&lt;li&gt;â€¢ glycerol backbone&lt;/li&gt;&lt;li&gt;â€¢ Option C: Sphingomyelin : Sphingomyelin is a type of sphingophospholipid that contains phosphocholine or phosphoethanolamine as its head group. It is not classified as a glycolipid because it lacks a sugar moiety.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Sphingomyelin&lt;/li&gt;&lt;li&gt;â€¢ type of sphingophospholipid&lt;/li&gt;&lt;li&gt;â€¢ phosphocholine&lt;/li&gt;&lt;li&gt;â€¢ phosphoethanolamine&lt;/li&gt;&lt;li&gt;â€¢ its head group.&lt;/li&gt;&lt;li&gt;â€¢ not classified&lt;/li&gt;&lt;li&gt;â€¢ glycolipid&lt;/li&gt;&lt;li&gt;â€¢ it lacks a sugar moiety.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lecithin : Lecithin, also known as phosphatidylcholine , is a phospholipid that is a major component of cell membranes but does not contain a sugar group , thus not a glycolipid.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lecithin&lt;/li&gt;&lt;li&gt;â€¢ phosphatidylcholine&lt;/li&gt;&lt;li&gt;â€¢ phospholipid&lt;/li&gt;&lt;li&gt;â€¢ major component&lt;/li&gt;&lt;li&gt;â€¢ cell membranes&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ sugar group&lt;/li&gt;&lt;li&gt;â€¢ not a glycolipid.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glycolipids or Glycosphingolipids include Cerebroside, Globoside and Ganglioside.&lt;/li&gt;&lt;li&gt;âž¤ Glycolipids or Glycosphingolipids&lt;/li&gt;&lt;li&gt;âž¤ Cerebroside, Globoside and Ganglioside.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p218&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p218&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Trans fatty acids (TFAs) have been the subject of much health-related research and public health policy due to their adverse effects on cardiovascular health. Considering the various aspects of TFAs, which of the following statements is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fried rice has high content of TFA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial Hydrogenation increases TFA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreases shelf-life&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;â†‘ LDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Decreases shelf-life&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Decreases shelf-life&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Fried rice has a high content of TFA : This can be true , especially if the frying oil has been hydrogenated or reused multiple times , which can lead to the formation of TFAs.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Fried rice has a high content of TFA&lt;/li&gt;&lt;li&gt;â€¢ true&lt;/li&gt;&lt;li&gt;â€¢ frying oil&lt;/li&gt;&lt;li&gt;â€¢ hydrogenated or reused multiple&lt;/li&gt;&lt;li&gt;â€¢ times&lt;/li&gt;&lt;li&gt;â€¢ lead&lt;/li&gt;&lt;li&gt;â€¢ TFAs.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Partial Hydrogenation increases TFA : True . The partial hydrogenation of vegetable oils is a major industrial source of TFAs. This process converts some unsaturated bonds to saturated and trans configurations.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Partial Hydrogenation increases TFA&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ partial hydrogenation of vegetable oils&lt;/li&gt;&lt;li&gt;â€¢ TFAs.&lt;/li&gt;&lt;li&gt;â€¢ unsaturated bonds to saturated and trans configurations.&lt;/li&gt;&lt;li&gt;â€¢ Option D: â†‘ LDL : True . TFAs are known to increase levels of low-density lipoprotein (LDL) cholesterol, which is often referred to as \&quot;bad\&quot; cholesterol due to its association with an increased risk of cardiovascular disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: â†‘ LDL&lt;/li&gt;&lt;li&gt;â€¢ True&lt;/li&gt;&lt;li&gt;â€¢ TFAs&lt;/li&gt;&lt;li&gt;â€¢ increase levels of low-density lipoprotein (LDL) cholesterol,&lt;/li&gt;&lt;li&gt;â€¢ \&quot;bad\&quot; cholesterol&lt;/li&gt;&lt;li&gt;â€¢ increased risk of cardiovascular disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trans fatty acids:&lt;/li&gt;&lt;li&gt;âž¤ Trans fatty acids:&lt;/li&gt;&lt;li&gt;âž¤ It is present in dairy products and partially hydrogenated edible oils Used in food industry to improve the shelf-life Present in high amounts in processed foods , fast foods, and bakery items Consumption of TFA for longer duration might increase the risk of atherosclerosis, CAD and Diabetes mellitus Exacerbate essential fatty acid deficiency by competing with them.&lt;/li&gt;&lt;li&gt;âž¤ It is present in dairy products and partially hydrogenated edible oils&lt;/li&gt;&lt;li&gt;âž¤ dairy products&lt;/li&gt;&lt;li&gt;âž¤ partially hydrogenated edible oils&lt;/li&gt;&lt;li&gt;âž¤ Used in food industry to improve the shelf-life&lt;/li&gt;&lt;li&gt;âž¤ Used&lt;/li&gt;&lt;li&gt;âž¤ improve the shelf-life&lt;/li&gt;&lt;li&gt;âž¤ Present in high amounts in processed foods , fast foods, and bakery items&lt;/li&gt;&lt;li&gt;âž¤ high amounts&lt;/li&gt;&lt;li&gt;âž¤ foods&lt;/li&gt;&lt;li&gt;âž¤ fast foods,&lt;/li&gt;&lt;li&gt;âž¤ bakery items&lt;/li&gt;&lt;li&gt;âž¤ Consumption of TFA for longer duration might increase the risk of atherosclerosis, CAD and Diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ TFA&lt;/li&gt;&lt;li&gt;âž¤ longer duration&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ atherosclerosis, CAD&lt;/li&gt;&lt;li&gt;âž¤ and Diabetes mellitus&lt;/li&gt;&lt;li&gt;âž¤ Exacerbate essential fatty acid deficiency by competing with them.&lt;/li&gt;&lt;li&gt;âž¤ essential fatty acid deficiency&lt;/li&gt;&lt;li&gt;âž¤ competing with them.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p241&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p241&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the clinical presentation (as shown in image), which of the following is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial Chylomicronemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial Hypercholesterolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Broad Beta Disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Familial Hypercholesterolemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_BiC30gi.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Familial Chylomicronemia: C/F- Hepatomegaly, eruptive xanthoma and abdominal pain.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Familial Chylomicronemia:&lt;/li&gt;&lt;li&gt;â€¢ Hepatomegaly, eruptive xanthoma and abdominal pain.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Abetalipoproteinemia: Low levels of serum triglycerides, cholesterol and phospholipids . C/F- Blindness due to degenerative changes in retina and spiny projections in erythrocytes (acanthocytes).&lt;/li&gt;&lt;li&gt;â€¢ Option C: Abetalipoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ Low levels of serum triglycerides,&lt;/li&gt;&lt;li&gt;â€¢ cholesterol and phospholipids&lt;/li&gt;&lt;li&gt;â€¢ Blindness&lt;/li&gt;&lt;li&gt;â€¢ degenerative changes&lt;/li&gt;&lt;li&gt;â€¢ retina&lt;/li&gt;&lt;li&gt;â€¢ spiny projections&lt;/li&gt;&lt;li&gt;â€¢ erythrocytes (acanthocytes).&lt;/li&gt;&lt;li&gt;â€¢ Option D: Broad Beta Disease: Palmar xanthoma and increased risk for vascular disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Broad Beta Disease:&lt;/li&gt;&lt;li&gt;â€¢ Palmar xanthoma&lt;/li&gt;&lt;li&gt;â€¢ increased risk for vascular disease.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Familial Hypercholesterolemia is characterized by high LDL cholesterol levels and the presence of xanthomas , which are deposits of cholesterol in the skin and tendons , due to a genetic defect in LDL receptors.&lt;/li&gt;&lt;li&gt;â€¢ Familial Hypercholesterolemia&lt;/li&gt;&lt;li&gt;â€¢ high LDL cholesterol levels&lt;/li&gt;&lt;li&gt;â€¢ xanthomas&lt;/li&gt;&lt;li&gt;â€¢ cholesterol in the skin and tendons&lt;/li&gt;&lt;li&gt;â€¢ genetic defect in LDL receptors.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Vasudevan 9 /ed: P245, 246.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Vasudevan 9 /ed: P245, 246.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male was prescribed a medication which inhibits the activity of the enzyme HMG-CoA reductase. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 2 diabetes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial hypercholesterolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperuricemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Familial hypercholesterolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Type 2 diabetes: Oral hypoglycemic agents - sulfonylurea and biguanides (Metformin), glitazones etc., Insulin injections.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Type 2 diabetes:&lt;/li&gt;&lt;li&gt;â€¢ Oral hypoglycemic agents&lt;/li&gt;&lt;li&gt;â€¢ sulfonylurea and biguanides (Metformin), glitazones etc., Insulin injections.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hypertension: Anti-hypertensives â€“ calcium channel blockers&lt;/li&gt;&lt;li&gt;â€¢ Option B: Hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Anti-hypertensives&lt;/li&gt;&lt;li&gt;â€¢ calcium channel blockers&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyperuricemia: Reduce dietary intake of purine and restrict alcohol, increase renal excretion of urate by uricosuric drugs, e.g. probenecid, reduce urate production by allopurinol , use of PEG (polyethylene glycol)-uricase that converts uric acid to allantoin , which is more water soluble and easily excreted.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyperuricemia:&lt;/li&gt;&lt;li&gt;â€¢ Reduce dietary intake of purine&lt;/li&gt;&lt;li&gt;â€¢ restrict alcohol,&lt;/li&gt;&lt;li&gt;â€¢ increase renal excretion of urate&lt;/li&gt;&lt;li&gt;â€¢ uricosuric drugs,&lt;/li&gt;&lt;li&gt;â€¢ probenecid,&lt;/li&gt;&lt;li&gt;â€¢ reduce urate production&lt;/li&gt;&lt;li&gt;â€¢ allopurinol&lt;/li&gt;&lt;li&gt;â€¢ PEG (polyethylene glycol)-uricase&lt;/li&gt;&lt;li&gt;â€¢ uric acid to&lt;/li&gt;&lt;li&gt;â€¢ allantoin&lt;/li&gt;&lt;li&gt;â€¢ more water soluble&lt;/li&gt;&lt;li&gt;â€¢ easily excreted.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ HMG-CoA reductase inhibitors , commonly known as statins, are primarily used to lower cholesterol levels in the blood , particularly in conditions like Familial Hypercholesterolemia, where there&#x27;s a genetic defect in LDL receptors leading to elevated cholesterol levels.&lt;/li&gt;&lt;li&gt;â€¢ HMG-CoA reductase inhibitors&lt;/li&gt;&lt;li&gt;â€¢ statins,&lt;/li&gt;&lt;li&gt;â€¢ used to lower cholesterol levels in the blood&lt;/li&gt;&lt;li&gt;â€¢ Familial Hypercholesterolemia,&lt;/li&gt;&lt;li&gt;â€¢ genetic defect&lt;/li&gt;&lt;li&gt;â€¢ LDL receptors&lt;/li&gt;&lt;li&gt;â€¢ elevated cholesterol&lt;/li&gt;&lt;li&gt;â€¢ levels.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 275,267.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Harper 30/e: p 275,267.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with established coronary artery disease returns with new complaints of numbness in his hands and feet. On examination, below finding is observed. His lipid panel reveals HDL cholesterol levels are markedly low. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypo alpha lipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tangier Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial alpha Lp-deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyper alpha lipoproteinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tangier Disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_T4chRaU.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tangier Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hypo alpha lipoproteinemia: Here serum HDL is decreased â†’ High risk for coronary artery diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Hypo alpha lipoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ HDL is decreased&lt;/li&gt;&lt;li&gt;â€¢ High risk for coronary artery diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Familial alpha Lp-deficiency: Have â†“â†“HDL and A-l, Normal- Cholesterol and TAG â†’ Increased risk of CAD.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Familial alpha Lp-deficiency:&lt;/li&gt;&lt;li&gt;â€¢ â†“â†“HDL and A-l, Normal- Cholesterol and TAG&lt;/li&gt;&lt;li&gt;â€¢ Increased risk of CAD.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyper alpha lipoproteinemia: Increased HDL and is a rare condition apparently beneficial to health.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hyper alpha lipoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ Increased HDL&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ beneficial to health.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Tangier disease by its classic presentation of orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.&lt;/li&gt;&lt;li&gt;â€¢ Tangier disease&lt;/li&gt;&lt;li&gt;â€¢ orange-yellow tonsillar hypertrophy, neuropathy, and low HDL levels.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Lippincott 7/e: P 236&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Lippincott 7/e: P 236&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Lecithin cholesterol acyl transferase (LCAT) deficiency leads to accumulation of nascent/discoidal HDL particles in the blood. Reasoning (R): LCAT is responsible for efflux of cholesterol from the membrane to the lipoprotein of low cholesterol HDL 3 , discoidal HDL or pre-beta HDL. What is the relationship between her condition and the role of LCAT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A as well as R is right, and R is a correct explanation of A&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A as well as R is right, and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/screenshot-2024-04-18-174018.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In an electrophoretic separation procedure, a technician observes the migration of lipoproteins from the cathode (-) to the anode (+) sidewhich of the following correctly orders the lipoproteins from cathode to anode?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CM &amp;gt; LDL &amp;gt; VLDL &amp;gt; HDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CM &amp;gt; VLDL &amp;gt; LDL &amp;gt; HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HDL &amp;gt; VLDL &amp;gt; LDL &amp;gt; CM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL &amp;gt; VLDL &amp;gt; LDL &amp;gt; CM&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CM &gt; LDL &gt; VLDL &gt; HDL&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/4_03T9YxQ.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Picture3_cTaOOJy.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â CM &amp;gt; LDL &amp;gt; VLDL &amp;gt; HDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein electrophoresis separates particles based on their protein content and charge. Understanding the typical migration pattern helps diagnose dyslipidemias and distinguish between different lipoprotein abnormalities.&lt;/li&gt;&lt;li&gt;âž¤ protein content and charge.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: 228.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man who consumes a fat-free, high-carbohydrate diet finds that he continues to gain weight. Considering the dietary influence on lipoprotein metabolism, which apoprotein is most likely to be elevated in his blood?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chylomicrons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;VLDL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. VLDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Chylomicrons: Carry TAG from gut to muscle and adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ Option A: Chylomicrons:&lt;/li&gt;&lt;li&gt;â€¢ TAG&lt;/li&gt;&lt;li&gt;â€¢ gut&lt;/li&gt;&lt;li&gt;â€¢ muscle and adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ Option B: HDL: Carry cholesterol from peripheral tissues to liver&lt;/li&gt;&lt;li&gt;â€¢ Option B: HDL:&lt;/li&gt;&lt;li&gt;â€¢ cholesterol&lt;/li&gt;&lt;li&gt;â€¢ peripheral tissues to liver&lt;/li&gt;&lt;li&gt;â€¢ Option C: LDL: Carry cholesterol from liver to peripheral tissues&lt;/li&gt;&lt;li&gt;â€¢ Option C: LDL:&lt;/li&gt;&lt;li&gt;â€¢ cholesterol&lt;/li&gt;&lt;li&gt;â€¢ liver to peripheral tissues&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A fat-free, high-carbohydrate diet can lead to increased synthesis of VLDL (Very Low-Density Lipoprotein) in the liver. VLDL is responsible for transporting endogenously synthesized triglycerides , which the body produces from excess carbohydrates, to adipose tissue for storage . This could contribute to ongoing obesity despite the absence of dietary fat.&lt;/li&gt;&lt;li&gt;âž¤ fat-free, high-carbohydrate diet&lt;/li&gt;&lt;li&gt;âž¤ increased synthesis of VLDL&lt;/li&gt;&lt;li&gt;âž¤ liver.&lt;/li&gt;&lt;li&gt;âž¤ VLDL&lt;/li&gt;&lt;li&gt;âž¤ transporting endogenously synthesized triglycerides&lt;/li&gt;&lt;li&gt;âž¤ body produces&lt;/li&gt;&lt;li&gt;âž¤ excess carbohydrates,&lt;/li&gt;&lt;li&gt;âž¤ adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ storage&lt;/li&gt;&lt;li&gt;âž¤ ongoing obesity&lt;/li&gt;&lt;li&gt;âž¤ absence of dietary fat.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 255-257.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 255-257.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with a familial history of increased cholesterol levels presents with an isolated elevation in LDL. His father and brother had similar lipid abnormalities. Given the isolated increase in LDL and family history, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial type III hyperlipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LDL receptor mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial LPL deficiency (type l)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. LDL receptor mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Familial type llI hyperlipoproteinemia: due to the abnormality in apoE , remnant clearance by the liver is defective resulting in increased levels of chylomicron and VLDL remnants. It can cause hypercholesterolemia, atherosclerosis, and xanthomas.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Familial type llI hyperlipoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ abnormality&lt;/li&gt;&lt;li&gt;â€¢ apoE&lt;/li&gt;&lt;li&gt;â€¢ clearance&lt;/li&gt;&lt;li&gt;â€¢ liver is defective&lt;/li&gt;&lt;li&gt;â€¢ in increased levels of chylomicron and VLDL remnants.&lt;/li&gt;&lt;li&gt;â€¢ hypercholesterolemia, atherosclerosis, and xanthomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Abetalipoproteinemia: Defective loading of apo B with lipid â†’ absence of formation of chylomicrons, VLDL or LDL , low blood acylglycerols with accumulation of it in the intestine and liver.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Abetalipoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ Defective&lt;/li&gt;&lt;li&gt;â€¢ apo B&lt;/li&gt;&lt;li&gt;â€¢ absence of formation of chylomicrons, VLDL or LDL&lt;/li&gt;&lt;li&gt;â€¢ low&lt;/li&gt;&lt;li&gt;â€¢ blood acylglycerols&lt;/li&gt;&lt;li&gt;â€¢ intestine and liver.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Familial LPL deficiency (type l): Due to deficiency of LPL or abnormal LPL or apo C-ll deficiency â†’ Hypertriacylglycerolemia with slow clearance of chylomicrons and VLDL, low levels of LDL and HDL.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Familial LPL deficiency (type l):&lt;/li&gt;&lt;li&gt;â€¢ Due to deficiency&lt;/li&gt;&lt;li&gt;â€¢ LPL or abnormal LPL or apo C-ll deficiency&lt;/li&gt;&lt;li&gt;â€¢ Hypertriacylglycerolemia&lt;/li&gt;&lt;li&gt;â€¢ low levels of LDL and HDL.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ LDL receptor gene mutation is characterized by isolated elevated LDL cholesterol levels and a family history of hypercholesterolemia and early cardiovascular disease.&lt;/li&gt;&lt;li&gt;â€¢ LDL receptor&lt;/li&gt;&lt;li&gt;â€¢ isolated elevated LDL cholesterol levels&lt;/li&gt;&lt;li&gt;â€¢ family history of hypercholesterolemia&lt;/li&gt;&lt;li&gt;â€¢ cardiovascular disease.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e:  p 275,276.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Harper 30/e:  p 275,276.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Three hours after a healthy middle-aged man eats a meal that includes carbohydrates, proteins, and fats, a blood sample is drawn to assess his lipid profile. Considering normal digestive physiology and the timing of the sample in relation to his meal, which component in his blood is likely to be elevated at this point?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucagon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycerol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chylomicrons&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chylomicrons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Fatty acids : Fatty acids in the blood usually increase during fasting when fat stores are mobilized for energy, not postprandially.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Fatty acids&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ increase during fasting&lt;/li&gt;&lt;li&gt;â€¢ fat stores&lt;/li&gt;&lt;li&gt;â€¢ energy,&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glucagon : Glucagon levels typically rise during fasting to promote glucose production and release by the liver, not after a meal when insulin is the predominant hormone.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glucagon&lt;/li&gt;&lt;li&gt;â€¢ rise during fasting&lt;/li&gt;&lt;li&gt;â€¢ promote glucose production&lt;/li&gt;&lt;li&gt;â€¢ liver, not&lt;/li&gt;&lt;li&gt;â€¢ meal&lt;/li&gt;&lt;li&gt;â€¢ insulin is the predominant hormone.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glycerol : Glycerol levels in the blood typically increase during triglyceride breakdown , which occurs during fasting or exercise, not postprandially.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glycerol&lt;/li&gt;&lt;li&gt;â€¢ Glycerol&lt;/li&gt;&lt;li&gt;â€¢ blood&lt;/li&gt;&lt;li&gt;â€¢ increase during triglyceride breakdown&lt;/li&gt;&lt;li&gt;â€¢ during fasting&lt;/li&gt;&lt;li&gt;â€¢ exercise,&lt;/li&gt;&lt;li&gt;â€¢ not postprandially.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The postprandial rise in chylomicron levels in response to a well-balanced meal , reflecting the normal physiological process of dietary fat transport.&lt;/li&gt;&lt;li&gt;âž¤ postprandial rise in chylomicron levels&lt;/li&gt;&lt;li&gt;âž¤ well-balanced meal&lt;/li&gt;&lt;li&gt;âž¤ normal physiological process&lt;/li&gt;&lt;li&gt;âž¤ dietary fat transport.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 257-259.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 257-259.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the relationship between this finding and the function of LCAT? Assertion (A): Excess cholesterol in the cell is esterified into cholesterol ester and is stored up there. Reasoning (R): LCAT converts free cholesterol to the cholesterol ester and plays a major role in reverse cholesterol transport.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A and R both are right but R is not the correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. A and R both are right but R is not the correct explanation of A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A) is correct â€” excess intracellular cholesterol is esterified and stored in the cholesterol pool within cells. This esterification allows for non-toxic storage of cholesterol in lipid droplets. However, the enzyme responsible for this process is ACAT (Acyl-CoA:cholesterol acyltransferase) , which is intracellular , not LCAT. Reason (R) is also correct â€” LCAT (Lecithin:cholesterol acyltransferase) is a plasma enzyme bound to HDL , and it converts free cholesterol (acquired from peripheral tissues) into cholesterol esters as part of reverse cholesterol transport , allowing HDL to carry cholesterol back to the liver.&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A) is correct â€” excess intracellular cholesterol is esterified and stored in the cholesterol pool within cells. This esterification allows for non-toxic storage of cholesterol in lipid droplets.&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A)&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ excess intracellular cholesterol&lt;/li&gt;&lt;li&gt;â€¢ cholesterol pool&lt;/li&gt;&lt;li&gt;â€¢ However, the enzyme responsible for this process is ACAT (Acyl-CoA:cholesterol acyltransferase) , which is intracellular , not LCAT.&lt;/li&gt;&lt;li&gt;â€¢ enzyme responsible for this process is ACAT (Acyl-CoA:cholesterol acyltransferase)&lt;/li&gt;&lt;li&gt;â€¢ intracellular&lt;/li&gt;&lt;li&gt;â€¢ Reason (R) is also correct â€” LCAT (Lecithin:cholesterol acyltransferase) is a plasma enzyme bound to HDL , and it converts free cholesterol (acquired from peripheral tissues) into cholesterol esters as part of reverse cholesterol transport , allowing HDL to carry cholesterol back to the liver.&lt;/li&gt;&lt;li&gt;â€¢ Reason (R)&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ LCAT (Lecithin:cholesterol acyltransferase)&lt;/li&gt;&lt;li&gt;â€¢ plasma enzyme&lt;/li&gt;&lt;li&gt;â€¢ HDL&lt;/li&gt;&lt;li&gt;â€¢ free cholesterol&lt;/li&gt;&lt;li&gt;â€¢ cholesterol esters&lt;/li&gt;&lt;li&gt;â€¢ reverse cholesterol transport&lt;/li&gt;&lt;li&gt;â€¢ Why R is not the correct explanation of A:&lt;/li&gt;&lt;li&gt;â€¢ Why R is not the correct explanation of A:&lt;/li&gt;&lt;li&gt;â€¢ LCAT esterifies plasma cholesterol during transport on HDL , not cholesterol in the intracellular cholesterol pool , which is the focus of A. The esterification of cholesterol for storage inside cells is performed by ACAT , not LCAT.&lt;/li&gt;&lt;li&gt;â€¢ plasma cholesterol&lt;/li&gt;&lt;li&gt;â€¢ HDL&lt;/li&gt;&lt;li&gt;â€¢ intracellular cholesterol pool&lt;/li&gt;&lt;li&gt;â€¢ esterification of cholesterol for storage inside cells&lt;/li&gt;&lt;li&gt;â€¢ ACAT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between the roles of LCAT and ACAT :&lt;/li&gt;&lt;li&gt;âž¤ LCAT&lt;/li&gt;&lt;li&gt;âž¤ ACAT&lt;/li&gt;&lt;li&gt;âž¤ LCAT : Acts in plasma , facilitates reverse cholesterol transport , esterifies free cholesterol on HDL . ACAT : Acts inside cells , esterifies intracellular cholesterol for storage .&lt;/li&gt;&lt;li&gt;âž¤ LCAT : Acts in plasma , facilitates reverse cholesterol transport , esterifies free cholesterol on HDL .&lt;/li&gt;&lt;li&gt;âž¤ LCAT&lt;/li&gt;&lt;li&gt;âž¤ plasma&lt;/li&gt;&lt;li&gt;âž¤ reverse cholesterol transport&lt;/li&gt;&lt;li&gt;âž¤ free cholesterol on HDL&lt;/li&gt;&lt;li&gt;âž¤ ACAT : Acts inside cells , esterifies intracellular cholesterol for storage .&lt;/li&gt;&lt;li&gt;âž¤ ACAT&lt;/li&gt;&lt;li&gt;âž¤ inside cells&lt;/li&gt;&lt;li&gt;âž¤ intracellular cholesterol for storage&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 259.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a clinical study examining lipid metabolism disorders, researchers observe participants with markedly elevated plasma levels of chylomicrons and triacylglycerols. Which type of hyperlipoproteinemia is most consistent with these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type I hyperlipoproteinemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type IV hyperlipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type IIb hyperlipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type V hyperlipoproteinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Type I hyperlipoproteinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Familial Endogenous type - due to over production of TG by liver, elevated VLDL level â†’ Cardiac manifestations. Associated with DM, obesity and impaired glucose tolerance.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Familial Endogenous type&lt;/li&gt;&lt;li&gt;â€¢ over production of TG&lt;/li&gt;&lt;li&gt;â€¢ elevated VLDL level&lt;/li&gt;&lt;li&gt;â€¢ Cardiac manifestations.&lt;/li&gt;&lt;li&gt;â€¢ DM, obesity and impaired glucose tolerance.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Elevation of both CHL and TG with excessive production of apo-B â†’ elevated LDL and VLDL.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Elevation&lt;/li&gt;&lt;li&gt;â€¢ both CHL and TG&lt;/li&gt;&lt;li&gt;â€¢ excessive production of apo-B&lt;/li&gt;&lt;li&gt;â€¢ elevated LDL and VLDL.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Elevated CM and VLDL. Hypertriglyceridemia secondary to disorders like obesity, excessive alcohol intake, renal failure, pancreatitis , etc. are common. Other causes: hepatic lipase defect, LCAT defect and Lp(a) excess and Wolmanâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Elevated CM and VLDL. Hypertriglyceridemia&lt;/li&gt;&lt;li&gt;â€¢ obesity, excessive alcohol intake, renal failure,&lt;/li&gt;&lt;li&gt;â€¢ pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ hepatic lipase defect, LCAT defect and Lp(a) excess and Wolmanâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type I hyperlipoproteinemia , also known as familial lipoprotein lipase deficiency, is characterized by markedly elevated plasma levels of chylomicrons due to a deficiency of lipoprotein lipase or its cofactor apolipoprotein C-II. This leads to an inability to hydrolyze the triglycerides carried by chylomicrons , resulting in high levels of both chylomicrons and triglycerides in the plasma.&lt;/li&gt;&lt;li&gt;âž¤ Type I hyperlipoproteinemia&lt;/li&gt;&lt;li&gt;âž¤ familial lipoprotein lipase deficiency,&lt;/li&gt;&lt;li&gt;âž¤ markedly elevated plasma&lt;/li&gt;&lt;li&gt;âž¤ levels of chylomicrons&lt;/li&gt;&lt;li&gt;âž¤ deficiency of lipoprotein lipase&lt;/li&gt;&lt;li&gt;âž¤ cofactor apolipoprotein C-II.&lt;/li&gt;&lt;li&gt;âž¤ inability to&lt;/li&gt;&lt;li&gt;âž¤ hydrolyze&lt;/li&gt;&lt;li&gt;âž¤ triglycerides&lt;/li&gt;&lt;li&gt;âž¤ chylomicrons&lt;/li&gt;&lt;li&gt;âž¤ high levels of both chylomicrons and triglycerides in the plasma.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p245, 246.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: p245, 246.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents with a two-year history of gradually declining cognitive function. PET imaging reveals widespread amyloid deposition, notably in the striatum. Considering the role of apolipoproteins in Alzheimer&#x27;s disease pathology, which apolipoprotein variant is most closely associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;APOE3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;APOE1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;APOE4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;APOE2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. APOE4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: APOE3 : This is the most common allele of APOE and is considered neutral in terms of Alzheimer&#x27;s risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A: APOE3&lt;/li&gt;&lt;li&gt;â€¢ most common allele of APOE&lt;/li&gt;&lt;li&gt;â€¢ neutral&lt;/li&gt;&lt;li&gt;â€¢ Alzheimer&#x27;s risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B: APOE1 : This is not a commonly recognized allele in the context of Alzheimer&#x27;s disease risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B: APOE1&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ recognized allele&lt;/li&gt;&lt;li&gt;â€¢ Alzheimer&#x27;s disease risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D: APOE2 : This allele is considered to have a protective effect against Alzheimer&#x27;s disease, associated with a lower risk of developing the condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D: APOE2&lt;/li&gt;&lt;li&gt;â€¢ allele&lt;/li&gt;&lt;li&gt;â€¢ protective effect against Alzheimer&#x27;s disease,&lt;/li&gt;&lt;li&gt;â€¢ lower risk&lt;/li&gt;&lt;li&gt;â€¢ developing the condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ APOE4 is a genetic risk factor for Alzheimer&#x27;s disease, associated with increased amyloid deposition in the brain and an elevated risk of developing the disease , particularly at an earlier age.&lt;/li&gt;&lt;li&gt;âž¤ APOE4&lt;/li&gt;&lt;li&gt;âž¤ genetic risk factor&lt;/li&gt;&lt;li&gt;âž¤ Alzheimer&#x27;s disease,&lt;/li&gt;&lt;li&gt;âž¤ increased amyloid deposition&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ elevated&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ disease&lt;/li&gt;&lt;li&gt;âž¤ earlier age.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 46, 275.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 46, 275.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman with poorly controlled type 2 diabetes reports fatigue and difficulty losing weight, without classic symptoms of polyuria, polydipsia, or polyphagia. Her blood sugar levels and lipid profile are abnormal. Considering the relationship between obesity and lipid metabolism, which of the following statements is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Less free fatty acids are delivered from the expanded adipose tissue to the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased insulin levels promote fatty acid synthesis in the liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased Insulin resistance causes increased LPL activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reduced clearance of chylomicron and VLDL due to reduced LPL activity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reduced clearance of chylomicron and VLDL due to reduced LPL activity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Less free fatty acids are delivered from the expanded adipose tissue to the liver: More free fatty acids are delivered from the expanded adipose tissue to the liver&lt;/li&gt;&lt;li&gt;â€¢ Option A: Less free fatty acids are delivered from the expanded adipose tissue to the liver:&lt;/li&gt;&lt;li&gt;â€¢ More free fatty acids&lt;/li&gt;&lt;li&gt;â€¢ expanded adipose tissue&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ Option B: Decreased insulin levels promote fatty acid synthesis in the liver: The increased insulin levels promote fatty acid synthesis in the liver.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Decreased insulin levels promote fatty acid synthesis in the liver:&lt;/li&gt;&lt;li&gt;â€¢ increased insulin levels&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ liver.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Increased Insulin resistance causes increased LPL activity: Increased Insulin resistance causes reduced LPL activity which causes reduced clearance of chylomicron and VLDL â†’  results in hypertriglyceridemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Increased Insulin resistance causes increased LPL activity:&lt;/li&gt;&lt;li&gt;â€¢ Increased Insulin resistance&lt;/li&gt;&lt;li&gt;â€¢ reduced LPL&lt;/li&gt;&lt;li&gt;â€¢ reduced clearance of chylomicron and VLDL&lt;/li&gt;&lt;li&gt;â€¢ hypertriglyceridemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obesity, particularly with insulin resistance , often leads to decreased activity of the enzyme lipoprotein lipase (LPL), impairing fat clearance from the blood and contributing to dyslipidemia . Contrary to other possibilities, this condition typically results in increased free fatty acids to the liver and does not promote fatty acid synthesis due to decreased, not increased, LPL activity.&lt;/li&gt;&lt;li&gt;âž¤ Obesity,&lt;/li&gt;&lt;li&gt;âž¤ insulin resistance&lt;/li&gt;&lt;li&gt;âž¤ leads to decreased activity&lt;/li&gt;&lt;li&gt;âž¤ lipoprotein lipase (LPL),&lt;/li&gt;&lt;li&gt;âž¤ impairing fat&lt;/li&gt;&lt;li&gt;âž¤ clearance&lt;/li&gt;&lt;li&gt;âž¤ blood&lt;/li&gt;&lt;li&gt;âž¤ dyslipidemia&lt;/li&gt;&lt;li&gt;âž¤ Contrary&lt;/li&gt;&lt;li&gt;âž¤ other possibilities,&lt;/li&gt;&lt;li&gt;âž¤ increased free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ does not&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis&lt;/li&gt;&lt;li&gt;âž¤ decreased, not increased, LPL activity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: 351-355.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: 351-355.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man with a sedentary lifestyle presents with abdominal pain. An ultrasound reveals hepatomegaly, and his lipid profile, characterized by a creamy layer over clear plasma 24 hours after collection, indicates elevated triglycerides and cholesterol levels. He is diagnosed with Type I hyperlipoproteinemia. Which of the following is a hallmark feature of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated LDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated lipoprotein lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated chylomicrons&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Elevated chylomicrons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman reports having yellowish, soft lesions at the inner corners of the upper eyelids on both eyes for the past three years. Recently, she has noticed an increase in their size. Based on the described location and appearance of the lesions, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Xanthelasma palpebrarum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Xanthoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arcus senilis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tendinous xanthoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Xanthelasma palpebrarum&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/7_4tAV0dx.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Xanthoma : While xanthomas are also lipid deposits in the skin , they can occur in various parts of the body , not specifically on the eyelids . Xanthelasma is a type of xanthoma that specifically occurs on the eyelids.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Xanthoma&lt;/li&gt;&lt;li&gt;â€¢ lipid deposits&lt;/li&gt;&lt;li&gt;â€¢ skin&lt;/li&gt;&lt;li&gt;â€¢ occur&lt;/li&gt;&lt;li&gt;â€¢ parts of the body&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ eyelids&lt;/li&gt;&lt;li&gt;â€¢ Xanthelasma&lt;/li&gt;&lt;li&gt;â€¢ type of xanthoma&lt;/li&gt;&lt;li&gt;â€¢ eyelids.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Arcus senilis : This is a gray or white arc visible above and below the outer part of the cornea, not on the eyelids , and it&#x27;s typically associated with aging or high cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Arcus senilis&lt;/li&gt;&lt;li&gt;â€¢ gray or white arc&lt;/li&gt;&lt;li&gt;â€¢ above and below&lt;/li&gt;&lt;li&gt;â€¢ cornea, not&lt;/li&gt;&lt;li&gt;â€¢ eyelids&lt;/li&gt;&lt;li&gt;â€¢ aging or high cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Tendinous xanthoma : These are lipid deposits found in tendons , particularly the Achilles tendon , not on the eyelids .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Tendinous xanthoma&lt;/li&gt;&lt;li&gt;â€¢ lipid deposits&lt;/li&gt;&lt;li&gt;â€¢ tendons&lt;/li&gt;&lt;li&gt;â€¢ Achilles tendon&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ eyelids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Xanthelasma palpebrarum is soft, yellowish plaques on the eyelids, indicative of lipid deposition in the skin , which may suggest underlying hyperlipidemia but can also occur in individuals with normal lipid profiles.&lt;/li&gt;&lt;li&gt;âž¤ Xanthelasma palpebrarum&lt;/li&gt;&lt;li&gt;âž¤ soft, yellowish plaques&lt;/li&gt;&lt;li&gt;âž¤ lipid deposition in the skin&lt;/li&gt;&lt;li&gt;âž¤ hyperlipidemia&lt;/li&gt;&lt;li&gt;âž¤ normal lipid profiles.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: P245, 246.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: P245, 246.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old student has been experiencing yellowish discoloration of the palms for the past seven months, with no changes in sclera or mucous membranes and no history of chemical exposure. His lipid profile shows the below results: Laboratory investigations: Total cholesterol: 240 mg/dl (N = &amp;lt; 200 mg/dl) LDL cholesterol: 145 mg/dl (N = &amp;lt; 100 mg/dl) TG: 250 mg/dl (N = 60-150 mg/dl) HDL cholesterol: 45 mg/dl (N = 40-75 mg/dl) Lipoprotein electrophoresis shows a broad beta band. Given these findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial Chylomicronemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type III Hyperlipoproteinemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type IIa Hyperlipoproteinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type III Hyperlipoproteinemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/8_IvdwEdI.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Type III Hyperlipoproteinemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Type III Hyperlipoproteinemia , also known as dysbetalipoproteinemia or broad beta disease , is caused by a defect in apolipoprotein E (apoE) , which impairs the clearance of chylomicron remnants and IDL from the plasma.&lt;/li&gt;&lt;li&gt;â€¢ Type III Hyperlipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ dysbetalipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ broad beta disease&lt;/li&gt;&lt;li&gt;â€¢ apolipoprotein E (apoE)&lt;/li&gt;&lt;li&gt;â€¢ chylomicron remnants and IDL&lt;/li&gt;&lt;li&gt;â€¢ Key features include:&lt;/li&gt;&lt;li&gt;â€¢ Key features include:&lt;/li&gt;&lt;li&gt;â€¢ Elevated total cholesterol and triglycerides (typically both increased) Broad beta band on electrophoresis , due to accumulation of remnant lipoproteins Palmar xanthomas â€” yellowish discoloration or deposits in the creases of the palms Increased risk of premature atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ Elevated total cholesterol and triglycerides (typically both increased)&lt;/li&gt;&lt;li&gt;â€¢ Elevated total cholesterol and triglycerides&lt;/li&gt;&lt;li&gt;â€¢ Broad beta band on electrophoresis , due to accumulation of remnant lipoproteins&lt;/li&gt;&lt;li&gt;â€¢ Broad beta band on electrophoresis&lt;/li&gt;&lt;li&gt;â€¢ Palmar xanthomas â€” yellowish discoloration or deposits in the creases of the palms&lt;/li&gt;&lt;li&gt;â€¢ Palmar xanthomas&lt;/li&gt;&lt;li&gt;â€¢ Increased risk of premature atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ Increased risk of premature atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ This patientâ€™s lipid pattern , broad beta band , and palmar discoloration (xanthomas) are classic for Type III Hyperlipoproteinemia .&lt;/li&gt;&lt;li&gt;â€¢ lipid pattern&lt;/li&gt;&lt;li&gt;â€¢ broad beta band&lt;/li&gt;&lt;li&gt;â€¢ palmar discoloration&lt;/li&gt;&lt;li&gt;â€¢ Type III Hyperlipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial Chylomicronemia (Type I) â€“ Presents with very high triglycerides , creamy plasma , and eruptive xanthomas , usually without a broad beta band. Option C. Abetalipoproteinemia â€“ Features very low or absent apoB-containing lipoproteins , leading to low cholesterol and triglycerides , fat malabsorption , and acanthocytosis . Not seen here. Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia) â€“ Characterized by isolated elevated LDL , normal triglycerides , and tendon xanthomas . Not compatible with this lipid profile.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial Chylomicronemia (Type I) â€“ Presents with very high triglycerides , creamy plasma , and eruptive xanthomas , usually without a broad beta band.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial Chylomicronemia (Type I)&lt;/li&gt;&lt;li&gt;â€¢ very high triglycerides&lt;/li&gt;&lt;li&gt;â€¢ creamy plasma&lt;/li&gt;&lt;li&gt;â€¢ eruptive xanthomas&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abetalipoproteinemia â€“ Features very low or absent apoB-containing lipoproteins , leading to low cholesterol and triglycerides , fat malabsorption , and acanthocytosis . Not seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Abetalipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ very low or absent apoB-containing lipoproteins&lt;/li&gt;&lt;li&gt;â€¢ low cholesterol and triglycerides&lt;/li&gt;&lt;li&gt;â€¢ fat malabsorption&lt;/li&gt;&lt;li&gt;â€¢ acanthocytosis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia) â€“ Characterized by isolated elevated LDL , normal triglycerides , and tendon xanthomas . Not compatible with this lipid profile.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)&lt;/li&gt;&lt;li&gt;â€¢ isolated elevated LDL&lt;/li&gt;&lt;li&gt;â€¢ normal triglycerides&lt;/li&gt;&lt;li&gt;â€¢ tendon xanthomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize Type III Hyperlipoproteinemia by its unique clinical features:&lt;/li&gt;&lt;li&gt;âž¤ Type III Hyperlipoproteinemia&lt;/li&gt;&lt;li&gt;âž¤ Combined elevation of cholesterol and triglycerides Broad beta band on electrophoresis Palmar xanthomas&lt;/li&gt;&lt;li&gt;âž¤ Combined elevation of cholesterol and triglycerides&lt;/li&gt;&lt;li&gt;âž¤ Broad beta band on electrophoresis&lt;/li&gt;&lt;li&gt;âž¤ Broad beta band&lt;/li&gt;&lt;li&gt;âž¤ Palmar xanthomas&lt;/li&gt;&lt;li&gt;âž¤ Palmar xanthomas&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p245, 246.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the listed apolipoproteins, which one serves as an activator for Lecithin Cholesterol Acyltransferase (LCAT), an enzyme critical in the process of cholesterol esterification within high-density lipoprotein (HDL) particles?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Apo B-100&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apo B-48&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apo A-II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Apo A-I&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Apo A-I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-101017.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ INHIBITOR OF ENZYMES: CI inhibits CETP , A-II, C-III inhibits LPL&lt;/li&gt;&lt;li&gt;âž¤ INHIBITOR&lt;/li&gt;&lt;li&gt;âž¤ CI&lt;/li&gt;&lt;li&gt;âž¤ CETP&lt;/li&gt;&lt;li&gt;âž¤ A-II, C-III&lt;/li&gt;&lt;li&gt;âž¤ LPL&lt;/li&gt;&lt;li&gt;âž¤ ACTIVATOR OF ENZYMES: A-I activates LCAT , C-I, II activates LPL&lt;/li&gt;&lt;li&gt;âž¤ ACTIVATOR&lt;/li&gt;&lt;li&gt;âž¤ A-I&lt;/li&gt;&lt;li&gt;âž¤ LCAT&lt;/li&gt;&lt;li&gt;âž¤ C-I, II&lt;/li&gt;&lt;li&gt;âž¤ LPL&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed, pg -272.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed, pg -272.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which human plasma lipoprotein has the highest percentage of triacylglycerol (TAG) by weight?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;VLDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chylomicron&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chylomicron&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HDL â€“ High protein , Phospholipid LDL â€“ High CHL , CHL Esters CM- High TAG (80%) VLDL - TAG (50%)&lt;/li&gt;&lt;li&gt;âž¤ HDL â€“ High protein , Phospholipid&lt;/li&gt;&lt;li&gt;âž¤ High protein , Phospholipid&lt;/li&gt;&lt;li&gt;âž¤ LDL â€“ High CHL , CHL Esters&lt;/li&gt;&lt;li&gt;âž¤ High CHL , CHL Esters&lt;/li&gt;&lt;li&gt;âž¤ CM- High TAG (80%)&lt;/li&gt;&lt;li&gt;âž¤ High TAG (80%)&lt;/li&gt;&lt;li&gt;âž¤ VLDL - TAG (50%)&lt;/li&gt;&lt;li&gt;âž¤ TAG (50%)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed, pg 254&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed, pg 254&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which lipoprotein is predominantly involved in delivering cholesterol to the tissues?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Very low density lipoproteins (VLDLs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low-density lipoproteins (LDLs)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High-density lipoproteins (HDLs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Albumin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low-density lipoproteins (LDLs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Low-density lipoproteins (LDLs) are recognized as the primary carriers of cholesterol in the bloodstream, delivering cholesterol to various tissues for use in cell membranes and other functions. LDLs bind to specific LDL receptors on cell surfaces, facilitating the uptake of cholesterol into cells .&lt;/li&gt;&lt;li&gt;âž¤ Low-density lipoproteins (LDLs)&lt;/li&gt;&lt;li&gt;âž¤ cholesterol in the bloodstream, delivering cholesterol&lt;/li&gt;&lt;li&gt;âž¤ cell membranes and other functions. LDLs&lt;/li&gt;&lt;li&gt;âž¤ specific LDL receptors&lt;/li&gt;&lt;li&gt;âž¤ facilitating&lt;/li&gt;&lt;li&gt;âž¤ uptake&lt;/li&gt;&lt;li&gt;âž¤ cholesterol into cells&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ed: p225.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/ed: p225.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following a substantial meal, an individual&#x27;s metabolic processes adjust to manage the influx of nutrients. In adipocytes, specifically, one enzyme becomes particularly active to facilitate the storage of excess energy. Which enzyme is primarily activated in adipocytes postprandially?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycogen phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycerol kinase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hormone-sensitive triacylglycerol lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphatidate phosphatase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phosphatidate phosphatase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A molecular biologist is explaining to a group of students the unique process through which Apo B48 is produced in the body. This protein is essential for the formation of chylomicrons, which transport dietary lipids from the intestines to other parts of the body. By what mechanism is Apo B48 generated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RNA alternate splicing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RNA editing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA editing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RNA interference&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. RNA editing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-103140.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: RNA alternate splicing : This process involves the removal or inclusion of segments of the pre-mRNA transcript , leading to the production of different mRNA variants and, consequently , different proteins from the same gene. However, it is not the mechanism by which Apo B48 is produced.&lt;/li&gt;&lt;li&gt;â€¢ Option A: RNA alternate splicing&lt;/li&gt;&lt;li&gt;â€¢ removal or inclusion&lt;/li&gt;&lt;li&gt;â€¢ pre-mRNA transcript&lt;/li&gt;&lt;li&gt;â€¢ different mRNA variants&lt;/li&gt;&lt;li&gt;â€¢ , different proteins from the same gene.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Apo B48&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA editing : DNA editing refers to direct changes to the DNA sequence itself , which is not applicable in the case of Apo B48 production .&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA editing&lt;/li&gt;&lt;li&gt;â€¢ direct changes to the DNA sequence itself&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ case of Apo B48 production&lt;/li&gt;&lt;li&gt;â€¢ Option D: RNA interference : RNA interference is a biological process in which RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. It does not involve the production of Apo B48 .&lt;/li&gt;&lt;li&gt;â€¢ Option D: RNA interference&lt;/li&gt;&lt;li&gt;â€¢ biological process&lt;/li&gt;&lt;li&gt;â€¢ RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules.&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ Apo B48&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Apo B48 is generated through RNA editing, a post-transcriptional modification that alters the nucleotide sequence of the RNA , resulting in a shorter protein variant crucial for chylomicron formation in the intestines.&lt;/li&gt;&lt;li&gt;âž¤ Apo B48&lt;/li&gt;&lt;li&gt;âž¤ RNA editing, a post-transcriptional modification&lt;/li&gt;&lt;li&gt;âž¤ nucleotide&lt;/li&gt;&lt;li&gt;âž¤ RNA&lt;/li&gt;&lt;li&gt;âž¤ shorter protein variant&lt;/li&gt;&lt;li&gt;âž¤ chylomicron formation in the intestines.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p226.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: p226.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A clinician is treating a patient presenting with tendon xanthomas, elevated LDL levels, and high serum cholesterol. The patient has been prescribed lovastatin, a cholesterol-lowering medication. Based on these clinical features, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LPL deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tangier disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial hypercholesterolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Familial hypercholesterolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: LPL deficiency : Lipoprotein lipase (LPL) deficiency leads to elevated chylomicrons , causing high triglycerides but not typically resulting in high LDL or tendon xanthomas .&lt;/li&gt;&lt;li&gt;â€¢ Option A: LPL deficiency&lt;/li&gt;&lt;li&gt;â€¢ elevated chylomicrons&lt;/li&gt;&lt;li&gt;â€¢ high triglycerides&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ high LDL or tendon xanthomas&lt;/li&gt;&lt;li&gt;â€¢ Option B: Tangier disease : Characterized by very low levels of high-density lipoprotein (HDL) and can lead to the deposition of cholesterol in tissues, but it does not typically present with elevated LDL levels and tendon xanthomas.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Tangier disease&lt;/li&gt;&lt;li&gt;â€¢ very low levels of high-density lipoprotein (HDL)&lt;/li&gt;&lt;li&gt;â€¢ deposition&lt;/li&gt;&lt;li&gt;â€¢ cholesterol&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ elevated LDL levels&lt;/li&gt;&lt;li&gt;â€¢ tendon xanthomas.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Abetalipoproteinemia : A rare condition characterized by the absence of apolipoprotein B -containing lipoproteins , leading to fat malabsorption and neurological symptoms , not high LDL or cholesterol levels .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Abetalipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ rare&lt;/li&gt;&lt;li&gt;â€¢ absence of apolipoprotein B&lt;/li&gt;&lt;li&gt;â€¢ lipoproteins&lt;/li&gt;&lt;li&gt;â€¢ fat malabsorption&lt;/li&gt;&lt;li&gt;â€¢ neurological&lt;/li&gt;&lt;li&gt;â€¢ , not high LDL or cholesterol levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation and appropriate treatment for familial hypercholesterolemia, includes high LDL cholesterol, tendon xanthomas , and the use of statin medications like lovastatin to lower cholesterol levels .&lt;/li&gt;&lt;li&gt;âž¤ familial hypercholesterolemia,&lt;/li&gt;&lt;li&gt;âž¤ high LDL cholesterol, tendon xanthomas&lt;/li&gt;&lt;li&gt;âž¤ use of statin&lt;/li&gt;&lt;li&gt;âž¤ lovastatin to lower cholesterol levels&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p245, 246.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: p245, 246.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man with abetalipoproteinemia presents with an abnormal blood picture showing acanthocytes, alongside symptoms of hyperkeratosis, acrodermatitis, and hypercholesterolemia. Considering the pathophysiology of abetalipoproteinemia and the patient&#x27;s symptoms, the abnormal red cell morphology and associated clinical manifestations are most likely due to the malabsorption of which essential nutrient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ascorbic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Folic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arachidonic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linoleic acid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Linoleic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Abetalipoproteinemia is a disorder characterized by the malabsorption and deficiency of fat-soluble vitamins and essential fatty acids , due to the inability to properly synthesize and secrete apolipoprotein B-containing lipoproteins.&lt;/li&gt;&lt;li&gt;âž¤ Abetalipoproteinemia&lt;/li&gt;&lt;li&gt;âž¤ malabsorption and deficiency of fat-soluble vitamins&lt;/li&gt;&lt;li&gt;âž¤ essential fatty&lt;/li&gt;&lt;li&gt;âž¤ acids&lt;/li&gt;&lt;li&gt;âž¤ inability&lt;/li&gt;&lt;li&gt;âž¤ synthesize&lt;/li&gt;&lt;li&gt;âž¤ secrete apolipoprotein B-containing lipoproteins.&lt;/li&gt;&lt;li&gt;âž¤ Linoleic acid is a polyunsaturated fatty acid crucial for maintaining membrane integrity and function, including that of red blood cells. The deficiency in linoleic acid disrupts normal membrane structure , leading to the formation of acanthocytes.&lt;/li&gt;&lt;li&gt;âž¤ Linoleic acid&lt;/li&gt;&lt;li&gt;âž¤ polyunsaturated fatty acid&lt;/li&gt;&lt;li&gt;âž¤ membrane integrity and function,&lt;/li&gt;&lt;li&gt;âž¤ red blood&lt;/li&gt;&lt;li&gt;âž¤ cells.&lt;/li&gt;&lt;li&gt;âž¤ deficiency in linoleic acid disrupts&lt;/li&gt;&lt;li&gt;âž¤ membrane structure&lt;/li&gt;&lt;li&gt;âž¤ leading&lt;/li&gt;&lt;li&gt;âž¤ acanthocytes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 182, 363.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 6/e: p 182, 363.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with abdominal pain is found to have hepatomegaly via ultrasound. On examination, he exhibits skin findings as shown in the image, with a blood sample that appears creamy and shows elevated triglycerides levels. Based on the clinical presentation and laboratory findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Broad beta disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abetalipoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial Hyper Chylomicronemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial Hypercholesterolemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Familial Hyper Chylomicronemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/11_XE3FVIl.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Familial Hyper Chylomicronemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Familial Hyper Chylomicronemia Syndrome (also known as Type I Hyperlipoproteinemia ) is a rare autosomal recessive disorder caused by lipoprotein lipase (LPL) deficiency or dysfunction, or by apo C-II deficiency , which is a necessary cofactor for LPL activation.&lt;/li&gt;&lt;li&gt;â€¢ Familial&lt;/li&gt;&lt;li&gt;â€¢ Chylomicronemia Syndrome&lt;/li&gt;&lt;li&gt;â€¢ Type I Hyperlipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ rare autosomal recessive disorder&lt;/li&gt;&lt;li&gt;â€¢ lipoprotein lipase (LPL) deficiency&lt;/li&gt;&lt;li&gt;â€¢ apo C-II deficiency&lt;/li&gt;&lt;li&gt;â€¢ Key clinical features:&lt;/li&gt;&lt;li&gt;â€¢ Key clinical features:&lt;/li&gt;&lt;li&gt;â€¢ Eruptive xanthomas (small, yellow papules, especially on the buttocks or extensor surfaces) Hepatomegaly Recurrent abdominal pain (may be related to pancreatitis) Milky or creamy plasma appearance Very high serum triglyceride levels , often &amp;gt;1000 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Eruptive xanthomas (small, yellow papules, especially on the buttocks or extensor surfaces)&lt;/li&gt;&lt;li&gt;â€¢ Eruptive xanthomas&lt;/li&gt;&lt;li&gt;â€¢ Hepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ Hepatomegaly&lt;/li&gt;&lt;li&gt;â€¢ Recurrent abdominal pain (may be related to pancreatitis)&lt;/li&gt;&lt;li&gt;â€¢ Recurrent abdominal pain&lt;/li&gt;&lt;li&gt;â€¢ Milky or creamy plasma appearance&lt;/li&gt;&lt;li&gt;â€¢ Milky or creamy plasma&lt;/li&gt;&lt;li&gt;â€¢ Very high serum triglyceride levels , often &amp;gt;1000 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Very high serum triglyceride levels&lt;/li&gt;&lt;li&gt;â€¢ Although this condition typically presents in childhood or adolescence , adult presentations can occur, especially if the diagnosis is delayed or partial enzyme activity exists.&lt;/li&gt;&lt;li&gt;â€¢ childhood or adolescence&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Broad Beta Disease (Type III Hyperlipoproteinemia) â€“ Associated with palmar xanthomas and elevated remnants . Presents with increased cardiovascular risk . Option B: Abetalipoproteinemia â€“ Features very low serum triglycerides and cholesterol , acanthocytosis , fat malabsorption , and retinal degeneration . Plasma is not creamy. Option D: Familial Hypercholesterolemia (Type IIa) â€“ Caused by LDL receptor mutations , presents with tendinous xanthomas , corneal arcus , and very high LDL cholesterol levels. Triglycerides are usually normal.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Broad Beta Disease (Type III Hyperlipoproteinemia) â€“ Associated with palmar xanthomas and elevated remnants . Presents with increased cardiovascular risk .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Broad Beta Disease (Type III Hyperlipoproteinemia)&lt;/li&gt;&lt;li&gt;â€¢ palmar xanthomas&lt;/li&gt;&lt;li&gt;â€¢ remnants&lt;/li&gt;&lt;li&gt;â€¢ increased cardiovascular risk&lt;/li&gt;&lt;li&gt;â€¢ Option B: Abetalipoproteinemia â€“ Features very low serum triglycerides and cholesterol , acanthocytosis , fat malabsorption , and retinal degeneration . Plasma is not creamy.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Abetalipoproteinemia&lt;/li&gt;&lt;li&gt;â€¢ very low serum triglycerides and cholesterol&lt;/li&gt;&lt;li&gt;â€¢ acanthocytosis&lt;/li&gt;&lt;li&gt;â€¢ fat malabsorption&lt;/li&gt;&lt;li&gt;â€¢ retinal degeneration&lt;/li&gt;&lt;li&gt;â€¢ Option D: Familial Hypercholesterolemia (Type IIa) â€“ Caused by LDL receptor mutations , presents with tendinous xanthomas , corneal arcus , and very high LDL cholesterol levels. Triglycerides are usually normal.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Familial Hypercholesterolemia (Type IIa)&lt;/li&gt;&lt;li&gt;â€¢ LDL receptor mutations&lt;/li&gt;&lt;li&gt;â€¢ tendinous xanthomas&lt;/li&gt;&lt;li&gt;â€¢ corneal arcus&lt;/li&gt;&lt;li&gt;â€¢ very high LDL cholesterol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize Familial Chylomicronemia Syndrome by:&lt;/li&gt;&lt;li&gt;âž¤ Familial Chylomicronemia Syndrome&lt;/li&gt;&lt;li&gt;âž¤ Eruptive xanthomas Creamy plasma with markedly elevated triglycerides&lt;/li&gt;&lt;li&gt;âž¤ Eruptive xanthomas&lt;/li&gt;&lt;li&gt;âž¤ Eruptive xanthomas&lt;/li&gt;&lt;li&gt;âž¤ Creamy plasma with markedly elevated triglycerides&lt;/li&gt;&lt;li&gt;âž¤ Creamy plasma with markedly elevated triglycerides&lt;/li&gt;&lt;li&gt;âž¤ It reflects a defect in chylomicron clearance , due to LPL enzyme deficiency or its apo C-II cofactor , resulting in accumulation of triglyceride-rich lipoproteins in plasma.&lt;/li&gt;&lt;li&gt;âž¤ chylomicron clearance&lt;/li&gt;&lt;li&gt;âž¤ LPL enzyme deficiency or its apo C-II cofactor&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 275.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician is advising a patient on target LDL cholesterol levels for optimal cardiovascular health. what is the recommended upper limit for LDL cholesterol in mg/dl?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;130&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;100&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;75&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;50&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 100&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. 100&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ For optimal cardiovascular health, particularly in primary prevention (patients without existing cardiovascular disease), the recommended upper limit for LDL cholesterol is typically â‰¤100 mg/dL.&lt;/li&gt;&lt;li&gt;â€¢ optimal cardiovascular health,&lt;/li&gt;&lt;li&gt;â€¢ primary prevention&lt;/li&gt;&lt;li&gt;â€¢ recommended upper limit for LDL cholesterol is typically â‰¤100 mg/dL.&lt;/li&gt;&lt;li&gt;â€¢ Key guidelines (such as those from the American Heart Association and NCEP ATP III ) suggest:&lt;/li&gt;&lt;li&gt;â€¢ American Heart Association&lt;/li&gt;&lt;li&gt;â€¢ NCEP ATP III&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;100 mg/dL: Optimal LDL level 100â€“129 mg/dL: Near or above optimal 130â€“159 mg/dL: Borderline high 160â€“189 mg/dL: High â‰¥190 mg/dL: Very high&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;100 mg/dL: Optimal LDL level&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;100 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ 100â€“129 mg/dL: Near or above optimal&lt;/li&gt;&lt;li&gt;â€¢ 100â€“129 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ 130â€“159 mg/dL: Borderline high&lt;/li&gt;&lt;li&gt;â€¢ 130â€“159 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ 160â€“189 mg/dL: High&lt;/li&gt;&lt;li&gt;â€¢ 160â€“189 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ â‰¥190 mg/dL: Very high&lt;/li&gt;&lt;li&gt;â€¢ â‰¥190 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 130 mg/dL: This is considered borderline high for LDL, not the optimal upper limit. Option C. 75 mg/dL: itâ€™s below the general upper limit for most patients. Option D. 50 mg/dL: Not a standard upper limit; too low for general recommendation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 130 mg/dL: This is considered borderline high for LDL, not the optimal upper limit.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 130 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ borderline high&lt;/li&gt;&lt;li&gt;â€¢ Option C. 75 mg/dL: itâ€™s below the general upper limit for most patients.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 75 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ below the general upper limit&lt;/li&gt;&lt;li&gt;â€¢ Option D. 50 mg/dL: Not a standard upper limit; too low for general recommendation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 50 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ too low&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ Understand that &amp;lt;100 mg/dL is the widely recommended upper limit for LDL cholesterol in general cardiovascular prevention.&lt;/li&gt;&lt;li&gt;âž¤ Understand that &amp;lt;100 mg/dL is the widely recommended upper limit for LDL cholesterol in general cardiovascular prevention.&lt;/li&gt;&lt;li&gt;âž¤ &amp;lt;100 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ upper limit&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a clinical discussion on the diagnostic significance of various lipoproteins, a medical instructor inquires about the clinical condition associated with elevated levels of Lipoprotein X. Which condition is indicated by the presence of Lipoprotein X?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atherosclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholestasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cholestasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein X is an abnormal lipoprotein that is often present in the plasma of patients with cholestasis, a condition characterized by impaired bile flow. The accumulation of lipids that are normally excreted in bile leads to the formation of this atypical lipoprotein . Its detection can serve as an indicator of cholestatic liver disease.&lt;/li&gt;&lt;li&gt;âž¤ Lipoprotein X&lt;/li&gt;&lt;li&gt;âž¤ abnormal lipoprotein&lt;/li&gt;&lt;li&gt;âž¤ plasma of patients with cholestasis,&lt;/li&gt;&lt;li&gt;âž¤ impaired bile flow.&lt;/li&gt;&lt;li&gt;âž¤ accumulation of lipids&lt;/li&gt;&lt;li&gt;âž¤ normally excreted in bile&lt;/li&gt;&lt;li&gt;âž¤ atypical&lt;/li&gt;&lt;li&gt;âž¤ lipoprotein&lt;/li&gt;&lt;li&gt;âž¤ detection&lt;/li&gt;&lt;li&gt;âž¤ indicator of cholestatic liver disease.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p 229.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: p 229.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician is consulting a patient about his elevated triglyceride levels. The patient is non-diabetic and has no history of alcohol overuse, factors known to influence triglyceride levels. The physician explains that a certain lipoprotein is primarily responsible for transporting triglycerides synthesized by the liver. Which lipoprotein does the liver use to transport these endogenous triglycerides?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chylomicrons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;VLDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. VLDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-110237.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) VLDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Chylomicrons : These transport dietary, or exogenous, lipids from the intestines to other tissues in the body after a meal.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Chylomicrons&lt;/li&gt;&lt;li&gt;â€¢ transport dietary, or exogenous, lipids&lt;/li&gt;&lt;li&gt;â€¢ intestines to other tissues&lt;/li&gt;&lt;li&gt;â€¢ meal.&lt;/li&gt;&lt;li&gt;â€¢ Option C: LDL : Primarily carries cholesterol to the body&#x27;s cells rather than triacylglycerol.&lt;/li&gt;&lt;li&gt;â€¢ Option C: LDL&lt;/li&gt;&lt;li&gt;â€¢ cholesterol to the body&#x27;s cells&lt;/li&gt;&lt;li&gt;â€¢ Option D: HDL : Involved in reverse cholesterol transport, carrying cholesterol from the tissues back to the liver , and is not a primary carrier of triacylglycerol.&lt;/li&gt;&lt;li&gt;â€¢ Option D: HDL&lt;/li&gt;&lt;li&gt;â€¢ reverse cholesterol transport,&lt;/li&gt;&lt;li&gt;â€¢ cholesterol from the tissues back to the liver&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ triacylglycerol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9 /ed: p 226.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9 /ed: p 226.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): In well-fed state, activity of acetyl CoA carboxylase activity is increased. Reasoning (R): Citrate produced from acetyl CoA in well-fed state acts as an allosteric activator of acetyl CoA carboxylase:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A as well as R are right, and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/picture22_WBxHtRE.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA carboxylase is an enzyme crucial in fatty acid synthesis. In a well-fed state, the abundance of acetyl CoA leads to the production of citrate , which can be transported out of the mitochondria into the cytosol .&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA carboxylase&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ well-fed state,&lt;/li&gt;&lt;li&gt;âž¤ acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ citrate&lt;/li&gt;&lt;li&gt;âž¤ out&lt;/li&gt;&lt;li&gt;âž¤ mitochondria into the cytosol&lt;/li&gt;&lt;li&gt;âž¤ Citrate serves as an allosteric activator of acetyl CoA carboxylase , increasing its activity. This upregulation is consistent with the body&#x27;s shift toward anabolic processes , like fatty acid synthesis , when there is a surplus of energy .&lt;/li&gt;&lt;li&gt;âž¤ Citrate&lt;/li&gt;&lt;li&gt;âž¤ allosteric activator of acetyl CoA carboxylase&lt;/li&gt;&lt;li&gt;âž¤ increasing&lt;/li&gt;&lt;li&gt;âž¤ activity.&lt;/li&gt;&lt;li&gt;âž¤ upregulation&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s shift toward anabolic processes&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis&lt;/li&gt;&lt;li&gt;âž¤ surplus of energy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 237-238&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 237-238&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following statement is correct regarding fatty acid synthase complex in mammals:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a dimer made of non-identical subunits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Two subunits are in parallel direction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intermediates of the reaction canâ€™t interact with enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;One gene codes for all the enzymes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. One gene codes for all the enzymes&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-111321.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a dimer with non-identical subunits: Is a homodimer with two identical polypeptide monomers .&lt;/li&gt;&lt;li&gt;â€¢ Option A: It is a dimer with non-identical subunits:&lt;/li&gt;&lt;li&gt;â€¢ homodimer&lt;/li&gt;&lt;li&gt;â€¢ two identical polypeptide monomers&lt;/li&gt;&lt;li&gt;â€¢ Option B: Two subunits are in parallel direction: Antiparallel direction (Head to tail)&lt;/li&gt;&lt;li&gt;â€¢ Option B: Two subunits are in parallel direction:&lt;/li&gt;&lt;li&gt;â€¢ Antiparallel direction&lt;/li&gt;&lt;li&gt;â€¢ Option C: Intermediates of the reaction canâ€™t interact with enzymes: Intermediates can interact with the active sites of the enzymes .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Intermediates of the reaction canâ€™t interact with enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Intermediates&lt;/li&gt;&lt;li&gt;â€¢ interact&lt;/li&gt;&lt;li&gt;â€¢ active sites of the enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The fatty acid synthase complex in mammals is a large, multifunctional enzyme complex . Each subunit of the dimeric complex contains all the enzymatic activities necessary for fatty acid synthesis . In mammals, a single gene codes for a polypeptide that has all the enzymatic activities required for the fatty acid synthesis cycle.&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthase complex&lt;/li&gt;&lt;li&gt;âž¤ large, multifunctional enzyme complex&lt;/li&gt;&lt;li&gt;âž¤ subunit&lt;/li&gt;&lt;li&gt;âž¤ dimeric complex&lt;/li&gt;&lt;li&gt;âž¤ enzymatic activities&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis&lt;/li&gt;&lt;li&gt;âž¤ single gene&lt;/li&gt;&lt;li&gt;âž¤ polypeptide&lt;/li&gt;&lt;li&gt;âž¤ all&lt;/li&gt;&lt;li&gt;âž¤ enzymatic activities&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis cycle.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 233-234&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 233-234&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team studying metabolic responses to nutrient deprivation measures enzymatic activities in subjects after a 24-hour fast. They aim to determine which enzyme associated with lipid metabolism shows decreased activity in this energy-conserving state. Which enzyme is the research team least likely to find elevated in the fasting state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CPSâ€“I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hormone sensitive lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycogen Phosphorylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetyl CoA carboxylase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acetyl CoA carboxylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During fasting , the body downregulates enzymes involved in synthesizing storage compounds, such as acetyl CoA carboxylase, while upregulating enzymes that facilitate the mobilization of stored nutrients, like hormone-sensitive lipase and glycogen phosphorylase.&lt;/li&gt;&lt;li&gt;âž¤ During fasting&lt;/li&gt;&lt;li&gt;âž¤ downregulates&lt;/li&gt;&lt;li&gt;âž¤ synthesizing storage&lt;/li&gt;&lt;li&gt;âž¤ acetyl CoA carboxylase,&lt;/li&gt;&lt;li&gt;âž¤ upregulating enzymes&lt;/li&gt;&lt;li&gt;âž¤ facilitate&lt;/li&gt;&lt;li&gt;âž¤ stored nutrients,&lt;/li&gt;&lt;li&gt;âž¤ hormone-sensitive lipase&lt;/li&gt;&lt;li&gt;âž¤ glycogen phosphorylase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 238&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 238&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which fatty acid listed below is not synthesized in humans and is considered essential?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Palmitoleic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Linoleic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oleic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stearic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Linoleic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Linoleic acid is an essential fatty acid because humans lack the enzymes necessary to insert a double bond at the omega-6 position of fatty acid chains. As a result, linoleic acid , an omega-6 fatty acid , must be obtained from the diet .&lt;/li&gt;&lt;li&gt;âž¤ Linoleic acid&lt;/li&gt;&lt;li&gt;âž¤ essential fatty acid&lt;/li&gt;&lt;li&gt;âž¤ lack&lt;/li&gt;&lt;li&gt;âž¤ enzymes&lt;/li&gt;&lt;li&gt;âž¤ insert&lt;/li&gt;&lt;li&gt;âž¤ double bond&lt;/li&gt;&lt;li&gt;âž¤ omega-6 position&lt;/li&gt;&lt;li&gt;âž¤ linoleic acid&lt;/li&gt;&lt;li&gt;âž¤ omega-6 fatty acid&lt;/li&gt;&lt;li&gt;âž¤ obtained&lt;/li&gt;&lt;li&gt;âž¤ diet&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p187.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p187.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is exploring the development of inhibitors targeting the initial steps of fatty acid synthesis for potential obesity treatments. They are particularly interested in the first committed step of this pathway, where acetyl-CoA is converted to malonyl-CoA. As they consider potential target sites for inhibition, they need to identify the essential cofactor involved in this enzymatic reaction. Which cofactor is utilized during this conversion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiamine pyrophosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acyl carrier protein (ACP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NAD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biotin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Biotin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/1_lvV2jET.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thiamine pyrophosphate : This cofactor is involved in decarboxylation reactions , such as those seen in the citric acid cycle , not in the carboxylation of acetyl-CoA to malonyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Thiamine pyrophosphate&lt;/li&gt;&lt;li&gt;â€¢ cofactor&lt;/li&gt;&lt;li&gt;â€¢ decarboxylation reactions&lt;/li&gt;&lt;li&gt;â€¢ citric acid cycle&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ carboxylation of acetyl-CoA to malonyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acyl carrier protein (ACP) : ACP is involved in fatty acid synthesis , but it does not function as a cofactor in the acetyl-CoA to malonyl-CoA conversion . Instead, it serves as a scaffold that carries the growing fatty acid chain.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acyl carrier protein (ACP)&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ cofactor in the acetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ malonyl-CoA conversion&lt;/li&gt;&lt;li&gt;â€¢ scaffold&lt;/li&gt;&lt;li&gt;â€¢ growing fatty acid chain.&lt;/li&gt;&lt;li&gt;â€¢ Option C: NAD : Nicotinamide adenine dinucleotide (NAD) is typically involved in oxidation-reduction reactions within the cell, not directly in the carboxylation reaction of acetyl-CoA carboxylase .&lt;/li&gt;&lt;li&gt;â€¢ Option C: NAD&lt;/li&gt;&lt;li&gt;â€¢ oxidation-reduction reactions&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ carboxylation reaction of acetyl-CoA carboxylase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The role of biotin is a cofactor in the carboxylation reaction catalyzed by acetyl-CoA carboxylase during the initial step of fatty acid synthesis .&lt;/li&gt;&lt;li&gt;âž¤ biotin is a cofactor&lt;/li&gt;&lt;li&gt;âž¤ carboxylation&lt;/li&gt;&lt;li&gt;âž¤ catalyzed&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA carboxylase&lt;/li&gt;&lt;li&gt;âž¤ initial&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed,p 233&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed,p 233&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the metabolic pathway that specifically utilizes NADPH as a reducing agent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fatty acid synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ketone synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fatty acid synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fatty acid synthesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid synthesis require Cofactors like: NADPH, ATP, Mn 2+ , HCO 3 - , Biotin&lt;/li&gt;&lt;li&gt;âž¤ Fatty acid synthesis require Cofactors like: NADPH, ATP, Mn 2+ , HCO 3 - , Biotin&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,p 232&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed ,p 232&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify which of the following is not utilized in the synthesis of fatty acids:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NADPH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FADH 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HCO 3 -&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FADH 2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Two major enzyme complexes are involved in the synthesis of fatty acids. The first is acetyl-CoA carboxylase , which synthesizes malonyl-CoA by  the  steps shown below for the synthesis of palmitate: 7 acetyl-CoA + 7 HCO 3 - + 7 ATP â†’ 7 malonyl-CoA + 7 ADP + 7 P i Using the malonyl-CoA, palmitate is then synthesized by seven cycles of the fatty acid synthetase complex, whose stoichiometry is summarized below: acetyl-CoA + 7 malonyl-CoA + 14 NADPH â†’ palmitate + 7 CO 2 +14 NAD + + 8 CoA + 6 H 2 O As can be seen from the equations above, the necessary amount of malonyl-CoA is synthesized. Palmitate is subsequently synthesized from malonyl-CoA and one initial acetyl-CoA. Thus, acetyl-CoA, NADPH, ATP, and HCO 3 - are all necessary in this process.&lt;/li&gt;&lt;li&gt;âž¤ Two major enzyme complexes are involved in the synthesis of fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ Two major enzyme complexes&lt;/li&gt;&lt;li&gt;âž¤ synthesis of fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ The first is acetyl-CoA carboxylase , which synthesizes malonyl-CoA by  the  steps shown below for the synthesis of palmitate:&lt;/li&gt;&lt;li&gt;âž¤ first&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA carboxylase&lt;/li&gt;&lt;li&gt;âž¤ synthesizes malonyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ below&lt;/li&gt;&lt;li&gt;âž¤ synthesis of&lt;/li&gt;&lt;li&gt;âž¤ palmitate:&lt;/li&gt;&lt;li&gt;âž¤ 7 acetyl-CoA + 7 HCO 3 - + 7 ATP â†’ 7 malonyl-CoA + 7 ADP + 7 P i&lt;/li&gt;&lt;li&gt;âž¤ 7 acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ HCO 3&lt;/li&gt;&lt;li&gt;âž¤ ATP&lt;/li&gt;&lt;li&gt;âž¤ 7 malonyl-CoA + 7 ADP + 7 P i&lt;/li&gt;&lt;li&gt;âž¤ Using the malonyl-CoA, palmitate is then synthesized by seven cycles of the fatty acid synthetase complex, whose stoichiometry is summarized below:&lt;/li&gt;&lt;li&gt;âž¤ malonyl-CoA, palmitate&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ seven cycles&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthetase complex,&lt;/li&gt;&lt;li&gt;âž¤ stoichiometry&lt;/li&gt;&lt;li&gt;âž¤ below:&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA + 7 malonyl-CoA + 14 NADPH â†’ palmitate + 7 CO 2 +14 NAD + + 8 CoA + 6 H 2 O&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA + 7 malonyl-CoA + 14 NADPH&lt;/li&gt;&lt;li&gt;âž¤ palmitate + 7 CO 2 +14 NAD + + 8 CoA + 6 H 2 O&lt;/li&gt;&lt;li&gt;âž¤ As can be seen from the equations above, the necessary amount of malonyl-CoA is synthesized. Palmitate is subsequently synthesized from malonyl-CoA and one initial acetyl-CoA. Thus, acetyl-CoA, NADPH, ATP, and HCO 3 - are all necessary in this process.&lt;/li&gt;&lt;li&gt;âž¤ necessary amount of malonyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ synthesized.&lt;/li&gt;&lt;li&gt;âž¤ Palmitate&lt;/li&gt;&lt;li&gt;âž¤ synthesized from malonyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ one initial acetyl-CoA.&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA, NADPH, ATP, and HCO 3 - are all necessary in this process.&lt;/li&gt;&lt;li&gt;âž¤ Ref: DM Vasudevan 9/e: p 156-160&lt;/li&gt;&lt;li&gt;âž¤ Ref:&lt;/li&gt;&lt;li&gt;âž¤ DM Vasudevan 9/e: p 156-160&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A group of researchers is exploring potential targets for the development of a new class of weight management drugs focused on inhibiting lipogenesis. In their discussions, they examine key regulatory enzymes within the fatty acid synthesis pathway. Which enzyme is recognized as the most crucial in regulating lipogenesis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetyl-CoA carboxylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medium-chain acetyl-CoA dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Short chain enoyl reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Long-chain enoyl hydratase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acetyl-CoA carboxylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acetyl-CoA carboxylase catalyzes the first step of lipogenesis in which acetyl-CoA is linked to malonyl-CoA. It is the rate limiting and regulatory enzyme of fatty acid synthesis . It is activated by citrate and inhibited by palmitate.&lt;/li&gt;&lt;li&gt;âž¤ Acetyl-CoA carboxylase&lt;/li&gt;&lt;li&gt;âž¤ first step of lipogenesis&lt;/li&gt;&lt;li&gt;âž¤ acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ malonyl-CoA.&lt;/li&gt;&lt;li&gt;âž¤ rate limiting&lt;/li&gt;&lt;li&gt;âž¤ regulatory enzyme of fatty acid synthesis&lt;/li&gt;&lt;li&gt;âž¤ activated by citrate&lt;/li&gt;&lt;li&gt;âž¤ inhibited by palmitate.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 158&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 158&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a laboratory studying cellular lipid metabolism, scientists are investigating the enzymatic pathways responsible for fatty acid modification. A particular focus is on understanding where in the cell long-chain fatty acids undergo elongation to produce extended lipid species. Which organelle is central to this process?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoplasmic reticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Golgi body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysosomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ribosomes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Endoplasmic reticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Microsomal system (microsomal fatty acid elongase system) elongates saturated or unsaturated fatty acyl CoA by addition of two-carbon units successively. Donor of 2 carbon acetyl groups: Malonyl CoA. NADPH is needed for the reaction. This system can elongate FA having 10C units onwards up to the length of 22 or 24C.&lt;/li&gt;&lt;li&gt;âž¤ The Microsomal system (microsomal fatty acid elongase system) elongates saturated or unsaturated fatty acyl CoA by addition of two-carbon units successively.&lt;/li&gt;&lt;li&gt;âž¤ Microsomal system (microsomal fatty acid elongase system)&lt;/li&gt;&lt;li&gt;âž¤ elongates saturated or unsaturated fatty acyl CoA&lt;/li&gt;&lt;li&gt;âž¤ two-carbon units&lt;/li&gt;&lt;li&gt;âž¤ Donor of 2 carbon acetyl groups: Malonyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ Donor&lt;/li&gt;&lt;li&gt;âž¤ 2 carbon&lt;/li&gt;&lt;li&gt;âž¤ acetyl groups: Malonyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ NADPH is needed for the reaction.&lt;/li&gt;&lt;li&gt;âž¤ NADPH&lt;/li&gt;&lt;li&gt;âž¤ reaction.&lt;/li&gt;&lt;li&gt;âž¤ This system can elongate FA having 10C units onwards up to the length of 22 or 24C.&lt;/li&gt;&lt;li&gt;âž¤ elongate FA having 10C units&lt;/li&gt;&lt;li&gt;âž¤ up to&lt;/li&gt;&lt;li&gt;âž¤ 22 or 24C.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 186&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 186&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Fatty acid synthesis occurs outside the mitochondria. Is this statement true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TRUE&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FALSE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;True/False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. TRUE&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid synthesis is indeed an extra-mitochondrial process, primarily occurring in the cytoplasm of cells. The cytoplasm houses the necessary enzymes for the de novo synthesis of fatty acids , distinguishing this pathway from mitochondrial processes like fatty acid oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ extra-mitochondrial process, primarily&lt;/li&gt;&lt;li&gt;â€¢ cytoplasm&lt;/li&gt;&lt;li&gt;â€¢ de novo synthesis of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ distinguishing&lt;/li&gt;&lt;li&gt;â€¢ pathway from mitochondrial processes&lt;/li&gt;&lt;li&gt;â€¢ fatty&lt;/li&gt;&lt;li&gt;â€¢ acid oxidation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fatty acids are synthesized mainly by a de novo synthetic pathway operating in cytoplasm . So, it is referred to as an extramitochondrial or cytoplasmic fatty acid synthase system.&lt;/li&gt;&lt;li&gt;âž¤ Fatty acids&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ de novo synthetic pathway&lt;/li&gt;&lt;li&gt;âž¤ cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ extramitochondrial or cytoplasmic fatty acid synthase system.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 156&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 156&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is primarily responsible for hydrolyzing stored triacylglycerols in adipose tissue to release fatty acids for energy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pancreatic Lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lipoprotein Lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lysosomal Lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hormone sensitive Lipase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hormone sensitive Lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pancreatic Lipase : This enzyme functions primarily in the digestive system to break down dietary fats into free fatty acids and monoglycerides , which can then be absorbed by the intestinal mucosa. It is not involved in the mobilization of stored triacylglycerols within adipose tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pancreatic Lipase&lt;/li&gt;&lt;li&gt;â€¢ digestive system&lt;/li&gt;&lt;li&gt;â€¢ dietary fats&lt;/li&gt;&lt;li&gt;â€¢ free fatty acids&lt;/li&gt;&lt;li&gt;â€¢ monoglycerides&lt;/li&gt;&lt;li&gt;â€¢ absorbed&lt;/li&gt;&lt;li&gt;â€¢ intestinal mucosa.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ mobilization of stored&lt;/li&gt;&lt;li&gt;â€¢ triacylglycerols&lt;/li&gt;&lt;li&gt;â€¢ adipose tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lipoprotein Lipase : Found on the surface of endothelial cells lining blood vessels, lipoprotein lipase acts on circulating lipoproteins , such as chylomicrons and VLDL, hydrolyzing their triglycerides to release free fatty acids for uptake by adjacent tissues. It is not directly involved in hydrolyzing stored triacylglycerols within adipocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lipoprotein Lipase&lt;/li&gt;&lt;li&gt;â€¢ Found&lt;/li&gt;&lt;li&gt;â€¢ surface of endothelial cells&lt;/li&gt;&lt;li&gt;â€¢ blood vessels, lipoprotein lipase&lt;/li&gt;&lt;li&gt;â€¢ circulating&lt;/li&gt;&lt;li&gt;â€¢ lipoproteins&lt;/li&gt;&lt;li&gt;â€¢ chylomicrons and VLDL, hydrolyzing&lt;/li&gt;&lt;li&gt;â€¢ release free fatty acids&lt;/li&gt;&lt;li&gt;â€¢ uptake&lt;/li&gt;&lt;li&gt;â€¢ adjacent tissues.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ hydrolyzing stored triacylglycerols within adipocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lysosomal Lipase : Also known as acid lipase , this enzyme is located within lysosomes and is involved in the intracellular breakdown of lipids , including the hydrolysis of cholesteryl esters and triglycerides within the lysosomes . While it does play a role in lipid metabolism , it is not the primary enzyme for mobilizing stored triacylglycerols in adipose tissue.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Lysosomal Lipase&lt;/li&gt;&lt;li&gt;â€¢ acid lipase&lt;/li&gt;&lt;li&gt;â€¢ located within lysosomes&lt;/li&gt;&lt;li&gt;â€¢ intracellular&lt;/li&gt;&lt;li&gt;â€¢ lipids&lt;/li&gt;&lt;li&gt;â€¢ hydrolysis of cholesteryl esters&lt;/li&gt;&lt;li&gt;â€¢ triglycerides&lt;/li&gt;&lt;li&gt;â€¢ lysosomes&lt;/li&gt;&lt;li&gt;â€¢ lipid metabolism&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ mobilizing stored triacylglycerols in adipose tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hormone sensitive lipase hydrolyze stored TGs in adipose tissue under fasting/starvation conditions. This enzyme is activated by glucagon and inhibited by insulin.&lt;/li&gt;&lt;li&gt;âž¤ Hormone sensitive lipase hydrolyze stored TGs in adipose tissue under fasting/starvation conditions.&lt;/li&gt;&lt;li&gt;âž¤ Hormone sensitive lipase hydrolyze stored TGs&lt;/li&gt;&lt;li&gt;âž¤ adipose tissue&lt;/li&gt;&lt;li&gt;âž¤ fasting/starvation conditions.&lt;/li&gt;&lt;li&gt;âž¤ This enzyme is activated by glucagon and inhibited by insulin.&lt;/li&gt;&lt;li&gt;âž¤ activated by glucagon&lt;/li&gt;&lt;li&gt;âž¤ inhibited by insulin.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p263&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p263&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Sources of NADPH for fatty acid synthesis include all the following reactions, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose-6-phosphate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;6-phosphogluconate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytoplasmic malate dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malic enzyme&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytoplasmic malate dehydrogenase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glucose-6-phosphate dehydrogenase : This enzyme is the first in the pentose phosphate pathway and is a major source of NADPH for fatty acid synthesis by oxidizing glucose-6-phosphate to 6-phosphogluconolactone.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glucose-6-phosphate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ first in the pentose phosphate pathway&lt;/li&gt;&lt;li&gt;â€¢ major source&lt;/li&gt;&lt;li&gt;â€¢ NADPH for fatty acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ glucose-6-phosphate to 6-phosphogluconolactone.&lt;/li&gt;&lt;li&gt;â€¢ Option B: 6-phosphogluconate dehydrogenase : Also part of the pentose phosphate pathway, this enzyme further contributes to NADPH production by oxidizing 6-phosphogluconate to ribulose-5-phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option B: 6-phosphogluconate dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ pentose phosphate pathway,&lt;/li&gt;&lt;li&gt;â€¢ NADPH production&lt;/li&gt;&lt;li&gt;â€¢ 6-phosphogluconate to ribulose-5-phosphate.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Malic enzyme : This enzyme catalyzes the decarboxylation of malate to pyruvate, producing NADPH in the process, and serves as an additional source of NADPH for fatty acid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Malic enzyme&lt;/li&gt;&lt;li&gt;â€¢ decarboxylation of malate to pyruvate,&lt;/li&gt;&lt;li&gt;â€¢ NADPH&lt;/li&gt;&lt;li&gt;â€¢ additional source of NADPH for fatty acid synthesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cytoplasmic malate dehydrogenase is not a source of NADPH for fatty acid synthesis, unlike glucose-6-phosphate dehydrogenase , 6-phosphogluconate dehydrogenase , and the malic enzyme, which all contribute to NADPH production in the cytoplasm for biosynthetic processes such as fatty acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Cytoplasmic malate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ NADPH for fatty acid synthesis,&lt;/li&gt;&lt;li&gt;âž¤ glucose-6-phosphate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ 6-phosphogluconate dehydrogenase&lt;/li&gt;&lt;li&gt;âž¤ malic enzyme,&lt;/li&gt;&lt;li&gt;âž¤ NADPH production&lt;/li&gt;&lt;li&gt;âž¤ cytoplasm&lt;/li&gt;&lt;li&gt;âž¤ biosynthetic&lt;/li&gt;&lt;li&gt;âž¤ fatty acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 159.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 159.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the diagram provided, which enzyme is not involved in shuttling fatty acids into the mitochondrial matrix for Î²-oxidation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carnitine palmitoyl transferase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acyl Co- dehydrogenase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carnitine palmitoyl transferase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carnitine acylcarnitine translocase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acyl Co- dehydrogenase&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(1).png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(2)_2MKFtfT.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The diagram shows the carnitine shuttle system, which is responsible for transporting long-chain fatty acids from the cytosol into the mitochondrial matrix, where Î²-oxidation occurs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acyl Co-A Dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acyl Co-A Dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ Location: Mitochondrial matrix Function: Catalyzes the first step of Î²-oxidation, dehydrogenating Acyl-CoA to form a trans double bond between the Î± and Î² carbons. Involved in shuttle?  No â€“ it acts after the fatty acid has already entered the matrix.&lt;/li&gt;&lt;li&gt;â€¢ Location: Mitochondrial matrix&lt;/li&gt;&lt;li&gt;â€¢ Function: Catalyzes the first step of Î²-oxidation, dehydrogenating Acyl-CoA to form a trans double bond between the Î± and Î² carbons.&lt;/li&gt;&lt;li&gt;â€¢ Involved in shuttle?  No â€“ it acts after the fatty acid has already entered the matrix.&lt;/li&gt;&lt;li&gt;â€¢ Other Options&lt;/li&gt;&lt;li&gt;â€¢ Other Options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carnitine Palmitoyl Transferase I (CPT I)&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carnitine Palmitoyl Transferase I (CPT I)&lt;/li&gt;&lt;li&gt;â€¢ Location: Outer mitochondrial membrane Function: Converts Acyl-CoA to Acyl-carnitine by transferring the fatty acid to carnitine. Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Location: Outer mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ Function: Converts Acyl-CoA to Acyl-carnitine by transferring the fatty acid to carnitine.&lt;/li&gt;&lt;li&gt;â€¢ Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carnitine Palmitoyl Transferase II (CPT II)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Carnitine Palmitoyl Transferase II (CPT II)&lt;/li&gt;&lt;li&gt;â€¢ Location: Inner mitochondrial membrane (matrix side) Function: Converts Acyl-carnitine back to Acyl-CoA and carnitine, allowing the fatty acid to enter Î²-oxidation. Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Location: Inner mitochondrial membrane (matrix side)&lt;/li&gt;&lt;li&gt;â€¢ Function: Converts Acyl-carnitine back to Acyl-CoA and carnitine, allowing the fatty acid to enter Î²-oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carnitine Acylcarnitine Translocase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Carnitine Acylcarnitine Translocase&lt;/li&gt;&lt;li&gt;â€¢ Location: Inner mitochondrial membrane Function: Transports Acyl-carnitine into the mitochondrial matrix while moving free carnitine back to the cytosol in a counter-transport manner. Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Location: Inner mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ Function: Transports Acyl-carnitine into the mitochondrial matrix while moving free carnitine back to the cytosol in a counter-transport manner.&lt;/li&gt;&lt;li&gt;â€¢ Involved in shuttle? Yes&lt;/li&gt;&lt;li&gt;â€¢ Role of carnitine in the transport of long-chain fatty acids through the inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;â€¢ Role of carnitine in the transport of long-chain fatty acids through the inner mitochondrial membrane.&lt;/li&gt;&lt;li&gt;â€¢ Long-chain acyl-CoA formed by acyl-CoA synthetase enters the intermembrane space. For transport across the inner membrane, acyl groups must be transferred from CoA to carnitine by carnitine palmitoyl transferase-I. The acylcarnitine formed is then carried into the matrix by a translocase enzyme in exchange for a free carnitine and acyl-CoA is reformed by carnitine palmitoyltransferase-II.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the carnitine shuttle system, which is essential for the mitochondrial import of long-chain fatty acids. Key enzymes involved include CPT I, CPT II, and the translocase. Acyl-CoA dehydrogenase is not involved in transportâ€”it functions after the fatty acid enters the matrix, initiating Î²-oxidation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ ed: p151, Harper 30/e: p 224&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old girl child brought by her parents with complaints of difficulty in swallowing food, impaired vision at night and hearing impairment for the past 5 months seems to be worsening. O/E: EYES: Bilateral nystagmus FEET: 4th phalange was short in both feet SKIN: dry Electroretinogram: Retinal pigmentation in both fundi. Lab reports: elevated VLCFA and phytanic acid. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infantile Refsumâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zellweger syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carnitine deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propionyl CoA carboxylase deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Infantile Refsumâ€™s disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man from Africa with a history of diabetes presents with severe vomiting, epigastric pain, and confusion. He has been using local herbal remedies to manage his blood sugar for the last 8 months and is concerned about possible overconsumption. On examination, he is comatose, dehydrated, and shows signs of tachycardia and tachypnea. Laboratory tests reveal hypoglycemia at 53 mg/dl and a significant electrolyte imbalance. His urine is positive for a high amount of dicarboxylic acid?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jamaican Vomiting Sickness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zellweger syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carnitine deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propionyl CoA carboxylase deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Jamaican Vomiting Sickness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old male long-distance runner presents to his primary care physician with complaints of muscle cramps and fatigue during exercise. He follows a strict low-carbohydrate, high-fat diet and is concerned about his energy levels. Intrigued by the metabolic processes that provide energy during prolonged exercise, he asks about the step in fatty acid oxidation that requires an input of energy. The physician, recognizing this as an important aspect of fatty acid metabolism that could impact the patientâ€™s symptoms, decides to review the biochemical pathway:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyl-CoA dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acyl-CoA synthetase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;2-Enoyl-CoA hydratase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;L (+)-3-Hydroxyacyl-CoA dehydrogenase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acyl-CoA synthetase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: The fatty acyl CoA is dehydrogenated to a transenoyl CoA by the enzyme Acyl-CoA dehydrogenase with FAD accepting the hydrogen atoms. FADH2 when oxidised in electron transport chain will produce 1.5 ATP molecules&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ fatty acyl CoA&lt;/li&gt;&lt;li&gt;â€¢ dehydrogenated&lt;/li&gt;&lt;li&gt;â€¢ transenoyl CoA&lt;/li&gt;&lt;li&gt;â€¢ enzyme Acyl-CoA dehydrogenase&lt;/li&gt;&lt;li&gt;â€¢ FAD&lt;/li&gt;&lt;li&gt;â€¢ FADH2&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ 1.5 ATP&lt;/li&gt;&lt;li&gt;â€¢ Option C: Enoyl CoA hydratase catalyzes the step which forms a beta-hydroxy fatty acyl CoA. The L isomer alone is formed during the hydration of the trans-double bond.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Enoyl CoA hydratase&lt;/li&gt;&lt;li&gt;â€¢ beta-hydroxy fatty acyl CoA.&lt;/li&gt;&lt;li&gt;â€¢ L isomer&lt;/li&gt;&lt;li&gt;â€¢ hydration&lt;/li&gt;&lt;li&gt;â€¢ trans-double bond.&lt;/li&gt;&lt;li&gt;â€¢ Option D: The beta-hydroxy fatty acyl CoA is again oxidized to form beta-keto fatty acyl CoA producing a NADH . which further gets oxidized in electron transport chain generating 2.5 ATPs .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ beta-hydroxy fatty acyl CoA&lt;/li&gt;&lt;li&gt;â€¢ oxidized&lt;/li&gt;&lt;li&gt;â€¢ beta-keto fatty acyl CoA&lt;/li&gt;&lt;li&gt;â€¢ NADH&lt;/li&gt;&lt;li&gt;â€¢ further&lt;/li&gt;&lt;li&gt;â€¢ electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ 2.5 ATPs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acyl-CoA synthetase is the enzyme responsible for catalyzing the initial step in fatty acid oxidation where a fatty acid is activated to form acyl-CoA . This reaction requires the hydrolysis of ATP to AMP and pyrophosphate (PPi) , making it the only step in fatty acid oxidation that requires an input of energy.&lt;/li&gt;&lt;li&gt;âž¤ Acyl-CoA synthetase&lt;/li&gt;&lt;li&gt;âž¤ catalyzing&lt;/li&gt;&lt;li&gt;âž¤ fatty acid oxidation&lt;/li&gt;&lt;li&gt;âž¤ fatty acid&lt;/li&gt;&lt;li&gt;âž¤ acyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ hydrolysis of ATP to AMP&lt;/li&gt;&lt;li&gt;âž¤ pyrophosphate (PPi)&lt;/li&gt;&lt;li&gt;âž¤ only step in fatty acid&lt;/li&gt;&lt;li&gt;âž¤ oxidation&lt;/li&gt;&lt;li&gt;âž¤ input of energy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 203&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 203&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of congestive heart failure is undergoing a cardiac rehabilitation program. His cardiologist explains the importance of fatty acid metabolism in cardiac muscle for energy production. She details how fatty acids are transported into the mitochondria for Î²-oxidation, a process especially vital in cardiac tissue, which primarily uses fatty acid oxidation to meet its energy needs. Given the heart&#x27;s reliance on fatty acids for energy, the cardiologist emphasizes one particular molecule&#x27;s role in transporting fatty acids across the inner mitochondrial membrane:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyl carrier protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carnitine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LCAT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CETP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Carnitine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acyl carrier protein: Forms a part of fatty acid synthase complex&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acyl carrier protein:&lt;/li&gt;&lt;li&gt;â€¢ fatty acid synthase complex&lt;/li&gt;&lt;li&gt;â€¢ Â© LCAT: Lecithin-cholesterol acyl transferase. Involved in HDL metabolism . Apo Al of HDL activates LCAT.&lt;/li&gt;&lt;li&gt;â€¢ Â© LCAT:&lt;/li&gt;&lt;li&gt;â€¢ Lecithin-cholesterol acyl transferase.&lt;/li&gt;&lt;li&gt;â€¢ HDL metabolism&lt;/li&gt;&lt;li&gt;â€¢ Apo Al of HDL&lt;/li&gt;&lt;li&gt;â€¢ LCAT.&lt;/li&gt;&lt;li&gt;â€¢ Option  D: CETP: The cholesterol ester from HDL is transferred to VLDL, IDL and LDL by a Cholesterol Ester Transfer Protein.&lt;/li&gt;&lt;li&gt;â€¢ Option  D: CETP:&lt;/li&gt;&lt;li&gt;â€¢ cholesterol ester&lt;/li&gt;&lt;li&gt;â€¢ HDL&lt;/li&gt;&lt;li&gt;â€¢ VLDL, IDL and LDL&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol Ester Transfer Protein.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carnitine is crucial for the transport of long-chain fatty acids across the inner mitochondrial membrane in cardiac muscle. It forms a complex with fatty acids to facilitate their translocation into the mitochondria, where Î²-oxidation occurs to generate ATP for energy.&lt;/li&gt;&lt;li&gt;âž¤ Carnitine&lt;/li&gt;&lt;li&gt;âž¤ long-chain fatty acids&lt;/li&gt;&lt;li&gt;âž¤ inner mitochondrial membrane&lt;/li&gt;&lt;li&gt;âž¤ cardiac muscle.&lt;/li&gt;&lt;li&gt;âž¤ complex with fatty acids&lt;/li&gt;&lt;li&gt;âž¤ translocation into the mitochondria,&lt;/li&gt;&lt;li&gt;âž¤ Î²-oxidation&lt;/li&gt;&lt;li&gt;âž¤ ATP for energy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 202&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 202&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old biochemist working on a project related to metabolic diseases encounters a patientâ€™s chart with a rare metabolic disorder affecting the metabolism of certain fatty acids. The patient has an abnormal accumulation of fatty acids with an odd number of carbon atoms. Intrigued, the biochemist considers the metabolic fate of such fatty acids, specifically the conversion of propionyl-CoA, a product of their Î²-oxidation. He reflects on the pathway this metabolite takes in the process leading towards the citric acid cycle:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetyl-CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetoacetyl-CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D-Methylmalonyl CoA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Butyryl CoA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. D-Methylmalonyl CoA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acetyl-CoA : Acetyl-CoA is a product of even-numbered fatty acid oxidation , not directly from propionyl-CoA derived from odd-numbered fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ even-numbered fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ propionyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ odd-numbered fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acetoacetyl-CoA : Acetoacetyl-CoA is an intermediate in ketone body synthesis and is not directly related to the metabolism of propionyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acetoacetyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ ketone body synthesis&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ propionyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Butyryl CoA : Butyryl CoA is a four-carbon acyl-CoA molecule that is not a direct product of propionyl-CoA metabolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Butyryl CoA&lt;/li&gt;&lt;li&gt;â€¢ four-carbon acyl-CoA&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ propionyl-CoA metabolism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Propionyl-CoA, which is derived from the oxidation of fatty acids with an odd number of carbon atoms , is converted into D-Methylmalonyl CoA. This conversion involves a carboxylation reaction, which is catalyzed by the enzyme propionyl-CoA carboxylase, with biotin as a cofactor. D-Methylmalonyl CoA is then converted into succinyl-CoA , which can enter the citric acid cycle .&lt;/li&gt;&lt;li&gt;âž¤ Propionyl-CoA,&lt;/li&gt;&lt;li&gt;âž¤ oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ odd number of carbon atoms&lt;/li&gt;&lt;li&gt;âž¤ D-Methylmalonyl CoA.&lt;/li&gt;&lt;li&gt;âž¤ carboxylation reaction,&lt;/li&gt;&lt;li&gt;âž¤ catalyzed&lt;/li&gt;&lt;li&gt;âž¤ propionyl-CoA carboxylase,&lt;/li&gt;&lt;li&gt;âž¤ biotin&lt;/li&gt;&lt;li&gt;âž¤ D-Methylmalonyl CoA&lt;/li&gt;&lt;li&gt;âž¤ succinyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ enter&lt;/li&gt;&lt;li&gt;âž¤ citric acid cycle&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Review the diagram of the cholesterol molecule, as shown in the image and identify incorrect statements about its structure:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They have cyclopentano perhydro phenanthrene ring system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is made up of 3 cyclohexane rings - A, B and C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An 8-carbon side chain attached to 17th carbon is characteristic of all sterols&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The OH group is beta oriented&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. An 8-carbon side chain attached to 17th carbon is characteristic of all sterols&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(3)_xPE2TG8.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â An 8-carbon side chain attached to 17th carbon is characteristic of all sterols&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the structural features of cholesterol , including its steroid nucleus (three cyclohexane + one cyclopentane ring), C-3 beta-hydroxyl group , and C-17 side chain . While cholesterol has an 8-carbon side chain at C-17, this is not shared by all sterols , which may have different modifications depending on function (e.g., hormones, bile acids, vitamin D).&lt;/li&gt;&lt;li&gt;âž¤ structural features of cholesterol&lt;/li&gt;&lt;li&gt;âž¤ steroid nucleus&lt;/li&gt;&lt;li&gt;âž¤ C-3 beta-hydroxyl group&lt;/li&gt;&lt;li&gt;âž¤ C-17 side chain&lt;/li&gt;&lt;li&gt;âž¤ not shared by all sterols&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 220-223.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatric gastroenterologist is assessing a child with liver failure. As part of the diagnostic workup, serum bile acid analysis is performed to evaluate liver function and bile acid metabolism. The gastroenterologist is explaining to the medical trainees that understanding bile salt synthesis is crucial for interpreting these results. She poses a question to the trainees to identify the incorrect statement regarding the synthesis of bile salts:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycocholic acid is a conjugate of cholic acid and glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;7Î±-hydroxylase is the regulatory enzyme in bile salt synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;7Î±-hydroxy cholesterol is a precursor of both chenodeoxycholate and cholate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Taurochenodeoxy cholate is derived from cholic acid&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Taurochenodeoxy cholate is derived from cholic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glycocholic acid is a conjugate of cholic acid and glycine : This is correct . Glycocholic acid is indeed a bile salt formed by the conjugation of cholic acid with glycine .&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glycocholic acid is a conjugate of cholic acid and glycine&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Glycocholic acid&lt;/li&gt;&lt;li&gt;â€¢ bile salt&lt;/li&gt;&lt;li&gt;â€¢ cholic acid with glycine&lt;/li&gt;&lt;li&gt;â€¢ Option B: 7Î±-hydroxylase is the regulatory enzyme in bile salt synthesis : True, 7Î±-hydroxylase is a key enzyme in the synthesis of bile acids , which is the initial and rate-limiting step in the bile acid synthesis pathway from cholesterol .&lt;/li&gt;&lt;li&gt;â€¢ Option B: 7Î±-hydroxylase is the regulatory enzyme in bile salt synthesis&lt;/li&gt;&lt;li&gt;â€¢ True, 7Î±-hydroxylase&lt;/li&gt;&lt;li&gt;â€¢ bile acids&lt;/li&gt;&lt;li&gt;â€¢ initial and rate-limiting step&lt;/li&gt;&lt;li&gt;â€¢ bile acid synthesis pathway&lt;/li&gt;&lt;li&gt;â€¢ cholesterol&lt;/li&gt;&lt;li&gt;â€¢ Option C: 7Î±-hydroxy cholesterol is a precursor of both chenodeoxycholate and cholate : This is also true. 7Î±-hydroxy cholesterol is an intermediate in the synthesis pathway of both cholic acid and chenodeoxycholic acid , which are primary bile acids .&lt;/li&gt;&lt;li&gt;â€¢ Option C: 7Î±-hydroxy cholesterol is a precursor of both chenodeoxycholate and cholate&lt;/li&gt;&lt;li&gt;â€¢ true. 7Î±-hydroxy cholesterol&lt;/li&gt;&lt;li&gt;â€¢ both cholic acid&lt;/li&gt;&lt;li&gt;â€¢ chenodeoxycholic acid&lt;/li&gt;&lt;li&gt;â€¢ primary bile acids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Taurochenodeoxycholate is incorrectly stated as being derived from cholic acid . In reality, taurochenodeoxycholate is a conjugate of chenodeoxycholic acid with taurine , not cholic acid . Bile salts are formed by the conjugation of bile acids (like cholic acid and chenodeoxycholic acid) with amino acids such as glycine or taurine , which enhances their solubility and function in the emulsification of lipids .&lt;/li&gt;&lt;li&gt;âž¤ Taurochenodeoxycholate&lt;/li&gt;&lt;li&gt;âž¤ incorrectly&lt;/li&gt;&lt;li&gt;âž¤ derived&lt;/li&gt;&lt;li&gt;âž¤ cholic acid&lt;/li&gt;&lt;li&gt;âž¤ taurochenodeoxycholate&lt;/li&gt;&lt;li&gt;âž¤ conjugate&lt;/li&gt;&lt;li&gt;âž¤ chenodeoxycholic acid&lt;/li&gt;&lt;li&gt;âž¤ taurine&lt;/li&gt;&lt;li&gt;âž¤ not cholic acid&lt;/li&gt;&lt;li&gt;âž¤ Bile salts&lt;/li&gt;&lt;li&gt;âž¤ conjugation of bile acids&lt;/li&gt;&lt;li&gt;âž¤ amino acids&lt;/li&gt;&lt;li&gt;âž¤ glycine or taurine&lt;/li&gt;&lt;li&gt;âž¤ enhances&lt;/li&gt;&lt;li&gt;âž¤ solubility&lt;/li&gt;&lt;li&gt;âž¤ emulsification of lipids&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 273, Vasudevan 9/e: p 231&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 273, Vasudevan 9/e: p 231&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old obese man presents to his family physician with a recent diagnosis of nonalcoholic fatty liver disease (NAFLD). He is seeking advice on dietary modifications and supplements that could help prevent the progression of his liver condition. The physician reviews his diet and nutritional intake to identify any deficiencies that could be contributing to his fatty liver?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thiamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Guanidinoacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dietary Choline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dimethyl propionate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dietary Choline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lipotropic factors can reverse the effects of fatty liver . It includes Betaine, B12, Choline, Methionine, Inositol, Lecithin, Folic acid, Glycine, Serine.&lt;/li&gt;&lt;li&gt;âž¤ Lipotropic factors&lt;/li&gt;&lt;li&gt;âž¤ reverse&lt;/li&gt;&lt;li&gt;âž¤ fatty liver&lt;/li&gt;&lt;li&gt;âž¤ Betaine, B12, Choline, Methionine, Inositol, Lecithin, Folic acid, Glycine, Serine.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e, p 261&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e, p 261&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with a history of chronic alcohol abuse presents to the emergency department with severe abdominal pain. An ultrasound of the abdomen reveals fatty liver. The emergency medicine physician begins to explain to the medical students present that chronic alcohol consumption can lead to hepatic steatosis and outlines the pathophysiological mechanisms behind this condition:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased hydrolysis of fat from adipocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased synthesis of fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased [NADH]/[NAD+) ratio&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Impaired beta oxidation of fatty acids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Impaired beta oxidation of fatty acids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Increased hydrolysis of fat from adipocytes : While alcohol can increase lipolysis , the key issue in alcoholic fatty liver disease is the impairment of fatty acid oxidation , rather than an increase in the hydrolysis of fat from adipocytes.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Increased hydrolysis of fat from adipocytes&lt;/li&gt;&lt;li&gt;â€¢ increase lipolysis&lt;/li&gt;&lt;li&gt;â€¢ alcoholic fatty liver disease&lt;/li&gt;&lt;li&gt;â€¢ impairment&lt;/li&gt;&lt;li&gt;â€¢ fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Decreased synthesis of fatty acids : Alcohol consumption typically leads to an increase , not a decrease , in the synthesis of fatty acids in the liver .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Decreased synthesis of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Alcohol consumption&lt;/li&gt;&lt;li&gt;â€¢ increase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ decrease&lt;/li&gt;&lt;li&gt;â€¢ synthesis&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ Option C: Decreased [NADH]/[NAD+] ratio : Alcohol metabolism actually increases the [NADH]/[NAD+] ratio , which is one factor contributing to impaired fatty acid oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Decreased [NADH]/[NAD+] ratio&lt;/li&gt;&lt;li&gt;â€¢ Alcohol metabolism&lt;/li&gt;&lt;li&gt;â€¢ increases&lt;/li&gt;&lt;li&gt;â€¢ [NADH]/[NAD+] ratio&lt;/li&gt;&lt;li&gt;â€¢ one factor&lt;/li&gt;&lt;li&gt;â€¢ impaired fatty acid oxidation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Increased level of acetyl CoA causes increased fatty acid synthesis. Impaired beta oxidation of fatty acids leads to increased TAG in the liver resulting in fatty liver and steatosis.&lt;/li&gt;&lt;li&gt;âž¤ Increased level of acetyl CoA causes increased fatty acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Increased&lt;/li&gt;&lt;li&gt;âž¤ acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ increased fatty acid synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Impaired beta oxidation of fatty acids leads to increased TAG in the liver resulting in fatty liver and steatosis.&lt;/li&gt;&lt;li&gt;âž¤ Impaired beta oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ increased TAG&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ fatty liver and steatosis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 7/e: p317.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 7/e: p317.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-years-old man weighing 90 kg doing sedentary work denies any health issues. Routine blood test results were all normal except for plasma total cholesterol of 288 mg/dl. He was not willing to take treatment for his hypercholesterolemia. So, analysis of his 1-day dietary chart comes as follows: So, which of the following can be decreased from the diet to reduce the high plasma cholesterol levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbohydrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholesterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unsaturated fat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Saturated fat&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Saturated fat&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/screenshot-2024-04-22-123952.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman embarks on a ketogenic diet as part of a weight loss plan. After a few weeks, she notices some symptoms and decides to consult her family physician. The healthcare provider explains the physiological state her body is in due to the high-fat, low-carbohydrate diet and discusses the signs and implications of this metabolic state:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketonemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ketonuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Smell of acetone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/10.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ketosis is characterized by elevated levels of ketone bodies , which can manifest as ketonemia (presence of ketones in the blood), ketonuria (presence of ketones in the urine), and a distinctive acetone smell in the breath. Understanding these manifestations provides insights into the body&#x27;s metabolic state during carbohydrate restriction , fasting, or uncontrolled diabetes , highlighting the body&#x27;s adaptive mechanisms to alternative energy sources .&lt;/li&gt;&lt;li&gt;âž¤ Ketosis&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ ketonemia&lt;/li&gt;&lt;li&gt;âž¤ ketonuria&lt;/li&gt;&lt;li&gt;âž¤ distinctive acetone smell&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s metabolic state&lt;/li&gt;&lt;li&gt;âž¤ carbohydrate restriction&lt;/li&gt;&lt;li&gt;âž¤ fasting, or uncontrolled diabetes&lt;/li&gt;&lt;li&gt;âž¤ body&#x27;s adaptive mechanisms&lt;/li&gt;&lt;li&gt;âž¤ alternative energy sources&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 213&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 213&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following is FALSE regarding regulation of cholesterol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Statins are competitive inhibitors of HMG CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin increases the activity of HMG CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HMG CoA Reductase active in Fed State&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short-term regulation by transcription of the gene for HMG CoA reductase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Short-term regulation by transcription of the gene for HMG CoA reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Short-term regulation by transcription of the gene for HMG CoA reductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cholesterol synthesis is tightly regulated at multiple levels, with HMG CoA reductase being the rate-limiting enzyme.&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Other Option:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Statins are competitive inhibitors of HMG CoA reductase: True. Statins competitively inhibit HMG CoA reductase, reducing cholesterol synthesis and are widely used in hypercholesterolemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Statins are competitive inhibitors of HMG CoA reductase: True.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin increases the activity of HMG CoA reductase: True. Insulin promotes the dephosphorylation (activation) of HMG CoA reductase, enhancing cholesterol synthesis, especially in the fed state.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Insulin increases the activity of HMG CoA reductase: True.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HMG CoA Reductase active in Fed State: True. In the fed state, when insulin is high, cholesterol synthesis is active.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HMG CoA Reductase active in Fed State: True.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understand the multi-level regulation of HMG-CoA reductase â€” the key control point in cholesterol biosynthesis â€” including:&lt;/li&gt;&lt;li&gt;âž¤ multi-level regulation&lt;/li&gt;&lt;li&gt;âž¤ key control point in cholesterol biosynthesis&lt;/li&gt;&lt;li&gt;âž¤ Short-term (minutes): Phosphorylation/dephosphorylation Long-term (hoursâ€“days): Gene transcription via SREBP Drug intervention: Competitive inhibition by statins&lt;/li&gt;&lt;li&gt;âž¤ Short-term (minutes): Phosphorylation/dephosphorylation&lt;/li&gt;&lt;li&gt;âž¤ Short-term (minutes):&lt;/li&gt;&lt;li&gt;âž¤ Long-term (hoursâ€“days): Gene transcription via SREBP&lt;/li&gt;&lt;li&gt;âž¤ Long-term (hoursâ€“days):&lt;/li&gt;&lt;li&gt;âž¤ Drug intervention: Competitive inhibition by statins&lt;/li&gt;&lt;li&gt;âž¤ Drug intervention:&lt;/li&gt;&lt;li&gt;âž¤ statins&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 223.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male developed breathing difficulty after intake of aspirin. Aspirin-induced asthma (AIA) is a severe reaction to NSAIDs, results in bronchoconstriction which lasts from 30 minutes to a few hours after ingestion of the medication. Which could be the correct statement that explains about the same:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibit the activity of the cystic fibrosis transmembrane conductance regulator protein, resulting in thickened secretions that block airways&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activate the cyclooxygenase activity of PGH synthase, resulting in increased synthesis of prostaglandins that promote vasodilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibits cyclooxygenase but not lipoxygenase, resulting in the flow of arachidonic acid to leukotriene synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activate phospholipases, resulting in decreased amounts of dipalmitoyl phosphatidyl choline and alveolar collapse (atelectasis)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Inhibits cyclooxygenase but not lipoxygenase, resulting in the flow of arachidonic acid to leukotriene synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aspirin can block a pathway in the body that usually helps keep airways open . When this pathway is blocked , another pathway that can make the airways tighten up becomes more active . This can lead to breathing difficulties in some people.&lt;/li&gt;&lt;li&gt;âž¤ Aspirin&lt;/li&gt;&lt;li&gt;âž¤ block&lt;/li&gt;&lt;li&gt;âž¤ body&lt;/li&gt;&lt;li&gt;âž¤ airways open&lt;/li&gt;&lt;li&gt;âž¤ pathway is blocked&lt;/li&gt;&lt;li&gt;âž¤ another pathway&lt;/li&gt;&lt;li&gt;âž¤ airways tighten&lt;/li&gt;&lt;li&gt;âž¤ more active&lt;/li&gt;&lt;li&gt;âž¤ breathing difficulties&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 240, 720-721.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 240, 720-721.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old obese woman started with Tab. Orlistat, as she fails to follow the lifestyle modifications advised by her physician. Which of the following steps of digestion and absorption of fats is directly inhibited by Orlistat?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bile salt formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Micelle formation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic and gastric lipase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absorption of Free fatty acids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pancreatic and gastric lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key takeaway is that Orlistat specifically inhibits the action of pancreatic and gastric lipases , enzymes critical for the breakdown of dietary fats into smaller, absorbable molecules like free fatty acids and monoglycerides . By doing so, it reduces the overall absorption of fats from the diet , aiding in weight management. It does not directly affect bile salt formation , micelle formation, or the absorption mechanism of free fatty acids .&lt;/li&gt;&lt;li&gt;âž¤ Orlistat&lt;/li&gt;&lt;li&gt;âž¤ inhibits&lt;/li&gt;&lt;li&gt;âž¤ pancreatic and gastric lipases&lt;/li&gt;&lt;li&gt;âž¤ breakdown of dietary fats&lt;/li&gt;&lt;li&gt;âž¤ smaller, absorbable&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ monoglycerides&lt;/li&gt;&lt;li&gt;âž¤ reduces&lt;/li&gt;&lt;li&gt;âž¤ fats&lt;/li&gt;&lt;li&gt;âž¤ diet&lt;/li&gt;&lt;li&gt;âž¤ aiding in weight&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ bile salt formation&lt;/li&gt;&lt;li&gt;âž¤ micelle formation,&lt;/li&gt;&lt;li&gt;âž¤ absorption&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 175-177.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Lippincott 6/e: p 175-177.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following best describes the precursors used in the synthesis of carotenoids?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amino acids through transamination reactions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isoprene units through condensation reactions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fatty acids through elongation processes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucose molecules through glycolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Isoprene units through condensation reactions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Isoprene units through condensation reactions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Amino acids are not directly involved in the synthesis of carotenoids. While amino acids are crucial for protein synthesis and other metabolic functions , they do not serve as precursors for carotenoid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Amino acids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ synthesis of carotenoids.&lt;/li&gt;&lt;li&gt;â€¢ amino acids&lt;/li&gt;&lt;li&gt;â€¢ protein synthesis&lt;/li&gt;&lt;li&gt;â€¢ metabolic functions&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ carotenoid synthesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C : Fatty acids are involved in various metabolic processes , including energy storage and membrane synthesis, but they are not directly converted into carotenoids . The elongation of fatty acids refers to the process of adding carbon units to a fatty acid chain, not the synthesis of carotenoids.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Fatty acids&lt;/li&gt;&lt;li&gt;â€¢ metabolic processes&lt;/li&gt;&lt;li&gt;â€¢ energy storage and membrane synthesis,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ converted into carotenoids&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ carbon units to a fatty acid&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ synthesis of carotenoids.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glucose is a central molecule in energy metabolism, participating in pathways such as glycolysis and the citric acid cycle. However, glucose is not directly used in the synthesis of carotenoids. While some of th e intermediates from glucose metabolism might contribute to the pool of precursors for isoprene unit synthesis, glucose itself is not a direct precursor for carotenoids.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Glucose&lt;/li&gt;&lt;li&gt;â€¢ central molecule&lt;/li&gt;&lt;li&gt;â€¢ glycolysis and the citric acid cycle.&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ synthesis of carotenoids.&lt;/li&gt;&lt;li&gt;â€¢ e intermediates&lt;/li&gt;&lt;li&gt;â€¢ glucose metabolism&lt;/li&gt;&lt;li&gt;â€¢ pool of precursors for isoprene unit synthesis, glucose&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ direct precursor for carotenoids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Isoprene units are precursors to many Isoprenoid compounds such as&lt;/li&gt;&lt;li&gt;âž¤ Isoprene units&lt;/li&gt;&lt;li&gt;âž¤ Isoprenoid compounds&lt;/li&gt;&lt;li&gt;âž¤ Vitamin A Vitamin K Carotenoids Ubiquinone (a component of electron transport chain) Dolichol (a compound involved in glycoprotein synthesis)&lt;/li&gt;&lt;li&gt;âž¤ Vitamin A&lt;/li&gt;&lt;li&gt;âž¤ Vitamin K&lt;/li&gt;&lt;li&gt;âž¤ Carotenoids&lt;/li&gt;&lt;li&gt;âž¤ Ubiquinone (a component of electron transport chain)&lt;/li&gt;&lt;li&gt;âž¤ Dolichol (a compound involved in glycoprotein synthesis)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Pankaja Naik 6/e: p276.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Pankaja Naik 6/e: p276.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A teenage boy, self-conscious about his weight, decides to follow a fat-free diet in hopes of improving his physique. After adhering to this dietary regimen for several weeks, he visits a nutritionist for a consultation. Concerned about potential nutritional deficiencies and their impact on lipid metabolism, the nutritionist reviews the boy&#x27;s diet and decides to assess his body&#x27;s ability to synthesize various essential lipids that might be affected by his restrictive diet:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholesterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prostaglandins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycolipids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phospholipids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prostaglandins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â Prostaglandins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins are synthesized from arachidonic acid. Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins are synthesized from arachidonic acid.&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins are synthesized from arachidonic acid.&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ arachidonic acid.&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic acid is synthesized from linoleic acid, which is an essential fatty acid supplied from dietary lipids in adequate amounts.&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic acid&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ linoleic acid,&lt;/li&gt;&lt;li&gt;âž¤ essential fatty acid&lt;/li&gt;&lt;li&gt;âž¤ dietary lipids&lt;/li&gt;&lt;li&gt;âž¤ adequate amounts.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 213-215, 238-240.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 213-215, 238-240.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man has been observing a fast as part of a cultural festival for several days. Despite significantly reduced food intake, he surprisingly reports feeling mentally alert and does not experience any dizziness or significant discomfort typically associated with low blood sugar levels. Intrigued by this adaptation, he visits a healthcare provider for a routine check-up. The provider explains how the body adapts to prolonged fasting by utilizing alternative energy sources to maintain brain function and overall metabolism:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coenzyme A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta-carotene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Beta-hydroxybutyrate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Apoprotein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Beta-hydroxybutyrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ During prolonged fasting , the body shifts to ketosis , a metabolic state where it uses ketone bodies as an alternative energy source. Beta-hydroxybutyrate is one of the primary ketone bodies produced by the liver from fatty acids in the absence of sufficient glucose. The brain can utilize beta-hydroxybutyrate efficiently in place of glucose, allowing for sustained cognitive function and energy levels despite low blood glucose.&lt;/li&gt;&lt;li&gt;âž¤ prolonged fasting&lt;/li&gt;&lt;li&gt;âž¤ body shifts to ketosis&lt;/li&gt;&lt;li&gt;âž¤ metabolic state&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ alternative energy source.&lt;/li&gt;&lt;li&gt;âž¤ Beta-hydroxybutyrate&lt;/li&gt;&lt;li&gt;âž¤ primary ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ liver from fatty acids&lt;/li&gt;&lt;li&gt;âž¤ absence&lt;/li&gt;&lt;li&gt;âž¤ glucose.&lt;/li&gt;&lt;li&gt;âž¤ brain can utilize beta-hydroxybutyrate&lt;/li&gt;&lt;li&gt;âž¤ glucose,&lt;/li&gt;&lt;li&gt;âž¤ sustained&lt;/li&gt;&lt;li&gt;âž¤ cognitive function&lt;/li&gt;&lt;li&gt;âž¤ energy levels&lt;/li&gt;&lt;li&gt;âž¤ low blood glucose.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 148-149.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 148-149.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is unable to utilize ketone bodies as an energy source?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skeletal muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RBCs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac muscle&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. RBCs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ketone bodies are formed in the liver by mitochondrial enzyme thiolase and are utilized by extrahepatic tissues such as heart muscle , renal cortex, skeletal muscle, and brain , which prefer the ketone bodies as alternate sources of energy , if glucose is not available. Ketone bodies are not utilised by RBCs due to the absence of mitochondria&lt;/li&gt;&lt;li&gt;âž¤ The ketone bodies are formed in the liver by mitochondrial enzyme thiolase and are utilized by extrahepatic tissues such as heart muscle , renal cortex, skeletal muscle, and brain , which prefer the ketone bodies as alternate sources of energy , if glucose is not available.&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ liver by mitochondrial enzyme thiolase&lt;/li&gt;&lt;li&gt;âž¤ extrahepatic tissues&lt;/li&gt;&lt;li&gt;âž¤ heart muscle&lt;/li&gt;&lt;li&gt;âž¤ renal cortex, skeletal muscle,&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ alternate sources&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ glucose&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ Ketone bodies are not utilised by RBCs due to the absence of mitochondria&lt;/li&gt;&lt;li&gt;âž¤ Ketone bodies&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ RBCs&lt;/li&gt;&lt;li&gt;âž¤ absence of mitochondria&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,pg 227&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,pg 227&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old male with a history of coronary artery disease (CAD), who recently underwent coronary artery bypass grafting (CABG), is scheduled for a postoperative follow-up visit. During the visit, the cardiologist reviews the patient&#x27;s postoperative recovery and emphasizes the importance of dietary and lifestyle modifications to manage his CAD and reduce the risk of future cardiac events. The cardiologist outlines several recommendations but also wants to clarify a common misconception about dietary guidelines for patients with a high risk of coronary heart disease. Which of the following dietary goals is NOT typically recommended for patients with a high risk of coronary heart disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LDL cholesterol &amp;lt; 100 mg/dl&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Saturated fat &amp;lt;7 % of total calories&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dietary cholesterol &amp;lt; 300 mg/day&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Avoid Alcohol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dietary cholesterol &lt; 300 mg/day&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dietary cholesterol &amp;lt; 300 mg/day&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: LDL cholesterol &amp;lt; 100 mg/dl : This target is recommended for individuals with CAD to reduce the risk of further coronary events . Lowering LDL cholesterol is a key focus in managing CAD because elevated LDL levels are directly linked to an increased risk of atherosclerosis and subsequent heart problems.&lt;/li&gt;&lt;li&gt;â€¢ Option A: LDL cholesterol &amp;lt; 100 mg/dl&lt;/li&gt;&lt;li&gt;â€¢ CAD to reduce the risk&lt;/li&gt;&lt;li&gt;â€¢ coronary&lt;/li&gt;&lt;li&gt;â€¢ events&lt;/li&gt;&lt;li&gt;â€¢ Lowering LDL cholesterol&lt;/li&gt;&lt;li&gt;â€¢ CAD&lt;/li&gt;&lt;li&gt;â€¢ elevated LDL levels&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ increased risk&lt;/li&gt;&lt;li&gt;â€¢ atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ heart problems.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Saturated fat &amp;lt;7% of total calories : Reducing saturated fat intake is crucial for individuals with CAD as saturated fats can raise LDL cholesterol levels, contributing to the buildup of plaques in arteries. Limiting saturated fats to less than 7% of total daily calories is part of a heart-healthy diet aimed at reducing cardiovascular risk .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Saturated fat &amp;lt;7% of total calories&lt;/li&gt;&lt;li&gt;â€¢ Reducing saturated fat&lt;/li&gt;&lt;li&gt;â€¢ CAD&lt;/li&gt;&lt;li&gt;â€¢ saturated fats&lt;/li&gt;&lt;li&gt;â€¢ raise LDL cholesterol&lt;/li&gt;&lt;li&gt;â€¢ buildup of plaques in arteries.&lt;/li&gt;&lt;li&gt;â€¢ saturated fats&lt;/li&gt;&lt;li&gt;â€¢ less&lt;/li&gt;&lt;li&gt;â€¢ 7%&lt;/li&gt;&lt;li&gt;â€¢ total daily calories&lt;/li&gt;&lt;li&gt;â€¢ heart-healthy diet&lt;/li&gt;&lt;li&gt;â€¢ reducing cardiovascular risk&lt;/li&gt;&lt;li&gt;â€¢ Option D: Avoid Alcohol : Moderation in alcohol consumption is generally advised for the general population . For patients with CAD, alcohol should be consumed with caution due to its potential effects on blood pressure, triglyceride levels, and caloric intake. While moderate alcohol intake may have some cardiovascular benefits in certain individuals, avoiding excessive alcohol is crucial, especially for those with CAD or those who have difficulty consuming alcohol in moderation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Avoid Alcohol&lt;/li&gt;&lt;li&gt;â€¢ Moderation&lt;/li&gt;&lt;li&gt;â€¢ alcohol consumption&lt;/li&gt;&lt;li&gt;â€¢ general population&lt;/li&gt;&lt;li&gt;â€¢ CAD,&lt;/li&gt;&lt;li&gt;â€¢ with caution&lt;/li&gt;&lt;li&gt;â€¢ its potential effects&lt;/li&gt;&lt;li&gt;â€¢ blood pressure, triglyceride levels, and caloric intake.&lt;/li&gt;&lt;li&gt;â€¢ moderate alcohol intake&lt;/li&gt;&lt;li&gt;â€¢ cardiovascular benefits&lt;/li&gt;&lt;li&gt;â€¢ certain individuals, avoiding excessive alcohol&lt;/li&gt;&lt;li&gt;â€¢ crucial,&lt;/li&gt;&lt;li&gt;â€¢ CAD&lt;/li&gt;&lt;li&gt;â€¢ difficulty consuming alcohol&lt;/li&gt;&lt;li&gt;â€¢ moderation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For managing coronary artery disease , dietary recommendations emphasize reducing saturated fat intake and maintaining LDL cholesterol levels below 100 mg/dl. The strict limit on dietary cholesterol (&amp;lt;300 mg/day) is less emphasized, while moderation in alcohol consumption is advised for overall heart health.&lt;/li&gt;&lt;li&gt;âž¤ For managing coronary artery disease , dietary recommendations emphasize reducing saturated fat intake and maintaining LDL cholesterol levels below 100 mg/dl. The strict limit on dietary cholesterol (&amp;lt;300 mg/day) is less emphasized, while moderation in alcohol consumption is advised for overall heart health.&lt;/li&gt;&lt;li&gt;âž¤ coronary artery disease&lt;/li&gt;&lt;li&gt;âž¤ dietary&lt;/li&gt;&lt;li&gt;âž¤ reducing saturated fat intake&lt;/li&gt;&lt;li&gt;âž¤ LDL cholesterol levels below 100 mg/dl.&lt;/li&gt;&lt;li&gt;âž¤ limit on dietary cholesterol (&amp;lt;300 mg/day)&lt;/li&gt;&lt;li&gt;âž¤ less&lt;/li&gt;&lt;li&gt;âž¤ emphasized,&lt;/li&gt;&lt;li&gt;âž¤ moderation&lt;/li&gt;&lt;li&gt;âž¤ alcohol consumption&lt;/li&gt;&lt;li&gt;âž¤ heart health.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 253.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 253.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female patient visits your clinic for a routine health check-up. During the consultation, she expresses her concern about high cholesterol levels and its implications on her health. She is particularly interested in understanding which substances in her body, related to her health concerns, do not contain cholesterol. Based on this context, which of the following does not have cholesterol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Estrogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progesterone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adrenaline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Specialized Products formed from Cholesterol includes&lt;/li&gt;&lt;li&gt;âž¤ Specialized Products formed from Cholesterol includes&lt;/li&gt;&lt;li&gt;âž¤ Bile Acids Vitamin D Sex Hormones Corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ Bile Acids&lt;/li&gt;&lt;li&gt;âž¤ Vitamin D&lt;/li&gt;&lt;li&gt;âž¤ Sex Hormones&lt;/li&gt;&lt;li&gt;âž¤ Corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p267&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p267&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Match the following enzymes with the pathway they are involved in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-b, 2-a, 3-d, 4-c&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-b, 2-d, 3-a, 4-c&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-b, 4-c&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-b, 2-a, 3-d, 4-c&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160529.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-160656.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)Â 1-b, 2-a, 3-d, 4-c&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct . 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct. Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate. Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct .&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA Reductase is a key enzyme in the biosynthesis of cholesterol , catalyzing the conversion of HMG-CoA to mevalonate , a rate-limiting step in cholesterol synthesis. Hence, 1-b is correct .&lt;/li&gt;&lt;li&gt;â€¢ HMG CoA Reductase&lt;/li&gt;&lt;li&gt;â€¢ biosynthesis of cholesterol&lt;/li&gt;&lt;li&gt;â€¢ catalyzing&lt;/li&gt;&lt;li&gt;â€¢ HMG-CoA to mevalonate&lt;/li&gt;&lt;li&gt;â€¢ rate-limiting step&lt;/li&gt;&lt;li&gt;â€¢ cholesterol synthesis.&lt;/li&gt;&lt;li&gt;â€¢ 1-b is correct&lt;/li&gt;&lt;li&gt;â€¢ 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct.&lt;/li&gt;&lt;li&gt;â€¢ 7-alpha-hydroxylase is the rate-limiting enzyme in the formation of bile acids from cholesterol . It catalyzes the introduction of a hydroxyl group at the 7th position of the steroid nucleus of cholesterol, which is the first step in the classical pathway of bile acid synthesis . Thus, 2-a is correct.&lt;/li&gt;&lt;li&gt;â€¢ 7-alpha-hydroxylase&lt;/li&gt;&lt;li&gt;â€¢ rate-limiting enzyme&lt;/li&gt;&lt;li&gt;â€¢ bile acids from cholesterol&lt;/li&gt;&lt;li&gt;â€¢ catalyzes&lt;/li&gt;&lt;li&gt;â€¢ hydroxyl group&lt;/li&gt;&lt;li&gt;â€¢ 7th position&lt;/li&gt;&lt;li&gt;â€¢ steroid&lt;/li&gt;&lt;li&gt;â€¢ cholesterol,&lt;/li&gt;&lt;li&gt;â€¢ first&lt;/li&gt;&lt;li&gt;â€¢ classical pathway&lt;/li&gt;&lt;li&gt;â€¢ bile acid synthesis&lt;/li&gt;&lt;li&gt;â€¢ 2-a is correct.&lt;/li&gt;&lt;li&gt;â€¢ Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate.&lt;/li&gt;&lt;li&gt;â€¢ Thiophorase , also known as succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), is involved in ketolysis, particularly in the utilization of ketone bodies by the tissues outside the liver, converting acetoacetate into acetoacetyl-CoA. Therefore, 3-d is accurate.&lt;/li&gt;&lt;li&gt;â€¢ Thiophorase&lt;/li&gt;&lt;li&gt;â€¢ succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT),&lt;/li&gt;&lt;li&gt;â€¢ ketolysis,&lt;/li&gt;&lt;li&gt;â€¢ utilization of ketone bodies&lt;/li&gt;&lt;li&gt;â€¢ tissues&lt;/li&gt;&lt;li&gt;â€¢ outside&lt;/li&gt;&lt;li&gt;â€¢ liver,&lt;/li&gt;&lt;li&gt;â€¢ acetoacetate into acetoacetyl-CoA.&lt;/li&gt;&lt;li&gt;â€¢ 3-d is accurate.&lt;/li&gt;&lt;li&gt;â€¢ Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.&lt;/li&gt;&lt;li&gt;â€¢ Carnitine acyl transferase I is a crucial enzyme in the beta-oxidation of fatty acids . It facilitates the transport of fatty acids into the mitochondria for oxidation by converting them into their acyl-carnitine derivatives , which can cross the mitochondrial membrane . Hence, 4-c is correct.&lt;/li&gt;&lt;li&gt;â€¢ Carnitine acyl transferase I&lt;/li&gt;&lt;li&gt;â€¢ beta-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ facilitates&lt;/li&gt;&lt;li&gt;â€¢ transport of fatty&lt;/li&gt;&lt;li&gt;â€¢ acids&lt;/li&gt;&lt;li&gt;â€¢ mitochondria&lt;/li&gt;&lt;li&gt;â€¢ oxidation&lt;/li&gt;&lt;li&gt;â€¢ converting&lt;/li&gt;&lt;li&gt;â€¢ acyl-carnitine derivatives&lt;/li&gt;&lt;li&gt;â€¢ cross&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial membrane&lt;/li&gt;&lt;li&gt;â€¢ 4-c&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 172,178&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 172,178&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Prostaglandins are derived from which type of fatty acids?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PUFA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MUFA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TFA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PUFA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Monounsaturated fatty acids (MUFA) and c) Trans fatty acids (TFA) are not direct precursors for prostaglandin synthesis. While MUFAs and TFAs are important dietary fats , they do not serve as substrates for the cyclooxygenase pathway that produces prostaglandins.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Monounsaturated fatty acids (MUFA)&lt;/li&gt;&lt;li&gt;â€¢ c) Trans fatty acids (TFA)&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ prostaglandin synthesis.&lt;/li&gt;&lt;li&gt;â€¢ MUFAs and TFAs&lt;/li&gt;&lt;li&gt;â€¢ dietary fats&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ substrates&lt;/li&gt;&lt;li&gt;â€¢ cyclooxygenase pathway&lt;/li&gt;&lt;li&gt;â€¢ prostaglandins.&lt;/li&gt;&lt;li&gt;â€¢ Option D: The statement that all the above fatty acids can serve as precursors for prostaglandins is incorrect, as prostaglandins are specifically derived from polyunsaturated fatty acids like arachidonic acid.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ precursors for prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ incorrect,&lt;/li&gt;&lt;li&gt;â€¢ prostaglandins&lt;/li&gt;&lt;li&gt;â€¢ derived&lt;/li&gt;&lt;li&gt;â€¢ polyunsaturated fatty acids&lt;/li&gt;&lt;li&gt;â€¢ arachidonic acid.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins are derived from the PUFA It has three series that are derived from the following fatty acids. 1 series (1 double bond)â€”from Linoleic acid 2 series (2 double bonds)â€”from Arachidonic acid 3 series (3 double bonds)â€” Eicosapentaenoic All naturally occurring PGs belong to the 2 series.&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins are derived from the PUFA&lt;/li&gt;&lt;li&gt;âž¤ Prostaglandins&lt;/li&gt;&lt;li&gt;âž¤ derived&lt;/li&gt;&lt;li&gt;âž¤ PUFA&lt;/li&gt;&lt;li&gt;âž¤ It has three series that are derived from the following fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ three series&lt;/li&gt;&lt;li&gt;âž¤ derived&lt;/li&gt;&lt;li&gt;âž¤ fatty acids.&lt;/li&gt;&lt;li&gt;âž¤ 1 series (1 double bond)â€”from Linoleic acid&lt;/li&gt;&lt;li&gt;âž¤ 1 series&lt;/li&gt;&lt;li&gt;âž¤ Linoleic acid&lt;/li&gt;&lt;li&gt;âž¤ 2 series (2 double bonds)â€”from Arachidonic acid&lt;/li&gt;&lt;li&gt;âž¤ 2 series&lt;/li&gt;&lt;li&gt;âž¤ Arachidonic acid&lt;/li&gt;&lt;li&gt;âž¤ 3 series (3 double bonds)â€” Eicosapentaenoic&lt;/li&gt;&lt;li&gt;âž¤ 3 series&lt;/li&gt;&lt;li&gt;âž¤ Eicosapentaenoic&lt;/li&gt;&lt;li&gt;âž¤ All naturally occurring PGs belong to the 2 series.&lt;/li&gt;&lt;li&gt;âž¤ PGs&lt;/li&gt;&lt;li&gt;âž¤ 2 series.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 254&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 254&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A): Bile acid protects the body from cholesterol over production. Reasoning (R): In liver, choles terol is continuously converted to bile acid.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right, but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right, and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A as well as R are right, and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A) is correct. Bile acids , which are derived from cholesterol, play a significant role in maintaining cholesterol homeostasis within the body. By converting cholesterol into bile acids , the body can regulate the levels of cholesterol, preventing its overproduction and accumulation , which can lead to conditions such as hypercholesterolemia and atherosclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Assertion (A)&lt;/li&gt;&lt;li&gt;â€¢ correct. Bile acids&lt;/li&gt;&lt;li&gt;â€¢ derived&lt;/li&gt;&lt;li&gt;â€¢ cholesterol,&lt;/li&gt;&lt;li&gt;â€¢ role&lt;/li&gt;&lt;li&gt;â€¢ cholesterol homeostasis&lt;/li&gt;&lt;li&gt;â€¢ body.&lt;/li&gt;&lt;li&gt;â€¢ cholesterol into bile acids&lt;/li&gt;&lt;li&gt;â€¢ levels of cholesterol, preventing&lt;/li&gt;&lt;li&gt;â€¢ overproduction and accumulation&lt;/li&gt;&lt;li&gt;â€¢ hypercholesterolemia and atherosclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Reasoning (R) is also correct and provides a correct explanation for Assertion (A) . The liver plays a crucial role in lipid metabolism , including the conversion of cholesterol into bile acids . This conversion is an important regulatory mechanism for controlling cholesterol levels in the body. Bile acids are then excreted into the intestine with bile , where they aid in the digestion and absorption of fats and fat-soluble vitamins. Some bile acids are reabsorbed from the intestine and returned to the liver, while others are lost in the feces . This loss of bile acids from the body necessitates the conversion of more cholesterol into bile acids, thus helping to regulate cholesterol levels and prevent overproduction.&lt;/li&gt;&lt;li&gt;â€¢ Reasoning (R)&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ correct explanation for Assertion (A)&lt;/li&gt;&lt;li&gt;â€¢ lipid metabolism&lt;/li&gt;&lt;li&gt;â€¢ conversion of cholesterol into bile acids&lt;/li&gt;&lt;li&gt;â€¢ controlling&lt;/li&gt;&lt;li&gt;â€¢ cholesterol levels&lt;/li&gt;&lt;li&gt;â€¢ Bile acids&lt;/li&gt;&lt;li&gt;â€¢ excreted&lt;/li&gt;&lt;li&gt;â€¢ intestine with bile&lt;/li&gt;&lt;li&gt;â€¢ aid&lt;/li&gt;&lt;li&gt;â€¢ digestion&lt;/li&gt;&lt;li&gt;â€¢ absorption of fats&lt;/li&gt;&lt;li&gt;â€¢ fat-soluble vitamins.&lt;/li&gt;&lt;li&gt;â€¢ bile acids&lt;/li&gt;&lt;li&gt;â€¢ reabsorbed&lt;/li&gt;&lt;li&gt;â€¢ intestine&lt;/li&gt;&lt;li&gt;â€¢ returned to the liver,&lt;/li&gt;&lt;li&gt;â€¢ lost in the feces&lt;/li&gt;&lt;li&gt;â€¢ loss of bile acids&lt;/li&gt;&lt;li&gt;â€¢ more cholesterol into bile acids,&lt;/li&gt;&lt;li&gt;â€¢ regulate cholesterol levels&lt;/li&gt;&lt;li&gt;â€¢ prevent overproduction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bile acid production is the most important catabolic pathway for cholesterol. Continuous conversation of cholesterol into bile acid in the liver prevents the body from becoming overloaded with cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Bile acid production is the most important catabolic pathway for cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Bile acid production&lt;/li&gt;&lt;li&gt;âž¤ catabolic pathway for cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Continuous conversation of cholesterol into bile acid in the liver prevents the body from becoming overloaded with cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Continuous&lt;/li&gt;&lt;li&gt;âž¤ cholesterol into bile acid&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ overloaded&lt;/li&gt;&lt;li&gt;âž¤ cholesterol.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 237-238&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 237-238&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-years-old female child has complaints of chronic diarrhoea with oily stools and failure to thrive. Her mother gave history of breastfeeding for 2 years and had no problems until she was weaned off. Which of the following enzyme is deficient followed by secretin stimulation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholesterol esterase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lipoprotein lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hormone sensitive lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreatic lipase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pancreatic lipase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of hypertension and hyperlipidemia presents to the emergency department with severe chest pain that started 2 hours ago. The pain is described as pressure-like, located in the center of the chest, and radiates to the left arm. An EKG reveals ST-segment elevations in the anterior leads. The patient is diagnosed with an anterior wall myocardial infarction and is treated with nitroglycerin among other medications. Which of the following best describes the mechanism of action of nitroglycerin in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methylation occurs to produce S-adenosylmethionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GTP hydrolysis accomplishes oxidation of LDL proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arginine is converted to a neurotransmitter that activates guanyl cyclase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acetyl-CoA and choline are condensed to form a neurotransmitter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Arginine is converted to a neurotransmitter that activates guanyl cyclase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nitroglycerin works primarily by releasing nitric oxide (NO) in the smooth muscle cells of blood vessels, which then activates guanylyl cyclase . This enzyme increases the synthesis of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation and vasodilation , particularly in the venous system but also in the coronary arteries .&lt;/li&gt;&lt;li&gt;âž¤ Nitroglycerin&lt;/li&gt;&lt;li&gt;âž¤ releasing nitric oxide (NO)&lt;/li&gt;&lt;li&gt;âž¤ blood vessels,&lt;/li&gt;&lt;li&gt;âž¤ activates&lt;/li&gt;&lt;li&gt;âž¤ guanylyl cyclase&lt;/li&gt;&lt;li&gt;âž¤ increases&lt;/li&gt;&lt;li&gt;âž¤ cyclic guanosine monophosphate (cGMP),&lt;/li&gt;&lt;li&gt;âž¤ smooth muscle relaxation&lt;/li&gt;&lt;li&gt;âž¤ vasodilation&lt;/li&gt;&lt;li&gt;âž¤ venous system&lt;/li&gt;&lt;li&gt;âž¤ coronary arteries&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 227,655&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 227,655&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is common to the synthesis pathways of both ketone bodies and cholesterol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HMG CoA Synthase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HMG CoA lyase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HMG CoA reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HMG CoA carboxylase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. HMG CoA Synthase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA combines with acetoacetyl CoA â†’ HMG CoA by the enzyme HMG CoA synthase . Mitochondrial HMG CoA is used for ketogenesis, and cytosoli c fraction is used for cholesterol synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA combines with acetoacetyl CoA â†’ HMG CoA by the enzyme HMG CoA synthase .&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ with acetoacetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ HMG CoA&lt;/li&gt;&lt;li&gt;âž¤ HMG CoA synthase&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial HMG CoA is used for ketogenesis, and cytosoli c fraction is used for cholesterol synthesis .&lt;/li&gt;&lt;li&gt;âž¤ Mitochondrial HMG CoA&lt;/li&gt;&lt;li&gt;âž¤ ketogenesis,&lt;/li&gt;&lt;li&gt;âž¤ cytosoli&lt;/li&gt;&lt;li&gt;âž¤ cholesterol synthesis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 170&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p 170&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a biotechnology company focused on metabolic engineering, a team is analyzing the fatty acid synthase (FAS) complex to identify potential targets for genetic modification to enhance biofuel production. During their review, they discuss the various enzymes that compose the FAS complex. They aim to clarify which enzyme listed is not a part of this complex. Which of the following enzymes is not contained within the fatty acid synthase complex?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Enoyl Reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ketoacyl reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetyl CoA carboxylase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dehydratase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acetyl CoA carboxylase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/2_RLNOM8O.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Six enzyme activities of Fatty acid synthase complex are:&lt;/li&gt;&lt;li&gt;âž¤ Six enzyme activities of Fatty acid synthase complex are:&lt;/li&gt;&lt;li&gt;âž¤ Ketoacyl Synthase Malonyl-Acetyl Transacylase Hydratase Enoyl Reductase Ketoacyl Reductase Thioesterase (Deacylase)&lt;/li&gt;&lt;li&gt;âž¤ Ketoacyl Synthase&lt;/li&gt;&lt;li&gt;âž¤ Malonyl-Acetyl Transacylase&lt;/li&gt;&lt;li&gt;âž¤ Hydratase&lt;/li&gt;&lt;li&gt;âž¤ Enoyl Reductase&lt;/li&gt;&lt;li&gt;âž¤ Ketoacyl Reductase&lt;/li&gt;&lt;li&gt;âž¤ Thioesterase (Deacylase)&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 156-158.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 156-158.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the furthest point, in terms of carbon atoms from the methyl end, at which human desaturase enzymes are unable to introduce a double bond in a fatty acid?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carbon 9&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbon 6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carbon 5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbon 3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Carbon 9&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carbon 6 : Human desaturase enzymes are capable of introducing double bonds at carbon atoms closer to the methyl end than carbon 6 . The limitation arises beyond carbon 9, making this option incorrect . Essential fatty acids with double bonds past carbon 9 , like those in omega-3 and omega-6 families, cannot be synthesized and must be obtained from the diet.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carbon 6&lt;/li&gt;&lt;li&gt;â€¢ Human desaturase&lt;/li&gt;&lt;li&gt;â€¢ double bonds at carbon atoms closer&lt;/li&gt;&lt;li&gt;â€¢ methyl end&lt;/li&gt;&lt;li&gt;â€¢ carbon 6&lt;/li&gt;&lt;li&gt;â€¢ limitation&lt;/li&gt;&lt;li&gt;â€¢ beyond carbon 9,&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ Essential fatty acids&lt;/li&gt;&lt;li&gt;â€¢ double bonds&lt;/li&gt;&lt;li&gt;â€¢ carbon 9&lt;/li&gt;&lt;li&gt;â€¢ omega-3 and omega-6 families, cannot&lt;/li&gt;&lt;li&gt;â€¢ synthesized&lt;/li&gt;&lt;li&gt;â€¢ from the diet.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Carbon 5 : Similar to carbon 6, human desaturase enzymes can introduce double bonds at positions closer to the methyl end than carbon 5. The restriction in humans is beyond carbon 9, so this option is also incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Carbon 5&lt;/li&gt;&lt;li&gt;â€¢ carbon 6,&lt;/li&gt;&lt;li&gt;â€¢ human desaturase enzymes&lt;/li&gt;&lt;li&gt;â€¢ double bonds&lt;/li&gt;&lt;li&gt;â€¢ positions closer&lt;/li&gt;&lt;li&gt;â€¢ methyl&lt;/li&gt;&lt;li&gt;â€¢ end&lt;/li&gt;&lt;li&gt;â€¢ restriction&lt;/li&gt;&lt;li&gt;â€¢ beyond carbon 9,&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Carbon 3 : The human body is capable of introducing double bonds at positions nearer to the methyl end than carbon 3. The critical limitation for human desaturase enzymes is beyond carbon 9 , which necessitates the dietary intake of certain essential fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Carbon 3&lt;/li&gt;&lt;li&gt;â€¢ double bonds&lt;/li&gt;&lt;li&gt;â€¢ methyl end&lt;/li&gt;&lt;li&gt;â€¢ carbon 3.&lt;/li&gt;&lt;li&gt;â€¢ human desaturase enzymes&lt;/li&gt;&lt;li&gt;â€¢ carbon 9&lt;/li&gt;&lt;li&gt;â€¢ dietary&lt;/li&gt;&lt;li&gt;â€¢ certain essential&lt;/li&gt;&lt;li&gt;â€¢ fatty acids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Humans can introduce double bonds up to the 9th carbon from the methyl end , but cannot synthesize fatty acids with double bonds beyond this point, such as certain essential omega-3 and omega-6 fatty acids, which must be obtained through the diet.&lt;/li&gt;&lt;li&gt;âž¤ Humans&lt;/li&gt;&lt;li&gt;âž¤ double bonds&lt;/li&gt;&lt;li&gt;âž¤ 9th carbon&lt;/li&gt;&lt;li&gt;âž¤ methyl end&lt;/li&gt;&lt;li&gt;âž¤ cannot&lt;/li&gt;&lt;li&gt;âž¤ fatty acids&lt;/li&gt;&lt;li&gt;âž¤ double bonds&lt;/li&gt;&lt;li&gt;âž¤ essential omega-3 and omega-6 fatty acids,&lt;/li&gt;&lt;li&gt;âž¤ obtained&lt;/li&gt;&lt;li&gt;âž¤ diet.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p187&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p187&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A team of endocrinologists is conducting a study on the regulation of fat metabolism by various hormones. Their research focuses on the activity of hormone-sensitive lipase (HSL) in adipose tissue, a crucial enzyme in the mobilization of stored fats. Through their investigations, they aim to determine which hormone does not stimulate an increase in HSL activity. Which hormone is NOT associated with an increase in the activity of hormone-sensitive lipase in adipose tissue?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenaline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Growth hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-121425.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Adrenaline : This hormone activates hormone-sensitive lipase via the cAMP signaling pathway, leading to increased lipolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Adrenaline&lt;/li&gt;&lt;li&gt;â€¢ activates hormone-sensitive lipase&lt;/li&gt;&lt;li&gt;â€¢ cAMP signaling pathway,&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ lipolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Growth hormone : Growth hormone can s timulate lipolysis in adipose tissue, partly by increasing HSL activity.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Growth hormone&lt;/li&gt;&lt;li&gt;â€¢ timulate lipolysis&lt;/li&gt;&lt;li&gt;â€¢ increasing HSL activity.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Corticosteroids : Corticosteroids can also promote lipolysis , although their effect may be more complex and context-dependent.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Corticosteroids&lt;/li&gt;&lt;li&gt;â€¢ promote lipolysis&lt;/li&gt;&lt;li&gt;â€¢ their effect&lt;/li&gt;&lt;li&gt;â€¢ more complex&lt;/li&gt;&lt;li&gt;â€¢ context-dependent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulin is known to inhibit the activity of hormone-sensitive lipase (HSL) in adipose tissue. HSL plays a key role in the hydrolysis of stored triglycerides into free fatty acids and glycerol, a process that is suppressed by insulin . Insulin promotes fat storage by inhibiting lipolysis , in contrast to hormones like adrenaline, growth hormone, and corticosteroids, which stimulate HSL activity and promote fat breakdown.&lt;/li&gt;&lt;li&gt;âž¤ Insulin is known to inhibit the activity of hormone-sensitive lipase (HSL) in adipose tissue.&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ inhibit the activity of hormone-sensitive lipase (HSL)&lt;/li&gt;&lt;li&gt;âž¤ adipose tissue.&lt;/li&gt;&lt;li&gt;âž¤ HSL plays a key role in the hydrolysis of stored triglycerides into free fatty acids and glycerol, a process that is suppressed by insulin .&lt;/li&gt;&lt;li&gt;âž¤ HSL&lt;/li&gt;&lt;li&gt;âž¤ hydrolysis of stored triglycerides&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ glycerol,&lt;/li&gt;&lt;li&gt;âž¤ suppressed&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;li&gt;âž¤ Insulin promotes fat storage by inhibiting lipolysis , in contrast to hormones like adrenaline, growth hormone, and corticosteroids, which stimulate HSL activity and promote fat breakdown.&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ fat storage&lt;/li&gt;&lt;li&gt;âž¤ inhibiting lipolysis&lt;/li&gt;&lt;li&gt;âž¤ adrenaline, growth hormone, and&lt;/li&gt;&lt;li&gt;âž¤ corticosteroids,&lt;/li&gt;&lt;li&gt;âž¤ stimulate HSL activity&lt;/li&gt;&lt;li&gt;âž¤ promote fat breakdown.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 159&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 159&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pediatric clinic, a physician evaluates a 7-month-old male infant presented by his mother with concerns about hypotonia, hepatomegaly, and delayed developmental milestones. Suspecting Zellweger syndrome, a peroxisomal disorder, the physician considers the metabolic abnormalities associated with this condition. Which type of fatty acids is known to accumulate in patients with Zellweger syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Short chain fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Long chain fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medium chain fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Very long chain fatty acids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Very long chain fatty acids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome is a peroxisomal disorder characterized by the absence or malfunction of peroxisomes in the cells. One of the key functions of peroxisomes is the Î²-oxidation of very long chain fatty acids (VLCFAs). In Zellweger syndrome , the inability to metabolize VLCFAs leads to their accumulation in tissues and blood, contributing to the clinical manifestations of the disorder.&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome&lt;/li&gt;&lt;li&gt;âž¤ peroxisomal&lt;/li&gt;&lt;li&gt;âž¤ absence or malfunction of peroxisomes&lt;/li&gt;&lt;li&gt;âž¤ peroxisomes is the Î²-oxidation of very long chain fatty acids (VLCFAs).&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome&lt;/li&gt;&lt;li&gt;âž¤ inability to&lt;/li&gt;&lt;li&gt;âž¤ metabolize VLCFAs&lt;/li&gt;&lt;li&gt;âž¤ accumulation in tissues and blood,&lt;/li&gt;&lt;li&gt;âž¤ clinical manifestations of the disorder.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 241,614&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 241,614&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a pediatric clinic, a teenage girl presents with complaints of fatigue and muscle weakness. After conducting lab tests, the diagnosis points towards a carnitine deficiency. The attending physician explains to the girl and her parents about carnitine&#x27;s role and its characteristics. Which of the following statements about carnitine is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is synthesized from lysine and methionine in liver and kidney&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a transporter for short chain fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B12 is essential for its synthesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It is synthesized from lysine and methionine in liver and kidney&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) It is synthesized from lysine and methionine in the liver and kidney.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate : This statement is a correct description of the chemical structure of carnitine , indicating that this option could also be considered correct.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is chemically Beta-hydroxy Gamma-Trimethyl amino butyrate&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ chemical&lt;/li&gt;&lt;li&gt;â€¢ structure of carnitine&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a transporter for short chain fatty acids : Carnitine primarily facilitates the transport of long-chain fatty acids into mitochondria for oxidation , not short-chain fatty acids.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It is a transporter for short chain fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Carnitine&lt;/li&gt;&lt;li&gt;â€¢ facilitates&lt;/li&gt;&lt;li&gt;â€¢ long-chain fatty acids&lt;/li&gt;&lt;li&gt;â€¢ mitochondria for oxidation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 is essential for its synthesis : While vitamin B12 is essential for many metabolic processes , it is not directly involved in the synthesis of carnitine . The synthesis of carnitine requires lysine, methionine, and other cofactors like vitamin C, but not vitamin B12.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Vitamin B12 is essential for its synthesis&lt;/li&gt;&lt;li&gt;â€¢ vitamin B12&lt;/li&gt;&lt;li&gt;â€¢ metabolic processes&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ synthesis of carnitine&lt;/li&gt;&lt;li&gt;â€¢ synthesis of carnitine&lt;/li&gt;&lt;li&gt;â€¢ lysine, methionine, and other cofactors like vitamin C,&lt;/li&gt;&lt;li&gt;â€¢ not vitamin B12.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carnitine, synthesized from lysine and methionine in the liver and kidneys , is essential for the transport of long-chain fatty acids into mitochondria for Î²-oxidation&lt;/li&gt;&lt;li&gt;âž¤ Carnitine, synthesized from lysine and methionine in the liver and kidneys&lt;/li&gt;&lt;li&gt;âž¤ transport of long-chain fatty acids&lt;/li&gt;&lt;li&gt;âž¤ mitochondria for Î²-oxidation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper30/e pg 224, Vasudevan 9/ed:p202&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper30/e pg 224, Vasudevan 9/ed:p202&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is this difference in the production of byproducts between beta-oxidation in peroxisomes and that in mitochondria?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;H2O2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetyl CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Different enzymes are found in different site&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NADH is required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. H2O2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acetyl CoA : Both peroxisomal and mitochondrial beta-oxidation generate acetyl CoA , so this is not a distinguishing feature.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Both peroxisomal and mitochondrial beta-oxidation&lt;/li&gt;&lt;li&gt;â€¢ acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Option C: Different enzymes are found in different sites : While it&#x27;s true that different enzymes catalyze the steps of beta-oxidation in peroxisomes and mitochondria , this option does not refer to a unique byproduct of the reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Different enzymes are found in different sites&lt;/li&gt;&lt;li&gt;â€¢ true that different enzymes catalyze&lt;/li&gt;&lt;li&gt;â€¢ beta-oxidation in peroxisomes and mitochondria&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ unique byproduct&lt;/li&gt;&lt;li&gt;â€¢ reaction&lt;/li&gt;&lt;li&gt;â€¢ Option D: NADH is required : NADH is a product of mitochondrial beta-oxidation where it is later used in the electron transport chain to generate ATP . Peroxisomal oxidation does not contribute directly to the electron transport chain and therefore the role of NADH in peroxisomal beta-oxidation is not a key distinguishing feature in the context of byproduct production.&lt;/li&gt;&lt;li&gt;â€¢ Option D: NADH is required&lt;/li&gt;&lt;li&gt;â€¢ mitochondrial beta-oxidation&lt;/li&gt;&lt;li&gt;â€¢ used in the electron transport chain&lt;/li&gt;&lt;li&gt;â€¢ ATP&lt;/li&gt;&lt;li&gt;â€¢ Peroxisomal oxidation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ electron&lt;/li&gt;&lt;li&gt;â€¢ NADH&lt;/li&gt;&lt;li&gt;â€¢ peroxisomal beta-oxidation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A modified beta-oxidation pathway takes place in peroxisomes for fatty Acids &amp;gt; C20, C22 (VLCFs) Oxidation in the Peroxisomes â†’ produces Acetyl CoA and H2O2 (instead of FADH2) No ATP is generated. Further oxidation of Acetyl CoA and Octanoyl CoA takes place in the mitochondria .&lt;/li&gt;&lt;li&gt;âž¤ A modified beta-oxidation pathway takes place in peroxisomes for fatty Acids &amp;gt; C20, C22 (VLCFs)&lt;/li&gt;&lt;li&gt;âž¤ modified beta-oxidation pathway&lt;/li&gt;&lt;li&gt;âž¤ peroxisomes for fatty Acids&lt;/li&gt;&lt;li&gt;âž¤ C20, C22 (VLCFs)&lt;/li&gt;&lt;li&gt;âž¤ Oxidation in the Peroxisomes â†’ produces Acetyl CoA and H2O2 (instead of FADH2)&lt;/li&gt;&lt;li&gt;âž¤ Oxidation&lt;/li&gt;&lt;li&gt;âž¤ Peroxisomes&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA and H2O2&lt;/li&gt;&lt;li&gt;âž¤ No ATP is generated.&lt;/li&gt;&lt;li&gt;âž¤ No ATP&lt;/li&gt;&lt;li&gt;âž¤ Further oxidation of Acetyl CoA and Octanoyl CoA takes place in the mitochondria .&lt;/li&gt;&lt;li&gt;âž¤ Further oxidation&lt;/li&gt;&lt;li&gt;âž¤ Acetyl CoA and Octanoyl CoA&lt;/li&gt;&lt;li&gt;âž¤ mitochondria&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e page 226&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e page 226&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pediatrician is evaluating a 7-month-old boy who was admitted with a seizure, gastrointestinal symptoms, and decreased appetite. Laboratory tests show severe hypoglycemia, normal blood carnitine levels, absence of ketones in the urine, and the presence of various dicarboxylic acids. These findings suggest a diagnosis of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. Considering the biochemistry of MCAD deficiency, what is the underlying cause of fasting hypoglycemia in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased ability to convert acetyl coenzyme A to glucose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased acetyl CoA production&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased conversion of acetyl coenzyme A to acetoacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased production of ATP and nicotinamide adenine dinucleotide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased acetyl CoA production&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MCAD deficiency leads to decreased acetyl CoA production from medium-chain fatty acids , which impairs gluconeogenesis and energy production during fasting , resulting in hypoglycemia . The disease also leads to an accumulation of fatty acid metabolites, such as dicarboxylic acids , in the blood and urine .&lt;/li&gt;&lt;li&gt;âž¤ MCAD deficiency&lt;/li&gt;&lt;li&gt;âž¤ decreased acetyl CoA&lt;/li&gt;&lt;li&gt;âž¤ medium-chain fatty acids&lt;/li&gt;&lt;li&gt;âž¤ impairs gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ energy&lt;/li&gt;&lt;li&gt;âž¤ fasting&lt;/li&gt;&lt;li&gt;âž¤ hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ disease&lt;/li&gt;&lt;li&gt;âž¤ accumulation of fatty acid&lt;/li&gt;&lt;li&gt;âž¤ dicarboxylic acids&lt;/li&gt;&lt;li&gt;âž¤ blood and urine&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p204.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p204.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonate in the NICU presents with seizures, poor muscle tone, feeding difficulties, distinct facial features, bilateral cataracts, and ultrasound findings of renal cysts. Blood work indicates elevated very long-chain fatty acids (VLCFAs), reduced levels of plasmalogen, and increased levels of cholestenoic acid. Based on these clinical findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Zellweger syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infantile Refsumâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Refsumâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Organic Acidurias&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Zellweger syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome , a peroxisomal biogenesis disorder , is characterized by the absence of functional peroxisomes , which leads to the accumulation of VLCFAs and defects in plasmalogen synthesis necessary for normal cell membrane function .&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome&lt;/li&gt;&lt;li&gt;âž¤ peroxisomal biogenesis disorder&lt;/li&gt;&lt;li&gt;âž¤ absence&lt;/li&gt;&lt;li&gt;âž¤ peroxisomes&lt;/li&gt;&lt;li&gt;âž¤ accumulation of VLCFAs&lt;/li&gt;&lt;li&gt;âž¤ defects&lt;/li&gt;&lt;li&gt;âž¤ plasmalogen&lt;/li&gt;&lt;li&gt;âž¤ normal cell membrane function&lt;/li&gt;&lt;li&gt;âž¤ The clinical presentation, including distinctive facial features, cataracts, and renal cysts , along with the specific biochemical abnormalities , strongly suggests Zellweger syndrome.&lt;/li&gt;&lt;li&gt;âž¤ facial features, cataracts, and renal cysts&lt;/li&gt;&lt;li&gt;âž¤ specific biochemical abnormalities&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p209, 254&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p209, 254&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the clinic with progressive difficulty in night vision and a recent history of unsteady gait. He reports no significant medical history except for a strict vegetarian diet for many years. Physical examination reveals mild hepatomegaly and decreased ankle reflexes. Laboratory tests show elevated plasma levels of a specific fatty acid. The patientâ€™s condition is suspected to be due to a metabolic disorder affecting fatty acid catabolism:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Accumulation of phytanic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Formation of dicarboxylic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Formation of propionyl CoA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Formation of acetyl CoA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Accumulation of phytanic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Formation of dicarboxylic acid : Dicarboxylic acids accumulate as a result of Ï‰-oxidation, which typically occurs when Î²-oxidation is impaired, not Î±-oxidation.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Formation of dicarboxylic acid&lt;/li&gt;&lt;li&gt;â€¢ Ï‰-oxidation,&lt;/li&gt;&lt;li&gt;â€¢ Î²-oxidation is impaired, not&lt;/li&gt;&lt;li&gt;â€¢ Option C: Formation of propionyl CoA : Propionyl CoA is a product of the Î²-oxidation of odd-chain fatty acids , not related to Î±-oxidation defects .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Formation of propionyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Î²-oxidation&lt;/li&gt;&lt;li&gt;â€¢ odd-chain fatty acids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ Î±-oxidation defects&lt;/li&gt;&lt;li&gt;â€¢ Option D: Formation of acetyl CoA : Acetyl CoA is a product of Î²-oxidation of fatty acids . Lack of Î±-oxidation does not directly lead to the formation of acetyl CoA.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Formation of acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Acetyl CoA&lt;/li&gt;&lt;li&gt;â€¢ Î²-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Lack&lt;/li&gt;&lt;li&gt;â€¢ Î±-oxidation&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ acetyl CoA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lack of Î±-oxidation of fatty acids leads to the accumulation of phytanic acid , a branched-chain fatty acid derived mainly from dietary sources , particularly ruminant fats . Humans lack the enzymes to introduce a double bond in phytanic acid , making Î±-oxidation necessary for its catabolism . Deficiencies in this pathway, such as in Refsum disease , lead to the accumulation of phytanic acid , which is toxic to cells and can cause symptoms like night blindness, ataxia, and peripheral neuropathy.&lt;/li&gt;&lt;li&gt;âž¤ Lack&lt;/li&gt;&lt;li&gt;âž¤ Î±-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ phytanic acid&lt;/li&gt;&lt;li&gt;âž¤ branched-chain fatty acid&lt;/li&gt;&lt;li&gt;âž¤ dietary sources&lt;/li&gt;&lt;li&gt;âž¤ ruminant fats&lt;/li&gt;&lt;li&gt;âž¤ lack&lt;/li&gt;&lt;li&gt;âž¤ double bond&lt;/li&gt;&lt;li&gt;âž¤ phytanic acid&lt;/li&gt;&lt;li&gt;âž¤ Î±-oxidation&lt;/li&gt;&lt;li&gt;âž¤ its catabolism&lt;/li&gt;&lt;li&gt;âž¤ Deficiencies&lt;/li&gt;&lt;li&gt;âž¤ Refsum disease&lt;/li&gt;&lt;li&gt;âž¤ phytanic acid&lt;/li&gt;&lt;li&gt;âž¤ toxic&lt;/li&gt;&lt;li&gt;âž¤ night blindness, ataxia, and peripheral neuropathy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,pg 231&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed ,pg 231&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old biochemistry researcher is analyzing energy yield from various metabolic pathways. He is particularly interested in the total ATP production from the complete oxidation of palmitic acid, a common saturated fatty acid. In his experimental setup, he meticulously accounts for all the steps involved in Î²-oxidation, the citric acid cycle, and the electron transport chain, ensuring accurate calculations of ATP yield:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;106 ATP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;142 ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;129 ATP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;139 ATP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 106 ATP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The total ATP yield in palmitic acid oxidation is 106 ATP&lt;/li&gt;&lt;li&gt;âž¤ total ATP&lt;/li&gt;&lt;li&gt;âž¤ palmitic acid&lt;/li&gt;&lt;li&gt;âž¤ 106 ATP&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,pg 225&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed ,pg 225&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-month-old infant presents to the pediatrician with hypotonia, hepatomegaly, and developmental delays. The mother reports that the baby has had difficulty feeding and exhibits poor responsiveness to stimuli. Physical examination notes a high forehead, hypertelorism, and epicanthic folds. The physician, suspecting a genetic disorder affecting cellular organelles, orders a series of diagnostic tests, including metabolic screening and imaging:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitochondria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysosomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Peroxisomes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nucleus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Peroxisomes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Peroxisomes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mitochondria: Disorders associated - Mitochondrial myopathies , Charcot-Marie-Tooth disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Mitochondria:&lt;/li&gt;&lt;li&gt;â€¢ Disorders&lt;/li&gt;&lt;li&gt;â€¢ Mitochondrial myopathies&lt;/li&gt;&lt;li&gt;â€¢ Charcot-Marie-Tooth disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lysosomes: Disorders associated â€“ Inclusion cell (I-cell) disease, sphingolipidoses , Mucopolysaccharidosis .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lysosomes:&lt;/li&gt;&lt;li&gt;â€¢ Disorders&lt;/li&gt;&lt;li&gt;â€¢ Inclusion cell (I-cell) disease, sphingolipidoses&lt;/li&gt;&lt;li&gt;â€¢ Mucopolysaccharidosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Nucleus: Autoimmune disorders , DNA repair defects .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Nucleus:&lt;/li&gt;&lt;li&gt;â€¢ Autoimmune disorders&lt;/li&gt;&lt;li&gt;â€¢ DNA repair defects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome is a rare congenital disorder caused by a defect in peroxisome biogenesis, leading to various clinical symptoms such as hypotonia, hepatomegaly, developmental delays , and distinct craniofacial features.&lt;/li&gt;&lt;li&gt;âž¤ Zellweger syndrome&lt;/li&gt;&lt;li&gt;âž¤ rare&lt;/li&gt;&lt;li&gt;âž¤ defect&lt;/li&gt;&lt;li&gt;âž¤ peroxisome biogenesis,&lt;/li&gt;&lt;li&gt;âž¤ hypotonia, hepatomegaly, developmental delays&lt;/li&gt;&lt;li&gt;âž¤ distinct craniofacial&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 209, 254&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 209, 254&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old boy is brought to a pediatric neurologist by his parents, who are concerned about recent changes in his behavior and academic performance. Over the past six months, he has exhibited signs of hyperactivity, vision problems, and hearing loss. His teachers have noted a significant decline in his attention span and comprehension skills. The neurologist, suspecting a genetic disorder affecting the metabolism of fatty acids, orders a comprehensive lipid panel including very long-chain fatty acid (VLCFA) levels:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Accumulation of very long chain fatty acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Accumulation of medium chain fatty acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased plasmalogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased pipecolic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Accumulation of very long chain fatty acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Accumulation of medium chain fatty acid : ALD does not typically involve the accumulation of medium-chain fatty acids .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Accumulation of medium chain fatty acid&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ medium-chain fatty acids&lt;/li&gt;&lt;li&gt;â€¢ Option C: Increased plasmalogen : Plasmalogens are a type of phospholipid ; their levels are not directly related to ALD , which is primarily concerned with the metabolism of VLCFAs .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Increased plasmalogen&lt;/li&gt;&lt;li&gt;â€¢ phospholipid&lt;/li&gt;&lt;li&gt;â€¢ not directly&lt;/li&gt;&lt;li&gt;â€¢ ALD&lt;/li&gt;&lt;li&gt;â€¢ metabolism of VLCFAs&lt;/li&gt;&lt;li&gt;â€¢ Option D: Decreased pipecolic acid : Pipecolic acid is associated with peroxisomal disorders like Zellweger syndrome , not specifically with ALD .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Decreased pipecolic acid&lt;/li&gt;&lt;li&gt;â€¢ peroxisomal disorders&lt;/li&gt;&lt;li&gt;â€¢ Zellweger syndrome&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ ALD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Deficient oxidation of VLCFA by peroxisomal enzyme systems â†’ VLCFAs are accumulated â†’ myelin sheaths are destroyed â†’ adrenoleukodystrophy .&lt;/li&gt;&lt;li&gt;âž¤ Deficient oxidation&lt;/li&gt;&lt;li&gt;âž¤ VLCFA&lt;/li&gt;&lt;li&gt;âž¤ peroxisomal enzyme systems&lt;/li&gt;&lt;li&gt;âž¤ VLCFAs&lt;/li&gt;&lt;li&gt;âž¤ myelin sheaths&lt;/li&gt;&lt;li&gt;âž¤ destroyed&lt;/li&gt;&lt;li&gt;âž¤ adrenoleukodystrophy&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify an incorrect statement about omega-oxidation of fatty acids:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Takes place in mitochondria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Produce dicarboxylic acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NADPH and cytochrome P-450 play a role&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Involves methyl group at omega end&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Takes place in mitochondria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Omega-oxidation of fatty acids takes place primarily in the endoplasmic reticulum of cells, not in mitochondria . This pathway serves as an alternative to the Î²-oxidation of fatty acids , which occurs in mitochondria and peroxisomes.&lt;/li&gt;&lt;li&gt;âž¤ Omega-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ endoplasmic reticulum&lt;/li&gt;&lt;li&gt;âž¤ not in mitochondria&lt;/li&gt;&lt;li&gt;âž¤ alternative to the Î²-oxidation of fatty acids&lt;/li&gt;&lt;li&gt;âž¤ mitochondria and peroxisomes.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 205&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following metabolic pathways generates the most ATP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Citric acid cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid oxidation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pentose phosphate pathway&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fatty acid oxidation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: The citric acid cycle produces a net of 10 ATP per turn of the cycle&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glycolysis produces a net of 7 ATP molecules per glucose under aerobic conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Option D: The pentose phosphate pathway does not generate any ATP but instead forms NADPH and ribose 5-phosphate&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid oxidation, specifically Î²-oxidation of fatty acids, generates the most AT, because the breakdown of fatty acids yields numerous molecules of acetyl-CoA, NADH, and FADH2, all of which enter the citric acid cycle and electron transport chain to produce ATP. Fatty acids are a dense form of energy storage, and their oxidation releases a significant amount of energy.&lt;/li&gt;&lt;li&gt;â€¢ Ref : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : DM Vasudevan 9/e: p 204.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with no significant medical history is referred to a gastroenterologist after experiencing recurrent episodes of intense epigastric pain that often radiates to the right shoulder, especially after meals rich in fat. Her laboratory workup reveals signs of jaundice, and an ultrasound of the abdomen shows cholelithiasis with cholecystitis and concurrent pancreatitis. During the consultation, the gastroenterologist educates the patient on the nature of the gallstones implicated in her condition:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amorphous cholesterol monohydrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Crystalline cholesterol monohydrate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amorphous cholesterol dehydrate + potassium bilirubinate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Crystalline Cholesterol dihydrate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Crystalline cholesterol monohydrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The majority of gallstones are composed of crystalline cholesterol monohydrate. These stones form when there is an imbalance in the composition of bile , leading to the precipitation of cholesterol . Cholesterol gallstones are often associated with obesity, rapid weight loss, or other metabolic conditions and are known to cause symptoms, particularly after the ingestion of fatty foods .&lt;/li&gt;&lt;li&gt;âž¤ gallstones&lt;/li&gt;&lt;li&gt;âž¤ crystalline cholesterol monohydrate.&lt;/li&gt;&lt;li&gt;âž¤ stones&lt;/li&gt;&lt;li&gt;âž¤ imbalance&lt;/li&gt;&lt;li&gt;âž¤ bile&lt;/li&gt;&lt;li&gt;âž¤ precipitation of cholesterol&lt;/li&gt;&lt;li&gt;âž¤ Cholesterol gallstones&lt;/li&gt;&lt;li&gt;âž¤ obesity, rapid weight loss,&lt;/li&gt;&lt;li&gt;âž¤ metabolic&lt;/li&gt;&lt;li&gt;âž¤ symptoms,&lt;/li&gt;&lt;li&gt;âž¤ ingestion of fatty foods&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 537&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 537&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man, recently treated with angioplasty for coronary artery disease (CAD), is being counseled by his cardiologist on discharge. The cardiologist emphasizes the importance of secondary prevention through lifestyle modifications to manage his cardiovascular risk factors. As part of the comprehensive plan, the cardiologist advises the patient on the optimal cholesterol levels he should aim to maintain to reduce the risk of future cardiac events:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Below 280&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt;250&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;200&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Below 200&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Below 200&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-145604.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In healthy persons , cholesterol level varies from 150 to 200 mg/dL With risk factors - cholesterol level should be kept below 180 mg/dL. Values around 220 mg/dL - moderate risk Values above 240 mg/dL - needs active treatment.&lt;/li&gt;&lt;li&gt;âž¤ In healthy persons , cholesterol level varies from 150 to 200 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ healthy persons&lt;/li&gt;&lt;li&gt;âž¤ cholesterol level&lt;/li&gt;&lt;li&gt;âž¤ 150 to 200 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ With risk factors - cholesterol level should be kept below 180 mg/dL.&lt;/li&gt;&lt;li&gt;âž¤ risk&lt;/li&gt;&lt;li&gt;âž¤ below 180 mg/dL.&lt;/li&gt;&lt;li&gt;âž¤ Values around 220 mg/dL - moderate risk&lt;/li&gt;&lt;li&gt;âž¤ 220 mg/dL - moderate risk&lt;/li&gt;&lt;li&gt;âž¤ Values above 240 mg/dL - needs active treatment.&lt;/li&gt;&lt;li&gt;âž¤ above 240 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ active treatment.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Fundamentals of Clinical Chemistry 6/e p 419, DM Vasudevan 7/e: p 140-141&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Fundamentals of Clinical Chemistry 6/e p 419, DM Vasudevan 7/e: p 140-141&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pharmaceutical researcher is developing a new class of lipid-lowering drugs aimed at targeting cholesterol biosynthesis. In a team meeting, he presents the biosynthetic pathway of cholesterol to identify potential targets for drug intervention. He highlights a crucial 30-carbon intermediate in the pathway and asks the team to identify this compound, emphasizing its significance in the synthesis of cholesterol:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoprenoid units&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squalene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Geranyl pyrophosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Farnesyl pyrophosphate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squalene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-152527.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/screenshot-2024-04-19-152606.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Squalene is the correct answer as it is a 30-carbon compound that serves as a key intermediate in the cholesterol biosynthesis pathway. Squalene is synthesized from the condensation of two farnesyl pyrophosphate molecules and is later cyclized to form lanosterol , which undergoes several modifications to become cholesterol .&lt;/li&gt;&lt;li&gt;âž¤ Squalene&lt;/li&gt;&lt;li&gt;âž¤ correct&lt;/li&gt;&lt;li&gt;âž¤ 30-carbon&lt;/li&gt;&lt;li&gt;âž¤ key&lt;/li&gt;&lt;li&gt;âž¤ cholesterol biosynthesis&lt;/li&gt;&lt;li&gt;âž¤ Squalene&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ condensation&lt;/li&gt;&lt;li&gt;âž¤ two farnesyl pyrophosphate molecules&lt;/li&gt;&lt;li&gt;âž¤ later cyclized&lt;/li&gt;&lt;li&gt;âž¤ lanosterol&lt;/li&gt;&lt;li&gt;âž¤ several&lt;/li&gt;&lt;li&gt;âž¤ cholesterol&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 222&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 222&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Secondary bile acids are:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholic acid and chenodeoxycholic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cholic acid and deoxycholic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deoxycholic acid and lithocholic acid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lithocholic acid and chenodeoxycholic acid&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Deoxycholic acid and lithocholic acid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary Bile Acids: Formed in Liver&lt;/li&gt;&lt;li&gt;âž¤ Primary Bile Acids: Formed in Liver&lt;/li&gt;&lt;li&gt;âž¤ Cholic Acid (Most abundant bile acids in mammals) Chenodeoxycholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Cholic Acid (Most abundant bile acids in mammals)&lt;/li&gt;&lt;li&gt;âž¤ Cholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Chenodeoxycholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Chenodeoxycholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Secondary Bile acids: Formed in Intestine&lt;/li&gt;&lt;li&gt;âž¤ Secondary Bile acids: Formed in Intestine&lt;/li&gt;&lt;li&gt;âž¤ Deoxycholic Acid Lithocholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Deoxycholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Deoxycholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Lithocholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Lithocholic Acid&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 232.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 232.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bile acids are primarily synthesized from which of the following substances?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholesterol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proteins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cholesterol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bile acids are synthesized from cholesterol in liver . Rate limiting enzyme : seven Î± hydroxylase , Microsomal enzyme: Cyt P450, O2, NADPH, Vit C .&lt;/li&gt;&lt;li&gt;âž¤ Bile acids are synthesized from cholesterol in liver .&lt;/li&gt;&lt;li&gt;âž¤ Bile acids&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ cholesterol&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ Rate limiting enzyme : seven Î± hydroxylase , Microsomal enzyme: Cyt P450, O2, NADPH, Vit C .&lt;/li&gt;&lt;li&gt;âž¤ Rate limiting enzyme&lt;/li&gt;&lt;li&gt;âž¤ Î± hydroxylase&lt;/li&gt;&lt;li&gt;âž¤ Cyt P450, O2, NADPH, Vit C&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/ed ,pg 273&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/ed ,pg 273&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neurologist is assessing a teenage girl who has been experiencing fatigue severe enough to prevent her participation in physical education classes. She presents with muscle weakness in her limbs. Lab tests indicate high serum levels of triacylglycerols esterified with long-chain fatty acids (LCFAs) and hypoglycemia. A muscle biopsy shows an abundance of lipid vacuoles. What condition do these clinical findings suggest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carnitine deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid synthase deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tay-Sachs disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biotin deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Carnitine deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Affects the de novo synthesis of fatty acids occurs in the cytoplasm with the help of a dimeric multi-enzyme complex termed Fatty acid synthase .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ de novo synthesis&lt;/li&gt;&lt;li&gt;â€¢ fatty acids&lt;/li&gt;&lt;li&gt;â€¢ cytoplasm&lt;/li&gt;&lt;li&gt;â€¢ dimeric multi-enzyme complex&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid synthase&lt;/li&gt;&lt;li&gt;â€¢ Option C: Deficiency of hexosaminidase A leads to accumulation of Ganglioside (GM2). C/F - Mental retardation, Cherry red spot in the macula with Progressive deterioration and death by 3â€“4 years.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of hexosaminidase A&lt;/li&gt;&lt;li&gt;â€¢ Ganglioside (GM2). C/F&lt;/li&gt;&lt;li&gt;â€¢ Mental retardation, Cherry red spot in the macula&lt;/li&gt;&lt;li&gt;â€¢ death by 3â€“4 years.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Biotin deficiency includes dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia and hallucinations .&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia&lt;/li&gt;&lt;li&gt;â€¢ hallucinations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical manifestations of carnitine deficiency , including muscle weakness, elevated serum triacylglycerols with LCFAs, hypoglycemia , and lipid accumulation in muscle cells , which reflect the impaired transport of fatty acids into mitochondria for Î²-oxidation .&lt;/li&gt;&lt;li&gt;âž¤ carnitine deficiency&lt;/li&gt;&lt;li&gt;âž¤ muscle weakness, elevated serum triacylglycerols&lt;/li&gt;&lt;li&gt;âž¤ LCFAs, hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ lipid accumulation in muscle cells&lt;/li&gt;&lt;li&gt;âž¤ impaired transport&lt;/li&gt;&lt;li&gt;âž¤ fatty acids&lt;/li&gt;&lt;li&gt;âž¤ Î²-oxidation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:p 224,231.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:p 224,231.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 130 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test8" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Miscellaneous&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Miscellaneous&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                51 Questions | 204 Total Marks | 61 min Duration | ~71.76 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 35 years old female patient has a BMI of 36 kg/m 2 . She has multiple comorbidities and hence presented to the bariatric surgeon for surgical options to lose weight. Which of the below parameters will make her unfit for surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary Artery Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Her BMI is below the Cut off for Surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Capable of Understanding Lifestyle Changes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe Depression&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Severe Depression&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-175730.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Severe Depression&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Let&#x27;s evaluate all the options to identify which parameter would make a 35-year-old female patient with a BMI of 36 kg/m^2 unfit for bariatric surgery:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Coronary artery disease is a significant comorbidity that needs to be well-managed before bariatric surgery, but it does not necessarily make a patient unfit for surgery if optimized. In fact, it is one of the co-morbidities which can be considered as an indication .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ significant comorbidity&lt;/li&gt;&lt;li&gt;â€¢ well-managed&lt;/li&gt;&lt;li&gt;â€¢ indication&lt;/li&gt;&lt;li&gt;â€¢ Option B . A BMI below the cut-off for surgery could make a patient ineligible for bariatric surgery. However, a BMI of 36 kg/m^2 is above the typical cut-off of 35 kg/m^2 with comorbidities or 40 kg/m^2 without comorbidities.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ patient ineligible&lt;/li&gt;&lt;li&gt;â€¢ Option C . Being capable of understanding lifestyle changes is a necessary criterion for suitability for bariatric surgery, not a disqualifying one.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ understanding lifestyle changes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Severe depression can make a patient unfit for bariatric surgery because it may affect their ability to understand and comply with the significant lifestyle changes required postoperatively .&lt;/li&gt;&lt;li&gt;âž¤ patient unfit&lt;/li&gt;&lt;li&gt;âž¤ affect their ability&lt;/li&gt;&lt;li&gt;âž¤ understand&lt;/li&gt;&lt;li&gt;âž¤ comply with&lt;/li&gt;&lt;li&gt;âž¤ significant lifestyle changes&lt;/li&gt;&lt;li&gt;âž¤ required postoperatively&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed., Pg 1184&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed., Pg 1184&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a bariatric surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Roux-en-Y Gastrojejunostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sleeve Gastrectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyloric Exclusion with Gastrojejunostomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Laparoscopic Gastric Banding&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pyloric Exclusion with Gastrojejunostomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture17_8K7nX0K.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture18_BtMblDG.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pyloric Exclusion with Gastrojejunostomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Roux-en-Y gastrojejunostomy is a common form of bariatric surgery that is both restrictive and malabsorptive . It involves creating a small stomach pouch and connecting it directly to the jejunum .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ common form&lt;/li&gt;&lt;li&gt;â€¢ both restrictive&lt;/li&gt;&lt;li&gt;â€¢ malabsorptive&lt;/li&gt;&lt;li&gt;â€¢ creating&lt;/li&gt;&lt;li&gt;â€¢ small stomach pouch&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ jejunum&lt;/li&gt;&lt;li&gt;â€¢ Option B . Sleeve gastrectomy is a restrictive bariatric surgery where a portion of the stomach is removed , leaving a smaller , tube-shaped stomach .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ restrictive bariatric surgery&lt;/li&gt;&lt;li&gt;â€¢ removed&lt;/li&gt;&lt;li&gt;â€¢ smaller&lt;/li&gt;&lt;li&gt;â€¢ tube-shaped stomach&lt;/li&gt;&lt;li&gt;â€¢ Option D. Laparoscopic gastric banding is a restrictive bariatric surgery that involves placing an adjustable band around the upper portion of the stomach to create a small stomach pouch .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ restrictive bariatric surgery&lt;/li&gt;&lt;li&gt;â€¢ placing&lt;/li&gt;&lt;li&gt;â€¢ adjustable band&lt;/li&gt;&lt;li&gt;â€¢ upper portion&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ small stomach pouch&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyloric exclusion with gastrojejunostomy is not a bariatric surgery; it is a technique used to repair duodenal and pancreatic injuries . Bariatric surgeries are primarily aimed at weight loss and include restrictive , malabsorptive , combined procedures , and endoscopic bariatric procedures.&lt;/li&gt;&lt;li&gt;âž¤ technique used&lt;/li&gt;&lt;li&gt;âž¤ repair duodenal&lt;/li&gt;&lt;li&gt;âž¤ pancreatic injuries&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ restrictive&lt;/li&gt;&lt;li&gt;âž¤ malabsorptive&lt;/li&gt;&lt;li&gt;âž¤ combined procedures&lt;/li&gt;&lt;li&gt;âž¤ endoscopic bariatric procedures.&lt;/li&gt;&lt;li&gt;âž¤ Types of Bariatric procedures:&lt;/li&gt;&lt;li&gt;âž¤ Types of Bariatric procedures:&lt;/li&gt;&lt;li&gt;âž¤ Restrictive: Where stomach is reduced in size Ã  reduction in meal size Ã  lower calorie intake Ã  Weight loss.&lt;/li&gt;&lt;li&gt;âž¤ Restrictive: Where stomach is reduced in size Ã  reduction in meal size Ã  lower calorie intake Ã  Weight loss.&lt;/li&gt;&lt;li&gt;âž¤ Restrictive:&lt;/li&gt;&lt;li&gt;âž¤ Examples: Sleeve gastrectomy, adjustable gastric band&lt;/li&gt;&lt;li&gt;âž¤ Examples:&lt;/li&gt;&lt;li&gt;âž¤ Malabsorptive: Where segment of intestine is bypassed Ã  less absorptive area Ã  Lesser absorption of food Ã  weight loss.&lt;/li&gt;&lt;li&gt;âž¤ Malabsorptive: Where segment of intestine is bypassed Ã  less absorptive area Ã  Lesser absorption of food Ã  weight loss.&lt;/li&gt;&lt;li&gt;âž¤ Malabsorptive:&lt;/li&gt;&lt;li&gt;âž¤ Examples: Biliopancreatic diversion/Duodenal switch, Mini-gastric bypass&lt;/li&gt;&lt;li&gt;âž¤ Examples:&lt;/li&gt;&lt;li&gt;âž¤ Combined: Where both of above effects are applicable.&lt;/li&gt;&lt;li&gt;âž¤ Combined: Where both of above effects are applicable.&lt;/li&gt;&lt;li&gt;âž¤ Combined:&lt;/li&gt;&lt;li&gt;âž¤ Example: Roux-en-Y gastric bypass&lt;/li&gt;&lt;li&gt;âž¤ Example:&lt;/li&gt;&lt;li&gt;âž¤ Endoscopic bariatric procedures: non-surgical, purely by endoscopic approach&lt;/li&gt;&lt;li&gt;âž¤ Endoscopic bariatric procedures: non-surgical, purely by endoscopic approach&lt;/li&gt;&lt;li&gt;âž¤ Endoscopic bariatric procedures:&lt;/li&gt;&lt;li&gt;âž¤ Example: Gastric balloon, Endoscopic gastroplasty (principally same as restrictive procedures)&lt;/li&gt;&lt;li&gt;âž¤ Example:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1185&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1185&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the principles of bariatric surgery, which of the following is/are considered as reversible bariatric surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Laparoscopic adjustable Gastric Banding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Laparoscopic Roux-en-Y Gastric Bypass&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Laparoscopic Sleeve Gastrectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and B&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Both A and B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture19_UXQeT7e.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Both A and B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Laparoscopic sleeve gastrectomy involves removing a portion of the stomach to create a smaller, sleeve-shaped stomach . This procedure is not considered reversible because the removed portion of the stomach cannot be replaced.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ removing&lt;/li&gt;&lt;li&gt;â€¢ portion&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ create&lt;/li&gt;&lt;li&gt;â€¢ smaller, sleeve-shaped stomach&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Laparoscopic adjustable gastric banding and RYGB considered a reversible bariatric surgery because the band can be removed or adjusted postoperatively , while the Roux-en-Y configuration can be reversed , unlike other forms of bariatric surgery that permanently alter the stomach or digestive tract .&lt;/li&gt;&lt;li&gt;âž¤ Laparoscopic adjustable gastric banding&lt;/li&gt;&lt;li&gt;âž¤ RYGB&lt;/li&gt;&lt;li&gt;âž¤ reversible bariatric surgery&lt;/li&gt;&lt;li&gt;âž¤ removed&lt;/li&gt;&lt;li&gt;âž¤ adjusted postoperatively&lt;/li&gt;&lt;li&gt;âž¤ Roux-en-Y configuration&lt;/li&gt;&lt;li&gt;âž¤ reversed&lt;/li&gt;&lt;li&gt;âž¤ permanently alter&lt;/li&gt;&lt;li&gt;âž¤ stomach&lt;/li&gt;&lt;li&gt;âž¤ digestive tract&lt;/li&gt;&lt;li&gt;âž¤ Complications of LAGB include:&lt;/li&gt;&lt;li&gt;âž¤ Complications of LAGB include:&lt;/li&gt;&lt;li&gt;âž¤ Prolapse / Slippage (most common) Band erosion of the stomach wall and rupture Increased risk of DVT and pulmonary embolism (highest risk within 1 month of surgery), managed with early ambulation, pressure stockings and LMWH.&lt;/li&gt;&lt;li&gt;âž¤ Prolapse / Slippage (most common)&lt;/li&gt;&lt;li&gt;âž¤ (most common)&lt;/li&gt;&lt;li&gt;âž¤ Band erosion of the stomach wall and rupture&lt;/li&gt;&lt;li&gt;âž¤ Increased risk of DVT and pulmonary embolism (highest risk within 1 month of surgery), managed with early ambulation, pressure stockings and LMWH.&lt;/li&gt;&lt;li&gt;âž¤ Increased risk of DVT and pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed Pg 1187&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed Pg 1187&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A morbidly obese patient fitting the NICE criteria arrives at your OPD to evaluate the surgical options for her weight reduction. Which is the most commonly done surgical procedure in bariatric today?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sleeve Gastrectomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastric Banding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Roux en Y Gastric Bypass&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mini-Gastric Bypass&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sleeve Gastrectomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture20_PT0Ffua.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sleeve Gastrectomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Gastric banding was once a popular bariatric surgery , but its frequency has decreased due to the higher prevalence and success rates of other procedures like the sleeve gastrectomy.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ popular bariatric surgery&lt;/li&gt;&lt;li&gt;â€¢ frequency has decreased&lt;/li&gt;&lt;li&gt;â€¢ higher prevalence&lt;/li&gt;&lt;li&gt;â€¢ success rates&lt;/li&gt;&lt;li&gt;â€¢ Option C . Roux en y gastric bypass is a procedure that involves creating a small pouch from the stomach and connecting it directly to the small intestine . Although it is a common and effective procedure , it is more complex than sleeve gastrectomy and carries a higher risk of complications like internal hernias.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ creating a small pouch&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ connecting&lt;/li&gt;&lt;li&gt;â€¢ directly&lt;/li&gt;&lt;li&gt;â€¢ small intestine&lt;/li&gt;&lt;li&gt;â€¢ common&lt;/li&gt;&lt;li&gt;â€¢ effective procedure&lt;/li&gt;&lt;li&gt;â€¢ more complex&lt;/li&gt;&lt;li&gt;â€¢ sleeve gastrectomy&lt;/li&gt;&lt;li&gt;â€¢ higher risk&lt;/li&gt;&lt;li&gt;â€¢ complications&lt;/li&gt;&lt;li&gt;â€¢ Option D . Mini-gastric bypass is a variation of the traditional gastric bypass but has not surpassed the sleeve gastrectomy in frequency of performance.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ traditional gastric bypass&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sleeve gastrectomy is the most commonly done surgical procedure in bariatrics today due to its simplicity relative to other options and its effectiveness in weight loss .&lt;/li&gt;&lt;li&gt;âž¤ Sleeve gastrectomy&lt;/li&gt;&lt;li&gt;âž¤ most commonly done surgical procedure&lt;/li&gt;&lt;li&gt;âž¤ simplicity&lt;/li&gt;&lt;li&gt;âž¤ effectiveness&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ Sleeve gastrectomy is a type of restrictive surgery which works on the following principle:&lt;/li&gt;&lt;li&gt;âž¤ restrictive surgery&lt;/li&gt;&lt;li&gt;âž¤ Where stomach is reduced in size (by creating a vertical sleeve, resecting much of the greater curvature) â†’ reduction in meal size â†’ lower calorie intake â†’ Weight loss. It is the most common surgery done today , since it is less challenging and there is reduction in number of internal hernias.&lt;/li&gt;&lt;li&gt;âž¤ most common surgery done today&lt;/li&gt;&lt;li&gt;âž¤ Complications of sleeve gastrectomy:&lt;/li&gt;&lt;li&gt;âž¤ Complications of sleeve gastrectomy:&lt;/li&gt;&lt;li&gt;âž¤ Bleed from staple line Leakage from staple line at angle of His ( upper end ) GERD in the long term&lt;/li&gt;&lt;li&gt;âž¤ Bleed from staple line&lt;/li&gt;&lt;li&gt;âž¤ Bleed&lt;/li&gt;&lt;li&gt;âž¤ staple line&lt;/li&gt;&lt;li&gt;âž¤ Leakage from staple line at angle of His ( upper end )&lt;/li&gt;&lt;li&gt;âž¤ Leakage&lt;/li&gt;&lt;li&gt;âž¤ staple line&lt;/li&gt;&lt;li&gt;âž¤ angle of His&lt;/li&gt;&lt;li&gt;âž¤ upper end&lt;/li&gt;&lt;li&gt;âž¤ GERD in the long term&lt;/li&gt;&lt;li&gt;âž¤ GERD&lt;/li&gt;&lt;li&gt;âž¤ long term&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1186&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1186&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45 years old lady underwent Roux-en-Y gastric bypass 2 years ago. She comes to the emergency with sudden onset abdominal pain and vomiting. She is afebrile. Abdomen exam shows vague diffuse tenderness. An urgent CECT abdomen is done, which shows dilated small bowel loops. Which of these is a dangerous late complication in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Narrowing of Gastro-Jejunostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Internal Hernia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leak from Staple Line&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary Embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Internal Hernia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Internal Hernia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Narrowing of gastro-jejunostomy can cause obstruction and vomiting but would typically not lead to diffuse abdominal tenderness and is more of an early complication post-surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ obstruction&lt;/li&gt;&lt;li&gt;â€¢ vomiting&lt;/li&gt;&lt;li&gt;â€¢ Option C. A leak from the staple line is generally an early postoperative complication and would typically present with signs of infection such as fever , which is not mentioned in this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ early postoperative complication&lt;/li&gt;&lt;li&gt;â€¢ present with signs of infection&lt;/li&gt;&lt;li&gt;â€¢ fever&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary embolism could cause sudden onset symptoms but would not explain the finding of dilated small bowel loops on the CECT abdomen.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ sudden onset symptoms&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An internal hernia is a dangerous late complication after Roux-en-Y gastric bypass that can present with symptoms of bowel obstruction and requires high priority for laparoscopic investigation , even in the face of normal imaging studies .&lt;/li&gt;&lt;li&gt;âž¤ dangerous late complication&lt;/li&gt;&lt;li&gt;âž¤ gastric bypass&lt;/li&gt;&lt;li&gt;âž¤ bowel obstruction&lt;/li&gt;&lt;li&gt;âž¤ requires high priority&lt;/li&gt;&lt;li&gt;âž¤ laparoscopic investigation&lt;/li&gt;&lt;li&gt;âž¤ face&lt;/li&gt;&lt;li&gt;âž¤ normal imaging studies&lt;/li&gt;&lt;li&gt;âž¤ Internal hernias develop as weight is lost and hernia spaces open up after gastric bypass . CT scanning has a high rate of false negatives for internal hernia , so anyone presenting with severe , cramping abdominal pain 2â€“3 years after surgery needs to be high priority for investigation by laparoscopy . Closure of the internal hernia spaces is now standard of care in Roux-en-Y gastric bypass.&lt;/li&gt;&lt;li&gt;âž¤ Internal hernias develop as weight is lost and hernia spaces open up after gastric bypass .&lt;/li&gt;&lt;li&gt;âž¤ weight is lost&lt;/li&gt;&lt;li&gt;âž¤ hernia spaces&lt;/li&gt;&lt;li&gt;âž¤ gastric bypass&lt;/li&gt;&lt;li&gt;âž¤ CT scanning has a high rate of false negatives for internal hernia , so anyone presenting with severe , cramping abdominal pain 2â€“3 years after surgery needs to be high priority for investigation by laparoscopy .&lt;/li&gt;&lt;li&gt;âž¤ high rate of false negatives&lt;/li&gt;&lt;li&gt;âž¤ internal hernia&lt;/li&gt;&lt;li&gt;âž¤ severe&lt;/li&gt;&lt;li&gt;âž¤ cramping abdominal pain 2â€“3 years&lt;/li&gt;&lt;li&gt;âž¤ investigation by laparoscopy&lt;/li&gt;&lt;li&gt;âž¤ Closure of the internal hernia spaces is now standard of care in Roux-en-Y gastric bypass.&lt;/li&gt;&lt;li&gt;âž¤ Closure&lt;/li&gt;&lt;li&gt;âž¤ internal hernia spaces&lt;/li&gt;&lt;li&gt;âž¤ care&lt;/li&gt;&lt;li&gt;âž¤ Complications of Bariatric Surgery:&lt;/li&gt;&lt;li&gt;âž¤ Complications of Bariatric Surgery:&lt;/li&gt;&lt;li&gt;âž¤ Related to Surgery : Postoperative bleed, post-operative staple line leak, internal hernia, band erosion. Related to Obesity : Deep vein thrombosis, pulmonary embolism (most common cause of death), respiratory failure. Related to Reduced Food Intake/Malabsorption : Hypo-proteinemia, anemia, vitamin deficiencies (Vit B12/Vit D etc.).&lt;/li&gt;&lt;li&gt;âž¤ Related to Surgery : Postoperative bleed, post-operative staple line leak, internal hernia, band erosion.&lt;/li&gt;&lt;li&gt;âž¤ Related to Surgery&lt;/li&gt;&lt;li&gt;âž¤ Related to Obesity : Deep vein thrombosis, pulmonary embolism (most common cause of death), respiratory failure.&lt;/li&gt;&lt;li&gt;âž¤ Related to Obesity&lt;/li&gt;&lt;li&gt;âž¤ Related to Reduced Food Intake/Malabsorption : Hypo-proteinemia, anemia, vitamin deficiencies (Vit B12/Vit D etc.).&lt;/li&gt;&lt;li&gt;âž¤ Related to Reduced Food Intake/Malabsorption&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1188-89&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1188-89&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these bariatric procedures leads to maximum weight loss and nutritional deficiencies?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric Band&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Roux en Y Gastric Bypass&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sleeve Gastrectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Duodenal Switch&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Duodenal Switch&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/screenshot-2023-12-30-183138.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Duodenal Switch&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastric band is a restrictive bariatric procedure that reduces food intake by creating a small pouch at the top of the stomach . It generally results in moderate weight loss and has a lower risk of nutritional deficiencies compared to more invasive surgeries .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ restrictive bariatric procedure&lt;/li&gt;&lt;li&gt;â€¢ reduces food intake&lt;/li&gt;&lt;li&gt;â€¢ small pouch&lt;/li&gt;&lt;li&gt;â€¢ top&lt;/li&gt;&lt;li&gt;â€¢ stomach&lt;/li&gt;&lt;li&gt;â€¢ moderate weight loss&lt;/li&gt;&lt;li&gt;â€¢ lower risk&lt;/li&gt;&lt;li&gt;â€¢ nutritional deficiencies&lt;/li&gt;&lt;li&gt;â€¢ more invasive surgeries&lt;/li&gt;&lt;li&gt;â€¢ Option B . Roux en Y gastric bypass is a combination of restrictive and malabsorptive procedures and can lead to significant weight loss and nutritional deficiencies , but not typically to the extent seen with more malabsorptive procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ combination&lt;/li&gt;&lt;li&gt;â€¢ restrictive&lt;/li&gt;&lt;li&gt;â€¢ malabsorptive procedures&lt;/li&gt;&lt;li&gt;â€¢ significant weight loss&lt;/li&gt;&lt;li&gt;â€¢ nutritional deficiencies&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sleeve gastrectomy is mainly a restrictive procedure that removes a portion of the stomach. It can lead to substantial weight loss , but because there is no bypass of the intestines, it generally causes fewer nutritional deficiencies than malabsorptive procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ restrictive procedure&lt;/li&gt;&lt;li&gt;â€¢ removes&lt;/li&gt;&lt;li&gt;â€¢ portion&lt;/li&gt;&lt;li&gt;â€¢ substantial weight loss&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The duodenal switch bariatric procedure leads to the most significant weight loss and the highest risk of nutritional deficiencies due to its extensive malabsorptive component .&lt;/li&gt;&lt;li&gt;âž¤ switch bariatric procedure&lt;/li&gt;&lt;li&gt;âž¤ most significant weight loss&lt;/li&gt;&lt;li&gt;âž¤ highest risk&lt;/li&gt;&lt;li&gt;âž¤ nutritional deficiencies&lt;/li&gt;&lt;li&gt;âž¤ extensive malabsorptive component&lt;/li&gt;&lt;li&gt;âž¤ Note: % EWL= Excess Weight Loss&lt;/li&gt;&lt;li&gt;âž¤ Note:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1185.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1185.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the mismatch in the bariatric procedures and associated complications:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sleeve Gastrectomy- GERD is a long term Complication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sleeve Gastrectomy- Leak from Upper Staple Line is the â€œAchilles Heelâ€&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Internal Hernia- Seen after Roux en Y gastric bypass&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric Band- Protein Energy Malnutrition&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Gastric Band- Protein Energy Malnutrition&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Gastric band- Protein Energy Malnutrition&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This statement is accurate . Sleeve gastrectomy may lead to the development or exacerbation of gastroesophageal reflux disease (GERD) as a long-term complication .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ accurate&lt;/li&gt;&lt;li&gt;â€¢ may lead&lt;/li&gt;&lt;li&gt;â€¢ development&lt;/li&gt;&lt;li&gt;â€¢ exacerbation&lt;/li&gt;&lt;li&gt;â€¢ gastroesophageal reflux disease (GERD)&lt;/li&gt;&lt;li&gt;â€¢ long-term complication&lt;/li&gt;&lt;li&gt;â€¢ Option B. This statement is accurate . One of the potential complications of sleeve gastrectomy is a leak from the upper staple line . The staple line is a vulnerable area where leakage can occur . Patients are typically in hospital for months and need multiple reinterventions , including any of: endoscopic interventions ( stenting, endoscopic vacuum therapy ), making a controlled fistula , conversion to gastric bypass and fistula enterostomy .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ accurate&lt;/li&gt;&lt;li&gt;â€¢ leak&lt;/li&gt;&lt;li&gt;â€¢ upper staple line&lt;/li&gt;&lt;li&gt;â€¢ vulnerable area&lt;/li&gt;&lt;li&gt;â€¢ leakage can occur&lt;/li&gt;&lt;li&gt;â€¢ hospital for months&lt;/li&gt;&lt;li&gt;â€¢ multiple reinterventions&lt;/li&gt;&lt;li&gt;â€¢ endoscopic interventions&lt;/li&gt;&lt;li&gt;â€¢ stenting, endoscopic vacuum therapy&lt;/li&gt;&lt;li&gt;â€¢ controlled fistula&lt;/li&gt;&lt;li&gt;â€¢ gastric bypass&lt;/li&gt;&lt;li&gt;â€¢ fistula enterostomy&lt;/li&gt;&lt;li&gt;â€¢ Option C. This statement is accurate . Internal hernias are a known complication after Roux-en-Y gastric bypass, through the Peterson space .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ accurate&lt;/li&gt;&lt;li&gt;â€¢ Peterson space&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey 28 th Ed. Pg 1188.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Bailey 28 th Ed. Pg 1188.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In Coronary artery bypass graft (CABG) surgery, conduit of choice for grafting the Left anterior descending coronary artery occlusion is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left Internal Mammary Artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Great Saphenous Vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right Internal Mammary Artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left Radial Artery Graft&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Left Internal Mammary Artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . The Great saphenous vein, while commonly used in CABG for its ease of harvest and length , is more prone to atherosclerosis and has a lower long-term patency rate compared to arterial grafts .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ ease&lt;/li&gt;&lt;li&gt;â€¢ harvest&lt;/li&gt;&lt;li&gt;â€¢ length&lt;/li&gt;&lt;li&gt;â€¢ more prone&lt;/li&gt;&lt;li&gt;â€¢ atherosclerosis&lt;/li&gt;&lt;li&gt;â€¢ lower long-term patency rate&lt;/li&gt;&lt;li&gt;â€¢ arterial grafts&lt;/li&gt;&lt;li&gt;â€¢ Option C . The Right internal mammary artery is also a good option for grafting and can be used for the LAD , but the LIMA is preferred because of its closer proximity and direct course to the LAD .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ good option&lt;/li&gt;&lt;li&gt;â€¢ grafting&lt;/li&gt;&lt;li&gt;â€¢ LAD&lt;/li&gt;&lt;li&gt;â€¢ LIMA&lt;/li&gt;&lt;li&gt;â€¢ closer proximity&lt;/li&gt;&lt;li&gt;â€¢ direct course&lt;/li&gt;&lt;li&gt;â€¢ LAD&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Left radial artery graft can be used for coronary bypass ; however, it is generally reserved for situations where the internal mammary arteries are not usable or in multiple arterial grafting strategies.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ coronary bypass&lt;/li&gt;&lt;li&gt;â€¢ internal mammary arteries&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The left internal mammary artery (LIMA) is the conduit of choice for grafting the left anterior descending (LAD) coronary artery occlusion in CABG surgery due to its excellent long-term patency and proximity to the LAD.&lt;/li&gt;&lt;li&gt;âž¤ excellent long-term patency&lt;/li&gt;&lt;li&gt;âž¤ proximity to the LAD.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 950&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 950&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these is not an indication of Cardiopulmonary bypass?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung Transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vascular Tumour Excision&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CABG (Coronary Artery Bypass Graft)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IVC filter insertion in Pulmonary Thromboembolism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IVC filter insertion in Pulmonary Thromboembolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) IVC filter insertion in Pulmonary Thromboembolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Lung transplant surgery is a complex procedure that often requires cardiopulmonary bypass to maintain circulation and oxygenation while the diseased lungs are replaced .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ complex procedure&lt;/li&gt;&lt;li&gt;â€¢ cardiopulmonary bypass&lt;/li&gt;&lt;li&gt;â€¢ circulation&lt;/li&gt;&lt;li&gt;â€¢ oxygenation&lt;/li&gt;&lt;li&gt;â€¢ diseased lungs are replaced&lt;/li&gt;&lt;li&gt;â€¢ Option B . Vascular tumor excision can necessitate the use of cardiopulmonary bypass , especially if the tumor is within or adjacent to the heart or great vessels , to maintain blood flow and organ perfusion during the surgery .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ cardiopulmonary bypass&lt;/li&gt;&lt;li&gt;â€¢ tumor&lt;/li&gt;&lt;li&gt;â€¢ within&lt;/li&gt;&lt;li&gt;â€¢ adjacent&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ great vessels&lt;/li&gt;&lt;li&gt;â€¢ blood flow&lt;/li&gt;&lt;li&gt;â€¢ organ perfusion&lt;/li&gt;&lt;li&gt;â€¢ surgery&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary artery bypass grafting (CABG) is a common indication for cardiopulmonary bypass as it allows the heart to be still while bypasses are created to route blood around clogged arteries .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ cardiopulmonary bypass&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ still&lt;/li&gt;&lt;li&gt;â€¢ bypasses&lt;/li&gt;&lt;li&gt;â€¢ route blood&lt;/li&gt;&lt;li&gt;â€¢ clogged arteries&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The insertion of an inferior vena cava (IVC) filter in the case of pulmonary thromboembolism is not an indication for cardiopulmonary bypass, as it is a minimally invasive procedure that does not necessitate the cessation of heart and lung function.&lt;/li&gt;&lt;li&gt;âž¤ minimally invasive procedure&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 945&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 945&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these are mechanical support devices for low cardiac output?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ECMO (Extra-Corporeal Membrane Oxygenation)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IABP (Intra-Aortic Balloon Pump)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;VAD (Ventricular Assist Devices)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/picture15_Liu8coh.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/picture16.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. ECMO, or Extracorporeal Membrane Oxygenation, is a device that provides both cardiac and respiratory support to patients whose heart and lungs are so severely diseased or damaged that they can no longer serve their function adequately. It does the function of oxygenation of blood .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ both cardiac&lt;/li&gt;&lt;li&gt;â€¢ respiratory support&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ lungs&lt;/li&gt;&lt;li&gt;â€¢ severely diseased&lt;/li&gt;&lt;li&gt;â€¢ damaged&lt;/li&gt;&lt;li&gt;â€¢ oxygenation of blood&lt;/li&gt;&lt;li&gt;â€¢ Option B . The IABP, or Intra-aortic Balloon Pump, is a mechanical device that increases myocardial oxygen perfusion and simultaneously increases cardiac output . It is inserted into the aorta and helps the heart by reducing afterload and increasing blood flow to the coronary arteries .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ mechanical device&lt;/li&gt;&lt;li&gt;â€¢ increases myocardial oxygen perfusion&lt;/li&gt;&lt;li&gt;â€¢ increases cardiac output&lt;/li&gt;&lt;li&gt;â€¢ inserted&lt;/li&gt;&lt;li&gt;â€¢ aorta&lt;/li&gt;&lt;li&gt;â€¢ heart&lt;/li&gt;&lt;li&gt;â€¢ reducing afterload&lt;/li&gt;&lt;li&gt;â€¢ increasing blood flow&lt;/li&gt;&lt;li&gt;â€¢ coronary arteries&lt;/li&gt;&lt;li&gt;â€¢ Option C. VADs, or Ventricular Assist Devices, are mechanical pumps that are used to support heart function and blood flow in individuals with refractory heart failure .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ mechanical pumps&lt;/li&gt;&lt;li&gt;â€¢ support heart function&lt;/li&gt;&lt;li&gt;â€¢ blood flow&lt;/li&gt;&lt;li&gt;â€¢ refractory heart failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ In the event of persistent low cardiac output that does not respond to inotropic support, mechanical support devices such as ECMO, IABP, and VADs may be employed to aid heart function .&lt;/li&gt;&lt;li&gt;âž¤ persistent low cardiac output&lt;/li&gt;&lt;li&gt;âž¤ employed&lt;/li&gt;&lt;li&gt;âž¤ aid heart function&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 952&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 952&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with h/o atherosclerosis comes to the hospital with sudden onset chest pain that mimics angina. The pain radiates to interscapular region. A CT thoracic angiography shows an aortic dissection involving the descending aorta alone, classified as Stanford class B. What would be the preferred treatment for the same?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Surgical Repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endovascular Stenting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Conservative Management&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Endovascular Stenting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Endovascular Stenting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Surgical repair is typically indicated for aortic dissections involving the ascending aorta ( Stanford Class A ) due to the higher risk of lethal complications such as rupture into the pericardial space , leading to cardiac tamponade .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ aortic dissections&lt;/li&gt;&lt;li&gt;â€¢ ascending aorta&lt;/li&gt;&lt;li&gt;â€¢ Stanford Class A&lt;/li&gt;&lt;li&gt;â€¢ higher risk&lt;/li&gt;&lt;li&gt;â€¢ lethal complications&lt;/li&gt;&lt;li&gt;â€¢ rupture&lt;/li&gt;&lt;li&gt;â€¢ pericardial space&lt;/li&gt;&lt;li&gt;â€¢ cardiac tamponade&lt;/li&gt;&lt;li&gt;â€¢ Option C. Conservative management, including blood pressure control , may be appropriate for cases of aortic dissection where surgical or endovascular intervention is not immediately indicated or if the patient has comorbid conditions that increase the risk of surgical procedures .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ blood pressure control&lt;/li&gt;&lt;li&gt;â€¢ aortic dissection&lt;/li&gt;&lt;li&gt;â€¢ surgical&lt;/li&gt;&lt;li&gt;â€¢ endovascular intervention&lt;/li&gt;&lt;li&gt;â€¢ increase the risk of surgical procedures&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recommended treatment for a Stanford Class B aortic dissection, which does not involve the ascending aorta, is endovascular stenting , following initial blood pressure management .&lt;/li&gt;&lt;li&gt;âž¤ endovascular stenting&lt;/li&gt;&lt;li&gt;âž¤ initial blood pressure management&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 970&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 970&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In TNM staging of Lung cancer, Stage T1c implies:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor size 2-3 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tumor size 3-4 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tumor size 4-5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tumor size 5-7 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tumor size 2-3 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/25/staging_page_1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tumor size 2-3 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TNM staging lung cancer&lt;/li&gt;&lt;li&gt;âž¤ TNM staging lung cancer&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 985-991&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 985-991&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common Posterior Mediastinal Mass is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thymoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neurogenic Tumors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paravertebral Abscess&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neurogenic Tumors&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-174047.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neurogenic Tumors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thymoma is a tumor originating from the thymic tissue and is most commonly located in the anterior mediastinum , not the posterior mediastinum.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ tumor&lt;/li&gt;&lt;li&gt;â€¢ thymic tissue&lt;/li&gt;&lt;li&gt;â€¢ anterior mediastinum&lt;/li&gt;&lt;li&gt;â€¢ Option C . Paravertebral abscesses are collections of pus near the vertebral column . They can present as a mass in the posterior mediastinum but are not the most common.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ collections of pus&lt;/li&gt;&lt;li&gt;â€¢ vertebral column&lt;/li&gt;&lt;li&gt;â€¢ mass&lt;/li&gt;&lt;li&gt;â€¢ posterior mediastinum&lt;/li&gt;&lt;li&gt;â€¢ Option D . Lymphomas can involve the mediastinum , but they are not the most common posterior mediastinal mass; they more frequently involve the anterior or superior mediastinum .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ mediastinum&lt;/li&gt;&lt;li&gt;â€¢ anterior&lt;/li&gt;&lt;li&gt;â€¢ superior mediastinum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common posterior mediastinal mass is a neurogenic tumor .&lt;/li&gt;&lt;li&gt;âž¤ posterior mediastinal mass&lt;/li&gt;&lt;li&gt;âž¤ neurogenic tumor&lt;/li&gt;&lt;li&gt;âž¤ Types of mediastinal masses&lt;/li&gt;&lt;li&gt;âž¤ Types of mediastinal masses&lt;/li&gt;&lt;li&gt;âž¤ MC Anterior Mediastinal Mass: Thymoma MC Post Mediastinal Mass: Neuromas/Neurogenic Tumors&lt;/li&gt;&lt;li&gt;âž¤ MC Anterior Mediastinal Mass: Thymoma&lt;/li&gt;&lt;li&gt;âž¤ Thymoma&lt;/li&gt;&lt;li&gt;âž¤ MC Post Mediastinal Mass: Neuromas/Neurogenic Tumors&lt;/li&gt;&lt;li&gt;âž¤ Neuromas/Neurogenic Tumors&lt;/li&gt;&lt;li&gt;âž¤ Ref: Bailey and Loveâ€™s short practice of surgery 28th edition pg 992-993&lt;/li&gt;&lt;li&gt;âž¤ Ref: Bailey and Loveâ€™s short practice of surgery 28th edition pg 992-993&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Masaoka staging is used to classify:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid Adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neuroma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thymoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchogenic Cyst&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thymoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Thymoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Masaoka staging system is used to classify thymoma , assessing the degree of tumor invasion to guide treatment, which commonly includes thymectomy .&lt;/li&gt;&lt;li&gt;âž¤ Masaoka staging system&lt;/li&gt;&lt;li&gt;âž¤ classify thymoma&lt;/li&gt;&lt;li&gt;âž¤ degree of tumor invasion&lt;/li&gt;&lt;li&gt;âž¤ thymectomy&lt;/li&gt;&lt;li&gt;âž¤ This is the most common anterior mediastinal tumour , accounting for 25% of the total , and is derived from the thymus gland . Thymomas vary in behaviour from benign to aggressively invasive, as classified in the Masoaka classification system used to stage thymomas and more recently the TNM classification. They are often related to myasthenia gravis , a neuromuscular condition that can have a high associated incidence of thymomas , and interestingly may respond to excision of the thymus gland even when the gland has no associated thymoma present. The only reliable indicator of malignancy is capsular invasion . Diagnosis and treatment are best achieved by complete thymectomy , which for large tumours (&amp;gt;5 cm) Treatment - Thymectomy : Open surgery / video assisted thoracoscopic surgery ( VATS )&lt;/li&gt;&lt;li&gt;âž¤ This is the most common anterior mediastinal tumour , accounting for 25% of the total , and is derived from the thymus gland .&lt;/li&gt;&lt;li&gt;âž¤ anterior mediastinal tumour&lt;/li&gt;&lt;li&gt;âž¤ 25%&lt;/li&gt;&lt;li&gt;âž¤ total&lt;/li&gt;&lt;li&gt;âž¤ thymus gland&lt;/li&gt;&lt;li&gt;âž¤ Thymomas vary in behaviour from benign to aggressively invasive, as classified in the Masoaka classification system used to stage thymomas and more recently the TNM classification.&lt;/li&gt;&lt;li&gt;âž¤ vary&lt;/li&gt;&lt;li&gt;âž¤ behaviour from benign&lt;/li&gt;&lt;li&gt;âž¤ aggressively invasive,&lt;/li&gt;&lt;li&gt;âž¤ They are often related to myasthenia gravis , a neuromuscular condition that can have a high associated incidence of thymomas , and interestingly may respond to excision of the thymus gland even when the gland has no associated thymoma present.&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;li&gt;âž¤ neuromuscular condition&lt;/li&gt;&lt;li&gt;âž¤ high associated incidence&lt;/li&gt;&lt;li&gt;âž¤ thymomas&lt;/li&gt;&lt;li&gt;âž¤ interestingly&lt;/li&gt;&lt;li&gt;âž¤ excision&lt;/li&gt;&lt;li&gt;âž¤ thymus gland&lt;/li&gt;&lt;li&gt;âž¤ The only reliable indicator of malignancy is capsular invasion .&lt;/li&gt;&lt;li&gt;âž¤ only reliable indicator&lt;/li&gt;&lt;li&gt;âž¤ capsular invasion&lt;/li&gt;&lt;li&gt;âž¤ Diagnosis and treatment are best achieved by complete thymectomy , which for large tumours (&amp;gt;5 cm)&lt;/li&gt;&lt;li&gt;âž¤ complete thymectomy&lt;/li&gt;&lt;li&gt;âž¤ large tumours&lt;/li&gt;&lt;li&gt;âž¤ (&amp;gt;5 cm)&lt;/li&gt;&lt;li&gt;âž¤ Treatment - Thymectomy : Open surgery / video assisted thoracoscopic surgery ( VATS )&lt;/li&gt;&lt;li&gt;âž¤ Thymectomy&lt;/li&gt;&lt;li&gt;âž¤ Open surgery&lt;/li&gt;&lt;li&gt;âž¤ video assisted thoracoscopic surgery&lt;/li&gt;&lt;li&gt;âž¤ VATS&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 992&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 992&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old child presents with obstructive hydrocephalus secondary to a suspected brain tumor. What is the first line investigation in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI Brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT Brain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CSF Manometry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lumbar Puncture&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT Brain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CT Brain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . MRI Brain provides detailed images of the brain&#x27;s anatomy and can be useful in assessing brain tumors . However, it is not typically the first-line investigation due to the time it takes to perform and the need for sedation in young children.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ brain&#x27;s anatomy&lt;/li&gt;&lt;li&gt;â€¢ assessing brain tumors&lt;/li&gt;&lt;li&gt;â€¢ Option C . CSF manometry is used to measure the pressure of the cerebrospinal fluid but is not the first-line investigation for a brain tumor or hydrocephalus, and it can be dangerous in the presence of increased intracranial pressure due to mass effect .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ measure&lt;/li&gt;&lt;li&gt;â€¢ pressure&lt;/li&gt;&lt;li&gt;â€¢ cerebrospinal fluid&lt;/li&gt;&lt;li&gt;â€¢ dangerous&lt;/li&gt;&lt;li&gt;â€¢ presence&lt;/li&gt;&lt;li&gt;â€¢ increased intracranial pressure&lt;/li&gt;&lt;li&gt;â€¢ mass effect&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lumbar puncture is contraindicated as an initial investigation in the presence of raised intracranial pressure due to the risk of brain herniation ; it is performed after imaging has excluded obstructive hydrocephalus .&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ contraindicated as an initial investigation&lt;/li&gt;&lt;li&gt;â€¢ risk of brain herniation&lt;/li&gt;&lt;li&gt;â€¢ after imaging&lt;/li&gt;&lt;li&gt;â€¢ obstructive hydrocephalus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first-line investigation for a child with obstructive hydrocephalus suspected to be secondary to a brain tumor is a CT brain scan to rapidly assess for mass effect and guide further management .&lt;/li&gt;&lt;li&gt;âž¤ first-line investigation&lt;/li&gt;&lt;li&gt;âž¤ child&lt;/li&gt;&lt;li&gt;âž¤ obstructive hydrocephalus&lt;/li&gt;&lt;li&gt;âž¤ CT brain scan&lt;/li&gt;&lt;li&gt;âž¤ assess for mass effect&lt;/li&gt;&lt;li&gt;âž¤ guide further management&lt;/li&gt;&lt;li&gt;âž¤ Types of Hydrocephalus&lt;/li&gt;&lt;li&gt;âž¤ Types of Hydrocephalus&lt;/li&gt;&lt;li&gt;âž¤ 1. Obstructive : masses/ tumours / infection&lt;/li&gt;&lt;li&gt;âž¤ Obstructive&lt;/li&gt;&lt;li&gt;âž¤ 2. Non obstructive / communicating : defective absorption&lt;/li&gt;&lt;li&gt;âž¤ Non obstructive / communicating&lt;/li&gt;&lt;li&gt;âž¤ Secondary to meningitis Secondary to sub arachnoid haemorrhage (lining which absorbs CSF is damaged)&lt;/li&gt;&lt;li&gt;âž¤ Secondary to meningitis&lt;/li&gt;&lt;li&gt;âž¤ Secondary to sub arachnoid haemorrhage (lining which absorbs CSF is damaged)&lt;/li&gt;&lt;li&gt;âž¤ 3. Excessive CSF production - very rare&lt;/li&gt;&lt;li&gt;âž¤ Excessive CSF production&lt;/li&gt;&lt;li&gt;âž¤ First line Investigation - CT BRAIN: dilated ventricles, provides clue to etiology&lt;/li&gt;&lt;li&gt;âž¤ Lumbar puncture done after CT scan: done only if it is non- obstructive.&lt;/li&gt;&lt;li&gt;âž¤ Lumbar puncture done after CT scan: done only if it is non- obstructive.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 703&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 703&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Ventriculoperitoneal Shunt Surgery, the upper end of the shunt is inserted into:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral Ventricles&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3 rd Ventricle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4 th Ventricle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisterna Magna&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lateral Ventricles&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lateral Ventricles&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . The 3rd ventricle is not a common site for shunt placement in ventriculoperitoneal shunting. It is, however, the site targeted in endoscopic third ventriculostomy , which is a different procedure.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ endoscopic third ventriculostomy&lt;/li&gt;&lt;li&gt;â€¢ Option C . The 4th ventricle is also not typically used for the insertion of the upper end of a ventriculoperitoneal shunt. Access to the fourth ventricle is more complex and not necessary for routine CSF shunting.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Access&lt;/li&gt;&lt;li&gt;â€¢ more complex&lt;/li&gt;&lt;li&gt;â€¢ Option D. The Cisterna magna is not used for the placement of a ventriculoperitoneal shunt. It is sometimes accessed in the placement of a lumboperitoneal shunt or for certain diagnostic procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ accessed&lt;/li&gt;&lt;li&gt;â€¢ placement&lt;/li&gt;&lt;li&gt;â€¢ lumboperitoneal shunt&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ventriculoperitoneal shunt surgery, the upper end of the shunt is inserted into the lateral ventricles to treat hydrocephalus . The lower end is placed into the intra-peritoneal cavity , and a valve regulates the flow of CSF .&lt;/li&gt;&lt;li&gt;âž¤ lateral ventricles&lt;/li&gt;&lt;li&gt;âž¤ treat hydrocephalus&lt;/li&gt;&lt;li&gt;âž¤ intra-peritoneal cavity&lt;/li&gt;&lt;li&gt;âž¤ valve regulates the flow of CSF&lt;/li&gt;&lt;li&gt;âž¤ Treatment of hydrocephalus&lt;/li&gt;&lt;li&gt;âž¤ External ventricular drain Endoscopic third ventriculostomy Ventriculoperitoneal shunt Upper end is put into lateral ventricles Lower end into Intra peritoneal cavity A shunt valve inserted between the proximal and distal catheters regulates flow through the system by opening at a predetermined pressure; the shunt valve typically incorporates a CSF reservoir, which allows for percutaneous sampling.&lt;/li&gt;&lt;li&gt;âž¤ External ventricular drain&lt;/li&gt;&lt;li&gt;âž¤ External ventricular drain&lt;/li&gt;&lt;li&gt;âž¤ Endoscopic third ventriculostomy&lt;/li&gt;&lt;li&gt;âž¤ Endoscopic third ventriculostomy&lt;/li&gt;&lt;li&gt;âž¤ Ventriculoperitoneal shunt Upper end is put into lateral ventricles Lower end into Intra peritoneal cavity A shunt valve inserted between the proximal and distal catheters regulates flow through the system by opening at a predetermined pressure; the shunt valve typically incorporates a CSF reservoir, which allows for percutaneous sampling.&lt;/li&gt;&lt;li&gt;âž¤ Ventriculoperitoneal shunt&lt;/li&gt;&lt;li&gt;âž¤ Upper end is put into lateral ventricles Lower end into Intra peritoneal cavity A shunt valve inserted between the proximal and distal catheters regulates flow through the system by opening at a predetermined pressure; the shunt valve typically incorporates a CSF reservoir, which allows for percutaneous sampling.&lt;/li&gt;&lt;li&gt;âž¤ Upper end is put into lateral ventricles&lt;/li&gt;&lt;li&gt;âž¤ Lower end into Intra peritoneal cavity&lt;/li&gt;&lt;li&gt;âž¤ A shunt valve inserted between the proximal and distal catheters regulates flow through the system by opening at a predetermined pressure; the shunt valve typically incorporates a CSF reservoir, which allows for percutaneous sampling.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 705&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Bailey and Loveâ€™s short practice of surgery 28 th edition pg 705&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common tissue of origin for brain metastases is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Kidney&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Breast&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lung&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Lung&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 715&lt;/li&gt;&lt;li&gt;âž¤ Ref :&lt;/li&gt;&lt;li&gt;âž¤ Bailey and Loveâ€™s short practice of surgery 28 th edition pg 715&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with personality change, gait disturbance and urinary incontinence since 2 months. A CT Brain is likely to show a mass in which lobe?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Temporal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parietal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occipital&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frontal&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Frontal&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-07-04-at-1256120_page_17_page_15.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Frontal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. The Temporal lobe is primarily involved with processing auditory information and memory . Lesions here might lead to problems with memory , understanding language , or disturbances in hearing .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ processing auditory information&lt;/li&gt;&lt;li&gt;â€¢ memory&lt;/li&gt;&lt;li&gt;â€¢ problems with memory&lt;/li&gt;&lt;li&gt;â€¢ understanding language&lt;/li&gt;&lt;li&gt;â€¢ disturbances in hearing&lt;/li&gt;&lt;li&gt;â€¢ Option B . The Parietal lobe integrates sensory information from various modalities, including spatial sense and navigation (proprioception) , the main sensory receptive area for the sense of touch . Disturbances here typically affect spatial awareness and proprioception .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ sensory information&lt;/li&gt;&lt;li&gt;â€¢ modalities,&lt;/li&gt;&lt;li&gt;â€¢ spatial sense&lt;/li&gt;&lt;li&gt;â€¢ navigation (proprioception)&lt;/li&gt;&lt;li&gt;â€¢ sense of touch&lt;/li&gt;&lt;li&gt;â€¢ affect spatial awareness&lt;/li&gt;&lt;li&gt;â€¢ proprioception&lt;/li&gt;&lt;li&gt;â€¢ Option C . The Occipital lobe is the visual processing center of the brain . Lesions in the occipital lobe can lead to visual deficits like blindness or visual field cuts .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ visual processing center&lt;/li&gt;&lt;li&gt;â€¢ brain&lt;/li&gt;&lt;li&gt;â€¢ occipital lobe&lt;/li&gt;&lt;li&gt;â€¢ visual deficits&lt;/li&gt;&lt;li&gt;â€¢ blindness&lt;/li&gt;&lt;li&gt;â€¢ visual field cuts&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ A mass in the frontal lobe of the brain can present with personality changes , gait disturbances , and urinary incontinence , correlating with the functions mediated by this area of the brain .&lt;/li&gt;&lt;li&gt;âž¤ frontal lobe&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ personality changes&lt;/li&gt;&lt;li&gt;âž¤ gait disturbances&lt;/li&gt;&lt;li&gt;âž¤ urinary incontinence&lt;/li&gt;&lt;li&gt;âž¤ area&lt;/li&gt;&lt;li&gt;âž¤ brain&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 714&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Bailey and Loveâ€™s short practice of surgery 28 th edition pg 714&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents to the emergency room with severe chest pain and difficulty swallowing. A CT scan with water soluble contrast reveals an esophageal perforation. What is the most common etiology of esophageal perforation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spontaneous&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blunt trauma to chest&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Instrumental&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Penetrating trauma to chest&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Instrumental&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Instrumental&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Spontaneous. Spontaneous perforation of the esophagus , also known as Boerhaave syndrome , is a serious condition but not the most common cause . It occurs due to vomiting against a closed glottis , which leads to a sudden increase in esophageal pressure and typically results in perforation of the lower esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Spontaneous.&lt;/li&gt;&lt;li&gt;â€¢ Spontaneous perforation&lt;/li&gt;&lt;li&gt;â€¢ esophagus&lt;/li&gt;&lt;li&gt;â€¢ Boerhaave syndrome&lt;/li&gt;&lt;li&gt;â€¢ serious condition but not the most common cause&lt;/li&gt;&lt;li&gt;â€¢ due to vomiting against a closed glottis&lt;/li&gt;&lt;li&gt;â€¢ increase in esophageal pressure&lt;/li&gt;&lt;li&gt;â€¢ perforation of the lower esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Blunt trauma to the chest. Blunt trauma can cause esophageal perforation ; however, it is less common than iatrogenic causes related to medical procedures.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Blunt trauma to the chest.&lt;/li&gt;&lt;li&gt;â€¢ cause esophageal perforation&lt;/li&gt;&lt;li&gt;â€¢ less common than iatrogenic&lt;/li&gt;&lt;li&gt;â€¢ Option D: Penetrating trauma to chest. Penetrating trauma is another possible cause of esophageal injury , but again, it is not as common as iatrogenic causes.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Penetrating trauma to chest.&lt;/li&gt;&lt;li&gt;â€¢ another possible cause of esophageal injury&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common cause of esophageal perforation is iatrogenic injury during instrumental procedures such as upper GI endoscopy, dilatation, and stenting .&lt;/li&gt;&lt;li&gt;âž¤ most common cause of esophageal perforation&lt;/li&gt;&lt;li&gt;âž¤ iatrogenic injury&lt;/li&gt;&lt;li&gt;âž¤ instrumental procedures&lt;/li&gt;&lt;li&gt;âž¤ upper GI endoscopy, dilatation, and stenting&lt;/li&gt;&lt;li&gt;âž¤ Iatrogenic perforation secondary to endoscopic procedures such as dilatation of strictures or achalasia is the most common cause. Esophageal perforation can occur due to instrumental procedures such as upper GI endoscopy , dilatation, and stenting. Spontaneous esophageal perforation , also known as Boerhaave syndrome , can occur when vomiting against a closed glottis , resulting in a massive increase in esophageal pressure and typically perforating the lower esophagus over the left pleura. CT with water-soluble contrast is the ideal imaging modality to diagnose esophageal perforation. Treatment options for esophageal perforation include conservative management for small perforations and surgery for septic load (Boerhaave syndrome), unstable mediastinitis, or intra-abdominal esophageal perforation.&lt;/li&gt;&lt;li&gt;âž¤ Iatrogenic perforation secondary to endoscopic procedures such as dilatation of strictures or achalasia is the most common cause.&lt;/li&gt;&lt;li&gt;âž¤ Iatrogenic perforation&lt;/li&gt;&lt;li&gt;âž¤ most common cause.&lt;/li&gt;&lt;li&gt;âž¤ Esophageal perforation can occur due to instrumental procedures such as upper GI endoscopy , dilatation, and stenting.&lt;/li&gt;&lt;li&gt;âž¤ Esophageal perforation&lt;/li&gt;&lt;li&gt;âž¤ instrumental procedures such as upper GI endoscopy&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous esophageal perforation , also known as Boerhaave syndrome , can occur when vomiting against a closed glottis , resulting in a massive increase in esophageal pressure and typically perforating the lower esophagus over the left pleura.&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous esophageal perforation&lt;/li&gt;&lt;li&gt;âž¤ Boerhaave syndrome&lt;/li&gt;&lt;li&gt;âž¤ vomiting against a closed glottis&lt;/li&gt;&lt;li&gt;âž¤ massive increase in esophageal pressure&lt;/li&gt;&lt;li&gt;âž¤ CT with water-soluble contrast is the ideal imaging modality to diagnose esophageal perforation.&lt;/li&gt;&lt;li&gt;âž¤ CT with water-soluble contrast&lt;/li&gt;&lt;li&gt;âž¤ ideal imaging modality&lt;/li&gt;&lt;li&gt;âž¤ Treatment options for esophageal perforation include conservative management for small perforations and surgery for septic load (Boerhaave syndrome), unstable mediastinitis, or intra-abdominal esophageal perforation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which type of esophageal perforation requires urgent surgical exploration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cervical&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Endoscope induced&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spontaneous&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malignant perforation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spontaneous&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Spontaneous&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cervical: Esophageal perforation in the cervical region is rare but can occur due to trauma or surgical procedures . Depending on the size and severity of the perforation, it may require urgent surgical exploration.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cervical:&lt;/li&gt;&lt;li&gt;â€¢ Esophageal perforation&lt;/li&gt;&lt;li&gt;â€¢ cervical region is rare&lt;/li&gt;&lt;li&gt;â€¢ due to trauma or surgical procedures&lt;/li&gt;&lt;li&gt;â€¢ Option B. Scope induced: Esophageal perforation induced by an upper GI endoscopy, dilatation, or stenting can range from small mucosal tears to full-thickness perforations. The size and extent of the perforation will determine the treatment approach. Small perforations may be managed conservatively, while larger perforations may require surgical exploration.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Scope induced:&lt;/li&gt;&lt;li&gt;â€¢ induced by an upper GI endoscopy, dilatation, or stenting&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Oesophageal cancer can perforate , and the prognosis is usually poor since it reflects the underlying advanced disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Oesophageal cancer&lt;/li&gt;&lt;li&gt;â€¢ perforate&lt;/li&gt;&lt;li&gt;â€¢ prognosis is usually poor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Urgent surgical exploration is most commonly required for spontaneous esophageal perforations , also known as Boerhaave syndrome , due to the typically large rupture and associated high septic load . It can occur when vomiting against a closed glottis, resulting in a massive increase in esophageal pressure and typically perforating the lower esophagus over the left pleura.&lt;/li&gt;&lt;li&gt;âž¤ Urgent surgical exploration&lt;/li&gt;&lt;li&gt;âž¤ commonly required for spontaneous esophageal perforations&lt;/li&gt;&lt;li&gt;âž¤ Boerhaave syndrome&lt;/li&gt;&lt;li&gt;âž¤ large rupture and associated high septic load&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1128.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1128.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which type of caustic injury to esophagus causes deeper tissue damage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acid poisons&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alkali poisons&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both acid and alkali poisons cause the same extent of damage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caustic injury does not cause tissue damage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alkali poisons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alkali poisons&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acid poisons cause coagulative necrosis , which results in superficial tissue damage . The extent of trauma is generally less than that caused by alkali poisons.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Acid poisons cause coagulative necrosis&lt;/li&gt;&lt;li&gt;â€¢ superficial tissue damage&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acid and alkali poisons cause different types of tissue damage, with alkali poisons causing deeper damage than acid poisons .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ alkali poisons causing deeper damage than acid poisons&lt;/li&gt;&lt;li&gt;â€¢ Option D. Caustic injury always causes tissue damage and can lead to scarring and strictures in the esophagus, stomach, and duodenum. It is a premalignant condition for esophageal carcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Caustic injury&lt;/li&gt;&lt;li&gt;â€¢ scarring and strictures&lt;/li&gt;&lt;li&gt;â€¢ premalignant condition&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the correct answer is B) Alkali poisons cause deeper tissue damage than acid poisons.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alkali poisons cause deeper tissue damage to the esophagus compared to acid poisons due to their mechanism of causing liquefactive necrosis , which allows for deeper penetration and more extensive injury .&lt;/li&gt;&lt;li&gt;âž¤ Alkali poisons&lt;/li&gt;&lt;li&gt;âž¤ deeper tissue damage to the esophagus&lt;/li&gt;&lt;li&gt;âž¤ acid poisons due to their mechanism of causing liquefactive necrosis&lt;/li&gt;&lt;li&gt;âž¤ deeper penetration and more extensive injury&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1129-30&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1129-30&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old child accidentally swallowed a foreign object while playing. What is the most dangerous foreign object that a child can swallow?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Food bolus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fish Bone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Battery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Coin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Battery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Battery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Food bolus . A food bolus can cause obstruction but is typically not as dangerous as other objects because it often softens and passes through the gastrointestinal tract or can be removed endoscopically without causing significant damage.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Food bolus&lt;/li&gt;&lt;li&gt;â€¢ obstruction&lt;/li&gt;&lt;li&gt;â€¢ not as dangerous as other objects because it often softens and passes through the gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fish Bone . A fish bone can be sharp and potentially puncture the esophagus or other parts of the gastrointestinal tract . However, it is generally less harmful compared to corrosive or electrically charged objects because it does not cause tissue necrosis or systemic toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fish Bone&lt;/li&gt;&lt;li&gt;â€¢ sharp and potentially puncture the esophagus&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ less harmful compared to corrosive or electrically charged objects&lt;/li&gt;&lt;li&gt;â€¢ does not cause tissue necrosis&lt;/li&gt;&lt;li&gt;â€¢ Option D: Coin. A coin can become lodged in the esophagus , particularly at one of the natural constrictions , but it generally does not cause the same degree of tissue damage as a battery . The coin can often be retrieved endoscopically without significant complication.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Coin.&lt;/li&gt;&lt;li&gt;â€¢ lodged in the esophagus&lt;/li&gt;&lt;li&gt;â€¢ one of the natural constrictions&lt;/li&gt;&lt;li&gt;â€¢ does not cause the same degree of tissue damage as a battery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most dangerous foreign object that a child can swallow is a battery due to the risk of electrical discharge , leakage of caustic substances, and the potential for rapid tissue damage and necrosis.&lt;/li&gt;&lt;li&gt;âž¤ most dangerous foreign object&lt;/li&gt;&lt;li&gt;âž¤ child can swallow is a battery&lt;/li&gt;&lt;li&gt;âž¤ risk of electrical discharge&lt;/li&gt;&lt;li&gt;âž¤ Swallowing a foreign object can be a serious medical emergency, especially in children. The most common foreign objects that are swallowed are food boluses and bones . However, the most dangerous foreign object that a child can swallow is a battery. The esophagus has several constrictions where foreign objects can become lodged. The three most common locations for foreign body impaction are at the cricopharynx (15cm from the incisors), at the left bronchus crossing the esophagus (25cm from the incisors), and at the diaphragmatic pleura (40cm from the incisors). The first step in managing a swallowed foreign body is to obtain a chest X-ray to determine the location of the object. If the object is in the esophagus or stomach, endoscopic retrieval may be possible . However, if the object is a battery, it must be removed as an emergency via endoscopy or colonoscopy , depending on the location of the foreign body.&lt;/li&gt;&lt;li&gt;âž¤ Swallowing a foreign object can be a serious medical emergency, especially in children. The most common foreign objects that are swallowed are food boluses and bones . However, the most dangerous foreign object that a child can swallow is a battery.&lt;/li&gt;&lt;li&gt;âž¤ The most common foreign objects that are swallowed are food boluses and bones&lt;/li&gt;&lt;li&gt;âž¤ The esophagus has several constrictions where foreign objects can become lodged. The three most common locations for foreign body impaction are at the cricopharynx (15cm from the incisors), at the left bronchus crossing the esophagus (25cm from the incisors), and at the diaphragmatic pleura (40cm from the incisors).&lt;/li&gt;&lt;li&gt;âž¤ cricopharynx&lt;/li&gt;&lt;li&gt;âž¤ left bronchus crossing the esophagus&lt;/li&gt;&lt;li&gt;âž¤ at the diaphragmatic pleura&lt;/li&gt;&lt;li&gt;âž¤ The first step in managing a swallowed foreign body is to obtain a chest X-ray to determine the location of the object. If the object is in the esophagus or stomach, endoscopic retrieval may be possible . However, if the object is a battery, it must be removed as an emergency via endoscopy or colonoscopy , depending on the location of the foreign body.&lt;/li&gt;&lt;li&gt;âž¤ If the object is in the esophagus or stomach, endoscopic retrieval may be possible&lt;/li&gt;&lt;li&gt;âž¤ if the object is a battery, it must be removed as an emergency via endoscopy or colonoscopy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1132&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1132&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents with colicky abdominal pain and bilious vomiting. She reports weight loss following a keto-diet in the past few months. On investigation, the small bowel appears normal, but a CECT of the abdomen reveals compression of the D3 segment of the duodenum due to narrowing of the angle of the superior mesenteric artery (SMA). Which of the following is the best option for treatment of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Surgery to remove the obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of medications to relieve pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Feeding the patient to promote weight gain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic intervention to widen the narrowed angle&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Feeding the patient to promote weight gain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Feeding the patient to promote weight gain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Surgery to remove the obstruction . Surgical intervention may be considered if conservative measures fail . It is not the first line of treatment because the syndrome is often caused by a lack of mesenteric fat padding, not an actual physical obstruction that needs to be removed.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Surgery to remove the obstruction&lt;/li&gt;&lt;li&gt;â€¢ Surgical intervention&lt;/li&gt;&lt;li&gt;â€¢ conservative measures fail&lt;/li&gt;&lt;li&gt;â€¢ not the first line of treatment&lt;/li&gt;&lt;li&gt;â€¢ Option B: Administration of medications to relieve pain . While pain management is an important aspect of patient care , medications alone will not address the underlying issue of the narrowed angle between the SMA and the aorta, which is causing the duodenal compression.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Administration of medications to relieve pain&lt;/li&gt;&lt;li&gt;â€¢ pain management is an important aspect of patient care&lt;/li&gt;&lt;li&gt;â€¢ medications alone will not address the underlying issue&lt;/li&gt;&lt;li&gt;â€¢ Option D: Endoscopic intervention to widen the narrowed angle . Endoscopic intervention is not the standard treatment for SMA Syndrome because the problem is not within the duodenal lumen but rather external compression.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Endoscopic intervention to widen the narrowed angle&lt;/li&gt;&lt;li&gt;â€¢ Endoscopic intervention&lt;/li&gt;&lt;li&gt;â€¢ not the standard treatment for SMA Syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for SMA Syndrome is conservative , focusing on nutritional support to promote weight gain and increase the mesenteric fat pad, thereby relieving the compression of the duodenum.&lt;/li&gt;&lt;li&gt;âž¤ initial treatment for SMA Syndrome is conservative&lt;/li&gt;&lt;li&gt;âž¤ SMA Syndrome , also known as Wilkie Syndrome , is a rare cause of intestinal obstruction . It occurs due to the narrowing of the angle between the superior mesenteric artery (SMA) and aorta, leading to compression of the third part of the duodenum (D3) .&lt;/li&gt;&lt;li&gt;âž¤ SMA Syndrome , also known as Wilkie Syndrome , is a rare cause of intestinal obstruction . It occurs due to the narrowing of the angle between the superior mesenteric artery (SMA) and aorta, leading to compression of the third part of the duodenum (D3) .&lt;/li&gt;&lt;li&gt;âž¤ SMA Syndrome&lt;/li&gt;&lt;li&gt;âž¤ Wilkie Syndrome&lt;/li&gt;&lt;li&gt;âž¤ rare cause of intestinal obstruction&lt;/li&gt;&lt;li&gt;âž¤ compression of the third part of the duodenum (D3)&lt;/li&gt;&lt;li&gt;âž¤ Risk factors:&lt;/li&gt;&lt;li&gt;âž¤ Risk factors:&lt;/li&gt;&lt;li&gt;âž¤ Sudden weight loss Anorexia nervosa Prolonged bed rest Scoliosis The clinical features of SMA Syndrome include colicky abdominal pain, bilious vomiting, and weight loss. On investigation, the small bowel appears normal, but a CECT of the abdomen may reveal compression of the D3 segment of the duodenum due to narrowing of the angle of the SMA. The initial treatment for SMA Syndrome is conservative and involves feeding the patient to promote weight gain and open the narrowed angle. This can be achieved through the placement of a naso-jejunostomy tube. If this fails, surgery may be required to bypass the duodenum and relieve the obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Sudden weight loss&lt;/li&gt;&lt;li&gt;âž¤ Anorexia nervosa&lt;/li&gt;&lt;li&gt;âž¤ Prolonged bed rest&lt;/li&gt;&lt;li&gt;âž¤ Scoliosis&lt;/li&gt;&lt;li&gt;âž¤ The clinical features of SMA Syndrome include colicky abdominal pain, bilious vomiting, and weight loss. On investigation, the small bowel appears normal, but a CECT of the abdomen may reveal compression of the D3 segment of the duodenum due to narrowing of the angle of the SMA.&lt;/li&gt;&lt;li&gt;âž¤ CECT of the abdomen may reveal compression of the D3 segment of the duodenum&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for SMA Syndrome is conservative and involves feeding the patient to promote weight gain and open the narrowed angle. This can be achieved through the placement of a naso-jejunostomy tube. If this fails, surgery may be required to bypass the duodenum and relieve the obstruction.&lt;/li&gt;&lt;li&gt;âž¤ initial treatment for SMA Syndrome is conservative&lt;/li&gt;&lt;li&gt;âž¤ Ref : Online article: https://doi.org/10.53347/rID-11142&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Online article:&lt;/li&gt;&lt;li&gt;âž¤ https://doi.org/10.53347/rID-11142&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male patient with a history of peptic ulcer disease presents with a complaint of non-bilious vomiting. On examination, a succussion splash is heard over abdomen. CECT reveals the presence of a pyloric stricture. Which of the following is the first step for management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Conservative management with nasogastric decompression and washout&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surgical reconstruction using Billroth II procedure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Endoscopic dilatation of the stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mikulicz stricturoplasty to relieve the obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Conservative management with nasogastric decompression and washout&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Conservative management with nasogastric decompression and washout&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Surgical reconstruction using Billroth II procedure . The Billroth II procedure is a surgical option (gastro-jejunostomy) that is generally considered after conservative management has failed.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Surgical reconstruction using Billroth II procedure&lt;/li&gt;&lt;li&gt;â€¢ surgical option&lt;/li&gt;&lt;li&gt;â€¢ generally considered after conservative management has failed.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Endoscopic dilatation of the stricture . Endoscopic dilatation is a less invasive treatment option compared to surgery and can be effective in managing strictures . However, it is not the first-line treatment before attempting nasogastric decompression.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Endoscopic dilatation of the stricture&lt;/li&gt;&lt;li&gt;â€¢ less invasive treatment option compared to surgery&lt;/li&gt;&lt;li&gt;â€¢ effective in managing strictures&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mikulicz strictureplasty to relieve the obstruction . Mikulicz strictureplasty is a surgical technique used when strictures are not amenable to endoscopic dilatation . It is considered a more advanced step if other less invasive measures fail.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Mikulicz strictureplasty to relieve the obstruction&lt;/li&gt;&lt;li&gt;â€¢ surgical technique used when strictures are not amenable to endoscopic dilatation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first step in managing a pyloric stricture is conservative management with nasogastric decompression and washout to provide symptomatic relief&lt;/li&gt;&lt;li&gt;âž¤ first step in managing a pyloric stricture&lt;/li&gt;&lt;li&gt;âž¤ conservative management&lt;/li&gt;&lt;li&gt;âž¤ nasogastric decompression&lt;/li&gt;&lt;li&gt;âž¤ Pyloric stricture is a late complication of peptic ulcer disease , which occurs due to the fibrosis and scarring that develop when the circumferential ulcers over the stomach heal. This can lead to narrowing of the stomach or gastric outlet obstruction, which usually occurs at the first part of the duodenum. Clinical features of pyloric stricture include a history of peptic ulcer disease and non-bilious vomiting . The management of pyloric stricture depends on the extent and severity of the obstruction . Initial conservative management involves nasogastric decompression and washout , which can provide symptomatic relief. Endoscopy can be used to confirm the presence of a stricture and to obtain a biopsy to rule out adenocarcinoma . If the stricture is benign, it can be treated with dilatation. If dilatation fails, surgery may be required to relieve the obstruction. Mikulicz stricturoplasty is a surgical procedure that involves opening the pylorus horizontally and closing it vertically to relieve the obstruction . This is a preferred option when the stricture is not amenable to endoscopic dilatation. Billroth II reconstruction is another surgical option that involves removal of the pylorus and reconstruction of the gastrointestinal tract to improve gastric emptying.&lt;/li&gt;&lt;li&gt;âž¤ Pyloric stricture is a late complication of peptic ulcer disease , which occurs due to the fibrosis and scarring that develop when the circumferential ulcers over the stomach heal. This can lead to narrowing of the stomach or gastric outlet obstruction, which usually occurs at the first part of the duodenum.&lt;/li&gt;&lt;li&gt;âž¤ Pyloric stricture is a late complication of peptic ulcer disease&lt;/li&gt;&lt;li&gt;âž¤ occurs due to the fibrosis&lt;/li&gt;&lt;li&gt;âž¤ scarring&lt;/li&gt;&lt;li&gt;âž¤ Clinical features of pyloric stricture include a history of peptic ulcer disease and non-bilious vomiting .&lt;/li&gt;&lt;li&gt;âž¤ Clinical features of pyloric stricture include a history of peptic ulcer disease and non-bilious vomiting&lt;/li&gt;&lt;li&gt;âž¤ The management of pyloric stricture depends on the extent and severity of the obstruction . Initial conservative management involves nasogastric decompression and washout , which can provide symptomatic relief.&lt;/li&gt;&lt;li&gt;âž¤ management of pyloric stricture&lt;/li&gt;&lt;li&gt;âž¤ extent and severity of the obstruction&lt;/li&gt;&lt;li&gt;âž¤ nasogastric decompression and washout&lt;/li&gt;&lt;li&gt;âž¤ Endoscopy can be used to confirm the presence of a stricture and to obtain a biopsy to rule out adenocarcinoma . If the stricture is benign, it can be treated with dilatation. If dilatation fails, surgery may be required to relieve the obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Endoscopy&lt;/li&gt;&lt;li&gt;âž¤ confirm the presence of a stricture&lt;/li&gt;&lt;li&gt;âž¤ obtain a biopsy to rule out adenocarcinoma&lt;/li&gt;&lt;li&gt;âž¤ Mikulicz stricturoplasty is a surgical procedure that involves opening the pylorus horizontally and closing it vertically to relieve the obstruction . This is a preferred option when the stricture is not amenable to endoscopic dilatation. Billroth II reconstruction is another surgical option that involves removal of the pylorus and reconstruction of the gastrointestinal tract to improve gastric emptying.&lt;/li&gt;&lt;li&gt;âž¤ Mikulicz stricturoplasty is a surgical procedure that involves opening the pylorus horizontally and closing it vertically&lt;/li&gt;&lt;li&gt;âž¤ to relieve the obstruction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1169&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1169&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male, a known case of chronic atrial fibrillation presents with acute abdominal pain and PR bleed. Abdominal examination revealed vague tenderness and diminished bowel sounds. Which of the following is the investigation of choice for diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum lipase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;USG abdomen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;X ray upper abdomen erect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CECT abdomen angiogram&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CECT abdomen angiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) CECT abdomen angiogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Serum lipase. While serum lipase can be useful in diagnosing pancreatitis , it would not be the most helpful initial test for a patient suspected of having mesenteric ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Serum lipase.&lt;/li&gt;&lt;li&gt;â€¢ serum lipase can be useful in diagnosing pancreatitis&lt;/li&gt;&lt;li&gt;â€¢ Option B: USG abdomen. An ultrasound of the abdomen can be useful for assessing many abdominal conditions, but it may not be the best choice for evaluating blood flow or identifying mesenteric ischemia, especially in an acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option B: USG abdomen.&lt;/li&gt;&lt;li&gt;â€¢ ultrasound of the abdomen can be useful for assessing many abdominal conditions,&lt;/li&gt;&lt;li&gt;â€¢ Option C: X-ray upper abdomen erect. An erect abdominal X-ray can show signs of bowel obstruction or free air under the diaphragm in cases of perforation but is not the most sensitive or specific test for mesenteric ischemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C: X-ray upper abdomen erect.&lt;/li&gt;&lt;li&gt;â€¢ erect abdominal X-ray&lt;/li&gt;&lt;li&gt;â€¢ show signs of bowel obstruction or free air under the diaphragm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a patient with suspected acute mesenteric ischemia , particularly in the context of chronic atrial fibrillation , the next best investigation is a CECT abdomen angiogram.&lt;/li&gt;&lt;li&gt;âž¤ suspected acute mesenteric ischemia&lt;/li&gt;&lt;li&gt;âž¤ context of chronic atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ next best investigation is a CECT abdomen angiogram.&lt;/li&gt;&lt;li&gt;âž¤ SMA emboli may be carried from the left atrium in atrial fibrillation , the left ventricle after mural myocardial infarction , vegetations on mitral and aortic valves associated with endocarditis or an atheromatous plaque from an aortic aneurysm Investigation for mesenteric ischemia includes a CECT scan, which can determine whether the occlusion is acute or chronic and assess bowel viability or gangrene. Treatment for mesenteric ischemia depends on the extent and severity of the obstruction. Conservative management with antibiotics and bowel rest may be used in some cases. For acute occlusion, mesenteric vascular intervention is the preferred treatment . If there is evidence of gangrene, laparotomy and bowel resection may be required. Chronic mesenteric ischemia typically presents with mesenteric angina (central abdominal pain) and diarrhoea. A CECT angiogram can reveal atherosclerosis of the mesentery. Treatment for chronic mesenteric ischemia involves mesenteric angioplasty bypass.&lt;/li&gt;&lt;li&gt;âž¤ SMA emboli may be carried from the left atrium in atrial fibrillation , the left ventricle after mural myocardial infarction , vegetations on mitral and aortic valves associated with endocarditis or an atheromatous plaque from an aortic aneurysm&lt;/li&gt;&lt;li&gt;âž¤ SMA emboli&lt;/li&gt;&lt;li&gt;âž¤ left atrium in atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ left ventricle after mural myocardial infarction&lt;/li&gt;&lt;li&gt;âž¤ vegetations on mitral and aortic valves&lt;/li&gt;&lt;li&gt;âž¤ endocarditis&lt;/li&gt;&lt;li&gt;âž¤ atheromatous plaque&lt;/li&gt;&lt;li&gt;âž¤ Investigation for mesenteric ischemia includes a CECT scan, which can determine whether the occlusion is acute or chronic and assess bowel viability or gangrene. Treatment for mesenteric ischemia depends on the extent and severity of the obstruction. Conservative management with antibiotics and bowel rest may be used in some cases.&lt;/li&gt;&lt;li&gt;âž¤ For acute occlusion, mesenteric vascular intervention is the preferred treatment . If there is evidence of gangrene, laparotomy and bowel resection may be required.&lt;/li&gt;&lt;li&gt;âž¤ For acute occlusion, mesenteric vascular intervention is the preferred treatment&lt;/li&gt;&lt;li&gt;âž¤ Chronic mesenteric ischemia typically presents with mesenteric angina (central abdominal pain) and diarrhoea. A CECT angiogram can reveal atherosclerosis of the mesentery. Treatment for chronic mesenteric ischemia involves mesenteric angioplasty bypass.&lt;/li&gt;&lt;li&gt;âž¤ Treatment for chronic mesenteric ischemia involves mesenteric angioplasty bypass.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1312-1313&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1312-1313&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the management protocol for enterocutaneous fistula?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sepsis control and skin care, TPN, CECT, and planned repair&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibiotics, enteral nutrition, MRI, and surgical intervention&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Conservative management, low-residue diet, ultrasound, and outpatient follow-up&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bowel rest, antibiotics, barium enema, and observation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sepsis control and skin care, TPN, CECT, and planned repair&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sepsis control and skin care, TPN, CECT, and planned repair&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Antibiotics, enteral nutrition, MRI, and surgical intervention . While antibiotics and surgical intervention may be part of the management , enteral nutrition may not be feasible with a high-output fistula, and MRI is not the standard imaging modality for this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Antibiotics, enteral nutrition, MRI, and surgical intervention&lt;/li&gt;&lt;li&gt;â€¢ antibiotics&lt;/li&gt;&lt;li&gt;â€¢ surgical intervention&lt;/li&gt;&lt;li&gt;â€¢ management&lt;/li&gt;&lt;li&gt;â€¢ enteral nutrition&lt;/li&gt;&lt;li&gt;â€¢ not be feasible&lt;/li&gt;&lt;li&gt;â€¢ Option C: Conservative management, low-residue diet, ultrasound, and outpatient follow-up . Conservative management may be indicated in some cases , but this option lacks the aggressive approach often required for enterocutaneous fistulas, such as TPN and detailed imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Conservative management, low-residue diet, ultrasound, and outpatient follow-up&lt;/li&gt;&lt;li&gt;â€¢ Conservative management&lt;/li&gt;&lt;li&gt;â€¢ indicated in some cases&lt;/li&gt;&lt;li&gt;â€¢ Option D: Bowel rest, antibiotics, barium enema, and observation . Bowel rest and observation are part of the initial management , but merely antibiotics might not be sufficient for sepsis control , and a barium enema is not typically used for fistula assessment due to the risk of extravasation and worsening sepsis.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Bowel rest, antibiotics, barium enema, and observation&lt;/li&gt;&lt;li&gt;â€¢ Bowel rest&lt;/li&gt;&lt;li&gt;â€¢ observation&lt;/li&gt;&lt;li&gt;â€¢ part of the initial management&lt;/li&gt;&lt;li&gt;â€¢ antibiotics might not be sufficient for sepsis control&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The management protocol for enterocutaneous fistula involves sepsis control, skin care, total parenteral nutrition (TPN), anatomical delineation with a CECT scan , and planned surgical repair following the SNAP protocol.&lt;/li&gt;&lt;li&gt;âž¤ management protocol for enterocutaneous fistula&lt;/li&gt;&lt;li&gt;âž¤ sepsis control, skin care, total parenteral nutrition&lt;/li&gt;&lt;li&gt;âž¤ anatomical delineation with a CECT scan&lt;/li&gt;&lt;li&gt;âž¤ planned surgical repair&lt;/li&gt;&lt;li&gt;âž¤ Enterocutaneous fistula is an abnormal communication between the bowel and the skin, which can be caused by postoperative complications, Crohn&#x27;s disease, GI malignancies, or radiation enteritis . The management of enterocutaneous fistula is based on the SNAP protocol . Sepsis control and skin care are essential for the management of enterocutaneous fistula, along with total parenteral nutrition (TPN) to provide adequate nutrition. Anatomical delineation, typically through a CECT scan, is necessary to identify the extent of the fistula and plan for repair. Planned repair is the ultimate goal of management, but high-output fistulas (&amp;gt;500ml) may not close spontaneously , and additional interventions may be required. Conservative management, a low-residue diet, and ultrasound are not effective for managing enterocutaneous fistula, and surgical intervention is required for definitive treatment.&lt;/li&gt;&lt;li&gt;âž¤ Enterocutaneous fistula is an abnormal communication between the bowel and the skin, which can be caused by postoperative complications, Crohn&#x27;s disease, GI malignancies, or radiation enteritis . The management of enterocutaneous fistula is based on the SNAP protocol .&lt;/li&gt;&lt;li&gt;âž¤ Enterocutaneous fistula&lt;/li&gt;&lt;li&gt;âž¤ caused by postoperative complications, Crohn&#x27;s disease, GI malignancies, or radiation enteritis&lt;/li&gt;&lt;li&gt;âž¤ SNAP protocol&lt;/li&gt;&lt;li&gt;âž¤ Sepsis control and skin care are essential for the management of enterocutaneous fistula, along with total parenteral nutrition (TPN) to provide adequate nutrition. Anatomical delineation, typically through a CECT scan, is necessary to identify the extent of the fistula and plan for repair.&lt;/li&gt;&lt;li&gt;âž¤ Anatomical delineation, typically through a CECT scan, is necessary to identify the extent of the fistula and plan for repair.&lt;/li&gt;&lt;li&gt;âž¤ Planned repair is the ultimate goal of management, but high-output fistulas (&amp;gt;500ml) may not close spontaneously , and additional interventions may be required. Conservative management, a low-residue diet, and ultrasound are not effective for managing enterocutaneous fistula, and surgical intervention is required for definitive treatment.&lt;/li&gt;&lt;li&gt;âž¤ high-output fistulas (&amp;gt;500ml) may not close spontaneously&lt;/li&gt;&lt;li&gt;âž¤ Principles of management of enterocutaneous fistulae (SNAP)&lt;/li&gt;&lt;li&gt;âž¤ Principles of management of enterocutaneous fistulae (SNAP)&lt;/li&gt;&lt;li&gt;âž¤ S - elimination of S epsis and S kin protection&lt;/li&gt;&lt;li&gt;âž¤ S&lt;/li&gt;&lt;li&gt;âž¤ S&lt;/li&gt;&lt;li&gt;âž¤ S&lt;/li&gt;&lt;li&gt;âž¤ N - N utrition â€“ a period of parenteral nutrition may well be required&lt;/li&gt;&lt;li&gt;âž¤ N&lt;/li&gt;&lt;li&gt;âž¤ N&lt;/li&gt;&lt;li&gt;âž¤ A - A natomical assessment&lt;/li&gt;&lt;li&gt;âž¤ A&lt;/li&gt;&lt;li&gt;âž¤ A&lt;/li&gt;&lt;li&gt;âž¤ P - definitive P lanned surgery&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ P&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1315-16&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28 th Ed. Pg 1315-16&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old patient underwent surgery for colon cancer, and a transverse colostomy was created. Which of the following complications is the patient unlikely to experience?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Excoriation of surrounding skin is more common than ileostomy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loop stomas are usually done for temporary indications&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loop ileostomy is easier to construct than loop transverse colostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ileostomy is spouted, whereas colostomy is flushed with the skin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Excoriation of surrounding skin is more common than ileostomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-115155.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Excoriation of surrounding skin is more common than ileostomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Temporary or defunctioning stomas are usually fashioned as loop stomas .&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ defunctioning stomas&lt;/li&gt;&lt;li&gt;â€¢ fashioned as loop stomas&lt;/li&gt;&lt;li&gt;â€¢ Option C: The advantage of a loop ileostomy over a loop colostomy is the ease with which the bowel can be brought to the surface .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ loop ileostomy over a loop colostomy&lt;/li&gt;&lt;li&gt;â€¢ ease with which the bowel can be brought to the surface&lt;/li&gt;&lt;li&gt;â€¢ Option D: An ileostomy is spouted ; a colostomy is flush because the ileostomy effluent is usually liquid , whereas colostomy effluent is usually solid . The spouts permit easier drainage of the secretions.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ ileostomy is spouted&lt;/li&gt;&lt;li&gt;â€¢ colostomy is flush because the ileostomy effluent is usually liquid&lt;/li&gt;&lt;li&gt;â€¢ colostomy effluent is usually solid&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ INTESTINAL STOMA:&lt;/li&gt;&lt;li&gt;â€¢ INTESTINAL STOMA:&lt;/li&gt;&lt;li&gt;â€¢ It is the surgical exteriorization of a portion of the small bowel or colon . In this case, the patient underwent surgery for colon cancer, and a transverse colostomy was created. Stoma creation is indicated to protect anastomosis and for intestinal obstruction.&lt;/li&gt;&lt;li&gt;â€¢ It is the surgical exteriorization of a portion of the small bowel or colon . In this case, the patient underwent surgery for colon cancer, and a transverse colostomy was created. Stoma creation is indicated to protect anastomosis and for intestinal obstruction.&lt;/li&gt;&lt;li&gt;â€¢ surgical exteriorization of a portion of the small bowel or colon&lt;/li&gt;&lt;li&gt;â€¢ Stoma creation&lt;/li&gt;&lt;li&gt;â€¢ protect anastomosis and for intestinal obstruction.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey and Love, 28 th Ed. Pg 1313-14.&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Bailey and Love, 28 th Ed. Pg 1313-14.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male, non-smoker presented with intermittent dysphagia for the past 3 months. Barium swallow showed the following characteristic appearance. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia cardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Plummer Vinson syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schatzki ring&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ca esophagus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Schatzki ring&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/03/untitled-589.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Achalasia cardia. Achalasia cardia typically presents with a dilated esophagus and a \&quot;bird&#x27;s beak\&quot; narrowing at the gastroesophageal junction. The absence of normal peristalsis in the body of the esophagus is also characteristic.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Achalasia cardia.&lt;/li&gt;&lt;li&gt;â€¢ Achalasia cardia&lt;/li&gt;&lt;li&gt;â€¢ dilated esophagus and a \&quot;bird&#x27;s beak\&quot; narrowing at the gastroesophageal junction.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Plummer Vinson syndrome. Plummer Vinson syndrome is associated with upper esophageal webs and iron deficiency anemia. Barium swallow may show thin web-like structures in the upper esophagus.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Plummer Vinson syndrome.&lt;/li&gt;&lt;li&gt;â€¢ associated with upper esophageal webs and iron deficiency anemia.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ca Esophagus. Esophageal cancer can present with various findings on a barium swallow, including irregular or nodular filling defects, luminal narrowing, and possibly evidence of tumor invasion . It does not typically present as a thin circumferential ring.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Ca Esophagus.&lt;/li&gt;&lt;li&gt;â€¢ present with various findings on a barium swallow, including irregular or nodular filling defects, luminal narrowing, and possibly evidence of tumor invasion&lt;/li&gt;&lt;li&gt;â€¢ The description of the image suggests that the most likely diagnosis is a Schatzki ring, as it is characterized by a thin circumferential ring in the distal esophagus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Schatzki ring , presenting as a thin circumferential constriction at the gastroesophageal junction on a barium swallow , is the most probable diagnosis in a patient with intermittent dysphagia.&lt;/li&gt;&lt;li&gt;âž¤ Schatzki ring&lt;/li&gt;&lt;li&gt;âž¤ thin circumferential constriction&lt;/li&gt;&lt;li&gt;âž¤ gastroesophageal junction on a barium swallow&lt;/li&gt;&lt;li&gt;âž¤ Schatzki ring is a benign condition There is a concentric, fibrous thickening and narrowing of the gastro-esophageal junction (GEJ), with squamous epithelium above and columnar cells below. Most common presentation - Dysphagia (if diameter &amp;lt; 13mm) and gastro-esophageal reflux disorder (GERD). Most common site - lower third of the esophagus. Treatment is endoscopic dilation with anti-reflux therapy&lt;/li&gt;&lt;li&gt;âž¤ Schatzki ring is a benign condition&lt;/li&gt;&lt;li&gt;âž¤ benign condition&lt;/li&gt;&lt;li&gt;âž¤ There is a concentric, fibrous thickening and narrowing of the gastro-esophageal junction (GEJ), with squamous epithelium above and columnar cells below.&lt;/li&gt;&lt;li&gt;âž¤ Most common presentation - Dysphagia (if diameter &amp;lt; 13mm) and gastro-esophageal reflux disorder (GERD).&lt;/li&gt;&lt;li&gt;âž¤ Most common presentation -&lt;/li&gt;&lt;li&gt;âž¤ Most common site - lower third of the esophagus.&lt;/li&gt;&lt;li&gt;âž¤ Most common site -&lt;/li&gt;&lt;li&gt;âž¤ Treatment is endoscopic dilation with anti-reflux therapy&lt;/li&gt;&lt;li&gt;âž¤ Treatment is endoscopic dilation with anti-reflux therapy&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1147&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1147&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young schizophrenic female presents with abdominal pain and vomiting. The surgeon notices that she has scanty hair on scalp, and on palpation of abdomen there is crepitus in the stomach. She is likely to be suffering from?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phytobezoar&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trichobezoar&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ca stomach&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric volvulus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Trichobezoar&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Trichobezoar&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Phytobezoar. Phytobezoars are composed of indigestible plant material and are typically found in patients with impaired gastric motility , often secondary to gastric surgery, and not necessarily associated with psychiatric conditions or hair ingestion.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Phytobezoar.&lt;/li&gt;&lt;li&gt;â€¢ composed of indigestible plant material and are typically found in patients with impaired gastric motility&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ca stomach. Gastric cancer (Ca stomach) could present with abdominal pain and vomiting but would not typically present with crepitus in the stomach or be associated with the ingestion of hair.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ca stomach.&lt;/li&gt;&lt;li&gt;â€¢ Gastric cancer&lt;/li&gt;&lt;li&gt;â€¢ present with abdominal pain and vomiting but would not typically present with crepitus&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gastric volvulus. Gastric volvulus presents with acute abdominal pain and may lead to vomiting, but it is unlikely to be associated with hair ingestion or crepitus on abdominal palpation unless there is associated gastric strangulation and perforation, which is a medical emergency.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gastric volvulus.&lt;/li&gt;&lt;li&gt;â€¢ acute abdominal pain and may lead to vomiting, but it is unlikely to be associated with hair ingestion or crepitus on abdominal palpation&lt;/li&gt;&lt;li&gt;â€¢ The clinical picture provided most consistently aligns with a trichobezoar , given the patient&#x27;s psychiatric history and the specific finding of crepitus in the stomach on palpation.&lt;/li&gt;&lt;li&gt;â€¢ trichobezoar&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a young psychiatric patient presenting with abdominal pain, vomiting, and evidence of scanty scalp hair, along with palpable crepitus in the stomach, the likely diagnosis is a trichobezoar.&lt;/li&gt;&lt;li&gt;âž¤ Trichobezoar (hair balls) are unusual and are virtually exclusively found in young psychiatric patients. It is caused by the ingestion of hair, which remains undigested in the stomach. The hair ball can lead to ulceration and gastrointestinal bleeding, perforation or obstruction . The diagnosis is made easily at endoscopy. Treatment consists of removal of the bezoar, which may require open surgical treatment. Phytobezoars are made of vegetable matter and are found principally in patients who have gastric stasis, usually following gastric surgery.&lt;/li&gt;&lt;li&gt;âž¤ Trichobezoar (hair balls) are unusual and are virtually exclusively found in young psychiatric patients.&lt;/li&gt;&lt;li&gt;âž¤ Trichobezoar&lt;/li&gt;&lt;li&gt;âž¤ It is caused by the ingestion of hair, which remains undigested in the stomach.&lt;/li&gt;&lt;li&gt;âž¤ The hair ball can lead to ulceration and gastrointestinal bleeding, perforation or obstruction .&lt;/li&gt;&lt;li&gt;âž¤ The hair ball can lead to ulceration and gastrointestinal bleeding, perforation or obstruction&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis is made easily at endoscopy.&lt;/li&gt;&lt;li&gt;âž¤ Treatment consists of removal of the bezoar, which may require open surgical treatment.&lt;/li&gt;&lt;li&gt;âž¤ Phytobezoars are made of vegetable matter and are found principally in patients who have gastric stasis, usually following gastric surgery.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1180&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1180&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of these are a part of Borchardtâ€™s triad seen in gastric volvulus except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute epigastric pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Abdominal distension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inability to pass Ryleâ€™s tube&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Abdominal distension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Abdominal distension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Borchardtâ€™s triad is a classical clinical presentation associated with gastric volvulus , which is a rotation of the stomach by more than 180 degrees, creating a closed-loop obstruction that can compromise the blood supply . The triad includes the following components:&lt;/li&gt;&lt;li&gt;â€¢ Borchardtâ€™s triad&lt;/li&gt;&lt;li&gt;â€¢ classical clinical presentation&lt;/li&gt;&lt;li&gt;â€¢ gastric volvulus&lt;/li&gt;&lt;li&gt;â€¢ rotation of the stomach&lt;/li&gt;&lt;li&gt;â€¢ more than 180 degrees,&lt;/li&gt;&lt;li&gt;â€¢ closed-loop obstruction&lt;/li&gt;&lt;li&gt;â€¢ compromise the blood supply&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute epigastric pain . Patients typically present with sudden onset of severe epigastric pain due to the rotation of the stomach and potential compromise of its blood supply.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute epigastric pain&lt;/li&gt;&lt;li&gt;â€¢ present with sudden onset of severe epigastric pain due to the rotation of the stomach&lt;/li&gt;&lt;li&gt;â€¢ Option C: Vomiting . Vomiting or retching is a common feature due to the obstruction of the GI tract . However, in some cases of complete volvulus, vomiting may not be possible as the rotation prevents gastric emptying.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Vomiting&lt;/li&gt;&lt;li&gt;â€¢ retching is a common feature due to the obstruction of the GI tract&lt;/li&gt;&lt;li&gt;â€¢ Option D: Inability to pass Ryleâ€™s tube . The inability to pass a nasogastric tube (Ryleâ€™s tube) into the stomach is due to the physical obstruction created by the volvulus , and it is a classic sign of this condition.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Inability to pass Ryleâ€™s tube&lt;/li&gt;&lt;li&gt;â€¢ inability to pass a nasogastric tube&lt;/li&gt;&lt;li&gt;â€¢ into the stomach is due to the physical obstruction&lt;/li&gt;&lt;li&gt;â€¢ volvulus&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey and Love, 28 th Ed. Pg 1180-81&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Bailey and Love, 28 th Ed. Pg 1180-81&lt;/li&gt;&lt;li&gt;â€¢ Online reference https://radiopaedia.org/articles/borchardts-triad-gastric-volvulus&lt;/li&gt;&lt;li&gt;â€¢ Online reference&lt;/li&gt;&lt;li&gt;â€¢ https://radiopaedia.org/articles/borchardts-triad-gastric-volvulus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 49 years old male presents with long-standing vague abdominal symptoms, early satiety, episodic abdominal pain, associated with vomiting. His imaging shows the following picture. What is the condition he is suffering from?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric volvulus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ca stomach&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SMA syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gastric ulcer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. SMA syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/16/image.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/24/surgery.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) SMA syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gastric volvulus . Gastric volvulus is an abnormal rotation of the stomach, which would typically show a distended stomach with an abnormal orientation on imaging . It often presents acutely with severe abdominal pain and retching without vomitus.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Gastric volvulus&lt;/li&gt;&lt;li&gt;â€¢ abnormal rotation of the stomach, which would typically show a distended stomach with an abnormal orientation on imaging&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ca stomach . Cancer of the stomach may present with nonspecific symptoms like weight loss, early satiety, and possibly a mass or irregularity on imaging , but it does not typically cause the acute angulation of the SMA leading to duodenal compression.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ca stomach&lt;/li&gt;&lt;li&gt;â€¢ present with nonspecific symptoms like weight loss, early satiety, and possibly a mass or irregularity on imaging&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gastric ulcer . A gastric ulcer may present with abdominal pain and symptoms related to eating , but it would not cause the compression of the duodenum as seen in SMA syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Gastric ulcer&lt;/li&gt;&lt;li&gt;â€¢ gastric ulcer&lt;/li&gt;&lt;li&gt;â€¢ abdominal pain&lt;/li&gt;&lt;li&gt;â€¢ symptoms related to eating&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient presenting with chronic vague abdominal symptoms, early satiety, and vomiting, along with imaging showing compression of the third part of the duodenum by the SMA, the diagnosis is likely Superior Mesenteric Artery Syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Superior mesenteric artery (SMA) syndrome , also known as Wilkie syndrome is a rare acquired vascular compression disorder in which acute angulation of the superior mesenteric artery (SMA) results in compression of the third part of the duodenum, leading to obstruction. Patients with SMA syndrome may present acutely, with chronic insidious symptomatology, or with an acute exacerbation of chronic symptoms: Acute presentation is usually characterised by signs and symptoms of duodenal obstruction Chronic cases may present with long-standing vague abdominal symptoms, early satiety and anorexia, or recurrent episodes of abdominal pain, associated with vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Superior mesenteric artery (SMA) syndrome , also known as Wilkie syndrome is a rare acquired vascular compression disorder in which acute angulation of the superior mesenteric artery (SMA) results in compression of the third part of the duodenum, leading to obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Superior mesenteric artery (SMA) syndrome , also known as Wilkie syndrome is a rare acquired vascular compression disorder in which acute angulation of the superior mesenteric artery (SMA) results in compression of the third part of the duodenum, leading to obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Superior mesenteric artery (SMA) syndrome&lt;/li&gt;&lt;li&gt;âž¤ Wilkie syndrome&lt;/li&gt;&lt;li&gt;âž¤ acute angulation of the superior mesenteric artery (SMA)&lt;/li&gt;&lt;li&gt;âž¤ Patients with SMA syndrome may present acutely, with chronic insidious symptomatology, or with an acute exacerbation of chronic symptoms:&lt;/li&gt;&lt;li&gt;âž¤ Patients with SMA syndrome may present acutely, with chronic insidious symptomatology, or with an acute exacerbation of chronic symptoms:&lt;/li&gt;&lt;li&gt;âž¤ Acute presentation is usually characterised by signs and symptoms of duodenal obstruction&lt;/li&gt;&lt;li&gt;âž¤ Acute presentation is usually characterised by signs and symptoms of duodenal obstruction&lt;/li&gt;&lt;li&gt;âž¤ Acute presentation&lt;/li&gt;&lt;li&gt;âž¤ Chronic cases may present with long-standing vague abdominal symptoms, early satiety and anorexia, or recurrent episodes of abdominal pain, associated with vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Chronic cases may present with long-standing vague abdominal symptoms, early satiety and anorexia, or recurrent episodes of abdominal pain, associated with vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Chronic cases&lt;/li&gt;&lt;li&gt;âž¤ Management:&lt;/li&gt;&lt;li&gt;âž¤ Management:&lt;/li&gt;&lt;li&gt;âž¤ Medical management - including decompression of the stomach and duodenum with a nasogastric tube , correction of nutritional and electrolytes deficiencies , through TPN , or preferably, if possible, enteral feeding with a naso-jejunal tube past the point of compression, which fulfils nutritional requirements while avoiding the complications of TPN. Surgical management - Duodenojejunostomy.&lt;/li&gt;&lt;li&gt;âž¤ Medical management - including decompression of the stomach and duodenum with a nasogastric tube , correction of nutritional and electrolytes deficiencies , through TPN , or preferably, if possible, enteral feeding with a naso-jejunal tube past the point of compression, which fulfils nutritional requirements while avoiding the complications of TPN.&lt;/li&gt;&lt;li&gt;âž¤ Medical management - including decompression of the stomach and duodenum with a nasogastric tube , correction of nutritional and electrolytes deficiencies , through TPN , or preferably, if possible, enteral feeding with a naso-jejunal tube past the point of compression, which fulfils nutritional requirements while avoiding the complications of TPN.&lt;/li&gt;&lt;li&gt;âž¤ Medical management -&lt;/li&gt;&lt;li&gt;âž¤ decompression of the stomach and duodenum with a nasogastric tube&lt;/li&gt;&lt;li&gt;âž¤ correction of nutritional and electrolytes deficiencies&lt;/li&gt;&lt;li&gt;âž¤ through TPN&lt;/li&gt;&lt;li&gt;âž¤ Surgical management - Duodenojejunostomy.&lt;/li&gt;&lt;li&gt;âž¤ Surgical management - Duodenojejunostomy.&lt;/li&gt;&lt;li&gt;âž¤ Surgical management -&lt;/li&gt;&lt;li&gt;âž¤ Duodenojejunostomy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Online reference https://radiopaedia.org/articles/superior-mesenteric-artery syndrome#:~:text=Superior%20mesenteric%20artery%20(SMA)%20syndrome,part%20of%20the%20duodenum%2C%20leading&lt;/li&gt;&lt;li&gt;âž¤ Ref : Online reference&lt;/li&gt;&lt;li&gt;âž¤ https://radiopaedia.org/articles/superior-mesenteric-artery syndrome#:~:text=Superior%20mesenteric%20artery%20(SMA)%20syndrome,part%20of%20the%20duodenum%2C%20leading&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of these are a part of Macklerâ€™s triad except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fever&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subcutaneous emphysema&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fever&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/03/untitled-591.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fever&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pain . Pain, especially sudden severe chest pain , is a key feature of Macklerâ€™s triad . It is typically retrosternal , exacerbated by swallowing , and may radiate to the back.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Pain&lt;/li&gt;&lt;li&gt;â€¢ sudden severe chest pain&lt;/li&gt;&lt;li&gt;â€¢ Macklerâ€™s triad&lt;/li&gt;&lt;li&gt;â€¢ retrosternal&lt;/li&gt;&lt;li&gt;â€¢ exacerbated by swallowing&lt;/li&gt;&lt;li&gt;â€¢ Option C: Vomiting . Vomiting is a part of Macklerâ€™s triad and is often the precipitating event leading to esophageal rupture in Boerhaaveâ€™s syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option C: Vomiting&lt;/li&gt;&lt;li&gt;â€¢ Macklerâ€™s triad&lt;/li&gt;&lt;li&gt;â€¢ precipitating event leading to esophageal rupture&lt;/li&gt;&lt;li&gt;â€¢ Boerhaaveâ€™s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D: Subcutaneous emphysema . Subcutaneous emphysema, which is air present in the subcutaneous tissue , can occur as a result of esophageal perforation with air escaping into the surrounding tissue . It is the third component of Mackler&#x27;s triad.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Subcutaneous emphysema&lt;/li&gt;&lt;li&gt;â€¢ air present in the subcutaneous tissue&lt;/li&gt;&lt;li&gt;â€¢ result of esophageal perforation with air escaping into the surrounding tissue&lt;/li&gt;&lt;li&gt;â€¢ The correct answer to the question is Option B: Fever , as it is not part of Macklerâ€™s triad.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fever&lt;/li&gt;&lt;li&gt;â€¢ not part of Macklerâ€™s triad.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Macklerâ€™s triad , indicative of Boerhaaveâ€™s syndrome , includes vomiting, pain, and subcutaneous emphysema , but not fever .&lt;/li&gt;&lt;li&gt;âž¤ Macklerâ€™s triad&lt;/li&gt;&lt;li&gt;âž¤ Boerhaaveâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ vomiting, pain, and subcutaneous emphysema&lt;/li&gt;&lt;li&gt;âž¤ not fever&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous emetogenic perforation (Boerhaaveâ€™s syndrome) results from a sudden increase in oesophageal pressure against a closed glottis from vomiting. Macklerâ€™s triad is a feature of Boerhaaveâ€™s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous emetogenic perforation (Boerhaaveâ€™s syndrome) results from a sudden increase in oesophageal pressure against a closed glottis from vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous emetogenic perforation (Boerhaaveâ€™s syndrome) results from a sudden increase in oesophageal pressure against a closed glottis from vomiting.&lt;/li&gt;&lt;li&gt;âž¤ Spontaneous emetogenic perforation (Boerhaaveâ€™s syndrome)&lt;/li&gt;&lt;li&gt;âž¤ sudden increase in oesophageal pressure against a closed glottis&lt;/li&gt;&lt;li&gt;âž¤ Macklerâ€™s triad is a feature of Boerhaaveâ€™s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Macklerâ€™s triad is a feature of Boerhaaveâ€™s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Typically, the site of perforation is the lower oesophagus towards the left pleural cavity . Hammanâ€™s sign refers to a crunching sound on auscultation of the heart owing to surgical emphysema. Because of high septic load, urgent surgical intervention is usually required.&lt;/li&gt;&lt;li&gt;âž¤ Typically, the site of perforation is the lower oesophagus towards the left pleural cavity .&lt;/li&gt;&lt;li&gt;âž¤ Typically, the site of perforation is the lower oesophagus towards the left pleural cavity .&lt;/li&gt;&lt;li&gt;âž¤ site of perforation is the lower oesophagus towards the left pleural cavity&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign refers to a crunching sound on auscultation of the heart owing to surgical emphysema.&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign refers to a crunching sound on auscultation of the heart owing to surgical emphysema.&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign&lt;/li&gt;&lt;li&gt;âž¤ Because of high septic load, urgent surgical intervention is usually required.&lt;/li&gt;&lt;li&gt;âž¤ Because of high septic load, urgent surgical intervention is usually required.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1127&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1127&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these is incorrect about caustic injury to upper gastro intestinal tract?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkali ingestion is more dangerous&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zargarâ€™s grading is used for severity of injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is a premalignant condition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple esophageal ulcers warrant urgent cervical esophagostomy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Multiple esophageal ulcers warrant urgent cervical esophagostomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-122231.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Multiple esophageal ulcers warrant urgent cervical esophagostomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alkali ingestion is more dangerous . Ingestion of alkali substances is indeed more dangerous compared to acids because alkalis cause liquefactive necrosis , allowing deeper tissue penetration and damage which can lead to more severe complications such as perforation.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Alkali ingestion is more dangerous&lt;/li&gt;&lt;li&gt;â€¢ Ingestion of alkali substances&lt;/li&gt;&lt;li&gt;â€¢ dangerous compared to acids because alkalis cause liquefactive necrosis&lt;/li&gt;&lt;li&gt;â€¢ deeper tissue penetration&lt;/li&gt;&lt;li&gt;â€¢ Option B: Zargarâ€™s grading is used for severity of injury . Zargarâ€™s grading system is a well-established scale used to classify the severity of caustic injuries to the esophagus based on endoscopic findings , helping to guide treatment decisions.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Zargarâ€™s grading is used for severity of injury&lt;/li&gt;&lt;li&gt;â€¢ Zargarâ€™s grading system&lt;/li&gt;&lt;li&gt;â€¢ well-established scale&lt;/li&gt;&lt;li&gt;â€¢ classify the severity of caustic injuries&lt;/li&gt;&lt;li&gt;â€¢ esophagus based on endoscopic findings&lt;/li&gt;&lt;li&gt;â€¢ Option C: It is a premalignant condition . Chronic injury from caustic ingestion can lead to esophageal strictures , which are a known risk factor for the development of esophageal cancer , thus making it a premalignant condition.&lt;/li&gt;&lt;li&gt;â€¢ Option C: It is a premalignant condition&lt;/li&gt;&lt;li&gt;â€¢ Chronic injury&lt;/li&gt;&lt;li&gt;â€¢ caustic ingestion&lt;/li&gt;&lt;li&gt;â€¢ esophageal strictures&lt;/li&gt;&lt;li&gt;â€¢ risk factor for the development of esophageal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of caustic injuries to the upper gastrointestinal tract , while alkali ingestion is indeed more dangerous, and Zargarâ€™s grading is used to assess the severity of injury , and such injuries can be premalignant , the presence of multiple esophageal ulcers does not universally warrant an urgent cervical esophagostomy.&lt;/li&gt;&lt;li&gt;âž¤ caustic injuries to the upper gastrointestinal tract&lt;/li&gt;&lt;li&gt;âž¤ alkali ingestion is indeed more dangerous,&lt;/li&gt;&lt;li&gt;âž¤ Zargarâ€™s grading is used to assess the severity of injury&lt;/li&gt;&lt;li&gt;âž¤ injuries can be premalignant&lt;/li&gt;&lt;li&gt;âž¤ presence of multiple esophageal ulcers does not universally warrant an urgent cervical esophagostomy.&lt;/li&gt;&lt;li&gt;âž¤ The substance ingested can be a strong acid, causing coagulative necrosis with eschar formation , which may limit penetration to deeper layers, or strong alkali, leading to liquefactive necrosis . The latter potentially penetrates deeper into the oesophageal wall, producing a more severe injury pattern. It is a premalignant condition - Delayed complications include stricture and malignancy. Treatment - Most caustic injuries can be managed conservatively with supportive measures. Deterioration requires surgical treatment, with emergency esophagectomy. The oesophagus can be mobilised transhiatally or via a thoracoscopic approach. Immediate reconstruction is not recommended . A cervical oesophagostomy and a gastrostomy can be done and future reconstruction planned. A feeding jejunostomy is an alternative for nutritional support if the stomach also requires resection.&lt;/li&gt;&lt;li&gt;âž¤ The substance ingested can be a strong acid, causing coagulative necrosis with eschar formation , which may limit penetration to deeper layers, or strong alkali, leading to liquefactive necrosis . The latter potentially penetrates deeper into the oesophageal wall, producing a more severe injury pattern.&lt;/li&gt;&lt;li&gt;âž¤ strong acid, causing&lt;/li&gt;&lt;li&gt;âž¤ coagulative necrosis with eschar formation&lt;/li&gt;&lt;li&gt;âž¤ strong alkali, leading to liquefactive necrosis&lt;/li&gt;&lt;li&gt;âž¤ It is a premalignant condition - Delayed complications include stricture and malignancy.&lt;/li&gt;&lt;li&gt;âž¤ premalignant condition&lt;/li&gt;&lt;li&gt;âž¤ Treatment - Most caustic injuries can be managed conservatively with supportive measures. Deterioration requires surgical treatment, with emergency esophagectomy. The oesophagus can be mobilised transhiatally or via a thoracoscopic approach. Immediate reconstruction is not recommended . A cervical oesophagostomy and a gastrostomy can be done and future reconstruction planned. A feeding jejunostomy is an alternative for nutritional support if the stomach also requires resection.&lt;/li&gt;&lt;li&gt;âž¤ Treatment -&lt;/li&gt;&lt;li&gt;âž¤ Immediate reconstruction is not recommended&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1129&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love&#x27;s Short Practice of Surgery 28th Edition pg 1129&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these food groups is avoided in patients with irritable bowel syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dairy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FODMAP group&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High glycemic index foods&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FODMAP group&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-122623.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) FODMAP group&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a true statement(s) about capsule endoscopy? It involves swallowing a small camera capsule that takes pictures of the digestive tract. It is used to diagnose conditions such as Crohn&#x27;s disease and small intestine tumors. The capsule is disposable and does not need to be retrieved after the procedure. It is an invasive procedure that requires sedation.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 and 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1 and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1,2 and 3&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1,2 and 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1,2 and 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Capsule endoscopy:&lt;/li&gt;&lt;li&gt;â€¢ Capsule endoscopy:&lt;/li&gt;&lt;li&gt;â€¢ It involves swallowing a small camera capsule that takes pictures of the digestive tract - This is a true statement about capsule endoscopy. The camera capsule is about the size of a large vitamin pill and contains a tiny camera and light source. The patient swallows the capsule, which then takes pictures of the digestive tract as it passes through the body. It is used to diagnose conditions such as Crohn&#x27;s disease and small intestine tumors - This is also a true statement about capsule endoscopy. The procedure is typically used to diagnose conditions that affect the small intestine, such as Crohn&#x27;s disease, celiac disease, and small intestine tumors. The capsule is disposable and does not need to be retrieved after the procedure - This is another true statement about capsule endoscopy. The camera capsule is disposable and does not need to be retrieved after the procedure. It is passed out of the body in the stool and can be safely disposed of. It is an invasive procedure that requires sedation - This statement is not true. Capsule endoscopy is a non-invasive procedure that does not require sedation . The patient can go about their normal activities during the procedure, although they may be asked to avoid certain foods and medications before and after the procedure.&lt;/li&gt;&lt;li&gt;â€¢ It involves swallowing a small camera capsule that takes pictures of the digestive tract - This is a true statement about capsule endoscopy. The camera capsule is about the size of a large vitamin pill and contains a tiny camera and light source. The patient swallows the capsule, which then takes pictures of the digestive tract as it passes through the body.&lt;/li&gt;&lt;li&gt;â€¢ camera capsule is about the size of a large vitamin pill&lt;/li&gt;&lt;li&gt;â€¢ It is used to diagnose conditions such as Crohn&#x27;s disease and small intestine tumors - This is also a true statement about capsule endoscopy. The procedure is typically used to diagnose conditions that affect the small intestine, such as Crohn&#x27;s disease, celiac disease, and small intestine tumors.&lt;/li&gt;&lt;li&gt;â€¢ used to diagnose conditions that affect the small intestine, such as Crohn&#x27;s disease, celiac disease, and small intestine tumors.&lt;/li&gt;&lt;li&gt;â€¢ The capsule is disposable and does not need to be retrieved after the procedure - This is another true statement about capsule endoscopy. The camera capsule is disposable and does not need to be retrieved after the procedure. It is passed out of the body in the stool and can be safely disposed of.&lt;/li&gt;&lt;li&gt;â€¢ It is an invasive procedure that requires sedation - This statement is not true. Capsule endoscopy is a non-invasive procedure that does not require sedation . The patient can go about their normal activities during the procedure, although they may be asked to avoid certain foods and medications before and after the procedure.&lt;/li&gt;&lt;li&gt;â€¢ not true. Capsule endoscopy is a non-invasive procedure that does not require sedation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Capsule endoscopy is a non-invasive diagnostic procedure that involves swallowing a small camera to take images of the digestive tract . It is used to diagnose conditions such as Crohn&#x27;s disease and small intestine tumors , and the capsule is disposable , exiting the body naturally without the need for retrieval or sedation .&lt;/li&gt;&lt;li&gt;âž¤ Capsule endoscopy&lt;/li&gt;&lt;li&gt;âž¤ non-invasive diagnostic procedure&lt;/li&gt;&lt;li&gt;âž¤ swallowing a small camera to take images of the digestive tract&lt;/li&gt;&lt;li&gt;âž¤ diagnose conditions such as Crohn&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ small intestine tumors&lt;/li&gt;&lt;li&gt;âž¤ capsule is disposable&lt;/li&gt;&lt;li&gt;âž¤ exiting the body naturally without the need for retrieval or sedation&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28th Ed. Pg 153&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28th Ed. Pg 153&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding hemobilia? It is a rare condition where blood flows into the biliary tree. It is commonly caused by gallstones or inflammation of the gallbladder. Symptoms may include abdominal pain, jaundice, and Malena. Diagnosis is usually made through a liver biopsy.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 and 3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 and 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1,2, and 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1 and 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1 and 3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. 1 and 3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ It is a rare condition where blood flows into the biliary tree - This statement is true. Hemobilia is a rare condition where bleeding occurs into the biliary tree . It is commonly caused by gallstones or inflammation of the gallbladder - This statement is not true. While gallstones or inflammation of the gallbladder can cause bleeding into the biliary tree, hemobilia is typically caused by trauma, surgery, or invasive procedures involving the liver or biliary tree. Symptoms of hemobilia may include abdominal pain, jaundice, and Malena (Sandbloomâ€™s triad). Diagnosis is usually made through a liver biopsy - This statement is not entirely true . While a liver biopsy may be used to diagnose hemobilia in some cases, diagnosis is typically made through imaging tests like CECT abdomen .&lt;/li&gt;&lt;li&gt;â€¢ It is a rare condition where blood flows into the biliary tree - This statement is true. Hemobilia is a rare condition where bleeding occurs into the biliary tree .&lt;/li&gt;&lt;li&gt;â€¢ rare condition where blood flows into the biliary tree&lt;/li&gt;&lt;li&gt;â€¢ bleeding occurs into the biliary tree&lt;/li&gt;&lt;li&gt;â€¢ It is commonly caused by gallstones or inflammation of the gallbladder - This statement is not true. While gallstones or inflammation of the gallbladder can cause bleeding into the biliary tree, hemobilia is typically caused by trauma, surgery, or invasive procedures involving the liver or biliary tree.&lt;/li&gt;&lt;li&gt;â€¢ Symptoms of hemobilia may include abdominal pain, jaundice, and Malena (Sandbloomâ€™s triad).&lt;/li&gt;&lt;li&gt;â€¢ hemobilia&lt;/li&gt;&lt;li&gt;â€¢ abdominal pain, jaundice, and Malena&lt;/li&gt;&lt;li&gt;â€¢ (Sandbloomâ€™s triad).&lt;/li&gt;&lt;li&gt;â€¢ Diagnosis is usually made through a liver biopsy - This statement is not entirely true . While a liver biopsy may be used to diagnose hemobilia in some cases, diagnosis is typically made through imaging tests like CECT abdomen .&lt;/li&gt;&lt;li&gt;â€¢ not entirely true&lt;/li&gt;&lt;li&gt;â€¢ diagnosis is typically made through imaging tests like CECT abdomen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hemobilia is a rare condition characterized by bleeding into the biliary tract and is often associated with trauma or iatrogenic injury rather than gallstones or gallbladder inflammation . It typically presents with abdominal pain, jaundice, and melena , and the diagnosis is usually made through imaging and endoscopic procedures , not liver biopsy.&lt;/li&gt;&lt;li&gt;âž¤ Hemobilia is a rare condition&lt;/li&gt;&lt;li&gt;âž¤ bleeding into the biliary tract and is often associated with trauma or iatrogenic injury&lt;/li&gt;&lt;li&gt;âž¤ gallstones or gallbladder inflammation&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain, jaundice, and melena&lt;/li&gt;&lt;li&gt;âž¤ diagnosis is usually made through imaging&lt;/li&gt;&lt;li&gt;âž¤ endoscopic procedures&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28th Ed. Pg 1202.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28th Ed. Pg 1202.&lt;/li&gt;&lt;li&gt;âž¤ Online source: https://www.sciencedirect.com/topics/medicine-and-dentistry/haemobilia&lt;/li&gt;&lt;li&gt;âž¤ Online source:&lt;/li&gt;&lt;li&gt;âž¤ https://www.sciencedirect.com/topics/medicine-and-dentistry/haemobilia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the role of Indocyanine green (ICG) dye during laparoscopic cholecystectomy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;To evaluate the function of the gallbladder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;To identify biliary anatomy and reduce the risk of injury to surrounding structures&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;To minimize bleeding during surgery by highlighting blood vessels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;To reduce the risk of surgical site infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. To identify biliary anatomy and reduce the risk of injury to surrounding structures&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/15/screenshot-2024-03-15-123326.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) To identify biliary anatomy and reduce the risk of injury to surrounding structures&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: To identify biliary anatomy and reduce the risk of injury to surrounding structures . This is the primary use of ICG during laparoscopic cholecystectomy. ICG binds to plasma proteins and is excreted into the bile , providing real-time cholangiography when viewed under near-infrared light , thus enhancing the visualization of the cystic duct, common bile duct, and other biliary structures to prevent injury.&lt;/li&gt;&lt;li&gt;â€¢ Option B: To identify biliary anatomy and reduce the risk of injury to surrounding structures&lt;/li&gt;&lt;li&gt;â€¢ This is the primary use&lt;/li&gt;&lt;li&gt;â€¢ ICG during laparoscopic cholecystectomy.&lt;/li&gt;&lt;li&gt;â€¢ ICG binds to plasma proteins and is excreted into the bile&lt;/li&gt;&lt;li&gt;â€¢ real-time cholangiography&lt;/li&gt;&lt;li&gt;â€¢ under near-infrared light&lt;/li&gt;&lt;li&gt;â€¢ Option C: To minimize bleeding during surgery by highlighting blood vessels . ICG does help to visualize blood vessels; however, its use in laparoscopic cholecystectomy is more focused on biliary tract visualization rather than to minimize bleeding.&lt;/li&gt;&lt;li&gt;â€¢ Option C: To minimize bleeding during surgery by highlighting blood vessels&lt;/li&gt;&lt;li&gt;â€¢ ICG does help to visualize blood vessels;&lt;/li&gt;&lt;li&gt;â€¢ use in laparoscopic cholecystectomy&lt;/li&gt;&lt;li&gt;â€¢ focused on biliary tract visualization&lt;/li&gt;&lt;li&gt;â€¢ Option D: To reduce the risk of surgical site infection . ICG has no antimicrobial properties and does not reduce the risk of surgical site infections .&lt;/li&gt;&lt;li&gt;â€¢ Option D: To reduce the risk of surgical site infection&lt;/li&gt;&lt;li&gt;â€¢ ICG has no antimicrobial properties&lt;/li&gt;&lt;li&gt;â€¢ does not reduce the risk of surgical site infections&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The primary role of Indocyanine green (ICG) dye during laparoscopic cholecystectomy is to enhance the visualization of biliary anatomy , such as the cystic duct and common bile duct , in order to reduce the risk of injury to these and other surrounding structures.&lt;/li&gt;&lt;li&gt;âž¤ primary role of Indocyanine green&lt;/li&gt;&lt;li&gt;âž¤ dye&lt;/li&gt;&lt;li&gt;âž¤ laparoscopic cholecystectomy&lt;/li&gt;&lt;li&gt;âž¤ enhance the visualization of biliary anatomy&lt;/li&gt;&lt;li&gt;âž¤ cystic duct&lt;/li&gt;&lt;li&gt;âž¤ bile duct&lt;/li&gt;&lt;li&gt;âž¤ Indocyanine green (ICG) dye is used during laparoscopic cholecystectomy to help identify biliary anatomy, such as the common bile duct and cystic duct, and reduce the risk of injury to surrounding structures. ICG dye can also help to highlight blood vessels, which can aid in minimizing bleeding during surgery. However, this is not the main application in cholecystectomy. While ICG dye can be used to evaluate the function of the gallbladder and assess blood flow during surgery, this is not its primary role in laparoscopic cholecystectomy.&lt;/li&gt;&lt;li&gt;âž¤ Indocyanine green (ICG) dye is used during laparoscopic cholecystectomy to help identify biliary anatomy, such as the common bile duct and cystic duct, and reduce the risk of injury to surrounding structures.&lt;/li&gt;&lt;li&gt;âž¤ help identify biliary anatomy, such as the common bile duct and cystic duct, and&lt;/li&gt;&lt;li&gt;âž¤ reduce the risk of injury to surrounding structures.&lt;/li&gt;&lt;li&gt;âž¤ ICG dye can also help to highlight blood vessels, which can aid in minimizing bleeding during surgery. However, this is not the main application in cholecystectomy.&lt;/li&gt;&lt;li&gt;âž¤ While ICG dye can be used to evaluate the function of the gallbladder and assess blood flow during surgery, this is not its primary role in laparoscopic cholecystectomy.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28th Ed. Pg 173&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Bailey and Love, 28th Ed. Pg 173&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these is the ideal donor for organ transplant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain dead donor who is an identical twin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Living donor who is an identical twin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain dead donor who has the same blood group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Living donor who has the same blood group&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Living donor who is an identical twin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Living donor who is an identical twin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. A brain-dead donor who is an identical twin would be an excellent match in terms of HLA compatibility . However, the organs may have suffered from the events leading to brain death and subsequent changes in physiology.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ excellent match&lt;/li&gt;&lt;li&gt;â€¢ HLA compatibility&lt;/li&gt;&lt;li&gt;â€¢ suffered&lt;/li&gt;&lt;li&gt;â€¢ events leading&lt;/li&gt;&lt;li&gt;â€¢ brain death&lt;/li&gt;&lt;li&gt;â€¢ changes in physiology.&lt;/li&gt;&lt;li&gt;â€¢ Option C . A brain-dead donor who has the same blood group can be a suitable donor , but without the genetic matching of an identical twin , there is a higher risk of rejection .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ can be a suitable donor&lt;/li&gt;&lt;li&gt;â€¢ without&lt;/li&gt;&lt;li&gt;â€¢ genetic matching&lt;/li&gt;&lt;li&gt;â€¢ identical twin&lt;/li&gt;&lt;li&gt;â€¢ higher risk of rejection&lt;/li&gt;&lt;li&gt;â€¢ Option D . A living donor who has the same blood group is better than a deceased donor in terms of organ quality, but the risk of rejection would still be higher compared to an identical twin.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ same blood group&lt;/li&gt;&lt;li&gt;â€¢ better&lt;/li&gt;&lt;li&gt;â€¢ deceased donor&lt;/li&gt;&lt;li&gt;â€¢ risk of rejection&lt;/li&gt;&lt;li&gt;â€¢ still be higher&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ideal organ donor is a living donor who is an identical twin of the recipient due to the perfect HLA match and the optimal condition of the donated organ , which significantly reduces the risk of rejection and improves transplant outcomes .&lt;/li&gt;&lt;li&gt;âž¤ identical twin&lt;/li&gt;&lt;li&gt;âž¤ perfect HLA match&lt;/li&gt;&lt;li&gt;âž¤ optimal condition&lt;/li&gt;&lt;li&gt;âž¤ donated organ&lt;/li&gt;&lt;li&gt;âž¤ reduces&lt;/li&gt;&lt;li&gt;âž¤ risk of rejection&lt;/li&gt;&lt;li&gt;âž¤ improves transplant outcomes&lt;/li&gt;&lt;li&gt;âž¤ Transplants from live donors have a number of advantages over deceased donor organs . Live donor organ from healthy individuals without the comorbidities commonly seen in deceased donors . In the agonal period , before death , deceased donors exhibit marked changes in physiology related to a catecholamine storm and this can cause organ dysfunction . Clearly, live donor organs are not subjected to this insult. Allograft rejection is directed against human leukocyte antigens (HLAs) . These are a group of cell surface glycoprotein molecules. HLA molecules are divided into class I (A, B and C) and class II (DR, DP and DQ). They are highly polymorphic , i.e., their amino acid sequences differ widely between individuals . To give an example, there are &amp;gt; 1000 variants of the HLA-B gene . This genetic variability means that most transplant donors and recipients have different HLA profiles . HLA profiles will be the same in identical twins, hence chance of mismatch is low.&lt;/li&gt;&lt;li&gt;âž¤ Transplants from live donors have a number of advantages over deceased donor organs . Live donor organ from healthy individuals without the comorbidities commonly seen in deceased donors .&lt;/li&gt;&lt;li&gt;âž¤ live donors&lt;/li&gt;&lt;li&gt;âž¤ number of advantages&lt;/li&gt;&lt;li&gt;âž¤ over deceased&lt;/li&gt;&lt;li&gt;âž¤ donor organs&lt;/li&gt;&lt;li&gt;âž¤ healthy individuals&lt;/li&gt;&lt;li&gt;âž¤ without&lt;/li&gt;&lt;li&gt;âž¤ comorbidities&lt;/li&gt;&lt;li&gt;âž¤ deceased donors&lt;/li&gt;&lt;li&gt;âž¤ In the agonal period , before death , deceased donors exhibit marked changes in physiology related to a catecholamine storm and this can cause organ dysfunction . Clearly, live donor organs are not subjected to this insult.&lt;/li&gt;&lt;li&gt;âž¤ agonal period&lt;/li&gt;&lt;li&gt;âž¤ before death&lt;/li&gt;&lt;li&gt;âž¤ deceased donors&lt;/li&gt;&lt;li&gt;âž¤ marked changes&lt;/li&gt;&lt;li&gt;âž¤ catecholamine storm&lt;/li&gt;&lt;li&gt;âž¤ organ dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Allograft rejection is directed against human leukocyte antigens (HLAs) . These are a group of cell surface glycoprotein molecules. HLA molecules are divided into class I (A, B and C) and class II (DR, DP and DQ).&lt;/li&gt;&lt;li&gt;âž¤ Allograft rejection is directed against human leukocyte antigens (HLAs)&lt;/li&gt;&lt;li&gt;âž¤ class I (A, B and C) and class II (DR, DP and DQ).&lt;/li&gt;&lt;li&gt;âž¤ They are highly polymorphic , i.e., their amino acid sequences differ widely between individuals . To give an example, there are &amp;gt; 1000 variants of the HLA-B gene . This genetic variability means that most transplant donors and recipients have different HLA profiles . HLA profiles will be the same in identical twins, hence chance of mismatch is low.&lt;/li&gt;&lt;li&gt;âž¤ highly polymorphic&lt;/li&gt;&lt;li&gt;âž¤ amino acid sequences&lt;/li&gt;&lt;li&gt;âž¤ between individuals&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt; 1000 variants&lt;/li&gt;&lt;li&gt;âž¤ HLA-B gene&lt;/li&gt;&lt;li&gt;âž¤ most transplant donors&lt;/li&gt;&lt;li&gt;âž¤ recipients&lt;/li&gt;&lt;li&gt;âž¤ different HLA profiles&lt;/li&gt;&lt;li&gt;âž¤ HLA profiles will be the same in identical twins, hence chance of mismatch is low.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1597-99&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Love, 28 th Ed. Pg 1597-99&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male has recently undergone a successful kidney transplant. To prevent graft rejection, his medical team plans to initiate maintenance immunosuppression therapy. Which of the following drugs is a mammalian target of rapamycin (mTOR) inhibitor that is suitable for this purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sirolimus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mycophenolate Mofetil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sirolimus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sirolimus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Tacrolimus is a calcineurin inhibitor , not an mTOR inhibitor, and is used for immunosuppression in transplant patients , but it works via a different mechanism.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ calcineurin inhibitor&lt;/li&gt;&lt;li&gt;â€¢ immunosuppression&lt;/li&gt;&lt;li&gt;â€¢ transplant patients&lt;/li&gt;&lt;li&gt;â€¢ Option C . Azathioprine is an antiproliferative agent and is used as an immunosuppressant ; however, it does not inhibit mTOR.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Azathioprine&lt;/li&gt;&lt;li&gt;â€¢ antiproliferative agent&lt;/li&gt;&lt;li&gt;â€¢ immunosuppressant&lt;/li&gt;&lt;li&gt;â€¢ Option D . Mycophenolate mofetil is also an antiproliferative agent that inhibits the proliferation of T and B cells but is not an mTOR inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Mycophenolate mofetil&lt;/li&gt;&lt;li&gt;â€¢ antiproliferative agent&lt;/li&gt;&lt;li&gt;â€¢ inhibits&lt;/li&gt;&lt;li&gt;â€¢ proliferation of T and B cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sirolimus is a mammalian target of rapamycin ( mTOR ) inhibitor used in the maintenance phase of immunosuppression following kidney transplantation to prevent graft rejection .&lt;/li&gt;&lt;li&gt;âž¤ mammalian target&lt;/li&gt;&lt;li&gt;âž¤ rapamycin&lt;/li&gt;&lt;li&gt;âž¤ mTOR&lt;/li&gt;&lt;li&gt;âž¤ inhibitor&lt;/li&gt;&lt;li&gt;âž¤ maintenance phase&lt;/li&gt;&lt;li&gt;âž¤ immunosuppression&lt;/li&gt;&lt;li&gt;âž¤ kidney transplantation&lt;/li&gt;&lt;li&gt;âž¤ prevent graft rejection&lt;/li&gt;&lt;li&gt;âž¤ Drugs used for immunosuppression in a patient for kidney transplant are:&lt;/li&gt;&lt;li&gt;âž¤ Calcineurin inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Calcineurin inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Calcineurin inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine Tacrolimus&lt;/li&gt;&lt;li&gt;âž¤ Cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Tacrolimus&lt;/li&gt;&lt;li&gt;âž¤ Antiproliferative agents&lt;/li&gt;&lt;li&gt;âž¤ Antiproliferative agents&lt;/li&gt;&lt;li&gt;âž¤ Antiproliferative agents&lt;/li&gt;&lt;li&gt;âž¤ Azathioprine Mycophenolic acid&lt;/li&gt;&lt;li&gt;âž¤ Azathioprine&lt;/li&gt;&lt;li&gt;âž¤ Mycophenolic acid&lt;/li&gt;&lt;li&gt;âž¤ Mammalian target of rapamycin (mTOR) inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Mammalian target of rapamycin (mTOR) inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Mammalian target of rapamycin (mTOR) inhibitors&lt;/li&gt;&lt;li&gt;âž¤ Sirolimus Rapamycin Everolimus&lt;/li&gt;&lt;li&gt;âž¤ Sirolimus&lt;/li&gt;&lt;li&gt;âž¤ Rapamycin&lt;/li&gt;&lt;li&gt;âž¤ Everolimus&lt;/li&gt;&lt;li&gt;âž¤ Immunosuppression for transplantation has two phases: Induction and maintenance . Induction therapy commonly consists of a combination of high-dose intravenous steroids and the anti-CD25 monoclonal antibody basiliximab, which blocks IL-2 receptors . Other induction agents for high-risk cases are ATG and the monoclonal antibody alemtuzumab.&lt;/li&gt;&lt;li&gt;âž¤ Immunosuppression for transplantation has two phases: Induction and maintenance . Induction therapy commonly consists of a combination of high-dose intravenous steroids and the anti-CD25 monoclonal antibody basiliximab, which blocks IL-2 receptors . Other induction agents for high-risk cases are ATG and the monoclonal antibody alemtuzumab.&lt;/li&gt;&lt;li&gt;âž¤ Immunosuppression for transplantation has two phases:&lt;/li&gt;&lt;li&gt;âž¤ Induction&lt;/li&gt;&lt;li&gt;âž¤ maintenance&lt;/li&gt;&lt;li&gt;âž¤ high-dose intravenous steroids&lt;/li&gt;&lt;li&gt;âž¤ anti-CD25 monoclonal antibody basiliximab, which blocks IL-2 receptors&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1601-02&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1601-02&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement of the following about the technique of renal transplant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The donor kidney is transplanted heterotopically into one of the iliac fossae&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The transplant renal vein is anastomosed end to side to the external or common iliac vein.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The renal artery is anastomosed end to side to the external iliac artery in a deceased donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Donor ureter is anastomosed to recipient ureter via a spatulated anastomosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Donor ureter is anastomosed to recipient ureter via a spatulated anastomosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Donor ureter is anastomosed to recipient ureter via a spatulated anastomosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. This is a correct statement as the donor kidney is typically placed in a location different from the original kidneys , which is in the retroperitoneal iliac fossa .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ correct statement&lt;/li&gt;&lt;li&gt;â€¢ donor kidney&lt;/li&gt;&lt;li&gt;â€¢ original kidneys&lt;/li&gt;&lt;li&gt;â€¢ retroperitoneal iliac fossa&lt;/li&gt;&lt;li&gt;â€¢ Option B . This is the standard practice for the venous anastomosis in renal transplantation , making this statement correct .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ standard practice&lt;/li&gt;&lt;li&gt;â€¢ venous anastomosis&lt;/li&gt;&lt;li&gt;â€¢ renal transplantation&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ Option C . This is also correct as the renal artery can be anastomosed to the external iliac artery via a â€œCarrel patchâ€ which can be obtained in deceased donor . In living donor transplants, the donor renal artery is anastomosed to recipient internal iliac artery .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ also correct&lt;/li&gt;&lt;li&gt;â€¢ renal artery&lt;/li&gt;&lt;li&gt;â€¢ anastomosed&lt;/li&gt;&lt;li&gt;â€¢ external iliac artery&lt;/li&gt;&lt;li&gt;â€¢ â€œCarrel patchâ€&lt;/li&gt;&lt;li&gt;â€¢ obtained&lt;/li&gt;&lt;li&gt;â€¢ deceased donor&lt;/li&gt;&lt;li&gt;â€¢ donor renal artery&lt;/li&gt;&lt;li&gt;â€¢ anastomosed&lt;/li&gt;&lt;li&gt;â€¢ recipient internal iliac artery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In renal transplantation , the donor ureter is not anastomosed to the recipient ureter but is instead anastomosed to the bladder as an extra-vesical anastomosis using the Lichâ€“GrÃ©goir technique .&lt;/li&gt;&lt;li&gt;âž¤ renal transplantation&lt;/li&gt;&lt;li&gt;âž¤ instead anastomosed&lt;/li&gt;&lt;li&gt;âž¤ bladder&lt;/li&gt;&lt;li&gt;âž¤ extra-vesical anastomosis&lt;/li&gt;&lt;li&gt;âž¤ Lichâ€“GrÃ©goir technique&lt;/li&gt;&lt;li&gt;âž¤ Renal transplant operative technique&lt;/li&gt;&lt;li&gt;âž¤ Renal transplant operative technique&lt;/li&gt;&lt;li&gt;âž¤ The donor kidney is transplanted heterotopically into one of the iliac fossa via a curvilinear incision. The transplant renal vein is anastomosed end to side to the external or common iliac vein. The renal artery is anastomosed either end to side to the external or common iliac artery (via Carrels aortic patch) or end to end to the divided internal iliac artery The internal iliac artery is used more commonly for live donor kidneys because of the lack of an aortic patch. After revascularisation of the transplant kidney the ureter is anastomosed to the bladder as an extra-vesical only (the Lichâ€“GreÌgoir technique)&lt;/li&gt;&lt;li&gt;âž¤ The donor kidney is transplanted heterotopically into one of the iliac fossa via a curvilinear incision.&lt;/li&gt;&lt;li&gt;âž¤ heterotopically into one of the iliac fossa&lt;/li&gt;&lt;li&gt;âž¤ The transplant renal vein is anastomosed end to side to the external or common iliac vein.&lt;/li&gt;&lt;li&gt;âž¤ renal vein is anastomosed end to side&lt;/li&gt;&lt;li&gt;âž¤ The renal artery is anastomosed either end to side to the external or common iliac artery (via Carrels aortic patch) or end to end to the divided internal iliac artery&lt;/li&gt;&lt;li&gt;âž¤ renal artery is anastomosed either end to side&lt;/li&gt;&lt;li&gt;âž¤ The internal iliac artery is used more commonly for live donor kidneys because of the lack of an aortic patch.&lt;/li&gt;&lt;li&gt;âž¤ After revascularisation of the transplant kidney the ureter is anastomosed to the bladder as an extra-vesical only (the Lichâ€“GreÌgoir technique)&lt;/li&gt;&lt;li&gt;âž¤ ureter is anastomosed to the bladder as an extra-vesical only&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1604&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1604&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Transplantation of a pair of marginal quality kidneys from the same donor into one recipient in order to provide adequate nephron mass is called as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sub-Optimal Kidney Transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dual Kidney Transplant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Additional Kidney Transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Domino Kidney Transplant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dual Kidney Transplant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dual Kidney Transplant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sub-optimal kidney transplant typically refers to a transplant involving a kidney that is not in optimal condition, but can be used a bridge to formal renal transplant .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ transplant&lt;/li&gt;&lt;li&gt;â€¢ kidney&lt;/li&gt;&lt;li&gt;â€¢ bridge&lt;/li&gt;&lt;li&gt;â€¢ formal renal transplant&lt;/li&gt;&lt;li&gt;â€¢ Option C . Additional kidney transplant is not a standard term used in transplant medicine for this scenario.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Option D . Domino kidney transplant refers to a specific type of transplant where an organ or tissue is transplanted from one person to another and then from that person to another recipient , which is not the case described.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ specific type of transplant&lt;/li&gt;&lt;li&gt;â€¢ organ or tissue&lt;/li&gt;&lt;li&gt;â€¢ transplanted&lt;/li&gt;&lt;li&gt;â€¢ one person&lt;/li&gt;&lt;li&gt;â€¢ another&lt;/li&gt;&lt;li&gt;â€¢ person&lt;/li&gt;&lt;li&gt;â€¢ another recipient&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dual kidney transplantation is the process where two marginal quality kidneys from the same donor are transplanted into one recipient to ensure adequate nephron mass and function .&lt;/li&gt;&lt;li&gt;âž¤ two marginal quality kidneys&lt;/li&gt;&lt;li&gt;âž¤ same donor&lt;/li&gt;&lt;li&gt;âž¤ transplanted&lt;/li&gt;&lt;li&gt;âž¤ one recipient&lt;/li&gt;&lt;li&gt;âž¤ adequate nephron mass&lt;/li&gt;&lt;li&gt;âž¤ function&lt;/li&gt;&lt;li&gt;âž¤ Dual kidney transplantation&lt;/li&gt;&lt;li&gt;âž¤ Dual kidney transplantation&lt;/li&gt;&lt;li&gt;âž¤ This involves the transplantation of a pair of marginal quality kidneys from the same donor into one recipient in order to provide adequate nephron mass. Both kidneys can be placed in the same iliac fossa . This approach is used for kidneys from elderly Donor after Circulatory Death and so-called expanded criteria donors, which are defined by age &amp;gt; 60 years or age &amp;gt;50 years with at least two of the following: hypertension; terminal creatinine &amp;gt;133 Î¼mol/L; death from stroke.&lt;/li&gt;&lt;li&gt;âž¤ This involves the transplantation of a pair of marginal quality kidneys from the same donor into one recipient in order to provide adequate nephron mass.&lt;/li&gt;&lt;li&gt;âž¤ Both kidneys can be placed in the same iliac fossa .&lt;/li&gt;&lt;li&gt;âž¤ Both kidneys can be placed in the same iliac fossa&lt;/li&gt;&lt;li&gt;âž¤ This approach is used for kidneys from elderly Donor after Circulatory Death and so-called expanded criteria donors, which are defined by age &amp;gt; 60 years or age &amp;gt;50 years with at least two of the following: hypertension; terminal creatinine &amp;gt;133 Î¼mol/L; death from stroke.&lt;/li&gt;&lt;li&gt;âž¤ expanded criteria donors, which are defined by age &amp;gt; 60 years or age &amp;gt;50 years with at least two of the following:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1604&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1604&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these is not a cause of early graft dysfunction in renal transplant patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recurrence of Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal Vein Thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal Artery Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dehydration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Recurrence of Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Recurrence of Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B : Renal vein thrombosis is a significant cause of early graft dysfunction due to the immediate impairment of blood flow it can cause in the transplanted kidney .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ significant cause&lt;/li&gt;&lt;li&gt;â€¢ early graft dysfunction&lt;/li&gt;&lt;li&gt;â€¢ immediate impairment&lt;/li&gt;&lt;li&gt;â€¢ blood flow&lt;/li&gt;&lt;li&gt;â€¢ transplanted kidney&lt;/li&gt;&lt;li&gt;â€¢ Option C : Renal artery stenosis can lead to early graft dysfunction by reducing blood flow to the transplanted kidney , causing ischemia and potentially acute renal failure .&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ early graft dysfunction&lt;/li&gt;&lt;li&gt;â€¢ reducing blood flow&lt;/li&gt;&lt;li&gt;â€¢ transplanted kidney&lt;/li&gt;&lt;li&gt;â€¢ ischemia&lt;/li&gt;&lt;li&gt;â€¢ potentially acute renal failure&lt;/li&gt;&lt;li&gt;â€¢ Option D : Dehydration can cause pre-renal acute kidney injury by decreasing blood flow to the kidneys , leading to early graft dysfunction if severe .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ pre-renal acute kidney injury&lt;/li&gt;&lt;li&gt;â€¢ decreasing blood flow&lt;/li&gt;&lt;li&gt;â€¢ kidneys&lt;/li&gt;&lt;li&gt;â€¢ early graft dysfunction&lt;/li&gt;&lt;li&gt;â€¢ severe&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recurrence of the original disease is not a common cause of early graft dysfunction in renal transplant patients; as such recurrences typically occur later in the post-transplant course . Early graft dysfunction is more often caused by factors such as acute rejection, vascular complications, infections, or technical issues .&lt;/li&gt;&lt;li&gt;âž¤ later&lt;/li&gt;&lt;li&gt;âž¤ post-transplant course&lt;/li&gt;&lt;li&gt;âž¤ Early graft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ acute rejection, vascular complications, infections, or technical issues&lt;/li&gt;&lt;li&gt;âž¤ Causes of early graft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Causes of early graft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Any rise in serum creatinine of &amp;gt;10% of baseline or â‰¥20 Î¼mol/L should be considered as acute allograft dysfunction that requires investigation . Possible causes are:&lt;/li&gt;&lt;li&gt;âž¤ Any rise&lt;/li&gt;&lt;li&gt;âž¤ serum creatinine&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;10% of baseline&lt;/li&gt;&lt;li&gt;âž¤ â‰¥20 Î¼mol/L&lt;/li&gt;&lt;li&gt;âž¤ acute allograft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ requires investigation&lt;/li&gt;&lt;li&gt;âž¤ Acute Rejection (Antibody Mediated or Cell Mediated) Calcineurin Inhibitor Toxicity Dehydration Urinary Tract Infection or Pyelonephritis Any other source of Sepsis Renal Vein or Renal Artery Thrombosis Ureteric Obstruction or Urine Leak&lt;/li&gt;&lt;li&gt;âž¤ Acute Rejection (Antibody Mediated or Cell Mediated)&lt;/li&gt;&lt;li&gt;âž¤ Calcineurin Inhibitor Toxicity&lt;/li&gt;&lt;li&gt;âž¤ Dehydration&lt;/li&gt;&lt;li&gt;âž¤ Urinary Tract Infection or Pyelonephritis&lt;/li&gt;&lt;li&gt;âž¤ Any other source of Sepsis&lt;/li&gt;&lt;li&gt;âž¤ Renal Vein or Renal Artery Thrombosis&lt;/li&gt;&lt;li&gt;âž¤ Ureteric Obstruction or Urine Leak&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1606&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1606&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male who underwent a kidney transplant 7 years ago presents with gradually worsening renal function over the past year. He has no signs of infection, maintains good hydration, and reports compliance with his immunosuppressive medications. A renal biopsy reveals interstitial fibrosis and tubular atrophy without evidence of acute inflammatory changes. Which of the following is the most likely cause of this patient&#x27;s renal dysfunction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Rejection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Rejection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal Artery Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dehydration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chronic Rejection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chronic Rejection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute rejection, both antibody-mediated (AMR) and cell-mediated (CMR) , can lead to early graft dysfunction (within few months).&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ both antibody-mediated (AMR)&lt;/li&gt;&lt;li&gt;â€¢ cell-mediated (CMR)&lt;/li&gt;&lt;li&gt;â€¢ early graft dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Option C . Renal artery stenosis can lead to graft dysfunction due to ischemia ; however, it is less common than chronic rejection and doesnâ€™t match the biopsy.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ ischemia&lt;/li&gt;&lt;li&gt;â€¢ Option D . Dehydration can cause acute pre-renal failure but is not a common cause of long-term graft failure in kidney transplant patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ acute pre-renal failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic rejection is the most common cause of graft failure/dysfunction in kidney transplant , typically presenting as progressive organ dysfunction over time due to immunological factors .&lt;/li&gt;&lt;li&gt;âž¤ most common cause&lt;/li&gt;&lt;li&gt;âž¤ graft failure/dysfunction&lt;/li&gt;&lt;li&gt;âž¤ kidney transplant&lt;/li&gt;&lt;li&gt;âž¤ progressive organ dysfunction&lt;/li&gt;&lt;li&gt;âž¤ immunological factors&lt;/li&gt;&lt;li&gt;âž¤ Causes of long-term graft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Causes of long-term graft dysfunction&lt;/li&gt;&lt;li&gt;âž¤ Immunological&lt;/li&gt;&lt;li&gt;âž¤ Immunological&lt;/li&gt;&lt;li&gt;âž¤ Chronic AMR (anti-body mediated rejection) Acute CMR (cell mediated rejection) or AMR, which can occur at any time&lt;/li&gt;&lt;li&gt;âž¤ Chronic AMR (anti-body mediated rejection)&lt;/li&gt;&lt;li&gt;âž¤ Acute CMR (cell mediated rejection) or AMR, which can occur at any time&lt;/li&gt;&lt;li&gt;âž¤ Non-immunological :&lt;/li&gt;&lt;li&gt;âž¤ Non-immunological&lt;/li&gt;&lt;li&gt;âž¤ Pre-existing damage in the donor kidney (especially relevant to DCD and extended criteria donor kidneys) Early ischaemia - Reperfusion injury Chronic calcineurin nephrotoxicity Ureteric or bladder outflow obstruction Recurrent urinary tract infection or pyelonephritis BK polyomavirus nephropathy Recurrent native disease: glomerulonephritis; focal segmental glomerulosclerosis; immunoglobulin A nephropathy Renal artery stenosis Poorly controlled hypertension Dyslipidaemia&lt;/li&gt;&lt;li&gt;âž¤ Pre-existing damage in the donor kidney (especially relevant to DCD and extended criteria donor kidneys)&lt;/li&gt;&lt;li&gt;âž¤ Early ischaemia - Reperfusion injury&lt;/li&gt;&lt;li&gt;âž¤ Early ischaemia - Reperfusion injury&lt;/li&gt;&lt;li&gt;âž¤ Chronic calcineurin nephrotoxicity&lt;/li&gt;&lt;li&gt;âž¤ Ureteric or bladder outflow obstruction&lt;/li&gt;&lt;li&gt;âž¤ Recurrent urinary tract infection or pyelonephritis&lt;/li&gt;&lt;li&gt;âž¤ BK polyomavirus nephropathy&lt;/li&gt;&lt;li&gt;âž¤ Recurrent native disease: glomerulonephritis; focal segmental glomerulosclerosis; immunoglobulin A nephropathy&lt;/li&gt;&lt;li&gt;âž¤ Recurrent native disease: glomerulonephritis; focal segmental glomerulosclerosis; immunoglobulin A nephropathy&lt;/li&gt;&lt;li&gt;âž¤ Renal artery stenosis&lt;/li&gt;&lt;li&gt;âž¤ Poorly controlled hypertension&lt;/li&gt;&lt;li&gt;âž¤ Dyslipidaemia&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1606-1607&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1606-1607&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old male, who received a kidney transplant 2 years ago and has been on chronic immunosuppressive therapy, presents with multiple hyperkeratotic lesions on sun-exposed areas of the skin. Biopsy of one lesion confirms malignancy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Post-Transplant Lymphoproliferative Disorder (PTLD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squamous Cell Carcinoma of the Skin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Kaposiâ€™s Sarcoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squamous Cell Carcinoma of the Skin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Squamous Cell Carcinoma of the Skin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . PTLD refers to a range of lymphoid proliferations that can occur following transplantation due to immunosuppression . However, it does not present with hyperkeratotic skin lesions.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ range&lt;/li&gt;&lt;li&gt;â€¢ lymphoid proliferations&lt;/li&gt;&lt;li&gt;â€¢ transplantation&lt;/li&gt;&lt;li&gt;â€¢ immunosuppression&lt;/li&gt;&lt;li&gt;â€¢ Option C . Leukemia can occur in the post-transplant setting but would not present with localized skin lesions, but with pancytopenia and splenomegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ post-transplant setting&lt;/li&gt;&lt;li&gt;â€¢ Option D . Kaposiâ€™s sarcoma can occur in transplant patients but typically presents as violaceous plaques or nodules and is less common than squamous cell carcinoma in these patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ transplant patients&lt;/li&gt;&lt;li&gt;â€¢ typically presents&lt;/li&gt;&lt;li&gt;â€¢ violaceous plaques&lt;/li&gt;&lt;li&gt;â€¢ nodules&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common malignancy seen post-transplant in patients on immunosuppressive therapy is squamous cell carcinoma of the skin , often occurring on sun-exposed areas .&lt;/li&gt;&lt;li&gt;âž¤ most common malignancy&lt;/li&gt;&lt;li&gt;âž¤ post-transplant&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressive therapy&lt;/li&gt;&lt;li&gt;âž¤ squamous cell carcinoma&lt;/li&gt;&lt;li&gt;âž¤ skin&lt;/li&gt;&lt;li&gt;âž¤ sun-exposed areas&lt;/li&gt;&lt;li&gt;âž¤ Most common malignancy seen post-transplant immunosuppressive therapy is Squamous cell carcinoma of skin&lt;/li&gt;&lt;li&gt;âž¤ Squamous cell carcinoma&lt;/li&gt;&lt;li&gt;âž¤ Complications of immunosuppression:&lt;/li&gt;&lt;li&gt;âž¤ Complications of immunosuppression:&lt;/li&gt;&lt;li&gt;âž¤ Infections:&lt;/li&gt;&lt;li&gt;âž¤ Infections:&lt;/li&gt;&lt;li&gt;âž¤ 1. CMV - 4 to 8 weeks Post-Transplant - Pneumonia/Retinitis/Encephalitis&lt;/li&gt;&lt;li&gt;âž¤ 1. CMV&lt;/li&gt;&lt;li&gt;âž¤ Treatment - Valganciclovir&lt;/li&gt;&lt;li&gt;âž¤ 2. Pneumocystis jirovecii - Fungal Pneumonia&lt;/li&gt;&lt;li&gt;âž¤ 2. Pneumocystis jirovecii&lt;/li&gt;&lt;li&gt;âž¤ Malignancy: - Skin Cancers (MC- Squamous Cell Carcinoma)&lt;/li&gt;&lt;li&gt;âž¤ Malignancy: -&lt;/li&gt;&lt;li&gt;âž¤ Ref: Bailey and Love 27 th Ed. Pg 1541, Box 82.5&lt;/li&gt;&lt;li&gt;âž¤ Ref: Bailey and Love 27 th Ed. Pg 1541, Box 82.5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Maastricht grading is used to categorize?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Living Related Donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Living Unrelated Donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deceased Brain-Dead Donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deceased Circulatory Dead Donor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Deceased Circulatory Dead Donor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture1_Cev8cvf.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Deceased Circulatory Dead Donor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male with a history of a brain lesion treated with surgical resection and no evidence of metastasis is evaluated for kidney transplantation. Which of the following conditions in the patient&#x27;s history is not considered an absolute contraindication to transplant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Severe Acute Pancreatitis with Sepsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignant Melanoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prion Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary CNS Tumor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Primary CNS Tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Primary CNS Tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Severe acute pancreatitis with sepsis is typically a contraindication , until the sepsis is under control . Active systemic sepsis at the time of transplant would be an absolute contraindication .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ contraindication&lt;/li&gt;&lt;li&gt;â€¢ sepsis&lt;/li&gt;&lt;li&gt;â€¢ under control&lt;/li&gt;&lt;li&gt;â€¢ Active systemic sepsis&lt;/li&gt;&lt;li&gt;â€¢ time of transplant&lt;/li&gt;&lt;li&gt;â€¢ absolute contraindication&lt;/li&gt;&lt;li&gt;â€¢ Option B . Melanoma is an absolute contraindication to transplant . Non-melanotic skin tumors are not.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ absolute contraindication&lt;/li&gt;&lt;li&gt;â€¢ transplant&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prion disease , such as Creutzfeldt-Jakob disease , is an absolute contraindication to organ transplantation due to the high risk of transmitting the disease through transplanted tissues .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Prion disease&lt;/li&gt;&lt;li&gt;â€¢ Creutzfeldt-Jakob disease&lt;/li&gt;&lt;li&gt;â€¢ absolute contraindication&lt;/li&gt;&lt;li&gt;â€¢ organ transplantation&lt;/li&gt;&lt;li&gt;â€¢ high risk&lt;/li&gt;&lt;li&gt;â€¢ transmitting&lt;/li&gt;&lt;li&gt;â€¢ disease&lt;/li&gt;&lt;li&gt;â€¢ transplanted tissues&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary CNS tumors, particularly those that are localized and have been treated without evidence of metastasis, are not considered an absolute contraindication to organ transplantation. This is in contrast to systemic malignancies and certain untreatable or high-risk infections.&lt;/li&gt;&lt;li&gt;âž¤ localized&lt;/li&gt;&lt;li&gt;âž¤ Contraindication to organ transplant:&lt;/li&gt;&lt;li&gt;âž¤ Contraindication to organ transplant:&lt;/li&gt;&lt;li&gt;âž¤ Absolute&lt;/li&gt;&lt;li&gt;âž¤ Absolute&lt;/li&gt;&lt;li&gt;âž¤ Creutzfeldt Jacobson Disease (Prion Disease) Active Systemic Sepsis Malignancy in previous 5 years (except Primary CNS tumour, Non-Melanotic Skin Ca and CIS of uterus)&lt;/li&gt;&lt;li&gt;âž¤ Creutzfeldt Jacobson Disease (Prion Disease)&lt;/li&gt;&lt;li&gt;âž¤ Active Systemic Sepsis&lt;/li&gt;&lt;li&gt;âž¤ Malignancy in previous 5 years (except Primary CNS tumour, Non-Melanotic Skin Ca and CIS of uterus)&lt;/li&gt;&lt;li&gt;âž¤ Relative&lt;/li&gt;&lt;li&gt;âž¤ Relative&lt;/li&gt;&lt;li&gt;âž¤ As a further response to the organ donor shortage , organs are now being transplanted from donors with meningitis/encephalitis , human immunodeficiency virus (HIV) , hepatitis B and C and high-risk behaviour with the potential for blood-borne infection&lt;/li&gt;&lt;li&gt;âž¤ As a further response to the organ donor shortage , organs are now being transplanted from donors with meningitis/encephalitis , human immunodeficiency virus (HIV) , hepatitis B and C and high-risk behaviour with the potential for blood-borne infection&lt;/li&gt;&lt;li&gt;âž¤ organ donor shortage&lt;/li&gt;&lt;li&gt;âž¤ transplanted from donors&lt;/li&gt;&lt;li&gt;âž¤ meningitis/encephalitis&lt;/li&gt;&lt;li&gt;âž¤ human immunodeficiency virus (HIV)&lt;/li&gt;&lt;li&gt;âž¤ hepatitis B&lt;/li&gt;&lt;li&gt;âž¤ C&lt;/li&gt;&lt;li&gt;âž¤ high-risk behaviour&lt;/li&gt;&lt;li&gt;âž¤ potential&lt;/li&gt;&lt;li&gt;âž¤ blood-borne infection&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1596-97&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1596-97&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old type 1 diabetic with ESRD underwent simultaneous pancreatic-kidney transplant (SPK). Which of these is not a complication of bladder drainage of transplanted pancreas?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic Alkalosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chemical Cystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reflux Pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prostatic Abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Metabolic Alkalosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Metabolic Alkalosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ If transplanted pancreas is drained into bladder instead of small bowel , there is loss of bicarbonates from the pancreatic secretions , leading to metabolic acidosis .&lt;/li&gt;&lt;li&gt;â€¢ transplanted pancreas&lt;/li&gt;&lt;li&gt;â€¢ drained&lt;/li&gt;&lt;li&gt;â€¢ bladder&lt;/li&gt;&lt;li&gt;â€¢ small bowel&lt;/li&gt;&lt;li&gt;â€¢ loss of bicarbonates&lt;/li&gt;&lt;li&gt;â€¢ pancreatic secretions&lt;/li&gt;&lt;li&gt;â€¢ metabolic acidosis&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1627&lt;/li&gt;&lt;li&gt;â€¢ Ref&lt;/li&gt;&lt;li&gt;â€¢ : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1627&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with Child C Cirrhosis and Hepatitis C is undergoing a liver transplant. Which anatomical structure should the surgeon prepare to anastomose first in the recipient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatic Artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Portal Vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bile Duct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IVC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IVC&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. IVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option D : The IVC, both supra-hepatic and infra-hepatic , is usually the first part to be anastomosed during liver transplantation to establish venous outflow from the liver , which is critical to providing immediate blood drainage from the graft .&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ both supra-hepatic&lt;/li&gt;&lt;li&gt;â€¢ infra-hepatic&lt;/li&gt;&lt;li&gt;â€¢ first part&lt;/li&gt;&lt;li&gt;â€¢ anastomosed&lt;/li&gt;&lt;li&gt;â€¢ liver transplantation&lt;/li&gt;&lt;li&gt;â€¢ establish venous outflow&lt;/li&gt;&lt;li&gt;â€¢ liver&lt;/li&gt;&lt;li&gt;â€¢ critical&lt;/li&gt;&lt;li&gt;â€¢ providing immediate blood drainage&lt;/li&gt;&lt;li&gt;â€¢ graft&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ The first structure to be anastomosed in the recipient of a liver transplant is the IVC , specifically starting with the supra-hepatic IVC , followed by the infra-hepatic IVC , to establish adequate venous outflow from the liver .&lt;/li&gt;&lt;li&gt;âž¤ first structure&lt;/li&gt;&lt;li&gt;âž¤ anastomosed&lt;/li&gt;&lt;li&gt;âž¤ recipient&lt;/li&gt;&lt;li&gt;âž¤ liver transplant&lt;/li&gt;&lt;li&gt;âž¤ IVC&lt;/li&gt;&lt;li&gt;âž¤ starting&lt;/li&gt;&lt;li&gt;âž¤ supra-hepatic IVC&lt;/li&gt;&lt;li&gt;âž¤ infra-hepatic IVC&lt;/li&gt;&lt;li&gt;âž¤ establish adequate venous outflow&lt;/li&gt;&lt;li&gt;âž¤ liver&lt;/li&gt;&lt;li&gt;âž¤ Order of anastomosis in recipient of liver transplant is:&lt;/li&gt;&lt;li&gt;âž¤ anastomosis&lt;/li&gt;&lt;li&gt;âž¤ recipient&lt;/li&gt;&lt;li&gt;âž¤ liver transplant&lt;/li&gt;&lt;li&gt;âž¤ Supra-hepatic IVC Infra-hepatic IVC Portal Vein Hepatic Artery Bile duct&lt;/li&gt;&lt;li&gt;âž¤ Supra-hepatic IVC&lt;/li&gt;&lt;li&gt;âž¤ Infra-hepatic IVC&lt;/li&gt;&lt;li&gt;âž¤ Portal Vein&lt;/li&gt;&lt;li&gt;âž¤ Hepatic Artery&lt;/li&gt;&lt;li&gt;âž¤ Bile duct&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1610-1611&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey and Loveâ€™s short practice of surgery 28 th edition pg 1610-1611&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a patient with graft-versus-host disease (GVHD) following a hematopoietic stem cell transplant, which organ is least likely to affect by this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Skin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastrointestinal tract&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lung&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lung&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A . The skin is commonly affected in GVHD, presenting with rashes and can progress to desquamation .&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ commonly affected&lt;/li&gt;&lt;li&gt;â€¢ rashes&lt;/li&gt;&lt;li&gt;â€¢ desquamation&lt;/li&gt;&lt;li&gt;â€¢ Option B. The gastrointestinal tract is frequently involved in GVHD, which can manifest as diarrhea, abdominal pain , and gastrointestinal bleeding .&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ frequently involved&lt;/li&gt;&lt;li&gt;â€¢ manifest&lt;/li&gt;&lt;li&gt;â€¢ diarrhea, abdominal pain&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal bleeding&lt;/li&gt;&lt;li&gt;â€¢ Option C. The liver can be affected in GVHD, leading to elevated liver enzymes , jaundice , and cholestasis .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ affected&lt;/li&gt;&lt;li&gt;â€¢ elevated liver enzymes&lt;/li&gt;&lt;li&gt;â€¢ jaundice&lt;/li&gt;&lt;li&gt;â€¢ cholestasis&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ While any organ can be affected by graft-versus-host disease , the lung is typically the least affected organ compared to the skin, liver , and gastrointestinal tract , which are more commonly involved in acute presentations of the disease .&lt;/li&gt;&lt;li&gt;â€¢ affected&lt;/li&gt;&lt;li&gt;â€¢ graft-versus-host disease&lt;/li&gt;&lt;li&gt;â€¢ least affected organ&lt;/li&gt;&lt;li&gt;â€¢ skin, liver&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal tract&lt;/li&gt;&lt;li&gt;â€¢ commonly&lt;/li&gt;&lt;li&gt;â€¢ acute presentations&lt;/li&gt;&lt;li&gt;â€¢ disease&lt;/li&gt;&lt;li&gt;â€¢ Graft-versus-host disease (GVHD) occurs due to the presence of immunocompetent T lymphocytes in the graft attacking the immunodeficient recipient tissue due to histocompatibility differences within 100 days , causing tissue damage. Organ most affected by GVHD - Skin Organ least affected by GVHD - Lung Any organ can be affected in GVH reaction. The most important is the involvement of immune system, skin, liver and intestines.&lt;/li&gt;&lt;li&gt;â€¢ Graft-versus-host disease (GVHD) occurs due to the presence of immunocompetent T lymphocytes in the graft attacking the immunodeficient recipient tissue due to histocompatibility differences within 100 days , causing tissue damage.&lt;/li&gt;&lt;li&gt;â€¢ the presence of immunocompetent T lymphocytes in the graft attacking the immunodeficient recipient tissue due to histocompatibility differences within 100 days&lt;/li&gt;&lt;li&gt;â€¢ Organ most affected by GVHD - Skin&lt;/li&gt;&lt;li&gt;â€¢ Skin&lt;/li&gt;&lt;li&gt;â€¢ Organ least affected by GVHD - Lung&lt;/li&gt;&lt;li&gt;â€¢ Lung&lt;/li&gt;&lt;li&gt;â€¢ Any organ can be affected in GVH reaction. The most important is the involvement of immune system, skin, liver and intestines.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Online reference â€“ Bailey and Love 27 th Ed. Pg 1537 .&lt;/li&gt;&lt;li&gt;â€¢ Ref : Online reference â€“&lt;/li&gt;&lt;li&gt;â€¢ Bailey and Love 27 th Ed. Pg 1537&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of these is incorrect about liver transplant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Most common indication in a child is biliary atresia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver transplant may be done in liver malignancies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In auxiliary liver transplant, native liver is left in situ&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver is resistant to acute rejection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Liver is resistant to acute rejection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Biliary atresia is indeed the most common indication for liver transplantation in children , making this statement correct.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Biliary atresia&lt;/li&gt;&lt;li&gt;â€¢ most common indication&lt;/li&gt;&lt;li&gt;â€¢ liver transplantation&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ Option B . Liver transplantation is an established treatment for selected patients with Hepato-Cellular Carcinoma (HCC) and fulfills specific criteria such as the Milan or UCSF criteria .&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ established&lt;/li&gt;&lt;li&gt;â€¢ selected patients&lt;/li&gt;&lt;li&gt;â€¢ Hepato-Cellular Carcinoma&lt;/li&gt;&lt;li&gt;â€¢ fulfills&lt;/li&gt;&lt;li&gt;â€¢ Milan&lt;/li&gt;&lt;li&gt;â€¢ UCSF criteria&lt;/li&gt;&lt;li&gt;â€¢ Option C. In auxiliary liver transplantation, part of the native liver is left in place, and a portion of a donor liver is implanted . This procedure may be considered for certain indications, making this statement correct.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ donor liver&lt;/li&gt;&lt;li&gt;â€¢ implanted&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The liver is not resistant to acute rejection ; it is susceptible to acute rejection like any other transplanted organ, and acute cellular rejection is a common cause of graft dysfunction early after liver transplantation .&lt;/li&gt;&lt;li&gt;â€¢ not resistant&lt;/li&gt;&lt;li&gt;â€¢ acute rejection&lt;/li&gt;&lt;li&gt;â€¢ susceptible&lt;/li&gt;&lt;li&gt;â€¢ acute rejection&lt;/li&gt;&lt;li&gt;â€¢ acute cellular rejection&lt;/li&gt;&lt;li&gt;â€¢ common cause&lt;/li&gt;&lt;li&gt;â€¢ graft dysfunction&lt;/li&gt;&lt;li&gt;â€¢ after liver transplantation&lt;/li&gt;&lt;li&gt;â€¢ In adults the most common causes are alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), chronic viral hepatitis (hepatitis B virus [HBV] and hepatitis C virus [HCV]) . In the last two decades hepatitis-related CLD (HBV and HCV) was the most common indication for LT. In children, who account for around 10â€“15% of all LTs, biliary atresia is the most common indication for transplantation. LTx is indicated as a curative treatment for selected patients with HCC , haemangioendothelioma and hepatoblastoma. Milan criteria (one lesion â‰¤5 cm, or three or fewer lesions â‰¤3 cm each) UCSF criteria (one lesion â‰¤6.5 cm, or three or fewer lesions â‰¤4.5 cm each, with a total tumour diameter â‰¤8 cm) Auxiliary LT involves implanting a healthy liver graft placed either heterotopically or orthotopically while leaving all or part of the native liver intact. Auxiliary heterotopic LT, where the graft is implanted below the native liver, was proposed as an alternative to orthotopic LT. Liver graft dysfunction can happen any time after transplantation; if not identified early and treated promptly, it can lead to graft loss. The most common presentation is an asymptomatic elevation of liver enzyme levels . Early after LT, acute cellular rejection is the most common cause of graft dysfunction and is usually treated by increasing the dose of immunosuppression.&lt;/li&gt;&lt;li&gt;â€¢ In adults the most common causes are alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), chronic viral hepatitis (hepatitis B virus [HBV] and hepatitis C virus [HCV]) . In the last two decades hepatitis-related CLD (HBV and HCV) was the most common indication for LT.&lt;/li&gt;&lt;li&gt;â€¢ most common causes are alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), chronic viral hepatitis (hepatitis B virus [HBV] and hepatitis C virus [HCV])&lt;/li&gt;&lt;li&gt;â€¢ In children, who account for around 10â€“15% of all LTs, biliary atresia is the most common indication for transplantation.&lt;/li&gt;&lt;li&gt;â€¢ biliary atresia is the most common indication for transplantation.&lt;/li&gt;&lt;li&gt;â€¢ LTx is indicated as a curative treatment for selected patients with HCC , haemangioendothelioma and hepatoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ curative treatment&lt;/li&gt;&lt;li&gt;â€¢ selected patients&lt;/li&gt;&lt;li&gt;â€¢ HCC&lt;/li&gt;&lt;li&gt;â€¢ haemangioendothelioma&lt;/li&gt;&lt;li&gt;â€¢ hepatoblastoma.&lt;/li&gt;&lt;li&gt;â€¢ Milan criteria (one lesion â‰¤5 cm, or three or fewer lesions â‰¤3 cm each)&lt;/li&gt;&lt;li&gt;â€¢ Milan criteria&lt;/li&gt;&lt;li&gt;â€¢ UCSF criteria (one lesion â‰¤6.5 cm, or three or fewer lesions â‰¤4.5 cm each, with a total tumour diameter â‰¤8 cm)&lt;/li&gt;&lt;li&gt;â€¢ UCSF criteria&lt;/li&gt;&lt;li&gt;â€¢ Auxiliary LT involves implanting a healthy liver graft placed either heterotopically or orthotopically while leaving all or part of the native liver intact. Auxiliary heterotopic LT, where the graft is implanted below the native liver, was proposed as an alternative to orthotopic LT.&lt;/li&gt;&lt;li&gt;â€¢ Auxiliary LT involves implanting a healthy liver graft placed either heterotopically or orthotopically while leaving all or part of the native liver intact.&lt;/li&gt;&lt;li&gt;â€¢ Liver graft dysfunction can happen any time after transplantation; if not identified early and treated promptly, it can lead to graft loss. The most common presentation is an asymptomatic elevation of liver enzyme levels . Early after LT, acute cellular rejection is the most common cause of graft dysfunction and is usually treated by increasing the dose of immunosuppression.&lt;/li&gt;&lt;li&gt;â€¢ The most common presentation is an asymptomatic elevation of liver enzyme levels&lt;/li&gt;&lt;li&gt;â€¢ acute cellular rejection is the most common cause&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey 28 th Ed. Pg 1608, 1610, 1614, 1618.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Bailey 28 th Ed. Pg 1608, 1610, 1614, 1618.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the incorrect statement about graft rejection:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperacute Rejection occurs due to T Cell Mediated Destruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Rejection occurs during first 6 Months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic Rejection is the most common cause of Graft Failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronic Rejection is characterized by Myo-Intimal Proliferation on Biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperacute Rejection occurs due to T Cell Mediated Destruction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hyperacute Rejection occurs due to T Cell Mediated Destruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ This statement is generally accurate . Acute rejection is most common in the early post-transplant period , and it often occurs within the first few months after transplantation . However, acute rejection can occur at any time post-transplant .&lt;/li&gt;&lt;li&gt;â€¢ This statement is generally accurate . Acute rejection is most common in the early post-transplant period , and it often occurs within the first few months after transplantation . However, acute rejection can occur at any time post-transplant .&lt;/li&gt;&lt;li&gt;â€¢ accurate&lt;/li&gt;&lt;li&gt;â€¢ early post-transplant period&lt;/li&gt;&lt;li&gt;â€¢ first few months&lt;/li&gt;&lt;li&gt;â€¢ transplantation&lt;/li&gt;&lt;li&gt;â€¢ any time post-transplant&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ This statement is correct . Chronic rejection can contribute to graft failure over time. Graft failure can result from various factors, including acute rejection , infections , vascular complications , and other non-immunological factors.&lt;/li&gt;&lt;li&gt;â€¢ This statement is correct . Chronic rejection can contribute to graft failure over time. Graft failure can result from various factors, including acute rejection , infections , vascular complications , and other non-immunological factors.&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ graft failure&lt;/li&gt;&lt;li&gt;â€¢ Graft failure&lt;/li&gt;&lt;li&gt;â€¢ acute rejection&lt;/li&gt;&lt;li&gt;â€¢ infections&lt;/li&gt;&lt;li&gt;â€¢ vascular complications&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ This statement is generally accurate . Chronic rejection is associated with long-term changes , including fibrosis and myo-intimal proliferation in the blood vessels of the transplanted organ . This can be observed on biopsy as a characteristic feature of chronic rejection .&lt;/li&gt;&lt;li&gt;â€¢ This statement is generally accurate . Chronic rejection is associated with long-term changes , including fibrosis and myo-intimal proliferation in the blood vessels of the transplanted organ . This can be observed on biopsy as a characteristic feature of chronic rejection .&lt;/li&gt;&lt;li&gt;â€¢ generally accurate&lt;/li&gt;&lt;li&gt;â€¢ Chronic rejection&lt;/li&gt;&lt;li&gt;â€¢ long-term changes&lt;/li&gt;&lt;li&gt;â€¢ fibrosis&lt;/li&gt;&lt;li&gt;â€¢ myo-intimal proliferation&lt;/li&gt;&lt;li&gt;â€¢ blood vessels&lt;/li&gt;&lt;li&gt;â€¢ transplanted organ&lt;/li&gt;&lt;li&gt;â€¢ biopsy&lt;/li&gt;&lt;li&gt;â€¢ chronic rejection&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Types of Graft Rejection&lt;/li&gt;&lt;li&gt;âž¤ Types of Graft Rejection&lt;/li&gt;&lt;li&gt;âž¤ Hyperacute rejection Immediate graft destruction due to ABO or preformed anti-HLA antibodies Characterised by intravascular thrombosis and interstitial haemorrhage Acute rejection Usually occurs during first 6 months T-cell dependent May be cell mediated, antibody mediated or both Usually reversible Chronic rejection Occurs after first 6 months Most common cause of graft failure Antibodies play an important role Noe-immune factors contribute to pathogenesis Characterised by myointimal proliferation in graft arteries leading to ischaemia and fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Hyperacute rejection Immediate graft destruction due to ABO or preformed anti-HLA antibodies Characterised by intravascular thrombosis and interstitial haemorrhage&lt;/li&gt;&lt;li&gt;âž¤ Hyperacute rejection&lt;/li&gt;&lt;li&gt;âž¤ Immediate graft destruction due to ABO or preformed anti-HLA antibodies Characterised by intravascular thrombosis and interstitial haemorrhage&lt;/li&gt;&lt;li&gt;âž¤ Immediate graft destruction due to ABO or preformed anti-HLA antibodies&lt;/li&gt;&lt;li&gt;âž¤ Characterised by intravascular thrombosis and interstitial haemorrhage&lt;/li&gt;&lt;li&gt;âž¤ Acute rejection Usually occurs during first 6 months T-cell dependent May be cell mediated, antibody mediated or both Usually reversible&lt;/li&gt;&lt;li&gt;âž¤ Acute rejection&lt;/li&gt;&lt;li&gt;âž¤ Usually occurs during first 6 months T-cell dependent May be cell mediated, antibody mediated or both Usually reversible&lt;/li&gt;&lt;li&gt;âž¤ Usually occurs during first 6 months&lt;/li&gt;&lt;li&gt;âž¤ T-cell dependent&lt;/li&gt;&lt;li&gt;âž¤ May be cell mediated, antibody mediated or both&lt;/li&gt;&lt;li&gt;âž¤ Usually reversible&lt;/li&gt;&lt;li&gt;âž¤ Chronic rejection Occurs after first 6 months Most common cause of graft failure Antibodies play an important role Noe-immune factors contribute to pathogenesis Characterised by myointimal proliferation in graft arteries leading to ischaemia and fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Chronic rejection&lt;/li&gt;&lt;li&gt;âž¤ Occurs after first 6 months Most common cause of graft failure Antibodies play an important role Noe-immune factors contribute to pathogenesis Characterised by myointimal proliferation in graft arteries leading to ischaemia and fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Occurs after first 6 months&lt;/li&gt;&lt;li&gt;âž¤ Most common cause of graft failure&lt;/li&gt;&lt;li&gt;âž¤ Antibodies play an important role&lt;/li&gt;&lt;li&gt;âž¤ Noe-immune factors contribute to pathogenesis&lt;/li&gt;&lt;li&gt;âž¤ Characterised by myointimal proliferation in graft arteries leading to ischaemia and fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey 27 th Ed. PG 1535.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Bailey 27 th Ed. PG 1535.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 61 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test9" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Proteins&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Proteins&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                62 Questions | 248 Total Marks | 72 min Duration | ~69.68 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A graduate student is preparing a presentation on protein folding and the role of molecular chaperones in maintaining cellular protein homeostasis. While researching, the student encounters various facts about chaperones but realizes one of the statements they&#x27;ve noted is incorrect. Which of the following statements about chaperones is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Belong to heat shock Proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Present from bacteria to human&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ubiquitin is the most important chaperones&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Also known as Stress Proteins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ubiquitin is the most important chaperones&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Some Properties of Chaperone Proteins:&lt;/li&gt;&lt;li&gt;âž¤ Some Properties of Chaperone Proteins:&lt;/li&gt;&lt;li&gt;âž¤ Present in a wide range of species from bacteria to humans Many are heat shock proteins (Hsp) and are known as stress proteins. Some are inducible by conditions which cause unfolding of newly synthesized proteins (e.g. elevated temperature and various chemicals). They bind to predominantly hydrophobic regions of unfolded proteins thus preventing their aggregation. They act as a quality control or editing mechanism for detecting misfolded or defective proteins. Most chaperones have associated ATPase activity, with ATP or ADP being involved in the protein-chaperone interaction. Found in various cellular compartments such as cytosol, mitochondria, and the lumen of the endoplasmic reticulum.&lt;/li&gt;&lt;li&gt;âž¤ Present in a wide range of species from bacteria to humans&lt;/li&gt;&lt;li&gt;âž¤ wide range of species from bacteria to humans&lt;/li&gt;&lt;li&gt;âž¤ Many are heat shock proteins (Hsp) and are known as stress proteins.&lt;/li&gt;&lt;li&gt;âž¤ heat shock proteins (Hsp)&lt;/li&gt;&lt;li&gt;âž¤ stress proteins.&lt;/li&gt;&lt;li&gt;âž¤ Some are inducible by conditions which cause unfolding of newly synthesized proteins (e.g. elevated temperature and various chemicals).&lt;/li&gt;&lt;li&gt;âž¤ inducible&lt;/li&gt;&lt;li&gt;âž¤ unfolding of newly synthesized proteins&lt;/li&gt;&lt;li&gt;âž¤ elevated temperature&lt;/li&gt;&lt;li&gt;âž¤ They bind to predominantly hydrophobic regions of unfolded proteins thus preventing their aggregation.&lt;/li&gt;&lt;li&gt;âž¤ bind&lt;/li&gt;&lt;li&gt;âž¤ hydrophobic&lt;/li&gt;&lt;li&gt;âž¤ unfolded proteins&lt;/li&gt;&lt;li&gt;âž¤ preventing their aggregation.&lt;/li&gt;&lt;li&gt;âž¤ They act as a quality control or editing mechanism for detecting misfolded or defective proteins.&lt;/li&gt;&lt;li&gt;âž¤ act&lt;/li&gt;&lt;li&gt;âž¤ quality control&lt;/li&gt;&lt;li&gt;âž¤ editing&lt;/li&gt;&lt;li&gt;âž¤ detecting misfolded or defective proteins.&lt;/li&gt;&lt;li&gt;âž¤ Most chaperones have associated ATPase activity, with ATP or ADP being involved in the protein-chaperone interaction.&lt;/li&gt;&lt;li&gt;âž¤ Most chaperones&lt;/li&gt;&lt;li&gt;âž¤ ATPase activity, with ATP or ADP&lt;/li&gt;&lt;li&gt;âž¤ protein-chaperone interaction.&lt;/li&gt;&lt;li&gt;âž¤ Found in various cellular compartments such as cytosol, mitochondria, and the lumen of the endoplasmic reticulum.&lt;/li&gt;&lt;li&gt;âž¤ cellular compartments&lt;/li&gt;&lt;li&gt;âž¤ cytosol, mitochondria, and the lumen of the endoplasmic reticulum.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 609.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 609.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In context of protein sequencing and the identification of the N-terminal amino acid, which of the following is known as Sangerâ€™s reagent?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-Fluoro 2, 4-dinitrobenzene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-Dimethyl-aminonapthelene-5-sulfonyl chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenyl isothiocyanate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carboxypeptidase A and B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-Fluoro 2, 4-dinitrobenzene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sanger&#x27;s reagent is 1-Fluoro 2, 4-dinitro benzene (FDNB). It was developed by Frederick Sanger , a British biochemist.&lt;/li&gt;&lt;li&gt;âž¤ Sanger&#x27;s reagent&lt;/li&gt;&lt;li&gt;âž¤ 1-Fluoro 2, 4-dinitro benzene (FDNB).&lt;/li&gt;&lt;li&gt;âž¤ Frederick Sanger&lt;/li&gt;&lt;li&gt;âž¤ Sanger&#x27;s reagent reacts specifically with the free amino group of the N-terminal amino acid in a protein, forming a dinitrophenyl (DNP) derivative. After hydrolysis , the DNP-amino acid can be identified , revealing the N-terminal amino acid of the protein.&lt;/li&gt;&lt;li&gt;âž¤ reacts&lt;/li&gt;&lt;li&gt;âž¤ free amino group&lt;/li&gt;&lt;li&gt;âž¤ N-terminal amino acid&lt;/li&gt;&lt;li&gt;âž¤ dinitrophenyl (DNP)&lt;/li&gt;&lt;li&gt;âž¤ hydrolysis&lt;/li&gt;&lt;li&gt;âž¤ DNP-amino acid&lt;/li&gt;&lt;li&gt;âž¤ identified&lt;/li&gt;&lt;li&gt;âž¤ N-terminal amino acid&lt;/li&gt;&lt;li&gt;âž¤ protein.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 29&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 29&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given the focus on peptide hormones and their amino acid count, which of the following hormones, known for its regulatory role in the endocrine system, is correctly identified as a tripeptide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxytocin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vasopressin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thyrotropin releasing hormone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Angiotensin II&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thyrotropin releasing hormone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Oxytocin - Oxytocin is a nonapeptide (containing nine amino acids ) with a peptide hormone structure that plays roles in social bonding, sexual reproduction, and during and after childbirth .&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Oxytocin -&lt;/li&gt;&lt;li&gt;â€¢ nonapeptide&lt;/li&gt;&lt;li&gt;â€¢ nine amino acids&lt;/li&gt;&lt;li&gt;â€¢ peptide hormone structure&lt;/li&gt;&lt;li&gt;â€¢ social bonding, sexual reproduction,&lt;/li&gt;&lt;li&gt;â€¢ during and after childbirth&lt;/li&gt;&lt;li&gt;â€¢ Option B: Vasopressin - Also known as antidiuretic hormone (ADH), vasopressin is a nonapeptide like oxytocin , involved in water retention and vascular tone regulation .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Vasopressin -&lt;/li&gt;&lt;li&gt;â€¢ antidiuretic hormone (ADH),&lt;/li&gt;&lt;li&gt;â€¢ nonapeptide like oxytocin&lt;/li&gt;&lt;li&gt;â€¢ water retention and vascular tone regulation&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiotensin II - Angiotensin II is an octapeptide (containing eight amino acids ) involved in blood pressure regulation and fluid balance .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Angiotensin II&lt;/li&gt;&lt;li&gt;â€¢ octapeptide&lt;/li&gt;&lt;li&gt;â€¢ eight amino acids&lt;/li&gt;&lt;li&gt;â€¢ blood pressure regulation&lt;/li&gt;&lt;li&gt;â€¢ fluid balance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When 10 or a smaller number of amino acids are joined together, it is known as an oligopeptide . Few of them are biologically active .&lt;/li&gt;&lt;li&gt;âž¤ 10 or a smaller number&lt;/li&gt;&lt;li&gt;âž¤ amino acids&lt;/li&gt;&lt;li&gt;âž¤ joined&lt;/li&gt;&lt;li&gt;âž¤ oligopeptide&lt;/li&gt;&lt;li&gt;âž¤ Few&lt;/li&gt;&lt;li&gt;âž¤ biologically active&lt;/li&gt;&lt;li&gt;âž¤ Biologically important peptides:&lt;/li&gt;&lt;li&gt;âž¤ Biologically important peptides:&lt;/li&gt;&lt;li&gt;âž¤ Thyrotropin releasing hormone (TRH) is a tripeptide with the sequence of Glu-His-Pro .&lt;/li&gt;&lt;li&gt;âž¤ Thyrotropin releasing hormone&lt;/li&gt;&lt;li&gt;âž¤ tripeptide&lt;/li&gt;&lt;li&gt;âž¤ Glu-His-Pro&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 44.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p 44.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which group among the following is responsible for buffering activity of proteins at physiological pH?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sulfhydryl group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indole group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phenyl group&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Imidazole group&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Imidazole group&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture28.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Only amino acid whose pKa value (6.1) is nearby physiological pH (7.4) is Histidine ( Imidazole group ), due to which it has buffering activity at physiological pH.&lt;/li&gt;&lt;li&gt;âž¤ amino acid&lt;/li&gt;&lt;li&gt;âž¤ pKa value (6.1)&lt;/li&gt;&lt;li&gt;âž¤ physiological pH (7.4)&lt;/li&gt;&lt;li&gt;âž¤ Histidine&lt;/li&gt;&lt;li&gt;âž¤ Imidazole group&lt;/li&gt;&lt;li&gt;âž¤ buffering&lt;/li&gt;&lt;li&gt;âž¤ activity&lt;/li&gt;&lt;li&gt;âž¤ physiological pH.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 28.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 28.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following can be homologous substitution for isoleucine in a protein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspartic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Valine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture13.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Methionine - Although methionine is also nonpolar and relatively hydrophobic, it has a different side chain that includes a sulfur atom , which can affect the protein differently than valine or isoleucine.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Methionine&lt;/li&gt;&lt;li&gt;â€¢ nonpolar&lt;/li&gt;&lt;li&gt;â€¢ relatively hydrophobic,&lt;/li&gt;&lt;li&gt;â€¢ different side chain&lt;/li&gt;&lt;li&gt;â€¢ sulfur atom&lt;/li&gt;&lt;li&gt;â€¢ can&lt;/li&gt;&lt;li&gt;â€¢ protein&lt;/li&gt;&lt;li&gt;â€¢ differently&lt;/li&gt;&lt;li&gt;â€¢ valine or isoleucine.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Aspartic acid - This amino acid is polar and carries a negative charge at physiological pH , making it a non-homologous substitution for the nonpolar isoleucine.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Aspartic acid&lt;/li&gt;&lt;li&gt;â€¢ amino acid&lt;/li&gt;&lt;li&gt;â€¢ polar&lt;/li&gt;&lt;li&gt;â€¢ carries a negative charge&lt;/li&gt;&lt;li&gt;â€¢ pH&lt;/li&gt;&lt;li&gt;â€¢ non-homologous&lt;/li&gt;&lt;li&gt;â€¢ substitution&lt;/li&gt;&lt;li&gt;â€¢ nonpolar isoleucine.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Arginine - Arginine is a positively charged amino acid at physiological pH and is much larger, making it a non-homologous substitution for isoleucine.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Arginine&lt;/li&gt;&lt;li&gt;â€¢ positively charged amino&lt;/li&gt;&lt;li&gt;â€¢ acid&lt;/li&gt;&lt;li&gt;â€¢ physiological pH&lt;/li&gt;&lt;li&gt;â€¢ larger,&lt;/li&gt;&lt;li&gt;â€¢ non-homologous&lt;/li&gt;&lt;li&gt;â€¢ substitution for isoleucine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Conservative (Homologous) Substitution:&lt;/li&gt;&lt;li&gt;âž¤ Conservative (Homologous) Substitution:&lt;/li&gt;&lt;li&gt;âž¤ One amino acid replaced by another amino acid of similar characteristics Examples of homologous substitutio n is shown in the diagram given below.B&lt;/li&gt;&lt;li&gt;âž¤ One amino acid replaced by another amino acid of similar characteristics&lt;/li&gt;&lt;li&gt;âž¤ One amino acid&lt;/li&gt;&lt;li&gt;âž¤ another amino acid&lt;/li&gt;&lt;li&gt;âž¤ similar characteristics&lt;/li&gt;&lt;li&gt;âž¤ Examples of homologous substitutio n is shown in the diagram given below.B&lt;/li&gt;&lt;li&gt;âž¤ homologous substitutio&lt;/li&gt;&lt;li&gt;âž¤ given below.B&lt;/li&gt;&lt;li&gt;âž¤ Nonconservative (Nonhomologous) Substitution:&lt;/li&gt;&lt;li&gt;âž¤ Nonconservative (Nonhomologous) Substitution:&lt;/li&gt;&lt;li&gt;âž¤ One amino acid replaced by another amino acid of different characteristics&lt;/li&gt;&lt;li&gt;âž¤ One amino acid replaced by another amino acid of different characteristics&lt;/li&gt;&lt;li&gt;âž¤ One amino acid&lt;/li&gt;&lt;li&gt;âž¤ another amino acid&lt;/li&gt;&lt;li&gt;âž¤ different characteristics&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 390.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 390.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which organelle is primarily responsible for sorting proteins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Golgi Bodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitochondria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ribosomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysosomes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Golgi Bodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mitochondria: Electron transport chain, ATP generation, TCA cycle, beta oxidation of fatty acids, ketone body production, urea synthesis (part), heme synthesis (part), gluconeogenesis (part), pyrimidine synthesis (part).&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Mitochondria:&lt;/li&gt;&lt;li&gt;â€¢ Option C: Ribosomes: Biosynthesis of proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Ribosomes:&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lysosomes: Degradation of proteins, carbohydrates, lipids and nucleotides&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Lysosomes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Functions of Golgi bodies:&lt;/li&gt;&lt;li&gt;âž¤ Functions of Golgi bodies:&lt;/li&gt;&lt;li&gt;âž¤ O-Glycosylation of proteins Protein sorting Processing of oligosaccharide chains of Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ O-Glycosylation of proteins&lt;/li&gt;&lt;li&gt;âž¤ Protein sorting&lt;/li&gt;&lt;li&gt;âž¤ Processing of oligosaccharide chains of Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 608.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 608.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following amino acids, is NOT considered an essential amino acid for adults?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Isoleucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Histidine - Histidine is generally considered an essential amino acid , particularly in infants , as the body cannot synthesize it in sufficient amounts.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Histidine&lt;/li&gt;&lt;li&gt;â€¢ essential amino acid&lt;/li&gt;&lt;li&gt;â€¢ infants&lt;/li&gt;&lt;li&gt;â€¢ cannot&lt;/li&gt;&lt;li&gt;â€¢ sufficient amounts.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Isoleucine - Isoleucine is one of the branched-chain essential amino acids that must be obtained from the diet , important for muscle metabolism and immune function.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Isoleucine&lt;/li&gt;&lt;li&gt;â€¢ one of the branched-chain essential amino acids&lt;/li&gt;&lt;li&gt;â€¢ obtained&lt;/li&gt;&lt;li&gt;â€¢ diet&lt;/li&gt;&lt;li&gt;â€¢ muscle metabolism and immune function.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Arginine - Arginine is considered semi-essential or conditionally essential , meaning it is essential under certain conditions or life stages, such as infancy, pregnancy, or disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Arginine&lt;/li&gt;&lt;li&gt;â€¢ semi-essential or conditionally essential&lt;/li&gt;&lt;li&gt;â€¢ essential under&lt;/li&gt;&lt;li&gt;â€¢ infancy, pregnancy, or disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Based on Nutritional Requirements amino acids can be classified as&lt;/li&gt;&lt;li&gt;âž¤ Based on Nutritional Requirements amino acids can be classified as&lt;/li&gt;&lt;li&gt;âž¤ Essential or indispensable Partially essential or Semi-essential Non-essential or Dispensable Conditionally essential amino acids&lt;/li&gt;&lt;li&gt;âž¤ Essential or indispensable&lt;/li&gt;&lt;li&gt;âž¤ Partially essential or Semi-essential&lt;/li&gt;&lt;li&gt;âž¤ Non-essential or Dispensable&lt;/li&gt;&lt;li&gt;âž¤ Conditionally essential amino acids&lt;/li&gt;&lt;li&gt;âž¤ Essential or indispensable: Their carbon skeleton cannot be synthesized by our body and are to be taken in food for normal growth . Normal growth and optimal health will not occur, if one such amino acid is deficient in the diet .&lt;/li&gt;&lt;li&gt;âž¤ Essential or indispensable:&lt;/li&gt;&lt;li&gt;âž¤ carbon skeleton cannot&lt;/li&gt;&lt;li&gt;âž¤ our body&lt;/li&gt;&lt;li&gt;âž¤ taken in food for normal growth&lt;/li&gt;&lt;li&gt;âž¤ Normal growth and optimal health&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ one such amino acid&lt;/li&gt;&lt;li&gt;âž¤ deficient in the diet&lt;/li&gt;&lt;li&gt;âž¤ E.g: Isoleucine (option B), Leucine, Threonine, Lysine, Methionine, Phenylalanine, Tryptophan, and Valine&lt;/li&gt;&lt;li&gt;âž¤ Isoleucine (option B), Leucine, Threonine,&lt;/li&gt;&lt;li&gt;âž¤ Lysine, Methionine, Phenylalanine, Tryptophan,&lt;/li&gt;&lt;li&gt;âž¤ and Valine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 27.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 27.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about the isoelectric pH (pI) of a molecule is INCORRECT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The molecule carries no net charge&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Solubility and buffering capacity will be maximum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The buffering capacity of plasma proteins are mainly due to Histidine residue.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There is no mobility in an electric field&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Solubility and buffering capacity will be maximum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Solubility and buffering capacity will be maximum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: The molecule carries no net charge - This is correct . At the isoelectric point, the number of positive charges equals the number of negative charges , resulting in no net charge .&lt;/li&gt;&lt;li&gt;â€¢ Option A: The molecule carries no net charge -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ isoelectric&lt;/li&gt;&lt;li&gt;â€¢ positive charges equals&lt;/li&gt;&lt;li&gt;â€¢ negative charges&lt;/li&gt;&lt;li&gt;â€¢ no net charge&lt;/li&gt;&lt;li&gt;â€¢ Option C: The buffering capacity of plasma proteins is mainly due to Histidine residue - This statement is generally correct as histidine residues in proteins, such as those in plasma proteins , play a significant role in buffering due to the pKa of the histidine side chain being close to physiological pH.&lt;/li&gt;&lt;li&gt;â€¢ Option C: The buffering capacity of plasma proteins is mainly due to Histidine residue -&lt;/li&gt;&lt;li&gt;â€¢ correct&lt;/li&gt;&lt;li&gt;â€¢ histidine&lt;/li&gt;&lt;li&gt;â€¢ proteins,&lt;/li&gt;&lt;li&gt;â€¢ plasma proteins&lt;/li&gt;&lt;li&gt;â€¢ buffering&lt;/li&gt;&lt;li&gt;â€¢ pKa of the histidine side chain&lt;/li&gt;&lt;li&gt;â€¢ physiological pH.&lt;/li&gt;&lt;li&gt;â€¢ Option D: There is no mobility in an electric field - This is correct. Since the molecule has no net charge at its isoelectric point , it will not move towards either electrode in an electric field .&lt;/li&gt;&lt;li&gt;â€¢ Option D: There is no mobility in an electric field -&lt;/li&gt;&lt;li&gt;â€¢ correct.&lt;/li&gt;&lt;li&gt;â€¢ no net charge&lt;/li&gt;&lt;li&gt;â€¢ isoelectric point&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ either electrode&lt;/li&gt;&lt;li&gt;â€¢ electric field&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The pH at which the molecule carries no net charge is called an isoelectric point or isoelectric pH (pI). At an isoelectric point , the amino acid will carry no net charge, all the groups are ionized but the charges will cancel each other. Hence, at isoelectric point, there is no mobility in an electrical field. Solubility and buffering capacity will be minimum at isoelectric pH. The buffering capacity of plasma proteins and hemoglobin is mainly due to histidine residue.&lt;/li&gt;&lt;li&gt;âž¤ The pH at which the molecule carries no net charge is called an isoelectric point or isoelectric pH (pI).&lt;/li&gt;&lt;li&gt;âž¤ pH&lt;/li&gt;&lt;li&gt;âž¤ no net charge&lt;/li&gt;&lt;li&gt;âž¤ isoelectric point or isoelectric pH (pI).&lt;/li&gt;&lt;li&gt;âž¤ At an isoelectric point , the amino acid will carry no net charge, all the groups are ionized but the charges will cancel each other. Hence, at isoelectric point, there is no mobility in an electrical field.&lt;/li&gt;&lt;li&gt;âž¤ isoelectric point&lt;/li&gt;&lt;li&gt;âž¤ amino acid&lt;/li&gt;&lt;li&gt;âž¤ carry no net charge,&lt;/li&gt;&lt;li&gt;âž¤ ionized&lt;/li&gt;&lt;li&gt;âž¤ at isoelectric point,&lt;/li&gt;&lt;li&gt;âž¤ no mobility in an electrical field.&lt;/li&gt;&lt;li&gt;âž¤ Solubility and buffering capacity will be minimum at isoelectric pH.&lt;/li&gt;&lt;li&gt;âž¤ Solubility and buffering capacity&lt;/li&gt;&lt;li&gt;âž¤ minimum&lt;/li&gt;&lt;li&gt;âž¤ isoelectric pH.&lt;/li&gt;&lt;li&gt;âž¤ The buffering capacity of plasma proteins and hemoglobin is mainly due to histidine residue.&lt;/li&gt;&lt;li&gt;âž¤ buffering capacity&lt;/li&gt;&lt;li&gt;âž¤ plasma proteins and hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ histidine residue.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 20.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 20.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is utilizing different analytical techniques to study protein structures. Each method has a specific utility in the determination of primary, secondary, tertiary, or quaternary structures of proteins. Among the listed techniques, which one does NOT directly determine the structure of proteins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High performance liquid chromatography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mass spectrometry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;X-ray crystallography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NMR spectrometry&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. High performance liquid chromatography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Mass spectrometry can determine the primary structure (sequence of amino acids) of proteins and post-translational modifications.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Mass spectrometry&lt;/li&gt;&lt;li&gt;â€¢ primary structure&lt;/li&gt;&lt;li&gt;â€¢ amino acids)&lt;/li&gt;&lt;li&gt;â€¢ proteins&lt;/li&gt;&lt;li&gt;â€¢ post-translational&lt;/li&gt;&lt;li&gt;â€¢ modifications.&lt;/li&gt;&lt;li&gt;â€¢ Option C: X-ray crystallography is used to determine the three-dimensional structure of a protein at atomic resolution.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ X-ray crystallography&lt;/li&gt;&lt;li&gt;â€¢ used to&lt;/li&gt;&lt;li&gt;â€¢ three-dimensional structure of a protein&lt;/li&gt;&lt;li&gt;â€¢ atomic resolution.&lt;/li&gt;&lt;li&gt;â€¢ Option D: NMR spectrometry can provide detailed information about the structure and dynamics of proteins , particularly in solution.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ NMR spectrometry&lt;/li&gt;&lt;li&gt;â€¢ information&lt;/li&gt;&lt;li&gt;â€¢ structure and dynamics of proteins&lt;/li&gt;&lt;li&gt;â€¢ solution.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Methods for Separating and Purifying Biomolecules&lt;/li&gt;&lt;li&gt;âž¤ Methods for Separating and Purifying Biomolecules&lt;/li&gt;&lt;li&gt;âž¤ Salt fractionation (e.g., precipitation of proteins with ammonium sulfate ) Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration Electrophoresis : Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel Ultracentrifugation&lt;/li&gt;&lt;li&gt;âž¤ Salt fractionation (e.g., precipitation of proteins with ammonium sulfate )&lt;/li&gt;&lt;li&gt;âž¤ Salt fractionation&lt;/li&gt;&lt;li&gt;âž¤ precipitation of proteins&lt;/li&gt;&lt;li&gt;âž¤ ammonium sulfate&lt;/li&gt;&lt;li&gt;âž¤ Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration&lt;/li&gt;&lt;li&gt;âž¤ Chromatography: Paper, ion exchange, affinity, thin-layer, gas-liquid, high-pressure liquid, gel filtration&lt;/li&gt;&lt;li&gt;âž¤ Electrophoresis : Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel&lt;/li&gt;&lt;li&gt;âž¤ Electrophoresis&lt;/li&gt;&lt;li&gt;âž¤ Paper, high-voltage, agarose, cellulose acetate, starch gel, polyacrylamide gel, SDS-polyacrylamide gel&lt;/li&gt;&lt;li&gt;âž¤ Ultracentrifugation&lt;/li&gt;&lt;li&gt;âž¤ Ultracentrifugation&lt;/li&gt;&lt;li&gt;âž¤ Methods for Determining Biomolecular Structures&lt;/li&gt;&lt;li&gt;âž¤ Methods for Determining Biomolecular Structures&lt;/li&gt;&lt;li&gt;âž¤ Elemental analysis UV, visible, infrared, and NMR spectroscopy Use of acid or alkaline hydrolysis to degrade the biomolecule understudy into its basic constituents Use of a battery of enzymes of known specificity to degrade the biomolecule under study (e.g., proteases, nucleases, glycosidases ) Mass spectrometry Specific sequencing methods (e.g., for proteins and nucleic acids ) X-ray crystallography&lt;/li&gt;&lt;li&gt;âž¤ Elemental analysis&lt;/li&gt;&lt;li&gt;âž¤ Elemental analysis&lt;/li&gt;&lt;li&gt;âž¤ UV, visible, infrared, and NMR spectroscopy&lt;/li&gt;&lt;li&gt;âž¤ UV, visible, infrared, and NMR spectroscopy&lt;/li&gt;&lt;li&gt;âž¤ Use of acid or alkaline hydrolysis to degrade the biomolecule understudy into its basic constituents&lt;/li&gt;&lt;li&gt;âž¤ acid or alkaline&lt;/li&gt;&lt;li&gt;âž¤ hydrolysis&lt;/li&gt;&lt;li&gt;âž¤ degrade&lt;/li&gt;&lt;li&gt;âž¤ basic constituents&lt;/li&gt;&lt;li&gt;âž¤ Use of a battery of enzymes of known specificity to degrade the biomolecule under study (e.g., proteases, nucleases, glycosidases )&lt;/li&gt;&lt;li&gt;âž¤ Use of a battery&lt;/li&gt;&lt;li&gt;âž¤ enzymes&lt;/li&gt;&lt;li&gt;âž¤ specificity&lt;/li&gt;&lt;li&gt;âž¤ degrade the biomolecule&lt;/li&gt;&lt;li&gt;âž¤ proteases, nucleases,&lt;/li&gt;&lt;li&gt;âž¤ glycosidases&lt;/li&gt;&lt;li&gt;âž¤ Mass spectrometry&lt;/li&gt;&lt;li&gt;âž¤ Mass spectrometry&lt;/li&gt;&lt;li&gt;âž¤ Specific sequencing methods (e.g., for proteins and nucleic acids )&lt;/li&gt;&lt;li&gt;âž¤ Specific sequencing methods&lt;/li&gt;&lt;li&gt;âž¤ proteins and nucleic acids&lt;/li&gt;&lt;li&gt;âž¤ X-ray crystallography&lt;/li&gt;&lt;li&gt;âž¤ X-ray crystallography&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 29/e: p 2, Vasudevan 9/e: p 45.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 29/e: p 2, Vasudevan 9/e: p 45.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Is the statement \&quot;Calreticulin is considered a chaperone protein\&quot; correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insufficient Information&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Molecular Chaperones are&lt;/li&gt;&lt;li&gt;âž¤ Molecular Chaperones are&lt;/li&gt;&lt;li&gt;âž¤ HSP 70 HSP 90 HSP 40 [ Cochaperone ] BiP [ Immunoglobulin heavy chain binding protein ] Glucose Regulated Protein [GRP-94] Calreticulin Calnexin.&lt;/li&gt;&lt;li&gt;âž¤ HSP 70&lt;/li&gt;&lt;li&gt;âž¤ HSP 90&lt;/li&gt;&lt;li&gt;âž¤ HSP 40 [ Cochaperone ]&lt;/li&gt;&lt;li&gt;âž¤ Cochaperone&lt;/li&gt;&lt;li&gt;âž¤ BiP [ Immunoglobulin heavy chain binding protein ]&lt;/li&gt;&lt;li&gt;âž¤ BiP&lt;/li&gt;&lt;li&gt;âž¤ Immunoglobulin&lt;/li&gt;&lt;li&gt;âž¤ binding protein&lt;/li&gt;&lt;li&gt;âž¤ Glucose Regulated Protein [GRP-94]&lt;/li&gt;&lt;li&gt;âž¤ Glucose Regulated Protein&lt;/li&gt;&lt;li&gt;âž¤ Calreticulin&lt;/li&gt;&lt;li&gt;âž¤ Calreticulin&lt;/li&gt;&lt;li&gt;âž¤ Calnexin.&lt;/li&gt;&lt;li&gt;âž¤ Calnexin.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 608-610.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 608-610.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Given the potential for certain amino acids to disrupt alpha-helical structures due to their properties, which of the following amino acids, if introduced by a missense mutation, is most likely to disrupt the alpha-helical conformation within the protein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspartic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glycine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proline canbe stably accommodated within the first turn of an Î±-helix . If present elsewhere, proline disrupts the conformation of the helix, thereby producing a bend . Because it possesses a small R group , glycine also induces bends within Î± helices frequently.&lt;/li&gt;&lt;li&gt;âž¤ Proline canbe stably accommodated within the first turn of an Î±-helix .&lt;/li&gt;&lt;li&gt;âž¤ Proline&lt;/li&gt;&lt;li&gt;âž¤ stably&lt;/li&gt;&lt;li&gt;âž¤ first turn of an Î±-helix&lt;/li&gt;&lt;li&gt;âž¤ If present elsewhere, proline disrupts the conformation of the helix, thereby producing a bend . Because it possesses a small R group , glycine also induces bends within Î± helices frequently.&lt;/li&gt;&lt;li&gt;âž¤ proline disrupts&lt;/li&gt;&lt;li&gt;âž¤ helix,&lt;/li&gt;&lt;li&gt;âž¤ bend&lt;/li&gt;&lt;li&gt;âž¤ a small R group&lt;/li&gt;&lt;li&gt;âž¤ glycine&lt;/li&gt;&lt;li&gt;âž¤ bends&lt;/li&gt;&lt;li&gt;âž¤ Î± helices frequently.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 37, 38&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 37, 38&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following color reactions is most likely used to confirm the presence of tyrosine in the protein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aldehyde test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Millonâ€™s test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ninhydrin test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biuret test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Millonâ€™s test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The phenol group of phenylalanine and tyrosine containing proteins, when heated with mercuric sulfate in sulphuric acid and sodium nitrite form red coloured mercury phenolate.&lt;/li&gt;&lt;li&gt;âž¤ The phenol group of phenylalanine and tyrosine containing proteins, when heated with mercuric sulfate in sulphuric acid and sodium nitrite form red coloured mercury phenolate.&lt;/li&gt;&lt;li&gt;âž¤ phenylalanine and tyrosine&lt;/li&gt;&lt;li&gt;âž¤ heated with mercuric sulfate&lt;/li&gt;&lt;li&gt;âž¤ sulphuric acid and sodium nitrite&lt;/li&gt;&lt;li&gt;âž¤ red coloured mercury phenolate.&lt;/li&gt;&lt;li&gt;âž¤ Done by Millon, 1812â€“1867. Chloride interferes with this reaction&lt;/li&gt;&lt;li&gt;âž¤ Done by Millon, 1812â€“1867.&lt;/li&gt;&lt;li&gt;âž¤ Millon, 1812â€“1867.&lt;/li&gt;&lt;li&gt;âž¤ Chloride interferes with this reaction&lt;/li&gt;&lt;li&gt;âž¤ Chloride&lt;/li&gt;&lt;li&gt;âž¤ reaction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 31.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p 31.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about creatinine is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycine, arginine, histidine are the amino acids required for synthesis of creatinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Creatinine is an anhydride product of guanidinoacetate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatinine is a product of enzymatic reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levels of CK are elevated in myocardial infarction&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Levels of CK are elevated in myocardial infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glycine, arginine and methionine are the amino acids required for synthesis of creatinine.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Glycine, arginine&lt;/li&gt;&lt;li&gt;â€¢ methionine&lt;/li&gt;&lt;li&gt;â€¢ synthesis of creatinine.&lt;/li&gt;&lt;li&gt;â€¢ Option B: The creatine phosphate is converted to its anhydride , creatinine&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ creatine phosphate&lt;/li&gt;&lt;li&gt;â€¢ converted&lt;/li&gt;&lt;li&gt;â€¢ anhydride&lt;/li&gt;&lt;li&gt;â€¢ creatinine&lt;/li&gt;&lt;li&gt;â€¢ Option C: Creatinine is the product of Non-Enzymatic spontaneous reaction .&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Creatinine&lt;/li&gt;&lt;li&gt;â€¢ Non-Enzymatic spontaneous reaction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Creatinine is a waste product derived from creatine , which is involved in energy storage in muscle cells . Creatine kinase (CK) is an enzyme that catalyzes the conversion of creatine and uses adenosine triphosphate (ATP) to create phosphocreatine (PCr) in muscle cells .&lt;/li&gt;&lt;li&gt;âž¤ Creatinine&lt;/li&gt;&lt;li&gt;âž¤ waste product&lt;/li&gt;&lt;li&gt;âž¤ creatine&lt;/li&gt;&lt;li&gt;âž¤ energy storage in muscle cells&lt;/li&gt;&lt;li&gt;âž¤ Creatine kinase (CK)&lt;/li&gt;&lt;li&gt;âž¤ catalyzes the conversion of creatine&lt;/li&gt;&lt;li&gt;âž¤ adenosine triphosphate&lt;/li&gt;&lt;li&gt;âž¤ phosphocreatine&lt;/li&gt;&lt;li&gt;âž¤ muscle cells&lt;/li&gt;&lt;li&gt;âž¤ Elevated CK levels are indeed a marker of muscle damage , including myocardial infarction .&lt;/li&gt;&lt;li&gt;âž¤ Elevated CK&lt;/li&gt;&lt;li&gt;âž¤ marker of muscle damage&lt;/li&gt;&lt;li&gt;âž¤ myocardial infarction&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 211.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p 211.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-months-old male infant presents with seizures, hypotonia, retardation of psychomotor functions and poor head control. Blood investigations show lactic acidosis and highly elevated plasma pyruvate levels, which are several times higher than the normal level. When the Pyruvate carboxylase activity was measured using the fibroblasts extracts, it is less than 1 percent of the normal level. Administration of which of the following amino acids would be the best therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glutamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Deficiency in pyruvate carboxylase leads to diminution of oxaloacetate , a C4 acid which acts as an acceptor for the acetyl group from acetyl-CoA . For the TCA cycle to function efficiently, C4 acids must be replenished by feeding the TCA with carbon skeletons of amino acids. Glutamine â†’ converted to alpha-ketoglutarate â†’ increase in all of C4 acids ( succinate, fumarate, malate, and oxaloacetate ).&lt;/li&gt;&lt;li&gt;âž¤ Deficiency in pyruvate carboxylase leads to diminution of oxaloacetate , a C4 acid which acts as an acceptor for the acetyl group from acetyl-CoA .&lt;/li&gt;&lt;li&gt;âž¤ Deficiency in pyruvate carboxylase&lt;/li&gt;&lt;li&gt;âž¤ diminution&lt;/li&gt;&lt;li&gt;âž¤ oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ C4 acid&lt;/li&gt;&lt;li&gt;âž¤ acceptor&lt;/li&gt;&lt;li&gt;âž¤ acetyl group from acetyl-CoA&lt;/li&gt;&lt;li&gt;âž¤ For the TCA cycle to function efficiently, C4 acids must be replenished by feeding the TCA with carbon skeletons of amino acids.&lt;/li&gt;&lt;li&gt;âž¤ TCA cycle&lt;/li&gt;&lt;li&gt;âž¤ function efficiently,&lt;/li&gt;&lt;li&gt;âž¤ C4 acids&lt;/li&gt;&lt;li&gt;âž¤ replenished by&lt;/li&gt;&lt;li&gt;âž¤ TCA with carbon skeletons&lt;/li&gt;&lt;li&gt;âž¤ amino acids.&lt;/li&gt;&lt;li&gt;âž¤ Glutamine â†’ converted to alpha-ketoglutarate â†’ increase in all of C4 acids ( succinate, fumarate, malate, and oxaloacetate ).&lt;/li&gt;&lt;li&gt;âž¤ Glutamine&lt;/li&gt;&lt;li&gt;âž¤ alpha-ketoglutarate&lt;/li&gt;&lt;li&gt;âž¤ increase&lt;/li&gt;&lt;li&gt;âž¤ C4&lt;/li&gt;&lt;li&gt;âž¤ acids&lt;/li&gt;&lt;li&gt;âž¤ succinate, fumarate, malate, and oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 164,165,188.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 164,165,188.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A researcher is analyzing the titration curve of a nonpolar amino acid as shown in the graph with points labeled A to D. Which of the following statements correctly interprets the designated regions on the curve?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Point A represents the region where the amino acid is deprotonated.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Point B represents a region of minimal buffering.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Point C represents the region where the net charge on the amino acid is zero.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Point D represents the pKa of the amino acid carboxyl group.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Point C represents the region where the net charge on the amino acid is zero.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Point A represents the region where the amino acid is deprotonated: The amino acid is fully protonated at Point A due to low pH and abundance of protons in the solvent.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Point A represents the region where the amino acid is deprotonated:&lt;/li&gt;&lt;li&gt;â€¢ amino acid&lt;/li&gt;&lt;li&gt;â€¢ fully protonated&lt;/li&gt;&lt;li&gt;â€¢ Point A&lt;/li&gt;&lt;li&gt;â€¢ low pH&lt;/li&gt;&lt;li&gt;â€¢ abundance of protons&lt;/li&gt;&lt;li&gt;â€¢ Option B: Point B represents a region of minimal buffering &amp;amp; Option D Point D represents the pK of the amino acid carboxyl group: Point B represents a region of maximum buffering , as does Point D which is the pKa of amino group.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Point B represents a region of minimal buffering &amp;amp; Option D Point D represents the pK of the amino acid carboxyl group:&lt;/li&gt;&lt;li&gt;â€¢ Point B&lt;/li&gt;&lt;li&gt;â€¢ maximum buffering&lt;/li&gt;&lt;li&gt;â€¢ Point D&lt;/li&gt;&lt;li&gt;â€¢ pKa of amino group.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ The amino acid could be lysine . C represents the isoelectric point , or pI, and as such is midway between pK1 and pK2 for a nonpolar amino acid . Lysine is a basic amino acid and has an ionizable side chain .&lt;/li&gt;&lt;li&gt;â€¢ The amino acid could be lysine . C represents the isoelectric point , or pI, and as such is midway between pK1 and pK2 for a nonpolar amino acid .&lt;/li&gt;&lt;li&gt;â€¢ amino acid&lt;/li&gt;&lt;li&gt;â€¢ lysine&lt;/li&gt;&lt;li&gt;â€¢ C represents the isoelectric point&lt;/li&gt;&lt;li&gt;â€¢ pI,&lt;/li&gt;&lt;li&gt;â€¢ pK1 and pK2 for a nonpolar amino acid&lt;/li&gt;&lt;li&gt;â€¢ Lysine is a basic amino acid and has an ionizable side chain .&lt;/li&gt;&lt;li&gt;â€¢ Lysine&lt;/li&gt;&lt;li&gt;â€¢ basic amino acid&lt;/li&gt;&lt;li&gt;â€¢ ionizable side chain&lt;/li&gt;&lt;li&gt;â€¢ Ref : Lippincott 7/e: p 6-9.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Lippincott 7/e: p 6-9.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has a point mutation at a specific site which results in disruption of the Î±-helical structure in a segment of the resultant mutant protein. The most likely change that can occur in the primary structure of the mutant protein is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutamate to aspartate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine to arginine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methionine to proline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valine to alanine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Methionine to proline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proline is known as a helix breaker because its cyclic structure creates a fixed kink that can disrupt the Î±-helix&#x27;s regular geometry . A substitution of methionine to proline in a protein&#x27;s primary structure is likely to disrupt an Î±-helical segment .&lt;/li&gt;&lt;li&gt;âž¤ Proline&lt;/li&gt;&lt;li&gt;âž¤ helix breaker&lt;/li&gt;&lt;li&gt;âž¤ cyclic structure&lt;/li&gt;&lt;li&gt;âž¤ fixed kink&lt;/li&gt;&lt;li&gt;âž¤ disrupt the Î±-helix&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ geometry&lt;/li&gt;&lt;li&gt;âž¤ methionine to proline&lt;/li&gt;&lt;li&gt;âž¤ primary structure&lt;/li&gt;&lt;li&gt;âž¤ disrupt an Î±-helical segment&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 38.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 38.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonatologist is assessing the nutritional content of various infant formulas to ensure they meet the requirements for normal growth and development of newborns. Essential amino acids, which must be sourced from the diet, are a critical component of these formulas. The neonatologist is considering an amino acid that, while beneficial, is not classified as essential and can be synthesized by the body. Which amino acid mentioned is not essential to be present in infant formula for the normal growth and development of a newborn?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alanine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tryptophan - Essential amino acid required from the diet for protein synthesis and other metabolic functions.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Tryptophan&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lysine - An essential amino acid that must be obtained through diet for proper growth and tissue repair.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Lysine&lt;/li&gt;&lt;li&gt;â€¢ Option D: Leucine - An essential branched-chain amino acid important for protein synthesis and many other metabolic functions.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Leucine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Essential Amino acids: Met, Arg, Trp, Thr, Val, Ile, Leu, Lys, Phe.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 282.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 282.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biochemist is optimizing a protein assay by enhancing the protein&#x27;s absorbance at 280 nm for better detection and quantification. The protein contains alanine, which does not contribute significantly to absorbance at this wavelength. The scientist is considering substituting alanine with another amino acid that naturally exhibits strong absorbance at 280 nm, which would increase the overall absorbance of the protein at this wavelength. Replacing alanine with which amino acid will increase the protein&#x27;s absorbance at 280 nm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Guanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tryptophan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amino Acids which absorb 250â€“290 nm ( Maximum at 280 nm ) UV light are tryptophan, phenylalanine, and tyrosine . Maximum absorption of UV light is by Tryptophan.&lt;/li&gt;&lt;li&gt;âž¤ Amino Acids which absorb 250â€“290 nm ( Maximum at 280 nm ) UV light are tryptophan, phenylalanine, and tyrosine .&lt;/li&gt;&lt;li&gt;âž¤ Amino Acids&lt;/li&gt;&lt;li&gt;âž¤ absorb 250â€“290 nm&lt;/li&gt;&lt;li&gt;âž¤ Maximum at 280 nm&lt;/li&gt;&lt;li&gt;âž¤ UV&lt;/li&gt;&lt;li&gt;âž¤ tryptophan, phenylalanine, and tyrosine&lt;/li&gt;&lt;li&gt;âž¤ Maximum absorption of UV light is by Tryptophan.&lt;/li&gt;&lt;li&gt;âž¤ Maximum absorption&lt;/li&gt;&lt;li&gt;âž¤ UV light&lt;/li&gt;&lt;li&gt;âž¤ Tryptophan.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e p 21, 22.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e p 21, 22.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which amino acid is the precursor for the synthesis of nitric oxide (NO)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arginine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alanine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glycine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Arginine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture10.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alanine - Alanine is not involved in the synthesis of nitric oxide .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Alanine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ synthesis of nitric oxide&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glycine - Glycine is also not a precursor for NO production.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Glycine&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ NO production.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lysine - Lysine does not participate in the biosynthesis of NO .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Lysine&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ biosynthesis of NO&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nitric oxide (NO) is synthesized from the amino acid arginine . The enzyme nitric oxide synthase (NOS) catalyzes the conversion of arginine to NO and citrulline. This reaction is fundamental in various physiological processes , including vasodilation , neurotransmission, and immune response .&lt;/li&gt;&lt;li&gt;âž¤ Nitric oxide (NO)&lt;/li&gt;&lt;li&gt;âž¤ synthesized&lt;/li&gt;&lt;li&gt;âž¤ amino acid arginine&lt;/li&gt;&lt;li&gt;âž¤ nitric oxide synthase (NOS)&lt;/li&gt;&lt;li&gt;âž¤ arginine to NO and citrulline.&lt;/li&gt;&lt;li&gt;âž¤ reaction&lt;/li&gt;&lt;li&gt;âž¤ physiological processes&lt;/li&gt;&lt;li&gt;âž¤ vasodilation&lt;/li&gt;&lt;li&gt;âž¤ neurotransmission, and immune response&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 227.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p 227.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which amino acid can be converted into an intermediate that plays a role in both the citric acid cycle and the urea cycle?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tyrosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspartate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Aspartate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aspartate can be converted to oxaloacetate , which is an intermediate in the citric acid cycle . Furthermore, aspartate is involved in the urea cycle , where it donates an amino group for the synthesis of arginine , which is then cleaved to form urea and ornithine. This connection highlights aspartate&#x27;s role in both energy production and nitrogen disposal .&lt;/li&gt;&lt;li&gt;âž¤ Aspartate&lt;/li&gt;&lt;li&gt;âž¤ converted to oxaloacetate&lt;/li&gt;&lt;li&gt;âž¤ intermediate&lt;/li&gt;&lt;li&gt;âž¤ citric acid cycle&lt;/li&gt;&lt;li&gt;âž¤ urea cycle&lt;/li&gt;&lt;li&gt;âž¤ donates an amino group&lt;/li&gt;&lt;li&gt;âž¤ synthesis of arginine&lt;/li&gt;&lt;li&gt;âž¤ cleaved&lt;/li&gt;&lt;li&gt;âž¤ urea and ornithine.&lt;/li&gt;&lt;li&gt;âž¤ aspartate&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ both energy production&lt;/li&gt;&lt;li&gt;âž¤ nitrogen disposal&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 203, 247.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e p 203, 247.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Pick out the TRUE statement about the given Image:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is an Affinity Chromatography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Separation is based on electrostatic attraction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Only resin used is cation exchange resins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cation exchange resins have a quaternary nitrogen (N+)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Separation is based on electrostatic attraction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture11.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Separation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The principles of ion exchange chromatography , where separation of molecules is based on their charge by using a resin that has the opposite charge , facilitating the separation based on their electrostatic interactions.&lt;/li&gt;&lt;li&gt;âž¤ principles of ion exchange chromatography&lt;/li&gt;&lt;li&gt;âž¤ separation of molecules&lt;/li&gt;&lt;li&gt;âž¤ their charge&lt;/li&gt;&lt;li&gt;âž¤ resin&lt;/li&gt;&lt;li&gt;âž¤ opposite charge&lt;/li&gt;&lt;li&gt;âž¤ facilitating&lt;/li&gt;&lt;li&gt;âž¤ electrostatic interactions.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 451.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 451.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a transport protein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transferrin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Collagen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceruloplasmin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemopexin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Collagen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture14.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture16.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PLASMA PROTEINS IN TRANSPORT FUNCTION&lt;/li&gt;&lt;li&gt;âž¤ PLASMA PROTEINS IN TRANSPORT FUNCTION&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 672.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 672.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which condition does NOT typically result in the precipitation of proteins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adding alcohol and acetone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;pH changes other than isoelectric pH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;With Trichloroacetic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;With heavy metals&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. pH changes other than isoelectric pH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Adding alcohol and acetone - These solvents can dehydrate proteins and disrupt hydrophobic interactions, leading to precipitation.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Adding alcohol and acetone&lt;/li&gt;&lt;li&gt;â€¢ dehydrate proteins&lt;/li&gt;&lt;li&gt;â€¢ disrupt hydrophobic interactions,&lt;/li&gt;&lt;li&gt;â€¢ precipitation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: With Trichloroacetic acid - TCA precipitates proteins by disrupting their hydration shell and altering their solubility.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ With Trichloroacetic acid&lt;/li&gt;&lt;li&gt;â€¢ TCA precipitates proteins&lt;/li&gt;&lt;li&gt;â€¢ disrupting their hydration shell&lt;/li&gt;&lt;li&gt;â€¢ altering their solubility.&lt;/li&gt;&lt;li&gt;â€¢ Option D: With heavy metals - Heavy metals can form insoluble complexes with proteins , leading to precipitation.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ With heavy metals&lt;/li&gt;&lt;li&gt;â€¢ insoluble complexes&lt;/li&gt;&lt;li&gt;â€¢ proteins&lt;/li&gt;&lt;li&gt;â€¢ precipitation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Proteins generally precipitate at their isoelectric pH , where they carry no net charge and thus have the lowest solubility in water. Changing the pH away from the isoelectric point will usually increase the protein&#x27;s net charge , enhancing its solubility and decreasing the likelihood of precipitation.&lt;/li&gt;&lt;li&gt;âž¤ Proteins&lt;/li&gt;&lt;li&gt;âž¤ precipitate&lt;/li&gt;&lt;li&gt;âž¤ isoelectric pH&lt;/li&gt;&lt;li&gt;âž¤ carry no net charge&lt;/li&gt;&lt;li&gt;âž¤ lowest solubility in water.&lt;/li&gt;&lt;li&gt;âž¤ Changing&lt;/li&gt;&lt;li&gt;âž¤ pH&lt;/li&gt;&lt;li&gt;âž¤ isoelectric point&lt;/li&gt;&lt;li&gt;âž¤ increase the protein&#x27;s net charge&lt;/li&gt;&lt;li&gt;âž¤ enhancing its solubility&lt;/li&gt;&lt;li&gt;âž¤ decreasing&lt;/li&gt;&lt;li&gt;âž¤ precipitation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 42.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 42.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research group is investigating various diseases characterized by abnormal protein folding, which can lead to the accumulation of misfolded proteins and associated pathologies. They are reviewing a list of conditions to include in their study but recognize that one of the diseases is not primarily caused by protein misfolding. Which disease does not fit the criteria of a protein misfolding disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prion Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ehlers-Danlos Syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ehlers-Danlos Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)Â Ehlers-Danlos Syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Protein misfolding underlies several neurodegenerative and systemic diseases, including Prion diseases, Alzheimerâ€™s, Huntingtonâ€™s, and amyloidoses . In contrast, Ehlers-Danlos Syndrome is due to structural or synthetic defects in collagen, not misfolding. Distinguishing between these categories is important for understanding disease mechanisms.&lt;/li&gt;&lt;li&gt;âž¤ Prion diseases, Alzheimerâ€™s, Huntingtonâ€™s, and amyloidoses&lt;/li&gt;&lt;li&gt;âž¤ Ehlers-Danlos Syndrome&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 45, 46, 618.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following groups of proteins assist in the folding of other proteins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proteases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proteasomes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Templates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chaperones&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chaperones&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Proteases: The enzyme which hydrolyses the peptide bond.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Proteases:&lt;/li&gt;&lt;li&gt;â€¢ hydrolyses the peptide bond.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Proteasomes: Consists of a macromolecular cylindrical complex of proteins that has a central pore that harbours the active sites of proteolytic enzymes , helps in degradation of proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Proteasomes:&lt;/li&gt;&lt;li&gt;â€¢ macromolecular cylindrical complex of proteins&lt;/li&gt;&lt;li&gt;â€¢ central pore&lt;/li&gt;&lt;li&gt;â€¢ active sites&lt;/li&gt;&lt;li&gt;â€¢ proteolytic enzymes&lt;/li&gt;&lt;li&gt;â€¢ degradation of proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Templates: In DNA replication , each strand serves as a template or mold, over which a new complementary strand is synthesized.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Templates:&lt;/li&gt;&lt;li&gt;â€¢ DNA replication&lt;/li&gt;&lt;li&gt;â€¢ template or mold,&lt;/li&gt;&lt;li&gt;â€¢ complementary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Molecular Chaperones are:&lt;/li&gt;&lt;li&gt;âž¤ Molecular Chaperones are:&lt;/li&gt;&lt;li&gt;âž¤ Hsp 70 Hsp 90 Hsp 40 [Cochaperone] BiP [Immunoglobulin heavy chain binding protein] Glucose Regulated Protein [GRP-94] Calreticulin Calnexin.&lt;/li&gt;&lt;li&gt;âž¤ Hsp 70&lt;/li&gt;&lt;li&gt;âž¤ Hsp 90&lt;/li&gt;&lt;li&gt;âž¤ Hsp 40 [Cochaperone]&lt;/li&gt;&lt;li&gt;âž¤ BiP [Immunoglobulin heavy chain binding protein]&lt;/li&gt;&lt;li&gt;âž¤ Glucose Regulated Protein [GRP-94]&lt;/li&gt;&lt;li&gt;âž¤ Calreticulin&lt;/li&gt;&lt;li&gt;âž¤ Calnexin.&lt;/li&gt;&lt;li&gt;âž¤ Enzymes assist folding are&lt;/li&gt;&lt;li&gt;âž¤ Enzymes assist folding are&lt;/li&gt;&lt;li&gt;âž¤ Protein Disulphide Isomerase Peptidyl prolyl isomerase&lt;/li&gt;&lt;li&gt;âž¤ Protein Disulphide Isomerase&lt;/li&gt;&lt;li&gt;âž¤ Peptidyl prolyl isomerase&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 609.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 609.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which amino acid can have an O-glycosylation linkage in an oligosaccharide molecule?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asparagine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucosamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cysteine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Asparagine - Typically involved in N-glycosylation , not O-glycosylation.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Asparagine&lt;/li&gt;&lt;li&gt;â€¢ N-glycosylation&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glucosamine - A monosaccharid e, not an amino acid , involved in the construction of glycoproteins and glycolipids.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Glucosamine&lt;/li&gt;&lt;li&gt;â€¢ monosaccharid&lt;/li&gt;&lt;li&gt;â€¢ not an amino acid&lt;/li&gt;&lt;li&gt;â€¢ glycoproteins and glycolipids.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cysteine - Contains a thiol (-SH) group, which is not a common site for glycosylation.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Cysteine&lt;/li&gt;&lt;li&gt;â€¢ thiol (-SH) group,&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ glycosylation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Major Classes of Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Major Classes of Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ O-linked Glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ O-linked Glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ O-glycosidic linkage between hydroxyl side chain of serine or threonine and N-acetyl galactosamine is present&lt;/li&gt;&lt;li&gt;âž¤ O-glycosidic linkage between hydroxyl side chain of serine or threonine and N-acetyl galactosamine is present&lt;/li&gt;&lt;li&gt;âž¤ O-glycosidic linkage&lt;/li&gt;&lt;li&gt;âž¤ hydroxyl side chain&lt;/li&gt;&lt;li&gt;âž¤ serine or threonine&lt;/li&gt;&lt;li&gt;âž¤ N-acetyl galactosamine&lt;/li&gt;&lt;li&gt;âž¤ N-linked Glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ N-linked Glycoprotein&lt;/li&gt;&lt;li&gt;âž¤ N-glycosidic linkage between amide nitrogen of asparagine and Nâ€“acetyl glucosamine is present.&lt;/li&gt;&lt;li&gt;âž¤ N-glycosidic linkage between amide nitrogen of asparagine and Nâ€“acetyl glucosamine is present.&lt;/li&gt;&lt;li&gt;âž¤ N-glycosidic linkage&lt;/li&gt;&lt;li&gt;âž¤ nitrogen of asparagine&lt;/li&gt;&lt;li&gt;âž¤ Nâ€“acetyl glucosamine&lt;/li&gt;&lt;li&gt;âž¤ Glycosylphosphatidylinositol anchored (GPI-anchored, or GPI-linked) glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Glycosylphosphatidylinositol anchored (GPI-anchored, or GPI-linked) glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Third major class of Glycoproteins, which link several proteins to Plasma membrane. Linked to the carboxyl terminal amino acid of a protein via a phosphoryl ethanolamine moiety joined to an oligosaccharide (glycan), which in turn is linked via glucosamine to phosphatidylinositol (PI).&lt;/li&gt;&lt;li&gt;âž¤ Third major class of Glycoproteins, which link several proteins to Plasma membrane.&lt;/li&gt;&lt;li&gt;âž¤ Third major class of Glycoproteins,&lt;/li&gt;&lt;li&gt;âž¤ link several proteins to Plasma membrane.&lt;/li&gt;&lt;li&gt;âž¤ Linked to the carboxyl terminal amino acid of a protein via a phosphoryl ethanolamine moiety joined to an oligosaccharide (glycan), which in turn is linked via glucosamine to phosphatidylinositol (PI).&lt;/li&gt;&lt;li&gt;âž¤ carboxyl terminal amino acid&lt;/li&gt;&lt;li&gt;âž¤ phosphoryl ethanolamine&lt;/li&gt;&lt;li&gt;âž¤ joined&lt;/li&gt;&lt;li&gt;âž¤ oligosaccharide (glycan),&lt;/li&gt;&lt;li&gt;âž¤ linked&lt;/li&gt;&lt;li&gt;âž¤ glucosamine to phosphatidylinositol (PI).&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 573.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 573.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Immunoglobulins are classified as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proteins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glycoproteins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proteoglycan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycoside&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glycoproteins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture18.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture19.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Proteins - While immunoglobulins are proteins , this term alone does not fully capture their nature as they also contain carbohydrate groups.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Proteins&lt;/li&gt;&lt;li&gt;â€¢ immunoglobulins are proteins&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ contain&lt;/li&gt;&lt;li&gt;â€¢ carbohydrate groups.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Proteoglycans - These are mainly found in the extracellular matrix and consist of a core protein with one or more covalently attached glycosaminoglycan (GAG) chains, which is different from the structure of immunoglobulins.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Proteoglycans&lt;/li&gt;&lt;li&gt;â€¢ mainly found&lt;/li&gt;&lt;li&gt;â€¢ extracellular matrix&lt;/li&gt;&lt;li&gt;â€¢ core protein&lt;/li&gt;&lt;li&gt;â€¢ one or more&lt;/li&gt;&lt;li&gt;â€¢ covalently attached glycosaminoglycan (GAG) chains,&lt;/li&gt;&lt;li&gt;â€¢ different from&lt;/li&gt;&lt;li&gt;â€¢ structure of immunoglobulins.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glycosides - These are molecules in which a sugar is bound to a non-carbohydrate moiety ; this term does not describe the nature of immunoglobulins.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Glycosides&lt;/li&gt;&lt;li&gt;â€¢ molecules&lt;/li&gt;&lt;li&gt;â€¢ sugar is bound&lt;/li&gt;&lt;li&gt;â€¢ non-carbohydrate moiety&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ immunoglobulins.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Biologically Important Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Biologically Important Glycoproteins&lt;/li&gt;&lt;li&gt;âž¤ Plasma proteins (except albumin) Blood group substances Hormones (HCG, TSH, LH, FSHQ) Enzyme- Alkaline Phosphatase Structural Protein - Collagen Transport Proteins-Ceruloplasmin, Transferrin.&lt;/li&gt;&lt;li&gt;âž¤ Plasma proteins (except albumin)&lt;/li&gt;&lt;li&gt;âž¤ Plasma proteins&lt;/li&gt;&lt;li&gt;âž¤ Blood group substances&lt;/li&gt;&lt;li&gt;âž¤ Blood group substances&lt;/li&gt;&lt;li&gt;âž¤ Hormones (HCG, TSH, LH, FSHQ)&lt;/li&gt;&lt;li&gt;âž¤ Hormones (HCG, TSH, LH, FSHQ)&lt;/li&gt;&lt;li&gt;âž¤ Enzyme- Alkaline Phosphatase&lt;/li&gt;&lt;li&gt;âž¤ Alkaline Phosphatase&lt;/li&gt;&lt;li&gt;âž¤ Structural Protein - Collagen&lt;/li&gt;&lt;li&gt;âž¤ Structural Protein&lt;/li&gt;&lt;li&gt;âž¤ Collagen&lt;/li&gt;&lt;li&gt;âž¤ Transport Proteins-Ceruloplasmin, Transferrin.&lt;/li&gt;&lt;li&gt;âž¤ Transport Proteins-Ceruloplasmin, Transferrin.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 569.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 569.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on the components of the immune system, a group of medical students examines the various roles of plasma proteins in immune defense. They explore the functions of different plasma proteins and their contribution to protecting the body against pathogens. Which of the following plasma proteins is directly involved in the immune defense of the body?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Globulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibrinogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both a and b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Globulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture22.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture23.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Albumin - Primarily functions as a carrier protein and contributes to plasma osmotic pressure , but it&#x27;s not directly involved in immune defense.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Albumin&lt;/li&gt;&lt;li&gt;â€¢ carrier protein&lt;/li&gt;&lt;li&gt;â€¢ plasma osmotic pressure&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ immune defense.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Fibrinogen - Involved in blood clotting and wound healing , not in direct immune response.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Fibrinogen&lt;/li&gt;&lt;li&gt;â€¢ blood clotting&lt;/li&gt;&lt;li&gt;â€¢ wound healing&lt;/li&gt;&lt;li&gt;â€¢ Option D: Both A and B - While globulins are involved in immune defense , albumin is not; hence, this option is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Both A and B&lt;/li&gt;&lt;li&gt;â€¢ globulins&lt;/li&gt;&lt;li&gt;â€¢ immune defense&lt;/li&gt;&lt;li&gt;â€¢ albumin is not;&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gamma globulins in the serum are increased in chronic liver diseases and chronic infections.&lt;/li&gt;&lt;li&gt;âž¤ Gamma globulins&lt;/li&gt;&lt;li&gt;âž¤ serum are increased&lt;/li&gt;&lt;li&gt;âž¤ chronic liver diseases and chronic infections.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 672.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 672.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A research team is investigating the endoplasmic reticulum-associated degradation (ERAD) pathway, specifically how misfolded proteins are identified and transported out of the ER lumen back to the cytosol. This retro-translocation is an important quality control mechanism for cellular proteostasis. They focus on identifying the transmembrane proteins facilitating this process. Which transmembrane proteins are involved in the retro-translocation of luminal proteins from the endoplasmic reticulum to the cytosol?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Translocon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Derlin 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Both&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Both&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture24.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transmembrane proteins that help in the retro translocation of misfolded membrane and luminal protein in ER to cytosol are:&lt;/li&gt;&lt;li&gt;âž¤ Transmembrane proteins&lt;/li&gt;&lt;li&gt;âž¤ retro translocation of misfolded membrane&lt;/li&gt;&lt;li&gt;âž¤ luminal protein in ER&lt;/li&gt;&lt;li&gt;âž¤ cytosol&lt;/li&gt;&lt;li&gt;âž¤ Sec61 ( Translocon ) Degradation in ER protein1 ( derlin 1 ) ERAD E3 ligases Hrd1 Doa 10&lt;/li&gt;&lt;li&gt;âž¤ Sec61 ( Translocon )&lt;/li&gt;&lt;li&gt;âž¤ Translocon&lt;/li&gt;&lt;li&gt;âž¤ Degradation in ER protein1 ( derlin 1 )&lt;/li&gt;&lt;li&gt;âž¤ derlin 1&lt;/li&gt;&lt;li&gt;âž¤ ERAD E3 ligases&lt;/li&gt;&lt;li&gt;âž¤ ERAD E3 ligases&lt;/li&gt;&lt;li&gt;âž¤ Hrd1&lt;/li&gt;&lt;li&gt;âž¤ Hrd1&lt;/li&gt;&lt;li&gt;âž¤ Doa 10&lt;/li&gt;&lt;li&gt;âž¤ Doa 10&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 615- 618.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 615- 618.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biochemistry professor is lecturing on the historical discovery of protein motifs and their structural significance in DNA binding and transcriptional regulation. The professor presents a timeline highlighting when various motifs were first described in scientific literature. The class is asked to identify which of the following motifs or super secondary structures was described first.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Helix-Turn-Helix motif&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Zinc finger motif&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine zipper motif&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Helix-Turn motif&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Helix-Turn-Helix motif&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Super Secondary Structure (MOTIFS)&lt;/li&gt;&lt;li&gt;âž¤ Super Secondary Structure (MOTIFS)&lt;/li&gt;&lt;li&gt;âž¤ Secondary structural elements join to form Super Secondary Structures.&lt;/li&gt;&lt;li&gt;âž¤ Secondary structural elements join to form Super Secondary Structures.&lt;/li&gt;&lt;li&gt;âž¤ Examples are:&lt;/li&gt;&lt;li&gt;âž¤ Examples are:&lt;/li&gt;&lt;li&gt;âž¤ Beta-alpha-beta motif Greek key motif Beta meander motif Beta barrel.&lt;/li&gt;&lt;li&gt;âž¤ Beta-alpha-beta motif&lt;/li&gt;&lt;li&gt;âž¤ Greek key motif&lt;/li&gt;&lt;li&gt;âž¤ Beta meander motif&lt;/li&gt;&lt;li&gt;âž¤ Beta barrel.&lt;/li&gt;&lt;li&gt;âž¤ DNA-binding Motifs are examples of Super Secondary Structure. They are:&lt;/li&gt;&lt;li&gt;âž¤ DNA-binding Motifs are examples of Super Secondary Structure. They are:&lt;/li&gt;&lt;li&gt;âž¤ Helix-Turn-Helix Motif - first Motif / Super Secondary Structure described Leucine zipper motif Zinc finger motif&lt;/li&gt;&lt;li&gt;âž¤ Helix-Turn-Helix Motif - first Motif / Super Secondary Structure described&lt;/li&gt;&lt;li&gt;âž¤ Helix-Turn-Helix Motif -&lt;/li&gt;&lt;li&gt;âž¤ Leucine zipper motif&lt;/li&gt;&lt;li&gt;âž¤ Zinc finger motif&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 39, 444.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 39, 444.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Amino acids present in human proteins are predominantly:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;L-forms&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D-forms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mostly D form&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D and L form&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. L-forms&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B: D-forms - This option is incorrect because D-forms of amino acids are not typically incorporated into proteins in humans.&lt;/li&gt;&lt;li&gt;â€¢ Option B: D-forms&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ D-forms of amino acids&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ incorporated into proteins&lt;/li&gt;&lt;li&gt;â€¢ Option C: Mostly D form - This is not accurate ; human proteins are made up of L-form amino acids, not D-form.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C: Mostly D form&lt;/li&gt;&lt;li&gt;â€¢ not accurate&lt;/li&gt;&lt;li&gt;â€¢ human proteins&lt;/li&gt;&lt;li&gt;â€¢ L-form amino acids,&lt;/li&gt;&lt;li&gt;â€¢ Option D: D and L form - While both forms exist in nature , only L-form amino acids are incorporated into proteins during biosynthesis in humans.&lt;/li&gt;&lt;li&gt;â€¢ Option D: D and L form&lt;/li&gt;&lt;li&gt;â€¢ both forms exist in nature&lt;/li&gt;&lt;li&gt;â€¢ L-form amino acids&lt;/li&gt;&lt;li&gt;â€¢ incorporated into proteins&lt;/li&gt;&lt;li&gt;â€¢ biosynthesis in humans.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Physical properties of Human amino acids:&lt;/li&gt;&lt;li&gt;âž¤ Physical properties of Human amino acids:&lt;/li&gt;&lt;li&gt;âž¤ All are L-É‘ amino acids Optically active (except glycine ) At their pI, they have buffering activity. ( Histidine has buffering action at our physiological pH of 7.0 ).&lt;/li&gt;&lt;li&gt;âž¤ All are L-É‘ amino acids&lt;/li&gt;&lt;li&gt;âž¤ L-É‘ amino acids&lt;/li&gt;&lt;li&gt;âž¤ Optically active (except glycine )&lt;/li&gt;&lt;li&gt;âž¤ Optically active&lt;/li&gt;&lt;li&gt;âž¤ glycine&lt;/li&gt;&lt;li&gt;âž¤ At their pI, they have buffering activity. ( Histidine has buffering action at our physiological pH of 7.0 ).&lt;/li&gt;&lt;li&gt;âž¤ Histidine&lt;/li&gt;&lt;li&gt;âž¤ buffering action&lt;/li&gt;&lt;li&gt;âž¤ pH of 7.0&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 29.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 29.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;â€‹â€‹â€‹â€‹â€‹â€‹ Match the following conjugated proteins:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1-d, 2-c, 3-b, 4-a&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1-a, 2-b, 3-c, 4-d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1-d, 2-a, 3-c, 4-b&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1-c, 2-d, 3-a, 4-b&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 1-d, 2-c, 3-b, 4-a&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture25.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture26.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture27.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 43.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 43.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a biochemistry tutorial, the discussion focuses on the various levels of protein structure and the types of bonds that stabilize each level. A key topic is the primary structure of proteins and the specific type of bond that links amino acids together in a polypeptide chain. Which type of bond is involved in the formation of the primary structure of a protein or polypeptide?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Covalent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amide Bond&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture2.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of cellular biology, understanding where protein biosynthesis, or protein synthesis, occurs is crucial for comprehending how proteins are produced and processed within the cell. Protein biosynthesis involves the translation of mRNA into a polypeptide chain, which forms the primary structure of proteins. Where does this process predominantly take place?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytoplasm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ER&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ribosomes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitochondria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ribosomes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture3.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 596.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 596.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following is an image of a Zinc finger domain of a steroid receptor. Which of the following molecule is stabilising Zinc in this structure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Finger-like projection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cysteine residues&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Leucine residues&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SH group of proteins&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cysteine residues&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture4.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture5.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Other DNA binding domains with their functions are shown in the following table.&lt;/li&gt;&lt;li&gt;âž¤ DNA binding domains&lt;/li&gt;&lt;li&gt;âž¤ their functions&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 444&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 444&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a discussion on protein synthesis, a molecular biology instructor outlines the role of aminoacyl tRNAs in the translation process. These molecules are essential for delivering the appropriate amino acids to the ribosome for incorporation into the growing polypeptide chain. However, one of the amino acids mentioned is not directly incorporated by this process. Which amino acid does not require an aminoacyl tRNA for its incorporation into a protein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydroxyproline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methionine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hydroxyproline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture7.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 25.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 25.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which one of the following statements is incorrect regarding hemoglobin A (HbA) and hemoglobin S (HbS).&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Electrophoretically HbS moves faster than HbA at alkaline pH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Structural difference is related to Î²-chain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HbS is more prone to polymerization under low oxygen conditions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lack of negative charge of glutamic acid is attributed to the electrophoretic movement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Electrophoretically HbS moves faster than HbA at alkaline pH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture11.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Electrophoretically HbS moves faster than HbA at alkaline pH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This statement is false because at alkaline pH (typically ~8.6) during electrophoresis , HbS moves slower than HbA .&lt;/li&gt;&lt;li&gt;â€¢ false&lt;/li&gt;&lt;li&gt;â€¢ alkaline pH (typically ~8.6)&lt;/li&gt;&lt;li&gt;â€¢ electrophoresis&lt;/li&gt;&lt;li&gt;â€¢ HbS moves slower&lt;/li&gt;&lt;li&gt;â€¢ HbA&lt;/li&gt;&lt;li&gt;â€¢ The reason lies in the structural difference :&lt;/li&gt;&lt;li&gt;â€¢ structural difference&lt;/li&gt;&lt;li&gt;â€¢ In Hemoglobin A (HbA) , the 6th amino acid of the Î²-globin chain is glutamic acid , a negatively charged residue at physiological and alkaline pH. In Hemoglobin S (HbS) , the same position is occupied by valine , which is neutral.&lt;/li&gt;&lt;li&gt;â€¢ In Hemoglobin A (HbA) , the 6th amino acid of the Î²-globin chain is glutamic acid , a negatively charged residue at physiological and alkaline pH.&lt;/li&gt;&lt;li&gt;â€¢ Hemoglobin A (HbA)&lt;/li&gt;&lt;li&gt;â€¢ 6th amino acid of the Î²-globin chain&lt;/li&gt;&lt;li&gt;â€¢ glutamic acid&lt;/li&gt;&lt;li&gt;â€¢ In Hemoglobin S (HbS) , the same position is occupied by valine , which is neutral.&lt;/li&gt;&lt;li&gt;â€¢ Hemoglobin S (HbS)&lt;/li&gt;&lt;li&gt;â€¢ valine&lt;/li&gt;&lt;li&gt;â€¢ This substitution reduces the overall negative charge of HbS compared to HbA, which leads to slower migration toward the anode (positive pole) during electrophoresis at alkaline pH.&lt;/li&gt;&lt;li&gt;â€¢ negative charge&lt;/li&gt;&lt;li&gt;â€¢ slower migration toward the anode (positive pole)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B) The structural difference is related to the Î²-chain: Correct â€” The mutation responsible for HbS is a single point mutation in the Î²-globin gene . Valine replaces glutamic acid at position 6 of the Î²-chain. Option C. HbS is more prone to polymerization under low oxygen conditions: Correct â€” Deoxygenated HbS tends to polymerize, causing red blood cells to assume a sickle shape. Option D) Lack of negative charge of glutamic acid is attributed to the electrophoretic movement: Correct â€” The substitution eliminates the negative charge of glutamic acid, reducing the net negative charge of HbS, which slows down its migration on electrophoresis at alkaline pH.&lt;/li&gt;&lt;li&gt;â€¢ Option B) The structural difference is related to the Î²-chain: Correct â€” The mutation responsible for HbS is a single point mutation in the Î²-globin gene . Valine replaces glutamic acid at position 6 of the Î²-chain.&lt;/li&gt;&lt;li&gt;â€¢ Option B) The structural difference is related to the Î²-chain:&lt;/li&gt;&lt;li&gt;â€¢ single point mutation&lt;/li&gt;&lt;li&gt;â€¢ Î²-globin gene&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbS is more prone to polymerization under low oxygen conditions: Correct â€” Deoxygenated HbS tends to polymerize, causing red blood cells to assume a sickle shape.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbS is more prone to polymerization under low oxygen conditions:&lt;/li&gt;&lt;li&gt;â€¢ Correct â€” Deoxygenated HbS tends to polymerize, causing red blood cells to assume a sickle shape.&lt;/li&gt;&lt;li&gt;â€¢ Option D) Lack of negative charge of glutamic acid is attributed to the electrophoretic movement: Correct â€” The substitution eliminates the negative charge of glutamic acid, reducing the net negative charge of HbS, which slows down its migration on electrophoresis at alkaline pH.&lt;/li&gt;&lt;li&gt;â€¢ Option D) Lack of negative charge of glutamic acid is attributed to the electrophoretic movement:&lt;/li&gt;&lt;li&gt;â€¢ slows down&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In sickle cell anemia , the substitution of valine for glutamic acid in the Î²-globin chain leads to the formation of HbS. This mutation decreases the negative charge of the hemoglobin molecule, causing it to migrate more slowly than HbA during electrophoresis at alkaline pH .&lt;/li&gt;&lt;li&gt;âž¤ sickle cell anemia&lt;/li&gt;&lt;li&gt;âž¤ valine for glutamic acid&lt;/li&gt;&lt;li&gt;âž¤ more slowly&lt;/li&gt;&lt;li&gt;âž¤ electrophoresis at alkaline pH&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 292.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man comes to the clinic with symptoms including a bluish tint to his skin on his face and extremities, shortness of breath, and headaches. His medical history reveals that he has been taking sulfa drugs. Given these clinical features and medication history, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carboxy hemoglobinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î²-Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methemoglobinemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Methemoglobinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Sickle cell anemia: Characterized by lifelong pain crises, chronic hemolytic anemia with hyperbilirubinemia and increased susceptibility to infections . Other symptoms - acute chest syndrome, stroke, splenic and renal dysfunction and bone changes due to marrow hyperplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Sickle cell anemia:&lt;/li&gt;&lt;li&gt;â€¢ lifelong pain crises,&lt;/li&gt;&lt;li&gt;â€¢ chronic hemolytic anemia&lt;/li&gt;&lt;li&gt;â€¢ hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ increased&lt;/li&gt;&lt;li&gt;â€¢ infections&lt;/li&gt;&lt;li&gt;â€¢ acute chest syndrome, stroke, splenic and renal dysfunction&lt;/li&gt;&lt;li&gt;â€¢ bone changes&lt;/li&gt;&lt;li&gt;â€¢ marrow hyperplasia.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Carboxy hemoglobinemia: Carbon monoxide binds to haemoglobin very avidly . The patient presents with confusion and symptoms of O2 deprivation, but not dyspnoea, since the hemoglobin is fully saturated, and lips have a typical red colour as a result of the hemoglobin getting oxygenated.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Carboxy hemoglobinemia:&lt;/li&gt;&lt;li&gt;â€¢ Carbon monoxide&lt;/li&gt;&lt;li&gt;â€¢ haemoglobin&lt;/li&gt;&lt;li&gt;â€¢ avidly&lt;/li&gt;&lt;li&gt;â€¢ confusion and&lt;/li&gt;&lt;li&gt;â€¢ O2 deprivation,&lt;/li&gt;&lt;li&gt;â€¢ not dyspnoea,&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin is fully saturated,&lt;/li&gt;&lt;li&gt;â€¢ lips&lt;/li&gt;&lt;li&gt;â€¢ red colour&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin getting oxygenated.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Î²-Thalassemia: Characterized by a decrease or absence of beta chains synthesis with compensatory increase in gamma or delta chains. They present with hypochromic microcytic anemia and ineffective erythropoiesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Î²-Thalassemia:&lt;/li&gt;&lt;li&gt;â€¢ decrease or absence of beta chains synthesis&lt;/li&gt;&lt;li&gt;â€¢ compensatory increase&lt;/li&gt;&lt;li&gt;â€¢ gamma or&lt;/li&gt;&lt;li&gt;â€¢ delta chains.&lt;/li&gt;&lt;li&gt;â€¢ present&lt;/li&gt;&lt;li&gt;â€¢ hypochromic microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ ineffective erythropoiesis.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Methemoglobinemia , associated with certain medications like sulfa drugs , leads to symptoms of cyanosis and dyspnea due to an altered oxygen-carrying state of hemoglobin . Sickle cell anemia and Î²-Thalassemia present with different hematological issues , while carboxyhemoglobinemia is typically linked to carbon monoxide exposure , not sulfa drugs.&lt;/li&gt;&lt;li&gt;â€¢ Methemoglobinemia&lt;/li&gt;&lt;li&gt;â€¢ sulfa drugs&lt;/li&gt;&lt;li&gt;â€¢ cyanosis and dyspnea&lt;/li&gt;&lt;li&gt;â€¢ altered oxygen-carrying state of hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ Sickle cell anemia and Î²-Thalassemia&lt;/li&gt;&lt;li&gt;â€¢ different hematological issues&lt;/li&gt;&lt;li&gt;â€¢ carboxyhemoglobinemia&lt;/li&gt;&lt;li&gt;â€¢ carbon monoxide exposure&lt;/li&gt;&lt;li&gt;â€¢ not sulfa drugs.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 692-693.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 692-693.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A) : AIP (acute intermittent porphyria) has abdominal pain and neuropsychiatric features as common presentation. Reasoning (R) : The above symptoms are due to accumulation of ALA and PBG. ALA inhibits ATPase in the nervous system leads to conduction paralysis. Which of the following is the most appropriate interpretation of the Assertion and Reasoning provided?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture8.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute Intermittent Porphyria (AIP) is marked by a lack of porphobilinogen deaminase , causing delta-aminolevulinic acid and porphobilinogen buildup , leading to abdominal pain and neuropsychiatric symptoms . This is due to ALA&#x27;s neurotoxicity, which inhibits ATPase in neurons, resulting in neuronal dysfunction and paralysis.&lt;/li&gt;&lt;li&gt;âž¤ Acute Intermittent Porphyria (AIP)&lt;/li&gt;&lt;li&gt;âž¤ lack of porphobilinogen deaminase&lt;/li&gt;&lt;li&gt;âž¤ delta-aminolevulinic acid&lt;/li&gt;&lt;li&gt;âž¤ porphobilinogen buildup&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain and neuropsychiatric symptoms&lt;/li&gt;&lt;li&gt;âž¤ due to ALA&#x27;s neurotoxicity,&lt;/li&gt;&lt;li&gt;âž¤ inhibits ATPase in neurons,&lt;/li&gt;&lt;li&gt;âž¤ neuronal dysfunction and paralysis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 328-329&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e:  p 328-329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents to the clinic for a routine health checkup. As part of his evaluation, a blood test is performed. When his blood sample is treated with Ehrlichâ€™s solution, it gives a purplish-brown color. Which of the following substances is most likely present in the patient&#x27;s blood to account for this color change?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Urobilinogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conjugated bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unconjugated bilirubin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemosiderin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Urobilinogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture9.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan, 9/e: page 279, 350&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan, 9/e: page 279, 350&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old boy presents to the pediatric clinic with a notably disfigured face, pronounced photosensitivity, stained teeth, and laboratory tests revealing elevated levels of Coproporphyrin-I. Based on these clinical findings, which enzyme deficiency is most likely responsible for this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Uroporphyrinogen Synthase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uroporphyrinogen III Synthase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uroporphyrinogen Decarboxylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Coproporphyrinogen Oxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Uroporphyrinogen III Synthase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Congenital Erythropoietic Porphyria (CEP), a rare disorder caused by a deficiency in Uroporphyrinogen III Synthase. The accumulation of specific porphyrins leads to symptoms including photosensitivity, facial disfigurement, and stained teeth, emphasizing the critical role of the heme biosynthesis pathway in maintaining normal physiological functions and the diverse clinical manifestations that can arise from its disruption.&lt;/li&gt;&lt;li&gt;âž¤ Congenital Erythropoietic Porphyria (CEP),&lt;/li&gt;&lt;li&gt;âž¤ rare disorder&lt;/li&gt;&lt;li&gt;âž¤ deficiency in Uroporphyrinogen III Synthase.&lt;/li&gt;&lt;li&gt;âž¤ specific porphyrins&lt;/li&gt;&lt;li&gt;âž¤ photosensitivity, facial disfigurement, and stained teeth,&lt;/li&gt;&lt;li&gt;âž¤ emphasizing&lt;/li&gt;&lt;li&gt;âž¤ heme biosynthesis pathway&lt;/li&gt;&lt;li&gt;âž¤ normal physiological functions&lt;/li&gt;&lt;li&gt;âž¤ diverse&lt;/li&gt;&lt;li&gt;âž¤ clinical manifestations&lt;/li&gt;&lt;li&gt;âž¤ arise&lt;/li&gt;&lt;li&gt;âž¤ its disruption.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 327-329&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 327-329&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 7-year-old boy is brought to the pediatric clinic with a history of yellowing skin and eyes. Laboratory tests reveal increased levels of serum bilirubin and bilirubin in the urine, but urobilinogen is not detected. Based on these findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gilbert Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obstructive jaundice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Viral hepatitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Obstructive jaundice&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture10.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diagnostic approach&lt;/li&gt;&lt;li&gt;âž¤ Diagnostic approach&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 332-334, DM Vasudevan 9/e: p 280-282&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Harper 30/e: p 332-334, DM Vasudevan 9/e: p 280-282&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3.5-year-old girl of Arabian descent presents to the clinic with severe anemia, thrombocytopenia, leukocytosis, and elevated ESR. The history provided by her parents includes fever, cough, pallor, weakness, and tachypnea. On examination, hepatomegaly is noted. Following diagnostic evaluations, sickle cell anemia (SCA) is diagnosed. Based on the information provided, which of the following statements about SCA is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RFLP result from a single base change&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Single nucleotide change results in change of Glutamate to Valine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HbS confers resistance against malaria in heterozygotes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;â€˜Sticky patchâ€™ is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. â€˜Sticky patchâ€™ is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) â€˜Sticky patchâ€™ is generated as a result of replacement of a nonpolar residue with a polar residue in Sickle Cell Anemia (HbS) â€” this is False.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In sickle cell anemia , the amino acid substitution involves replacing a polar residue Glutamate with a nonpolar residue (valine) at the 6th position of the Î²-globin chain.&lt;/li&gt;&lt;li&gt;â€¢ sickle cell anemia&lt;/li&gt;&lt;li&gt;â€¢ polar residue Glutamate&lt;/li&gt;&lt;li&gt;â€¢ nonpolar residue (valine)&lt;/li&gt;&lt;li&gt;â€¢ This substitution creates a hydrophobic â€œsticky patchâ€ on the surface of the deoxygenated hemoglobin S (HbS) molecule. These hydrophobic patches interact abnormally with each other, leading to polymerization of HbS inside red cells, which causes the characteristic \&quot;sickling\&quot; shape of RBCs under hypoxic conditions.&lt;/li&gt;&lt;li&gt;â€¢ hydrophobic â€œsticky patchâ€&lt;/li&gt;&lt;li&gt;â€¢ polymerization of HbS&lt;/li&gt;&lt;li&gt;â€¢ So the false statement is that the â€œsticky patchâ€ arises from a nonpolar â†’ polar substitution â€” the reality is the opposite: â†’ Itâ€™s a polar (glutamate) â†’ nonpolar (valine) substitution.&lt;/li&gt;&lt;li&gt;â€¢ nonpolar â†’ polar substitution&lt;/li&gt;&lt;li&gt;â€¢ polar (glutamate) â†’ nonpolar (valine)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) RFLP result from a single base change: Correct â€” The sickle cell mutation involves a single nucleotide change ( A â†’ T at the 6th codon), which eliminates a restriction enzyme site. This difference can be detected using Restriction Fragment Length Polymorphism (RFLP) analysis. Option B) Single nucleotide change results in change of Glutamate to Valine: Correction: this statement is Correct . Option C) HbS confers resistance against malaria in heterozygotes: Correct â€” Heterozygotes for the HbS gene (sickle cell trait) are relatively protected against Plasmodium falciparum malaria , explaining its evolutionary persistence in malaria-endemic regions.&lt;/li&gt;&lt;li&gt;â€¢ Option A) RFLP result from a single base change: Correct â€” The sickle cell mutation involves a single nucleotide change ( A â†’ T at the 6th codon), which eliminates a restriction enzyme site. This difference can be detected using Restriction Fragment Length Polymorphism (RFLP) analysis.&lt;/li&gt;&lt;li&gt;â€¢ Option A) RFLP result from a single base change:&lt;/li&gt;&lt;li&gt;â€¢ A â†’ T&lt;/li&gt;&lt;li&gt;â€¢ Restriction Fragment Length Polymorphism (RFLP)&lt;/li&gt;&lt;li&gt;â€¢ Option B) Single nucleotide change results in change of Glutamate to Valine: Correction: this statement is Correct .&lt;/li&gt;&lt;li&gt;â€¢ Option B) Single nucleotide change results in change of Glutamate to Valine:&lt;/li&gt;&lt;li&gt;â€¢ Correction:&lt;/li&gt;&lt;li&gt;â€¢ Correct&lt;/li&gt;&lt;li&gt;â€¢ Option C) HbS confers resistance against malaria in heterozygotes: Correct â€” Heterozygotes for the HbS gene (sickle cell trait) are relatively protected against Plasmodium falciparum malaria , explaining its evolutionary persistence in malaria-endemic regions.&lt;/li&gt;&lt;li&gt;â€¢ Option C) HbS confers resistance against malaria in heterozygotes:&lt;/li&gt;&lt;li&gt;â€¢ Plasmodium falciparum malaria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Sickle Cell Anemia (SCA) , a single point mutation (A â†’ T) at the 6th codon of the Î²-globin gene results in the substitution of Glutamate (polar) with valine (nonpolar) . This creates a hydrophobic site (\&quot;sticky patch\&quot;) on deoxygenated HbS, triggering polymerization, red cell sickling, hemolysis, and vaso-occlusive complications.&lt;/li&gt;&lt;li&gt;âž¤ Sickle Cell Anemia (SCA)&lt;/li&gt;&lt;li&gt;âž¤ Î²-globin gene&lt;/li&gt;&lt;li&gt;âž¤ Glutamate (polar)&lt;/li&gt;&lt;li&gt;âž¤ valine (nonpolar)&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e p 417, 693.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents to the clinic with a history of skin fragility and blistering on sun-exposed areas. He also reports significant liver disease history and excessive alcohol consumption. Laboratory tests show elevated porphyrins in urine. The patient&#x27;s symptoms and laboratory findings suggest a diagnosis related to porphyrin metabolism. Which of the following types of porphyria is characterized by a deficiency in the enzyme uroporphyrinogen decarboxylase?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute intermittent porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Porphyria cutanea tarda&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Congenital erythropoietic porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hereditary coproporphyria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Porphyria cutanea tarda&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: A cute intermittent porphyria: Deficiency of Uroporphyrinogen I synthase ; C/F- Abdominal pain, neuropsychiatric symptoms with increased urinary ALA and PBG.&lt;/li&gt;&lt;li&gt;â€¢ Option A: A&lt;/li&gt;&lt;li&gt;â€¢ cute intermittent porphyria:&lt;/li&gt;&lt;li&gt;â€¢ Uroporphyrinogen I synthase&lt;/li&gt;&lt;li&gt;â€¢ Abdominal pain, neuropsychiatric&lt;/li&gt;&lt;li&gt;â€¢ symptoms&lt;/li&gt;&lt;li&gt;â€¢ increased urinary ALA and PBG.&lt;/li&gt;&lt;li&gt;â€¢ Option C: C ongenital erythropoietic porphyria: Deficiency of Uroporphyrinogen III synthase ; C/F- Photosensitivity with increased u roporphyrin I in urinary, faecal, and red cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C: C&lt;/li&gt;&lt;li&gt;â€¢ ongenital erythropoietic porphyria:&lt;/li&gt;&lt;li&gt;â€¢ Uroporphyrinogen III synthase&lt;/li&gt;&lt;li&gt;â€¢ Photosensitivity with increased&lt;/li&gt;&lt;li&gt;â€¢ roporphyrin I&lt;/li&gt;&lt;li&gt;â€¢ urinary, faecal, and red cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hereditary coproporphyria: Deficiency of Coproporphyrinogen oxidase ; C/F -Photosensitivity, abdominal pain, neuropsychiatric symptoms with urinary ALA, PBG , and coproporphyrin III and faecal coproporphyrin III increased.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hereditary coproporphyria:&lt;/li&gt;&lt;li&gt;â€¢ Coproporphyrinogen oxidase&lt;/li&gt;&lt;li&gt;â€¢ -Photosensitivity, abdominal pain,&lt;/li&gt;&lt;li&gt;â€¢ neuropsychiatric symptoms&lt;/li&gt;&lt;li&gt;â€¢ urinary ALA, PBG&lt;/li&gt;&lt;li&gt;â€¢ coproporphyrin III&lt;/li&gt;&lt;li&gt;â€¢ faecal coproporphyrin III increased.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Porphyria cutanea tarda (PCT) is the most common form of porphyria and is characterized by a deficiency of the enzyme uroporphyrinogen decarboxylase (UROD).&lt;/li&gt;&lt;li&gt;âž¤ Porphyria cutanea tarda (PCT)&lt;/li&gt;&lt;li&gt;âž¤ porphyria&lt;/li&gt;&lt;li&gt;âž¤ deficiency of the enzyme&lt;/li&gt;&lt;li&gt;âž¤ uroporphyrinogen decarboxylase (UROD).&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 274.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 274.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old male child presents to the pediatric outpatient department with a history of recurrent gastrointestinal disturbances and lethargy over the past few weeks. Laboratory investigations reveal a microcytic, hypochromic anemia and elevated blood lead levels, suggestive of lead poisoning. Given this child&#x27;s condition, which of the following enzymes would likely exhibit increased activity in the liver as a compensatory or pathophysiological response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilirubin UDP-glucuronosyltransferase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ferrochelatase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heme oxygenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î´-Aminolevulinic acid synthase&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Î´-Aminolevulinic acid synthase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Î´ -Aminolevulinic acid synthase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Bilirubin UDP-glucuronosyltransferase: This enzyme is involved in the conjugation of bilirubin , not directly affected in lead poisoning.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Bilirubin UDP-glucuronosyltransferase:&lt;/li&gt;&lt;li&gt;â€¢ conjugation of bilirubin&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ferrochelatase: Lead poisoning actually inhibits ferrochelatase, decreasing its activity . Ferrochelatase catalyzes the insertion of iron into protoporphyrin IX to form heme .&lt;/li&gt;&lt;li&gt;â€¢ Option B: Ferrochelatase:&lt;/li&gt;&lt;li&gt;â€¢ Lead poisoning&lt;/li&gt;&lt;li&gt;â€¢ inhibits ferrochelatase, decreasing its activity&lt;/li&gt;&lt;li&gt;â€¢ Ferrochelatase&lt;/li&gt;&lt;li&gt;â€¢ insertion of iron&lt;/li&gt;&lt;li&gt;â€¢ protoporphyrin IX&lt;/li&gt;&lt;li&gt;â€¢ heme&lt;/li&gt;&lt;li&gt;â€¢ Option C: Heme oxygenase: This enzyme catalyzes the degradation of heme to biliverdin, free iron, and carbon monoxide . It is not specifically upregulated in lead poisoning.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Heme oxygenase:&lt;/li&gt;&lt;li&gt;â€¢ degradation of heme to biliverdin, free iron, and carbon monoxide&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ upregulated&lt;/li&gt;&lt;li&gt;â€¢ lead poisoning.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The effects of lead poisoning on the heme biosynthesis pathway, particularly the inhibition of specific enzymes like ALA dehydratase and ferrochelatase, leading to a compensatory increase in Î´-ALAS activity.&lt;/li&gt;&lt;li&gt;âž¤ effects of lead poisoning&lt;/li&gt;&lt;li&gt;âž¤ heme biosynthesis pathway,&lt;/li&gt;&lt;li&gt;âž¤ inhibition of specific enzymes like ALA dehydratase&lt;/li&gt;&lt;li&gt;âž¤ ferrochelatase,&lt;/li&gt;&lt;li&gt;âž¤ compensatory increase&lt;/li&gt;&lt;li&gt;âž¤ Î´-ALAS activity.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 326-327, 334.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 326-327, 334.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male, who works as a golf instructor, presents to the clinic with sudden onset of painful blisters on the backs of his hands. He reports no recent exposure to skin irritants. His medical history is significant for complex partial seizures following a head injury, for which he has been taking phenytoin. He admits to consuming alcohol on a weekly basis. Laboratory tests reveal reddish-orange urine with elevated levels of uroporphyrin. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute intermittent porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital erythropoietic porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythropoietic protoporphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Porphyria cutanea tarda&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Porphyria cutanea tarda&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture13.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Porphyria cutanea tarda (PCT) is the most common form of porphyria and is characterized by photosensitivity leading to skin fragility and blistering on sun-exposed areas , such as the backs of the hands . Factors that can precipitate PCT include alcohol consumption, liver disease, and estrogen use . Additionally, certain medications, such as phenytoin, can exacerbate the condition. The elevated levels of uroporphyrin in the urine, along with the clinical presentation and history, are indicative of PCT.&lt;/li&gt;&lt;li&gt;âž¤ Porphyria cutanea tarda (PCT)&lt;/li&gt;&lt;li&gt;âž¤ porphyria&lt;/li&gt;&lt;li&gt;âž¤ photosensitivity&lt;/li&gt;&lt;li&gt;âž¤ skin&lt;/li&gt;&lt;li&gt;âž¤ fragility and blistering&lt;/li&gt;&lt;li&gt;âž¤ sun-exposed areas&lt;/li&gt;&lt;li&gt;âž¤ backs of the hands&lt;/li&gt;&lt;li&gt;âž¤ precipitate PCT&lt;/li&gt;&lt;li&gt;âž¤ alcohol&lt;/li&gt;&lt;li&gt;âž¤ consumption, liver disease, and estrogen use&lt;/li&gt;&lt;li&gt;âž¤ phenytoin,&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of uroporphyrin&lt;/li&gt;&lt;li&gt;âž¤ urine,&lt;/li&gt;&lt;li&gt;âž¤ clinical presentation and history,&lt;/li&gt;&lt;li&gt;âž¤ indicative of PCT.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 280.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Lippincott 6/e: p 280.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 14-week pregnant woman visits her obstetrician for a routine check-up. This is her first pregnancy, and she expresses concerns about a blood disease prevalent in her family. Her laboratory results reveal a low hemoglobin level characterized by a hypochromic, microcytic anemia. Hemoglobin electrophoresis indicates an increased level of fetal hemoglobin (HbF), a finding consistent with Î±-thalassemia minor. Which of the following is true regarding the structure or function of HbF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It has 2 alpha and 2 epsilon chains&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrophoretically moves faster than HbA, under alkaline conditions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It can strongly bind with 2, 3 BPG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It has high affinity for oxygen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. It has high affinity for oxygen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The structural and functional differences between fetal hemoglobin (HbF) and adult hemoglobin (HbA), with a focus on HbF&#x27;s higher oxygen affinity due to its reduced interaction with 2, 3-bisphosphoglycerate (2, 3-BPG). This characteristic is essential for efficient oxygen transfer from the maternal to the fetal circulation.&lt;/li&gt;&lt;li&gt;âž¤ structural and functional differences between fetal hemoglobin (HbF) and adult hemoglobin (HbA),&lt;/li&gt;&lt;li&gt;âž¤ HbF&#x27;s&lt;/li&gt;&lt;li&gt;âž¤ higher oxygen affinity&lt;/li&gt;&lt;li&gt;âž¤ reduced interaction with 2, 3-bisphosphoglycerate (2, 3-BPG).&lt;/li&gt;&lt;li&gt;âž¤ efficient oxygen transfer&lt;/li&gt;&lt;li&gt;âž¤ maternal to the fetal circulation.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ed: p 293, Harper30/e: p 57.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/ed: p 293, Harper30/e: p 57.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23 days old infant with severe neonatal jaundice receives an exchange blood transfusion. Advised monthly red blood cell transfusion and splenectomy at 6 months of age. Histologic examination of the spleen reveals marked hemosiderosis and laboratory studies shows: Analysis of red cell glycolytic intermediates shows markedly elevated concentrations of 2, 3-bisphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate and PEP. Which is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pyruvate kinase deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sickle cell anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beta-Thalassemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pyruvate kinase deficiency&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture15.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate kinase deficiency is a cause of congenital non-spherocytic hemolytic anemia , characterized by elevated levels of certain glycolytic intermediates due to impaired ATP production in red blood cells.&lt;/li&gt;&lt;li&gt;âž¤ Pyruvate kinase deficiency&lt;/li&gt;&lt;li&gt;âž¤ congenital non-spherocytic hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ elevated levels of certain&lt;/li&gt;&lt;li&gt;âž¤ glycolytic intermediates&lt;/li&gt;&lt;li&gt;âž¤ impaired ATP production&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 168, 693-694.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e:  p 168, 693-694.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Assertion (A) : ALA synthase is the rate-limiting enzyme of HEME synthesis, regulated allosterically. Reasoning (R): If there is excess of free heme, Fe++ is oxidized to Fe+++ forming hematin, which in turn regulates the enzyme. Assess the statements.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and R both are right but R is not the correct explanation of A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A is wrong but R is a right statement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A as well as R are right and R is a correct explanation of A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A and R both are wrong&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A as well as R are right and R is a correct explanation of A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase is regulated by a repression mechanism: Heme inhibits the synthesis of ALA synthase by acting as a co-repressor. ALA synthase is also allosterically inhibited by hematin: When there is excess of free heme, the Fe++ is oxidized to Fe+++ (ferric) , thus forming hematin. Also regulated by compartmentalization of the enzymes.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase is regulated by a repression mechanism: Heme inhibits the synthesis of ALA synthase by acting as a co-repressor.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase&lt;/li&gt;&lt;li&gt;â€¢ mechanism:&lt;/li&gt;&lt;li&gt;â€¢ inhibits the synthesis of ALA synthase&lt;/li&gt;&lt;li&gt;â€¢ co-repressor.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase is also allosterically inhibited by hematin: When there is excess of free heme, the Fe++ is oxidized to Fe+++ (ferric) , thus forming hematin.&lt;/li&gt;&lt;li&gt;â€¢ ALA synthase&lt;/li&gt;&lt;li&gt;â€¢ allosterically inhibited by hematin:&lt;/li&gt;&lt;li&gt;â€¢ excess of free heme,&lt;/li&gt;&lt;li&gt;â€¢ Fe++&lt;/li&gt;&lt;li&gt;â€¢ oxidized&lt;/li&gt;&lt;li&gt;â€¢ Fe+++ (ferric)&lt;/li&gt;&lt;li&gt;â€¢ hematin.&lt;/li&gt;&lt;li&gt;â€¢ Also regulated by compartmentalization of the enzymes.&lt;/li&gt;&lt;li&gt;â€¢ compartmentalization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ALA synthase is the rate-limiting enzyme in the heme synthesis pathway and its activity is regulated. The feedback inhibition mechanism of heme synthesis where excess heme (and the formation of hematin ) directly inhibits ALA synthase , thereby reducing the synthesis of more heme and maintaining homeostasis.&lt;/li&gt;&lt;li&gt;âž¤ ALA synthase is the rate-limiting enzyme in the heme synthesis pathway and its activity is regulated.&lt;/li&gt;&lt;li&gt;âž¤ ALA synthase&lt;/li&gt;&lt;li&gt;âž¤ rate-limiting enzyme&lt;/li&gt;&lt;li&gt;âž¤ heme synthesis pathway&lt;/li&gt;&lt;li&gt;âž¤ The feedback inhibition mechanism of heme synthesis where excess heme (and the formation of hematin ) directly inhibits ALA synthase , thereby reducing the synthesis of more heme and maintaining homeostasis.&lt;/li&gt;&lt;li&gt;âž¤ feedback inhibition&lt;/li&gt;&lt;li&gt;âž¤ heme synthesis&lt;/li&gt;&lt;li&gt;âž¤ excess heme&lt;/li&gt;&lt;li&gt;âž¤ formation of hematin&lt;/li&gt;&lt;li&gt;âž¤ directly&lt;/li&gt;&lt;li&gt;âž¤ inhibits ALA synthase&lt;/li&gt;&lt;li&gt;âž¤ reducing the synthesis of more heme&lt;/li&gt;&lt;li&gt;âž¤ homeostasis.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 272-273.&lt;/li&gt;&lt;li&gt;âž¤ Ref: Harper 30/e: p 272-273.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most likely diagnosis based on the image given below:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute intermittent porphyria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital erythropoietic porphyria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Porphyria cutanea tarda&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hereditary coproporphyria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congenital erythropoietic porphyria&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture17.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Acute intermittent porphyria (AIP): Deficiency of Uroporphyrinogen I synthase; C/F- Abdominal pain, neuropsychiatric symptoms with increased urinary ALA and PBG.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Acute intermittent porphyria (AIP):&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of Uroporphyrinogen I synthase;&lt;/li&gt;&lt;li&gt;â€¢ Abdominal pain, neuropsychiatric&lt;/li&gt;&lt;li&gt;â€¢ symptoms&lt;/li&gt;&lt;li&gt;â€¢ increased urinary ALA and PBG.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Porphyria cutanea tarda: Deficiency of uroporphyrinogen decarboxylase. Porphyrin accumulates in circulation leads to cutaneous symptoms and gets excreted in urine, turns it red to brown.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ Porphyria cutanea tarda:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of uroporphyrinogen decarboxylase. Porphyrin&lt;/li&gt;&lt;li&gt;â€¢ cutaneous symptoms&lt;/li&gt;&lt;li&gt;â€¢ excreted in urine,&lt;/li&gt;&lt;li&gt;â€¢ red to brown.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Hereditary coproporphyria: Deficiency of Coproporphyrinogen oxidase ; C/F- Photosensitivity, abdominal pain, neuropsychiatric symptoms with urinary ALA, PBG, and coproporphyrin III and faecal coproporphyrin III increased.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ Hereditary coproporphyria:&lt;/li&gt;&lt;li&gt;â€¢ Deficiency of Coproporphyrinogen oxidase&lt;/li&gt;&lt;li&gt;â€¢ Photosensitivity, abdominal pain,&lt;/li&gt;&lt;li&gt;â€¢ neuropsychiatric symptoms&lt;/li&gt;&lt;li&gt;â€¢ urinary ALA, PBG, and coproporphyrin III&lt;/li&gt;&lt;li&gt;â€¢ faecal coproporphyrin III increased.&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Congenital erythropoietic porphyria (CEP), also known as GÃ¼nther&#x27;s disease , is a rare autosomal recessive disorder characterized by the defective synthesis of heme , leading to the accumulation of porphyrins in various tissues, including the bones and teeth . The clinical findings of reddish-brown discoloration of teeth ( erythrodontia ) that fluoresce under UV light , and red urine that may darken upon exposure to light, are pathognomonic for CEP.&lt;/li&gt;&lt;li&gt;â€¢ Congenital erythropoietic porphyria (CEP),&lt;/li&gt;&lt;li&gt;â€¢ GÃ¼nther&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ rare autosomal recessive disorder&lt;/li&gt;&lt;li&gt;â€¢ defective synthesis of heme&lt;/li&gt;&lt;li&gt;â€¢ accumulation of porphyrins&lt;/li&gt;&lt;li&gt;â€¢ bones and teeth&lt;/li&gt;&lt;li&gt;â€¢ reddish-brown discoloration of teeth&lt;/li&gt;&lt;li&gt;â€¢ erythrodontia&lt;/li&gt;&lt;li&gt;â€¢ fluoresce under UV light&lt;/li&gt;&lt;li&gt;â€¢ red urine&lt;/li&gt;&lt;li&gt;â€¢ darken&lt;/li&gt;&lt;li&gt;â€¢ exposure to light,&lt;/li&gt;&lt;li&gt;â€¢ pathognomonic&lt;/li&gt;&lt;li&gt;â€¢ CEP.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 327-329.&lt;/li&gt;&lt;li&gt;â€¢ Ref : Harper 30/e: p 327-329.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The parents of a 6-year-old boy seek medical attention for their son&#x27;s mental retardation. Laboratory tests reveal microcytic anemia with basophilic stippling of red blood cells. A thorough history reveals that the child has been eating paint chips from the radiators in their old apartment. What is the most likely cause of the boy&#x27;s anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhibition of iron transport&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduction of heme synthesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibition of the phosphatidylinositol cycle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Blockage of reticulocyte DNA synthesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Reduction of heme synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Inhibition of iron transport: While lead can interfere with iron metabolism , the specific findings of basophilic stippling and the context of paint chip consumption point more directly to disrupted heme synthesis rather than iron transport.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Inhibition of iron transport:&lt;/li&gt;&lt;li&gt;â€¢ lead can&lt;/li&gt;&lt;li&gt;â€¢ iron metabolism&lt;/li&gt;&lt;li&gt;â€¢ basophilic stippling&lt;/li&gt;&lt;li&gt;â€¢ paint chip consumption point more&lt;/li&gt;&lt;li&gt;â€¢ disrupted heme synthesis&lt;/li&gt;&lt;li&gt;â€¢ Option C: Inhibition of the phosphatidylinositol cycle: This is not a recognized mechanism by which lead causes anemia. The phosphatidylinositol cycle is more relevant to signal transduction processes.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Inhibition of the phosphatidylinositol cycle:&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ lead causes anemia.&lt;/li&gt;&lt;li&gt;â€¢ phosphatidylinositol cycle&lt;/li&gt;&lt;li&gt;â€¢ more&lt;/li&gt;&lt;li&gt;â€¢ signal transduction processes.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Blockage of reticulocyte DNA synthesis: Lead poisoning can affect nucleic acid metabolism , but the basophilic stippling and microcytic anemia are more characteristic of heme synthesis disruption.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Blockage of reticulocyte DNA synthesis:&lt;/li&gt;&lt;li&gt;â€¢ Lead poisoning&lt;/li&gt;&lt;li&gt;â€¢ nucleic acid metabolism&lt;/li&gt;&lt;li&gt;â€¢ basophilic stippling&lt;/li&gt;&lt;li&gt;â€¢ microcytic anemia&lt;/li&gt;&lt;li&gt;â€¢ heme synthesis disruption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lead poisoning is known to cause microcytic anemia with basophilic stippling . One of the mechanisms by which lead poisoning causes anemia is by inhibiting several key enzymes involved in the heme synthesis pathway, including ALA dehydratase and ferrochelatase.&lt;/li&gt;&lt;li&gt;âž¤ Lead poisoning&lt;/li&gt;&lt;li&gt;âž¤ microcytic anemia&lt;/li&gt;&lt;li&gt;âž¤ basophilic stippling&lt;/li&gt;&lt;li&gt;âž¤ mechanisms&lt;/li&gt;&lt;li&gt;âž¤ lead poisoning&lt;/li&gt;&lt;li&gt;âž¤ anemia&lt;/li&gt;&lt;li&gt;âž¤ inhibiting&lt;/li&gt;&lt;li&gt;âž¤ enzymes&lt;/li&gt;&lt;li&gt;âž¤ heme synthesis pathway,&lt;/li&gt;&lt;li&gt;âž¤ ALA dehydratase&lt;/li&gt;&lt;li&gt;âž¤ ferrochelatase.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 273.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 273.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old boy presents with mild anemia, photosensitivity, and skin blistering. His symptoms exacerbated while on rifampin treatment for a methicillin-resistant Staphylococcus aureus (MRSA) infection. Considering his clinical presentation, which biochemical pathway is most likely impaired in this boy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glycogen synthesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fatty acid oxidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DNA repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heme synthesis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Heme synthesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glycogen synthesis: Defects in glycogen synthesis or its metabolism usually present with muscle cramps, exercise intolerance, or hypoglycemia , not photosensitivity or skin blistering.&lt;/li&gt;&lt;li&gt;â€¢ Option A:&lt;/li&gt;&lt;li&gt;â€¢ Glycogen synthesis: Defects&lt;/li&gt;&lt;li&gt;â€¢ glycogen synthesis&lt;/li&gt;&lt;li&gt;â€¢ its metabolism&lt;/li&gt;&lt;li&gt;â€¢ muscle cramps, exercise&lt;/li&gt;&lt;li&gt;â€¢ intolerance, or hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ Option B: Fatty acid oxidation: Disorders in fatty acid oxidation typically manifest with hypoketotic hypoglycemia, hepatomegaly, or muscle weakness, not the symptoms described in the vignette.&lt;/li&gt;&lt;li&gt;â€¢ Option B:&lt;/li&gt;&lt;li&gt;â€¢ Fatty acid oxidation:&lt;/li&gt;&lt;li&gt;â€¢ Disorders in fatty acid oxidation&lt;/li&gt;&lt;li&gt;â€¢ hypoketotic hypoglycemia, hepatomegaly,&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness, not&lt;/li&gt;&lt;li&gt;â€¢ Option C: DNA repair: While defects in DNA repair mechanisms can lead to photosensitivity (e.g., xeroderma pigmentosum ), they would not explain the anemia or the worsening of symptoms with rifampin.&lt;/li&gt;&lt;li&gt;â€¢ Option C:&lt;/li&gt;&lt;li&gt;â€¢ DNA repair:&lt;/li&gt;&lt;li&gt;â€¢ defects in DNA repair&lt;/li&gt;&lt;li&gt;â€¢ photosensitivity&lt;/li&gt;&lt;li&gt;â€¢ xeroderma pigmentosum&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ anemia&lt;/li&gt;&lt;li&gt;â€¢ worsening of symptoms&lt;/li&gt;&lt;li&gt;â€¢ rifampin.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ The clinical manifestations of disorders of heme synthesis , such as porphyrias , which can present with photosensitivity , skin blistering, and anemia. It is also important to recognize that certain medications, like rifampin, can exacerbate these conditions by inducing hepatic enzymes and thus increasing the demand for heme synthesis.&lt;/li&gt;&lt;li&gt;âž¤ clinical manifestations&lt;/li&gt;&lt;li&gt;âž¤ heme synthesis&lt;/li&gt;&lt;li&gt;âž¤ porphyrias&lt;/li&gt;&lt;li&gt;âž¤ photosensitivity&lt;/li&gt;&lt;li&gt;âž¤ skin&lt;/li&gt;&lt;li&gt;âž¤ blistering, and anemia.&lt;/li&gt;&lt;li&gt;âž¤ important&lt;/li&gt;&lt;li&gt;âž¤ certain medications,&lt;/li&gt;&lt;li&gt;âž¤ rifampin,&lt;/li&gt;&lt;li&gt;âž¤ exacerbate&lt;/li&gt;&lt;li&gt;âž¤ inducing hepatic enzymes&lt;/li&gt;&lt;li&gt;âž¤ increasing the demand for heme synthesis.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 271.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 271.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the Positive Acute Phase Reactants?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transthyretin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RBP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î±-1-antiprotease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Î±-1-antiprotease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture20.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: Albumin - Albumin is a negative acute phase reactant ; its levels typically decrease during inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Albumin&lt;/li&gt;&lt;li&gt;â€¢ negative acute phase reactant&lt;/li&gt;&lt;li&gt;â€¢ decrease during inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Transthyretin - Also known as prealbumin , transthyretin is a negative acute phase reactant, with serum levels decreasing during the acute phase response.&lt;/li&gt;&lt;li&gt;â€¢ Option B: Transthyretin&lt;/li&gt;&lt;li&gt;â€¢ prealbumin&lt;/li&gt;&lt;li&gt;â€¢ transthyretin&lt;/li&gt;&lt;li&gt;â€¢ negative acute phase reactant,&lt;/li&gt;&lt;li&gt;â€¢ decreasing&lt;/li&gt;&lt;li&gt;â€¢ acute phase response.&lt;/li&gt;&lt;li&gt;â€¢ Option C: RBP - Retinol Binding Protein is also considered a negative acute phase reactant, with levels decreasing in response to inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option C: RBP&lt;/li&gt;&lt;li&gt;â€¢ Retinol Binding Protein&lt;/li&gt;&lt;li&gt;â€¢ negative acute phase reactant,&lt;/li&gt;&lt;li&gt;â€¢ decreasing&lt;/li&gt;&lt;li&gt;â€¢ inflammation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 383.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 383.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a study group session focusing on stereochemistry in biological molecules, a debate arises regarding the chiral properties of amino acids. One of the points of discussion is whether tyrosine, known for its aromatic ring and role in protein structure, possesses double chirality. Is the statement \&quot;Amino acid with double chiral centers is Tyrosine\&quot; true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insufficient Information&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. False&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Î±-carbon of amino acids has four different groups attached to it and so is a chiral or asymmetric carbon All amino acids have one chiral carbon, except-&lt;/li&gt;&lt;li&gt;âž¤ The Î±-carbon of amino acids has four different groups attached to it and so is a chiral or asymmetric carbon&lt;/li&gt;&lt;li&gt;âž¤ Î±-carbon of amino acids&lt;/li&gt;&lt;li&gt;âž¤ four different groups&lt;/li&gt;&lt;li&gt;âž¤ it&lt;/li&gt;&lt;li&gt;âž¤ chiral or asymmetric carbon&lt;/li&gt;&lt;li&gt;âž¤ All amino acids have one chiral carbon, except-&lt;/li&gt;&lt;li&gt;âž¤ amino acids&lt;/li&gt;&lt;li&gt;âž¤ one chiral carbon,&lt;/li&gt;&lt;li&gt;âž¤ except-&lt;/li&gt;&lt;li&gt;âž¤ Amino acid with no chiral carbon â†’ Glycine Amino acid with two chiral centers â†’ Threonine &amp;amp; isoleucine&lt;/li&gt;&lt;li&gt;âž¤ Amino acid with no chiral carbon â†’ Glycine&lt;/li&gt;&lt;li&gt;âž¤ Amino acid&lt;/li&gt;&lt;li&gt;âž¤ no chiral carbon â†’ Glycine&lt;/li&gt;&lt;li&gt;âž¤ Amino acid with two chiral centers â†’ Threonine &amp;amp; isoleucine&lt;/li&gt;&lt;li&gt;âž¤ Amino acid&lt;/li&gt;&lt;li&gt;âž¤ two chiral centers â†’ Threonine &amp;amp; isoleucine&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 29.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 29.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Is the statement \&quot;Serotonin is a neurotransmitter\&quot; true or false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;True&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Information Insufficient&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. True&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Serotonin is indeed a neurotransmitter . It is a monoamine that is widely found in the brain and the rest of the body, where it plays a role in regulating mood, appetite, and sleep , among other functions. Serotonin is known for contributing to feelings of well-being and happiness.&lt;/li&gt;&lt;li&gt;â€¢ Serotonin&lt;/li&gt;&lt;li&gt;â€¢ neurotransmitter&lt;/li&gt;&lt;li&gt;â€¢ monoamine&lt;/li&gt;&lt;li&gt;â€¢ widely&lt;/li&gt;&lt;li&gt;â€¢ brain&lt;/li&gt;&lt;li&gt;â€¢ rest of the body,&lt;/li&gt;&lt;li&gt;â€¢ regulating mood, appetite, and sleep&lt;/li&gt;&lt;li&gt;â€¢ Serotonin&lt;/li&gt;&lt;li&gt;â€¢ feelings of well-being&lt;/li&gt;&lt;li&gt;â€¢ happiness.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amino Acid Derivatives as Neurotransmitters&lt;/li&gt;&lt;li&gt;âž¤ Amino Acid Derivatives as Neurotransmitters&lt;/li&gt;&lt;li&gt;âž¤ Dopamine Epinephrine Norepinephrine Serotonin Gamma Amino Butyric Acid (GABA)&lt;/li&gt;&lt;li&gt;âž¤ Dopamine&lt;/li&gt;&lt;li&gt;âž¤ Dopamine&lt;/li&gt;&lt;li&gt;âž¤ Epinephrine&lt;/li&gt;&lt;li&gt;âž¤ Epinephrine&lt;/li&gt;&lt;li&gt;âž¤ Norepinephrine&lt;/li&gt;&lt;li&gt;âž¤ Norepinephrine&lt;/li&gt;&lt;li&gt;âž¤ Serotonin&lt;/li&gt;&lt;li&gt;âž¤ Serotonin&lt;/li&gt;&lt;li&gt;âž¤ Gamma Amino Butyric Acid (GABA)&lt;/li&gt;&lt;li&gt;âž¤ Gamma Amino Butyric Acid (GABA)&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 240&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 240&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old marathon runner is admitted to the hospital after collapsing during a race. He is found to have rhabdomyolysis secondary to exertional muscle damage. Laboratory investigations are underway to understand the oxygen-binding properties of muscle proteins, particularly myoglobin, in this context. Which of the following best describes the oxygen dissociation curve (ODC) of myoglobin?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperbolic&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sigmoidal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exponential&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Linear&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperbolic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture12.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hyperbolic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MYOGLOBIN&lt;/li&gt;&lt;li&gt;âž¤ MYOGLOBIN&lt;/li&gt;&lt;li&gt;âž¤ Seen in Muscle and is a Monomer with MW is 17000 KDa Oxygen is stored in red muscle myoglobin and is released during severe exercise for use in muscle mitochondria for aerobic synthesis of ATP. It is rich in alpha helix Bind only one mol of Oxygen and has high affinity for Oxygen than Hb. Exhibit no Bohr effect and no Cooperativity and no interaction with 2, 3 BPG. ODC is Hyperbolic.&lt;/li&gt;&lt;li&gt;âž¤ Seen in Muscle and is a Monomer with MW is 17000 KDa&lt;/li&gt;&lt;li&gt;âž¤ Muscle and is a Monomer&lt;/li&gt;&lt;li&gt;âž¤ MW is 17000 KDa&lt;/li&gt;&lt;li&gt;âž¤ Oxygen is stored in red muscle myoglobin and is released during severe exercise for use in muscle mitochondria for aerobic synthesis of ATP.&lt;/li&gt;&lt;li&gt;âž¤ Oxygen&lt;/li&gt;&lt;li&gt;âž¤ red muscle myoglobin&lt;/li&gt;&lt;li&gt;âž¤ severe exercise&lt;/li&gt;&lt;li&gt;âž¤ muscle mitochondria&lt;/li&gt;&lt;li&gt;âž¤ aerobic synthesis of ATP.&lt;/li&gt;&lt;li&gt;âž¤ It is rich in alpha helix&lt;/li&gt;&lt;li&gt;âž¤ alpha helix&lt;/li&gt;&lt;li&gt;âž¤ Bind only one mol of Oxygen and has high affinity for Oxygen than Hb.&lt;/li&gt;&lt;li&gt;âž¤ Bind&lt;/li&gt;&lt;li&gt;âž¤ one mol of Oxygen&lt;/li&gt;&lt;li&gt;âž¤ high affinity for Oxygen than Hb.&lt;/li&gt;&lt;li&gt;âž¤ Exhibit no Bohr effect and no Cooperativity and no interaction with 2, 3 BPG.&lt;/li&gt;&lt;li&gt;âž¤ no Bohr effect&lt;/li&gt;&lt;li&gt;âž¤ no Cooperativity&lt;/li&gt;&lt;li&gt;âž¤ no interaction&lt;/li&gt;&lt;li&gt;âž¤ 2, 3 BPG.&lt;/li&gt;&lt;li&gt;âž¤ ODC is Hyperbolic.&lt;/li&gt;&lt;li&gt;âž¤ ODC is Hyperbolic.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 295.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 295.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A dietician is explaining the concept of ketogenic and glucogenic amino acids to a group of medical students. These terms refer to the fate of the amino acids during metabolism, specifically whether they are converted to ketone bodies or glucose. The dietician asks the group to identify which amino acid listed is not solely ketogenic. Ketogenic amino acids are all except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leucine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lysine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tryptophan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Histidine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Histidine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture6.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 27.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 27.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A team of molecular biologists is conducting research on a novel therapeutic protein that must remain within the endoplasmic reticulum (ER) to exert its function. However, during initial trials, they observe that a significant portion of the protein is incorrectly trafficked to the Golgi apparatus. To rectify this, they plan to engineer a sequence into the C-terminus of the protein to ensure its retention in the ER. Which amino acid sequence should they incorporate to achieve this goal?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;KDEL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;KDAL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;DALK&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;KDUL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. KDEL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/18/picture17.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding the interaction of hemoglobin with 2, 3-BPG&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2, 3 BPG is an intermediate of Gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Binding of 2,3 BPG stabilises the R state&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2, 3 BPG has increased interaction with HbF&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Binding of 2,3 BPG decreases the affinity of Hb to O2 and shifts the ODC to right&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture18.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A: 2, 3-BPG is an intermediate of gluconeogenesis: This statement is incorrect. 2, 3-BPG is formed from 1,3-bisphosphoglycerate during glycolysis, not gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option A: 2, 3-BPG is an intermediate of gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ 2, 3-BPG&lt;/li&gt;&lt;li&gt;â€¢ 1,3-bisphosphoglycerate&lt;/li&gt;&lt;li&gt;â€¢ glycolysis, not gluconeogenesis.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Binding of 2,3-BPG stabilizes the R state: This is incorrect. 2, 3-BPG binds to and stabilizes the T (tense) state of Hb , not the R (relaxed) state , which has a higher affinity for oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Binding of 2,3-BPG stabilizes the R state:&lt;/li&gt;&lt;li&gt;â€¢ incorrect.&lt;/li&gt;&lt;li&gt;â€¢ 2, 3-BPG&lt;/li&gt;&lt;li&gt;â€¢ T (tense) state of Hb&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ R (relaxed) state&lt;/li&gt;&lt;li&gt;â€¢ higher affinity for oxygen.&lt;/li&gt;&lt;li&gt;â€¢ Option D: 2, 3-BPG has increased interaction with HbF: This is incorrect . HbF has a lower affinity for 2, 3-BPG than adult hemoglobin (HbA), which contributes to its higher affinity for oxygen , facilitating oxygen transfer from the mother to the fetus.&lt;/li&gt;&lt;li&gt;â€¢ Option D:&lt;/li&gt;&lt;li&gt;â€¢ 2, 3-BPG has increased interaction with HbF:&lt;/li&gt;&lt;li&gt;â€¢ incorrect&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ lower affinity for 2, 3-BPG&lt;/li&gt;&lt;li&gt;â€¢ adult hemoglobin&lt;/li&gt;&lt;li&gt;â€¢ its higher affinity for oxygen&lt;/li&gt;&lt;li&gt;â€¢ facilitating oxygen&lt;/li&gt;&lt;li&gt;â€¢ mother to the fetus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-BPG is a metabolite in the glycolytic pathway that binds to deoxyhemoglobin ( Hb in the T or tense state) and stabilizes it , which decreases the oxygen affinity of Hb . This interaction is crucial for the release of O2 in tissues.&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-BPG&lt;/li&gt;&lt;li&gt;âž¤ metabolite&lt;/li&gt;&lt;li&gt;âž¤ glycolytic pathway&lt;/li&gt;&lt;li&gt;âž¤ deoxyhemoglobin&lt;/li&gt;&lt;li&gt;âž¤ Hb&lt;/li&gt;&lt;li&gt;âž¤ T or tense state)&lt;/li&gt;&lt;li&gt;âž¤ stabilizes it&lt;/li&gt;&lt;li&gt;âž¤ decreases&lt;/li&gt;&lt;li&gt;âž¤ oxygen affinity of Hb&lt;/li&gt;&lt;li&gt;âž¤ interaction&lt;/li&gt;&lt;li&gt;âž¤ release of O2 in tissues.&lt;/li&gt;&lt;li&gt;âž¤ Binding of 2, 3-BPG to Hb thus facilitates the delivery of oxygen to tissues by promoting the release of oxygen from Hb , which is reflected as a rightward shift in the ODC.&lt;/li&gt;&lt;li&gt;âž¤ 2, 3-BPG to Hb&lt;/li&gt;&lt;li&gt;âž¤ facilitates the delivery of oxygen&lt;/li&gt;&lt;li&gt;âž¤ promoting the release of oxygen&lt;/li&gt;&lt;li&gt;âž¤ Hb&lt;/li&gt;&lt;li&gt;âž¤ rightward shift in the ODC.&lt;/li&gt;&lt;li&gt;âž¤ Ref : DM Vasudevan 9/e: p 288.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : DM Vasudevan 9/e: p 288.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newly married couple visits a genetic counseling clinic as they are expecting their first child. Their medical history reveals that both the husband and wife carry the sickle-cell trait. The couple is aware of the genetic implications and is seeking advice on the likelihood of their child being affected by sickle-cell anemia. Given that both parents are carriers of the sickle-cell trait, what is the risk that their offspring will inherit sickle-cell anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;100 %&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;75%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;25%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 25%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture16.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inheritance Pattern â€“&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e: p 608-611.&lt;/li&gt;&lt;li&gt;âž¤ Ref&lt;/li&gt;&lt;li&gt;âž¤ : Vasudevan 9/e: p 608-611.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A biochemistry instructor is discussing protein denaturation with medical students. The instructor emphasizes the resilience of certain bonds within a protein&#x27;s structure in the face of denaturing agents like heat or chemicals. The instructor asks which bond in a protein&#x27;s structure is most resistant to denaturation.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peptide bond&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrogen bond&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Disulfide bond&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electrostatic bond&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Peptide bond&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denaturation of proteins:&lt;/li&gt;&lt;li&gt;âž¤ Denaturation of proteins:&lt;/li&gt;&lt;li&gt;âž¤ Conditions such as mild heating, treating with urea, salicylate, X-ray, ultraviolet rays, high pressure, vigorous shaking, and other physicochemical agents cause denaturation. Primary structure is not altered during denaturation; hence peptide bond is not broken . Secondary and tertiary structure is lost and there is loss of folding. During the process the solubility is decreased and precipitability of the protein is increased. Denatured proteins can be renatured when the physical agent is removed e.g. Ribonuclease&lt;/li&gt;&lt;li&gt;âž¤ Conditions such as mild heating, treating with urea, salicylate, X-ray, ultraviolet rays, high pressure, vigorous shaking, and other physicochemical agents cause denaturation.&lt;/li&gt;&lt;li&gt;âž¤ mild heating, treating&lt;/li&gt;&lt;li&gt;âž¤ urea, salicylate, X-ray, ultraviolet rays, high pressure, vigorous shaking,&lt;/li&gt;&lt;li&gt;âž¤ physicochemical agents&lt;/li&gt;&lt;li&gt;âž¤ denaturation.&lt;/li&gt;&lt;li&gt;âž¤ Primary structure is not altered during denaturation; hence peptide bond is not broken .&lt;/li&gt;&lt;li&gt;âž¤ Primary structure is not altered&lt;/li&gt;&lt;li&gt;âž¤ peptide bond is not broken&lt;/li&gt;&lt;li&gt;âž¤ Secondary and tertiary structure is lost and there is loss of folding.&lt;/li&gt;&lt;li&gt;âž¤ Secondary and tertiary structure&lt;/li&gt;&lt;li&gt;âž¤ lost&lt;/li&gt;&lt;li&gt;âž¤ loss of folding.&lt;/li&gt;&lt;li&gt;âž¤ During the process the solubility is decreased and precipitability of the protein is increased.&lt;/li&gt;&lt;li&gt;âž¤ solubility is decreased&lt;/li&gt;&lt;li&gt;âž¤ precipitability of the protein&lt;/li&gt;&lt;li&gt;âž¤ increased.&lt;/li&gt;&lt;li&gt;âž¤ Denatured proteins can be renatured when the physical agent is removed e.g. Ribonuclease&lt;/li&gt;&lt;li&gt;âž¤ Denatured proteins&lt;/li&gt;&lt;li&gt;âž¤ renatured&lt;/li&gt;&lt;li&gt;âž¤ physical agent&lt;/li&gt;&lt;li&gt;âž¤ removed e.g. Ribonuclease&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 38&lt;/li&gt;&lt;li&gt;âž¤ Ref : Harper 30/e: p 38&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which enzyme is known to contain the amino acid selenocysteine?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glutathione reductase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glutathione peroxidase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thioredoxin peroxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thioredoxin oxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glutathione peroxidase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glutathione reductase - This enzyme does not contain selenocysteine ; it catalyzes the reduction of glutathione disulfide to the sulfhydryl form glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option A: Glutathione reductase&lt;/li&gt;&lt;li&gt;â€¢ does not&lt;/li&gt;&lt;li&gt;â€¢ selenocysteine&lt;/li&gt;&lt;li&gt;â€¢ reduction&lt;/li&gt;&lt;li&gt;â€¢ glutathione disulfide&lt;/li&gt;&lt;li&gt;â€¢ sulfhydryl form glutathione.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Thioredoxin peroxidase - Also known as peroxiredoxins, these do not typically contain selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option C: Thioredoxin peroxidase&lt;/li&gt;&lt;li&gt;â€¢ Also&lt;/li&gt;&lt;li&gt;â€¢ peroxiredoxins,&lt;/li&gt;&lt;li&gt;â€¢ do not&lt;/li&gt;&lt;li&gt;â€¢ selenocysteine.&lt;/li&gt;&lt;li&gt;â€¢ Option D: Thioredoxin oxidase - This is not a commonly recognized enzyme with selenocysteine .&lt;/li&gt;&lt;li&gt;â€¢ Option D: Thioredoxin oxidase&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ recognized&lt;/li&gt;&lt;li&gt;â€¢ selenocysteine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Selenocysteine (SeCys) is seen at the active site of the following enzymes:&lt;/li&gt;&lt;li&gt;âž¤ Selenocysteine (SeCys)&lt;/li&gt;&lt;li&gt;âž¤ active site&lt;/li&gt;&lt;li&gt;âž¤ Thioredoxin reductase Glutathione peroxidase , which scavenges peroxides Deiodinase that removes iodine from thyroxine to make triiodothyronine Selenoprotein P , a glycoprotein seen in mammalian blood&lt;/li&gt;&lt;li&gt;âž¤ Thioredoxin reductase&lt;/li&gt;&lt;li&gt;âž¤ Thioredoxin reductase&lt;/li&gt;&lt;li&gt;âž¤ Glutathione peroxidase , which scavenges peroxides&lt;/li&gt;&lt;li&gt;âž¤ Glutathione peroxidase&lt;/li&gt;&lt;li&gt;âž¤ Deiodinase that removes iodine from thyroxine to make triiodothyronine&lt;/li&gt;&lt;li&gt;âž¤ Deiodinase&lt;/li&gt;&lt;li&gt;âž¤ Selenoprotein P , a glycoprotein seen in mammalian blood&lt;/li&gt;&lt;li&gt;âž¤ Selenoprotein P&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 215.&lt;/li&gt;&lt;li&gt;âž¤ Ref : Vasudevan 9/e p 215.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 72 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

</body>
</html>
